PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Weaver, ICG; Cervoni, N; Champagne, FA; D'Alessio, AC; Sharma, S; Seckl, JR; Dymov, S; Szyf, M; Meaney, MJ				Weaver, ICG; Cervoni, N; Champagne, FA; D'Alessio, AC; Sharma, S; Seckl, JR; Dymov, S; Szyf, M; Meaney, MJ			Epigenetic programming by maternal behavior	NATURE NEUROSCIENCE			English	Article							EARLY ENVIRONMENTAL-REGULATION; RECEPTOR GENE-EXPRESSION; TRANSCRIPTION FACTORS; CARE; METHYLATION; RESPONSES; RAT; 5-METHYLCYTOSINE; TRANSMISSION; SENSITIVITY	Here we report that increased pup licking and grooming (LG) and arched-back nursing (ABN) by rat mothers altered the offspring epigenome at a glucocorticoid receptor (GR) gene promoter in the hippocampus. Offspring of mothers that showed high levels of LG and ABN were found to have differences in DNA methylation, as compared to offspring of 'low-LG-ABN' mothers. These differences emerged over the first week of life, were reversed with cross-fostering, persisted into adulthood and were associated with altered histone acetylation and transcription factor (NGFI-A) binding to the GR promoter. Central infusion of a histone deacetylase inhibitor removed the group differences in histone acetylation, DNA methylation, NGFI-A binding, GR expression and hypothalamic-pituitary- adrenal (HPA) responses to stress, suggesting a causal relation among epigenomic state, GR expression and the maternal effect on stress responses in the offspring. Thus we show that an epigenomic state of a gene can be established through behavioral programming, and it is potentially reversible.	Douglas Hosp, Res Ctr, Montreal, PQ H4H 1R3, Canada; McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; Western Gen Hosp, Mol Med Ctr, Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; McGill Univ, McGill Program Study Behav Genes & Environm, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; University of Edinburgh; McGill University	Szyf, M (corresponding author), Douglas Hosp, Res Ctr, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.	moshe.szyf@mcgill.ca; michael.meaney@mcgill.ca	Meaney, Michael/N-5931-2019; Weaver, Ian/AAH-6671-2020; Seckl, Jonathan R/C-3555-2013; Champagne, Frances Anne/Q-1220-2018	Weaver, Ian/0000-0001-8709-8941; Champagne, Frances Anne/0000-0002-3922-084X				Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Brinton RD, 1998, MOL BRAIN RES, V57, P73; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Cervoni N, 2001, J BIOL CHEM, V276, P40778, DOI 10.1074/jbc.M103921200; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; CINTRA A, 1994, ANN NY ACAD SCI, V746, P42; CINTRA A, 1994, NEUROSCIENCE, V62, P843, DOI 10.1016/0306-4522(94)90481-2; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Crane-Robinson C, 1999, METHOD ENZYMOL, V304, P533; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Hershko AY, 2003, GENE, V302, P65, DOI 10.1016/S0378111902010910; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; KESHET I, 1985, P NATL ACAD SCI USA, V82, P2560, DOI 10.1073/pnas.82.9.2560; Laplante P, 2002, DEV BRAIN RES, V139, P199, DOI 10.1016/S0165-3806(02)00550-3; LEVINE S, 1994, ANN NY ACAD SCI, V746, P275, DOI 10.1111/j.1749-6632.1994.tb39245.x; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; Meaney MJ, 2000, J NEUROSCI, V20, P3926, DOI 10.1523/JNEUROSCI.20-10-03926.2000; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; MEANEY MJ, 1989, NEUROENDOCRINOLOGY, V50, P597, DOI 10.1159/000125287; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MYERS MM, 1989, DEV PSYCHOBIOL, V22, P55, DOI 10.1002/dev.420220105; RAZIN A, 1977, P NATL ACAD SCI USA, V74, P2725, DOI 10.1073/pnas.74.7.2725; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Rossiter M.C., 1999, MATERNAL EFFECTS ADA; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; SAPIENZA C, 1990, SCI AM, V263, P52, DOI 10.1038/scientificamerican1090-52; Stern JM, 1997, DEV PSYCHOBIOL, V31, P19, DOI 10.1002/(SICI)1098-2302(199707)31:1<19::AID-DEV3>3.0.CO;2-X; Weaver ICG, 2001, MOL CELL ENDOCRINOL, V185, P205, DOI 10.1016/S0303-7207(01)00635-9	33	4019	4131	6	925	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					847	854		10.1038/nn1276	http://dx.doi.org/10.1038/nn1276			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15220929				2022-12-17	WOS:000222930800015
J	Madisen, L; Zwingman, TA; Sunkin, SM; Oh, SW; Zariwala, HA; Gu, H; Ng, LL; Palmiter, RD; Hawrylycz, MJ; Jones, AR; Lein, ES; Zeng, HK				Madisen, Linda; Zwingman, Theresa A.; Sunkin, Susan M.; Oh, Seung Wook; Zariwala, Hatim A.; Gu, Hong; Ng, Lydia L.; Palmiter, Richard D.; Hawrylycz, Michael J.; Jones, Allan R.; Lein, Ed S.; Zeng, Hongkui			A robust and high-throughput Cre reporting and characterization system for the whole mouse brain	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; TRANSGENIC MICE; SYNAPTIC-TRANSMISSION; FLUORESCENT PROTEIN; DOPAMINE; NEURONS; RECOMBINATION; MANIPULATION; RECEPTORS	The Cre/lox system is widely used in mice to achieve cell-type-specific gene expression. However, a strong and universally responding system to express genes under Cre control is still lacking. We have generated a set of Cre reporter mice with strong, ubiquitous expression of fluorescent proteins of different spectra. The robust native fluorescence of these reporters enables direct visualization of fine dendritic structures and axonal projections of the labeled neurons, which is useful in mapping neuronal circuitry, imaging and tracking specific cell populations in vivo. Using these reporters and a high-throughput in situ hybridization platform, we are systematically profiling Cre-directed gene expression throughout the mouse brain in several Cre-driver lines, including new Cre lines targeting different cell types in the cortex. Our expression data are displayed in a public online database to help researchers assess the utility of various Cre-driver lines for cell-type-specific genetic manipulation.	[Madisen, Linda; Zwingman, Theresa A.; Sunkin, Susan M.; Oh, Seung Wook; Zariwala, Hatim A.; Gu, Hong; Ng, Lydia L.; Hawrylycz, Michael J.; Jones, Allan R.; Lein, Ed S.; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA; [Palmiter, Richard D.] Univ Washington, Dept Biochem, Howard Hughes Med Inst, Seattle, WA 98195 USA	Allen Institute for Brain Science; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zeng, HK (corresponding author), Allen Inst Brain Sci, Seattle, WA USA.	hongkuiz@alleninstitute.org		OH, SEUNG WOOK/0000-0001-7632-6822	Allen Institute for Brain Science; US National Institutes of Health [MH085500]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085500] Funding Source: NIH RePORTER	Allen Institute for Brain Science; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful for the professional support of the entire Atlas production team, led by P. Wohnoutka, and the Information Technology team, led by C. Dang, at the Allen Institute, without which the work would have not been possible to accomplish. We are thankful to A. Bernard for her contribution in establishing the DFISH process, L. Kuan for ISH data quantification and R. Hunter for coordinating transgenic mice production. We also gratefully acknowledge the following researchers for providing various research materials: R. Tsien (University of California at San Diego) for the tdTomato DNA construct, L. Luo (Stanford University) for the Rosa-CAG targeting construct, K. Deisseroth (Stanford University) for the WPRE-containing DNA construct, B. Sauer (National Institute of Diabetes and Digestive and Kidney Diseases) via Addgene for the Cre and EGFP-Cre DNA constructs, P. Chambon (Institut de Genetique et de Biologie Moleculaire et Cellulaire) for the CreERT2 DNA construct, P. Soriano (Fred Hutchinson Cancer Research Center) via Addgene for the PhiC31o, FLPo and pPGKneotpAlox2 DNA constructs, A. Nagy (Mount Sinai Hospital in Toronto) for the G4 ES cell line, G. Oliver (St. Jude's Children's Research Hospital) for the Six3-Cre mice, N. Heintz (Rockefeller University) via Mutant Mouse Regional Resource Centers (MMRRC) for the Ntsr1-Cre mice and X. Zhuang (University of Chicago) for the Slc6a3-Cre mice. The authors thank the Allen Institute founders, P. G. Allen and J. Patton, for their vision, encouragement and support. This work was funded by the Allen Institute for Brain Science and a US National Institutes of Health grant (MH085500) to H.Z.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Barth AL, 2007, CURR OPIN NEUROBIOL, V17, P567, DOI 10.1016/j.conb.2007.10.003; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Coulter CL, 1996, DEV BRAIN RES, V92, P172, DOI 10.1016/0165-3806(96)00004-1; Dong H. W., 2008, ALLEN REFERENCE ATLA; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gorski JA, 2002, J NEUROSCI, V22, P6309; Heusner CL, 2008, GENESIS, V46, P357, DOI 10.1002/dvg.20405; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lau C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-153; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Ng L, 2007, IEEE ACM T COMPUT BI, V4, P382, DOI 10.1109/TCBB.2007.1035; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Tsai PS, 2002, METH NE FRO NEUROSCI, P113; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Xu XM, 2006, J COMP NEUROL, V499, P144, DOI 10.1002/cne.21101; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	46	3672	3725	16	305	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					133	U311		10.1038/nn.2467	http://dx.doi.org/10.1038/nn.2467			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	20023653	Green Published, Green Accepted			2022-12-17	WOS:000273056300024
J	Giedd, JN; Blumenthal, J; Jeffries, NO; Castellanos, FX; Liu, H; Zijdenbos, A; Paus, T; Evans, AC; Rapoport, JL				Giedd, JN; Blumenthal, J; Jeffries, NO; Castellanos, FX; Liu, H; Zijdenbos, A; Paus, T; Evans, AC; Rapoport, JL			Brain development during childhood and adolescence: a longitudinal MRI study	NATURE NEUROSCIENCE			English	Article							CEREBRAL-CORTEX; SYNAPTOGENESIS; OVERPRODUCTION; IMAGES; AGE		NIMH, Child Psychiat Branch, Bethesda, MD 20892 USA; NINDS, Biometry Branch, Bethesda, MD 20892 USA; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); McGill University	Giedd, JN (corresponding author), NIMH, Child Psychiat Branch, Bldg 10,Room 4C110,10 Ctr Dr,MSC 1367, Bethesda, MD 20892 USA.		Giedd, Jay/J-9644-2015; Evans, Alan C/B-2373-2013; Castellanos, Francisco Xavier/K-1892-2014; Giedd, Jay N/B-7302-2012; Giedd, Jay N./A-3080-2008	Giedd, Jay/0000-0003-2002-8978; Evans, Alan C/0000-0003-3841-6098; Castellanos, Francisco Xavier/0000-0001-9192-9437; Giedd, Jay N/0000-0003-0827-3460; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002652] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BOURGEOIS JP, 1989, P NATL ACAD SCI USA, V86, P4297, DOI 10.1073/pnas.86.11.4297; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; FEINBERG I, 1974, J PSYCHIATR RES, V10, P283, DOI 10.1016/0022-3956(74)90011-9; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Giedd JN, 1999, PROG NEURO-PSYCHOPH, V23, P571; HAND D, 1996, PRACTICAL LONGITUDIN; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; JERNIGAN TL, 1991, BRAIN, V114, P2037, DOI 10.1093/brain/114.5.2037; Kleim JA, 1996, J NEUROSCI, V16, P4529; LANGE N, IN PRESS PSYCHIAT RE; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; ZIJDENBOS AP, 1994, COMPUT MED IMAG GRAP, V18, P11, DOI 10.1016/0895-6111(94)90057-4	15	3634	3686	11	403	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					861	863		10.1038/13158	http://dx.doi.org/10.1038/13158			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491603				2022-12-17	WOS:000083883200008
J	Boyden, ES; Zhang, F; Bamberg, E; Nagel, G; Deisseroth, K				Boyden, ES; Zhang, F; Bamberg, E; Nagel, G; Deisseroth, K			Millisecond-timescale, genetically targeted optical control of neural activity	NATURE NEUROSCIENCE			English	Article							RAT BARREL CORTEX; REMOTE-CONTROL; LASER PHOTOSTIMULATION; HIPPOCAMPAL-NEURONS; ION CHANNELS; MICROSTIMULATION; LIGHT; CHLAMYDOMONAS; CIRCUITS; DEPENDENCE	Temporally precise, noninvasive control of activity in well-defined neuronal populations is a long-sought goal of systems neuroscience. We adapted for this purpose the naturally occurring algal protein Channelrhodopsin-2, a rapidly gated light-sensitive cation channel, by using lentiviral gene delivery in combination with high-speed optical switching to photostimulate mammalian neurons. We demonstrate reliable, millisecond-timescale control of neuronal spiking, as well as control of excitatory and inhibitory synaptic transmission. This technology allows the use of light to alter neural processing at the level of single spikes and synaptic events, yielding a widely applicable tool for neuroscientists and biomedical engineers.	Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; Max Planck Inst Biophys, Dept Biophys Chem, D-60438 Frankfurt, Germany; Univ Frankfurt, Dept Biochem Chem & Pharmaceut, D-60439 Frankfurt, Germany; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Max Planck Society; Goethe University Frankfurt; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, 318 Campus Dr W, Stanford, CA 94305 USA.	deissero@stanford.edu	Macrae, Rhiannon/AAX-1536-2020	Nagel, Georg/0000-0001-8174-8712				Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; HARZ H, 1991, NATURE, V351, P489, DOI 10.1038/351489a0; Hirase H, 2002, J NEUROBIOL, V51, P237, DOI 10.1002/neu.10056; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P225, DOI 10.1152/jn.1961.24.3.225; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Pettit DL, 1999, J NEUROPHYSIOL, V81, P1424, DOI 10.1152/jn.1999.81.3.1424; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	30	3020	3195	48	757	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1263	1268		10.1038/nn1525	http://dx.doi.org/10.1038/nn1525			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116447				2022-12-17	WOS:000231483800028
J	van Praag, H; Kempermann, G; Gage, FH				van Praag, H; Kempermann, G; Gage, FH			Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus	NATURE NEUROSCIENCE			English	Article							FIBROBLAST GROWTH-FACTOR; HIPPOCAMPAL THETA-RHYTHM; RAT HIPPOCAMPUS; ENRICHED ENVIRONMENT; SPATIAL MEMORY; MESSENGER-RNA; NEURONS; BRAIN; EXPERIENCE; FOREBRAIN	Exposure to an enriched environment increases neurogenesis in the dentate gyrus of adult rodents. Environmental enrichment, however, typically consists of many components, such as expanded learning opportunities, increased social interaction, more physical activity and larger housing. We attempted to separate components by assigning adult mice to various conditions: water-maze learning (learner), swim-time-yoked control (swimmer), voluntary wheel running (runner), and enriched (enriched) and standard housing (control) groups. Neither maze training nor yoked swimming had any effect on bromodeoxyuridine (BrdU)-positive cell number. However, running doubled the number of surviving newborn cells, in amounts similar to enrichment conditions. Our findings demonstrate that voluntary exercise is sufficient for enhanced neurogenesis in the adult mouse dentate gyrus.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Regensburg, Dept Neurol, D-93053 Regensburg, Germany	Salk Institute; University of Regensburg	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	fgage@salk.edu	van Praag, Henriette/F-3939-2015; Kempermann, Gerd/F-5416-2010	van Praag, Henriette/0000-0002-5727-434X; Kempermann, Gerd/0000-0002-5304-4061				Adams RD, 1991, PRINCIPLES NEUROLOGY; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Barnea A, 1996, P NATL ACAD SCI USA, V93, P714, DOI 10.1073/pnas.93.2.714; BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; BENNETT EL, 1979, BEHAV NEURAL BIOL, V26, P1, DOI 10.1016/S0163-1047(79)92842-5; BLOMQUIST KB, 1987, PERCEPT MOTOR SKILL, V65, P175, DOI 10.2466/pms.1987.65.1.175; BOYES BE, 1986, NEUROSCIENCE, V17, P857, DOI 10.1016/0306-4522(86)90050-3; CAMERON HA, 1995, J NEUROSCI, V15, P4687; CONRAD CD, 1993, J NEUROSCI, V13, P2582, DOI 10.1523/JNEUROSCI.13-06-02582.1993; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; DUDAR JD, 1979, NEUROPHARMACOLOGY, V18, P673, DOI 10.1016/0028-3908(79)90034-0; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; FORDYCE DE, 1993, BRAIN RES, V619, P111, DOI 10.1016/0006-8993(93)91602-O; GENSBURGER C, 1987, FEBS LETT, V217, P1, DOI 10.1016/0014-5793(87)81230-9; Gomez-Pinilla F, 1998, NEUROSCIENCE, V85, P53, DOI 10.1016/S0306-4522(97)00576-9; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Gould E, 1996, DEV NEUROSCI-BASEL, V18, P22, DOI 10.1159/000111392; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; GREENOUGH WT, 1975, AM SCI, V63, P37; Johansson BB, 1996, EXP NEUROL, V139, P322, DOI 10.1006/exnr.1996.0106; JURASKA JM, 1985, BRAIN RES, V333, P73, DOI 10.1016/0006-8993(85)90125-8; JURASKA JM, 1989, BRAIN RES, V479, P115, DOI 10.1016/0006-8993(89)91341-3; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Parent JM, 1997, J NEUROSCI, V17, P3727; PARK GAS, 1992, NEUROSCI LETT, V143, P259, DOI 10.1016/0304-3940(92)90278-F; Patel SN, 1997, BEHAV BRAIN RES, V89, P115, DOI 10.1016/S0166-4328(97)00051-X; RASOOL CG, 1986, ANN NEUROL, V20, P482, DOI 10.1002/ana.410200407; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; ROSENZWEIG MR, 1962, J COMP PHYSIOL PSYCH, V55, P429, DOI 10.1037/h0041137; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; STAUBLI U, 1995, J NEUROSCI, V15, P2445, DOI 10.1523/JNEUROSCI.15-03-02445.1995; Tao Y, 1996, J COMP NEUROL, V376, P653, DOI 10.1002/(SICI)1096-9861(19961223)376:4<653::AID-CNE11>3.0.CO;2-N; UHL GR, 1985, NEUROLOGY, V35, P1215, DOI 10.1212/WNL.35.8.1215; Valentinuzzi VS, 1997, AM J PHYSIOL-REG I, V273, pR1957, DOI 10.1152/ajpregu.1997.273.6.R1957; vanPraag H, 1997, BRAIN RES, V768, P233, DOI 10.1016/S0006-8993(97)00647-1	49	2833	2887	12	330	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					266	270		10.1038/6368	http://dx.doi.org/10.1038/6368			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195220				2022-12-17	WOS:000081684500015
J	Betarbet, R; Sherer, TB; MacKenzie, G; Garcia-Osuna, M; Panov, AV; Greenamyre, JT				Betarbet, R; Sherer, TB; MacKenzie, G; Garcia-Osuna, M; Panov, AV; Greenamyre, JT			Chronic systemic pesticide exposure reproduces features of Parkinson's disease	NATURE NEUROSCIENCE			English	Article							TOXIN 3-NITROPROPIONIC ACID; ELECTRON-TRANSPORT CHAIN; ALPHA-SYNUCLEIN; COMPLEX-I; SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL-FUNCTION; BRAIN MITOCHONDRIA; SUBSTANTIA-NIGRA; LEWY BODIES	The cause of Parkinson's disease (PD) is unknown, but epidemiological studies suggest an association with pesticides and other environmental toxins, and biochemical studies implicate a systemic defect in mitochondrial complex I. We report that chronic, systemic inhibition of complex I by the lipophilic pesticide, rotenone, causes highly selective nigrostriatal dopaminergic degeneration that is associated behaviorally with hypokinesia and rigidity. Nigral neurons in rotenone-treated rats accumulate fibrillar cytoplasmic inclusions that contain ubiquitin and alpha -synuclein. These results indicate that chronic exposure to a common pesticide can reproduce the anatomical, neurochemical, behavioral and neuropathological features of PD.	Emory Univ, Dept Neurol, Atlanta, GA 30322 USA	Emory University	Greenamyre, JT (corresponding author), Emory Univ, Dept Neurol, 1639 Pierce Dr,WMB 6000, Atlanta, GA 30322 USA.	jgreena@emory.edu	Greenamyre, J. Timothy/B-4049-2011	Sherer, Todd/0000-0001-9667-6600; Greenamyre, J. Timothy/0000-0003-3468-7878	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033779, P50NS038399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010133] Funding Source: NIH RePORTER; NIA NIH HHS [P30AG10133] Funding Source: Medline; NINDS NIH HHS [NS33779, NS38399] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baba M, 1998, AM J PATHOL, V152, P879; BEAL MF, 1993, J NEUROSCI, V13, P4181; BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2; BLIN O, 1994, J NEUROL SCI, V125, P95, DOI 10.1016/0022-510X(94)90248-8; BUTTERFIELD PG, 1993, NEUROLOGY, V43, P1150, DOI 10.1212/WNL.43.6.1150; CARDELLACH F, 1993, NEUROLOGY, V43, P2258, DOI 10.1212/WNL.43.11.2258; Davey GP, 1996, J NEUROCHEM, V66, P1617; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Ferrante RJ, 1997, BRAIN RES, V753, P157, DOI 10.1016/S0006-8993(97)00008-5; Forno LS, 1996, ADV NEUROL, V69, P217; Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346; Hashimoto M, 1999, J BIOL CHEM, V274, P28849, DOI 10.1074/jbc.274.41.28849; HEDREEN JC, 1985, J HISTOCHEM CYTOCHEM, V33, P134, DOI 10.1177/33.2.2578498; Hensley K, 1998, J NEUROCHEM, V71, P2549; Higgins DS, 1996, J NEUROSCI, V16, P3807; HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; MANN VM, 1992, BRAIN, V115, P333, DOI 10.1093/brain/115.2.333; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Menegon A, 1998, LANCET, V352, P1344, DOI 10.1016/S0140-6736(98)03453-9; Miller GW, 1997, ANN NEUROL, V41, P530, DOI 10.1002/ana.410410417; Mizuno Y, 1998, ANN NEUROL, V44, pS99, DOI 10.1002/ana.410440715; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Ouary S, 2000, NEUROSCIENCE, V97, P521, DOI 10.1016/S0306-4522(00)00020-8; Panos G, 1996, J CHEMOTHERAPY, V8, P270, DOI 10.1179/joc.1996.8.4.270; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; PORTER RHP, 1994, J NEUROSCI, V14, P7192; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Seaton TA, 1997, BRAIN RES, V777, P110; SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; TIPTON KF, 1993, J NEUROCHEM, V61, P1191, DOI 10.1111/j.1471-4159.1993.tb13610.x; Tolwani RJ, 1999, LAB ANIM SCI, V49, P363	41	2684	2820	5	349	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1301	1306		10.1038/81834	http://dx.doi.org/10.1038/81834			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100151	Bronze			2022-12-17	WOS:000167177900016
J	Hanisch, UK; Kettenmann, H				Hanisch, Uwe-Karsten; Kettenmann, Helmut			Microglia: active sensor and versatile effector cells in the normal and pathologic brain	NATURE NEUROSCIENCE			English	Review							CENTRAL-NERVOUS-SYSTEM; SCAVENGER-RECEPTOR-AI/II; MYELIN PHAGOCYTOSIS; INTERFERON-GAMMA; IFN-GAMMA; DOWN-REGULATION; IMMUNE-SYSTEM; MACROPHAGES; ACTIVATION; EXPRESSION	Microglial cells constitute the resident macrophage population of the CNS. Recent in vivo studies have shown that microglia carry out active tissue scanning, which challenges the traditional notion of 'resting' microglia in the normal brain. Transformation of microglia to reactive states in response to pathology has been known for decades as microglial activation, but seems to be more diverse and dynamic than ever anticipated-in both transcriptional and nontranscriptional features and functional consequences. This may help to explain why engagement of microglia can be either neuroprotective or neurotoxic, resulting in containment or aggravation of disease progression. Moreover, little is known about the heterogeneity of microglial responses in different pathologic contexts that results from regional adaptations or from the progression of a disease. In this review, we focus on several key observations that illustrate the multi-faceted activities of microglia in the normal and pathologic brain.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Univ Gottingen, Inst Neuropathol, D-37075 Gottingen, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Gottingen	Kettenmann, H (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	kettenmann@mdc-berlin.de	Kettenmann, Helmut/AAJ-5142-2021; Calabrese, Massimiliano/I-6195-2012	Kettenmann, Helmut/0000-0001-8208-0291				Bartnik BL, 2000, MULT SCLER, V6, P37, DOI 10.1191/135245800678827400; Bechmann I, 2001, EXP NEUROL, V168, P242, DOI 10.1006/exnr.2000.7618; Bechmann I, 2001, EUR J NEUROSCI, V14, P1651, DOI 10.1046/j.0953-816x.2001.01793.x; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boucsein C, 2003, EUR J NEUROSCI, V17, P2267, DOI 10.1046/j.1460-9568.2003.02663.x; Butovsky O, 2006, J CLIN INVEST, V116, P905, DOI 10.1172/JCI26836; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; Butovsky O, 2007, MOL CELL NEUROSCI, V35, P490, DOI 10.1016/j.mcn.2007.04.009; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DENES A, 2007, J CEREB BLOOD F 0418; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Elkabes S, 1996, J NEUROSCI, V16, P2508; Farber K, 2006, PFLUG ARCH EUR J PHY, V452, P615, DOI 10.1007/s00424-006-0064-7; Fan R, 2007, J NEUROSCI, V27, P3057, DOI 10.1523/JNEUROSCI.4371-06.2007; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Flugel A, 2001, J NEUROSCI RES, V66, P74, DOI 10.1002/jnr.1198; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Glanzer JG, 2007, J NEUROCHEM, V102, P627, DOI 10.1111/j.1471-4159.2007.04568.x; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hanisch UK, 2001, EUR J IMMUNOL, V31, P2104, DOI 10.1002/1521-4141(200107)31:7<2104::AID-IMMU2104>3.0.CO;2-3; Hausler KG, 2002, EUR J NEUROSCI, V16, P2113, DOI 10.1046/j.1460-9568.2002.02287.x; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Jack C, 2005, J NEUROSCI RES, V81, P363, DOI 10.1002/jnr.20482; Kempermann G, 2003, SCIENCE, V302, P1689, DOI 10.1126/science.1092864; Kim HJ, 2004, J IMMUNOL, V172, P7144, DOI 10.4049/jimmunol.172.11.7144; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kitamura Y, 2004, J PHARMACOL SCI, V94, P203, DOI 10.1254/jphs.94.203; Kitamura Y, 2000, J NEUROIMMUNOL, V106, P95, DOI 10.1016/S0165-5728(00)00239-3; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kuwabara Y, 2003, J NEUROSCI RES, V73, P22, DOI 10.1002/jnr.10637; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liu B, 2006, AAPS J, V8, pE606, DOI 10.1208/aapsj080369; Liu Y, 2006, J NEUROSCI, V26, P12904, DOI 10.1523/JNEUROSCI.2531-06.2006; Lyons SA, 2000, J CEREBR BLOOD F MET, V20, P1537, DOI 10.1097/00004647-200011000-00003; Magnus T, 2001, J IMMUNOL, V167, P5004, DOI 10.4049/jimmunol.167.9.5004; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Makranz C, 2004, NEUROBIOL DIS, V15, P279, DOI 10.1016/j.nbd.2003.11.007; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Nakamura Y, 2002, BIOL PHARM BULL, V25, P945, DOI 10.1248/bpb.25.945; Nathan C, 2005, J EXP MED, V202, P1163, DOI 10.1084/jem.20051529; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Persson M, 2005, GLIA, V51, P111, DOI 10.1002/glia.20191; POCOCK JM, IN PRESS TRENDS NEUR; Polazzi E, 2002, REV NEUROSCIENCE, V13, P221; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; Qian L, 2006, J NEURAL TRANSM-SUPP, P367; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Reichert F, 2003, NEUROBIOL DIS, V12, P65, DOI 10.1016/S0969-9961(02)00008-6; Ren LQ, 1999, MOL BRAIN RES, V65, P198, DOI 10.1016/S0169-328X(99)00016-9; Rezaie Payam, 2002, J Hist Neurosci, V11, P325, DOI 10.1076/jhin.11.4.325.8531; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Sliwa M, 2007, BRAIN, V130, P476, DOI 10.1093/brain/awl263; Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com; Stadelmann C, 2002, BRAIN, V125, P75, DOI 10.1093/brain/awf015; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Synowitz M, 2006, CANCER RES, V66, P8550, DOI 10.1158/0008-5472.CAN-06-0365; Takata K, 2007, FEBS LETT, V581, P475, DOI 10.1016/j.febslet.2007.01.009; Thomas WE, 1999, BRAIN RES REV, V31, P42, DOI 10.1016/S0165-0173(99)00024-7; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van Rossum D, 2004, METAB BRAIN DIS, V19, P393, DOI 10.1023/B:MEBR.0000043984.73063.d8; Wirenfeldt M, 2005, J NEUROSCI RES, V82, P507, DOI 10.1002/jnr.20659; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Xu HP, 2007, GLIA, V55, P1189, DOI 10.1002/glia.20535; Yang MS, 2002, GLIA, V38, P273, DOI 10.1002/glia.10057; Yokoyama A, 2006, GLIA, V53, P754, DOI 10.1002/glia.20332; Yokoyama A, 2004, GLIA, V45, P96, DOI 10.1002/glia.10306; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	100	2560	2620	10	387	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1387	1394		10.1038/nn1997	http://dx.doi.org/10.1038/nn1997			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17965659				2022-12-17	WOS:000250508400013
J	Everitt, BJ; Robbins, TW				Everitt, BJ; Robbins, TW			Neural systems of reinforcement for drug addiction: from actions to habits to compulsion	NATURE NEUROSCIENCE			English	Review							NUCLEUS-ACCUMBENS CORE; COCAINE-SEEKING BEHAVIOR; MEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; ORBITOFRONTAL CORTEX; CONDITIONED REINFORCEMENT; 2ND-ORDER SCHEDULES; EXCITOTOXIC LESIONS; DORSAL STRIATUM; D-AMPHETAMINE	Drug addiction is increasingly viewed as the endpoint of a series of transitions from initial drug use-when a drug is voluntarily taken because it has reinforcing, often hedonic, effects-through loss of control over this behavior, such that it becomes habitual and ultimately compulsive. Here we discuss evidence that these transitions depend on interactions between pavlovian and instrumental learning processes. We hypothesize that the change from voluntary drug use to more habitual and compulsive drug use represents a transition at the neural level from prefrontal cortical to striatal control over drug seeking and drug taking behavior as well as a progression from ventral to more dorsal domains of the striatum, involving its dopaminergic innervation. These neural transitions may themselves depend on the neuroplasticity in both cortical and striatal structures that is induced by chronic self-administration of drugs.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Cambridge, MRC Wellcome Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England	University of Cambridge; University of Cambridge	Everitt, BJ (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	bje10@cam.ac.uk	Robbins, Trevor W/A-7551-2008	Everitt, Barry/0000-0003-4431-6536; Robbins, Trevor/0000-0003-0642-5977	MRC [G9537855] Funding Source: UKRI; Medical Research Council [G9537855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alderson HL, 2000, PSYCHOPHARMACOLOGY, V153, P111, DOI 10.1007/s002130000527; Altman J, 1996, PSYCHOPHARMACOLOGY, V125, P285, DOI 10.1007/BF02246016; BARRETT JE, 1981, J PHARMACOL EXP THER, V218, P692; Berridge KC, 2003, BRAIN COGNITION, V52, P106, DOI 10.1016/S0278-2626(03)00014-9; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; BURNS LH, 1993, BEHAV BRAIN RES, V55, P167, DOI 10.1016/0166-4328(93)90113-5; Caine SB, 2001, BEHAV NEUROSCI, V115, P880, DOI 10.1037//0735-7044.115.4.880; Cardinal RN, 2000, PSYCHOPHARMACOLOGY, V152, P362, DOI 10.1007/s002130000536; Cardinal RN, 2004, CURR OPIN NEUROBIOL, V14, P156, DOI 10.1016/j.conb.2004.03.004; Cardinal RN, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-9; Corbit LH, 2003, BEHAV BRAIN RES, V146, P145, DOI 10.1016/j.bbr.2003.09.023; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Crombag HS, 2005, CEREB CORTEX, V15, P341, DOI 10.1093/cercor/bhh136; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Di Chiara G, 1998, J PSYCHOPHARMACOL, V12, P54, DOI 10.1177/026988119801200108; Di Ciano P, 2004, NEUROPHARMACOLOGY, V47, P202, DOI 10.1016/j.neuropharm.2004.06.005; Di Ciano P, 2004, J NEUROSCI, V24, P7167, DOI 10.1523/JNEUROSCI.1581-04.2004; Di Ciano P, 2003, BEHAV NEUROSCI, V117, P952, DOI 10.1037/0735-7044.117.5.952; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Dickinson A, 2002, Q J EXP PSYCHOL-B, V55, P331, DOI 10.1080/0272499024400016; DICKINSON A, 1983, Q J EXP PSYCHOL-B, V35, P35, DOI 10.1080/14640748308400912; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Everitt BJ, 2000, PSYCHOPHARMACOLOGY, V153, P17, DOI 10.1007/s002130000566; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Fenu S, 2001, J NEUROSCI, V21, P6897, DOI 10.1523/JNEUROSCI.21-17-06897.2001; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Floresco SB, 2001, J NEUROSCI, V21, P2851, DOI 10.1523/JNEUROSCI.21-08-02851.2001; Fuchs RA, 2004, J NEUROSCI, V24, P6600, DOI 10.1523/JNEUROSCI.1924-04.2004; Fuchs RA, 2005, NEUROPSYCHOPHARMACOL, V30, P296, DOI 10.1038/sj.npp.1300579; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Grace AA, 2004, INT J NEUROPSYCHOPH, V7, pS15; Grimm JW, 2000, PSYCHOBIOLOGY, V28, P383; Groenewegen HJ, 1996, PROG BRAIN RES, V107, P485; Haber SN, 2000, J NEUROSCI, V20, P2369; Hall J, 2001, EUR J NEUROSCI, V13, P1984, DOI 10.1046/j.0953-816x.2001.01577.x; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Hutcheson DM, 2003, ANN NY ACAD SCI, V1003, P410, DOI 10.1196/annals.1300.038; Hutcheson DM, 2001, PSYCHOPHARMACOLOGY, V153, P464, DOI 10.1007/s002130000635; Ikemoto S, 2005, J NEUROSCI, V25, P5061, DOI 10.1523/JNEUROSCI.0892-05.2005; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Ito R, 2002, J NEUROSCI, V22, P6247; Ito R, 2000, J NEUROSCI, V20, P7489; Jakes I., 1996, THEORETICAL APPROACH; Kadohisa M, 2004, NEUROSCIENCE, V127, P207, DOI 10.1016/j.neuroscience.2004.04.037; Kalivas PW, 2003, PSYCHOPHARMACOLOGY, V168, P44, DOI 10.1007/s00213-003-1393-2; Kearns DN, 2004, LEARN BEHAV, V32, P463; Kelley AE, 2002, J NEUROSCI, V22, P3306; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; Letchworth SR, 2001, J NEUROSCI, V21, P2799, DOI 10.1523/JNEUROSCI.21-08-02799.2001; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; McFarland K, 2003, J NEUROSCI, V23, P3531; McFarland K, 2001, J NEUROSCI, V21, P8655; Meil WM, 1997, BEHAV BRAIN RES, V87, P139, DOI 10.1016/S0166-4328(96)02270-X; Miles FJ, 2003, BEHAV NEUROSCI, V117, P927, DOI 10.1037/0735-7044.117.5.927; Nader MA, 2002, NEUROPSYCHOPHARMACOL, V27, P35, DOI 10.1016/S0893-133X(01)00427-4; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Donnell P, 2003, EUR J NEUROSCI, V17, P429, DOI 10.1046/j.1460-9568.2003.02463.x; OBrien CP, 1996, LANCET, V347, P237, DOI 10.1016/S0140-6736(96)90409-2; Ostlund SB, 2005, J NEUROSCI, V25, P7763, DOI 10.1523/JNEUROSCI.1921-05.2005; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Pears A, 2003, J NEUROSCI, V23, P11189; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; Porrino LJ, 2004, J NEUROSCI, V24, P3554, DOI 10.1523/JNEUROSCI.5578-03.2004; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; ROBBINS TW, 1992, SEMIN NEUROSCI, V4, P119; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rogers RD, 2001, CURR OPIN NEUROBIOL, V11, P250, DOI 10.1016/S0959-4388(00)00204-X; Salloway S, 2001, FRONTAL LOBES NEUROP; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; See RE, 2001, PSYCHOPHARMACOLOGY, V154, P301, DOI 10.1007/s002130000636; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; Stewart J., 1987, METHODS ASSESSING RE, P211; TAYLOR JR, 1984, PSYCHOPHARMACOLOGY, V84, P405, DOI 10.1007/BF00555222; Taylor JR, 1999, PSYCHOPHARMACOLOGY, V142, P31, DOI 10.1007/s002130050859; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Weissenborn R, 1997, PSYCHOPHARMACOLOGY, V134, P242, DOI 10.1007/s002130050447; White NM, 2002, NEUROBIOL LEARN MEM, V77, P125, DOI 10.1006/nlme.2001.4008; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WOLFFGRAMM J, 1995, BEHAV BRAIN RES, V70, P77, DOI 10.1016/0166-4328(95)00131-C; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	100	2548	2579	9	578	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1481	1489		10.1038/nn1579	http://dx.doi.org/10.1038/nn1579			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16251991				2022-12-17	WOS:000232966600019
J	Rao, RPN; Ballard, DH				Rao, RPN; Ballard, DH			Predictive coding in the visual cortex: a functional interpretation of some extra-classical receptive-field effects	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE-NUCLEUS; RESPONSE PROPERTIES; NATURAL SCENES; RECOGNITION; GENERATION; NEURONS; MECHANISMS; INHIBITION; NEOCORTEX; MACAQUE	We describe a model of visual processing in which feedback connections from a higher- to a lower-order visual cortical area carry predictions of lower-level neural activities, whereas the feedforward connections carry the residual errors between the predictions and the actual lower-level activities. When exposed to natural images, a hierarchical network of model neurons implementing such a model developed simple-cell-like receptive fields. A subset of neurons responsible for carrying the residual errors showed endstopping and other extra-classical receptive-field effects. These results suggest that rather than being exclusively feedforward phenomena, nonclassical surround effects in the visual cortex may also result from cortico-cortical feedback as a consequence of the visual system using an efficient hierarchical strategy for encoding natural images.	Salk Inst Biol Studies, Sloan Ctr Theoret Neurobiol, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA; Univ Rochester, Dept Comp Sci, Rochester, NY 14627 USA	Salk Institute; Salk Institute; University of Rochester	Rao, RPN (corresponding author), Salk Inst Biol Studies, Sloan Ctr Theoret Neurobiol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Rao, Rajesh P. N./0000-0003-0682-8952				ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI 10.3109/0954898X.2011.638888; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H., 1961, SENSORY COMMUNICATIO, P217; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; BOLZ J, 1989, TRENDS NEUROSCI, V12, P292, DOI 10.1016/0166-2236(89)90009-X; BUCHSBAUM G, 1983, PROC R SOC SER B-BIO, V220, P89, DOI 10.1098/rspb.1983.0090; CREUTZFELDT OD, 1977, NATURWISSENSCHAFTEN, V64, P507, DOI 10.1007/BF00483547; Dan Y, 1996, J NEUROSCI, V16, P3351; DAYAN P, 1995, NEURAL COMPUT, V7, P889, DOI 10.1162/neco.1995.7.5.889; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P159, DOI 10.1088/0954-898X/6/2/003; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Gallant JL, 1998, NEUROREPORT, V9, P2153, DOI 10.1097/00001756-199806220-00045; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Gross C G, 1992, Curr Opin Neurobiol, V2, P156, DOI 10.1016/0959-4388(92)90004-5; Grossberg S, 1997, TRENDS NEUROSCI, V20, P106, DOI 10.1016/S0166-2236(96)01002-8; Heeger DJ, 1996, P NATL ACAD SCI USA, V93, P623, DOI 10.1073/pnas.93.2.623; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1987, J NEUROSCI, V7, P3378; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Lee DD, 1997, ADV NEUR IN, V9, P515; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; LUETTGEN MR, 1995, IEEE T IMAGE PROCESS, V4, P194, DOI 10.1109/83.342185; MacKay D. M., 1956, ANN MATH STUD, V34, P235, DOI DOI 10.1515/9781400882618-012; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; PECE AEC, 1992, ARTIFICIAL NEURAL NE, V2, P865; PETERHANS E, 1991, TRENDS NEUROSCI, V14, P112, DOI 10.1016/0166-2236(91)90072-3; Peterhans E., 1991, REPRESENTATIONS VISI, P111; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Rao RPN, 1997, NEURAL COMPUT, V9, P721, DOI 10.1162/neco.1997.9.4.721; RAO RPN, IN PRESS VISION RES; Rissanen Jorma, 1989, STOCHASTIC COMPLEXIT; SANDELL JH, 1982, J NEUROPHYSIOL, V48, P38, DOI 10.1152/jn.1982.48.1.38; Schultz W., 1995, MODELS INFORM PROCES, P233; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Softky WR, 1996, ADV NEUR IN, V8, P809; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; ULLMAN S, 1994, LARGE SCALE THEORIES, P257; Zipser K, 1996, J NEUROSCI, V16, P7376	50	2536	2573	7	182	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					79	87		10.1038/4580	http://dx.doi.org/10.1038/4580			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195184				2022-12-17	WOS:000078409300017
J	Davalos, D; Grutzendler, J; Yang, G; Kim, JV; Zuo, Y; Jung, S; Littman, DR; Dustin, ML; Gan, WB				Davalos, D; Grutzendler, J; Yang, G; Kim, JV; Zuo, Y; Jung, S; Littman, DR; Dustin, ML; Gan, WB			ATP mediates rapid microglial response to local brain injury in vivo	NATURE NEUROSCIENCE			English	Article							ASTROCYTES; CELLS; ACTIVATION; RELEASE; PROTEIN; EXPRESSION; MOTILITY	Parenchymal microglia are the principal immune cells of the brain. Time-lapse two-photon imaging of GFP-labeled microglia demonstrates that the fine termini of microglial processes are highly dynamic in the intact mouse cortex. Upon traumatic brain injury, microglial processes rapidly and autonomously converge on the site of injury without cell body movement, establishing a potential barrier between the healthy and injured tissue. This rapid chemotactic response can be mimicked by local injection of ATP and can be inhibited by the ATP-hydrolyzing enzyme apyrase or by blockers of G protein - coupled purinergic receptors and connexin channels, which are highly expressed in astrocytes. The baseline motility of microglial processes is also reduced significantly in the presence of apyrase and connexin channel inhibitors. Thus, extracellular ATP regulates microglial branch dynamics in the intact brain, and its release from the damaged tissue and surrounding astrocytes mediates a rapid microglial response towards injury.	NYU, Sch Med, Skirball Inst, Dept Physiol & Neurosci,Mol Neurobiol Program, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program, New York, NY 10016 USA	New York University; New York University	Gan, WB (corresponding author), NYU, Sch Med, Skirball Inst, Dept Physiol & Neurosci,Mol Neurobiol Program, 540 1st Ave, New York, NY 10016 USA.	gan@saturn.med.nyu.edu	Jung, Steffen/K-1409-2012; Dustin, Michael/AAM-4611-2020; Grutzendler, Jaime/F-3691-2010; Davalos, Dimitrios/G-8627-2011	Jung, Steffen/0000-0003-4290-5716; Davalos, Dimitrios/0000-0001-9038-6688; Dustin, Michael/0000-0003-4983-6389; Yang, Guang/0000-0002-5739-9126; Zuo, Yi/0000-0001-9020-0003				Anderson CM, 2004, J NEUROCHEM, V88, P246, DOI 10.1046/j.1471-4159.2003.02204.x; Aschner M, 1999, ANNU REV PHARMACOL, V39, P151, DOI 10.1146/annurev.pharmtox.39.1.151; BEYER EC, 1991, J BIOL CHEM, V266, P7971; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; Brockhaus J, 1996, GLIA, V16, P81, DOI 10.1002/(SICI)1098-1136(199601)16:1<81::AID-GLIA9>3.0.CO;2-E; Ciccarelli R, 2001, INT J DEV NEUROSCI, V19, P395, DOI 10.1016/S0736-5748(00)00084-8; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.0.CO;2-9; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Galbraith JA, 2003, MOL BIOL CELL, V14, P1808, DOI 10.1091/mbc.E02-03-0163; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Illes P, 2004, EUR J PHARMACOL, V483, P5, DOI 10.1016/j.ejphar.2003.10.030; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Nakki R, 1996, EXP NEUROL, V137, P234, DOI 10.1006/exnr.1996.0022; Nolte C, 1996, NEUROSCIENCE, V73, P1091, DOI 10.1016/0306-4522(96)00106-6; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Rouach N, 2002, BIOL CELL, V94, P457, DOI 10.1016/S0248-4900(02)00016-3; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; SMITH SJ, 1990, SYMP MED H, V23, P49; Srinivas M, 2003, MOL PHARMACOL, V63, P1389, DOI 10.1124/mol.63.6.1389; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; THOMAS WE, 1992, BRAIN RES REV, V17, P61; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; von Zahn J, 1997, NEUROREPORT, V8, P3851, DOI 10.1097/00001756-199712220-00003; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Wang ZQ, 2000, ANAL CHEM, V72, P2001, DOI 10.1021/ac9912146; Zimmermann H, 1996, J AUTON PHARMACOL, V16, P397, DOI 10.1111/j.1474-8673.1996.tb00062.x	40	2518	2595	7	256	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					752	758		10.1038/nn1472	http://dx.doi.org/10.1038/nn1472			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895084				2022-12-17	WOS:000229345300015
J	Critchley, HD; Wiens, S; Rotshtein, P; Ohman, A; Dolan, RJ				Critchley, HD; Wiens, S; Rotshtein, P; Ohman, A; Dolan, RJ			Neural systems supporting interoceptive awareness	NATURE NEUROSCIENCE			English	Article							VOXEL-BASED MORPHOMETRY; VISCERAL PERCEPTION; BRAIN ACTIVATION; HEARTBEAT; FEAR; EMOTION; AROUSAL	Influential theories of human emotion argue that subjective feeling states involve representation of bodily responses elicited by emotional events. Within this framework, individual differences in intensity of emotional experience reflect variation in sensitivity to internal bodily responses. We measured regional brain activity by functional magnetic resonance imaging (fMRI) during an interoceptive task wherein subjects judged the timing of their own heartbeats. We observed enhanced activity in insula, somatomotor and cingulate cortices. In right anterior insular/opercular cortex, neural activity predicted subjects' accuracy in the heartbeat detection task. Furthermore, local gray matter volume in the same region correlated with both interoceptive accuracy and subjective ratings of visceral awareness. Indices of negative emotional experience correlated with interoceptive accuracy across subjects. These findings indicate that right anterior insula supports a representation of visceral responses accessible to awareness, providing a substrate for subjective feeling states.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL Hosp, Natl Hosp Neurol & Neurosurg, Auton Unit, London WC1N 3BG, England; Karolinska Hosp, Dept Clin Neurosci, Psychol Sect, SE-17176 Stockholm, Sweden	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Karolinska Institutet; Karolinska University Hospital	Critchley, HD (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	h.critchley@fil.ion.ucl.ac.uk	Wiens, Stefan/D-1268-2017; critchley, hugo d/G-9267-2011	Wiens, Stefan/0000-0003-4531-4313; critchley, hugo d/0000-0002-2445-9284; Dolan, Ray/0000-0001-9356-761X; Rotshtein, Pia/0000-0002-0301-9511				Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Aziz Q, 2000, J CLIN NEUROPHYSIOL, V17, P604, DOI 10.1097/00004691-200011000-00006; Barsky AJ, 2001, ANN INTERN MED, V134, P832, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00006; Beck A, 1993, MANUAL BECK DEPRESSI; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Cameron OG, 2002, PSYCHOSOM MED, V64, P851, DOI 10.1097/01.PSY.0000038939.33335.32; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A.R., 1999, FEELING WHAT HAPPENS; DAMASIO AR, 1994, DESCARTES ERROR; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Ehlers A, 1996, BIOL PSYCHOL, V42, P165, DOI 10.1016/0301-0511(95)05153-8; Ferguson ML, 1996, BIOL PSYCHOL, V42, P131, DOI 10.1016/0301-0511(95)05151-1; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hamilton M. C., 1995, SOURCEBOOK ADULT ASS, P154; Harper RM, 2000, J COMP NEUROL, V417, P195, DOI 10.1002/(SICI)1096-9861(20000207)417:2<195::AID-CNE5>3.0.CO;2-V; JAMES W, 1994, PSYCHOL REV, V101, P205, DOI 10.1037/0033-295X.101.2.205; James W., 1922, EMOTIONS; JENNINGS JR, 1992, PSYCHOPHYSIOLOGY, V29, P369, DOI 10.1111/j.1469-8986.1992.tb01710.x; Jennings JR, 2002, PSYCHOL RES-PSYCH FO, V66, P337, DOI 10.1007/s00426-002-0106-5; Jones G. E., 1994, ADV PSYCHOP, V5, P55; Katkin ES, 2001, PSYCHOL SCI, V12, P366, DOI 10.1111/1467-9280.00368; LUDWICKROSENTHAL R, 1985, INT J PSYCHOPHYSIOL, V3, P57, DOI 10.1016/0167-8760(85)90020-0; MELMED RN, 2002, MIND BODY MED; MUMFORD DB, 1991, BRIT J PSYCHIAT, V158, P379, DOI 10.1192/bjp.158.3.379; Peyron R, 2002, NEUROIMAGE, V17, P1336, DOI 10.1006/nimg.2002.1315; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Porges S., 1993, BODY PERCEPTION QUES; Stewart SH, 2001, J ANXIETY DISORD, V15, P535, DOI 10.1016/S0887-6185(01)00080-9; Van TK, 2000, J AQUAT PLANT MANAGE, V38, P62; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1020, DOI 10.1037/0022-3514.54.6.1020; WHITEHEAD WE, 1977, BIOFEEDBACK SELF-REG, V2, P371, DOI 10.1007/BF00998623; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905; Wiens S, 2001, BIOL PSYCHOL, V58, P159, DOI 10.1016/S0301-0511(01)00110-7; YATES AJ, 1985, PSYCHOPHYSIOLOGY, V22, P561, DOI 10.1111/j.1469-8986.1985.tb01651.x; Zoellner LA, 1999, BEHAV RES THER, V37, P1141, DOI 10.1016/S0005-7967(98)00202-2	47	2217	2244	3	204	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					189	195		10.1038/nn1176	http://dx.doi.org/10.1038/nn1176			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	767TJ	14730305	Green Submitted			2022-12-17	WOS:000188468500018
J	McGowan, PO; Sasaki, A; D'Alessio, AC; Dymov, S; Labonte, B; Szyf, M; Turecki, G; Meaney, MJ				McGowan, Patrick O.; Sasaki, Aya; D'Alessio, Ana C.; Dymov, Sergiy; Labonte, Benoit; Szyf, Moshe; Turecki, Gustavo; Meaney, Michael J.			Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse	NATURE NEUROSCIENCE			English	Article							MAJOR DEPRESSION; MATERNAL-CARE; STRESS RESPONSES; GENETIC-ANALYSIS; DNA METHYLATION; MOOD DISORDERS; MESSENGER-RNA; YOUNG-ADULTS; LIFE; SCHIZOPHRENIA	Maternal care influences hypothalamic-pituitary-adrenal (HPA) function in the rat through epigenetic programming of glucocorticoid receptor expression. In humans, childhood abuse alters HPA stress responses and increases the risk of suicide. We examined epigenetic differences in a neuron-specific glucocorticoid receptor (NR3C1) promoter between postmortem hippocampus obtained from suicide victims with a history of childhood abuse and those from either suicide victims with no childhood abuse or controls. We found decreased levels of glucocorticoid receptor mRNA, as well as mRNA transcripts bearing the glucocorticoid receptor 1(F) splice variant and increased cytosine methylation of an NR3C1 promoter. Patch-methylated NR3C1 promoter constructs that mimicked the methylation state in samples from abused suicide victims showed decreased NGFI-A transcription factor binding and NGFI-A-inducible gene transcription. These findings translate previous results from rat to humans and suggest a common effect of parental care on the epigenetic regulation of hippocampal glucocorticoid receptor expression.	[Labonte, Benoit; Turecki, Gustavo; Meaney, Michael J.] Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ H4H 1R3, Canada; [McGowan, Patrick O.; Sasaki, Aya; Szyf, Moshe; Meaney, Michael J.] McGill Univ, Sackler Program Epigenet & Dev Psychobiol, Montreal, PQ H3G 1Y6, Canada; [D'Alessio, Ana C.; Dymov, Sergiy; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Meaney, Michael J.] Brenner Ctr Mol Med, Singapore Inst Clin Sci, Singapore 117609, Singapore	McGill University; McGill University; McGill University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Meaney, MJ (corresponding author), Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.	moshe.szyf@mcgill.ca; gustavo.turecki@mcgill.ca; michael.meaney@mcgill.ca	Turecki, Gustavo/K-5100-2015; Meaney, Michael/N-5931-2019; Labonte, Benoit/GPF-5629-2022	Labonte, Benoit/0000-0002-1251-5605; Turecki, Gustavo/0000-0003-4075-2736	US National Institutes of Health (National Institute of Child Health and Human Development); Canadian Institutes for Health Research; Human Frontiers Science Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051897] Funding Source: NIH RePORTER	US National Institutes of Health (National Institute of Child Health and Human Development)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Human Frontiers Science Program(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grants from the US National Institutes of Health (National Institute of Child Health and Human Development; M.J.M. and M. S.), the Canadian Institutes for Health Research (M.J.M., M.S. and G.T.), a Team Grant from the Human Frontiers Science Program (M.J.M. and M.S.) and a Maternal Adversity, Vulnerability and Neurodevelopment Project grant from the Canadian Institutes for Health Research (M.J.M. and M. S.).	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Bird A, 2001, SCIENCE, V294, P2113, DOI 10.1126/science.1066726; Boyle MP, 2005, P NATL ACAD SCI USA, V102, P473, DOI 10.1073/pnas.0406458102; Breslin MB, 2001, MOL ENDOCRINOL, V15, P1381, DOI 10.1210/me.15.8.1381; Brezo J, 2008, BRIT J PSYCHIAT, V193, P134, DOI 10.1192/bjp.bp.107.037994; Brezo J, 2007, PSYCHOL MED, V37, P1563, DOI 10.1017/S003329170700058X; Cervoni N, 2001, J BIOL CHEM, V276, P40778, DOI 10.1074/jbc.M103921200; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; DEBELLIS MD, 1994, J CLIN ENDOCR METAB, V78, P249, DOI 10.1210/jc.78.2.249; Dumais A, 2005, AM J PSYCHIAT, V162, P2116, DOI 10.1176/appi.ajp.162.11.2116; ENCIO IJ, 1991, J BIOL CHEM, V266, P7182; Ernst C, 2008, J NEUROSCI METH, V174, P123, DOI 10.1016/j.jneumeth.2008.06.027; Fergusson DM, 1996, J AM ACAD CHILD PSY, V35, P1365, DOI 10.1097/00004583-199610000-00024; Fisher PA, 2000, J AM ACAD CHILD PSY, V39, P1356, DOI 10.1097/00004583-200011000-00009; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; HIGLEY JD, 1991, P NATL ACAD SCI USA, V88, P7261, DOI 10.1073/pnas.88.16.7261; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; ISOMETSA ET, 1994, AM J PSYCHIAT, V151, P530; Kaufman J, 2000, BIOL PSYCHIAT, V48, P778, DOI 10.1016/S0006-3223(00)00998-7; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Neigh GN, 2006, TRENDS ENDOCRIN MET, V17, P124, DOI 10.1016/j.tem.2006.03.002; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pilowsky DJ, 2008, AM J PSYCHIAT, V165, P1136, DOI 10.1176/appi.ajp.2008.07081286; Plotsky PM, 2005, NEUROPSYCHOPHARMACOL, V30, P2192, DOI 10.1038/sj.npp.1300769; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; Reichardt HM, 2000, BIOL CHEM, V381, P961, DOI 10.1515/BC.2000.118; Ridder S, 2005, J NEUROSCI, V25, P6243, DOI 10.1523/JNEUROSCI.0736-05.2005; SCHATZBERG AF, 1985, J PSYCHIAT RES, V19, P57, DOI 10.1016/0022-3956(85)90068-8; Seguin M, 2007, PSYCHOL MED, V37, P1575, DOI 10.1017/S0033291707000955; Sequeira A, 2006, OMICS, V10, P444, DOI 10.1089/omi.2006.10.444; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Teicher MH, 2002, PSYCHIAT CLIN N AM, V25, P397, DOI 10.1016/S0193-953X(01)00003-X; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Webster MJ, 2002, MOL PSYCHIATR, V7, P985, DOI 10.1038/sj.mp.4001139; Widom CS, 2007, ARCH GEN PSYCHIAT, V64, P49; Yamada K, 2007, P NATL ACAD SCI USA, V104, P2815, DOI 10.1073/pnas.0610765104	50	2185	2244	6	447	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2009	12	3					342	348		10.1038/nn.2270	http://dx.doi.org/10.1038/nn.2270			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	410LF	19234457	Green Accepted			2022-12-17	WOS:000263577900020
J	Riesenhuber, M; Poggio, T				Riesenhuber, M; Poggio, T			Hierarchical models of object recognition in cortex	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; VISUAL-SYSTEM; 3-DIMENSIONAL OBJECTS; NEURAL CIRCUITRY; FACE DETECTION; MACAQUE; VIEW; RESPONSES; SHAPE; ATTENTION	Visual processing in cortex is classically modeled as a hierarchy of increasingly sophisticated representations, naturally extending the model of simple to complex cells of Hubel and Wiesel. Surprisingly, little quantitative modeling has been done to explore the biological feasibility of this class of models to explain aspects of higher-level visual processing such as object recognition. We describe a new hierarchical model consistent with physiological data from inferotemporal cortex that accounts for this complex visual task and makes testable predictions. The model is based on a MAX-like operation applied to inputs to certain cortical neurons that may have a general role in cortical function.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02142 USA; MIT, Ctr Biol & Computat Learning, Cambridge, MA 02142 USA; MIT, Artificial Intelligence Lab, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Poggio, T (corresponding author), MIT, Dept Brain & Cognit Sci, Cambridge, MA 02142 USA.	tp@ai.mit.edu		Riesenhuber, Maximilian/0000-0002-5744-0408				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ANDERSON CH, 1987, P NATL ACAD SCI USA, V84, P6297, DOI 10.1073/pnas.84.17.6297; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Conner CE, 1997, J NEUROSCI, V17, P3201; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; GROSSBERG S, 1988, NEURAL NETWORKS, V1, P17, DOI 10.1016/0893-6080(88)90021-4; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Logothetis N, 1998, CURR OPIN NEUROBIOL, V8, P536; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; LOGOTHETIS NK, 1994, CURR BIOL, V4, P401, DOI 10.1016/S0960-9822(00)00089-0; Mel BW, 1997, NEURAL COMPUT, V9, P777, DOI 10.1162/neco.1997.9.4.777; Missal M, 1997, CEREB CORTEX, V7, P758, DOI 10.1093/cercor/7.8.758; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; NOWLAN SJ, 1995, J NEUROSCI, V15, P1195; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; PERRETT DI, 1991, EXP BRAIN RES, V86, P159; PERRETT DI, 1993, IMAGE VISION COMPUT, V11, P317, DOI 10.1016/0262-8856(93)90011-5; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; REICHARDT W, 1983, BIOL CYBERN, V46, P1, DOI 10.1007/BF00595226; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Riesenhuber M, 1997, ADV NEUR IN, V9, P17; Riesenhuber M, 1999, NEURON, V24, P87, DOI 10.1016/S0896-6273(00)80824-7; Riesenhuber M, 1998, ADV NEUR IN, V10, P215; ROLLS ET, 1995, EXP BRAIN RES, V103, P409; Rowley HA, 1998, IEEE T PATTERN ANAL, V20, P23, DOI 10.1109/34.655647; Salinas E, 1997, J NEUROPHYSIOL, V77, P3267, DOI 10.1152/jn.1997.77.6.3267; SATO T, 1989, EXP BRAIN RES, V77, P23; Sung KK, 1998, IEEE T PATTERN ANAL, V20, P39, DOI 10.1109/34.655648; TARR MJ, 1995, PSYCHON B REV, V2, P55, DOI 10.3758/BF03214412; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wang G, 1998, NEUROSCI RES, V32, P33, DOI 10.1016/S0168-0102(98)00062-5	47	1982	2084	6	173	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					1019	1025		10.1038/14819	http://dx.doi.org/10.1038/14819			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526343				2022-12-17	WOS:000083883300021
J	Todorov, E; Jordan, MI				Todorov, E; Jordan, MI			Optimal feedback control as a theory of motor coordination	NATURE NEUROSCIENCE			English	Article							INERTIAL ANISOTROPY; ARM MOVEMENTS; MODEL; TASK; ACCURACY; SPEECH; GRASP	A central problem in motor control is understanding how the many biomechanical degrees of freedom are coordinated to achieve a common goal. An especially puzzling aspect of coordination is that behavioral goals are achieved reliably and repeatedly with movements rarely reproducible in their detail. Existing theoretical frameworks emphasize either goal achievement or the richness of motor variability, but fail to reconcile the two. Here we propose an alternative theory based on stochastic optimal feedback control. We show that the optimal strategy in the face of uncertainty is to allow variability in redundant (task-irrelevant) dimensions. This strategy does not enforce a desired trajectory, but uses feedback more intelligently, correcting only those deviations that interfere with task goals. From this framework, task-constrained variability, goal-directed corrections, motor synergies, controlled parameters, simplifying rules and discrete coordination modes emerge naturally. We present experimental results from a range of motor tasks to support this theory.	Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	University of California System; University of California San Diego; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Todorov, E (corresponding author), Univ Calif San Diego, Dept Cognit Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Jordan, Michael I/C-5253-2013					Balasubramaniam R, 2000, GAIT POSTURE, V11, P12, DOI 10.1016/S0966-6362(99)00051-X; Bernstein NA., 1967, COORDINATION REGULAT; BIZZI E, 1984, J NEUROSCI, V4, P2738; COLE KJ, 1987, J NEUROPHYSIOL, V57, P1498, DOI 10.1152/jn.1987.57.5.1498; COLE KJ, 1986, J NEUROPHYSIOL, V55, P1407, DOI 10.1152/jn.1986.55.6.1407; d'Avella A, 1998, P NATL ACAD SCI USA, V95, P7711, DOI 10.1073/pnas.95.13.7711; Davis M., 1985, STOCHASTIC MODELLING; Domkin D, 2002, EXP BRAIN RES, V143, P11, DOI 10.1007/s00221-001-0944-1; Flanagan JR, 2001, J NEUROSCI, V21, P1361; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Gel'fand IM., 1971, MODELS STRUCTURAL FU; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Gottlieb GL, 1996, J NEUROPHYSIOL, V76, P3207, DOI 10.1152/jn.1996.76.5.3207; GRACCO VL, 1986, EXP BRAIN RES, V65, P156; GRACCO VL, 1985, J NEUROPHYSIOL, V54, P418, DOI 10.1152/jn.1985.54.2.418; Haggard P, 1995, EXP BRAIN RES, V107, P254; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HINTON G, 1984, J MOTOR BEHAV, V16, P171; Hoff B., 1992, THESIS U SO CALIFORN; JORDAN MI, 1990, ATTENTION PERFORM, V13, P796; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Kelso J.A.S., 1995, DYNAMIC PATTERNS SEL; KOMILIS E, 1993, J MOTOR BEHAV, V25, P299, DOI 10.1080/00222895.1993.9941651; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; Li ZM, 1998, EXP BRAIN RES, V119, P276, DOI 10.1007/s002210050343; LOEB GE, 1990, COLD SH Q B, V55, P791; Marr D., 1982, VISION; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; NELSON WL, 1983, BIOL CYBERN, V46, P135, DOI 10.1007/BF00339982; Newell KM, 2001, HUM MOVEMENT SCI, V20, P695, DOI 10.1016/S0167-9457(01)00073-2; Robertson EM, 1997, EXP BRAIN RES, V117, P148, DOI 10.1007/s002210050208; Sabes PN, 1998, J NEUROSCI, V18, P5948; Santello M, 2000, EXP BRAIN RES, V133, P457, DOI 10.1007/s002210000420; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.1111/j.1467-8624.1993.tb04182.x; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 1997, J MOTOR BEHAV, V29, P147, DOI 10.1080/00222899709600829; Todorov E, 2002, NEURAL COMPUT, V14, P1233, DOI 10.1162/089976602753712918; Todorov E, 1998, J NEUROPHYSIOL, V80, P696, DOI 10.1152/jn.1998.80.2.696; Todorov EV, 1998, THESIS MIT; Tseng YW, 2002, MOTOR CONTROL, V6, P183, DOI 10.1123/mcj.6.2.183; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; VEREIJKEN B, 1992, J MOTOR BEHAV, V24, P133, DOI 10.1080/00222895.1992.9941608; WINTER DA, 1989, PERSPECTIVES COORDIN, P329; WOLPERT DM, 1995, EXP BRAIN RES, V103, P460; WRIGHT CE, 1990, ATTENTION PERFORM, V13, P294	50	1842	1854	10	194	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1226	1235		10.1038/nn963	http://dx.doi.org/10.1038/nn963			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12404008				2022-12-17	WOS:000178884600027
J	Kriegeskorte, N; Simmons, WK; Bellgowan, PSF; Baker, CI				Kriegeskorte, Nikolaus; Simmons, W. Kyle; Bellgowan, Patrick S. F.; Baker, Chris I.			Circular analysis in systems neuroscience: the dangers of double dipping	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL LOCALIZERS; FMRI DATA; BRAIN; CORTEX	A neuroscientific experiment typically generates a large amount of data, of which only a small fraction is analyzed in detail and presented in a publication. However, selection among noisy measurements can render circular an otherwise appropriate analysis and invalidate results. Here we argue that systems neuroscience needs to adjust some widespread practices to avoid the circularity that can arise from selection. In particular, 'double dipping', the use of the same dataset for selection and selective analysis, will give distorted descriptive statistics and invalid statistical inference whenever the results statistics are not inherently independent of the selection criteria under the null hypothesis. To demonstrate the problem, we apply widely used analyses to noise data known to not contain the experimental effects in question. Spurious effects can appear in the context of both univariate activation analysis and multivariate pattern-information analysis. We suggest a policy for avoiding circularity.	[Kriegeskorte, Nikolaus; Simmons, W. Kyle; Bellgowan, Patrick S. F.; Baker, Chris I.] US Natl Inst Mental Hlth, Lab Brain & Cognit, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Kriegeskorte, N (corresponding author), US Natl Inst Mental Hlth, Lab Brain & Cognit, Bethesda, MD USA.	nikokriegeskorte@gmail.com; bakerchris@mail.nih.gov	Simmons, William/K-8925-2015; Simmons, W. Kyle/V-6846-2019; Kennedy, Kristen M/B-4699-2008	Simmons, William/0000-0002-0399-9003; Simmons, W. Kyle/0000-0002-0399-9003; Kennedy, Kristen M/0000-0001-5373-9026; Baker, Chris/0000-0001-6861-8964; Kriegeskorte, Nikolaus/0000-0001-7433-9005; Bellgowan, Patrick/0000-0002-6753-8302	US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002909] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank P. A. Bandettini, R. W. Cox, J.V. Haxby, D.J. Kravitz, A. Martin, R. A. Poldrack, R. D. Raizada, Z.S. Saad, J.T. Serences and E. Vul for helpful discussions. This work was supported by the Intramural Research Program of the US National Institute of Mental Health.	Baker CI, 2007, NAT NEUROSCI, V10, P3, DOI 10.1038/nn0107-3; BAKER CI, 2007, SOC NEUR ABSTR; Benjamini Y, 2008, STAT SCI, V23, P23, DOI 10.1214/07-STS236B; Bishop, 2016, PATTERN RECOGN; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Duda R.O., 2001, PATTERN CLASSIFICATI, V20; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kant I., 1781, CRITIQUE PURE REASON; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mitchell TM., 1997, MACH LEARN; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; SIMMONS WK, 2006, SOC NEUR ABSTR; Strother S, 2004, NEUROIMAGE, V23, pS196, DOI 10.1016/j.neuroimage.2004.07.022; Strothert SC, 2002, NEUROIMAGE, V15, P747, DOI 10.1006/nimg.2001.1034; VUL E, FDN PHILOS IN PRESS; VUL E, PERSPECT PS IN PRESS; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	24	1836	1843	0	126	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2009	12	5					535	540		10.1038/nn.2303	http://dx.doi.org/10.1038/nn.2303			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438SJ	19396166	Bronze, Green Accepted, Green Published			2022-12-17	WOS:000265575400006
J	Behrens, TEJ; Johansen-Berg, H; Woolrich, MW; Smith, SM; Wheeler-Kingshott, CAM; Boulby, PA; Barker, GJ; Sillery, EL; Sheehan, K; Ciccarelli, O; Thompson, AJ; Brady, JM; Matthews, PM				Behrens, TEJ; Johansen-Berg, H; Woolrich, MW; Smith, SM; Wheeler-Kingshott, CAM; Boulby, PA; Barker, GJ; Sillery, EL; Sheehan, K; Ciccarelli, O; Thompson, AJ; Brady, JM; Matthews, PM			Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging	NATURE NEUROSCIENCE			English	Article							RHESUS-MONKEY; WHITE-MATTER; HUMAN BRAIN; CORTICAL CONNECTIONS; AXONAL PROJECTIONS; PREFRONTAL CORTEX; FRONTAL-LOBE; TENSOR; NUCLEUS; TRACTOGRAPHY	Evidence concerning anatomical connectivities in the human brain is sparse and based largely on limited post-mortem observations. Diffusion tensor imaging has previously been used to define large white-matter tracts in the living human brain, but this technique has had limited success in tracing pathways into gray matter. Here we identified specific connections between human thalamus and cortex using a novel probabilistic tractography algorithm with diffusion imaging data. Classification of thalamic gray matter based on cortical connectivity patterns revealed distinct subregions whose locations correspond to nuclei described previously in histological studies. The connections that we found between thalamus and cortex were similar to those reported for non-human primates and were reproducible between individuals. Our results provide the first quantitative demonstration of reliable inference of anatomical connectivity between human gray matter structures using diffusion data and the first connectivity-based segmentation of gray matter.	Univ Oxford, John Radcliffe Hosp, Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England; Univ Oxford, Dept Engn Sci, Med Vis Lab, Oxford OX1 3PJ, England; UCL, Inst Neurol, London WC1N 3BG, England	University of Oxford; University of Oxford; University of London; University College London	Johansen-Berg, H (corresponding author), Univ Oxford, John Radcliffe Hosp, Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England.	heidi@fmrib.ox.ac.uk	Thompson, Alan J/C-2654-2008; Barker, Gareth J/C-9616-2009; Wheeler-Kingshott, Claudia A M Gandini/AAH-7480-2019; Warfield, Simon/B-3352-2009	Thompson, Alan J/0000-0002-4333-8496; Barker, Gareth J/0000-0002-5214-7421; Wheeler-Kingshott, Claudia A M Gandini/0000-0002-4832-1300; Warfield, Simon/0000-0002-7659-3880; Smith, Stephen/0000-0001-8166-069X; Behrens, Timothy/0000-0003-0048-1177; Woolrich, Mark/0000-0001-8460-8854; Matthews, Paul M/0000-0002-1619-8328; Johansen-Berg, Heidi/0000-0002-4134-9730; Smith, Shubulade/0000-0002-3797-6985				AGGLETON JP, 1984, J COMP NEUROL, V222, P56, DOI 10.1002/cne.902220106; Anderson AW, 2001, MAGNET RESON MED, V46, P1174, DOI 10.1002/mrm.1315; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; ASANUMA C, 1983, BRAIN RES REV, V5, P219, DOI 10.1016/0165-0173(83)90014-0; ASANUMA C, 1983, BRAIN RES REV, V5, P237, DOI 10.1016/0165-0173(83)90015-2; BARBAS H, 1987, J COMP NEUROL, V256, P211, DOI 10.1002/cne.902560203; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408; CARPENTER M, 1978, NEUROANATOMY; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Gilks WR, 1996, MARKOV CHAIN MONTE C; GOLDMANRAKIC PS, 1985, J COMP NEUROL, V242, P535, DOI 10.1002/cne.902420406; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; JONES EG, 1979, J COMP NEUROL, V183, P833, DOI 10.1002/cne.901830410; JONES EG, 1970, BRAIN, V93, P37, DOI 10.1093/brain/93.1.37; Jones EG, 1985, THALAMUS; KIEVIT J, 1977, EXP BRAIN RES, V29, P299; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Lee PM., 2012, BAYESIAN STAT INTRO; Magnotta VA, 2000, NEUROIMAGE, V11, P341, DOI 10.1006/nimg.2000.0552; MARKOWITSCH HJ, 1985, J COMP NEUROL, V242, P425, DOI 10.1002/cne.902420310; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Morel A, 1997, J COMP NEUROL, V387, P588, DOI 10.1002/(SICI)1096-9861(19971103)387:4<588::AID-CNE8>3.0.CO;2-Z; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; MUFSON EJ, 1990, NEUROBIOL AGING, V11, P649, DOI 10.1016/0197-4580(90)90031-T; PARENT A, 1983, NEUROSCIENCE, V10, P1137, DOI 10.1016/0306-4522(83)90104-5; Parker GJM, 2002, NEUROIMAGE, V15, P797, DOI 10.1006/nimg.2001.0994; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Pollak P, 2002, MOVEMENT DISORD, V17, pS75, DOI 10.1002/mds.10146; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; RACZKOWSKI D, 1980, J COMP NEUROL, V193, P1, DOI 10.1002/cne.901930102; RUSSCHEN FT, 1987, J COMP NEUROL, V256, P175, DOI 10.1002/cne.902560202; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Speelman JD, 2002, MOVEMENT DISORD, V17, pS84, DOI 10.1002/mds.10147; TANAKA D, 1976, BRAIN RES, V110, P21, DOI 10.1016/0006-8993(76)90206-7; TOBIAS TJ, 1975, BRAIN RES, V83, P191, DOI 10.1016/0006-8993(75)90930-0; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; VANBUREN JM, 1972, VARIATIONS CONNECTIO, V1; VANESSEN DC, 1986, J COMP NEUROL, V244, P451, DOI 10.1002/cne.902440405; WEBSTER MJ, 1993, J COMP NEUROL, V335, P73, DOI 10.1002/cne.903350106; YARITA H, 1980, J NEUROPHYSIOL, V43, P69, DOI 10.1152/jn.1980.43.1.69; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	50	1738	1773	5	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					750	757		10.1038/nn1075	http://dx.doi.org/10.1038/nn1075			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12808459				2022-12-17	WOS:000183780400024
J	Song, S; Miller, KD; Abbott, LF				Song, S; Miller, KD; Abbott, LF			Competitive Hebbian learning through spike-timing-dependent synaptic plasticity	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; RECEPTIVE-FIELDS; PYRAMIDAL CELLS; MODEL; RAT; DEPRESSION; EFFICACY; CORTEX; LTP	Hebbian models of development and learning require both activity-dependent synaptic plasticity and a mechanism that induces competition between different synapses. One form of experimentally observed long-term synaptic plasticity, which we call spike-timing-dependent plasticity (STDP), depends on the relative timing of pre- and postsynaptic action potentials. In modeling studies, we find that this form of synaptic modification can automatically balance synaptic strengths to make postsynaptic firing irregular but more sensitive to presynaptic spike timing. It has been argued that neurons in vivo operate in such a balanced regime. Synapses modifiable by STDP compete for control of the timing of postsynaptic action potentials. Inputs that fire the postsynaptic neuron with short latency or that act in correlated groups are able to compete most successfully and develop strong synapses, while synapses of longer-latency or less-effective inputs are weakened.	Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA; Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; Univ Calif San Francisco, Sloan Ctr Theoret Neurobiol, WM Keck Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sloan Ctr Theoret Neurobiol, WM Keck Ctr Integrat Neurosci, Dept Otolaryngol,Neurosci Grad Program, San Francisco, CA 94143 USA	Brandeis University; Brandeis University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Abbott, LF (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA.				NATIONAL EYE INSTITUTE [R01EY011001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058754] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY11001] Funding Source: Medline; NIMH NIH HHS [MH58754] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; Abbott LF, 1999, ADV NEUR IN, V11, P69; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Bugmann G, 1997, NEURAL COMPUT, V9, P985, DOI 10.1162/neco.1997.9.5.985; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; GERSTNER W, 1993, BIOL CYBERN, V69, P503, DOI 10.1007/BF01185422; Gerstner W, 1997, COMPUTATIONAL NEUROSCIENCE: TRENDS IN RESEARCH, 1997, P665; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gerstner W, 1997, J COMPUT NEUROSCI, V4, P79, DOI 10.1023/A:1008820728122; GUILLERY RW, 1972, J COMP NEUROL, V144, P117, DOI 10.1002/cne.901440106; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Mehta MR, 2000, NEUROCOMPUTING, V32, P905, DOI 10.1016/S0925-2312(00)00259-9; Miller K. D., 1996, MODELS NEURAL NETWOR, P55, DOI [10.1007/978-1-4612-0723-8_2, DOI 10.1007/978-1-4612-0723-8_2]; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; Minai A. A., 1993, INNS WORLD C NEUR NE, P505; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Rao RPN, 2000, ADV NEUR IN, V12, P164; Roberts PD, 1999, J COMPUT NEUROSCI, V7, P235, DOI 10.1023/A:1008910918445; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; STRYKER MP, 1986, BIOL CHANGE OTOLARYN, P211; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; Troyer TW, 1997, COMPUTATIONAL NEUROSCIENCE: TRENDS IN RESEARCH, 1997, P197; Tsodyks M., 1995, NETWORK, V6, P1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	50	1712	1775	11	274	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					919	926		10.1038/78829	http://dx.doi.org/10.1038/78829			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966623				2022-12-17	WOS:000167177400019
J	Sowell, ER; Peterson, BS; Thompson, PM; Welcome, SE; Henkenius, AL; Toga, AW				Sowell, ER; Peterson, BS; Thompson, PM; Welcome, SE; Henkenius, AL; Toga, AW			Mapping cortical change across the human life span	NATURE NEUROSCIENCE			English	Article							AGE-RELATED-CHANGES; IN-VIVO; HUMAN BRAIN; REGIONAL BRAIN; ADOLESCENCE; MATURATION; CHILDHOOD; VOLUMES; MRI; MYELINATION	We used magnetic resonance imaging and cortical matching algorithms to map gray matter density (GMD) in 176 normal individuals ranging in age from 7 to 87 years. We found a significant, nonlinear decline in GMD with age, which was most rapid between 7 and about 60 years, over dorsal frontal and parietal association cortices on both the lateral and interhemispheric surfaces. Age effects were inverted in the left posterior temporal region, where GMD gain continued up to age 30 and then rapidly declined. The trajectory of maturational and aging effects varied considerably over the cortex. Visual, auditory and limbic cortices, which are known to myelinate early, showed a more linear pattern of aging than the frontal and parietal neocortices, which continue myelination into adulthood. Our findings also indicate that the posterior temporal cortices, primarily in the left hemisphere, which typically support language functions, have a more protracted course of maturation than any other cortical region.	Univ Calif Los Angeles, Lab Neuro Imaging, Dept Neurol, Los Angeles, CA 90095 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA	University of California System; University of California Los Angeles; Columbia University; New York State Psychiatry Institute	Sowell, ER (corresponding author), Univ Calif Los Angeles, Lab Neuro Imaging, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.		Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001232, P20MH052176, T32MH016381, R01MH059139] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR13642] Funding Source: Medline; NIMH NIH HHS [MH59139, MH01733, MH01232, 5T32 MH16381, P20 MH/DA52176] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; BENES FM, 1989, SCHIZOPHRENIA BULL, V15, P585, DOI 10.1093/schbul/15.4.585; Burke DM, 1997, PHILOS T R SOC B, V352, P1845, DOI 10.1098/rstb.1997.0170; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; MacDonald D, 1994, P SOC PHOTO-OPT INS, V2359, P160; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Ono M, 1990, ATLAS CEREBRAL SULCI; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Peterson BS, 2000, ARCH GEN PSYCHIAT, V57, P364, DOI 10.1001/archpsyc.57.4.364; Peterson BS, 2001, ARCH GEN PSYCHIAT, V58, P427, DOI 10.1001/archpsyc.58.5.427; Ravid D, 2002, J CHILD LANG, V29, P417, DOI 10.1017/S0305000902005111; SALM, 2002, NEUROIMAGE, V17, P1027; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Sowell ER, 2002, CEREB CORTEX, V12, P856, DOI 10.1093/cercor/12.8.856; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Sowell ER, 2002, CEREB CORTEX, V12, P17, DOI 10.1093/cercor/12.1.17; TERRY RD, 1987, ANN NEUROL, V21, P530, DOI 10.1002/ana.410210603; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; THOMPSON PM, 2002, COMPUTING VISUALIZAT, V5, P1; THOMPSON PM, INPRESS J NEUROSCI; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Yakovlev PL, 1967, REGIONAL DEV BRAIN E, P3	35	1610	1629	3	152	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					309	315		10.1038/nn1008	http://dx.doi.org/10.1038/nn1008			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12548289				2022-12-17	WOS:000181178300020
J	Gould, E; Beylin, A; Tanapat, P; Reeves, A; Shors, TJ				Gould, E; Beylin, A; Tanapat, P; Reeves, A; Shors, TJ			Learning enhances adult neurogenesis in the hippocampal formation	NATURE NEUROSCIENCE			English	Article							NICTITATING-MEMBRANE RESPONSE; DENTATE GRANULE CELLS; RECEPTOR ACTIVATION; PSYCHOSOCIAL STRESS; BRAIN SYSTEMS; TOTAL NUMBER; GYRUS; RAT; NEURONS; MEMORY	Thousands of hippocampal neurons are born in adulthood, suggesting that new cells could be important for hippocampal function. To determine whether hippocampus-dependent learning affects adult-generated neurons, we examined the fate of new cells labeled with the thymidine analog bromodeoxyuridine following specific behavioral tasks. Here we report that the number of adult-generated neurons doubles in the rat dentate gyrus in response to training on associative learning tasks that require the hippocampus. In contrast, training on associative learning tasks that do not require the hippocampus did not alter the number of new cells. These findings indicate that adult-generated hippocampal neurons are specifically affected by, and potentially involved in, associative memory formation.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Neurosci, Piscataway, NJ 08854 USA	Princeton University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Gould, E (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH052423, R01MH059970] Funding Source: NIH RePORTER; NIMH NIH HHS [MH52423, MH59970] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; BAYER SA, 1982, EXP BRAIN RES, V46, P315; Beylin AV, 1998, BEHAV NEUROSCI, V112, P1327, DOI 10.1037/0735-7044.112.6.1327; BODNOFF SR, 1995, J NEUROSCI, V15, P61; Cameron H, 1996, J COMP NEUROL, V369, P56, DOI 10.1002/(SICI)1096-9861(19960520)369:1<56::AID-CNE4>3.0.CO;2-J; Cameron HA, 1998, NEUROSCIENCE, V82, P349; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; GOULD E, 1990, NEUROSCIENCE, V37, P367, DOI 10.1016/0306-4522(90)90407-U; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Krugers HJ, 1997, HIPPOCAMPUS, V7, P427, DOI 10.1002/(SICI)1098-1063(1997)7:4<427::AID-HIPO8>3.3.CO;2-L; Kuhn HG, 1996, J NEUROSCI, V16, P2027; MARKOWSKA AL, 1993, BEHAV NEUROSCI, V107, P627; McCormick CM, 1997, BEHAV NEUROSCI, V111, P518; Milner B, 1972, Clin Neurosurg, V19, P421; MINTURN JE, 1995, J COMP NEUROL, V355, P369, DOI 10.1002/cne.903550304; MOGHADDAM B, 1994, BRAIN RES, V655, P251, DOI 10.1016/0006-8993(94)91622-5; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOYER JR, 1990, BEHAV NEUROSCI, V104, P243, DOI 10.1037/0735-7044.104.2.243; SCHMALTZ LW, 1972, J COMP PHYSIOL PSYCH, V79, P328, DOI 10.1037/h0032531; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; Shors TJ, 1998, LEARN MEMORY, V5, P220; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; SQUIRE LR, 1982, ANNU REV NEUROSCI, V5, P241, DOI 10.1146/annurev.ne.05.030182.001325; Squire LR, 1997, PHILOS T R SOC B, V352, P1663, DOI 10.1098/rstb.1997.0148; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; WEISS C, IN PRESS BEHAV BRAIN; WEISZ DJ, 1984, BEHAV BRAIN RES, V12, P145, DOI 10.1016/0166-4328(84)90037-8; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	34	1602	1674	0	128	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					260	265		10.1038/6365	http://dx.doi.org/10.1038/6365			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195219				2022-12-17	WOS:000081684500014
J	Noctor, SC; Martinez-Cerdeno, V; Ivic, L; Kriegstein, AR				Noctor, SC; Martinez-Cerdeno, V; Ivic, L; Kriegstein, AR			Cortical neurons arise in symmetric and asymmetric division zones and migrate through specific phases	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; RADIAL GLIAL-CELLS; SUBVENTRICULAR ZONE; BASAL FOREBRAIN; MAMMALIAN BRAIN; VISUAL-CORTEX; NEOCORTEX; NEUROGENESIS; ASTROCYTES; MOUSE	Precise patterns of cell division and migration are crucial to transform the neuroepithelium of the embryonic forebrain into the adult cerebral cortex. Using time-lapse imaging of clonal cells in rat cortex over several generations, we show here that neurons are generated in two proliferative zones by distinct patterns of division. Neurons arise directly from radial glial cells in the ventricular zone (VZ) and indirectly from intermediate progenitor cells in the subventricular zone (SVZ). Furthermore, newborn neurons do not migrate directly to the cortex; instead, most exhibit four distinct phases of migration, including a phase of retrograde movement toward the ventricle before migration to the cortical plate. These findings provide a comprehensive and new view of the dynamics of cortical neurogenesis and migration.	Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Noctor, SC (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, 630 W 168th St, New York, NY 10032 USA.	scn8@columbia.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021223, R01NS035710, R37NS038658] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38658, NS21223, NS35710] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bayer S.A., 1991, NEOCORTICAL DEV; BERRY M, 1965, J ANAT, V99, P691; BOULDER C, 1970, ANAT REC, V166, P257; Cai L, 2002, J NEUROSCI RES, V69, P731, DOI 10.1002/jnr.10398; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Kakita A, 2002, ACTA NEUROPATHOL, V104, P649, DOI 10.1007/s00401-002-0594-9; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MILLER MW, 1986, DEV BRAIN RES, V25, P271, DOI 10.1016/0165-3806(86)90217-8; MIONE MC, 1994, J NEUROSCI, V14, P107; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; MOREST DK, 1970, Z ANAT ENTWICKLUNGS, V130, P265, DOI 10.1007/BF00520999; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Parnavelas JG, 1991, CEREB CORTEX, V1, P463, DOI 10.1093/cercor/1.6.463; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; PARNAVELAS JG, 1979, ANAT EMBRYOL, V157, P311, DOI 10.1007/BF00304996; PRIVAT A, 1975, INT REV CYTOL, V40, P281, DOI 10.1016/S0074-7696(08)60955-9; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Reid CB, 1997, DEVELOPMENT, V124, P2441; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SCHWARTZ ML, 1991, P NATL ACAD SCI USA, V88, P1354, DOI 10.1073/pnas.88.4.1354; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shen Q, 2002, DEVELOPMENT, V129, P4843; SHOUKIMAS GM, 1978, J COMP NEUROL, V179, P795, DOI 10.1002/cne.901790407; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Tabata H, 2003, J NEUROSCI, V23, P9996; Takahashi T, 1996, J NEUROSCI, V16, P6183; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zhong WM, 1997, DEVELOPMENT, V124, P1887; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	50	1541	1576	5	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					136	144		10.1038/nn1172	http://dx.doi.org/10.1038/nn1172			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14703572				2022-12-17	WOS:000188468500011
J	Erny, D; de Angelis, ALH; Jaitin, D; Wieghofer, P; Staszewski, O; David, E; Keren-Shaul, H; Mahlakoiv, T; Jakobshagen, K; Buch, T; Schwierzeck, V; Utermohlen, O; Chun, E; Garrett, WS; Mccoy, KD; Diefenbach, A; Staeheli, P; Stecher, B; Amit, I; Prinz, M				Erny, Daniel; de Angelis, Anna Lena Hrabe; Jaitin, Diego; Wieghofer, Peter; Staszewski, Ori; David, Eyal; Keren-Shaul, Hadas; Mahlakoiv, Tanel; Jakobshagen, Kristin; Buch, Thorsten; Schwierzeck, Vera; Utermoehlen, Olaf; Chun, Eunyoung; Garrett, Wendy S.; Mccoy, Kathy D.; Diefenbach, Andreas; Staeheli, Peter; Stecher, Baerbel; Amit, Ido; Prinz, Marco			Host microbiota constantly control maturation and function of microglia in the CNS	NATURE NEUROSCIENCE			English	Article							GUT MICROBIOTA; COMMON VARIANTS; CELLS; ACTIVATION; HEMATOPOIESIS; MACROPHAGES; METABOLITES; PHYSIOLOGY; EXPRESSION; MONOCYTES	As the tissue macrophages of the CNS, microglia are critically involved in diseases of the CNS. However, it remains unknown what controls their maturation and activation under homeostatic conditions. We observed substantial contributions of the host microbiota to microglia homeostasis, as germ-free (GF) mice displayed global defects in microglia with altered cell proportions and an immature phenotype, leading to impaired innate immune responses. Temporal eradication of host microbiota severely changed microglia properties. Limited microbiota complexity also resulted in defective microglia. In contrast, recolonization with a complex microbiota partially restored microglia features. We determined that short-chain fatty acids (SCFA), microbiota-derived bacterial fermentation products, regulated microglia homeostasis. Accordingly, mice deficient for the SCFA receptor FFAR2 mirrored microglia defects found under GF conditions. These findings suggest that host bacteria vitally regulate microglia maturation and function, whereas microglia impairment can be rectified to some extent by complex microbiota.	[Erny, Daniel; de Angelis, Anna Lena Hrabe; Wieghofer, Peter; Staszewski, Ori; Prinz, Marco] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Jaitin, Diego; David, Eyal; Keren-Shaul, Hadas; Amit, Ido] Weizmann Inst Sci, Lab ImmunoGenom, IL-76100 Rehovot, Israel; [Wieghofer, Peter] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Mahlakoiv, Tanel; Staeheli, Peter] Univ Freiburg, Dept Virol, D-79106 Freiburg, Germany; [Jakobshagen, Kristin; Utermoehlen, Olaf] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50931 Cologne, Germany; [Jakobshagen, Kristin; Utermoehlen, Olaf] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Buch, Thorsten] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Schwierzeck, Vera; Diefenbach, Andreas] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Microbiol & Hyg, D-55122 Mainz, Germany; [Chun, Eunyoung; Garrett, Wendy S.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Mccoy, Kathy D.] Univ Bern, Mucosal Immunol Lab, Dept Clin Res, Bern, Switzerland; [Stecher, Baerbel] Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst, German Ctr Infect Res DZIF, Munich, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79106 Freiburg, Germany	University of Freiburg; Weizmann Institute of Science; University of Freiburg; University of Freiburg; University of Cologne; University of Cologne; Technical University of Munich; Johannes Gutenberg University of Mainz; Harvard University; Harvard T.H. Chan School of Public Health; University of Bern; German Center for Infection Research; University of Munich; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Inst Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de	Wieghofer, Peter/AAV-9572-2020; McCoy, Kathy/ABD-5814-2021; Buch, Thorsten/P-1659-2019; Diefenbach, Andreas/T-2589-2018; Erny, Daniel/AAU-7015-2020; Stecher, Barbel/B-9940-2019; Stecher, Bärbel/A-2911-2015; Schwierzeck, Vera/AAL-3028-2020	Buch, Thorsten/0000-0002-2236-9074; Diefenbach, Andreas/0000-0002-9176-9530; Erny, Daniel/0000-0001-6000-8838; Stecher, Bärbel/0000-0002-7445-5193; Schwierzeck, Vera/0000-0003-4254-3700; Staszewski, Ori/0000-0002-0579-6701; Garrett, Wendy/0000-0002-5092-0150; Mahlakoiv, Tanel/0000-0001-9059-0486	BMBF; Sobek Foundation; DFG [SFB 992, FOR1336, PR 577/8-1]; Fritz-Thyssen Foundation; Gemeinnutzige Hertie Foundation (GHST);  [SPP1656];  [STE 1971/4-1]; NATIONAL CANCER INSTITUTE [R01CA154426] Funding Source: NIH RePORTER	BMBF(Federal Ministry of Education & Research (BMBF)); Sobek Foundation; DFG(German Research Foundation (DFG)); Fritz-Thyssen Foundation; Gemeinnutzige Hertie Foundation (GHST); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is dedicated to our former friend Uwe-Karsten Hanisch, past Professor for Neuroscience at the Paul-Flechsig-Institute for Brain Research, Leipzig, who devoted his whole life to the exploration of microglia function. We thank M. Oberle, M. Ditter and T. el Gaz for excellent technical assistance. We are grateful to J. Bodinek-Wersing and G. Rappl for cell sorting and to A. Spies for providing cDNA from cell cultures. M.P. was supported by the BMBF-funded competence network of multiple sclerosis (KKNMS), the Sobek Foundation, the DFG (SFB 992, FOR1336, PR 577/8-1), the Fritz-Thyssen Foundation and the Gemeinnutzige Hertie Foundation (GHST). B.S. was supported by the SPP1656 "Intestinal Microbiota" (STE 1971/4-1).	Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bindels LB, 2013, TRENDS PHARMACOL SCI, V34, P226, DOI 10.1016/j.tips.2013.02.002; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Dann A, 2012, NAT NEUROSCI, V15, P98, DOI 10.1038/nn.2964; Deshmukh HS, 2014, NAT MED, V20, P528, DOI 10.1038/nm.3542; Dorrestein PC, 2014, IMMUNITY, V40, P824, DOI 10.1016/j.immuni.2014.05.015; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fiedler K, 2013, AM J BLOOD RES, V3, P124; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Grenham S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00094; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Herz J, 2009, NAT IMMUNOL, V10, P761, DOI 10.1038/ni.1757; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kierdorf K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00044; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Markle JGM, 2013, J IMMUNOL, V190, P5392, DOI 10.4049/jimmunol.1203502; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Perez-Burgos A, 2013, AM J PHYSIOL-GASTR L, V304, pG211, DOI 10.1152/ajpgi.00128.2012; Prinz M, 1999, J NEUROPATH EXP NEUR, V58, P1078, DOI 10.1097/00005072-199910000-00006; Prinz M, 2014, ACTA NEUROPATHOL, V128, P319, DOI 10.1007/s00401-014-1267-1; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Raasch J, 2011, BRAIN, V134, P1184, DOI 10.1093/brain/awq359; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; SCHAEDLER RUSSELL W., 1962, JOUR EXPTL MED, V115, P1149, DOI 10.1084/jem.115.6.1149; Schafer DP, 2013, CURR OPIN NEUROBIOL, V23, P1034, DOI 10.1016/j.conb.2013.09.012; Schele E, 2013, ENDOCRINOLOGY, V154, P3643, DOI 10.1210/en.2012-2151; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641	60	1540	1628	36	359	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2015	18	7					965	+		10.1038/nn.4030	http://dx.doi.org/10.1038/nn.4030			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL3QU	26030851	Green Accepted			2022-12-17	WOS:000356866200012
J	Butovsky, O; Jedrychowski, MP; Moore, CS; Cialic, R; Lanser, AJ; Gabriely, G; Koeglsperger, T; Dake, B; Wu, PM; Doykan, CE; Fanek, Z; Liu, LP; Chen, ZX; Rothstein, JD; Ransohoffl, RM; Gygi, SP; Antel, JP; Weiner, HL				Butovsky, Oleg; Jedrychowski, Mark P.; Moore, Craig S.; Cialic, Ron; Lanser, Amanda J.; Gabriely, Galina; Koeglsperger, Thomas; Dake, Ben; Wu, Pauline M.; Doykan, Camille E.; Fanek, Zain; Liu, LiPing; Chen, Zhuoxun; Rothstein, Jeffrey D.; Ransohoffl, Richard M.; Gygi, Steven P.; Antel, Jack P.; Weiner, Howard L.			Identification of a unique TGF-beta dependent molecular and functional signature in microglia	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR-BETA; EPIDERMAL LANGERHANS CELLS; MYELOID CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; TISSUE MACROPHAGES; BRAIN-DEVELOPMENT; ADULT MICROGLIA; NERVOUS-SYSTEM; MOUSE-BRAIN; STEM-CELLS	Microglia are myeloid cells of the CNS that participate both in normal CNS function and in disease. We investigated the molecular signature of microglia and identified 239 genes and 8 microRNAs that were uniquely or highly expressed in microglia versus myeloid and other immune cells. Of the 239 genes, 106 were enriched in microglia as compared with astrocytes, oligodendrocytes and neurons. This microglia signature was not observed in microglial lines or in monocytes recruited to the CNS, and was also observed in human microglia. We found that TGF-beta was required for the in vitro development of microglia that express the microglial molecular signature characteristic of adult microglia and that microglia were absent in the CNS of TGF-beta 1 deficient mice. Our results identify a unique microglial signature that is dependent on TGF-beta signaling and provide insights into microglial biology and the possibility of targeting microglia for the treatment of CNS disease.	[Butovsky, Oleg; Cialic, Ron; Lanser, Amanda J.; Gabriely, Galina; Koeglsperger, Thomas; Dake, Ben; Wu, Pauline M.; Doykan, Camille E.; Fanek, Zain; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA; [Jedrychowski, Mark P.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Moore, Craig S.; Antel, Jack P.] McGill Univ, Montreal Neurol Inst, Neuroimmunol Unit, Montreal, PQ, Canada; [Liu, LiPing; Ransohoffl, Richard M.] Cleveland Clin, Dept Immunol, Cleveland, OH 44106 USA; [Chen, Zhuoxun; Rothstein, Jeffrey D.] Johns Hopkins Univ, Brain Sci Inst, Baltimore, MD USA; [Chen, Zhuoxun; Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; McGill University; Cleveland Clinic Foundation; Johns Hopkins University; Johns Hopkins University	Butovsky, O (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis,Dept Neurol, Boston, MA 02115 USA.	obutovsky@rics.bwh.harvard.edu; hweiner@rics.bwh.harvard.edu	Cialic, Ron/ABB-8565-2020; liu, li/HGC-0900-2022; Moore, Craig/I-9205-2014; Butovsky, Oleg/ABG-9086-2020	Moore, Craig/0000-0003-3333-435X; Butovsky, Oleg/0000-0003-0186-8867; Cialic, Ron/0000-0002-1589-2262; antel, jack/0000-0002-5148-0636	US National Institutes [AG027437]; US National Institutes Transformative [AG-043975]; Amyotrophic Lateral Sclerosis Association [1V78RI, ALSA 2087]; Department of Defense ALS Research Program [AL120029]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085207, R01NS088137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043975, R21AG046399, R01AG027437, R01AG054672] Funding Source: NIH RePORTER	US National Institutes; US National Institutes Transformative; Amyotrophic Lateral Sclerosis Association; Department of Defense ALS Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Julius (University of California, San Francisco) for providing polyclonal antibody to P2ry12 and N. Kassam for support in antibody generation, A. Krichevsky and A. Wong Hon-Kit (Brigham and Women's Hospital, Harvard Medical School) for providing neurons, and L. Spangler for technical assistance for oligodendrocyte isolation. We thank D. Kozoriz for the FACS sorting. This work was supported by US National Institutes grant AG027437, US National Institutes Transformative Grant AG-043975, a grant from the Amyotrophic Lateral Sclerosis Association (1V78RI, ALSA 2087), a grant from Department of Defense ALS Research Program (AL120029), a Thome Foundation AMD grant, and philanthropic support. We thank Prize4Life for providing SOD1 mice.	Abutbul S, 2012, GLIA, V60, P1160, DOI 10.1002/glia.22343; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Beutner C, 2010, NAT PROTOC, V5, P1481, DOI 10.1038/nprot.2010.90; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Brionne TC, 2003, NEURON, V40, P1133, DOI 10.1016/S0896-6273(03)00766-9; Butovsky O, 2006, J CLIN INVEST, V116, P905, DOI 10.1172/JCI26836; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Carrier Y, 2007, J IMMUNOL, V178, P172, DOI 10.4049/jimmunol.178.1.172; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; FLANDERS KC, 1991, DEVELOPMENT, V113, P183; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Hamby ME, 2010, GLIA, V58, P1282, DOI 10.1002/glia.21005; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; HenrichNoack P, 1996, STROKE, V27, P1609, DOI 10.1161/01.STR.27.9.1609; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Koeglsperger T, 2013, GLIA, V61, P985, DOI 10.1002/glia.22490; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Schilling T, 2001, EUR J NEUROSCI, V14, P463, DOI 10.1046/j.0953-816x.2001.01661.x; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; WIESSNER C, 1993, ACTA NEUROPATHOL, V86, P439; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	50	1517	1535	7	164	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					131	143		10.1038/nn.3599	http://dx.doi.org/10.1038/nn.3599			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24316888	Green Accepted, Green Submitted			2022-12-17	WOS:000329080000023
J	Pezawas, L; Meyer-Lindenberg, A; Drabant, EM; Verchinski, BA; Munoz, KE; Kolachana, BS; Egan, MF; Mattay, VS; Hariri, AR; Weinberger, DR				Pezawas, L; Meyer-Lindenberg, A; Drabant, EM; Verchinski, BA; Munoz, KE; Kolachana, BS; Egan, MF; Mattay, VS; Hariri, AR; Weinberger, DR			5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression	NATURE NEUROSCIENCE			English	Article							SEROTONIN TRANSPORTER; MAJOR DEPRESSION; FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX; PROMOTER POLYMORPHISM; AFFECTIVE-DISORDERS; ANTERIOR CINGULATE; GLUCOSE-METABOLISM; MOOD DISORDERS; HUMAN BRAIN	Carriers of the short allele of a functional 5' promoter polymorphism of the serotonin transporter gene have increased anxiety-related temperamental traits, increased amygdala reactivity and elevated risk of depression. Here, we used multimodal neuroimaging in a large sample of healthy human subjects to elucidate neural mechanisms underlying this complex genetic association. Morphometrical analyses showed reduced gray matter volume in short-allele carriers in limbic regions critical for processing of negative emotion, particularly perigenual cingulate and amygdala. Functional analysis of those regions during perceptual processing of fearful stimuli demonstrated tight coupling as a feedback circuit implicated in the extinction of negative affect. Short-allele carriers showed relative uncoupling of this circuit. Furthermore, the magnitude of coupling inversely predicted almost 30% of variation in temperamental anxiety. These genotype-related alterations in anatomy and function of an amygdala-cingulate feedback circuit critical for emotion regulation implicate a developmental, systems- level mechanism underlying normal emotional reactivity and genetic susceptibility for depression.	NIMH, Genes Cognit & Psychosis Program, NIH, Bethesda, MD 20892 USA; Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Weinberger, DR (corresponding author), NIMH, Genes Cognit & Psychosis Program, NIH, 10 Ctr Dr 4S235, Bethesda, MD 20892 USA.	weinberd@intra.nimh.nih.gov	Pezawas, Lukas/A-2367-2011; Hariri, Ahmad/D-5761-2011; Meyer-Lindenberg, Andreas/H-1076-2011	Pezawas, Lukas/0000-0002-1329-6352; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002867, ZIAMH002734, Z01MH002734, Z01MH002716, ZIAMH002716] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Drevets WC, 2002, EUR NEUROPSYCHOPHARM, V12, P527, DOI 10.1016/S0924-977X(02)00102-5; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Ghashghaei HT, 2002, NEUROSCIENCE, V115, P1261, DOI 10.1016/S0306-4522(02)00446-3; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gross C, 2004, NAT REV NEUROSCI, V5, P545, DOI 10.1038/nrn1429; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; HAYDON PG, 1984, SCIENCE, V226, P561, DOI 10.1126/science.6093252; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Keightley ML, 2003, NEUROIMAGE, V20, P2031, DOI 10.1016/j.neuroimage.2003.08.022; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; Mega MS, 1997, J NEUROPSYCH CLIN N, V9, P315; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Murphy DL, 2004, MOL INTERV, V4, P109, DOI 10.1124/mi.4.2.8; Murphy GM, 2004, ARCH GEN PSYCHIAT, V61, P1163, DOI 10.1001/archpsyc.61.11.1163; Nemeroff CB, 2002, NAT NEUROSCI, V5, P1068, DOI 10.1038/nn943; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Ramnani N, 2004, BIOL PSYCHIAT, V56, P613, DOI 10.1016/j.biopsych.2004.02.004; Reif A, 2003, BEHAV BRAIN RES, V139, P1, DOI 10.1016/S0166-4328(02)00267-X; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Schinka JA, 2004, MOL PSYCHIATR, V9, P197, DOI 10.1038/sj.mp.4001405; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Shirao N, 2005, BRIT J PSYCHIAT, V186, P48, DOI 10.1192/bjp.186.1.48; Sotres-Bayon F, 2004, LEARN MEMORY, V11, P525, DOI 10.1101/lm.79504; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Varnas K, 2004, HUM BRAIN MAPP, V22, P246, DOI 10.1002/hbm.20035; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Wu JC, 2001, NEUROPSYCHOPHARMACOL, V25, pS74, DOI 10.1016/S0893-133X(01)00336-0	50	1477	1514	2	254	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					828	834		10.1038/nn1463	http://dx.doi.org/10.1038/nn1463			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15880108				2022-12-17	WOS:000229345300025
J	O'Doherty, J; Kringelbach, ML; Rolls, ET; Hornak, J; Andrews, C				O'Doherty, J; Kringelbach, ML; Rolls, ET; Hornak, J; Andrews, C			Abstract reward and punishment representations in the human orbitofrontal cortex	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED FMRI; INFERIOR PREFRONTAL CORTEX; HEMODYNAMIC-RESPONSE; MACAQUE MONKEYS; BRAIN ACTIVITY; ACTIVATION; LESIONS; DAMAGE; CONNECTIONS; EMOTION	The orbitofrontal cortex (OFC) is implicated in emotion and emotion-related learning. Using event-related functional magnetic resonance imaging (fMRI), we measured brain activation in human subjects doing an emotion-related visual reversal-learning task in which choice of the correct stimulus led to a probabilistically determined 'monetary' reward and choice of the incorrect stimulus led to a monetary loss. Distinct areas of the OFC were activated by monetary rewards and punishments. Moreover, in these areas, we found a correlation between the magnitude of the brain activation and the magnitude of the rewards and punishments received. These findings indicate that one emotional involvement of the human orbitofrontal cortex is its representation of the magnitudes of abstract rewards and punishments, such as receiving or losing money.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; John Radcliffe Hosp, Oxford Ctr Funct Magnet Resonance Imaging, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Rolls, ET (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.		Kringelbach, Morten L/AAF-5508-2020; O'Doherty, John P/F-1204-2013; Kringelbach, Morten/AAW-5847-2021	Kringelbach, Morten/0000-0002-3908-6898; Rolls, Edmund/0000-0003-3025-1292				Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Birn RM, 1999, HUM BRAIN MAPP, V7, P106, DOI 10.1002/(SICI)1097-0193(1999)7:2<106::AID-HBM4>3.0.CO;2-O; Buckner RL, 1998, NEUROIMAGE, V7, P163, DOI 10.1006/nimg.1998.0328; Buckner RL, 1998, HUM BRAIN MAPP, V6, P373, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<373::AID-HBM8>3.3.CO;2-G; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; DAMASIO AR, 1994, DESCARTES ERROR; DAVIDSON RJ, 1992, COGNITION EMOTION, V6, P245, DOI 10.1080/02699939208411071; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Elliott R, 1997, NEUROPSYCHOLOGIA, V35, P1395, DOI 10.1016/S0028-3932(97)00055-9; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Freedman M, 1998, CEREB CORTEX, V8, P18, DOI 10.1093/cercor/8.1.18; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Konishi S, 1998, NAT NEUROSCI, V1, P80, DOI 10.1038/283; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; ROLLS ET, 1990, J NEUROPHYSIOL, V64, P1055, DOI 10.1152/jn.1990.64.4.1055; ROLLS ET, 1994, J NEUROSCI, V14, P5437; ROLLS ET, IN PRESS FRONTAL LOB; ROLLS ET, 1999, BRAIN EMOTION; Talairach J., 1988, COPLANAR STEREOTAXIC; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525	36	1455	1474	3	164	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					95	102		10.1038/82959	http://dx.doi.org/10.1038/82959			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135651				2022-12-17	WOS:000167178000020
J	Cleary, JP; Walsh, DM; Hofmeister, JJ; Shankar, GM; Kuskowski, MA; Selkoe, DJ; Ashe, KH				Cleary, JP; Walsh, DM; Hofmeister, JJ; Shankar, GM; Kuskowski, MA; Selkoe, DJ; Ashe, KH			Natural oligomers of the amyloid-protein specifically disrupt cognitive function	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; MEMORY DEFICITS; TRANSGENIC MICE; NEURONAL LOSS; MOUSE MODEL; BRAIN; PLAQUES; DEPOSITS	A central unresolved problem in research on Alzheimer disease is the nature of the molecular entity causing dementia. Here we provide the first direct experimental evidence that a defined molecular species of the amyloid-protein interferes with cognitive function. Soluble oligomeric forms of amyloid-beta, including trimers and dimers, were both necessary and sufficient to disrupt learned behavior in a manner that was rapid, potent and transient; they produced impaired cognitive function without inducing permanent neurological deficits. Although beta-amyloidosis has long been hypothesized to affect cognition, the abnormally folded protein species associated with this or any other neurodegenerative disease has not previously been isolated, defined biochemically and then specifically characterized with regard to its effects on cognitive function. The biochemical isolation of discrete amyloid-moieties with pathophysiological properties sets the stage for a new approach to studying the molecular mechanisms of cognitive impairment in Alzheimer disease and related neurodegenerative disorders.	Minneapolis Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA; Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Univ Coll Dublin, Conway Inst Biomed & Biomol Res, Lab Neurodegenerat Res, Dublin 4, Ireland; Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University College Dublin; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ashe, KH (corresponding author), Minneapolis Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA.	hsiao005@umn.edu						Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; CLEARY J, 1995, BRAIN RES, V682, P69, DOI 10.1016/0006-8993(95)00323-I; CUMMINGS BJ, 1995, LANCET, V346, P1524, DOI 10.1016/S0140-6736(95)92053-6; DELAERE P, 1990, NEUROSCI LETT, V116, P87, DOI 10.1016/0304-3940(90)90391-L; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dudai Y., 2002, MEMORY KEYWORDS CONC; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Irizarry MC, 1997, J NEUROSCI, V17, P7053; Johnson D, 1997, EDN, V42, P94; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; MCDONALD MP, 1994, BEHAV NEURAL BIOL, V62, P60, DOI 10.1016/S0163-1047(05)80059-7; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mishima K, 2000, JPN J PHARMACOL, V84, P163, DOI 10.1254/jjp.84.163; Moechars D, 1996, EMBO J, V15, P1265, DOI 10.1002/j.1460-2075.1996.tb00468.x; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; O'Hare E, 1999, BRAIN RES, V815, P1, DOI 10.1016/S0006-8993(98)01002-6; OHare E, 1996, BEHAV PHARMACOL, V7, P742; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Pederson ES, 2001, REGUL PEPTIDES, V102, P147, DOI 10.1016/S0167-0115(01)00312-3; PIKE CJ, 1991, EUR J PHARM-MOLEC PH, V207, P367, DOI 10.1016/0922-4106(91)90014-9; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Richardson RL, 2002, BRAIN RES, V954, P1, DOI 10.1016/S0006-8993(02)03006-8; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; Sweeney WA, 1997, NEUROBIOL LEARN MEM, V68, P97, DOI 10.1006/nlme.1997.3770; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Walsh Dominic M., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P277, DOI 10.2174/1568013033483311; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Weldon DT, 1996, PHARMACOL BIOCHEM BE, V54, P753, DOI 10.1016/0091-3057(96)00014-7; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002	46	1409	1499	1	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					79	84		10.1038/nn1372	http://dx.doi.org/10.1038/nn1372			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15608634				2022-12-17	WOS:000225967600019
J	Daw, ND; Niv, Y; Dayan, P				Daw, ND; Niv, Y; Dayan, P			Uncertainty-based competition between prefrontal and dorsolateral striatal systems for behavioral control	NATURE NEUROSCIENCE			English	Article							LINKING BASAL GANGLIA; REINFORCER DEVALUATION; COMPUTATIONAL MODEL; CEREBRAL-CORTEX; HABIT FORMATION; LESIONS; REWARD; DOPAMINE; MEMORY; SENSITIVITY	A broad range of neural and behavioral data suggests that the brain contains multiple systems for behavioral choice, including one associated with prefrontal cortex and another with dorsolateral striatum. However, such a surfeit of control raises an additional choice problem: how to arbitrate between the systems when they disagree. Here, we consider dual-action choice systems from a normative perspective, using the computational theory of reinforcement learning. We identify a key trade-off pitting computational simplicity against the flexible and statistically efficient use of experience. The trade-off is realized in a competition between the dorsolateral striatal and prefrontal systems. We suggest a Bayesian principle of arbitration between them according to uncertainty, so each controller is deployed when it should be most accurate. This provides a unifying account of a wealth of experimental evidence about the factors favoring dominance by either system.	UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel	University of London; University College London; Hebrew University of Jerusalem	Daw, ND (corresponding author), UCL, Gatsby Computat Neurosci Unit, Alexandra House,17 Queen Sq, London WC1N 3AR, England.	daw@gatsby.ucl.ac.uk		Dayan, Peter/0000-0003-3476-1839				ADAMS CD, 1982, Q J EXP PSYCHOL-B, V34, P77, DOI 10.1080/14640748208400878; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BALLEINE BW, 1995, J EXP PSYCHOL ANIM B, V21, P203, DOI 10.1037/0097-7403.21.3.203; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Balleine BW, 2000, J NEUROSCI, V20, P8954; Baum EB, 1997, ARTIF INTELL, V97, P195, DOI 10.1016/S0004-3702(97)00059-3; Blundell P, 2003, J NEUROSCI, V23, P7702; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Chavarriaga R, 2005, NEUROINFORMATICS, V3, P223, DOI 10.1385/NI:3:3:223; COLWILL RM, 1985, J EXP PSYCHOL ANIM B, V11, P520, DOI 10.1037/0097-7403.11.4.520; Coutureau E, 2003, BEHAV BRAIN RES, V146, P167, DOI 10.1016/j.bbr.2003.09.025; DAW ND, 2003, ADV NEURAL INFORM PR, V15, P99; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dearden R, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P761; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Dickinson A., 2002, STEVENS HDB EXPT PSY, V3, P497, DOI DOI 10.1002/0471214426.PAS0312; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Hartley T, 2005, TRENDS NEUROSCI, V28, P169, DOI 10.1016/j.tins.2005.02.004; Holland P, 1998, NEUROPHARMACOLOGY, V37, P461, DOI 10.1016/S0028-3908(98)00038-0; Holland PC, 2004, J EXP PSYCHOL-ANIM B, V30, P104, DOI 10.1037/0097-7403.30.2.104; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Houk JC, 1995, MODELS INFORM PROCES, P249; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kahneman Daniel., 2011, THINKING FAST SLOW, DOI DOI 10.1017/CBO9780511808098.004; Killcross A.S., 2002, EMOTIONAL COGNITION, P35; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Lieberman M.D., 2003, SOCIAL JUDGMENTS IMP, P44; LOEWENSTEIN G, 2004, 0414 CORN U CTR AN E; MANNOR S, 2004, P 21 INT C MACH LEAR, P568; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Nakahara H, 2001, J COGNITIVE NEUROSCI, V13, P626, DOI 10.1162/089892901750363208; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Owen AM, 1997, PROG NEUROBIOL, V53, P431, DOI 10.1016/S0301-0082(97)00042-7; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Parkinson JA, 2005, Q J EXP PSYCHOL-B, V58, P19, DOI 10.1080/02724990444000023; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Smith AJ, 2005, NEURAL COMPUT, V17, P361, DOI 10.1162/0899766053011546; Suri RE, 2001, EXP BRAIN RES, V140, P234, DOI 10.1007/s002210100814; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	1407	1422	1	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1704	1711		10.1038/nn1560	http://dx.doi.org/10.1038/nn1560			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988FC	16286932				2022-12-17	WOS:000233576200019
J	Benilova, I; Karran, E; De Strooper, B				Benilova, Iryna; Karran, Eric; De Strooper, Bart			The toxic A beta oligomer and Alzheimer's disease: an emperor in need of clothes	NATURE NEUROSCIENCE			English	Review							LONG-TERM POTENTIATION; SOLUBLE AMYLOID OLIGOMERS; SYNAPTIC PLASTICITY; PROTEIN OLIGOMERS; IN-VITRO; TAU-HYPERPHOSPHORYLATION; ANTIBODIES RECOGNIZE; MONOCLONAL-ANTIBODY; SECRETED OLIGOMERS; DIFFUSIBLE LIGANDS	The 'toxic A beta oligomer' hypothesis has attracted considerable attention among Alzheimer's disease researchers as a way of resolving the lack of correlation between deposited amyloid-beta (A beta) in amyloid plaques-in terms of both amount and location- and cognitive impairment or neurodegeneration. However, the lack of a common, agreed-upon experimental description of the toxic A beta oligomer makes interpretation and direct comparison of data between different research groups impossible. Here we critically review the evidence supporting toxic A beta oligomers as drivers of neurodegeneration and make some suggestions that might facilitate progress in this complex field.	[Benilova, Iryna; Karran, Eric; De Strooper, Bart] Katholieke Univ Leuven, Ctr Human Genet, Leuven Inst Neurodegenerat Dis LIND, Louvain, Belgium; [Benilova, Iryna; De Strooper, Bart] VIB Ctr Biol Dis, Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB)	De Strooper, B (corresponding author), Katholieke Univ Leuven, Ctr Human Genet, Leuven Inst Neurodegenerat Dis LIND, Louvain, Belgium.	bart.destrooper@cme.vib-kuleuven.be	Benilova, Iryna/H-6533-2019; de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819	European Research Council (ERC); Fund for Scientific Research, Flanders; University of Leuven; VIB; Flemish government; Foundation for Alzheimer Research (SAO/FRMA); Interuniversity Attraction Poles Program	European Research Council (ERC)(European Research Council (ERC)European Commission); Fund for Scientific Research, Flanders(FWO); University of Leuven(KU Leuven); VIB; Flemish government(European Commission); Foundation for Alzheimer Research (SAO/FRMA); Interuniversity Attraction Poles Program(Belgian Federal Science Policy Office)	The authors acknowledge funding from the European Research Council (ERC); the Fund for Scientific Research, Flanders; the University of Leuven; the VIB; the Methusalem grant from the University of Leuven and the Flemish government; the Foundation for Alzheimer Research (SAO/FRMA); and the Interuniversity Attraction Poles Program. B. D. S. is the Arthur Bax and Anna Vanluffelen Chair for Alzheimer's Disease at the University of Leuven. The authors acknowledge T. Golde, D. Teplow, T. Hard and D. Walsh for fruitful discussions and/or sharing their amyloid-beta preparations.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; [Anonymous], 2011, NAT NEUROSCI, V14, P399; BAKER HF, 1994, MOL NEUROBIOL, V8, P25, DOI 10.1007/BF02778005; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Baumketner A, 2006, PROTEIN SCI, V15, P420, DOI 10.1110/ps.051762406; Bezprozvanny I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263pe16; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/nchembio.283, 10.1038/NCHEMBIO.283]; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Galeazzi L, 1999, AMYLOID, V6, P7, DOI 10.3109/13506129908993282; Gardberg AS, 2007, P NATL ACAD SCI USA, V104, P15659, DOI 10.1073/pnas.0705888104; Giuffrida ML, 2010, REV NEUROSCIENCE, V21, P83; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hillen H, 2010, J NEUROSCI, V30, P10369, DOI 10.1523/JNEUROSCI.5721-09.2010; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lafaye P, 2009, MOL IMMUNOL, V46, P695, DOI 10.1016/j.molimm.2008.09.008; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lasagna-Reeves C.A., 2011, J BIOL CHEM; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/NCHEMBIO.624, 10.1038/nchembio.624]; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Liu C, 2011, J AM CHEM SOC, V133, P6736, DOI 10.1021/ja200222n; Lord A, 2009, NEUROBIOL DIS, V36, P425, DOI 10.1016/j.nbd.2009.08.007; Matsumura S, 2011, J BIOL CHEM; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Meli G, 2009, J MOL BIOL, V387, P584, DOI 10.1016/j.jmb.2009.01.061; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2011, MOL PSYCHIAT; Moretto N, 2007, J BIOL CHEM, V282, P11436, DOI 10.1074/jbc.M609690200; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; O'Nuallain B, 2011, J NEUROCHEM, V119, P189, DOI 10.1111/j.1471-4159.2011.07389.x; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Portelius E, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-2; Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Schupf N, 2008, P NATL ACAD SCI USA, V105, P14052, DOI 10.1073/pnas.0805902105; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Shughrue PJ, 2010, NEUROBIOL AGING, V31, P189, DOI 10.1016/j.neurobiolaging.2008.04.003; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Soucek T, 2003, NEURON, V39, P43, DOI 10.1016/S0896-6273(03)00367-2; Thathiah A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293re8; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; van Helmond Z, 2009, J NEUROSCI METH, V176, P206, DOI 10.1016/j.jneumeth.2008.09.002; Villemagne VL, 2010, J NEUROSCI, V30, P6315, DOI 10.1523/JNEUROSCI.5180-09.2010; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang XL, 2010, NEURODEGENER DIS, V7, P56, DOI 10.1159/000283484; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Yamin G, 2009, J NEUROSCI RES, V87, P1729, DOI 10.1002/jnr.21998; Zameer A, 2008, J MOL BIOL, V384, P917, DOI 10.1016/j.jmb.2008.09.068; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010	100	1405	1459	10	516	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					349	357		10.1038/nn.3028	http://dx.doi.org/10.1038/nn.3028			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22286176				2022-12-17	WOS:000300793100006
J	Damasio, AR; Grabowski, TJ; Bechara, A; Damasio, H; Ponto, LLB; Parvizi, J; Hichwa, RD				Damasio, AR; Grabowski, TJ; Bechara, A; Damasio, H; Ponto, LLB; Parvizi, J; Hichwa, RD			Subcortical and cortical brain activity during the feeling of self-generated emotions	NATURE NEUROSCIENCE			English	Article							HUMAN AMYGDALA; FUNCTIONAL NEUROANATOMY; PET; ACTIVATION; REGISTRATION; RECOGNITION; DEPRESSION; HAPPINESS; SADNESS; ANXIETY	In a series of [O-15]PET experiments aimed at investigating the neural basis of emotion and feeling, 41 normal subjects recalled and re-experienced personal life episodes marked by sadness, happiness, anger or fear. We tested the hypothesis that the process of feeling emotions requires the participation of brain regions, such as the somatosensory cortices and the upper brainstem nuclei, that are involved in the mapping and/or regulation of internal organism states. Such areas were indeed engaged, underscoring the close relationship between emotion and homeostasis. The findings also lend support to the idea that the subjective process of feeling emotions is partly grounded in dynamic neural maps, which represent several aspects of the organism's continuously changing internal state.	Univ Iowa, Coll Med, Dept Neurol, Div Cognit Nauroscu, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, PET Imaging Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Damasio, AR (corresponding author), Univ Iowa, Coll Med, Dept Neurol, Div Cognit Nauroscu, 200 Hawkins Dr, Iowa City, IA 52242 USA.	antonio-damasio@uiowa.edu	Damasio, Antonio/AAD-1342-2019; anand, amit/A-7222-2009	Ponto, Laura/0000-0003-1197-6714	NIDCD NIH HHS [1 P50 DC 03189-01A1] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P50DC003189] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adolphs R, 1996, J NEUROSCI, V16, P7678; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Bejjani BP, 1999, NEW ENGL J MED, V340, P1476, DOI 10.1056/NEJM199905133401905; Bernard JF, 1998, J COMP NEUROL, V401, P429; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A.R., 1999, FEELING WHAT HAPPENS; Damasio AR, 1997, NATURE, V386, P769, DOI 10.1038/386769a0; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Dolan RJ, 1998, BRAIN, V121, P545, DOI 10.1093/brain/121.4.545; Dougherty DD, 1999, BIOL PSYCHIAT, V46, P466, DOI 10.1016/S0006-3223(99)00063-3; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Friston KJ, 1996, HUM BRAIN MAPP, V4, P140, DOI 10.1002/(SICI)1097-0193(1996)4:2<140::AID-HBM5>3.0.CO;2-3; Gemar M C, 1996, Depression, V4, P81, DOI 10.1002/(SICI)1522-7162(1996)4:2<81::AID-DEPR8>3.0.CO;2-I; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Grabowski TJ, 1996, HUM BRAIN MAPP, V4, P23, DOI 10.1002/(SICI)1097-0193(1996)4:1<23::AID-HBM2>3.0.CO;2-R; HICHWA RD, 1995, CHEMISTS' VIEWS OF IMAGING CENTERS, P401; Kimbrell TA, 1999, BIOL PSYCHIAT, V46, P454, DOI 10.1016/S0006-3223(99)00103-1; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Lane RD, 1997, AM J PSYCHIAT, V154, P926; LeDoux J., 1998, EMOTIONAL BRAIN MYST; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Panksepp J, 1997, ANN NY ACAD SCI, V807, P78, DOI 10.1111/j.1749-6632.1997.tb51914.x; Panksepp J, 2004, AFFECTIVE NEUROSCIEN; PARDO JV, 1993, AM J PSYCHIAT, V150, P713; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Whalen PJ, 1998, J NEUROSCI, V18, P411; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Woods RP, 1999, HUM BRAIN MAPP, V8, P73, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<73::AID-HBM1>3.0.CO;2-7; WORSLEY KJ, 1994, ADV APPL PROBAB, V26, P13, DOI 10.2307/1427576	39	1395	1427	1	184	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					1049	1056		10.1038/79871	http://dx.doi.org/10.1038/79871			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017179				2022-12-17	WOS:000167177500024
J	Bechara, A				Bechara, A			Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective	NATURE NEUROSCIENCE			English	Article							COCAINE-DEPENDENT PATIENTS; PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; PERFORMANCE; ABUSERS; BRAIN; ADDICTION; INDIVIDUALS; INHIBITION; DEFICITS	Here I argue that addicted people become unable to make drug-use choices on the basis of long-term outcome, and I propose a neural framework that explains this myopia for future consequences. I suggest that addiction is the product of an imbalance between two separate, but interacting, neural systems that control decision making: an impulsive, amygdala system for signaling pain or pleasure of immediate prospects, and a reflective, prefrontal cortex system for signaling pain or pleasure of future prospects. After an individual learns social rules, the reflective system controls the impulsive system via several mechanisms. However, this control is not absolute; hyperactivity within the impulsive system can override the reflective system. I propose that drugs can trigger bottom-up, involuntary signals originating from the amygdala that modulate, bias or even hijack the goal-driven cognitive resources that are needed for the normal operation of the reflective system and for exercising the willpower to resist drugs.	Univ So Calif, Dept Psychol, Inst Neurol Study Emot & Creat, Los Angeles, CA 90089 USA	University of Southern California	Bechara, A (corresponding author), Univ So Calif, Dept Psychol, Inst Neurol Study Emot & Creat, Los Angeles, CA 90089 USA.	bechara@usc.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011779, R21DA016708, R01DA012487] Funding Source: NIH RePORTER; NIDA NIH HHS [DA12487, DA16708, DA11779] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bartzokis G, 1999, AM J NEURORADIOL, V20, P1628; Bechara A, 2004, NEUROPSYCHOLOGY, V18, P152, DOI 10.1037/0894-4105.18.1.152; Bechara A, 2001, Semin Clin Neuropsychiatry, V6, P205, DOI 10.1053/scnp.2001.22927; Bechara A, 2004, INT REV NEUROBIOL, V62, P159, DOI 10.1016/S0074-7742(04)62006-X; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Crone EA, 2004, DEV PSYCHOL, V40, P1228, DOI 10.1037/0012-1649.40.6.1228; Damasio A.R., 1994, DESCARTES ERROR EMOT; de Arcos FA, 2005, DRUG ALCOHOL DEPEN, V78, P159, DOI 10.1016/j.drugalcdep.2004.10.010; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; ESLINGER PJ, 1999, ATTENTION MEMORY EXE, P420; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Fishbein D, 2005, EXP CLIN PSYCHOPHARM, V13, P25, DOI 10.1037/1064-1297.13.1.25; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Garavan H, 2005, TRENDS COGN SCI, V9, P195, DOI 10.1016/j.tics.2005.02.008; Goldman D, 1998, ARCH GEN PSYCHIAT, V55, P964, DOI 10.1001/archpsyc.55.11.964; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lim KO, 2002, BIOL PSYCHIAT, V51, P890, DOI 10.1016/S0006-3223(01)01355-5; London ED, 2000, CEREB CORTEX, V10, P334, DOI 10.1093/cercor/10.3.334; Martin EM, 2003, BIOL PSYCHIAT, V53, p97S; Martin EM, 2003, NEUROPSYCHOLOGY, V17, P283, DOI 10.1037/0894-4105.17.2.283; Matochik JA, 2003, NEUROIMAGE, V19, P1095, DOI 10.1016/S1053-8119(03)00244-1; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Monterosso J, 2001, ADDICTION, V96, P1825, DOI 10.1046/j.1360-0443.2001.9612182512.x; Nader K, 1997, ANNU REV PSYCHOL, V48, P85, DOI 10.1146/annurev.psych.48.1.85; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Noel X, 2005, ADDICTION, V100, P1302, DOI 10.1111/j.1360-0443.2005.01125.x; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Overman WH, 2004, NEUROPSYCHOLOGIA, V42, P1838, DOI 10.1016/j.neuropsychologia.2004.03.014; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Rahman S, 2001, TRENDS COGN SCI, V5, P271, DOI 10.1016/S1364-6613(00)01650-8; Ricaurte George A., 2003, Science (Washington D C), V301, P1479; Rogers RD, 2004, PSYCHOPHARMACOLOGY, V172, P157, DOI 10.1007/s00213-003-1641-5; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	49	1388	1430	4	252	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1458	1463		10.1038/nn1584	http://dx.doi.org/10.1038/nn1584			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16251988				2022-12-17	WOS:000232966600016
J	Corbetta, M; Kincade, JM; Ollinger, JM; McAvoy, MP; Shulman, GL				Corbetta, M; Kincade, JM; Ollinger, JM; McAvoy, MP; Shulman, GL			Voluntary orienting is dissociated from target detection in human posterior parietal cortex	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; SELECTIVE VISUAL-ATTENTION; HUMAN WORKING-MEMORY; VISUOSPATIAL ATTENTION; UNILATERAL NEGLECT; BRAIN ACTIVATION; SYSTEM; FMRI; DISENGAGEMENT; LOCALIZATION	Human ability to attend to visual stimuli based on their spatial locations requires the parietal cortex. One hypothesis maintains that parietal cortex controls the voluntary orienting of attention toward a location of interest. Another hypothesis emphasizes its role in reorienting attention toward visual targets appearing at unattended locations. Here, using event-related functional magnetic resonance (ER-fMRI), we show that distinct parietal regions mediated these different attentional processes. Cortical activation occurred primarily in the intraparietal sulcus when a location was attended before visual-target presentation, but in the right temporoparietal junction when the target was detected, particularly at an unattended location.	Washington Univ, Sch Med, Dept Neurol & Neurol Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Sch Med, Dept Neurol & Neurol Surg, 4525 Scott Ave, St Louis, MO 63110 USA.		Corbetta, Maurizio/AAZ-5219-2020	CORBETTA, MAURIZIO/0000-0001-8295-3304	NEI NIH HHS [EY12148, EY00379] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012148] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANTONUCCI G, 1995, J CLIN EXP NEUROPSYC, V17, P383, DOI 10.1080/01688639508405131; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; COLBY CL, 1988, J COMP NEUROL, V238, P1257; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DIPELLEGRINO G, 1995, NEUROPSYCHOLOGIA, V33, P353, DOI 10.1016/0028-3932(94)00106-Y; Dupont P, 1997, CEREB CORTEX, V7, P283, DOI 10.1093/cercor/7.3.283; FOOTE SL, 1987, ANNU REV NEUROSCI, V10, P67, DOI 10.1146/annurev.ne.10.030187.000435; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Gitelman DR, 1996, ANN NEUROL, V39, P174, DOI 10.1002/ana.410390206; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HALLIGAN PW, 1994, COGNITIVE NEUROPSYCH, V11, P167, DOI 10.1080/02643299408251973; Heilman K.M., 1985, INT J CLIN NEUROPSYC, V2nd, P243; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Knight RT, 1998, J CLIN NEUROPHYSIOL, V15, P3, DOI 10.1097/00004691-199801000-00003; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Mendola JD, 1999, J NEUROSCI, V19, P8560; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; MORROW LA, 1988, PSYCHOBIOLOGY, V16, P261; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Parasuraman R, 1998, ATTENTIVE BRAIN, P221; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, J NEUROSCI, V4, P1863; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Shulman GL, 1999, J NEUROSCI, V19, P9480; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Vandenberghe R, 1996, BRAIN, V119, P1263, DOI 10.1093/brain/119.4.1263; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WEINBERG J, 1977, ARCH PHYS MED REHAB, V58, P479; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	46	1388	1421	9	109	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					292	297		10.1038/73009	http://dx.doi.org/10.1038/73009			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700263				2022-12-17	WOS:000085810500020
J	Hopfinger, JB; Buonocore, MH; Mangun, GR				Hopfinger, JB; Buonocore, MH; Mangun, GR			The neural mechanisms of top-down attentional control	NATURE NEUROSCIENCE			English	Article							SPATIAL SELECTIVE ATTENTION; WORKING-MEMORY; FUNCTIONAL MRI; VISUAL-CORTEX; RETINOTOPIC ORGANIZATION; VISUOSPATIAL ATTENTION; DIRECTING ATTENTION; PARIETAL CORTEX; AREAS; PET	Selective visual attention involves dynamic interplay between attentional control systems and sensory brain structures. We used event-related functional magnetic resonance imaging (fMRI) during a cued spatial-attention task to dissociate brain activity related to attentional control from that related to selective processing of target stimuli. Distinct networks were engaged by attention-directing cues versus subsequent targets. Superior frontal, inferior parietal and superior temporal cortex were selectively activated by cues, indicating that these structures are part of a network for voluntary attentional control. This control biased activity in multiple visual cortical areas, resulting in selective sensory processing of relevant visual targets.	Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; Univ Calif Davis, Med Ctr, Dept Radiol, Sacramento, CA 95817 USA	Duke University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Mangun, GR (corresponding author), Duke Univ, Ctr Cognit Neurosci, LSRC Bldg,Rm B203, Durham, NC 27708 USA.		Li, Chong/F-4265-2015		NIMH NIH HHS [MH55714, MH57138] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057138, R56MH055714, R01MH055714] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BUCKNER RL, 1996, P NATL ACAD SCI USA, V93, P14302; Buonocore MH, 1997, MAGNET RESON MED, V38, P89, DOI 10.1002/mrm.1910380114; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 1998, ATTENTIVE BRAIN, P95; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, J NEUROSCI, V18, P7426; D'Esposito M, 1998, NEUROIMAGE, V8, P274, DOI 10.1006/nimg.1998.0364; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Harter M R, 1989, J Cogn Neurosci, V1, P223, DOI 10.1162/jocn.1989.1.3.223; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; HENIK A, 1994, J COGNITIVE NEUROSCI, V6, P400, DOI 10.1162/jocn.1994.6.4.400; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KOJIMA S, 1982, BRAIN RES, V248, P43, DOI 10.1016/0006-8993(82)91145-3; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; Mangun GR, 1998, HUM BRAIN MAPP, V6, P383, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<383::AID-HBM10>3.3.CO;2-Q; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Pashler HE., 1998, PSYCHOL ATTENTION, DOI [10.7551/mitpress/5677.001.0001, DOI 10.7551/MITPRESS/5677.001.0001]; Petit L, 1999, HUM BRAIN MAPP, V8, P28, DOI 10.1002/(SICI)1097-0193(1999)8:1<28::AID-HBM3>3.0.CO;2-T; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI, 1998, ATTENTIVE BRAIN, P401; Rosen AC, 1999, J COGNITIVE NEUROSCI, V11, P135, DOI 10.1162/089892999563283; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; VANVOORHIS S, 1977, PERCEPT PSYCHOPHYS, V22, P54, DOI 10.3758/BF03206080; WATSON RT, 1994, ARCH NEUROL-CHICAGO, V51, P1014, DOI 10.1001/archneur.1994.00540220060015; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I	50	1369	1394	5	171	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					284	291		10.1038/72999	http://dx.doi.org/10.1038/72999			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	292TE	10700262				2022-12-17	WOS:000085810500019
J	Abbott, LF; Nelson, SB				Abbott, L. F.; Nelson, Sacha B.			Synaptic plasticity: taming the beast	NATURE NEUROSCIENCE			English	Review								Synaptic plasticity provides the basis for most models of learning, memory and development in neural circuits. To generate realistic results, synapse-specific Hebbian forms of plasticity, such as long-term potentiation and depression, must be augmented by global processes that regulate overall levels of neuronal and network activity. Regulatory processes are often as important as the more intensively studied Hebbian processes in determining the consequences of synaptic plasticity for network function. Recent experimental results suggest several novel mechanisms for regulating levels of activity in conjunction with Hebbian synaptic modification. We review three of them-synaptic scaling, spike-timing dependent plasticity and synaptic redistribution-and discuss their functional implications.	[Abbott, L. F.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Abbott, LF (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	abbott@brandeis.edu		Nelson, Sacha/0000-0002-0108-8599	Sloan Center for Theoretical Neurobiology at Brandeis University; W.M. Keck Foundation;  [NIH-MH58754];  [NIH-EY11116]; NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058754] Funding Source: NIH RePORTER	Sloan Center for Theoretical Neurobiology at Brandeis University; W.M. Keck Foundation(W.M. Keck Foundation); ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research supported by NIH-MH58754, NIH-EY11116, the Sloan Center for Theoretical Neurobiology at Brandeis University and the W.M. Keck Foundation. We thank Gina Turrigiano, Eve Marder and Jesper Sjostrom for comments.	Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Artun OB, 1998, P NATL ACAD SCI USA, V95, P11999, DOI 10.1073/pnas.95.20.11999; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Buonomano DV, 1999, J NEUROSCI, V19, P6748, DOI 10.1523/JNEUROSCI.19-16-06748.1999; Chance FS, 1998, J NEUROSCI, V18, P4785; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; GROSSBERG S, 1984, BRAIN INFORMATION EV, P58; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Liaw JS, 1996, HIPPOCAMPUS, V6, P591; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; Minai A. A., 1993, INNS WORLD C NEUR NE, P505; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; ODonovan MJ, 1997, TRENDS NEUROSCI, V20, P431, DOI 10.1016/S0166-2236(97)01124-7; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Rao RPN, 2000, ADV NEUR IN, V12, P164; Roberts PD, 1999, J COMPUT NEUROSCI, V7, P235, DOI 10.1023/A:1008910918445; RUBIN J, PHYS REV LE IN PRESS; Selig DK, 1999, J NEUROSCI, V19, P1236; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sourdet V, 1999, LEARN MEMORY, V6, P422, DOI 10.1101/lm.6.5.422; THOMSON AM, 1994, TRENDS NEUROSCI, V17, P119, DOI 10.1016/0166-2236(94)90121-X; Tsodyks M, 2000, J NEUROSCI, V20; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Turrigiano GG, 1998, NEURON, V21, P933, DOI 10.1016/S0896-6273(00)80607-8; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; VANROSSUM MC, J NEUROSCI IN PRESS; Volgushev M, 1997, EUR J NEUROSCI, V9, P1656, DOI 10.1111/j.1460-9568.1997.tb01523.x; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	50	1356	1402	13	235	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11		S			1178	1183		10.1038/81453	http://dx.doi.org/10.1038/81453			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V18OV	11127835				2022-12-17	WOS:000208015000011
J	Nestler, EJ; Hyman, SE				Nestler, Eric J.; Hyman, Steven E.			Animal models of neuropsychiatric disorders	NATURE NEUROSCIENCE			English	Review							CATECHOL-O-METHYLTRANSFERASE; MOUSE MODELS; LITHIUM ACTION; PSYCHIATRIC-DISORDERS; MENTAL-DISORDERS; DRUG DISCOVERY; SCHIZOPHRENIA; BRAIN; MICE; NEUROBIOLOGY	Modeling of human neuropsychiatric disorders in animals is extremely challenging given the subjective nature of many symptoms, the lack of biomarkers and objective diagnostic tests, and the early state of the relevant neurobiology and genetics. Nonetheless, progress in understanding pathophysiology and in treatment development would benefit greatly from improved animal models. Here we review the current state of animal models of mental illness, with a focus on schizophrenia, depression and bipolar disorder. We argue for areas of focus that might increase the likelihood of creating more useful models, at least for some disorders, and for explicit guidelines when animal models are reported.	[Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA; [Hyman, Steven E.] Harvard Univ, Off Provost, Cambridge, MA 02138 USA	Icahn School of Medicine at Mount Sinai; Harvard University	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA.	eric.nestler@mssm.edu	Yan, Shuo/B-8381-2009		NIDA NIH HHS [R01 DA014133] Funding Source: Medline; NIMH NIH HHS [P50 MH090963, P50 MH066172, R01 MH051399] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963, P50MH066172, R01MH051399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014133] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; [Anonymous], 2000, DIAGNOSTIC STAT MANU, V4th; Arguello PA, 2010, DIS MODEL MECH, V3, P22, DOI 10.1242/dmm.003996; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Belmaker RH, 2007, NEUROSCI BIOBEHAV R, V31, P843, DOI 10.1016/j.neubiorev.2007.05.001; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Brandon NJ, 2009, J NEUROSCI, V29, P12768, DOI 10.1523/JNEUROSCI.3355-09.2009; Buxbaum Joseph D, 2009, Dialogues Clin Neurosci, V11, P35; Cannon TD, 2002, P NATL ACAD SCI USA, V99, P3228, DOI 10.1073/pnas.052023499; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Carlezon WA, 2007, NAT PROTOC, V2, P2987, DOI 10.1038/nprot.2007.441; Chadman KK, 2009, AM J MED GENET B, V150B, P1, DOI 10.1002/ajmg.b.30777; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chuang JC, 2010, BIOL PSYCHIAT, V67, P1075, DOI 10.1016/j.biopsych.2009.12.003; Craddock N, 2009, TRENDS GENET, V25, P99, DOI 10.1016/j.tig.2008.12.002; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Diaz-Asper CM, 2008, BIOL PSYCHIAT, V63, P72, DOI 10.1016/j.biopsych.2007.03.031; Einat H, 2006, BIOL PSYCHIAT, V59, P1160, DOI 10.1016/j.biopsych.2005.11.004; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Gourley SL, 2008, BIOL PSYCHIAT, V64, P884, DOI 10.1016/j.biopsych.2008.06.016; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Hyman SE, 2008, NATURE, V455, P890, DOI 10.1038/nature07454; Hyman SE, 2010, ANNU REV CLIN PSYCHO, V6, P155, DOI 10.1146/annurev.clinpsy.3.022806.091532; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Kegeles LS, 2010, ARCH GEN PSYCHIAT, V67, P231, DOI 10.1001/archgenpsychiatry.2010.10; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Maier SF, 2005, NEUROSCI BIOBEHAV R, V29, P829, DOI 10.1016/j.neubiorev.2005.03.021; Malkesman O, 2009, DIS MODEL MECH, V2, P238, DOI 10.1242/dmm.001628; Markou A, 2005, NEUROSCI BIOBEHAV R, V29, P501, DOI 10.1016/j.neubiorev.2005.03.004; Markou A, 2009, NEUROPSYCHOPHARMACOL, V34, P74, DOI 10.1038/npp.2008.173; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Morrissette DA, 2009, J BIOL CHEM, V284, P6033, DOI 10.1074/jbc.R800030200; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Moy SS, 2008, MOL PSYCHIATR, V13, P4, DOI 10.1038/sj.mp.4002082; Muller MB, 2006, BIOL PSYCHIAT, V59, P1104, DOI 10.1016/j.biopsych.2006.02.008; Nestler E.J., 2009, MOL NEUROPHARMACOLOG, V2nd; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI 10.1038/sj.mp.4002144; Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shaldubina A, 2001, PROG NEURO-PSYCHOPH, V25, P855, DOI 10.1016/S0278-5846(01)00154-3; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Simpson EH, 2010, NEURON, V65, P585, DOI 10.1016/j.neuron.2010.02.014; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tamminga CA, 2006, J CLIN PSYCHIAT, V67, P9; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; World Health Organization, 2001, WORLD HLTH REPORT 20	71	1323	1358	1	318	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1161	1169		10.1038/nn.2647	http://dx.doi.org/10.1038/nn.2647			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	654MB	20877280	Green Accepted			2022-12-17	WOS:000282171300007
J	Tsankova, NM; Berton, O; Renthal, W; Kumar, A; Neve, RL; Nestler, EJ				Tsankova, NM; Berton, O; Renthal, W; Kumar, A; Neve, RL; Nestler, EJ			Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC-FACTOR; HISTONE ACETYLATION; SOCIAL STRESS; LONG-TERM; RAT HIPPOCAMPUS; GENE-EXPRESSION; MESSENGER-RNA; BRAIN; BDNF; MEMORY	To better understand the molecular mechanisms of depression and antidepressant action, we administered chronic social defeat stress followed by chronic imipramine (a tricyclic antidepressant) to mice and studied adaptations at the levels of gene expression and chromatin remodeling of five brain-derived neurotrophic factor (Bdnf) splice variant mRNAs (I-V) and their unique promoters in the hippocampus. Defeat stress induced lasting downregulation of Bdnf transcripts III and IV and robustly increased repressive histone methylation at their corresponding promoters. Chronic imipramine reversed this downregulation and increased histone acetylation at these promoters. This hyperacetylation by chronic imipramine was associated with a selective downregulation of histone deacetylase (Hdac) 5. Furthermore, viral-mediated HDAC5 overexpression in the hippocampus blocked imipramine's ability to reverse depression-like behavior. These experiments underscore an important role for histone remodeling in the pathophysiology and treatment of depression and highlight the therapeutic potential for histone methylation and deacetylation inhibitors in depression.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Belmont, MA 02178 USA; McLean Hosp 202 MRC, Dept Psychiat, Belmont, MA 02178 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard University; McLean Hospital	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu	Winwood, Peter/A-6363-2008; Yan, Shuo/B-8381-2009; Kumar, Arvind/B-6094-2009	Renthal, William/0000-0003-0206-2101; Kumar, Arvind/0000-0003-2879-3826				Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Buwalda B, 2005, NEUROSCI BIOBEHAV R, V29, P83, DOI 10.1016/j.neubiorev.2004.05.005; Chen J, 2001, LAB INVEST, V81, P913, DOI 10.1038/labinvest.3780300; Clark MS, 2002, J NEUROSCI, V22, P4550, DOI 10.1523/JNEUROSCI.22-11-04550.2002; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Dennis KE, 2005, MOL BRAIN RES, V140, P1, DOI 10.1016/j.molbrainres.2005.06.014; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fuchs E, 2003, PHYSIOL BEHAV, V79, P417, DOI 10.1016/S0031-9384(03)00161-6; Fuchs E, 2002, PHARMACOL BIOCHEM BE, V73, P247, DOI 10.1016/S0091-3057(02)00795-5; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hoshino M, 2003, J NEUROCHEM, V87, P257, DOI 10.1046/j.1471-4159.2003.01991.x; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Huang YF, 2002, J NEUROSCI, V22, P8422; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Koolhaas JM, 1997, ACTA PHYSIOL SCAND, V161, P69; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; McEwen BS, 2002, EUR PSYCHIAT, V17, p318S; Miczek KA, 2004, NEUROSCI BIOBEHAV R, V27, P787, DOI 10.1016/j.neubiorev.2003.11.005; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Newton SS, 2003, J NEUROSCI, V23, P10841; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Pizarro JM, 2004, BRAIN RES, V1025, P10, DOI 10.1016/j.brainres.2004.06.085; Russo-Neustadt A, 1999, NEUROPSYCHOPHARMACOL, V21, P679, DOI 10.1016/S0893-133X(99)00059-7; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Tapia-Arancibia L, 2004, FRONT NEUROENDOCRIN, V25, P77, DOI 10.1016/j.yfrne.2004.04.001; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yeh SH, 2004, MOL PHARMACOL, V65, P1286, DOI 10.1124/mol.65.5.1286	50	1296	1369	0	185	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					519	525		10.1038/nn1659	http://dx.doi.org/10.1038/nn1659			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16501568				2022-12-17	WOS:000236310700019
J	Wolpert, DM; Ghahramani, Z				Wolpert, Daniel M.; Ghahramani, Zoubin			Computational principles of movement neuroscience	NATURE NEUROSCIENCE			English	Review							PARIETAL CORTEX; REACHING MOVEMENTS; INTERNAL-MODELS; ARM MOVEMENTS; MOTOR; REPRESENTATION; DYNAMICS; COORDINATION; CEREBELLUM; PERCEPTION	Unifying principles of movement have emerged from the computational study of motor control. We review several of these principles and show how they apply to processes such as motor planning, control, estimation, prediction and learning. Our goal is to demonstrate how specific models emerging from the computational approach provide a theoretical framework for movement neuroscience.	[Wolpert, Daniel M.] UCL, Sobell Dept Neurophysiol, Inst Neurol, London WC1N 3BG, England; [Ghahramani, Zoubin] UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Wolpert, DM (corresponding author), UCL, Sobell Dept Neurophysiol, Inst Neurol, London WC1N 3BG, England.	wolpert@hera.ucl.ac.uk		Wolpert, Daniel/0000-0003-2011-2790	Wellcome Trust; Gatsby Charitable Foundation; Human Frontiers Science Organization	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; Human Frontiers Science Organization	We thank Pierre Baraduc, Robert van Beers, James Ingram, Kelvin Jones and Philipp Vetter for comments on the manuscript. This work was supported by grants from the Wellcome Trust, the Gatsby Charitable Foundation and the Human Frontiers Science Organization.	Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bellman, 1957, DYNAMIC PROGRAMMING; Bhushan N, 1999, BIOL CYBERN, V81, P39, DOI 10.1007/s004220050543; BIZZI E, 1984, J NEUROSCI, V4, P2738; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Cohn JV, 2000, J NEUROPHYSIOL, V83, P3230, DOI 10.1152/jn.2000.83.6.3230; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Eskandar EN, 1999, NAT NEUROSCI, V2, P88, DOI 10.1038/4594; FELDMAN AG, 1966, BIOPHYS-USSR, V11, P766; Flanagan JR, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0005.1999; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FLASH T, 1987, BIOL CYBERN, V57, P257, DOI 10.1007/BF00338819; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; GEORGOPOULOS AP, 1995, TRENDS NEUROSCI, V18, P506, DOI 10.1016/0166-2236(95)92775-L; Ghahramani Z, 1997, NATURE, V386, P392, DOI 10.1038/386392a0; GISZTER SF, 1993, J NEUROSCI, V13, P467; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; Goodwin GC., 2014, ADAPTIVE FILTERING P; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOGAN N, 1984, J NEUROSCI, V4, P2745; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; KAWATO M, 1992, TRENDS NEUROSCI, V15, P445, DOI 10.1016/0166-2236(92)90008-V; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Merfeld DM, 1999, NATURE, V398, P615, DOI 10.1038/19303; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mussa-Ivaldi FA, 1999, CURR OPIN NEUROBIOL, V9, P713, DOI 10.1016/S0959-4388(99)00029-X; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; SANGER TD, 1994, NEURAL COMPUT, V6, P29, DOI 10.1162/neco.1994.6.1.29; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245	50	1283	1292	6	143	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11		S			1212	1217		10.1038/81497	http://dx.doi.org/10.1038/81497			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V18OV	11127840				2022-12-17	WOS:000208015000021
J	Hardingham, GE; Fukunaga, Y; Bading, H				Hardingham, GE; Fukunaga, Y; Bading, H			Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways	NATURE NEUROSCIENCE			English	Article							FAMILY TRANSCRIPTION FACTOR; D-ASPARTATE RECEPTOR; GENE-EXPRESSION; MITOCHONDRIAL DEPOLARIZATION; DEPENDENT SURVIVAL; CALCIUM; GLUTAMATE; PHOSPHORYLATION; NUCLEAR; DEPHOSPHORYLATION	Here we report that synaptic and extrasynaptic NMDA (N-methyl-D-aspartate) receptors have opposite effects on CREB (cAMP response element binding protein) function, gene regulation and neuron survival. Calcium entry through synaptic NMDA receptors induced CREB activity and brain-derived neurotrophic factor (BDNF) gene expression as strongly as did stimulation of L-type calcium channels. In contrast, calcium entry through extrasynaptic NMDA receptors, triggered by bath glutamate exposure or hypoxic/ischemic conditions, activated a general and dominant CREB shut-off pathway that blocked induction of BDNF expression. Synaptic NMDA receptors have anti-apoptotic activity, whereas stimulation of extrasynaptic NMDA receptors caused loss of mitochondrial membrane potential (an early marker for glutamate-induced neuronal damage) and cell death. Specific blockade of extrasynaptic NMDA receptors may effectively prevent neuron loss following stroke and other neuropathological conditions associated with glutamate toxicity.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bading, H (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Neurosci, Dept Neurobiol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	Hilmar.Bading@uni-hd.de		Hardingham, Giles/0000-0002-7629-5314				Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bittigau P, 1997, J CHILD NEUROL, V12, P471, DOI 10.1177/088307389701200802; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; Chawla S, 2001, J NEUROCHEM, V79, P849, DOI 10.1046/j.1471-4159.2001.00645.x; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Fields RD, 1997, J NEUROSCI, V17, P7252; Fujikawa DG, 2000, NEUROSCIENCE, V98, P41, DOI 10.1016/S0306-4522(00)00085-3; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; HOSSMANN KA, 1994, ANN NEUROL, V36, P557, DOI 10.1002/ana.410360404; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Keelan J, 1999, J PHYSIOL-LONDON, V520, P797, DOI 10.1111/j.1469-7793.1999.00797.x; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lipsky RH, 2001, J NEUROCHEM, V78, P254, DOI 10.1046/j.1471-4159.2001.00386.x; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Olney J W, 1986, Adv Neurol, V44, P857; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sattler R, 1998, J NEUROCHEM, V71, P2349; Schinder AF, 1996, J NEUROSCI, V16, P6125; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tovar KR, 1999, J NEUROSCI, V19, P4180; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Vergun O, 1999, J PHYSIOL-LONDON, V519, P451, DOI 10.1111/j.1469-7793.1999.0451m.x; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; WHITFIELD W, 1988, J ROYAL SOC HLTH, V1, P1; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449	50	1254	1300	1	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					405	414		10.1038/nn835	http://dx.doi.org/10.1038/nn835			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11953750				2022-12-17	WOS:000175272000010
J	Scholz, J; Woolf, CJ				Scholz, Joachim; Woolf, Clifford J.			The neuropathic pain triad: Neurons, immune cells and glia	NATURE NEUROSCIENCE			English	Review							PERIPHERAL-NERVE INJURY; DORSAL-ROOT GANGLION; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECROSIS-FACTOR-ALPHA; CHRONIC CONSTRICTION INJURY; RAT SCIATIC-NERVE; RANDOMIZED CONTROLLED-TRIAL; PRIMARY SENSORY NEURONS; SPINAL-CORD MICROGLIA; WALLERIAN DEGENERATION	Nociceptive pain results from the detection of intense or noxious stimuli by specialized high-threshold sensory neurons (nociceptors), a transfer of action potentials to the spinal cord, and onward transmission of the warning signal to the brain. In contrast, clinical pain such as pain after nerve injury (neuropathic pain) is characterized by pain in the absence of a stimulus and reduced nociceptive thresholds so that normally innocuous stimuli produce pain. The development of neuropathic pain involves not only neuronal pathways, but also Schwann cells, satellite cells in the dorsal root ganglia, components of the peripheral immune system, spinal microglia and astrocytes. As we increasingly appreciate that neuropathic pain has many features of a neuroimmune disorder, immunosuppression and blockade of the reciprocal signaling pathways between neuronal and non-neuronal cells offer new opportunities for disease modification and more successful management of pain.	Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Nueral Plast Res Grp, Charlestown, MA 02129 USA	Harvard University; Harvard University; Massachusetts General Hospital	Scholz, J (corresponding author), Harvard Univ, Sch Med, 149 13th St,Room 4309, Charlestown, MA 02129 USA.	scholz.joachim@mgh.harvard.edu	Woolf, Clifford/A-9784-2010					Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Arden NK, 2005, RHEUMATOLOGY, V44, P1399, DOI 10.1093/rheumatology/kei028; Arruda JL, 2000, BRAIN RES, V879, P216, DOI 10.1016/S0006-8993(00)02807-9; Beggs S, 2007, BRAIN BEHAV IMMUN, V21, P624, DOI 10.1016/j.bbi.2006.10.017; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Carroll SL, 1997, J NEUROSCI, V17, P1642; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Chen Y, 2005, PAIN, V119, P38, DOI 10.1016/j.pain.2005.09.007; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Dorf ME, 2000, J NEUROIMMUNOL, V111, P109, DOI 10.1016/S0165-5728(00)00371-4; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; ECHEVERRY S, 2007, PAIN            0608; Esper RM, 2004, J NEUROSCI, V24, P6218, DOI 10.1523/JNEUROSCI.1692-04.2004; George A, 2000, PAIN, V88, P267, DOI 10.1016/S0304-3959(00)00333-X; Goncharov NV, 2006, J APPL TOXICOL, V26, P148, DOI 10.1002/jat.1118; Griffin RS, 2007, J NEUROSCI, V27, P8699, DOI 10.1523/JNEUROSCI.2018-07.2007; Guertin AD, 2005, J NEUROSCI, V25, P3478, DOI 10.1523/JNEUROSCI.3766-04.2005; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hu P, 2003, EXP NEUROL, V184, P590, DOI 10.1016/S0014-4886(03)00307-8; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Jin SX, 2003, J NEUROSCI, V23, P4017; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Katsura H, 2006, J NEUROSCI, V26, P8680, DOI 10.1523/JNEUROSCI.1771-06.2006; Keswani SC, 2003, ANN NEUROL, V54, P287, DOI 10.1002/ana.10645; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kobayashi K, 2005, J COMP NEUROL, V481, P377, DOI 10.1002/cne.20393; Kobayashi K, 2006, J COMP NEUROL, V498, P443, DOI 10.1002/cne.21066; Kotani N, 2000, NEW ENGL J MED, V343, P1514, DOI 10.1056/NEJM200011233432102; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Li HY, 2007, STEM CELLS, V25, P2053, DOI 10.1634/stemcells.2007-0080; LINDHOLM D, 1987, NATURE, V330, P658, DOI 10.1038/330658a0; Ma W, 2003, NEUROSCIENCE, V121, P691, DOI 10.1016/S0306-4522(03)00495-0; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Malin SA, 2006, J NEUROSCI, V26, P8588, DOI 10.1523/JNEUROSCI.1726-06.2006; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; McGaraughty S, 2007, NEUROSCIENCE, V146, P1817, DOI 10.1016/j.neuroscience.2007.03.035; McGaraughty S, 2005, DRUG NEWS PERSPECT, V18, P501, DOI 10.1358/dnp.2005.18.8.942082; Melli G, 2006, BRAIN, V129, P1330, DOI 10.1093/brain/awl058; Milligan ED, 2004, EUR J NEUROSCI, V20, P2294, DOI 10.1111/j.1460-9568.2004.03709.x; Milligan ED, 2006, PAIN, V126, P294, DOI 10.1016/j.pain.2006.07.009; Morin N, 2007, J NEUROIMMUNOL, V184, P164, DOI 10.1016/j.jneuroim.2006.12.009; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; Myers RR, 2006, DRUG DISCOV TODAY, V11, P8, DOI 10.1016/S1359-6446(05)03637-8; Nakatsuka T, 2001, J NEUROSCI, V21, P6522, DOI 10.1523/JNEUROSCI.21-17-06522.2001; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; Perkins NM, 2000, NEUROSCIENCE, V101, P745, DOI 10.1016/S0306-4522(00)00396-1; Perrin FE, 2005, BRAIN, V128, P854, DOI 10.1093/brain/awh407; Raghavendra V, 2003, J PHARMACOL EXP THER, V306, P624, DOI 10.1124/jpet.103.052407; Ramer MS, 1998, PAIN, V78, P115, DOI 10.1016/S0304-3959(98)00121-3; Schafers M, 2003, J NEUROSCI, V23, P2517; Schafers M, 2003, J NEUROSCI, V23, P3028; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Sharp CJ, 2006, BRIT J PHARMACOL, V148, P845, DOI 10.1038/sj.bjp.0706790; Shi TJS, 2001, NEUROSCIENCE, V105, P249, DOI 10.1016/S0306-4522(01)00148-8; Shubayev VI, 2006, MOL CELL NEUROSCI, V31, P407, DOI 10.1016/j.mcn.2005.10.011; Si QS, 1998, BRAIN RES, V812, P97, DOI 10.1016/S0006-8993(98)00954-8; Sommer C, 1998, PAIN, V74, P83, DOI 10.1016/S0304-3959(97)00154-1; Sommer C, 1998, BRAIN RES, V784, P154, DOI 10.1016/S0006-8993(97)01327-9; Stella N, 2004, GLIA, V48, P267, DOI 10.1002/glia.20084; Stoll G, 2002, J PERIPHER NERV SYST, V7, P13, DOI 10.1046/j.1529-8027.2002.02002.x; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Svensson CI, 2005, J NEUROCHEM, V92, P1508, DOI 10.1111/j.1471-4159.2004.02996.x; Sweitzer SM, 2002, J PAIN, V3, P360, DOI 10.1054/jpai.2002.125181; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tawfik VL, 2007, BRAIN BEHAV IMMUN, V21, P238, DOI 10.1016/j.bbi.2006.07.001; Tofaris GK, 2002, J NEUROSCI, V22, P6696; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Umapathi T, 2005, CURR OPIN NEUROL, V18, P574, DOI 10.1097/01.wco.0000180158.34713.aa; Valenzano KJ, 2005, NEUROPHARMACOLOGY, V48, P658, DOI 10.1016/j.neuropharm.2004.12.008; van Wijck AJM, 2006, LANCET, V367, P219, DOI 10.1016/S0140-6736(06)68032-X; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Watkins LR, 2002, PHYSIOL REV, V82, P981, DOI 10.1152/physrev.00011.2002; White FA, 2005, NAT REV DRUG DISCOV, V4, P834, DOI 10.1038/nrd1852; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Winkelstein BA, 2001, J COMP NEUROL, V439, P127; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Zemke D, 2004, CLIN NEUROPHARMACOL, V27, P293, DOI 10.1097/01.wnf.0000150867.98887.3e; Zhang J, 2006, J NEUROCHEM, V97, P772, DOI 10.1111/j.1471-4159.2006.03746.x; Zhang N, 2005, P NATL ACAD SCI USA, V102, P4536, DOI 10.1073/pnas.0406030102; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zochodne DW, 1999, NEUROSCIENCE, V91, P1515, DOI 10.1016/S0306-4522(98)00729-5	100	1238	1303	10	257	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1361	1368		10.1038/nn1992	http://dx.doi.org/10.1038/nn1992			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17965656				2022-12-17	WOS:000250508400010
J	Snyder, EM; Nong, Y; Almeida, CG; Paul, S; Moran, T; Choi, EY; Nairn, AC; Salter, MW; Lombroso, PJ; Gouras, GK; Greengard, P				Snyder, EM; Nong, Y; Almeida, CG; Paul, S; Moran, T; Choi, EY; Nairn, AC; Salter, MW; Lombroso, PJ; Gouras, GK; Greengard, P			Regulation of NMDA receptor trafficking by amyloid-beta	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; FAMILY TRANSCRIPTION FACTOR; TYROSINE PHOSPHATASE STEP; ELEMENT-BINDING PROTEIN; LONG-TERM POTENTIATION; HIPPOCAMPUS IN-VIVO; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; GLUTAMATE RECEPTORS	Amyloid-beta peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-beta reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-beta promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-beta by treating neurons with a gamma-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-beta application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-beta dependent endocytosis of NMDA receptors required the alpha- 7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-beta can cause synaptic dysfunction and contribute to Alzheimer disease pathology.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Hosp Sick Children, Program Brain & Behav, Toronto, ON M5G 1X8, Canada; Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA; Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA	Rockefeller University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Cornell University; Yale University; Yale University	Snyder, EM (corresponding author), McKinsey & Co Inc, 600 Campus Dr, Florham Pk, NJ 07932 USA.	ericmaltesnyder@gmail.com	Gouras, Gunnar/B-3021-2010; de Almeida, Cláudia Guimas/AAN-8935-2020	Gouras, Gunnar/0000-0002-5500-6325; de Almeida, Cláudia Guimas/0000-0001-9384-2896; Choi, Eun Young/0000-0003-3226-1486; Nairn, Angus/0000-0002-7075-0195	NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER; NIA NIH HHS [AG09464] Funding Source: Medline; PHS HHS [52711, 01527] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alvestad RM, 2003, J BIOL CHEM, V278, P11020, DOI 10.1074/jbc.M210167200; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Freir DB, 2001, J NEUROPHYSIOL, V85, P708, DOI 10.1152/jn.2001.85.2.708; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim JH, 2001, J NEUROSCI, V21, P1327; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Levy RB, 2002, J NEUROSCI, V22, P5001, DOI 10.1523/JNEUROSCI.22-12-05001.2002; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Mammen AL, 1997, J NEUROSCI, V17, P7351; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Pelkey KA, 2002, NEURON, V34, P127, DOI 10.1016/S0896-6273(02)00633-5; PERDAHL E, 1984, NEUROBEH TOXICOL TER, V6, P425; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Scott DB, 2004, J NEUROSCI, V24, P7096, DOI 10.1523/JNEUROSCI.0780-04.2004; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Stevens TR, 2003, J NEUROSCI, V23, P10093; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Wang HY, 2000, J BIOL CHEM, V275, P5626, DOI 10.1074/jbc.275.8.5626; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Yamamoto-Sasaki M, 1999, BRAIN RES, V824, P300, DOI 10.1016/S0006-8993(99)01220-2	40	1230	1301	0	128	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1051	1058		10.1038/nn1503	http://dx.doi.org/10.1038/nn1503			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025111				2022-12-17	WOS:000230760200017
J	Finn, ES; Shen, XL; Scheinost, D; Rosenberg, MD; Huang, J; Chun, MM; Papademetris, X; Constable, RT				Finn, Emily S.; Shen, Xilin; Scheinost, Dustin; Rosenberg, Monica D.; Huang, Jessica; Chun, Marvin M.; Papademetris, Xenophon; Constable, R. Todd			Functional connectome fingerprinting: identifying individuals using patterns of brain connectivity	NATURE NEUROSCIENCE			English	Article							RESTING-STATE; HEMISPHERIC ASYMMETRIES; CEREBRAL-CORTEX; INTELLIGENCE; ORGANIZATION; FMRI; PARCELLATION; ARCHITECTURE; MODULATION; ACTIVATION	Functional magnetic resonance imaging (fMRI) studies typically collapse data from many subjects, but brain functional organization varies between individuals. Here we establish that this individual variability is both robust and reliable, using data from the Human Connectome Project to demonstrate that functional connectivity profiles act as a 'fingerprint' that can accurately identify subjects from a large group. Identification was successful across scan sessions and even between task and rest conditions, indicating that an individual's connectivity profile is intrinsic, and can be used to distinguish that individual regardless of how the brain is engaged during imaging. Characteristic connectivity patterns were distributed throughout the brain, but the frontoparietal network emerged as most distinctive. Furthermore, we show that connectivity profiles predict levels of fluid intelligence: the same networks that were most discriminating of individuals were also most predictive of cognitive behavior. Results indicate the potential to draw inferences about single subjects on the basis of functional connectivity fMRI.	[Finn, Emily S.; Chun, Marvin M.; Constable, R. Todd] Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA; [Shen, Xilin; Scheinost, Dustin; Huang, Jessica; Papademetris, Xenophon; Constable, R. Todd] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Rosenberg, Monica D.; Chun, Marvin M.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Chun, Marvin M.] Yale Univ, Dept Neurobiol, New Haven, CT USA; [Papademetris, Xenophon] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Constable, R. Todd] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Finn, ES (corresponding author), Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA.	emily.finn@yale.edu	Constable, R. Todd/ABE-8038-2021; Finn, Emily S./I-2205-2019; Rosenberg, Monica D./J-6487-2019; Scheinost, Dustin/Q-2857-2018; Pan, Pedro M/I-5167-2013	Constable, R. Todd/0000-0001-5661-9521; Finn, Emily S./0000-0001-8591-3068; Rosenberg, Monica D./0000-0001-6179-4025; Scheinost, Dustin/0000-0002-6301-1167; Pan, Pedro M/0000-0002-1943-6520; Shen, Xilin/0000-0003-1006-7404; Chun, Marvin/0000-0003-1070-7993	16 US National Institutes of Health (NIH) [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; NIH [EB009666, T32 DA022975]; US National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA022975] Funding Source: NIH RePORTER	16 US National Institutes of Health (NIH); McDonnell Center for Systems Neuroscience at Washington University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Data were provided in part by the Human Connectome Project, WU-Minn Consortium (principal investigators, D. Van Essen and K. Ugurbil; 1U54MH091657) funded by the 16 US National Institutes of Health (NIH) institutes and centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. This work was also supported by NIH grant EB009666 (R.T.C.), T32 DA022975 (D.S.) and the US National Science Foundation Graduate Research Fellowship Program (E.S.F. and M.D.R.).	Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Bianciardi M, 2009, NEUROIMAGE, V45, P160, DOI 10.1016/j.neuroimage.2008.10.034; Bilker WB, 2012, ASSESSMENT, V19, P354, DOI 10.1177/1073191112446655; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Castellanos FX, 2013, NEUROIMAGE, V80, P527, DOI 10.1016/j.neuroimage.2013.04.083; Cattell R. B., 1987, INTELLIGENCE ITS STR; Chandola T, 2006, INT J OBESITY, V30, P1422, DOI 10.1038/sj.ijo.0803279; Choi YY, 2008, J NEUROSCI, V28, P10323, DOI 10.1523/JNEUROSCI.3259-08.2008; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Colom R, 2007, INTELLIGENCE, V35, P243, DOI 10.1016/j.intell.2006.07.008; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fornito Alex, 2012, Front Psychiatry, V3, P72, DOI 10.3389/fpsyt.2012.00072; Gabrieli JDE, 2015, NEURON, V85, P11, DOI 10.1016/j.neuron.2014.10.047; Gottfredson LS, 2004, J PERS SOC PSYCHOL, V86, P174, DOI 10.1037/0022-3514.86.1.174; Grabner RH, 2007, NEUROIMAGE, V38, P346, DOI 10.1016/j.neuroimage.2007.07.041; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Hampson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044067; Hill J, 2010, J NEUROSCI, V30, P2268, DOI 10.1523/JNEUROSCI.4682-09.2010; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kelly C, 2012, TRENDS COGN SCI, V16, P181, DOI 10.1016/j.tics.2012.02.001; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Miranda-Dominguez O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111048; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Newman SD, 2003, NEUROPSYCHOLOGIA, V41, P1668, DOI 10.1016/S0028-3932(03)00091-5; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Scheinost D, 2015, HUM BRAIN MAPP, V36, P1524, DOI 10.1002/hbm.22720; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stevens WD, 2010, CEREB CORTEX, V20, P1997, DOI 10.1093/cercor/bhp270; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699	49	1229	1247	33	249	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2015	18	11					1664	1671		10.1038/nn.4135	http://dx.doi.org/10.1038/nn.4135			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8YT	26457551	Green Published, Green Accepted			2022-12-17	WOS:000363830700025
J	Kamitani, Y; Tong, F				Kamitani, Y; Tong, F			Decoding the visual and subjective contents of the human brain	NATURE NEUROSCIENCE			English	Article							FEATURE-BASED ATTENTION; MONKEY STRIATE CORTEX; ORIENTATION SELECTIVITY; FUNCTIONAL ARCHITECTURE; RECEPTIVE FIELDS; MOTION; AREAS; REPRESENTATIONS; SPECTROSCOPY; ORGANIZATION	The potential for human neuroimaging to read out the detailed contents of a person's mental state has yet to be fully explored. We investigated whether the perception of edge orientation, a fundamental visual feature, can be decoded from human brain activity measured with functional magnetic resonance imaging (fMRI). Using statistical algorithms to classify brain states, we found that ensemble fMRI signals in early visual areas could reliably predict on individual trials which of eight stimulus orientations the subject was seeing. Moreover, when subjects had to attend to one of two overlapping orthogonal gratings, feature-based attention strongly biased ensemble activity toward the attended orientation. These results demonstrate that fMRI activity patterns in early visual areas, including primary visual cortex (V1), contain detailed orientation information that can reliably predict subjective perception. Our approach provides a framework for the readout of fine-tuned representations in the human brain and their subjective contents.	ATR Computat Neurosci Labs, Keihanna Sci City, Kyoto 6190288, Japan; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Kamitani, Y (corresponding author), ATR Computat Neurosci Labs, 2-2-2 Hikaridai, Keihanna Sci City, Kyoto 6190288, Japan.	kmtn@atr.jp	Patanaik, Amiya/G-4336-2010		NATIONAL EYE INSTITUTE [R01EY014202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY14202, R01 EY014202] Funding Source: Medline; NIMH NIH HHS [P50-MH62196, P50 MH062196] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; BAUER R, 1989, EXP BRAIN RES, V76, P503, DOI 10.1007/BF00248906; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; Boynton GM, 2003, J NEUROSCI, V23, P8781; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; COX AN, 1970, ASTROPHYS J SUPPL S, V19, P261, DOI 10.1086/190208; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KAHNEMAN D, 1970, PERCEPT PSYCHOPHYS, V8, P161, DOI 10.3758/BF03210195; Kamitani Y, 1999, NAT NEUROSCI, V2, P767, DOI 10.1038/11245; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; Koch C., 2004, QUEST CONSCIOUSNESS, P260; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; MINSKY LM, 1987, PERCEPTRONS EXPANDED; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Pouget A, 2000, NAT REV NEUROSCI, V1, P125, DOI 10.1038/35039062; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SCHALL JD, 1986, BRAIN RES, V368, P18, DOI 10.1016/0006-8993(86)91037-1; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 2003, CURR OPIN NEUROBIOL, V13, P428, DOI 10.1016/S0959-4388(03)00105-3; Vanduffel W, 2002, CEREB CORTEX, V12, P647, DOI 10.1093/cercor/12.6.647; Vapnik V., 1998, STAT LEARNING THEORY; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wilson H. R., 1990, VISUAL PERCEPTION NE, P231, DOI DOI 10.1016/B978-0-12-657675-7.50016-8; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; ZEKI S, 1991, J NEUROSCI, V11, P641	40	1210	1232	7	173	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					679	685		10.1038/nn1444	http://dx.doi.org/10.1038/nn1444			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852014	Green Accepted			2022-12-17	WOS:000228895100030
J	Aron, AR; Fletcher, PC; Bullmore, ET; Sahakian, BJ; Robbins, TW				Aron, AR; Fletcher, PC; Bullmore, ET; Sahakian, BJ; Robbins, TW			Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL MRI		Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 2QQ, England	University of Cambridge; University of Cambridge	Robbins, TW (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	twr2@cam.ac.uk	Li, Chong/F-4265-2015; Robbins, Trevor W/A-7551-2008; Bullmore, Ed/C-1706-2012; Sahakian, Barbara/AAW-1198-2020; Fletcher, Paul/F-5380-2011	Bullmore, Ed/0000-0002-8955-8283; Sahakian, Barbara/0000-0001-7352-1745; Fletcher, Paul/0000-0001-8257-1517; Robbins, Trevor/0000-0003-0642-5977	Wellcome Trust [064351] Funding Source: Medline; ESRC [ES/F028814/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Logan G. D., 2000, ATTENTION PERFORM, P653; Logan Gordon D., 1994, P189; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; WILLIAMS EJ, 1959, J ROY STAT SOC B, V21, P396	13	1197	1222	5	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					115	116		10.1038/nn1003	http://dx.doi.org/10.1038/nn1003			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536210				2022-12-17	WOS:000180669100009
J	Kable, JW; Glimcher, PW				Kable, Joseph W.; Glimcher, Paul W.			The neural correlates of subjective value during intertemporal choice	NATURE NEUROSCIENCE			English	Article							POSTERIOR CINGULATE CORTEX; DECISION-MAKING; PARIETAL CORTEX; ORBITOFRONTAL CORTEX; PRIMATE STRIATUM; MONETARY REWARDS; VENTRAL STRIATUM; PREFERENCE; RESPONSES; RISK	Neuroimaging studies of decision-making have generally related neural activity to objective measures (such as reward magnitude, probability or delay), despite choice preferences being subjective. However, economic theories posit that decision-makers behave as though different options have different subjective values. Here we use functional magnetic resonance imaging to show that neural activity in several brain regions-particularly the ventral striatum, medial prefrontal cortex and posterior cingulate cortex-tracks the revealed subjective value of delayed monetary rewards. This similarity provides unambiguous evidence that the subjective value of potential rewards is explicitly represented in the human brain.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Kable, JW (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl,Room 809, New York, NY 10003 USA.	kable@cns.nyu.edu; glimcher@cns.nyu.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH075544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054775] Funding Source: NIH RePORTER; NIMH NIH HHS [F32 MH075544, F32-MH75544] Funding Source: Medline; NINDS NIH HHS [R01 NS054775, R01 NS054775-02, R01-NS054775] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; BENHABIB J, 2006, PESENT BIAS QUASI HY; BERNOULLI D, 1982, WORKS; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Camerer CF, 1999, J RISK UNCERTAINTY, V19, P7, DOI 10.1023/A:1007850605129; Coller M., 1999, Experimental Economics, V2, P107, DOI 10.1007/BF01673482; Cromwell HC, 2005, EXP BRAIN RES, V162, P520, DOI 10.1007/s00221-005-2223-z; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Fechner G. T., 1860, BREITKOPF HARTEL; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; GUI F, 2005, CASE MINDLESS EC; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Johnson KO, 2002, NEUROSCIENTIST, V8, P111, DOI 10.1177/107385840200800207; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5, P55; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Paulus MP, 2006, NEUROIMAGE, V30, P668, DOI 10.1016/j.neuroimage.2005.09.061; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; Samuelson PaulA., 1947, FDN EC ANAL; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; SMITH VL, 1993, ECON INQ, V31, P245, DOI 10.1111/j.1465-7295.1993.tb00881.x; STEVENS SS, 1970, SCIENCE, V170, P1043, DOI 10.1126/science.170.3962.1043; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; TELLER DY, 1983, LINKING PROPOSITIONS, P577; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Von Neuman J, 1944, THEORY GAMES EC BEHA; Weber E. H., 1834, PULSU RESORPTIONE AU; WERNERM GERHARD, 1968, P112; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	49	1194	1220	9	195	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1625	1633		10.1038/nn2007	http://dx.doi.org/10.1038/nn2007			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	17982449	Green Accepted			2022-12-17	WOS:000251172900021
J	Weissman, DH; Roberts, KC; Visscher, KM; Woldorff, MG				Weissman, D. H.; Roberts, K. C.; Visscher, K. M.; Woldorff, M. G.			The neural bases of momentary lapses in attention	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; SUSTAINED ATTENTION; FUNCTIONAL MRI; DEFICIT/HYPERACTIVITY DISORDER; SELECTIVE ATTENTION; FRONTAL LESIONS; BRAIN ACTIVITY; VISUAL-CORTEX; DEFAULT-MODE; TASK	Momentary lapses in attention frequently impair goal-directed behavior, sometimes with serious consequences. Nevertheless, we lack an integrated view of the brain mechanisms underlying such lapses. By investigating trial-by-trial relationships between brain activity and response time in humans, we determined that attentional lapses begin with reduced prestimulus activity in anterior cingulate and right prefrontal regions involved in controlling attention. Less efficient stimulus processing during attentional lapses was also characterized by less deactivation of a 'default-mode' network, reduced stimulus-evoked sensory activity, and increased activity in widespread regions of frontal and parietal cortex. Finally, consistent with a mechanism for recovering from attentional lapses, increased stimulus-evoked activity in the right inferior frontal gyrus and the right temporal-parietal junction predicted better performance on the next trial. Our findings provide a new, system-wide understanding of the patterns of brain activity that are associated with brief attentional lapses, which informs both theoretical and clinical models of goal-directed behavior.	Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; Duke Univ, Dept Psychiat, Durham, NC 27708 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Duke University; Duke University; Brandeis University	Weissman, DH (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA.	weissman@duke.edu		Woldorff, Marty/0000-0002-2683-4551; Visscher, Kristina/0000-0003-0737-4024; Roberts, Kenneth/0000-0002-8033-0864	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS041328, F32NS041867] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60415] Funding Source: Medline; NINDS NIH HHS [1 F32 NS41867-01, P01 NS41328] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Beede KE, 2006, ACCIDENT ANAL PREV, V38, P415, DOI 10.1016/j.aap.2005.10.015; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Czeisler CA, 2005, NEW ENGL J MED, V353, P476, DOI 10.1056/NEJMoa041292; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Drummond SPA, 2005, SLEEP, V28, P1059; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FRISTON KJ, 1997, HUMAN BRAIN FUNCTION, P141; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Indovina I, 2004, MAGN RESON IMAGING, V22, P1477, DOI 10.1016/j.mri.2004.10.016; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; Klingberg T, 1997, CEREB CORTEX, V7, P465, DOI 10.1093/cercor/7.5.465; Lavie N, 2003, PERCEPT PSYCHOPHYS, V65, P202, DOI 10.3758/BF03194795; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Petrides M, 1995, ANN NY ACAD SCI, V769, P85, DOI 10.1111/j.1749-6632.1995.tb38133.x; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reimer B, 2005, ACCIDENT ANAL PREV, V37, P996, DOI 10.1016/j.aap.2005.05.002; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Schacter D. L., 2001, 7 SINS MEMORY MIND F; TALAIRCH J, 1988, CO PLANAR STEREOTACT; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Weissman DH, 2004, J NEUROSCI, V24, P10941, DOI 10.1523/JNEUROSCI.3669-04.2004; Weissman DH, 1999, J EXP PSYCHOL GEN, V128, P283, DOI 10.1037/0096-3445.128.3.283; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; WOLDORFF MG, 1993, P NATL ACAD SCI USA, V90, P8722, DOI 10.1073/pnas.90.18.8722; Woldorff MG, 2004, J COGNITIVE NEUROSCI, V16, P149, DOI 10.1162/089892904322755638; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258	50	1136	1153	0	145	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					971	978		10.1038/nn1727	http://dx.doi.org/10.1038/nn1727			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16767087				2022-12-17	WOS:000238590800025
J	Lupien, SJ; de Leon, M; de Santi, S; Convit, A; Tarshish, C; Thakur, M; McEwen, BS; Hauger, RL; Meaney, MJ				Lupien, SJ; de Leon, M; de Santi, S; Convit, A; Tarshish, C; Thakur, M; McEwen, BS; Hauger, RL; Meaney, MJ			Cortisol levels during human aging predict hippocampal atrophy and memory deficits	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; RAT-BRAIN; STRESS; CORTICOSTERONE; MODULATION; HYPOTHESIS; BASAL	Elevated glucocorticoid levels produce hippocampal dysfunction and correlate with individual deficits in spatial learning in aged rats. Previously we related persistent cortisol increases to memory impairments in elderly humans studied over five years. Here we demonstrate that aged humans with significant prolonged cortisol elevations showed reduced hippocampal volume and deficits in hippocampus-dependent memory tasks compared to normal-cortisol controls. Moreover, the degree of hippocampal atrophy correlated strongly with both the degree of cortisol elevation over time and current basal cortisol levels. Therefore, basal cortisol elevation may cause hippocampal damage and impair hippocampus-dependent learning and memory in humans.	McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr,Aging Res Program, Verdun, PQ H4H 1R3, Canada; Geriatr Inst Montreal, Human Psychoneuroendocrine Res Lab, Montreal, PQ H3W 1W5, Canada; NYU, Med Ctr, Aging & Dementia Res Ctr, New York, NY 10016 USA; Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10021 USA; Univ Calif San Diego, Dept Psychiat, San Diego, CA 92161 USA; VA Med Ctr, San Diego, CA 92161 USA	McGill University; Universite de Montreal; New York University; Rockefeller University; University of California System; University of California San Diego	Lupien, SJ (corresponding author), McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr,Aging Res Program, 6875 Blvd Lasalle, Verdun, PQ H4H 1R3, Canada.	lupiens@magellan.umontreal.ca	McEwen, Bruce/Z-1630-2019; de Leon, Mony/AAP-7890-2021	Convit, Antonio/0000-0003-2201-2689; de Leon, Mony/0000-0003-2245-4380	NIA NIH HHS [AG13616, AG09488, AG12101] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG009488, R01AG013616, R01AG012101] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BRINDLEY DN, 1989, CLIN SCI, V77, P453, DOI 10.1042/cs0770453; DAVIS KL, 1986, AM J PSYCHIAT, V143, P300; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; deLeon MJ, 1997, NEUROBIOL AGING, V18, P1, DOI 10.1016/S0197-4580(96)00213-8; DELEON MJ, 1988, LANCET, V2, P391; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; FISCHETTE CT, 1980, BRAIN RES, V195, P373, DOI 10.1016/0006-8993(80)90073-6; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; ISSA AM, 1990, J NEUROSCI, V10, P3247; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; JOELS M, 1989, SCIENCE, V245, P1502, DOI 10.1126/science.2781292; JOELS M, 1997, FRONT NEUROENDOCRIN, V18, P495; KERR DS, 1989, SCIENCE, V245, P1505, DOI 10.1126/science.2781293; LANDFIELD PW, 1978, SCIENCE, V202, P1098, DOI 10.1126/science.715460; LANDFIELD PW, 1994, NEUROBIOL AGING, V15, P579, DOI 10.1016/0197-4580(94)90101-5; LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791; LUPIEN S, 1994, J NEUROSCI, V14, P2893, DOI 10.1523/jneurosci.14-05-02893.1994; Lupien S, 1996, NEUROBIOL AGING, V17, P95, DOI 10.1016/0197-4580(95)02005-5; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Magarinos AM, 1996, J NEUROSCI, V16, P3534; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Sapolsky RM, 1992, STRESS AGING BRAIN M; SCOLVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11; SLOVITER RS, 1989, SCIENCE, V243, P535, DOI 10.1126/science.2911756; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STARKMAN MN, 1992, BIOL PSYCHIAT, V32, P756, DOI 10.1016/0006-3223(92)90079-F; Wolkowitz OM, 1997, ANN NY ACAD SCI, V823, P81, DOI 10.1111/j.1749-6632.1997.tb48381.x	30	1133	1188	2	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					69	73		10.1038/271	http://dx.doi.org/10.1038/271			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195112				2022-12-17	WOS:000076361000021
J	Buzsaki, G				Buzsaki, G			Large-scale recording of neuronal ensembles	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL PYRAMIDAL CELLS; CENTRAL NERVOUS-SYSTEM; IN-VIVO; ACTION-POTENTIALS; BEHAVING RAT; SINGLE UNITS; CORTEX; CODE; BACKPROPAGATION; CLASSIFICATION	How does the brain orchestrate perceptions, thoughts and actions from the spiking activity of its neurons? Early single-neuron recording research treated spike pattern variability as noise that needed to be averaged out to reveal the brain's representation of invariant input. Another view is that variability of spikes is centrally coordinated and that this brain-generated ensemble pattern in cortical structures is itself a potential source of cognition. Large-scale recordings from neuronal ensembles now offer the opportunity to test these competing theoretical frameworks. Currently, wire and micro-machined silicon electrode arrays can record from large numbers of neurons and monitor local neural circuits at work. Achieving the full potential of massively parallel neuronal recordings, however, will require further development of the neuron-electrode interface, automated and efficient spike-sorting algorithms for effective isolation and identification of single neurons, and new mathematical insights for the analysis of network properties.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu		Buzsaki, Gyorgy/0000-0002-3100-4800	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS043157] Funding Source: NIH RePORTER; NCRR NIH HHS [1P41RR09754] Funding Source: Medline; NIMH NIH HHS [MH54671] Funding Source: Medline; NINDS NIH HHS [NS43157, NS34994] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARTHO P, IN PRESS J NEUROPHYS; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Buzsaki G, 1996, P NATL ACAD SCI USA, V93, P9921, DOI 10.1073/pnas.93.18.9921; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G., 2003, CURRENT PRACTICE CLI, P1; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 2004, NAT NEUROSCI, V7, P452, DOI 10.1038/nn1234; Churchland P. S., 1992, COMPUTATIONAL BRAIN, DOI 10.7551/mitpress/2010.001.0001; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; DEADWYLER SA, 1995, SCIENCE, V270, P1316, DOI 10.1126/science.270.5240.1316; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; DOUGLAS RJ, 1991, TRENDS NEUROSCI, V14, P286, DOI 10.1016/0166-2236(91)90139-L; EICHENBAUM H, 1988, NEURONAL ENSEMBLES S; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; GEORGOPOULOS AP, 1989, SCIENCE, V243, P234, DOI 10.1126/science.2911737; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Hampson R E, 2001, Prog Brain Res, V130, P345; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V70, P387, DOI 10.1152/jn.1993.70.1.387; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Letelier JC, 2000, J NEUROSCI METH, V101, P93, DOI 10.1016/S0165-0270(00)00250-8; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; Musial PG, 2002, J NEUROSCI METH, V115, P29, DOI 10.1016/S0165-0270(01)00516-7; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; NICOLELIS MAL, 1993, NATURE, V361, P533, DOI 10.1038/361533a0; Norlin P, 2002, J MICROMECH MICROENG, V12, P414, DOI 10.1088/0960-1317/12/4/312; OLSSON RH, 2003, IEEE ENG MED BIOL, V22, P1968; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; QUIROGA RQ, IN PRESS NEURAL COMP; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shoham S, 2003, J NEUROSCI METH, V127, P111, DOI 10.1016/S0165-0270(03)00120-1; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Takahashi S, 2003, J NEUROPHYSIOL, V89, P2245, DOI 10.1152/jn.00827.2002; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wise KD, 1998, SENSOR MATER, V10, P385; WISE KD, 1991, SCIENCE, V254, P1335, DOI 10.1126/science.1962192	65	1129	1161	9	240	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					446	451		10.1038/nn1233	http://dx.doi.org/10.1038/nn1233			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114356				2022-12-17	WOS:000221101300011
J	Matsuzaki, M; Ellis-Davies, GCR; Nemoto, T; Miyashita, Y; Iino, M; Kasai, H				Matsuzaki, M; Ellis-Davies, GCR; Nemoto, T; Miyashita, Y; Iino, M; Kasai, H			Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; 2-PHOTON EXCITATION; GLUTAMATE RECEPTORS; SURFACE EXPRESSION; SILENT SYNAPSES; CROSS-SECTIONS; NMDA RECEPTORS; NONSATURATION; VARIABILITY	Dendritic spines serve as preferential sites of excitatory synaptic connections and are pleomorphic. To address the structure-function relationship of the dendritic spines, we used two-photon uncaging of glutamate to allow mapping of functional glutamate receptors at the level of the single synapse. Our analyses of the spines of CA1 pyramidal neurons reveal that AMPA (alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)-type glutamate receptors are abundant (up to 150/spine) in mushroom spines but sparsely distributed in thin spines and filopodia. The latter may be serving as the structural substrates of the silent synapses that have been proposed to play roles in development and plasticity of synaptic transmission. Our data indicate that distribution of functional AMPA receptors is tightly correlated with spine geometry and that receptor activity is independently regulated at the level of single spines.	Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Med Coll Penn & Hahnemann Univ, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); University of Tokyo; Drexel University	Kasai, H (corresponding author), Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan.	hkasai@nips.ac.jp	Miyashita, Yasushi/B-7171-2019; Nemoto, Tomomi/B-4412-2012	Miyashita, Yasushi/0000-0003-3496-8637; Nemoto, Tomomi/0000-0001-6102-1495; Kasai, Haruo/0000-0003-2327-9027; Matsuzaki, Masanori/0000-0003-3872-4322	NIGMS NIH HHS [R01 GM053395, GM53395] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arbib MA, 1995, HDB BRAIN THEORY NEU; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brown EB, 1999, BIOPHYS J, V76, P489, DOI 10.1016/S0006-3495(99)77217-6; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Crank J., 1979, MATH DIFFUSION; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; Diamond JS, 1997, J NEUROSCI, V17, P4672; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Papageorgiou G, 2000, TETRAHEDRON, V56, P8197, DOI 10.1016/S0040-4020(00)00745-6; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Pettit DL, 1997, NEURON, V19, P465, DOI 10.1016/S0896-6273(00)80361-X; Ramon y Cajal S, 1909, HISTOLOGIE SYSTEME N; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Segal M, 2000, TRENDS NEUROSCI, V23, P53, DOI 10.1016/S0166-2236(99)01499-X; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd GM, 1996, J NEUROPHYSIOL, V75, P2197, DOI 10.1152/jn.1996.75.6.2197; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	50	1121	1145	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1086	1092		10.1038/nn736	http://dx.doi.org/10.1038/nn736			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11687814	Green Accepted			2022-12-17	WOS:000171970900011
J	Behrens, TEJ; Woolrich, MW; Walton, ME; Rushworth, MFS				Behrens, Timothy E. J.; Woolrich, Mark W.; Walton, Mark E.; Rushworth, Matthew F. S.			Learning the value of information in an uncertain world	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; DECISION-MAKING; DOPAMINE NEURONS; REWARD; PERFORMANCE; HUMANS; NEUROMODULATION; REPRESENTATION; PREDICTION	Our decisions are guided by outcomes that are associated with decisions made in the past. However, the amount of influence each past outcome has on our next decision remains unclear. To ensure optimal decision-making, the weight given to decision outcomes should reflect their salience in predicting future outcomes, and this salience should be modulated by the volatility of the reward environment. We show that human subjects assess volatility in an optimal manner and adjust decision-making accordingly. This optimal estimate of volatility is reflected in the fMRI signal in the anterior cingulate cortex ( ACC) when each trial outcome is observed. When a new piece of information is witnessed, activity levels reflect its salience for predicting future outcomes. Furthermore, variations in this ACC signal across the population predict variations in subject learning rates. Our results provide a formal account of how we weigh our different experiences in guiding our future actions.	Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; University of Oxford	Behrens, TEJ (corresponding author), Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England.	behrens@fmrib.ox.ac.uk		Woolrich, Mark/0000-0001-8460-8854; Behrens, Timothy/0000-0003-0048-1177; Rushworth, Matthew/0000-0002-5578-9884	MRC [G0501316, G0600994] Funding Source: UKRI; Medical Research Council [G0501316, G0600994] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; COX RT, 1946, AM J PHYS, V14, P1, DOI 10.1119/1.1990764; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; DICKINSON A, 1978, ANNU REV PSYCHOL, V29, P587, DOI 10.1146/annurev.ps.29.020178.003103; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Gallistel CR, 2001, J EXP PSYCHOL ANIM B, V27, P354, DOI 10.1037//0097-7403.27.4.354; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Kahneman D, 2000, CHOICES VALUES FRAME; Kakade S, 2002, PSYCHOL REV, V109, P533, DOI 10.1037//0033-295X.109.3.533; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; KUNISHIO K, 1994, J COMP NEUROL, V350, P337, DOI 10.1002/cne.903500302; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Preuschoff K, 2007, ANN NY ACAD SCI, V1104, P135, DOI 10.1196/annals.1390.005; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Smith SK, 2004, POPUL RES POLICY REV, V23, P1, DOI 10.1023/B:POPU.0000019918.24143.c9; Strick PL, 1998, NOVART FDN SYMP, V218, P64; STRICK PL, 1998, NOVART FDN SYMP, V218, P75; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; VANHOESEN GW, 1993, NEUROBIOLOGY CINGULA; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	51	1115	1119	7	182	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1214	1221		10.1038/nn1954	http://dx.doi.org/10.1038/nn1954			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17676057				2022-12-17	WOS:000249144000025
J	Palop, JJ; Mucke, L				Palop, Jorge J.; Mucke, Lennart			Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks	NATURE NEUROSCIENCE			English	Review							HIPPOCAMPAL SYNAPTIC PLASTICITY; PROTEIN TRANSGENIC MICE; LONG-TERM POTENTIATION; PRECURSOR PROTEIN; MOUSE MODEL; IN-VIVO; COGNITIVE IMPAIRMENTS; NATURAL OLIGOMERS; LOBE EPILEPSY; MEMORY	Alzheimer's disease is the most frequent neurodegenerative disorder and the most common cause of dementia in the elderly. Diverse lines of evidence suggest that amyloid-beta (A beta) peptides have a causal role in its pathogenesis, but the underlying mechanisms remain uncertain. Here we discuss recent evidence that A beta may be part of a mechanism controlling synaptic activity, acting as a positive regulator presynaptically and a negative regulator postsynaptically. The pathological accumulation of oligomeric A beta assemblies depresses excitatory transmission at the synaptic level, but also triggers aberrant patterns of neuronal circuit activity and epileptiform discharges at the network level. A beta-induced dysfunction of inhibitory interneurons likely increases synchrony among excitatory principal cells and contributes to the destabilization of neuronal networks. Strategies that block these A beta effects may prevent cognitive decline in Alzheimer's disease. Potential obstacles and next steps toward this goal are discussed.	[Palop, Jorge J.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Palop, JJ (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA.	jpalop@gladstone.ucsf.edu; lmucke@gladstone.ucsf.edu	Palop, Jorge/AAH-9014-2020; Palop, Jorge J./D-8128-2011	Mucke, Lennart/0000-0001-6256-9559; Palop, Jorge/0000-0001-6086-1070	Stephen D. Bechtel, Jr. Foundation; US National Institutes of Health [AG022074, NS041787]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	Stephen D. Bechtel, Jr. Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Stephen D. Bechtel, Jr. Foundation Young Investigator Award to J.J.P. and US National Institutes of Health grants AG022074 and NS041787 to L.M. We thank A. Kreitzer for comments on the manuscript and G. Howard and S. Ordway for editorial review.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dineley KT, 2002, J BIOL CHEM, V277, P25056, DOI 10.1074/jbc.M200066200; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Frisoni GB, 2007, BRAIN, V130, P720, DOI 10.1093/brain/awl377; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Henry TR, 2004, NEUROIMAG CLIN N AM, V14, P517, DOI 10.1016/j.nic.2004.04.011; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jayadev S, 2010, BRAIN, V133, P1143, DOI 10.1093/brain/awq033; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kim JH, 2001, J NEUROSCI, V21, P1327; Klaassen A, 2006, P NATL ACAD SCI USA, V103, P19152, DOI 10.1073/pnas.0608215103; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Kullmann DM, 2007, NAT REV NEUROSCI, V8, P687, DOI 10.1038/nrn2207; Kumar-Singh S, 2000, NEUROBIOL DIS, V7, P9, DOI 10.1006/nbdi.1999.0272; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849, DOI 10.1001/archneur.1989.00520440031017; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lalonde R, 2005, BEHAV BRAIN RES, V157, P91, DOI 10.1016/j.bbr.2004.06.020; Larner AJ, 2006, J NEUROL, V253, P139, DOI 10.1007/s00415-005-0019-5; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leonard AS, 2007, NEURON, V55, P677, DOI 10.1016/j.neuron.2007.08.014; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Meilandt WJ, 2008, J NEUROSCI, V28, P5007, DOI 10.1523/JNEUROSCI.0590-08.2008; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Origlia N, 2009, EXPERT REV NEUROTHER, V9, P1635, DOI [10.1586/ern.09.107, 10.1586/ERN.09.107]; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Snider BJ, 2005, ARCH NEUROL-CHICAGO, V62, P1821, DOI 10.1001/archneur.62.12.1821; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Tackenberg C, 2009, J NEUROSCI, V29, P14439, DOI 10.1523/JNEUROSCI.3590-09.2009; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Yang L, 2009, J NEUROSCI, V29, P15660, DOI 10.1523/JNEUROSCI.4104-09.2009; Zhu YJ, 2000, FASEB J, V14, P1244, DOI 10.1096/fasebj.14.9.1244	75	1107	1169	5	325	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					812	818		10.1038/nn.2583	http://dx.doi.org/10.1038/nn.2583			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20581818	Green Accepted			2022-12-17	WOS:000279173900011
J	Cone, RD				Cone, RD			Anatomy and regulation of the central melanocortin system	NATURE NEUROSCIENCE			English	Review							GROWTH-HORMONE SECRETAGOGUE; HYPOTHALAMIC ARCUATE NUCLEUS; RECEPTOR MESSENGER-RNA; FOOD-INTAKE; NEUROPEPTIDE-Y; PROOPIOMELANOCORTIN NEURONS; FRAMESHIFT MUTATION; TRACTUS-SOLITARIUS; BODY-WEIGHT; GUT HORMONE	The central melanocortin system is perhaps the best-characterized neuronal pathway involved in the regulation of energy homeostasis. This collection of circuits is unique in having the capability of sensing signals from a staggering array of hormones, nutrients and afferent neural inputs. It is likely to be involved in integrating long-term adipostatic signals from leptin and insulin, primarily received by the hypothalamus, with acute signals regulating hunger and satiety, primarily received by the brainstem. The system is also unique from a regulatory point of view in that it is composed of fibers expressing both agonists and antagonists of melanocortin receptors. Given that the central melanocortin system is an active target for development of drugs for the treatment of obesity, diabetes and cachexia, it is important to understand the system in its full complexity, including the likelihood that the system also regulates the cardiovascular and reproductive systems.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Ctr Study Weight Regulat, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Cone, RD (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	cone@ohsu.edu						Adan RAH, 2000, RECEPTORS, P109; ADRIAN TE, 1985, GASTROENTEROLOGY, V89, P1070, DOI 10.1016/0016-5085(85)90211-2; ALTSCHULER SM, 1989, J COMP NEUROL, V283, P248, DOI 10.1002/cne.902830207; Andersson U, 2005, BIOCHEM BIOPH RES CO, V329, P719, DOI 10.1016/j.bbrc.2005.02.027; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; APPLEYARD SM, IN PRESS J NEUROSCI; Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; BLUM M, 1989, ENDOCRINOLOGY, V124, P2283, DOI 10.1210/endo-124-5-2283; Branson R, 2003, NEW ENGL J MED, V348, P1096, DOI 10.1056/NEJMoa021971; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Cannon CM, 2003, AM J PHYSIOL-REG I, V284, pR1384, DOI 10.1152/ajpregu.00689.2002; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Collin M, 2003, EUR J NEUROSCI, V18, P1265, DOI 10.1046/j.1460-9568.2003.02840.x; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; CRAWLEY JN, 1983, NATURE, V302, P703, DOI 10.1038/302703a0; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; DOURISH CT, 1989, EUR J PHARMACOL, V173, P233, DOI 10.1016/0014-2999(89)90528-1; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Fan W, 2004, NAT NEUROSCI, V7, P335, DOI 10.1038/nn1214; Farooqi I.S., 2003, NEW ENGL J MED, V348, P1160, DOI DOI 10.1056/NEJM0A002050; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; GIBBS J, 1976, AM J PHYSIOL, V230, P15, DOI 10.1152/ajplegacy.1976.230.1.15; GRANDT D, 1994, REGUL PEPTIDES, V51, P151, DOI 10.1016/0167-0115(94)90204-6; Grill HJ, 1998, J NEUROSCI, V18, P10128; Hakansson ML, 1996, NEUROREPORT, V7, P3087, DOI 10.1097/00001756-199611250-00059; Halatchev IG, 2004, ENDOCRINOLOGY, V145, P2585, DOI 10.1210/en.2003-1754; Halatchev IG, 2005, CELL METAB, V1, P159, DOI 10.1016/j.cmet.2005.02.003; Haskell-Luevano C, 1999, ENDOCRINOLOGY, V140, P1408, DOI 10.1210/en.140.3.1408; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hentges ST, 2004, J NEUROSCI, V24, P1578, DOI 10.1523/JNEUROSCI.3952-03.2004; Hewson AK, 2000, J NEUROENDOCRINOL, V12, P1047, DOI 10.1046/j.1365-2826.2000.00584.x; Horvath TL, 1999, J NEUROSCI, V19, P1072; Humphreys MH, 2004, AM J PHYSIOL-REG I, V286, pR417, DOI 10.1152/ajpregu.00365.2003; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; JACOBOWITZ DM, 1978, P NATL ACAD SCI USA, V75, P6300, DOI 10.1073/pnas.75.12.6300; JOSEPH SA, 1983, NEUROSCI LETT, V38, P221, DOI 10.1016/0304-3940(83)90372-5; JOSEPH SA, 1988, PEPTIDES, V9, P193, DOI 10.1016/0196-9781(88)90027-7; Kamegai J, 2000, ENDOCRINOLOGY, V141, P4797, DOI 10.1210/en.141.12.4797; Kelly MJ, 2003, ANN NY ACAD SCI, V1007, P6, DOI 10.1196/annals.1286.001; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2001, TRENDS ENDOCRIN MET, V12, P118, DOI 10.1016/S1043-2760(00)00362-3; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Li SJ, 1996, J NEUROSCI, V16, P5182; Martin WJ, 2004, EUR UROL, V45, P706, DOI 10.1016/j.eururo.2003.03.001; Matson CA, 2000, AM J PHYSIOL-REG I, V278, pR882, DOI 10.1152/ajpregu.2000.278.4.R882; Matson CA, 1997, PEPTIDES, V18, P1275, DOI 10.1016/S0196-9781(97)00138-1; MAYER J, 1955, ANN NY ACAD SCI, V63, P15, DOI 10.1111/j.1749-6632.1955.tb36543.x; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P814, DOI 10.1210/en.140.2.814; Morgan K, 2004, J BIOL CHEM, V279, P31139, DOI 10.1074/jbc.M400458200; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Ni XP, 2003, J CLIN INVEST, V111, P1251, DOI 10.1172/JCI200316993; Ni XP, 1998, AM J PHYSIOL-REG I, V274, pR931, DOI 10.1152/ajpregu.1998.274.4.R931; NILAVER G, 1979, J CELL BIOL, V81, P50; Niswender KD, 2004, TRENDS ENDOCRIN MET, V15, P362, DOI 10.1016/j.tem.2004.07.009; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Obici S, 2002, DIABETES, V51, P271, DOI 10.2337/diabetes.51.2.271; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; PALKOVITS M, 1987, BRAIN RES, V436, P323, DOI 10.1016/0006-8993(87)91676-3; PILCHER WH, 1986, PEPTIDES, V7, P783, DOI 10.1016/0196-9781(86)90096-3; RAYBOULD HE, 1985, BRAIN RES, V342, P187, DOI 10.1016/0006-8993(85)91373-3; RIEDY CA, 1995, PHYSIOL BEHAV, V58, P755, DOI 10.1016/0031-9384(95)00108-U; RINAMAN L, 1993, J COMP NEUROL, V338, P475, DOI 10.1002/cne.903380402; Roseberry AG, 2004, NEURON, V41, P711, DOI 10.1016/S0896-6273(04)00074-1; Rosen RC, 2004, INT J IMPOT RES, V16, P135, DOI 10.1038/sj.ijir.3901200; Saper Clifford B., 1995, P107; Schwartz GJ, 2000, NUTRITION, V16, P866, DOI 10.1016/S0899-9007(00)00464-0; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Tamura H, 2002, ENDOCRINOLOGY, V143, P3268, DOI 10.1210/en.2002-220268; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tschop M, 2002, ENDOCRINOLOGY, V143, P558, DOI 10.1210/en.143.2.558; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Wang LX, 2002, NEUROSCI LETT, V325, P47; WATSON SJ, 1978, NATURE, V275, P226, DOI 10.1038/275226a0; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Williams DL, 2000, ENDOCRINOLOGY, V141, P1332, DOI 10.1210/en.141.4.1332; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; YEN TT, 1994, FASEB J, V8, P479, DOI 10.1096/fasebj.8.8.8181666; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; ZHANG XG, 1995, J COMP NEUROL, V363, P37, DOI 10.1002/cne.903630105	100	1102	1142	4	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					571	578		10.1038/nn1455	http://dx.doi.org/10.1038/nn1455			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15856065				2022-12-17	WOS:000228895100015
J	Rauschecker, JP; Scott, SK				Rauschecker, Josef P.; Scott, Sophie K.			Maps and streams in the auditory cortex: nonhuman primates illuminate human speech processing	NATURE NEUROSCIENCE			English	Review							CORTICAL-NEURONS; DISCONNECTION SYNDROMES; INTELLIGIBLE SPEECH; SENSITIVE NEURONS; NEURAL MECHANISMS; MOTOR CONTROL; BELT CORTEX; REPRESENTATION; PERCEPTION; SOUNDS	Speech and language are considered uniquely human abilities: animals have communication systems, but they do not match human linguistic skills in terms of recursive structure and combinatorial power. Yet, in evolution, spoken language must have emerged from neural mechanisms at least partially available in animals. In this paper, we will demonstrate how our understanding of speech perception, one important facet of language, has profited from findings and theory in nonhuman primate studies. Chief among these are physiological and anatomical studies showing that primate auditory cortex, across species, shows patterns of hierarchical structure, topographic mapping and streams of functional processing. We will identify roles for different cortical areas in the perceptual processing of speech and review functional imaging work in humans that bears on our understanding of how the brain decodes and monitors speech. A new model connects structures in the temporal, frontal and parietal lobes linking speech perception and production.	[Rauschecker, Josef P.] Georgetown Univ, Med Ctr, Lab Integrat Neurosci & Cognit, Washington, DC 20007 USA; [Rauschecker, Josef P.] Aalto Univ, Dept Biomed Engn & Computat Sci, Ctr Excellence Computat Complex Syst Res, FIN-02150 Espoo, Finland; [Scott, Sophie K.] UCL, Inst Cognit Neurosci, London, England	Georgetown University; Aalto University; University of London; University College London	Rauschecker, JP (corresponding author), Georgetown Univ, Med Ctr, Lab Integrat Neurosci & Cognit, Washington, DC 20007 USA.	rauschej@georgetown.edu; sophie.scott@ucl.ac.uk	Rauschecker, Josef P/A-4120-2013; Scott, Sophie K/A-1843-2010	Scott, Sophie K/0000-0001-7510-6297; Rauschecker, Josef P./0000-0003-4353-9084	US National Institutes of Health [R01NS52494]; US National Science Foundation [BCS-0519127, PIRE-OISE-0730255]; Wellcome Trust [WT074414MA]; NATIONAL EYE INSTITUTE [R01EY018923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003489, RC1DC010720] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We wish to thank D. Klemm for help with graphic design and T. Tan for help with editing. The work was supported by grants from the US National Institutes of Health (R01NS52494) and the US National Science Foundation (BCS-0519127 and PIRE-OISE-0730255) to J. P. R., and by Wellcome Trust Grant WT074414MA to S. K. S	Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; BADDELEY A, 1984, Q J EXP PSYCHOL-A, V36, P233, DOI 10.1080/14640748408402157; BAILEY PJ, 1980, J EXP PSYCHOL HUMAN, V6, P536; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Belin P, 2003, NEUROREPORT, V14, P2105, DOI 10.1097/00001756-200311140-00019; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Broca P., 1861, B MEM SOC ANTHRO PAR, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Buchsbaum BR, 2008, J COGNITIVE NEUROSCI, V20, P762, DOI 10.1162/jocn.2008.20501; BURTON H, 1976, J COMP NEUROL, V168, P249, DOI 10.1002/cne.901680204; CAPLAN D, 1992, Q J EXP PSYCHOL-A, V45, P177, DOI 10.1080/14640749208401323; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; CHEVILLET M, 2007, SOC NEUR ABSTR; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Dhanjal NS, 2008, J NEUROSCI, V28, P9969, DOI 10.1523/JNEUROSCI.2607-08.2008; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Fu KMG, 2003, J NEUROSCI, V23, P7510; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Gelfand JR, 2003, NEURON, V38, P831, DOI 10.1016/S0896-6273(03)00285-X; GESCHWIN.N, 1965, BRAIN, V88, P585, DOI 10.1093/brain/88.3.585; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Gibson J.J., 1977, PERCEIVING ACTING KN, P67, DOI DOI 10.2307/1421838; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hershberger W. A., 1976, Cybernetics Forum, V8, P97; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Hyde KL, 2008, NEUROPSYCHOLOGIA, V46, P632, DOI 10.1016/j.neuropsychologia.2007.09.004; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jacquemot C, 2006, TRENDS COGN SCI, V10, P480, DOI 10.1016/j.tics.2006.09.002; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaas JH, 1999, NAT NEUROSCI, V2, P1045, DOI 10.1038/15967; Kayser C, 2007, J NEUROSCI, V27, P1824, DOI 10.1523/JNEUROSCI.4737-06.2007; Kikuchi Y., 2008, Society for Neuroscience Abstract Viewer and Itinerary Planner, V38; Kumar S, 2007, PLOS COMPUT BIOL, V3, P977, DOI 10.1371/journal.pcbi.0030100; Leaver AM, 2009, J NEUROSCI, V29, P2477, DOI 10.1523/JNEUROSCI.4921-08.2009; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; MULLERPREUSS P, 1981, BRAIN RES, V215, P61, DOI 10.1016/0006-8993(81)90491-1; Narain C, 2003, CEREB CORTEX, V13, P1362, DOI 10.1093/cercor/bhg083; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; Numminen J, 1999, NEUROSCI LETT, V265, P119, DOI 10.1016/S0304-3940(99)00218-9; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; Obleser J, 2007, J NEUROSCI, V27, P2283, DOI 10.1523/JNEUROSCI.4663-06.2007; Obleser J, 2006, HUM BRAIN MAPP, V27, P562, DOI 10.1002/hbm.20201; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Petkov CI, 2006, PLOS BIOL, V4, P1213, DOI 10.1371/journal.pbio.0040215; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Poremba A, 2003, SCIENCE, V299, P568, DOI 10.1126/science.1078900; Rauschecker Josef P., 2007, P389, DOI 10.1007/978-0-387-71978-8_20; Rauschecker JP, 2004, J NEUROPHYSIOL, V91, P2578, DOI 10.1152/jn.00834.2003; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723, DOI 10.1152/jn.2000.83.5.2723; Recanzone GH, 2008, ANNU REV PSYCHOL, V59, P119, DOI 10.1146/annurev.psych.59.103006.093544; RIZZOLATTI G, 2006, NOVART FDN SYMP, V270, P140; RIZZOLATTI G, 2006, NOVART FDN SYMP, V270, P164; Rizzolatti Giacomo, 2006, Novartis Found Symp, V270, P129; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 2005, J NEUROPHYSIOL, V93, P734, DOI 10.1152/jn.00675.2004; Russ BE, 2008, J NEUROPHYSIOL, V99, P87, DOI 10.1152/jn.01069.2007; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Scott SK, 2005, CURR OPIN NEUROBIOL, V15, P197, DOI 10.1016/j.conb.2005.03.009; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Scott SK, 2006, J ACOUST SOC AM, V120, P1075, DOI 10.1121/1.2216725; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; Shamma S, 2008, PLOS BIOL, V6, P1141, DOI 10.1371/journal.pbio.0060155; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; SUGA N, 1979, SCIENCE, V203, P270, DOI 10.1126/science.760193; Tian B, 2004, J NEUROPHYSIOL, V92, P2993, DOI 10.1152/jn.00472.2003; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Warren JD, 2006, NEUROIMAGE, V31, P1389, DOI 10.1016/j.neuroimage.2006.01.034; Warren JE, 2005, TRENDS NEUROSCI, V28, P636, DOI 10.1016/j.tins.2005.09.010; Wernicke C., 1874, APHASISCHE SYMPTOMEN; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wise RJS, 2003, BRIT MED BULL, V65, P95, DOI 10.1093/bmb/65.1.95; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Zatorre RJ, 2004, J NEUROSCI, V24, P3637, DOI 10.1523/JNEUROSCI.5458-03.2004	103	1084	1093	7	179	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2009	12	6					718	724		10.1038/nn.2331	http://dx.doi.org/10.1038/nn.2331			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	450DJ	19471271	Green Accepted			2022-12-17	WOS:000266380900013
J	Zonta, M; Angulo, MC; Gobbo, S; Rosengarten, B; Hossmann, KA; Pozzan, T; Carmignoto, G				Zonta, M; Angulo, MC; Gobbo, S; Rosengarten, B; Hossmann, KA; Pozzan, T; Carmignoto, G			Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; NITRIC-OXIDE; SOMATOSENSORY STIMULATION; INTRACELLULAR CALCIUM; FUNCTIONAL HYPEREMIA; NMDA RECEPTORS; GLUTAMATE; MICROVESSELS; RAT; ACTIVATION	The cellular mechanisms underlying functional hyperemia-the coupling of neuronal activation to cerebral blood vessel responses-are not yet known. Here we show in rat cortical slices that the dilation of arterioles triggered by neuronal activity is dependent on glutamate-mediated [Ca2+](i) oscillations in astrocytes. Inhibition of these Ca2+ responses resulted in the impairment of activity-dependent vasodilation, whereas selective activation-by patch pipette-of single astrocytes that were in contact with arterioles triggered vessel relaxation. We also found that a cyclooxygenase product is centrally involved in this astrocyte-mediated control of arterioles. In vivo blockade of glutamate-mediated [Ca2+](i) elevations in astrocytes reduced the blood flow increase in the somatosensory cortex during contralateral forepaw stimulation. Taken together, our findings show that neuron-to-astrocyte signaling is a key mechanism in functional hyperemia.	Univ Padua, CNR, Ist Neurosci, I-35121 Padua, Italy; Univ Padua, Dipartimento Sci Biomed Sperimentali, I-35121 Padua, Italy; Ciudad Univ, Ed manuel Ancizar, Ctr Int Fis, Bogota, Colombia; Max Planck Inst Neurol Res, Dept Expt Neurol, D-50931 Cologne, Germany	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; Universidad Nacional de Colombia; Max Planck Society	Carmignoto, G (corresponding author), Univ Padua, CNR, Ist Neurosci, Viale G Colombo 3, I-35121 Padua, Italy.	gcarmi@bio.unipd.it	Angulo, Maria Cecilia/B-8236-2014; Carmignoto, Giorgio/A-8375-2018; Zonta, Micaela/AAX-3505-2020	Angulo, Maria Cecilia/0000-0002-0758-0496; Carmignoto, Giorgio/0000-0003-3063-6774; Zonta, Micaela/0000-0002-9982-6405	Telethon [1095] Funding Source: Medline	Telethon(Fondazione Telethon)		Alkayed NJ, 1997, STROKE, V28, P1066, DOI 10.1161/01.STR.28.5.1066; Araque A, 1998, J NEUROSCI, V18, P6822; Bakalova R, 2002, EXP BIOL MED, V227, P465, DOI 10.1177/153537020222700710; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Brinker G, 1999, MAGNET RESON MED, V41, P469, DOI 10.1002/(SICI)1522-2594(199903)41:3<469::AID-MRM7>3.0.CO;2-9; Carmignoto G, 2000, PROG NEUROBIOL, V62, P561, DOI 10.1016/S0301-0082(00)00029-0; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Farber NE, 1997, ANESTHESIOLOGY, V87, P1191, DOI 10.1097/00000542-199711000-00024; FERGUS A, 1995, BRAIN RES, V694, P78, DOI 10.1016/0006-8993(95)00768-L; Fergus A, 1997, BRAIN RES, V754, P35, DOI 10.1016/S0006-8993(97)00040-1; FOX PT, 1988, SCIENCE, V241, P462, DOI 10.1126/science.3260686; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; Gartner R, 2001, BIOFACTORS, V14, P199; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; GOLANOV EV, 1994, J CEREBR BLOOD F MET, V14, P492, DOI 10.1038/jcbfm.1994.61; Golgi C, 1885, RIV SPER FREMIAT MED, V11, P72; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; IADECOLA C, 1993, AM J PHYSIOL, V264, pR738, DOI 10.1152/ajpregu.1993.264.4.R738; IADECOLA C, 1993, TRENDS NEUROSCI, V16, P206, DOI 10.1016/0166-2236(93)90156-G; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Krimer LS, 1998, NAT NEUROSCI, V1, P286, DOI 10.1038/1099; Lindauer U, 1999, AM J PHYSIOL-HEART C, V277, pH799, DOI 10.1152/ajpheart.1999.277.2.H799; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Monn JA, 1999, J MED CHEM, V42, P1027, DOI 10.1021/jm980616n; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Paspalas CD, 1998, BRAIN RES BULL, V45, P247, DOI 10.1016/S0361-9230(97)00327-4; Pasti L, 1997, J NEUROSCI, V17, P7817; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PETERS A, 1991, FINE STRUCTURE NERVO, P276; Porter JT, 1996, J NEUROSCI, V16, P5073; Raichle ME, 2001, NATURE, V412, P128, DOI 10.1038/35084300; REINHARD JF, 1979, SCIENCE, V206, P85, DOI 10.1126/science.482930; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Roy C S, 1890, J Physiol, V11, P85; SAGHER O, 1993, J CEREBR BLOOD F MET, V13, P676, DOI 10.1038/jcbfm.1993.86; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schmitz B, 1997, J CEREBR BLOOD F MET, V17, P1202, DOI 10.1097/00004647-199711000-00009; Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3; VAUCHER E, 1995, J NEUROSCI, V15, P7427; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; White RP, 1998, STROKE, V29, P467, DOI 10.1161/01.STR.29.2.467; Yang G, 1999, AM J PHYSIOL-REG I, V277, pR1760, DOI 10.1152/ajpregu.1999.277.6.R1760; Yang G, 2000, J NEUROSCI, V20, P6968, DOI 10.1523/JNEUROSCI.20-18-06968.2000	48	1083	1113	3	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					43	50		10.1038/nn980	http://dx.doi.org/10.1038/nn980			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469126				2022-12-17	WOS:000180089300014
J	Ajami, B; Bennett, JL; Krieger, C; Tetzlaff, W; Rossi, FMV				Ajami, Bahareh; Bennett, Jami L.; Krieger, Charles; Tetzlaff, Wolfram; Rossi, Fabio M. V.			Local self-renewal can sustain CNS microglia maintenance and function throughout adult life	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; HEMATOPOIETIC STEM-CELLS; MOUSE MODEL; ORIGIN; TRANSPLANTATION; DEGENERATION; ENGRAFTMENT; ACTIVATION; PRECURSORS; PROGENITOR	Microgliosis is a common response to multiple types of damage in the CNS. However, the origin of the cells involved in this process is still controversial and the relative importance of local expansion versus recruitment of microglia progenitors from the bloodstream is unclear. Here, we investigated the origin of microglia using chimeric animals obtained by parabiosis. We found no evidence of microglia progenitor recruitment from the circulation in denervation or CNS neurodegenerative disease, suggesting that maintenance and local expansion of microglia are solely dependent on the self-renewal of CNS resident cells in these models.	Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Simon Fraser Univ, Dept Kinesiol, Burnaby, BC V5A 1S6, Canada; Vancouver Hosp & Hlth Sci Ctr, Dept Med, Div Neurol, Neuromuscular Dis Unit, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Zool, Dept Surg, Int Collaborat Repair Discoveries, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; Simon Fraser University; University of British Columbia; University of British Columbia	Rossi, FMV (corresponding author), Univ British Columbia, Biomed Res Ctr, 2222 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fabio@brc.ubc.ca	Rossi, Fabio MV/B-5587-2013; Tetzlaff, Wolfram/AAY-4430-2020; Ajami, Bahareh/AAA-7262-2019	Rossi, Fabio MV/0000-0002-0368-2620; 				Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Asheuer M, 2004, P NATL ACAD SCI USA, V101, P3557, DOI 10.1073/pnas.0306431101; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Diserbo M, 2002, CAN J PHYSIOL PHARM, V80, P670, DOI 10.1139/Y02-070; DONSKOY E, 1992, J IMMUNOL, V148, P1604; Flugel A, 2001, J NEUROSCI RES, V66, P74, DOI 10.1002/jnr.1198; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; GRAEBER MB, 1988, NEUROSCI LETT, V85, P317, DOI 10.1016/0304-3940(88)90585-X; Graeber MB, 1998, BRAIN RES, V813, P241, DOI 10.1016/S0006-8993(98)00859-2; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; JENSEN MB, 1994, EXP BRAIN RES, V98, P245; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; KRALL WJ, 1994, BLOOD, V83, P2737; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lehrmann E, 1997, J COMP NEUROL, V386, P461; Li SP, 2004, MOL BRAIN RES, V125, P156, DOI 10.1016/j.molbrainres.2004.02.025; Li YQ, 2004, RADIAT RES, V161, P143, DOI 10.1667/RR3117; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; McPhail LT, 2004, EXP NEUROL, V188, P331, DOI 10.1016/j.expneurol.2004.04.010; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Moran LB, 2004, BRAIN RES REV, V44, P154, DOI 10.1016/j.brainresrev.2003.11.004; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rossi FMV, 2005, NAT IMMUNOL, V6, P626, DOI 10.1038/ni1203; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; STREIT WJ, 1988, J COMP NEUROL, V268, P248, DOI 10.1002/cne.902680209; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	44	1082	1100	2	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1538	1543		10.1038/nn2014	http://dx.doi.org/10.1038/nn2014			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	18026097				2022-12-17	WOS:000251172900010
J	Todorov, E				Todorov, E			Optimality principles in sensorimotor control	NATURE NEUROSCIENCE			English	Review							OPTIMAL FEEDBACK-CONTROL; OPTIMAL-CONTROL MODEL; ARM MOVEMENTS; DYNAMIC OPTIMIZATION; TRAJECTORY FORMATION; REACHING MOVEMENTS; MUSCLE RECRUITMENT; MOTOR-PERFORMANCE; INTERNAL-MODELS; FORCE CONTROL	The sensorimotor system is a product of evolution, development, learning and adaptation - which work on different time scales to improve behavioral performance. Consequently, many theories of motor function are based on 'optimal performance': they quantify task goals as cost functions, and apply the sophisticated tools of optimal control theory to obtain detailed behavioral predictions. The resulting models, although not without limitations, have explained more empirical phenomena than any other class. Traditional emphasis has been on optimizing desired movement trajectories while ignoring sensory feedback. Recent work has redefined optimality in terms of feedback control laws, and focused on the mechanisms that generate behavior online. This approach has allowed researchers to fit previously unrelated concepts and observations into what may become a unified theoretical framework for interpreting motor function. At the heart of the framework is the relationship between high-level goals, and the real-time sensorimotor control strategies most suitable for accomplishing those goals.	Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Todorov, E (corresponding author), Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA.	todorov@cogsci.ucsd.edu			NINDS NIH HHS [R01-NS045915, R01 NS045915] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045915] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson FC, 2001, J BIOMECH ENG-T ASME, V123, P381, DOI 10.1115/1.1392310; Barlow H., 1961, SENSORY COMMUNICATIO, P217; Bernstein N.A., 1996, RES ECOL PS; Bernstein N.A., 1947, CONSTRUCTION MOVEMEN; Bernstein NA., 1967, COORDINATION REGULAT; BERTSEKAS D, 1997, NEURODYNAMIC PROGRAM; BIZZI E, 1984, J NEUROSCI, V4, P2738; BIZZI E, 1992, BEHAV BRAIN SCI, V15, P603, DOI 10.1017/S0140525X00072538; Bryson AE., 1969, APPL OPTIMAL CONTROL; BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Camacho E., 1999, MODEL PREDICTIVE CON; CHOW C K, 1971, Mathematical Biosciences, V10, P239, DOI 10.1016/0025-5564(71)90062-9; Cisek P, 1998, J COGNITIVE NEUROSCI, V10, P425, DOI 10.1162/089892998562852; COLE KJ, 1987, J NEUROPHYSIOL, V57, P1498, DOI 10.1152/jn.1987.57.5.1498; COLLINS JJ, 1995, J BIOMECH, V28, P251, DOI 10.1016/0021-9290(94)00072-C; Conditt MA, 1999, P NATL ACAD SCI USA, V96, P11625, DOI 10.1073/pnas.96.20.11625; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; Davis M., 1985, STOCHASTIC MODELLING; DAVY DT, 1987, J BIOMECH, V20, P187, DOI 10.1016/0021-9290(87)90310-1; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Fagg AH, 2002, J NEUROPHYSIOL, V88, P3348, DOI 10.1152/jn.00621.2002; FELDMAN AG, 1995, BEHAV BRAIN SCI, V18, P723, DOI 10.1017/S0140525X0004070X; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Flanagan JR, 2001, J NEUROSCI, V21, P1361; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FLASH T, 1991, J COGNITIVE NEUROSCI, V3, P220, DOI 10.1162/jocn.1991.3.3.220; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; GRACCO VL, 1985, J NEUROPHYSIOL, V54, P418, DOI 10.1152/jn.1985.54.2.418; Gribble PL, 1999, J NEUROPHYSIOL, V82, P2310, DOI 10.1152/jn.1999.82.5.2310; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Hamilton AFD, 2002, J NEUROPHYSIOL, V87, P2434, DOI 10.1152/jn.00875.2001; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Harwood MR, 1999, J NEUROSCI, V19, P9098, DOI 10.1523/JNEUROSCI.19-20-09098.1999; HATZE H, 1977, BIOL CYBERN, V27, P9, DOI 10.1007/BF00357705; HINTON G, 1984, J MOTOR BEHAV, V16, P171; HOFF B, 1993, J MOTOR BEHAV, V25, P175, DOI 10.1080/00222895.1993.9942048; Hoff B., 1992, THESIS U SO CALIFORN; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; HOGAN N, 1984, J NEUROSCI, V4, P2745; HUMPHREY DR, 1983, ADV NEUROLOGY MOTOR, P347; Ijspeert AJ, 2001, BIOL CYBERN, V84, P331, DOI 10.1007/s004220000211; Ivanchenko V, 2003, NEURAL COMPUT, V15, P2051, DOI 10.1162/089976603322297287; Ivanenko YP, 2003, J NEUROPHYSIOL, V90, P3555, DOI 10.1152/jn.00223.2003; Kalaska JF, 1998, NOVART FDN SYMP, V218, P176; Kalman R.E., 1964, J FLUID ENG-T ASME, V86, P51, DOI [10.1115/1.3653115, DOI 10.1115/1.3653115]; Kawagoe A, 1999, IEEE T APPL SUPERCON, V9, P727, DOI 10.1109/77.783398; Kelso J.A.S., 1995, DYNAMIC PATTERNS SEL; KHATIB O, 1987, IEEE T ROBOTIC AUTOM, V3, P43, DOI 10.1109/JRA.1987.1087068; Kirk D.E., 2004, OPTIMAL CONTROL THEO; Knill DC, 1996, PERCEPTION BAYESIAN; KOMILIS E, 1993, J MOTOR BEHAV, V25, P299, DOI 10.1080/00222895.1993.9941651; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; KORENBERG A, 2003, THESIS U COLL LONDON; KUO AD, 1995, IEEE T BIO-MED ENG, V42, P87, DOI 10.1109/10.362914; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Latash M. L., 1999, MOTOR CONTROL TODAY, P181; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; LI W, IN PRESS P 26 ANN IN; LI W, IN PRESS P 1 INT C I; Li ZM, 1998, EXP BRAIN RES, V119, P276, DOI 10.1007/s002210050343; Loeb GE, 1999, EXP BRAIN RES, V126, P1, DOI 10.1007/s002210050712; Loeb GE, 2001, MED ENG PHYS, V23, P9, DOI 10.1016/S1350-4533(01)00011-X; LOEB GE, 1990, COLD SH Q B, V55, P791; Marr D., 1982, VISION; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; MILNER TE, 1990, NEUROSCIENCE, V35, P365, DOI 10.1016/0306-4522(90)90090-Q; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; MOYLAN PJ, 1973, IEEE T AUTOMAT CONTR, VAC18, P460, DOI 10.1109/TAC.1973.1100365; Nakano E, 1999, J NEUROPHYSIOL, V81, P2140, DOI 10.1152/jn.1999.81.5.2140; NELSON WL, 1983, BIOL CYBERN, V46, P135, DOI 10.1007/BF00339982; Ng A. Y., 2000, INT C MACH LEARN ICM; NICHOLS TR, 1976, J NEUROPHYSIOL, V39, P119, DOI 10.1152/jn.1976.39.1.119; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Ostry DJ, 2003, EXP BRAIN RES, V153, P275, DOI 10.1007/s00221-003-1624-0; PANDY MG, 1995, J BIOMECH ENG-T ASME, V117, P15, DOI 10.1115/1.2792265; PANDY MG, 1990, J BIOMECH, V23, P1185, DOI 10.1016/0021-9290(90)90376-E; PELLIONISZ AJ, 1984, J THEOR BIOL, V110, P353, DOI 10.1016/S0022-5193(84)80179-4; Popovic D, 1999, IEEE Trans Rehabil Eng, V7, P69, DOI 10.1109/86.750554; Pratt J, 2001, INT J ROBOT RES, V20, P129, DOI 10.1177/02783640122067309; Rasmussen J, 2001, J BIOMECH, V34, P409, DOI 10.1016/S0021-9290(00)00191-3; Robertson EM, 1997, EXP BRAIN RES, V117, P148, DOI 10.1007/s002210050208; Rosenbaum D. A., 1991, HUMAN MOTOR CONTROL; Sabes PN, 1998, J NEUROSCI, V18, P5948; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; Scholz JP, 2000, EXP BRAIN RES, V135, P382, DOI 10.1007/s002210000540; Scholz JP, 1999, EXP BRAIN RES, V126, P289, DOI 10.1007/s002210050738; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shimansky YP, 2004, BIOL CYBERN, V90, P133, DOI 10.1007/s00422-003-0452-4; Shimansky YP, 2000, BIOL CYBERN, V83, P379, DOI 10.1007/s004220000159; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.1111/j.1467-8624.1993.tb04182.x; SUTTON GG, 1967, J PHYSIOL-LONDON, V191, P699, DOI 10.1113/jphysiol.1967.sp008276; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Todorov E, 2003, P ANN INT IEEE EMBS, V25, P1750, DOI 10.1109/IEMBS.2003.1279744; Todorov E, 2002, NEURAL COMPUT, V14, P1233, DOI 10.1162/089976602753712918; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; Todorov E, 1998, J NEUROPHYSIOL, V80, P696, DOI 10.1152/jn.1998.80.2.696; TODOROV E, 2003, P 25 ANN INT C IEEE; Todorov E., 2002, ADV NEURAL INFORM PR, V15, P27; Torres EB, 2002, J NEUROPHYSIOL, V88, P2355, DOI 10.1152/jn.00030.2002; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Valero-Cuevas FJ, 1998, J BIOMECH, V31, P693, DOI 10.1016/S0021-9290(98)00082-7; Wang T, 2001, BIOL CYBERN, V85, P437, DOI 10.1007/s004220100277; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; WOODWORTH RS, 1899, PSYCHOL REV MONOGR, V3; Zhu G, 1997, SIAM J CONTROL OPTIM, V35, P341, DOI 10.1137/S0363012994263974	119	1082	1098	7	132	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2004	7	9					907	915		10.1038/nn1309	http://dx.doi.org/10.1038/nn1309			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849NX	15332089	Green Accepted			2022-12-17	WOS:000223546700006
J	Cardona, AE; Pioro, EP; Sasse, ME; Kostenko, V; Cardona, SM; Dijkstra, IM; Huang, DR; Kidd, G; Dombrowski, S; Dutta, R; Lee, JC; Cook, DN; Jung, S; Lira, SA; Littman, DR; Ransohoff, RM				Cardona, Astrid E.; Pioro, Erik P.; Sasse, Margaret E.; Kostenko, Volodymyr; Cardona, Sandra M.; Dijkstra, Ineke M.; Huang, DeRen; Kidd, Grahame; Dombrowski, Stephen; Dutta, RanJan; Lee, Jar-Chi; Cook, Donald N.; Jung, Steffen; Lira, Sergio A.; Littman, Dan R.; Ransohoff, Richard M.			Control of microglial neurotoxicity by the fractalkine receptor	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; CHEMOKINE FRACTALKINE; TARGETED DELETION; IN-VIVO; BRAIN; MICE; MECHANISMS; EXPRESSION; NEURONS	Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor ( CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1(-/-) mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1(-/-) mice showed more extensive neuronal cell loss than Cx3cr(+) littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.	Cleveland Clin, Neuroinflammat Res Ctr, Cleveland, OH 44195 USA; Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin, Dept Neurosurg, Cleveland, OH 44195 USA; Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; NIEHS, Res Triangle Pk, NC 27709 USA; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Weizmann Institute of Science; Howard Hughes Medical Institute; New York University; New York University; Icahn School of Medicine at Mount Sinai	Ransohoff, RM (corresponding author), Cleveland Clin, Neuroinflammat Res Ctr, Cleveland, OH 44195 USA.	ransohr@ccf.org	Pioro, Erik P/AAZ-5318-2020; Cook, Donald/E-5079-2019; Cardona, Astrid E/K-4749-2013; Jung, Steffen/K-1409-2012	Pioro, Erik P/0000-0002-0737-6065; Cook, Donald/0000-0002-0052-3755; Cardona, Astrid E/0000-0002-5093-8078; Jung, Steffen/0000-0003-4290-5716; Kidd, Grahame/0000-0003-3956-2206	NINDS NIH HHS [NS32151] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES102025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032151] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boehme SA, 2000, J IMMUNOL, V165, P397, DOI 10.4049/jimmunol.165.1.397; Carson MJ, 1999, AM J PATHOL, V154, P481, DOI 10.1016/S0002-9440(10)65294-7; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cook DN, 2001, MOL CELL BIOL, V21, P3159, DOI 10.1128/MCB.21.9.3159-3165.2001; Cybulsky MI, 2003, J CLIN INVEST, V111, P1118, DOI 10.1172/JCI200318237; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Facchinetti F, 1999, NEUROSCIENCE, V90, P1483, DOI 10.1016/S0306-4522(98)00492-8; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Hulshof S, 2003, J NEUROPATH EXP NEUR, V62, P899, DOI 10.1093/jnen/62.9.899; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kust BM, 2003, AMYOTROPH LATERAL SC, V4, P100, DOI 10.1080/14660820301185; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Meucci O, 2001, P NATL ACAD SCI USA, V98, P15393; Milligan E, 2005, EUR J NEUROSCI, V22, P2775, DOI 10.1111/j.1460-9568.2005.04470.x; Milligan ED, 2004, EUR J NEUROSCI, V20, P2294, DOI 10.1111/j.1460-9568.2004.03709.x; Mitsumoto H, 2001, MUSCLE NERVE, V24, P769, DOI 10.1002/mus.1068; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Soriano SG, 2002, J NEUROIMMUNOL, V125, P59, DOI 10.1016/S0165-5728(02)00033-4; Sugama S, 2003, BRAIN RES, V964, P288, DOI 10.1016/S0006-8993(02)04085-4; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; WEST RW, 1993, CARCINOGENESIS, V14, P285, DOI 10.1093/carcin/14.2.285; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	38	1080	1109	3	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					917	924		10.1038/nn1715	http://dx.doi.org/10.1038/nn1715			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16732273				2022-12-17	WOS:000238590800018
J	Usoskin, D; Furlan, A; Islam, S; Abdo, H; Lonnerberg, P; Lou, D; Hjerling-Leffler, J; Haeggstrom, J; Kharchenko, O; Kharchenko, PV; Linnarsson, S; Ernfors, P				Usoskin, Dmitry; Furlan, Alessandro; Islam, Saiful; Abdo, Hind; Lonnerberg, Peter; Lou, Daohua; Hjerling-Leffler, Jens; Haeggstrom, Jesper; Kharchenko, Olga; Kharchenko, Peter V.; Linnarsson, Sten; Ernfors, Patrik			Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing	NATURE NEUROSCIENCE			English	Article							GASTRIN-RELEASING-PEPTIDE; LYSOPHOSPHATIDIC ACID; NOCICEPTIVE NEURONS; SOMATIC SENSATIONS; NEUROPATHIC PAIN; ITCH SENSATION; NOXIOUS HEAT; SPINAL-CORD; RECEPTOR; SEQ	The primary sensory system requires the integrated function of multiple cell types, although its full complexity remains unclear. We used comprehensive transcriptome analysis of 622 single mouse neurons to classify them in an unbiased manner, independent of any a priori knowledge of sensory subtypes. Our results reveal eleven types: three distinct low-threshold mechanoreceptive neurons, two proprioceptive, and six principal types of thermosensitive, itch sensitive, type C low-threshold mechanosensitive and nociceptive neurons with markedly different molecular and operational properties. Confirming previously anticipated major neuronal types, our results also classify and provide markers for new, functionally distinct subtypes. For example, our results suggest that itching during inflammatory skin diseases such as atopic dermatitis is linked to a distinct itch-generating type. We demonstrate single-cell RNA-seq as an effective strategy for dissecting sensory responsive cells into distinct neuronal types. The resulting catalog illustrates the diversity of sensory types and the cellular complexity underlying somatic sensation.	[Usoskin, Dmitry; Furlan, Alessandro; Islam, Saiful; Abdo, Hind; Lonnerberg, Peter; Lou, Daohua; Hjerling-Leffler, Jens; Kharchenko, Olga; Linnarsson, Sten; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, Stockholm, Sweden; [Haeggstrom, Jesper] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem, Stockholm, Sweden; [Kharchenko, Peter V.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Kharchenko, Peter V.] Childrens Hosp, Div Hematol & Oncol, Boston, MA 02115 USA	Karolinska Institutet; Karolinska Institutet; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Ernfors, P (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, Stockholm, Sweden.	sten.linnarsson@ki.se; patrik.ernfors@ki.se	Linnarsson, Sten/HCH-3909-2022; Furlan, Alessandro/AAM-4680-2021; Hjerling Leffler, Jens/E-3775-2012	Furlan, Alessandro/0000-0001-5149-6331; Hjerling Leffler, Jens/0000-0002-4539-1776; Abdo, Hind/0000-0002-6910-9165	Wallenberg Foundation; Swedish Research Council for Medicine and Health; Swedish Foundation for Strategic Research and Linne grants (DBRM grants); Swedish Brain Foundation; Hallsten Foundation; Torsten Soderberg Foundation; European Research Council [261063, 232675]	Wallenberg Foundation(European Commission); Swedish Research Council for Medicine and Health; Swedish Foundation for Strategic Research and Linne grants (DBRM grants); Swedish Brain Foundation; Hallsten Foundation; Torsten Soderberg Foundation; European Research Council(European Research Council (ERC)European Commission)	The authors thank the CLICK Imaging Facility, supported by the Wallenberg Foundation. This work was supported by the Swedish Research Council for Medicine and Health, the Swedish Foundation for Strategic Research and Linne grants (DBRM grants), the Swedish Brain Foundation, Hallsten Foundation, Torsten Soderberg Foundation, Wallenberg Scholar and European Research Council advanced grant (232675) to P.E.; and by European Research Council starting grant (261063) to S.L.	Abdo H, 2011, EUR J NEUROSCI, V34, P1529, DOI 10.1111/j.1460-9568.2011.07883.x; ANDRES KH, 1961, Z ZELLFORSCH MIK ANA, V55, P1, DOI 10.1007/BF00319327; Angelova-Fischer I, 2005, ACTA DERMATOVEN ALP, V14, P115; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chi XX, 2010, J NEUROPHYSIOL, V104, P2741, DOI 10.1152/jn.00709.2010; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dobner PR, 2006, PEPTIDES, V27, P2405, DOI 10.1016/j.peptides.2006.04.025; Doyle T, 2011, PAIN, V152, P643, DOI 10.1016/j.pain.2010.12.011; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Furlan A, 2013, EMBO J, V32, P1613, DOI 10.1038/emboj.2013.85; Gascon E, 2010, J NEUROSCI, V30, P12414, DOI 10.1523/JNEUROSCI.3135-10.2010; Goswami SC, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-44; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Lallemend F, 2012, TRENDS NEUROSCI, V35, P373, DOI 10.1016/j.tins.2012.03.006; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Lieberman A. R., 1976, THE PERIPHERAL NERVE, P188; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu T, 2013, PFLUG ARCH EUR J PHY, V465, P1671, DOI 10.1007/s00424-013-1284-2; Liu XY, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-4; Liu Y, 2011, CURR OPIN NEUROBIOL, V21, P52, DOI 10.1016/j.conb.2010.09.003; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Ma QF, 2012, NEUROSCI BULL, V28, P91, DOI 10.1007/s12264-012-1201-2; Ma QF, 2010, J CLIN INVEST, V120, P3773, DOI 10.1172/JCI43426; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Smith MT, 2013, PAIN MED, V14, P1557, DOI 10.1111/pme.12157; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Ueda H, 2013, BBA-MOL CELL BIOL L, V1831, P61, DOI 10.1016/j.bbalip.2012.08.014; Usoskin D, 2010, P NATL ACAD SCI USA, V107, P16336, DOI 10.1073/pnas.0914705107; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Welch SP, 2012, BIOCHEM PHARMACOL, V84, P1551, DOI 10.1016/j.bcp.2012.08.010; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Wichterle H, 2013, SCIENCE, V341, P726, DOI 10.1126/science.1235884; Wilson SR, 2011, NAT NEUROSCI, V14, P595, DOI 10.1038/nn.2789; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016	57	1064	1080	6	222	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2015	18	1					145	+		10.1038/nn.3881	http://dx.doi.org/10.1038/nn.3881			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AX5WH	25420068				2022-12-17	WOS:000346995000022
J	Sanchez-Vives, MV; McCormick, DA				Sanchez-Vives, MV; McCormick, DA			Cellular and network mechanisms of rhythmic recurrent activity in neocortex	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; MEMBRANE-POTENTIAL FLUCTUATIONS; NEURONS IN-VIVO; CORTICAL RESPONSES; ONGOING ACTIVITY; WORKING-MEMORY; HZ OSCILLATION; NMDA RECEPTORS; ELECTROENCEPHALOGRAM; EXCITABILITY	The neocortex generates periods of recurrent activity, such as the slow (0.1-0.5 Hz) oscillation during slow-wave sleep. Here we demonstrate that slices of ferret neocortex maintained in vitro generate this slow (< 1 Hz) rhythm when placed in a bathing medium that mimics the extracellular ionic composition in situ. This slow oscillation seems to be initiated in layer 5 as an excitatory interaction between pyramidal neurons and propagates through the neocortex. Our results demonstrate that the cerebral cortex generates an 'up' or depolarized state through recurrent excitation that is regulated by inhibitory networks, thereby allowing local cortical circuits to enter into temporarily activated and self-maintained excitatory states. The spontaneous generation and failure of this self-excited state may account for the generation of a subset of cortical rhythms during sleep.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.		McCormick, David A/J-2649-2015; Kobelt, Liza/F-5926-2011; Sanchez-Vives, Maria/J-8526-2014	McCormick, David A/0000-0002-9803-8335; Sanchez-Vives, Maria/0000-0002-8437-9083				Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; AVOLI M, 1991, ANN NEUROL, V30, P589, DOI 10.1002/ana.410300412; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; De No RL, 1938, J NEUROPHYSIOL, V1, P207; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FOEHRING RC, 1989, J NEUROPHYSIOL, V61, P245, DOI 10.1152/jn.1989.61.2.245; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Haj-Dahmane S, 1998, J NEUROPHYSIOL, V80, P1197, DOI 10.1152/jn.1998.80.3.1197; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; LEWANDOWSKI MH, 1993, EXP BRAIN RES, V96, P1; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; METHERATE R, 1993, J NEUROSCI, V13, P5312, DOI 10.1523/JNEUROSCI.13-12-05312.1993; MOUNTCASTLE VB, 1987, J NEUROSCI, V7, P2239; Nowak LG, 1997, CEREBR CORT, V12, P205; PHILLIS J W, 1968, Brain Research, V7, P378, DOI 10.1016/0006-8993(68)90004-8; Raman IM, 1999, J NEUROSCI, V19, P1663; Reid RC, 1996, CURR OPIN NEUROBIOL, V6, P475, DOI 10.1016/S0959-4388(96)80052-3; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCHWINDT PC, 1989, J NEUROPHYSIOL, V61, P233, DOI 10.1152/jn.1989.61.2.233; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; SOMERS D, 1995, J NEUROSCI, V15, P5449; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROPHYSIOL, V70, P1385, DOI 10.1152/jn.1993.70.4.1385; STERIADE M, 1995, J NEUROSCI, V15, P623; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Telfeian AE, 1999, EPILEPSIA, V40, P1499, DOI 10.1111/j.1528-1157.1999.tb02032.x; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Wang XJ, 1999, J NEUROSCI, V19, P9587; YAMAGUCHI T, 1986, Bulletin of Tokyo Medical and Dental University, V33, P1; ZHANG ET, 1990, J CEREBR BLOOD F MET, V10, P136, DOI 10.1038/jcbfm.1990.18	43	1054	1063	0	57	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2000	3	10					1027	1034		10.1038/79848	http://dx.doi.org/10.1038/79848			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TW	11017176				2022-12-17	WOS:000167177500021
J	Miron, VE; Boyd, A; Zhao, JW; Yuen, TJ; Ruckh, JM; Shadrach, JL; van Wijngaarden, P; Wagers, AJ; Williams, A; Franklin, RJM; Ffrench-Constant, C				Miron, Veronique E.; Boyd, Amanda; Zhao, Jing-Wei; Yuen, Tracy J.; Ruckh, Julia M.; Shadrach, Jennifer L.; van Wijngaarden, Peter; Wagers, Amy J.; Williams, Anna; Franklin, Robin J. M.; Ffrench-Constant, Charles			M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination	NATURE NEUROSCIENCE			English	Article							GADOLINIUM CHLORIDE; PROGENITOR CELLS; GENE-EXPRESSION; ACTIVIN-A; IDENTIFICATION; MONOCYTES; INJURY; BETA; REGENERATION; PROGRESSION	The lack of therapies for progressive multiple sclerosis highlights the need to understand the regenerative process of remyelination that can follow CNS demyelination. This involves an innate immune response consisting of microglia and macrophages, which can be polarized to distinct functional phenotypes: pro-inflammatory (M1) and anti-inflammatory or immunoregulatory (M2). We found that a switch from an M1- to an M2-dominant response occurred in microglia and peripherally derived macrophages as remyelination started. Oligodendrocyte differentiation was enhanced in vitro with M2 cell conditioned media and impaired in vivo following intra-lesional M2 cell depletion. M2 cell densities were increased in lesions of aged mice in which remyelination was enhanced by parabiotic coupling to a younger mouse and in multiple sclerosis lesions that normally show remyelination. Blocking M2 cell-derived activin-A inhibited oligodendrocyte differentiation during remyelination in cerebellar slice cultures. Thus, our results indicate that M2 cell polarization is essential for efficient remyelination and identify activin-A as a therapeutic target for CNS regeneration.	[Miron, Veronique E.; Boyd, Amanda; Yuen, Tracy J.; Williams, Anna; Ffrench-Constant, Charles] Univ Edinburgh, Multiple Sclerosis Soc Ctr Translat Res, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland; [Zhao, Jing-Wei; Yuen, Tracy J.; Ruckh, Julia M.; van Wijngaarden, Peter; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, MRC Cambridge Stem Cell Inst, Wellcome Trust, Cambridge, England; [Shadrach, Jennifer L.; Wagers, Amy J.] Harvard Univ, Howard Hughes Med Inst, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Shadrach, Jennifer L.; Wagers, Amy J.] Joslin Diabet Ctr, Cambridge, MA USA	University of Edinburgh; University of Cambridge; Wellcome Trust Sanger Institute; Harvard University; Howard Hughes Medical Institute; Harvard University; Joslin Diabetes Center, Inc.	Miron, VE (corresponding author), Univ Edinburgh, Multiple Sclerosis Soc Ctr Translat Res, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland.	vmiron@staffmail.ed.ac.uk	Zhao, Jing-Wei/A-6887-2012; Zhao, Jing-Wei/L-9964-2014; Miron, Veronique E./H-4280-2019	Zhao, Jing-Wei/0000-0002-1135-9743; Miron, Veronique E./0000-0003-1738-0647; Franklin, Robin/0000-0001-6522-2104; Williams, Anna/0000-0002-6329-382X; Yuen, Tracy/0000-0002-3451-9279; van Wijngaarden, Peter/0000-0002-8800-7834	UK Multiple Sclerosis Society; Wellcome Trust; Multiple Sclerosis Society of Canada; Medical Research Council [MR/K017047/1B, G0300336, G0802545] Funding Source: researchfish; MRC [G0300336, G0802545] Funding Source: UKRI	UK Multiple Sclerosis Society; Wellcome Trust(Wellcome TrustEuropean Commission); Multiple Sclerosis Society of Canada; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the UK Multiple Sclerosis Tissue Bank for providing human brain tissue, F. Roncaroli (Imperial College London) for neuropathological diagnosis of lesions and R. Nicholas (Imperial College London) for providing clinical history of patients. We also thank W. Mungall, J. Huang, M. Harrisingh, A. Jarjour, M. Bechler, M. Swire, A.-C. Nunes-Fonseca, D. Morrison, and C. Watkins for technical assistance. This work was funded by the UK Multiple Sclerosis Society (R.J.M.F. and C.ff.-C.) and the Wellcome Trust (A.W. and C.ff.-C.), and V.E.M. holds a post-doctoral fellowship from the Multiple Sclerosis Society of Canada.	Abdel-Zaher AO, 2007, TOXICOLOGY, V234, P124, DOI 10.1016/j.tox.2007.02.014; Ahn M, 2012, BRAIN RES, V1453, P77, DOI 10.1016/j.brainres.2012.03.023; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Attisano L, 1996, MOL CELL BIOL, V16, P1066; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; CASH E, 1993, CELL IMMUNOL, V147, P129, DOI 10.1006/cimm.1993.1053; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11; Diemel LT, 2003, J NEUROSCI RES, V74, P858, DOI 10.1002/jnr.10837; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Etxeberria A, 2010, NAT NEUROSCI, V13, P287, DOI 10.1038/nn.2500; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Guardiola-Diaz HM, 2012, GLIA, V60, P476, DOI 10.1002/glia.22281; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; He JT, 2012, MOLECULES, V17, P315, DOI 10.3390/molecules17010315; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Kuhlmann T, 2008, BRAIN, V131, P1749, DOI 10.1093/brain/awn096; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; MATZUK MM, 1995, TRENDS ENDOCRIN MET, V6, P120, DOI 10.1016/1043-2760(95)00032-D; MCKINNON RD, 1993, J CELL BIOL, V121, P1397, DOI 10.1083/jcb.121.6.1397; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Mizgerd JP, 1996, J LEUKOCYTE BIOL, V59, P189, DOI 10.1002/jlb.59.2.189; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; PENDINO KJ, 1995, AM J RESP CELL MOL, V13, P125, DOI 10.1165/ajrcmb.13.2.7542894; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sakai T, 2012, CELL TRANSPLANT, V21, P355, DOI 10.3727/096368911X580545; Schaier M, 2009, AM J PHYSIOL-RENAL, V297, pF769, DOI 10.1152/ajprenal.90530.2008; Serrats J, 2010, NEURON, V65, P94, DOI 10.1016/j.neuron.2009.11.032; Thurnherr T, 2006, J NEUROSCI, V26, P10110, DOI 10.1523/JNEUROSCI.2158-06.2006; Voss EV, 2012, NEUROBIOL DIS, V45, P519, DOI 10.1016/j.nbd.2011.09.008; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Woodruff RH, 1999, NEUROPATH APPL NEURO, V25, P226; Yuen TJ, 2013, BRAIN, V136, P1035, DOI 10.1093/brain/awt024	48	1050	1080	11	192	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1211	U75		10.1038/nn.3469	http://dx.doi.org/10.1038/nn.3469			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23872599	Green Accepted			2022-12-17	WOS:000323597500012
J	Gilbertson, MW; Shenton, ME; Ciszewski, A; Kasai, K; Lasko, NB; Orr, SP; Pitman, RK				Gilbertson, MW; Shenton, ME; Ciszewski, A; Kasai, K; Lasko, NB; Orr, SP; Pitman, RK			Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma	NATURE NEUROSCIENCE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ERA TWIN REGISTRY; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; SEXUAL ABUSE; PTSD; BRAIN; MRI; DAMAGE; SIZE	In animals, exposure to severe stress can damage the hippocampus. Recent human studies show smaller hippocampal volume in individuals with the stress-related psychiatric condition posttraumatic stress disorder (PTSD). Does this represent the neurotoxic effect of trauma, or is smaller hippocampal volume a pre-existing condition that renders the brain more vulnerable to the development of pathological stress responses? In monozygotic twins discordant for trauma exposure, we found evidence that smaller hippocampi indeed constitute a risk factor for the development of stress-related psychopathology. Disorder severity in PTSD patients who were exposed to trauma was negatively correlated with the hippocampal volume of both the patients and the patients' trauma-unexposed identical co-twin. Furthermore, severe PTSD twin pairs-both the trauma-exposed and unexposed members-had significantly smaller hippocampi than non-PTSD pairs.	Vet Adm Med Ctr, Res Serv, Manchester, NH 03104 USA; Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; Vet Adm Boston Healthcare Syst, Psychiat Serv, Brockton, MA 02301 USA; Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02129 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Gilbertson, MW (corresponding author), Vet Adm Med Ctr, Res Serv, 718 Smyth Rd, Manchester, NH 03104 USA.	mark.gilbertson@med.va.gov	Shenton, Martha/V-8780-2019	Kasai, Kiyoto/0000-0002-4443-4535	NIMH NIH HHS [R01-MH54636, K02-MH01110, R01 MH054636, K02 MH001110-10] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001110, R01MH054636] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANTELMAN SM, 1972, PHYSIOL BEHAV, V9, P15, DOI 10.1016/0031-9384(72)90257-0; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Bremner JD, 2001, HIPPOCAMPUS, V11, P75, DOI 10.1002/hipo.1023; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; BRESLAU N, 1992, AM J PSYCHIAT, V149, P671; CRUSIO WE, 1989, BEHAV BRAIN RES, V32, P81, DOI 10.1016/S0166-4328(89)80075-0; De Bellis MD, 2000, AM J PSYCHIAT, V157, P737, DOI 10.1176/appi.ajp.157.5.737; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; EISEN S, 1987, ACTA GENET MED GEMEL, V36, P61, DOI 10.1017/S0001566000004591; EISEN S, 1989, CLIN GENET, V35, P423, DOI 10.1111/j.1399-0004.1989.tb02967.x; Falls William A., 1995, P177; Freeman TW, 1998, MAGNET RESON MED, V40, P66, DOI 10.1002/mrm.1910400110; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; HENDERSON WG, 1990, PUBLIC HEALTH REP, V105, P368; JANES GR, 1991, J CLIN PSYCHOL, V47, P80, DOI 10.1002/1097-4679(199101)47:1<80::AID-JCLP2270470112>3.0.CO;2-9; Keane TM, 1997, ANN NY ACAD SCI, V821, P24, DOI 10.1111/j.1749-6632.1997.tb48266.x; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kulka R.A., 1990, TRAUMA VIETNAM WAR G; Laakso MP, 2000, BEHAV BRAIN RES, V109, P177, DOI 10.1016/S0166-4328(99)00172-2; Lyons DM, 2001, ARCH GEN PSYCHIAT, V58, P1145, DOI 10.1001/archpsyc.58.12.1145; McEwen Bruce S., 1995, P1117; McEwen BS, 2001, HIPPOCAMPUS, V11, P82, DOI 10.1002/hipo.1024; MELLMAN TA, 1992, AM J PSYCHIAT, V149, P1568; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; ORR SP, IN PRESS ARCH GEN PS; Pennington BF, 2000, J COGNITIVE NEUROSCI, V12, P223, DOI 10.1162/089892900561850; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pitman RK, 2001, HIPPOCAMPUS, V11, P73, DOI 10.1002/hipo.1022; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Schuff N, 2001, BIOL PSYCHIAT, V50, P952, DOI 10.1016/S0006-3223(01)01245-8; Schuff N, 1997, ANN NY ACAD SCI, V821, P516, DOI 10.1111/j.1749-6632.1997.tb48319.x; SCHWEGLER H, 1983, BEHAV BRAIN RES, V7, P1, DOI 10.1016/0166-4328(83)90002-5; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Sheline YI, 1999, J NEUROSCI, V19, P5034; SHENTON ME, 1992, NEW ENGL J MED, V327, P604, DOI 10.1056/NEJM199208273270905; SPITZER R. L., 1994, STRUCTURED CLIN INTE; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; WIMER CC, 1971, J COMP PHYSIOL PSYCH, V76, P57, DOI 10.1037/h0031036; WIMER RE, 1981, DEV BRAIN RES, V2, P129, DOI 10.1016/0165-3806(81)90064-X; Yehuda R, 2001, HIPPOCAMPUS, V11, P85, DOI 10.1002/hipo.1025; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	50	1027	1053	0	150	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1242	1247		10.1038/nn958	http://dx.doi.org/10.1038/nn958			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	609CG	12379862	Green Submitted, Green Accepted			2022-12-17	WOS:000178884600029
J	Dapretto, M; Davies, MS; Pfeifer, JH; Scott, AA; Sigman, M; Bookheimer, SY; Iacoboni, M				Dapretto, M; Davies, MS; Pfeifer, JH; Scott, AA; Sigman, M; Bookheimer, SY; Iacoboni, M			Understanding emotions in others: mirror neuron dysfunction in children with autism spectrum disorders	NATURE NEUROSCIENCE			English	Article							IMITATION; INDIVIDUALS; ACTIVATION; MECHANISMS; EMPATHY; FACES	To examine mirror neuron abnormalities in autism, high-functioning children with autism and matched controls underwent fMRI while imitating and observing emotional expressions. Although both groups performed the tasks equally well, children with autism showed no mirror neuron activity in the inferior frontal gyrus (pars opercularis). Notably, activity in this area was inversely related to symptom severity in the social domain, suggesting that a dysfunctional 'mirror neuron system' may underlie the social deficits observed in autism.	Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Dapretto, M (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA.	mirella@loni.ucla.edu		Bookheimer, Susan/0000-0002-3417-5891	NCRR NIH HHS [RR13642, RR08655, P41 RR013642, C06 RR012169] Funding Source: Medline; NICHD NIH HHS [P50 HD055784, P01 HD035470] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD035470] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012169, P41RR013642] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; Hadjikhani N, 2004, NEUROIMAGE, V22, P1141, DOI 10.1016/j.neuroimage.2004.03.025; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M., 2005, PERSPECTIVES IMITATI, P77; Johnson-Frey SH, 2003, NEURON, V39, P1053, DOI 10.1016/S0896-6273(03)00524-5; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Nishitani N, 2004, ANN NEUROL, V55, P558, DOI 10.1002/ana.20031; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Theoret H, 2005, CURR BIOL, V15, pR84, DOI 10.1016/j.cub.2005.01.022; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8	15	1019	1057	11	615	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					28	30		10.1038/nn1611	http://dx.doi.org/10.1038/nn1611			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16327784	Green Accepted			2022-12-17	WOS:000234288000014
J	Zatorre, RJ; Fields, RD; Johansen-Berg, H				Zatorre, Robert J.; Fields, R. Douglas; Johansen-Berg, Heidi			Plasticity in gray and white: neuroimaging changes in brain structure during learning	NATURE NEUROSCIENCE			English	Review							IN-VIVO; VAL66MET POLYMORPHISM; CORTICAL THICKNESS; STRUCTURE PREDICTS; ACTION-POTENTIALS; CORPUS-CALLOSUM; HESCHLS GYRUS; MATTER; NEUROGENESIS; MYELINATION	Human brain imaging has identified structural changes in gray and white matter that occur with learning. However, ascribing imaging measures to underlying cellular and molecular events is challenging. Here we review human neuroimaging findings of structural plasticity and then discuss cellular and molecular level changes that could underlie observed imaging effects. Greater dialog between researchers in these different fields would help to facilitate cross-talk between cellular and systems level explanations of how learning sculpts brain structure.	[Johansen-Berg, Heidi] John Radcliffe Hosp, Oxford Ctr Funct MRI Brain FMRIB, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Fields, R. Douglas] NICHHD, Nervous Syst Dev, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Fields, R. Douglas] NICHHD, Plast Sect, US Natl Inst Hlth, Bethesda, MD 20892 USA	University of Oxford; McGill University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Johansen-Berg, H (corresponding author), John Radcliffe Hosp, Oxford Ctr Funct MRI Brain FMRIB, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	heidi@fmrib.ox.ac.uk		Johansen-Berg, Heidi/0000-0002-4134-9730	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; US National Institutes of Health; Wellcome Trust; MRC [G0700399] Funding Source: UKRI; Medical Research Council [G0700399] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	R.J.Z. is supported by the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada; R.D.F. is supported by funds for intramural research at the US National Institutes of Health; H.J.-B. is supported by the Wellcome Trust.	Adams B, 1997, BRAIN RES, V775, P193, DOI 10.1016/S0006-8993(97)01061-5; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Ashburner J, 1998, HUM BRAIN MAPP, V6, P348, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<348::AID-HBM4>3.3.CO;2-G; Avram AV, 2010, NEUROIMAGE, V53, P132, DOI 10.1016/j.neuroimage.2010.06.019; Back SA, 2002, J NEUROPATH EXP NEUR, V61, P197, DOI 10.1093/jnen/61.2.197; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Barbier EL, 2001, J MAGN RESON IMAGING, V13, P496, DOI 10.1002/jmri.1073; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Bohbot VD, 2007, J NEUROSCI, V27, P10078, DOI 10.1523/JNEUROSCI.1763-07.2007; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Canu MH, 2009, BRAIN RES, V1252, P45, DOI 10.1016/j.brainres.2008.10.079; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Chiang MC, 2009, J NEUROSCI, V29, P2212, DOI 10.1523/JNEUROSCI.4184-08.2009; Cohen JE, 2008, NEURON GLIA BIOL, V4, P43, DOI 10.1017/S1740925X09000076; Concha L, 2010, J NEUROSCI, V30, P996, DOI 10.1523/JNEUROSCI.1619-09.2010; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Dong WK, 2004, MENT RETARD DEV D R, V10, P85, DOI 10.1002/mrdd.20016; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields RD, 2010, SCIENCE, V330, P768, DOI 10.1126/science.1199139; Fields RD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001128; Floel A, 2009, NEUROIMAGE, V47, P1974, DOI 10.1016/j.neuroimage.2009.05.046; Foster NEV, 2010, NEUROIMAGE, V53, P26, DOI 10.1016/j.neuroimage.2010.06.042; Golestani N, 2007, CEREB CORTEX, V17, P575, DOI 10.1093/cercor/bhk001; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Horsfield MA, 2005, J NEUROIMAGING, V15, p58S, DOI 10.1177/1051228405282242; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Iordanova B, 2012, NEUROIMAGE, V59, P1004, DOI 10.1016/j.neuroimage.2011.08.068; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Johansen-Berg H, 2007, CURR BIOL, V17, pR141, DOI 10.1016/j.cub.2006.12.022; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Kang XJ, 2011, NEUROIMAGE, V56, P2011, DOI 10.1016/j.neuroimage.2011.03.016; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Kleim JA, 2007, BEHAV BRAIN RES, V178, P244, DOI 10.1016/j.bbr.2006.12.022; Klintsova AY, 2004, BRAIN RES, V1028, P92, DOI 10.1016/j.brainres.2004.09.003; Kolb B, 2008, NEUROBIOL LEARN MEM, V90, P295, DOI 10.1016/j.nlm.2008.04.012; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; Lee HJ, 2008, J NEUROSCI, V28, P2753, DOI 10.1523/JNEUROSCI.5586-07.2008; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Licht T, 2011, P NATL ACAD SCI USA, V108, P5081, DOI 10.1073/pnas.1007640108; Lohmann G, 1999, CEREB CORTEX, V9, P754, DOI 10.1093/cercor/9.7.754; Maguire EA, 2003, HIPPOCAMPUS, V13, P250, DOI 10.1002/hipo.10087; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Markham JA, 2009, BRAIN RES, V1288, P9, DOI 10.1016/j.brainres.2009.06.087; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Nieman BJ, 2010, NEUROIMAGE, V50, P456, DOI 10.1016/j.neuroimage.2009.12.107; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Peters A, 2008, GLIA, V56, P1151, DOI 10.1002/glia.20686; Petrinovic MM, 2010, DEVELOPMENT, V137, P2539, DOI 10.1242/dev.048371; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Ramirez-Amaya V, 1999, HIPPOCAMPUS, V9, P631, DOI 10.1002/(SICI)1098-1063(1999)9:6<631::AID-HIPO3>3.0.CO;2-3; Raznahan A, 2011, NEURON, V72, P873, DOI 10.1016/j.neuron.2011.09.028; Rhyu IJ, 2010, NEUROSCIENCE, V167, P1239, DOI 10.1016/j.neuroscience.2010.03.003; Ruegg DG, 2003, CLIN NEUROPHYSIOL, V114, P86, DOI 10.1016/S1388-2457(02)00329-2; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Stankoff B, 2011, ANN NEUROL, V69, P673, DOI 10.1002/ana.22320; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Takahashi M, 2002, P NATL ACAD SCI USA, V99, P16192, DOI 10.1073/pnas.252249999; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Taveggia C, 2010, NAT REV NEUROL, V6, P276, DOI 10.1038/nrneurol.2010.37; Thomas AG, 2009, NEUROIMAGE, V48, P117, DOI 10.1016/j.neuroimage.2009.05.097; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Toscano-Silva M, 2010, PHYSIOL BEHAV, V101, P302, DOI 10.1016/j.physbeh.2010.05.012; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Tronel S, 2010, P NATL ACAD SCI USA, V107, P7963, DOI 10.1073/pnas.0914613107; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang Xiaohai, 2009, V489, P93, DOI 10.1007/978-1-59745-543-5_5; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wong PCM, 2008, CEREB CORTEX, V18, P828, DOI 10.1093/cercor/bhm115; Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032; Xiao JH, 2010, NEUROSIGNALS, V18, P186, DOI 10.1159/000323170; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yasuda M, 2011, NEURON, V70, P1128, DOI 10.1016/j.neuron.2011.04.027; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	100	1018	1034	8	215	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					528	536		10.1038/nn.3045	http://dx.doi.org/10.1038/nn.3045			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22426254	Green Accepted			2022-12-17	WOS:000302114500010
J	Ji, DY; Wilson, MA				Ji, Daoyun; Wilson, Matthew A.			Coordinated memory replay in the visual cortex and hippocampus during sleep	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL NEURONS; PHASE-LOCKING; SPATIAL MAP; REACTIVATION; OSCILLATION; SEQUENCES; NETWORK; STATE; EXPERIENCE; PATTERNS	Sleep replay of awake experience in the cortex and hippocampus has been proposed to be involved in memory consolidation. However, whether temporally structured replay occurs in the cortex and whether the replay events in the two areas are related are unknown. Here we studied multicell spiking patterns in both the visual cortex and hippocampus during slow-wave sleep in rats. We found that spiking patterns not only in the cortex but also in the hippocampus were organized into frames, defined as periods of stepwise increase in neuronal population activity. The multicell firing sequences evoked by awake experience were replayed during these frames in both regions. Furthermore, replay events in the sensory cortex and hippocampus were coordinated to reflect the same experience. These results imply simultaneous reactivation of coherent memory traces in the cortex and hippocampus during sleep that may contribute to or reflect the result of the memory consolidation process.	MIT, Picower Inst Learning & Memory, RIKEN, Neurosci Res Ctr,Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT)	Wilson, MA (corresponding author), MIT, Picower Inst Learning & Memory, RIKEN, Neurosci Res Ctr,Dept Brain & Cognit Sci, Bldg 46,Room 5233,43 Vassar St, Cambridge, MA 02139 USA.	dji@mit.edu; mwilson@mit.edu						Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Amzica F, 1998, NEUROSCIENCE, V82, P671; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Harris JA, 2001, NEURON, V30, P315, DOI 10.1016/S0896-6273(01)00300-2; Hasselmo ME, 1999, CURR OPIN NEUROBIOL, V9, P184, DOI 10.1016/S0959-4388(99)80025-7; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.0.CO;2-5; Lee AK, 2004, J NEUROPHYSIOL, V92, P2555, DOI 10.1152/jn.01030.2003; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; McClelland JL, 1996, HIPPOCAMPUS, V6, P654; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; O'Reilly RC, 2000, HIPPOCAMPUS, V10, P389, DOI 10.1002/1098-1063(2000)10:4<389::AID-HIPO5>3.0.CO;2-P; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Qin YL, 1997, PHILOS T R SOC B, V352, P1525, DOI 10.1098/rstb.1997.0139; Ribeiro S, 2004, PLOS BIOL, V2, P126, DOI 10.1371/journal.pbio.0020024; Robert C, 1999, J NEUROSCI METH, V88, P111, DOI 10.1016/S0165-0270(99)00027-8; Rolls ET, 2000, HIPPOCAMPUS, V10, P380, DOI 10.1002/1098-1063(2000)10:4<380::AID-HIPO4>3.0.CO;2-0; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steriade M, 1998, J SLEEP RES, V7, P30, DOI 10.1046/j.1365-2869.7.s1.4.x; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Suzuki WA, 2006, NEURON, V50, P19, DOI 10.1016/j.neuron.2006.03.029; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006	50	1015	1040	1	140	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					100	107		10.1038/nn1825	http://dx.doi.org/10.1038/nn1825			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17173043				2022-12-17	WOS:000243096100021
J	Dalton, KM; Nacewicz, BM; Johnstone, T; Schaefer, HS; Gernsbacher, MA; Goldsmith, HH; Alexander, AL; Davidson, RJ				Dalton, KM; Nacewicz, BM; Johnstone, T; Schaefer, HS; Gernsbacher, MA; Goldsmith, HH; Alexander, AL; Davidson, RJ			Gaze fixation and the neural circuitry of face processing in autism	NATURE NEUROSCIENCE			English	Article							EARLY RECOGNITION; FUNCTIONAL MRI; INDIVIDUALS; CHILDREN; DISORDERS; AREA	Diminished gaze fixation is one of the core features of autism and has been proposed to be associated with abnormalities in the neural circuitry of affect. We tested this hypothesis in two separate studies using eye tracking while measuring functional brain activity during facial discrimination tasks in individuals with autism and in typically developing individuals. Activation in the fusiform gyrus and amygdala was strongly and positively correlated with the time spent fixating the eyes in the autistic group in both studies, suggesting that diminished gaze fixation may account for the fusiform hypoactivation to faces commonly reported in autism. In addition, variation in eye fixation within autistic individuals was strongly and positively associated with amygdala activation across both studies, suggesting a heightened emotional response associated with gaze fixation in autism.	Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53705 USA; Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Dalton, KM (corresponding author), Univ Wisconsin, Waisman Ctr, 1500 Highland Ave, Madison, WI 53705 USA.	kmdalton@wisc.edu; rjdavids@wisc.edu	Johnstone, Tom/C-5909-2011; Warfield, Simon/B-3352-2009	Johnstone, Tom/0000-0001-8635-8158; Warfield, Simon/0000-0002-7659-3880; Gernsbacher, Morton Ann/0000-0003-0397-3329; Davidson, Richard/0000-0002-8506-4964	NICHD NIH HHS [T32 HD07489, P30 HD03352, T32 HD007489, P30 HD003352] Funding Source: Medline; NIMH NIH HHS [U54MH066398, R01 MH069793, U54 MH066398] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352, T32HD007489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069793, U54MH066398] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Ellis H, 1998, FACE MIND, P67; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; GEROGE N, 1999, NAT NEUROSCI, V2, P547; Glutting J., 2000, WIDE RANGE INTELLIGE; Joseph RM, 2003, J CHILD PSYCHOL PSYC, V44, P529, DOI 10.1111/1469-7610.00142; Joseph RM, 1997, J AUTISM DEV DISORD, V27, P385, DOI 10.1023/A:1025853321118; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Lehmann C, 2004, NEUROIMAGE, V21, P75, DOI 10.1016/j.neuroimage.2003.08.038; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lundqvist D., 1998, KAROLINSKA DIRECTED; Mundy P, 1994, UNDERSTANDING OTHER, P181; Ogai Masahiro, 2003, Neuroreport, V14, P559, DOI 10.1097/00001756-200303240-00006; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Osterling JA, 2002, DEV PSYCHOPATHOL, V14, P239, DOI 10.1017/S0954579402002031; Pierce K, 2001, BRAIN, V124, P2059, DOI 10.1093/brain/124.10.2059; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Talairach J., 1988, COPLANAR STEREOTAXIC	23	1014	1035	8	241	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					519	526		10.1038/nn1421	http://dx.doi.org/10.1038/nn1421			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	911XP	15750588	Green Accepted			2022-12-17	WOS:000228040400024
J	Sowell, ER; Thompson, PM; Holmes, CJ; Jernigan, TL; Toga, AW				Sowell, ER; Thompson, PM; Holmes, CJ; Jernigan, TL; Toga, AW			In vivo evidence for post-adolescent brain maturation in frontal and striatal regions	NATURE NEUROSCIENCE			English	Article							MYELINATION		Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90095 USA; Univ Calif San Diego, Sch Med, Dept Vet Affairs Med Ctr, La Jolla, CA 90095 USA; Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 90095 USA; Univ Calif San Diego, Sch Med, Dept Radiol, La Jolla, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Sowell, ER (corresponding author), Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, 710 Westwood Plaza,Room 4-238, Los Angeles, CA 90095 USA.		Thompson, Paul M/C-4194-2018	Thompson, Paul M/0000-0002-4720-8867	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH016381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS022343] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD 23854] Funding Source: Medline; NIMH NIH HHS [5T32 MH16381] Funding Source: Medline; NINDS NIH HHS [P50 NS22343] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Cohen MJ, 1992, HDB NEUROPSYCHOLOGIC, P49; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Fuster J.M., 1989, PREFRONTAL CORTEX; HUDSPETH WJ, 1990, INT J PSYCHOPHYSIOL, V21, P19; JERNIGAN TL, 1991, BRAIN, V114, P2037, DOI 10.1093/brain/114.5.2037; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; ROLLS ET, 1994, REV NEUROL-FRANCE, V150, P648; Sowell ER, 1999, NEUROIMAGE, V9, P587, DOI 10.1006/nimg.1999.0436; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; WORSLEY KJ, IN PRESS HUM BRAIN M, V8; Yakovlev PL, 1967, REGIONAL DEV BRAIN E, P3	15	1010	1017	1	80	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					859	861		10.1038/13154	http://dx.doi.org/10.1038/13154			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FE	10491602	Green Published			2022-12-17	WOS:000083883200007
J	Born, J; Lange, T; Kern, W; McGregor, GP; Bickel, U; Fehm, HL				Born, J; Lange, T; Kern, W; McGregor, GP; Bickel, U; Fehm, HL			Sniffing neuropeptides: a transnasal approach to the human brain	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; INSULIN; TRANSPORT; BARRIER; PLASMA		Univ Lubeck, Dept Neuroendocrinol, D-23538 Lubeck, Germany; Univ Lubeck, Dept Internal Med, D-23538 Lubeck, Germany; Univ Marburg, Dept Physiol, D-35037 Marburg, Germany; Texas Tech Univ, Hlth Sci Ctr, Dept Pharmaceut Sci, Amarillo, TX 79106 USA	University of Lubeck; University of Lubeck; Philipps University Marburg; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Born, J (corresponding author), Univ Lubeck, Dept Neuroendocrinol, Ratzeburger Allee 160, D-23538 Lubeck, Germany.		Born, Jan/K-2596-2016; Bickel, Ulrich/AAZ-1553-2020; Lange, Tanja/Z-1688-2018	Born, Jan/0000-0002-1847-6248; Lange, Tanja/0000-0001-8309-2112; mcgregor, gerard/0000-0003-3087-0018; Bickel, Ulrich/0000-0002-2721-299X				BICKEL U, 1988, EUR J CLIN PHARMACOL, V35, P371, DOI 10.1007/BF00561367; Chen Xue-Qing, 1998, J Alzheimers Dis, V1, P35; de Wied D, 1976, Prog Brain Res, V45, P181, DOI 10.1016/S0079-6123(08)60990-5; Fehm HL, 2000, EUR J PHARMACOL, V405, P43, DOI 10.1016/S0014-2999(00)00540-9; Fehm HL, 2001, J CLIN ENDOCR METAB, V86, P1144, DOI 10.1210/jc.86.3.1144; Illum L, 2000, EUR J PHARM SCI, V11, P1, DOI 10.1016/S0928-0987(00)00087-7; Kern W, 1999, DIABETES, V48, P557, DOI 10.2337/diabetes.48.3.557; Pardridge WM, 1999, J NEUROVIROL, V5, P556, DOI 10.3109/13550289909021285; RIEKKINEN P, 1987, PEPTIDES, V8, P261, DOI 10.1016/0196-9781(87)90101-X; SCHWARTZ MW, 1991, J CLIN INVEST, V88, P1272, DOI 10.1172/JCI115431; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sigurdsson P, 1997, DRUG DELIV, V4, P195, DOI 10.3109/10717549709051892; Strand FL, 1999, NEUROPEPTIDES REGULA; THORNE RG, 1995, BRAIN RES, V692, P278, DOI 10.1016/0006-8993(95)00637-6; WALLUM BJ, 1987, J CLIN ENDOCR METAB, V64, P190, DOI 10.1210/jcem-64-1-190	15	995	1043	0	86	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					514	516		10.1038/nn849	http://dx.doi.org/10.1038/nn849			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	11992114				2022-12-17	WOS:000175874600009
J	Young, LJ; Wang, ZX				Young, LJ; Wang, ZX			The neurobiology of pair bonding	NATURE NEUROSCIENCE			English	Review							VOLES MICROTUS-OCHROGASTER; FEMALE PRAIRIE VOLES; PARTNER-PREFERENCE FORMATION; VASOPRESSIN RECEPTOR; SEXUAL-BEHAVIOR; NUCLEUS-ACCUMBENS; SOCIAL RECOGNITION; MONOGAMOUS VOLE; LATERAL SEPTUM; ROMANTIC LOVE	A neurobiological model for pair-bond formation has emerged from studies in monogamous rodents. The neuropeptides oxytocin and vasopressin contribute to the processing of social cues necessary for individual recognition. Mesolimbic dopamine is involved in reinforcement and reward learning. Concurrent activation of neuropeptide and dopamine receptors in the reward centers of the brain during mating results in a conditioned partner preference, observed as a pair bond. Differential regulation of neuropeptide receptor expression may explain species differences in the ability to form pair bonds. These and other studies discussed here have intriguing implications for the neurobiology of social attachment in our own species.	Emory Univ, Dept Psychiat & Behav Sci, Ctr Behav Neurosci, Atlanta, GA 30322 USA; Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA	Emory University; Emory University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Young, LJ (corresponding author), Emory Univ, Dept Psychiat & Behav Sci, Ctr Behav Neurosci, Atlanta, GA 30322 USA.	lyoun03@emory.edu	Young, Larry/HGE-5031-2022					Aragona BJ, 2003, J NEUROSCI, V23, P3483, DOI 10.1523/jneurosci.23-08-03483.2003; Aragona BJ, 2003, HORM BEHAV, V44, P37; Bales KL, 2003, BEHAV NEUROSCI, V117, P854, DOI 10.1037/0735-7044.117.4.854; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Becker JB, 2001, J NEUROSCI, V21, P3236, DOI 10.1523/JNEUROSCI.21-09-03236.2001; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; CARMICHAEL MS, 1987, J CLIN ENDOCR METAB, V64, P27, DOI 10.1210/jcem-64-1-27; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; CHRISTENSSON K, 1989, ACTA OBSTET GYN SCAN, V68, P205, DOI 10.3109/00016348909020990; Cushing BS, 2000, HORM BEHAV, V37, P49, DOI 10.1006/hbeh.1999.1558; DeVries AC, 2002, PSYCHONEUROENDOCRINO, V27, P705, DOI 10.1016/S0306-4530(01)00073-7; DEVRIES AC, 1995, P NATL ACAD SCI USA, V92, P7744, DOI 10.1073/pnas.92.17.7744; DeVries AC, 1996, P NATL ACAD SCI USA, V93, P11980, DOI 10.1073/pnas.93.21.11980; DEVRIES GJ, 1983, BRAIN RES, V273, P307, DOI 10.1016/0006-8993(83)90855-7; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Everts HGJ, 1999, BEHAV BRAIN RES, V99, P7, DOI 10.1016/S0166-4328(98)00004-7; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Ferguson JN, 2001, J NEUROSCI, V21, P8278; FERRIS CF, 1984, SCIENCE, V224, P521, DOI 10.1126/science.6538700; Getz LL, 1996, AM SCI, V84, P56; Gingrich B, 2000, BEHAV NEUROSCI, V114, P173, DOI 10.1037/0735-7044.114.1.173; Goodson JL, 2001, BRAIN RES REV, V35, P246, DOI 10.1016/S0165-0173(01)00043-1; Hammock EAD, 2004, MOL BIOL EVOL, V21, P1057, DOI 10.1093/molbev/msh104; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; Holstege G, 2003, J NEUROSCI, V23, P9185; INSEL TR, 1994, J NEUROSCI, V14, P5381; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Insel TR, 2003, PHYSIOL BEHAV, V79, P351, DOI 10.1016/S0031-9384(03)00148-3; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; INSEL TR, 1995, PHYSIOL BEHAV, V57, P615, DOI 10.1016/0031-9384(94)00362-9; INSEL TR, 1995, BEHAV NEUROSCI, V109, P782, DOI 10.1037/0735-7044.109.4.782; JENKINS JS, 1984, BRAIN RES, V291, P111, DOI 10.1016/0006-8993(84)90656-5; Kalivas PW, 1993, LIMBIC MOTOR CIRCUIT, P237; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kendrick KM, 1997, BRAIN RES BULL, V44, P383, DOI 10.1016/S0361-9230(97)00218-9; KENDRICK KM, 1986, NEUROENDOCRINOLOGY, V44, P149, DOI 10.1159/000124638; Kim SJ, 2002, MOL PSYCHIATR, V7, P503, DOI 10.1038/sj.mp.4001125; KLEIMAN DG, 1977, Q REV BIOL, V52, P39, DOI 10.1086/409721; KLITENICK MA, 1992, NEUROSCIENCE, V50, P371, DOI 10.1016/0306-4522(92)90430-A; Koob GF, 1997, J NEUROPSYCH CLIN N, V9, P482; KOOB GF, 1988, ANN N Y ACAD SCI, V537, P216; Kovacs GL, 1998, PSYCHONEUROENDOCRINO, V23, P945; Landgraf R, 2003, EUR J NEUROSCI, V18, P403, DOI 10.1046/j.1460-9568.2003.02750.x; LANDGRAF R, 1995, J NEUROSCI, V15, P4250; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lim MM, 2004, NATURE, V429, P754, DOI 10.1038/nature02539; Lim MM, 2004, NEUROSCIENCE, V125, P35, DOI 10.1016/j.neuroscience.2003.12.008; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Liu Y, 2001, BEHAV NEUROSCI, V115, P910, DOI 10.1037//0735-7044.115.4.910; LOUP F, 1991, BRAIN RES, V555, P220, DOI 10.1016/0006-8993(91)90345-V; MELIS MR, 1989, NEUROSCI LETT, V98, P351, DOI 10.1016/0304-3940(89)90427-8; Michelhaugh SK, 2001, J NEUROCHEM, V79, P1033, DOI 10.1046/j.1471-4159.2001.00647.x; MURPHY MR, 1987, J CLIN ENDOCR METAB, V65, P738, DOI 10.1210/jcem-65-4-738; Paredes RG, 1997, BEHAV NEUROSCI, V111, P123, DOI 10.1037/0735-7044.111.1.123; Pfaus JG, 1997, BRAIN RES BULL, V44, P397, DOI 10.1016/S0361-9230(97)00219-0; PFAUS JG, 1990, BRAIN RES, V530, P345, DOI 10.1016/0006-8993(90)91309-5; Pfaus JG, 2001, HORM BEHAV, V40, P291, DOI 10.1006/hbeh.2001.1686; PFAUS JG, 1991, BEHAV NEUROSCI, V105, P727, DOI 10.1037/0735-7044.105.5.727; PFISTER HP, 1989, INT J NEUROSCI, V45, P221, DOI 10.3109/00207458908986235; Pitkow LJ, 2001, J NEUROSCI, V21, P7392, DOI 10.1523/JNEUROSCI.21-18-07392.2001; Wang ZX, 1996, J COMP NEUROL, V366, P726; Wang ZX, 1999, BEHAV NEUROSCI, V113, P602, DOI 10.1037/0735-7044.113.3.602; WANG ZX, 1996, ADV STUD BEHAV, V25, P361, DOI DOI 10.1016/S0065-3454(08)60338-1; WASSINK TH, 2004, MOL PSYCHIAT; WILLIAMS JR, 1992, HORM BEHAV, V26, P339, DOI 10.1016/0018-506X(92)90004-F; WILLIAMS JR, 1994, J NEUROENDOCRINOL, V6, P247, DOI 10.1111/j.1365-2826.1994.tb00579.x; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wolff JO, 2002, BEHAVIOUR, V139, P1147, DOI 10.1163/15685390260437308; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691	76	991	1003	4	342	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1048	1054		10.1038/nn1327	http://dx.doi.org/10.1038/nn1327			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452576				2022-12-17	WOS:000224156900012
J	Renton, AE; Chio, A; Traynor, BJ				Renton, Alan E.; Chio, Adriano; Traynor, Bryan J.			State of play in amyotrophic lateral sclerosis genetics	NATURE NEUROSCIENCE			English	Review							GENOME-WIDE ASSOCIATION; FRONTOTEMPORAL LOBAR DEGENERATION; HEXANUCLEOTIDE REPEAT EXPANSION; SUPEROXIDE-DISMUTASE; SPORADIC ALS; SUSCEPTIBILITY LOCI; SQSTM1 MUTATIONS; VCP MUTATIONS; PAGET-DISEASE; C9ORF72	Considerable progress has been made in unraveling the genetic etiology of amyotrophic lateral sclerosis (ALS), the most common form of adult-onset motor neuron disease and the third most common neurodegenerative disease overall. Here we review genes implicated in the pathogenesis of motor neuron degeneration and how this new information is changing the way we think about this fatal disorder. Specifically, we summarize current literature of the major genes underlying ALS, SOD1, TARDBP, FUS, OPTN, VCP, UBQLN2, C90RF72 and PFN1, and evaluate the information being gleaned from genome-wide association studies. We also outline emerging themes in ALS research, such as next-generation sequencing approaches to identify de novo mutations, the genetic convergence of familial and sporadic ALS, the proposed oligogenic basis for the disease, and how each new genetic discovery is broadening the phenotype associated with the clinical entity we know as ALS.	[Renton, Alan E.; Traynor, Bryan J.] NIA, Neuromuscular Dis Res Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Chio, Adriano] Univ Turin, Rita Levi Montalcini Dept Neurosci, Turin, Italy; [Traynor, Bryan J.] Johns Hopkins Univ, Dept Neurol, Brain Sci Inst, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Turin; Johns Hopkins University	Traynor, BJ (corresponding author), NIA, Neuromuscular Dis Res Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	traynorb@mail.nih.gov	Sander-Effron, Samuel/AAX-2231-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Chio, Adriano/K-3425-2016; Traynor, Bryan J/G-5690-2010	Chio, Adriano/0000-0001-9579-5341; Renton, Alan E./0000-0001-6702-8268	Intramural Research Programs of the US National Institutes of Health; National Institute on Aging [Z01-AG000949-02]; National Institute of Neurological Disorders and Stroke; Packard Center for ALS Research at Hopkins; ALS Association; Microsoft Research; AriSLA; Italian Health Ministry (Ricerca Sanitaria Finalizzata); Fondazione Vialli e Mauro ONLUS; Federazione Italiana Giuoco Calcio; Compagnia di San Paolo; European Community [259867]; NATIONAL INSTITUTE ON AGING [Z01AG000949, ZIAAG000933] Funding Source: NIH RePORTER	Intramural Research Programs of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Packard Center for ALS Research at Hopkins; ALS Association; Microsoft Research(Microsoft); AriSLA(Fondazione AriSLA); Italian Health Ministry (Ricerca Sanitaria Finalizzata)(Ministry of Health, Italy); Fondazione Vialli e Mauro ONLUS; Federazione Italiana Giuoco Calcio; Compagnia di San Paolo(Compagnia di San Paolo); European Community(European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Intramural Research Programs of the US National Institutes of Health, National Institute on Aging (Z01-AG000949-02) and National Institute of Neurological Disorders and Stroke. The work was also supported by the Packard Center for ALS Research at Hopkins (B.J.T.), the ALS Association (B.J.T., A.C.), Microsoft Research (B.J.T.), AriSLA (B.J.T., A.C.), the Italian Health Ministry (Ricerca Sanitaria Finalizzata 2007 to A.C.), Fondazione Vialli e Mauro ONLUS (A.C.), Federazione Italiana Giuoco Calcio (A.C., B.J.T.), Compagnia di San Paolo (A.C.) and the European Community's Health Seventh Framework Programme under grant agreement 259867 (A.C.).	Ahmeti K.B., 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.07.017; Albagha OME, 2010, NAT GENET, V42, P520, DOI 10.1038/ng.562; Alexander MD, 2002, ANN NEUROL, V52, P680, DOI 10.1002/ana.10369; Andersen PM, 2006, CURR NEUROL NEUROSCI, V6, P37, DOI 10.1007/s11910-996-0008-9; Andersen PM, 1996, BRAIN, V119, P1153, DOI 10.1093/brain/119.4.1153; Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028; Beck J, 2013, AM J HUM GENET, V92, P345, DOI 10.1016/j.ajhg.2013.01.011; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chesi A, 2013, NAT NEUROSCI, V16, P851, DOI 10.1038/nn.3412; Chio A, 2008, NEUROLOGY, V70, P533, DOI 10.1212/01.wnl.0000299187.90432.3f; Chio A, 2014, J NEUROL NEUROSUR PS, V85, P478, DOI 10.1136/jnnp-2013-305546; Chio A, 2012, NEUROLOGY, V79, P1983, DOI 10.1212/WNL.0b013e3182735d36; Chio A, 2012, J NEUROL NEUROSUR PS, V83, P730, DOI 10.1136/jnnp-2012-302219; Chio A, 2012, BRAIN, V135, P784, DOI 10.1093/brain/awr366; Chio A, 2011, ARCH NEUROL-CHICAGO, V68, P594, DOI 10.1001/archneurol.2010.352; Chio A, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.016; Chio A, 2010, ARCH NEUROL-CHICAGO, V67, P1002, DOI 10.1001/archneurol.2010.173; Chio A, 2009, HUM MOL GENET, V18, P1524, DOI 10.1093/hmg/ddp059; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Cox LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009872; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Cronin S, 2007, NEUROLOGY, V68, P1002, DOI 10.1212/01.wnl.0000258551.96893.6f; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; Daoud H., 2012, NEUROBIOL AGING, V33; Daoud H, 2010, ARCH NEUROL-CHICAGO, V67, P516, DOI 10.1001/archneurol.2010.46; DeJesus-Hernandez M, 2011, NEUROLOGY, V77, P1102, DOI 10.1212/WNL.0b013e31822e563c; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DeJesus-Hernandez M, 2010, HUM MUTAT, V31, pE1377, DOI 10.1002/humu.21241; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Deng M, 2013, NAT GENET, V45, P697, DOI 10.1038/ng.2627; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; Duquette A, 2005, ANN NEUROL, V57, P408, DOI 10.1002/ana.20408; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Eymard-Pierre E, 2002, AM J HUM GENET, V71, P518, DOI 10.1086/342359; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Fogh I, 2011, NEUROBIOL AGING, V32, P966, DOI 10.1016/j.neurobiolaging.2009.05.014; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Gwinn K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001254; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Ivanchuk SM, 1996, HUM MOL GENET, V5, P2023, DOI 10.1093/hmg/5.12.2023; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kachaner D, 2012, CELL CYCLE, V11, P2808, DOI 10.4161/cc.20946; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Koppers M., 2012, NEUROBIOL AGING, V33; Kwee LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032768; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Landers JE, 2008, NEUROLOGY, V70, P1179, DOI 10.1212/01.wnl.0000289760.85237.4e; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; Lattante S., 2013, NEUROBIOL AGING, V34; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Lesage S, 2013, BRAIN, V136, P385, DOI 10.1093/brain/aws357; LITTLER M, 1990, J MED GENET, V27, P307, DOI 10.1136/jmg.27.5.307; Ludolph Albert C, 2007, Amyotroph Lateral Scler, V8, P217, DOI 10.1080/17482960701292837; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Majounie E, 2012, NEW ENGL J MED, V366, P283, DOI 10.1056/NEJMc1113592; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Millecamps S, 2010, J MED GENET, V47, P554, DOI 10.1136/jmg.2010.077180; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; Mitchell J, 2010, P NATL ACAD SCI USA, V107, P7556, DOI 10.1073/pnas.0914128107; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Rubino E, 2012, NEUROLOGY, V79, P1556, DOI 10.1212/WNL.0b013e31826e25df; Schymick JC, 2007, HUM MOL GENET, V16, pR233, DOI 10.1093/hmg/ddm215; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Shatunov A, 2010, LANCET NEUROL, V9, P986, DOI 10.1016/S1474-4422(10)70197-6; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Teyssou E, 2013, ACTA NEUROPATHOL, V125, P511, DOI 10.1007/s00401-013-1090-0; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Traynor BJ, 2010, P NATL ACAD SCI USA, V107, P12335, DOI 10.1073/pnas.0914079107; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Turner MR, 2005, BRAIN, V128, P1323, DOI 10.1093/brain/awh509; van Blitterswijk M, 2012, HUM MOL GENET, V21, P3776, DOI 10.1093/hmg/dds199; Van Damme P, 2011, NEUROLOGY, V76, P2066, DOI 10.1212/WNL.0b013e31821f445b; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; van Es MA, 2007, LANCET NEUROL, V6, P869, DOI 10.1016/S1474-4422(07)70222-3; van Es MA, 2011, ANN NEUROL, V70, P964, DOI 10.1002/ana.22611; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Xi ZR, 2013, AM J HUM GENET, V92, P981, DOI 10.1016/j.ajhg.2013.04.017	100	988	1026	9	290	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					17	23		10.1038/nn.3584	http://dx.doi.org/10.1038/nn.3584			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24369373	Green Accepted, Green Published			2022-12-17	WOS:000329080000007
J	Scholz, J; Klein, MC; Behrens, TEJ; Johansen-Berg, H				Scholz, Jan; Klein, Miriam C.; Behrens, Timothy E. J.; Johansen-Berg, Heidi			Training induces changes in white-matter architecture	NATURE NEUROSCIENCE			English	Article							VISUAL-CORTEX; MYELINATION; SKILLS; RAT	Although experience-dependent structural changes have been found in adult gray matter, there is little evidence for such changes in white matter. Using diffusion imaging, we detected a localized increase in fractional anisotropy, a measure of microstructure, in white matter underlying the intraparietal sulcus following training of a complex visuo-motor skill. This provides, to the best of our knowledge, the first evidence for training-related changes in white-matter structure in the healthy human adult brain.	[Scholz, Jan; Klein, Miriam C.; Behrens, Timothy E. J.; Johansen-Berg, Heidi] Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford, England; [Klein, Miriam C.; Behrens, Timothy E. J.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; University of Oxford	Scholz, J (corresponding author), Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford, England.	jscholz@fmrib.ox.ac.uk	Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026; Behrens, Timothy/0000-0003-0048-1177; Klein-Flugge, Miriam/0000-0002-5156-9833; Johansen-Berg, Heidi/0000-0002-4134-9730	Wellcome Trust; UK Medical Research Council; MRC [G0501316, G0800578] Funding Source: UKRI; Medical Research Council [G0501316, G0800578] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Anderson, M. Jenkinson, G. Douaud and M. Woolrich for technical assistance, M. Rushworth for useful discussions on functional anatomy, R. Mars for providing additional control data, and M. Mangham for juggling support. We are grateful for financial support from the Wellcome Trust (H. J.- B. and J. S.) and the UK Medical Research Council (J. S. and T. E. J. B.).	Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Hihara S, 2006, NEUROPSYCHOLOGIA, V44, P2636, DOI 10.1016/j.neuropsychologia.2005.11.020; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445	14	978	994	0	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2009	12	11					1370	1371		10.1038/nn.2412	http://dx.doi.org/10.1038/nn.2412			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511UE	19820707	Green Accepted			2022-12-17	WOS:000271194100008
J	Anderson, SW; Bechara, A; Damasio, H; Tranel, D; Damasio, AR				Anderson, SW; Bechara, A; Damasio, H; Tranel, D; Damasio, AR			Impairment of social and moral behavior related to early damage in human prefrontal cortex	NATURE NEUROSCIENCE			English	Article							ANTISOCIAL PERSONALITY-DISORDER; FRONTAL-LOBE DAMAGE; STRATEGY; DEFICITS	The long-term consequences of early prefrontal cortex lesions occurring before 16 months were investigated in two adults. As is the case when such damage occurs in adulthood, the two early-onset patients had severely impaired social behavior despite normal basic cognitive abilities, and showed insensitivity to future consequences of decisions, defective autonomic responses to punishment contingencies and failure to respond to behavioral interventions. Unlike adult-onset patients, however, the two patients had defective social and moral reasoning, suggesting that the acquisition of complex social conventions and moral rules had been impaired. Thus early-onset prefrontal damage resulted in a syndrome resembling psychopathy.	Univ Iowa, Coll Med, Dept Neurol, Div Behav Neurol & Cognit Neurosci, Iowa City, IA 52242 USA	University of Iowa	Damasio, AR (corresponding author), Univ Iowa, Coll Med, Dept Neurol, Div Behav Neurol & Cognit Neurosci, Iowa City, IA 52242 USA.	antonio-damasio@uiowa.edu	Damasio, Antonio/AAD-1342-2019	Tranel, Daniel/0000-0002-1338-1389; Anderson, Steven/0000-0002-7364-1680	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS19632] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACKERLY SS, 1947, ASS RES NERV MENT DI, V27, P479; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; [Anonymous], 1987, MEASUREMENT MORAL JU; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Blair RJR, 1997, PERS INDIV DIFFER, V22, P731, DOI 10.1016/S0191-8869(96)00249-8; CAMPAGNA AF, 1975, J PERS SOC PSYCHOL, V31, P199, DOI 10.1037/h0076318; Damasio A. R., 1993, CLIN NEUROPSYCHOLOGY, V3, P409; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; DAMASIO AR, 1994, DESCARTES ERROR; DAMASIO H, 1992, ARCH NEUROL-CHICAGO, V49, P137, DOI 10.1001/archneur.1992.00530260037016; DAVIS HP, 1995, TOWER HANOI TEST COL; Deckel AW, 1996, J CLIN PSYCHOL, V52, P639; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; HEATON RK, 1981, WISCONSIN CARD SORTI; Kuruoglu AC, 1996, BRIT J PSYCHIAT, V169, P348, DOI 10.1192/bjp.169.3.348; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Newman JD, 1997, BRAIN RES, V758, P180, DOI 10.1016/S0006-8993(97)00212-6; Platt J., 1977, MEASURES INTERPERSON; Platt J.J., 1975, MANUAL MEANS ENDS PR; PRICE BH, 1990, BRAIN, V113, P1383, DOI 10.1093/brain/113.5.1383; Raine A, 1998, NEUROPSY NEUROPSY BE, V11, P1; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Scarpa A, 1997, PSYCHIAT CLIN N AM, V20, P375, DOI 10.1016/S0193-953X(05)70318-X; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Stuss DT., 1986, FRONTAL LOBES	29	978	1009	3	344	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					1032	1037		10.1038/14833	http://dx.doi.org/10.1038/14833			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FF	10526345				2022-12-17	WOS:000083883300023
J	Mathis, A; Mamidanna, P; Cury, KM; Abe, T; Murthy, VN; Mathis, MW; Bethge, M				Mathis, Alexander; Mamidanna, Pranav; Cury, Kevin M.; Abe, Taiga; Murthy, Venkatesh N.; Mathis, Mackenzie Weygandt; Bethge, Matthias			DeepLabCut: markerless pose estimation of user-defined body parts with deep learning	NATURE NEUROSCIENCE			English	Article							BEHAVIOR; TRACKING	Quantifying behavior is crucial for many applications in neuroscience. Videography provides easy methods for the observation and recording of animal behavior in diverse settings, yet extracting particular aspects of a behavior for further analysis can be highly time consuming. In motor control studies, humans or other animals are often marked with reflective markers to assist with computer-based tracking, but markers are intrusive, and the number and location of the markers must be determined a priori. Here we present an efficient method for markerless pose estimation based on transfer learning with deep neural networks that achieves excellent results with minimal training data. We demonstrate the versatility of this framework by tracking various body parts in multiple species across a broad collection of behaviors. Remarkably, even when only a small number of frames are labeled (similar to 200), the algorithm achieves excellent tracking performance on test frames that is comparable to human accuracy.	[Mathis, Alexander; Mamidanna, Pranav; Mathis, Mackenzie Weygandt; Bethge, Matthias] Eberhard Karls Univ Tubingen, Inst Theoret Phys, Tubingen, Germany; [Mathis, Alexander; Mamidanna, Pranav; Mathis, Mackenzie Weygandt; Bethge, Matthias] Eberhard Karls Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Mathis, Alexander; Murthy, Venkatesh N.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Mathis, Alexander; Murthy, Venkatesh N.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Cury, Kevin M.; Abe, Taiga] Columbia Univ, Dept Neurosci, New York, NY USA; [Cury, Kevin M.; Abe, Taiga] Columbia Univ, Mortimer B Zuckerman Mind Brain Behav Inst, New York, NY USA; [Mathis, Mackenzie Weygandt] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02138 USA; [Bethge, Matthias] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Bethge, Matthias] Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Bethge, Matthias] Baylor Coll Med, Ctr Neurosci & Artificial Intelligence, Houston, TX 77030 USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Harvard University; Harvard University; Columbia University; Columbia University; Harvard University; Max Planck Society; Baylor College of Medicine	Mathis, MW (corresponding author), Eberhard Karls Univ Tubingen, Inst Theoret Phys, Tubingen, Germany.; Mathis, MW (corresponding author), Eberhard Karls Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany.; Mathis, MW (corresponding author), Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02138 USA.	mackenzie@post.harvard.edu		Mathis, Alexander/0000-0002-3777-2202; Murthy, Venkatesh/0000-0003-2443-4252; Mamidanna, Pranav/0000-0002-2095-3314; Cury, Kevin Michael/0000-0002-3740-4151; Mathis, Mackenzie/0000-0001-7368-4456	Marie Sklodowska-Curie International Fellowship within the 7th European Community Framework Program [622943]; DFG [MA 6176/1-1]; Project ALS (Women and the Brain Fellowship for Advancement in Neuroscience); Rowland Fellowship from the Rowland Institute at Harvard; German Science Foundation (DFG) through the "Robust Vision" [CRC 1233]; IARPA through the MICrONS program	Marie Sklodowska-Curie International Fellowship within the 7th European Community Framework Program; DFG(German Research Foundation (DFG)); Project ALS (Women and the Brain Fellowship for Advancement in Neuroscience); Rowland Fellowship from the Rowland Institute at Harvard; German Science Foundation (DFG) through the "Robust Vision"(German Research Foundation (DFG)); IARPA through the MICrONS program	Marie Sklodowska-Curie International Fellowship within the 7th European Community Framework Program under grant agreement No. 622943 and DFG grant MA 6176/1-1 (A.M.); Project ALS (Women and the Brain Fellowship for Advancement in Neuroscience) and a Rowland Fellowship from the Rowland Institute at Harvard (M.W.M.); German Science Foundation (DFG) through the CRC 1233 on "Robust Vision" and from IARPA through the MICrONS program (M.B.).	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Anderson DJ, 2014, NEURON, V84, P18, DOI 10.1016/j.neuron.2014.09.005; Andriluka M, 2014, PROC CVPR IEEE, P3686, DOI 10.1109/CVPR.2014.471; Ben-Shaul Y, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0377-3; Berman GJ, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0494-7; Bernstein N. A., 1967, COORDINATION REGULAT, V1; Carreira J, 2017, PROC CVPR IEEE, P4724, DOI 10.1109/CVPR.2017.502; de Chaumont F, 2012, NAT METHODS, V9, P410, DOI [10.1038/NMETH.1924, 10.1038/nmeth.1924]; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Dollar P, 2010, PROC CVPR IEEE, P1078, DOI 10.1109/CVPR.2010.5540094; Donahue J, 2014, PR MACH LEARN RES, V32; Drai D, 2001, NEUROSCI BIOBEHAV R, V25, P409, DOI 10.1016/S0149-7634(01)00022-7; Feichtenhofer C, 2017, IEEE I CONF COMP VIS, P3057, DOI 10.1109/ICCV.2017.330; Felzenszwalb PF, 2005, INT J COMPUT VISION, V61, P55, DOI 10.1023/B:VISI.0000042934.15159.49; Gomez-Marin A, 2014, NAT NEUROSCI, V17, P1455, DOI 10.1038/nn.3812; Gomez-Marin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041642; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Guo JZ, 2015, ELIFE, V4, DOI 10.7554/eLife.10774; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Insafutdinov E, 2017, PROC CVPR IEEE, P1293, DOI 10.1109/CVPR.2017.142; Insafutdinov E, 2016, LECT NOTES COMPUT SC, V9910, P34, DOI 10.1007/978-3-319-46466-4_3; Khan AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1712; Kim CK, 2017, NAT REV NEUROSCI, V18, P222, DOI 10.1038/nrn.2017.15; Klikauer T, 2016, TRIPLEC-COMMUN CAPIT, V14, P260; Krakauer JW, 2017, NEURON, V93, P480, DOI 10.1016/j.neuron.2016.12.041; Krizhevsky A., 2012, COMMUN ACM, P1097, DOI DOI 10.1145/3065386; Kummerer M, 2016, PREPRINT; Li Y, 2017, CELL, V171, P1176, DOI 10.1016/j.cell.2017.10.015; Machado AS, 2015, ELIFE, V4, DOI 10.7554/eLife.07892; Maghsoudi O. H, 2017, PREPRINT; Mathis MW, 2017, NEURON, V93, P1493, DOI 10.1016/j.neuron.2017.02.049; Matsumoto J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078460; Nakamura T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166154; Ota N, 2015, SCI REP-UK, V5, DOI 10.1038/srep16614; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Pishchulin L, 2016, PROC CVPR IEEE, P4929, DOI 10.1109/CVPR.2016.533; Ristic B., 2004, KALMAN FILTER PARTIC; Robie AA, 2017, J EXP BIOL, V220, P25, DOI 10.1242/jeb.142281; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sousa N, 2006, GENES BRAIN BEHAV, V5, P5, DOI 10.1111/j.1601-183X.2006.00228.x; Stauffer C., 1999, Proceedings. 1999 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No PR00149), P246, DOI 10.1109/CVPR.1999.784637; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Toshev A, 2014, PROC CVPR IEEE, P1653, DOI 10.1109/CVPR.2014.214; Uhlmann V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173433; Vargas-Irwin CE, 2010, J NEUROSCI, V30, P9659, DOI 10.1523/JNEUROSCI.5443-09.2010; Wade NJ, 2016, J HIST NEUROSCI, V25, P3, DOI 10.1080/0964704X.2015.1070029; Wei SE, 2016, PROC CVPR IEEE, P4724, DOI 10.1109/CVPR.2016.511; Wenger N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008325; Winter D.A., 1990, BIOMECHANICS MOTOR C, DOI DOI 10.1002/9780470549148; Yosinski J., 2014, ADV NEURAL INFORM PR, P3320; Zhang C., 2017, ICLR	51	974	980	30	206	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2018	21	9					1281	+		10.1038/s41593-018-0209-y	http://dx.doi.org/10.1038/s41593-018-0209-y			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GS0DU	30127430				2022-12-17	WOS:000443157700017
J	Penzes, P; Cahill, ME; Jones, KA; VanLeeuwen, JE; Woolfrey, KM				Penzes, Peter; Cahill, Michael E.; Jones, Kelly A.; VanLeeuwen, Jon-Eric; Woolfrey, Kevin M.			Dendritic spine pathology in neuropsychiatric disorders	NATURE NEUROSCIENCE			English	Review							AUTISM SPECTRUM DISORDERS; FRAGILE-X-SYNDROME; ALZHEIMERS-DISEASE; AMYLOID-BETA; MOUSE MODEL; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; BEHAVIORAL PHENOTYPES; MENTAL-RETARDATION; SOCIAL-INTERACTION	Substantial progress has been made toward understanding the genetic architecture, cellular substrates, brain circuits and endophenotypic profiles of neuropsychiatric disorders, including autism spectrum disorders (ASD), schizophrenia and Alzheimer's disease. Recent evidence implicates spiny synapses as important substrates of pathogenesis in these disorders. Although synaptic perturbations are not the only alterations relevant for these diseases, understanding the molecular underpinnings of spine pathology may provide insight into their etiologies and may reveal new drug targets. Here we discuss recent neuropathological, genetic, molecular and animal model studies that implicate structural alterations at spiny synapses in the pathogenesis of major neurological disorders, focusing on ASD, schizophrenia and Alzheimer's disease as representatives of these categories across different ages of onset. We stress the importance of reverse translation, collaborative and multidisciplinary approaches, and the study of the spatio-temporal roles of disease molecules in the context of synaptic regulatory pathways and neuronal circuits that underlie disease endophenotypes.	[Penzes, Peter; Cahill, Michael E.; Jones, Kelly A.; VanLeeuwen, Jon-Eric; Woolfrey, Kevin M.] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Penzes, Peter] Northwestern Univ, Dept Psychiat & Behav Sci, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Penzes, P (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	p-penzes@northwestern.edu	Penzes, Peter/L-3987-2016	Penzes, Peter/0000-0001-5449-1640; Cahill, Michael/0000-0003-0574-2655	US National Institutes of Health (NIH) National Institute of Mental Health [MH071316, MH071533]; National Alliance for Research on Schizophrenia and Depression and Alzheimer's Association; NIH [1F31AG031621, 1F31MH085362, 1F31MH087043]; American Heart Association; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071316, R01MH071533, F31MH085362, F31MH087043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG031621] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression and Alzheimer's Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the US National Institutes of Health (NIH) National Institute of Mental Health (MH071316, MH071533), National Alliance for Research on Schizophrenia and Depression and Alzheimer's Association (to P.P.), NIH 1F31AG031621 (M.E.C.), NIH 1F31MH085362 (K.A.J.), NIH 1F31MH087043 (J.V.) and a predoctoral American Heart Association fellowship (K.M.W.).	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; Ayhan Y, 2011, MOL PSYCHIATR, V16, P293, DOI 10.1038/mp.2009.144; Bacchelli E, 2003, MOL PSYCHIATR, V8, P916, DOI 10.1038/sj.mp.4001340; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Barros CS, 2009, P NATL ACAD SCI USA, V106, P4507, DOI 10.1073/pnas.0900355106; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Cahill ME, 2009, P NATL ACAD SCI USA, V106, P13058, DOI 10.1073/pnas.0904636106; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Cook EH, 1997, AM J HUM GENET, V60, P928; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fraser MM, 2008, NEUROSCIENCE, V151, P476, DOI 10.1016/j.neuroscience.2007.10.048; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Gogtay N, 2008, SCHIZOPHRENIA BULL, V34, P30, DOI 10.1093/schbul/sbm103; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Hill JJ, 2006, MOL PSYCHIATR, V11, P557, DOI 10.1038/sj.mp.4001792; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Ji Y, 2003, NEUROSCIENCE, V122, P305, DOI 10.1016/j.neuroscience.2003.08.007; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kolluri N, 2005, AM J PSYCHIAT, V162, P1200, DOI 10.1176/appi.ajp.162.6.1200; Kolomeets NS, 2005, SYNAPSE, V57, P47, DOI 10.1002/syn.20153; Kristiansen LV, 2006, MOL PSYCHIATR, V11, P737, DOI 10.1038/sj.mp.4001844; Kushima I, 2012, SCHIZOPHRENIA BULL, V38, P552, DOI 10.1093/schbul/sbq118; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Schumacher J, 2009, HUM MOL GENET, V18, P2719, DOI 10.1093/hmg/ddp204; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Sleegers K, 2010, TRENDS GENET, V26, P84, DOI 10.1016/j.tig.2009.12.004; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tackenberg C, 2009, CURR ALZHEIMER RES, V6, P261, DOI 10.2174/156720509788486554; Tackenberg C, 2009, J NEUROSCI, V29, P14439, DOI 10.1523/JNEUROSCI.3590-09.2009; Tan HY, 2007, CEREB CORTEX, V17, pI171, DOI 10.1093/cercor/hhm069; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Woolfrey KM, 2009, NAT NEUROSCI, V12, P1275, DOI 10.1038/nn.2386; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Xie Z, 2010, MOL CELL NEUROSCI, V43, P81, DOI 10.1016/j.mcn.2009.09.006; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327; Yoshida T, 2009, SCHIZOPHR RES, V113, P84, DOI 10.1016/j.schres.2009.05.004; Youn HS, 2007, J ALZHEIMERS DIS, V11, P385; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	100	962	984	8	184	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					285	293		10.1038/nn.2741	http://dx.doi.org/10.1038/nn.2741			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21346746	Green Accepted			2022-12-17	WOS:000287650100006
J	Giraud, AL; Poeppel, D				Giraud, Anne-Lise; Poeppel, David			Cortical oscillations and speech processing: emerging computational principles and operations	NATURE NEUROSCIENCE			English	Article							TIME-COMPRESSED SPEECH; AUDITORY-CORTEX; TEMPORAL ENVELOPE; PERCEPTION; SENSITIVITY; PATTERNS; RHYTHMS; SPECIALIZATION; COMPREHENSION	Neuronal oscillations are ubiquitous in the brain and may contribute to cognition in several ways: for example, by segregating information and organizing spike timing. Recent data show that delta, theta and gamma oscillations are specifically engaged by the multi-timescale, quasi-rhythmic properties of speech and can track its dynamics. We argue that they are foundational in speech and language processing, 'packaging' incoming information into units of the appropriate temporal granularity. Such stimulus-brain alignment arguably results from auditory and motor tuning throughout the evolution of speech and language and constitutes a natural model system allowing auditory research to make a unique contribution to the issue of how neural oscillatory activity affects human cognition.	[Giraud, Anne-Lise] Ecole Normale Super, INSERM, U960, Dept Etud Cognit, F-75231 Paris, France; [Poeppel, David] NYU, Dept Psychol, New York, NY 10003 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); New York University	Giraud, AL (corresponding author), Ecole Normale Super, INSERM, U960, Dept Etud Cognit, 24 Rue Lhomond, F-75231 Paris, France.	annelise.giraud@gmail.com			Centre National de la Recherche Scientifique of France; European Research Council; US National Institutes of Health [2R01 DC05660]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005660] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique of France(Centre National de la Recherche Scientifique (CNRS)); European Research Council(European Research Council (ERC)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are deeply grateful to C. Liegeois-Chauvel for providing stereotactic EEG data and C.-G. Benar for related methodological support. In A.-L.G.'s team we thank Y. Beigneux, B. Morillon and L. Arnal, who analyzed these data; A. Hyafil, C. Kapdebon and L. Fontolan, who carried out the computational modeling work; and K. Lehongre and D. Roussillon, who conducted the experiments in human subjects. In D.P.'s team, we thank H. Luo, M. Howard and G. Cogan for pioneering work and many discussions of these issues. We also thank our colleagues O. Ghitza, S. Greenberg, B. Gutkin, V. Wyart, C. Lorenzi, F. Ramus and C. Schroeder for motivating and discussing various aspects of this research. This work is supported by the Centre National de la Recherche Scientifique of France and the European Research Council (A.-L.G.), and US National Institutes of Health grant 2R01 DC05660 (D.P.).	Abrams DA, 2008, J NEUROSCI, V28, P3958, DOI 10.1523/JNEUROSCI.0187-08.2008; Adank P, 2009, J ACOUST SOC AM, V126, P2649, DOI 10.1121/1.3216914; Ahissar E, 2001, P NATL ACAD SCI USA, V98, P13367, DOI 10.1073/pnas.201400998; Atencio CA, 2008, NEURON, V58, P956, DOI 10.1016/j.neuron.2008.04.026; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Borgers C, 2005, P NATL ACAD SCI USA, V102, P7002, DOI 10.1073/pnas.0502366102; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Chandrasekaran C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002165; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; Ding N, 2009, J NEUROPHYSIOL, V102, P2731, DOI 10.1152/jn.00523.2009; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Ghitza O, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00130; Ghitza O, 2009, PHONETICA, V66, P113, DOI 10.1159/000208934; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Heimbauer LA, 2011, CURR BIOL, V21, P1210, DOI 10.1016/j.cub.2011.06.007; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Holcombe AO, 2009, TRENDS COGN SCI, V13, P216, DOI 10.1016/j.tics.2009.02.005; Hutsler J, 2003, TRENDS NEUROSCI, V26, P429, DOI 10.1016/S0166-2236(03)00198-X; Jamison HL, 2006, CEREB CORTEX, V16, P1266, DOI 10.1093/cercor/bhj068; Kayser C, 2010, P NATL ACAD SCI USA, V107, P16976, DOI 10.1073/pnas.1012656107; Kopell N, 2011, HIPPOCAMPAL MICROCIR; Lehongre K, 2011, NEURON, V72, P1080, DOI 10.1016/j.neuron.2011.11.002; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Liegeois-Chauvel C, 2004, CEREB CORTEX, V14, P731, DOI 10.1093/cercor/bhh033; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Morillon B, 2010, P NATL ACAD SCI USA, V107, P18688, DOI 10.1073/pnas.1007189107; Nourski KV, 2009, J NEUROSCI, V29, P15564, DOI 10.1523/JNEUROSCI.3065-09.2009; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Obleser J, 2008, J NEUROSCI, V28, P8116, DOI 10.1523/JNEUROSCI.1290-08.2008; Pagnamenta AT, 2010, BIOL PSYCHIAT, V68, P320, DOI 10.1016/j.biopsych.2010.02.002; Peschansky VJ, 2010, CEREB CORTEX, V20, P884, DOI 10.1093/cercor/bhp154; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Ramus F, 2008, Q J EXP PSYCHOL, V61, P129, DOI 10.1080/17470210701508822; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schroeder CE, 2010, CURR OPIN NEUROBIOL, V20, P172, DOI 10.1016/j.conb.2010.02.010; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Shamir M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000370; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Telkemeyer S, 2009, J NEUROSCI, V29, P14726, DOI 10.1523/JNEUROSCI.1246-09.2009; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang Y, 2011, NEUROSCIENCE, V190, P398, DOI 10.1016/j.neuroscience.2011.06.010; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x	50	955	965	7	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2012	15	4					511	517		10.1038/nn.3063	http://dx.doi.org/10.1038/nn.3063			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	916PA	22426255	Green Published, Green Accepted			2022-12-17	WOS:000302114500008
J	Bates, E; Wilson, SM; Saygin, AP; Dick, F; Sereno, MI; Knight, RT; Dronkers, NF				Bates, E; Wilson, SM; Saygin, AP; Dick, F; Sereno, MI; Knight, RT; Dronkers, NF			Voxel-based lesion-symptom mapping	NATURE NEUROSCIENCE			English	Article							ARTICULATION; TOMOGRAPHY; PARIETAL; APHASIA; ANATOMY; CORTEX		VA No Calif Hlth Care Syst, Ctr Aphasia & Related Disorders, Martinez, CA 94553 USA; Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; Univ Calif Davis, Dept Linguist, Davis, CA 95616 USA; Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Diego	Dronkers, NF (corresponding author), VA No Calif Hlth Care Syst, Ctr Aphasia & Related Disorders, Martinez, CA 94553 USA.		Sereno, Martin I/F-7657-2012; Hoogkamer, Wouter/G-4498-2010; Saygin, Ayse Pinar/A-7126-2009; Saygin, Ayse Pinar/B-1494-2010; Dronkers, Nina F/K-6312-2015	Sereno, Martin I/0000-0002-7598-7829; Saygin, Ayse Pinar/0000-0002-0859-9500; Wilson, Stephen/0000-0001-9884-2852; Dick, Frederic/0000-0002-2933-3912	NIDCD NIH HHS [2 R01 DC00216] Funding Source: Medline; NINDS NIH HHS [P01 NS17778, P01 NS40813] Funding Source: Medline; PHS HHS [21135] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040813, P01NS017778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000216] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adolphs R, 2000, J NEUROSCI, V20, P2683; Blank SC, 2002, BRAIN, V125, P1829, DOI 10.1093/brain/awf191; Chao LL, 1998, J COGNITIVE NEUROSCI, V10, P167, DOI 10.1162/089892998562636; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; DRONKERS NF, IN PRESS COGNITION; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; KERTESZ A, 1979, APHASIA ASS DISORDER; KNIGHT RT, 1988, ELECTROEN CLIN NEURO, V70, P499, DOI 10.1016/0013-4694(88)90148-4; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; METTER EJ, 1990, ARCH NEUROL-CHICAGO, V47, P1235, DOI 10.1001/archneur.1990.00530110097024; NAESER MA, 1978, NEUROLOGY, V28, P545, DOI 10.1212/WNL.28.6.545; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; Wise RJS, 1999, LANCET, V353, P1057, DOI 10.1016/S0140-6736(98)07491-1	15	953	957	0	74	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					448	450		10.1038/nn1050	http://dx.doi.org/10.1038/nn1050			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12704393				2022-12-17	WOS:000182553200009
J	Husi, H; Ward, MA; Choudhary, JS; Blackstock, WP; Grant, SGN				Husi, H; Ward, MA; Choudhary, JS; Blackstock, WP; Grant, SGN			Proteomic analysis of NMDA receptor-adhesion protein signaling complexes	NATURE NEUROSCIENCE			English	Review							LONG-TERM POTENTIATION; POSTSYNAPTIC DENSITY PROTEINS; D-ASPARTATE RECEPTOR; MASS-SPECTROMETRY; SYNAPTIC TRANSMISSION; GLUTAMATE RECEPTORS; POLYACRYLAMIDE GELS; MAP KINASE; PLASTICITY; MOLECULES	N-methyl-D-aspartate receptors (NMDAR) mediate long-lasting changes in synapse strength via downstream signaling pathways. We report proteomic characterization with mass spectrometry and immunoblotting of NMDAR multiprotein complexes (NRC) isolated from mouse brain. The NRC comprised 77 proteins organized into receptor, adaptor, signaling, cytoskeletal and novel proteins, of which 30 are implicated from binding studies and another 19 participate in NMDAR signaling. NMDAR and metabotropic glutamate receptor subtypes were linked to cadherins and L1 cell-adhesion molecules in complexes lacking AMPA receptors. These neurotransmitter-adhesion receptor complexes were bound to kinases, phosphatases, GTPase-activating proteins and Ras with effecters including MAPK pathway components. Several proteins were encoded by activity-dependent genes. Genetic or pharmacological interference with 15 NRC proteins impairs learning and with 22 proteins alters synaptic plasticity in rodents. Mutations in three human genes (NF1, Rsk-2 L1) are associated with learning impairments, indicating the NRC also participates in human cognition.	Univ Edinburgh, Ctr Neurosci, Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland; Glaxo Wellcome Res & Dev Ltd, Stevenage SG1 2NY, Herts, England	University of Edinburgh; GlaxoSmithKline	Grant, SGN (corresponding author), Univ Edinburgh, Ctr Neurosci, Ctr Genome Res, W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.		; choudhary, jyoti/S-1232-2017	Grant, Seth/0000-0001-8732-8735; choudhary, jyoti/0000-0003-0881-5477				Allison DW, 1998, J NEUROSCI, V18, P2423; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fransen E, 1998, J MED GENET, V35, P399, DOI 10.1136/jmg.35.5.399; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; GRANT SGN, 1999, HDB MOL GENETIC TECH, P315; Heresco-Levy U, 1998, EUR NEUROPSYCHOPHARM, V8, P141, DOI 10.1016/S0924-977X(97)00050-3; Hisatsune C, 1999, GENES CELLS, V4, P657, DOI 10.1046/j.1365-2443.1999.00287.x; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hsueh YP, 1998, PROG BRAIN RES, V116, P123, DOI 10.1016/S0079-6123(08)60434-3; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kim CH, 1999, J NEUROSCI, V19, P4314; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lin SY, 1999, MOL BRAIN RES, V70, P18, DOI 10.1016/S0169-328X(99)00122-9; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mendelsohn AR, 1999, SCIENCE, V284, P1948, DOI 10.1126/science.284.5422.1948; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; Ozonoff S, 1999, AM J MED GENET, V89, P45, DOI 10.1002/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.0.CO;2-J; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	50	952	989	0	47	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					661	669		10.1038/76615	http://dx.doi.org/10.1038/76615			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862698	Green Published			2022-12-17	WOS:000167177200012
J	Gauthier, I; Skudlarski, P; Gore, JC; Anderson, AW				Gauthier, I; Skudlarski, P; Gore, JC; Anderson, AW			Expertise for cars and birds recruits brain areas involved in face recognition	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; HUMAN FUSIFORM GYRUS; PROSOPAGNOSIA; AGNOSIA; MECHANISMS; PERCEPTION; ATTENTION	Expertise with unfamiliar objects ('greebles') recruits face-selective areas in the fusiform gyrus (FFA) and occipital lobe (OFA). Here we extend this finding to other homogeneous categories. Bird and car experts were tested with functional magnetic resonance imaging during tasks with faces, familiar objects, cars and birds. Homogeneous categories activated the FFA more than familiar objects. Moreover, the right FFA and OFA showed significant expertise effects. An independent behavioral test of expertise predicted relative activation in the right FFA for birds versus cars within each group. The results suggest that level of categorization and expertise, rather than superficial properties of objects, determine the specialization of the FFA.	Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA	Yale University	Gauthier, I (corresponding author), Vanderbilt Univ, Dept Psychol, Wilson Hall, Nashville, TN 37240 USA.		Tudusciuc, Oana/C-1339-2011	Gauthier, Isabel/0000-0002-6249-4769	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033332] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 56037] Funding Source: Medline; NINDS NIH HHS [NS33332] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; Archambault A, 1999, PSYCHOL SCI, V10, P249, DOI 10.1111/1467-9280.00145; ASSAL G, 1984, REV NEUROL, V140, P580; Bornstein B., 1963, PROBLEMS DYNAMIC NEU, P283; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; de Gelder B, 1998, VISION RES, V38, P2855, DOI 10.1016/S0042-6989(97)00458-6; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Dixon MJ, 1998, J COGNITIVE NEUROSCI, V10, P362, DOI 10.1162/089892998562799; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; FARAH MJ, 1995, NEUROPSYCHOLOGIA, V33, P661, DOI 10.1016/0028-3932(95)00002-K; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Gauthier I, 1998, VISION RES, V38, P2401, DOI 10.1016/S0042-6989(97)00442-2; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; GAUTHIER I, IN PRESS COGNIT NEUR; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1999, NEUROREPORT, V10, P183, DOI 10.1097/00001756-199901180-00035; Kanwisher N, 1997, J NEUROSCI, V17, P4302; LHERMITTE F, 1972, REV NEUROL-FRANCE, V126, P329; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MCNEIL JE, 1993, Q J EXP PSYCHOL-A, V46, P1, DOI 10.1080/14640749308401064; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Puce A, 1996, J NEUROSCI, V16, P5205; PUCE A, 1996, NEUROPHYSIOLOGY, V74, P1192; RIDDOCH MJ, 1987, COGN NEUROPSYCHOL, V4, P131, DOI 10.1080/02643298708252038; ROLLS ET, 1986, EXP BRAIN RES, V65, P38; ROSNOW RL, 1995, PSYCHOL SCI, V6, P3, DOI 10.1111/j.1467-9280.1995.tb00297.x; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SERGENT J, 1992, CEREB CORTEX, V2, P375, DOI 10.1093/cercor/2.5.375; Skudlarski P, 1999, NEUROIMAGE, V9, P311, DOI 10.1006/nimg.1999.0402; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1329, DOI 10.1016/S0028-3932(97)00086-9; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	38	950	975	0	217	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					191	197		10.1038/72140	http://dx.doi.org/10.1038/72140			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	292TC	10649576				2022-12-17	WOS:000085810300018
J	Johnson, PM; Kenny, PJ				Johnson, Paul M.; Kenny, Paul J.			Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats	NATURE NEUROSCIENCE			English	Article							SELF-STIMULATION; LATERAL HYPOTHALAMUS; DRUG-ADDICTION; DARK SIDE; BRAIN; LEPTIN; DIET; FOOD; SENSITIVITY; CONSUMPTION	We found that development of obesity was coupled with emergence of a progressively worsening deficit in neural reward responses. Similar changes in reward homeostasis induced by cocaine or heroin are considered to be crucial in triggering the transition from casual to compulsive drug-taking. Accordingly, we detected compulsive-like feeding behavior in obese but not lean rats, measured as palatable food consumption that was resistant to disruption by an aversive conditioned stimulus. Striatal dopamine D2 receptors (D2Rs) were downregulated in obese rats, as has been reported in humans addicted to drugs. Moreover, lentivirus-mediated knockdown of striatal D2Rs rapidly accelerated the development of addiction-like reward deficits and the onset of compulsive-like food seeking in rats with extended access to palatable high-fat food. These data demonstrate that overconsumption of palatable food triggers addiction-like neuroadaptive responses in brain reward circuits and drives the development of compulsive eating. Common hedonic mechanisms may therefore underlie obesity and drug addiction.	[Johnson, Paul M.; Kenny, Paul J.] Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL USA	Scripps Research Institute; State University System of Florida; University of Florida	Kenny, PJ (corresponding author), Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL USA.	pjkenny@scripps.edu			Bank of America; Landenberger Foundation; US National Institutes of Health [DA025983]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025983] Funding Source: NIH RePORTER	Bank of America; Landenberger Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a Bank of America Fellowship (P.M.J.), the Landenberger Foundation (P.J.K.) and a grant from the US National Institutes of Health (DA025983; P.J.K.). This is publication number 19,563 from the Scripps Research Institute.	Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; *AM MED ASS, 1994, DIAGN STAT MAN MENT; BALAGURA S, 1967, PHYSIOL BEHAV, V2, P337, DOI 10.1016/0031-9384(67)90048-0; Batterham RL, 2007, NATURE, V450, P106, DOI 10.1038/nature06212; BLUNDELL JE, 1968, NATURE, V219, P627, DOI 10.1038/219627a0; Booth ML, 2008, J PAEDIATR CHILD H, V44, P248, DOI 10.1111/j.1440-1754.2007.01267.x; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Cottone P, 2008, NEUROPSYCHOPHARMACOL, V33, P524, DOI 10.1038/sj.npp.1301430; Cottone P, 2009, P NATL ACAD SCI USA, V106, P20016, DOI 10.1073/pnas.0908789106; DAVID C, 1993, BIOCHEMISTRY-US, V32, P8179, DOI 10.1021/bi00083a018; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Frank GK, 2005, BIOL PSYCHIAT, V58, P908, DOI 10.1016/j.biopsych.2005.05.003; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; HOEBEL BG, 1969, J COMP PHYSIOL PSYCH, V68, P536, DOI 10.1037/h0027651; HOEBEL BG, 1969, ANN NY ACAD SCI, V157, P758, DOI 10.1111/j.1749-6632.1969.tb12919.x; HOEBEL BG, 1962, SCIENCE, V135, P375, DOI 10.1126/science.135.3501.375; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Huang XF, 2006, BEHAV BRAIN RES, V175, P415, DOI 10.1016/j.bbr.2006.08.034; Kenny PJ, 2007, TRENDS PHARMACOL SCI, V28, P135, DOI 10.1016/j.tips.2007.01.008; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Llado I, 2000, INT J OBESITY, V24, P1396, DOI 10.1038/sj.ijo.0801390; MARKOU A, 1992, PHYSIOL BEHAV, V51, P111, DOI 10.1016/0031-9384(92)90211-J; MARKOU A, 1991, NEUROPSYCHOPHARMACOL, V4, P17; Mastronardi CA, 2001, P NATL ACAD SCI USA, V98, P14720, DOI 10.1073/pnas.251543598; Mount G., 1967, PSYCHON SCI, V9, P265; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Noble EP, 2000, EUR PSYCHIAT, V15, P79, DOI 10.1016/S0924-9338(00)00208-X; Pellegrino L. J., 1979, STEREOTAXIC ATLAS RA; Puhl RM, 2008, HEALTH EDUC RES, V23, P347, DOI 10.1093/her/cym052; ROLLS BJ, 1980, J PHYSIOL-LONDON, V298, P415, DOI 10.1113/jphysiol.1980.sp013091; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Teegarden SL, 2007, BIOL PSYCHIAT, V61, P1021, DOI 10.1016/j.biopsych.2006.09.032; Thanos PK, 2008, SYNAPSE, V62, P50, DOI 10.1002/syn.20468; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Volkow ND, 2007, AM J PSYCHIAT, V164, P708, DOI 10.1176/appi.ajp.164.5.708; Wang GJ, 2008, NEUROIMAGE, V39, P1824, DOI 10.1016/j.neuroimage.2007.11.008; Wang Gene-Jack, 2002, Expert Opin Ther Targets, V6, P601, DOI 10.1517/14728222.6.5.601; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Zheng HY, 2007, CURR OPIN PHARMACOL, V7, P607, DOI 10.1016/j.coph.2007.10.011	46	943	970	2	186	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					635	641		10.1038/nn.2519	http://dx.doi.org/10.1038/nn.2519			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20348917	Green Accepted			2022-12-17	WOS:000277065700023
J	Haynes, SE; Hollopeter, G; Yang, G; Kurpius, D; Dailey, ME; Gan, WB; Julius, D				Haynes, Sharon E.; Hollopeter, Gunther; Yang, Guang; Kurpius, Dana; Dailey, Michael E.; Gan, Wen-Biao; Julius, David			The P2Y(12) receptor regulates microglial activation by extracellular nucleotides	NATURE NEUROSCIENCE			English	Article							ANTITHROMBOTIC DRUGS; IN-VIVO; ADP; ATP; INJURY; BRAIN; CELLS; IDENTIFICATION; RELEASE; CHEMOTAXIS	Microglia are primary immune sentinels of the CNS. Following injury, these cells migrate or extend processes toward sites of tissue damage. CNS injury is accompanied by release of nucleotides, serving as signals for microglial activation or chemotaxis. Microglia express several purinoceptors, including a G(i)-coupled subtype that has been implicated in ATP- and ADP-mediated migration in vitro. Here we show that microglia from mice lacking G(i)-coupled P2Y(12) receptors exhibit normal baseline motility but are unable to polarize, migrate or extend processes toward nucleotides in vitro or in vivo. Microglia in P2ry(12)(-/-) mice show significantly diminished directional branch extension toward sites of cortical damage in the living mouse. Moreover, P2Y(12) expression is robust in the 'resting' state, but dramatically reduced after microglial activation. These results imply that P2Y(12) is a primary site at which nucleotides act to induce microglial chemotaxis at early stages of the response to local CNS injury.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; NYU, Sch Med, Skirball Inst, Program Mol Neurobiol,Dept Physiol & Neurosci, New York, NY 10016 USA; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; New York University; University of Iowa	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, 600 16th St, San Francisco, CA 94158 USA.	julius@cmp.ucsf.edu		Yang, Guang/0000-0002-5739-9126	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043468] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR017941] Funding Source: Medline; NINDS NIH HHS [NS434468, R01 NS043468] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; Brass S, 2001, NATURE, V409, P145, DOI 10.1038/35051688; Burnstock G, 1996, CIBA F SYMP, V198, P1; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chakfe Y, 2002, J NEUROSCI, V22, P3061, DOI 10.1523/JNEUROSCI.22-08-03061.2002; CHAO CC, 1992, J IMMUNOL, V149, P2736; Communi D, 2001, J BIOL CHEM, V276, P41479, DOI 10.1074/jbc.M105912200; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Hanisch Uwe-Karsten, 2002, P79; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Herbert Jean-Marc, 2003, Semin Vasc Med, V3, P113; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kurpius D, 2006, GLIA, V54, P58, DOI 10.1002/glia.20355; Lee JC, 2005, GLIA, V50, P168, DOI 10.1002/glia.20164; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Moller T, 2000, BRAIN RES, V853, P49, DOI 10.1016/S0006-8993(99)02244-1; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Salimi K, 2002, BRAIN RES, V946, P283, DOI 10.1016/S0006-8993(02)02896-2; Sasaki Y, 2003, GLIA, V44, P242, DOI 10.1002/glia.10293; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Streit Wolfgang J., 2002, P1; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Zhang FL, 2001, J BIOL CHEM, V276, P8608, DOI 10.1074/jbc.M009718200	34	928	954	2	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1512	1519		10.1038/nn1805	http://dx.doi.org/10.1038/nn1805			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17115040	Green Published			2022-12-17	WOS:000242404000015
J	Bassett, DS; Sporns, O				Bassett, Danielle S.; Sporns, Olaf			Network neuroscience	NATURE NEUROSCIENCE			English	Review							RICH-CLUB ORGANIZATION; FUNCTIONAL CONNECTIVITY; DYNAMIC RECONFIGURATION; COMMUNITY STRUCTURE; BRAIN NETWORKS; BIG DATA; COMPUTATIONAL MODEL; HUMAN CONNECTOME; SOCIAL-SCIENCE; SCALE	Despite substantial recent progress, our understanding of the principles and mechanisms underlying complex brain function and cognition remains incomplete. Network neuroscience proposes to tackle these enduring challenges. Approaching brain structure and function from an explicitly integrative perspective, network neuroscience pursues new ways to map, record, analyze and model the elements and interactions of neurobiological systems. Two parallel trends drive the approach: the availability of new empirical tools to create comprehensive maps and record dynamic patterns among molecules, neurons, brain areas and social systems; and the theoretical framework and computational tools of modern network science. The convergence of empirical and computational advances opens new frontiers of scientific inquiry, including network dynamics, manipulation and control of brain networks, and integration of network processes across spatiotemporal domains. We review emerging trends in network neuroscience and attempt to chart a path toward a better understanding of the brain as a multiscale networked system.	[Bassett, Danielle S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bassett, Danielle S.] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Sporns, Olaf] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Sporns, Olaf] Indiana Univ, Indiana Univ Network Sci Inst, Bloomington, IN 47405 USA	University of Pennsylvania; University of Pennsylvania; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Sporns, O (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.; Sporns, O (corresponding author), Indiana Univ, Indiana Univ Network Sci Inst, Bloomington, IN 47405 USA.	osporns@indiana.edu	Sporns, Olaf/A-1667-2010	Sporns, Olaf/0000-0001-7265-4036	John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation; National Science Foundation [BCS-1430087, NCS BCS-1631550, CAREER PHY-1554488, 1636892]; US National Institutes of Health [R01-HD086888, R21-M MH-106799, R01NS099348, R01-AT009036, R01-B022574, P30-AG010133]; Indiana Clinical Translational Sciences Institute [NIH ULITR0011808]; J.S. McDonnell Foundation [220020387]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD086888] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT009036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH106799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010133] Funding Source: NIH RePORTER	John D. and Catherine T. MacArthur Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana Clinical Translational Sciences Institute; J.S. McDonnell Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors gratefully acknowledge helpful comments by A. Avena-Koenigsberger, R. Betzel, L. Chai and G. Rosenthal. D.S.B. acknowledges support from the John D. and Catherine T. MacArthur Foundation, the Alfred P. Sloan Foundation, the National Science Foundation (BCS-1430087, NCS BCS-1631550, CAREER PHY-1554488) and the US National Institutes of Health (R01-HD086888, R21-M MH-106799, R01NS099348). O.S. acknowledges support from the Indiana Clinical Translational Sciences Institute (NIH ULITR0011808), the J.S. McDonnell Foundation (220020387), the National Science Foundation (1636892) and the US National Institutes of Health (R01-AT009036, R01-B022574 and P30-AG010133).	Albert R, 2014, WIRES SYST BIOL MED, V6, P353, DOI 10.1002/wsbm.1273; Avena-Koenigsberger A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0881; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bassett DS, 2017, NEUROSCIENTIST, V23, P499, DOI 10.1177/1073858416667720; Bassett DS, 2015, NAT NEUROSCI, V18, P744, DOI 10.1038/nn.3993; Bassett DS, 2014, CHAOS, V24, DOI 10.1063/1.4858457; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Battiston F., 2016, PREPRINT; Beagan JA, 2016, CELL STEM CELL, V18, P611, DOI 10.1016/j.stem.2016.04.004; Bentley B, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005283; Betzel R. F., 2015, PREPRINT; Betzel R. F., 2017, NETWORK NEUROSCI; Betzel RF, 2016, SCI REP-UK, V6, DOI 10.1038/srep30770; Betzel Richard F, 2016, Neuroimage, V124, P1054, DOI 10.1016/j.neuroimage.2015.09.041; Bota M, 2015, P NATL ACAD SCI USA, V112, pE2093, DOI 10.1073/pnas.1504394112; Braun U, 2015, P NATL ACAD SCI USA, V112, P11678, DOI 10.1073/pnas.1422487112; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burns SP, 2014, P NATL ACAD SCI USA, V111, pE5321, DOI 10.1073/pnas.1401752111; Byrge L, 2014, TRENDS COGN SCI, V18, P395, DOI 10.1016/j.tics.2014.04.010; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chai L., 2017, NETW NEUROSCI; Chaudhuri R, 2015, NEURON, V88, P419, DOI 10.1016/j.neuron.2015.09.008; Ching SN, 2013, ANESTHESIOLOGY, V119, P848, DOI 10.1097/ALN.0b013e31829d4ab4; Ching SN, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021920; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Conaco C, 2012, P NATL ACAD SCI USA, V109, P10612, DOI 10.1073/pnas.1201890109; Courtney O. T., 2016, PREPRINT; Crofts JJ, 2011, NEUROIMAGE, V54, P161, DOI 10.1016/j.neuroimage.2010.08.032; Crossley NA, 2013, P NATL ACAD SCI USA, V110, P11583, DOI 10.1073/pnas.1220826110; Cunningham JP, 2014, NAT NEUROSCI, V17, P1500, DOI 10.1038/nn.3776; De Domenico M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI [10.3389/j.nins.2016.00326, 10.3389/fnins.2016.00326]; de la Torre-Ubieta L, 2016, NAT MED, V22, P345, DOI 10.1038/nm.4071; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Donahue CJ, 2016, J NEUROSCI, V36, P6758, DOI 10.1523/JNEUROSCI.0493-16.2016; Dotko P., 2016, PREPRINT; Falk EB, 2015, P NATL ACAD SCI USA, V112, P1977, DOI 10.1073/pnas.1500247112; Fornito A., 2016, FUNDAMENTALS BRAIN N, DOI [DOI 10.1016/C2012-0-06036-X, 10.1016/C2012-0-06036-X]; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fornito Alex, 2012, Front Psychiatry, V3, P32, DOI 10.3389/fpsyt.2012.00032; Freeman J, 2014, NAT METHODS, V11, P941, DOI [10.1038/NMETH.3041, 10.1038/nmeth.3041]; French L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001049; Fulcher BD, 2016, P NATL ACAD SCI USA, V113, P1435, DOI 10.1073/pnas.1513302113; Ganmor E, 2011, P NATL ACAD SCI USA, V108, P9679, DOI 10.1073/pnas.1019641108; Geschwind DH, 2015, SCIENCE, V349, P1489, DOI 10.1126/science.aaa8954; Gibson G, 2008, NAT REV GENET, V9, P575, DOI 10.1038/nrg2383; Giusti C, 2016, J COMPUT NEUROSCI, V41, P1, DOI 10.1007/s10827-016-0608-6; Giusti C, 2015, P NATL ACAD SCI USA, V112, P13455, DOI 10.1073/pnas.1506407112; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; Goulas A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003529; Gratton C, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00124; Gu S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9414; Hamel EJO, 2015, NEURON, V86, P140, DOI 10.1016/j.neuron.2015.03.055; Harrington DL, 2015, BRAIN, V138, P2332, DOI 10.1093/brain/awv145; Hasson U, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0366; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Hermundstad AM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003591; Hernandez LM, 2015, NEUROPSYCHOPHARMACOL, V40, P171, DOI 10.1038/npp.2014.172; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hinne M, 2013, NEUROIMAGE, V66, P543, DOI 10.1016/j.neuroimage.2012.09.068; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Horvat S, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002512; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Jbabdi S, 2015, NAT NEUROSCI, V18, P1546, DOI 10.1038/nn.4134; Jirsa VK, 2010, ARCH ITAL BIOL, V148, P189; Johnson MD, 2013, IEEE T BIO-MED ENG, V60, P610, DOI 10.1109/TBME.2013.2244890; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jorgenson LA, 2015, PHILOS T R SOC B, V370, P8, DOI 10.1098/rstb.2014.0164; Kailath T., 1980, LINEAR SYSTEMS; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kebschull JM, 2016, NEURON, V91, P975, DOI 10.1016/j.neuron.2016.07.036; Keller PJ, 2015, NEURON, V85, P462, DOI 10.1016/j.neuron.2014.12.039; Khambhati AN, 2016, NEURON, V91, P1170, DOI 10.1016/j.neuron.2016.07.039; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Kopell NJ, 2014, NEURON, V83, P1319, DOI 10.1016/j.neuron.2014.08.016; Kuiper JS, 2016, INT J EPIDEMIOL, V45, P1169, DOI 10.1093/ije/dyw089; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lewis PM, 2016, NEUROSCIENTIST, V22, P406, DOI 10.1177/1073858416646707; Li LC, 2013, NEUROIMAGE, V80, P462, DOI 10.1016/j.neuroimage.2013.04.024; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; lzquierdo E. J., 2013, PLOS COMPUT BIOL, V9; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; Markov NT, 2013, SCIENCE, V342, P578, DOI 10.1126/science.1238406; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Medaglia JD, 2015, J COGNITIVE NEUROSCI, V27, P1471, DOI 10.1162/jocn_a_00810; Mier D., 2016, CURR TOP BEHAY NEURO; Misic B, 2016, CURR OPIN NEUROBIOL, V40, P1, DOI 10.1016/j.conb.2016.05.003; Misic B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003427; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Muldoon SF, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005076; Muldoon SF, 2015, BRAIN, V138, P2875, DOI 10.1093/brain/awv227; Muldoon SF, 2013, P NATL ACAD SCI USA, V110, P3567, DOI 10.1073/pnas.1216958110; Murphy A. C., 2016, PREPRINT; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Nigam S, 2016, J NEUROSCI, V36, P670, DOI 10.1523/JNEUROSCI.2177-15.2016; O'Donnell MB, 2015, ANN AM ACAD POLIT SS, V659, P274, DOI 10.1177/0002716215569446; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Onnela JP, 2016, NEUROPSYCHOPHARMACOL, V41, P1691, DOI 10.1038/npp.2016.7; Pasqualetti F, 2014, IEEE T CONTROL NETW, V1, P40, DOI 10.1109/TCNS.2014.2310254; Pescosolido B., 2015, HDB APPL SYSTEMS SCI, P25; Pinotsis DA, 2012, NEUROIMAGE, V59, P1261, DOI [10.1016/j.neuroimage.2011.08.020, 10.1016/j.neuroimage.2010.12.039]; Poldrack RA, 2014, NAT NEUROSCI, V17, P1510, DOI 10.1038/nn.3818; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Ramsey LE, 2016, ANN NEUROL, V80, P127, DOI 10.1002/ana.24690; Richiardi J, 2015, SCIENCE, V348, P1241, DOI 10.1126/science.1255905; Rosenthal G., 2016, CEREB CORTEX; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Rubinov M, 2015, P NATL ACAD SCI USA, V112, P10032, DOI 10.1073/pnas.1420315112; Sacchet MD, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00021; Santaniello S, 2015, P NATL ACAD SCI USA, V112, pE586, DOI 10.1073/pnas.1406549111; Schmaelzle R., 2017, PREPRINT; Schneider CJ, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00083; Sejnowski TJ, 2014, NAT NEUROSCI, V17, P1440, DOI 10.1038/nn.3839; Shih CT, 2015, CURR BIOL, V25, P1249, DOI 10.1016/j.cub.2015.03.021; Simony E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12141; Sizemore A., 2015, J COMPLEX NETW; Sizemore A., 2016, PREPRINT; Sporns O., 2010, NETWORKS BRAIN; Sporns O, 2016, ANNU REV PSYCHOL, V67, P613, DOI 10.1146/annurev-psych-122414-033634; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Stephan KE, 2001, PHILOS T ROY SOC B, V356, P1159, DOI 10.1098/rstb.2001.0908; Stephan KE, 2015, NEURON, V87, P716, DOI 10.1016/j.neuron.2015.07.008; Szigeti B, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00137; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Tost H, 2015, NAT NEUROSCI, V18, P1421, DOI 10.1038/nn.4108; Uddin LQ, 2015, TRENDS NEUROSCI, V38, P261, DOI 10.1016/j.tins.2015.03.004; van den Heuvel MP, 2016, TRENDS COGN SCI, V20, P345, DOI 10.1016/j.tics.2016.03.001; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Vogelstein JT, 2014, SCIENCE, V344, P386, DOI 10.1126/science.1250298; Wang GZ, 2015, NEURON, V88, P659, DOI 10.1016/j.neuron.2015.10.022; Watanabe T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5765; Wendling F, 2016, J NEUROSCI METH, V260, P233, DOI 10.1016/j.jneumeth.2015.03.027; Wheeler DW, 2015, ELIFE, V4, DOI 10.7554/eLife.09960; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wolf L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002040; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zamora-Lopez Gorka, 2010, Front Neuroinform, V4, P1, DOI 10.3389/neuro.11.001.2010	150	920	932	42	564	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2017	20	3					353	364		10.1038/nn.4502	http://dx.doi.org/10.1038/nn.4502			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EL9DU	28230844	Green Accepted			2022-12-17	WOS:000394920400008
J	Chao, LL; Haxby, JV; Martin, A				Chao, LL; Haxby, JV; Martin, A			Attribute-based neural substrates in temporal cortex for perceiving and knowing about objects	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; SEMANTIC CATEGORY; BIOLOGICAL MOTION; LEXICAL RETRIEVAL; KNOWLEDGE; RECOGNITION; ACTIVATION; IMPAIRMENT; SYSTEMS; REGIONS	The cognitive and neural mechanisms underlying category-specific knowledge remain controversial. Here we report that, across multiple tasks (viewing, delayed match to sample, naming), pictures of animals and tools were associated with highly consistent, category-related patterns of activation in ventral (fusiform gyrus) and lateral (superior and middle temporal gyri) regions of the posterior temporal lobes. In addition, similar patterns of category-related activity occurred when subjects read the names of, and answered questions about, animals and tools. These findings suggest that semantic object information is represented in distributed networks that include sites for storing information about specific object attributes such as form (ventral temporal cortex) and motion (lateral temporal cortex).	NIMH, Lab Brain & Cognit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Martin, A (corresponding author), NIMH, Lab Brain & Cognit, Bldg 10,4C104, Bethesda, MD 20892 USA.	alex@codon.nih.gov	martin, alex/B-6176-2009	Chao, Linda/0000-0002-8593-2434				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Bonda E, 1996, J NEUROSCI, V16, P3737; Bookheimer SY, 1995, HUM BRAIN MAPP, V3, P93, DOI 10.1002/hbm.460030206; Buchel C, 1998, NATURE, V394, P274, DOI 10.1038/28389; Cappa SF, 1998, NEUROIMAGE, V8, P350, DOI 10.1006/nimg.1998.0368; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Clark VP, 1996, NEUROIMAGE, V4, P1, DOI 10.1006/nimg.1996.0025; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; FARAH MJ, 1991, COGN NEUROPSYCHOL, V3, P25; Fiez JA, 1996, CEREB CORTEX, V6, P1, DOI 10.1093/cercor/6.1.1; Forde EME, 1999, APHASIOLOGY, V13, P169, DOI 10.1080/026870399402172; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Funnell E, 1996, NEUROCASE, V2, P461, DOI 10.1080/13554799608402422; GAINOTTI G, 1995, MEMORY, V3, P247, DOI 10.1080/09658219508253153; Grabowski TJ, 1998, NEUROIMAGE, V7, P232, DOI 10.1006/nimg.1998.0324; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; HAXBY JV, IN PRESS MAPPING MOD; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Laiacona M, 1997, CORTEX, V33, P441, DOI 10.1016/S0010-9452(08)70229-6; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; MARTIN A, IN PRESS COGNITIVE N; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MCNEIL JE, 1993, Q J EXP PSYCHOL-A, V46, P1, DOI 10.1080/14640749308401064; Moore CJ, 1999, BRAIN, V122, P943, DOI 10.1093/brain/122.5.943; Mummery CJ, 1996, P ROY SOC B-BIOL SCI, V263, P989, DOI 10.1098/rspb.1996.0146; Mummery CJ, 1998, J COGNITIVE NEUROSCI, V10, P766, DOI 10.1162/089892998563059; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; PERANI D, 1995, NEUROREPORT, V6, P1637, DOI 10.1097/00001756-199508000-00012; Perani D, 1999, NEUROPSYCHOLOGIA, V37, P293, DOI 10.1016/S0028-3932(98)00073-6; PERRETT D I, 1990, International Journal of Comparative Psychology, V4, P25; PIETRINI V, 1988, J NEUROL NEUROSUR PS, V51, P1284, DOI 10.1136/jnnp.51.10.1284; Polk TA, 1998, P NATL ACAD SCI USA, V95, P847, DOI 10.1073/pnas.95.3.847; Price CJ, 1996, P ROY SOC B-BIOL SCI, V263, P1501, DOI 10.1098/rspb.1996.0219; Puce A, 1996, J NEUROSCI, V16, P5205; Puce A, 1998, J NEUROSCI, V18, P2188; Ricci PT, 1999, NEUROIMAGE, V9, P88, DOI 10.1006/nimg.1998.0386; Samson D, 1998, NEUROCASE, V4, P273; SARTORI G, 1993, Q J EXP PSYCHOL-A, V46, P489, DOI 10.1080/14640749308401058; SHERIDAN J, 1993, COGNITIVE NEUROPSYCH, V10, P143, DOI 10.1080/02643299308253459; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 1999, NEUROPSYCHOLOGIA, V37, P671, DOI 10.1016/S0028-3932(98)00126-2; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; ZEKI S, 1991, J NEUROSCI, V11, P641	50	914	925	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					913	919		10.1038/13217	http://dx.doi.org/10.1038/13217			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	259FE	10491613				2022-12-17	WOS:000083883200018
J	Nestler, EJ				Nestler, EJ			Is there a common molecular pathway for addiction?	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; ELEMENT-BINDING PROTEIN; DRUG-ADDICTION; SYNAPTIC PLASTICITY; NUCLEUS-ACCUMBENS; MEDIATED TRANSCRIPTION; NEUROTROPHIC FACTOR; DOPAMINE NEURONS; GENE-EXPRESSION; COCAINE-SEEKING	Drugs of abuse have very different acute mechanisms of action but converge on the brain's reward pathways by producing a series of common functional effects after both acute and chronic administration. Some similar actions occur for natural rewards as well. Researchers are making progress in understanding the molecular and cellular basis of these common effects. A major goal for future research is to determine whether such common underpinnings of addiction can be exploited for the development of more effective treatments for a wide range of addictive disorders.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.nestler@utsouthwestern.edu						Avena NM, 2003, NEUROSCIENCE, V122, P17, DOI 10.1016/S0306-4522(03)00502-5; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Boehm SL, 2004, BIOCHEM PHARMACOL, V68, P1581, DOI 10.1016/j.bcp.2004.07.023; Bolanos CA, 2004, NEUROMOL MED, V5, P69, DOI 10.1385/NMM:5:1:069; Bonci A, 1997, J NEUROSCI, V17, P796; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Brunzell DH, 2003, J NEUROCHEM, V84, P1431, DOI 10.1046/j.1471-4159.2003.01640.x; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Constantinescu A, 2004, J BIOL CHEM, V279, P43321, DOI 10.1074/jbc.M406994200; Dani JA, 2001, NEURON, V31, P349, DOI 10.1016/S0896-6273(01)00379-8; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Eisch AJ, 2002, PROG BRAIN RES, V138, P315, DOI 10.1016/S0079-6123(02)38085-3; Everitt BJ, 2003, ANN NY ACAD SCI, V985, P233; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Hall FS, 2003, NEUROPSYCHOPHARMACOL, V28, P1485, DOI 10.1038/sj.npp.1300192; Heinrichs SC, 2004, J PHARMACOL EXP THER, V311, P427, DOI 10.1124/jpet.103.052092; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Kelley AE, 2002, J NEUROSCI, V22, P3306; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Kreek MJ, 2001, ANN NY ACAD SCI, V937, P27; Littleton J, 2003, AM J ADDICTION, V12, pS3, DOI 10.1111/j.1521-0391.2003.tb00492.x; Lu L, 2004, J NEUROSCI, V24, P1604, DOI 10.1523/JNEUROSCI.5124-03.2004; Lu L, 2003, J NEUROCHEM, V85, P1604, DOI 10.1046/j.1471-4159.2003.01824.x; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; NESTLER EJ, 1992, J NEUROSCI, V12, P2439; Olson VG, 2005, J NEUROSCI, V25, P5553, DOI 10.1523/JNEUROSCI.0345-05.2005; Pandey SC, 2004, J NEUROSCI, V24, P5022, DOI 10.1523/JNEUROSCI.5557-03.2004; Pierce RC, 2001, REV NEUROSCIENCE, V12, P95; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Self DW, 1998, J NEUROSCI, V18, P1848; Shaw-Lutchman TZ, 2003, SYNAPSE, V48, P10, DOI 10.1002/syn.10172; Shaw-Lutchman TZ, 2002, J NEUROSCI, V22, P3663; Thomas MJ, 2003, PHILOS T ROY SOC B, V358, P815, DOI 10.1098/rstb.2002.1236; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Walters CL, 2005, BRAIN RES, V1032, P193, DOI 10.1016/j.brainres.2004.11.013; Walters CL, 2005, NEURON, V46, P933, DOI 10.1016/j.neuron.2005.05.005; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	50	913	947	1	125	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1445	1449		10.1038/nn1578	http://dx.doi.org/10.1038/nn1578			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16251986				2022-12-17	WOS:000232966600014
J	Atkins, CM; Selcher, JC; Petraitis, JJ; Trzaskos, JM; Sweatt, JD				Atkins, CM; Selcher, JC; Petraitis, JJ; Trzaskos, JM; Sweatt, JD			The MAPK cascade is required for mammalian associative learning	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; RABBIT FOLLOWING STIMULATION; II MUTANT MICE; SYNAPTIC TRANSMISSION; LASTING POTENTIATION; RETROGRADE-AMNESIA; CONTEXTUAL FEAR; PERFORANT PATH; DENTATE AREA	Mitogen-activated protein kinase (MAPK) is an integral component of cellular signaling during mitogenesis and differentiation of mitotic cells. Recently MAPK activation in post-mitotic cells has been implicated in hippocampal long-term potentiation (LTP), a potential cellular mechanism of learning and memory Here we investigate the involvement of MAPK in learning and memory in behaving animals. MAPK activation increased in the rat. hippocampus after an associative learning task, contextual fear conditioning. Two other protein kinases known to be activated during hippocampal LTP, protein kinase C and alpha-calcium/calmodulin protein kinase II, also were activated in the hippocampus after learning. Inhibition of the specific upstream activator of MAPK, MAPK kinase (MEK), blocked fear conditioning. Thus, classical conditioning in mammals activates MAPK, which is necessary for consolidation of the resultant learning.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; DuPont Pharmaceut Res Labs, Chem & Phys Sci, Wilmington, DE 19880 USA; DuPont Pharmaceut Res Labs, Inflammatory Dis Res, Wilmington, DE 19880 USA	Baylor College of Medicine; DuPont; DuPont	Sweatt, JD (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.	david@ligand.neusc.bcm.tmc.edu		Sweatt, J. David/0000-0003-3567-485X; Atkins, Coleen/0000-0003-4718-7493	NIMH NIH HHS [MH 57014] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057014] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bordi F, 1996, NEUROPHARMACOLOGY, V35, P1557, DOI 10.1016/S0028-3908(96)00101-3; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735; Brunet A, 1997, ESSAYS BIOCHEM, V32, P1; Crow T, 1998, J NEUROSCI, V18, P3480; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FIORE RS, 1993, NEUROSCIENCE, V55, P463, DOI 10.1016/0306-4522(93)90516-I; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; Grunbaum L, 1998, J NEUROSCI, V18, P4384; HARGREAVES EL, 1992, BEHAV BRAIN RES, V47, P23, DOI 10.1016/S0166-4328(05)80249-9; IZQUIERDO I, 1995, NEUROBIOL LEARN MEM, V63, P19, DOI 10.1006/nlme.1995.1002; JERUSALINSKY D, 1994, BEHAV NEURAL BIOL, V61, P107, DOI 10.1016/S0163-1047(05)80063-9; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KIM JJ, 1991, BEHAV NEUROSCI, V105, P126, DOI 10.1037/0735-7044.105.1.126; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Michael D, 1998, P NATL ACAD SCI USA, V95, P1864, DOI 10.1073/pnas.95.4.1864; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Nogues X, 1996, BEHAV BRAIN RES, V75, P139, DOI 10.1016/0166-4328(96)00194-5; PAYLOR R, IN PRESS LEARN MEM; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Roberson ED, 1996, LEARN MEMORY, V3, P1, DOI 10.1101/lm.3.1.1; ROBERTS TM, 1992, NATURE, V360, P534, DOI 10.1038/360534a0; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; Sweatt JD, 1998, J NEUROCHEM, V71, P1075; Tan SE, 1996, BRAIN RES, V711, P234, DOI 10.1016/0006-8993(95)01411-X; Tan SE, 1997, BRAIN RES, V748, P227, DOI 10.1016/S0006-8993(96)01298-X; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; WOLFMAN C, 1994, BEHAV NEURAL BIOL, V61, P203, DOI 10.1016/S0163-1047(05)80001-9; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yasoshima Y, 1997, NEUROREPORT, V8, P1363, DOI 10.1097/00001756-199704140-00009	50	912	928	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					602	609		10.1038/2836	http://dx.doi.org/10.1038/2836			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196568				2022-12-17	WOS:000077437100016
J	Hickman, SE; Kingery, ND; Ohsumi, TK; Borowsky, ML; Wang, LC; Means, TK; El Khoury, J				Hickman, Suzanne E.; Kingery, Nathan D.; Ohsumi, Toshiro K.; Borowsky, Mark L.; Wang, Li-chong; Means, Terry K.; El Khoury, Joseph			The microglial sensome revealed by direct RNA sequencing	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; ALZHEIMERS-DISEASE; ALTERNATIVE ACTIVATION; BRAIN; NEURODEGENERATION; NEUROTOXICITY; TRANSCRIPTION; MACROPHAGES; PHENOTYPE; PATHWAYS	Microglia, the principal neuroimmune sentinels of the brain, continuously sense changes in their environment and respond to invading pathogens, toxins and cellular debris. Microglia exhibit plasticity and can assume neurotoxic or neuroprotective priming states that determine their responses to danger. We used direct RNA sequencing, without amplification or cDNA synthesis, to determine the quantitative transcriptomes of microglia of healthy adult and aged mice. We validated our findings using fluorescence dual in situ hybridization, unbiased proteomic analysis and quantitative PCR. We found that microglia have a distinct transcriptomic signature and express a unique cluster of transcripts encoding proteins for sensing endogenous ligands and microbes that we refer to as the sensome. With aging, sensome transcripts for endogenous ligand recognition were downregulated, whereas those involved in microbe recognition and host defense were upregulated. In addition, aging was associated with an overall increase in the expression of microglial genes involved in neuroprotection.	[Hickman, Suzanne E.; Kingery, Nathan D.; Means, Terry K.; El Khoury, Joseph] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Ohsumi, Toshiro K.; Borowsky, Mark L.] Massachusetts Gen Hosp, Dept Mol Biol, Charlestown, MA USA; [Ohsumi, Toshiro K.; Borowsky, Mark L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Wang, Li-chong] Adv Cell Diagnost, Hayward, CA USA; [El Khoury, Joseph] Massachusetts Gen Hosp, Div Infect Dis, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Hickman, SE (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA.	shickman@partners.org; jelkhoury@partners.org			National Institute of Neurological Disorders and Stroke [NS059005]; National Institute of Aging [AG032349]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032349] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Ozsolak (Helicos) for supervising the sequencing experiments, R. Mylvaganam for performing cell sorting and J. Liao (Applied Biomics) for analysis of the proteomic data. This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS059005) and the National Institute of Aging (AG032349) to J.E.K.	Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; El Khoury J, 2010, NAT MED, V16, P1369, DOI 10.1038/nm1210-1369; ElKhoury J, 1996, NATURE, V382, P716; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gomes-Leal W, 2012, BRAIN BEHAV, V2, P345, DOI 10.1002/brb3.51; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kremsky I, 2012, BRAIN BEHAV IMMUN, V26, P797, DOI 10.1016/j.bbi.2011.12.008; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee DC, 2013, NEUROBIOL AGING, V34, P1610, DOI 10.1016/j.neurobiolaging.2012.12.014; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Muzio L, 2007, J NEUROIMMUNOL, V191, P39, DOI 10.1016/j.jneuroim.2007.09.016; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagalakshmi Ugrappa, 2010, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0411s89; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ohsumi TK, 2012, BIOINFORMATICS, V28, P2412, DOI 10.1093/bioinformatics/bts458; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Rezaie Payam, 2002, J Hist Neurosci, V11, P325, DOI 10.1076/jhin.11.4.325.8531; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thrash JC, 2009, NEUROCHEM RES, V34, P38, DOI 10.1007/s11064-008-9657-1; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Xu ZF, 2005, NEUROBIOL DIS, V19, P461, DOI 10.1016/j.nbd.2005.01.027	50	906	917	4	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2013	16	12					1896	1905		10.1038/nn.3554	http://dx.doi.org/10.1038/nn.3554			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	257VV	24162652	Green Accepted, Green Submitted			2022-12-17	WOS:000327416800029
J	Cole, MW; Reynolds, JR; Power, JD; Repovs, G; Anticevic, A; Braver, TS				Cole, Michael W.; Reynolds, Jeremy R.; Power, Jonathan D.; Repovs, Grega; Anticevic, Alan; Braver, Todd S.			Multi-task connectivity reveals flexible hubs for adaptive task control	NATURE NEUROSCIENCE			English	Article							HUMAN CEREBRAL-CORTEX; FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX; PSYCHOPHYSIOLOGICAL INTERACTIONS; COGNITIVE CONTROL; HUMAN BRAIN; NETWORK; REGIONS; RULES; REPRESENTATION	Extensive evidence suggests that the human ability to adaptively implement a wide variety of tasks is preferentially a result of the operation of a fronto-parietal brain network (FPN). We hypothesized that this network's adaptability is made possible by flexible hubs: brain regions that rapidly update their pattern of global functional connectivity according to task demands. Using recent advances in characterizing brain network organization and dynamics, we identified mechanisms consistent with the flexible hub theory. We found that the FPN's brain-wide functional connectivity pattern shifted more than those of other networks across a variety of task states and that these connectivity patterns could be used to identify the current task. Furthermore, these patterns were consistent across practiced and novel tasks, suggesting that reuse of flexible hub connectivity patterns facilitates adaptive (novel) task performance. Together, these findings support a central role for fronto-parietal flexible hubs in cognitive control and adaptive implementation of task demands.	[Cole, Michael W.; Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Reynolds, Jeremy R.] Univ Denver, Dept Psychol, Denver, CO 80208 USA; [Power, Jonathan D.] Washington Univ, Dept Psychol, St Louis, MO USA; [Repovs, Grega] Univ Ljubljana, Dept Psychol, Ljubljana 61000, Slovenia; [Anticevic, Alan] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Anticevic, Alan] Yale Univ, Abraham Ribicoff Res Facil, New Haven, CT USA; [Anticevic, Alan] Natl Inst Alcohol Abuse, New Haven, CT USA; [Anticevic, Alan] Alcoholism Ctr Translat Neurosci Alcoholism, New Haven, CT USA	Washington University (WUSTL); University of Denver; Washington University (WUSTL); University of Ljubljana; Yale University; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Cole, MW (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	mwcole@mwcole.net	Cole, Michael W/G-1056-2010	Cole, Michael W/0000-0003-4329-438X; Braver, Todd/0000-0002-2631-3393; Power, Jonathan/0000-0002-6922-100X; Repovs, Grega/0000-0003-1837-3879	US National Institutes of Health [K99MH096801, DP5OD012109-01]; Brain and Behavior Research Foundation (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH096801, R37MH066078, R00MH096801] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012109] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation (NARSAD) Young Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Petersen, D. Bassett and J. Etzel for helpful feedback and suggestions during preparation of this manuscript. We also thank W. Schneider for access to data from his laboratory. Our work was supported by the US National Institutes of Health under awards K99MH096801 (M.W.C.), DP5OD012109-01 (A.A.) and a Brain and Behavior Research Foundation (NARSAD) Young Investigator Award (A.A.).	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buschman TJ, 2012, NEURON, V76, P838, DOI 10.1016/j.neuron.2012.09.029; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Cole MW, 2013, COGN AFFECT BEHAV NE, V13, P1, DOI 10.3758/s13415-012-0125-7; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Cole MW, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00142; Cole MW, 2010, J NEUROSCI, V30, P14245, DOI 10.1523/JNEUROSCI.1662-10.2010; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cromer JA, 2010, NEURON, V66, P796, DOI 10.1016/j.neuron.2010.05.005; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Dumontheil I, 2011, J COGNITIVE NEUROSCI, V23, P168, DOI 10.1162/jocn.2010.21439; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Gazzaley A, 2007, CEREB CORTEX, V17, pI125, DOI 10.1093/cercor/bhm113; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; HEBB D. O., 1949; Heinzle J, 2012, J NEUROSCI, V32, P9960, DOI 10.1523/JNEUROSCI.1604-12.2012; Kim J, 2008, MAGN RESON IMAGING, V26, P583, DOI 10.1016/j.mri.2007.10.011; Kriegeskorte Nikolaus, 2008, Front Syst Neurosci, V2, P4, DOI 10.3389/neuro.06.004.2008; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Niendam T.A., 2012, COGN AFFECT BEHAV NE; O'Reilly JX, 2012, SOC COGN AFFECT NEUR, V7, P604, DOI 10.1093/scan/nss055; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Repovs G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00137; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Sakai K, 2008, ANNU REV NEUROSCI, V31, P219, DOI 10.1146/annurev.neuro.31.060407.125642; Schneider W., 2002, E PRIME USERS GUIDE; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; SINGLEY MK, 1985, INT J MAN MACH STUD, V22, P403, DOI 10.1016/S0020-7373(85)80047-X; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Todd MT, 2013, NEUROIMAGE, V77, P157, DOI 10.1016/j.neuroimage.2013.03.039; Urfer-Parnas A, 2010, PSYCHOL MED, V40, P547, DOI 10.1017/S0033291709990754; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Woolgar A, 2011, NEUROIMAGE, V56, P744, DOI 10.1016/j.neuroimage.2010.04.035; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	58	905	915	12	197	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2013	16	9					1348	U247		10.1038/nn.3470	http://dx.doi.org/10.1038/nn.3470			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	207KN	23892552	Green Published, Green Accepted			2022-12-17	WOS:000323597500028
J	Cai, HB; Wang, YS; McCarthy, D; Wen, HJ; Borchelt, DR; Price, DL; Wong, PC				Cai, HB; Wang, YS; McCarthy, D; Wen, HJ; Borchelt, DR; Price, DL; Wong, PC			BACE1 is the major beta-secretase for generation of A beta peptides by neurons	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; CLEAVAGE; VARIANTS; BRAIN		Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21205 USA; Ciphergen Biosyst, Fremont, CA 94555 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wong, PC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.		Cai, Huaibin/H-3359-2013	Cai, Huaibin/0000-0002-8596-6108	NATIONAL INSTITUTE ON AGING [P01AG014248] Funding Source: NIH RePORTER; NIA NIH HHS [2P50 AG05146, 1P01 AG14248] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Gouras GK, 1998, J NEUROCHEM, V71, P1920; Haniu M, 2000, J BIOL CHEM, V275, P21099, DOI 10.1074/jbc.M002095200; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; SHI XP, 2000, J BIOL CHEM; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	15	901	955	1	68	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					233	234		10.1038/85064	http://dx.doi.org/10.1038/85064			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224536				2022-12-17	WOS:000167178300007
J	Klengel, T; Mehta, D; Anacker, C; Rex-Haffner, M; Pruessner, JC; Pariante, CM; Pace, TWW; Mercer, KB; Mayberg, HS; Bradley, B; Nemeroff, CB; Holsboer, F; Heim, CM; Ressler, KJ; Rein, T; Binder, EB				Klengel, Torsten; Mehta, Divya; Anacker, Christoph; Rex-Haffner, Monika; Pruessner, Jens C.; Pariante, Carmine M.; Pace, Thaddeus W. W.; Mercer, Kristina B.; Mayberg, Helen S.; Bradley, Bekh; Nemeroff, Charles B.; Holsboer, Florian; Heim, Christine M.; Ressler, Kerry J.; Rein, Theo; Binder, Elisabeth B.			Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions	NATURE NEUROSCIENCE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; GLUCOCORTICOID-RECEPTOR; ADULT DEPRESSION; POLYMORPHISMS; METHYLATION; MODERATION; ABUSE; RISK; EXPRESSION; INCREASES	Although the fact that genetic predisposition and environmental exposures interact to shape development and function of the human brain and, ultimately, the risk of psychiatric disorders has drawn wide interest, the corresponding molecular mechanisms have not yet been elucidated. We found that a functional polymorphism altering chromatin interaction between the transcription start site and long-range enhancers in the FK506 binding protein 5 (FKBP5) gene, an important regulator of the stress hormone system, increased the risk of developing stress-related psychiatric disorders in adulthood by allele-specific, childhood trauma-dependent DNA demethylation in functional glucocorticoid response elements of FKBP5. This demethylation was linked to increased stress-dependent gene transcription followed by a long-term dysregulation of the stress hormone system and a global effect on the function of immune cells and brain areas associated with stress regulation. This identification of molecular mechanisms of genotype-directed long-term environmental reactivity will be useful for designing more effective treatment strategies for stress-related disorders.	[Klengel, Torsten; Mehta, Divya; Rex-Haffner, Monika; Holsboer, Florian; Rein, Theo; Binder, Elisabeth B.] Max Planck Inst Psychiat, Munich, Germany; [Anacker, Christoph; Pariante, Carmine M.] Kings Coll London, Inst Psychiat, Sect Perinatal Psychiat & Stress Psychiat & Immun, Dept Psychol Med, London WC2R 2LS, England; [Pruessner, Jens C.] McGill Univ, Fac Med, McGill Ctr Studies Aging, Verdun, PQ, Canada; [Pace, Thaddeus W. W.; Mayberg, Helen S.; Bradley, Bekh; Heim, Christine M.; Ressler, Kerry J.; Binder, Elisabeth B.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Mercer, Kristina B.; Ressler, Kerry J.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Bradley, Bekh] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Nemeroff, Charles B.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Heim, Christine M.] Charite, Inst Med Psychol, D-13353 Berlin, Germany; [Ressler, Kerry J.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Max Planck Society; University of London; King's College London; McGill University; Emory University; Howard Hughes Medical Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Miami; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Emory University	Klengel, T (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	klengel@mpipsykl.mpg.de	Heim, Christine/J-4693-2014; Ressler, Kerry J/N-8741-2018; Pariante, Carmine Maria/B-1297-2011; Anacker, Christoph/V-6021-2019; Binder, Elisabeth B/K-8905-2014; Bradley, Bekh/H-8399-2012; Mehta, Divya/ABD-4551-2021; Klengel, Torsten/E-5629-2010	Ressler, Kerry J/0000-0002-5158-1103; Pariante, Carmine Maria/0000-0002-9132-5091; Klengel, Torsten/0000-0001-7045-9229; Mehta, Divya Deepak/0000-0002-7359-348X; Pruessner, Jens/0000-0002-8582-2980; Nemeroff, Charles/0000-0001-7867-1160; Mehta, Divya/0000-0001-7971-7255; Heim, Christine/0000-0002-6580-6326; Rein, Theo/0000-0003-2850-4289	European Research Council [281338]; National Alliance for Research in Schizophrenia and Affective Disorders; Behrens Weise Stiftung; National Institute of Mental Health [MH071538, MH58922]; National Institute for Health Research Biomedical Research Centre for Mental Health; Institute of Psychiatry; South London and Maudsley National Health System Foundation Trust; UK Medical Research Council [G108/603]; Commission of European Communities 7th Framework Programme Collaborative Project [22963]; Public Health Service from the Clinical and Translational Science Award program [UL1 RR025008]; US National Institutes of Health; National Center for Research Resources; K Award [K01 MH073698-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH073698, P50MH058922] Funding Source: NIH RePORTER; Medical Research Council [G108/603] Funding Source: researchfish; MRC [G108/603] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); National Alliance for Research in Schizophrenia and Affective Disorders(NARSAD); Behrens Weise Stiftung; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Health Research Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); Institute of Psychiatry; South London and Maudsley National Health System Foundation Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Commission of European Communities 7th Framework Programme Collaborative Project; Public Health Service from the Clinical and Translational Science Award program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); K Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank T. Mletzko, K. Hafner and N.C. Gassen for their help in acquiring and interpreting data, and P. Weber for data visualization. Special thanks to A. W. Graham, A. Brown, D. Crain and D. Cross for their assistance in recruiting subjects and managing the Grady Trauma Project. This work was supported by a European Research Council starting grant (grant #281338, GxE molmech), a grant from the National Alliance for Research in Schizophrenia and Affective Disorders and a grant from the Behrens Weise Stiftung to E. B. B., a grant from the National Institute of Mental Health (MH071538) to K.J.R., and a grant from the National Institute of Mental Health (MH58922) to C.B.N., C. M. P. and C. A. have received funding from the National Institute for Health Research Biomedical Research Centre for Mental Health, Institute of Psychiatry and South London and Maudsley National Health System Foundation Trust, a Clinician Scientist Fellowship from the UK Medical Research Council (G108/603) to C. M. P., and the Commission of European Communities 7th Framework Programme Collaborative Project Grant Agreement n 22963 (Mood Inflame), also to C. M. P., C. M. H. is supported in part by Public Health Service Grant UL1 RR025008 from the Clinical and Translational Science Award program, the US National Institutes of Health, the National Center for Research Resources and by a K Award (K01 MH073698-01, Neural Substrates of Depression Risk after Child Abuse).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anacker C, 2011, MOL PSYCHIATR, V16, P738, DOI 10.1038/mp.2011.26; Appel K, 2011, NEUROPSYCHOPHARMACOL, V36, P1982, DOI 10.1038/npp.2011.81; Attwood BK, 2011, NATURE, V473, P372, DOI 10.1038/nature09938; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI [10.1016/j.psyneuen.2008.08.018, 10.1016/j.psyneuen.2009.05.021]; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Danese A, 2008, ARCH GEN PSYCHIAT, V65, P409, DOI 10.1001/archpsyc.65.4.409; DeRijk RH, 1996, J CLIN ENDOCR METAB, V81, P228, DOI 10.1210/jc.81.1.228; FINK LA, 1995, AM J PSYCHIAT, V152, P1329, DOI 10.1176/ajp.152.9.1329; Gillespie CF, 2009, GEN HOSP PSYCHIAT, V31, P505, DOI 10.1016/j.genhosppsych.2009.05.003; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Heim C, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.041.2009; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Ising M, 2008, EUR J NEUROSCI, V28, P389, DOI 10.1111/j.1460-9568.2008.06332.x; Jaaskelainen T, 2011, CURR OPIN PHARMACOL, V11, P326, DOI 10.1016/j.coph.2011.04.006; Kelder T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006447; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Koenen KC, 2005, MOL PSYCHIATR, V10, P1058, DOI 10.1038/sj.mp.4001727; Lee RS, 2010, ENDOCRINOLOGY, V151, P4332, DOI 10.1210/en.2010-0225; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mehta D, 2011, ARCH GEN PSYCHIAT, V68, P901, DOI 10.1001/archgenpsychiatry.2011.50; Miller GE, 2005, PSYCHOSOM MED, V67, P679, DOI 10.1097/01.psy.0000174172.82428.ce; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; O'Leary JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024840; Paakinaho V, 2010, MOL ENDOCRINOL, V24, P511, DOI 10.1210/me.2009-0443; Pace TWW, 2006, AM J PSYCHIAT, V163, P1630, DOI 10.1176/appi.ajp.163.9.1630; Pace TWW, 2011, BRAIN BEHAV IMMUN, V25, P6, DOI 10.1016/j.bbi.2010.10.003; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Roy A, 2010, NEUROPSYCHOPHARMACOL, V35, P1674, DOI 10.1038/npp.2009.236; Scammell JG, 2001, GEN COMP ENDOCR, V124, P152, DOI 10.1006/gcen.2001.7696; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sommershof A, 2009, BRAIN BEHAV IMMUN, V23, P1117, DOI 10.1016/j.bbi.2009.07.003; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Touma C, 2011, BIOL PSYCHIAT, V70, P928, DOI 10.1016/j.biopsych.2011.07.023; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; Zimmermann P, 2011, AM J PSYCHIAT, V168, P1107, DOI 10.1176/appi.ajp.2011.10111577	49	895	910	6	185	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2013	16	1					33	41		10.1038/nn.3275	http://dx.doi.org/10.1038/nn.3275			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058KZ	23201972	Green Accepted			2022-12-17	WOS:000312633900010
J	Hoffman, EA; Haxby, JV				Hoffman, EA; Haxby, JV			Distinct representations of eye gaze and identity in the distributed human neural system for face perception	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; HUMAN EXTRASTRIATE CORTEX; TEMPORAL CORTEX; FUNCTIONAL-ORGANIZATION; FACIAL EXPRESSION; RHESUS-MONKEYS; HUMAN AMYGDALA; ATTENTION; RECOGNITION; ACTIVATION	Face perception requires representation of invariant aspects that underlie identity recognition as well as representation of changeable aspects, such as eye gaze and expression, that facilitate social communication. Using functional magnetic resonance imaging (fMRI), we investigated the perception of face identity and eye gaze in the human brain. Perception of face identity was mediated more by regions in the inferior occipital and fusiform gyri, and perception of eye gaze was mediated more by regions in the superior temporal sulci. Eye-gaze perception also seemed to recruit the spatial cognition system in the intraparietal sulcus to encode the direction of another's gate and to focus attention in that direction.	NIMH, Sect Funct Brain Imaging, Lab Brain & Cognit, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Hoffman, EA (corresponding author), NIMH, Sect Funct Brain Imaging, Lab Brain & Cognit, Bldg 10,Room 4C104, Bethesda, MD 20892 USA.	elizabeth_hoffman@nih.gov		Hoffman, Eric/0000-0001-8456-9437				Aguirre GK, 1999, NEUROREPORT, V10, P189, DOI 10.1097/00001756-199901180-00036; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; CAMPY M., 1990, KARSTOLOGIA, V2, P11; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; Emery NJ, 1997, J COMP PSYCHOL, V111, P286, DOI 10.1037/0735-7036.111.3.286; Farah MJ, 1996, BEHAV BRAIN RES, V76, P181, DOI 10.1016/0166-4328(95)00198-0; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; GALE A, 1978, BEHAV PROCESS, V3, P271, DOI 10.1016/0376-6357(78)90019-0; Hains SMJ, 1996, CHILD DEV, V67, P1940; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; HARRIES MH, 1991, J COGNITIVE NEUROSCI, V3, P9, DOI 10.1162/jocn.1991.3.1.9; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HEYWOOD CA, 1992, PHILOS T ROY SOC B, V335, P31, DOI 10.1098/rstb.1992.0004; Hood BM, 1998, PSYCHOL SCI, V9, P131, DOI 10.1111/1467-9280.00024; Kanwisher N, 1999, NEUROREPORT, V10, P183, DOI 10.1097/00001756-199901180-00035; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kawashima R, 1999, BRAIN, V122, P779, DOI 10.1093/brain/122.4.779; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; MENDELSON MJ, 1982, DEV PSYCHOL, V18, P222, DOI 10.1037/0012-1649.18.2.222; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; PERRETT D I, 1990, International Journal of Comparative Psychology, V4, P25; PERRETT DI, 1994, CAH PSYCHOL COGN, V13, P683; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; PERRETT DI, 1984, HUM NEUROBIOL, V3, P197; Perrett DI., 1990, COMP PERCEPTION, P187; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Puce A, 1998, J NEUROSCI, V18, P2188; PUCE A, IN PRESS COGNIT NEUR; SERGENT J, 1992, PHILOS T ROY SOC B, V335, P55, DOI 10.1098/rstb.1992.0007; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Sergent J., 1994, VIS COGN, V1, P349, DOI [10.1080/13506289408402305, DOI 10.1080/13506289408402305]; Talairach J., 1988, COPLANAR STEREOTAXIC; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; TRANEL D, 1988, NEUROLOGY, V38, P690, DOI 10.1212/WNL.38.5.690; van HOOFF J. A. R. A. M., 1962, SYMPOSIA ZOOL SOC LONDON, V8, P97; Vecera S. P., 1995, Visual Cognition, V2, P59, DOI 10.1080/13506289508401722; Wicker B, 1998, NEUROIMAGE, V8, P221, DOI 10.1006/nimg.1998.0357	46	895	913	4	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					80	84		10.1038/71152	http://dx.doi.org/10.1038/71152			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	292TB	10607399				2022-12-17	WOS:000085810200016
J	Buzsaki, G; Moser, EI				Buzsaki, Gyoergy; Moser, Edvard I.			Memory, navigation and theta rhythm in the hippocampal-entorhinal system	NATURE NEUROSCIENCE			English	Review							MULTIITEM WORKING-MEMORY; PLACE CELLS; PATH-INTEGRATION; GRID CELLS; SPATIAL REPRESENTATION; PATTERN SEPARATION; PHASE PRECESSION; NEURAL BASIS; OSCILLATIONS; DYNAMICS	Theories on the functions of the hippocampal system are based largely on two fundamental discoveries: the amnestic consequences of removing the hippocampus and associated structures in the famous patient H.M. and the observation that spiking activity of hippocampal neurons is associated with the spatial position of the rat. In the footsteps of these discoveries, many attempts were made to reconcile these seemingly disparate functions. Here we propose that mechanisms of memory and planning have evolved from mechanisms of navigation in the physical world and hypothesize that the neuronal algorithms underlying navigation in real and mental space are fundamentally the same. We review experimental data in support of this hypothesis and discuss how specific firing patterns and oscillatory dynamics in the entorhinal cortex and hippocampus can support both navigation and memory.	[Buzsaki, Gyoergy] NYU, NYU Neurosci Inst, New York, NY USA; [Buzsaki, Gyoergy] NYU, Ctr Neural Sci, New York, NY USA; [Moser, Edvard I.] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7034 Trondheim, Norway	New York University; New York University; Norwegian University of Science & Technology (NTNU)	Buzsaki, G (corresponding author), NYU, NYU Neurosci Inst, New York, NY USA.	gyorgy.buzsaki@nyumc.org		Buzsaki, Gyorgy/0000-0002-3100-4800	US National Institutes of Health [NS34994, MH54671, NS 074015]; International Human Frontiers Science Program Organization [RGP0032/2011]; James S. McDonnell Foundation; Global Institute for Scientific Thinking; European Research Council ('CIRCUIT' Advanced Investigator Grant) [232608]; Louis-Jeantet Prize for Medicine; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074015, R01NS034994] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontiers Science Program Organization(Human Frontier Science Program); James S. McDonnell Foundation; Global Institute for Scientific Thinking; European Research Council ('CIRCUIT' Advanced Investigator Grant); Louis-Jeantet Prize for Medicine; Kavli Foundation; Centre of Excellence scheme of the Research Council of Norway; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Fishell for comments, Heather McKellar for assistance, and the US National Institutes of Health (NS34994; MH54671; NS 074015), International Human Frontiers Science Program Organization (RGP0032/2011), James S. McDonnell Foundation, Global Institute for Scientific Thinking, European Research Council ('CIRCUIT' Advanced Investigator Grant, Grant Agreement 232608), Louis-Jeantet Prize for Medicine, Kavli Foundation and Centre of Excellence scheme of the Research Council of Norway for support.	Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Boccara CN, 2010, NAT NEUROSCI, V13, P987, DOI 10.1038/nn.2602; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burgess N, 2011, CURR OPIN NEUROBIOL, V21, P734, DOI 10.1016/j.conb.2011.07.002; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Diba K, 2008, J NEUROSCI, V28, P13448, DOI 10.1523/JNEUROSCI.3824-08.2008; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Fell J, 2002, REV NEUROSCIENCE, V13, P299; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Gothard KM, 1996, J NEUROSCI, V16, P823; Griesmayr B, 2010, NEUROBIOL LEARN MEM, V93, P208, DOI 10.1016/j.nlm.2009.09.013; Gupta AS, 2012, NAT NEUROSCI, V15, P1032, DOI 10.1038/nn.3138; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hampson RE, 1996, HIPPOCAMPUS, V6, P281, DOI 10.1002/(SICI)1098-1063(1996)6:3<281::AID-HIPO6>3.0.CO;2-Q; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hasselmo ME, 2012, WE REMEMBER BRAIN ME; Hasselmo ME, 2007, LEARN MEMORY, V14, P782, DOI 10.1101/lm.686607; HEIT G, 1988, NATURE, V333, P773, DOI 10.1038/333773a0; Howard MW, 1999, J EXP PSYCHOL LEARN, V25, P923, DOI 10.1037/0278-7393.25.4.923; Itskov V, 2008, J NEUROSCI, V28, P5959, DOI 10.1523/JNEUROSCI.5262-07.2008; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jezek K, 2011, NATURE, V478, P246, DOI 10.1038/nature10439; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; Koch C, 1996, CEREB CORTEX, V6, P93, DOI 10.1093/cercor/6.2.93; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Krupic J, 2012, SCIENCE, V337, P853, DOI 10.1126/science.1222403; Kumaran D, 2012, PSYCHOL REV, V119, P573, DOI 10.1037/a0028681; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Mankin EA, 2012, P NATL ACAD SCI USA, V109, P19462, DOI 10.1073/pnas.1214107109; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Menzel R, 1998, ANIM BEHAV, V55, P139, DOI 10.1006/anbe.1997.0574; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1994, J NEUROSCI, V14, P7235; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Navigli R, 2010, IEEE T PATTERN ANAL, V32, P678, DOI 10.1109/TPAMI.2009.36; Naya Y, 2011, SCIENCE, V333, P773, DOI 10.1126/science.1206773; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shrager Y, 2008, P NATL ACAD SCI USA, V105, P12034, DOI 10.1073/pnas.0805414105; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Thompson E, 2001, TRENDS COGN SCI, V5, P418, DOI 10.1016/S1364-6613(00)01750-2; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Tulving E., 2002, PRINCIPLES FRONTAL L, P311, DOI [DOI 10.1093/ACPROF:OSO/9780195134971.003.0020, 10.1093/acprof:oso/9780195134971.003.0020]; Tulving E., 1972, ORG MEMORY, P423; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Wickelgren WA, 1999, CAN J EXP PSYCHOL, V53, P118, DOI 10.1037/h0087304; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583	100	889	906	19	334	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2013	16	2					130	138		10.1038/nn.3304	http://dx.doi.org/10.1038/nn.3304			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	080RE	23354386	Green Accepted			2022-12-17	WOS:000314260200008
J	Nagai, M; Re, DB; Nagata, T; Chalazonitis, A; Jessell, TM; Wichterle, H; Przedborski, S				Nagai, Makiko; Re, Diane B.; Nagata, Tetsuya; Chalazonitis, Alcmene; Jessell, Thomas M.; Wichterle, Hynek; Przedborski, Serge			Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; TRANSGENIC MOUSE MODEL; EMBRYONIC STEM-CELLS; SPINAL-CORD; EXTEND SURVIVAL; IN-VITRO; DISEASE; MICE; DEGENERATION	Mutations in superoxide dismutase-1 ( SOD1) cause a form of the fatal paralytic disorder amyotrophic lateral sclerosis ( ALS), presumably by a combination of cell-autonomous and non - cell- autonomous processes. Here, we show that expression of mutated human SOD1 in primary mouse spinal motor neurons does not provoke motor neuron degeneration. Conversely, rodent astrocytes expressing mutated SOD1 kill spinal primary and embryonic mouse stem cell - derived motor neurons. This is triggered by soluble toxic factor( s) through a Bax- dependent mechanism. However, mutant astrocytes do not cause the death of spinal GABAergic or dorsal root ganglion neurons or of embryonic stem cell - derived interneurons. In contrast to astrocytes, fibroblasts, microglia, cortical neurons and myocytes expressing mutated SOD1 do not cause overt neurotoxicity. These findings indicate that astrocytes may play a role in the specific degeneration of spinal motor neurons in ALS. Identification of the astrocyte- derived soluble factor( s) may have far- reaching implications for ALS from both a pathogenic and therapeutic standpoint.	Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Przedborski, S (corresponding author), Columbia Univ, Dept Neurol, 710 W 168th St, New York, NY 10032 USA.	SP30@Columbia.edu		Nagata, Tetsuya/0000-0003-4111-2693; Re, Diane/0000-0002-6842-6759; Wichterle, Hynek/0000-0002-7817-0080	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011766, R01NS042269, P01NS011766, P50NS038370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021617] Funding Source: NIH RePORTER; NIA NIH HHS [AG 21617, R01 AG021617] Funding Source: Medline; NIDDK NIH HHS [DK58056, R01 DK058056] Funding Source: Medline; NIEHS NIH HHS [ES013177, R21 ES013177] Funding Source: Medline; NINDS NIH HHS [NS11766, P50 NS038370, NS38370, P01 NS011766, R01 NS042269, NS42269] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; CHALAZONITIS A, 1988, BRAIN RES, V458, P231, DOI 10.1016/0006-8993(88)90466-0; CHALAZONITIS A, 1992, J NEUROSCI, V12, P583; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; DAS S, 1995, NEURON, V14, P447, DOI 10.1016/0896-6273(95)90300-3; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; KAJI K, 1979, EXP CELL RES, V119, P231, DOI 10.1016/0014-4827(79)90351-3; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Kuo JJ, 2005, J PHYSIOL-LONDON, V563, P843, DOI 10.1113/jphysiol.2004.074138; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lukas TJ, 2006, MOL CELL PROTEOMICS, V5, P1233, DOI 10.1074/mcp.M500431-MCP200; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Przedborski S, 1996, J NEUROCHEM, V67, P1383; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Ricart K, 2006, J NEUROCHEM, V97, P222, DOI 10.1111/j.1471-4159.2006.03739.x; Rideout HJ, 2004, J BIOL CHEM, V279, P46915, DOI 10.1074/jbc.M405146200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Scheffler B, 2003, DEVELOPMENT, V130, P5533, DOI 10.1242/dev.00714; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Silva GA, 1998, J NEUROSCI METH, V80, P75, DOI 10.1016/S0165-0270(97)00198-2; Suurmeijer AJH, 1999, LAB INVEST, V79, P619; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zona C, 2006, J NEUROPHYSIOL, V96, P3314, DOI 10.1152/jn.00566.2006	38	889	921	2	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					615	622		10.1038/nn1876	http://dx.doi.org/10.1038/nn1876			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17435755	Green Accepted			2022-12-17	WOS:000245948000018
J	Haggard, P; Clark, S; Kalogeras, J				Haggard, P; Clark, S; Kalogeras, J			Voluntary action and conscious awareness	NATURE NEUROSCIENCE			English	Article							INTENTION	Humans have the conscious experience of 'free will': we feel we can generate our actions, and thus affect our environment. Here we used the perceived time of intentional actions and of their sensory consequences as a means to study consciousness of action. These perceived times were attracted together in conscious awareness, so that subjects perceived voluntary movements as occurring later and their sensory consequences as occurring earlier than they actually did. Comparable involuntary movements caused by magnetic brain stimulation reversed this attraction effect. We conclude that the CNS applies a specific neural mechanism to produce intentional binding of actions and their effects in conscious awareness.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London	Haggard, P (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	p.haggard@ucl.ac.uk	Haggard, Patrick/A-5081-2010	Haggard, Patrick/0000-0001-7798-793X				Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; BREITMEYER BG, 1985, BEHAV BRAIN SCI, V8, P539, DOI 10.1017/S0140525X00044915; Daprati E, 1997, COGNITION, V65, P71, DOI 10.1016/S0010-0277(97)00039-5; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Haggard P, 1999, EXP BRAIN RES, V126, P128, DOI 10.1007/s002210050722; Haggard P, 1999, EXP BRAIN RES, V127, P102, DOI 10.1007/s002210050778; Hommel B, 1996, PSYCHOL RES-PSYCH FO, V59, P176, DOI 10.1007/BF00425832; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Reason J.T., 1990, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Shore DI, 2001, PSYCHOL SCI, V12, P205, DOI 10.1111/1467-9280.00337; Sternberg S., 1973, ATTENTION PERFORM, VIV, P629; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497	15	888	897	9	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					382	385		10.1038/nn827	http://dx.doi.org/10.1038/nn827			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	534UQ	11896397				2022-12-17	WOS:000174606900020
J	Dehaene, S; Naccache, L; Cohen, L; Le Bihan, D; Mangin, JF; Poline, JB; Riviere, D				Dehaene, S; Naccache, L; Cohen, L; Le Bihan, D; Mangin, JF; Poline, JB; Riviere, D			Cerebral mechanisms of word masking and unconscious repetition priming	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; VISUAL AWARENESS; NEUROPHYSIOLOGY; ACTIVATION; FREQUENCY; ATTENTION; WORKSPACE; AREA	We used functional magnetic resonance imaging (fMRI) and event-related potentials (ERPs) to visualize the cerebral processing of unseen masked words. Within the areas associated with conscious reading, masked words activated left extrastriate, fusiform and precentral areas. Furthermore, masked words reduced the amount of activation evoked by a subsequent conscious presentation of the same word. In the left fusiform gyrus, this repetition suppression phenomenon was independent of whether the prime and target shared the same case, indicating that case-independent information about letter strings was extracted unconsciously. In comparison to an unmasked situation, however, the activation evoked by masked words was drastically reduced and was undetectable in prefrontal and parietal areas, correlating with participants' inability to report the masked words.	Serv Hosp Frederic Joliot, CEA, DSV, IFR 49,INSERM,U334, F-91401 Orsay, France; Serv Hosp Frederic Joliot, CEA, DSV, IFR 49,Unite Neuroactivat Fonct, F-91401 Orsay, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Dehaene, S (corresponding author), Serv Hosp Frederic Joliot, CEA, DSV, IFR 49,INSERM,U334, 4 Pl Gen Leclerc, F-91401 Orsay, France.	dehaene@shfj.cea.fr	Mangin, Jean-Francois/AAI-8983-2020	naccache, lionel/0000-0002-2874-1009; cohen, laurent/0000-0002-5010-9085				Bar M, 1999, P NATL ACAD SCI USA, V96, P1790, DOI 10.1073/pnas.96.4.1790; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Bowers JS, 1998, J EXP PSYCHOL HUMAN, V24, P1705, DOI 10.1037/0096-1523.24.6.1705; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; CHEESMAN J, 1984, PERCEPT PSYCHOPHYS, V36, P387, DOI 10.3758/BF03202793; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; COMPTON PE, 1991, J COGNITIVE NEUROSCI, V3, P304, DOI 10.1162/jocn.1991.3.4.304; Deacon D, 2000, COGNITIVE BRAIN RES, V9, P137, DOI 10.1016/S0926-6410(99)00050-6; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; FERRAND L, 1994, Q J EXP PSYCHOL-A, V47, P365, DOI 10.1080/14640749408401116; Fiez JA, 1999, NEURON, V24, P205, DOI 10.1016/S0896-6273(00)80833-8; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Kiefer M, 2000, NEUROREPORT, V11, P2401, DOI 10.1097/00001756-200008030-00013; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; MARSOLEK CJ, 1995, J EXP PSYCHOL HUMAN, V21, P375, DOI 10.1037/0096-1523.21.2.375; MARSOLEK CJ, 1992, J EXP PSYCHOL LEARN, V18, P492, DOI 10.1037/0278-7393.18.3.492; McIntosh AR, 1999, SCIENCE, V284, P1531, DOI 10.1126/science.284.5419.1531; NACCACHE L, IN PRESS CEREB CORTE; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Portas CM, 2000, NEURON, V28, P991, DOI 10.1016/S0896-6273(00)00169-0; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; POSNER MI, 1993, PSYCHOL SCI, V4, P305, DOI 10.1111/j.1467-9280.1993.tb00569.x; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; Rees G, 2000, BRAIN, V123, P1624, DOI 10.1093/brain/123.8.1624; Rolls ET, 1999, J COGNITIVE NEUROSCI, V11, P300, DOI 10.1162/089892999563409; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schnyer DM, 1997, NEUROPSYCHOLOGY, V11, P243, DOI 10.1037/0894-4105.11.2.243; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	46	883	895	3	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					752	758		10.1038/89551	http://dx.doi.org/10.1038/89551			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	448HK	11426233				2022-12-17	WOS:000169621300022
J	Blakemore, SJ; Wolpert, DM; Frith, CD				Blakemore, SJ; Wolpert, DM; Frith, CD			Central cancellation of self-produced tickle sensation	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; MOTOR CONTROL; CEREBELLUM; TRANSMISSION; ACQUISITION; MOVEMENT; NEURONS; TOUCH; AREAS; CAT	A self-produced tactile stimulus is perceived as less ticklish than the same stimulus generated externally. We used fMRI to examine neural responses when subjects experienced a tactile stimulus that was either self-produced or externally produced. More activity was found in somatosensory cortex when the stimulus was externally produced. In the cerebellum, less activity was associated with a movement that generated a tactile stimulus than with a movement that did not. This difference suggests that the cerebellum is involved in predicting the specific sensory consequences of movements, providing the signal that is used to cancel the sensory response to self-generated stimulation.	Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Inst Neurol, Sobell Dept, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Blakemore, SJ (corresponding author), Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	s.blakemore@ucl.ac.uk	Galantucci, Bruno/E-5770-2010; Hoogkamer, Wouter/G-4498-2010; Blakemore, Sarah-Jayne/A-1792-2010; Frith, Chris D/A-2171-2009	Blakemore, Sarah-Jayne/0000-0002-1690-2805; Frith, Chris D/0000-0002-8665-0690; Wolpert, Daniel/0000-0003-2011-2790	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSSON G, 1987, J PHYSIOL-LONDON, V385, P107, DOI 10.1113/jphysiol.1987.sp016487; ANDERSSON G, 1985, NEUROSCI LETT S, V22, pS27; Bower JM, 1997, INT REV NEUROBIOL, V41, P489, DOI 10.1016/S0074-7742(08)60367-0; Bower JM, 1997, PROG BRAIN RES, V114, P463; CHAPIN JK, 1982, EXP NEUROL, V78, P654, DOI 10.1016/0014-4886(82)90082-6; CHAPMAN CE, 1994, CAN J PHYSIOL PHARM, V72, P558, DOI 10.1139/y94-080; CLAXTON G, 1975, PERCEPT MOTOR SKILL, V41, P335, DOI 10.2466/pms.1975.41.1.335; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Decety J, 1996, REV NEUROSCIENCE, V7, P285; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FRISTON KJ, 1990, J CEREBR BLOOD F MET, V10, P458, DOI 10.1038/jcbfm.1990.88; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; FRISTON KJ, 1997, HUMAN BRAIN FUNCTION, P107; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; GELLMAN R, 1985, J NEUROPHYSIOL, V54, P40, DOI 10.1152/jn.1985.54.1.40; ITO M, 1970, INT J NEUROL, V7, P162; Jansma JM, 1998, NEUROREPORT, V9, P501; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Jeannerod M., 1997, COGNITIVE NEUROSCIEN; JIANG W, 1991, EXP BRAIN RES, V84, P342; KRUBITZER L, 1995, J NEUROSCI, V15, P3821; LEINER HC, 1995, HUMAN BRAIN MAPPING, V2, P244; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Morissette J, 1996, EXP BRAIN RES, V109, P240; Oscarsson O., 1980, INFERIOR OLIVARY NUC, P279; Paulesu E., 1997, HUMAN BRAIN FUNCTION, P183; PAULIN MG, 1989, DYNAMIC INTERACTIONS, P241; PORRINO LJ, 1993, PSYCHOPHARMACOLOGY, V112, P343, DOI 10.1007/BF02244931; SIMPSON JL, 1995, BRAIN BEHAV SCI, V19, P368; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Talairach J., 1988, COPLANAR STEREOTAXIC; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Vogt BA, 1993, NEUROBIOLOGY CINGULA; VONHOLST E, 1902, BRIT J ANIM BEHAV, V289, P54; WEISKRANTZ L, 1971, NATURE, V230, P598, DOI 10.1038/230598a0; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	41	879	887	4	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					635	640		10.1038/2870	http://dx.doi.org/10.1038/2870			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196573				2022-12-17	WOS:000077437100021
J	Luo, Y; Bolon, B; Kahn, S; Bennett, BD; Babu-Khan, S; Denis, P; Fan, W; Kha, H; Zhang, JH; Gong, YH; Martin, L; Louis, JC; Yan, Q; Richards, WG; Citron, M; Vassar, R				Luo, Y; Bolon, B; Kahn, S; Bennett, BD; Babu-Khan, S; Denis, P; Fan, W; Kha, H; Zhang, JH; Gong, YH; Martin, L; Louis, JC; Yan, Q; Richards, WG; Citron, M; Vassar, R			Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation	NATURE NEUROSCIENCE			English	Article							PRECURSOR PROTEIN; PEPTIDE; DISEASE		Amgen Inc, Thousand Oaks, CA 91320 USA	Amgen	Vassar, R (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	r-vassar@northwestern.edu						Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Gouras GK, 1998, J NEUROCHEM, V71, P1920; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Saunders AJ, 1999, SCIENCE, V286; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 1999, AM J HUM GENET, V65, P7, DOI 10.1086/302475; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2000, NEURON, V27, P419, DOI 10.1016/S0896-6273(00)00051-9; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Younkin SG, 1998, J PHYSIOLOGY-PARIS, V92, P289, DOI 10.1016/S0928-4257(98)80035-1	15	878	994	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					231	232		10.1038/85059	http://dx.doi.org/10.1038/85059			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224535				2022-12-17	WOS:000167178300006
J	Ransohoff, RM				Ransohoff, Richard M.			A polarizing question: do M1 and M2 microglia exist?	NATURE NEUROSCIENCE			English	Article							PRONEUROGENIC PHENOTYPE; MACROPHAGE ACTIVATION; ANALYSIS REVEALS; ADULT MICROGLIA; NEURONAL DEATH; MYELOID CELLS; MOUSE; EXPRESSION; FATE; TRANSCRIPTOME	Microglial research has entered a fertile, dynamic phase characterized by novel technologies including two-photon imaging, whole-genome transcriptomic and epigenomic analysis with complementary bioinformatics, unbiased proteomics, cytometry by time of flight (CyTOF; Fluidigm) cytometry, and complex high-content experimental models including slice culture and zebrafish. Against this vivid background of newly emerging data, investigators will encounter in the microglial research literature a body of published work using the terminology of macrophage polarization, most commonly into the M1 and M2 phenotypes. It is the assertion of this opinion piece that microglial polarization has not been established by research findings. Rather, the adoption of this schema was undertaken in an attempt to simplify data interpretation at a time when the ontogeny and functional significance of microglia had not yet been characterized. Now, terminology suggesting established meaningful pathways of microglial polarization hinders rather than aids research progress and should be discarded.	[Ransohoff, Richard M.] Biogen Inc, Neuroimmunol, 14 Cambridge Ctr, Cambridge, MA 02142 USA	Biogen	Ransohoff, RM (corresponding author), Biogen Inc, Neuroimmunol, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	richard.ransohoff@biogen.com						Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; ALLIOT F, 1991, P NATL ACAD SCI USA, V88, P1541, DOI 10.1073/pnas.88.4.1541; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Fields RD, 2014, NEUROSCIENTIST, V20, P426, DOI 10.1177/1073858413504465; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Hellwig S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14624; Hellwig S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00071; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Holtman IR, 2015, GLIA, V63, P1495, DOI 10.1002/glia.22810; Hoshiko M, 2012, J NEUROSCI, V32, P15106, DOI 10.1523/JNEUROSCI.1167-12.2012; Kan MJ, 2015, J NEUROSCI, V35, P5969, DOI 10.1523/JNEUROSCI.4668-14.2015; Kim CC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0581-z; Kohman RA, 2012, BRAIN BEHAV IMMUN, V26, P803, DOI 10.1016/j.bbi.2011.10.006; Kumar D, 2016, MOL CELL PROTEOMICS, V15, P329, DOI 10.1074/mcp.M114.047126; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Link V.M., 2015, COLD SPRING HARB SYM; Lyons DA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020586; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Olah M, 2012, GLIA, V60, P96, DOI 10.1002/glia.21251; Oosterhof N, 2015, GLIA, V63, P719, DOI 10.1002/glia.22780; Panatier A, 2012, DEV CELL, V23, P1125, DOI 10.1016/j.devcel.2012.11.015; Paolicelli RC, 2011, NEURON GLIA BIOL, V7, P77, DOI 10.1017/S1740925X12000105; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Perdiguero EG, 2013, GLIA, V61, P112, DOI 10.1002/glia.22393; Pont-Lezica L, 2014, EUR J NEUROSCI, V39, P1551, DOI 10.1111/ejn.12508; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Romanoski CE, 2015, TRENDS IMMUNOL, V36, P507, DOI 10.1016/j.it.2015.07.006; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Squarzoni P, 2014, CELL REP, V8, P1271, DOI 10.1016/j.celrep.2014.07.042; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Sun SY, 2015, P NATL ACAD SCI USA, V112, pE6993, DOI 10.1073/pnas.1520639112; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; Viader A, 2016, ELIFE, V5, DOI 10.7554/eLife.12345; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wakselman S, 2008, J NEUROSCI, V28, P8138, DOI 10.1523/JNEUROSCI.1006-08.2008; Wes PD, 2016, GLIA, V64, P197, DOI 10.1002/glia.22866; Xu J, 2015, DEV CELL, V34, P632, DOI 10.1016/j.devcel.2015.08.018; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	65	870	891	15	231	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2016	19	8					987	991		10.1038/nn.4338	http://dx.doi.org/10.1038/nn.4338			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS4TB	27459405				2022-12-17	WOS:000380773200004
J	Kierdorf, K; Erny, D; Goldmann, T; Sander, V; Schulz, C; Perdiguero, EG; Wieghofer, P; Heinrich, A; Riemke, P; Holscher, C; Muller, DN; Luckow, B; Brocker, T; Debowski, K; Fritz, G; Opdenakker, G; Diefenbach, A; Biber, K; Heikenwalder, M; Geissmann, F; Rosenbauer, F; Prinz, M				Kierdorf, Katrin; Erny, Daniel; Goldmann, Tobias; Sander, Victor; Schulz, Christian; Perdiguero, Elisa Gomez; Wieghofer, Peter; Heinrich, Annette; Riemke, Pia; Hoelscher, Christoph; Mueller, Dominik N.; Luckow, Bruno; Brocker, Thomas; Debowski, Katharina; Fritz, Guenter; Opdenakker, Ghislain; Diefenbach, Andreas; Biber, Knut; Heikenwalder, Mathias; Geissmann, Frederic; Rosenbauer, Frank; Prinz, Marco			Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION FACTORS; FRACTALKINE RECEPTOR; MYELOID CELLS; YOLK-SAC; MACROPHAGES; DIFFERENTIATION; HETEROGENEITY; PROGENITORS; MONOCYTES; SURVIVAL	Microglia are crucial for immune responses in the brain. Although their origin from the yolk sac has been recognized for some time, their precise precursors and the transcription program that is used are not known. We found that mouse microglia were derived from primitive c-kit(+) erythromyeloid precursors that were detected in the yolk sac as early as 8 d post conception. These precursors developed into CD45(+) c-kit(lo) CX(3)CR1(-) immature (A1) cells and matured into CD45(+) c-kit(-) CX(3)CR1(+) (A2) cells, as evidenced by the downregulation of CD31 and concomitant upregulation of F4/80 and macrophage colony stimulating factor receptor (MCSF-R). Proliferating A2 cells became microglia and invaded the developing brain using specific matrix metalloproteinases. Notably, microgliogenesis was not only dependent on the transcription factor Pu.1 (also known as Sfpi), but also required Irf8, which was vital for the development of the A2 population, whereas Myb, Id2, Batf3 and Klf4 were not required. Our data provide cellular and molecular insights into the origin and development of microglia.	[Kierdorf, Katrin; Erny, Daniel; Goldmann, Tobias; Sander, Victor; Wieghofer, Peter; Fritz, Guenter; Prinz, Marco] Univ Freiburg, Dept Neuropathol, D-79106 Freiburg, Germany; [Kierdorf, Katrin; Wieghofer, Peter] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Schulz, Christian; Perdiguero, Elisa Gomez; Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England; [Schulz, Christian; Perdiguero, Elisa Gomez; Geissmann, Frederic] Kings Coll London, Peter Gorer Dept Immunobiol, London WC2R 2LS, England; [Heinrich, Annette; Biber, Knut] Univ Freiburg, Dept Psychiat, D-79106 Freiburg, Germany; [Riemke, Pia; Rosenbauer, Frank] Univ Munster, Inst Mol Tumor Biol, D-48149 Munster, Germany; [Hoelscher, Christoph] Res Ctr Borstel, Div Infect Immunol, Borstel, Germany; [Hoelscher, Christoph] Cluster Excellence Inflammat Interfaces Borstel K, Kiel, Germany; [Mueller, Dominik N.] Fac Med Charite, Expt & Clin Res Ctr, Berlin, Germany; [Mueller, Dominik N.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Luckow, Bruno] Klinikum Univ Munchen, Klin & Poliklin 4, Arbeitsgrp Klin Biochem, Munich, Germany; [Brocker, Thomas] Univ Munich, Inst Immunol, D-80539 Munich, Germany; [Debowski, Katharina] German Primate Ctr, Cell Res Grp, Gottingen, Germany; [Opdenakker, Ghislain] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Louvain, Belgium; [Diefenbach, Andreas] Univ Freiburg, Dept Microbiol, D-79106 Freiburg, Germany; [Biber, Knut] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Heikenwalder, Mathias] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munich, D-80290 Munich, Germany; [Prinz, Marco] Univ Freiburg, Ctr Biol Signaling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of London; King's College London; University of London; King's College London; University of Freiburg; University of Munster; Forschungszentrum Borstel; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Munich; University of Munich; Deutsches Primatenzentrum (DPZ); KU Leuven; University of Freiburg; University of Groningen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Dept Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.	marco.prinz@uniklinik-freiburg.de	Kierdorf, Katrin/AAO-6288-2021; Erny, Daniel/AAU-7015-2020; Perdiguero, Elisa Gomez/U-2120-2018; Opdenakker, Ghislain/V-8562-2019; Fritz, Guenter/E-2933-2013; Heikenwalder, Mathias/AAA-2269-2020; Diefenbach, Andreas/T-2589-2018; Schulz, Christian/J-8545-2012; Hölscher, Christoph/O-1732-2018; Opdenakker, Ghislain/Q-3130-2017; Wieghofer, Peter/AAV-9572-2020	Erny, Daniel/0000-0001-6000-8838; Perdiguero, Elisa Gomez/0000-0002-7717-7897; Opdenakker, Ghislain/0000-0003-1714-2294; Fritz, Guenter/0000-0002-4571-8812; Diefenbach, Andreas/0000-0002-9176-9530; Schulz, Christian/0000-0003-3878-7833; Hölscher, Christoph/0000-0002-7520-9146; Opdenakker, Ghislain/0000-0003-1714-2294; Rosenbauer, Frank/0000-0001-7977-9421; Kierdorf, Katrin/0000-0002-9272-4780; Brocker, Thomas/0000-0001-7060-5433; geissmann, frederic/0000-0001-5029-2468; Goldmann, Tobias/0000-0001-9754-9144; Masuch, Annette/0000-0002-8168-5042; Muller, Dominik N/0000-0003-3650-5644	Deutsche Forschungsgemeinschaft (DFG); Bundesministerium fur Bildung und Forschung; Competence Network of Neurodegenerative Disorders (Deutsches Zentrum fur Neurodegenerative Erkrankungen); Centre of Chronic Immunodeficiency; DFG [SFB 620, PR 577/8-1]; Heisenberg fellowship [DFG FR 1488/3-2]; Helmholtz-Zentrum Munchen, a European Research Council; Swiss National Foundation; Geconcentreerde OnderzoeksActies [2012/017]; Fund for Scientific Research-Flanders; German National Academy of Sciences Leopoldina [LPDS 2009-31]; Medical Research Council [MRCG0900867]; European Research Council [ERC-2010-StG-261299]; Medical Research Council [G0900867] Funding Source: researchfish; MRC [G0900867] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Competence Network of Neurodegenerative Disorders (Deutsches Zentrum fur Neurodegenerative Erkrankungen); Centre of Chronic Immunodeficiency; DFG(German Research Foundation (DFG)); Heisenberg fellowship(German Research Foundation (DFG)); Helmholtz-Zentrum Munchen, a European Research Council; Swiss National Foundation(Swiss National Science Foundation (SNSF)); Geconcentreerde OnderzoeksActies; Fund for Scientific Research-Flanders(FWO); German National Academy of Sciences Leopoldina; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank M. Oberle, A. Holscher and U. Muller for excellent technical assistance, M. Mann for help with the heat map, A. Muller for assistance with the electron microscopy and S. Brendecke for critical reading and editing. The authors are indebted to S. McKercher (Sanford-Burnham Medical Research Institute) for providing Sfpi<SUP>+/-</SUP> mice and to J. Frampton (University of Birmingham) for providing Myb<SUP>+/-</SUP> mice. We thank S. Heck and the Flow facility of the Biomedical Research Centre at King's Health Partners. M.P., K.B. and ER. are supported by the Deutsche Forschungsgemeinschaft (DFG)-funded research unit 1336 "From monocytes to brain macrophages-conditions influencing the fate of myeloid cells in the brain". M.P. is supported by the Bundesministerium fur Bildung und Forschung-funded Competence Network of Multiple Sclerosis (Kompetenznetz Multiple Sklerose), the Competence Network of Neurodegenerative Disorders (Deutsches Zentrum fur Neurodegenerative Erkrankungen), the Centre of Chronic Immunodeficiency and the DFG (SFB 620, PR 577/8-1). G.F. is supported by a Heisenberg fellowship (DFG FR 1488/3-2). M.H. is supported by the Helmholtz-Zentrum Munchen, a European Research Council starting grant and the Swiss National Foundation. G.O. is supported by the Geconcentreerde OnderzoeksActies 2012/017 and the Fund for Scientific Research-Flanders. CS. is supported by a fellowship program of the German National Academy of Sciences Leopoldina (LPDS 2009-31). F.G. is supported by grants MRCG0900867 from the Medical Research Council and ERC-2010-StG-261299 from the European Research Council.	Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Anderson KL, 2000, J IMMUNOL, V164, P1855, DOI 10.4049/jimmunol.164.4.1855; Bakri Y, 2005, BLOOD, V105, P2707, DOI 10.1182/blood-2004-04-1448; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Hu JL, 2006, COMB CHEM HIGH T SCR, V9, P599, DOI 10.2174/138620706778249758; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Palis J, 1999, DEVELOPMENT, V126, P5073; Palis J, 2001, P NATL ACAD SCI USA, V98, P4528, DOI 10.1073/pnas.071002398; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Takahashi K, 1996, PATHOL INT, V46, P473, DOI 10.1111/j.1440-1827.1996.tb03641.x; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Vinet J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-27; Wegiel J, 1998, BRAIN RES, V804, P135, DOI 10.1016/S0006-8993(98)00618-0	30	869	895	1	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					273	280		10.1038/nn.3318	http://dx.doi.org/10.1038/nn.3318			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23334579				2022-12-17	WOS:000315474800009
J	Nilsberth, C; Westlind-Danielsson, A; Eckman, CB; Condron, MM; Axelman, K; Forsell, C; Stenh, C; Luthman, J; Teplow, DB; Younkin, SG; Naslund, J; Lannfelt, L				Nilsberth, C; Westlind-Danielsson, A; Eckman, CB; Condron, MM; Axelman, K; Forsell, C; Stenh, C; Luthman, J; Teplow, DB; Younkin, SG; Naslund, J; Lannfelt, L			The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced A beta protofibril formation	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; FIBRIL FORMATION; IN-VITRO; CEREBRAL-HEMORRHAGE; GENE; FIBRILLOGENESIS; A-BETA(1-42); PRESENILINS; PEPTIDES; PLASMA	Several pathogenic Alzheimer's disease (AD) mutations have been described, all of which cause increased amyloid beta -protein (A beta) levels. Here we present studies of a pathogenic amyloid precursor protein (APP) mutation, located within the A beta sequence at codon 693 (E693G), that causes AD in a Swedish family. Carriers of this 'Arctic' mutation showed decreased A beta 42 and A beta 40 levels in plasma. Additionally, low levels of A beta 42 were detected in conditioned media from cells transfected with APP(E693G). Fibrillization studies demonstrated no difference in fibrillization rate, but A beta with the Arctic mutation formed protofibrils at a much higher rate and in larger quantities than wild-type (wt) A beta. The finding of increased protofibril formation and decreased A beta plasma levels in the Arctic AD may reflect an alternative pathogenic mechanism for AD involving rapid A beta protofibril formation leading to accelerated buildup of insoluble A beta intra- and/or extracellularly.	AstraZeneca, Discovery Res Area CNS & Pain Control, S-15185 Sodertalje, Sweden; Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	AstraZeneca; Mayo Clinic; Harvard University; Brigham & Women's Hospital	Lannfelt, L (corresponding author), Karolinska Inst, Novum KFC, Dept Neurotec, S-14186 Huddinge, Sweden.	lars.lannfelt@neurotec.ki.se			NIA NIH HHS [AG14366] Funding Source: Medline; NINDS NIH HHS [NS38328] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038328] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; De Jonghe C, 1998, NEUROBIOL DIS, V5, P281, DOI 10.1006/nbdi.1998.0202; FORSELL C, 1995, NEUROSCI LETT, V184, P90, DOI 10.1016/0304-3940(94)11176-J; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; HAASS C, 1994, J BIOL CHEM, V269, P17741; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Iwatsubo T, 1998, NEUROBIOL AGING, V19, P161, DOI 10.1016/S0197-4580(98)00015-3; JOHNSTON JA, 1994, FEBS LETT, V354, P274, DOI 10.1016/0014-5793(94)01137-0; KAMINO K, 1992, AM J HUM GENET, V51, P998; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Mayeux R, 1999, ANN NEUROL, V46, P412, DOI 10.1002/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tagliavini F., 1999, ALZHEIMERS REP, V2, pS28; Tamaoka A, 1996, J NEUROL SCI, V141, P65, DOI 10.1016/0022-510X(96)00143-8; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2001, BIOCHEM J, V355, P869, DOI 10.1042/bj3550869; Watson DJ, 1999, BIOCHEM J, V340, P703, DOI 10.1042/0264-6021:3400703; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001	40	869	903	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					887	893		10.1038/nn0901-887	http://dx.doi.org/10.1038/nn0901-887			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528419				2022-12-17	WOS:000170698600014
J	Gauthier, I; Tarr, MJ; Anderson, AW; Skudlarski, P; Gore, JC				Gauthier, I; Tarr, MJ; Anderson, AW; Skudlarski, P; Gore, JC			Activation of the middle fusiform 'face area' increases with expertise in recognizing novel objects	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; FUNCTIONAL MRI; RECOGNITION; PROSOPAGNOSIA; MECHANISMS; REGIONS	Part of the ventral temporal robe is thought to be critical for face perception, but what determines this specialization remains unknown. We present evidence that expertise recruits the fusiform gyrus 'face area'. Functional magnetic resonance imaging (fMRI) was used to measure changes associated with increasing expertise in brain areas selected for their face preference. Acquisition of expertise with novel objects (greebles) led to increased activation in the right hemisphere face areas for matching of upright greebles as compared to matching inverted greebles. The same areas were also more activated in experts than in novices during passive viewing of greebles. Expertise seems to be one factor that leads to specialization in the face area.	Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA	Yale University; Brown University	Gauthier, I (corresponding author), Yale Univ, Sch Med, Dept Diagnost Radiol, 333 Cedar St,Fitkin Basement, New Haven, CT 06510 USA.		Tudusciuc, Oana/C-1339-2011	Gauthier, Isabel/0000-0002-6249-4769				ALLISON T, 1994, J NEUROPHYSIOL, V71, P821, DOI 10.1152/jn.1994.71.2.821; BRUYER R, 1992, B PSYCHONOMIC SOC, V30, P501; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 1998, VISION RES, V38, P2401, DOI 10.1016/S0042-6989(97)00442-2; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; GAUTHIER I, IN PRESS COGNIT NEUR; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Kanwisher N, 1997, J COGNITIVE NEUROSCI, V9, P133, DOI 10.1162/jocn.1997.9.1.133; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KANWISHER N, 1998, COGNITION B, V68, P1; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Puce A, 1997, HUM BRAIN MAPP, V5, P298, DOI 10.1002/(SICI)1097-0193(1997)5:4<298::AID-HBM16>3.0.CO;2-A; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; PUCE A, 1996, NEUROPHYSIOLOGY, V74, P1192; RHODES G, 1989, BRIT J PSYCHOL, V80, P313, DOI 10.1111/j.2044-8295.1989.tb02323.x; RHODES G, 1994, VIS COGN, V1, P275, DOI DOI 10.1080/13506289408402303; SCHACTER DL, 1995, NATURE, V376, P587, DOI 10.1038/376587a0; SCHWEICH M, 1993, COGN NEUROPSYCHOL, V10, P529, DOI 10.1080/02643299308253472; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Tovee MJ, 1998, NEURON, V21, P1239, DOI 10.1016/S0896-6273(00)80644-3; TRANEL D, 1988, NEUROLOGY, V38, P690, DOI 10.1212/WNL.38.5.690; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	35	867	885	2	198	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					568	573		10.1038/9224	http://dx.doi.org/10.1038/9224			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	273YA	10448223				2022-12-17	WOS:000084735900018
J	Sahay, A; Hen, R				Sahay, Amar; Hen, Rene			Adult hippocampal neurogenesis in depression	NATURE NEUROSCIENCE			English	Review							GENERATED GRANULE CELLS; POSITRON-EMISSION-TOMOGRAPHY; ENHANCED SYNAPTIC PLASTICITY; DORSAL-VENTRAL AXIS; LONG-TERM-MEMORY; DENTATE GYRUS; MAJOR DEPRESSION; ENTORHINAL CORTEX; NEURONAL DIFFERENTIATION; PATTERN SEPARATION	The development of new treatments for depression is predicated upon identification of neural substrates and mechanisms that underlie its etiology and pathophysiology. The heterogeneity of depression indicates that its origin may lie in dysfunction of multiple brain regions. Here we evaluate adult hippocampal neurogenesis as a candidate mechanism for the etiology of depression and as a substrate for antidepressant action. Current evidence indicates that adult hippocampal neurogenesis may not be a major contributor to the development of depression, but may be required for some of the behavioral effects of antidepressants. We next revisit the functional differentiation of the hippocampus along the septo-temporal axis within the context of adult hippocampal neurogenesis and suggest that neurogenesis in the ventral dentate gyrus may be preferentially involved in regulation of emotion. Finally, we speculate on how increased adult hippocampal neurogenesis may modulate dentate gyrus function to confer the behavioral effects of antidepressants.	Columbia Univ, Div Integrat Neurosci, Dept Neurosci, New York, NY 10032 USA; Columbia Univ, Div Integrat Neurosci, Dept Psychiat, New York, NY 10032 USA	Columbia University; Columbia University	Sahay, A (corresponding author), Columbia Univ, Div Integrat Neurosci, Dept Neurosci, 1051 Riverside Dr,Box 87,Pl Annex,Room 767B, New York, NY 10032 USA.	as2619@columbia.edu; rh95@columbia.edu	Yan, Shuo/B-8381-2009; Sahay, Amar/J-3696-2014					Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; AIRAN RD, 2007, SCIENCE; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Barbas H, 1995, HIPPOCAMPUS, V5, P511, DOI 10.1002/hipo.450050604; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bjarkam CR, 2003, HIPPOCAMPUS, V13, P21, DOI 10.1002/hipo.10042; Burwell RD, 1998, J COMP NEUROL, V391, P293, DOI 10.1002/(SICI)1096-9861(19980216)391:3<293::AID-CNE2>3.0.CO;2-X; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; CARROLL BJ, 1968, BRIT MED J, V3, P285, DOI 10.1136/bmj.3.5613.285; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; CZEH B, 2007, EUR ARCH PSYCHIAT CL; David DJ, 2007, J PHARMACOL EXP THER, V321, P237, DOI 10.1124/jpet.106.109678; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Drevets WC, 1999, ANN NY ACAD SCI, V877, P614, DOI 10.1111/j.1749-6632.1999.tb09292.x; Duman Ronald S, 2002, CNS Spectr, V7, P140; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; DUMAN RS, 2002, CNS SPECTRUMS, V7, P144, DOI DOI 10.1017/S1092852900017454; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fujise N, 1998, NEUROSCIENCE, V82, P181; GAGE FH, 1980, BRAIN RES BULL, V5, P771, DOI 10.1016/0361-9230(80)90220-8; GARCIA AD, 2007, NAT NEUROSCI, V11, P70; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gould NF, 2007, AM J PSYCHIAT, V164, P516, DOI 10.1176/appi.ajp.164.3.516; HERMAN JP, 1995, J NEUROENDOCRINOL, V7, P475, DOI 10.1111/j.1365-2826.1995.tb00784.x; HOLICK KA, 2007, NEUROPSYCHOPHARMACOL; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Jinno S, 2003, J COMP NEUROL, V461, P333, DOI 10.1002/cne.10700; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Leonardo ED, 2006, NEUROSCIENCE, V137, P177, DOI 10.1016/j.neuroscience.2005.08.082; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Madsen TM, 2000, BIOL PSYCHIAT, V47, P1043, DOI 10.1016/S0006-3223(00)00228-6; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 2003, NEUROIMAG CLIN N AM, V13, P805, DOI 10.1016/S1052-5149(03)00104-7; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Meltzer LA, 2005, TRENDS NEUROSCI, V28, P653, DOI 10.1016/j.tins.2005.09.007; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; MOSER E, 1993, J NEUROSCI, V13, P3916; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Ngwenya LB, 2006, J COMP NEUROL, V498, P204, DOI 10.1002/cne.21045; O'Donnell P, 1998, NEUROSCIENCE, V87, P823, DOI 10.1016/S0306-4522(98)00190-0; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Perera TD, 2007, J NEUROSCI, V27, P4894, DOI 10.1523/JNEUROSCI.0237-07.2007; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scharfman HE, 2007, SCIENCE, V315, P336, DOI 10.1126/science.1138711; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Stockmeier CA, 2004, BIOL PSYCHIAT, V56, P640, DOI 10.1016/j.biopsych.2004.08.022; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Verwer RWH, 1997, HIPPOCAMPUS, V7, P397, DOI 10.1002/(SICI)1098-1063(1997)7:4<397::AID-HIPO5>3.0.CO;2-G; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; WILSON MA, 1991, NEUROSCIENCE, V44, P555, DOI 10.1016/0306-4522(91)90077-2; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9	101	863	891	4	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1110	1115		10.1038/nn1969	http://dx.doi.org/10.1038/nn1969			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17726477				2022-12-17	WOS:000249144000009
J	Hahn, TM; Breininger, JF; Baskin, DG; Schwartz, MW				Hahn, TM; Breininger, JF; Baskin, DG; Schwartz, MW			Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons	NATURE NEUROSCIENCE			English	Article							NEUROPEPTIDE-Y; MESSENGER-RNA; ARCUATE NUCLEUS; EXPRESSION; LEPTIN; OBESITY; AGOUTI; MICE; RECEPTOR; MOUSE		Univ Washington, Harborview Med Ctr, Dept Med, Seattle, WA 98108 USA; Univ Washington, Harborview Med Ctr, Dept Biol Struct, Seattle, WA 98108 USA; VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Schwartz, MW (corresponding author), Univ Washington, Harborview Med Ctr, Dept Med, 1660 S Columbian Way, Seattle, WA 98108 USA.		Schwartz, Michael W/H-9950-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK012829, R01DK052989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032273, R01NS032273] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-52989, DK-12829] Funding Source: Medline; NINDS NIH HHS [NS-32273] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRADY LS, 1990, NEUROENDOCRINOLOGY, V52, P441, DOI 10.1159/000125626; Cheung CC, 1997, ENDOCRINOLOGY, V138, P4489, DOI 10.1210/en.138.10.4489; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Mercer JG, 1996, J NEUROENDOCRINOL, V8, P733, DOI 10.1046/j.1365-2826.1996.05161.x; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Schwartz MW, 1997, NEW ENGL J MED, V336, P1802, DOI 10.1056/NEJM199706193362507; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; STANLEY BG, 1986, PEPTIDES, V7, P1189; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; WHITE J D, 1990, Molecular and Cellular Neuroscience, V1, P41; WILDING JPH, 1993, ENDOCRINOLOGY, V132, P1939, DOI 10.1210/en.132.5.1939	15	862	884	1	48	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					271	272		10.1038/1082	http://dx.doi.org/10.1038/1082			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195157				2022-12-17	WOS:000076361300007
J	Ma, WJ; Beck, JM; Latham, PE; Pouget, A				Ma, Wei Ji; Beck, Jeffrey M.; Latham, Peter E.; Pouget, Alexandre			Bayesian inference with probabilistic population codes	NATURE NEUROSCIENCE			English	Article							ORIENTATION SELECTIVITY; INTEGRATION; NEURONS; INFORMATION; RESPONSES; CORTEX; REPRESENTATION; COMPUTATION; DECISION; NOISE	Recent psychophysical experiments indicate that humans perform near-optimal Bayesian inference in a wide variety of tasks, ranging from cue integration to decision making to motor control. This implies that neurons both represent probability distributions and combine those distributions according to a close approximation to Bayes' rule. At first sight, it would seem that the high variability in the responses of cortical neurons would make it difficult to implement such optimal statistical inference in cortical circuits. We argue that, in fact, this variability implies that populations of neurons automatically represent probability distributions over the stimulus, a type of code we call probabilistic population codes. Moreover, we demonstrate that the Poisson-like variability observed in cortex reduces a broad class of Bayesian inference to simple linear combinations of populations of neural activity. These results hold for arbitrary probability distributions over the stimulus, for tuning curves of arbitrary shape and for realistic neuronal variability.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Gatsby Computat Neurosci Unit, London WC1N 3AR, England	University of Rochester; University of London; University College London	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	alex@bcs.rochester.edu		Pouget, Alexandre/0000-0003-3054-6365; Ma, Wei Ji/0000-0002-9835-9083	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062447, T32MH019942] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anastasio TJ, 2000, NEURAL COMPUT, V12, P1165, DOI 10.1162/089976600300015547; ANDERSON CH, 1994, COMPUTATIONAL INTELL, P213; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BARLOW HB, 1969, ANN NY ACAD SCI, V156, P872, DOI 10.1111/j.1749-6632.1969.tb14019.x; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Clark J.J., 1990, DATA FUSION SENSORY; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; DENEVE S, 2005, NEURAL INFORM PROCES; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FOLDIAK P, 1993, COMPUTATION AND NEURAL SYSTEMS, P55; Gepshtein S, 2003, CURR BIOL, V13, P483, DOI 10.1016/S0960-9822(03)00133-7; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gur M, 2006, CEREB CORTEX, V16, P888, DOI 10.1093/cercor/bhj032; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hinton GE, 1999, IEE CONF PUBL, P1, DOI 10.1049/cp:19991075; HOYER PO, 2003, NEURAL INFORM PROCES, P277; HUYS Q, IN PRESS NEURAL COMP; Jazayeri M, 2006, NAT NEUROSCI, V9, P690, DOI 10.1038/nn1691; Knill DC, 1998, VISION RES, V38, P1683, DOI 10.1016/S0042-6989(97)00325-8; Knill DC, 1996, PERCEPTION BAYESIAN; Koechlin E, 1999, BIOL CYBERN, V80, P25, DOI 10.1007/s004220050502; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; NELSON JI, 1992, VISUAL NEUROSCI, V9, P21, DOI 10.1017/S0952523800006349; Perrault TJ, 2005, J NEUROPHYSIOL, V93, P2575, DOI 10.1152/jn.00926.2004; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; Rao RPN, 2004, NEURAL COMPUT, V16, P1, DOI 10.1162/08997660460733976; Sahani M, 2003, NEURAL COMPUT, V15, P2255, DOI 10.1162/089976603322362356; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; SCLAR G, 1982, EXP BRAIN RES, V46, P457; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SIMONCELLI EP, 1991, IEEE C COMP VIS PATT, P310, DOI 10.1109/CVPR.1991.139707; Snippe HP, 1996, NEURAL COMPUT, V8, P511, DOI 10.1162/neco.1996.8.3.511; Stanford TR, 2005, J NEUROSCI, V25, P6499, DOI 10.1523/JNEUROSCI.5095-04.2005; Stein B E, 1989, J Cogn Neurosci, V1, P12, DOI 10.1162/jocn.1989.1.1.12; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Weiss Y, 2002, NEU INF PRO, P77; Wu S, 2001, NEURAL COMPUT, V13, P775, DOI 10.1162/089976601300014349; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818	48	856	860	3	89	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2006	9	11					1432	1438		10.1038/nn1790	http://dx.doi.org/10.1038/nn1790			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TN	17057707				2022-12-17	WOS:000242403800022
J	Tasic, B; Menon, V; Nguyen, TN; Kim, TK; Jarsky, T; Yao, ZZ; Levi, B; Gray, LT; Sorensen, SA; Dolbeare, T; Bertagnolli, D; Goldy, J; Shapovalova, N; Parry, S; Lee, C; Smith, K; Bernard, A; Madisen, L; Sunkin, SM; Hawrylycz, M; Koch, C; Zeng, HK				Tasic, Bosiljka; Menon, Vilas; Thuc Nghi Nguyen; Kim, Tae Kyung; Jarsky, Tim; Yao, Zizhen; Levi, Boaz; Gray, Lucas T.; Sorensen, Staci A.; Dolbeare, Tim; Bertagnolli, Darren; Goldy, Jeff; Shapovalova, Nadiya; Parry, Sheana; Lee, Changkyu; Smith, Kimberly; Bernard, Amy; Madisen, Linda; Sunkin, Susan M.; Hawrylycz, Michael; Koch, Christof; Zeng, Hongkui			Adult mouse cortical cell taxonomy revealed by single cell transcriptomics	NATURE NEUROSCIENCE			English	Article							RNA-SEQ; LAYER 6; NEUROGLIAFORM CELLS; GABAERGIC NEURONS; GENE-EXPRESSION; TRANSGENIC MICE; VISUAL-CORTEX; DRIVER LINES; INTERNEURONS; CONNECTIONS	Nervous systems are composed of various cell types, but the extent of cell type diversity is poorly understood. We constructed a cellular taxonomy of one cortical region, primary visual cortex, in adult mice on the basis of single-cell RNA sequencing. We identified 49 transcriptomic cell types, including 23 GABAergic, 19 glutamatergic and 7 non-neuronal types. We also analyzed cell type-specific mRNA processing and characterized genetic access to these transcriptomic types by many transgenic Cre lines. Finally, we found that some of our transcriptomic cell types displayed specific and differential electrophysiological and axon projection properties, thereby confirming that the single-cell transcriptomic signatures can be associated with specific cellular properties.	[Tasic, Bosiljka; Menon, Vilas; Thuc Nghi Nguyen; Kim, Tae Kyung; Jarsky, Tim; Yao, Zizhen; Levi, Boaz; Gray, Lucas T.; Sorensen, Staci A.; Dolbeare, Tim; Bertagnolli, Darren; Goldy, Jeff; Shapovalova, Nadiya; Parry, Sheana; Lee, Changkyu; Smith, Kimberly; Bernard, Amy; Madisen, Linda; Sunkin, Susan M.; Hawrylycz, Michael; Koch, Christof; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA	Allen Institute for Brain Science	Tasic, B (corresponding author), Allen Inst Brain Sci, Seattle, WA USA.	bosiljkat@alleninstitute.org	Jarsky, Tim/S-1879-2019; Menon, Vilas/AAG-4109-2021	Menon, Vilas/0000-0002-4096-8601; Yao, Zizhen/0000-0002-9361-5607; Bernard, Amy/0000-0003-2540-1153; Graybuck, Lucas/0000-0002-8814-6818; Koch, Christof/0000-0001-6482-8067; Nguyen, Thuc Nghi/0000-0002-6466-5883	Allen Institute for Brain Science; US National Institutes of Health [R01EY023173, U01MH105982]; NATIONAL EYE INSTITUTE [R01EY023173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105982] Funding Source: NIH RePORTER	Allen Institute for Brain Science; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank M. Chillon Rodrigues (Universitat Autonoma de Barcelona) for providing CAV-Cre, S. Mihalas for advice on data analysis, H. Gu, M. Mills, H. Gill and K. Hadley for technical assistance, C. Ye and A. Kaykas for help with the next generation sequencing, and the Department of In vivo Sciences, especially R. Larsen, L. Pearson and J. Harrington for mouse husbandry. We thank J. Waters and E. Lein for comments on the manuscript. The authors thank the Allen Institute founders, Paul G. Allen and Jody Allen, for their vision, encouragement and support. This work was funded by the Allen Institute for Brain Science, and by US National Institutes of Health grants R01EY023173 and U01MH105982 to H.Z.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Belgard TG, 2011, NEURON, V71, P605, DOI 10.1016/j.neuron.2011.06.039; Bortone DS, 2014, NEURON, V82, P474, DOI 10.1016/j.neuron.2014.02.021; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/NMETH.2645, 10.1038/nmeth.2645]; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chu ZG, 2003, J NEUROSCI, V23, P96; DeFelipe J, 2002, PROG BRAIN RES, V136, P215; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Dehorter N, 2015, SCIENCE, V349, P1216, DOI 10.1126/science.aab3415; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Franco SJ, 2012, SCIENCE, V337, P746, DOI 10.1126/science.1223616; Franklin K. B. J., 2008, MOUSE BRAIN STEREOTA; Gerashchenko D, 2008, P NATL ACAD SCI USA, V105, P10227, DOI 10.1073/pnas.0803125105; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Glickfeld LL, 2014, CURR OPIN NEUROBIOL, V24, P28, DOI 10.1016/j.conb.2013.08.009; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Harris JA, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00076; Harris Julie A, 2012, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0120s59; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hempel CM, 2007, NAT PROTOC, V2, P2924, DOI 10.1038/nprot.2007.416; Herculano-Houzel S, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00035; Hestrin S, 1996, J NEUROSCI, V16, P5290; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Hu H, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00195; Huang ZJ, 2014, NEURON, V83, P1284, DOI 10.1016/j.neuron.2014.08.041; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Karayannis T, 2010, J NEUROSCI, V30, P9898, DOI 10.1523/JNEUROSCI.5883-09.2010; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JE, 2005, MOL CELLS, V19, P408; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Muralidhar S, 2014, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00052; NIKKARI ST, 1994, AM J PATHOL, V144, P1348; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Povysheva NV, 2007, J NEUROPHYSIOL, V97, P1030, DOI 10.1152/jn.00794.2006; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Rossier J, 2015, MOL PSYCHIATR, V20, P154, DOI 10.1038/mp.2014.162; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sando R, 2013, NAT METHODS, V10, P1085, DOI [10.1038/NMETH.2640, 10.1038/nmeth.2640]; Seress L, 2005, BRAIN RES, V1056, P183, DOI 10.1016/j.brainres.2005.07.034; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Simon A, 2005, J NEUROSCI, V25, P6278, DOI 10.1523/JNEUROSCI.1431-05.2005; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Sorensen SA, 2015, CEREB CORTEX, V25, P433, DOI 10.1093/cercor/bht243; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Tomioka R, 2005, EUR J NEUROSCI, V21, P1587, DOI 10.1111/j.1460-9568.2005.03989.x; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Velez-Fort M, 2014, NEURON, V83, P1431, DOI 10.1016/j.neuron.2014.08.001; von Engelhardt J, 2007, J NEUROSCI, V27, P5633, DOI 10.1523/JNEUROSCI.4647-06.2007; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu XM, 2006, J COMP NEUROL, V499, P144, DOI 10.1002/cne.21101; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	81	853	864	13	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2016	19	2					335	+		10.1038/nn.4216	http://dx.doi.org/10.1038/nn.4216			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DC4EG	26727548	Green Accepted			2022-12-17	WOS:000369172600023
J	Fung, TC; Olson, CA; Hsiao, EY				Fung, Thomas C.; Olson, Christine A.; Hsiao, Elaine Y.			Interactions between the microbiota, immune and nervous systems in health and disease	NATURE NEUROSCIENCE			English	Review							CHAIN FATTY-ACIDS; BLOOD-BRAIN-BARRIER; GUT MICROBIOTA; MULTIPLE-SCLEROSIS; MAST-CELLS; MOUSE MODEL; INFLAMMATION; STRESS; CNS; MICROGLIA	The diverse collection of microorganisms that inhabit the gastrointestinal tract, collectively called the gut microbiota, profoundly influences many aspects of host physiology, including nutrient metabolism, resistance to infection and immune system development. Studies investigating the gut-brain axis demonstrate a critical role for the gut microbiota in orchestrating brain development and behavior, and the immune system is emerging as an important regulator of these interactions. Intestinal microbes modulate the maturation and function of tissue-resident immune cells in the CNS. Microbes also influence the activation of peripheral immune cells, which regulate responses to neuroinflammation, brain injury, autoimmunity and neurogenesis. Accordingly, both the gut microbiota and immune system are implicated in the etiopathogenesis or manifestation of neurodevelopmental, psychiatric and neurodegenerative diseases, such as autism spectrum disorder, depression and Alzheimer's disease. In this review, we discuss the role of CNS-resident and peripheral immune pathways in microbiota-gut-brain communication during health and neurological disease.	[Fung, Thomas C.; Olson, Christine A.; Hsiao, Elaine Y.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Fung, TC; Hsiao, EY (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	tcfung@ucla.edu; ehsiao@ucla.edu	Olson, Christine/ABB-8296-2021	Olson, Christine/0000-0002-5382-1393	NIH Director's Early Independence award [5DP5OD017924]; Alfred P. Sloan Fellowship in Neuroscience; NIH Ruth L. Kirschstein National Research Service Award [T32GM065823]; UCLA Life Sciences Division, Department of Integrative Biology Physiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065823] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017924] Funding Source: NIH RePORTER	NIH Director's Early Independence award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Fellowship in Neuroscience; NIH Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Life Sciences Division, Department of Integrative Biology Physiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are supported by funding from the NIH Director's Early Independence award (5DP5OD017924 to E.Y.H.), Alfred P. Sloan Fellowship in Neuroscience (to E.Y.H.), NIH Ruth L. Kirschstein National Research Service Award (T32GM065823 to C.A.O.) and UCLA Life Sciences Division, Department of Integrative Biology & Physiology.	Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; Ahern GP, 2011, CURR OPIN PHARMACOL, V11, P29, DOI 10.1016/j.coph.2011.02.004; Ait-Belgnaoui A, 2012, PSYCHONEUROENDOCRINO, V37, P1885, DOI 10.1016/j.psyneuen.2012.03.024; Aizawa E, 2016, J AFFECT DISORDERS, V202, P254, DOI 10.1016/j.jad.2016.05.038; Arentsen T., 2016, MOL PSYCHIAT; Arseneault-Breard J, 2012, BRIT J NUTR, V107, P1793, DOI 10.1017/S0007114511005137; Asano Y, 2012, AM J PHYSIOL-GASTR L, V303, pG1288, DOI 10.1152/ajpgi.00341.2012; Baganz NL, 2013, ACS CHEM NEUROSCI, V4, P48, DOI 10.1021/cn300186b; Banks WA, 2015, BRAIN BEHAV IMMUN, V44, P1, DOI 10.1016/j.bbi.2014.08.007; Barragan A, 2015, ACTA PHYSIOL, V213, P819, DOI 10.1111/apha.12467; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bellavance MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00136; Ben-Shaanan TL, 2016, NAT MED, V22, P940, DOI 10.1038/nm.4133; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; Bilbo SD, 2012, FRONT NEUROENDOCRIN, V33, P267, DOI 10.1016/j.yfrne.2012.08.006; Bogie JFJ, 2014, ACTA NEUROPATHOL, V128, P191, DOI 10.1007/s00401-014-1310-2; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Bu XL, 2015, EUR J NEUROL, V22, P1519, DOI 10.1111/ene.12477; Buffington SA, 2016, CELL, V165, P1762, DOI 10.1016/j.cell.2016.06.001; Cantarel BL, 2015, J INVEST MED, V63, P729, DOI 10.1097/JIM.0000000000000192; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Chen SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep34477; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Crack PJ, 2007, IMMUNOL CELL BIOL, V85, P476, DOI 10.1038/sj.icb.7100103; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; D'Mello C, 2015, J NEUROSCI, V35, P10821, DOI 10.1523/JNEUROSCI.0575-15.2015; D'Mello C, 2014, BRAIN BEHAV IMMUN, V35, P9, DOI 10.1016/j.bbi.2013.10.009; Da Silva S, 2014, AM J PHYSIOL-GASTR L, V307, pG420, DOI 10.1152/ajpgi.00290.2013; De Angelis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076993; De Palma G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8735; Demaude J, 2006, GUT, V55, P655, DOI 10.1136/gut.2005.078675; Desbonnet L, 2010, NEUROSCIENCE, V170, P1179, DOI 10.1016/j.neuroscience.2010.08.005; Desbonnet L, 2008, J PSYCHIATR RES, V43, P164, DOI 10.1016/j.jpsychires.2008.03.009; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Devos D, 2013, NEUROBIOL DIS, V50, P42, DOI 10.1016/j.nbd.2012.09.007; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Elmer BM, 2012, TRENDS NEUROSCI, V35, P660, DOI 10.1016/j.tins.2012.08.001; Erickson MA, 2012, NEUROIMMUNOMODULAT, V19, P121, DOI 10.1159/000330247; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Fasano A, 2015, LANCET NEUROL, V14, P625, DOI 10.1016/S1474-4422(15)00007-1; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Forsythe P, 2016, EUR J PHARMACOL, V778, P169, DOI 10.1016/j.ejphar.2015.06.034; Fouts DE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-174; Frohlich EE, 2016, BRAIN BEHAV IMMUN, V56, P140, DOI 10.1016/j.bbi.2016.02.020; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Graff LA, 2009, INFLAMM BOWEL DIS, V15, P1105, DOI 10.1002/ibd.20873; GUE M, 1991, GASTROENTEROLOGY, V100, P964, DOI 10.1016/0016-5085(91)90270-U; GUE M, 1989, GASTROENTEROLOGY, V97, P1101, DOI 10.1016/0016-5085(89)91678-8; Gungor B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145878; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Hammond CJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-121; Harach T., 2015, REDUCTION ALZHEIMERS; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Hsiao EY, 2012, P NATL ACAD SCI USA, V109, P12776, DOI 10.1073/pnas.1202556109; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Huang WS, 2014, J CLIN NEUROSCI, V21, P1355, DOI 10.1016/j.jocn.2013.11.018; Hueston CM, 2014, PHYSIOL BEHAV, V124, P77, DOI 10.1016/j.physbeh.2013.10.035; Humann J, 2016, CELL HOST MICROBE, V19, P388, DOI [10.1016/j.chom.2016.02.009, 10.1016/j.chom.2016.05.017]; Weinstein LI, 2015, ANN NY ACAD SCI, V1351, P39, DOI 10.1111/nyas.12792; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015; Jensen CJ, 2013, J NEUROIMMUNE PHARM, V8, P824, DOI 10.1007/s11481-013-9480-6; Jiang HY, 2015, BRAIN BEHAV IMMUN, V48, P186, DOI 10.1016/j.bbi.2015.03.016; Kadowaki A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11639; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Karim S, 2014, CNS NEUROL DISORD-DR, V13, P429, DOI 10.2174/18715273113126660164; Kelly JR, 2016, J PSYCHIATR RES, V82, P109, DOI 10.1016/j.jpsychires.2016.07.019; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lennon EM, 2013, INFLAMM BOWEL DIS, V19, P712, DOI 10.1097/MIB.0b013e3182802a4e; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lurain NS, 2013, J INFECT DIS, V208, P564, DOI 10.1093/infdis/jit210; Lyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003726; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Messaoudi M, 2011, BRIT J NUTR, V105, P755, DOI 10.1017/S0007114510004319; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Minter MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30028; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Mohle L, 2016, CELL REP, V15, P1945, DOI 10.1016/j.celrep.2016.04.074; Mohammadi AA, 2016, NUTR NEUROSCI, V19, P387, DOI 10.1179/1476830515Y.0000000023; Moussaoui N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088382; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nayak Debasis, 2012, Intravital, V1, P95, DOI 10.4161/intv.22823; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Ogbonnaya ES, 2015, BIOL PSYCHIAT, V78, pE7, DOI 10.1016/j.biopsych.2014.12.023; Park AJ, 2013, NEUROGASTROENT MOTIL, V25, P733, DOI 10.1111/nmo.12153; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Pisa D, 2015, SCI REP-UK, V5, DOI 10.1038/srep15015; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Prandota J, 2014, AM J ALZHEIMERS DIS, V29, P205, DOI 10.1177/1533317513517049; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Radjavi A, 2014, MOL PSYCHIATR, V19, P531, DOI 10.1038/mp.2013.79; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Rea K, 2016, NEUROBIOL STRESS, V4, P23, DOI 10.1016/j.ynstr.2016.03.001; Reigstad CS, 2015, FASEB J, V29, P1395, DOI 10.1096/fj.14-259598; Ribatti D, 2015, EXP CELL RES, V338, P119, DOI 10.1016/j.yexcr.2015.05.013; Rook GAW, 2014, ADV EXP MED BIOL, V817, P319, DOI 10.1007/978-1-4939-0897-4_15; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Rossi D, 2015, PROG NEUROBIOL, V130, P86, DOI 10.1016/j.pneurobio.2015.04.003; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Rubio C A, 1992, In Vivo, V6, P81; Sampson TR, 2015, CELL HOST MICROBE, V17, P565, DOI 10.1016/j.chom.2015.04.011; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Shannon KM, 2012, MOVEMENT DISORD, V27, P709, DOI 10.1002/mds.23838; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Tennoune N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.98; Tomova A, 2015, PHYSIOL BEHAV, V138, P179, DOI 10.1016/j.physbeh.2014.10.033; Tremlett H, 2016, EUR J NEUROL, V23, P1308, DOI 10.1111/ene.13026; van der Kleij H, 2008, AM J PHYSIOL-REG I, V295, pD1131, DOI 10.1152/ajpregu.90434.2008; Walsh JT, 2015, J CLIN INVEST, V125, P2547, DOI 10.1172/JCI82458; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42; Wang T, 2015, BENEF MICROBES, V6, P707, DOI 10.3920/BM2014.0177; Wang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5432; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585; Williams BB, 2014, CELL HOST MICROBE, V16, P495, DOI 10.1016/j.chom.2014.09.001; Winek K, 2016, STROKE, V47, P1354, DOI 10.1161/STROKEAHA.115.011800; Yaddanapudi K, 2010, MOL PSYCHIATR, V15, P712, DOI 10.1038/mp.2009.77; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44	154	844	884	42	836	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2017	20	2					145	155		10.1038/nn.4476	http://dx.doi.org/10.1038/nn.4476			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ5PU	28092661	Green Accepted			2022-12-17	WOS:000393271000007
J	Ziv, Y; Ron, N; Butovsky, O; Landa, G; Sudai, E; Greenberg, N; Cohen, H; Kipnis, J; Schwartz, M				Ziv, Y; Ron, N; Butovsky, O; Landa, G; Sudai, E; Greenberg, N; Cohen, H; Kipnis, J; Schwartz, M			Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; T-CELLS; PROTECTIVE AUTOIMMUNITY; SYNAPTIC PLASTICITY; NEUROPROTECTIVE AUTOIMMUNITY; THERAPEUTIC VACCINATION; ENRICHED ENVIRONMENT; NEUROTROPHIC FACTOR; GRANULE CELLS; BRAIN	Neurogenesis is known to take place in the adult brain. This work identifies T lymphocytes and microglia as being important to the maintenance of hippocampal neurogenesis and spatial learning abilities in adulthood. Hippocampal neurogenesis induced by an enriched environment was associated with the recruitment of T cells and the activation of microglia. In immune-deficient mice, hippocampal neurogenesis was markedly impaired and could not be enhanced by environmental enrichment, but was restored and boosted by T cells recognizing a specific CNS antigen. CNS-specific T cells were also found to be required for spatial learning and memory and for the expression of brain-derived neurotrophic factor in the dentate gyrus, implying that a common immune-associated mechanism underlies different aspects of hippocampal plasticity and cell renewal in the adult brain.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Minist Hlth, Mental Hlth Ctr,Anxiety & Stress Res Unit, IL-84105 Beer Sheva, Israel	Weizmann Institute of Science; Ben Gurion University	Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	jkipnis@unmc.edu; michal.schwartz@weizmann.ac.il	Kipnis, Jonathan/AGG-9735-2022	Kipnis, Jonathan/0000-0002-3714-517X; Butovsky, Oleg/0000-0003-0186-8867				Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Butovsky O, 2005, MOL CELL NEUROSCI, V29, P381, DOI 10.1016/j.mcn.2005.03.005; BUTOVSKY O, 2005, MOL CELL NEUROSCI; Butovsky Oleg, 2001, FASEB Journal, V15, P1065; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Carro E, 2001, J NEUROSCI, V21, P5678, DOI 10.1523/JNEUROSCI.21-15-05678.2001; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; COHEN H, IN PRESS J NEUROBIOL; Diesing Thomas S, 2002, AIDS Read, V12, P358; Ehninger D, 2003, CEREB CORTEX, V13, P845, DOI 10.1093/cercor/13.8.845; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Gaillard RC, 1998, ANN NY ACAD SCI, V840, P480, DOI 10.1111/j.1749-6632.1998.tb09586.x; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kipnis J, 2002, P NATL ACAD SCI USA, V99, P15620, DOI 10.1073/pnas.232565399; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Muhallab S, 2002, SCAND J IMMUNOL, V55, P264, DOI 10.1046/j.0300-9475.2002.01038.x; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Olivares-Villagomez D, 1998, J EXP MED, V188, P1883, DOI 10.1084/jem.188.10.1883; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Schwartz M, 2002, TRENDS IMMUNOL, V23, P530, DOI 10.1016/S1471-4906(02)02322-0; Schwartz M, 2001, TRENDS MOL MED, V7, P252, DOI 10.1016/S1471-4914(01)01993-1; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wekerle H, 2005, P NATL ACAD SCI USA, V102, P3, DOI 10.1073/pnas.0408495101; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001	48	843	879	2	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					268	275		10.1038/nn1629	http://dx.doi.org/10.1038/nn1629			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415867				2022-12-17	WOS:000234990100023
J	Martinowich, K; Manji, H; Lu, B				Martinowich, Keri; Manji, Husseini; Lu, Bai			New insights into BDNF function in depression and anxiety	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR TRANSCRIPTS; LONG-TERM DEPRESSION; BIPOLAR DISORDER; MESSENGER-RNA; KNOCKOUT MICE; BRAIN; EXPRESSION; RECEPTOR; STRESS; ACTIVATION	The 'neurotrophin hypothesis of depression' is based largely on correlations between stress or antidepressant treatment and down- or upregulation, respectively, of brain-derived neurotrophic factor ( BDNF). Genetic disruption of the signaling pathways involving BDNF and its receptor, the tyrosine kinase TrkB, does not seem to cause depressive behaviors, but does hamper the effect of antidepressant drugs. Thus, BDNF may be a target of antidepressants, but not the sole mediator of depression or anxiety. Advances in BDNF cell biology, including its transcription through multiple promoters, trafficking and secretion, may provide new insights into its role in mood disorders. Moreover, as the precursor proBDNF and the mature protein mBDNF can elicit opposite effects on cellular functions, the impact of proBDNF and its cleavage on mood should be considered. Opposing influences of mBDNF and proBDNF on long-term potentiation and long-term depression might contribute to the dichotomy of BDNF actions on behaviors mediated by the brain stress and reward systems.	NIMH, Mood & Anxiety Program, Bethesda, MD 20892 USA; NICHHD, Sect Neural Dev & Plastic, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Martinowich, K (corresponding author), NIMH, Mood & Anxiety Program, Bldg 35,Room 1C1004,35 Convent Dr,MSC 3714, Bethesda, MD 20892 USA.	bailu@mail.nih.gov	Yan, Shuo/B-8381-2009; Lu, Bai/A-4018-2012; Martinowich, Keri/F-9841-2012	Lu, Bai/0000-0001-5418-9759; Martinowich, Keri/0000-0002-5237-0789	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CHARNEY DS, 2004, SCI STKE; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Dias BG, 2003, NEUROPHARMACOLOGY, V45, P553, DOI 10.1016/S0028-3908(03)00198-9; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; Holderbach R, 2007, BIOL PSYCHIAT, V62, P92, DOI 10.1016/j.biopsych.2006.07.007; Kim J, 2002, FRONT BIOSCI-LANDMRK, V7, pD341, DOI 10.2741/kim; Kohen R, 2005, PHARMACOGENOMICS J, V5, P278, DOI 10.1038/sj.tpj.6500322; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; MacQueen GM, 2001, BEHAV NEUROSCI, V115, P1145, DOI 10.1037//0735-7044.115.5.1145; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McEwen BS, 2000, PROG BRAIN RES, V122, P25; Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Neves-Pereira M, 2002, AM J HUM GENET, V71, P651, DOI 10.1086/342288; NIBUYA M, 1995, J NEUROSCI, V15, P7539; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Pattabiraman PP, 2005, MOL CELL NEUROSCI, V28, P556, DOI 10.1016/j.mcn.2004.11.010; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Ren-Patterson RF, 2005, J NEUROSCI RES, V79, P756, DOI 10.1002/jnr.20410; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Russo-Neustadt AA, 2000, NEUROSCIENCE, V101, P305, DOI 10.1016/S0306-4522(00)00349-3; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhou XF, 2004, J NEUROCHEM, V91, P704, DOI 10.1111/j.1471-4159.2004.02775.x; Zorner B, 2003, BIOL PSYCHIAT, V54, P972, DOI 10.1016/S0006-3223(03)00418-9	50	836	880	2	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1089	1093		10.1038/nn1971	http://dx.doi.org/10.1038/nn1971			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17726474				2022-12-17	WOS:000249144000006
J	Asai, H; Ikezu, S; Tsunoda, S; Medalla, M; Luebke, J; Haydar, T; Wolozin, B; Butovsky, O; Kugler, S; Ikezu, T				Asai, Hirohide; Ikezu, Seiko; Tsunoda, Satoshi; Medalla, Maria; Luebke, Jennifer; Haydar, Tank; Wolozin, Benjamin; Butovsky, Oleg; Kuegler, Sebastian; Ikezu, Tsuneya			Depletion of microglia and inhibition of exosome synthesis halt tau propagation	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; IN-VIVO; NEUROFIBRILLARY TANGLES; CEREBROSPINAL-FLUID; TRANSGENIC MICE; PRION STRAINS; NEURONAL LOSS; TAUOPATHY; BRAIN	Accumulation of pathological tau protein is a major hallmark of Alzheimer's disease. Tau protein spreads from the entorhinal cortex to the hippocampal region early in the disease. Microglia, the primary phagocytes in the brain, are positively correlated with tau pathology, but their involvement in tau propagation is unknown. We developed an adeno-associated virus-based model exhibiting rapid tau propagation from the entorhinal cortex to the dentate gyrus in 4 weeks. We found that depleting microglia dramatically suppressed the propagation of tau and reduced excitability in the dentate gyrus in this mouse model. Moreover, we demonstrate that microglia spread tau via exosome secretion, and inhibiting exosome synthesis significantly reduced tau propagation in vitro and in vivo. These data suggest that microglia and exosomes contribute to the progression of tauopathy and that the exosome secretion pathway may be a therapeutic target.	[Asai, Hirohide; Ikezu, Seiko; Tsunoda, Satoshi; Wolozin, Benjamin; Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Medalla, Maria; Luebke, Jennifer; Haydar, Tank] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Wolozin, Benjamin; Ikezu, Tsuneya] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Wolozin, Benjamin; Ikezu, Tsuneya] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Butovsky, Oleg] Boston Univ, Sch Med, Brigham & Womens Hosp, Dept Neurol,Ctr Neurol Dis,Harvard Univ,Med Sch, Boston, MA 02118 USA; [Kuegler, Sebastian] Univ Med Gottingen, Ctr Nanoscale Microscopy & Physiol Brain, Dept Neurol, Gottingen, Germany	Boston University; Boston University; Boston University; Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Gottingen	Ikezu, T (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.	tikezu@bu.edu	Butovsky, Oleg/ABG-9086-2020	Butovsky, Oleg/0000-0003-0186-8867; Tsunoda, Satoshi/0000-0002-5486-5750; Luebke, Jennifer/0000-0003-1399-6073; Wolozin, Benjamin/0000-0003-2068-1475; Ikezu, Tsuneya/0000-0002-3979-8596; Haydar, Tarik/0000-0001-6772-3076; Medalla, Maria/0000-0003-4890-2532	Alzheimer's Association; Alzheimer's Art Quilt Initiative; Boston University Alzheimer's Disease Center [P30AG013846]; BrightFocus Foundation; Coins for Alzheimer's Research Trust; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089544, R01NS088137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG050471, P30AG013846] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); Alzheimer's Art Quilt Initiative; Boston University Alzheimer's Disease Center; BrightFocus Foundation(BrightFocus Foundation); Coins for Alzheimer's Research Trust; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank M. Ericsson (Electron Microscopy Facility Harvard Medical School) for electron microscopic imaging services; P. Davies (Albert Einstein College of Medicine) for providing the MC1, CP13 and PHF1 antibodies; R. Kayed (University of Texas Medical Branch) for providing the T22 polyclonal antibody; Plexxikon, Inc. for providing PLX3397 and control chows; and M. Hasselmo and S. Przedborski for critical reading of the manuscript. This work is supported in part by grants from Alzheimer's Association (T.I.), Alzheimer's Art Quilt Initiative (T.I.), Boston University Alzheimer's Disease Center (P30AG013846, T.I.), BrightFocus Foundation (H.A.) and Coins for Alzheimer's Research Trust (T.I.).	Agosta F, 2014, ANN NEUROL, V76, P813, DOI 10.1002/ana.24235; Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Arellano-Anaya ZE, 2015, CELL MOL LIFE SCI, V72, P1185, DOI 10.1007/s00018-014-1735-8; Boluda S, 2015, ACTA NEUROPATHOL, V129, P221, DOI 10.1007/s00401-014-1373-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Fricker M, 2012, J NEUROSCI, V32, P2657, DOI 10.1523/JNEUROSCI.4837-11.2012; Ghoshal N, 2001, J NEUROCHEM, V77, P1372, DOI 10.1046/j.1471-4159.2001.00346.x; Harris JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045881; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kadiu I, 2012, J IMMUNOL, V189, P744, DOI 10.4049/jimmunol.1102244; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lu ZJ, 2011, NAT CELL BIOL, V13, P1076, DOI 10.1038/ncb2299; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Peeraer E, 2015, NEUROBIOL DIS, V73, P83, DOI 10.1016/j.nbd.2014.08.032; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schofield E, 2003, BRAIN, V126, P827, DOI 10.1093/brain/awg085; Serrano-Pozo A, 2011, AM J PATHOL, V179, P1373, DOI 10.1016/j.ajpath.2011.05.047; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Vingtdeux V, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00229; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	42	828	851	10	237	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2015	18	11					1584	1593		10.1038/nn.4132	http://dx.doi.org/10.1038/nn.4132			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CU8YT	26436904	Green Accepted			2022-12-17	WOS:000363830700016
J	Soon, CS; Brass, M; Heinze, HJ; Haynes, JD				Soon, Chun Siong; Brass, Marcel; Heinze, Hans-Jochen; Haynes, John-Dylan			Unconscious determinants of free decisions in the human brain	NATURE NEUROSCIENCE			English	Article							VOLUNTARY MOVEMENTS; CONSCIOUS WILL; COGNITION; INTENTION	There has been a long controversy as to whether subjectively 'free' decisions are determined by brain activity ahead of time. We found that the outcome of a decision can be encoded in brain activity of prefrontal and parietal cortex up to 10 s before it enters awareness. This delay presumably reflects the operation of a network of high-level control areas that begin to prepare an upcoming decision long before it enters awareness.	[Soon, Chun Siong; Brass, Marcel; Haynes, John-Dylan] Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany; [Soon, Chun Siong; Haynes, John-Dylan] Charite Univ Med Berlin, Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany; [Brass, Marcel] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; Univ Ghent, Ghent Inst Funct & Metab Imaging, B-9000 Ghent, Belgium; [Heinze, Hans-Jochen] Otto VonGuericke Univ Magdegurg, Dept Neurol 2, D-39120 Magdeburg, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ghent University; Ghent University; Otto von Guericke University	Haynes, JD (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Stephanstr 1A, D-04103 Leipzig, Germany.	haynes@bccn-berlin.de	Brass, Marcel/J-7082-2012; Haynes, John-Dylan/Q-1148-2016; Soon, Chun Siong/O-8409-2017	Brass, Marcel/0000-0002-3364-4019; Haynes, John-Dylan/0000-0003-1786-6954; Soon, Chun Siong/0000-0003-2073-4557				Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; ECCLES JC, 1982, ARCH PSYCHIAT NERVEN, V231, P423, DOI 10.1007/BF00342722; GLYNN IM, 1990, NATURE, V348, P477, DOI 10.1038/348477a0; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 1999, EXP BRAIN RES, V126, P128, DOI 10.1007/s002210050722; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Joordens S, 2002, CONSCIOUS COGN, V11, P231, DOI 10.1006/ccog.2002.0559; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; van de Grind W, 2002, CONSCIOUS COGN, V11, P241, DOI 10.1006/ccog.2002.0560; Wegner DM, 2003, TRENDS COGN SCI, V7, P65, DOI 10.1016/S1364-6613(03)00002-0	15	828	850	12	275	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2008	11	5					543	545		10.1038/nn.2112	http://dx.doi.org/10.1038/nn.2112			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293HV	18408715				2022-12-17	WOS:000255327300012
J	Olesen, PJ; Westerberg, H; Klingberg, T				Olesen, PJ; Westerberg, H; Klingberg, T			Increased prefrontal and parietal activity after training of working memory	NATURE NEUROSCIENCE			English	Article							NEURAL MECHANISMS; ACTIVATION; PERFORMANCE; CHILDREN	Working memory capacity has traditionally been thought to be constant. Recent studies, however, suggest that working memory can be improved by training. In this study, we have investigated the changes in brain activity that are induced by working memory training. Two experiments were carried out in which healthy, adult human subjects practiced working memory tasks for 5 weeks. Brain activity was measured with functional magnetic resonance imaging (fMRI) before, during and after training. After training, brain activity that was related to working memory increased in the middle frontal gyrus and superior and inferior parietal cortices. The changes in cortical activity could be evidence of training-induced plasticity in the neural systems that underlie working memory.	Karolinska Inst, Dept Neuropediat, Astrid Lindgrens Childrens Hosp Q2 07, S-17176 Stockholm, Sweden	Karolinska Institutet	Olesen, PJ (corresponding author), Karolinska Inst, Dept Neuropediat, Astrid Lindgrens Childrens Hosp Q2 07, S-17176 Stockholm, Sweden.	pernille.olesen@kbh.ki.se		Klingberg, Torkel/0000-0002-3175-2171; Olesen, Jes/0000-0002-6712-2702				[Anonymous], 1981, WAIS R MANUAL; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Engle RW., 1999, INDIVIDUAL DIFFERENC, DOI DOI 10.1017/CBO9781139174909.007; Fletcher P, 1999, CEREB CORTEX, V9, P168, DOI 10.1093/cercor/9.2.168; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Garavan H, 2000, MICROSC RES TECHNIQ, V51, P54, DOI 10.1002/1097-0029(20001001)51:1<54::AID-JEMT6>3.3.CO;2-A; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Hale S, 1997, DEV PSYCHOL, V33, P364, DOI 10.1037/0012-1649.33.2.364; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Kaplan E., 1991, WAIS R NEUROPSYCHOLO; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kemps E, 2001, MEMORY, V9, P13, DOI 10.1080/09658210042000012; Klingberg T, 1998, CEREB CORTEX, V8, P593, DOI 10.1093/cercor/8.7.593; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 1998, CEREB CORTEX, V8, P73, DOI 10.1093/cercor/8.1.73; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Poldrack RA, 2001, BRAIN, V124, P67, DOI 10.1093/brain/124.1.67; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Raven J.C, 1990, ADV PROGR MATRICES S; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Rypma B, 2003, COGNITIVE BRAIN RES, V16, P162, DOI 10.1016/S0926-6410(02)00247-1; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Seitz R J, 1990, Neuroreport, V1, P57, DOI 10.1097/00001756-199009000-00016; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Wexler BE, 2000, AM J PSYCHIAT, V157, P1694, DOI 10.1176/appi.ajp.157.10.1694	33	827	855	7	171	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2004	7	1					75	79		10.1038/nn1165	http://dx.doi.org/10.1038/nn1165			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	758LN	14699419				2022-12-17	WOS:000187636000016
J	Liu, D; Diorio, J; Day, JC; Francis, DD; Meaney, MJ				Liu, D; Diorio, J; Day, JC; Francis, DD; Meaney, MJ			Maternal care, hippocampal synaptogenesis and cognitive development in rats	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; MESSENGER-RNA; NMDA RECEPTOR; MEMORY; BRAIN; EXPRESSION; RESPONSES; STRESS	We report that variations in maternal care in the rat promote hippocampal synaptogenesis and spatial learning and memory through systems known to mediate experience-dependent neural development. Thus, the offspring of mothers that show high levels of pup licking and grooming and arched-back nursing showed increased expression of NMDA receptor subunit and brain-derived neurotrophic factor (BDNF) mRNA, increased cholinergic innervation of the hippocampus and enhanced spatial learning and memory. A cross-fostering study provided evidence for a direct relationship between maternal behavior and hippocampal development, although not all neonates were equally sensitive to variations in maternal care.	McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr,Dev Neuroendocrinol Lab, Verdun, PQ H4H 1R3, Canada; McGill Univ, Dept Neurol & Neurosurg, Douglas Hosp, Res Ctr,Dev Neuroendocrinol Lab, Verdun, PQ H4H 1R3, Canada	McGill University; McGill University	Meaney, MJ (corresponding author), McGill Univ, Dept Psychiat, Douglas Hosp, Res Ctr,Dev Neuroendocrinol Lab, 6875 Boul LaSalle, Verdun, PQ H4H 1R3, Canada.	mdmm@musica.mcgill.ca	Meaney, Michael/N-5931-2019					AINSWORTH MDS, 1991, AM PSYCHOL, V46, P333, DOI 10.1037/0003-066X.46.4.333; ALBERTS JR, 1989, HDB BEHAV NEUROBIOLO, V9, P1; ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; AMMERMAN RT, 1986, CLIN PSYCHOL REV, V6, P291, DOI 10.1016/0272-7358(86)90003-6; Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; ARAUJO DM, 1988, J NEUROCHEM, V50, P1914, DOI 10.1111/j.1471-4159.1988.tb02497.x; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calabresi P, 1998, EUR J NEUROSCI, V10, P3020, DOI 10.1046/j.1460-9568.1998.00348.x; Chao HM, 1998, ENDOCRINOLOGY, V139, P3112, DOI 10.1210/en.139.7.3112; COGILL SR, 1986, BMJ-BRIT MED J, V292, P1165, DOI 10.1136/bmj.292.6529.1165; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; Fields RD, 1996, TRENDS NEUROSCI, V19, P473, DOI 10.1016/S0166-2236(96)30013-1; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; FRIEDMAN B, 1995, J NEUROSCI, V15, P1044; GAGE FH, 1986, J NEUROSCI, V6, P2837; Jablonska B, 1996, NEUROBIOL LEARN MEM, V66, P36, DOI 10.1006/nlme.1996.0041; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; KUCHEL GA, 1992, EXP NEUROL, V118, P73, DOI 10.1016/0014-4886(92)90024-K; Levine S, 1994, ANN NY ACAD SCI, V746, P260; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; MACCARI S, 1995, J NEUROSCI, V15, P110; Marini AM, 1998, J BIOL CHEM, V273, P29394, DOI 10.1074/jbc.273.45.29394; McCarty Richard, 1996, Physiology and Behavior, V59, P71, DOI 10.1016/0031-9384(95)02034-9; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Mesulam M, 1982, TRACING NEURAL CONNE, P1; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; QUIRION R, 1995, J NEUROSCI, V15, P1455; SCHANBERG SM, 1987, CHILD DEV, V58, P1431, DOI 10.2307/1130683; SHATZ CJ, 1990, NEURON, V5, P745, DOI 10.1016/0896-6273(90)90333-B; Stern JM, 1997, DEV PSYCHOBIOL, V31, P19, DOI 10.1002/(SICI)1098-2302(199707)31:1<19::AID-DEV3>3.0.CO;2-X; Suomi SJ, 1997, BRIT MED BULL, V53, P170; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRICKETT PK, 1995, DEV REV, V15, P311, DOI 10.1006/drev.1995.1012; van Oers HJJ, 1998, J NEUROSCI, V18, P10171; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Whishaw IQ, 1998, NEUROSCI BIOBEHAV R, V22, P209, DOI 10.1016/S0149-7634(97)00002-X; WHITTEMORE SR, 1988, J NEUROSCI RES, V20, P403, DOI 10.1002/jnr.490200402; WILLIAMS K, 1991, MOL PHARMACOL, V40, P774; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	50	825	850	1	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					799	806		10.1038/77702	http://dx.doi.org/10.1038/77702			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903573				2022-12-17	WOS:000167177300015
J	Ruby, P; Decety, J				Ruby, P; Decety, J			Effect of subjective perspective taking during simulation of action: a PET investigation of agency	NATURE NEUROSCIENCE			English	Article							IMAGINED HAND MOVEMENTS; SCHIZOPHRENIC-PATIENTS; FUNCTIONAL NEUROANATOMY; MENTAL REPRESENTATION; MOTION; IMAGERY; SELF; PERCEPTION; MECHANISMS; ACTIVATION	Perspective taking is an essential component in the mechanisms that account for intersubjectivity and agency. Mental simulation of action can be used as a natural protocol to explore the cognitive and neural processing involved in agency. Here we took PET measurements while subjects simulated actions with either a first-person or a third-person perspective. Both conditions were associated with common activation in the SMA, the precentral gyrus, the precuneus and the MT/VS complex. When compared to the first-person perspective, the third-person perspective recruited right inferior parietal, precuneus, posterior cingulate and frontopolar cortex. The opposite contrast revealed activation in left inferior parietal and somatosensory cortex. We suggest that the right inferior parietal, precuneus and somatosensory cortex are specifically involved in distinguishing self-produced actions from those generated by others.	INSERM, U280, F-69424 Lyon 3, France; Cermep, F-69003 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Decety, J (corresponding author), INSERM, U280, 151 Cours Albert Thomas, F-69424 Lyon 3, France.		Ruby, Perrine Marie/K-8903-2017					Bisiach Edoardo, 1995, P1331; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Daprati E, 1997, COGNITION, V65, P71, DOI 10.1016/S0010-0277(97)00039-5; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; DECETY J, IN PRESS IMITATIVE M; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Goldman A., 2000, METAREPRESENTATION, P171; Gopnik A, 1998, WORDS THOUGHTS THEOR; Grezes J, 1998, COGN NEUROPSYCHOL, V15, P553, DOI 10.1080/026432998381023; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; HURLEY SL, 1997, COMMUNICATION COGN 1, V30, P207; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Kalus P, 2000, NEUROREPORT, V11, P3621, DOI 10.1097/00001756-200011090-00044; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Maquet P, 1999, BIOL PSYCHIAT, V45, P327, DOI 10.1016/S0006-3223(97)00546-5; MESULAM MM, 1981, ARCH NEUROL-CHICAGO, V38, P176, DOI 10.1001/archneur.1981.00510030070010; Ochipa C, 1997, NEUROLOGY, V49, P474, DOI 10.1212/WNL.49.2.474; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Rainville P, 1999, J COGNITIVE NEUROSCI, V11, P110, DOI 10.1162/089892999563175; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Spence SA, 1997, BRAIN, V120, P1997, DOI 10.1093/brain/120.11.1997; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Stevens JA, 2000, NEUROREPORT, V11, P109, DOI 10.1097/00001756-200001170-00022; Talairach J., 1988, APPROACH CEREBRAL IM; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245	38	823	838	3	59	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					546	550		10.1038/87510	http://dx.doi.org/10.1038/87510			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	427NN	11319565				2022-12-17	WOS:000168412600020
J	Bareyre, FM; Kerschensteiner, M; Raineteau, O; Mettenleiter, TC; Weinmann, O; Schwab, ME				Bareyre, FM; Kerschensteiner, M; Raineteau, O; Mettenleiter, TC; Weinmann, O; Schwab, ME			The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; C3-C5 PROPRIOSPINAL NEURONS; PSEUDORABIES VIRUS; MOTOR CORTEX; CAT; PLASTICITY; RECOVERY; ORGANIZATION; LESIONS; AXONS	In contrast to peripheral nerves, central axons do not regenerate. Partial injuries to the spinal cord, however, are followed by functional recovery. We investigated the anatomical basis of this recovery and found that after incomplete spinal cord injury in rats, transected hindlimb corticospinal tract (CST) axons sprouted into the cervical gray matter to contact short and long propriospinal neurons (PSNs). Over 12 weeks, contacts with long PSNs that bridged the lesion were maintained, whereas contacts with short PSNs that did not bridge the lesion were lost. In turn, long PSNs arborize on lumbar motor neurons, creating a new intraspinal circuit relaying cortical input to its original spinal targets. We confirmed the functionality of this circuit by electrophysiological and behavioral testing before and after CST re-lesion. Retrograde transynaptic tracing confirmed its integrity, and revealed changes of cortical representation. Hence, after incomplete spinal cord injury, spontaneous extensive remodeling occurs, based on axonal sprout formation and removal. Such remodeling may be crucial for rehabilitation in humans.	Univ Zurich, Inst Brain Res, Dept Neuromorphol, CH-8057 Zurich, Switzerland; ETH, Dept Biol, CH-8057 Zurich, Switzerland; Univ Zurich, Inst Brain Res, Dept Neurophysiol, CH-8057 Zurich, Switzerland; Fed Res Ctr Virus Dis Anim, Friedrich Loeffler Inst, Inst Mol & Cellular Virol, D-17498 Insel Riems, Germany	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Friedrich Loeffler Institute	Bareyre, FM (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid,Box 8108, St Louis, MO USA.	florence@pcg.wustl.edu	Mettenleiter, h. c. Thomas C./U-1016-2019; Schwab, Martin E/B-6818-2016; Raineteau, Olivier/I-1190-2014	Raineteau, Olivier/0000-0003-4294-2496				ALSTERMARK B, 1987, BRAIN RES, V404, P382, DOI 10.1016/0006-8993(87)91400-4; ALSTERMARK B, 1987, BRAIN RES, V404, P395, DOI 10.1016/0006-8993(87)91402-8; ALSTERMARK B, 1990, NEUROSCI RES, V8, P131, DOI 10.1016/0168-0102(90)90065-M; ALSTERMARK B, 1987, NEUROSCI LETT, V74, P291, DOI 10.1016/0304-3940(87)90312-0; AOKI M, 1986, Neuroscience Research, V3, P617, DOI 10.1016/0168-0102(86)90058-1; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; CARD JP, 1990, J NEUROSCI, V10, P1974; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen R, 1998, J NEUROSCI, V18, P3443; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; DERYCK M, 1992, BRAIN RES, V573, P44; Dietz V, 1998, SPINAL CORD, V36, P380, DOI 10.1038/sj.sc.3100590; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GIOVANELLIBARIL.M, 1969, BRAIN RES, V14, P321; GORDON T, 1993, BRAIN RES BULL, V30, P477, DOI 10.1016/0361-9230(93)90281-F; Herzog A, 1997, J NEUROSCI METH, V72, P57, DOI 10.1016/S0165-0270(96)00156-2; Hiersemenzel LP, 2000, NEUROLOGY, V54, P1574, DOI 10.1212/WNL.54.8.1574; Holaday J W, 1983, Adv Shock Res, V10, P95; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; JANKOWSKA E, 1973, BRAIN RES, V53, P227, DOI 10.1016/0006-8993(73)90786-5; JANKOWSKA E, 1974, EXP BRAIN RES, V21, P169; Jankowska E, 2002, BRAIN RES REV, V40, P19, DOI 10.1016/S0165-0173(02)00185-6; Jons A, 1997, J VIROL METHODS, V66, P283, DOI 10.1016/S0166-0934(97)00065-7; Kaas JH, 1999, NEURON, V22, P657, DOI 10.1016/S0896-6273(00)80725-4; LAWRENCE DG, 1968, BRAIN, V91, P1, DOI 10.1093/brain/91.1.1; LI WWY, 1994, NEUROSCIENCE, V61, P133, DOI 10.1016/0306-4522(94)90066-3; MARIANI J, 1983, PROG BRAIN RES, V58, P383, DOI 10.1016/S0079-6123(08)60041-2; MASSON RL, 1991, J COMP NEUROL, V307, P120, DOI 10.1002/cne.903070111; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; MILLER S, 1973, J PHYSIOL-LONDON, V230, pP30; MURRAY M, 1974, J COMP NEUROL, V158, P19, DOI 10.1002/cne.901580103; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Pettersson LG, 1997, NEUROSCI RES, V29, P241, DOI 10.1016/S0168-0102(97)00093-X; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Raineteau O, 2001, P NATL ACAD SCI USA, V98, P6929, DOI 10.1073/pnas.111165498; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Rossignol S, 1999, PROG BRAIN RES, V123, P349, DOI 10.1016/S0079-6123(08)62870-8; SANES JN, 1990, EXP BRAIN RES, V79, P479; SCHNELL L, 1993, EUR J NEUROSCI, V5, P1156, DOI 10.1111/j.1460-9568.1993.tb00970.x; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Sloan TB, 1998, J CLIN NEUROPHYSIOL, V15, P217, DOI 10.1097/00004691-199805000-00005; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; STRACK AM, 1989, BRAIN RES, V491, P274, DOI 10.1016/0006-8993(89)90063-2; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; WERNIG A, 1992, PARAPLEGIA, V30, P229, DOI 10.1038/sc.1992.61; Z'Graggen WJ, 2000, J NEUROSCI, V20, P6561, DOI 10.1523/JNEUROSCI.20-17-06561.2000	50	818	840	3	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					269	277		10.1038/nn1195	http://dx.doi.org/10.1038/nn1195			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966523				2022-12-17	WOS:000189197900017
J	Murgatroyd, C; Patchev, AV; Wu, Y; Micale, V; Bockmuhl, Y; Fischer, D; Holsboer, F; Wotjak, CT; Almeida, OFX; Spengler, D				Murgatroyd, Chris; Patchev, Alexandre V.; Wu, Yonghe; Micale, Vincenzo; Bockmuehl, Yvonne; Fischer, Dieter; Holsboer, Florian; Wotjak, Carsten T.; Almeida, Osborne F. X.; Spengler, Dietmar			Dynamic DNA methylation programs persistent adverse effects of early-life stress	NATURE NEUROSCIENCE			English	Article							PITUITARY-ADRENAL AXIS; GENE-EXPRESSION; MOUSE MODEL; EPIGENETIC REGULATION; BDNF TRANSCRIPTION; RETT-SYNDROME; DISORDERS; ANXIETY; MECP2; BRAIN	Adverse early life events can induce long-lasting changes in physiology and behavior. We found that early-life stress (ELS) in mice caused enduring hypersecretion of corticosterone and alterations in passive stress coping and memory. This phenotype was accompanied by a persistent increase in arginine vasopressin (AVP) expression in neurons of the hypothalamic paraventricular nucleus and was reversed by an AVP receptor antagonist. Altered Avp expression was associated with sustained DNA hypomethylation of an important regulatory region that resisted age-related drifts in methylation and centered on those CpG residues that serve as DNA-binding sites for the methyl CpG-binding protein 2 (MeCP2). We found that neuronal activity controlled the ability of MeCP2 to regulate activity-dependent transcription of the Avp gene and induced epigenetic marking. Thus, ELS can dynamically control DNA methylation in postmitotic neurons to generate stable changes in Avp expression that trigger neuroendocrine and behavioral alterations that are frequent features in depression.	[Murgatroyd, Chris; Patchev, Alexandre V.; Wu, Yonghe; Micale, Vincenzo; Bockmuehl, Yvonne; Fischer, Dieter; Holsboer, Florian; Wotjak, Carsten T.; Almeida, Osborne F. X.; Spengler, Dietmar] Max Planck Inst Psychiat, Munich, Germany	Max Planck Society	Spengler, D (corresponding author), Max Planck Inst Psychiat, Munich, Germany.	spengler@mpipsykl.mpg.de	micale, vincenzo/D-7272-2012; Wotjak, Carsten T./S-3200-2019; Wu, Yonghe/N-2269-2019	Wu, Yonghe/0000-0001-9667-8198; Almeida, Osborne F.X./0000-0001-7331-6928; Murgatroyd, Chris/0000-0002-6885-7794	European Union [LSHM-CT-2005-018652]; Deutsche Forschungsgemeinschaft [SP 386/4-2]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank A. Hoffmann and R. Stoffel for their excellent technical assistance, A. Varga and B. Wrle for help with animal care, N. Sousa, J.-P. Schulke, T. Bettecken, F. Roselli and R. Spanagel for support. We thank S. Aventis for supplying SSR149415. This work was funded by the European Union (CRESCENDO-European Union contract number LSHM-CT-2005-018652 to O.F.X.A. and D.S.) and the Deutsche Forschungsgemeinschaft (SP 386/4-2 to D. S.).	Aguilera G, 2000, REGUL PEPTIDES, V96, P23, DOI 10.1016/S0167-0115(00)00196-8; ALLIS C.D., 2007, EPIGENETICS; Bachli H, 2008, BEHAV BRAIN RES, V187, P67, DOI 10.1016/j.bbr.2007.08.029; Barz T, 2006, CANCER RES, V66, P11975, DOI 10.1158/0008-5472.CAN-06-1529; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Bessa JM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.001.2009; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cryan JF, 2007, CURR OPIN PSYCHIATR, V20, P1, DOI 10.1097/YCO.0b013e3280117733; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Engelmann M, 2004, FRONT NEUROENDOCRIN, V25, P132, DOI 10.1016/j.yfrne.2004.09.001; Fields RL, 2003, J NEUROSCI, V23, P7801; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Fumagalli F, 2007, PROG NEUROBIOL, V81, P197, DOI 10.1016/j.pneurobio.2007.01.002; Gainer H, 2001, EXP NEUROL, V171, P190, DOI 10.1006/exnr.2001.7769; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Hoffmann A, 2003, MOL CELL BIOL, V23, P988, DOI 10.1128/MCB.23.3.988-1003.2003; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.011; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kalueff AV, 2007, BEHAV BRAIN RES, V179, P1, DOI 10.1016/j.bbr.2007.01.023; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Levine S, 2005, PSYCHONEUROENDOCRINO, V30, P939, DOI 10.1016/j.psyneuen.2005.03.013; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Malaspina D, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-71; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Murgatroyd C, 2004, J NEUROSCI, V24, P7762, DOI 10.1523/JNEUROSCI.1614-04.2004; Patchev AV, 2007, FASEB J, V21, P231, DOI 10.1096/fj.06-6952com; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Serradeil-Le Gal C, 2005, CNS DRUG REV, V11, P53; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Touma C, 2008, PSYCHONEUROENDOCRINO, V33, P839, DOI 10.1016/j.psyneuen.2008.03.013; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	50	816	840	3	165	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1559	U108		10.1038/nn.2436	http://dx.doi.org/10.1038/nn.2436			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19898468				2022-12-17	WOS:000272065600016
J	Bezzi, P; Domercq, M; Brambilla, L; Galli, R; Schols, D; De Clercq, E; Vescovi, A; Bagetta, G; Kollias, G; Meldolesi, J; Volterra, A				Bezzi, P; Domercq, M; Brambilla, L; Galli, R; Schols, D; De Clercq, E; Vescovi, A; Bagetta, G; Kollias, G; Meldolesi, J; Volterra, A			CXCR4-activated astrocyte glutamate release via TNFa: amplification by microglia triggers neurotoxicity	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; COAT PROTEIN GP120; GLIAL-CELLS; SYNAPTIC TRANSMISSION; SIGNAL-TRANSDUCTION; CHEMOKINE RECEPTORS; IN-SITU; CXCR4; MODULATION; ALPHA	Astrocytes actively participate in synaptic integration by releasing transmitter (glutamate) via a calcium-regulated, exocytosis-like process. Here we show that this process follows activation of the receptor CXCR4 by the chemokine stromal cell-derived factor 1 (SDF-1). An extraordinary feature of the ensuing signaling cascade is the rapid extracellular release of tumor necrosis factor-alpha (TNF alpha). Autocrine/paracrine TNF alpha -dependent signaling leading to prostaglandin (PG) formation not only controls glutamate release and astrocyte communication, but also causes their derangement when activated microglia cooperate to dramatically enhance release of the cytokine in response to CXCR4 stimulation. We demonstrate that altered glial communication has direct neuropathological consequences and that agents interfering with CXCR4-dependent astrocyte-microglia signaling prevent neuronal apoptosis induced by the HIV-1 coat glycoprotein, gp120(IIIB) Our results identify a new pathway for glia-glia and glia-neuron communication that is relevant to both normal brain function and neurodegenerative diseases.	Univ Milan, Ctr Excellence Neurodegenerat Dis, Dept Pharmacol Sci, I-20133 Milan, Italy; San Raffaele Sci Inst, Dept Neurosci, DIBIT, I-20132 Milan, Italy; Vita Salute Univ, I-20132 Milan, Italy; Hosp San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy; Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; Univ Calabria, Dept Pharmacobiol, I-87036 Cosenza, Italy; Biomed Sci Res Ctr Al Fleming, Inst Immunol, Vari 16672, Greece	University of Milan; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; KU Leuven; University of Calabria; Alexander Fleming Biomedical Sciences Research Center	Volterra, A (corresponding author), Univ Milan, Ctr Excellence Neurodegenerat Dis, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.		Bezzi, Paola/AAP-2440-2020; Vescovi, Angelo Luigi/A-4919-2015; Schols, Dominique/S-9057-2017; Brambilla, Liliana/AAA-3303-2021; Kollias, George/A-7079-2012; Domercq, Maria/Z-2274-2019; Bagetta, Giacinto/E-8402-2012; Galli, Rossella/AAI-8028-2020; Bagetta, Giacinto/N-9716-2018; Schols, Dominique/AAC-1309-2021	Vescovi, Angelo Luigi/0000-0002-1742-4112; Schols, Dominique/0000-0003-3256-5850; Brambilla, Liliana/0000-0001-5714-3625; Kollias, George/0000-0003-1867-3150; Domercq, Maria/0000-0002-4918-9276; Bagetta, Giacinto/0000-0001-8540-6218; Galli, Rossella/0000-0001-9023-7033; Bagetta, Giacinto/0000-0001-8540-6218; Schols, Dominique/0000-0003-3256-5850; De Clercq, Erik/0000-0002-2985-8890; Volterra, Andrea/0000-0003-1069-1602	Telethon [754, GGP02052] Funding Source: Medline	Telethon(Fondazione Telethon)		ABELE AE, 1990, NEURON, V4, P413, DOI 10.1016/0896-6273(90)90053-I; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Araque A, 1998, J NEUROSCI, V18, P6822; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Bagetta G, 1999, NEUROSCIENCE, V89, P1051, DOI 10.1016/S0306-4522(98)00363-7; Benveniste EN, 1995, FASEB J, V9, P1577, DOI 10.1096/fasebj.9.15.8529837; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Dreyer EB, 1995, EUR J NEUROSCI, V7, P2502, DOI 10.1111/j.1460-9568.1995.tb01048.x; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hesselgesser J, 1997, CURR BIOL, V7, P112, DOI 10.1016/S0960-9822(06)00055-8; Innocenti B, 2000, J NEUROSCI, V20, P1800; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Limatola C, 2000, EUR J NEUROSCI, V12, P2497, DOI 10.1046/j.1460-9568.2000.00139.x; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Miller RJ, 1999, TRENDS NEUROSCI, V22, P471, DOI 10.1016/S0166-2236(99)01408-3; Nagasawa T, 1999, Adv Immunol, V71, P211; Newman EA, 1998, J NEUROSCI, V18, P4022; Noda M, 2000, J NEUROSCI, V20, P251, DOI 10.1523/JNEUROSCI.20-01-00251.2000; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pasti L, 1997, J NEUROSCI, V17, P7817; Porter JT, 1996, J NEUROSCI, V16, P5073; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Streit Wolfgang J., 1995, P85; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Zheng JL, 1999, J VIROL, V73, P8256, DOI 10.1128/JVI.73.10.8256-8267.1999; Zheng JL, 1999, J NEUROIMMUNOL, V98, P185, DOI 10.1016/S0165-5728(99)00049-1; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	50	816	852	0	66	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					702	710		10.1038/89490	http://dx.doi.org/10.1038/89490			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426226				2022-12-17	WOS:000169621300015
J	d'Avella, A; Saltiel, P; Bizzi, E				d'Avella, A; Saltiel, P; Bizzi, E			Combinations of muscle synergies in the construction of a natural motor behavior	NATURE NEUROSCIENCE			English	Article							NONNEGATIVE MATRIX FACTORIZATION; SPINAL-CORD; ELECTROMYOGRAPHIC ACTIVITY; DIFFERENT DIRECTIONS; BLIND SEPARATION; MOVEMENTS; FROG; GENERATION; PATTERNS; ARM	A central issue in motor control is how the central nervous system generates the muscle activity patterns necessary to achieve a variety of behavioral goals. The many degrees of freedom of the musculoskeletal apparatus provide great flexibility but make the control problem extremely complex. Muscle synergies-coherent activations, in space or time, of a group of muscles-have been proposed as building blocks that could simplify the construction of motor behaviors. To evaluate this hypothesis, we developed a new method to extract invariant spatiotemporal components from the simultaneous recordings of the activity of many muscles. We used this technique to analyze the muscle patterns of intact and unrestrained frogs during kicking, a natural defensive behavior. Here we show that combinations of three time-varying muscle synergies underlie the variety of muscle patterns required to kick in different directions, that the recruitment of these synergies is related to movement kinematics, and that there are similarities among the synergies extracted from different behaviors.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; IRCCS, Fdn Santa Lucia, Human Physiol Sect, I-00179 Rome, Italy	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); IRCCS Santa Lucia	Bizzi, E (corresponding author), MIT, Dept Brain & Cognit Sci, 45 Carleton St, Cambridge, MA 02139 USA.	ebizzi@mit.edu	d'Avella, Andrea/K-6856-2018	d'Avella, Andrea/0000-0002-3393-4956; /0000-0002-7644-4498	NINDS NIH HHS [NS09343] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009343] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bernstein NA., 1967, COORDINATION REGULAT; Bishop Christopher M., 1995, NEURAL NETWORKS PATT; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; BUCHANAN TS, 1986, J NEUROPHYSIOL, V56, P1225, DOI 10.1152/jn.1986.56.5.1225; Cheng JG, 1998, J NEUROSCI, V18, P4295; d'Avella A, 2002, ADV NEUR IN, V14, P141; ECKER A, 1989, ANATOMY FROG; FLANDERS M, 1994, J NEUROPHYSIOL, V71, P811, DOI 10.1152/jn.1994.71.2.811; GISZTER SF, 1993, J NEUROSCI, V13, P467; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; Henry SM, 1998, J NEUROPHYSIOL, V80, P1939, DOI 10.1152/jn.1998.80.4.1939; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; HOGAN N, 1988, CAN J PHYSIOL PHARM, V66, P508, DOI 10.1139/y88-080; Kargo WJ, 2002, J EXP BIOL, V205, P1987; Kargo WJ, 2000, J NEUROSCI, V20, P409, DOI 10.1523/JNEUROSCI.20-01-00409.2000; KARST GM, 1991, J NEUROPHYSIOL, V66, P1594, DOI 10.1152/jn.1991.66.5.1594; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee DD, 2001, ADV NEUR IN, V13, P556; LEE WA, 1984, J MOTOR BEHAV, V16, P135; Lombard WP, 1907, AM J PHYSIOL, V20, P1, DOI 10.1152/ajplegacy.1907.20.1.1; MACPHERSON JM, 1991, LIFE SCI R, V50, P33; MACPHERSON JM, 1988, J NEUROPHYSIOL, V60, P218, DOI 10.1152/jn.1988.60.1.218; MAIER MA, 1995, EXP BRAIN RES, V103, P123, DOI 10.1007/BF00241970; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Mardia KV, 1979, MULTIVARIATE ANAL; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Rossignol Serge, 1994, Current Opinion in Neurobiology, V4, P894, DOI 10.1016/0959-4388(94)90139-2; Saltiel P, 2001, J NEUROPHYSIOL, V85, P605, DOI 10.1152/jn.2001.85.2.605; Saltiel P, 1998, J NEUROPHYSIOL, V80, P2323, DOI 10.1152/jn.1998.80.5.2323; Scott SH, 1997, J NEUROPHYSIOL, V77, P1016, DOI 10.1152/jn.1997.77.2.1016; Sherrington C, 1948, INTEGRATIVE ACTION N; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; SOECHTING JF, 1989, EXP BRAIN RES, V74, P535; Stein PSG, 1998, ANN NY ACAD SCI, V860, P142, DOI 10.1111/j.1749-6632.1998.tb09045.x; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; WADMAN W J, 1980, Journal of Human Movement Studies, V6, P19	39	812	817	6	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					300	308		10.1038/nn1010	http://dx.doi.org/10.1038/nn1010			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12563264				2022-12-17	WOS:000181178300019
J	Salimpoor, VN; Benovoy, M; Larcher, K; Dagher, A; Zatorre, RJ				Salimpoor, Valorie N.; Benovoy, Mitchel; Larcher, Kevin; Dagher, Alain; Zatorre, Robert J.			Anatomically distinct dopamine release during anticipation and experience of peak emotion to music	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NUCLEUS-ACCUMBENS; DORSAL STRIATUM; HEALTHY-MEN; REWARD; PET; REGISTRATION; VALIDATION; PREDICTION; SUBSTRATE	Music, an abstract stimulus, can arouse feelings of euphoria and craving, similar to tangible rewards that involve the striatal dopaminergic system. Using the neurochemical specificity of [C-11]raclopride positron emission tomography scanning, combined with psychophysiological measures of autonomic nervous system activity, we found endogenous dopamine release in the striatum at peak emotional arousal during music listening. To examine the time course of dopamine release, we used functional magnetic resonance imaging with the same stimuli and listeners, and found a functional dissociation: the caudate was more involved during the anticipation and the nucleus accumbens was more involved during the experience of peak emotional responses to music. These results indicate that intense pleasure in response to music can lead to dopamine release in the striatal system. Notably, the anticipation of an abstract reward can result in dopamine release in an anatomical pathway distinct from that associated with the peak pleasure itself. Our results help to explain why music is of such high value across all human societies.	[Salimpoor, Valorie N.; Larcher, Kevin; Dagher, Alain; Zatorre, Robert J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Salimpoor, Valorie N.; Zatorre, Robert J.] Int Lab Brain Mus & Sound Res, Montreal, PQ, Canada; [Salimpoor, Valorie N.; Benovoy, Mitchel; Zatorre, Robert J.] Ctr Interdisciplinary Res Mus Media & Technol, Montreal, PQ, Canada; [Benovoy, Mitchel] McGill Univ, Ctr Intelligent Machines, Montreal, PQ, Canada	McGill University; Universite de Montreal; McGill University	Salimpoor, VN (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	valorie.salimpoor@mail.mcgill.ca; robert.zatorre@mcgill.ca			Canadian Institutes of Health Research; Natural Science and Engineering Research Council; Jeanne Timmins Costello award; Centre for Interdisciplinary Research in Music Media and Technology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Jeanne Timmins Costello award; Centre for Interdisciplinary Research in Music Media and Technology	We thank the staff of the Montreal Neurological Institute PET and MR Units and the staff of the Centre for Interdisciplinary Research in Music Media and Technology for help with data acquisition, M. Ferreira and M. Bouffard for their assistance with data analysis, and G. Longo for assistance with stimulus preparation. This research was supported by funding from the Canadian Institutes of Health Research to R.J.Z., a Natural Science and Engineering Research Council stipend to V.N.S., a Jeanne Timmins Costello award to V.N.S. and Centre for Interdisciplinary Research in Music Media and Technology awards to V.N.S. and M.B.	Aston JAD, 2000, NEUROIMAGE, V12, P245, DOI 10.1006/nimg.2000.0620; Barrett SP, 2004, SYNAPSE, V54, P65, DOI 10.1002/syn.20066; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1997, INT J PATTERN RECOGN, V11, P1271, DOI 10.1142/S0218001497000597; Costes N, 2009, NEUROIMAGE, V47, P1496, DOI 10.1016/j.neuroimage.2009.05.052; Dube L, 2003, COGNITION EMOTION, V17, P263, DOI 10.1080/02699930302295; Egerton A, 2009, NEUROSCI BIOBEHAV R, V33, P1109, DOI 10.1016/j.neubiorev.2009.05.005; Endres CJ, 1997, J CEREBR BLOOD F MET, V17, P932, DOI 10.1097/00004647-199709000-00002; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Grewe O, 2007, EMOTION, V7, P774, DOI 10.1037/1528-3542.7.4.774; Grewe O, 2009, ANN NY ACAD SCI, V1169, P351, DOI 10.1111/j.1749-6632.2009.04783.x; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Huron D, 2009, MUSIC EMOTION; Huron D., 2006, SWEET ANTICIPATION M, DOI [https://doi.org/10.7551/mitpress/6575.001.0001, DOI 10.7551/MITPRESS/6575.001.0001]; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; LITTON JE, 1994, J CEREBR BLOOD F MET, V14, P358, DOI 10.1038/jcbfm.1994.45; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Meyer L., 1956, EMOTION MEANING MUSI; Mitterschiffthaler MT, 2007, HUM BRAIN MAPP, V28, P1150, DOI 10.1002/hbm.20337; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Panksepp J, 1995, MUSIC PERCEPT, V13, P171; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Slifstein M, 2010, SYNAPSE, V64, P350, DOI 10.1002/syn.20734; Sloboda J.A., 2001, MUSIC EMOTION THEORY, P71; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Valentin VV, 2009, J NEUROPHYSIOL, V102, P3384, DOI 10.1152/jn.91195.2008; Volkow ND, 1997, NATURE, V386, P827, DOI 10.1038/386827a0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zald D. H., 2011, NEUROBIOLOGY SENSATI; Zald DH, 2004, J NEUROSCI, V24, P4105, DOI 10.1523/JNEUROSCI.4643-03.2004; Zijdenbos A, 1998, LECT NOTES COMPUT SC, V1496, P439, DOI 10.1007/BFb0056229	49	810	840	10	292	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					257	U355		10.1038/nn.2726	http://dx.doi.org/10.1038/nn.2726			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21217764				2022-12-17	WOS:000286595400025
J	Romanski, LM; Tian, B; Fritz, J; Mishkin, M; Goldman-Rakic, PS; Rauschecker, JP				Romanski, LM; Tian, B; Fritz, J; Mishkin, M; Goldman-Rakic, PS; Rauschecker, JP			Dual streams of auditory afferents target multiple domains in the primate prefrontal cortex	NATURE NEUROSCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; SUPERIOR TEMPORAL SULCUS; RHESUS-MONKEY; MACAQUE MONKEYS; FRONTAL-CORTEX; TONOTOPIC ORGANIZATION; CORTICAL CONNECTIONS; FUNCTIONAL MRI; COMPLEX SOUNDS; MEMORY	'What' and 'where' visual streams define ventrolateral object and dorsolateral spatial processing domains in the prefrontal cortex of nonhuman primates. We looked for similar streams for auditory-prefrontal connections in rhesus macaques by combining microelectrode recording with anatomical tract-tracing. Injection of multiple tracers into physiologically mapped regions AL, ML and CL of the auditory belt cortex revealed that anterior belt cortex was reciprocally connected with the frontal pole (area 10), rostral principal sulcus (area 46) and ventral prefrontal regions (areas 12 and 45), whereas the caudal belt was mainly connected with the caudal principal sulcus (area 46) and frontal eye fields (area 8a). Thus separate auditory streams originate in caudal and rostral auditory cortex and target spatial and non-spatial domains of the frontal lobe, respectively.	Yale Univ, Sch Med, New Haven, CT 06510 USA; Georgetown Univ, Med Ctr, Georgetown Inst Cognit & Computat Sci, Washington, DC 20007 USA; NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA	Yale University; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Romanski, LM (corresponding author), Yale Univ, Sch Med, B 413 SHM,333 Cedar St, New Haven, CT 06510 USA.		Rauschecker, Josef P/A-4120-2013; Fritz, Jonathan/AAK-4863-2020	Rauschecker, Josef P./0000-0003-4353-9084; Fritz, Jonathan/0000-0002-0625-172X	NIDCD NIH HHS [R01 DC004845-01, R01 DC004845] Funding Source: Medline; NIMH NIH HHS [R01 MH038546-21] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004845] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; AZUMA M, 1984, BRAIN RES, V298, P343, DOI 10.1016/0006-8993(84)91434-3; BARBAS H, 1988, J COMP NEUROL, V276, P313, DOI 10.1002/cne.902760302; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; BENSON DA, 1981, BRAIN RES, V219, P249, DOI 10.1016/0006-8993(81)90290-0; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Bodner M, 1996, NEUROREPORT, V7, P1905, DOI 10.1097/00001756-199608120-00006; BUCKNER RL, 1995, J NEUROPHYSIOL, V74, P2163, DOI 10.1152/jn.1995.74.5.2163; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; CHAVIS DA, 1976, BRAIN RES, V117, P369, DOI 10.1016/0006-8993(76)90089-5; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; DEACON TW, 1992, BRAIN RES, V573, P8, DOI 10.1016/0006-8993(92)90109-M; DEMB JB, 1995, J NEUROSCI, V15, P5870; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fuster J.M., 1989, PREFRONTAL CORTEX; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GALABURDA AM, 1983, J COMP NEUROL, V221, P169, DOI 10.1002/cne.902210206; GOLDMAN PS, 1970, EXP NEUROL, V27, P291, DOI 10.1016/0014-4886(70)90222-0; Goldman-Rakic PS, 1987, HDB PHYSL 1, V5, P373, DOI DOI 10.1002/CPHY.CP010509; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; GROSS CG, 1962, EXP NEUROL, V5, P453, DOI 10.1016/0014-4886(62)90057-2; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; Hackett TA, 1998, J COMP NEUROL, V400, P271, DOI 10.1002/(SICI)1096-9861(19981019)400:2<271::AID-CNE8>3.0.CO;2-6; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Kosaki H, 1997, J COMP NEUROL, V386, P304; LAWICKA W, 1966, P C POLISH PHYSIOL S, V10, P178; LEINONEN L, 1980, EXP BRAIN RES, V39, P203; Mazzoni P, 1996, J NEUROPHYSIOL, V75, P1233, DOI 10.1152/jn.1996.75.3.1233; McCarthy G, 1996, CEREB CORTEX, V6, P600, DOI 10.1093/cercor/6.4.600; MOREL A, 1993, J COMP NEUROL, V335, P437, DOI 10.1002/cne.903350312; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; PANDYA DN, 1969, BRAIN RES, V13, P13, DOI 10.1016/0006-8993(69)90141-3; PETRIDES M, 1986, J NEUROSCI, V6, P2054; PETRIDES M, 1988, J COMP NEUROL, V273, P52, DOI 10.1002/cne.902730106; PREUSS TM, 1991, J COMP NEUROL, V310, P429, DOI 10.1002/cne.903100402; Rauschecker JP, 1997, J COMP NEUROL, V382, P89; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; SELTZER B, 1989, J COMP NEUROL, V281, P97, DOI 10.1002/cne.902810108; Stevens AA, 1998, ARCH GEN PSYCHIAT, V55, P1097, DOI 10.1001/archpsyc.55.12.1097; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; TANILA H, 1993, BEHAV BRAIN RES, V53, P3; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; VAADIA E, 1986, J NEUROPHYSIOL, V56, P934, DOI 10.1152/jn.1986.56.4.934; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	50	809	820	0	43	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1131	1136		10.1038/16056	http://dx.doi.org/10.1038/16056			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570492	Green Accepted			2022-12-17	WOS:000085810100019
J	Polymenidou, M; Lagier-Tourenne, C; Hutt, KR; Huelga, SC; Moran, J; Liang, TY; Ling, SC; Sun, E; Wancewicz, E; Mazur, C; Kordasiewicz, H; Sedaghat, Y; Donohue, JP; Shiue, L; Bennett, CF; Yeo, GW; Cleveland, DW				Polymenidou, Magdalini; Lagier-Tourenne, Clotilde; Hutt, Kasey R.; Huelga, Stephanie C.; Moran, Jacqueline; Liang, Tiffany Y.; Ling, Shuo-Chien; Sun, Eveline; Wancewicz, Edward; Mazur, Curt; Kordasiewicz, Holly; Sedaghat, Yalda; Donohue, John Paul; Shiue, Lily; Bennett, C. Frank; Yeo, Gene W.; Cleveland, Don W.			Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; BINDING-PROTEIN; TARDBP MUTATIONS; GENE; EXPRESSION; REGULATOR; TAU; ASSOCIATION	We used cross-linking and immunoprecipitation coupled with high-throughput sequencing to identify binding sites in 6,304 genes as the brain RNA targets for TDP-43, an RNA binding protein that, when mutated, causes amyotrophic lateral sclerosis. Massively parallel sequencing and splicing-sensitive junction arrays revealed that levels of 601 mRNAs were changed (including Fus (Tls), progranulin and other transcripts encoding neurodegenerative disease-associated proteins) and 965 altered splicing events were detected (including in sortilin, the receptor for progranulin) following depletion of TDP-43 from mouse adult brain with antisense oligonucleotides. RNAs whose levels were most depleted by reduction in TDP-43 were derived from genes with very long introns and that encode proteins involved in synaptic activity. Lastly, we found that TDP-43 autoregulates its synthesis, in part by directly binding and enhancing splicing of an intron in the 3' untranslated region of its own transcript, thereby triggering nonsense-mediated RNA degradation.	[Polymenidou, Magdalini; Lagier-Tourenne, Clotilde; Moran, Jacqueline; Ling, Shuo-Chien; Sun, Eveline; Kordasiewicz, Holly; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Polymenidou, Magdalini; Lagier-Tourenne, Clotilde; Hutt, Kasey R.; Huelga, Stephanie C.; Moran, Jacqueline; Liang, Tiffany Y.; Ling, Shuo-Chien; Sun, Eveline; Kordasiewicz, Holly; Yeo, Gene W.; Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hutt, Kasey R.; Huelga, Stephanie C.; Liang, Tiffany Y.; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Hutt, Kasey R.; Huelga, Stephanie C.; Liang, Tiffany Y.; Yeo, Gene W.] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA; [Wancewicz, Edward; Mazur, Curt; Sedaghat, Yalda; Bennett, C. Frank] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Donohue, John Paul; Shiue, Lily] Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, RNA Ctr, Santa Cruz, CA 95064 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Isis Pharmaceuticals Inc; University of California System; University of California Santa Cruz	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	geneyeo@ucsd.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; lagier-Tourenne, Clotilde/ABE-6303-2020; Polymenidou, Magdalini/D-2254-2014; Yeo, Gene/AAE-7676-2019	lagier-Tourenne, Clotilde/0000-0002-3058-8322; Yeo, Gene/0000-0002-0799-6037; Cleveland, Don/0000-0002-1934-3682; Liang, Tiffany/0000-0002-1986-5966; LING, Shuo-Chien/0000-0002-0300-8812	Human Frontier Science Program; Amyotrophic Lateral Sclerosis Association; Ludwig Institute for Cancer Research; National Science Foundation; US National Institutes of Health [R37 NS27036, HG004659, GM084317]; University of California, San Diego; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Amyotrophic Lateral Sclerosis Association; Ludwig Institute for Cancer Research; National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego(University of California System); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank members of B. Ren's laboratory, especially Z. Ye, S. Kuan and L. Edsall for technical help with the Illumina sequencing and U. Wagner for helpful discussions, K. Clutario and J. Boubaker for technical help, as well as all of the members of the Yeo and Cleveland laboratories, M. Ares Jr for generous support, and the neuro-team of ISIS Pharmaceuticals for critical comments and suggestions on this project. M. P. is the recipient of a Human Frontier Science Program Long Term Fellowship. C. L.-T. is the recipient of the Milton-Safenowitz post-doctoral fellowship from the Amyotrophic Lateral Sclerosis Association. D. W. C. receives salary support from the Ludwig Institute for Cancer Research. S. C. H. is funded by a National Science Foundation Graduate Research Fellowship. This work was supported by grants from the US National Institutes of Health (R37 NS27036 and an American Recovery and Reinvestment Act Challenge grant) to D. W. C and partially by grants from the US National Institutes of Health (HG004659 and GM084317) and the Stem Cell Program at the University of California, San Diego to G.W.Y.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; BERGERON C, 1994, J NEUROPATH EXP NEUR, V53, P221, DOI 10.1097/00005072-199405000-00002; Birve A, 2010, HUM MOL GENET, V19, P4201, DOI 10.1093/hmg/ddq338; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Dreumont N, 2010, NUCLEIC ACIDS RES, V38, P1353, DOI 10.1093/nar/gkp1086; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Le Hir H, 2000, GENE DEV, V14, P1098; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Perlick HA, 1996, P NATL ACAD SCI USA, V93, P10928, DOI 10.1073/pnas.93.20.10928; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Valdmanis PN, 2009, ANN HUM GENET, V73, P652, DOI 10.1111/j.1469-1809.2009.00546.x; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745	50	804	817	6	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					459	U92		10.1038/nn.2779	http://dx.doi.org/10.1038/nn.2779			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21358643	Green Accepted			2022-12-17	WOS:000288849400017
J	Vuilleumier, P; Armony, JL; Driver, J; Dolan, RJ				Vuilleumier, P; Armony, JL; Driver, J; Dolan, RJ			Distinct spatial frequency sensitivities for processing faces and emotional expressions	NATURE NEUROSCIENCE			English	Article							BILATERAL AMYGDALA DAMAGE; RETINAL GANGLION-CELLS; SUPERIOR COLLICULUS; MEDIAL PULVINAR; RECOGNITION; PERCEPTION; CORTEX; MONKEY; INPUT; IDENTIFICATION	High and low spatial frequency information in visual images is processed by distinct neural channels. Using event-related functional magnetic resonance imaging (fMRI) in humans, we show dissociable roles of such visual channels for processing faces and emotional fearful expressions. Neural responses in fusiform cortex, and effects of repeating the same face identity upon fusiform activity, were greater with intact or high-spatial-frequency face stimuli than with low-frequency faces, regardless of emotional expression. In contrast, amygdala responses to fearful expressions were greater for intact or low-frequency faces than for high-frequency faces. An activation of pulvinar and superior colliculus by fearful expressions occurred specifically with low-frequency faces, suggesting that these subcortical pathways may provide coarse fear-related inputs to the amygdala.	Univ Geneva, Ctr Med, Dept Clin Neurosci & Physiol, Lab Neurol & Imaging Cognit, CH-1211 Geneva, Switzerland; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; McGill Univ, Douglas Hosp, Res Ctr, Verdun, PQ H4H 1R3, Canada; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of Geneva; University of London; University College London; McGill University; University of London; University College London	Vuilleumier, P (corresponding author), Univ Geneva, Ctr Med, Dept Clin Neurosci & Physiol, Lab Neurol & Imaging Cognit, 1 Michel Servet, CH-1211 Geneva, Switzerland.	patrik.vuilleumier@medecine.unige.ch	Driver, Jon/A-4779-2010; Vuilleumier, Patrik/AAJ-1839-2021	Vuilleumier, Patrik/0000-0002-8198-9214; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 1999, NEUROPSYCHOLOGIA, V37, P1111, DOI 10.1016/S0028-3932(99)00039-1; BENEVENTO LA, 1983, J COMP NEUROL, V217, P307, DOI 10.1002/cne.902170307; BERSON DM, 1988, PROG BRAIN RES, V75, P17; BISTI S, 1976, VISION RES, V16, P247, DOI 10.1016/0042-6989(76)90107-3; BRUCE V, 1991, PERCEPTION, V20, P755, DOI 10.1068/p200755; Burton AM, 2001, VISION RES, V41, P3185, DOI 10.1016/S0042-6989(01)00186-9; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Costen NP, 1996, PERCEPT PSYCHOPHYS, V58, P602, DOI 10.3758/BF03213093; COWEY A, 1994, NEUROSCIENCE, V61, P691, DOI 10.1016/0306-4522(94)90445-6; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; FIORENTINI A, 1983, PERCEPTION, V12, P195, DOI 10.1068/p120195; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; Goshen-Gottstein Y, 2000, J EXP PSYCHOL LEARN, V26, P1198, DOI 10.1037//0278-7393.26.5.1198; Hamann SB, 1999, NEUROPSYCHOLOGIA, V37, P1135, DOI 10.1016/S0028-3932(99)00027-5; HARTING JK, 1980, J COMP NEUROL, V192, P853, DOI 10.1002/cne.901920414; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HAYES T, 1986, PERCEPTION, V15, P595, DOI 10.1068/p150595; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Hill H, 1997, COGNITION, V62, P201, DOI 10.1016/S0010-0277(96)00785-8; JOHNSON MH, 1993, CORTICAL PARCELLATIO; JONES EG, 1976, BRAIN RES, V104, P142, DOI 10.1016/0006-8993(76)90654-5; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; KLINE DW, 1993, HUM FACTORS, V35, P25, DOI 10.1177/001872089303500102; LeDoux J. E., 1996, EMOTIONAL BRAIN; LEVENTHAL AG, 1985, J COMP NEUROL, V237, P216, DOI 10.1002/cne.902370206; Linke R, 2000, EXP BRAIN RES, V134, P520, DOI 10.1007/s002210000475; Liu CH, 2000, J EXP PSYCHOL HUMAN, V26, P956, DOI 10.1037//0096-1523.26.3.956; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Lomber SG, 2002, P NATL ACAD SCI USA, V99, P4049, DOI 10.1073/pnas.062551899; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; MORRIS JS, 1998, J COMP NEUROL, V394, P91; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; NORMAN J, 1987, VISION RES, V27, P87, DOI 10.1016/0042-6989(87)90145-3; O'Brien BJ, 2001, NEUROSCI LETT, V312, P145, DOI 10.1016/S0304-3940(01)02220-0; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; ROBINSON DL, 1992, TRENDS NEUROSCI, V15, P127, DOI 10.1016/0166-2236(92)90354-B; Sahraie A, 2002, EXP BRAIN RES, V143, P249, DOI 10.1007/s00221-001-0989-1; SCHILLER PH, 1979, J NEUROPHYSIOL, V42, P1124, DOI 10.1152/jn.1979.42.4.1124; Schyns PG, 1999, COGNITION, V69, P243, DOI 10.1016/S0010-0277(98)00069-9; SERGENT J, 1985, J EXP PSYCHOL HUMAN, V11, P846, DOI 10.1037/0096-1523.11.6.846; TIEGER T, 1979, PERCEPT PSYCHOPHYS, V26, P163, DOI 10.3758/BF03208310; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Weiskrantz L., 1986, BLINDSIGHT CASE STUD; Whalen PJ, 1998, J NEUROSCI, V18, P411	50	804	823	3	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					624	631		10.1038/nn1057	http://dx.doi.org/10.1038/nn1057			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	683GQ	12740580	Green Published			2022-12-17	WOS:000183140400020
J	Yamanaka, K; Chun, SJ; Boillee, S; Fujimori-Tonou, N; Yamashita, H; Gutmann, DH; Takahashi, R; Misawa, H; Cleveland, DW				Yamanaka, Koji; Chun, Seung Joo; Boillee, Severine; Fujimori-Tonou, Noriko; Yamashita, Hirofumi; Gutmann, David H.; Takahashi, Ryosuke; Misawa, Hidemi; Cleveland, Don W.			Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis	NATURE NEUROSCIENCE			English	Article							MOTOR-NEURONS; EXTEND SURVIVAL; RAT MODEL; ALS; MICE; MICROGLIA	Dominant mutations in superoxide dismutase cause amyotrophic lateral sclerosis (ALS), an adult-onset neurodegenerative disease that is characterized by the loss of motor neurons. Using mice carrying a deletable mutant gene, diminished mutant expression in astrocytes did not affect onset, but delayed microglial activation and sharply slowed later disease progression. These findings demonstrate that mutant astrocytes are viable targets for therapies for slowing the progression of non-cell autonomous killing of motor neurons in ALS.	[Yamanaka, Koji; Chun, Seung Joo; Boillee, Severine; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Yamanaka, Koji; Chun, Seung Joo; Boillee, Severine; Cleveland, Don W.] Univ Calif San Diego, Dept Med & Neurosci, La Jolla, CA 92093 USA; [Yamanaka, Koji; Fujimori-Tonou, Noriko; Yamashita, Hirofumi] RIKEN, Brain Sci Inst, Yamanaka Res Unit, Wako, Saitama 3510198, Japan; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto 6068507, Japan; [Misawa, Hidemi] Kyoritsu Univ Pharm, Dept Pharmacol, Minato Ku, Tokyo 1058512, Japan	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; RIKEN; Washington University (WUSTL); Kyoto University	Yamanaka, K (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	kyamanaka@brain.riken.jp; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; Yamanaka, Koji/ABD-1034-2020; Boillee, Severine/J-4027-2017; Yamanaka, Koji/H-5806-2011	Yamanaka, Koji/0000-0003-4655-0035; Yamanaka, Koji/0000-0003-4655-0035; BOILLEE, Severine/0000-0001-5518-9005; Cleveland, Don/0000-0002-1934-3682; Gutmann, David/0000-0002-3127-5045	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R01NS027036] Funding Source: NIH RePORTER; NINDS NIH HHS [R37 NS027036-22, R01 NS027036, R37 NS027036-23, R37 NS027036, NS 27036] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Son M, 2001, ANN NEUROL, V50, P273, DOI 10.1002/ana.1104; Vermeiren C, 2006, J NEUROCHEM, V96, P719, DOI 10.1111/j.1471-4159.2005.03577.x	15	803	842	4	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					251	253		10.1038/nn2047	http://dx.doi.org/10.1038/nn2047			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18246065	Green Accepted			2022-12-17	WOS:000253548300006
J	Girardeau, G; Benchenane, K; Wiener, SI; Buzsaki, G; Zugaro, MB				Girardeau, Gabrielle; Benchenane, Karim; Wiener, Sidney I.; Buzsaki, Gyoergy; Zugaro, Michael B.			Selective suppression of hippocampal ripples impairs spatial memory	NATURE NEUROSCIENCE			English	Article							SLOW-WAVE SLEEP; REACTIVATION; OSCILLATIONS; STATE	Sharp wave-ripple (SPW-R) complexes in the hippocampus-entorhinal cortex are believed to be important for transferring labile memories from the hippocampus to the neocortex for long-term storage. We found that selective elimination of SPW-Rs during post-training consolidation periods resulted in performance impairment in rats trained on a hippocampus-dependent spatial memory task. Our results provide evidence for a prominent role of hippocampal SPW-Rs in memory consolidation.	[Girardeau, Gabrielle; Benchenane, Karim; Wiener, Sidney I.; Zugaro, Michael B.] CNRS, Coll France, Lab Physiol Percept & Act, Paris, France; [Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Universite Paris Cite; Rutgers State University Newark; Rutgers State University New Brunswick	Zugaro, MB (corresponding author), CNRS, Coll France, Lab Physiol Percept & Act, Paris, France.	buzsaki@axon.rutgers.edu; michael.zugaro@college-de-france.fr	benchenane, karim/D-8023-2015	benchenane, karim/0000-0001-7118-0748; Girardeau, Gabrielle/0000-0002-5265-9697; Wiener, Sidney/0000-0002-5819-1319; Buzsaki, Gyorgy/0000-0002-3100-4800; Zugaro, Michael/0000-0002-6199-2635	International Human Frontiers Science Program Organization [CDA0061/2007-C]; US National Institutes of Health [NS34994]; European Projects NeuroProbes [IST-027017]; Integrating Cognition, Emotion and Autonomy [FP6-IST 027819]; College de France Visiting Professor Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	International Human Frontiers Science Program Organization(Human Frontier Science Program); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Projects NeuroProbes; Integrating Cognition, Emotion and Autonomy; College de France Visiting Professor Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Sara, A. Larrieu, L. Hazan, A. Fruchart, P. Ruther, S. Kisban, S. Herwik, S. Doutremer, M.- A. Thomas, Y. Dupraz, M. Ehrette and S. Rateau for advice and technical support. This work was supported by the International Human Frontiers Science Program Organization (CDA0061/2007-C), the US National Institutes of Health (NS34994), European Projects NeuroProbes (IST-027017) and Integrating Cognition, Emotion and Autonomy (FP6-IST 027819), and a College de France Visiting Professor Fellowship.	Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Eschenko O, 2008, LEARN MEMORY, V15, P222, DOI 10.1101/lm.726008; Jarrard LE, 1995, BEHAV BRAIN RES, V71, P1, DOI 10.1016/0166-4328(95)00034-8; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zugaro MB, 2005, NAT NEUROSCI, V8, P67, DOI 10.1038/nn1369	15	798	806	5	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1222	1223		10.1038/nn.2384	http://dx.doi.org/10.1038/nn.2384			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19749750				2022-12-17	WOS:000270170200008
J	Hama, H; Kurokawa, H; Kawano, H; Ando, R; Shimogori, T; Noda, H; Fukami, K; Sakaue-Sawano, A; Miyawaki, A				Hama, Hiroshi; Kurokawa, Hiroshi; Kawano, Hiroyuki; Ando, Ryoko; Shimogori, Tomomi; Noda, Hisayori; Fukami, Kiyoko; Sakaue-Sawano, Asako; Miyawaki, Atsushi			Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain	NATURE NEUROSCIENCE			English	Article							OPTICAL PROJECTION TOMOGRAPHY; VASCULAR NICHE; TOOL; VISUALIZATION; PROTEINS; DEEP	Optical methods for viewing neuronal populations and projections in the intact mammalian brain are needed, but light scattering prevents imaging deep into brain structures. We imaged fixed brain tissue using Scale, an aqueous reagent that renders biological samples optically transparent but completely preserves fluorescent signals in the clarified structures. In Scale-treated mouse brain, neurons labeled with genetically encoded fluorescent proteins were visualized at an unprecedented depth in millimeter-scale networks and at subcellular resolution. The improved depth and scale of imaging permitted comprehensive three-dimensional reconstructions of cortical, callosal and hippocampal projections whose extent was limited only by the working distance of the objective lenses. In the intact neurogenic niche of the dentate gyrus, Scale allowed the quantitation of distances of neural stem cells to blood vessels. Our findings suggest that the Scale method will be useful for light microscopy-based connectomics of cellular networks in brain and other tissues.	[Hama, Hiroshi; Kurokawa, Hiroshi; Kawano, Hiroyuki; Ando, Ryoko; Shimogori, Tomomi; Noda, Hisayori; Sakaue-Sawano, Asako; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Kurokawa, Hiroshi; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo, Japan; [Kawano, Hiroyuki; Sakaue-Sawano, Asako; Miyawaki, Atsushi] Japan Sci & Technol Agcy, Wako, Saitama, Japan; [Noda, Hisayori] Tokyo Inst Technol, Meguro Ku, Tokyo 152, Japan	RIKEN; Tokyo University of Pharmacy & Life Sciences; Japan Science & Technology Agency (JST); Tokyo Institute of Technology	Miyawaki, A (corresponding author), RIKEN, Brain Sci Inst, Wako, Saitama, Japan.	matsushi@brain.riken.jp	Shimogori, Tomomi/L-2893-2013; Tuluc, Petronel/C-2527-2011; Miyawaki, Atsushi/K-3569-2014	Shimogori, Tomomi/0000-0002-6931-5401; Miyawaki, Atsushi/0000-0002-2329-3235; Sakaue-Sawano, Asako/0000-0002-6975-0390	Japan Ministry of Education, Culture, Sports, Science and Technology; Human Frontier Science Program; Grants-in-Aid for Scientific Research [10J08371] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Sakurai, H. Otsuka and M. Hirano for general assistance, F. Ishidate, B. Zimmermann, R. Wolleschensky, Y. Watanabe, E. Nakasho, H. Kimura, T. Tajima and S. Horie for help with acquiring and analyzing images, RIKEN BSI-Olympus Collaboration Center for technical support, Y. Yoshihara (RIKEN), M. Yamaguchi and K. Mori (The University of Tokyo) for the Nestin promoter-GFP transgenic mice, J.R. Sanes (Harvard) for the YFP-H and GFP-M lines, E. Takahashi (RIKEN) for helpful advice on transgenic mice, S. J. Smith (Stanford) and J. W. Lichtman (Harvard) for helpful advice on tissue clearing, and D. Mou (Harvard), A. Govindarajan, K. Rockland and S. Tonegawa (Massachusetts Institute of Technology), A. Moore and C. Yokoyama (RIKEN) for critical comments. This work was partly supported by grants from Japan Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid for Scientific Research on Priority Areas and the Human Frontier Science Program.	Alkaabi KM, 2005, APPL BIOCHEM BIOTECH, V126, P149, DOI 10.1385/ABAB:126:2:149; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Chiang AS, 2002, P NATL ACAD SCI USA, V99, P37, DOI 10.1073/pnas.012318899; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Denk Winfried, 1995, P445; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fritzsch B, 2005, BRAIN RES BULL, V66, P249, DOI 10.1016/j.brainresbull.2005.05.016; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Jahrling N, 2009, ORGANOGENESIS, V5, P227, DOI 10.4161/org.5.4.10403; KELLER HE, 2001, CURR PROTOC CYTOM; Lichtman JW, 2008, NEURON, V60, P441, DOI 10.1016/j.neuron.2008.10.040; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; Liu YC, 2003, METHODS, V30, P86, DOI 10.1016/S1046-2023(03)00010-0; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Parra SG, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3454391; Porrero C, 2010, BRAIN RES, V1345, P59, DOI 10.1016/j.brainres.2010.05.061; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Sharpe J, 2003, J ANAT, V202, P175, DOI 10.1046/j.1469-7580.2003.00155.x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shimogori T, 2008, DEV GROWTH DIFFER, V50, P499, DOI [10.1111/j.1440-169x.2008.01045.x, 10.1111/j.1440-169X.2008.01045.x]; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Theer P, 2006, J OPT SOC AM A, V23, P3139, DOI 10.1364/JOSAA.23.003139; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Zacharakis G, 2005, P NATL ACAD SCI USA, V102, P18252, DOI 10.1073/pnas.0504628102; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	42	796	837	6	196	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1481	U166		10.1038/nn.2928	http://dx.doi.org/10.1038/nn.2928			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	21878933				2022-12-17	WOS:000296518600026
J	Crick, F; Koch, C				Crick, F; Koch, C			A framework for consciousness	NATURE NEUROSCIENCE			English	Article							PERCEPTION; VISION; NEUROSCIENCE; MECHANISMS; ILLUSION	Here we summarize our present approach to the problem of consciousness. After an introduction outlining our general strategy, we describe what is meant by the term 'framework' and set it out under ten headings. This framework offers a coherent scheme for explaining the neural correlates of (visual) consciousness in terms of competing cellular assemblies. Most of the ideas we favor have been suggested before, but their combination is original. We also outline some general experimental approaches to the problem and, finally, acknowledge some relevant aspects of the brain that have been left out of the proposed framework.	Salk Inst Biol Studies, La Jolla, CA 92037 USA; CALTECH, Pasadena, CA 91125 USA	Salk Institute; California Institute of Technology	Koch, C (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	koch@klab.caltech.edu		Koch, Christof/0000-0001-6482-8067				ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Attneave F., 1961, SENS COMMUN, P777; Baars BJ., 1997, THEATER CONSCIOUSNES, DOI [10.1093/acprof:oso/9780195102659.001.1, DOI 10.1093/ACPROF:OSO/9780195102659.001.1]; Bachmann Talis, 2000, MICROGENETIC APPROAC; BAYNE T, IN PRESS UNITY CONSC; BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; Chalmers D., 1995, CONSCIOUS MIND SEARC; Crick F., 1990, Seminars in the Neurosciences, V2, P263; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; Crick F, 2000, NEURAL CORRELATES OF CONSCIOUSNESS, P103; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; CRICK F, 1995, SCI AM, V273, P84; CRICK FC, 2003, PROBLEMS SYSTEMS NEU; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; DELIMA AD, 1990, J COMP NEUROL, V296, P159, DOI 10.1002/cne.902960110; Dennett D, 2001, COGNITION, V79, P221, DOI 10.1016/S0010-0277(00)00130-X; Dennett D. C., 1991, CONSCIOUSNESS EXPLAI; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Edelman G, 1989, REMEMBERED PRESENT B; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fried I, 1998, NATURE, V391, P650, DOI 10.1038/35536; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; GROSSBERG S, 1995, AM SCI, V83, P438; HEBB D. O., 1949; HESS RH, 1989, J NEUROSCI, V9, P1628; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Jackendoff R., 1987, CONSCIOUSNESS COMPUT; JACKSON AP, 1996, BIOMEMBR, V4, P1; Koch C, 2001, NATURE, V411, P893, DOI 10.1038/35082161; KOCH C, IN PRESS QUEST CONSC; Kreiman G, 2002, P NATL ACAD SCI USA, V99, P8378, DOI 10.1073/pnas.072194099; LEHKY SR, 1988, NATURE, V333, P452, DOI 10.1038/333452a0; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Milner A. D., 1995, VISUAL BRAIN ACTION; Mountcastle V.B., 1998, PERCEPTUAL NEUROSCIE; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; POGGIO T, 1985, NATURE, V317, P314, DOI 10.1038/317314a0; Purves D, 1996, P NATL ACAD SCI USA, V93, P3693, DOI 10.1073/pnas.93.8.3693; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; Revonsuo A, 1997, NEUROREPORT, V8, P3867, DOI 10.1097/00001756-199712220-00006; Rossetti Y, 1998, CONSCIOUS COGN, V7, P520, DOI 10.1006/ccog.1998.0370; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; SCHACTER DL, 1992, J COGNITIVE NEUROSCI, V4, P244, DOI 10.1162/jocn.1992.4.3.244; Shadlen M.N., 1999, NEURON, V24.1, P111, DOI DOI 10.1016/S0896-627380822-3; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shear J., 1997, EXPLAINING CONSCIOUS; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; SIMPSON WA, 1994, VISION RES, V34, P2547, DOI 10.1016/0042-6989(94)90241-0; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Stroud J.M., 1956, INFORMATION THEORY P, P174; Tononi G, 2000, UNIVERSE CONSCIOUSNE; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; VARELA FJ, 1981, NEUROPSYCHOLOGIA, V19, P675; Wegner D., 2002, ILLUSION CONSCIOUS W; Wolfe JM, 1997, VISION RES, V37, P25, DOI 10.1016/S0042-6989(96)00111-3; Zeki S, 1999, CONSCIOUS COGN, V8, P225, DOI 10.1006/ccog.1999.0390; Zeki S, 1998, NEUROSCIENTIST, V4, P365, DOI 10.1177/107385849800400518; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	60	796	825	0	224	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					119	126		10.1038/nn0203-119	http://dx.doi.org/10.1038/nn0203-119			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12555104	Green Published			2022-12-17	WOS:000180669100011
J	Takano, T; Tian, GF; Peng, WG; Lou, NH; Libionka, W; Han, XN; Nedergaard, M				Takano, T; Tian, GF; Peng, WG; Lou, NH; Libionka, W; Han, XN; Nedergaard, M			Astrocyte-mediated control of cerebral blood flow	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL HYPEREMIA; PHOSPHOLIPASE A(2); BRAIN ACTIVATION; ARACHIDONIC-ACID; CALCIUM; RAT; CYCLOOXYGENASE-1; INDOMETHACIN; INHIBITION; METABOLISM	Local increase in blood flow during neural activity forms the basis for functional brain imaging, but its mechanism remains poorly defined. Here we show that cortical astrocytes in vivo possess a powerful mechanism for rapid vasodilation. We imaged the activity of astrocytes labeled with the calcium ( Ca2+)-sensitive indicator rhod-2 in somatosensory cortex of adult mice. Photolysis of caged Ca2+ in astrocytic endfeet ensheathing the vessel wall was associated with an 18% increase in arterial cross-section area that corresponded to a 37% increase in blood flow. Vasodilation occurred with a latency of only 1-2 s, and both indomethacin and the cyclooxygenase-1 inhibitor SC-560 blocked the photolysis-induced hyperemia. These observations implicate astrocytes in the control of local microcirculation and suggest that one of their physiological roles is to mediate vasodilation in response to increased neural activity.	Univ Rochester, Sch Med, Dept Neurosurg, Ctr Aging & Dev Biol, Rochester, NY 14642 USA; Jagiellonian Univ, Dept Neurosurg, Krakow, Poland	University of Rochester; Jagiellonian University	Takano, T (corresponding author), Univ Rochester, Sch Med, Dept Neurosurg, Ctr Aging & Dev Biol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Takahiro_Takano@URMC.Rochester.edu		Takano, Takahiro/0000-0002-6235-6673				Anderson CM, 2003, TRENDS NEUROSCI, V26, P340, DOI 10.1016/S0166-2236(03)00141-3; Bakalova RA, 2002, PROSTAG LEUKOTR ESS, V67, P379, DOI 10.1054/plef.2002.0445; Bruhn H, 2001, J MAGN RESON IMAGING, V13, P325, DOI 10.1002/jmri.1047; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; DAVALOS D, 2005, NAT NEUROSCI; del Zoppo GJ, 2000, THROMB RES, V98, pV73; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; ELLIS EF, 1979, AM J PHYSIOL, V237, pH381, DOI 10.1152/ajpheart.1979.237.3.H381; Farooqui AA, 1997, J NEUROCHEM, V69, P889; Filosa JA, 2004, CIRC RES, V95, pE73, DOI 10.1161/01.RES.0000148636.60732.2e; Gibson CL, 2005, GLIA, V50, P417, DOI 10.1002/glia.20143; GORDON EL, 1995, J NEUROSURG, V83, P875, DOI 10.3171/jns.1995.83.5.0875; Grossman M, 2003, NEUROPSYCHOLOGY, V17, P658, DOI 10.1037/0894-4105.17.4.658; Hademenos GJ, 1996, NEUROSURGERY, V38, P1005, DOI 10.1097/00006123-199605000-00030; HARDER DR, 1995, J VASC RES, V32, P79, DOI 10.1159/000159080; Hirase H, 2005, TRENDS NEUROSCI, V28, P217, DOI 10.1016/j.tins.2005.03.002; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Niwa K, 2002, AM J PHYSIOL-HEART C, V283, pH315, DOI 10.1152/ajpheart.00022.2002; Niwa K, 2001, CIRC RES, V88, P600, DOI 10.1161/01.RES.88.6.600; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Peng XQ, 2002, AM J PHYSIOL-HEART C, V283, pH2029, DOI 10.1152/ajpheart.01130.2000; Rombouts SARB, 2002, J NEUROL NEUROSUR PS, V73, P665, DOI 10.1136/jnnp.73.6.665; SAKABE T, 1979, ACTA PHYSIOL SCAND, V107, P283, DOI 10.1111/j.1748-1716.1979.tb06476.x; Simard M, 2003, J NEUROSCI, V23, P9254; Smith CD, 1999, NEUROLOGY, V53, P1391, DOI 10.1212/WNL.53.7.1391; STEPHENSON DT, 1994, BRAIN RES, V637, P97, DOI 10.1016/0006-8993(94)91221-1; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; UEKI M, 1992, ACTA ANAESTH SCAND, V36, P318, DOI 10.1111/j.1399-6576.1992.tb03474.x; Vavilala Monica S, 2002, Anesthesiol Clin North Am, V20, P247, DOI 10.1016/S0889-8537(01)00012-8; Wang MH, 1998, J PHARMACOL EXP THER, V284, P966; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Xu J, 2003, PROSTAG LEUKOTR ESS, V69, P437, DOI 10.1016/j.plefa.2003.08.016; Xu JF, 2003, FREE RADICAL BIO MED, V34, P1531, DOI 10.1016/S0891-5849(03)00152-7; Yang G, 1999, AM J PHYSIOL-REG I, V277, pR1760, DOI 10.1152/ajpregu.1999.277.6.R1760; Yermakova AV, 1999, J NEUROPATH EXP NEUR, V58, P1135, DOI 10.1097/00005072-199911000-00003; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	45	794	820	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					260	267		10.1038/nn1623	http://dx.doi.org/10.1038/nn1623			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16388306				2022-12-17	WOS:000234990100022
J	Hambardzumyan, D; Gutmann, DH; Kettenmann, H				Hambardzumyan, Dolores; Gutmann, David H.; Kettenmann, Helmut			The role of microglia and macrophages in glioma maintenance and progression	NATURE NEUROSCIENCE			English	Review							TUMOR-ASSOCIATED MACROPHAGES; CENTRAL-NERVOUS-SYSTEM; STEM-LIKE CELLS; MOUSE MODEL; PILOCYTIC ASTROCYTOMAS; GLIOBLASTOMA INVASION; HEMATOPOIETIC-CELLS; MT1-MMP EXPRESSION; GROWTH; RECEPTOR	There is a growing recognition that gliomas are complex tumors composed of neoplastic and non-neoplastic cells, which each individually contribute to cancer formation, progression and response to treatment. The majority of the non-neoplastic cells are tumor-associated macrophages (TAMs), either of peripheral origin or representing brain-intrinsic microglia, that create a supportive stroma for neoplastic cell expansion and invasion. TAMs are recruited to the glioma environment, have immune functions, and can release a wide array of growth factors and cytokines in response to those factors produced by cancer cells. In this manner, TAMs facilitate tumor proliferation, survival and migration. Through such iterative interactions, a unique tumor ecosystem is established, which offers new opportunities for therapeutic targeting.	[Hambardzumyan, Dolores] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA; [Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Kettenmann, Helmut] Max Delbruck Ctr Mol Med, Berlin, Germany	Cleveland Clinic Foundation; Washington University (WUSTL); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kettenmann, H (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	kettenmann@mdc-berlin.de	Kettenmann, Helmut/AAJ-5142-2021	Kettenmann, Helmut/0000-0001-8208-0291; Gutmann, David/0000-0002-3127-5045	Deutsche Forschungsgemeinschaft [TR 43, KE 329/30-1]; Neurocure; Department of Defense [W81XWH-13-1-0094]; James S. McDonnell Foundation; National Cancer Institute [U01-CA160882]; NATIONAL CANCER INSTITUTE [U01CA160882] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Neurocure; Department of Defense(United States Department of Defense); James S. McDonnell Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank D. Schumick for his great work with illustrations. This work was supported by the Deutsche Forschungsgemeinschaft (TR 43, KE 329/30-1; H.K.) and Neurocure (H.K.) as well as funding from the Department of Defense (W81XWH-13-1-0094, D.H.G.) and James S. McDonnell Foundation (D.H.G.) and a collaborative U01 grant from the National Cancer Institute (U01-CA160882; D.H., D.H.G. and H.K.).	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Badie B, 1999, NEUROSURGERY, V44, P1077, DOI 10.1097/00006123-199905000-00075; Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; Bajenaru ML, 2005, ANN NEUROL, V57, P119, DOI 10.1002/ana.20337; Bajenaru ML, 2003, CANCER RES, V63, P8573; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bettinger I, 2002, ACTA NEUROPATHOL, V103, P351, DOI 10.1007/s00401-001-0472-x; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; da Fonseca ACC, 2014, J NEUROIMMUNOL, V274, P71, DOI 10.1016/j.jneuroim.2014.06.021; Chen XB, 2014, CANCER RES, V74, P7285, DOI 10.1158/0008-5472.CAN-14-1240; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Daginakatte GC, 2007, HUM MOL GENET, V16, P1098, DOI 10.1093/hmg/ddm059; Daginakatte GC, 2008, CANCER RES, V68, P10358, DOI 10.1158/0008-5472.CAN-08-2506; Dorward IG, 2010, J NEUROSURG-PEDIATR, V6, P346, DOI 10.3171/2010.7.PEDS10129; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Feng X, 2015, ONCOTARGET, V6, P15077, DOI 10.18632/oncotarget.3730; Flugel A, 2001, J NEUROSCI RES, V66, P74, DOI 10.1002/jnr.1198; Frazier JL, 2003, J NEURO-ONCOL, V64, P203, DOI 10.1023/A:1025695423097; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gutmann DH, 2013, GENOME RES, V23, P431, DOI 10.1101/gr.142604.112; Hambardzumyan D, 2006, CANCER CELL, V10, P454, DOI 10.1016/j.ccr.2006.11.008; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Hortega P.D.R., 1919, B SOC ESP BIOL, V9, P69; Hu F, 2015, NEURO-ONCOLOGY, V17, P200, DOI 10.1093/neuonc/nou324; Hu F, 2014, INT J CANCER, V135, P2569, DOI 10.1002/ijc.28908; Kees T, 2012, NEURO-ONCOLOGY, V14, P64, DOI 10.1093/neuonc/nor182; Kennedy BC, 2013, J ONCOL, V2013, DOI 10.1155/2013/486912; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kim KY, 2010, NEUROSCIENCE, V170, P178, DOI 10.1016/j.neuroscience.2010.06.017; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Klein R, 2001, ACTA NEUROPATHOL, V101, P245; Komohara Y, 2008, J PATHOL, V216, P15, DOI 10.1002/path.2370; Ku MC, 2013, ACTA NEUROPATHOL, V125, P609, DOI 10.1007/s00401-013-1079-8; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li W, 2012, NEURO-ONCOLOGY, V14, P958, DOI 10.1093/neuonc/nos116; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; Lisi L, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-125; LISTERNICK R, 1989, J PEDIATR-US, V114, P778, DOI 10.1016/s0022-3476(89)80137-4; Liu C, 2008, J NEUROIMMUNOL, V198, P98, DOI 10.1016/j.jneuroim.2008.04.016; Lu-Emerson C, 2013, NEURO-ONCOLOGY, V15, P1079, DOI 10.1093/neuonc/not082; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Markovic DS, 2009, P NATL ACAD SCI USA, V106, P12530, DOI 10.1073/pnas.0804273106; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; MORANTZ RA, 1979, J NEUROSURG, V50, P305, DOI 10.3171/jns.1979.50.3.0305; Muller A, 2015, INT J CANCER, V137, P278, DOI 10.1002/ijc.29379; Okada M, 2009, INT J ONCOL, V34, P1621, DOI 10.3892/ijo_00000292; Paolicelli RC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00129; Parney IF, 2009, J NEUROSURG, V110, P572, DOI 10.3171/2008.7.JNS08475; Piao YJ, 2012, NEURO-ONCOLOGY, V14, P1379, DOI 10.1093/neuonc/nos158; Platten M, 2003, ANN NEUROL, V54, P388, DOI 10.1002/ana.10679; Poli A, 2013, ONCOTARGET, V4, P1527, DOI 10.18632/oncotarget.1291; Pong WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077571; Pong WW, 2013, ANN NEUROL, V73, P303, DOI 10.1002/ana.23813; Prada CE, 2013, ACTA NEUROPATHOL, V125, P159, DOI 10.1007/s00401-012-1056-7; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qin T, 2015, TOXICOL APPL PHARM, V286, P112, DOI 10.1016/j.taap.2015.03.021; Rodero M, 2008, J CLIN ONCOL, V26, P5957, DOI 10.1200/JCO.2008.17.2833; ROSSI ML, 1987, ACTA NEUROPATHOL, V74, P269, DOI 10.1007/BF00688191; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sielska M, 2013, J PATHOL, V230, P310, DOI 10.1002/path.4192; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Simmons GW, 2011, J NEUROPATH EXP NEUR, V70, P51, DOI 10.1097/NEN.0b013e3182032d37; Solga AC, 2015, NEOPLASIA, V17, P776, DOI 10.1016/j.neo.2015.10.002; Solga AC, 2015, GLIA, V63, P531, DOI 10.1002/glia.22754; Szulzewsky F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116644; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Vinnakota K, 2013, NEURO-ONCOLOGY, V15, P1457, DOI 10.1093/neuonc/not115; Wang S., 2013, SEL TOP SIGNAL PROCE, V1, P1, DOI DOI 10.1016/J.SUSC0M.2010.10.002.(AVAILABLE; Wang SC, 2012, LAB INVEST, V92, P151, DOI 10.1038/labinvest.2011.128; Warrington NM, 2007, CANCER RES, V67, P8588, DOI 10.1158/0008-5472.CAN-06-2220; Warrington NM, 2010, CANCER RES, V70, P5717, DOI 10.1158/0008-5472.CAN-09-3769; Wesolowska A, 2008, ONCOGENE, V27, P918, DOI 10.1038/sj.onc.1210683; Wick W, 2001, J NEURO-ONCOL, V53, P177, DOI 10.1023/A:1012209518843; Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082; Xu S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju162; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Yang I, 2011, J NEUROSURG, V115, P505, DOI 10.3171/2011.4.JNS101172; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Yi LA, 2011, J NEUROIMMUNOL, V232, P75, DOI 10.1016/j.jneuroim.2010.10.011; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zeiner PS, 2015, BRAIN PATHOL, V25, P491, DOI 10.1111/bpa.12194; Zhang J, 2012, CARCINOGENESIS, V33, P312, DOI 10.1093/carcin/bgr289; Zhang LY, 2009, GLIA, V57, P1458, DOI 10.1002/glia.20863; Zhou WC, 2015, NAT CELL BIOL, V17, P170, DOI 10.1038/ncb3090	96	789	800	19	234	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2016	19	1					20	27		10.1038/nn.4185	http://dx.doi.org/10.1038/nn.4185			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7BH	26713745	Green Accepted			2022-12-17	WOS:000367254400007
J	Floresco, SB; West, AR; Ash, B; Moore, H; Grace, AA				Floresco, SB; West, AR; Ash, B; Moore, H; Grace, AA			Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS NEURONS; EXTRACELLULAR DOPAMINE; IN-VIVO; RECEPTORS; ACTIVATION; EFFLUX; SIGNAL; HIPPOCAMPAL; TRANSPORTER; RESPONSES	The mesolimbic dopamine system is centrally involved in reward and goal-directed behavior, and it has been implicated in multiple psychiatric disorders. Understanding the mechanism by which dopamine participates in these activities requires comprehension of the dynamics of dopamine release. Here we report dissociable regulation of dopamine neuron discharge by two separate afferent systems in rats; inhibition of pallidal afferents selectively increased the population activity of dopamine neurons, whereas activation of pedunculopontine inputs increased burst firing. Only the increase in population activity increased ventral striatal dopamine efflux. After blockade of dopamine reuptake, however, enhanced bursting increased dopamine efflux three times more than did enhanced population activity. These results provide insight into multiple regulatory systems that modulate dopamine system function: burst firing induces massive synaptic dopamine release, which is rapidly removed by reuptake before escaping the synaptic cleft, whereas increased population activity modulates tonic extrasynaptic dopamine levels that are less influenced by reuptake.	Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Floresco, SB (corresponding author), Univ Pittsburgh, Dept Neurosci, 446 Crawford Hall, Pittsburgh, PA 15260 USA.	floresco@psych.ubc.ca; grace@bns.pitt.edu	Floresco, Stan B/F-8160-2012	Floresco, Stan B/0000-0002-5633-243X; Grace, Anthony/0000-0003-1864-5504	NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH011305] Funding Source: NIH RePORTER; NIMH NIH HHS [F32 MH011305] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CLEMENTS JR, 1990, NEUROSCI LETT, V120, P70, DOI 10.1016/0304-3940(90)90170-E; Datla KP, 2002, EUR J NEUROSCI, V16, P1987, DOI 10.1046/j.1460-9568.2002.02249.x; Floresco SB, 2001, J NEUROSCI, V21, P4915, DOI 10.1523/JNEUROSCI.21-13-04915.2001; Floresco SB, 2001, J NEUROSCI, V21, P2851, DOI 10.1523/JNEUROSCI.21-08-02851.2001; GARRIS PA, 1994, J NEUROSCI, V14, P6084; GONO FG, 1993, NEUROSCIENCE, V24, P19; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; GRACE AA, 1993, J NEURAL TRANSM-GEN, V91, P111, DOI 10.1007/BF01245228; Gronier B, 1998, BRIT J PHARMACOL, V124, P455, DOI 10.1038/sj.bjp.0701850; Howland JG, 2002, J NEUROSCI, V22, P1137, DOI 10.1523/JNEUROSCI.22-03-01137.2002; Karreman M, 1996, J NEUROCHEM, V67, P601; Kitai ST, 1999, CURR OPIN NEUROBIOL, V9, P690, DOI 10.1016/S0959-4388(99)00040-9; Kitamura M, 2001, NEUROSCIENCE, V104, P117, DOI 10.1016/S0306-4522(01)00053-7; LAURELLE M, 2000, BRAIN RES REV, V1, P371; MASLOWSKICOBUZZI RJ, 1994, NEUROSCIENCE, V62, P1103, DOI 10.1016/0306-4522(94)90347-6; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MEIERGERD SM, 1993, J NEUROCHEM, V61, P764; MILNER KL, 1988, BRAIN RES, V452, P273, DOI 10.1016/0006-8993(88)90031-5; Moore H, 1998, J NEUROSCI, V18, P5068; Nirenberg MJ, 1997, J NEUROSCI, V17, P6899; OAKMAN SA, 1995, J NEUROSCI, V15, P5859; ODONNELL P, 1994, BRAIN RES, V634, P105, DOI 10.1016/0006-8993(94)90263-1; PHILLIPS AG, 1993, CAN J PHYSIOL PHARM, V71, P387, DOI 10.1139/y93-059; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; Samson HH, 2001, ALCOHOL, V23, P41, DOI 10.1016/S0741-8329(00)00122-1; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sesack SR, 2002, HANDB EXP PHARM 1, P63; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shim SS, 1996, NEUROPSYCHOPHARMACOL, V15, P437; TSAI CT, 1985, BRAIN RES, V49, P422; West AR, 2000, J NEUROPHYSIOL, V83, P1796, DOI 10.1152/jn.2000.83.4.1796; West AR, 1997, NEUROPHARMACOLOGY, V36, P1571, DOI 10.1016/S0028-3908(97)00148-2; Wickens JR, 1996, NEUROSCIENCE, V70, P1, DOI 10.1016/0306-4522(95)00436-M; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; Wu M, 1996, BRAIN RES, V740, P151, DOI 10.1016/S0006-8993(96)00859-1; YANG CR, 1987, NEUROSCIENCE, V23, P1041, DOI 10.1016/0306-4522(87)90179-5; ZAHM DS, 1990, J COMP NEUROL, V302, P437, DOI 10.1002/cne.903020302	39	788	792	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					968	973		10.1038/nn1103	http://dx.doi.org/10.1038/nn1103			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	715KH	12897785				2022-12-17	WOS:000184970400016
J	Mildner, A; Schmidt, H; Nitsche, M; Merkler, D; Hanisch, UK; Mack, M; Heikenwalder, M; Bruck, W; Priller, J; Prinz, M				Mildner, Alexander; Schmidt, Hauke; Nitsche, Mirko; Merkler, Doron; Hanisch, Uwe-Karsten; Mack, Matthias; Heikenwalder, Mathias; Brueck, Wolfgang; Priller, Josef; Prinz, Marco			Microglia in the adult brain arise from Ly-6C(hi)CCR2(+) monocytes only under defined host conditions	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; GREEN FLUORESCENT PROTEIN; MARROW-DERIVED MICROGLIA; BETA-AMYLOID DEPOSITION; NF-KAPPA-B; BONE-MARROW; HEMATOPOIETIC-CELLS; STEM-CELLS; IN-VIVO; AUTOIMMUNE ENCEPHALOMYELITIS	Microglia are crucially important myeloid cells in the CNS and constitute the first immunological barrier against pathogens and environmental insults. The factors controlling microglia recruitment from the blood remain elusive and the direct circulating microglia precursor has not yet been identified in vivo. Using a panel of bone marrow chimeric and adoptive transfer experiments, we found that circulating Ly-6C(hi)CCR2(+) monocytes were preferentially recruited to the lesioned brain and differentiated into microglia. Notably, microglia engraftment in CNS pathologies, which are not associated with overt blood-brain barrier disruption, required previous conditioning of brain (for example, by direct tissue irradiation). Our results identify Ly-6C(hi)CCR2(+) monocytes as direct precursors of microglia in the adult brain and establish the importance of local factors in the adult CNS for microglia engraftment.	Univ Gottingen, Inst Neuropathol, D-3400 Gottingen, Germany; Univ Gottingen, Dept Radiat Oncol, D-3400 Gottingen, Germany; Univ Regensburg, Dept Internal Med, D-8400 Regensburg, Germany; Univ Zurich Spital, Inst Neuropathol, Zurich, Switzerland; Univ Gottingen, Inst Multiple Sclerosis Res, D-3400 Gottingen, Germany; Charite Univ Med Berlin, Mol Psychiat Lab, Berlin, Germany	University of Gottingen; University of Gottingen; University of Regensburg; University of Zurich; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Prinz, M (corresponding author), Univ Gottingen, Inst Neuropathol, D-3400 Gottingen, Germany.	mprinz@med.uni-goettingen.de	Merkler, Doron/N-9157-2016; Heikenwalder, Mathias/AAA-2269-2020; Mildner, Alexander/ABG-6122-2020; Nitsche, Mirko/K-8851-2019; mildner, alexander/AFK-2161-2022; Priller, Josef/ABW-3835-2022; mildner, alexander/GQA-3761-2022; mildner, alexander/AAF-9451-2022	Merkler, Doron/0000-0002-0247-2007; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Priller, Josef/0000-0001-7596-0979				Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; BAKKER DA, 1987, J NEUROL SCI, V78, P125, DOI 10.1016/0022-510X(87)90055-4; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Biffi A, 2004, J CLIN INVEST, V113, P1118, DOI 10.1172/JCI200419205; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Furuya T, 2003, NEUROREPORT, V14, P629, DOI 10.1097/00001756-200303240-00021; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kokovay E, 2005, NEUROBIOL DIS, V19, P471, DOI 10.1016/j.nbd.2005.01.023; KONDO A, 1987, BRAIN RES, V425, P186, DOI 10.1016/0006-8993(87)90499-9; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; McMahon EJ, 2002, J NEUROIMMUNOL, V130, P32, DOI 10.1016/S0165-5728(02)00205-9; Merkler D, 2005, NMR BIOMED, V18, P395, DOI 10.1002/nbm.972; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Prinz M, 1999, J NEUROCHEM, V72, P2215, DOI 10.1046/j.1471-4159.1999.0722215.x; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Remington LT, 2007, AM J PATHOL, V170, P1713, DOI 10.2353/ajpath.2007.060783; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Vallieres L, 2003, J NEUROSCI, V23, P5197; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Wegiel J, 1998, BRAIN RES, V804, P135, DOI 10.1016/S0006-8993(98)00618-0; Wehner T, 2003, J NEUROSCI, V23, P5004; WILLIAMS AE, 1994, NEUROPATH APPL NEURO, V20, P47, DOI 10.1111/j.1365-2990.1994.tb00956.x; WSIRSKI FK, 2007, J CLIN INVEST, V117, P195; Yamamoto M, 2005, AM J PATHOL, V166, P1475, DOI 10.1016/S0002-9440(10)62364-4	50	787	804	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1544	1553		10.1038/nn2015	http://dx.doi.org/10.1038/nn2015			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	18026096				2022-12-17	WOS:000251172900011
J	Anderson, AK; Christoff, K; Stappen, I; Panitz, D; Ghahremani, DG; Glover, G; Gabrieli, JDE; Sobel, N				Anderson, AK; Christoff, K; Stappen, I; Panitz, D; Ghahremani, DG; Glover, G; Gabrieli, JDE; Sobel, N			Dissociated neural representations of intensity and valence in human olfaction	NATURE NEUROSCIENCE			English	Article							EVENT-RELATED POTENTIALS; HUMAN AMYGDALA; ORBITOFRONTAL CORTEX; EMOTIONAL AROUSAL; PREFRONTAL CORTEX; ODOR PLEASANTNESS; MOOD DISORDERS; TEMPORAL-LOBE; ACTIVATION; STIMULI	Affective experience has been described in terms of two primary dimensions: intensity and valence. In the human brain, it is intrinsically difficult to dissociate the neural coding of these affective dimensions for visual and auditory stimuli, but such dissociation is more readily achieved in olfaction, where intensity and valence can be manipulated independently. Using event-related functional magnetic resonance imaging (fMRI), we found amygdala activation to be associated with intensity, and not valence, of odors. Activity in regions of orbitofrontal cortex, in contrast, were associated with valence independent of intensity. These findings show that distinct olfactory regions subserve the analysis of the degree and quality of olfactory stimulation, suggesting that the affective representations of intensity and valence draw upon dissociable neural substrates.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Univ Vienna, Inst Pharmaceut Chem, A-1090 Vienna, Austria; Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Stanford University; University of Vienna; Stanford University; University of California System; University of California Berkeley	Anderson, AK (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, 349 Mulford Hall, Berkeley, CA 94720 USA.	adam.k.anderson@stanford.edu; nsobel@socrates.berkeley.edu	Gabrieli, John/AAJ-2869-2020	Sobel, Noam/0000-0002-3232-9391				Adolphs R, 1999, PSYCHOL SCI, V10, P167, DOI 10.1111/1467-9280.00126; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Anderson AK, 2002, J COGNITIVE NEUROSCI, V14, P709, DOI 10.1162/08989290260138618; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bensafi M, 2002, CHEM SENSES, V27, P703, DOI 10.1093/chemse/27.8.703; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; CAIN WS, 1978, PERCEPTION, V7, P459, DOI 10.1068/p070459; Canli T, 1998, NEUROREPORT, V9, P3233, DOI 10.1097/00001756-199810050-00019; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033; DOTY RL, 1975, PERCEPT PSYCHOPHYS, V17, P492, DOI 10.3758/BF03203300; Dravnieks A., 1985, ATLAS ODOR CHARACTER; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; Gallagher M, 2000, AMYGDALA FUNCTIONAL, P311; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; HENION KE, 1971, J EXP PSYCHOL, V90, P275, DOI 10.1037/h0031549; Irwin W, 1996, NEUROREPORT, V7, P1765, DOI 10.1097/00001756-199607290-00014; JonesGotman M, 1997, BRAIN, V120, P1845, DOI 10.1093/brain/120.10.1845; LaBar KS, 1998, PSYCHOL SCI, V9, P490, DOI 10.1111/1467-9280.00090; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lazarus R. S., 1991, EMOTION ADAPTATION; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; MOSKOWITZ HR, 1976, PERCEPT PSYCHOPHYS, V19, P122, DOI 10.3758/BF03204218; O'Doherty J, 2000, NEUROREPORT, V11, P893, DOI 10.1097/00001756-200003200-00046; Pause BM, 1997, CHEM SENSES, V22, P9, DOI 10.1093/chemse/22.1.9; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; Price JL, 1990, HUMAN NERVOUS SYSTEM, P979; ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81; Rolls ET, 2001, CHEM SENSES, V26, P595, DOI 10.1093/chemse/26.5.595; Royet JP, 2000, J NEUROSCI, V20, P7752; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; SAKAMOTO N, 1999, HDB CHEM NEUROANATOM, V15, P15; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; Wilson DA, 1997, J NEUROPHYSIOL, V78, P160, DOI 10.1152/jn.1997.78.1.160; Zald DH, 1998, J CEREBR BLOOD F MET, V18, P896, DOI 10.1097/00004647-199808000-00010; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zatorre RJ, 2000, NEUROREPORT, V11, P2711, DOI 10.1097/00001756-200008210-00021; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	48	786	796	3	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					196	202		10.1038/nn1001	http://dx.doi.org/10.1038/nn1001			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536208				2022-12-17	WOS:000180669100021
J	Madisen, L; Mao, TY; Koch, H; Zhuo, JM; Berenyi, A; Fujisawa, S; Hsu, YWA; Garcia, AJ; Gu, X; Zanella, S; Kidney, J; Gu, H; Mao, YM; Hooks, BM; Boyden, ES; Buzsaki, G; Ramirez, JM; Jones, AR; Svoboda, K; Han, X; Turner, EE; Zeng, HK				Madisen, Linda; Mao, Tianyi; Koch, Henner; Zhuo, Jia-min; Berenyi, Antal; Fujisawa, Shigeyoshi; Hsu, Yun-Wei A.; Garcia, Alfredo J., III; Gu, Xuan; Zanella, Sebastien; Kidney, Jolene; Gu, Hong; Mao, Yimei; Hooks, Bryan M.; Boyden, Edward S.; Buzsaki, Gyoergy; Ramirez, Jan Marino; Jones, Allan R.; Svoboda, Karel; Han, Xue; Turner, Eric E.; Zeng, Hongkui			A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing	NATURE NEUROSCIENCE			English	Article							NEURAL CIRCUITRY; IN-VIVO; MILLISECOND-TIMESCALE; GABAERGIC NEURONS; PYRAMIDAL CELLS; CEREBRAL-CORTEX; OPTICAL CONTROL; CHANNELRHODOPSIN-2; BRAIN; ORGANIZATION	Cell type specific expression of optogenetic molecules allows temporally precise manipulation of targeted neuronal activity. Here we present a toolbox of four knock-in mouse lines engineered for strong, Cre-dependent expression of channelrhodopsins ChR2-tdTomato and ChR2-EYFP, halorhodopsin eNpHR3.0 and archaerhodopsin Arch-ER2. All four transgenes mediated Cre-dependent, robust activation or silencing of cortical pyramidal neurons in vitro and in vivo upon light stimulation, with ChR2-EYFP and Arch-ER2 demonstrating light sensitivity approaching that of in utero or virally transduced neurons. We further show specific photoactivation of parvalbumin-positive interneurons in behaving ChR2-EYFP reporter mice. The robust, consistent and inducible nature of our ChR2 mice represents a significant advance over previous lines, and the Arch-ER2 and eNpHR3.0 mice are to our knowledge the first demonstration of successful conditional transgenic optogenetic silencing. When combined with the hundreds of available Cre driver lines, this optimized toolbox of reporter mice will enable widespread investigations of neural circuit function with unprecedented reliability and accuracy.	[Madisen, Linda; Kidney, Jolene; Gu, Hong; Jones, Allan R.; Zeng, Hongkui] Allen Inst Brain Sci, Seattle, WA USA; [Mao, Tianyi; Hooks, Bryan M.; Svoboda, Karel] Howard Hughes Med Inst, Ashburn, VA USA; [Koch, Henner; Hsu, Yun-Wei A.; Garcia, Alfredo J., III; Zanella, Sebastien; Ramirez, Jan Marino; Turner, Eric E.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA; [Zhuo, Jia-min; Gu, Xuan; Mao, Yimei; Han, Xue] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Berenyi, Antal; Fujisawa, Shigeyoshi; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA	Allen Institute for Brain Science; Howard Hughes Medical Institute; Seattle Children's Hospital; Boston University; Rutgers State University Newark; Rutgers State University New Brunswick; Massachusetts Institute of Technology (MIT)	Zeng, HK (corresponding author), Allen Inst Brain Sci, Seattle, WA USA.	hongkuiz@alleninstitute.org	Chee, Melissa/G-4150-2014; Turner, Eric e/K-3556-2015; Berényi, Antal/A-9174-2013; Zhuo, Jia-Min/M-7546-2014; Fujisawa, Shigeyoshi/N-6439-2015	Chee, Melissa/0000-0003-3815-9095; Turner, Eric e/0000-0001-5499-6788; Berényi, Antal/0000-0003-0084-8530; Zhuo, Jia-Min/0000-0001-9199-5485; Fujisawa, Shigeyoshi/0000-0003-3963-4281; Buzsaki, Gyorgy/0000-0002-3100-4800; Mao, Tianyi/0000-0002-3532-8319; Hsu, Yun-Wei/0000-0001-7851-2733; Ramirez, Jan-Marino/0000-0002-5626-3999	Allen Institute for Brain Science; Howard Hughes Medical Institute; US National Institutes of Health (NIH) [DA028298, MH085944, NS034994, MH54671]; Alfred P. Sloan Foundation; US National Science Foundation; Marie Curie Fellowship; EU [2009 IOF 254780]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671, R01MH093667, K99MH085944, R00MH085944, R21MH090478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028298] Funding Source: NIH RePORTER	Allen Institute for Brain Science; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); US National Science Foundation(National Science Foundation (NSF)); Marie Curie Fellowship(European Commission); EU(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful for the technical support of the Atlas Production Team, led by P. Wohnoutka, and the Technology Team, led by C. Dang, at the Allen Institute. We thank A. Nagy (Mount Sinai Hospital in Toronto) for providing the G4 ES cell line and K. Deisseroth (Stanford University) for providing the eNpHR3.0 construct. The authors wish to thank the Allen Institute founders, PG. Allen and J. Allen, for their vision, encouragement and support. This work was funded by the Allen Institute for Brain Science and the Howard Hughes Medical Institute, US National Institutes of Health (NIH) grant DA028298 to H.Z., NIH grants MH90478 and MH093667 to E.E.T., NIH grant MH085944 and an Alfred P. Sloan Foundation grant to X.H., NIH grants NS034994 and MH54671 and a US National Science Foundation grant to GB., and a Marie Curie Fellowship (EU FP7 PEOPLE 2009 IOF 254780) to A.B.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Chuhma N, 2011, J NEUROSCI, V31, P1183, DOI 10.1523/JNEUROSCI.3833-10.2011; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Hegemann P, 2011, NAT METHODS, V8, P39, DOI 10.1038/NMETH.F.327; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lewis TL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001021; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Liu XB, 2011, J COMP NEUROL, V519, P1181, DOI 10.1002/cne.22567; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Peron S, 2011, NAT METHODS, V8, P30, DOI [10.1038/nmeth.f.325, 10.1038/NMETH.F.325]; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Ren J, 2011, NEURON, V69, P445, DOI 10.1016/j.neuron.2010.12.038; Royer S, 2010, EUR J NEUROSCI, V31, P2279, DOI 10.1111/j.1460-9568.2010.07250.x; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tanahira C, 2009, NEUROSCI RES, V63, P213, DOI 10.1016/j.neures.2008.12.007; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tsunematsu T, 2011, J NEUROSCI, V31, P10529, DOI 10.1523/JNEUROSCI.0784-11.2011; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	43	785	794	5	158	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					793	802		10.1038/nn.3078	http://dx.doi.org/10.1038/nn.3078			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22446880	Green Submitted, Green Accepted			2022-12-17	WOS:000303270200025
J	Iadecola, C; Nedergaard, M				Iadecola, Costantino; Nedergaard, Maiken			Glial regulation of the cerebral microvasculature	NATURE NEUROSCIENCE			English	Review							NITRIC-OXIDE SYNTHASE; BLOOD-FLOW; NEURONAL-ACTIVITY; IN-VIVO; ASTROCYTE ENDFEET; SOMATOSENSORY STIMULATION; BRAIN MICROCIRCULATION; FUNCTIONAL HYPEREMIA; OXIDATIVE-METABOLISM; ALZHEIMERS-DISEASE	The brain is a heterogeneous organ with regionally varied and constantly changing energetic needs. Blood vessels in the brain are equipped with control mechanisms that match oxygen and glucose delivery through blood flow with the local metabolic demands that are imposed by neural activity. However, the cellular bases of this mechanism have remained elusive. A major advance has been the demonstration that astrocytes, cells with extensive contacts with both synapses and cerebral blood vessels, participate in the increases in flow evoked by synaptic activity. Their organization in nonoverlapping spatial domains indicates that they are uniquely positioned to shape the spatial distribution of the vascular responses that are evoked by neural activity. Astrocytic calcium is an important determinant of microvascular function and may regulate flow independently of synaptic activity. The involvement of astrocytes in neurovascular coupling has broad implications for the interpretation of functional imaging signals and for the understanding of brain diseases that are associated with neurovascular dysfunction.	Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY 10021 USA; Univ Rochester, Sch Med & Dent, Ctr Aging & Dev Biol, Dept Neurosurg, Rochester, NY 14642 USA	Cornell University; University of Rochester	Iadecola, C (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, 411 E 69th St, New York, NY 10021 USA.	coi2001@med.cornell.edu; nedergaard@urmc.rochester.edu	Iadecola, c/ABB-8377-2020	Iadecola, Costantino/0000-0001-9797-073X	NHLBI NIH HHS [HL18974] Funding Source: Medline; NINDS NIH HHS [NS37853, NS50315, NS56188] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS050315, R01NS037853, R01NS056188] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ances BM, 2004, J CEREBR BLOOD F MET, V24, P1, DOI 10.1097/01.WCB.0000103920.96801.12; Ances BM, 2001, NEUROSCI LETT, V306, P106, DOI 10.1016/S0304-3940(01)01868-7; ARMSTEAD WM, 1989, CIRC RES, V64, P136, DOI 10.1161/01.RES.64.1.136; ASTRUP J, 1978, CIBA F S, V56, P313; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Barres BA, 2001, SCIENCE, V294, P1296, DOI 10.1126/science.1066724; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chaban VV, 2004, ENDOCRINOLOGY, V145, P3788, DOI 10.1210/en.2004-0149; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; Cipolla MJ, 2007, HYPERTENSION, V50, P14, DOI 10.1161/HYPERTENSIONAHA.106.079442; Cohen Z, 1996, PROG NEUROBIOL, V50, P335, DOI 10.1016/S0301-0082(96)00033-0; Cotrina ML, 1998, P NATL ACAD SCI USA, V95, P15735, DOI 10.1073/pnas.95.26.15735; COX SB, 1993, J CEREBR BLOOD F MET, V13, P899, DOI 10.1038/jcbfm.1993.113; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; del Valle-Rodriguez A, 2006, P NATL ACAD SCI USA, V103, P4316, DOI 10.1073/pnas.0508781103; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Dreher JC, 2007, P NATL ACAD SCI USA, V104, P2465, DOI 10.1073/pnas.0605569104; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Fleming I, 2006, HYPERTENSION, V47, P629, DOI 10.1161/01.HYP.0000208597.87957.89; Frahm J, 1996, MAGNET RESON MED, V35, P143, DOI 10.1002/mrm.1910350202; GARCIAROLDAN JL, 1990, CIRC RES, V66, P1445, DOI 10.1161/01.RES.66.5.1445; GOLGI C, 1886, SULLA FINA ANATOMIA; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Hamel E, 2006, J APPL PHYSIOL, V100, P1059, DOI 10.1152/japplphysiol.00954.2005; HARDER DR, 1988, PFLUG ARCH EUR J PHY, V411, P698, DOI 10.1007/BF00580870; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hill MA, 2007, TRENDS PHARMACOL SCI, V28, P308, DOI 10.1016/j.tips.2007.05.006; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; IADECOLA C, 1993, TRENDS NEUROSCI, V16, P206, DOI 10.1016/0166-2236(93)90156-G; IADECOLA C, 2002, CEREBRAL BLOOD FLOW, P295; Iadecola C, 2007, NEURON, V54, P3, DOI 10.1016/j.neuron.2007.03.013; JONES EG, 1970, J ANAT, V106, P507; Kacem K, 1998, GLIA, V23, P1; KLEIN B, 1986, AM J PHYSIOL, V251, pH1333, DOI 10.1152/ajpheart.1986.251.6.H1333; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Koehler RC, 2006, J APPL PHYSIOL, V100, P307, DOI 10.1152/japplphysiol.00938.2005; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; Lebon V, 2002, J NEUROSCI, V22, P1523, DOI 10.1523/JNEUROSCI.22-05-01523.2002; Leffler CW, 2006, AM J PHYSIOL-HEART C, V291, pH2897, DOI 10.1152/ajpheart.00722.2006; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; LOVATT D, 2007, IN PRESS J NEUROSCI; Marrelli SP, 2001, AM J PHYSIOL-HEART C, V281, pH1759, DOI 10.1152/ajpheart.2001.281.4.H1759; Martin C, 2006, NEUROIMAGE, V32, P33, DOI 10.1016/j.neuroimage.2006.02.021; MathieuCostello O, 1996, J APPL PHYSIOL, V80, P904, DOI 10.1152/jappl.1996.80.3.904; Metea MR, 2007, J NEUROSCI, V27, P2468, DOI 10.1523/JNEUROSCI.3204-06.2007; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Mintun MA, 2001, P NATL ACAD SCI USA, V98, P6859, DOI 10.1073/pnas.111164398; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; NGAI AC, 1988, AM J PHYSIOL, V254, P133; Niwa K, 2001, CIRC RES, V88, P600, DOI 10.1161/01.RES.88.6.600; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; Oz G, 2004, J NEUROSCI, V24, P11273, DOI 10.1523/JNEUROSCI.3564-04.2004; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; PAULSON OB, 1987, SCIENCE, V237, P896, DOI 10.1126/science.3616619; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Peters A., 1991, FINE STRUCTURE NERVO, P494; Phillis John W., 2004, Critical Reviews in Neurobiology, V16, P237, DOI 10.1615/CritRevNeurobiol.v16.i4.20; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rancillac A, 2006, J NEUROSCI, V26, P6997, DOI 10.1523/JNEUROSCI.5515-05.2006; REIS DJ, 1991, ADV NEUROSC, V1, P523; ROGGENDORF W, 1976, P23; RUBIO R, 1975, AM J PHYSIOL, V228, P1896, DOI 10.1152/ajplegacy.1975.228.6.1896; SAGHER O, 1993, J CEREBR BLOOD F MET, V13, P676, DOI 10.1038/jcbfm.1993.86; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; Simard M, 2003, J NEUROSCI, V23, P9254; Sloan Tod B, 2002, Anesthesiol Clin North Am, V20, P265, DOI 10.1016/S0889-8537(01)00002-5; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takano T, 2007, ANN NY ACAD SCI, V1097, P40, DOI 10.1196/annals.1379.004; TAMAKI K, 1986, AM J PHYSIOL, V251, pH1176, DOI 10.1152/ajpheart.1986.251.6.H1176; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; UEKI M, 1992, ACTA ANAESTH SCAND, V36, P318, DOI 10.1111/j.1399-6576.1992.tb03474.x; VAUCHER E, 1995, J NEUROSCI, V15, P7427; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang H, 2005, CEREB CORTEX, V15, P1250, DOI 10.1093/cercor/bhi008; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; WILLIAMS LR, 1989, CLIN PHYS PHYSIOL M, V10, P187, DOI 10.1088/0143-0815/10/3/001; Winship IR, 2007, J NEUROSCI, V27, P6268, DOI 10.1523/JNEUROSCI.4801-06.2007; Xu HL, 2007, EXP PHYSIOL, V92, P647, DOI 10.1113/expphysiol.2006.036863; Yang G, 2003, AM J PHYSIOL-HEART C, V285, pH298, DOI 10.1152/ajpheart.00043.2003; Yang G, 2000, J NEUROSCI, V20, P6968, DOI 10.1523/JNEUROSCI.20-18-06968.2000; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	96	782	810	1	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1369	1376		10.1038/nn2003	http://dx.doi.org/10.1038/nn2003			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17965657				2022-12-17	WOS:000250508400011
J	Panov, AV; Gutekunst, CA; Leavitt, BR; Hayden, MR; Burke, JR; Strittmatter, WJ; Greenamyre, JT				Panov, AV; Gutekunst, CA; Leavitt, BR; Hayden, MR; Burke, JR; Strittmatter, WJ; Greenamyre, JT			Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines	NATURE NEUROSCIENCE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; MUTANT HUNTINGTIN; WILD-TYPE; CELLULAR TOXICITY; MOUSE MODEL; IN-VIVO; BRAIN; PROTEIN; TRANSCRIPTION; NEURODEGENERATION	Huntington's disease (HD) is caused by an expansion of exonic CAG triplet repeats in the gene encoding huntingtin protein (Htt), but the mechanisms by which this mutant protein causes neurodegeneration remain unknown. Here we show that lymphoblast mitochondria from patients with HD have a lower membrane potential and depolarize at lower calcium loads than do mitochondria from controls. We found a similar defect in brain mitochondria from transgenic mice expressing full-length mutant huntingtin, and this defect preceded the onset of pathological or behavioral abnormalities by months. By electron microscopy, we identified N-terminal mutant huntingtin on neuronal mitochondrial membranes, and by incubating normal mitochondria with a fusion protein containing an abnormally long polyglutamine repeat, we reproduced the mitochondrial calcium defect seen in human patients and transgenic animals. Thus, mitochondrial calcium abnormalities occur early in HD pathogenesis and may be a direct effect of mutant huntingtin on the organelle.	Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5C 4H4, Canada; Duke Univ, Med Ctr, Div Neurol, Durham, NC 27616 USA	Emory University; University of British Columbia; Duke University	Greenamyre, JT (corresponding author), Emory Univ, Sch Med, Dept Neurol, Whitehead Biomed Res Bldg,615 Michael St, Atlanta, GA 30322 USA.		Hayden, Michael R/D-8581-2011; Greenamyre, J. Timothy/B-4049-2011; Burke, James R/E-4245-2016; Leavitt, Blair R/G-1934-2012	Hayden, Michael R/0000-0001-5159-1419; Burke, James R/0000-0002-3408-7787; Greenamyre, J. Timothy/0000-0003-3468-7878	NATIONAL INSTITUTE ON AGING [R01AG014648] Funding Source: NIH RePORTER; NIA NIH HHS [AG14648] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Cattaneo E, 2001, TRENDS NEUROSCI, V24, P182, DOI 10.1016/S0166-2236(00)01721-5; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Greene JG, 1996, PROG NEUROBIOL, V48, P613, DOI 10.1016/0301-0082(96)00006-8; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Monoi H, 2000, BIOPHYS J, V78, P2892, DOI 10.1016/S0006-3495(00)76830-5; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	34	780	805	2	50	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					731	736		10.1038/nn884	http://dx.doi.org/10.1038/nn884			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12089530				2022-12-17	WOS:000177088900015
J	Ehlers, MD				Ehlers, MD			Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system	NATURE NEUROSCIENCE			English	Article							LONG-TERM FACILITATION; NMDA RECEPTORS; GLUTAMATE RECEPTORS; PROTEIN-SYNTHESIS; AMPA RECEPTORS; DENSITY; SYNAPSES; CREB; MODULATION; ACTIVATION	Experience-dependent remodeling of the postsynaptic density (PSD) is critical for synapse formation and plasticity in the mammalian brain. Here, in cultured rat hippocampal neurons, I found long-lasting, global changes in the molecular composition of the PSD dictated by synaptic activity. These changes were bidirectional, reversible, modular, and involved multiple classes of PSD proteins. Moreover, activity-dependent remodeling was accompanied by altered protein turnover, occurred with corresponding increases or decreases in ubiquitin conjugation of synaptic proteins and required proteasome-mediated degradation. These modifications, in turn, reciprocally altered synaptic signaling to the downstream effectors CREB (cyclic AMP response element binding protein) and ERK-MAPK (extracellular signal regulated kinase-MAP kinase). These results indicate that activity regulates postsynaptic composition and signaling through the ubiquitin-proteasome system, providing a mechanistic link between synaptic activity, protein turnover and the functional reorganization of synapses.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehlers@neuro.duke.edu			NIMH NIH HHS [MH64748] Funding Source: Medline; NINDS NIH HHS [NS39402] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; CHAPMAN AP, 1994, NEUROSCI LETT, V168, P238, DOI 10.1016/0304-3940(94)90459-6; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mammen AL, 1997, J NEUROSCI, V17, P7351; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Meyer T, 2000, TRENDS CELL BIOL, V10, P238, DOI 10.1016/S0962-8924(00)01764-5; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tovar KR, 2002, NEURON, V34, P253; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WILSON SM, 2002, NAT GENET, V7, P7; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	50	775	800	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					231	242		10.1038/nn1013	http://dx.doi.org/10.1038/nn1013			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12577062				2022-12-17	WOS:000181178300011
J	Hollerman, JR; Schultz, W				Hollerman, JR; Schultz, W			Dopamine neurons report an error in the temporal prediction of reward during learning	NATURE NEUROSCIENCE			English	Article							LOCUS-COERULEUS NEURONS; DELAYED-RESPONSE TASK; VENTRAL STRIATUM; UNIT-ACTIVITY; MONKEY; STIMULI; EXPECTATION; REINFORCEMENT; MOTIVATION; PLASTICITY	Many behaviors are affected by rewards, undergoing long-term changes when rewards are different than predicted but remaining unchanged when rewards occur exactly as predicted. The discrepancy between reward occurrence and reward prediction is termed an 'error in reward prediction'. Dopamine neurons in the substantia nigra and the ventral tegmental area are believed to be involved in reward-dependent behaviors. Consistent with this role, they are activated by rewards, and because they are activated more strongly by unpredicted than by predicted rewards they may play a role in learning. The present study investigated whether monkey dopamine neurons code an error in reward prediction during the course of learning. Dopamine neuron responses reflected the changes in reward prediction during individual learning episodes; dopamine neurons were activated by rewards during early trials, when errors were frequent and rewards unpredictable, but activation was progressively reduced as performance was consolidated and rewards became more predictable. These neurons were also activated when rewards occurred at unpredicted times and were depressed when rewards were omitted at the predicted times. Thus, dopamine neurons code errors in the prediction of both the occurrence and the time of rewards. In this respect, their responses resemble the teaching signals that have been employed in particularly efficient computational learning models.	Univ Fribourg, Inst Physiol, CH-1700 Fribourg, Switzerland	University of Fribourg	Schultz, W (corresponding author), Allegheny Coll, Dept Psychol, Meadville, PA 16335 USA.	Wolfram.Schultz@unifr.ch						AOSAKI T, 1994, J NEUROSCI, V14, P3969; Apicella P, 1997, EXP BRAIN RES, V116, P456, DOI 10.1007/PL00005773; APICELLA P, 1991, EXP BRAIN RES, V85, P491; ASTONJONES G, 1981, J NEUROSCI, V1, P887; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; BARTO AG, 1983, IEEE T SYST MAN CYB, V13, P834, DOI 10.1109/TSMC.1983.6313077; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1997, J NEUROSCI, V17, P4536; DICKINSON A, 1976, J EXP PSYCHOL ANIM B, V2, P313, DOI 10.1037/0097-7403.2.4.313; Dickinson A., 1980, CONT ANIMAL LEARNING; GRAFFAN EA, 1988, J NEUROSCI, V8, P3144; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Horvitz JC, 1997, BRAIN RES, V759, P251, DOI 10.1016/S0006-8993(97)00265-5; Houk JC, 1995, MODELS INFORM PROCES, P249; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; MATSUMURA M, 1992, J NEUROPHYSIOL, V67, P1615, DOI 10.1152/jn.1992.67.6.1615; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; MONTAGUE PR, 1995, NATURE, V377, P725, DOI 10.1038/377725a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; NISHIJO H, 1988, J NEUROSCI, V8, P3556; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; RICHARDSON RT, 1986, BRAIN RES, V399, P364, DOI 10.1016/0006-8993(86)91529-5; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; SARA SJ, 1991, PROG BRAIN RES, V88, P571; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SMITH MC, 1968, J COMP PHYSIOL PSYCH, V66, P679, DOI 10.1037/h0026550; STEINFELS GF, 1983, BRAIN RES, V258, P217, DOI 10.1016/0006-8993(83)91145-9; SURI RE, IN PRESS EXP BRAIN R; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; TESAURO G, 1994, NEURAL COMPUT, V6, P215, DOI 10.1162/neco.1994.6.2.215; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; WATANABE M, 1989, NEUROSCI LETT, V101, P113, DOI 10.1016/0304-3940(89)90450-3; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Wickens JR, 1996, NEUROSCIENCE, V70, P1, DOI 10.1016/0306-4522(95)00436-M; WILLIAMS GV, 1993, BEHAV BRAIN RES, V55, P243, DOI 10.1016/0166-4328(93)90120-F; WILSON FAW, 1990, BRAIN RES, V509, P213, DOI 10.1016/0006-8993(90)90546-N; WISE RA, 1982, BEHAV BRAIN SCI, V5, P39, DOI 10.1017/S0140525X00010372; [No title captured]	47	775	779	2	116	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					304	309		10.1038/1124	http://dx.doi.org/10.1038/1124			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	127QD	10195164				2022-12-17	WOS:000076361300014
J	Egner, T; Hirsch, J				Egner, T; Hirsch, J			Cognitive control mechanisms resolve conflict through cortical amplification of task-relevant information	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; HUMAN VISUAL-CORTEX; SELECTIVE ATTENTION; NEURAL MECHANISMS; SIMON TASK; AREAS; FMRI; INTEGRATION; PERCEPTION; MODULATION	A prominent model of how the brain regulates attention proposes that the anterior cingulate cortex monitors the occurrence of conflict between incompatible response tendencies and signals this information to a cognitive control system in dorsolateral prefrontal cortex. Cognitive control is thought to resolve conflict through the attentional biasing of perceptual processing, emphasizing task-relevant stimulus information. It is not known, however, whether conflict resolution is mediated by amplifying neural representations of task-relevant information, inhibiting representations of task-irrelevant information, or both. Here we manipulated trial-by-trial levels of conflict and control during a Stroop task using face stimuli, while recording hemodynamic responses from human visual cortex specialized for face processing. We show that, in response to high conflict, cognitive control mechanisms enhance performance by transiently amplifying cortical responses to task-relevant information rather than by inhibiting responses to task-irrelevant information. These results implicate attentional target-feature amplification as the primary mechanism for conflict resolution through cognitive control.	Columbia Univ, Neurol Inst, Funct MRI Res Ctr, New York, NY 10032 USA	Columbia University	Egner, T (corresponding author), Columbia Univ, Neurol Inst, Funct MRI Res Ctr, Box 108,710 W 168th St, New York, NY 10032 USA.	te2111@columbia.edu	Egner, Tobias/AAD-5864-2022; Egner, Tobias/A-5237-2009	Egner, Tobias/0000-0001-7956-3241; Egner, Tobias/0000-0001-7956-3241; Hirsch, Joy/0000-0002-1418-6489				Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Cho IH, 2002, WA SCI TECHNOL, V2, P299, DOI 10.2166/ws.2002.0035; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Egner T, 2005, J COGNITIVE NEUROSCI, V17, P1774, DOI 10.1162/089892905774589226; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ., 2004, HUMAN BRAIN FUNCTION, P971, DOI DOI 10.1016/B978-012264841-0/50050-0; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Jones AD, 2002, COGN AFFECT BEHAV NE, V2, P300, DOI 10.3758/CABN.2.4.300; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; NIEUWENHUIS S, IN PRESS MEM COGNIT; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Serences JT, 2004, CEREB CORTEX, V14, P1346, DOI 10.1093/cercor/bhh095; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; SUMMERFIELD C, 2005, CEREB CORTEX    0713; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Wylie GR, 2004, HUM BRAIN MAPP, V21, P279, DOI 10.1002/hbm.20003	44	773	784	2	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2005	8	12					1784	1790		10.1038/nn1594	http://dx.doi.org/10.1038/nn1594			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	988FC	16286928				2022-12-17	WOS:000233576200029
J	Chapman, PF; White, GL; Jones, MW; Cooper-Blacketer, D; Marshall, VJ; Irizarry, M; Younkin, L; Good, MA; Bliss, TVP; Hyman, BT; Younkin, SG; Hsiao, KK				Chapman, PF; White, GL; Jones, MW; Cooper-Blacketer, D; Marshall, VJ; Irizarry, M; Younkin, L; Good, MA; Bliss, TVP; Hyman, BT; Younkin, SG; Hsiao, KK			Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; FAMILIAL ALZHEIMERS-DISEASE; PATHOGENIC MUTATION; BETA-PROTEIN; APP GENE; MEMORY; PRESENILIN-1; HIPPOCAMPUS; INCREASES; PLAQUES	We investigated synaptic communication and plasticity in hippocampal slices from mice overexpressing mutated 695-amino-acid human amyloid precursor protein (APP(695)SWE), which show behavioral and histopathological abnormalities simulating Alzheimer's disease. Although aged APP transgenic mice exhibit normal fast synaptic transmission and short term plasticity, they are severely impaired in in-vitro and in-vivo long-term potentiation (LTP) in both the CA1 and dentate gyrus regions of the hippocampus. The LTP deficit was correlated with impaired performance in a spatial working memory task in aged transgenics. These deficits are accompanied by minimal or no loss of presynaptic or postsynaptic elementary structural elements in the hippocampus, suggesting that impairments in functional synaptic plasticity may underlie some of the cognitive deficits in these mice and, possibly, in Alzheimer's patients.	Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA; Cardiff Univ, Cardiff Business Sch, Cardiff CF1 3US, S Glam, Wales; Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England; Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; Cardiff Univ, Sch Psychol, Cardiff CF1 3US, S Glam, Wales	University of Minnesota System; University of Minnesota Twin Cities; Cardiff University; MRC National Institute for Medical Research; Harvard University; Massachusetts General Hospital; Mayo Clinic; Cardiff University	Hsiao, KK (corresponding author), Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA.	hsiao005@maroon.tc.umn.edu	Sancheti, Harsh/H-3538-2012	Jones, Matthew/0000-0001-5396-3108	NIA NIH HHS [AG08487, K08-AG00793] Funding Source: Medline; NINDS NIH HHS [NS33249] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008487, R29AG008487, K08AG000793] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Castillo PE, 1997, NATURE, V388, P590, DOI 10.1038/41574; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Dragunow M, 1996, BEHAV GENET, V26, P293, DOI 10.1007/BF02359385; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Errington ML, 1997, NATURE, V387, P666, DOI 10.1038/42625; FINCH CE, 1993, TRENDS NEUROSCI, V16, P104, DOI 10.1016/0166-2236(93)90134-8; Frautschy SA, 1998, AM J PATHOL, V152, P307; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Ikezu T, 1996, EMBO J, V15, P2468, DOI 10.1002/j.1460-2075.1996.tb00604.x; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KLANN E, 1991, J BIOL CHEM, V266, P24253; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	32	771	812	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					271	276		10.1038/6374	http://dx.doi.org/10.1038/6374			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	220TX	10195221				2022-12-17	WOS:000081684500016
J	Cheng, LC; Pastrana, E; Tavazoie, M; Doetsch, F				Cheng, Li-Chun; Pastrana, Erika; Tavazoie, Masoud; Doetsch, Fiona			miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche	NATURE NEUROSCIENCE			English	Article							RADIAL GLIAL-CELLS; NEURONAL DIFFERENTIATION; MAMMALIAN BRAIN; SELF-RENEWAL; SPINAL-CORD; MICRORNA; EXPRESSION; SOX9; PRECURSORS; REST	The subventricular zone (SVZ) is the largest neurogenic niche in the adult mammalian brain. We found that the brain-enriched microRNA miR-124 is an important regulator of the temporal progression of adult neurogenesis in mice. Knockdown of endogenous miR-124 maintained purified SVZ stem cells as dividing precursors, whereas ectopic expression led to precocious and increased neuron formation. Furthermore, blocking miR-124 function during regeneration led to hyperplasias, followed by a delayed burst of neurogenesis. We identified the SRY-box transcription factor Sox9 as being a physiological target of miR-124 at the transition from the transit amplifying cell to the neuroblast stage. Sox9 overexpression abolished neuronal differentiation, whereas Sox9 knockdown led to increased neuron formation. Thus miR-124-mediated repression of Sox9 is important for progression along the SVZ stem cell lineage to neurons.	[Cheng, Li-Chun; Pastrana, Erika; Doetsch, Fiona] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Tavazoie, Masoud] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY USA; Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY USA; [Doetsch, Fiona] Columbia Univ, Coll Phys & Surg, Ctr Motor Neuron Biol & Dis, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Doetsch, F (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA.	fkd2101@columbia.edu		Pastrana, Erika/0000-0003-1745-8635	US National Institutes of Health National Institute of Neurological Disorders and Stroke; US National Institutes of Health; Spanish Ministerio de Educacion y Ciencia; Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies; Anne and Bernard Spitzer Fund for Cell Replacement Therapy; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053884] Funding Source: NIH RePORTER	US National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Educacion y Ciencia(Spanish Government); Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies; Anne and Bernard Spitzer Fund for Cell Replacement Therapy; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Gordon for assistance with FACS at the Herbert Irving Comprehensive Cancer Center at Columbia University. We thank members of the Doetsch and Wichterle laboratories for critical reading of the manuscript. We are grateful to C. Troy for advice on penetratin 1-mediated delivery, N. Heintz for antibody to BLBP and R. Tsien for pCMV-Cherry plasmid. The nestin, M2 and M6 antibodies developed by S. Hockfield and C. Lagenaur, respectively, were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by the University of Iowa. This work was supported by a US National Institutes of Health National Institute of Neurological Disorders and Stroke grant to F. D. E. P. was supported by a US National Institutes of Health training grant and a grant from the Spanish Ministerio de Educacion y Ciencia. M. T. was supported by a Medical Scientist Training Program fellowship from the US National Institutes of Health, F. D. is a Packard Foundation Fellow and an Irma T. Hirschl Fellow, and this work was partially supported by the Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies and the Anne and Bernard Spitzer Fund for Cell Replacement Therapy. We dedicate this article to the memory of Emily Spiegel.	Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Davidson TJ, 2004, J NEUROSCI, V24, P10040, DOI 10.1523/JNEUROSCI.3643-04.2004; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Finzsch M, 2008, DEVELOPMENT, V135, P637, DOI 10.1242/dev.010454; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lachapelle F, 2002, MOL CELL NEUROSCI, V20, P390, DOI 10.1006/mcne.2002.1124; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Nyfeler Y, 2005, EMBO J, V24, P3504, DOI 10.1038/sj.emboj.7600816; Panganiban G, 2002, DEVELOPMENT, V129, P4371; PASTRANA E, P NATL ACAD IN PRESS; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	42	767	817	1	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2009	12	4					399	408		10.1038/nn.2294	http://dx.doi.org/10.1038/nn.2294			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	424JN	19287386	Green Accepted			2022-12-17	WOS:000264563100014
J	Masland, RH				Masland, RH			The fundamental plan of the retina	NATURE NEUROSCIENCE			English	Review							LATERAL GENICULATE-NUCLEUS; GANGLION-CELL TYPE; MACAQUE MONKEY RETINA; STARBURST AMACRINE CELLS; ACCESSORY OPTIC-SYSTEM; HUMAN COLOR-VISION; INNER PLEXIFORM LAYER; CONE BIPOLAR CELLS; RABBIT RETINA; CAT RETINA	The retina, like many other central nervous system structures, contains a huge diversity of neuronal types. Mammalian retinas contain approximately 55 distinct cell types, each with a different function. The census of cell types is nearing completion, as the development of quantitative methods makes it possible to be reasonably confident that few additional types exist. Although much remains to be learned, the fundamental structural principles are now becoming clear. They give a bottom-up view of the strategies used in the retina's processing of visual information and suggest new questions for physiological experiments and modeling.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Masland, RH (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Howard Hughes Med Inst, Wellman 429, Boston, MA 02114 USA.	masland@helix.mgh.harvard.edu						[Anonymous], 1988, EYE BRAIN VISION; Awatramani GB, 2000, J NEUROSCI, V20, P7087, DOI 10.1523/JNEUROSCI.20-18-07087.2000; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Berson DM, 1999, J COMP NEUROL, V408, P204; Berson DM, 1998, J COMP NEUROL, V399, P269, DOI 10.1002/(SICI)1096-9861(19980921)399:2<269::AID-CNE9>3.0.CO;2-Z; BOOS R, 1993, J NEUROSCI, V13, P2874; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; BOYCOTT BB, 1987, PROC R SOC SER B-BIO, V229, P345, DOI 10.1098/rspb.1987.0001; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; BRUENNER U, 1986, INVEST OPHTH VIS SCI, V27, P1634; BUHL EH, 1986, J COMP NEUROL, V253, P163, DOI 10.1002/cne.902530204; Calkins DJ, 1999, NEURON, V24, P313, DOI 10.1016/S0896-6273(00)80846-6; Calkins DJ, 1998, J NEUROSCI, V18, P3373; CALKINS DJ, 1994, NATURE, V371, P70, DOI 10.1038/371070a0; COHEN E, 1990, PHILOS T R SOC B, V330, P305, DOI 10.1098/rstb.1990.0201; Conway BR, 2001, J NEUROSCI, V21, P2768, DOI 10.1523/JNEUROSCI.21-08-02768.2001; COOK PB, 1994, J NEUROSCI, V14, P3852; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; DACEY DM, 1994, CIBA F SYMP, V184, P12; Dacey DM, 1996, SCIENCE, V271, P656, DOI 10.1126/science.271.5249.656; DACEY DM, 1993, VISUAL NEUROSCI, V10, P1081, DOI 10.1017/S0952523800010191; DACEY DM, 1989, J COMP NEUROL, V284, P275, DOI 10.1002/cne.902840210; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Dowling J.E., 1987, RETINA APPROACHABLE; DOWLING JE, 1986, TRENDS NEUROSCI, V9, P236, DOI 10.1016/0166-2236(86)90065-2; EHINGER B, 1983, PROGR RETINAL RES, V2, P213, DOI DOI 10.1016/0278-4327(83)90009-3; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Euler T, 1998, J NEUROPHYSIOL, V79, P1384, DOI 10.1152/jn.1998.79.3.1384; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; FAMIGLIETTI EV, 1992, J COMP NEUROL, V316, P406, DOI 10.1002/cne.903160403; Freed MA, 2000, J NEUROSCI, V20, P3956; FREED MA, 1988, J NEUROSCI, V8, P2303; GREFERATH U, 1995, J COMP NEUROL, V353, P553, DOI 10.1002/cne.903530407; GRUNERT U, 1994, J COMP NEUROL, V348, P607, DOI 10.1002/cne.903480410; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Hack I, 1999, EUR J NEUROSCI, V11, P2261, DOI 10.1046/j.1460-9568.1999.00647.x; HAMPSON ECGM, 1992, J NEUROSCI, V12, P4911; HARTLEY P, 1994, EUR EAT DISORD REV, V2, P1; Haverkamp S, 2000, J COMP NEUROL, V424, P1; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; HUBEL D, 1990, COLD SPRING HARB SYM, V55, P643; Isayama T, 2000, J COMP NEUROL, V417, P32, DOI 10.1002/(SICI)1096-9861(20000131)417:1<32::AID-CNE3>3.0.CO;2-S; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; Jacoby R, 1996, J NEUROSCI, V16, P8041; JENSEN RJ, 1984, J NEUROSCI, V4, P2972; JENSEN RJ, 1986, NEUROSCIENCE, V17, P837, DOI 10.1016/0306-4522(86)90049-7; Jeon CJ, 1998, J NEUROSCI, V18, P8936; JOHNSON RL, 1993, BIOCHEMISTRY-US, V32, P208, DOI 10.1021/bi00052a027; Kalloniatis M, 1996, J NEUROSCI, V16, P6807; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; KOUYAMA N, 1992, J NEUROSCI, V12, P1233; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; Macneil MA, 1999, J COMP NEUROL, V413, P305; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; MARTIN PR, 1992, J COMP NEUROL, V323, P269, DOI 10.1002/cne.903230210; Masland RH, 1996, CURR OPIN NEUROBIOL, V6, P467, DOI 10.1016/S0959-4388(96)80051-1; Masland RH, 2001, CURR OPIN NEUROBIOL, V11, P431, DOI 10.1016/S0959-4388(00)00230-0; MASLAND RH, 1986, TRENDS NEUROSCI, V9, P218, DOI 10.1016/0166-2236(86)90062-7; MCBILLEM GS, 2001, N PRESS INVEST OPHTH; MCGUIRE BA, 1984, J NEUROSCI, V4, P2920; MCILWAIN JT, 1964, J NEUROPHYSIOL, V27, P1154, DOI 10.1152/jn.1964.27.6.1154; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Menger N, 1998, J COMP NEUROL, V401, P34, DOI 10.1002/(SICI)1096-9861(19981109)401:1<34::AID-CNE3>3.0.CO;2-P; MOLLON JD, 1991, EVOLUTION EYE VISUAL, P306; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NAWY S, 1991, NEURON, V7, P677, DOI 10.1016/0896-6273(91)90380-I; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; NELSON R, 1975, SCIENCE, V189, P137, DOI 10.1126/science.1138370; NELSON R, 1982, J NEUROPHYSIOL, V47, P928, DOI 10.1152/jn.1982.47.5.928; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; NOLTE J, 1988, HUMAN BRAIN; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; OYSTER CW, 1980, J COMP NEUROL, V190, P49, DOI 10.1002/cne.901900105; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; Packer OS, 1996, J NEUROSCI, V16, P2251; PASIK P, 1964, OCULOMOTOR SYSTEM, P40; Peichl L, 1998, NATO ADV SCI I A-LIF, V299, P147; Peterson BB, 1999, VISUAL NEUROSCI, V16, P107, DOI 10.1017/S0952523899161066; PICCOLINO M, 1987, J NEUROSCI, V7, P2273; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; PU M, 1994, J NEUROSCI, V14, P4338; Puopolo M, 2001, NEURON, V30, P211, DOI 10.1016/S0896-6273(01)00274-4; Ramon y Cajal S, 1972, STRUCTURE RETINA; RODIECK RW, 1993, J COMP NEUROL, V338, P289, DOI 10.1002/cne.903380211; Rodieck RW., 1998, 1 STEPS SEEING, V1; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; Shapley R., 1984, PROG RETIN RES, V3, P263, DOI [10.1016/0278-4327(84)90011-7, DOI 10.1016/0278-4327(84)90011-7]; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; SMITH RG, 1986, J NEUROSCI, V6, P3505; Stafford DK, 1997, VISUAL NEUROSCI, V14, P507, DOI 10.1017/S0952523800012165; STERLING P, 1998, SYNAPTIC ORG BRAIN, V4, P205; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; STRETTOI E, 1990, J COMP NEUROL, V295, P449, DOI 10.1002/cne.902950309; STRETTOI E, 1995, J NEUROSCI, V15, P875; TAUCHI M, 1985, J NEUROSCI, V5, P2494; TAUCHI M, 1990, J COMP NEUROL, V293, P178, DOI 10.1002/cne.902930203; Taylor WR, 1996, VISUAL NEUROSCI, V13, P599, DOI 10.1017/S0952523800008506; TSO DY, 1988, J NEUROSCI, V8, P1712; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; Vaney DI, 1997, INVEST OPHTH VIS SCI, V38, P267; VANEY DI, 1994, PROG RETIN EYE RES, V13, P301, DOI 10.1016/1350-9462(94)90014-0; VANEY DI, 1980, J COMP NEUROL, V189, P215, DOI 10.1002/cne.901890202; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; WESTHEIMER G, 1966, VISION RES, V6, P669, DOI 10.1016/0042-6989(66)90078-2; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; WILLIAMS DR, 1986, TRENDS NEUROSCI, V9, P193, DOI 10.1016/0166-2236(86)90058-5; WILLIAMS RW, 1993, J NEUROSCI, V13, P208; WITKOVSKY P, 1991, PROG RETIN RES, V11, P247, DOI 10.1016/0278-4327(91)90031-V; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000; YANG G, 1992, SCIENCE, V258, P1949, DOI 10.1126/science.1470920; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	125	760	785	3	152	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					877	886		10.1038/nn0901-877	http://dx.doi.org/10.1038/nn0901-877			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528418				2022-12-17	WOS:000170698600013
J	Borst, A; Theunissen, FE				Borst, A; Theunissen, FE			Information theory and neural coding	NATURE NEUROSCIENCE			English	Review							CRICKET CERCAL SYSTEM; PRIMARY SENSORY INTERNEURONS; GRADED POTENTIAL NEURONS; AFFERENT VISUAL SYSTEM; SPIKE TRAINS; EXTENDED APPLICATION; SENSITIVE NEURONS; ELECTRIC FISH; TYTO-ALBA; BARN OWL	Information theory quantifies how much information a neural response carries about the stimulus. This can be compared to the information transferred in particular models of the stimulus-response function and to maximum possible information transfer. Such comparisons are crucial because they validate assumptions present in any neurophysiological analysis. Here we review information-theory basics before demonstrating its use in neural coding. We show how to use information theory to validate simple stimulus-response models of neural coding of dynamic stimuli. Because these models require specification of spike timing precision, they can reveal which time scales contain information in neural coding. This approach shows that dynamic stimuli can be encoded efficiently by single neurons and that each spike contributes to information transmission. We argue, however, that the data obtained so far do not suggest a temporal code, in which the placement of spikes relative to each other yields additional information.	Univ Calif Berkeley, ESPM Div Insect Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Borst, A (corresponding author), Univ Calif Berkeley, ESPM Div Insect Biol, Berkeley, CA 94720 USA.	borst@nature.berkeley.edu		Theunissen, Frederic/0000-0001-8980-0650				ABBOTT LF, 1994, Q REV BIOPHYS, V27, P291, DOI 10.1017/S0033583500003024; ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Clague H, 1997, J NEUROPHYSIOL, V77, P207, DOI 10.1152/jn.1997.77.1.207; DEANGELIS GC, 1995, TRENDS NEUROSCI, V18, P451, DOI 10.1016/0166-2236(95)94496-R; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; ECKHORN R, 1974, KYBERNETIK, V16, P191, DOI 10.1007/BF00288979; ECKHORN R, 1975, BIOL CYBERN, V17, P7, DOI 10.1007/BF00326705; EGGERMONT JJ, 1983, Q REV BIOPHYS, V16, P341, DOI 10.1017/S0033583500005126; FERSTER D, 1995, SCIENCE, V270, P756, DOI 10.1126/science.270.5237.756; Gabbiani F, 1996, NATURE, V384, P564, DOI 10.1038/384564a0; Gabbiani F, 1996, NETWORK-COMP NEURAL, V7, P61, DOI 10.1080/0954898X.1996.11978655; Golomb D, 1997, NEURAL COMPUT, V9, P649, DOI 10.1162/neco.1997.9.3.649; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Haag J, 1997, J NEUROSCI, V17, P4809; Haag J, 1998, J NEUROSCI, V18, P7972; Kjaer T W, 1994, J Comput Neurosci, V1, P109, DOI 10.1007/BF00962721; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; Koppl C, 1997, J NEUROSCI, V17, P3312; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, NEURON, V16, P473, DOI 10.1016/S0896-6273(00)80066-5; MacKAY DONALD M., 1952, BULL MATH BIOPHYS, V14, P127, DOI 10.1007/BF02477711; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARMARELIS P, 1978, WHITE NOISE APPROACH; MCCLURKIN JW, 1991, SCIENCE, V253, P675, DOI 10.1126/science.1908118; Miller GA., 1955, INF THEORY PSYCHOL P, V2, P95; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Perkel D. H., 1967, NEUROSCI RES PROG B, V6, P223; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Rieke F., 1997, SPIKES EXPLORING NEU; Roddey JC, 1996, J NEUROPHYSIOL, V75, P1365, DOI 10.1152/jn.1996.75.4.1365; RODDEY JC, IN PRESS J COMPUT NE; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SIMMONS JA, 1979, SCIENCE, V204, P1336, DOI 10.1126/science.451543; STEIN RB, 1972, BIOPHYS J, V12, P295, DOI 10.1016/S0006-3495(72)86087-9; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; SUGA N, 1990, NEURAL NETWORKS, V3, P3, DOI 10.1016/0893-6080(90)90043-K; Theunissen F, 1996, J NEUROPHYSIOL, V75, P1345, DOI 10.1152/jn.1996.75.4.1345; THEUNISSEN F, 1995, J COMPUT NEUROSCI, V2, P149, DOI 10.1007/BF00961885; THEUNISSEN FE, 1991, J NEUROPHYSIOL, V66, P1690, DOI 10.1152/jn.1991.66.5.1690; Theunissen FE, 1998, J NEUROSCI, V18, P3786; THEUNISSEN FE, 1993, THESIS U CALIFORNIA; Thomson D. J, 1991, ADV SPECTRUM ANAL AR, VI, P58; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Warland D., 1991, ANAL MODELING NEURAL, P327; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Wessel R, 1996, J NEUROPHYSIOL, V75, P2280, DOI 10.1152/jn.1996.75.6.2280	54	758	766	2	110	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					947	957		10.1038/14731	http://dx.doi.org/10.1038/14731			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526332				2022-12-17	WOS:000083883300010
J	McKernan, RM; Rosahl, TW; Reynolds, DS; Sur, C; Wafford, KA; Atack, JR; Farrar, S; Myers, J; Cook, G; Ferris, P; Garrett, L; Bristow, L; Marshall, G; Macaulay, A; Brown, N; Howell, O; Moore, KW; Carling, RW; Street, LJ; Castro, JL; Ragan, CI; Dawson, GR; Whiting, PJ				McKernan, RM; Rosahl, TW; Reynolds, DS; Sur, C; Wafford, KA; Atack, JR; Farrar, S; Myers, J; Cook, G; Ferris, P; Garrett, L; Bristow, L; Marshall, G; Macaulay, A; Brown, N; Howell, O; Moore, KW; Carling, RW; Street, LJ; Castro, JL; Ragan, CI; Dawson, GR; Whiting, PJ			Sedative but not anxiolytic properties of benzodiazepines ave mediated by the GABA(A) receptor alpha(1) subtype	NATURE NEUROSCIENCE			English	Article							AMINOBUTYRIC ACID(A) RECEPTOR; SUBUNIT-SPECIFIC ANTIBODIES; ELEVATED PLUS-MAZE; RAT-BRAIN; MESSENGER-RNAS; SYNAPSIN-I; PHARMACOLOGY; EXPRESSION; CELLS; ANTAGONIST	GInhibitory neurotransmission in the brain is largely mediated by GABA(A) receptors. Potentiation of GABA receptor activation through an allosteric benzodiazepine (BZ) site produces the sedative, anxiolytic, muscle relaxant, anticonvulsant and cognition-impairing effects of clinically used BZs such as diazepam. We created genetically modified mice (alpha(1) H101R) with a diazepam-insensitive alpha(1) subtype and a selective BZ site ligand, L-838,417, to explore GABA(A) receptor subtypes mediating specific physiological effects. These two complimentary approaches revealed that the alpha(1) subtype mediated the sedative, but not the anxiolytic effects of benzodiazepines. This finding suggests ways to improve anxiolytics and to develop drugs for other neurological disorders based on their specificity for GABA(A) receptor subtypes in distinct neuronal circuits.	Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England	Merck & Company	McKernan, RM (corresponding author), Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Terlings Pk,Eastwick Rd, Harlow CM20 2QR, Essex, England.	Ruth_McKernan@Merck.com	Sur, Cyrille/G-1154-2010	Whiting, Paul/0000-0002-4121-1379; Atack, John/0000-0002-3410-791X; Howell, Owain/0000-0003-2157-9157				Atack JR, 1999, NEUROPSYCHOPHARMACOL, V20, P255, DOI 10.1016/S0893-133X(98)00052-9; Barnard EA, 1998, PHARMACOL REV, V50, P291; Bayley PJ, 1996, J PSYCHOPHARMACOL, V10, P206, DOI 10.1177/026988119601000305; BROUGHTON H, 1998, Patent No. 04559; Collinson N, 1997, PSYCHOPHARMACOLOGY, V132, P35, DOI 10.1007/s002130050317; DAWSON GR, 1995, TRENDS PHARMACOL SCI, V16, P33, DOI 10.1016/S0165-6147(00)88973-7; DUGGAN MJ, 1990, J BIOL CHEM, V265, P3831; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; FRITSCHY JM, 1992, P NATL ACAD SCI USA, V89, P6726, DOI 10.1073/pnas.89.15.6726; GAO B, 1993, NEUROSCIENCE, V54, P881, DOI 10.1016/0306-4522(93)90582-Z; HADINGHAM KL, 1992, P NATL ACAD SCI USA, V89, P6378, DOI 10.1073/pnas.89.14.6378; HADINGHAM KL, 1993, MOL PHARMACOL, V43, P970; KEHNE JH, 1988, PSYCHOPHARMACOLOGY, V94, P8, DOI 10.1007/BF00735872; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; MCKERNAN RM, 1991, NEURON, V7, P667, DOI 10.1016/0896-6273(91)90379-E; PRITCHETT DB, 1990, J NEUROCHEM, V54, P1802, DOI 10.1111/j.1471-4159.1990.tb01237.x; PRITCHETT DB, 1989, SCIENCE, V245, P1389, DOI 10.1126/science.2551039; QUIRK K, 1994, J BIOL CHEM, V269, P16020; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; SIEGHART W, 1995, PHARMACOL REV, V47, P181; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Sur C, 1999, BRAIN RES, V822, P265, DOI 10.1016/S0006-8993(99)01152-X; TREIT D, 1985, NEUROSCI BIOBEHAV R, V9, P203, DOI 10.1016/0149-7634(85)90046-6; Whiting PJ, 1997, J NEUROSCI, V17, P5027; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; WISDEN W, 1991, FEBS LETT, V289, P227, DOI 10.1016/0014-5793(91)81076-K; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wisden W, 1999, NATURE, V401, P751, DOI 10.1038/44482	34	757	782	1	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					587	592		10.1038/75761	http://dx.doi.org/10.1038/75761			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816315				2022-12-17	WOS:000087249500015
J	Viventi, J; Kim, DH; Vigeland, L; Frechette, ES; Blanco, JA; Kim, YS; Avrin, AE; Tiruvadi, VR; Hwang, SW; Vanleer, AC; Wulsin, DF; Davis, K; Gelber, CE; Palmer, L; Van der Spiegel, J; Wu, J; Xiao, JL; Huang, YG; Contreras, D; Rogers, JA; Litt, B				Viventi, Jonathan; Kim, Dae-Hyeong; Vigeland, Leif; Frechette, Eric S.; Blanco, Justin A.; Kim, Yun-Soung; Avrin, Andrew E.; Tiruvadi, Vineet R.; Hwang, Suk-Won; Vanleer, Ann C.; Wulsin, Drausin F.; Davis, Kathryn; Gelber, Casey E.; Palmer, Larry; Van der Spiegel, Jan; Wu, Jian; Xiao, Jianliang; Huang, Yonggang; Contreras, Diego; Rogers, John A.; Litt, Brian			Flexible, foldable, actively multiplexed, high-density electrode array for mapping brain activity in vivo	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; ELECTRICAL-ACTIVITY; MOTOR CORTEX; NEOCORTEX; EPILEPSY; SILICON; WAVES; ELECTROCORTICOGRAMS; ARRANGEMENTS; VARIABILITY	Arrays of electrodes for recording and stimulating the brain are used throughout clinical medicine and basic neuroscience research, yet are unable to sample large areas of the brain while maintaining high spatial resolution because of the need to individually wire each passive sensor at the electrode-tissue interface. To overcome this constraint, we developed new devices that integrate ultrathin and flexible silicon nanomembrane transistors into the electrode array, enabling new dense arrays of thousands of amplified and multiplexed sensors that are connected using fewer wires. We used this system to record spatial properties of cat brain activity in vivo, including sleep spindles, single-trial visual evoked responses and electrographic seizures. We found that seizures may manifest as recurrent spiral waves that propagate in the neocortex. The developments reported here herald a new generation of diagnostic and therapeutic brain-machine interface devices.	[Frechette, Eric S.; Davis, Kathryn; Litt, Brian] Hosp Univ Penn, Dept Neurol, Penn Epilepsy Ctr, Philadelphia, PA 19104 USA; [Viventi, Jonathan] NYU, Polytech Inst, Dept Elect & Comp Engn, Brooklyn, NY USA; [Viventi, Jonathan] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Kim, Dae-Hyeong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul, South Korea; [Vigeland, Leif; Palmer, Larry; Contreras, Diego] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Blanco, Justin A.] USN Acad, Dept Elect & Comp Engn, Annapolis, MD 21402 USA; [Kim, Yun-Soung; Hwang, Suk-Won; Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Mat Sci & Engn, Urbana, IL USA; [Kim, Yun-Soung; Hwang, Suk-Won; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL USA; [Avrin, Andrew E.; Van der Spiegel, Jan] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Tiruvadi, Vineet R.; Vanleer, Ann C.; Wulsin, Drausin F.; Gelber, Casey E.; Litt, Brian] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Wu, Jian] Tsinghua Univ, Dept Engn Mech, Beijing 100084, Peoples R China; [Xiao, Jianliang] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Evanston, IL USA; [Huang, Yonggang] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA	University of Pennsylvania; Pennsylvania Medicine; New York University; New York University Tandon School of Engineering; New York University; Seoul National University (SNU); University of Pennsylvania; United States Department of Defense; United States Navy; United States Naval Academy; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Pennsylvania; University of Pennsylvania; Tsinghua University; University of Colorado System; University of Colorado Boulder; Northwestern University; Northwestern University	Litt, B (corresponding author), Hosp Univ Penn, Dept Neurol, Penn Epilepsy Ctr, 3400 Spruce St, Philadelphia, PA 19104 USA.	jrogers@uiuc.edu; littb@mail.med.upenn.edu	Huang, Yonggang/B-6998-2009; huang, yonggang/O-6236-2019; Wu, Jian/I-3466-2012; Rogers, John/L-2798-2016; Xiao, Jianliang/B-4535-2008; HWANG, SUKWON/Q-8329-2018	Wu, Jian/0000-0003-2295-6815; Kim, Dae-Hyeong/0000-0002-4722-1893; HWANG, SUKWON/0000-0002-6883-201X	National Science Foundation [DMI0328162]; US Department of Energy, Division of Materials Sciences through the Materials Research Laboratory and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign [DE-FG02-07ER46471, DE-FG02-07ER46453]; US National Institutes of Health (National Institute of Neurological Disorders and Stroke) [RO1-NS041811, RO1-NS48598]; Citizens United for Research in Epilepsy; Dr. Michel and Mrs. Anna Mirowski Discovery Fund for Epilepsy Research; Ruth L. Kirschstein National Research Service from the US National Institutes of Health, National Heart, Lung and Blood Institute [2T32HL007954]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031724] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [T32EY007035, R01EY020765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041811, R01NS048598] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Division of Materials Sciences through the Materials Research Laboratory and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign(United States Department of Energy (DOE)); US National Institutes of Health (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Citizens United for Research in Epilepsy; Dr. Michel and Mrs. Anna Mirowski Discovery Fund for Epilepsy Research; Ruth L. Kirschstein National Research Service from the US National Institutes of Health, National Heart, Lung and Blood Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Science Foundation (grant DMI0328162) and the US Department of Energy, Division of Materials Sciences (Award No. DE-FG02-07ER46471), through the Materials Research Laboratory and Center for Microanalysis of Materials (DE-FG02-07ER46453) at the University of Illinois at Urbana-Champaign. J.A.R. acknowledges a National Security Science and Engineering Faculty Fellowship. Work at the University of Pennsylvania was supported by grants from the US National Institutes of Health (National Institute of Neurological Disorders and Stroke RO1-NS041811 and RO1-NS48598), the Julie's Hope Award from the Citizens United for Research in Epilepsy, and the Dr. Michel and Mrs. Anna Mirowski Discovery Fund for Epilepsy Research. J.V. received a Ruth L. Kirschstein National Research Service Award (2T32HL007954) from the US National Institutes of Health, National Heart, Lung and Blood Institute.	Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Andersen RA, 2004, CURR OPIN NEUROBIOL, V14, P720, DOI 10.1016/j.conb.2004.10.005; Anderson WS, 2007, BIOL CYBERN, V97, P173, DOI 10.1007/s00422-007-0166-0; Besson P, 2008, BRAIN, V131, P3246, DOI 10.1093/brain/awn224; Blanco JA, 2010, J NEUROPHYSIOL, V104, P2900, DOI 10.1152/jn.01082.2009; Branco DM, 2003, J CLIN NEUROPHYSIOL, V20, P17, DOI 10.1097/00004691-200302000-00002; Brunner P, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00005; CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588; Cardin JA, 2008, NEURON, V59, P150, DOI 10.1016/j.neuron.2008.05.002; Cardin JA, 2007, J NEUROSCI, V27, P10333, DOI 10.1523/JNEUROSCI.1692-07.2007; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Fox PT, 2001, NEUROIMAGE, V13, P196, DOI 10.1006/nimg.2000.0659; Freeman WJ, 2000, J NEUROSCI METH, V95, P111, DOI 10.1016/S0165-0270(99)00160-0; Gais S, 2002, J NEUROSCI, V22, P6830; Griffith RW, 2006, NEUROSCI LETT, V406, P81, DOI 10.1016/j.neulet.2006.07.018; Hastie T., 2001, ELEMENTS STAT LEARNI, P236, DOI DOI 10.1007/978-0-387-21606-5; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Huang XY, 2010, NEURON, V68, P978, DOI 10.1016/j.neuron.2010.11.007; Huang XY, 2004, J NEUROSCI, V24, P9897, DOI 10.1523/JNEUROSCI.2705-04.2004; Kellis S, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/5/056007; Kellis SS, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0974; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Kitzmiller JP, 2007, J NEUROSCI METH, V162, P155, DOI 10.1016/j.jneumeth.2007.01.004; Larochelle H., 2007, P 24 INT C MACHINE L, P473, DOI [DOI 10.1145/1273496.1273556, 10.1145/1273496.1273556]; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Margalit E, 2003, J NEUROSCI METH, V123, P129, DOI 10.1016/S0165-0270(02)00345-X; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Padnick LB, 1999, VISION RES, V39, P2833, DOI 10.1016/S0042-6989(99)00016-4; PAULLET JE, 1994, SIAM J APPL MATH, V54, P1720, DOI 10.1137/S0036139993250683; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Prechtl JC, 1997, P NATL ACAD SCI USA, V94, P7621, DOI 10.1073/pnas.94.14.7621; Ryu SI, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0987; Schevon CA, 2008, J CLIN NEUROPHYSIOL, V25, P321, DOI 10.1097/WNP.0b013e31818e8010; SCHMIDT S, 1993, J BIOMED MATER RES, V27, P1393, DOI 10.1002/jbm.820271106; Sekitani T, 2007, NAT MATER, V6, P413, DOI 10.1038/nmat1903; Stead M, 2010, BRAIN, V133, P2789, DOI 10.1093/brain/awq190; Stieglitz T, 2002, SENSOR ACTUAT B-CHEM, V83, P8, DOI 10.1016/S0925-4005(01)01021-8; Stieglitz T, 2001, SENSOR ACTUAT A-PHYS, V90, P203, DOI 10.1016/S0924-4247(01)00520-9; Streetman B. G., 1981, SOLID STATE ELECT DE; Tamminen J, 2010, J NEUROSCI, V30, P14356, DOI 10.1523/JNEUROSCI.3028-10.2010; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Thompson SE, 2004, IEEE T ELECTRON DEV, V51, P1790, DOI 10.1109/TED.2004.836648; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; TUSA RJ, 1979, J COMP NEUROL, V185, P657, DOI 10.1002/cne.901850405; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; Viventi J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000738; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170; Yanagisawa T, 2009, NEUROIMAGE, V45, P1099, DOI 10.1016/j.neuroimage.2008.12.069; Yeager JD, 2008, J NEUROSCI METH, V173, P279, DOI 10.1016/j.jneumeth.2008.06.024	50	754	791	33	522	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1599	U138		10.1038/nn.2973	http://dx.doi.org/10.1038/nn.2973			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22081157	Green Accepted, Green Submitted			2022-12-17	WOS:000297546300021
J	Guzowski, JF; McNaughton, BL; Barnes, CA; Worley, PF				Guzowski, JF; McNaughton, BL; Barnes, CA; Worley, PF			Environment-specific expression of the immediate-early gene Arc in hippocampal neuronal ensembles	NATURE NEUROSCIENCE			English	Article							LONG-TERM STABILITY; MESSENGER-RNA; RAT-BRAIN; PLACE CELLS; CA1; ACTIVATION; DENDRITES; PATTERNS; ENCODES; PROTEIN	We used fluorescent in-situ hybridization and confocal microscopy to monitor the subcellular distribution of the immediate-early gene Arc. Arc RNA appeared in discrete intranuclear foci within minutes of neuronal activation and subsequently disappeared from the nucleus and accumulated in the cytoplasm by 30 minutes. The time course of nuclear versus cytoplasmic Arc RNA accumulation was distinct, and could therefore be used to infer the activity history of individual neurons at two times. Following sequential exposure of rats to two different environments or to the same environment twice, the proportion of CA1 neurons with cytoplasmic, nuclear or overlapping Are expression profiles matched predictions derived from ensemble neurophysiological recordings of hippocampal neuronal ensembles. Are gene induction is thus specifically linked to neural encoding processes.	Virion Syst Inc, Rockville, MD 20850 USA; Univ Arizona, Dept Psychol, Tucson, AZ 85724 USA; Univ Arizona, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	University of Arizona; University of Arizona; Johns Hopkins University; Johns Hopkins University	Guzowski, JF (corresponding author), Virion Syst Inc, 9610 Med Ctr Dr,Suite 100, Rockville, MD 20850 USA.							CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; CIRELLI C, 1995, REGUL PEPTIDES, V59, P151, DOI 10.1016/0167-0115(95)00097-U; COLE AJ, 1990, J NEUROCHEM, V55, P1920, DOI 10.1111/j.1471-4159.1990.tb05777.x; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gothard KM, 1996, J NEUROSCI, V16, P823; Grimm R, 1997, BEHAV BRAIN RES, V84, P109, DOI 10.1016/S0166-4328(97)83330-X; HESS US, 1995, J NEUROSCI, V15, P4786; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; Kubie J. L., 1983, NEUROBIOLOGY HIPPOCA, P433; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Skaggs WE, 1998, J NEUROSCI, V18, P8455; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Tanila H, 1997, HIPPOCAMPUS, V7, P613, DOI 10.1002/(SICI)1098-1063(1997)7:6<613::AID-HIPO4>3.0.CO;2-F; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; Trembleau A, 1998, BIOL CELL, V90, P39, DOI 10.1016/S0248-4900(98)80231-1; Wallace CS, 1998, J NEUROSCI, V18, P26; Wan HM, 1999, J NEUROSCI, V19, P1142; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	28	750	761	0	58	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1120	1124		10.1038/16046	http://dx.doi.org/10.1038/16046			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570490				2022-12-17	WOS:000085810100017
J	Martinez, A; Anllo-Vento, L; Sereno, MI; Frank, LR; Buxton, RB; Dubowitz, DJ; Wong, EC; Hinrichs, H; Heinze, HJ; Hillyard, SA				Martinez, A; Anllo-Vento, L; Sereno, MI; Frank, LR; Buxton, RB; Dubowitz, DJ; Wong, EC; Hinrichs, H; Heinze, HJ; Hillyard, SA			Involvement of striate and extrastriate visual cortical areas in spatial attention	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; SELECTIVE ATTENTION; NEURAL MECHANISMS; FUNCTIONAL MRI; HUMAN BRAIN; CORTEX; POTENTIALS; DYNAMICS; NETWORKS; MODEL	We investigated the cortical mechanisms of visual-spatial attention while subjects discriminated patterned targets within distracter arrays. Functional magnetic resonance imaging (fMRI) was used to map the boundaries of retinotopic visual areas and to localize attention-related changes in neural activity within several of those areas, including primary visual (striate) cortex. Event-related potentials (ERPs) and modeling of their neural sources, however, indicated that the initial sensory input to striate cortex at 50-55 milliseconds after the stimulus was not modulated by attention. The earliest facilitation of attended signals was observed in extrastriate visual areas, at 70-75 milliseconds. We hypothesize that the striate cortex modulation found with fMRI may represent a delayed, re-entrant feedback from higher visual areas or a sustained biasing of striate cortical neurons during attention. ERP recordings provide critical temporal information for analyzing the functional neuroanatomy of visual attention.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Otto von Guericke Univ, Dept Clin Neurophysiol, Magdeburg, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; California Institute of Technology; Otto von Guericke University	Hillyard, SA (corresponding author), Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Sereno, Martin I/F-7657-2012; Martinez, Antigona/X-2317-2019	Sereno, Martin I/0000-0002-7598-7829; Martinez, Antigona/0000-0003-4806-5199	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH025594, R37MH025594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036722] Funding Source: NIH RePORTER; NIMH NIH HHS [MH25594] Funding Source: Medline; NINDS NIH HHS [NS36722] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aine C J, 1995, Int J Neurosci, V80, P79, DOI 10.3109/00207459508986095; Anllo-Vento L, 1998, HUM BRAIN MAPP, V6, P216, DOI 10.1002/(SICI)1097-0193(1998)6:4<216::AID-HBM3>3.0.CO;2-6; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Clark V.P., 1994, HUMAN BRAIN MAPPING, V2, P170, DOI [10.1002/hbm.460020306, DOI 10.1002/HBM.460020306]; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; COLBY CL, 1991, J CHILD NEUROL, V6, P90; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DUPONT P, 1993, P NATL ACAD SCI USA, V90, P10927, DOI 10.1073/pnas.90.23.10927; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Gratton G, 1997, NEUROREPORT, V8, P1749, DOI 10.1097/00001756-199705060-00036; HEINZE HJ, 1990, ELECTROEN CLIN NEURO, V75, P511, DOI 10.1016/0013-4694(90)90138-A; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; LABERGE D, 1995, ATTENTION PROCESSING; Luck SJ, 1996, J EXP PSYCHOL HUMAN, V22, P725, DOI 10.1037/0096-1523.22.3.725; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Mangun GR, 1998, HUM BRAIN MAPP, V6, P383, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<383::AID-HBM10>3.3.CO;2-Q; Motter BC, 1998, ATTENTIVE BRAIN, P51; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Rees G, 1997, SCIENCE, V275, P835, DOI 10.1126/science.275.5301.835; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Scherg M., 1990, ADV AUDIOLOGY, P40; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Skinner J. E., 1977, ATTENTION VOLUNTARY, P30; Talairach J., 1988, COPLANAR STEREOTAXIC; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; Watanabe T, 1998, J NEUROPHYSIOL, V79, P2218, DOI 10.1152/jn.1998.79.4.2218; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I	38	750	762	3	73	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					364	369		10.1038/7274	http://dx.doi.org/10.1038/7274			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204544				2022-12-17	WOS:000080532000016
J	Imayoshi, I; Sakamoto, M; Ohtsuka, T; Takao, K; Miyakawa, T; Yamaguchi, M; Mori, K; Ikeda, T; Itohara, S; Kageyama, R				Imayoshi, Itaru; Sakamoto, Masayuki; Ohtsuka, Toshiyuki; Takao, Keizo; Miyakawa, Tsuyoshi; Yamaguchi, Masahiro; Mori, Kensaku; Ikeda, Toshio; Itohara, Shigeyoshi; Kageyama, Ryoichiro			Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; GENERATED GRANULE CELLS; MOUSE OLFACTORY-BULB; RAT DENTATE GYRUS; CENTRAL-NERVOUS-SYSTEM; LONG-TERM SURVIVAL; HIPPOCAMPAL NEUROGENESIS; NEURONS; MICE; MEMORY	Neurogenesis occurs continuously in the forebrain of adult mammals, but the functional importance of adult neurogenesis is still unclear. Here, using a genetic labeling method in adult mice, we found that continuous neurogenesis results in the replacement of the majority of granule neurons in the olfactory bulb and a substantial addition of granule neurons to the hippocampal dentate gyrus. Genetic ablation of newly formed neurons in adult mice led to a gradual decrease in the number of granule cells in the olfactory bulb, inhibition of increases in the granule cell number in the dentate gyrus and impairment of behaviors in contextual and spatial memory, which are known to depend on hippocampus. These results suggest that continuous neurogenesis is required for the maintenance and reorganization of the whole interneuron system in the olfactory bulb, the modulation and refinement of the existing neuronal circuits in the dentate gyrus and the normal behaviors involved in hippocampal-dependent memory.	[Imayoshi, Itaru; Sakamoto, Masayuki; Ohtsuka, Toshiyuki; Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; [Imayoshi, Itaru; Sakamoto, Masayuki] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; [Imayoshi, Itaru; Ohtsuka, Toshiyuki; Kageyama, Ryoichiro] Japan Sci & Technol Agcy, CREST, Sakyo Ku, Kyoto 6068507, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Kyoto Univ, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Fujita Hlth Univ, Aichi 4701192, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Inst Bioinformat Res & Dev, Kawaguchi, Saitama 3320012, Japan; [Yamaguchi, Masahiro; Mori, Kensaku] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Ikeda, Toshio; Itohara, Shigeyoshi] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] CREST, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Fujita Health University; University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Kageyama, R (corresponding author), Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan.	rkageyam@virus.kyoto-u.ac.jp	Itohara, Shigeyoshi/I-8769-2012; Miyakawa, Tsuyoshi/A-7741-2008; Takao, Keizo/B-9527-2008; Oka, Yoshitaka/C-9670-2010	Itohara, Shigeyoshi/0000-0002-2410-9989; Miyakawa, Tsuyoshi/0000-0003-0137-8200; Takao, Keizo/0000-0002-4734-3583; Oka, Yoshitaka/0000-0002-3482-3051; Mori, Kensaku/0000-0001-7853-9370; Sakamoto, Masayuki/0000-0001-6458-113X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank P. Soriano, F. Costantini and C. Lobe for materials, and K. Nakanishi, N. Tsunekawa, M. Hayashi, M. Fujioka, H. Kohda and K. Okamoto- Furuta for technical help. This work was supported by Grants- in- aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. I. I. was supported by the 21st Century Center of Excellence Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan and Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; BOSS BD, 1985, BRAIN RES, V338, P144, DOI 10.1016/0006-8993(85)90257-4; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; CRESPO D, 1986, EXP BRAIN RES, V62, P541; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; KAPLAN MS, 1981, J COMP NEUROL, V195, P323, DOI 10.1002/cne.901950211; KAPLAN MS, 1985, J COMP NEUROL, V239, P117, DOI 10.1002/cne.902390110; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 1998, CURR BIOL, V8, P939, DOI 10.1016/S0960-9822(07)00377-6; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lemasson M, 2005, J NEUROSCI, V25, P6816, DOI 10.1523/JNEUROSCI.1114-05.2005; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Petreanu L, 2002, J NEUROSCI, V22, P6106; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rosselli-Austin L, 1979, J Dev Physiol, V1, P295; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	50	749	771	3	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2008	11	10					1153	1161		10.1038/nn.2185	http://dx.doi.org/10.1038/nn.2185			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	352WQ	18758458				2022-12-17	WOS:000259528500012
J	Gray, JR; Chabris, CF; Braver, TS				Gray, JR; Chabris, CF; Braver, TS			Neural mechanisms of general fluid intelligence	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; PROGRESSIVE MATRICES TEST; WORKING-MEMORY CAPACITY; SHORT-TERM-MEMORY; PREFRONTAL CORTEX; BRAIN ACTIVATION; COGNITIVE CONTROL; TASK-PERFORMANCE; FMRI; INTERFERENCE	We used an individual-differences approach to test whether general fluid intelligence (gF) is mediated by brain regions that support attentional (executive) control, including subregions of the prefrontal cortex. Forty-eight participants first completed a standard measure of gF (Raven's Advanced Progressive Matrices). They then performed verbal and nonverbal versions of a challenging working-memory task (three-back) while their brain activity was measured using functional magnetic resonance imaging (fMRI). Trials within the three-back task varied greatly in the demand for attentional control because of differences in trial-to-trial interference. On high-interference trials specifically, participants with higher gF were more accurate and had greater event-related neural activity in several brain regions. Multiple regression analyses indicated that lateral prefrontal and parietal regions may mediate the relation between ability (gF) and performance (accuracy despite interference), providing constraints on the neural mechanisms that support gF.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Washington University (WUSTL); Harvard University	Braver, TS (corresponding author), Washington Univ, Dept Psychol, Campus Box 1125, St Louis, MO 63130 USA.		Gray, Jeremy/A-2635-2013; Gray, Jeremy/A-9719-2008; Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026; Braver, Todd/0000-0002-2631-3393				BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bischoff-Grethe A, 2002, J NEUROSCI, V22, P546, DOI 10.1523/JNEUROSCI.22-02-00546.2002; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Brodmann Karl, 1912, Anatomischer Anzeiger, V41; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cattell R., 1971, ABILITIES THEIR STRU; CECI SJ, 1991, DEV PSYCHOL, V27, P703, DOI 10.1037/0012-1649.27.5.703; Ceci SJ, 1997, AM PSYCHOL, V52, P1051, DOI 10.1037/0003-066X.52.10.1051; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen J., 2013, APPL MULTIPLE REGRES, V3rd ed.; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; CRONBACH LJ, 1957, AM PSYCHOL, V12, P671, DOI 10.1037/h0043943; D'Esposito M, 1999, P NATL ACAD SCI USA, V96, P7514, DOI 10.1073/pnas.96.13.7514; DEARY IJ, 2000, LOOKING DOWN HUMAN I; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Engle RW., 1999, INDIVIDUAL DIFFERENC, DOI DOI 10.1017/CBO9781139174909.007; Fritsch G, 1870, ARCH ANAT PHYSL WISS, V37, P300, DOI 10.1007/bf01759916; Gray JR, 2002, COGN AFFECT BEHAV NE, V2, P64, DOI 10.3758/CABN.2.1.64; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; Gruber O, 2001, CEREB CORTEX, V11, P1047, DOI 10.1093/cercor/11.11.1047; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; KANE MJ, IN PRESS PSYCHONOM B; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Kosslyn SM, 2002, AM PSYCHOL, V57, P341, DOI 10.1037//0003-066X.57.5.341; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Markowitsch HJ, 2000, EXP BRAIN RES, V133, P94, DOI 10.1007/s002210000404; McAvoy MP, 2001, NEUROIMAGE, V13, pS198; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Raven J.C., 1998, ADV PROGR MATRICES; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Sternberg RJ, 2000, SCIENCE, V289, P399, DOI 10.1126/science.289.5478.399; STERNBERG RJ, 1985, BEYOND IQ TRIARCHIC; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Williams W. M., 1998, RISING CURVE LONG TE, P125	48	749	768	2	113	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2003	6	3					316	322		10.1038/nn1014	http://dx.doi.org/10.1038/nn1014			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648YB	12592404				2022-12-17	WOS:000181178300021
J	Pfeffer, CK; Xue, MS; He, M; Huang, ZJ; Scanziani, M				Pfeffer, Carsten K.; Xue, Mingshan; He, Miao; Huang, Z. Josh; Scanziani, Massimo			Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons	NATURE NEUROSCIENCE			English	Article							PRIMARY SOMATOSENSORY CORTEX; GREEN FLUORESCENT PROTEIN; GABAERGIC CELL SUBTYPES; RAT FRONTAL-CORTEX; CEREBRAL-CORTEX; JUVENILE RAT; TRANSGENIC MICE; LAYER 2/3; NEURONS; NEOCORTEX	Cortical inhibitory neurons contact each other to form a network of inhibitory synaptic connections. Our knowledge of the connectivity pattern underlying this inhibitory network is, however, still incomplete. Here we describe a simple and complementary interaction scheme between three large, molecularly distinct interneuron populations in mouse visual cortex: parvalbumin-expressing interneurons strongly inhibit one another but provide little inhibition to other populations. In contrast, somatostatin-expressing interneurons avoid inhibiting one another yet strongly inhibit all other populations. Finally, vasoactive intestinal peptide-expressing interneurons preferentially inhibit somatostatin-expressing interneurons. This scheme occurs in supragranular and infragranular layers, suggesting that inhibitory networks operate similarly at the input and output of the visual cortex. Thus, as the specificity of connections between excitatory neurons forms the basis for the cortical canonical circuit, the scheme described here outlines a standard connectivity pattern among cortical inhibitory neurons.	[Pfeffer, Carsten K.; Scanziani, Massimo] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Xue, Mingshan; He, Miao; Scanziani, Massimo] Univ Calif San Diego, Ctr Neural Circuits & Behav, Neurobiol Sect, La Jolla, CA 92093 USA; [Xue, Mingshan; He, Miao; Scanziani, Massimo] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [He, Miao; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Cold Spring Harbor Laboratory	Pfeffer, CK (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	cpfeffer10@gmail.com; massimo@ucsd.edu	He, Miao/AAQ-1044-2020	He, Miao/0000-0003-0731-6801; Xue, Mingshan/0000-0003-1463-8884; Huang, Z. Josh/0000-0003-0592-028X	National Alliance for Research on Schizophrenia and Depression; US National Institutes of Health [NS047101]; European Molecular Biology Organization [EMBO LTF 1114_2009]; Howard Hughes Medical Institute; Jane Coffin Childs Memorial Fund for Medical Research; Gatsby charitable foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH078844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression(NARSAD); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Jane Coffin Childs Memorial Fund for Medical Research; Gatsby charitable foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Evora for help with genotyping and mouse husbandry, M. Chan for immunohistochemical labeling, J. Isaacson for critical reading of the manuscript and the members of the Scanziani and Isaacson laboratories for advice during the course of the study. This work was supported in part by grants from the National Alliance for Research on Schizophrenia and Depression and US National Institutes of Health (NS047101). C. K. P. was supported by a European Molecular Biology Organization long-term fellowship (EMBO LTF 1114_2009) and the Howard Hughes Medical Institute. M. X. was supported by a fellowship from Jane Coffin Childs Memorial Fund for Medical Research. M. S. was supported by the Gatsby charitable foundation and the Howard Hughes Medical Institute.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Avermann M, 2012, J NEUROPHYSIOL, V107, P3116, DOI 10.1152/jn.00917.2011; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Caputi A, 2009, CEREB CORTEX, V19, P1345, DOI 10.1093/cercor/bhn175; Cauli B, 1997, J NEUROSCI, V17, P3894; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Dalezios Y, 2002, CEREB CORTEX, V12, P961, DOI 10.1093/cercor/12.9.961; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Dumitriu D, 2007, CEREB CORTEX, V17, P81, DOI 10.1093/cercor/bhj126; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2008, CEREB CORTEX, V18, P2296, DOI 10.1093/cercor/bhm253; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu H, 2011, J NEUROSCI, V31, P3351, DOI 10.1523/JNEUROSCI.4881-10.2011; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kaneko T, 1998, NEUROSCIENCE, V86, P765, DOI 10.1016/S0306-4522(98)00036-0; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; Kubota Y, 2011, CEREB CORTEX, V21, P1803, DOI 10.1093/cercor/bhq252; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Ma YY, 2012, J NEUROSCI, V32, P983, DOI 10.1523/JNEUROSCI.5007-11.2012; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McGarry LM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00012; Olah S, 2007, FRONT NEURAL CIRCUIT, V1, DOI [10.3389/neuro.04/004.2007, 10.3389/neuro.04.004.2007]; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Staiger JF, 1997, EUR J NEUROSCI, V9, P2259, DOI 10.1111/j.1460-9568.1997.tb01644.x; Staiger JF, 2004, J COMP NEUROL, V468, P179, DOI 10.1002/cne.10953; Staiger JF, 2002, EUR J NEUROSCI, V16, P11, DOI 10.1046/j.1460-9568.2002.02048.x; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Toledo-Rodriguez M, 2005, J PHYSIOL-LONDON, V567, P401, DOI 10.1113/jphysiol.2005.089250; Vruwink M, 2001, J COMP NEUROL, V441, P288, DOI 10.1002/cne.1413; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Woodruff A, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.015.2009; Xu XM, 2006, J COMP NEUROL, V499, P144, DOI 10.1002/cne.21101; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229	54	748	755	10	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1068	U130		10.1038/nn.3446	http://dx.doi.org/10.1038/nn.3446			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23817549	Green Submitted, Green Accepted			2022-12-17	WOS:000322323000017
J	Volkow, ND; Wise, RA				Volkow, ND; Wise, RA			How can drug addiction help us understand obesity?	NATURE NEUROSCIENCE			English	Editorial Material							CORTICOTROPIN-RELEASING-FACTOR; BRAIN DOPAMINE; FOOD-STIMULI; COCAINE; RISK; DEPENDENCE; REWARD; ABUSE; REINSTATEMENT; VULNERABILITY		Natl Inst Drug Abuse, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Volkow, ND (corresponding author), Natl Inst Drug Abuse, NIH, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov	Wise, Roy A/A-6465-2012		NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000550, ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000471, Z01DA000471] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Adriani W, 2003, J NEUROSCI, V23, P4712; Baessler A, 2005, DIABETES, V54, P259, DOI 10.2337/diabetes.54.1.259; Barrett E, 2004, OBES RES, V12, P362; Bassareo V, 1999, NEUROSCIENCE, V89, P637, DOI 10.1016/S0306-4522(98)00583-1; BOZARTH MA, 1981, LIFE SCI, V28, P551, DOI 10.1016/0024-3205(81)90148-X; Buka SL, 2003, AM J PSYCHIAT, V160, P1978, DOI 10.1176/appi.ajp.160.11.1978; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; Carroll ME, 1999, PHARM TOXIC, P286; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; DALLMAN MF, IN PRESS BRAIN BEHAV; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; FRIEDMAN JM, 1992, CELL, V69, P217, DOI 10.1016/0092-8674(92)90402-X; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Gautier JF, 2000, DIABETES, V49, P838, DOI 10.2337/diabetes.49.5.838; Geary N, 2004, PHYSIOL BEHAV, V83, P659, DOI 10.1016/j.physbeh.2004.08.041; Heinz A, 2005, ARCH GEN PSYCHIAT, V62, P57, DOI 10.1001/archpsyc.62.1.57; Hu M, 2004, NEUROPSYCHOPHARMACOL, V29, P81, DOI 10.1038/sj.npp.1300301; JOHANSON CE, 1976, PHARMACOL BIOCHEM BE, V4, P45, DOI 10.1016/0091-3057(76)90174-X; Johnson JG, 2002, AM J PSYCHIAT, V159, P394, DOI 10.1176/appi.ajp.159.3.394; JOSEFSSON JO, 1979, NATURE, V282, P78, DOI 10.1038/282078a0; KAVALIERS M, 1987, FASEB J, V46, P168; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P886, DOI 10.1001/archpsyc.57.9.886; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Kosten TA, 1997, BRAIN RES, V778, P418, DOI 10.1016/S0006-8993(97)01205-5; Kreek MJ, 1998, DRUG ALCOHOL DEPEN, V51, P23, DOI 10.1016/S0376-8716(98)00064-7; Levine AS, 2003, AM J CLIN NUTR, V78, p834S, DOI 10.1093/ajcn/78.4.834S; MacDonald AF, 2004, BRAIN RES, V1018, P78, DOI 10.1016/j.brainres.2004.05.043; McFarland K, 2004, J NEUROSCI, V24, P1551, DOI 10.1523/JNEUROSCI.4177-03.2004; Mennella JA, 2004, PEDIATRICS, V113, P840, DOI 10.1542/peds.113.4.840; *NAT CTR HLTH STAT, 2004, FASTATS A Z; Pijl H, 2003, EUR J PHARMACOL, V480, P125, DOI 10.1016/j.ejphar.2003.08.100; Porrino LJ, 2004, J NEUROSCI, V24, P3554, DOI 10.1523/JNEUROSCI.5578-03.2004; Ranaldi R, 2001, BEHAV PHARMACOL, V12, P527, DOI 10.1097/00008877-200111000-00014; Reale D, 1999, HEREDITY, V83, P526, DOI 10.1038/sj.hdy.6885430; Richard D, 2002, EUR J PHARMACOL, V440, P189, DOI 10.1016/S0014-2999(02)01428-0; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; ROZIN P, 1969, J COMP PHYSIOL PSYCH, V69, P126, DOI 10.1037/h0027940; Sarnyai Z, 2001, PHARMACOL REV, V53, P209; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shalev U, 2001, J NEUROSCI, V21; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; SWANSON LW, 1983, NEUROENDOCRINOLOGY, V36, P165, DOI 10.1159/000123454; Toschke AM, 2003, J PERINAT MED, V31, P251, DOI 10.1515/JPM.2003.034; Uhl GR, 2002, TRENDS GENET, V18, P420, DOI 10.1016/S0168-9525(02)02719-1; Volkow ND, 2000, LIFE SCI, V67, pPL1507; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Wagner FA, 2002, NEUROPSYCHOPHARMACOL, V26, P479, DOI 10.1016/S0893-133X(01)00367-0; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WISE RA, 1986, BRAIN RES, V368, P62, DOI 10.1016/0006-8993(86)91042-5; Yeomans MR, 2002, NEUROSCI BIOBEHAV R, V26, P713, DOI 10.1016/S0149-7634(02)00041-6; Zhang M, 1998, J PHARMACOL EXP THER, V285, P908; Zubieta JK, 1996, NAT MED, V2, P1225, DOI 10.1038/nm1196-1225	60	748	763	1	107	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					555	560		10.1038/nn1452	http://dx.doi.org/10.1038/nn1452			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	923FM	15856062				2022-12-17	WOS:000228895100012
J	Kessaris, N; Fogarty, M; Iannarelli, P; Grist, M; Wegner, M; Richardson, WD				Kessaris, N; Fogarty, M; Iannarelli, P; Grist, M; Wegner, M; Richardson, WD			Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage	NATURE NEUROSCIENCE			English	Article							ANTERIOR MEDULLARY VELUM; DORSAL SPINAL-CORD; SONIC-HEDGEHOG; NEURAL-TUBE; CEREBRAL-CORTEX; SUBVENTRICULAR ZONE; GABAERGIC NEURONS; BASAL FOREBRAIN; PRECURSOR CELLS; TRANSGENIC MICE	The developmental origin of oligodendrocyte progenitors ( OLPs) in the forebrain has been controversial. We now show, by Cre-lox fate mapping in transgenic mice, that the first OLPs originate in the medial ganglionic eminence ( MGE) and anterior entopeduncular area ( AEP) in the ventral forebrain. From there, they populate the entire embryonic telencephalon including the cerebral cortex before being joined by a second wave of OLPs from the lateral and/or caudal ganglionic eminences ( LGE and CGE). Finally, a third wave arises within the postnatal cortex. When any one population is destroyed at source by the targeted expression of diphtheria toxin, the remaining cells take over and the mice survive and behave normally, with a normal complement of oligodendrocytes and myelin. Thus, functionally redundant populations of OLPs compete for space in the developing brain. Notably, the embryonic MGE- and AEP-derived population is eliminated during postnatal life, raising questions about the nature and purpose of the competition.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Biol, London WC1E 6BT, England; Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany	University of London; University College London; University of London; University College London; University of Erlangen Nuremberg	Richardson, WD (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	n.tekki-kessaris@ucl.ac.uk; w.richardson@ucl.ac.uk	Kessaris, Nicoletta/AAD-6774-2019; Richardson, William/C-1762-2008; Messier, Claude/A-2322-2008; Kessaris, Nicoletta/C-7249-2008	Kessaris, Nicoletta/0000-0003-1191-6009; Richardson, William/0000-0001-7261-2485; Messier, Claude/0000-0002-4791-1763; Kessaris, Nicoletta/0000-0003-1191-6009; Wegner, Michael/0000-0002-4586-3294	Medical Research Council [G9708005, G0800575, G0501173] Funding Source: Medline; Wellcome Trust [066745] Funding Source: Medline; MRC [G0501173, G9708005] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALTMAN J, 1966, EXP NEUROL, V16, P263, DOI 10.1016/0014-4886(66)90063-X; BJARTMAR C, 1994, GLIA, V11, P235, DOI 10.1002/glia.440110304; BREITMAN ML, 1987, SCIENCE, V238, P1563, DOI 10.1126/science.3685993; BUTT AM, 1995, GLIA, V14, P185, DOI 10.1002/glia.440140304; Butt AM, 1997, J NEUROCYTOL, V26, P327, DOI 10.1023/A:1018556702353; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Fogarty M, 2005, DEVELOPMENT, V132, P1951, DOI 10.1242/dev.01777; Fuccillo M, 2004, DEVELOPMENT, V131, P5031, DOI 10.1242/dev.01349; Gorski JA, 2002, J NEUROSCI, V22, P6309; Hall A, 1996, DEVELOPMENT, V122, P4085; HART IK, 1989, DEVELOPMENT, V105, P595; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Ivanova A, 2003, J NEUROSCI RES, V73, P581, DOI 10.1002/jnr.10717; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; LUSKIN MB, 1994, GLIA, V11, P211, DOI 10.1002/glia.440110302; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marshall CAG, 2002, J NEUROSCI, V22, P9821; MAXWELL F, 1987, MOL CELL BIOL, V7, P1576, DOI 10.1128/MCB.7.4.1576; Nery S, 2001, DEVELOPMENT, V128, P527; Olivier C, 2001, DEVELOPMENT, V128, P1757; Orentas DM, 1999, DEVELOPMENT, V126, P2419; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Poncet C, 1996, MECH DEVELOP, V60, P13, DOI 10.1016/S0925-4773(96)00595-3; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 2001, DEVELOPMENT, V128, P4993; Spassky N, 1998, J NEUROSCI, V18, P8331; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; van Heyningen P, 2001, CURR BIOL, V11, P232, DOI 10.1016/S0960-9822(01)00075-6; Villegas EMP, 1999, DEV BIOL, V216, P98, DOI 10.1006/dbio.1999.9438; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	50	746	757	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					173	179		10.1038/nn1620	http://dx.doi.org/10.1038/nn1620			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16388308	Green Accepted			2022-12-17	WOS:000234990100011
J	Dodart, JC; Bales, KR; Gannon, KS; Greene, SJ; DeMattos, RB; Mathis, C; DeLong, CA; Wu, S; Wu, X; Holtzman, DM; Paul, SM				Dodart, JC; Bales, KR; Gannon, KS; Greene, SJ; DeMattos, RB; Mathis, C; DeLong, CA; Wu, S; Wu, X; Holtzman, DM; Paul, SM			Immunization reverses memory deficits without reducing brain A beta burden in Alzheimer's disease model	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; APP(V717F) TRANSGENIC MICE; MOUSE MODEL; APOLIPOPROTEIN-E; PEPTIDE; PATHOLOGY; HYPOTHESIS; PLAQUES	We have previously shown that chronic treatment with the monoclonal antibody m266, which is specific for amyloid beta-peptide (Abeta), increases plasma concentrations of Abeta and reduces Abeta burden in the PDAPP transgenic mouse model of Alzheimer's disease (AD). We now report that administration of m266 to PDAPP mice can rapidly reverse memory deficits in both an object recognition task and a holeboard learning and memory task, but without altering brain Abeta burden. We also found that an Abeta/antibody complex was present in both the plasma and the cerebrospinal fluid of m266-treated mice. Our data indicate that passive immunization with this anti-Abeta monoclonal antibody can very rapidly reverse memory impairment in certain learning and memory tasks in the PDAPP mouse model of AD, owing perhaps to enhanced peripheral clearance and (or) sequestration of a soluble brain Abeta species.	Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA; Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, Alzheimers Dis Res Ctr,Dept Neurol Mol Biol & Pha, St Louis, MO 63110 USA; Univ Strasbourg 1, CNRS, UMR 7521, F-67000 Strasbourg, France	Eli Lilly; Washington University (WUSTL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Paul, SM (corresponding author), Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA.		Paul, Steve/ABE-5400-2020; MATHIS, CHANTAL mb/B-6399-2013	MATHIS, CHANTAL mb/0000-0002-6663-5282				Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2000, NEUROBIOL DIS, V7, P71, DOI 10.1006/nbdi.1999.0278; Dodart JC, 1997, NEUROREPORT, V8, P1173, DOI 10.1097/00001756-199703240-00023; Dodart JC, 2000, REV NEUROSCIENCE, V11, P75; Dodart JC, 1999, BEHAV NEUROSCI, V113, P982, DOI 10.1037/0735-7044.113.5.982; Dodart JC, 2000, NEUROREPORT, V11, P603, DOI 10.1097/00001756-200002280-00034; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Johnson D, 1997, EDN, V42, P94; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Neve RL, 1998, TRENDS NEUROSCI, V21, P15, DOI 10.1016/S0166-2236(97)01168-5; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Sigurdsson EM, 2001, AM J PATHOL, V159, P439, DOI 10.1016/S0002-9440(10)61715-4; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N	22	746	842	0	58	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					452	457		10.1038/nn842	http://dx.doi.org/10.1038/nn842			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11941374				2022-12-17	WOS:000175272000016
J	Arnett, HA; Mason, J; Marino, M; Suzuki, K; Matsushima, GK; Ting, JPY				Arnett, HA; Mason, J; Marino, M; Suzuki, K; Matsushima, GK; Ting, JPY			TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CUPRIZONE-INDUCED DEMYELINATION; GLUTATHIONE-S-TRANSFERASE; NECROSIS-FACTOR RECEPTORS; MULTIPLE-SCLEROSIS; GERMINAL-CENTERS; GENE-EXPRESSION; DEFICIENT MICE; APOPTOSIS	Here we used mice lacking tumor necrosis factor-alpha (TNF alpha) and its associated receptors to study a model of demyelination and remyelination in which these events could be carefully controlled using a toxin, cuprizone. Unexpectedly, the lack of TNF alpha led to a significant delay in remyelination as assessed by histology, immunohistochemistry for myelin proteins and electron microscopy coupled with morphometric analysis. Failure of repair correlated with a reduction in the pool of proliferating oligodendrocyte progenitors (bromodeoxyuridine-labeled NG2(+) cells) followed by a reduction in the number of mature oligodendrocytes. Analysis of mice lacking TNF receptor 1 (TNFR1) or TNFR2 indicated that TNFR2, not TNFR1, is critical to oligodendrocyte regeneration. This unexpected reparative role for TNF alpha in the CNS is important for understanding oligodendrocyte regeneration/proliferation, nerve remyelination and the design of new therapeutics for demyelinating diseases.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med CB7295, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; Mem Sloan Kettering Canc Ctr, Ludwig Inst, New York, NY 10017 USA; Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med CB7295, Chapel Hill, NC 27599 USA.		Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034190] Funding Source: NIH RePORTER; NINDS NIH HHS [NS34190] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; Chaplin DD, 1998, CURR OPIN IMMUNOL, V10, P289, DOI 10.1016/S0952-7915(98)80167-2; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Croxford JL, 2000, J IMMUNOL, V164, P2776, DOI 10.4049/jimmunol.164.5.2776; Declercq W, 1998, J IMMUNOL, V161, P390; Dopp JM, 1997, J NEUROIMMUNOL, V75, P104, DOI 10.1016/S0165-5728(97)00009-X; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Hajihosseini M, 1996, J NEUROSCI, V16, P7981; Haridas V, 1998, J IMMUNOL, V160, P3152; Hinks GL, 2000, MOL CELL NEUROSCI, V16, P542, DOI 10.1006/mcne.2000.0897; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Keirstead HS, 1999, ADV EXP MED BIOL, V468, P183; Korner H, 1997, J EXP MED, V186, P1585, DOI 10.1084/jem.186.9.1585; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; LUDWIN SK, 1978, LAB INVEST, V39, P597; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Mason JL, 2000, J NEUROSCI RES, V61, P251, DOI 10.1002/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; MILLER DJ, 1994, J NEUROSCI, V14, P6230; Morell P, 1998, MOL CELL NEUROSCI, V12, P220, DOI 10.1006/mcne.1998.0715; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.3.CO;2-3; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Raine CS, 1998, REV NEUROL-FRANCE, V154, P577; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; Schiffenbauer J, 2000, CLIN IMMUNOL, V95, P117, DOI 10.1006/clim.2000.4851; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Sidman Richard L., 1971, ATLAS MOUSE BRAIN SP; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; TANSEY FA, 1991, J NEUROCHEM, V57, P95, DOI 10.1111/j.1471-4159.1991.tb02104.x; Tansey FA, 1997, MOL CHEM NEUROPATHOL, V31, P161, DOI 10.1007/BF02815240; TCHELINGERIAN JL, 1995, J NEUROCHEM, V65, P2377; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Weiss T, 1998, J IMMUNOL, V161, P3136; Wu JP, 2000, NEUROSCI LETT, V292, P203, DOI 10.1016/S0304-3940(00)01472-5; YAJIMA K, 1979, LAB INVEST, V41, P385; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2	46	746	763	1	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1116	1122		10.1038/nn738	http://dx.doi.org/10.1038/nn738			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11600888				2022-12-17	WOS:000171970900015
J	Winston, JS; Strange, BA; O'Doherty, J; Dolan, RJ				Winston, JS; Strange, BA; O'Doherty, J; Dolan, RJ			Automatic and intentional brain responses during evaluation of trustworthiness of faces	NATURE NEUROSCIENCE			English	Article							FACIAL EXPRESSIONS; HUMAN AMYGDALA; NEURAL RESPONSES; PERCEPTION; RECOGNITION; EMOTION; FEAR; MIND; ACTIVATION; MECHANISMS	Successful social interaction partly depends on appraisal of others from their facial appearance. A critical aspect of this appraisal relates to whether we consider others to be trustworthy. We determined the neural basis for such trustworthiness judgments using event-related functional magnetic resonance imaging. Subjects viewed faces and assessed either trustworthiness or age. In a parametric factorial design, trustworthiness ratings were correlated with BOLD signal change to reveal task-independent increased activity in bilateral amygdala and right insula in response to faces judged untrustworthy. Right superior temporal sulcus (STS) showed enhanced signal change during explicit trustworthiness judgments alone. The findings extend a proposed model of social cognition by highlighting a functional dissociation between automatic engagement of amygdala versus intentional engagement of STS in social judgment.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Inst Cognit Neurosci, London WC1N 3AR, England; UCL Royal Free & Univ Coll Med Sch, London NW3 2PF, England	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School	Winston, JS (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	j.winston@fil.ion.ucl.ac.uk	O'Doherty, John P/F-1204-2013; Winston, Joel/F-6180-2010; Strange, Bryan A/L-9466-2014; Strange, Bryan/AAF-3805-2019	Winston, Joel/0000-0002-3957-0612; Strange, Bryan A/0000-0001-6476-4091; Strange, Bryan/0000-0001-6476-4091; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Bonda E, 1996, J NEUROSCI, V16, P3737; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Buchel C, 1999, J NEUROSCI, V19, P10869; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Cohen DonaldJ., 2000, UNDERSTANDING OTHER, P334; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A.R., 1999, FEELING WHAT HAPPENS; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Duvernoy HM, 1999, HUMAN BRAIN; Ekman P., 1975, PICTURES FACIAL AFFE; Elliott R, 1998, J NEUROSCI, V18, P4697; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Humphrey N, 1983, CONSCIOUSNESS REGAIN; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 2001, NEUROIMAGE, V13, P1044, DOI 10.1006/nimg.2000.0721; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; Talairach J., 1988, COPLANAR STEREOTAXIC; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Whalen PJ, 1998, J NEUROSCI, V18, P411; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	50	745	753	6	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					277	283		10.1038/nn816	http://dx.doi.org/10.1038/nn816			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850635	Green Published			2022-12-17	WOS:000174146000020
J	Bengtsson, SL; Nagy, Z; Skare, S; Forsman, L; Forssberg, H; Ullen, F				Bengtsson, SL; Nagy, Z; Skare, S; Forsman, L; Forssberg, H; Ullen, F			Extensive piano practicing has regionally specific effects on white matter development	NATURE NEUROSCIENCE			English	Article							CORPUS-CALLOSUM; BRAIN; ADOLESCENTS; MATURATION; CHILDHOOD; CHILDREN; MRI	Using diffusion tensor imaging, we investigated effects of piano practicing in childhood, adolescence and adulthood on white matter, and found positive correlations between practicing and fiber tract organization in different regions for each age period. For childhood, practicing correlations were extensive and included the pyramidal tract, which was more structured in pianists than in non-musicians. Long-term training within critical developmental periods may thus induce regionally specific plasticity in myelinating tracts.	Karolinska Inst, Dept Woman & Child Hlth, SE-17177 Stockholm, Sweden; Karolinska Hosp, Karolinska MR Res Ctr, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Ullen, F (corresponding author), Karolinska Inst, Dept Woman & Child Hlth, SE-17177 Stockholm, Sweden.	Fredrik.Ullen@neuro.ki.se	Nagy, Zoltan/AAI-2485-2019; Forssberg, Hans/A-2944-2009	Nagy, Zoltan/0000-0001-6611-6362; Forssberg, Hans/0000-0003-2069-6618; Bengtsson, Sara/0000-0003-0887-7344; Bengtsson, Sara/0000-0003-4567-102X				Armand J., 1996, P125, DOI 10.1016/B978-012759440-8/50010-4; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Gaser C, 2003, J NEUROSCI, V23, P9240; Giedd JN, 1996, DEV BRAIN RES, V91, P274; GYLLENSTEN L, 1963, J EMBRYOL EXP MORPH, V11, P255; Keshavan MS, 2002, LIFE SCI, V70, P1909, DOI 10.1016/S0024-3205(02)01492-3; Krampe RT, 1996, J EXP PSYCHOL GEN, V125, P331, DOI 10.1037/0096-3445.125.4.331; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Yakovlev PL, 1967, REGIONAL DEV BRAIN E, P3	15	737	751	1	166	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2005	8	9					1148	1150		10.1038/nn1516	http://dx.doi.org/10.1038/nn1516			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	958YJ	16116456				2022-12-17	WOS:000231483800013
J	Ajami, B; Bennett, JL; Krieger, C; McNagny, KM; Rossi, FMV				Ajami, Bahareh; Bennett, Jami L.; Krieger, Charles; McNagny, Kelly M.; Rossi, Fabio M. V.			Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool	NATURE NEUROSCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; PERIVASCULAR CELLS; CNS; MACROPHAGES; MIGRATION; PATHOGENESIS	In multiple sclerosis and the experimental autoimmune encephalitis (EAE) mouse model, two pools of morphologically indistinguishable phagocytic cells, microglia and inflammatory macrophages, accrue from proliferating resident precursors and recruitment of blood-borne progenitors, respectively. Whether these cell types are functionally equivalent is hotly debated, but is challenging to address experimentally. Using a combination of parabiosis and myeloablation to replace circulating progenitors without affecting CNS-resident microglia, we found a strong correlation between monocyte infiltration and progression to the paralytic stage of EAE. Inhibition of chemokine receptor-dependent recruitment of monocytes to the CNS blocked EAE progression, suggesting that these infiltrating cells are essential for pathogenesis. Finally, we found that, although microglia can enter the cell cycle and return to quiescence following remission, recruited monocytes vanish, and therefore do not ultimately contribute to the resident microglial pool. In conclusion, we identified two distinct subsets of myelomonocytic cells with distinct roles in neuroinflammation and disease progression.	[Ajami, Bahareh; Bennett, Jami L.; Krieger, Charles; McNagny, Kelly M.; Rossi, Fabio M. V.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada	University of British Columbia	Rossi, FMV (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	fabio@brc.ubc.ca	Ajami, Bahareh/AAA-7262-2019; McNagny, Kelly/P-5239-2014; Rossi, Fabio MV/B-5587-2013	McNagny, Kelly/0000-0003-4737-3499; Rossi, Fabio MV/0000-0002-0368-2620	Canadian Institute for Health Research (CIHR) [MOP 81382]; Multiple Sclerosis Society of Canada; Amyotrophic Lateral Sclerosis Society of Canada; Muscular Dystrophy Canada [JNM-69682]; Natural Science and Engineering Research Council of Canada [CHRP 299119]; Michael Smith Foundation for Health Research Senior Scholar; Michael Smith Foundation; Canadian Research Chairs program	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Amyotrophic Lateral Sclerosis Society of Canada; Muscular Dystrophy Canada(Muscular Dystrophy Association); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Foundation for Health Research Senior Scholar(Michael Smith Foundation for Health Research); Michael Smith Foundation(Michael Smith Foundation for Health Research); Canadian Research Chairs program(Canada Research Chairs)	We thank B. Chua, T. Godbey, K. Ranta, M. Cowan, L. Rollins and the Biomedical Research Center animal unit personnel for advice and help on animal welfare. We thank A. Johnson, C. K. Chang, J. Kang and D. Mahdaviani for their technical help. This work was supported by Canadian Institute for Health Research (CIHR, MOP 81382) grants and a grant from the Multiple Sclerosis Society of Canada to F.M. V.R., a Neuromuscular Research Partnership grant from the CIHR, a grant from the Amyotrophic Lateral Sclerosis Society of Canada and Muscular Dystrophy Canada to C.K. and F.M.V.R. (JNM-69682), a Collaborative Health Research grant from the CIHR and the Natural Science and Engineering Research Council of Canada to C.K. and F.M.V.R. (CHRP 299119), and a research grant from the Multiple Sclerosis Society of Canada to K.M.M. K.M.M. is a Michael Smith Foundation for Health Research Senior Scholar. B. A is supported by a Michael Smith Foundation Senior Graduate Studentship and a CIHR-Amyotrophic Lateral Sclerosis Doctoral Research Award. J.L.B. is supported by a Multiple Sclerosis Society of Canada Postdoctoral Research Fellowship. This research was undertaken, in part, thanks to funding from the Canadian Research Chairs program to F.M.V.R.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Bauer J, 1995, GLIA, V15, P437, DOI 10.1002/glia.440150407; BAUER J, 1994, J NEUROSCI RES, V38, P365, DOI 10.1002/jnr.490380402; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; BROSNAN CF, 1981, J IMMUNOL, V126, P614; BUKILICA M, 1991, INT J NEUROSCI, V59, P167, DOI 10.3109/00207459108985460; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Diserbo M, 2002, CAN J PHYSIOL PHARM, V80, P670, DOI 10.1139/Y02-070; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Hickey WF, 1991, BRAIN PATHOL, V1, P97, DOI 10.1111/j.1750-3639.1991.tb00646.x; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kennedy DW, 1997, BLOOD, V90, P986, DOI 10.1182/blood.V90.3.986.986_986_993; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; KRALL WJ, 1994, BLOOD, V83, P2737; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Li YQ, 2004, RADIAT RES, V161, P143, DOI 10.1667/RR3117; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; MASON D, 1991, IMMUNOL TODAY, V12, P57, DOI 10.1016/0167-5699(91)90158-P; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Raivich G, 2005, TRENDS NEUROSCI, V28, P571, DOI 10.1016/j.tins.2005.09.001; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Santambrogio L, 2001, P NATL ACAD SCI USA, V98, P6295, DOI 10.1073/pnas.111152498; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Streit WJ, 2002, E SCHERING RES FDN W, V39, P11; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; SWANBORG RH, 1995, CLIN IMMUNOL IMMUNOP, V77, P4, DOI 10.1016/0090-1229(95)90130-2; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732, DOI 10.1002/jlb.56.6.732; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Wujek JR, 2002, J NEUROPATH EXP NEUR, V61, P23, DOI 10.1093/jnen/61.1.23; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	50	735	748	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1142	U263		10.1038/nn.2887	http://dx.doi.org/10.1038/nn.2887			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	812ID	21804537				2022-12-17	WOS:000294284900014
J	Yu, FH; Mantegazza, M; Westenbroek, RE; Robbins, CA; Kalume, F; Burton, KA; Spain, WJ; McKnight, GS; Scheuer, T; Catterall, WA				Yu, Frank H.; Mantegazza, Massimo; Westenbroek, Ruth E.; Robbins, Carol A.; Kalume, Franck; Burton, Kimberly A.; Spain, William J.; McKnight, G. Stanley; Scheuer, Todd; Catterall, William A.			Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; SCN1A MUTATIONS; CHANNEL SUBTYPES; NERVOUS-SYSTEM; GENE SCN1A; SUBUNIT; SUSCEPTIBILITY; SEIZURES; MICE; EXPRESSION	Voltage-gated sodium channels (Na-V) are critical for initiation of action potentials. Heterozygous loss-of-function mutations in Na(V)1.1 channels cause severe myoclonic epilepsy in infancy (SMEI). Homozygous null Scn1a(-/-) mice developed ataxia and died on postnatal day (P) 15 but could be sustained to P17.5 with manual feeding. Heterozygous Scn1a(+/-) mice had spontaneous seizures and sporadic deaths beginning after P21, with a notable dependence on genetic background. Loss of Na(V)1.1 did not change voltage-dependent activation or inactivation of sodium channels in hippocampal neurons. The sodium current density was, however, substantially reduced in inhibitory interneurons of Scn1a(+/-) and Scn1a(-/-) mice but not in their excitatory pyramidal neurons. An immunocytochemical survey also showed a specific upregulation of Na(V)1.3 channels in a subset of hippocampal interneurons. Our results indicate that reduced sodium currents in GABAergic inhibitory interneurons in Scn1a(+/-) heterozygotes may cause the hyperexcitability that leads to epilepsy in patients with SMEI.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Inst Neurol Besta, Dept Neurophysiol, I-20126 Milan, Italy	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; IRCCS Istituto Neurologico Besta	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@u.washington.edu	Ritter, Stefanie L/D-9312-2012; Mantegazza, Massimo/J-8802-2016	Mantegazza, Massimo/0000-0002-1070-7929; Yu, Frank/0000-0001-9306-1731				BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; BRANDON EP, 1995, RECENT PROG HORM RES, V50, P403; Buckmaster PS, 1999, J NEUROSCI, V19, P9519; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Cantrell AR, 1996, NEURON, V16, P1019, DOI 10.1016/S0896-6273(00)80125-7; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Ceulemans B, 2004, J CHILD NEUROL, V19, P516, DOI 10.1177/08830738040190070701; Claes L, 2003, HUM MUTAT, V21, P615, DOI 10.1002/humu.10217; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Coppola G, 2002, EPILEPSY RES, V49, P45, DOI 10.1016/S0920-1211(02)00010-4; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Dravet Charlotte, 1992, P75; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Escayg A, 2001, AM J HUM GENET, V68, P866, DOI 10.1086/319524; FERRARO TN, 1995, EPILEPSIA, V36, P301, DOI 10.1111/j.1528-1157.1995.tb00999.x; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Ferraro TN, 2002, BRAIN RES, V936, P82, DOI 10.1016/S0006-8993(02)02565-9; Frankel WN, 2001, GENOMICS, V74, P306, DOI 10.1006/geno.2001.6564; Fujiwara T, 2003, BRAIN, V126, P531, DOI 10.1093/brain/awg053; Fukuma G, 2004, EPILEPSIA, V45, P140, DOI 10.1111/j.0013-9580.2004.15103.x; Gong B, 1999, J COMP NEUROL, V412, P342; GORDON D, 1987, P NATL ACAD SCI USA, V84, P8682, DOI 10.1073/pnas.84.23.8682; Guerrini R, 1998, EPILEPSIA, V39, P508, DOI 10.1111/j.1528-1157.1998.tb01413.x; Isom LL, 2002, FRONT BIOSCI, V7, P12; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Krzemien DM, 2000, J COMP NEUROL, V420, P70; LOTHMAN EW, 1992, EPILEPSY RES, P301; Mulley JC, 2005, HUM MUTAT, V25, P535, DOI 10.1002/humu.20178; Nabbout R, 2003, NEUROLOGY, V60, P1961, DOI 10.1212/01.WNL.0000069463.41870.2F; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Oguni H, 2001, BRAIN DEV-JPN, V23, P736, DOI 10.1016/S0387-7604(01)00276-5; Ohmori I, 2002, BIOCHEM BIOPH RES CO, V295, P17, DOI 10.1016/S0006-291X(02)00617-4; Royle SJ, 1999, BRAIN RES, V816, P337, DOI 10.1016/S0006-8993(98)01122-6; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; SCHEINMAN RI, 1989, J BIOL CHEM, V264, P10660; SCHWARTZKROIN PA, 1994, HIPPOCAMPUS, V4, P239, DOI 10.1002/hipo.450040302; Singh R, 2001, EPILEPSIA, V42, P837, DOI 10.1046/j.1528-1157.2001.042007837.x; Sugawara T, 2002, NEUROLOGY, V58, P1122, DOI 10.1212/WNL.58.7.1122; Walls A. F., 2001, Clinical and Experimental Allergy Reviews, V1, P68, DOI 10.1046/j.1472-9725.2001.00009.x; WESTENBROEK RE, 1992, J NEUROSCI, V12, P2259, DOI 10.1523/jneurosci.12-06-02259.1992; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Yu FH, 2003, J NEUROSCI, V23, P7577; YU FH, 2004, SCI STKE; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	50	733	800	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1142	1149		10.1038/nn1754	http://dx.doi.org/10.1038/nn1754			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921370				2022-12-17	WOS:000240080800015
J	Dias, BG; Ressier, KJ				Dias, Brian G.; Ressier, Kerry J.			Parental olfactory experience influences behavior and neural structure in subsequent generations	NATURE NEUROSCIENCE			English	Article							EPIGENETIC INHERITANCE; TRANSGENERATIONAL INHERITANCE; ODORANT RECEPTORS; GENE-EXPRESSION; MATERNAL-CARE; STRESS; EXPOSURE; ANXIETY; MOUSE; METHYLATION	Using olfactory molecular specificity, we examined the inheritance of parental traumatic exposure, a phenomenon that has been frequently observed, but not understood. We subjected F0 mice to odor fear conditioning before conception and found that subsequently conceived F1 and F2 generations had an increased behavioral sensitivity to the F0-conditioned odor, but not to other odors. When an odor (acetophenone) that activates a known odorant receptor (Olfr151) was used to condition F0 mice, the behavioral sensitivity of the F1 and F2 generations to acetophenone was complemented by an enhanced neuroanatomical representation of the Olfr151 pathway. Bisulfite sequencing of sperm DNA from conditioned F0 males and F1 naive offspring revealed CpG hypomethylation in the Olfr151 gene. In addition, in vitro fertilization, F2 inheritance and cross-fostering revealed that these transgenerational effects are inherited via parental gametes. Our findings provide a framework for addressing how environmental information may be inherited transgenerationally at behavioral, neuroanatomical and epigenetic levels.	[Dias, Brian G.; Ressier, Kerry J.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Dias, Brian G.; Ressier, Kerry J.] Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Ressier, Kerry J.] Howard Hughes Med Inst, Chevy Chase, MD USA	Emory University; Howard Hughes Medical Institute	Dias, BG (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	bdias@emory.edu	Ressler, Kerry J/N-8741-2018	Ressler, Kerry J/0000-0002-5158-1103	Howard Hughes Medical Institute; Burroughs Wellcome Fund; US National Institutes of Health NCRR base grant [P51RR00-0165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); US National Institutes of Health NCRR base grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank the animal care staff in the Yerkes Neuroscience Vivarium for assistance with animal husbandry. A. Magldara, S. Lomvardas, B. Carone, O. Rando and A.F.H.M. Peters provided invaluable input on the ChIP experiments. We would like to thank H. Zhang and the staff of the Emory Transgenic Mouse/Gene Targeting Core Facility for assistance with IVF studies. Bisulfite conversion of sperm DNA and sequencing was carried out by Active Motif and we especially thank P. Labhart for addressing our data interpretation queries. Finally, we are grateful to S. Banerjee, R. Andero-Gali, D. Choi, J. Goodman and F. Morrison for help with ensuring double-blindness of data acquisition and analysis, and members of the Ressler laboratory, S. Gourley and M. Davis for helpful feedback on the manuscript. Funding for this study was provided by the Howard Hughes Medical Institute and the Burroughs Wellcome Fund to K.J.R., and a US National Institutes of Health NCRR base grant (P51RR00-0165) to Yerkes National Primate Research Center.	Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Crews D, 2007, P NATL ACAD SCI USA, V104, P5942, DOI 10.1073/pnas.0610410104; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; Dietz DM, 2011, BIOL PSYCHIAT, V70, P408, DOI 10.1016/j.biopsych.2011.05.005; Fleischmann A, 2008, NEURON, V60, P1068, DOI 10.1016/j.neuron.2008.10.046; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Glinka ME, 2012, J NEUROSCI, V32, P6718, DOI 10.1523/JNEUROSCI.4287-11.2012; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hebb ALO, 2003, BRAIN RES, V982, P195, DOI 10.1016/S0006-8993(03)03008-7; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones SV, 2008, J NEUROSCI, V28, P13106, DOI 10.1523/JNEUROSCI.4465-08.2008; Jovanovic T, 2011, J CHILD PSYCHOL PSYC, V52, P844, DOI 10.1111/j.1469-7610.2011.02410.x; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; MARUNIAK JA, 1983, BRAIN RES, V265, P312, DOI 10.1016/0006-8993(83)90348-7; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rechavi O, 2011, CELL, V147, P1248, DOI 10.1016/j.cell.2011.10.042; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; STICKROD G, 1982, PHYSIOL BEHAV, V28, P5, DOI 10.1016/0031-9384(82)90093-2; Storm JJ, 2010, AM NAT, V175, P382, DOI 10.1086/650443; Todrank J, 2011, P ROY SOC B-BIOL SCI, V278, P1949, DOI 10.1098/rspb.2010.2314; van der Heijden GW, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-34; Vanderhaeghen P, 1997, GENOMICS, V39, P239, DOI 10.1006/geno.1996.4490; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Vassoler FM, 2013, NAT NEUROSCI, V16, P42, DOI 10.1038/nn.3280; Weaver ICG, 2007, EPIGENETICS, V2, P22, DOI 10.4161/epi.2.1.3881; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weinstock M, 2010, ISR J PSYCHIATR REL, V47, P36	50	725	743	15	413	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2014	17	1					89	96		10.1038/nn.3594	http://dx.doi.org/10.1038/nn.3594			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	281DL	24292232	Green Accepted			2022-12-17	WOS:000329080000018
J	Bjorklund, A; Lindvall, O				Bjorklund, A; Lindvall, O			Cell replacement therapies for central nervous system disorders	NATURE NEUROSCIENCE			English	Editorial Material							NEURAL PROGENITOR CELLS; PARKINSONS-DISEASE; STEM-CELLS; DOPAMINERGIC TRANSPLANTS; NEURONAL DIFFERENTIATION; STRIATAL TRANSPLANTS; FUNCTIONAL RECOVERY; CEREBRAL-ISCHEMIA; BRAIN INFARCTS; PRIMATE MODEL	In animal models, immature neural precursors can replace lest neurons, restore function and promote brain self-repair Clinical trials in Parkinson's disease suggest that similar approaches may also work in the diseased human brain. But how realistic is it that cell replacement can he developed into effective clinical therapy?	Univ Lund, Wallenberg Neurosci Ctr, S-22362 Lund, Sweden	Lund University	Bjorklund, A (corresponding author), Univ Lund, Wallenberg Neurosci Ctr, Solvegatan 17, S-22362 Lund, Sweden.		Björklund, Anders/ABA-1326-2020	Bjorklund, Anders/0000-0002-5676-6203				ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ANNETT LE, 1994, FUNCTIONAL NEURAL TR, P71; Bachoud-Levi AC, 2000, EXP NEUROL, V161, P194, DOI 10.1006/exnr.1999.7239; Bjorklund A, 1992, Curr Opin Neurobiol, V2, P683, DOI 10.1016/0959-4388(92)90039-N; Bjorklund A., 1994, FUNCTIONAL NEURAL TR, P157; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; Borlongan CV, 1998, NEUROREPORT, V9, P3703, DOI 10.1097/00001756-199811160-00025; Brasted PJ, 1999, P NATL ACAD SCI USA, V96, P10524, DOI 10.1073/pnas.96.18.10524; Brundin P, 1994, FUNCTIONAL NEURAL TR, V2, P9; Clough R, 1996, NEUROREPORT, V8, P341, DOI 10.1097/00001756-199612200-00067; DOUCET G, 1989, EXP NEUROL, V106, P1, DOI 10.1016/0014-4886(89)90139-8; Duncan ID, 1997, MOL MED TODAY, V3, P554, DOI 10.1016/S1357-4310(97)01162-3; Dunnett S. B., 1994, FUNCTIONAL NEURAL TR, P531; DUNNETT SB, 1987, BRAIN RES, V415, P63, DOI 10.1016/0006-8993(87)90269-1; DUNNETT SB, 1995, BEHAV BRAIN RES, V66, P133, DOI 10.1016/0166-4328(94)00134-2; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Ferencz I, 1998, EUR J NEUROSCI, V10, P213; FISHER LJ, 1991, NEUROSCIENCE, V40, P109, DOI 10.1016/0306-4522(91)90178-Q; Flax JD, 1998, NAT BIOTECHNOL, V16, P1033, DOI 10.1038/3473; FORNI C, 1989, EXP BRAIN RES, V76, P75, DOI 10.1007/BF00253625; Freeman TB, 1999, NEW ENGL J MED, V341, P988, DOI 10.1056/NEJM199909233411311; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; HERMAN JP, 1994, PROG NEUROBIOL, V44, P1, DOI 10.1016/0301-0082(94)90055-8; HernitGrant CS, 1996, EXP NEUROL, V139, P131, DOI 10.1006/exnr.1996.0088; Hodges H, 1996, NEUROSCIENCE, V72, P959, DOI 10.1016/0306-4522(96)00004-8; Hodges H, 1994, FUNCTIONAL NEURAL TR, P347; HUDSON JL, 1994, J NEUROSCI, V14, P283; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Kendall AL, 1998, NAT MED, V4, P727, DOI 10.1038/nm0698-727; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; KOKAIA M, 1994, EXP BRAIN RES, V100, P385, DOI 10.1007/BF02738399; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; Kordower JH, 1998, MOVEMENT DISORD, V13, P383, DOI 10.1002/mds.870130303; Lindvall O, 1999, MOVEMENT DISORD, V14, P201, DOI 10.1002/1531-8257(199903)14:2<201::AID-MDS1001>3.3.CO;2-H; Lindvall O, 1994, FUNCTIONAL NEURAL TR, P387; Ling ZD, 1998, EXP NEUROL, V149, P411, DOI 10.1006/exnr.1998.6715; Loscher W, 1998, J NEUROSCI RES, V51, P196; Lundberg C, 1996, NEUROBIOL DIS, V3, P33, DOI 10.1006/nbdi.1996.0004; Mattsson B, 1997, STROKE, V28, P1225, DOI 10.1161/01.STR.28.6.1225; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; Olanow CW, 1996, TRENDS NEUROSCI, V19, P102, DOI 10.1016/S0166-2236(96)80038-5; Palfi S, 1998, NAT MED, V4, P963, DOI 10.1038/nm0898-963; Philpott LM, 1997, CELL TRANSPLANT, V6, P203, DOI 10.1016/S0963-6897(97)00028-6; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Potter ED, 1999, CELL TISSUE RES, V296, P235, DOI 10.1007/s004410051285; Raisman G, 1997, REV NEUROL, V153, P521; Shihabuddin LS, 1996, EXP NEUROL, V139, P61, DOI 10.1006/exnr.1996.0081; Sinden JD, 1997, NEUROSCIENCE, V81, P599, DOI 10.1016/S0306-4522(97)00330-8; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Sorensen JC, 1996, EXP NEUROL, V138, P227, DOI 10.1006/exnr.1996.0061; SOTELO C, 1991, TRENDS NEUROSCI, V14, P350, DOI 10.1016/0166-2236(91)90161-M; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Thompson K, 2000, EXP NEUROL, V161, P481, DOI 10.1006/exnr.1999.7305; Wagner J, 1999, NAT BIOTECHNOL, V17, P653, DOI 10.1038/10862; WICTORIN K, 1992, PROG NEUROBIOL, V38, P611, DOI 10.1016/0301-0082(92)90044-F; Winkler C, 1999, EXP NEUROL, V155, P165, DOI 10.1006/exnr.1998.6916; ZUDDAS A, 1991, EUR J NEUROSCI, V3, P72, DOI 10.1111/j.1460-9568.1991.tb00813.x	61	725	806	0	98	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					537	544		10.1038/75705	http://dx.doi.org/10.1038/75705			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816308				2022-12-17	WOS:000087249500008
J	Krajbich, I; Armel, C; Rangel, A				Krajbich, Ian; Armel, Carrie; Rangel, Antonio			Visual fixations and the computation and comparison of value in simple choice	NATURE NEUROSCIENCE			English	Article							PERCEPTUAL DECISION-MAKING; 2-CHOICE REACTION-TIME; ORBITOFRONTAL CORTEX; SENSORY STIMULI; FIELD-THEORY; NEURAL BASIS; AREA LIP; MODELS; BEHAVIOR; MICROSTIMULATION	Most organisms facing a choice between multiple stimuli will look repeatedly at them, presumably implementing a comparison process between the items' values. Little is known about the nature of the comparison process in value-based decision-making or about the role of visual fixations in this process. We created a computational model of value-based binary choice in which fixations guide the comparison process and tested it on humans using eye-tracking. We found that the model can quantitatively explain complex relationships between fixation patterns and choices, as well as several fixation-driven decision biases.	[Krajbich, Ian; Rangel, Antonio] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; [Armel, Carrie] Stanford Univ, Precourt Inst Energy Efficiency, Palo Alto, CA 94304 USA	California Institute of Technology; Stanford University	Rangel, A (corresponding author), CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA.	rangel@hss.caltech.edu			Moore Foundation	Moore Foundation(Gordon and Betty Moore Foundation)	We thank E. Johnson, P. Bossaerts and C. Koch for comments and J. Pulst-Korenberg for help with data collection. This work received financial support from the Moore Foundation.	Arana FS, 2003, J NEUROSCI, V23, P9632; Armel KC, 2008, JUDGM DECIS MAK, V3, P396; Bogacz R, 2007, TRENDS COGN SCI, V11, P118, DOI 10.1016/j.tics.2006.12.006; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Busemeyer J. R., 2004, BLACKWELL HDB JUDGME, P133, DOI DOI 10.1002/9780470752937.CH7; BUSEMEYER JR, 1993, PSYCHOL REV, V100, P432, DOI 10.1037/0033-295X.100.3.432; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Erk S, 2002, NEUROREPORT, V13, P2499, DOI 10.1097/00001756-200212200-00024; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; LAMING D, 1979, ACTA PSYCHOL, V43, P431, DOI 10.1016/0001-6918(79)90001-5; Link SW, 1992, WAVE THEORY DIFFEREN; Luce RD, 1986, RESPONSE TIMES; Mas-Colell A., 1995, MICROECONOMIC THEORY; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Paulus MP, 2003, NEUROREPORT, V14, P1311, DOI 10.1097/01.wnr.0000078543.07662.02; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Roe RM, 2001, PSYCHOL REV, V108, P370, DOI 10.1037//0033-295X.108.2.370; Roitman JD, 2002, J NEUROSCI, V22, P9475; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Smith PL, 2000, J MATH PSYCHOL, V44, P408, DOI 10.1006/jmps.1999.1260; SMITH PL, 1995, PSYCHOL REV, V102, P567, DOI 10.1037/0033-295X.102.3.567; Spezio ML, 2007, J AUTISM DEV DISORD, V37, P929, DOI 10.1007/s10803-006-0232-9; STONE M, 1960, PSYCHOMETRIKA, V25, P251, DOI 10.1007/BF02289729; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Valentin VV, 2007, J NEUROSCI, V27, P4019, DOI 10.1523/JNEUROSCI.0564-07.2007; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334	46	722	733	9	169	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2010	13	10					1292	1298		10.1038/nn.2635	http://dx.doi.org/10.1038/nn.2635			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	654MB	20835253				2022-12-17	WOS:000282171300023
J	Denise, A; Garcia, R; Doan, NB; Imura, T; Bush, TG; Sofroniew, MV				Denise, A; Garcia, R; Doan, NB; Imura, T; Bush, TG; Sofroniew, MV			GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain	NATURE NEUROSCIENCE			English	Article							FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; RADIAL GLIAL-CELLS; NEURAL STEM-CELLS; INTERMEDIATE-FILAMENT PROTEIN; SITE-SPECIFIC RECOMBINATION; TRANSGENIC MICE; IN-VIVO; MAMMALIAN FOREBRAIN; SUBVENTRICULAR ZONE	Establishing the cellular identity in vivo of adult multipotent neural progenitors is fundamental to understanding their biology. We used two transgenic strategies to determine the relative contribution of glial fibrillary acidic protein (GFAP)-expressing progenitors to constitutive neurogenesis in the adult forebrain. Transgenically targeted ablation of dividing GFAP-expressing cells in the adult mouse subependymal and subgranular zones stopped the generation of immunohistochemically identified neuroblasts and new neurons in the olfactory bulb and the hippocampal dentate gyrus. Transgenically targeted cell fate mapping showed that essentially all neuroblasts and neurons newly generated in the adult mouse forebrain in vivo, and in adult multipotent neurospheres in vitro, derived from progenitors that expressed GFAP. Constitutively dividing GFAP-expressing progenitors showed predominantly bipolar or unipolar morphologies with significantly fewer processes than non-neurogenic multipolar astrocytes. These findings identify morphologically distinctive GFAP-expressing progenitor cells as the predominant sources of constitutive adult neurogenesis, and provide new methods for manipulating and investigating these cells.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sofroniew, MV (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	sofroniew@mednet.ucla.edu	Sofroniew, Michael/ABE-8857-2020; Garcia, Anna Denise/G-5884-2013		NINDS NIH HHS [NS47386, NS042693] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS042693, R01NS047386] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Balzarini J, 1998, GENE THER, V5, P419, DOI 10.1038/sj.gt.3300586; BORRELLI E, 1989, NATURE, V339, P538, DOI 10.1038/339538a0; Buniatian G, 1998, BIOL CELL, V90, P53, DOI 10.1016/S0248-4900(98)80232-3; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Imura T, 2003, J NEUROSCI, V23, P2824; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; JOHNSON WB, 1995, GLIA, V13, P174, DOI 10.1002/glia.440130304; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Mathis C, 2000, J NEUROSCI, V20, P7698; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Morshead CM, 2003, EUR J NEUROSCI, V18, P76, DOI 10.1046/j.1460-9568.2003.02727.x; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Neubauer K, 1996, J HEPATOL, V24, P719, DOI 10.1016/S0168-8278(96)80269-8; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICKMANN M, 1987, J COMP NEUROL, V264, P449, DOI 10.1002/cne.902640403; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sauer Brian, 1994, Current Opinion in Biotechnology, V5, P521, DOI 10.1016/0958-1669(94)90068-X; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	50	721	758	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1233	1241		10.1038/nn1340	http://dx.doi.org/10.1038/nn1340			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494728				2022-12-17	WOS:000224749400016
J	Chapin, JK; Moxon, KA; Markowitz, RS; Nicolelis, MAL				Chapin, JK; Moxon, KA; Markowitz, RS; Nicolelis, MAL			Real-time control of a robot arm using simultaneously recorded neurons in the motor cortex	NATURE NEUROSCIENCE			English	Article							SOMATIC SENSORY TRANSMISSION; MOVEMENT; RAT; PATTERNS; RESTORATION; MODULATION; ENSEMBLES; THALAMUS	To determine whether simultaneously recorded motor cortex neurons can be used for real-time device control, rats were trained to position a robot arm to obtain water by pressing a lever. Mathematical transformations, including neural networks, converted multineuron signals into 'neuronal population functions' that accurately predicted lever trajectory. Next, these functions were electronically converted into real-time signals for robot arm control. After switching to this 'neurorobotic' mode, 4 of 6 animals (those with >25 task-related neurons) routinely used these brain-derived signals to position the robot arm and obtain water. With continued training in neurorobotic mode, the animals' lever movement diminished or stopped. These results suggest a possible means for movement restoration in paralysis patients.	MCP Hahnemann Sch Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Drexel University; Duke University	Chapin, JK (corresponding author), MCP Hahnemann Sch Med, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA.	chapinj@mcphu.edu	Moxon, Karen/K-7407-2012	Moxon, Karen/0000-0002-5790-097X	NINDS NIH HHS [NS26722, NS62352] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026722] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bhadra N, 1997, J CLIN NEUROPHYSIOL, V14, P378, DOI 10.1097/00004691-199709000-00004; CHAPIN JK, 1982, EXP NEUROL, V78, P654, DOI 10.1016/0014-4886(82)90082-6; CHAPIN JK, 1986, EXP NEUROL, V91, P502, DOI 10.1016/0014-4886(86)90048-8; Chapin JK, 1996, EEG CL N SU, P113; CHAPIN JK, 1982, EXP NEUROL, V78, P670, DOI 10.1016/0014-4886(82)90083-8; CHAPIN JK, 1998, NEURONAL POPULATION, P193; CHAPIN JK, 1987, NEURAL BEHAV APPROAC, P201; Deadwyler SA, 1997, ANNU REV NEUROSCI, V20, P217, DOI 10.1146/annurev.neuro.20.1.217; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DONOGHUE JP, 1985, BRAIN RES, V333, P173, DOI 10.1016/0006-8993(85)90141-6; DORMONT JF, 1982, EXP BRAIN RES, V48, P315; ERICKSON RP, 1968, PSYCHOL REV, V75, P447, DOI 10.1037/h0026752; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; FETZ E, 1972, BRAIN RES, V40, P19, DOI 10.1016/0006-8993(72)90100-X; FETZ EB, 1971, SCIENCE, V174, P431, DOI 10.1126/science.174.4007.431; FETZ EE, 1973, J NEUROPHYSIOL, V36, P179, DOI 10.1152/jn.1973.36.2.179; FETZ EE, 1969, SCIENCE, V163, P955, DOI 10.1126/science.163.3870.955; FETZ EE, 1975, EXP BRAIN RES, V23, P217; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Ghez C, 1982, Electroencephalogr Clin Neurophysiol Suppl, V36, P409; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Kennedy PR, 1998, NEUROREPORT, V9, P1707, DOI 10.1097/00001756-199806010-00007; Lukashin AV, 1996, NEUROREPORT, V7, P2597, DOI 10.1097/00001756-199611040-00038; MOORE GP, 1966, ANNU REV PHYSIOL, V28, P493, DOI 10.1146/annurev.ph.28.030166.002425; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; NICOLELIS MAL, 1993, P NATL ACAD SCI USA, V90, P2212, DOI 10.1073/pnas.90.6.2212; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; Nicolelis MAL, 1997, J NEUROPHYSIOL, V78, P1691, DOI 10.1152/jn.1997.78.3.1691; SANES JN, 1988, P NATL ACAD SCI USA, V85, P2003, DOI 10.1073/pnas.85.6.2003; SCHMIDT EM, 1980, ANN BIOMED ENG, V8, P339, DOI 10.1007/BF02363437; SCHMIDT EM, 1975, BRAIN RES, V83, P213, DOI 10.1016/0006-8993(75)90931-2; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; SHIN HC, 1990, EXP BRAIN RES, V81, P515, DOI 10.1007/BF02423500; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462	36	720	775	4	150	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					664	670		10.1038/10223	http://dx.doi.org/10.1038/10223			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404201				2022-12-17	WOS:000083882600019
J	Thompson, PM; Cannon, TD; Narr, KL; van Erp, T; Poutanen, VP; Huttunen, M; Lonnqvist, J; Standertskjold-Nordenstam, CG; Kaprio, J; Khaledy, M; Dail, R; Zoumalan, CI; Toga, AW				Thompson, PM; Cannon, TD; Narr, KL; van Erp, T; Poutanen, VP; Huttunen, M; Lonnqvist, J; Standertskjold-Nordenstam, CG; Kaprio, J; Khaledy, M; Dail, R; Zoumalan, CI; Toga, AW			Genetic influences on brain structure	NATURE NEUROSCIENCE			English	Article							MONOZYGOTIC TWINS; COGNITIVE-ABILITIES; HERITABILITY; INTELLIGENCE; SCHIZOPHRENIA; CORTEX; SIZE; IQ; ABNORMALITIES; VARIABILITY	Here we report on detailed three-dimensional maps revealing how brain structure is influenced by individual genetic differences. A genetic continuum was detected in which brain structure was increasingly similar in subjects with increasing genetic affinity. Genetic factors significantly influenced cortical structure in Broca's and Wernicke's language areas, as well as frontal brain regions (r(MZ)(2) > 0.8, p < 0.05). Preliminary correlations were performed suggesting that frontal gray matter differences may be linked to Spearman's g, which measures successful test performance across multiple cognitive domains (p < 0.05). These genetic brain maps reveal how genes determine individual differences, and may shed light on the heritability of cognitive and linguistic skills, as well as genetic liability for diseases that affect the human cortex.	Univ Calif Los Angeles, Sch Med, Dept Neurol, Reed Neurol Res Ctr,Lab Neuroimaging, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Neurol, Reed Neurol Res Ctr,Brain Mapping Div, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Helsinki, Cent Hosp, Dept Radiol, Meilahti Clin, FIN-00290 Helsinki, Finland; Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, SF-00300 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; Univ Oulu, FIN-00014 Helsinki, Finland	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; University of Oulu	Thompson, PM (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurol, Reed Neurol Res Ctr,Lab Neuroimaging, Rm 4238,710 Westwood Plaza, Los Angeles, CA 90095 USA.		Thompson, Paul M/C-4194-2018; Kaprio, Jaakko/A-1820-2008	Thompson, Paul M/0000-0002-4720-8867; Kaprio, Jaakko/0000-0002-3716-2455	NCRR NIH HHS [P41 RR13642] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Alarcon M, 1998, BEHAV GENET, V28, P255, DOI 10.1023/A:1021667213066; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bartley AJ, 1997, BRAIN, V120, P257, DOI 10.1093/brain/120.2.257; Biondi A, 1998, AM J NEURORADIOL, V19, P1361; Cannon TD, 2000, AM J HUM GENET, V67, P369, DOI 10.1086/303006; CANNON TD, 1994, ARCH GEN PSYCHIAT, V51, P651; CHIPUER HM, 1990, INTELLIGENCE, V14, P11, DOI 10.1016/0160-2896(90)90011-H; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; Devlin B, 1997, NATURE, V388, P468, DOI 10.1038/41319; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Eley TC, 1997, CURR OPIN NEUROBIOL, V7, P279, DOI 10.1016/S0959-4388(97)80017-7; Falconer D. S., 1989, Introduction to quantitative genetics.; Feldman MW, 1997, SCIENCE, V278, P1383; Finkel D, 1998, DEV PSYCHOL, V34, P1400, DOI 10.1037/0012-1649.34.6.1400; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Gayan J, 1999, EUR CHILD ADOLES PSY, V8, P52; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; HEDEKER D, 1994, J CONSULT CLIN PSYCH, V62, P757, DOI 10.1037/0022-006X.62.4.757; Hill L, 1999, NEUROREPORT, V10, P843, DOI 10.1097/00001756-199903170-00032; HUERTA MF, 1996, NEUROIMAGE, V4, P4; HUNTLEY RMC, 1966, GENETIC ENV FACTORS; KAPRIO J, 1990, BEHAV GENET, V20, P265, DOI 10.1007/BF01067794; Kreft I, 1998, INTRO MULTILEVEL MOD; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Loehlin J., 1976, HEREDITY ENV PERSONA, DOI DOI 10.7560/730038; LOEHLIN JC, 1989, AM PSYCHOL, V44, P1285, DOI 10.1037/0003-066X.44.10.1285; MacDonald D, 1994, P SOC PHOTO-OPT INS, V2359, P160; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; OPPENHEIM JS, 1989, ANN NEUROL, V26, P100, DOI 10.1002/ana.410260117; Pennington BF, 2000, J COGNITIVE NEUROSCI, V12, P223, DOI 10.1162/089892900561850; Pfefferbaum A, 2000, NEUROBIOL AGING, V21, P63, DOI 10.1016/S0197-4580(00)00086-5; Plomin R, 1997, INTELLIGENCE, V24, P53, DOI 10.1016/S0160-2896(97)90013-1; PLOMIN R, 1989, BEHAV GENET, V19, P331, DOI 10.1007/BF01066162; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P323, DOI 10.1093/cercor/5.4.323; Rutter M, 1999, J CHILD PSYCHOL PSYC, V40, P3, DOI 10.1111/1469-7610.00422; SMITH C, 1975, TXB HUMAN GENETICS; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; SUDDATH RL, 1990, NEW ENGL J MED, V322, P789, DOI 10.1056/NEJM199003223221201; SWAN GE, 1990, ARCH NEUROL-CHICAGO, V47, P259, DOI 10.1001/archneur.1990.00530030025010; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; THOMPSON PM, 2000, HDB MED IMAGE PROCES, P1066; TRAMO MJ, 1995, J COGNITIVE NEUROSCI, V7, P292, DOI 10.1162/jocn.1995.7.2.292; Tramo MJ, 1998, NEUROLOGY, V50, P1246, DOI 10.1212/WNL.50.5.1246; WEINBERGER DR, 1981, PSYCHIAT RES, V4, P65, DOI 10.1016/0165-1781(81)90009-3; Williams K, 1998, PHYS WORLD, V11, P18; Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032; Zijdenbos Alex P., 1994, Critical Reviews in Biomedical Engineering, V22, P401	49	719	729	0	114	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1253	1258		10.1038/nn758	http://dx.doi.org/10.1038/nn758			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	498RV	11694885				2022-12-17	WOS:000172525000023
J	Gapp, K; Jawaid, A; Sarkies, P; Bohacek, J; Pelczar, P; Prados, J; Farinelli, L; Miska, E; Mansuy, IM				Gapp, Katharina; Jawaid, Ali; Sarkies, Peter; Bohacek, Johannes; Pelczar, Pawel; Prados, Julien; Farinelli, Laurent; Miska, Eric; Mansuy, Isabelle M.			Implication of sperm RNAs in transgenerational inheritance of the effects of early trauma in mice	NATURE NEUROSCIENCE			English	Article							PROTEIN; EXPRESSION; MICRORNAS; RESPONSES; ALIGNMENT; CLEAVAGE	Small non-coding RNAs (sncRNAs) are potential vectors at the interface between genes and environment. We found that traumatic stress in early life altered mouse microRNA (miRNA) expression, and behavioral and metabolic responses in the progeny. Injection of sperm RNAs from traumatized males into fertilized wild-type oocytes reproduced the behavioral and metabolic alterations in the resulting offspring.	[Gapp, Katharina; Jawaid, Ali; Bohacek, Johannes; Mansuy, Isabelle M.] Univ Zurich, Neurosci Ctr Zurich, Brain Res Inst, Zurich, Switzerland; [Gapp, Katharina; Jawaid, Ali; Bohacek, Johannes; Mansuy, Isabelle M.] Swiss Fed Inst Technol, Zurich, Switzerland; [Sarkies, Peter; Miska, Eric] Gurdon Inst, Cambridge, England; [Pelczar, Pawel] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland; [Prados, Julien; Farinelli, Laurent] FASTERIS SA, Plan Les Ouates, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Mansuy, IM (corresponding author), Univ Zurich, Neurosci Ctr Zurich, Brain Res Inst, Zurich, Switzerland.	mansuy@hifo.uzh.ch	Gapp, Katharina/Z-1538-2019; Bohacek, Johannes/A-4583-2014; Mansuy, Isabelle M/N-3042-2015	Gapp, Katharina/0000-0002-9622-1478; Bohacek, Johannes/0000-0002-8442-653X; Mansuy, Isabelle M/0000-0001-7785-5371; Prados, Julien/0000-0002-8546-241X; Sarkies, Peter/0000-0003-0279-6199; Miska, Eric/0000-0002-4450-576X; Jawaid, Ali/0000-0002-5126-6744	Austrian Academy of Sciences; University of Zurich; Swiss Federal Institute of Technology, Roche; Swiss National Science Foundation; National Center of Competence in Research "Neural Plasticity and Repair"; Gonville and Caius College fellowship; Cancer Research UK [11832] Funding Source: researchfish	Austrian Academy of Sciences; University of Zurich; Swiss Federal Institute of Technology, Roche; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research "Neural Plasticity and Repair"(Swiss National Science Foundation (SNSF)); Gonville and Caius College fellowship; Cancer Research UK(Cancer Research UK)	We thank M. Rassoulzadegan and V. Grandjean for help with the sperm purification, F. Manuella and H. Horster for assistance with the MSUS paradigm, H. Welzl for help with behavior, G. Vernaz for help with western blotting, R. Tweedie-Cullen and P. Nanni for help with mass spectrometry, A. Patrignani for advice on DNA and RNA quality assessment, and A. Chen and A. Brunner for constructive discussions. This work was supported by the Austrian Academy of Sciences, the University of Zurich, the Swiss Federal Institute of Technology, Roche, the Swiss National Science Foundation, and The National Center of Competence in Research "Neural Plasticity and Repair". P. S. was supported by a Gonville and Caius College fellowship.	Abe M, 2013, TRENDS CELL BIOL, V23, P30, DOI 10.1016/j.tcb.2012.08.013; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Burton NO, 2011, P NATL ACAD SCI USA, V108, P19683, DOI 10.1073/pnas.1113310108; Drake Amanda J, 2011, Pediatr Endocrinol Rev, V9, P566; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Franklin TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021842; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; HOGAN B, 1994, MANIPULATING MOUSE E; Johnson GD, 2011, MOL HUM REPROD, V17, P721, DOI 10.1093/molehr/gar054; Kawano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044542; Koshibu K, 2009, J NEUROSCI, V29, P13079, DOI 10.1523/JNEUROSCI.3610-09.2009; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Maguschak KA, 2012, J NEUROIMMUNE PHARM, V7, P763, DOI 10.1007/s11481-012-9350-7; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Pena FJ, 2009, REPROD DOMEST ANIM, V44, P345, DOI 10.1111/j.1439-0531.2008.01211.x; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Rose AJ, 2013, MOL CELL ENDOCRINOL, V380, P65, DOI 10.1016/j.mce.2013.03.007; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Sharma A, 2013, PROG BIOPHYS MOL BIO, V113, P439, DOI 10.1016/j.pbiomolbio.2012.12.003; Tweedie-Cullen RY, 2009, J PROTEOME RES, V8, P4966, DOI 10.1021/pr9003739; Weiss IC, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00003; Zhang N, 2013, J BIOL CHEM, V288, P10361, DOI 10.1074/jbc.M112.425504	31	714	734	8	185	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2014	17	5					667	+		10.1038/nn.3695	http://dx.doi.org/10.1038/nn.3695			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF9DS	24728267	Green Accepted			2022-12-17	WOS:000335016200009
J	Hoglinger, GU; Rizk, P; Muriel, MP; Duyckaerts, C; Oertel, WH; Caille, I; Hirsch, EC				Hoglinger, GU; Rizk, P; Muriel, MP; Duyckaerts, C; Oertel, WH; Caille, I; Hirsch, EC			Dopamine depletion impairs precursor cell proliferation in Parkinson disease	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; ADULT-RAT HIPPOCAMPUS; SUBVENTRICULAR ZONE; DENTATE GYRUS; INCREASES NEUROGENESIS; MAMMALIAN BRAIN; OLFACTORY-BULB; SPATIAL MEMORY; NEURONS; HALOPERIDOL	Cerebral dopamine depletion is the hallmark of Parkinson disease. Because dopamine modulates ontogenetic neurogenesis, depletion of dopamine might affect neural precursors in the subependymal zone and subgranular zone of the adult brain. Here we provide ultrastructural evidence showing that highly proliferative precursors in the adult subependymal zone express dopamine receptors and receive dopaminergic afferents. Experimental depletion of dopamine in rodents decreases precursor cell proliferation in both the subependymal zone and the subgranular zone. Proliferation is restored completely by a selective agonist of D2-like (D2L) receptors. Experiments with neural precursors from the adult subependymal zone grown as neurosphere cultures confirm that activation of D2L receptors directly increases the proliferation of these precursors. Consistently, the numbers of proliferating cells in the subependymal zone and neural precursor cells in the subgranular zone and olfactory bulb are reduced in postmortem brains of individuals with Parkinson disease. These observations suggest that the generation of neural precursor cells is impaired in Parkinson disease as a consequence of dopaminergic denervation.	Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris, France; Univ Marburg, Dept Neurol, D-35039 Marburg, Germany; Hop La Pitie Salpetriere, Dept Neuropathol, F-75651 Paris, France; Ecole Normale Super, CNRS, UMR 8542, F-75230 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Philipps University Marburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite	Hoglinger, GU (corresponding author), Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris, France.	gunter@ccr.jussieu.fr	Caillé, Isabelle/AAC-9575-2021; Hirsch, Etienne/AAC-7655-2019; Höglinger, Günter U/F-2388-2015	Hirsch, Etienne/0000-0003-4823-276X; Höglinger, Günter U/0000-0001-7587-6187; Caille, Isabelle/0000-0002-9054-2641				Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; BACKHOUSE B, 1982, NEUROPATH APPL NEURO, V8, P109, DOI 10.1111/j.1365-2990.1982.tb00266.x; Berendse HW, 2001, ANN NEUROL, V50, P34, DOI 10.1002/ana.1049; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brezun JM, 1999, NEUROSCIENCE, V89, P999, DOI 10.1016/S0306-4522(98)00693-9; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Camicioli R, 2003, MOVEMENT DISORD, V18, P784, DOI 10.1002/mds.10444; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Dawirs RR, 1998, J NEURAL TRANSM, V105, P317, DOI 10.1007/s007020050061; Diaz J, 1997, J NEUROSCI, V17, P4282; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Franklin BJ, 1996, MOUSE BRAIN STEREOTA; Gasbarri A, 1997, PROG NEURO-PSYCHOPH, V21, P1, DOI 10.1016/S0278-5846(96)00157-1; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hoogland PV, 2003, NEUROPATH APPL NEURO, V29, P303, DOI 10.1046/j.1365-2990.2003.00459.x; Kulkarni VA, 2002, EUR J NEUROSCI, V16, P2008, DOI 10.1046/j.1460-9568.2002.02268.x; Laakso MP, 1996, NEUROLOGY, V46, P678, DOI 10.1212/WNL.46.3.678; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LIDOW MS, 1995, J COMP NEUROL, V360, P393, DOI 10.1002/cne.903600303; Liu ZP, 2003, J COMP NEUROL, V459, P368, DOI 10.1002/cne.10664; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Oertel WH, 2001, ADV NEUROL, V86, P373; Ohtani N, 2003, J NEUROSCI, V23, P2840; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pillon B, 1997, NEUROPSYCHOLOGIA, V35, P221, DOI 10.1016/S0028-3932(96)00091-7; Przedborski S, 2003, ANN NY ACAD SCI, V991, P189; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Ridet JL, 2000, TRENDS NEUROSCI, V23, P58, DOI 10.1016/S0166-2236(99)01523-4; Riekkinen P, 1998, NEUROREPORT, V9, P1507, DOI 10.1097/00001756-199805110-00048; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Scotto-Lomassese S, 2003, J NEUROSCI, V23, P9289; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wakade CG, 2002, J NEUROSCI RES, V69, P72, DOI 10.1002/jnr.10281; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	47	712	748	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					726	735		10.1038/nn1265	http://dx.doi.org/10.1038/nn1265			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15195095				2022-12-17	WOS:000222274400014
J	You, XT; Vlatkovic, I; Babic, A; Will, T; Epstein, I; Tushev, G; Akbalik, G; Wang, MT; Glock, C; Quedenau, C; Wang, X; Hou, JY; Liu, HY; Sun, W; Sambandan, S; Chen, T; Schuman, EM; Chen, W				You, Xintian; Vlatkovic, Irena; Babic, Ana; Will, Tristan; Epstein, Irina; Tushev, Georgi; Akbalik, Gueney; Wang, Mantian; Glock, Caspar; Quedenau, Claudia; Wang, Xi; Hou, Jingyi; Liu, Hongyu; Sun, Wei; Sambandan, Sivakumar; Chen, Tao; Schuman, Erin M.; Chen, Wei			Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity	NATURE NEUROSCIENCE			English	Article							LONG NONCODING RNAS; MICRORNA; SEQUENCE; GENOME; SEQ; IDENTIFICATION; TRANSCRIPTOME; ENRICHMENT; DENDRITES; REVEALS	Circular RNAs (circRNAs) have re-emerged as an interesting RNA species. Using deep RNA profiling in different mouse tissues, we observed that circRNAs were substantially enriched in brain and a disproportionate fraction of them were derived from host genes that encode synaptic proteins. Moreover, on the basis of separate profiling of the RNAs localized in neuronal cell bodies and neuropil, circRNAs were, on average, more enriched in the neuropil than their host gene mRNA isoforms. Using high-resolution in situ hybridization, we visualized circRNA punctae in the dendrites of neurons. Consistent with the idea that circRNAs might regulate synaptic function during development, many circRNAs changed their abundance abruptly at a time corresponding to synaptogenesis. In addition, following a homeostatic downscaling of neuronal activity many circRNAs exhibited substantial up- or downregulation. Together, our data indicate that brain circRNAs are positioned to respond to and regulate synaptic function.	[You, Xintian; Babic, Ana; Quedenau, Claudia; Wang, Xi; Hou, Jingyi; Liu, Hongyu; Sun, Wei; Chen, Tao; Chen, Wei] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Berlin, Germany; [Vlatkovic, Irena; Will, Tristan; Epstein, Irina; Tushev, Georgi; Akbalik, Gueney; Wang, Mantian; Glock, Caspar; Sambandan, Sivakumar; Schuman, Erin M.] Max Planck Inst Brain Res, Dept Synapt Plast, Frankfurt, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society	Schuman, EM (corresponding author), Max Planck Inst Brain Res, Dept Synapt Plast, Frankfurt, Germany.	erin.schuman@brain.mpg.de; wei.chen@mdc-berlin.de	Chen, Wei/C-1273-2011; Wang, Xi/N-9527-2014; Sun, Wei/A-4417-2018; Schuman, Erin M/D-6204-2011	Wang, Xi/0000-0002-7572-6354; Sun, Wei/0000-0001-9607-1361; Sambandan, Sivakumar/0000-0001-5471-6141; YOU, Xintian/0000-0002-1684-7084; Vlatkovic, Irena/0000-0001-8745-4299; Akbalik, Guney/0000-0002-3219-401X	Max Planck Society; Advanced Investigator award from the European Research Council; DFG [CRC 902, CRC 1080]; DFG Cluster of Excellence for Macromolecular Complexes, Goethe University; Federal Ministry for Education and Research (BMBF); Senate of Berlin, Germany [BIMSB 0315362A, 0315362C]; Chinese Scholarship Council (CSC)	Max Planck Society(Max Planck SocietyFoundation CELLEX); Advanced Investigator award from the European Research Council(European Research Council (ERC)); DFG(German Research Foundation (DFG)); DFG Cluster of Excellence for Macromolecular Complexes, Goethe University; Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Senate of Berlin, Germany; Chinese Scholarship Council (CSC)(China Scholarship Council)	We thank I. Bartnik, N. Fuerst and A. Staab for the preparation of cultured hippocampal neurons and M. Feldkamp and C. Langnick for their excellent technical assistance on sequencing. We thank C. Schanzenbaecher and J. Langer for generating mass spectrometry data and for the bioinformatic evaluation of circRNA translation. E.M.S. is funded by the Max Planck Society, an Advanced Investigator award from the European Research Council, DFG CRC 902: Molecular Principles of RNA-based Regulation, DFG CRC 1080: Molecular and Cellular Mechanisms of Neural Homeostasis, and the DFG Cluster of Excellence for Macromolecular Complexes, Goethe University. As part of the Berlin Institute for Medical Systems Biology at the MDC, the research group of W.C. is funded by the Federal Ministry for Education and Research (BMBF) and the Senate of Berlin, Germany (BIMSB 0315362A, 0315362C). H.L., T.C. and W.S. are supported by the Chinese Scholarship Council (CSC).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Danan M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/nar/gkr1009; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hanus C, 2013, NAT REV NEUROSCI, V14, P638, DOI 10.1038/nrn3546; Hentze MW, 2013, EMBO J, V32, P923, DOI 10.1038/emboj.2013.53; Hu JH, 2010, NEURON, V68, P1128, DOI 10.1016/j.neuron.2010.11.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Ng SY, 2013, MOL CELL, V51, P349, DOI 10.1016/j.molcel.2013.07.017; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Schlogl A, 2013, BIOMED ENG-BIOMED TE, V58, DOI 10.1515/bmt-2013-4181; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sun W, 2013, EMBO J, V32, P2029, DOI 10.1038/emboj.2013.144; Tai HC, 2006, CURR BIOL, V16, pR121, DOI 10.1016/j.cub.2006.02.006; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Westholm JO, 2014, CELL REP, V9, P1966, DOI 10.1016/j.celrep.2014.10.062; YAMASHITA K, 1981, STAIN TECHNOL, V56, P29, DOI 10.3109/10520298109067271; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yu Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4230; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	42	711	769	1	144	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2015	18	4					603	+		10.1038/nn.3975	http://dx.doi.org/10.1038/nn.3975			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CE4DL	25714049	Green Accepted			2022-12-17	WOS:000351780900025
J	Downar, J; Crawley, AP; Mikulis, DJ; Davis, KD				Downar, J; Crawley, AP; Mikulis, DJ; Davis, KD			A multimodal cortical network for the detection of changes in the sensory environment	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION TOMOGRAPHY; TEMPORAL-PARIETAL JUNCTION; VISUAL AWARENESS; ATTENTION; NEGLECT; CORTEX; FMRI; RESPONSES; LESIONS; STIMULI	Sensory stimuli undergoing sudden changes draw attention and preferentially enter our awareness. We used event-related functional magnetic-resonance imaging (fMRI) to identify brain regions responsive to changes in visual, auditory and tactile stimuli. Unimodally responsive areas included visual, auditory and somatosensory association cortex. Multimodally responsive areas comprised a right-lateralized network including the temporoparietal junction, inferior frontal gyrus, insula and left cingulate and supplementary motor areas. These results reveal a distributed, multimodal network for involuntary attention to events in the sensory environment. This network contains areas thought to underlie the P300 event-related potential and closely corresponds to the set of cortical regions damaged in patients with hemineglect syndromes.	Univ Toronto, Inst Med Sci, Toronto, ON M5T 2S8, Canada; Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Med Imaging, Toronto, ON M5T 2S8, Canada; Univ Toronto, Toronto Western Hosp, Dept Surg, Div Neurosurg, Toronto, ON M5T 2S8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Davis, KD (corresponding author), Univ Toronto, Inst Med Sci, MP14-322,399 Bathurst St, Toronto, ON M5T 2S8, Canada.	kdavis@playfair.utoronto.ca	Downar, Jonathan/I-9002-2016; Mikulis, David J/H-5167-2019	Downar, Jonathan/0000-0002-5140-174X; Mikulis, David/0000-0003-3956-0892				Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; Buckner RL, 1998, HUM BRAIN MAPP, V6, P373, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<373::AID-HBM8>3.3.CO;2-G; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; DONG WK, 1989, BRAIN RES, V484, P314, DOI 10.1016/0006-8993(89)90375-2; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; GLOVER GH, 1995, MAGNET RESON MED, V33, P624, DOI 10.1002/mrm.1910330507; Halligan PW, 1998, CONSCIOUS COGN, V7, P356, DOI 10.1006/ccog.1998.0362; Ikeda A, 1999, BRAIN, V122, P915, DOI 10.1093/brain/122.5.915; Katayama J, 1998, PSYCHOPHYSIOLOGY, V35, P23, DOI 10.1017/S0048577298961479; KAWASHIMA R, 1995, P NATL ACAD SCI USA, V92, P5969, DOI 10.1073/pnas.92.13.5969; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; KNIGHT RT, 1984, ELECTROEN CLIN NEURO, V59, P9, DOI 10.1016/0168-5597(84)90016-9; KNIGHT RT, 1989, BRAIN RES, V502, P109, DOI 10.1016/0006-8993(89)90466-6; Knight RT, 1998, REV NEUROSCIENCE, V9, P57; Maldjian JA, 1999, BRAIN RES, V824, P291, DOI 10.1016/S0006-8993(99)01126-9; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Opitz B, 1999, CEREB CORTEX, V9, P379, DOI 10.1093/cercor/9.4.379; Pollmann S, 1998, NEUROIMAGE, V8, P327, DOI 10.1006/nimg.1998.0373; Ro T, 1998, BRAIN COGNITION, V37, P461, DOI 10.1006/brcg.1998.1008; ROBINSON CJ, 1980, J COMP NEUROL, V192, P43, DOI 10.1002/cne.901920104; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Swick D, 1998, ATTENTIVE BRAIN, P143; Talairach J., 1988, COPLANAR STEREOTAXIC; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; TULVING E, 1994, NEUROREPORT, V5, P2525, DOI 10.1097/00001756-199412000-00030; Vallar G, 1998, TRENDS COGN SCI, V2, P87, DOI 10.1016/S1364-6613(98)01145-0; YAMAGUCHI S, 1991, ELECTROEN CLIN NEURO, V78, P50, DOI 10.1016/0013-4694(91)90018-Y; YAMAGUCHI S, 1991, J NEUROSCI, V11, P2039	31	710	716	3	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					277	283		10.1038/72991	http://dx.doi.org/10.1038/72991			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TE	10700261				2022-12-17	WOS:000085810500018
J	McEwen, BS; Bowles, NP; Gray, JD; Hill, MN; Hunter, RG; Karatsoreos, IN; Nasca, C				McEwen, Bruce S.; Bowles, Nicole P.; Gray, Jason D.; Hill, Matthew N.; Hunter, Richard G.; Karatsoreos, Ilia N.; Nasca, Carla			Mechanisms of stress in the brain	NATURE NEUROSCIENCE			English	Review							TISSUE-PLASMINOGEN ACTIVATOR; GLUCOCORTICOID-RECEPTOR; POLYSIALIC ACID; TRANSPOSABLE ELEMENTS; EPIGENETIC REGULATION; DENDRITIC MORPHOLOGY; GENE-EXPRESSION; DENTATE GYRUS; INDIVIDUAL-DIFFERENCES; MOLECULAR-MECHANISMS	The brain is the central organ involved in perceiving and adapting to social and physical stressors via multiple interacting mediators, from the cell surface to the cytoskeleton to epigenetic regulation and nongenomic mechanisms. A key result of stress is structural remodeling of neural architecture, which may be a sign of successful adaptation, whereas persistence of these changes when stress ends indicates failed resilience. Excitatory amino acids and glucocorticoids have key roles in these processes, along with a growing list of extra- and intracellular mediators that includes endocannabinoids and brain-derived neurotrophic factor (BDNF). The result is a continually changing pattern of gene expression mediated by epigenetic mechanisms involving histone modifications and CpG methylation and hydroxymethylation as well as by the activity of retrotransposons that may alter genomic stability. Elucidation of the underlying mechanisms of plasticity and vulnerability of the brain provides a basis for understanding the efficacy of interventions for anxiety and depressive disorders as well as age-related cognitive decline.	[McEwen, Bruce S.; Bowles, Nicole P.; Gray, Jason D.; Nasca, Carla] Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10065 USA; [Hill, Matthew N.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Hunter, Richard G.] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA; [Karatsoreos, Ilia N.] Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA	Rockefeller University; University of Calgary; University of Massachusetts System; University of Massachusetts Boston; Washington State University	McEwen, BS (corresponding author), Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10065 USA.	mcewen@rockefeller.edu	Hill, Matthew N/J-4610-2013; Karatsoreos, Ilia/AAR-8774-2020; Nasca, Carla/L-8956-2017; McEwen, Bruce/Z-1630-2019; Hunter, Richard G./F-1314-2014	Karatsoreos, Ilia/0000-0001-5605-4962; Nasca, Carla/0000-0003-3348-6783; Hunter, Richard G./0000-0002-3130-0941	US National Institutes of Health [R01 MH41256]; Hope for Depression Research Network; American Foundation for Suicide Prevention [F32 MH102065]; National Research Service Award [F32 MH102065]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH041256, F32MH102065] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope for Depression Research Network; American Foundation for Suicide Prevention; National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The McEwen laboratory acknowledges research support from US National Institutes of Health (R01 MH41256), and the Hope for Depression Research Network and the American Foundation for Suicide Prevention to C.N. and National Research Service Award F32 MH102065 to J.D.G.	AKANA SF, 1988, ENDOCRINOLOGY, V122, P1337, DOI 10.1210/endo-122-4-1337; Arendt T, 2003, J NEUROSCI, V23, P6972, DOI 10.1523/JNEUROSCI.23-18-06972.2003; ARMANINI MP, 1990, BRAIN RES, V532, P7, DOI 10.1016/0006-8993(90)91734-X; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Bennur S, 2007, NEUROSCIENCE, V144, P8, DOI 10.1016/j.neuroscience.2006.08.075; Bortolato M, 2007, BIOL PSYCHIAT, V62, P1103, DOI 10.1016/j.biopsych.2006.12.001; Bowles NP, 2012, NEUROSCIENCE, V204, P83, DOI 10.1016/j.neuroscience.2011.08.048; Cameron H.A., 1996, PHARM TOXIC, P141; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Chen Y, 2006, MOL PSYCHIATR, V11, P992, DOI 10.1038/sj.mp.4001863; Daskalakis NP, 2014, P NATL ACAD SCI USA, V111, P13529, DOI 10.1073/pnas.1401660111; Datson NA, 2013, ENDOCRINOLOGY, V154, P3261, DOI 10.1210/en.2012-2233; de Kloet ER, 2009, BRAIN RES, V1293, P129, DOI 10.1016/j.brainres.2009.03.039; Du Jing, 2009, Commun Integr Biol, V2, P350; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; Dyrvig M, 2015, MOL CELL NEUROSCI, V67, P137, DOI 10.1016/j.mcn.2015.06.011; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Goldwater DS, 2009, NEUROSCIENCE, V164, P798, DOI 10.1016/j.neuroscience.2009.08.053; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; Gray JD, 2014, MOL PSYCHIATR, V19, P1171, DOI 10.1038/mp.2013.175; Gray JD, 2013, NEUROSCIENCE, V239, P214, DOI 10.1016/j.neuroscience.2012.08.034; Gray JM, 2015, J NEUROSCI, V35, P3879, DOI 10.1523/JNEUROSCI.2737-14.2015; Griffiths BB, 2014, NEUROSCIENCE, V275, P420, DOI 10.1016/j.neuroscience.2014.06.041; Gunduz-Cinar O, 2013, TRENDS PHARMACOL SCI, V34, P637, DOI 10.1016/j.tips.2013.08.008; Halfon N, 2014, MATERN CHILD HLTH J, V18, P344, DOI 10.1007/s10995-013-1346-2; Heller EA, 2014, NAT NEUROSCI, V17, P1720, DOI 10.1038/nn.3871; Hill MN, 2013, MOL PSYCHIATR, V18, P1125, DOI 10.1038/mp.2012.90; Hill MN, 2011, CEREB CORTEX, V21, P2056, DOI 10.1093/cercor/bhq280; Hill MN, 2011, J NEUROSCI, V31, P10506, DOI 10.1523/JNEUROSCI.0496-11.2011; Hill MN, 2010, PROG NEURO-PSYCHOPH, V34, P791, DOI 10.1016/j.pnpbp.2009.11.001; Hill MN, 2010, P NATL ACAD SCI USA, V107, P9406, DOI 10.1073/pnas.0914661107; Hill MN, 2005, NEUROPSYCHOPHARMACOL, V30, P508, DOI 10.1038/sj.npp.1300601; Hunter RG, 2015, P NATL ACAD SCI USA, V112, P6828, DOI 10.1073/pnas.1411260111; Hunter Richard G, 2013, Mob Genet Elements, V3, pe24555; Hunter RG, 2013, EPIGENOMICS-UK, V5, P177, DOI [10.2217/EPI.13.8, 10.2217/epi.13.8]; Hunter RG, 2009, P NATL ACAD SCI USA, V106, P20912, DOI 10.1073/pnas.0911143106; Jacobson L, 2014, BRAIN RES, V1583, P109, DOI 10.1016/j.brainres.2014.07.054; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Johnson R, 2014, RNA, V20, P959, DOI 10.1261/rna.044560.114; Karatsoreos Ilia N, 2014, F1000Res, V3, P273, DOI 10.12688/f1000research.5756.1; Karatsoreos IN, 2011, TRENDS COGN SCI, V15, P576, DOI 10.1016/j.tics.2011.10.005; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Khalil AM, 2011, SEMIN CELL DEV BIOL, V22, P359, DOI 10.1016/j.semcdb.2011.02.016; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kinoshita Y, 2014, P NATL ACAD SCI USA, V111, P16130, DOI 10.1073/pnas.1418896111; Lakshminarasimhan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030481; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Lee TTY, 2014, BEHAV BRAIN RES, V271, P106, DOI 10.1016/j.bbr.2014.05.064; Leuner B, 2012, HIPPOCAMPUS, V22, P861, DOI 10.1002/hipo.20947; Leuner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011597; Lightman SL, 2008, EUR J PHARMACOL, V583, P255, DOI 10.1016/j.ejphar.2007.11.073; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liston C, 2013, NAT NEUROSCI, V16, P698, DOI 10.1038/nn.3387; Liston C, 2011, P NATL ACAD SCI USA, V108, P16074, DOI 10.1073/pnas.1110444108; Lomazzo E, 2015, NEUROPSYCHOPHARMACOL, V40, P488, DOI 10.1038/npp.2014.198; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Magarinos AM, 2006, P NATL ACAD SCI USA, V103, P18775, DOI 10.1073/pnas.0608785103; Martin KP, 2011, CEREB CORTEX, V21, P2366, DOI 10.1093/cercor/bhr021; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; Matys T, 2004, P NATL ACAD SCI USA, V101, P16345, DOI 10.1073/pnas.0407355101; McCall T, 2013, EXP NEUROL, V241, P5, DOI 10.1016/j.expneurol.2012.11.028; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2015, NEUROBIOL STRESS, V1, P1, DOI 10.1016/j.ynstr.2014.09.001; McEwen BS, 2013, NEURON, V79, P16, DOI 10.1016/j.neuron.2013.06.028; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; McEwen Bruce S, 2010, Ann N Y Acad Sci, V1204 Suppl, pE38, DOI 10.1111/j.1749-6632.2010.05568.x; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; MCEWEN BS, 1968, NATURE, V220, P911, DOI 10.1038/220911a0; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McEwen BS, 2007, HDB NEUROCHEMISTRY M, P572; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Monteggia LM, 2015, CURR OPIN NEUROBIOL, V30, P139, DOI 10.1016/j.conb.2014.12.004; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Mucha M, 2011, P NATL ACAD SCI USA, V108, P18436, DOI 10.1073/pnas.1107936108; Nasca C, 2015, MOL PSYCHIATR, V20, P755, DOI 10.1038/mp.2014.96; Nasca C, 2013, P NATL ACAD SCI USA, V110, P4804, DOI 10.1073/pnas.1216100110; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Pham K, 2003, EUR J NEUROSCI, V17, P879, DOI 10.1046/j.1460-9568.2003.02513.x; Phillips DJ, 2015, BRAIN BEHAV IMMUN, V47, P14, DOI 10.1016/j.bbi.2014.12.008; Ponomarev I, 2012, J NEUROSCI, V32, P1884, DOI 10.1523/JNEUROSCI.3136-11.2012; Ponomarev I, 2010, NEUROPSYCHOPHARMACOL, V35, P1402, DOI 10.1038/npp.2010.10; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; POPOV VI, 1992, NEUROSCIENCE, V48, P45, DOI 10.1016/0306-4522(92)90336-Z; Radley JJ, 2004, NEUROSCIENCE, V125, P1, DOI 10.1016/j.neuroscience.2004.01.006; Rao RP, 2012, BIOL PSYCHIAT, V72, P466, DOI 10.1016/j.biopsych.2012.04.008; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Reilly MT, 2013, J NEUROSCI, V33, P17577, DOI 10.1523/JNEUROSCI.3369-13.2013; Reul JMHM, 2007, PSYCHONEUROENDOCRINO, V32, pS21, DOI 10.1016/j.psyneuen.2007.03.016; Reul JMHM, 2014, FRONT PSYCHIATRY, V5, DOI [10.3389/fpsyt.2014.00005, 10.3389/fpsyt.2004.0005]; Revollo JR, 2009, ANN NY ACAD SCI, V1179, P167, DOI 10.1111/j.1749-6632.2009.04986.x; Rossi S, 2010, MOL PHARMACOL, V78, P260, DOI 10.1124/mol.110.064196; Rubin TG, 2014, BIOESSAYS, V36, P1072, DOI 10.1002/bies.201400095; Rusiecki JA, 2012, EPIGENOMICS-UK, V4, P29, DOI [10.2217/EPI.11.116, 10.2217/epi.11.116]; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Schelling G, 2004, ANN NY ACAD SCI, V1032, P158, DOI 10.1196/annals.1314.013; Seeman T, 2010, ANN NY ACAD SCI, V1186, P223, DOI 10.1111/j.1749-6632.2009.05341.x; Seki T, 1999, J COMP NEUROL, V410, P115, DOI 10.1002/(SICI)1096-9861(19990719)410:1<115::AID-CNE10>3.0.CO;2-C; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Skrzypiec AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061046; Suri D, 2013, BIOL PSYCHIAT, V73, P658, DOI 10.1016/j.biopsych.2012.10.023; Szyf M, 2005, FRONT NEUROENDOCRIN, V26, P139, DOI 10.1016/j.yfrne.2005.10.002; Theodosis DT, 1999, J NEUROSCI, V19, P10228; Tochigi M, 2008, NEUROSCI RES, V60, P184, DOI 10.1016/j.neures.2007.10.010; Tost H, 2015, NAT NEUROSCI, V18, P1421, DOI 10.1038/nn.4108; Treccani G, 2014, MOL PSYCHIATR, V19, P433, DOI 10.1038/mp.2014.5; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; van der Kooij MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5995; van der Kooij MA, 2014, NEUROPSYCHOPHARMACOL, V39, P1148, DOI 10.1038/npp.2013.315; Vyas A, 2002, J NEUROSCI, V22, P6810; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Wang K, 2010, J NEUROCHEM, V113, P1436, DOI 10.1111/j.1471-4159.2010.06679.x; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; Wood GE, 2003, HORM BEHAV, V43, P205, DOI 10.1016/S0018-506X(02)00026-0; Yan XX, 1998, HIPPOCAMPUS, V8, P231, DOI 10.1002/(SICI)1098-1063(1998)8:3<231::AID-HIPO6>3.0.CO;2-M; Zohar J, 2011, EUR NEUROPSYCHOPHARM, V21, P796, DOI 10.1016/j.euroneuro.2011.06.001; Zoppi S, 2011, NEUROPSYCHOPHARMACOL, V36, P805, DOI 10.1038/npp.2010.214	139	708	724	18	336	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2015	18	10					1353	1363		10.1038/nn.4086	http://dx.doi.org/10.1038/nn.4086			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CS2OK	26404710	Green Accepted			2022-12-17	WOS:000361910600004
J	Tollervey, JR; Curk, T; Rogelj, B; Briese, M; Cereda, M; Kayikci, M; Konig, J; Hortobagyi, T; Nishimura, AL; Zupunski, V; Patani, R; Chandran, S; Rot, G; Zupan, B; Shaw, CE; Ule, J				Tollervey, James R.; Curk, Tomaz; Rogelj, Boris; Briese, Michael; Cereda, Matteo; Kayikci, Melis; Koenig, Julian; Hortobagyi, Tibor; Nishimura, Agnes L.; Zupunski, Vera; Patani, Rickie; Chandran, Siddharthan; Rot, Gregor; Zupan, Blaz; Shaw, Christopher E.; Ule, Jernej			Characterizing the RNA targets and position-dependent splicing regulation by TDP-43	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; BINDING PROTEIN; BCL-2 FAMILY; ROLES; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; EVOLUTION; APOPTOSIS	TDP-43 is a predominantly nuclear RNA-binding protein that forms inclusion bodies in frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). The mRNA targets of TDP-43 in the human brain and its role in RNA processing are largely unknown. Using individual nucleotide-resolution ultraviolet cross-linking and immunoprecipitation (ICLIP), we found that TDP-43 preferentially bound long clusters of UG-rich sequences in vivo. Analysis of RNA binding by TDP-43 in brains from subjects with FTLD revealed that the greatest increases in binding were to the MALAT1 and NEAT1 noncoding RNAs. We also found that binding of TDP-43 to pre-mRNAs influenced alternative splicing in a similar position-dependent manner to Nova proteins. In addition, we identified unusually long clusters of TDP-43 binding at deep intronic positions downstream of silenced exons. A substantial proportion of alternative mRNA isoforms regulated by TDP-43 encode proteins that regulate neuronal development or have been implicated in neurological diseases, highlighting the importance of TDP-43 for the regulation of splicing in the brain.	[Tollervey, James R.; Briese, Michael; Cereda, Matteo; Kayikci, Melis; Koenig, Julian; Ule, Jernej] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Curk, Tomaz; Rot, Gregor; Zupan, Blaz] Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia; [Rogelj, Boris; Hortobagyi, Tibor; Nishimura, Agnes L.; Zupunski, Vera; Shaw, Christopher E.] Kings Coll London, MRC, Ctr Neurodegenerat Res, London WC2R 2LS, England; [Cereda, Matteo] Sci Inst IRCCS E Medea, Bosisio Parini, LC, Italy; [Zupunski, Vera] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Patani, Rickie; Chandran, Siddharthan] MRC, Lab Regenerat Med, Dept Clin Neurosci, Cambridge, England; [Chandran, Siddharthan] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH8 9YL, Midlothian, Scotland	MRC Laboratory Molecular Biology; University of Ljubljana; University of London; King's College London; IRCCS Eugenio Medea; University of Ljubljana; University of Edinburgh	Ule, J (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	jule@mrc-lmb.cam.ac.uk	Zupan, Blaz/L-1595-2019; Rogelj, Boris/G-9252-2011; Patani, R/J-3107-2018; Curk, Tomaž/D-9836-2015; Nishimura, Agnes L/B-2905-2011; Ule, Jernej/C-6315-2013; Cereda, Matteo/V-5988-2019	Rogelj, Boris/0000-0003-3898-1943; Patani, R/0000-0002-3825-7675; Curk, Tomaž/0000-0003-4888-7256; Ule, Jernej/0000-0002-2452-4277; Cereda, Matteo/0000-0003-1799-5537; Zupan, Blaz/0000-0002-5864-7056; Konig, Julian/0000-0002-9398-5421; Shaw, Christopher/0000-0003-0251-0146; Nishimura, Agnes/0000-0001-5295-797X; Briese, Michael/0000-0001-7137-8260	European Research Council [206726-CLIP]; Slovenian Research Agency [P2-0209, J2-2197, L2-1112, Z7-3665]; Wellcome Trust; MRC [089701/Z/09/Z]; Motor Neuron Disease Association; Heaton-Ellis Trust; Psychiatry Research Trust; Medical Research Council [G0500289B, MC_U105185858, G0700711B] Funding Source: researchfish; MRC [MC_U105185858] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neuron Disease Association; Heaton-Ellis Trust; Psychiatry Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank K. Zarnack for advice and comments on the manuscript, F. Baralle, Y. Ayalla and A. D. Ambrogio for HeLa knockdown RNA, and J. Hadfield and the genomic team at CRI for Illumina sequencing. This work was supported by the European Research Council (206726-CLIP), the MRC, Slovenian Research Agency (P2-0209, J2-2197, L2-1112, Z7-3665), Wellcome Trust and MRC Strategic Grant Award (089701/Z/09/Z), Motor Neuron Disease Association, Heaton-Ellis Trust and Psychiatry Research Trust.	Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Becker EBE, 2007, CELL CYCLE, V6, P1332, DOI 10.4161/cc.6.11.4316; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2010, FEBS J, V277, P2268, DOI 10.1111/j.1742-4658.2010.07643.x; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kametani F, 2009, BIOCHEM BIOPH RES CO, V382, P405, DOI 10.1016/j.bbrc.2009.03.038; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kouchi Z, 2009, J BIOL CHEM, V284, P1954, DOI 10.1074/jbc.M806250200; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Ness JM, 2006, BRAIN RES, V1099, P150, DOI 10.1016/j.brainres.2006.04.132; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Wang Z, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000530; Witten JT, 2011, TRENDS GENET, V27, P89, DOI 10.1016/j.tig.2010.12.001; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088	38	708	718	2	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2011	14	4					452	U180		10.1038/nn.2778	http://dx.doi.org/10.1038/nn.2778			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	741FQ	21358640	Green Accepted			2022-12-17	WOS:000288849400016
J	Vijayraghavan, S; Wang, M; Birnbaum, SG; Williams, GV; Arnsten, AFT				Vijayraghavan, Susheel; Wang, Min; Birnbaum, Shari G.; Williams, Graham V.; Arnsten, Amy F. T.			Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory	NATURE NEUROSCIENCE			English	Article							PYRAMIDAL NEURONS; MODULATION; GENOTYPE; CORTEX; MECHANISMS; INTERNEURONS; PERFORMANCE; ACTIVATION; INHIBITION; EXCITABILITY	Dopamine (DA) D1 receptor (D1R) stimulation in prefrontal cortex (PFC) produces an 'inverted-U' dose-response, whereby either too little or too much D1R stimulation impairs spatial working memory. This response has been observed across species, including genetic linkages with human cognitive abilities, PFC activation states and DA synthesis. The cellular basis for the inverted U has long been sought, with in vitro intracellular recordings supporting a variety of potential mechanisms. The current study demonstrates that the D1R agonist inverted-U response can be observed in PFC neurons of behaving monkeys: low levels of D1R stimulation enhance spatial tuning by suppressing responses to nonpreferred directions, whereas high levels reduce delay-related firing for all directions, eroding tuning. These sculpting actions of D1R stimulation are mediated in monkeys and rats by cyclic AMP intracellular signaling. The evidence for an inverted U at the cellular level in behaving animals promises to bridge in vitro molecular analyses with human cognitive experience.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA	Yale University; Yale University	Arnsten, AFT (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06520 USA.	amy.arnsten@yale.edu			NIMH NIH HHS [P50MH068789] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068789] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; Arnsten AFT, 2005, TRENDS MOL MED, V11, P121, DOI 10.1016/j.molmed.2005.01.006; ARNSTEN AFT, 1994, PSYCHOPHARMACOLOGY, V116, P143, DOI 10.1007/BF02245056; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Cai JX, 1997, J PHARMACOL EXP THER, V283, P183; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; Chudasama Y, 2004, NEUROPSYCHOPHARMACOL, V29, P1628, DOI 10.1038/sj.npp.1300490; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Diamond A, 2004, AM J PSYCHIAT, V161, P125, DOI 10.1176/appi.ajp.161.1.125; Floresco SB, 2001, BEHAV NEUROSCI, V115, P934, DOI 10.1037/0735-7044.115.4.934; FRANKE P, 1994, PSYCHIAT RES, V54, P259, DOI 10.1016/0165-1781(94)90020-5; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; Gibbs SEB, 2005, PSYCHOPHARMACOLOGY, V180, P644, DOI 10.1007/s00213-005-0077-5; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gorelova N, 2002, J NEUROPHYSIOL, V88, P3150, DOI 10.1152/jn.00335.2002; Gorelova NA, 2000, J NEUROPHYSIOL, V84, P75, DOI 10.1152/jn.2000.84.1.75; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Henze DA, 2000, J NEUROPHYSIOL, V84, P2799, DOI 10.1152/jn.2000.84.6.2799; Lidow MS, 2003, SYNAPSE, V47, P101, DOI 10.1002/syn.10143; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; Mehta MA, 2000, J NEUROSCI, V20; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Minzenberg MJ, 2006, PSYCHIAT GENET, V16, P117, DOI 10.1097/01.ypg.0000199448.00163.e6; NUECHTERLEIN KH, 1992, SCHIZOPHRENIA BULL, V18, P387, DOI 10.1093/schbul/18.3.387; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; ROBBINS TW, 1979, NEUROPHARMACOLOGY, V18, P931, DOI 10.1016/0028-3908(79)90157-6; SAWAGUCHI T, 1990, J NEUROPHYSIOL, V63, P1401, DOI 10.1152/jn.1990.63.6.1401; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHWARTZ ML, 1988, J NEUROSCI, V8, P1962; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2001, J NEUROSCI, V21, P3628, DOI 10.1523/JNEUROSCI.21-10-03628.2001; Trantham-Davidson H, 2004, J NEUROSCI, V24, P10652, DOI 10.1523/JNEUROSCI.3179-04.2004; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Urban NN, 2002, J PHYSIOL-LONDON, V539, P707, DOI 10.1113/jphysiol.2001.015024; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Yan Z, 1997, NEURON, V19, P1115, DOI 10.1016/S0896-6273(00)80402-X; Yang CR, 1996, J NEUROSCI, V16, P1922; Yang CR, 1996, J NEUROSCI, V16, P1904; Zahrt J, 1997, J NEUROSCI, V17, P8528; Zhen XC, 2005, PHARMACOL BIOCHEM BE, V80, P597, DOI 10.1016/j.pbb.2005.01.016; Zhou FM, 1999, J NEUROPHYSIOL, V81, P967, DOI 10.1152/jn.1999.81.3.967	47	707	719	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					376	384		10.1038/nn1846	http://dx.doi.org/10.1038/nn1846			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17277774				2022-12-17	WOS:000244480300021
J	Laughlin, SB; van Steveninck, RRD; Anderson, JC				Laughlin, SB; van Steveninck, RRD; Anderson, JC			The metabolic cost of neural information	NATURE NEUROSCIENCE			English	Article							EXPENSIVE-TISSUE HYPOTHESIS; COMPOUND EYE; DROSOPHILA PHOTORECEPTORS; BLOWFLY PHOTORECEPTORS; SODIUM-PUMP; CHANNELS; HISTAMINE; SYNAPSE; KINESIN; BRAIN	We derive experimentally based estimates of the energy used by neural mechanisms to code known quantities of information. Biophysical measurements from cells in the blowfly retina yield estimates of the ATP required to generate graded (analog) electrical signals that transmit known amounts of information. Energy consumption is several orders of magnitude greater than the thermodynamic minimum. It costs 10(4) ATP molecules to transmit a bit at a chemical synapse, and 10(6) - 10(7) ATP for graded signals in an interneuron or a photoreceptor, or for spike coding. Therefore, in noise-limited signaling systems, a weak pathway of low capacity transmits information more economically, which promotes the distribution of information among multiple pathways.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; NEC Res Inst, Princeton, NJ 08540 USA; Univ Sussex, Sussex Ctr Neurosci, Brighton BN1 9QG, E Sussex, England	University of Cambridge; NEC Corporation; University of Sussex	Laughlin, SB (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.							Aiello LC, 1997, BRAZ J GENET, V20, P141, DOI 10.1590/S0100-84551997000100023; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; AMES A, 1992, CAN J PHYSIOL PHARM, V70, pS158, DOI 10.1139/y92-257; Ames Adelbert Iii, 1997, P17; BEERSMA DGM, 1977, J COMP PHYSIOL, V119, P207, DOI 10.1007/BF00656634; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; BRAY D, 1998, IN PRESS ANN REV BIO; Diamond JM, 1996, NATURE, V382, P756, DOI 10.1038/382756a0; FROHLICH A, 1985, J COMP NEUROL, V241, P311, DOI 10.1002/cne.902410306; Gerster U, 1997, J COMP PHYSIOL A, V180, P113, DOI 10.1007/s003590050032; HALL ZW, 1992, INTRO MOL NEUROBIOLO, V555; HAMDORF K, 1988, J COMP PHYSIOL A, V162, P285, DOI 10.1007/BF00606117; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HARDIE RC, 1995, CELL CALCIUM, V18, P256, DOI 10.1016/0143-4160(95)90023-3; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; Hille B., 1992, IONIC CHANNELS EXCIT; Howard J, 1996, ANNU REV PHYSIOL, V58, P703, DOI 10.1146/annurev.ph.58.030196.003415; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; JANSONIUS NM, 1990, J COMP PHYSIOL A, V167, P461, DOI 10.1007/BF00190816; KEISTER M, 1974, PHYSL INSECTA, V6; Kety S.S., 1957, METABOLISM NERVOUS S, P221; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; LAUGHLIN SB, 1994, PROG RETIN EYE RES, V13, P165, DOI 10.1016/1350-9462(94)90009-4; LAUGHLIN SB, 1989, J EXP BIOL, V144, P113; LEFF HS, 1990, MAXWELLS DEMON ENTRO, V349; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Martin RD, 1996, NEWS PHYSIOL SCI, V11, P149, DOI 10.1152/physiologyonline.1996.11.4.149; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; NICOL D, 1982, J COMP NEUROL, V207, P29, DOI 10.1002/cne.902070104; RIEKE F, 1997, SPIKES EXPLORING NEU, V395; SARPESHKAR R, 1998, IN PRESS NEURAL COMP; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; SKINGSLEY DR, 1995, J COMP PHYSIOL A, V176, P611, DOI 10.1007/BF01021581; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; Stuart AE, 1996, J NEUROSCI, V16, P3178; Szilard L, 1929, Z PHYS, V53, P840, DOI 10.1007/BF01341281; TSACOPOULOS M, 1994, J NEUROSCI, V14, P1339, DOI 10.1523/JNEUROSCI.14-03-01339.1994; UUSITALO RO, 1994, J NEUROPHYSIOL, V71, P1381, DOI 10.1152/jn.1994.71.4.1381; VANHATEREN JH, 1990, J COMP PHYSIOL A, V166, P437, DOI 10.1007/BF00192015; vanSteveninck RRD, 1996, NATURE, V379, P642, DOI 10.1038/379642a0; WECKSTROM M, 1992, PFLUG ARCH EUR J PHY, V421, P469, DOI 10.1007/BF00370258; WECKSTROM M, 1991, J PHYSIOL-LONDON, V440, P635, DOI 10.1113/jphysiol.1991.sp018729	43	707	716	11	106	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1998	1	1					36	41		10.1038/236	http://dx.doi.org/10.1038/236			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QA	10195106				2022-12-17	WOS:000076361000015
J	Craig, AD; Chen, K; Bandy, D; Reiman, EM				Craig, AD; Chen, K; Bandy, D; Reiman, EM			Thermosensory activation of insular cortex	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; LAMINA-I NEURONS; COLD PAIN; NUCLEUS; MONKEY; PROJECTIONS; CONNECTIONS; TEMPERATURE; SENSATION; RESPONSES	Temperature sensation is regarded as a submodality of touch, but evidence suggests involvement of insular cortex rather than parietal somatosensory cortices. Using positron emission tomography (PEI), we found contralateral activity correlated with graded cooling stimuli only in the dorsal margin of the middle/posterior insula in humans. This corresponds to the thermoreceptive- and nociceptive-specific lamina I spinothalamocortical pathway in monkeys, and can be considered an enteroceptive area within limbic sensory cortex. Because lesions at this site can produce the poststroke central pain syndrome, this finding supports the proposal that central pain results from loss of the normal inhibition of pain by cold. Notably, perceived thermal intensity was well correlated with activation in the right (ipsilateral) anterior insular and orbitofrontal cortices.	Barrow Neurol Inst, Div Neurosurg, Phoenix, AZ 85013 USA; Good Samaritan Reg Med Ctr, Positron Emiss Tomog Ctr, Phoenix, AZ 85006 USA; Arizona State Univ, Dept Math, Tempe, AZ 85280 USA; Univ Arizona, Dept Psychiat, Tucson, AZ 85721 USA	Barrow Neurological Institute; Arizona State University; Arizona State University-Tempe; University of Arizona	Craig, AD (corresponding author), Barrow Neurol Inst, Div Neurosurg, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	bcraig@mha.chw.edu	Chen, Kewei/P-6304-2015	Chen, Kewei/0000-0001-8497-3069				ADAMS RW, 1989, ELECTROEN CLIN NEURO, V73, P443, DOI 10.1016/0013-4694(89)90094-1; ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BECKSTEAD RM, 1980, J COMP NEUROL, V190, P259, DOI 10.1002/cne.901900205; BENKELFAT C, 1995, AM J PSYCHIAT, V152, P1180; BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0; Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; CHRISTENSEN BN, 1970, J NEUROPHYSIOL, V33, P293, DOI 10.1152/jn.1970.33.2.293; CRAIG AD, 1994, NATURE, V372, P770, DOI 10.1038/372770a0; Craig AD, 1999, J COMP NEUROL, V404, P221; Craig AD, 1995, FRONTIER PAIN RES, P13; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Craig ADB, 1998, PAIN FORUM, V7, P1; DAMASIO AR, 1993, DESCARTES ERROR EMOT, P312; DARIANSMITH I, 1984, HDB PHYSL 1, V3, P879; Davis KD, 1999, J NEUROPHYSIOL, V81, P1970, DOI 10.1152/jn.1999.81.4.1970; Denton D, 1999, P NATL ACAD SCI USA, V96, P5304, DOI 10.1073/pnas.96.9.5304; Derbyshire SWG, 1998, PAIN, V76, P127, DOI 10.1016/S0304-3959(98)00034-7; DOSTROVSKY JO, 1978, J PHYSIOL-LONDON, V277, P29, DOI 10.1113/jphysiol.1978.sp012258; Dostrovsky JO, 1996, J NEUROPHYSIOL, V76, P3656, DOI 10.1152/jn.1996.76.6.3656; Dostrovsky JO, 1992, INT C SERIES, V989, P115; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Han ZS, 1998, NAT NEUROSCI, V1, P218, DOI 10.1038/665; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; King AB, 1999, J COMP NEUROL, V413, P572; KINOMURA S, 1994, BRAIN RES, V659, P263, DOI 10.1016/0006-8993(94)90890-7; LENZ FA, 1993, BRAIN RES, V623, P235, DOI 10.1016/0006-8993(93)91433-S; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; MOWER GD, 1976, J COMP PHYSIOL PSYCH, V90, P1152, DOI 10.1037/h0077284; NORRSELL U, 1989, EXP BRAIN RES, V78, P369; Norrsell U, 1999, J NEUROPHYSIOL, V82, P611, DOI 10.1152/jn.1999.82.2.611; PAGNI CA, 1998, CENTRAL PAIN NEUROSU; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; PRITCHARD TC, 1986, J COMP NEUROL, V244, P213, DOI 10.1002/cne.902440208; Reiman EM, 1997, J CLIN PSYCHIAT, V58, P4; SCHMAHMANN JD, 1992, ARCH NEUROL-CHICAGO, V49, P1032, DOI 10.1001/archneur.1992.00530340048017; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; Talairach J., 1988, COPLANAR STEREOTAXIC; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; VOLKOW ND, 1991, J NUCL MED, V32, P58; White JC, 1969, PAIN NEUROSURGEON 40; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; YARNITSKY D, 1990, BRAIN, V113, P893, DOI 10.1093/brain/113.4.893; YASUI Y, 1991, J COMP NEUROL, V303, P355, DOI 10.1002/cne.903030303	50	706	725	0	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					184	190		10.1038/72131	http://dx.doi.org/10.1038/72131			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649575				2022-12-17	WOS:000085810300017
J	Mcnab, F; Klingberg, T				McNab, Fiona; Klingberg, Torkel			Prefrontal cortex and basal ganglia control access to working memory	NATURE NEUROSCIENCE			English	Article							SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; CAPACITY; ATTENTION; PERFORMANCE; SET	Our capacity to store information in working memory might be determined by the degree to which only relevant information is remembered. The question remains as to how this selection of relevant items to be remembered is accomplished. Here we show that activity in the prefrontal cortex and basal ganglia preceded the filtering of irrelevant information and that activity, particularly in the globus pallidus, predicted the extent to which only relevant information is stored. The preceding frontal and basal ganglia activity were also associated with inter-individual differences in working memory capacity. These findings reveal a mechanism by which frontal and basal ganglia activity exerts attentional control over access to working memory storage in the parietal cortex in humans, and makes an important contribution to inter-individual differences in working memory capacity.	[McNab, Fiona; Klingberg, Torkel] Karolinska Inst, Stockholm Brain Inst, MR Centrum, S-17176 Stockholm, Sweden	Karolinska Institutet	Klingberg, T (corresponding author), Karolinska Inst, Stockholm Brain Inst, MR Centrum, N8 00, S-17176 Stockholm, Sweden.	Torkel.Klingberg@ki.se		Klingberg, Torkel/0000-0002-3175-2171				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Bleckley MK, 2003, PSYCHON B REV, V10, P884, DOI 10.3758/BF03196548; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Conway ARA, 1996, MEMORY, V4, P577, DOI 10.1080/741940997; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; Grabli D, 2004, BRAIN, V127, P2039, DOI 10.1093/brain/awh220; Gruber AJ, 2006, J COMPUT NEUROSCI, V20, P153, DOI 10.1007/s10827-005-5705-x; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Menon V, 2000, NEUROREPORT, V11, P3641, DOI 10.1097/00001756-200011090-00048; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Mushiake H, 1995, J NEUROPHYSIOL, V74, P2754, DOI 10.1152/jn.1995.74.6.2754; Postle BR, 1999, COGNITIVE BRAIN RES, V8, P107, DOI 10.1016/S0926-6410(99)00010-5; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; SCHNEIDER JS, 1984, BIOL PSYCHIAT, V19, P1693; Suss HM, 2002, INTELLIGENCE, V30, P261, DOI 10.1016/S0160-2896(01)00100-3; Taylor PE, 1996, TRANSPLANT P, V28, P281; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447	29	703	725	4	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2008	11	1					103	107		10.1038/nn2024	http://dx.doi.org/10.1038/nn2024			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	247YG	18066057				2022-12-17	WOS:000252117900018
J	Kreek, MJ; Nielsen, DA; Butelman, ER; LaForge, KS				Kreek, MJ; Nielsen, DA; Butelman, ER; LaForge, KS			Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction	NATURE NEUROSCIENCE			English	Article							COCAINE-INDUCED PARANOIA; PITUITARY-ADRENAL AXIS; RECEPTOR GENE; OPIOID RECEPTOR; SUBSTANCE-ABUSE; ALCOHOL DEPENDENCE; ASSOCIATION ANALYSIS; MOLECULAR-GENETICS; OPIATE ADDICTION; NOVELTY SEEKING	Genetic variation may partially underlie complex personality and physiological traits-such as impulsivity, risk taking and stress responsivity-as well as a substantial proportion of vulnerability to addictive diseases. Furthermore, personality and physiological traits themselves may differentially affect the various stages of addiction, defined chronologically as initiation of drug use, regular drug use, addiction/dependence and potentially relapse. Here we focus on recent approaches to the study of genetic variation in these personality and physiological traits, and their influence on and interaction with addictive diseases.	Rockefeller Univ, Lab Biol Addict Dis, New York, NY 10021 USA	Rockefeller University	Kreek, MJ (corresponding author), Rockefeller Univ, Lab Biol Addict Dis, 1230 York Ave, New York, NY 10021 USA.	kreek@rockefeller.edu	Nielsen, David A/B-4655-2009		NCRR NIH HHS [M01-RR00102] Funding Source: Medline; NIDA NIH HHS [K05-DA00049, P60-DA05130] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000049, P60DA005130] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bart G, 2005, NEUROPSYCHOPHARMACOL, V30, P417, DOI 10.1038/sj.npp.1300598; Bart G, 2004, MOL PSYCHIATR, V9, P547, DOI 10.1038/sj.mp.4001504; Bond C, 1998, P NATL ACAD SCI USA, V95, P9608, DOI 10.1073/pnas.95.16.9608; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290; COCCARO EF, 1994, ARCH GEN PSYCHIAT, V51, P318; Comings DE, 1997, MOL PSYCHIATR, V2, P161, DOI 10.1038/sj.mp.4000247; Cubells JF, 2000, MOL PSYCHIATR, V5, P56, DOI 10.1038/sj.mp.4000657; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Foroud T, 2000, ALCOHOL CLIN EXP RES, V24, P933, DOI 10.1097/00000374-200007000-00001; Gelernter J, 2005, AM J MED GENET B, V136B, P45, DOI 10.1002/ajmg.b.30189; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; Horowitz R, 2000, AM J MED GENET, V96, P599, DOI 10.1002/1096-8628(20001009)96:5<599::AID-AJMG4>3.3.CO;2-F; Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Kosten TA, 1997, BRAIN RES, V778, P418, DOI 10.1016/S0006-8993(97)01205-5; Kreek MJ, 2002, NAT REV DRUG DISCOV, V1, P710, DOI 10.1038/nrd897; Kreek MJ, 2005, PHARMACOL REV, V57, P1, DOI 10.1124/pr.57.1.1; Kreek MJ, 2004, NEUROMOL MED, V5, P85, DOI 10.1385/NMM:5:1:085; Kreek MJ, 1996, MOL PSYCHIATR, V1, P232; KREEK MJ, 1972, P 4 NAT C METH TREAT, P171, DOI DOI 10.1001/JAMA.223.6.665; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; LaForge KS, 2000, EUR J PHARMACOL, V410, P249, DOI 10.1016/S0014-2999(00)00819-0; LEVIN FR, 1995, HARVARD REV PSYCHIAT, V2, P246, DOI 10.3109/10673229509017144; Li T, 2004, AM J MED GENET B, V129B, P120, DOI 10.1002/ajmg.b.30024; Limosin F, 2005, EUR PSYCHIAT, V20, P304, DOI 10.1016/j.eurpsy.2005.02.004; Lusher JM, 2001, MOL PSYCHIATR, V6, P497, DOI 10.1038/sj.mp.4000918; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Nielsen DA, 1998, ARCH GEN PSYCHIAT, V55, P593, DOI 10.1001/archpsyc.55.7.593; NIELSEN DA, 1994, ARCH GEN PSYCHIAT, V51, P34; O'Malley SS, 2002, PSYCHOPHARMACOLOGY, V160, P19, DOI 10.1007/s002130100919; Oswald LM, 2004, BIOL PSYCHIAT, V55, P102, DOI 10.1016/j.biopsych.2003.07.003; Ott J, 2004, HUM HERED, V58, P171, DOI 10.1159/000083544; Primus RJ, 1997, J PHARMACOL EXP THER, V282, P1020; ROUNSAVILLE BJ, 1982, ARCH GEN PSYCHIAT, V39, P151; Schinka JA, 2002, AM J MED GENET, V114, P643, DOI 10.1002/ajmg.10649; Schluger JH, 2001, NEUROPSYCHOPHARMACOL, V24, P568, DOI 10.1016/S0893-133X(00)00222-0; Schmidt LG, 2002, DRUG ALCOHOL DEPEN, V65, P221, DOI 10.1016/S0376-8716(01)00164-8; Sinha R, 2003, PSYCHOPHARMACOLOGY, V170, P62, DOI 10.1007/s00213-003-1525-8; Sipe JC, 2002, P NATL ACAD SCI USA, V99, P8394, DOI 10.1073/pnas.082235799; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Tsuang MT, 1999, BEHAV GENET, V29, P473, DOI 10.1023/A:1021635223370; UHL G, 1993, TRENDS NEUROSCI, V16, P83, DOI 10.1016/0166-2236(93)90128-9; Uhl GR, 2004, ANN NY ACAD SCI, V1025, P1, DOI 10.1196/annals.1316.001; Uhl GR, 2002, TRENDS GENET, V18, P420, DOI 10.1016/S0168-9525(02)02719-1; Vandenbergh DJ, 1997, AM J MED GENET, V74, P439, DOI 10.1002/(SICI)1096-8628(19970725)74:4<439::AID-AJMG16>3.0.CO;2-J; Wang JC, 2004, HUM MOL GENET, V13, P1903, DOI 10.1093/hmg/ddh194; Yuferov V, 2004, PHARMACOGENETICS, V14, P793, DOI 10.1097/00008571-200412000-00002; Zhang PW, 2004, MOL PSYCHIATR, V9, P916, DOI 10.1038/sj.mp.4001560; Zhou Y, 1996, J PHARMACOL EXP THER, V279, P351	50	703	728	5	227	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1450	1457		10.1038/nn1583	http://dx.doi.org/10.1038/nn1583			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16251987				2022-12-17	WOS:000232966600015
J	Ulanovsky, N; Las, L; Nelken, I				Ulanovsky, N; Las, L; Nelken, I			Processing of low-probability sounds by cortical neurons	NATURE NEUROSCIENCE			English	Article							PRIMARY AUDITORY-CORTEX; MISMATCH NEGATIVITY; VISUAL-CORTEX; INTRACORTICAL MECHANISMS; STIMULUS DEVIANCE; ACOUSTIC CHANGE; CAT; ADAPTATION; FREQUENCY; PLASTICITY	The ability to detect rare auditory events can be critical for survival. We report here that neurons in cat primary auditory cortex (A1) responded more strongly to a rarely presented sound than to the same sound when it was common. For the rare stimuli, we used both frequency and amplitude deviants. Moreover, some A1 neurons showed hyperacuity for frequency deviants-a frequency resolution one order of magnitude better than receptive field widths in A1. In contrast, auditory thalamic neurons were insensitive to the probability of frequency deviants. These phenomena resulted from stimulus-specific adaptation in A1, which may be a single-neuron correlate of an extensively studied cortical potential-mismatch negativity-that is evoked by rare sounds. Our results thus indicate that A1 neurons, in addition to processing the acoustic features of sounds, may also be involved in sensory memory and novelty detection.	Hebrew Univ Jerusalem, Dept Physiol, Hadassah Med Sch, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Nelken, I (corresponding author), Hebrew Univ Jerusalem, Dept Physiol, Hadassah Med Sch, Box 12272, IL-91120 Jerusalem, Israel.		Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X; Ulanovsky, Nachum/0000-0001-8598-4667				Ahissar M, 2000, P NATL ACAD SCI USA, V97, P6832, DOI 10.1073/pnas.97.12.6832; Amitay S, 2002, JARO-J ASSOC RES OTO, V3, P302, DOI 10.1007/s101620010093; ANDERSEN RA, 1980, J COMP NEUROL, V194, P663, DOI 10.1002/cne.901940312; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; CONDON CD, 1991, BEHAV NEUROSCI, V105, P416, DOI 10.1037/0735-7044.105.3.416; CSEPE V, 1987, ELECTROEN CLIN NEURO, V66, P571, DOI 10.1016/0013-4694(87)90103-9; CSEPE V, 1989, SLEEP 88, P210; Delgutte B., 1996, AUDITORY COMPUTATION, P157, DOI DOI 10.1007/978-1-4612-4070-9_5; Deouell LY, 2000, AUDIOL NEURO-OTOL, V5, P225, DOI 10.1159/000013884; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fischer C, 2000, AUDIOL NEURO-OTOL, V5, P192, DOI 10.1159/000013880; GREEN DM, 1966, SIGNAL DETECTION THE; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1111/1469-8986.3840723; JAVITT DC, 1994, BRAIN RES, V667, P192, DOI 10.1016/0006-8993(94)91496-6; Javitt DC, 2000, AUDIOL NEURO-OTOL, V5, P207, DOI 10.1159/000013882; KING C, 1995, HEARING RES, V85, P45, DOI 10.1016/0378-5955(95)00028-3; KRAUS N, 1994, J ACOUST SOC AM, V96, P2758, DOI 10.1121/1.411282; KRAUS N, 1994, J NEUROPHYSIOL, V72, P1270, DOI 10.1152/jn.1994.72.3.1270; Kujala T, 2001, NEUROSCI BIOBEHAV R, V25, P535, DOI 10.1016/S0149-7634(01)00032-X; LIBERMAN MC, 1978, J ACOUST SOC AM, V63, P442, DOI 10.1121/1.381736; Malone BJ, 2002, J NEUROSCI, V22, P4625, DOI 10.1523/JNEUROSCI.22-11-04625.2002; Malone BJ, 2001, J NEUROPHYSIOL, V86, P1113, DOI 10.1152/jn.2001.86.3.1113; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; MASTERTON RB, 1992, HEARING RES, V63, P57, DOI 10.1016/0378-5955(92)90074-W; May P, 1999, J COMPUT NEUROSCI, V6, P99, DOI 10.1023/A:1008896417606; Moore BCJ., 1993, HUMAN PSYCHOPHYSICS, P56, DOI 10.1007/978-1-4612-2728-1_3; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; Naatanen R., 1992, ATTENTION BRAIN FUNC; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; PHILLIPS DP, 1985, EXP BRAIN RES, V58, P443; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Pincze Z, 2001, CLIN NEUROPHYSIOL, V112, P778, DOI 10.1016/S1388-2457(01)00509-0; Sanes DH, 1998, J NEUROSCI, V18, P794; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0	42	702	720	3	47	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					391	398		10.1038/nn1032	http://dx.doi.org/10.1038/nn1032			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12652303				2022-12-17	WOS:000181833100017
J	Pesaran, B; Pezaris, JS; Sahani, M; Mitra, PP; Andersen, RA				Pesaran, B; Pezaris, JS; Sahani, M; Mitra, PP; Andersen, RA			Temporal structure in neuronal activity during working memory in macaque parietal cortex	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; LATERAL INTRAPARIETAL AREA; SHORT-TERM-MEMORY; PREFRONTAL CORTEX; UNIT-ACTIVITY; SYNCHRONIZATION; OSCILLATIONS; MONKEY; ATTENTION; AWAKE	Many cortical structures have elevated firing rates during working memory, but it is not known how the activity is maintained. To investigate whether reverberating activity is important, we studied the temporal structure of local field potential (LFP) activity and spiking from area LIP in two awake macaques during a memory-saccade task. Using spectral analysis, we found spatially tuned elevated power in the gamma band (25-90 Hz) in LFP and spiking activity during the memory period. Spiking and LFP activity were also coherent in the gamma band but not at lower frequencies. Finally, we decoded LFP activity on a single-trial basis and found that LFP activity in parietal cortex discriminated between preferred and anti-preferred direction with approximately the same accuracy as the spike rate and predicted the time of a planned movement with better accuracy than the spike rate. This finding could accelerate the development of a cortical neural prosthesis.	CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA; CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Alcatel-Lucent; Lucent Technologies; AT&T; California Institute of Technology	Andersen, RA (corresponding author), CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA.			Pesaran, Bijan/0000-0003-4116-0038; Mitra, Partha/0000-0001-8818-6804	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062528] Funding Source: NIH RePORTER; NEI NIH HHS [EY05522-21] Funding Source: Medline; NIMH NIH HHS [MH62528-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; BRILLINGER DR, 1974, TIME SERIES; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; ECKHORN R, 1993, NEUROREPORT, V4, P243, DOI 10.1097/00001756-199303000-00004; Efron B., 1993, INTRO BOOTSTRAP; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; EPRCIVAL DB, 1993, SPECTRAL ANAL PHYSIC; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster JM, 1995, MEMORY CEREBRAL CORT; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; KOCH KW, 1989, EXP BRAIN RES, V76, P292; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Lebedev MA, 2000, EXP BRAIN RES, V130, P195, DOI 10.1007/s002210050022; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Miller EK, 1996, J NEUROSCI, V16, P5154; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3949, DOI 10.1152/jn.1996.76.6.3949; NAKAMURA K, 1992, NEUROREPORT, V3, P117, DOI 10.1097/00001756-199201000-00031; Pezaris JS, 1999, NEUROCOMPUTING, V26-7, P471, DOI 10.1016/S0925-2312(99)00053-3; PEZARIS JS, 1996, COMPUTATIONAL NEUROS, P937; Ripley B.D., 1996, PATTERN RECOGN, DOI 10.1017/CBO9780511812651; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; ROUGEUL A, 1979, ELECTROEN CLIN NEURO, V46, P310, DOI 10.1016/0013-4694(79)90205-0; Sahani M, 1998, ADV NEUR IN, V10, P222; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Thomson DJ, 1991, ADV SPECTRUM ANAL AR; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	47	701	711	3	49	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2002	5	8					805	811		10.1038/nn890	http://dx.doi.org/10.1038/nn890			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	577XT	12134152	Green Submitted			2022-12-17	WOS:000177088900025
J	Hamann, SB; Ely, TD; Grafton, ST; Kilts, CD				Hamann, SB; Ely, TD; Grafton, ST; Kilts, CD			Amygdala activity related to enhanced memory for pleasant and aversive stimuli	NATURE NEUROSCIENCE			English	Article							AUTOMATED IMAGE REGISTRATION; DECLARATIVE MEMORY; LONG-TERM; FREE-RECALL; HUMANS; HIPPOCAMPAL; INFORMATION; MECHANISMS; VALIDATION; AROUSAL	Pleasant or aversive events are better remembered than neutral events. Emotional enhancement of episodic memory has been linked to the amygdala in animal and neuropsychological studies. Using positron emission tomography, we show that bilateral amygdala activity during memory encoding is correlated with enhanced episodic recognition memory for both pleasant and aversive visual stimuli relative to neutral stimuli, and that this relationship is specific to emotional stimuli. Furthermore, data suggest that the amygdala enhances episodic memory in part through modulation of hippocampal activity The human amygdala seems to modulate the strength of conscious memory for events according to emotional importance, regardless of whether the emotion is pleasant or aversive.	Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; Emory Univ, Ctr PET, Atlanta, GA 30322 USA	Emory University; Emory University	Hamann, SB (corresponding author), Emory Univ, Dept Psychol, Atlanta, GA 30322 USA.			Ely, Timothy/0000-0002-5690-5234				Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Alkire MT, 1998, P NATL ACAD SCI USA, V95, P14506, DOI 10.1073/pnas.95.24.14506; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CAHILL L, 1990, BEHAV NEUROSCI, V104, P532, DOI 10.1037/0735-7044.104.4.532; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Center for the Study of Emotion and Attention National Institute of Mental Health, 1999, INT AFF PICT SYST; DAVIS M, 1992, P255; EICHENBAUM H, 1992, J COGNITIVE NEUROSCI, V4, P217, DOI 10.1162/jocn.1992.4.3.217; GAFFAN D, 1992, P471; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; Ikemoto S, 1997, J NEUROSCI, V17, P8580; LABAR KS, 1995, J NEUROSCI, V15, P6846; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Macmillan N, 1991, DETECTION THEORY USE; MAZZIOTTA JC, 1985, J CEREBR BLOOD F MET, V5, P70, DOI 10.1038/jcbfm.1985.10; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; Merali Z, 1998, J NEUROSCI, V18, P4758; Packard MG, 1998, NEUROBIOL LEARN MEM, V69, P163, DOI 10.1006/nlme.1997.3815; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Talairach I., 1988, COPLANAR STEREOTACTI; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027	28	699	715	1	67	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	1999	2	3					289	293		10.1038/6404	http://dx.doi.org/10.1038/6404			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	220TX	10195224				2022-12-17	WOS:000081684500019
J	Patel, AD				Patel, AD			Language, music, syntax and the brain	NATURE NEUROSCIENCE			English	Review							HUMAN AUDITORY-CORTEX; SENTENCE COMPREHENSION; WORKING-MEMORY; COMPLEXITY; CONTEXT; CHORDS; BROCAS; SPEECH; EXPECTANCY; ACTIVATION	The comparative study of music and language is drawing an increasing amount of research interest. Like language, music is a human universal involving perceptually discrete elements organized into hierarchically structured sequences. Music and language can thus serve as foils for each other in the study of brain mechanisms underlying complex sound processing, and comparative research can provide novel insights into the functional and neural architecture of both domains. This review focuses on syntax, using recent neuroimaging data and cognitive theory to propose a specific point of convergence between syntactic processing in language and music. This leads to testable predictions, including the prediction that that syntactic comprehension problems in Broca's aphasia are not selective to language but influence music perception as well.	Inst Neurosci, San Diego, CA 92121 USA		Patel, AD (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.							[Anonymous], [No title captured]; Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Ayotte J, 2000, BRAIN, V123, P1926, DOI 10.1093/brain/123.9.1926; Babyonyshev M, 1999, LANGUAGE, V75, P423, DOI 10.2307/417056; Bates E., 1996, RETHINKING INNATENES; Besson M, 1998, PSYCHOL SCI, V9, P494, DOI 10.1111/1467-9280.00091; BHARUCHA JJ, 1986, J EXP PSYCHOL HUMAN, V12, P403, DOI 10.1037/0096-1523.12.4.403; BHARUCHA JJ, 1987, PERCEPT PSYCHOPHYS, V41, P519, DOI 10.3758/BF03210486; Bigand E, 1999, PSYCHOL RES-PSYCH FO, V62, P237, DOI 10.1007/s004260050053; Bigand E, 1997, PERCEPT PSYCHOPHYS, V59, P1098, DOI 10.3758/BF03205524; Bigand E, 1999, J EXP PSYCHOL HUMAN, V25, P184, DOI 10.1037/0096-1523.25.1.184; Bigand E, 2003, MUSIC SCI, V7, P121, DOI 10.1177/102986490300700107; Bigand E, 2003, J EXP PSYCHOL HUMAN, V29, P159, DOI 10.1037/0096-1523.29.1.159; Bigand E, 2001, COGNITION, V81, pB11, DOI 10.1016/S0010-0277(01)00117-2; BLUMSTEIN SE, 1991, BRAIN LANG, V40, P393, DOI 10.1016/0093-934X(91)90138-Q; Bonnel AM, 2001, PERCEPT PSYCHOPHYS, V63, P1201, DOI 10.3758/BF03194534; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Chomsky Noam, 1965, ASPECTS THEORY SYNTA; Deutsch D., 1999, PSYCHOL MUSIC; Fodor J.A., 1983, MODULARITY MIND; FRANCES R, 1973, REV INT PSYCHOL APPL, V22, P117; Frisch S, 2003, CLIN NEUROPHYSIOL, V114, P336, DOI 10.1016/S1388-2457(02)00366-8; Gandour J, 2000, J COGNITIVE NEUROSCI, V12, P207, DOI 10.1162/089892900561841; Gibson E, 2000, IMAGE, LANGUAGE, BRAIN, P95; Gibson E, 1998, COGNITION, V68, P1, DOI 10.1016/S0010-0277(98)00034-1; Gibson E, 1998, TRENDS COGN SCI, V2, P262, DOI 10.1016/S1364-6613(98)01187-5; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; HAARMANN HJ, 1991, COGNITIVE SCI, V15, P49, DOI 10.1207/s15516709cog1501_2; HAARMANN HJ, 1991, APHASIOLOGY, V5, P247, DOI 10.1080/02687039108248527; Hagoort Peter, 1999, NEUROCOGNITION LANGU; Hebert S, 2001, BRAIN COGNITION, V46, P169, DOI 10.1016/S0278-2626(01)80058-0; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; HSIAO F, IN PRESS COGNITION; Jackendoff Ray, 2002, FDN LANGUAGE; Jakobson LS, 2003, MUSIC PERCEPT, V20, P307, DOI 10.1525/mp.2003.20.3.307; Justus TC, 2001, J EXP PSYCHOL HUMAN, V27, P1000, DOI 10.1037/0096-1523.27.4.1000; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kaan E, 2002, TRENDS COGN SCI, V6, P350, DOI 10.1016/S1364-6613(02)01947-2; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Koelsch S, 2001, NEUROREPORT, V12, P1385, DOI 10.1097/00001756-200105250-00019; KOLK HHJ, 1985, CORTEX, V21, P47, DOI 10.1016/S0010-9452(85)80015-0; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; KRUMHANSL CL, 1979, COGNITIVE PSYCHOL, V11, P346, DOI 10.1016/0010-0285(79)90016-1; KRUMHANSL CL, 1982, PSYCHOL REV, V89, P334, DOI 10.1037/0033-295X.89.4.334; KRUMHANSL CL, 1982, J EXP PSYCHOL HUMAN, V8, P24, DOI 10.1037/0096-1523.8.1.24; Krumhansl CL, 1996, MUSIC PERCEPT, V13, P401; LERDAHL F, 1983, GENERATIVE THEORY TO; LERDAHL F, IN PRESS ULTIMOS DIE; LERDAHL F., 2001, TONAL PITCH SPACE; Levelt WJM, 1999, TRENDS COGN SCI, V3, P223, DOI 10.1016/S1364-6613(99)01319-4; Luria A R, 1965, J Neurol Sci, V2, P288, DOI 10.1016/0022-510X(65)90113-9; MacDonald MC, 2002, PSYCHOL REV, V109, P35, DOI 10.1037//0033-295X.109.1.35; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Marin O.S.M., 1999, PSYCHOL MUSIC, P653; McNellis MG, 2001, J COGNITIVE NEUROSCI, V13, P151, DOI 10.1162/089892901564216; Menning H, 2002, LEARN MEMORY, V9, P253, DOI 10.1101/lm.49402; Nettl B, 2000, ORIGINS OF MUSIC, P463; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Patel AD, 2003, COGNITION, V87, pB35, DOI 10.1016/S0010-0277(02)00187-7; Patel AD, 1998, BRAIN LANG, V61, P123, DOI 10.1006/brln.1997.1862; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; PERETZ I, 1994, BRAIN, V117, P1283, DOI 10.1093/brain/117.6.1283; PERETZ I, 1993, COGNITIVE NEUROPSYCH, V10, P21, DOI 10.1080/02643299308253455; Peretz Isabelle, 2003, COGNITIVE NEUROSCIEN; Phillips C., 1996, THESIS MIT; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; SCHON D, IN PRESS PSYCHOPHYSI; Sloboda J., 1985, THE MUSICAL MIND, V1999; SMITH N, IN PRESS MUSICAE SCI; Swaab TY, 1998, NEUROPSYCHOLOGIA, V36, P737, DOI 10.1016/S0028-3932(97)00174-7; Swain J., 1997, MUSICAL LANGUAGES; Tekman HG, 1998, J EXP PSYCHOL HUMAN, V24, P252, DOI 10.1037/0096-1523.24.1.252; Tervaniemi M, 1999, NEUROIMAGE, V9, P330, DOI 10.1006/nimg.1999.0405; Tillmann B, 1998, MUSIC PERCEPT, V16, P99; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885; Tillmann B, 2003, COGNITIVE BRAIN RES, V16, P145, DOI 10.1016/S0926-6410(02)00245-8; Tillmann B, 2001, J EXP PSYCHOL HUMAN, V27, P1185, DOI 10.1037//0096-1523.27.5.1185; TREHUB SE, 1993, ADV CHILD DEV BEHAV, V24, P1, DOI 10.1016/S0065-2407(08)60298-0; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Vega D, 2003, MUSIC SCI, V7, P35, DOI 10.1177/102986490300700103; WALLACE WT, 1994, J EXP PSYCHOL LEARN, V20, P1471, DOI 10.1037/0278-7393.20.6.1471; Warren T, 2002, COGNITION, V85, P79, DOI 10.1016/S0010-0277(02)00087-2; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	89	698	718	14	286	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					674	681		10.1038/nn1082	http://dx.doi.org/10.1038/nn1082			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	694NJ	12830158				2022-12-17	WOS:000183780400011
J	Wong, E; Cuervo, AM				Wong, Esther; Cuervo, Ana Maria			Autophagy gone awry in neurodegenerative diseases	NATURE NEUROSCIENCE			English	Review							CHAPERONE-MEDIATED AUTOPHAGY; AGGREGATE-PRONE PROTEINS; ALPHA-SYNUCLEIN; CELL-DEATH; REGULATES AUTOPHAGY; SIGNALING PATHWAYS; MUTANT HUNTINGTIN; ALZHEIMER-DISEASE; UP-REGULATION; C MICE	Autophagy is essential for neuronal homeostasis, and its dysfunction has been directly linked to a growing number of neurodegenerative disorders. The reasons behind autophagic failure in degenerating neurons can be very diverse because of the different steps required for autophagy and the characterization of the molecular players involved in each of them. Understanding the step(s) affected in the autophagic process in each disorder could explain differences in the course of these pathologies and will be essential to developing targeted therapeutic approaches for each disease based on modulation of autophagy. Here we present examples of different types of autophagic dysfunction described in common neurodegenerative disorders and discuss the prospect of exploring some of the recently identified autophagic variants and the interactions among autophagic and non-autophagic proteolytic systems as possible future therapeutic targets.	[Cuervo, Ana Maria] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Dev & Mol Biol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Dev & Mol Biol, Bronx, NY 10467 USA.	ana-maria.cuervo@einstein.yu.edu	Wong, Esther/E-1344-2011	Cuervo, Ana Maria/0000-0002-0771-700X; Wong, Esther/0000-0003-2421-7346	US National Institutes of Health, National Institute on Aging [AG021904, AG031782]; National Institute of Diabetes and Digestive and Kidney Diseases [DK041918]; National Institute of Neurological Disorders and Stroke [NS038370]; Glenn Foundation; Hirsch/Weill-Caulier Career Scientist Award; Hereditary Disease Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021904, P01AG031782, R37AG021904] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Glenn Foundation; Hirsch/Weill-Caulier Career Scientist Award; Hereditary Disease Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the numerous colleagues in the field of autophagy who through their animated discussions have helped shape this review and S. Kaushik and S. Orenstein for critically reading the manuscript. Work in our laboratory is supported by US National Institutes of Health grants from the National Institute on Aging (AG021904, AG031782), the National Institute of Diabetes and Digestive and Kidney Diseases (DK041918), the National Institute of Neurological Disorders and Stroke (NS038370), a Glenn Foundation Award and a Hirsch/Weill-Caulier Career Scientist Award. E. W. is supported by a Hereditary Disease Foundation Fellowship.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bi XN, 2007, AUTOPHAGY, V3, P646, DOI 10.4161/auto.5074; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2010, TRENDS ENDOCRIN MET, V21, P142, DOI 10.1016/j.tem.2009.10.003; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Ding QX, 2003, J NEUROCHEM, V86, P489, DOI 10.1046/j.1471-4159.2003.01885.x; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heiseke A, 2010, CURR ISSUES MOL BIOL, V12, P87; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kaasik A, 2005, EUR J NEUROSCI, V22, P1023, DOI 10.1111/j.1460-9568.2005.04279.x; Kanazawa T, 2004, J BIOL CHEM, V279, P8452, DOI 10.1074/jbc.M306337200; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kirkin V, 2009, AUTOPHAGY, V5, P732, DOI 10.4161/auto.5.5.8566; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kovacs GG, 2008, AM J PATHOL, V172, P555, DOI 10.2353/ajpath.2008.070442; Kraft C, 2009, BBA-MOL CELL RES, V1793, P1404, DOI 10.1016/j.bbamcr.2009.02.006; LEE JH, CELL IN PRESS; Lee JA, 2009, J NEUROSCI, V29, P8506, DOI 10.1523/JNEUROSCI.0924-09.2009; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li L, 2008, AUTOPHAGY, V4, P290, DOI 10.4161/auto.5524; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Massey AC, 2008, AUTOPHAGY, V4, P442, DOI 10.4161/auto.5654; Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mookerjee S, 2009, J NEUROSCI, V29, P15134, DOI 10.1523/JNEUROSCI.4720-09.2009; Morimoto N, 2007, BRAIN RES, V1167, P112, DOI 10.1016/j.brainres.2007.06.045; MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Pacheco CD, 2009, HUM MOL GENET, V18, P956, DOI 10.1093/hmg/ddn423; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sarkar S, 2009, METHOD ENZYMOL, V453, P83, DOI 10.1016/S0076-6879(08)04005-6; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tan JMM, 2008, AUTOPHAGY, V4, P251, DOI 10.4161/auto.5444; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Uchiyama Y, 2009, METHOD ENZYMOL, V453, P33, DOI 10.1016/S0076-6879(08)04003-2; Urwin H, 2009, BIOCHEM SOC T, V37, P208, DOI 10.1042/BST0370208; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Winslow AR, 2008, BBA-MOL BASIS DIS, V1782, P723, DOI 10.1016/j.bbadis.2008.06.010; Wong ESP, 2008, HUM MOL GENET, V17, P2570, DOI 10.1093/hmg/ddn157; Yang Y, 2007, EUR J NEUROSCI, V26, P2979, DOI 10.1111/j.1460-9568.2007.05914.x; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang XD, 2009, AUTOPHAGY, V5, P339, DOI 10.4161/auto.5.3.8174; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	99	697	717	1	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					805	811		10.1038/nn.2575	http://dx.doi.org/10.1038/nn.2575			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20581817	Green Accepted			2022-12-17	WOS:000279173900010
J	Feng, J; Zhou, Y; Campbell, SL; Le, T; Li, E; Sweatt, JD; Silva, AJ; Fan, GP				Feng, Jian; Zhou, Yu; Campbell, Susan L.; Le, Thuc; Li, En; Sweatt, J. David; Silva, Alcino J.; Fan, Guoping			Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons	NATURE NEUROSCIENCE			English	Article							METHYLTRANSFERASES DNMT3A; GENE; HYPOMETHYLATION; EXPRESSION; PLASTICITY; CELLS; 5-HYDROXYMETHYLCYTOSINE; LOCALIZATION; DEGENERATION; MAINTENANCE	Dnmt1 and Dnmt3a are important DNA methyltransferases that are expressed in postmitotic neurons, but their function in the CNS is unclear. We generated conditional mutant mice that lack Dnmt1, Dnmt3a or both exclusively in forebrain excitatory neurons and found that only double knockout (DKO) mice showed abnormal long-term plasticity in the hippocampal CA1 region together with deficits in learning and memory. Although we found no neuronal loss, hippocampal neurons in DKO mice were smaller than in the wild type; furthermore, DKO neurons showed deregulated expression of genes, including the class I MHC genes and Stat1, that are known to contribute to synaptic plasticity. In addition, we observed a significant decrease in DNA methylation in DKO neurons. We conclude that Dnmt1 and Dnmt3a are required for synaptic plasticity, learning and memory through their overlapping roles in maintaining DNA methylation and modulating neuronal gene expression in adult CNS neurons.	[Feng, Jian; Le, Thuc; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Zhou, Yu; Silva, Alcino J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Campbell, Susan L.; Sweatt, J. David] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA; [Le, Thuc] Univ Calif Los Angeles, David Geffen Sch Med, Interdepartmental Neurosci Program, Los Angeles, CA 90095 USA; [Li, En] Novartis Inst Biomed Res, Epigenet Program, Cambridge, MA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Novartis	Fan, GP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	gfan@mednet.ucla.edu	Silva, Alcino/ABD-7684-2021; feng, jian/G-9313-2011	Silva, Alcino/0000-0002-1587-4558; Sweatt, J. David/0000-0003-3567-485X; Silva, Alcino/0000-0001-5525-0494; Fan, Guoping/0000-0001-5235-6410	US National Institutes of Health [RO1 NS051411, P50-MH0779720, AG031722, MH57014, NS057098]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057014, P50MH077972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051411, P30NS057098, R56NS051411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013622, R01AG013622, R01AG031722] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank X.-H. Lu and X. W. Yang for help with stereology analysis, T. Chailangkarn and S. Fouse for technical support and P. Golshani for critical reading of the paper. We also thank all members of the Fan laboratory for help and advice. Funding was provided by grants from the US National Institutes of Health to G. F. (RO1 NS051411), A. J. S. (P50-MH0779720) and J. D. S. (AG031722, MH57014 and NS057098). G. F. is a Carol Moss Spivak Scholar in Neuroscience.	Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Brooks PJ, 1996, J NEUROSCI, V16, P939; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Endres M, 2001, NEUROREPORT, V12, P3763, DOI 10.1097/00001756-200112040-00032; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Feng JA, 2007, PEDIATR RES, V61, p58R, DOI 10.1203/pdr.0b013e3180457635; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Golshani Peyman, 2005, Thalamus & Related Systems, V3, P227, DOI 10.1017/S1472928807000222; GOTO K, 1994, DIFFERENTIATION, V56, P39, DOI 10.1046/j.1432-0436.1994.56120039.x; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; Lu XH, 2009, J NEUROSCI, V29, P1962, DOI 10.1523/JNEUROSCI.5351-08.2009; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; Perry VH, 2008, NAT REV NEUROSCI, V9, P807, DOI 10.1038/nrn2394; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	49	696	729	3	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2010	13	4					423	U37		10.1038/nn.2514	http://dx.doi.org/10.1038/nn.2514			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	575NI	20228804	Green Accepted			2022-12-17	WOS:000276073500011
J	Zhan, Y; Paolicelli, RC; Sforazzini, F; Weinhard, L; Bolasco, G; Pagani, F; Vyssotski, AL; Bifone, A; Gozzi, A; Ragozzino, D; Gross, CT				Zhan, Yang; Paolicelli, Rosa C.; Sforazzini, Francesco; Weinhard, Laetitia; Bolasco, Giulia; Pagani, Francesca; Vyssotski, Alexei L.; Bifone, Angelo; Gozzi, Alessandro; Ragozzino, Davide; Gross, Cornelius T.			Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; MOUSE MODEL; FRONTAL-CORTEX; AUTISM; RATS; REVEALS; EXCITATION/INHIBITION; VISUALIZATION; HIPPOCAMPUS; ELIMINATION	Microglia are phagocytic cells that infiltrate the brain during development and have a role in the elimination of synapses during brain maturation. Changes in microglial morphology and gene expression have been associated with neurodevelopmental disorders. However, it remains unknown whether these changes are a primary cause or a secondary consequence of neuronal deficits. Here we tested whether a primary deficit in microglia was sufficient to induce some autism-related behavioral and functional connectivity deficits. Mice lacking the chemokine receptor Cx3cr1 exhibit a transient reduction of microglia during the early postnatal period and a consequent deficit in synaptic pruning. We show that deficient synaptic pruning is associated with weak synaptic transmission, decreased functional brain connectivity, deficits in social interaction and increased repetitive-behavior phenotypes that have been previously associated with autism and other neurodevelopmental and neuropsychiatric disorders. These findings open the possibility that disruptions in microglia-mediated synaptic pruning could contribute to neurodevelopmental and neuropsychiatric disorders.	[Zhan, Yang; Paolicelli, Rosa C.; Weinhard, Laetitia; Bolasco, Giulia; Gross, Cornelius T.] EMBL, Mouse Biol Unit, Monterotondo, Italy; [Sforazzini, Francesco; Bifone, Angelo] IIT, Ctr Neurosci & Cognit Syst UniTn, Rovereto, Italy; [Sforazzini, Francesco] IMT, Inst Adv Studies, Lucca, Italy; [Pagani, Francesca] Univ Roma La Sapienza, IIT, Ctr Life Nano Sci, Rome, Italy; [Vyssotski, Alexei L.] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Vyssotski, Alexei L.] ETH, Swiss Fed Inst Technol, Zurich, Switzerland; [Ragozzino, Davide] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Ragozzino, Davide] IRCCS Neuromed, Pozzilli, Italy	European Molecular Biology Laboratory (EMBL); Istituto Italiano di Tecnologia - IIT; IMT School for Advanced Studies Lucca; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Sapienza University Rome; IRCCS Neuromed	Gross, CT (corresponding author), EMBL, Mouse Biol Unit, Monterotondo, Italy.	gross@embl.it	ragozzino, davide/K-6521-2016; Gozzi, Alessandro/K-6342-2016; Weinhard, Laetitia/N-8532-2017	ragozzino, davide/0000-0002-3290-7665; Gozzi, Alessandro/0000-0002-5731-4137; Weinhard, Laetitia/0000-0003-2017-7746; Paolicelli, Rosa Chiara/0000-0001-6851-0849; Zhan, Yang/0000-0002-1150-6344; Vyssotski, Alexei/0000-0002-9021-1471	EMBL; IIT; Italian Ministry of University and Scientific Research PRIN; Forschungskredit of the University of Zurich	EMBL; IIT(Istituto Italiano di Tecnologia - IIT); Italian Ministry of University and Scientific Research PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Forschungskredit of the University of Zurich	We thank F. Zonfrillo for expert mouse husbandry, I. Charo (University of California San Francisco) and T. Deller (University of Frankfurt) for providing mice, the EMBL Transgenic Facility for help in rederiving mouse lines, the EMBL Microscopy Facility for access to light and electron microscopes, J. Griesbach and M. Al Banchaabouchi for help in videoscoring, A. Jain, J. Gordon and T. Sigurdsson for assistance in establishing in vivo electrophysiology, A. Galbusera for help in performing MRI acquisitions and F. D'Amato and V. Carola for advice in behavioral testing and analysis. This work was supported by funds from EMBL to C. T. G., R. C. P. and Y.Z. (Y.Z. is an EMBL Interdisciplinary Postdocs (EIPOD) fellow), the IIT to A. G., A. B. and F. S., the Italian Ministry of University and Scientific Research PRIN 2009 to D. R. and a Forschungskredit of the University of Zurich to A.L.V.	Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Avale ME, 2011, FASEB J, V25, P2145, DOI 10.1096/fj.10-178558; Barber MJ, 1999, J NEUROSCI, V19, P9975; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Brankack J, 2010, BRAIN RES, V1322, P59, DOI 10.1016/j.brainres.2010.01.069; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Courchesne E, 2005, DEV PSYCHOPATHOL, V17, P577, DOI 10.1017/S0954579405050285; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Crespel A, 2002, BRAIN RES, V952, P159, DOI 10.1016/S0006-8993(02)03050-0; Dichter Gabriel S, 2012, Dialogues Clin Neurosci, V14, P319; Dinstein I, 2011, NEURON, V70, P1218, DOI 10.1016/j.neuron.2011.04.018; Drai D, 2001, NEUROSCI BIOBEHAV R, V25, P409, DOI 10.1016/S0149-7634(01)00022-7; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferrari L, 2012, J NEUROSCI METH, V204, P9, DOI 10.1016/j.jneumeth.2011.10.020; Fillman SG, 2013, MOL PSYCHIATR, V18, P206, DOI 10.1038/mp.2012.110; Frith U., 2003, AUTISM EXPLAINING EN; Glascher J, 2012, P NATL ACAD SCI USA, V109, P14681, DOI 10.1073/pnas.1206608109; Gozzi A, 2012, NEURON, V73, P854, DOI 10.1016/j.neuron.2012.02.007; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; He LM, 2009, NATURE, V459, P93, DOI 10.1038/nature07860; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Karbasforoushan H, 2012, CURR TOP MED CHEM, V12, P2404, DOI 10.2174/156802612805289863; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0020701, 10.1371/journal.pone.0026520]; LAMANTIA AS, 1990, J NEUROSCI, V10, P2156; Liu XA, 2011, CEREB CORTEX, V21, P374, DOI 10.1093/cercor/bhq105; Marchand WR, 2012, NEUROSCI LETT, V514, P86, DOI 10.1016/j.neulet.2012.02.063; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Mitra P., 2008, OBSERVED BRAIN DYNAM; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Paolicelli RC, 2011, NEURON GLIA BIOL, V7, P77, DOI 10.1017/S1740925X12000105; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pernot F, 2011, EPILEPSIA, V52, P2315, DOI 10.1111/j.1528-1167.2011.03273.x; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scattoni ML, 2005, BEHAV BRAIN RES, V161, P169, DOI 10.1016/j.bbr.2005.01.011; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schipul SE, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00010; Schwarz AJ, 2013, NEUROSCIENCE, V228, P243, DOI 10.1016/j.neuroscience.2012.10.032; Sforazzini F, 2014, NEUROIMAGE, V87, P403, DOI 10.1016/j.neuroimage.2013.09.050; Sigurdsson T, 2010, NATURE, V464, P763, DOI 10.1038/nature08855; Silverman JL, 2010, NEUROPSYCHOPHARMACOL, V35, P976, DOI 10.1038/npp.2009.201; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; SORRA KE, 1993, J NEUROSCI, V13, P3736; Steffey MA, 2003, AM J VET RES, V64, P470, DOI 10.2460/ajvr.2003.64.470; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Vyssotski AL, 2009, CURR BIOL, V19, P1159, DOI 10.1016/j.cub.2009.05.070; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	62	693	710	5	164	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2014	17	3					400	406		10.1038/nn.3641	http://dx.doi.org/10.1038/nn.3641			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8CA	24487234				2022-12-17	WOS:000332016500013
J	Aponte, Y; Atasoy, D; Sternson, SM				Aponte, Yexica; Atasoy, Deniz; Sternson, Scott M.			AGRP neurons are sufficient to orchestrate feeding behavior rapidly and without training	NATURE NEUROSCIENCE			English	Article							AGOUTI-RELATED-PROTEIN; NEUROPEPTIDE-Y; ARCUATE NUCLEUS; IN-VIVO; HYPOTHALAMIC CART; MICE; LEPTIN; MELANOCORTIN; RATS; STIMULATION	Two intermingled hypothalamic neuron populations specified by expression of agouti-related peptide (AGRP) or proopiomelanocortin (POMC) positively and negatively influence feeding behavior, respectively, possibly by reciprocally regulating downstream melanocortin receptors. However, the sufficiency of these neurons to control behavior and the relationship of their activity to the magnitude and dynamics of feeding are unknown. To measure this, we used channelrhodopsin-2 for cell type-specific photostimulation. Activation of only 800 AGRP neurons in mice evoked voracious feeding within minutes. The behavioral response increased with photoexcitable neuron number, photostimulation frequency and stimulus duration. Conversely, POMC neuron stimulation reduced food intake and body weight, which required melanocortin receptor signaling. However, AGRP neuron-mediated feeding was not dependent on suppressing this melanocortin pathway, indicating that AGRP neurons directly engage feeding circuits. Furthermore, feeding was evoked selectively over drinking without training or prior photostimulus exposure, which suggests that AGRP neurons serve a dedicated role coordinating this complex behavior.	[Aponte, Yexica; Atasoy, Deniz; Sternson, Scott M.] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute	Sternson, SM (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.	sternsons@janelia.hhmi.org	Aponte, Yeka/AAL-4643-2020; Atasoy, Deniz/AAR-7917-2020; Atasoy, Deniz/B-3414-2018	Aponte, Yeka/0000-0002-5967-2579; Atasoy, Deniz/0000-0002-3325-8820; Sternson, Scott/0000-0002-0835-444X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank G. Shtengel for assistance with photostimulation equipment and software, R. Shusterman for assistance with data analysis, H. Peng for image analysis tools, J. Osborne and T. Tabachnik for equipment design and fabrication, A. Arnold for imaging support, B. Shields and A. Hu for histology support, and J. Cox for mouse breeding and genotyping support. K. Svoboda, G. Murphy, J. Dudman, A. Lee, and S.E.R. Egnor commented on the manuscript. This research was funded by the Howard Hughes Medical Institute.	Abbott SBG, 2009, J NEUROSCI, V29, P5806, DOI 10.1523/JNEUROSCI.1106-09.2009; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Cowley MA, 2003, ANN NY ACAD SCI, V994, P175, DOI 10.1111/j.1749-6632.2003.tb03178.x; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Kaelin CB, 2004, ENDOCRINOLOGY, V145, P5798, DOI 10.1210/en.2004-0956; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; LEVINE AS, 1984, PEPTIDES, V5, P1025, DOI 10.1016/0196-9781(84)90165-7; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Roseberry AG, 2004, NEURON, V41, P711, DOI 10.1016/S0896-6273(04)00074-1; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; STANLEY BG, 1984, LIFE SCI, V35, P2635, DOI 10.1016/0024-3205(84)90032-8; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Tolkamp BJ, 1999, ANIM BEHAV, V57, P807, DOI 10.1006/anbe.1998.1022; Tolkamp BJ, 1998, J THEOR BIOL, V194, P235, DOI 10.1006/jtbi.1998.0759; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; TSUJII S, 1989, BRAIN RES BULL, V23, P165, DOI 10.1016/0361-9230(89)90142-1; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Wu Q, 2008, P NATL ACAD SCI USA, V105, P2687, DOI 10.1073/pnas.0712062105; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506	34	693	707	9	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2011	14	3					351	355		10.1038/nn.2739	http://dx.doi.org/10.1038/nn.2739			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	725MW	21209617	Green Accepted			2022-12-17	WOS:000287650100016
J	Amat, J; Baratta, MV; Paul, E; Bland, ST; Watkins, LR; Maier, SF				Amat, J; Baratta, MV; Paul, E; Bland, ST; Watkins, LR; Maier, SF			Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus	NATURE NEUROSCIENCE			English	Article							CONDITIONED FEAR; EXTRACELLULAR LEVELS; INDUCED SEROTONIN; PRELIMBIC CORTEX; AMYGDALA; EXPOSURE; PROJECTIONS; EXTINCTION; ANXIETY; 5-HT	The degree of behavioral control that an organism has over a stressor is a potent modulator of the stressor's impact; uncontrollable stressors produce numerous outcomes that do not occur if the stressor is controllable. Research on controllability has focused on brainstem nuclei such as the dorsal raphe nucleus (DRN). Here we find that the infralimbic and prelimbic regions of the ventral medial prefrontal cortex (mPFCv) in rats detect whether a stressor is under the organism's control. When a stressor is controllable, stress-induced activation of the DRN is inhibited by the mPFCv, and the behavioral sequelae of uncontrollable stress are blocked. This suggests a new function for the mPFCv and implies that the presence of control inhibits stress-induced neural activity in brainstem nuclei, in contrast to the prevalent view that such activity is induced by a lack of control.	Univ Colorado, Dept Psychol, Boulder, CO 80903 USA; Univ Colorado, Ctr Neurosci, Boulder, CO 80903 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Maier, SF (corresponding author), Univ Colorado, Dept Psychol, Campus Box 345, Boulder, CO 80903 USA.	smaier@psych.colorado.edu		Paul, Evan/0000-0002-7011-8050; Bland, Sondra/0000-0002-5790-089X	NIDA NIH HHS [DA13159] Funding Source: Medline; NIMH NIH HHS [MH50479, F31 MH075213] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH050479, F31MH075213, R01MH050479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013159] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Amat J, 1998, BRAIN RES, V812, P113, DOI 10.1016/S0006-8993(98)00960-3; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Basoglu M., 1992, TORTURE ITS CONSEQUE, P182; Bland ST, 2003, NEUROPSYCHOPHARMACOL, V28, P1589, DOI 10.1038/sj.npp.1300206; Bland ST, 2003, SYNAPSE, V49, P206, DOI 10.1002/syn.10229; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; Corbit LH, 2003, BEHAV BRAIN RES, V146, P145, DOI 10.1016/j.bbr.2003.09.023; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; FANSELOW MS, 1988, J EXP ANAL BEHAV, V50, P361, DOI 10.1901/jeab.1988.50-361; Graeff FG, 1996, PHARMACOL BIOCHEM BE, V54, P129, DOI 10.1016/0091-3057(95)02135-3; Grahn RE, 2002, BEHAV BRAIN RES, V134, P387, DOI 10.1016/S0166-4328(02)00061-X; Grahn RE, 1999, BRAIN RES, V826, P35, DOI 10.1016/S0006-8993(99)01208-1; Hajos M, 1998, NEUROSCIENCE, V87, P95, DOI 10.1016/S0306-4522(98)00157-2; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Jankowski MP, 2004, J COMP NEUROL, V468, P518, DOI 10.1002/cne.10976; MAIER SF, 1990, J EXP PSYCHOL ANIM B, V16, P137, DOI 10.1037/0097-7403.16.2.137; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/0278-5846(84)90120-9; Maier SF, 1998, COGNITIVE THER RES, V22, P595, DOI 10.1023/A:1018794104325; MAIER SF, 1995, BEHAV NEUROSCI, V109, P404, DOI 10.1037/0735-7044.109.3.404; MAIER SF, 1993, BEHAV NEUROSCI, V107, P377, DOI 10.1037/0735-7044.107.2.377; Maswood S, 1998, BRAIN RES, V783, P115, DOI 10.1016/S0006-8993(97)01313-9; McDonald AJ, 1996, NEUROSCIENCE, V71, P55, DOI 10.1016/0306-4522(95)00417-3; Mesulam M., 2002, PRINCIPLES FRONTAL L, P8, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Morgan MA, 2003, BEHAV BRAIN RES, V146, P121, DOI 10.1016/j.bbr.2003.09.021; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peyron C, 1998, NEUROSCIENCE, V82, P443; Puig MV, 2005, CEREB CORTEX, V15, P1, DOI 10.1093/cercor/bhh104; Quirk GJ, 2002, LEARN MEMORY, V9, P402, DOI 10.1101/lm.49602; Quirk GJ, 2003, ANN NY ACAD SCI, V985, P263; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Robbins TW, 2000, PROG BRAIN RES, V126, P469; Royer S, 2002, NEUROSCIENCE, V115, P455, DOI 10.1016/S0306-4522(02)00455-4; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; Tao R, 2000, J PHARMACOL EXP THER, V294, P571; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; WEISS JM, 1980, NEUROCHEM RES, V5, P9, DOI 10.1007/BF00964456; WEISS JM, 1968, J COMP PHYSIOL PSYCH, V65, P251, DOI 10.1037/h0025562; WEISS JM, 1986, CIBA F SYMP, V123, P191; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	41	690	706	0	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					365	371		10.1038/nn1399	http://dx.doi.org/10.1038/nn1399			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15696163				2022-12-17	WOS:000227354600022
J	Vuilleumier, P; Richardson, MP; Armony, JL; Driver, J; Dolan, RJ				Vuilleumier, P; Richardson, MP; Armony, JL; Driver, J; Dolan, RJ			Distant influences of amygdala lesion on visual cortical activation during emotional face processing	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; FACIAL EXPRESSIONS; T2 RELAXATION; CORTEX; RECOGNITION; AROUSAL; PROJECTIONS; ATTENTION; NUCLEUS; MONKEYS	Emotional visual stimuli evoke enhanced responses in the visual cortex. To test whether this reflects modulatory influences from the amygdala on sensory processing, we used event-related functional magnetic resonance imaging (fMRI) in human patients with medial temporal lobe sclerosis. Twenty-six patients with lesions in the amygdala, the hippocampus or both, plus 13 matched healthy controls, were shown pictures of fearful or neutral faces in task-relevant or task-irrelevant positions on the display. All subjects showed increased fusiform cortex activation when the faces were in task-relevant positions. Both healthy individuals and those with hippocampal damage showed increased activation in the fusiform and occipital cortex when they were shown fearful faces, but this was not the case for individuals with damage to the amygdala, even though visual areas were structurally intact. The distant influence of the amygdala was also evidenced by the parametric relationship between amygdala damage and the level of emotional activation in the fusiform cortex. Our data show that combining the fMRI and lesion approaches can help reveal the source of functional modulatory influences between distant but interconnected brain regions.	Univ Geneva, Ctr Med Univ, Dept Neurol, Lab Neurol & Imaging Cognit, CH-1211 Geneva 4, Switzerland; Univ Geneva, Ctr Med Univ, Dept Neurosci, Lab Neurol & Imaging Cognit, CH-1211 Geneva 4, Switzerland; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1N 3AR, England; Inst Neurol, Dept Clin & Expt Epilepsy, Epilepsy Imaging Grp, London WC1N 3BG, England; McGill Univ, Douglas Hosp, Res Ctr, Verdun, PQ H4H 1R3, Canada; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of Geneva; University of Geneva; University of London; University College London; University of London; University College London; University of London; University College London; McGill University; University of London; University College London	Vuilleumier, P (corresponding author), Univ Geneva, Ctr Med Univ, Dept Neurol, Lab Neurol & Imaging Cognit, CH-1211 Geneva 4, Switzerland.	patrik.vuilleumier@medecine.unige.ch	Driver, Jon/A-4779-2010; Vuilleumier, Patrik/AAJ-1839-2021; Richardson, Mark P/E-5385-2010	Vuilleumier, Patrik/0000-0002-8198-9214; Richardson, Mark P/0000-0001-8925-3140; Dolan, Ray/0000-0001-9356-761X				Adam C, 1996, ACTA NEUROL SCAND, V94, P1, DOI 10.1111/j.1600-0404.1996.tb00031.x; Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; AGGLETON JP, 1993, TRENDS NEUROSCI, V16, P328, DOI 10.1016/0166-2236(93)90110-8; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Amaral DG, 2003, NEUROSCIENCE, V118, P1099, DOI 10.1016/S0306-4522(02)01001-1; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Anderson AK, 2002, J COGNITIVE NEUROSCI, V14, P709, DOI 10.1162/08989290260138618; Armony JL, 1998, J NEUROSCI, V18, P2592; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bartlett PA, 2002, J NEUROL NEUROSUR PS, V73, P753, DOI 10.1136/jnnp.73.6.753; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dringenberg HC, 2001, NEUROREPORT, V12, P2395, DOI 10.1097/00001756-200108080-00022; Ekman P., 1976, PICTURE FACIAL AFFEC; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Hamann SB, 1999, NEUROPSYCHOLOGIA, V37, P1135, DOI 10.1016/S0028-3932(99)00027-5; HUDSON LP, 1993, ANN NEUROL, V33, P622, DOI 10.1002/ana.410330611; KAPP BS, 1994, BEHAV NEUROSCI, V108, P81, DOI 10.1037/0735-7044.108.1.81; Kilpatrick L, 2003, NEUROIMAGE, V20, P2091, DOI 10.1016/j.neuroimage.2003.08.006; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; LeDoux J. E., 1996, EMOTIONAL BRAIN; Meletti S, 2003, NEUROLOGY, V60, P426, DOI 10.1212/WNL.60.3.426; Meunier M, 2002, EMOTION, V2, P147, DOI 10.1037//1528-3542.2.2.147; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Seeck M, 1999, EPILEPTIC DISORD, V1, P179; Siebert M, 2003, BRAIN, V126, P2627, DOI 10.1093/brain/awg271; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; VanPaesschen W, 1997, ANN NEUROL, V42, P756, DOI 10.1002/ana.410420512; VanPaesschen W, 1996, NEUROLOGY, V47, P1021, DOI 10.1212/WNL.47.4.1021; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2002, CURR OPIN PSYCHIATR, V15, P291, DOI 10.1097/00001504-200205000-00011; Vuilleumier P, 2001, NEUROLOGY, V56, P153, DOI 10.1212/WNL.56.2.153; VUILLEUMIER P, IN PRESS VISUAL COGN; Whalen PJ, 1998, J NEUROSCI, V18, P411; Wieshmann UC, 1996, J NEUROL NEUROSUR PS, V61, P357, DOI 10.1136/jnnp.61.4.357; Woermann FG, 1998, J NEUROL NEUROSUR PS, V65, P656, DOI 10.1136/jnnp.65.5.656; Woermann FG, 1999, NEUROIMAGE, V10, P373, DOI 10.1006/nimg.1999.0481; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Wolf HK, 1997, ACTA NEUROPATHOL, V93, P606, DOI 10.1007/s004010050658	50	690	703	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1271	1278		10.1038/nn1341	http://dx.doi.org/10.1038/nn1341			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15494727	Green Published			2022-12-17	WOS:000224749400021
J	Sorge, RE; Mapplebeck, JCS; Rosen, S; Beggs, S; Taves, S; Alexander, JK; Martin, LJ; Austin, JS; Sotocinal, SG; Chen, D; Yang, M; Shi, XQ; Huang, H; Pillon, NJ; Bilan, PJ; Tu, YS; Klip, A; Ji, RR; Zhang, J; Salter, MW; Mogil, JS				Sorge, Robert E.; Mapplebeck, Josiane C. S.; Rosen, Sarah; Beggs, Simon; Taves, Sarah; Alexander, Jessica K.; Martin, Loren J.; Austin, Jean-Sebastien; Sotocinal, Susana G.; Chen, Di; Yang, Mu; Shi, Xiang Qun; Huang, Hao; Pillon, Nicolas J.; Bilan, Philip J.; Tu, YuShan; Klip, Amira; Ji, Ru-Rong; Zhang, Ji; Salter, Michael W.; Mogil, Jeffrey S.			Different immune cells mediate mechanical pain hypersensitivity in male and female mice	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD; TACTILE ALLODYNIA; NEUROPATHIC PAIN; SEX-DIFFERENCES; MICROGLIA; ANALGESIA; RAT; TRANSECTION; STRESS; MOUSE	A large and rapidly increasing body of evidence indicates that microglia-to-neuron signaling is essential for chronic pain hypersensitivity. Using multiple approaches, we found that microglia are not required for mechanical pain hypersensitivity in female mice; female mice achieved similar levels of pain hypersensitivity using adaptive immune cells, likely T lymphocytes. This sexual dimorphism suggests that male mice cannot be used as proxies for females in pain research.	[Sorge, Robert E.; Mapplebeck, Josiane C. S.; Rosen, Sarah; Martin, Loren J.; Austin, Jean-Sebastien; Sotocinal, Susana G.; Chen, Di; Mogil, Jeffrey S.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Sorge, Robert E.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; [Mapplebeck, Josiane C. S.; Beggs, Simon; Alexander, Jessica K.; Tu, YuShan; Salter, Michael W.] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Mapplebeck, Josiane C. S.; Beggs, Simon; Alexander, Jessica K.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Mapplebeck, Josiane C. S.; Beggs, Simon; Alexander, Jessica K.; Salter, Michael W.] Univ Toronto, Ctr Study Pain, Toronto, ON, Canada; [Taves, Sarah; Ji, Ru-Rong] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Yang, Mu; Shi, Xiang Qun; Huang, Hao; Zhang, Ji] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Pillon, Nicolas J.; Bilan, Philip J.; Klip, Amira] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Zhang, Ji; Mogil, Jeffrey S.] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada	McGill University; University of Alabama System; University of Alabama Birmingham; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Duke University; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University	Mogil, JS (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.	mike.salter@utoronto.ca; jeffrey.mogil@mcgill.ca	Ji, Ru-Rong/L-7070-2017; Zhang, Ji/L-5922-2019; Beggs, Simon/AAI-4438-2021; Mogil, Jeffrey/AAA-9611-2019; Pillon, Nicolas J/M-4170-2019	Ji, Ru-Rong/0000-0002-9355-3688; Beggs, Simon/0000-0002-1582-8391; Mogil, Jeffrey/0000-0003-1359-5720; Pillon, Nicolas J/0000-0003-1107-9490; Mapplebeck, Josiane/0000-0001-7787-9840; Martin, Loren/0000-0003-0579-2441; Tu, YuShan/0000-0001-7008-6071	Canadian Institutes of Health Research [MOP-123307]; Canada Research Chair Program; Louise and Alan Edwards Foundation; Anne and Max Tanenbaum Chair Program; US National Institutes of Health [R01-DE17794]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017794] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair Program(Canada Research Chairs); Louise and Alan Edwards Foundation; Anne and Max Tanenbaum Chair Program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Canadian Institutes of Health Research (MOP-123307; M.W.S. and J.S.M.), the Canada Research Chair Program (M.W.S. and J.S.M.), the Louise and Alan Edwards Foundation (J.S.M.), the Anne and Max Tanenbaum Chair Program (M.W.S.), and the US National Institutes of Health (R01-DE17794; R.-R.J.).	Beggs S, 2012, NAT NEUROSCI, V15, P1068, DOI 10.1038/nn.3155; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bourquin AF, 2006, PAIN, V122, P14, DOI 10.1016/j.pain.2005.10.036; Cao L, 2008, EUR J IMMUNOL, V38, P448, DOI 10.1002/eji.200737485; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Draleau Ks, 2014, J Pain Relief, VSuppl 3, P003; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Jin SX, 2003, J NEUROSCI, V23, P4017; Juni A, 2010, ANESTHESIOLOGY, V112, P181, DOI 10.1097/ALN.0b013e3181c53849; Kim CF, 2011, J PAIN, V12, P370, DOI 10.1016/j.jpain.2010.08.003; Mogil JS, 2006, PAIN, V126, P24, DOI 10.1016/j.pain.2006.06.004; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; MOGIL JS, 1993, PAIN, V53, P17, DOI 10.1016/0304-3959(93)90050-Y; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Scotland RS, 2011, BLOOD, V118, P5918, DOI 10.1182/blood-2011-03-340281; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/NMETH.2935, 10.1038/nmeth.2935]; Sorge RE, 2011, J NEUROSCI, V31, P15450, DOI 10.1523/JNEUROSCI.3859-11.2011; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Watkins LR, 2003, NAT REV DRUG DISCOV, V2, P973, DOI 10.1038/nrd1251; Yang M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-5; Zhang MA, 2012, P NATL ACAD SCI USA, V109, P9505, DOI 10.1073/pnas.1118458109	27	688	698	6	164	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2015	18	8					1081	+		10.1038/nn.4053	http://dx.doi.org/10.1038/nn.4053			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN7HO	26120961	Green Accepted			2022-12-17	WOS:000358605400007
J	Ressler, KJ; Mayberg, HS				Ressler, Kerry J.; Mayberg, Helen S.			Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic	NATURE NEUROSCIENCE			English	Review							TRANSCRANIAL MAGNETIC STIMULATION; DEEP-BRAIN-STIMULATION; VAGUS NERVE-STIMULATION; POSTTRAUMATIC-STRESS-DISORDER; OBSESSIVE-COMPULSIVE DISORDER; TREATMENT-RESISTANT DEPRESSION; CONDITIONED FEAR EXTINCTION; RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; CEREBRAL-BLOOD-FLOW	Recent decades have witnessed tremendous advances in the neuroscience of emotion, learning and memory, and in animal models for understanding depression and anxiety. This review focuses on new rationally designed psychiatric treatments derived from preclinical human and animal studies. Nonpharmacological treatments that affect disrupted emotion circuits include vagal nerve stimulation, rapid transcranial magnetic stimulation and deep brain stimulation, all borrowed from neurological interventions that attempt to target known pathological foci. Other approaches include drugs that are given in relation to specific learning events to enhance or disrupt endogenous emotional learning processes. Imaging data suggest that common regions of brain activation are targeted with pharmacological and somatic treatments as well as with the emotional learning in psychotherapy. Although many of these approaches are experimental, the rapidly developing understanding of emotional circuit regulation is likely to provide exciting and powerful future treatments for debilitating mood and anxiety disorders.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30329 USA; Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30329 USA	Emory University; Emory University; Emory University	Ressler, KJ (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 954 Gatewood Dr, Atlanta, GA 30329 USA.	kressle@emory.edu	Ressler, Kerry J/N-8741-2018; Bullmore, Ed/C-1706-2012; Jovicich, Jorge/D-2293-2010	Ressler, Kerry J/0000-0002-5158-1103; Bullmore, Ed/0000-0002-8955-8283; 	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077083, R01MH071537, R01MH073719, P50MH058922, R56MH071537, K01MH069884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019624] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-019624, R01 DA019624-02, R01 DA019624, R01 DA019624-01A2] Funding Source: Medline; NIMH NIH HHS [MH069884, R01 MH071537, P50 MH058922, P50 MH077083, R01 MH073719, R56 MH071537, P50 MH58922, 1R01MH073719, K01 MH069884, MH071537] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aouizerate B, 2004, J NEUROSURG, V101, P682, DOI 10.3171/jns.2004.101.4.0682; BARKER AT, 1985, LANCET, V1, P1106; Bejjani BP, 1999, NEW ENGL J MED, V340, P1476, DOI 10.1056/NEJM199905133401905; Benabid AL, 2003, CURR OPIN NEUROBIOL, V13, P696, DOI 10.1016/j.conb.2003.11.001; BENMENACHEM E, 1995, EPILEPSY RES, V20, P221, DOI 10.1016/0920-1211(94)00083-9; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bohning DE, 1997, NEUROREPORT, V8, P2535, DOI 10.1097/00001756-199707280-00023; Bohning DE, 2001, INVEST RADIOL, V36, P470, DOI 10.1097/00004424-200108000-00006; BORNSTEIN SR, 1966, MOL PSYCHIATR, V11, P892; BORRELL J, 1983, BEHAV NEURAL BIOL, V39, P241, DOI 10.1016/S0163-1047(83)90910-X; Botreau F, 2006, BEHAV BRAIN RES, V172, P173, DOI 10.1016/j.bbr.2006.05.012; Brody AL, 2001, ARCH GEN PSYCHIAT, V58, P631, DOI 10.1001/archpsyc.58.7.631; Cai WH, 2006, J NEUROSCI, V26, P9560, DOI 10.1523/JNEUROSCI.2397-06.2006; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Carpenter LL, 2006, J PSYCHOPHARMACOL, V20, P35, DOI 10.1177/1359786806064327; Couturier JL, 2005, J PSYCHIATR NEUROSCI, V30, P83; Cox CL, 1997, P NATL ACAD SCI USA, V94, P8854, DOI 10.1073/pnas.94.16.8854; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Davis KD, 1997, NAT MED, V3, P671, DOI 10.1038/nm0697-671; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Eisenberg M, 2004, EUR J NEUROSCI, V20, P3397, DOI 10.1111/j.1460-9568.2004.03818.x; EPSTEIN CM, 1990, NEUROLOGY, V40, P666, DOI 10.1212/WNL.40.4.666; Ferry B, 1999, J NEUROSCI, V19, P5119; Furmark T, 2002, ARCH GEN PSYCHIAT, V59, P425, DOI 10.1001/archpsyc.59.5.425; George Mark S, 2007, Expert Rev Neurother, V7, P63, DOI 10.1586/14737175.7.1.63; George MS, 1997, AM J PSYCHIAT, V154, P1752, DOI 10.1176/ajp.154.12.1752; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Gorman J M, 1996, Depress Anxiety, V4, P160, DOI 10.1002/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; Greenberg PE, 1999, J CLIN PSYCHIAT, V60, P427, DOI 10.4088/JCP.v60n0702; Guarraci FA, 2000, BEHAV NEUROSCI, V114, P647, DOI 10.1037/0735-7044.114.3.647; Guastella AJ, 2007, BEHAV RES THER, V45, P663, DOI 10.1016/j.brat.2006.07.005; Guastella AJ, 2007, J PSYCHIATR RES, V41, P466, DOI 10.1016/j.jpsychires.2006.05.006; Harbishettar V, 2005, PARKINSONISM RELAT D, V11, P85, DOI 10.1016/j.parkreldis.2004.07.006; Henry TR, 1998, EPILEPSIA, V39, P983, DOI 10.1111/j.1528-1157.1998.tb01448.x; Henry TR, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.6_suppl_4.S3; Hermann LL, 2006, J CLIN PSYCHIAT, V67, P1870, DOI 10.4088/JCP.v67n1206; Hofmann SG, 2006, ARCH GEN PSYCHIAT, V63, P298, DOI 10.1001/archpsyc.63.3.298; KELLER MB, 1992, ARCH GEN PSYCHIAT, V49, P809; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kim EJ, 2006, NEUROSCI LETT, V405, P79, DOI 10.1016/j.neulet.2006.06.023; Kimbrell TA, 1999, BIOL PSYCHIAT, V46, P1603, DOI 10.1016/S0006-3223(99)00195-X; Kopell BH, 2004, J CLIN NEUROPHYSIOL, V21, P51, DOI 10.1097/00004691-200401000-00007; Kosel M, 2003, NEUROPSYCHOPHARMACOL, V28, P2045, DOI 10.1038/sj.npp.1300293; Krahl SE, 2000, EPILEPSY RES, V38, P171, DOI 10.1016/S0920-1211(99)00089-3; Kushner MG, 2007, BIOL PSYCHIAT, V62, P835, DOI 10.1016/j.biopsych.2006.12.020; Ledgerwood L, 2003, BEHAV NEUROSCI, V117, P341, DOI 10.1037/0735-7044.117.2.341; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Lisanby SH, 2003, CNS SPECTR, V8, P529, DOI 10.1017/S1092852900019003; Lozano AM, 2002, LANCET NEUROL, V1, P225, DOI 10.1016/S1474-4422(02)00101-1; Malow BA, 2001, NEUROLOGY, V57, P879, DOI 10.1212/WNL.57.5.879; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; MONAHAN JB, 1989, PHARMACOL BIOCHEM BE, V34, P649, DOI 10.1016/0091-3057(89)90571-6; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nahas Z, 2007, NEUROPSYCHOPHARMACOL, V32, P1649, DOI 10.1038/sj.npp.1301288; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nobler MS, 2000, DEPRESS ANXIETY, V12, P144; Nuttin B, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02376-4; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Otto MW, 2002, BIOL PSYCHIAT, V52, P917, DOI 10.1016/S0006-3223(02)01719-5; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P282, DOI 10.1001/archpsyc.62.3.282; Paus T, 2004, J PSYCHIATR NEUROSCI, V29, P268; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Pitman RK, 2005, CNS SPECTRUMS, V10, P99, DOI 10.1017/S109285290001943X; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; SACKEIM HA, 1986, ANN NY ACAD SCI, V462, P326, DOI 10.1111/j.1749-6632.1986.tb51267.x; Sackeim HA, 2007, INT J NEUROPSYCHOPH, V10, P817, DOI 10.1017/S1461145706007425; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Schelling G, 2001, BIOL PSYCHIAT, V50, P978, DOI 10.1016/S0006-3223(01)01270-7; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Siegle GJ, 2006, AM J PSYCHIAT, V163, P735, DOI 10.1176/appi.ajp.163.4.735; Speer AM, 2000, BIOL PSYCHIAT, V48, P1133, DOI 10.1016/S0006-3223(00)01065-9; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; Tronel S, 2007, BIOL PSYCHIAT, V62, P33, DOI 10.1016/j.biopsych.2006.09.009; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8; Walker BR, 1999, EPILEPSIA, V40, P1051, DOI 10.1111/j.1528-1157.1999.tb00818.x; Walker DL, 2002, J NEUROSCI, V22, P2343, DOI 10.1523/JNEUROSCI.22-06-02343.2002; Yang YL, 2005, NEUROSCIENCE, V134, P247, DOI 10.1016/j.neuroscience.2005.04.003; Yehuda R, 2004, BIOL PSYCHIAT, V55, P1110, DOI 10.1016/j.biopsych.2004.02.010; YEHUDA R, 1995, AM J PSYCHIAT, V152, P982; Zobel A, 2005, PSYCHIAT RES-NEUROIM, V139, P165, DOI 10.1016/j.pscychresns.2005.02.010	100	687	711	6	208	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1116	1124		10.1038/nn1944	http://dx.doi.org/10.1038/nn1944			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17726478	Green Accepted			2022-12-17	WOS:000249144000010
J	Eldridge, LL; Knowlton, BT; Furmanski, CS; Bookheimer, SY; Engel, SA				Eldridge, LL; Knowlton, BT; Furmanski, CS; Bookheimer, SY; Engel, SA			Remembering episodes: a selective role for the hippocampus during retrieval	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; ENDURING MEMORY IMPAIRMENT; RECOGNITION MEMORY; SEMANTIC MEMORY; BRAIN ACTIVITY; AMNESIA; FMRI; CONSCIOUSNESS; EXPERIENCE; HYPOTHESIS	Some memories are linked to a specific time and place, allowing one to re-experience the original event, whereas others are accompanied only by a feeling of familiarity. To uncover the distinct neural bases for these two types of memory, we measured brain activity during memory retrieval using event-related functional magnetic resonance imaging. We show that activity in the hippocampus increased only when retrieval was accompanied by conscious recollection of the learning episode. Hippocampal activity did not increase for items recognized based on familiarity or for unrecognized items. These results indicate that the hippocampus selectively supports the retrieval of episodic memories.	Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Mapping Div, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Eldridge, LL (corresponding author), Univ Calif Los Angeles, Dept Psychol, Box 951563,Franz Hall, Los Angeles, CA 90095 USA.			Bookheimer, Susan/0000-0002-3417-5891				Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1998, NEUROIMAGE, V7, P163, DOI 10.1006/nimg.1998.0328; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Dolan RJ, 1999, HIPPOCAMPUS, V9, P25, DOI 10.1002/(SICI)1098-1063(1999)9:1<25::AID-HIPO3>3.0.CO;2-4; Fernandez G, 1998, J NEUROSCI, V18, P1841; GARDINER JM, 1990, MEM COGNITION, V18, P579, DOI 10.3758/BF03197100; Henson RNA, 1999, J NEUROSCI, V19, P3962; Hicks JL, 1999, PSYCHON B REV, V6, P117, DOI 10.3758/BF03210818; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Knowlton BJ, 1998, ACTA PSYCHOL, V98, P253, DOI 10.1016/S0001-6918(97)00045-0; MOSCOVITCH M, 1995, J CLIN EXP NEUROPSYC, V17, P276, DOI 10.1080/01688639508405123; Murray EA, 1998, J NEUROSCI, V18, P6568; OSTERGAARD A, 1990, BRAIN COGNITION, V14, P127, DOI 10.1016/0278-2626(90)90024-I; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Rombouts SARB, 1997, HIPPOCAMPUS, V7, P594, DOI 10.1002/(SICI)1098-1063(1997)7:6<594::AID-HIPO2>3.3.CO;2-I; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Rugg MD, 1998, NEUROIMAGE, V8, P262, DOI 10.1006/nimg.1998.0363; Saykin AJ, 1999, BRAIN, V122, P1963, DOI 10.1093/brain/122.10.1963; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; SQUIRE LR, 1999, NEW COGNITIVE NEUROS, P765; Talairach J., 1988, COPLANAR STEREOTAXIC; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; TULVING E, 1991, J EXP PSYCHOL LEARN, V17, P595, DOI 10.1037/0278-7393.17.4.595; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Woods RP, 1999, HUM BRAIN MAPP, V8, P73, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<73::AID-HBM1>3.0.CO;2-7; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	33	684	689	4	76	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1149	1152		10.1038/80671	http://dx.doi.org/10.1038/80671			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036273				2022-12-17	WOS:000167177600021
J	Essrich, C; Lorez, M; Benson, JA; Fritschy, JM; Luscher, B				Essrich, C; Lorez, M; Benson, JA; Fritschy, JM; Luscher, B			Postsynaptic clustering of major GABA(A) receptor subtypes requires the gamma 2 subunit and gephyrin	NATURE NEUROSCIENCE			English	Article							RAT SPINAL-CORD; GLYCINE-RECEPTOR; HIPPOCAMPAL-NEURONS; A RECEPTORS; GABA(A)-RECEPTOR; EXPRESSION; CELLS; COLOCALIZATION; SYNAPSES; RETINA	Most fast inhibitory neurotransmission in the brain is mediated by GABA(A) receptors, which are mainly postsynaptic and consist of diverse alpha and beta subunits together with the gamma 2 subunit. Although the gamma 2 subunit is not necessary for receptor assembly and translocation to the cell surface, we show here that it is required for clustering of major postsynaptic GABA(A) receptor subtypes. Loss of GABA(A) receptor clusters in mice deficient in the gamma 2 subunit, and in cultured cortical neurons from these mice, is paralleled by loss of the synaptic clustering molecule gephyrin and synaptic GABAergic function. Conversely, inhibiting gephyrin expression causes loss of GABA(A) receptor clusters. The gamma 2 subunit and gephyrin are thus interdependent components of the same synaptic complex that is critical for postsynaptic clustering of abundant subtypes of GABA(A) receptors in vivo.	Univ Zurich, Inst Pharmacol, CH-8057 Zurich, Switzerland	University of Zurich	Luscher, B (corresponding author), Univ Zurich, Inst Pharmacol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	luscher@pharma.unizh.ch	Luscher, Bernhard/C-3528-2009	Luscher, Bernhard/0000-0003-1375-1906; Fritschy, Jean-Marc/0000-0002-8552-3702				Benke D, 1996, NEUROPHARMACOLOGY, V35, P1413, DOI 10.1016/S0028-3908(96)00068-8; BERNINGER B, 1995, DEVELOPMENT, V121, P2327; BOHLHALTER S, 1994, BRAIN RES, V642, P59, DOI 10.1016/0006-8993(94)90905-9; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CABOT JB, 1995, J COMP NEUROL, V356, P418, DOI 10.1002/cne.903560309; Colledge M, 1998, P NATL ACAD SCI USA, V95, P3341, DOI 10.1073/pnas.95.7.3341; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Craig AM, 1996, J NEUROSCI, V16, P3166; CRAIG AM, 1994, P NATL ACAD SCI USA, V91, P12373, DOI 10.1073/pnas.91.26.12373; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Fritschy JM, 1997, NEUROSCIENCE, V81, P1043, DOI 10.1016/S0306-4522(97)00244-3; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Fritschy JM, 1998, J COMP NEUROL, V390, P194; Giustetto M, 1998, J COMP NEUROL, V395, P231, DOI 10.1002/(SICI)1096-9861(19980601)395:2<231::AID-CNE7>3.0.CO;2-3; Gorrie GH, 1997, J NEUROSCI, V17, P6587; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Hedblom E, 1997, J BIOL CHEM, V272, P15346, DOI 10.1074/jbc.272.24.15346; HERB A, 1992, P NATL ACAD SCI USA, V89, P1433, DOI 10.1073/pnas.89.4.1433; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Jones A, 1997, J NEUROSCI, V17, P1350; Kannenberg K, 1997, J NEUROCHEM, V68, P1352; KIRSCH J, 1995, MOL CELL NEUROSCI, V6, P450, DOI 10.1006/mcne.1995.1033; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Kirsch J, 1996, MOL CELL NEUROSCI, V8, P93, DOI 10.1006/mcne.1996.0048; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KNOFLACH F, 1991, FEBS LETT, V293, P191, DOI 10.1016/0014-5793(91)81184-A; Koulen P, 1996, J NEUROSCI, V16, P2127; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Levi S, 1998, J CELL SCI, V111, P335; LUSCHER B, 1987, EMBO J, V6, P1721, DOI 10.1002/j.1460-2075.1987.tb02423.x; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Mohler H, 1996, Ion Channels, V4, P89; Mohler H, 1998, LIFE SCI, V62, P1611, DOI 10.1016/S0024-3205(98)00116-7; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; SASSOEPOGNETTO M, 1995, J COMP NEUROL, V357, P1, DOI 10.1002/cne.903570102; SassoePognetto M, 1997, J COMP NEUROL, V381, P158, DOI 10.1002/(SICI)1096-9861(19970505)381:2<158::AID-CNE4>3.0.CO;2-2; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Todd AJ, 1996, J NEUROSCI, V16, P974; TODD AJ, 1995, EUR J NEUROSCI, V7, P1, DOI 10.1111/j.1460-9568.1995.tb01014.x; Whatley VJ, 1996, J NEUROCHEM, V66, P1318; Whiting PJ, 1997, J NEUROSCI, V17, P5027; Wisden W, 1997, BIOCHEM SOC T, V25, P820, DOI 10.1042/bst0250820; YMER S, 1990, EMBO J, V9, P3261, DOI 10.1002/j.1460-2075.1990.tb07525.x	48	681	696	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					563	571		10.1038/2798	http://dx.doi.org/10.1038/2798			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196563				2022-12-17	WOS:000077437100011
J	Canli, T; Lesch, KP				Canli, Turhan; Lesch, Klaus-Peter			Long story short: the serotonin transporter in emotion regulation and social cognition	NATURE NEUROSCIENCE			English	Review							ANXIETY-RELATED TRAITS; STRESSFUL LIFE EVENTS; PROMOTER POLYMORPHISM; MAJOR DEPRESSION; GENETIC-VARIATION; HIPPOCAMPAL VOLUME; PERSONALITY-TRAITS; HUMAN AMYGDALA; FUNCTIONAL POLYMORPHISM; PSYCHIATRIC-DISORDERS	The gene encoding the serotonin transporter ( 5-HTT) contains a regulatory variation that has been associated with anxiety-related traits and susceptibility for depression. Here we highlight recent discoveries related to allelic variation of 5-HTT function with respect to emotion regulation and social behavior, drawing from an interdisciplinary perspective of behavioral genetics and cognitive neuroscience. Following a reductionistic path that leads from gene-behavior association studies to neuroimaging and epigenetic studies, we compare two models of 5-HTT-dependent modulation of brain activity and discuss the role of life stress experience in modifying 5-HTT function in the brain. Integration of these findings suggests that the impact of the 5-HTT gene on behavior is much broader than is commonly appreciated and may have a role in social cognition.	SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; Univ Wurzburg, Dept Psychiat & Psychotherapy, D-97080 Wurzburg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wurzburg	Canli, T (corresponding author), SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA.	turhan.canli@sunysb.edu; kplesch@mail.uni-wuerzburg.de	Lesch, Klaus-Peter/J-4906-2013; Canli, Turhan/F-9274-2019	Lesch, Klaus-Peter/0000-0001-8348-153X; Canli, Turhan/0000-0003-3646-239X	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER; NCRR NIH HHS [5-M01-RR10710] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; Amat J, 2004, NEUROSCIENCE, V129, P509, DOI 10.1016/j.neuroscience.2004.07.052; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Ball D, 1997, NEUROREPORT, V8, P1301, DOI 10.1097/00001756-199703240-00048; Barr CS, 2004, ARCH GEN PSYCHIAT, V61, P1146, DOI 10.1001/archpsyc.61.11.1146; Barr CS, 2003, ALCOHOL CLIN EXP RES, V27, P812, DOI 10.1097/01.ALC.0000067976.62827.ED; BAUMEISTER RF, 1990, J SOC CLIN PSYCHOL, V9, P165, DOI 10.1521/jscp.1990.9.2.165; Bennett AJ, 2002, MOL PSYCHIATR, V7, P118, DOI 10.1038/sj/mp/4000949; Bertolino A, 2005, BIOL PSYCHIAT, V57, P1517, DOI 10.1016/j.biopsych.2005.02.031; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102; Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Champoux M, 2002, MOL PSYCHIATR, V7, P1058, DOI 10.1038/sj.mp.4001157; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; David SP, 2005, J NEUROSCI, V25, P2586, DOI 10.1523/JNEUROSCI.3769-04.2005; de Geus EJC, 2001, BEHAV GENET, V31, P489, DOI 10.1023/A:1013360909048; Deary IJ, 1999, PSYCHOL MED, V29, P735, DOI 10.1017/S0033291798007557; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546; Fallgatter AJ, 2002, J NEURAL TRANSM, V109, P977, DOI 10.1007/s007020200080; Fallgatter AJ, 1999, INT J NEUROPSYCHOP, V2, P115, DOI 10.1017/S1461145799001455; Fisher PM, 2006, NAT NEUROSCI, V9, P1362, DOI 10.1038/nn1780; Flint J, 2007, PSYCHOL MED, V37, P163, DOI 10.1017/S0033291706008750; Forster GL, 2006, NEUROSCIENCE, V141, P1047, DOI 10.1016/j.neuroscience.2006.04.006; Frodl T, 2004, ARCH GEN PSYCHIAT, V61, P177, DOI 10.1001/archpsyc.61.2.177; Furmark T, 2004, NEUROSCI LETT, V362, P189, DOI 10.1016/j.neulet.2004.02.070; Gillespie NA, 2005, PSYCHOL MED, V35, P101, DOI 10.1017/S0033291704002727; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; GOTTESMAN II, 1973, BRIT J PSYCHIAT, V122, P15, DOI 10.1192/bjp.122.1.15; Grabe HJ, 2005, MOL PSYCHIATR, V10, P220, DOI 10.1038/sj.mp.4001555; Greenberg BD, 2000, AM J MED GENET, V96, P202, DOI 10.1002/(SICI)1096-8628(20000403)96:2<202::AID-AJMG16>3.0.CO;2-J; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hamer D, 2002, SCIENCE, V298, P71, DOI 10.1126/science.1077582; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2005, ARCH GEN PSYCHIAT, V62, P146, DOI 10.1001/archpsyc.62.2.146; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Heinz A, 2000, BIOL PSYCHIAT, V47, P643, DOI 10.1016/S0006-3223(99)00171-7; HEINZ A, 2004, BIOL PSYCHIAT, V161, P1957; Herrmann MJ, 2007, CEREB CORTEX, V17, P1160, DOI 10.1093/cercor/bhl026; HIGLEY JD, 1991, PSYCHOPHARMACOLOGY, V103, P551, DOI 10.1007/BF02244258; Jorm AF, 1998, MOL PSYCHIATR, V3, P449, DOI 10.1038/sj.mp.4000424; Kaufman J, 2004, P NATL ACAD SCI USA, V101, P17316, DOI 10.1073/pnas.0404376101; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; KENDLER KS, 1995, ARCH GEN PSYCHIAT, V52, P374; Kovas Y, 2006, TRENDS COGN SCI, V10, P198, DOI 10.1016/j.tics.2006.03.001; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; LOANNIDIS JP, 2006, JNCI-J NATL CANCER I, V98, P1350; Mazzanti CM, 1998, ARCH GEN PSYCHIAT, V55, P936, DOI 10.1001/archpsyc.55.10.936; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Moerk KC, 2000, J AFFECT DISORDERS, V58, P117, DOI 10.1016/S0165-0327(99)00102-0; Morales JC, 1998, J HUM EVOL, V34, P1, DOI 10.1006/jhev.1997.0171; Munafo MR, 2005, MOL PSYCHIATR, V10, P895, DOI 10.1038/sj.mp.4001706; Munafo MR, 2005, MOL PSYCHIATR, V10, P415, DOI 10.1038/sj.mp.4001627; Nakamura T, 1997, AM J MED GENET, V74, P544, DOI 10.1002/(SICI)1096-8628(19970919)74:5<544::AID-AJMG18>3.0.CO;2-C; Parsey RV, 2006, AM J PSYCHIAT, V163, P48, DOI 10.1176/appi.ajp.163.1.48; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; Praschak-Rieder N, 2007, BIOL PSYCHIAT, V62, P327, DOI 10.1016/j.biopsych.2006.09.022; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028; Reif A, 2003, BEHAV BRAIN RES, V139, P1, DOI 10.1016/S0166-4328(02)00267-X; Reimold M, 2007, J NEURAL TRANSM, V114, P635, DOI 10.1007/s00702-006-0609-0; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rusch BD, 2001, BIOL PSYCHIAT, V50, P960, DOI 10.1016/S0006-3223(01)01248-3; Schinka JA, 2004, MOL PSYCHIATR, V9, P197, DOI 10.1038/sj.mp.4001405; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Shioe K, 2003, SYNAPSE, V48, P184, DOI 10.1002/syn.10204; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sirota LA, 1999, PSYCHIATR GENET, V9, P35, DOI 10.1097/00041444-199903000-00006; Surtees PG, 2006, BIOL PSYCHIAT, V59, P224, DOI 10.1016/j.biopsych.2005.07.014; Thapar A, 1997, J CHILD PSYCHOL PSYC, V38, P651, DOI 10.1111/j.1469-7610.1997.tb01692.x; Thierry B, 2000, ETHOLOGY, V106, P713, DOI 10.1046/j.1439-0310.2000.00583.x; Thierry Bernard, 2000, P106; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; Wendland JR, 2006, BEHAV GENET, V36, P163, DOI 10.1007/s10519-005-9017-8; Wessel J, 2007, GENOMICS, V90, P132, DOI 10.1016/j.ygeno.2007.03.003; Willis-Owen SAG, 2005, BIOL PSYCHIAT, V58, P451, DOI 10.1016/j.biopsych.2005.04.050; Zapala MA, 2006, P NATL ACAD SCI USA, V103, P19430, DOI 10.1073/pnas.0609333103	92	680	691	4	237	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2007	10	9					1103	1109		10.1038/nn1964	http://dx.doi.org/10.1038/nn1964			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205VZ	17726476				2022-12-17	WOS:000249144000008
J	Aglioti, SM; Cesari, P; Romani, M; Urgesi, C				Aglioti, Salvatore M.; Cesari, Paola; Romani, Michela; Urgesi, Cosimo			Action anticipation and motor resonance in elite basketball players	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; GRASP REPRESENTATIONS; BIOLOGICAL MOTION; COIL ORIENTATION; VISUAL-SEARCH; PERCEPTION; IMITATION; SYSTEM; CORTEX; BRAIN	We combined psychophysical and transcranial magnetic stimulation studies to investigate the dynamics of action anticipation and its underlying neural correlates in professional basketball players. Athletes predicted the success of free shots at a basket earlier and more accurately than did individuals with comparable visual experience (coaches or sports journalists) and novices. Moreover, performance between athletes and the other groups differed before the ball was seen to leave the model's hands, suggesting that athletes predicted the basket shot's fate by reading the body kinematics. Both visuo-motor and visual experts showed a selective increase of motor-evoked potentials during observation of basket shots. However, only athletes showed a time-specific motor activation during observation of erroneous basket throws. Results suggest that achieving excellence in sports may be related to the fine-tuning of specific anticipatory 'resonance' mechanisms that endow elite athletes' brains with the ability to predict others' actions ahead of their realization.	[Aglioti, Salvatore M.] Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; [Aglioti, Salvatore M.] Ctr Rech Neuropsicol, Ist Ricovero & Cura, I-00179 Rome, Italy; [Cesari, Paola; Romani, Michela] Univ Verona, Sez Sci Motorie, Dipartimento Sci Neurol & Vis, I-37131 Verona, Italy; [Cesari, Paola; Romani, Michela] Univ Verona, Fac Sci Motorie, I-37131 Verona, Italy; [Urgesi, Cosimo] Ist Ricovero & Cura, I-37078 San Vito Al Tagliamento, Pordenone, Italy	Sapienza University Rome; University of Verona; University of Verona	Aglioti, SM (corresponding author), Univ Roma La Sapienza, Dipartimento Psicol, Via Marsi 78, I-00185 Rome, Italy.	salvatoremaria.aglioti@uniroma1.it	; Urgesi, Cosimo/K-4688-2016	Cesari, Paola/0000-0002-1705-6065; Urgesi, Cosimo/0000-0003-0572-1328; Aglioti, Salvatore Maria/0000-0001-8175-7563	Ministero Istruzione Universitae Ricerca (PRIN); Fondo Investimenti per la Ricerca di Base, Italy	Ministero Istruzione Universitae Ricerca (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Fondo Investimenti per la Ricerca di Base, Italy	We thank Luca Orlandi and Marco Veronese for their technical help. This research was supported by grants from the Ministero Istruzione Universitae Ricerca (PRIN) and Fondo Investimenti per la Ricerca di Base, Italy, both awarded to S. M. A.	ABERNETHY B, 1990, PERCEPTION, V19, P63, DOI 10.1068/p190063; Abernethy B, 2007, J MOTOR BEHAV, V39, P353, DOI 10.3200/JMBR.39.5.353-368; ALLARD F, 1980, Journal of Sport Psychology, V2, P14; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; BRIGGS G G, 1975, Cortex, V11, P230; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Farrow D, 2003, PERCEPTION, V32, P1127, DOI 10.1068/p3323; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Grafton ST, 1996, EXP BRAIN RES, V112, P103; GRAY J T, 1991, Ecological Psychology, V3, P121, DOI 10.1207/s15326969eco0302_4; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hodges NJ, 2007, J SPORT SCI, V25, P531, DOI 10.1080/02640410600946860; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; Koelewijn T, 2008, NEUROIMAGE, V40, P767, DOI 10.1016/j.neuroimage.2007.12.018; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Meltzoff AN, 2003, PHILOS T R SOC B, V358, P491, DOI 10.1098/rstb.2002.1261; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Nielsen JB, 2008, J PHYSIOL-LONDON, V586, P65, DOI 10.1113/jphysiol.2007.142661; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Romani M, 2005, NEUROIMAGE, V26, P755, DOI 10.1016/j.neuroimage.2005.02.027; STARKES JL, 1987, J SPORT EXERCISE PSY, V9, P146, DOI 10.1123/jsp.9.2.146; STARKES JL, 1983, J SPORT PSYCHOL, V5, P189, DOI 10.1123/jsp.5.2.189; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Vogt S, 2007, J SPORT SCI, V25, P497, DOI 10.1080/02640410600946779; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Williams AM, 1998, RES Q EXERCISE SPORT, V69, P111, DOI 10.1080/02701367.1998.10607677	46	678	687	8	215	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2008	11	9					1109	1116		10.1038/nn.2182	http://dx.doi.org/10.1038/nn.2182			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	341NA	19160510				2022-12-17	WOS:000258720000022
J	Shmuel, A; Augath, M; Oeltermann, A; Logothetis, NK				Shmuel, A; Augath, M; Oeltermann, A; Logothetis, NK			Negative functional MRI response correlates with decreases in neuronal activity in monkey visual area V1	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; RESONANCE-IMAGING SIGNAL; RAT SOMATOSENSORY CORTEX; HUMAN-BRAIN; SENSORY STIMULATION; OXYGEN-CONSUMPTION; HEMODYNAMIC-RESPONSE; INTRINSIC SIGNALS; ACTIVATION; FMRI	Most functional brain imaging studies use task-induced hemodynamic responses to infer underlying changes in neuronal activity. In addition to increases in cerebral blood flow and blood oxygenation level-dependent (BOLD) signals, sustained negative responses are pervasive in functional imaging. The origin of negative responses and their relationship to neural activity remain poorly understood. Through simultaneous functional magnetic resonance imaging and electrophysiological recording, we demonstrate a negative BOLD response (NBR) beyond the stimulated regions of visual cortex, associated with local decreases in neuronal activity below spontaneous activity, detected 7.15 +/- 3.14 mm away from the closest positively responding region in V1. Trial-by-trial amplitude fluctuations revealed tight coupling between the NBR and neuronal activity decreases. The NBR was associated with comparable decreases in local field potentials and multiunit activity. Our findings indicate that a significant component of the NBR originates in neuronal activity decreases.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Logothetis, NK (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	Nikos.Logothetis@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019; Shmuel, Amir/G-8690-2013					Allison JD, 2000, NEUROLOGY, V54, P135, DOI 10.1212/WNL.54.1.135; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brewer AA, 2002, J NEUROSCI, V22, P10416; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Devor A, 2005, P NATL ACAD SCI USA, V102, P3822, DOI 10.1073/pnas.0407789102; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Gold L, 2002, P NATL ACAD SCI USA, V99, P7699, DOI 10.1073/pnas.112012499; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kannurpatti SS, 2004, J CEREBR BLOOD F MET, V24, P703, DOI 10.1097/01.WCB.0000121232.04853.46; Kayser C, 2004, CEREB CORTEX, V14, P881, DOI 10.1093/cercor/bhh047; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Lu HZ, 2004, J CEREBR BLOOD F MET, V24, P764, DOI 10.1097/01.WCB.0000124322.60992.5C; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Pfeuffer J, 2004, MAGN RESON IMAGING, V22, P1343, DOI 10.1016/j.mri.2004.10.004; RAICHLE ME, 1983, J NUCL MED, V24, P790; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; ROCKLAND KS, 1983, J COMP NEUROL, V216, P303, DOI 10.1002/cne.902160307; Saad ZS, 2001, HUM BRAIN MAPP, V13, P74, DOI 10.1002/hbm.1026; Sheth S, 2003, NEUROIMAGE, V19, P884, DOI 10.1016/S1053-8119(03)00086-7; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Stefanovic B, 2004, NEUROIMAGE, V22, P771, DOI 10.1016/j.neuroimage.2004.01.036; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013	50	678	685	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					569	577		10.1038/nn1675	http://dx.doi.org/10.1038/nn1675			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547508				2022-12-17	WOS:000236310700025
J	Howard, DM; Adams, MJ; Clarke, TK; Hafferty, JD; Gibson, J; Shirali, M; Coleman, JRI; Hagenaars, SP; Ward, J; Wigmore, EM; Alloza, C; Shen, X; Barbu, MC; Xu, EY; Whalley, HC; Marioni, RE; Porteous, DJ; Davies, G; Deary, IJ; Hemani, G; Berger, K; Teismann, H; Rawal, R; Arolt, V; Baune, BT; Dannlowski, U; Domschke, K; Tian, C; Hinds, DA; Agee, M; Alipanahi, B; Auton, A; Bell, RK; Bryc, K; Elson, SL; Fontanillas, P; Furlotte, NA; Hicks, B; Huber, KE; Jewett, EM; Jiang, Y; Kleinman, A; Lin, KH; Litterman, NK; McIntyre, MH; Mountain, JL; Noblin, ES; Northover, CAM; Pitts, SJ; Poznik, GD; Sathirapongsasuti, JF; Sazonova, OV; Shelton, JF; Shringarpure, S; Tung, JY; Vacic, V; Wang, X; Wilson, CH; Trzaskowski, M; Byrne, EM; Ripke, S; Smith, DJ; Sullivan, PF; Wray, NR; Breen, G; Lewis, CM; McIntosh, AM				Howard, David M.; Adams, Mark J.; Clarke, Toni-Kim; Hafferty, Jonathan D.; Gibson, Jude; Shirali, Masoud; Coleman, Jonathan R. I.; Hagenaars, Saskia P.; Ward, Joey; Wigmore, Eleanor M.; Alloza, Clara; Shen, Xueyi; Barbu, Miruna C.; Xu, Eileen Y.; Whalley, Heather C.; Marioni, Riccardo E.; Porteous, David J.; Davies, Gail; Deary, Ian J.; Hemani, Gibran; Berger, Klaus; Teismann, Henning; Rawal, Rajesh; Arolt, Volker; Baune, Bernhard T.; Dannlowski, Udo; Domschke, Katharina; Tian, Chao; Hinds, David A.; Agee, M.; Alipanahi, B.; Auton, A.; Bell, R. K.; Bryc, K.; Elson, S. L.; Fontanillas, P.; Furlotte, N. A.; Hicks, B.; Huber, K. E.; Jewett, E. M.; Jiang, Y.; Kleinman, A.; Lin, K. Han.; Litterman, N. K.; McIntyre, M. H.; Mountain, J. L.; Noblin, E. S.; Northover, C. A. M.; Pitts, S. J.; Poznik, G. D.; Sathirapongsasuti, J. F.; Sazonova, O. V.; Shelton, J. F.; Shringarpure, S.; Tung, J. Y.; Vacic, V.; Wang, X.; Wilson, C. H.; Trzaskowski, Maciej; Byrne, Enda M.; Ripke, Stephan; Smith, Daniel J.; Sullivan, Patrick F.; Wray, Naomi R.; Breen, Gerome; Lewis, Cathryn M.; McIntosh, Andrew M.		23andMe Res Team; Major Depressive Disorder Working	Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions	NATURE NEUROSCIENCE			English	Article							LD SCORE REGRESSION; PARTITIONING HERITABILITY; CIGARETTE-SMOKING; MAJOR DEPRESSION; VRK2 RS2312147; ASSOCIATION; SCHIZOPHRENIA; DISORDERS; GENETICS; LOCI	Major depression is a debilitating psychiatric illness that is typically associated with low mood and anhedonia. Depression has a heritable component that has remained difficult to elucidate with current sample sizes due to the polygenic nature of the disorder. To maximize sample size, we meta-analyzed data on 807,553 individuals (246,363 cases and 561,190 controls) from the three largest genome-wide association studies of depression. We identified 102 independent variants, 269 genes, and 15 genesets associated with depression, including both genes and gene pathways associated with synaptic structure and neuro-transmission. An enrichment analysis provided further evidence of the importance of prefrontal brain regions. In an independent replication sample of 1,306,354 individuals (414,055 cases and 892,299 controls), 87 of the 102 associated variants were significant after multiple testing correction. These findings advance our understanding of the complex genetic architecture of depression and provide several future avenues for understanding etiology and developing new treatment approaches.	[Howard, David M.; Adams, Mark J.; Clarke, Toni-Kim; Hafferty, Jonathan D.; Gibson, Jude; Shirali, Masoud; Wigmore, Eleanor M.; Alloza, Clara; Shen, Xueyi; Barbu, Miruna C.; Xu, Eileen Y.; Whalley, Heather C.; McIntosh, Andrew M.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland; [Coleman, Jonathan R. I.; Hagenaars, Saskia P.; Breen, Gerome; Lewis, Cathryn M.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Social Genet & Dev Psychiat Ctr, London, England; [Coleman, Jonathan R. I.; Hagenaars, Saskia P.; Breen, Gerome; Lewis, Cathryn M.] South London & Maudsley NHS Trust, NIHR Biomed Res Ctr Mental Hlth, London, England; [Ward, Joey; Smith, Daniel J.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Marioni, Riccardo E.; Porteous, David J.; Davies, Gail; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Marioni, Riccardo E.; Porteous, David J.] Univ Edinburgh, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; [Davies, Gail; Deary, Ian J.; McIntosh, Andrew M.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Hemani, Gibran] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, MRC,Integrat Epidemiol Unit, Bristol, Avon, England; [Berger, Klaus; Teismann, Henning; Rawal, Rajesh] Univ Munster, Inst Epidemiol & Social Med, Munster, Germany; [Arolt, Volker; Dannlowski, Udo] Univ Munster, Dept Psychiat, Munster, Germany; [Baune, Bernhard T.] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Domschke, Katharina] Univ Freiburg, Fac Med, Med Ctr, Dept Psychiat & Psychotherapy, Freiburg, Germany; [Tian, Chao; Hinds, David A.] 23andMe Inc, Mountain View, CA USA; [Trzaskowski, Maciej; Byrne, Enda M.; Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Ripke, Stephan] Charite Univ Med Berlin, Campus Benjamin Franklin, Dept Psychiat, Berlin, Germany; [Ripke, Stephan] Broad Inst, Med & Populat Genet, Cambridge, MA USA; [Ripke, Stephan] Massachusetts Gen Hosp, Anal & Translat Genet Unit, Boston, MA 02114 USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA	Royal Infirmary of Edinburgh; University of Edinburgh; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; University of Glasgow; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Bristol; University of Munster; University of Munster; University of Melbourne; University of Freiburg; University of Queensland; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Karolinska Institutet; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Howard, DM (corresponding author), Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland.	D.Howard@ed.ac.uk	McIntosh, Andrew M/B-9379-2008; Wray, Naomi/C-8639-2015; Alloza, Clara/AAA-8555-2020; Porteous, David/AAA-3446-2021; Webb, Bradley T/B-1459-2009; tian, chao/GYD-3462-2022; Coleman, Jonathan/T-9412-2019; Lewis, Cathryn M/A-5225-2010; Howard, David/I-6500-2019; Shen, Xueyi/AAS-8960-2020; Shirali, Masoud/AAZ-5633-2020; Breen, Gerome/Y-2706-2019; Shirali, Masoud/GYH-0339-2022; Ripke, Stephan/AAK-5486-2021; Clarke, Toni/AAE-7069-2019; Grove, Jakob/K-8112-2015; Agerbo, Esben/A-2645-2012; Colodro Conde, Lucia/L-5515-2014; Buttenschon, Henriette/U-2060-2018	McIntosh, Andrew M/0000-0002-0198-4588; Wray, Naomi/0000-0001-7421-3357; Porteous, David/0000-0003-1249-6106; Webb, Bradley T/0000-0002-0576-5366; Coleman, Jonathan/0000-0002-6759-0944; Lewis, Cathryn M/0000-0002-8249-8476; Howard, David/0000-0002-6005-1972; Shen, Xueyi/0000-0002-0538-4774; Shirali, Masoud/0000-0002-5401-0541; Breen, Gerome/0000-0003-2053-1792; Shirali, Masoud/0000-0002-5401-0541; Clarke, Toni/0000-0002-7745-6351; Christensen, Jane Hvarregaard/0000-0002-0009-2991; Hagenaars, Saskia/0000-0001-9697-8596; Grove, Jakob/0000-0003-2284-5744; Gibson, Jude/0000-0002-3745-8360; Smith, Daniel/0000-0002-2267-1951; Adams, Mark James/0000-0002-3599-6018; Rawal, Rajesh/0000-0002-0151-9344; Hemani, Gibran/0000-0003-0920-1055; Agerbo, Esben/0000-0002-2849-524X; ripke, stephan/0000-0003-3622-835X; Colodro Conde, Lucia/0000-0002-9004-364X; Whalley, Heather/0000-0002-4505-8869; Trzaskowski, Maciej/0000-0001-8559-6525; Buttenschon, Henriette/0000-0003-3800-9169; Alloza, Clara/0000-0002-2092-8055; Barbu, Miruna Carmen/0000-0001-8967-683X	Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6]; Scottish Funding Council [HR03006]; Medical Research Council UK; Wellcome Trust [104036/Z/14/Z, 208806/Z/17/Z]; Centre for Cognitive Ageing and Cognitive Epidemiology; Medical Research Council; Biotechnology and Biological Sciences Research Council [MR/K026992/1]; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; Lister Institute; NMHRC [1078901, 1087889]; German Ministry of Research and Education (BMBF) [01ER0816, 01ER1506]; German Research Foundation (DFG) [FOR2107 DA1151/5-1, DA1151/5-2, SFB-TRR58]; Interdisciplinary Center for Clinical Research (IZKF) of the medical faculty of Munster [Dan3/012/17]; US National Institute of Mental Health; US National Institute of Drug Abuse [U01 MH109528, U01 MH1095320]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH109536] Funding Source: NIH RePORTER; Medical Research Council [MC_PC_17209] Funding Source: researchfish; MRC [MC_PC_17209, MR/S015132/1, MR/J000914/1, G0700704] Funding Source: UKRI	Chief Scientist Office of the Scottish Government Health Directorates; Scottish Funding Council; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Centre for Cognitive Ageing and Cognitive Epidemiology; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London(General Electric); Lister Institute; NMHRC; German Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) of the medical faculty of Munster; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was conducted using the UK Biobank resource, application number 4844. We are grateful to the UK Biobank and all its voluntary participants. The UK Biobank study was conducted under generic approval from the NHS National Research Ethics Service (approval letter dated June 17, 2011, Ref 11/NW/0382). All participants gave full informed written consent. The authors acknowledge the help, advice and support from all members of the UK Biobank Psychiatric Genetics Group. The BiDirect cohort and the Munster cohort were approved by the ethics committee of the University of Munster and the Westphalian Chamber of Physicians in Munster, North-Rhine-Westphalia, Germany, and written informed consent was obtained from all participants. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006]. Genotyping of the GS: SFHS samples was carried out by the Genetics Core Laboratory at the Wellcome Trust Clinical Research Facility, Edinburgh, Scotland and was funded by the Medical Research Council UK and the Wellcome Trust (Wellcome Trust Strategic Award "STratifying Resilience and Depression Longitudinally" (STRADL) Reference 104036/Z/14/Z). Ethics approval for the Generation Scotland was given by the NHS Tayside committee on research ethics (reference 15/ES/0040), and all participants provided written informed consent for the use of their data. The study protocol used by 23andMe was approved by an external AAHRPP-accredited institutional review board. Details of the manuscripts containing approvals for the 35 PGC cohorts are listed in Supplementary Table 1 and Supplementary Table 2 of Wray et al<SUP>9</SUP>. We are grateful to the participants and research teams behind the Psychiatric Genomics Consortium, UK Biobank and 23andMe. We thank the following members of the 23andMe Research Team: M. Agee, B. Alipanahi, A. Auton, R. K. Bell, K. Bryc, S. L. Elson, P. Fontanillas, N. A. Furlotte, B. Hicks, K. E. Huber, E. M. Jewett, Y. Jiang, A. Kleinman, K. Han. Lin, N. K. Litterman, M. H. McIntyre, J. L. Mountain, E. S. Noblin, C. A. M. Northover, S. J. Pitts, G. D. Poznik, J. F. Sathirapongsasuti, O. V. Sazonova, J. F. Shelton, S. Shringarpure, J. Y. Tung, V. Vacic, X. Wang and C. H. Wilson. We would like to thank N. Skene for his advice on analyzing the expression-weighted enrichment for brain cell types and N. Martin for his suggestions on polygenic risk scores. A. M. McI and I. J. D. acknowledge support from the Wellcome Trust (Wellcome Trust Strategic Award 'STratifying Resilience and Depression Longitudinally' (STRADL) Reference 104036/Z/14/Z and the Dr Mortimer and Theresa Sackler Foundation. I. J. D. is supported by the Centre for Cognitive Ageing and Cognitive Epidemiology, which is funded by the Medical Research Council and the Biotechnology and Biological Sciences Research Council (MR/K026992/1). This investigation represents independent research part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. G.H. is supported by the Wellcome Trust (208806/Z/17/Z). D. J. S. is supported by the Lister Institute Prize Fellowship 2016-2021. N.R.W. acknowledges NMHRC grants 1078901 and 1087889.; The BiDirect Study is supported by grants of the German Ministry of Research and Education (BMBF) to the University of Munster (01ER0816 and 01ER1506). The Munster cohort was funded by the German Research Foundation (DFG, grant FOR2107 DA1151/5-1 and DA1151/5-2 to U. D.; SFB-TRR58, Projects C09 and Z02 to U. D.) and the Interdisciplinary Center for Clinical Research (IZKF) of the medical faculty of Munster (grant Dan3/012/17 to U. D.). The PGC has received major funding from the US National Institute of Mental Health and the US National Institute of Drug Abuse (U01 MH109528 and U01 MH1095320).	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Allen NE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008601; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Anttila V, 2018, SCIENCE, V360, P1313, DOI 10.1126/science.aap8757; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bi LL, 2015, NEUROPSYCHOPHARMACOL, V40, P974, DOI 10.1038/npp.2014.274; Biernacka JM, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.47; Boden JM, 2010, BRIT J PSYCHIAT, V196, P440, DOI 10.1192/bjp.bp.109.065912; Bonci A, 2005, NEURON, V47, P335, DOI 10.1016/j.neuron.2005.07.015; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burgess S, 2016, GENET EPIDEMIOL, V40, P597, DOI 10.1002/gepi.21998; Bycroft C., 2017, BIORXIV, DOI [DOI 10.1101/16629824, DOI 10.1101/166298]; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cai N, 2015, NATURE, V523, P588, DOI 10.1038/nature14659; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chang H, 2016, WORLD J BIOL PSYCHIA, V17, P457, DOI 10.1080/15622975.2016.1200746; Chronis-Tuscano A, 2010, ARCH GEN PSYCHIAT, V67, P1044, DOI 10.1001/archgenpsychiatry.2010.127; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunn EC, 2015, HARVARD REV PSYCHIAT, V23, P1, DOI 10.1097/HRP.0000000000000054; Espallergues J, 2011, PSYCHOPHARMACOLOGY, V214, P455, DOI 10.1007/s00213-010-2053-y; Estrada-Camarena E, 2003, NEUROPSYCHOPHARMACOL, V28, P830, DOI 10.1038/sj.npp.1300097; Fernandez-Pujals AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142197; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; First M.B., 2015, SCID 2 PERSONALITY Q; Fogel BL, 2012, HUM MOL GENET, V21, P4171, DOI 10.1093/hmg/dds240; Fuxe K, 2015, EXPERT OPIN INV DRUG, V24, P1247, DOI 10.1517/13543784.2015.1074175; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hagenaars SP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02837-3; Halgren C, 2012, EUR J HUM GENET, V20, P1315, DOI 10.1038/ejhg.2012.92; Hek K, 2013, BIOL PSYCHIAT, V73, P667, DOI 10.1016/j.biopsych.2012.09.033; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Howard DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03819-3; Hyde CL, 2016, NAT GENET, V48, P1031, DOI 10.1038/ng.3623; Kaltiala-Heino R, 2003, J ADOLESCENCE, V26, P531, DOI 10.1016/S0140-1971(03)00053-8; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Li M, 2012, SCHIZOPHR RES, V142, P200, DOI 10.1016/j.schres.2012.10.008; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Luciano M, 2018, NAT GENET, V50, P6, DOI 10.1038/s41588-017-0013-8; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McGee SL, 2009, J PHYSIOL-LONDON, V587, P5951, DOI 10.1113/jphysiol.2009.181065; Mossakowska-Wojcik J, 2018, PROG NEURO-PSYCHOPH, V80, P304, DOI 10.1016/j.pnpbp.2017.03.014; Mota NR, 2015, AM J MED GENET B, V168, P433, DOI 10.1002/ajmg.b.32317; Munafo MR, 2010, BRIT J PSYCHIAT, V196, P425, DOI 10.1192/bjp.bp.109.074880; MunafuO, 2018, CAUSAL EFFECTS LIFET, DOI 10.1101/381301; Nagy R, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0414-4; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Potkin SG, 2009, MOL PSYCHIATR, V14, P416, DOI 10.1038/mp.2008.127; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Quarto T, 2017, NEUROSCIENCE, V341, P9, DOI 10.1016/j.neuroscience.2016.11.010; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Rannals MD, 2016, NEURON, V90, P43, DOI 10.1016/j.neuron.2016.02.021; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sequeira ME, 2017, BRIT J PSYCHIAT, V210, P39, DOI 10.1192/bjp.bp.115.168617; Skene NG, 2018, NAT GENET, V50, P825, DOI 10.1038/s41588-018-0129-5; Smith BH, 2013, INT J EPIDEMIOL, V42, P689, DOI 10.1093/ije/dys084; Smith DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075362; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Teismann H, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-174; TheGeneOntologyConsortium, 2017, Nucleic Acids Res, V45, pD331, DOI 10.1093/nar/gkw1108; van den Berg SM, 2014, BEHAV GENET, V44, P295, DOI 10.1007/s10519-014-9654-x; Wagnon JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003067; Wei YB, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.136; Whitmer AJ, 2012, COGN AFFECT BEHAV NE, V12, P741, DOI 10.3758/s13415-012-0112-z; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010; Wium-Andersen MK, 2015, INT J EPIDEMIOL, V44, P566, DOI 10.1093/ije/dyv090; World Health Organization, 2017, DEPR OTH COMM MENT D, V1th; Wray Naomi R, 2018, Nat Genet, V50, P668, DOI 10.1038/s41588-018-0090-3; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613	85	676	685	17	150	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2019	22	3					343	+		10.1038/s41593-018-0326-7	http://dx.doi.org/10.1038/s41593-018-0326-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HM4DL	30718901	Green Accepted, Green Submitted			2022-12-17	WOS:000459423800006
J	Kee, N; Teixeira, CM; Wang, AH; Frankland, PW				Kee, Nohjin; Teixeira, Catia M.; Wang, Afra H.; Frankland, Paul W.			Preferential incorporation of adult-generated granule cells into spatial memory networks in the dentate gyrus	NATURE NEUROSCIENCE			English	Article							HIPPOCAMPAL NEUROGENESIS; RETROGRADE-AMNESIA; NEURONS; INTEGRATION; EXPRESSION; MATURATION; BRAIN; YOUNG; BORN; TIME	Throughout adulthood, new neurons are continuously added to the dentate gyrus, a hippocampal subregion that is important in spatial learning. Whether these adult-generated granule cells become functionally integrated into memory networks is not known. We used immunohistochemical approaches to visualize the recruitment of new neurons into circuits supporting water maze memory in intact mice. We show that as new granule cells mature, they are increasingly likely to be incorporated into circuits supporting spatial memory. By the time the cells are 4 or more weeks of age, they are more likely than existing granule cells to be recruited into circuits supporting spatial memory. This preferential recruitment supports the idea that new neurons make a unique contribution to memory processing in the dentate gyrus.	Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; Univ Porto, Grad Program Areas Basic & Appl Biol, P-4050465 Oporto, Portugal	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Universidade do Porto	Frankland, PW (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	paul.frankland@sickkids.ca		Teixeira, Catia/0000-0002-6577-0730				Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Clark RE, 2005, HIPPOCAMPUS, V15, P260, DOI 10.1002/hipo.20056; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Dupret D, 2005, EUR J NEUROSCI, V22, P778, DOI 10.1111/j.1460-9568.2005.04262.x; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Guzowski JF, 2006, P NATL ACAD SCI USA, V103, P1077, DOI 10.1073/pnas.0505519103; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Magavi SSP, 2005, J NEUROSCI, V25, P10729, DOI 10.1523/JNEUROSCI.2250-05.2005; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; MCNAUGHTON BL, 1989, EXP BRAIN RES, V76, P485, DOI 10.1007/BF00248904; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Overstreet-Wadiche LS, 2006, HIPPOCAMPUS, V16, P208, DOI 10.1002/hipo.20152; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Song HJ, 2005, J NEUROSCI, V25, P10366, DOI 10.1523/JNEUROSCI.3452-05.2005; Takehara K, 2003, J NEUROSCI, V23, P9897; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Teixeira CM, 2006, J NEUROSCI, V26, P7555, DOI 10.1523/JNEUROSCI.1068-06.2006; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Zhang WP, 2005, LEARN MEMORY, V12, P239, DOI 10.1101/lm.90005; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	50	676	696	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					355	362		10.1038/nn1847	http://dx.doi.org/10.1038/nn1847			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17277773				2022-12-17	WOS:000244480300018
J	Grill-Spector, K; Knouf, N; Kanwisher, N				Grill-Spector, K; Knouf, N; Kanwisher, N			The fusiform face area subserves face perception, not generic within-category identification	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; HUMAN NEURAL SYSTEM; SELECTIVE ACTIVATION; FUNCTIONAL MRI; VISUAL-CORTEX; BRAIN-AREAS; RECOGNITION; OBJECTS; EXPERTISE; GYRUS	The function of the fusiform face area (FFA), a face-selective region in human extrastriate cortex, is a matter of active debate. Here we measured the correlation between FFA activity measured by functional magnetic resonance imaging (fMRI) and behavioral outcomes in perceptual tasks to determine the role of the FFA in the detection and within-category identification of faces and objects. Our data show that FFA activation is correlated on a trial-by-trial basis with both detecting the presence of faces and identifying specific faces. However, for most non-face objects (including cars seen by car experts), within-category identification performance was correlated with activation in other regions of the ventral occipitotemporal cortex, not the FFA. These results indicate that the FFA is involved in both detection and identification of faces, but that it has little involvement in within-category identification of non-face objects (including objects of expertise).	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Stanford University; Massachusetts Institute of Technology (MIT)	Grill-Spector, K (corresponding author), Stanford Univ, Dept Psychol, Jordan Hall, Stanford, CA 94305 USA.	kalanit@psych.stanford.edu		Grill-Spector, Kalanit/0000-0002-5404-9606	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER; NCRR NIH HHS [P41RR14075] Funding Source: Medline; NEI NIH HHS [EY13455] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLISON T, 1994, CEREB CORTEX, V4, P544, DOI 10.1093/cercor/4.5.544; Andrews TJ, 2002, NEUROIMAGE, V17, P890, DOI 10.1006/nimg.2002.1243; Avidan G, 2002, CURR BIOL, V12, P964, DOI 10.1016/S0960-9822(02)00872-2; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farah M.J., 1990, VISUAL AGNOSIA DISOR; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; George N, 1999, NAT NEUROSCI, V2, P574, DOI 10.1038/9230; George N, 2001, NEUROIMAGE, V13, P1102, DOI 10.1006/nimg.2001.0769; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; GRILLSPECTOR K, IN PRESS PSYCHOL SCI; GRILLSPECTOR K, 2003, ATTENTION PERFORM, V20, P169; Hasson U, 2001, J COGNITIVE NEUROSCI, V13, P744, DOI 10.1162/08989290152541412; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2004, VISUAL NEUROSCIENCES, P1179; KANWISHER N, 1998, COGNITION B, V68, P1; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; MCKONE E, IN PRESS MONKEY BRAI; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Puce A, 1998, J NEUROSCI, V18, P2188; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Rossion B, 2003, NEUROIMAGE, V19, P877, DOI 10.1016/S1053-8119(03)00105-8; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Thompson KG, 1999, NAT NEUROSCI, V2, P283, DOI 10.1038/6398; Thompson KG, 2000, VISION RES, V40, P1523, DOI 10.1016/S0042-6989(99)00250-3; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057	49	676	682	1	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					555	562		10.1038/nn1224	http://dx.doi.org/10.1038/nn1224			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15077112				2022-12-17	WOS:000221101300034
J	Jones, MW; Errington, ML; French, PJ; Fine, A; Bliss, TVP; Garel, S; Charnay, P; Bozon, B; Laroche, S; Davis, S				Jones, MW; Errington, ML; French, PJ; Fine, A; Bliss, TVP; Garel, S; Charnay, P; Bozon, B; Laroche, S; Davis, S			A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN-SYNTHESIS; DENTATE GYRUS; HIPPOCAMPAL-NEURONS; SYNTHESIS INHIBITOR; RAT HIPPOCAMPUS; SPATIAL MEMORY; GROWTH-FACTOR; IN-VIVO; POTENTIATION	The induction of long-term potentiation (LTP) in the dentate gyrus of the hippocampus is associated with a rapid and robust transcription of the immediate early gene Zif268. We used a mutant mouse with a targeted disruption of Zif268 to ask whether this gene, which encodes a zinc finger transcription factor, is required for the maintenance of late LTP and for the expression of long-term memory. We show that whereas mutant mice exhibit early LTP in the dentate gyrus, late LTP is absent when measured 24 and 48 hours after tetanus in the freely moving animal. In both spatial and non-spatial learning tasks, short-term memory remained intact, whereas performance was impaired in tests requiring long-term memory. Thus, Zif268 is essential for the transition from short- to long-term synaptic plasticity and for the expression of long-term memories.	Univ Paris Sud, CNRS, UMR 8620, Lab Neurobiol Apprentissage Memoire & Commun, F-91405 Orsay, France; Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England; Ecole Normale Super, INSERM, U368, F-75230 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; MRC National Institute for Medical Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Davis, S (corresponding author), Univ Paris Sud, CNRS, UMR 8620, Lab Neurobiol Apprentissage Memoire & Commun, F-91405 Orsay, France.		Garel, Sonia/P-4538-2017; Fine, Alan/P-5936-2014	Garel, Sonia/0000-0003-2984-3645; Fine, Alan/0000-0002-4960-6973; French, Pim/0000-0002-0668-9529; Charnay, Patrick/0000-0002-3847-6042; Jones, Matthew/0000-0001-5396-3108				ABRAHAM WC, 1991, MOL NEUROBIOL, V5, P297, DOI 10.1007/BF02935553; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blum S, 1999, J NEUROSCI, V19, P3535; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CHANGELIAN PS, 1989, P NATL ACAD SCI USA, V86, P377, DOI 10.1073/pnas.86.1.377; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Davis S, 1998, CR ACAD SCI III-VIE, V321, P97, DOI 10.1016/S0764-4469(97)89808-3; Davis S, 1997, J NEUROSCI METH, V75, P75, DOI 10.1016/S0165-0270(97)00053-8; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; FAZELI MS, 1993, J NEUROSCI, V13, P1346; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; GARCIA J, 1955, SCIENCE, V122, P157; Gerlai R, 1998, BEHAV BRAIN RES, V95, P91, DOI 10.1016/S0166-4328(97)00214-3; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Jones MR, 1999, J NEURO-OPHTHALMOL, V19, P1; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; KOGAN JH, 1996, CURR BIOL, V7, P1; KOSAKA T, 1987, BRAIN RES, V419, P119, DOI 10.1016/0006-8993(87)90575-0; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Meiri N, 1998, BRAIN RES, V789, P48, DOI 10.1016/S0006-8993(97)01528-X; MILBRANDT J, 1987, SCIENCE, V85, P7857; Miyashita Y, 1998, NEUROBIOL LEARN MEM, V70, P197, DOI 10.1006/nlme.1998.3848; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; OTANI S, 1989, NEUROSCI LETT, V106, P175, DOI 10.1016/0304-3940(89)90222-X; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; RASMUSSEN M, 1989, PSYCHOBIOLOGY, V17, P335; RICHARDSON CL, 1992, BRAIN RES, V580, P147, DOI 10.1016/0006-8993(92)90938-6; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; SAKAMOTO KM, 1991, ONCOGENE, V6, P867; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; SQUIRE LR, 1973, BRAIN RES, V56, P215, DOI 10.1016/0006-8993(73)90336-3; STRUPP BJ, 1984, J COMP PSYCHOL, V98, P257, DOI 10.1037/0735-7036.98.3.257; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; WALKER DL, 1994, BEHAV NEURAL BIOL, V62, P151, DOI 10.1016/S0163-1047(05)80036-6; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	47	676	700	1	58	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					289	296		10.1038/85138	http://dx.doi.org/10.1038/85138			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224546				2022-12-17	WOS:000167178300017
J	Phelps, EA; O'Connor, KJ; Gatenby, JC; Gore, JC; Grillon, C; Davis, M				Phelps, EA; O'Connor, KJ; Gatenby, JC; Gore, JC; Grillon, C; Davis, M			Activation of the left amygdala to a cognitive representation of fear	NATURE NEUROSCIENCE			English	Article							POTENTIATED STARTLE; NEURONS; HUMANS; BRAIN; ANTICIPATION; RESPONSES; REFLEX; STRESS; CORTEX; FMRI	We examined the neural substrates involved when subjects encountered an event linked verbally, but not experientially, to an aversive outcome. This instructed fear task models a primary way humans learn about the emotional nature of events. Subjects were told that one stimulus (threat) represents an aversive event (a shock may be given), whereas another (safe) represents safety (no shock will be given). Using functional magnetic resonance imaging (fMRI), activation of the left amygdala was observed in response to threat versus safe conditions, which correlated with the expression of the fear response as measured by skin conductance. Additional activation observed in the insular cortex is proposed to be involved in conveying a cortical representation of fear to the amygdala. These results suggest that the neural substrates that support conditioned fear across species have a similar but somewhat different role in more abstract representations of fear in humans.	NYU, Dept Psychol, New York, NY 10003 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Yale Univ, Sch Med, Dept Radiol, New Haven, CT 06520 USA; NIMH, Bethesda, MD 20892 USA; Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	New York University; Massachusetts Institute of Technology (MIT); Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Emory University	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl,8th Floor, New York, NY 10003 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH050812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033332] Funding Source: NIH RePORTER; NIMH NIH HHS [MH50812] Funding Source: Medline; NINDS NIH HHS [NS33332] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angrilli A, 1996, BRAIN, V119, P1991, DOI 10.1093/brain/119.6.1991; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Collins DR, 1999, J NEUROSCI, V19, P836; Constable RT, 1998, MAGN RESON IMAGING, V16, P289, DOI 10.1016/S0730-725X(97)00278-6; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; DEANE GE, 1961, J EXP PSYCHOL, V61, P489, DOI 10.1037/h0049220; FUNAYAMA ES, IN PRESS J COGN NEUR; GRILLON C, 1991, PSYCHOPHYSIOLOGY, V28, P588, DOI 10.1111/j.1469-8986.1991.tb01999.x; Grillon C, 1997, PSYCHOPHYSIOLOGY, V34, P511, DOI 10.1111/j.1469-8986.1997.tb01737.x; Kapp BS, 1984, NEUROPSYCHOLOGY MEMO, P473; LABAR KS, 1995, J NEUROSCI, V15, P6846; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; LeDoux J. E., 1996, EMOTIONAL BRAIN; MAEDA H, 1993, CAN J PHYSIOL PHARM, V71, P374, DOI 10.1139/y93-057; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; PASCOE JP, 1985, BRAIN RES BULL, V14, P331, DOI 10.1016/0361-9230(85)90194-7; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Shi CJ, 1998, J COMP NEUROL, V399, P469, DOI 10.1002/(SICI)1096-9861(19981005)399:4<469::AID-CNE3>3.0.CO;2-#; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Talairach J., 1988, COPLANAR STEREOTAXIC	28	674	683	4	54	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					437	441		10.1038/86110	http://dx.doi.org/10.1038/86110			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276236				2022-12-17	WOS:000168762200026
J	Deisseroth, K				Deisseroth, Karl			Optogenetics: 10 years of microbial opsins in neuroscience	NATURE NEUROSCIENCE			English	Article							RESTORES VISUAL RESPONSES; LIGHT-INDUCED ACTIVATION; VENTRAL TEGMENTAL AREA; DEEP BRAIN-STIMULATION; IN-VIVO CONTROL; PREFRONTAL CORTEX; NEURAL CIRCUITRY; OPTICAL CONTROL; REMOTE-CONTROL; GREEN-ALGAE	Over the past 10 years, the development and convergence of microbial opsin engineering, modular genetic methods for cell-type targeting and optical strategies for guiding light through tissue have enabled versatile optical control of defined cells in living systems, defining modern optogenetics. Despite widespread recognition of the importance of spatiotemporally precise causal control over cellular signaling, for nearly the first half (2005-2009) of this 10-year period, as optogenetics was being created, there were difficulties in implementation, few publications and limited biological findings. In contrast, the ensuing years have witnessed a substantial acceleration in the application domain, with the publication of thousands of discoveries and insights into the function of nervous systems and beyond. This Historical Commentary reflects on the scientific landscape of this decade-long transition.	[Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu	mohamady, mahin/G-2175-2016		Howard Hughes Medical Institute Funding Source: Medline; NIDA NIH HHS [R37 DA035377] Funding Source: Medline; NIMH NIH HHS [R01 MH075957] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075957] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott SBG, 2011, J NEUROSCI, V31, P16410, DOI 10.1523/JNEUROSCI.3280-11.2011; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Ahmari SE, 2013, SCIENCE, V340, P1234, DOI 10.1126/science.1234733; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Amo R, 2014, NEURON, V84, P1034, DOI 10.1016/j.neuron.2014.10.035; Anaclet C, 2014, NAT NEUROSCI, V17, P1217, DOI 10.1038/nn.3789; Anthony TE, 2014, CELL, V156, P522, DOI 10.1016/j.cell.2013.12.040; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Barish PA, 2013, EUR J PHARMACOL, V705, P42, DOI 10.1016/j.ejphar.2013.01.065; Bartho P, 2014, NEURON, V82, P1367, DOI 10.1016/j.neuron.2014.04.046; Basu J, 2013, NEURON, V79, P1208, DOI 10.1016/j.neuron.2013.07.001; Beltramo R, 2013, NAT NEUROSCI, V16, P227, DOI 10.1038/nn.3306; Berndt A, 2015, SCIENCE, V349, P590, DOI 10.1126/science.aac7889; Berndt A, 2014, SCIENCE, V344, P420, DOI 10.1126/science.1252367; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brown MTC, 2012, NATURE, V492, P452, DOI 10.1038/nature11657; Buetfering C, 2014, NAT NEUROSCI, V17, P710, DOI 10.1038/nn.3696; Burguiere E, 2013, SCIENCE, V340, P1243, DOI 10.1126/science.1232380; Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Buzsaki G, 2015, NEURON, V86, P92, DOI 10.1016/j.neuron.2015.01.028; Canty AJ, 2009, J NEUROSCI, V29, P10695, DOI 10.1523/JNEUROSCI.2658-09.2009; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Carvalho-de-Souza JL, 2015, NEURON, V86, P207, DOI 10.1016/j.neuron.2015.02.033; Cepeda C, 2013, J NEUROSCI, V33, P7393, DOI 10.1523/JNEUROSCI.2137-12.2013; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chen BT, 2013, NATURE, V496, P359, DOI 10.1038/nature12024; Chen CH, 2014, NAT NEUROSCI, V17, P1767, DOI 10.1038/nn.3868; Chen R, 2015, SCIENCE, V347, P1477, DOI 10.1126/science.1261821; Cheng MY, 2014, P NATL ACAD SCI USA, V111, P12913, DOI 10.1073/pnas.1404109111; Choi GB, 2011, CELL, V146, P1003, DOI 10.1016/j.cell.2011.07.041; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cosentino C, 2015, SCIENCE, V348, P707, DOI 10.1126/science.aaa2787; Cowansage KK, 2014, NEURON, V84, P432, DOI 10.1016/j.neuron.2014.09.022; Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Deisseroth K, 2014, NATURE, V505, P309, DOI 10.1038/nature12982; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Domingos AI, 2011, NAT NEUROSCI, V14, P1562, DOI 10.1038/nn.2977; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; Duan X, 2014, CELL, V158, P793, DOI 10.1016/j.cell.2014.06.047; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Fenno LE, 2014, NAT METHODS, V11, P763, DOI [10.1038/NMETH.2996, 10.1038/nmeth.2996]; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; FOSTER KW, 1984, NATURE, V311, P756, DOI 10.1038/311756a0; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Govorunova EG, 2015, SCIENCE, V349, P647, DOI 10.1126/science.aaa7484; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Halassa MM, 2014, CELL, V158, P808, DOI 10.1016/j.cell.2014.06.025; HARZ H, 1991, NATURE, V351, P489, DOI 10.1038/351489a0; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; HOFFMANN A, 1994, P NATL ACAD SCI USA, V91, P9367, DOI 10.1073/pnas.91.20.9367; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Hunnicutt BJ, 2014, NAT NEUROSCI, V17, P1276, DOI 10.1038/nn.3780; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Iyer SM, 2014, NAT BIOTECHNOL, V32, P274, DOI 10.1038/nbt.2834; Jackson J, 2014, NAT NEUROSCI, V17, P1362, DOI 10.1038/nn.3803; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Jensen M, 2012, CELL, V149, P173, DOI 10.1016/j.cell.2011.12.038; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Jones JR, 2015, NAT NEUROSCI, V18, P373, DOI 10.1038/nn.3937; Jorgenson LA, 2015, PHILOS T R SOC B, V370, P8, DOI 10.1098/rstb.2014.0164; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Kim T, 2015, P NATL ACAD SCI USA, V112, P3535, DOI 10.1073/pnas.1413625112; Kim T, 2015, ANGEW CHEM INT EDIT, V54, P5933, DOI 10.1002/anie.201412204; Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kong D, 2012, CELL, V151, P645, DOI 10.1016/j.cell.2012.09.020; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kress GJ, 2013, NAT NEUROSCI, V16, P665, DOI 10.1038/nn.3397; Krook-Magnuson E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2376; Kunwar PS, 2015, ELIFE, V4, DOI 10.7554/eLife.06633; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Larsen RS, 2014, NEURON, V83, P879, DOI 10.1016/j.neuron.2014.07.039; Ledri M, 2012, EUR J NEUROSCI, V36, P1971, DOI 10.1111/j.1460-9568.2012.08080.x; Lee AM, 2014, NEURON, V83, P455, DOI 10.1016/j.neuron.2014.06.031; Lee H, 2014, NATURE, V509, P627, DOI 10.1038/nature13169; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lepousez G, 2013, NEURON, V80, P1010, DOI 10.1016/j.neuron.2013.07.025; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Li P, 2015, MOL PSYCHIATR, V20, P1339, DOI 10.1038/mp.2014.182; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Lim DH, 2014, J NEUROSCI, V34, P16455, DOI 10.1523/JNEUROSCI.3384-14.2014; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Lu Y, 2015, J NEUROPHYSIOL, V113, P3574, DOI 10.1152/jn.00792.2014; Lucantonio F, 2014, NAT NEUROSCI, V17, P1092, DOI 10.1038/nn.3763; MacAskill AF, 2014, NAT NEUROSCI, V17, P1198, DOI 10.1038/nn.3783; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; Markopoulos F, 2012, NEURON, V76, P1175, DOI 10.1016/j.neuron.2012.10.028; MATSUNOYAGI A, 1977, BIOCHEM BIOPH RES CO, V78, P237, DOI 10.1016/0006-291X(77)91245-1; McDevitt RA, 2014, CELL REP, V8, P1857, DOI 10.1016/j.celrep.2014.08.037; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; Mutoh H, 2012, ACS CHEM NEUROSCI, V3, P585, DOI 10.1021/cn300041b; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; O'Connor DH, 2013, NAT NEUROSCI, V16, P958, DOI 10.1038/nn.3419; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Oka Y, 2015, NATURE, V520, P349, DOI 10.1038/nature14108; Packer AM, 2015, NAT METHODS, V12, P140, DOI 10.1038/nmeth.3217; Packer AM, 2012, NAT METHODS, V9, P1202, DOI [10.1038/NMETH.2249, 10.1038/nmeth.2249]; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Poulet JFA, 2012, NAT NEUROSCI, V15, P370, DOI 10.1038/nn.3035; Prakash R, 2012, NAT METHODS, V9, P1171, DOI 10.1038/NMETH.2215; Proville RD, 2014, NAT NEUROSCI, V17, P1233, DOI 10.1038/nn.3773; Ramdya P, 2015, NATURE, V519, P233, DOI 10.1038/nature14024; Redondo RL, 2014, NATURE, V513, P426, DOI 10.1038/nature13725; Rickgauer JP, 2014, NAT NEUROSCI, V17, P1816, DOI 10.1038/nn.3866; Roberts TF, 2012, NAT NEUROSCI, V15, P1454, DOI 10.1038/nn.3206; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Siegle JH, 2014, NAT NEUROSCI, V17, P1371, DOI 10.1038/nn.3797; Siegle JH, 2014, ELIFE, V3, DOI 10.7554/eLife.03061; Siuda ER, 2015, NEURON, V86, P923, DOI 10.1016/j.neuron.2015.03.066; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Stark E, 2014, NEURON, V83, P467, DOI 10.1016/j.neuron.2014.06.023; Steinbeck JA, 2015, NAT BIOTECHNOL, V33, P204, DOI 10.1038/nbt.3124; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Stryer L, 1996, P NATL ACAD SCI USA, V93, P557, DOI 10.1073/pnas.93.2.557; Stryer L., 1988, BIOCHEMISTRY-US, P962; Stuber GD, 2011, NATURE, V475, P377, DOI 10.1038/nature10194; Suarez R, 2014, NEURON, V82, P1289, DOI 10.1016/j.neuron.2014.04.040; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Temprana SG, 2015, NEURON, V85, P116, DOI 10.1016/j.neuron.2014.11.023; Thanos PK, 2013, J NEUROSCI, V33, P6343, DOI 10.1523/JNEUROSCI.4997-12.2013; Thiele TR, 2014, NEURON, V83, P679, DOI 10.1016/j.neuron.2014.04.018; Tochitsky I, 2014, NEURON, V81, P800, DOI 10.1016/j.neuron.2014.01.003; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; van Wyk M., 2015, PLOS BIOL, V13; Venkatesh HS, 2015, CELL, V161, P803, DOI 10.1016/j.cell.2015.04.012; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Wang L, 2015, NEURON, V85, P1344, DOI 10.1016/j.neuron.2014.12.025; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Wietek J, 2014, SCIENCE, V344, P409, DOI 10.1126/science.1249375; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Wu YW, 2015, CELL REP, V10, P75, DOI 10.1016/j.celrep.2014.12.005; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Yamamoto K, 2015, CELL REP, V11, P859, DOI 10.1016/j.celrep.2015.04.017; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F., 2008, L KATZ MEM LECT COLD; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7; Zhao XY, 2014, NEURON, V84, P202, DOI 10.1016/j.neuron.2014.08.037; Znamenskiy P, 2013, NATURE, V497, P482, DOI 10.1038/nature12077	200	671	692	33	437	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2015	18	9					1213	1225		10.1038/nn.4091	http://dx.doi.org/10.1038/nn.4091			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CQ0NI	26308982	Green Accepted			2022-12-17	WOS:000360292600008
J	Cohen, MR; Maunsell, JHR				Cohen, Marlene R.; Maunsell, John H. R.			Attention improves performance primarily by reducing interneuronal correlations	NATURE NEUROSCIENCE			English	Article							NEURONAL CORRELATION; NORMALIZATION MODEL; SPATIAL ATTENTION; SINGLE NEURONS; MACAQUE; MODULATION; V4; STIMULUS; RELIABILITY; SENSITIVITY	Visual attention can improve behavioral performance by allowing observers to focus on the important information in a complex scene. Attention also typically increases the firing rates of cortical sensory neurons. Rate increases improve the signal-to-noise ratio of individual neurons, and this improvement has been assumed to underlie attention-related improvements in behavior. We recorded dozens of neurons simultaneously in visual area V4 and found that changes in single neurons accounted for only a small fraction of the improvement in the sensitivity of the population. Instead, over 80% of the attentional improvement in the population signal was caused by decreases in the correlations between the trial-to-trial fluctuations in the responses of pairs of neurons. These results suggest that the representation of sensory information in populations of neurons and the way attention affects the sensitivity of the population may only be understood by considering the interactions between neurons.	[Cohen, Marlene R.] Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Cohen, MR (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	marlene_cohen@hms.harvard.edu	Maunsell, John/G-5702-2010	Maunsell, John/0000-0003-0018-4439	US National Institutes of Health [R01EY005911]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY005911, P30EY012196] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Ruff for spike sorting and monkey training assistance, M. Churchland for code and advice regarding mean-matching and Fano factor analysis, and M. Histed for many helpful discussions. They, A. Ni and A. Smolyanskaya provided comments on an earlier version of the manuscript. This work was supported by US National Institutes of Health grant R01EY005911 and the Howard Hughes Medical Institute.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Assad JA, 2003, CURR OPIN NEUROBIOL, V13, P194, DOI 10.1016/S0959-4388(03)00045-X; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Babiloni C, 2004, COGNITIVE BRAIN RES, V19, P259, DOI 10.1016/j.cogbrainres.2003.12.010; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Bastiaansen MCM, 2001, CLIN NEUROPHYSIOL, V112, P393, DOI 10.1016/S1388-2457(00)00537-X; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Boynton GM, 2009, VISION RES, V49, P1129, DOI 10.1016/j.visres.2008.11.001; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; CHURCHLAND MM, 2009, FRONT SYST NEUROSCI, DOI DOI 10.3389/CONF.NEURO.06.2009.03.295; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; GATTASS R, 1988, J NEUROSCI, V8, P1831; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Kohn A, 2009, CURR OPIN NEUROBIOL, V19, P434, DOI 10.1016/j.conb.2009.06.007; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Poort J, 2009, CEREB CORTEX, V19, P543, DOI 10.1093/cercor/bhn103; Pouget A, 2008, NAT NEUROSCI, V11, P1371, DOI 10.1038/nn1208-1371; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Roelfsema PR, 2001, NEURON, V31, P853, DOI 10.1016/S0896-6273(01)00408-1; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sundberg KA, 2009, NEURON, V61, P952, DOI 10.1016/j.neuron.2009.02.023; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Yantis S, 2003, CURR OPIN NEUROBIOL, V13, P187, DOI 10.1016/S0959-4388(03)00033-3; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	45	671	675	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2009	12	12					1594	U148		10.1038/nn.2439	http://dx.doi.org/10.1038/nn.2439			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	523II	19915566	Green Accepted			2022-12-17	WOS:000272065600020
J	Richmond, JE; Davis, WS; Jorgensen, EM				Richmond, JE; Davis, WS; Jorgensen, EM			UNC-13 is required for synaptic vesicle fusion in C-elegans	NATURE NEUROSCIENCE			English	Article							PHORBOL ESTER RECEPTOR; CAENORHABDITIS-ELEGANS; NEUROTRANSMITTER RELEASE; GENE; SYNTAXIN; PROTEINS; HOMOLOG; MUNC13-1; COMPLEX; MUTANTS	We analyzed the synaptic physiology of unc-13 mutants in the nematode C, elegans. Mutants of unc-13 had normal nervous system architecture, and the densities of synapses and postsynaptic receptors were normal at the neuromuscular junction. However, the number of synaptic vesicles at neuromuscular junctions was two- to threefold greater in unc-13 mutants than in wild-type animals. Most importantly, evoked release at both GABAergic and cholinergic synapses was almost absent in unc-13 null alleles, as determined by whole-cell, voltage-clamp techniques. Although mutant synapses had morphologically docked vesicles, these vesicles were not competent for release as assayed by spontaneous release in calcium-free solution or by the application of hyperosmotic saline. These experiments support models in which UNC-13 mediates either fusion of vesicles during exocytosis or priming of vesicles for fusion.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS009820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH059820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034307] Funding Source: NIH RePORTER; AHRQ HHS [R03 HS009820] Funding Source: Medline; NIMH NIH HHS [R03 MH059820-01, R03 MH29820-01] Funding Source: Medline; NIMH NIH HHS [R03 MH059820-01, R03 MH059820-02, R03 MHS9820-01] Funding Source: Medline; NINDS NIH HHS [R01 NS34307, R01 NS034307] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHMED S, 1992, BIOCHEM J, V287, P995, DOI 10.1042/bj2870995; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bamber BA, 1999, J NEUROSCI, V19, P5348; Betz A, 1997, J BIOL CHEM, V272, P2520; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BRENNER S, 1974, GENETICS, V77, P71; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; HOSONO R, 1989, ZOOL SCI, V6, P697; Jin YS, 1999, J NEUROSCI, V19, P539; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P10777, DOI 10.1074/jbc.270.18.10777; Li J, 1999, PHILOS T ROY SOC B, V354, P299, DOI 10.1098/rstb.1999.0381; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NGUYEN M, 1995, GENETICS, V140, P527; NILES WD, 1982, J PHYSIOL-LONDON, V329, P185, DOI 10.1113/jphysiol.1982.sp014297; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Ogawa H, 1998, J BIOL CHEM, V273, P2192, DOI 10.1074/jbc.273.4.2192; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROSE AM, 1980, GENETICS, V96, P639; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sassa T, 1999, J NEUROSCI, V19, P4772; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Xu XZS, 1998, J BIOL CHEM, V273, P31297, DOI 10.1074/jbc.273.47.31297	33	669	695	2	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					959	964		10.1038/12160	http://dx.doi.org/10.1038/12160			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526333	Green Accepted			2022-12-17	WOS:000083883300011
J	Richmond, JE; Jorgensen, EM				Richmond, JE; Jorgensen, EM			One GABA and two acetylcholine receptors function at the C-elegans neuromuscular junction	NATURE NEUROSCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; SYMPATHETIC NEURONS; LEVAMISOLE RESISTANCE; SEGREGATION; MUSCLE; PHOSPHORYLATION; GENETICS; SUBUNITS; SYNAPSES; GENES	We describe an electrophysiological preparation of the neuromuscular junction of the nematode C. elegans, which adds to its considerable genetic and genomic resources. Mutant analysis, pharmacology and patch-clamp recording showed that the body wall muscles of wild-type animals expressed a GABA receptor and two acetylcholine receptors. The muscle GABA response was abolished in animals lacking the GABA receptor gene unc-49. One acetylcholine receptor was activated by the nematocide levamisole. This response was eliminated in mutants lacking either the unc-38 or unc-29 genes, which encode alpha and non-alpha acetylcholine receptor subunits, respectively. The second, previously undescribed, acetylcholine receptor was activated by nicotine, desensitized rapidly and was selectively blocked by dihydro-beta-erythroidine, thus explaining the residual motility of unc-38 and unc-29 mutants. By recording spontaneous endogenous currents and selectively eliminating each of these receptors, we demonstrated that all three receptor types function at neuromuscular synapses.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Richmond, JE (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	richmond@biology.utah.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R03HS009820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH059820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034307] Funding Source: NIH RePORTER; AHRQ HHS [R03 HS009820] Funding Source: Medline; NIMH NIH HHS [R03 MH059820-01, R03 MH29820-01] Funding Source: Medline; NIMH NIH HHS [R03 MH059820-01, R03 MH059820-02, R03 MHS9820-01] Funding Source: Medline; NINDS NIH HHS [R01 NS34307, R01 NS034307] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamber BA, 1999, J NEUROSCI, V19, P5348; BRENNER S, 1974, GENETICS, V77, P71; BYERLY L, 1979, J PHYSIOL-LONDON, V288, P263; Chalfie M, 1998, TRENDS GENET, V14, P506, DOI 10.1016/S0168-9525(98)01623-0; DeKoninck P, 1995, J NEUROSCI, V15, P7966; ESHHAR N, 1993, NEUROSCIENCE, V57, P943, DOI 10.1016/0306-4522(93)90040-M; Fleming JT, 1997, J NEUROSCI, V17, P5843; GARDETTE R, 1991, DEV BIOL, V147, P83, DOI 10.1016/S0012-1606(05)80009-0; HARTMAN DS, 1990, NATURE, V343, P372, DOI 10.1038/343372a0; HUME RI, 1991, J NEUROBIOL, V22, P249, DOI 10.1002/neu.480220305; Jorgensen Erik M., 1995, Seminars in Developmental Biology, V6, P207, DOI 10.1016/S1044-5781(06)80030-7; LACKNER MR, 1994, GENE DEV, V8, P160, DOI 10.1101/gad.8.2.160; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; LEWIS JA, 1987, J NEUROSCI, V7, P3059; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; MOSS BL, 1993, J NEUROSCI, V13, P13; Nimnual AS, 1998, BIOCHEMISTRY-US, V37, P14823, DOI 10.1021/bi9802824; Nishizaki T, 1998, BRAIN RES, V812, P242, DOI 10.1016/S0006-8993(98)00836-1; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nusser Z, 1998, J NEUROSCI, V18, P1693; OWENS JL, 1989, J NEUROSCI, V9, P2575; Paradiso K, 1998, J NEUROSCI, V18, P9227; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; ROBERTSON SJ, 1993, BRIT J PHARMACOL, V108, P170, DOI 10.1111/j.1476-5381.1993.tb13458.x; Role L W, 1992, Curr Opin Neurobiol, V2, P254, DOI 10.1016/0959-4388(92)90112-X; SILLAR KT, 1991, BRAIN RES, V545, P24, DOI 10.1016/0006-8993(91)91265-3; Tempia F, 1996, EUR J NEUROSCI, V8, P2690, DOI 10.1111/j.1460-9568.1996.tb01564.x; WALROND JP, 1985, J NEUROSCI, V5, P16; Zoli M, 1998, J NEUROSCI, V18, P4461	32	669	695	2	22	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1999	2	9					791	797		10.1038/12160	http://dx.doi.org/10.1038/12160			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FB	10526333	Green Accepted			2022-12-17	WOS:000083882900009
J	Sisk, CL; Foster, DL				Sisk, CL; Foster, DL			The neural basis of puberty and adolescence	NATURE NEUROSCIENCE			English	Review							GONADOTROPIN-RELEASING-HORMONE; DOPAMINE-RECEPTOR OVERPRODUCTION; TESTOSTERONE NEGATIVE FEEDBACK; EPISODIC BURSTING ACTIVITY; EXCITATORY AMINO-ACIDS; PRIMARY VISUAL-CORTEX; MALE SYRIAN-HAMSTER; SEX-DIFFERENCES; GNRH NEURONS; MALE-RATS	The pubertal transition to adulthood involves both gonadal and behavioral maturation. A developmental clock, along with permissive signals that provide information on somatic growth, energy balance and season, time the awakening of gonadotropin releasing hormone (GnRH) neurons at the onset of puberty. High-frequency GnRH release results from disinhibition and activation of GnRH neurons at puberty onset, leading to gametogenesis and an increase in gonadal steroid hormone secretion. Steroid hormones, in turn, both remodel and activate neural circuits during adolescent brain development, leading to the development of sexual salience of sensory stimuli, sexual motivation, and expression of copulatory behaviors in specific social contexts. These influences of hormones on reproductive behavior depend in part on changes in the adolescent brain that occur independently of gonadal maturation. Reproductive maturity is therefore the product of developmentally timed, brain-driven and recurrent interactions between steroid hormones and the adolescent nervous system.	Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; Univ Michigan, Dept Obstet & Gynecol, Reprod Sci Program, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Michigan State University; Michigan State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sisk, CL (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.	sisk@msu.edu	Sisk, Cheryl L/C-1199-2012; Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X				Abraham IM, 2003, J NEUROSCI, V23, P5771; Andersen SL, 2000, NEUROSCI BIOBEHAV R, V24, P137, DOI 10.1016/S0149-7634(99)00044-5; Andersen SL, 1997, NEUROREPORT, V8, P1495, DOI 10.1097/00001756-199704140-00034; Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Andersen SL, 2002, PSYCHONEUROENDOCRINO, V27, P683, DOI 10.1016/S0306-4530(01)00069-5; BAUM MJ, 1972, J COMP PHYSIOL PSYCH, V78, P356, DOI 10.1037/h0032288; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Blaustein J. D., 2002, HORMONES BRAIN BEHAV, P139; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; Brann DW, 1997, ENDOCR REV, V18, P678, DOI 10.1210/er.18.5.678; BRONSON FH, 1986, BIOL REV, V61, P157, DOI 10.1111/j.1469-185X.1986.tb00465.x; BRONSON FH, 1975, BIOL REPROD, V13, P94, DOI 10.1095/biolreprod13.1.94; Cheung CC, 2001, NEUROENDOCRINOLOGY, V74, P12, DOI 10.1159/000054666; Chung WCJ, 2002, J NEUROSCI, V22, P1027, DOI 10.1523/JNEUROSCI.22-03-01027.2002; CONTE FA, 1975, J CLIN ENDOCR METAB, V40, P670, DOI 10.1210/jcem-40-4-670; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; Davis EC, 1996, NEUROENDOCRINOLOGY, V63, P142, DOI 10.1159/000126950; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; EBLING FJP, 1989, EXPERIENTIA, V45, P946, DOI 10.1007/BF01953052; Ebling FJP, 2000, NEUROREPORT, V11, pR23, DOI 10.1097/00001756-200011090-00002; Eichmann F, 1999, PHYSIOL BEHAV, V65, P785; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Eyigor O, 1997, NEUROENDOCRINOLOGY, V66, P122, DOI 10.1159/000127229; FEINBERG I, 1983, J PSYCHIAT RES, V17, P319, DOI 10.1016/0022-3956(82)90038-3; FLOODY OR, 1987, HORM BEHAV, V21, P17, DOI 10.1016/0018-506X(87)90027-4; FOSTER DL, 1988, REPROD NUTR DEV, V28, P349, DOI 10.1051/rnd:19880302; Foster DL, 2002, REPRODUCTION, P83; Foster DL, 1999, BIOL REPROD, V60, P205, DOI 10.1095/biolreprod60.2.205; FOSTER DL, 1980, PROBLEMS PEDIATRIC E, P193; Foster Douglas L., 1994, P411; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GOLDSMITH PC, 1987, J COMP NEUROL, V257, P130, DOI 10.1002/cne.902570110; GOLDSTEIN LA, 1990, J NEUROSCI, V10, P935; Gore AC, 1996, J NEUROSCI, V16, P5281; Han SK, 2002, ENDOCRINOLOGY, V143, P1459, DOI 10.1210/en.143.4.1459; Han SK, 2004, ENDOCRINOLOGY, V145, P495, DOI 10.1210/en.2003-1333; Hebbard PC, 2003, EXP NEUROL, V182, P470, DOI 10.1016/S0014-4886(03)00119-5; Herdt G, 2000, ARCH SEX BEHAV, V29, P587, DOI 10.1023/A:1002006521067; Hull EM, 1999, BEHAV BRAIN RES, V105, P105, DOI 10.1016/S0166-4328(99)00086-8; Hull EM, 2002, HORMONES BRAIN BEHAV, P3, DOI DOI 10.1016/B978-012532104-4/50003-2; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; JENNES LJ, 2002, HORMONES BRAIN BEHAV, P51; JOHNSTON RE, 1979, BEHAV NEURAL BIOL, V25, P473, DOI 10.1016/S0163-1047(79)90242-5; Kelley AE, 2004, ANN NY ACAD SCI, V1021, P27, DOI 10.1196/annals.1308.003; Kelly MJ, 2003, ANN NY ACAD SCI, V1007, P6, DOI 10.1196/annals.1286.001; Kelly MJ, 2002, TRENDS ENDOCRIN MET, V13, P409, DOI 10.1016/S1043-2760(02)00698-7; Kim SJ, 1999, BIOL REPROD, V61, P599, DOI 10.1095/biolreprod61.3.599; Kuehl-Kovarik MC, 2002, J NEUROSCI, V22, P2313, DOI 10.1523/JNEUROSCI.22-06-02313.2002; Lee BJ, 2001, MOL CELL NEUROSCI, V17, P107, DOI 10.1006/mcne.2000.0933; Mann DR, 2002, SEMIN REPROD MED, V20, P93, DOI 10.1055/s-2002-32500; Meek LR, 1997, HORM BEHAV, V31, P75, DOI 10.1006/hbeh.1997.1371; Meisel Robert L., 1994, P3; Moenter SM, 2003, ANN NY ACAD SCI, V1007, P143, DOI 10.1196/annals.1286.014; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Nunez JL, 2002, J NEUROBIOL, V52, P312, DOI 10.1002/neu.10092; Nunez JL, 2000, DEV BRAIN RES, V125, P83, DOI 10.1016/S0165-3806(00)00126-7; Nunez JL, 2001, J COMP NEUROL, V436, P32; Ojeda SR, 1999, ENDOCRINOLOGY, V140, P3774, DOI 10.1210/en.140.8.3774; Ojeda SR, 2003, ANN MED, V35, P244, DOI 10.1080/07853890310005164; Ojeda SR, 2002, HORMONES BRAIN BEHAV, P589, DOI [10.1016/B978-012532104-4/50077-9, DOI 10.1016/B978-012532104-4/50077-9]; OJEDA SR, 1994, PHYSL REPRODUCTION, P452; OLSTER DH, 1989, BRAIN RES, V484, P168, DOI 10.1016/0006-8993(89)90359-4; Paredes RG, 1998, HORM BEHAV, V33, P48, DOI 10.1006/hbeh.1998.1435; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; Peterson S. L., 1993, ENDOCR J, V1, P29; Pfaff Donald W., 1994, P107; Pfaus JG, 1999, CURR OPIN NEUROBIOL, V9, P751, DOI 10.1016/S0959-4388(99)00034-3; Pinos H, 2001, BRAIN RES BULL, V56, P73, DOI 10.1016/S0361-9230(01)00540-8; Plant TM, 2001, FRONT NEUROENDOCRIN, V22, P107, DOI 10.1006/frne.2001.0211; Plant Tony M., 1994, P453; PRIMUS RJ, 1990, HORM BEHAV, V24, P311, DOI 10.1016/0018-506X(90)90012-M; PRIMUS RJ, 1989, DEV PSYCHOBIOL, V22, P633, DOI 10.1002/dev.420220608; RAMIREZ VD, 1965, ENDOCRINOLOGY, V76, P412, DOI 10.1210/endo-76-3-412; RAPISARDA JJ, 1983, ENDOCRINOLOGY, V112, P1172, DOI 10.1210/endo-112-4-1172; RISSMAN EF, 1992, BIOL REPROD, V47, P473, DOI 10.1095/biolreprod47.3.473; Romeo RD, 2002, NEUROSCI BIOBEHAV R, V26, P381, DOI 10.1016/S0149-7634(02)00009-X; Romeo RD, 2001, BRAIN RES, V889, P71, DOI 10.1016/S0006-8993(00)03111-5; Romeo RD, 1998, HORM BEHAV, V34, P48, DOI 10.1006/hbeh.1998.1463; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; SCHNEIDER JE, 2002, HORMONES BRAIN BEHAV, P435, DOI DOI 10.1016/B978-012532104-4/50009-3; Schulz KM, 2004, HORM BEHAV, V45, P242, DOI 10.1016/j.yhbeh.2003.12.007; Schulz KM, 2003, BRAIN RES, V988, P139, DOI 10.1016/S0006-8993(03)03358-4; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Silverman Ann-Judith, 1994, P1683; SISK CL, 1987, BIOL REPROD, V37, P73, DOI 10.1095/biolreprod37.1.73; Sisk CL, 2003, ANN NY ACAD SCI, V1007, P189, DOI 10.1196/annals.1286.019; SISK CL, 1983, ENDOCRINOLOGY, V112, P1208, DOI 10.1210/endo-112-4-1208; SISK CL, 1992, J BIOL RHYTHM, V7, P329, DOI 10.1177/074873049200700406; SODERSTEN P, 1977, HORM BEHAV, V8, P320, DOI 10.1016/0018-506X(77)90006-X; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Terasawa E, 2001, ENDOCR REV, V22, P111, DOI 10.1210/er.22.1.111; Turek Fred W., 1994, P487; Urbanski HF, 2001, TRENDS ENDOCRIN MET, V12, P428, DOI 10.1016/S1043-2760(01)00505-7; URBANSKI HF, 1987, ENDOCRINOLOGY, V121, P907, DOI 10.1210/endo-121-3-907; Wallen K, 2004, J SEX RES, V41, P101, DOI 10.1080/00224490409552218; Wallen K, 2001, HORM BEHAV, V40, P339, DOI 10.1006/hbeh.2001.1696; Wierman ME, 1997, MOL CELL BIOL, V17, P1652, DOI 10.1128/MCB.17.3.1652; Wilson M. E., 1992, SEXUAL DIFFERENTIATI, P275, DOI 10.1007/978-1-4899-2453-7_9; WINTER JSD, 1972, J CLIN ENDOCR METAB, V35, P561, DOI 10.1210/jcem-35-4-561; WITKIN JW, 1995, J NEUROENDOCRINOL, V7, P665, DOI 10.1111/j.1365-2826.1995.tb00807.x; WITKIN JW, 1995, NEUROSCIENCE, V64, P1145, DOI 10.1016/0306-4522(94)00432-5; Woo TU, 1997, NEUROSCIENCE, V80, P1149, DOI 10.1016/S0306-4522(97)00059-6; Wood R., 1995, NEUROBIOLOGICAL EFFE, P3; Wood RI, 2000, INT CONGR SER, V1202, P269; WOOD RI, 1992, NEUROENDOCRINOLOGY, V55, P427, DOI 10.1159/000126154; Woodley SK, 2003, HORM BEHAV, V44, P110, DOI 10.1016/S0018-506X(03)00126-0; WRAY S, 1986, NEUROENDOCRINOLOGY, V43, P93, DOI 10.1159/000124516	112	667	677	2	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1040	1047		10.1038/nn1326	http://dx.doi.org/10.1038/nn1326			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452575				2022-12-17	WOS:000224156900011
J	Carrasco, M; Ling, S; Read, S				Carrasco, M; Ling, S; Read, S			Attention alters appearance	NATURE NEUROSCIENCE			English	Article							COVERT ATTENTION; CONTRAST; SENSITIVITY; BRIGHTNESS	Does attention alter appearance? This critical issue, debated for over a century, remains unsettled. From psychophysical evidence that covert attention affects early vision-it enhances contrast sensitivity and spatial resolution- and from neurophysiological evidence that attention increases the neuronal contrast sensitivity (contrast gain), one could infer that attention changes stimulus appearance. Surprisingly, few studies have directly investigated this issue. Here we developed a psychophysical method to directly assess the phenomenological correlates of attention in humans. We show that attention alters appearance; it boosts the apparent stimulus contrast. These behavioral results are consistent with neurophysiological findings suggesting that attention changes the strength of a stimulus by increasing its 'effective contrast' or salience.	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Dept Neural Sci, New York, NY 10003 USA	New York University; New York University	Carrasco, M (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	marisa.carrasco@nyu.edu			NATIONAL EYE INSTITUTE [R01EY016200] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016200] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baldassi S, 2000, VISION RES, V40, P1293, DOI 10.1016/S0042-6989(00)00029-8; Blaser E, 1999, P NATL ACAD SCI USA, V96, P11681, DOI 10.1073/pnas.96.20.11681; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Carrasco M, 1998, J EXP PSYCHOL HUMAN, V24, P673, DOI 10.1037/0096-1523.24.2.673; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; CARRASCO M, IN PRESS VISION RES; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; CHEAL ML, 1991, Q J EXP PSYCHOL-A, V43, P859, DOI 10.1080/14640749108400960; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Helmholtz H., 1866, TREATISE PHYSL OPTIC, V2; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; James W., 1890, PRINCIPLES PSYCHOL, V2; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; MACKEBEN M, 1993, VISION RES, V33, P85, DOI 10.1016/0042-6989(93)90061-Z; Mangun GR, 1998, HUM BRAIN MAPP, V6, P383, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<383::AID-HBM10>3.3.CO;2-Q; Martinez-Trujillo JC, 2002, NEURON, V35, P365, DOI 10.1016/S0896-6273(02)00778-X; Mayfrank L., 1987, EYE MOVEMENTS PHYSL, P37, DOI DOI 10.1167/4.12.12; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Mood A. M., 1974, INTRO THEORY STAT, P440; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; PASHLER HE, 1998, PSYCHOL ATTENTION; PELLI DG, 1991, VISION RES, V31, P1337, DOI 10.1016/0042-6989(91)90055-A; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Princ FG, 1998, J PINEAL RES, V24, P1, DOI 10.1111/j.1600-079X.1998.tb00359.x; Prinzmetal W, 1997, CONSCIOUS COGN, V6, P372, DOI 10.1006/ccog.1997.0313; PRINZMETAL W, 1986, J EXP PSYCHOL HUMAN, V12, P361, DOI 10.1037/0096-1523.12.3.361; REMINGTON RW, 1992, PERCEPT PSYCHOPHYS, V51, P279, DOI 10.3758/BF03212254; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Sperling G., 1986, HDB PERCEPTION PERFO, V1, P1; TALGAR C, 2004, J VIS, V41, P23; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; TSAL Y, 1994, Q J EXP PSYCHOL-A, V47, P865, DOI 10.1080/14640749408401100; von Helmholtz H., 1866, TREATISE PHYSL OPTIC, VIII; Yeshurun Y, 2000, NAT NEUROSCI, V3, P622, DOI 10.1038/75804; Yeshurun Y, 1998, NATURE, V396, P72, DOI 10.1038/23936	46	667	673	17	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					308	313		10.1038/nn1194	http://dx.doi.org/10.1038/nn1194			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	777UU	14966522	Green Accepted			2022-12-17	WOS:000189197900022
J	Bishop, S; Duncan, J; Lawrence, AD				Bishop, S; Duncan, J; Lawrence, AD			Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; EMOTION; FMRI; SELECTION; MODEL; FEAR	Threat-related stimuli are strong competitors for attention, particularly in anxious individuals. We used functional magnetic resonance imaging (fMRI) with healthy human volunteers to study how the processing of threat-related distractors is controlled and whether this alters as anxiety levels increase. Our work builds upon prior analyses of the cognitive control functions of lateral prefrontal cortex (lateral PFC) and anterior cingulate cortex (ACC). We found that rostral ACC was strongly activated by infrequent threat-related distractors, consistent with a role for this area in responding to unexpected processing conflict caused by salient emotional stimuli. Participants with higher anxiety levels showed both less rostral ACC activity overall and reduced recruitment of lateral PFC as expectancy of threat- related distractors was established. This supports the proposal that anxiety is associated with reduced top-down control over threat- related distractors. Our results suggest distinct roles for rostral ACC and lateral PFC in governing the processing of task-irrelevant, threat- related stimuli, and indicate reduced recruitment of this circuitry in anxiety.	MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England		Bishop, S (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.	sonia.bishop@mrc-cbu.cam.ac.uk	Bishop, Sonia J/I-7729-2012; Lawrence, Andrew/A-1673-2010	Duncan, John S/0000-0002-1373-0681; Duncan, John/0000-0002-9695-2764	Medical Research Council [G0001237, G9439390] Funding Source: Medline; MRC [G0001237, G9439390] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Armony J.L., 1999, COGNITIVE NEUROSCIEN, P1067; Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brett M, 2001, NEUROIMAGE, V13, pS85; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Calder AJ, 2001, NAT REV NEUROSCI, V2, P352, DOI 10.1038/35072584; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chen NK, 2003, NEUROIMAGE, V19, P817, DOI 10.1016/S1053-8119(03)00091-0; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ekman P., 1976, PICTURES FACIAL AFFE; Eysenck M. W., 1997, ANXIETY COGNITION UN; Henik A., 1997, 2 ABSTRACTS PSYCHONO, P57; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; LANZETTA JT, 1986, J PERS SOC PSYCHOL, V50, P190, DOI 10.1037/0022-3514.50.1.190; LAWRENCE AD, 2001, HDB NEUROPSYCHOLOGY, V5, P235; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mathews A, 1998, COGNITIVE THER RES, V22, P539, DOI 10.1023/A:1018738019346; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; Posner MI, 1998, ATTENTIVE BRAIN, P401; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Spielberger CD, 1989, STATE TRAIT ANXIETY; TZELGOV J, 1992, MEM COGNITION, V20, P727, DOI 10.3758/BF03202722; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VOGT BA, 1997, HAND CHEM N, V13, P455; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	36	667	689	4	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					184	188		10.1038/nn1173	http://dx.doi.org/10.1038/nn1173			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	767TJ	14703573				2022-12-17	WOS:000188468500017
J	Kim, JN; Shadlen, MN				Kim, JN; Shadlen, MN			Neural correlates of a decision in the dorsolateral prefrontal cortex of the macaque	NATURE NEUROSCIENCE			English	Article							FRONTAL EYE FIELD; POSTERIOR PARIETAL CORTEX; PRIMARY MOTOR CORTEX; VISUAL AREA MT; FUNCTIONAL-PROPERTIES; MOTION PERCEPTION; WORKING-MEMORY; MONKEY; NEURONS; PERFORMANCE	To make a visual discrimination, the brain must extract relevant information from the retina, represent appropriate variables in the visual cortex and read out this representation to decide which of two or more alternatives is more likely. We recorded from neurons in the dorsolateral prefrontal cortex (areas 8 and 46) of the rhesus monkey while it performed a motion discrimination task. The monkey indicated its judgment of direction by making appropriate eye movements. As the monkey viewed the motion stimulus, the neural response predicted the monkey's subsequent gaze shift, hence its judgment of direction. The response comprised a mixture of high-level oculomotor signals and weaker visual sensory signals that reflected the strength and direction of motion. This combination of sensory integration and motor planning could reflect the conversion of visual motion information into a categorical decision about direction and thus give insight into the neural computations behind a simple cognitive act.	Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Sch Med, Reg Primate Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	shadlen@u.washington.edu	Shadlen, Michael Neil/AAL-1870-2020	Kim, Jong nam/0000-0003-0991-7731; Shadlen, Michael/0000-0002-2002-2210	NCRR NIH HHS [RR00166] Funding Source: Medline; NEI NIH HHS [EY11378] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011378] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P164, DOI 10.1152/jn.1990.64.1.164; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; COMMENGES D, 1986, MATH BIOSCI, V80, P81, DOI 10.1016/0025-5564(86)90068-4; DIPELLEGRINO G, 1993, J NEUROSCI, V13, P1227; DRAPER N, 1966, APPL REGRESION ANAL; FRIEDMAN HR, 1994, J NEUROSCI, V14, P2775; FUNAHASHI S, 1993, J NEUROSCI, V13, P1479; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J.M., 1989, PREFRONTAL CORTEX; GNADT JW, 1988, EXP BRAIN RES, V70, P216; GOLDMANRAKIC PS, 1987, HDB PHYSL NERVOUS SY, P373; Goodale MA, 1998, CURR BIOL, V8, pR489, DOI 10.1016/S0960-9822(98)70314-8; GREEN DM, 1966, SIGNAL DETECTION THE; Hasegawa R, 1998, J NEUROPHYSIOL, V79, P322, DOI 10.1152/jn.1998.79.1.322; Hays A., 1982, WESCON C P, V2, P1; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; HUERTA MF, 1987, J COMP NEUROL, V265, P332, DOI 10.1002/cne.902650304; HUERTA MF, 1986, J COMP NEUROL, V253, P415, DOI 10.1002/cne.902530402; Jacobsen CF, 1935, ARCH NEURO PSYCHIATR, V33, P558, DOI 10.1001/archneurpsyc.1935.02250150108009; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; LYNCH JC, 1985, J COMP NEUROL, V235, P241, DOI 10.1002/cne.902350207; Miller EK, 1996, J NEUROSCI, V16, P5154; Mood AM., 1963, INTRO THEORY STAT, V2nd ed.; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Newsome WT, 1997, J COMP PHYSIOL A, V181, P5, DOI 10.1007/s003590050087; Press W. H., 2007, NUMERICAL RECIPES C, V3rd; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; RIEHLE A, 1994, NEUROREPORT, V5, P2462, DOI 10.1097/00001756-199412000-00014; ROMO R, 1993, J NEUROPHYSIOL, V70, P2690, DOI 10.1152/jn.1993.70.6.2690; Salinas E, 1998, J NEUROSCI, V18, P499; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SEAL J, 1985, EXP BRAIN RES, V58, P144; SEAL J, 1989, BRAIN BEHAV EVOLUT, V33, P113, DOI 10.1159/000115911; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; Seidemann E, 1998, NATURE, V394, P72, DOI 10.1038/27906; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shen LM, 1997, J NEUROPHYSIOL, V77, P1171, DOI 10.1152/jn.1997.77.3.1171; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; STANTON GB, 1988, J COMP NEUROL, V271, P473, DOI 10.1002/cne.902710402; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Zhang J, 1997, J NEUROSCI, V17, P2227	49	666	671	1	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					176	185		10.1038/5739	http://dx.doi.org/10.1038/5739			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195203				2022-12-17	WOS:000078231600018
J	Gehring, WJ; Knight, RT				Gehring, WJ; Knight, RT			Prefrontal-cingulate interactions in action monitoring	NATURE NEUROSCIENCE			English	Article							ERROR-DETECTION; NEURAL SYSTEM; CORTEX; BEHAVIOR; TASK; COMPENSATION; PERFORMANCE; POTENTIALS; SELECTION	We found that medial frontal cortex activity associated with action monitoring (detecting errors and behavioral conflict) depended on activity in the lateral prefrontal cortex. We recorded the error-related negativity (ERN), an event-related brain potential proposed to reflect anterior cingulate action monitoring, from individuals with lateral prefrontal damage or age-matched or young control participants. In controls, error trials generated greater ERN activity than correct trials. In individuals with lateral prefrontal damage, however, correct-trial ERN activity was equal to error-trial ERN activity. Lateral prefrontal damage also affected corrective behavior. Thus the lateral prefrontal cortex seemed to interact with the anterior cingulate cortex in monitoring behavior and in guiding compensatory systems.	Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of Michigan System; University of Michigan; University of California System; University of California Berkeley	Gehring, WJ (corresponding author), Univ Michigan, Dept Psychol, 525 E Univ Ave, Ann Arbor, MI 48109 USA.				NINDS NIH HHS [NS21135, 1 F32 NS09577-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021135, F32NS009577] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baddeley Alan, 1986, WORKING MEMORY; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; FALKENSTEIN M, 1995, PERSPECTIVES EVENT S, V44, P287; FRITH CD, 1991, NEUROPSYCHOLOGIA, V29, P1137, DOI 10.1016/0028-3932(91)90029-8; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; GEHRING WJ, 1995, PERSPECTIVES EVENT R, V44, P261; Goldman-Rakic PS, 1987, HDB PHYSL 1, V5, P373, DOI DOI 10.1002/CPHY.CP010509; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; INSEL TR, 1992, ARCH GEN PSYCHIAT, V49, P739; KIEHL KA, IN PRESS PSYCHOPHYSI; LOGAN GD, 1985, ACTA PSYCHOL, V60, P193, DOI 10.1016/0001-6918(85)90055-1; LUU P, IN PRESS J EXP PSYCH; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Norman D.A., 1980, ATTENTION ACTION WIL, DOI DOI 10.1007/978-1-4757-0629-1_1; PETERSEN SE, 1988, NATURE, V331, P583; Posner MI, 1998, ATTENTIVE BRAIN, P401; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Scheffers MK, 1996, PSYCHOPHYSIOLOGY, V33, P42, DOI 10.1111/j.1469-8986.1996.tb02107.x; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stuss DT., 1986, FRONTAL LOBES; TAYLOR SF, 1994, NEUROPSYCHOLOGIA, V32, P249, DOI 10.1016/0028-3932(94)90010-8; Tucker DM, 1999, BIOL PSYCHOL, V50, P103, DOI 10.1016/S0301-0511(99)00005-8; Turken AU, 1999, NAT NEUROSCI, V2, P920, DOI 10.1038/13224	32	663	676	2	49	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					516	520		10.1038/74899	http://dx.doi.org/10.1038/74899			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	309DG	10769394				2022-12-17	WOS:000086752000023
J	DeLong, KA; Urbach, TP; Kutas, M				DeLong, KA; Urbach, TP; Kutas, M			Probabilistic word pre-activation during language comprehension inferred from electrical brain activity	NATURE NEUROSCIENCE			English	Article							INCREMENTAL INTERPRETATION; POTENTIALS; CONTEXT; INTEGRATION; INFORMATION; SENTENCES; HYPOTHESIS; EXPECTANCY; DISCOURSE; AGREEMENT	Despite the numerous examples of anticipatory cognitive processes at micro and macro levels in many animal species, the idea that anticipation of specific words plays an integral role in real-time language processing has been contentious. Here we exploited a phonological regularity of English indefinite articles ('an' precedes nouns beginning with vowel sounds, whereas 'a' precedes nouns beginning with consonant sounds) in combination with event-related brain potential recordings from the human scalp to show that readers' brains can pre-activate individual words in a graded fashion to a degree that can be estimated from the probability that each word is given as a continuation for a sentence fragment offline. These findings are evidence that readers use the words in a sentence ( as cues to their world knowledge) to estimate relative likelihoods for upcoming words.	Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	DeLong, KA (corresponding author), Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA.	kadelong@cogsci.ucsd.edu		Urbach, Thomas/0000-0001-7993-142X	NIA NIH HHS [AG08313] Funding Source: Medline; NICHD NIH HHS [HD22614] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD022614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008313] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTMANN G, 1988, COGNITION, V30, P191, DOI 10.1016/0010-0277(88)90020-0; Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Boland JE, 1995, J MEM LANG, V34, P774, DOI 10.1006/jmla.1995.1034; CARROLL J, 1978, HDB PERCEPTION, V7, P299; Chambers CG, 1998, J MEM LANG, V39, P593, DOI 10.1006/jmla.1998.2575; DANEMAN M, 1983, J EXP PSYCHOL LEARN, V9, P561, DOI 10.1037/0278-7393.9.4.561; Federmeier KD, 1999, J MEM LANG, V41, P469, DOI 10.1006/jmla.1999.2660; GUNTER TC, 1992, PSYCHOPHYSIOLOGY, V29, P38, DOI 10.1111/j.1469-8986.1992.tb02009.x; JUST MA, 1980, PSYCHOL REV, V87, P329, DOI 10.1037/0033-295X.87.4.329; Kamide Y, 2003, J PSYCHOLINGUIST RES, V32, P37, DOI 10.1023/A:1021933015362; KING JW, 1995, CRL NEWSLETTER, V10, P1; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; KLUENDER R, 1993, LANG COGNITIVE PROC, V8, P573, DOI 10.1080/01690969308407588; KUTAS M, 1983, MEM COGNITION, V11, P539, DOI 10.3758/BF03196991; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P406; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; MARSLENWILSON W, 1980, COGNITION, V8, P1, DOI 10.1016/0010-0277(80)90015-3; MARSLENWILSON WD, 1975, SCIENCE, V189, P226, DOI 10.1126/science.189.4198.226; MITCHELL DC, 1978, Q J EXP PSYCHOL, V30, P609, DOI 10.1080/14640747808400689; OREGAN K, 1979, PERCEPT PSYCHOPHYS, V25, P501, DOI 10.3758/BF03213829; PICKERING MJ, 1994, J PSYCHOLINGUIST RES, V23, P323, DOI 10.1007/BF02145045; Sedivy JC, 1999, COGNITION, V71, P109, DOI 10.1016/S0010-0277(99)00025-6; STANOVICH KE, 1979, MEM COGNITION, V7, P77, DOI 10.3758/BF03197588; Steedman Mark, 1989, LEXICAL REPRESENTATI, P463; Tanenhaus MK, 2000, J PSYCHOLINGUIST RES, V29, P557, DOI 10.1023/A:1026464108329; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Traxler MJ, 1997, Q J EXP PSYCHOL-A, V50, P481, DOI 10.1080/027249897391982; TYLER LK, 1977, J VERB LEARN VERB BE, V16, P683, DOI 10.1016/S0022-5371(77)80027-3; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; Wicha NYY, 2004, J COGNITIVE NEUROSCI, V16, P1272, DOI 10.1162/0898929041920487; Wicha NYY, 2003, NEUROSCI LETT, V346, P165, DOI 10.1016/S0304-3940(03)00599-8	32	662	670	5	69	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1117	1121		10.1038/nn1504	http://dx.doi.org/10.1038/nn1504			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	949BP	16007080				2022-12-17	WOS:000230760200025
J	Parkes, L; Lund, J; Angelucci, A; Solomon, JA; Morgan, M				Parkes, L; Lund, J; Angelucci, A; Solomon, JA; Morgan, M			Compulsory averaging of crowded orientation signals in human vision	NATURE NEUROSCIENCE			English	Article							VISUAL-SEARCH; LATERAL INTERACTIONS; VERNIER ACUITY; TEXTURE; MECHANISMS; DISCRIMINATION; INTERFERENCE; FACILITATION; HYPERACUITY; INTEGRATION	A shape can be more difficult to identify when other shapes are near it. For example, when several grating patches are viewed parafoveally, observers are unable to report the orientation of the central patch. This phenomenon, known as 'crowding,' has historically been confused with lateral masking, in which one stimulus attenuates signals generated by another stimulus. Here we show that despite their inability to report the orientation of an individual patch, observers can reliably estimate the average orientation, demonstrating that the local orientation signals are combined rather than lost. Our results imply that crowding is distinct from ordinary masking, and is perhaps related to texture perception. Under crowded conditions, the orientation signals in primary visual cortex are pooled before they reach consciousness.	City Univ London, Appl Vis Res Ctr, London EC1V 0HB, England; UCL, Inst Neurol, London WC1N 3BG, England; Univ Utah, Moran Eye Ctr, Salt Lake City, UT 84132 USA	City University London; University of London; University College London; Utah System of Higher Education; University of Utah	Morgan, M (corresponding author), City Univ London, Appl Vis Res Ctr, Northampton Sq, London EC1V 0HB, England.	m.morgan@city.ac.uk	Angelucci, Alessandra/AAH-8195-2021	Angelucci, Alessandra/0000-0002-1957-2231; Parkes, Laura/0000-0001-6488-507X				ANDRIESSEN JJ, 1976, VISION RES, V16, P71, DOI 10.1016/0042-6989(76)90078-X; Baldassi S, 2000, VISION RES, V40, P1293, DOI 10.1016/S0042-6989(00)00029-8; BENNETT A, 1989, CLIN VISION; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dakin SC, 1997, VISION RES, V37, P3181, DOI 10.1016/S0042-6989(97)00133-8; Dakin SC, 1999, SPATIAL VISION, V12, P1, DOI 10.1163/156856899X00012; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; GREEN DM, 1966, SIGNAL DETECTION THE; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Heeley DW, 1996, VISION RES, V36, P3607, DOI 10.1016/0042-6989(96)00077-6; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; KOLB FC, 1995, NATURE, V377, P336, DOI 10.1038/377336a0; LEVI DM, 1985, VISION RES, V25, P963, DOI 10.1016/0042-6989(85)90207-X; LEVI DM, 1982, NATURE, V298, P268, DOI 10.1038/298268a0; Lin LM, 1996, VISION RES, V36, P1907, DOI 10.1016/0042-6989(95)00260-X; MALIK J, 1990, J OPT SOC AM A, V7, P923, DOI 10.1364/JOSAA.7.000923; MORGAN MJ, 1990, J OPT SOC AM A, V7, P297, DOI 10.1364/JOSAA.7.000297; Morgan MJ, 1997, NATURE, V385, P401, DOI 10.1038/385401b0; Morgan MJ, 1998, Q J EXP PSYCHOL-A, V51, P347, DOI 10.1080/713755766; Morgan MJ, 1997, CURR BIOL, V7, P999, DOI 10.1016/S0960-9822(06)00421-0; MORGAN MJ, 1989, VISION RES, V29, P1005, DOI 10.1016/0042-6989(89)90115-6; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; PELLI DG, 1991, VISION RES, V31, P1337, DOI 10.1016/0042-6989(91)90055-A; POLAT U, 1994, VISION RES, V34, P73, DOI 10.1016/0042-6989(94)90258-5; SAGI D, 1985, SCIENCE, V228, P1217, DOI 10.1126/science.4001937; Solomon JA, 2000, VISION RES, V40, P279, DOI 10.1016/S0275-5408(99)00059-9; Solomon JA, 1999, VISION RES, V39, P987, DOI 10.1016/S0042-6989(98)00143-6; Solomon JA, 2001, J VISION, V1, P9, DOI 10.1167/1.1.2; Usher M, 1999, SPATIAL VISION, V12, P187, DOI 10.1163/156856899X00111; Watson AB, 1997, SPATIAL VISION, V10, P447, DOI 10.1163/156856897X00384; WESTHEIMER G, 1975, VISION RES, V15, P1137, DOI 10.1016/0042-6989(75)90012-7; WESTHEIMER G, 1976, J OPT SOC AM, V66, P332, DOI 10.1364/JOSA.66.000332; Wilkinson F, 1997, J OPT SOC AM A, V14, P2057, DOI 10.1364/JOSAA.14.002057	34	659	665	5	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					739	744		10.1038/89532	http://dx.doi.org/10.1038/89532			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	448HK	11426231				2022-12-17	WOS:000169621300020
J	Blood, AJ; Zatorre, RJ; Bermudez, P; Evans, AC				Blood, AJ; Zatorre, RJ; Bermudez, P; Evans, AC			Emotional responses to pleasant and unpleasant music correlate with activity in paralimbic brain regions	NATURE NEUROSCIENCE			English	Article							CEREBRAL BLOOD-FLOW; FRONTAL-LOBE DAMAGE; PREFRONTAL CORTEX; HUMAN AMYGDALA; MEMORY; PITCH; IDENTIFICATION; MECHANISMS; ACTIVATION; PERCEPTION	Neural correlates of the often-powerful emotional responses to music are poorly understood. Here we used positron emission tomography to examine cerebral blood flow (CBF) changes related to affective responses to music. Ten volunteers were scanned while listening to six versions of a novel musical passage varying systematically in degree of dissonance. Reciprocal CBF covariations were observed in several distinct paralimbic and neocortical regions as a function of dissonance and of perceived pleasantness/unpleasantness. The findings suggest that music may recruit neural mechanisms similar to those previously associated with pleasant/unpleasant emotional states, but different from those underlying other components of music perception, and other emotions such as fear.	McGill Univ, Montreal Neurol Inst, Neuropsychol Cognit Neurosci Unit, Montreal, PQ H3A 2B4, Canada	McGill University	Blood, AJ (corresponding author), McGill Univ, Montreal Neurol Inst, Neuropsychol Cognit Neurosci Unit, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	ablood@bic.mni.mcgill.ca	Evans, Alan C/B-2373-2013	Evans, Alan C/0000-0003-3841-6098; Bermudez, Patrick/0000-0002-0806-7352				ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Berthoz A, 1997, PHILOS T R SOC B, V352, P1437, DOI 10.1098/rstb.1997.0130; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; BUNSEY M, 1993, BEHAV NEUROSCI, V107, P740, DOI 10.1037/0735-7044.107.5.740; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DAVIS WB, 1989, J MUSIC THER, V26, P168, DOI 10.1093/jmt/26.4.168; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; DOWLING WJ, 1986, MUSIC COGNITION, P62; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Erhan H, 1998, BRAIN COGNITION, V37, P286, DOI 10.1006/brcg.1998.0984; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; GOLDSTEIN A, 1980, PHYSIOL PSYCHOL, V8, P126; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; HUGDAHL K, 1995, NEUROREPORT, V6, P1723, DOI 10.1097/00001756-199509000-00005; Krumhansl C. L., 1990, OXFORD PSYCHOL SERIE, V17; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; LANE RD, 1995, NEUROPSYCHOLOGIA, V33, P525, DOI 10.1016/0028-3932(94)00131-8; Lane RD, 1997, AM J PSYCHIAT, V154, P926; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; MILNER B, 1962, INTERHEMISPHER RELAT, P177; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Paradiso S, 1997, AM J PSYCHIAT, V154, P384; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Peretz I, 1998, COGNITION, V68, P111, DOI 10.1016/S0010-0277(98)00043-2; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; RAICHLE ME, 1983, J NUCL MED, V24, P790; ROBAZZA C, 1994, PERCEPT MOTOR SKILL, V79, P939, DOI 10.2466/pms.1994.79.2.939; Rogan MT, 1996, CELL, V85, P469, DOI 10.1016/S0092-8674(00)81247-7; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Sokal R.R., 1981, BIOMETRY, V2nd ed.; Stefanacci L, 1996, J COMP NEUROL, V375, P552; Talairach J., 1988, COPLANAR STEREOTAXIC; WHEELER RE, 1993, PSYCHOPHYSIOLOGY, V30, P82, DOI 10.1111/j.1469-8986.1993.tb03207.x; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; ZATORRE RJ, 1991, BRAIN, V114, P2403, DOI 10.1093/brain/114.6.2403; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355	47	659	678	3	169	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					382	387		10.1038/7299	http://dx.doi.org/10.1038/7299			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204547				2022-12-17	WOS:000080532000019
J	Picconi, B; Centonze, D; Hakansson, K; Bernardi, G; Greengard, P; Fisone, G; Cenci, MA; Calabresi, P				Picconi, B; Centonze, D; Hakansson, K; Bernardi, G; Greengard, P; Fisone, G; Cenci, MA; Calabresi, P			Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CAMP-REGULATED PHOSPHOPROTEIN; LOW-FREQUENCY STIMULATION; PARKINSONS-DISEASE; RAT NEOSTRIATUM; IN-VIVO; RECEPTOR; DEPOTENTIATION; MODEL; PATHOPHYSIOLOGY	Long-term treatment with the dopamine precursor levodopa (L-DOPA) induces dyskinesia in Parkinson's disease (PD) patients. We divided hemiparkinsonian rats treated chronically with L-DOPA into two groups: one showed motor improvement without dyskinesia, and the other developed debilitating dyskinesias in response to the treatment. We then compared the plasticity of corticostriatal synapses between the two groups. High-frequency stimulation of cortical afferents induced long-term potentiation (LTP) of corticostriatal synapses in both groups of animals. Control and non-dyskinetic rats showed synaptic depotentiation in response to subsequent low-frequency synaptic stimulation, but dyskinetic rats did not. The depotentiation seen in both L-DOPA-treated non-dyskinetic rats and intact controls was prevented by activation of the D1 subclass of dopamine receptors or inhibition of protein phosphatases. The striata of dyskinetic rats contained abnormally high levels of phospho[Thr34]-DARPP-32, an inhibitor of protein phosphatase 1. These results indicate that abnormal information storage in corticostriatal synapses is linked with the development of L-DOPA-induced dyskinesia.	Univ Roma Tor Vergata, Clin Neurol, Dipartimento Neurosci, I-00133 Rome, Italy; IRCCS, Lab Neurofisiol, Fdn Santa Lucia, I-00179 Rome, Italy; Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Lund Univ, Wallenberg Neurosci Ctr, Div Neurobiol, S-22362 Lund, Sweden	University of Rome Tor Vergata; IRCCS Santa Lucia; Karolinska Institutet; Rockefeller University; Lund University	Calabresi, P (corresponding author), Univ Roma Tor Vergata, Clin Neurol, Dipartimento Neurosci, Via Montpellier 1, I-00133 Rome, Italy.	calabre@uniroma2.it	Calabresi, Paolo/G-8496-2011; Centonze, Diego/J-7767-2016; Picconi, Barbara/G-8299-2011	Calabresi, Paolo/0000-0003-0326-5509; Centonze, Diego/0000-0002-8390-8545; Picconi, Barbara/0000-0001-6020-1021; Fisone, Gilberto/0000-0002-0719-8000; Cenci Nilsson, M. Angela/0000-0003-2216-2900	NIDA NIH HHS [DA10044] Funding Source: Medline; NIMH NIH HHS [MH40899] Funding Source: Medline; Telethon [GGP02035] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH040899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Andersson M, 1999, NEUROBIOL DIS, V6, P461, DOI 10.1006/nbdi.1999.0259; BASHIR ZI, 1994, EXP BRAIN RES, V100, P437, DOI 10.1007/BF02738403; Bedard PJ, 1999, MOVEMENT DISORD, V14, P4; Bezard E, 2001, NAT REV NEUROSCI, V2, P577, DOI 10.1038/35086062; Calabresi P, 2000, ANN NEUROL, V47, pS60; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Calabresi P, 2000, TRENDS NEUROSCI, V23, pS57, DOI 10.1016/S1471-1931(00)00017-3; Cenci MA, 1998, EUR J NEUROSCI, V10, P2694, DOI 10.1046/j.1460-9568.1998.t01-1-00285.x; Centonze D, 1999, J NEUROPHYSIOL, V82, P3575, DOI 10.1152/jn.1999.82.6.3575; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; Chase TN, 2000, TRENDS NEUROSCI, V23, pS86, DOI 10.1016/S1471-1931(00)00018-5; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hagell P, 1999, MOVEMENT DISORD, V14, P448, DOI 10.1002/1531-8257(199905)14:3<448::AID-MDS1010>3.0.CO;2-0; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; HEMMINGS HC, 1986, J NEUROSCI, V6, P1469; Huang CC, 2001, J BIOL CHEM, V276, P48108, DOI 10.1074/jbc.M106388200; Huang CC, 2001, REV NEUROSCIENCE, V12, P51; Ingham CA, 1998, J NEUROSCI, V18, P4732; Jankovic J, 2002, NEUROLOGY, V58, pS19, DOI 10.1212/WNL.58.suppl_1.S19; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lundblad M, 2002, EUR J NEUROSCI, V15, P120, DOI 10.1046/j.0953-816x.2001.01843.x; MARSDEN CD, 1982, LANCET, V2, P1141; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; O'Dell T J, 1994, Learn Mem, V1, P129; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS2, DOI 10.1016/S1471-1931(00)00031-8; Otmakhova NA, 1998, J NEUROSCI, V18, P1270; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Rozas G, 1997, BRAIN RES PROTOC, V2, P75, DOI 10.1016/S1385-299X(97)00034-2; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SCHMIDT RH, 1982, J NEUROCHEM, V38, P737, DOI 10.1111/j.1471-4159.1982.tb08693.x; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Svenningsson P, 2000, P NATL ACAD SCI USA, V97, P1856, DOI 10.1073/pnas.97.4.1856	37	657	667	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					501	506		10.1038/nn1040	http://dx.doi.org/10.1038/nn1040			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12665799				2022-12-17	WOS:000182553200017
J	Gazzaley, A; Cooney, JW; Rissman, J; D'Esposito, M				Gazzaley, A; Cooney, JW; Rissman, J; D'Esposito, M			Top-down suppression deficit underlies working memory impairment in normal aging	NATURE NEUROSCIENCE			English	Article							INHIBITORY CONTROL; ATTENTION; FMRI	In this study, we assess the impact of normal aging on top-down modulation, a cognitive control mechanism that supports both attention and memory by the suppression and enhancement of sensory processing in accordance with task goals. Using fMRI ( functional magnetic resonance imaging), we show that healthy older adults demonstrated a prominent deficit in the suppression of cortical activity associated with task-irrelevant representations, whereas enhancement of task-relevant activity was preserved. Moreover, this suppression-specific attention deficit correlated with impaired working memory performance.	Univ Calif Berkeley, Henry H Wheeler Jr Brain Imaging Ctr, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Gazzaley, A (corresponding author), Univ Calif San Francisco, 1700 4th St,Room 102C, San Francisco, CA 94143 USA.	adamgazz@comewander.com	Rissman, Jesse/ABH-2217-2021	Rissman, Jesse/0000-0001-8889-5539; Cooney, Jeffrey/0000-0002-9903-5400				Alain C, 1999, PSYCHOL AGING, V14, P507, DOI 10.1037/0882-7974.14.3.507; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Chao LL, 1997, CEREB CORTEX, V7, P63, DOI 10.1093/cercor/7.1.63; CRAIK FI, 2000, HDB AGING COGNITION, V2; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Hasher L., 1988, WORKING MEMORY COMPR, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; May CP, 1999, MEM COGNITION, V27, P759, DOI 10.3758/BF03198529; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; Ploner CJ, 2001, EUR J NEUROSCI, V13, P357, DOI 10.1046/j.1460-9568.2001.01397.x; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; West R, 1999, MEM COGNITION, V27, P1064, DOI 10.3758/BF03201235; [No title captured]	15	653	661	0	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1298	1300		10.1038/nn1543	http://dx.doi.org/10.1038/nn1543			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	968EY	16158065				2022-12-17	WOS:000232145900012
J	Leopold, DA; O'Toole, AJ; Vetter, T; Blanz, V				Leopold, DA; O'Toole, AJ; Vetter, T; Blanz, V			Prototype-referenced shape encoding revealed by high-level after effects	NATURE NEUROSCIENCE			English	Article							TEMPORAL VISUAL-CORTEX; FUSIFORM FACE AREA; INFEROTEMPORAL CORTEX; UNIFIED ACCOUNT; NEURONS; MONKEY; DISTINCTIVENESS; RECOGNITION; PERCEPTION; REPRESENTATIONS	We used high-level configural aftereffects induced by adaptation to realistic faces to investigate visual representations underlying complex pattern perception. We found that exposure to an individual face for a few seconds generated a significant and precise bias in the subsequent perception of face identity. In the context of a computationally derived 'face space,' adaptation specifically shifted perception along a trajectory passing through the adapting and average faces, selectively facilitating recognition of a test face lying on this trajectory and impairing recognition of other faces. The results suggest that the encoding of faces and other complex patterns draws upon contrastive neural mechanisms that reference the central tendency of the stimulus category.	Max Planck Inst Biol Kybernet, D-72076 Tubingen, Germany; Univ Texas, Sch Human Dev, Richardson, TX 75083 USA	Max Planck Society; University of Texas System; University of Texas Dallas	Leopold, DA (corresponding author), Max Planck Inst Biol Kybernet, Spemannstr 38, D-72076 Tubingen, Germany.			Leopold, David/0000-0002-1345-6360; O'Toole, Alice/0000-0001-7981-1508				ASHBY FG, 1993, J MATH PSYCHOL, V37, P372, DOI 10.1006/jmps.1993.1023; BENSON PJ, 1994, PERCEPTION, V23, P75, DOI 10.1068/p230075; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Blanz V, 2000, PERCEPTION, V29, P885, DOI 10.1068/p2851; BLANZ V, 1999, 1999 S INT 3D GRAPH, P187; Cabeza R, 1999, MEM COGNITION, V27, P139, DOI 10.3758/BF03201220; Deffenbacher KA, 1998, PERCEPTION, V27, P1233, DOI 10.1068/p271233; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Estes W.K., 1994, CLASSIFICATION COGNI; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; HASSELMO ME, 1989, BEHAV BRAIN RES, V32, P203, DOI 10.1016/S0166-4328(89)80054-3; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KOEHLER W, 1944, P AM PHILOS SOC, V88, P269; Lewis MB, 1999, VIS COGN, V6, P1, DOI 10.1080/713756800; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Mather G., 1998, MOTION AFTEREFFECT M; NOSOFSKY RM, 1991, J EXP PSYCHOL HUMAN, V17, P3, DOI 10.1037/0096-1523.17.1.3; OJEMANN JG, 1992, BRAIN, V115, P1, DOI 10.1093/brain/115.1.1; OToole AJ, 1997, PERCEPTION, V26, P75, DOI 10.1068/p260075; OTOOLE AJ, 1994, MEM COGNITION, V22, P208, DOI 10.3758/BF03208892; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; POSNER MI, 1968, J EXP PSYCHOL, V77, P353, DOI 10.1037/h0025953; POSNER MI, 1970, J EXP PSYCHOL, V83, P394; Rhodes G, 1998, VISION RES, V38, P2307, DOI 10.1016/S0042-6989(97)00470-7; RHODES G, 1987, COGNITIVE PSYCHOL, V19, P473, DOI 10.1016/0010-0285(87)90016-8; STEVENAGE SV, 1995, BRIT J PSYCHOL, V86, P127, DOI 10.1111/j.2044-8295.1995.tb02550.x; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Suzuki S, 1998, J EXP PSYCHOL HUMAN, V24, P1315, DOI 10.1037/0096-1523.24.5.1315; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; YAMANE S, 1988, EXP BRAIN RES, V73, P209, DOI 10.1007/BF00279674; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	35	653	656	1	63	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					89	94		10.1038/82947	http://dx.doi.org/10.1038/82947			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405UB	11135650				2022-12-17	WOS:000167178000019
J	Thiebaut de Schotten, M; Dell'Acqua, F; Forkel, SJ; Simmons, A; Vergani, F; Murphy, DGM; Catani, M				Thiebaut de Schotten, Michel; Dell'Acqua, Flavio; Forkel, Stephanie J.; Simmons, Andrew; Vergani, Francesco; Murphy, Declan G. M.; Catani, Marco			A lateralized brain network for visuospatial attention	NATURE NEUROSCIENCE			English	Article							NEGLECT; PSEUDONEGLECT; FIBERS	Right hemisphere dominance for visuospatial attention is characteristic of most humans, but its anatomical basis remains unknown. We report the first evidence in humans for a larger parieto-frontal network in the right than left hemisphere, and a significant correlation between the degree of anatomical lateralization and asymmetry of performance on visuospatial tasks. Our results suggest that hemispheric specialization is associated with an unbalanced speed of visuospatial processing.	[Thiebaut de Schotten, Michel; Dell'Acqua, Flavio; Forkel, Stephanie J.; Murphy, Declan G. M.; Catani, Marco] Kings Coll London, Natbrainlab, Dept Forens & Neurodev Sci, Inst Psychiat, London WC2R 2LS, England; [Thiebaut de Schotten, Michel] Univ Paris 06, INSERM, UMR, Grp Hosp Pitie Salpetriere, Paris, France; [Thiebaut de Schotten, Michel; Dell'Acqua, Flavio; Simmons, Andrew; Catani, Marco] Kings Coll London, Dept Neuroimaging, Inst Psychiat, London WC2R 2LS, England; [Dell'Acqua, Flavio; Simmons, Andrew] Biomed Res Ctr Mental Hlth, Natl Inst Hlth Res, London, England; [Simmons, Andrew] Kings Coll London, MRC, Ctr Neurodegenerat Res, London WC2R 2LS, England; [Vergani, Francesco] Royal Victoria Infirm, Dept Neurosurg, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; King's College London; University of London; King's College London; University of London; King's College London; Newcastle University - UK	Thiebaut de Schotten, M (corresponding author), Kings Coll London, Natbrainlab, Dept Forens & Neurodev Sci, Inst Psychiat, London WC2R 2LS, England.	michel.thiebaut@gmail.com	Dell'Acqua, Flavio/I-1407-2012; de Schotten, Michel Thiebaut/H-1496-2011; Forkel, Stephanie J./A-4018-2011; Catani, Marco/AFK-2769-2022; Simmons, Andrew/B-8848-2008; Catani, Marco/AAG-1094-2022; Catani, Marco/H-7801-2012	de Schotten, Michel Thiebaut/0000-0002-0329-1814; Forkel, Stephanie J./0000-0003-0493-0283; Catani, Marco/0000-0002-5488-6463; Simmons, Andrew/0000-0003-2306-5811; Catani, Marco/0000-0002-5488-6463; Catani, Marco/0000-0002-5488-6463	Marie Curie Intra Fellowship; European Fellowship; Bettencourt-Schueller Foundation; Guy's and St Thomas Charity; Wellcome Trust; UK National Institute for Health Research Biomedical Research Centre for Mental Health at the South London; Maudsley National Health Service Foundation Trust; Institute of Psychiatry; King's College; Agence Nationale de la Recherche of France [ANR-09-RPDOC-004-01, ANR-09-EMER-006]	Marie Curie Intra Fellowship; European Fellowship; Bettencourt-Schueller Foundation; Guy's and St Thomas Charity; Wellcome Trust(Wellcome TrustEuropean Commission); UK National Institute for Health Research Biomedical Research Centre for Mental Health at the South London; Maudsley National Health Service Foundation Trust; Institute of Psychiatry; King's College; Agence Nationale de la Recherche of France(French National Research Agency (ANR))	We would like to thank the members of the Natbrainlab, D. H. ffytche, P. Bartolomeo and F. Doricchi for discussion. This work was supported by the Marie Curie Intra-European Fellowships for Career Development (FP7), the Bettencourt-Schueller Foundation, the Guy's and St Thomas Charity, the Wellcome Trust, the UK National Institute for Health Research Biomedical Research Centre for Mental Health at the South London and Maudsley National Health Service Foundation Trust and Institute of Psychiatry, King's College and the Agence Nationale de la Recherche of France (project CAFORPFC, no. ANR-09-RPDOC-004-01 and project HM-TC, no. ANR-09-EMER-006).	Beis JM, 2004, NEUROLOGY, V63, P1600, DOI 10.1212/01.WNL.0000142967.60579.32; BOWERS D, 1980, NEUROPSYCHOLOGIA, V18, P491, DOI 10.1016/0028-3932(80)90151-7; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dell'Acqua F, 2010, NEUROIMAGE, V49, P1446, DOI 10.1016/j.neuroimage.2009.09.033; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Hursh JB, 1939, AM J PHYSIOL, V127, P131, DOI 10.1152/ajplegacy.1939.127.1.131; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Sperry RW, 1974, LATERAL SPECIALIZATI; WAXMAN SG, 1972, NATURE-NEW BIOL, V238, P217, DOI 10.1038/newbio238217a0	15	648	649	2	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1245	1246		10.1038/nn.2905	http://dx.doi.org/10.1038/nn.2905			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ		Green Submitted			2022-12-17	WOS:000295254200010
J	Rivers, LE; Young, KM; Rizzi, M; Jamen, F; Psachoulia, K; Wade, A; Kessaris, N; Richardson, WD				Rivers, Leanne E.; Young, Kaylene M.; Rizzi, Matteo; Jamen, Francoise; Psachoulia, Konstantina; Wade, Anna; Kessaris, Nicoletta; Richardson, William D.			PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice	NATURE NEUROSCIENCE			English	Article							PDGF-ALPHA-RECEPTOR; PROGENITOR CELLS; SUBVENTRICULAR ZONE; PRECURSOR CELLS; NG2-EXPRESSING CELLS; STEM-CELLS; NEUROGENESIS; NEOCORTEX; CNS; POPULATION	Platelet-derived growth factor a receptor (PDGFRA)/NG2-expressing glia are distributed throughout the adult CNS. They are descended from oligodendrocyte precursors (OLPs) in the perinatal CNS, but it is not clear whether they continue to generate myelinating oligodendrocytes or other differentiated cells during normal adult life. We followed the fates of adult OLPs in Pdgfra-creER(T2)/Rosa26-YFP double-transgenic mice and found that they generated many myelinating oligodendrocytes during adulthood; > 20% of all oligodendrocytes in the adult mouse corpus callosum were generated after 7 weeks of age, raising questions about the function of the late-myelinating axons. OLPs also produced some myelinating cells in the cortex, but the majority of adult-born cortical cells did not appear to myelinate. We found no evidence for astrocyte production in gray or white matter. However, small numbers of projection neurons were generated in the forebrain, especially in the piriform cortex, which is the main target of the olfactory bulb.	[Rivers, Leanne E.; Young, Kaylene M.; Rizzi, Matteo; Jamen, Francoise; Psachoulia, Konstantina; Wade, Anna; Kessaris, Nicoletta; Richardson, William D.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London	Richardson, WD (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	w.richardson@ucl.ac.uk	Kessaris, Nicoletta/C-7249-2008; Richardson, William/C-1762-2008; Kessaris, Nicoletta/AAD-6774-2019; Messier, Claude/A-2322-2008	Kessaris, Nicoletta/0000-0003-1191-6009; Richardson, William/0000-0001-7261-2485; Kessaris, Nicoletta/0000-0003-1191-6009; Messier, Claude/0000-0002-4791-1763; Jamen, Francoise/0000-0003-4116-395X; Rizzi, Matteo/0000-0003-4922-397X; Young, Kaylene/0000-0002-1686-3463	Biotechnology and Biological Sciences Research Council; University College London; European Union; Wellcome Trust; Medical Research Council; Medical Research Council [G0501173, G9708005] Funding Source: researchfish; MRC [G0501173, G9708005] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University College London(General Electric); European Union(European Commission); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank our colleagues in the Wolfson Institute for Biomedical Research for discussions, help and encouragement. Special thanks to M. Grist and U. Dennehy for expert technical assistance and to T. Mitsumori for helping to construct the Fgfr3-icreER<SUP>T2</SUP> transgene. Thanks also to D. Attwell for critically reading the manuscript and L. Dimou and M. Gotz for exchanging data before publication. L. E. R. was supported by a collaborative studentship from the Biotechnology and Biological Sciences Research Council and Eisai London Research Laboratories at University College London. F.J. held a Marie Curie Fellowship from the European Union. K.M.Y. is an Alzheimer's Society Fellow in Stem Cell Research. M. R. and A. W. hold studentships from The Wellcome Trust and K. P. has a studentship from the Medical Research Council. We are grateful to the Gatsby Foundation for the purchase of a two-photon microscope and to M. Hausser for providing access to it. This work was also supported by Programme grants from the Medical Research Council and The Wellcome Trust.	Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; BUTT AM, 1989, GLIA, V2, P470, DOI 10.1002/glia.440020609; Butt AM, 1997, MOL CELL NEUROSCI, V8, P311, DOI 10.1006/mcne.1996.0590; Butt AM, 2002, J NEUROCYTOL, V31, P551, DOI 10.1023/A:1025751900356; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.0.CO;2-L; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Hachem S, 2005, GLIA, V51, P81, DOI 10.1002/glia.20184; Hall A, 1996, DEVELOPMENT, V122, P4085; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.0.CO;2-A; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MCCARTHY GF, 1988, J COMP NEUROL, V271, P589, DOI 10.1002/cne.902710409; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nishiyama A, 1999, J NEUROPATH EXP NEUR, V58, P1113, DOI 10.1097/00005072-199911000-00001; Nishiyama A, 2002, J NEUROCYTOL, V31, P437, DOI 10.1023/A:1025783412651; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Ong WY, 1999, NEUROSCIENCE, V92, P83, DOI 10.1016/S0306-4522(98)00751-9; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Rakic P, 2002, J NEUROSCI, V22, P614, DOI 10.1523/JNEUROSCI.22-03-00614.2002; Shapiro LA, 2007, BRAIN STRUCT FUNCT, V212, P133, DOI 10.1007/s00429-007-0151-3; Shi JY, 1998, J NEUROSCI, V18, P4627; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STURROCK RR, 1980, NEUROPATH APPL NEURO, V6, P415, DOI 10.1111/j.1365-2990.1980.tb00219.x; Suzuki N, 2006, J NEUROSCI, V26, P11938, DOI 10.1523/JNEUROSCI.3473-06.2006; Tamura Y, 2007, EUR J NEUROSCI, V25, P3489, DOI 10.1111/j.1460-9568.2007.05617.x; van Heyningen P, 2001, CURR BIOL, V11, P232, DOI 10.1016/S0960-9822(01)00075-6; Watanabe M, 2002, J NEUROSCI RES, V69, P826, DOI 10.1002/jnr.10338; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Ziskin JL, 2007, NAT NEUROSCI, V10, P321, DOI 10.1038/nn1854	50	647	658	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2008	11	12					1392	1401		10.1038/nn.2220	http://dx.doi.org/10.1038/nn.2220			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	375JF	18849983	Green Accepted, Green Submitted			2022-12-17	WOS:000261109300012
J	Xu, BJ; Goulding, EH; Zang, KL; Cepoi, D; Cone, RD; Jones, KR; Tecott, LH; Reichardt, LF				Xu, BJ; Goulding, EH; Zang, KL; Cepoi, D; Cone, RD; Jones, KR; Tecott, LH; Reichardt, LF			Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; VENTROMEDIAL NUCLEUS; FOOD-INTAKE; EFFERENT CONNECTIONS; TARGETED DISRUPTION; OBESITY; HYPOTHALAMUS; LESIONS; MICE; LEPTIN	The melanocortin-4 receptor (MC4R) is critically involved in regulating energy balance, and obesity has been observed in mice with mutations in the gene for brain-derived neurotrophic factor (BDNF). Here we report that BDNF is expressed at high levels in the ventromedial hypothalamus (VMH) where its expression is regulated by nutritional state and by MC4R signaling. In addition, similar to MC4R mutants, mouse mutants that expresses the BDNF receptor TrkB at a quarter of the normal amount showed hyperphagia and excessive weight gain on higher-fat diets. Furthermore, BDNF infusion into the brain suppressed the hyperphagia and excessive weight gain observed on higher-fat diets in mice with deficient MC4R signaling. These results show that MC4R signaling controls BDNF expression in the VMH and support the hypothesis that BDNF is an important effector through which MC4R signaling controls energy balance.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Neurobiol & Psychiat, San Francisco, CA 94143 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon Health & Science University; University of Colorado System; University of Colorado Boulder	Xu, BJ (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	bx3@georgetown.edu; lfr@cgl.ucsf.edu		JONES, KEVIN/0000-0002-3802-7562	NINDS NIH HHS [P01 NS016033, P01 NS016033-21] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bagnol D, 1999, J NEUROSCI, V19; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Bennett JL, 1999, INVEST OPHTH VIS SCI, V40, P2996; Benoit SC, 2002, J NEUROSCI, V22, P9048; Bernardis LL, 1998, P SOC EXP BIOL MED, V218, P284; BROOKS CM, 1946, AM J PHYSIOL, V147, P735, DOI 10.1152/ajplegacy.1946.147.4.735; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Cone RD, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801913; DECKNER ML, 1993, NEUROREPORT, V5, P301, DOI 10.1097/00001756-199312000-00030; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fritzsch B, 1997, INT J DEV NEUROSCI, V15, P563, DOI 10.1016/S0736-5748(96)00111-6; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hetherington AW, 1942, J COMP NEUROL, V76, P475, DOI 10.1002/cne.900760308; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; KRIEGER MS, 1979, J COMP NEUROL, V183, P785, DOI 10.1002/cne.901830408; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Nakagawa T, 2000, DIABETES, V49, P436, DOI 10.2337/diabetes.49.3.436; Nonomura T, 2001, Int J Exp Diabetes Res, V2, P201, DOI 10.1155/EDR.2001.201; Ono M, 1997, BIOCHEM BIOPH RES CO, V238, P633, DOI 10.1006/bbrc.1997.7220; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; SAPER CB, 1976, J COMP NEUROL, V169, P409, DOI 10.1002/cne.901690403; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SHIMIZU N, 1987, BRAIN RES, V416, P153, DOI 10.1016/0006-8993(87)91508-3; SKULTETY FM, 1966, ARCH NEUROL-CHICAGO, V14, P670, DOI 10.1001/archneur.1966.00470120102013; SMITH AI, 1988, ENDOCR REV, V9, P159, DOI 10.1210/edrv-9-1-159; TERHORST GJ, 1987, BRAIN RES BULL, V18, P191, DOI 10.1016/0361-9230(87)90190-0; Tsuchida A, 2001, INT J OBESITY, V25, P1286, DOI 10.1038/sj.ijo.0801678; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Zhang CX, 1997, NEUROREPORT, V8, P1013, DOI 10.1097/00001756-199703030-00039	45	646	673	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					736	742		10.1038/nn1073	http://dx.doi.org/10.1038/nn1073			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12796784	Green Accepted			2022-12-17	WOS:000183780400022
J	Miller, KL; Alfaro-Almagro, F; Bangerter, NK; Thomas, DL; Yacoub, E; Xu, JQ; Bartsch, AJ; Jbabdi, S; Sotiropoulos, SN; Andersson, JLR; Griffanti, L; Douaud, G; Okell, TW; Weale, P; Dragonu, J; Garratt, S; Hudson, S; Collins, R; Jenkinson, M; Matthews, PM; Smith, SM				Miller, Karla L.; Alfaro-Almagro, Fidel; Bangerter, Neal K.; Thomas, David L.; Yacoub, Essa; Xu, Jungian; Bartsch, Andreas J.; Jbabdi, Saad; Sotiropoulos, Stamatios N.; Andersson, Jesper L. R.; Griffanti, Ludovica; Douaud, Gwenaelle; Okell, Thomas W.; Weale, Peter; Dragonu, Julius; Garratt, Steve; Hudson, Sarah; Collins, Rory; Jenkinson, Mark; Matthews, Paul M.; Smith, Stephen M.			Multimodal population brain imaging in the UK Biobank prospective epidemiological study	NATURE NEUROSCIENCE			English	Article							CEREBRAL WHITE-MATTER; BONE-MINERAL DENSITY; MAGNETIC-RESONANCE; DIFFUSION TENSOR; ALZHEIMERS-DISEASE; CONNECTIVITY; DETERMINANTS; TRACTOGRAPHY; FRAMEWORK; AMYGDALA	Medical imaging has enormous potential for early disease prediction, but is impeded by the difficulty and expense of acquiring data sets before symptom onset. UK Biobank aims to address this problem directly by acquiring high-quality, consistently acquired imaging data from 100,000 predominantly healthy participants, with health outcomes being tracked over the coming decades. The brain imaging includes structural, diffusion and functional modalities. Along with body and cardiac imaging, genetics, lifestyle measures, biological phenotyping and health records, this imaging is expected to enable discovery of imaging markers of a broad range of diseases at their earliest stages, as well as provide unique insight into disease mechanisms. We describe UK Biobank brain imaging and present results derived from the first 5,000 participants' data release. Although this covers just 5% of the ultimate cohort, it has already yielded a rich range of associations between brain imaging and other measures collected by UK Biobank.	[Miller, Karla L.; Alfaro-Almagro, Fidel; Jbabdi, Saad; Sotiropoulos, Stamatios N.; Andersson, Jesper L. R.; Griffanti, Ludovica; Douaud, Gwenaelle; Okell, Thomas W.; Jenkinson, Mark; Smith, Stephen M.] Univ Oxford, Oxford Ctr Funct MRI Brain FMRIB, Oxford, England; [Bangerter, Neal K.] Brigham Young Univ, Dept Elect Engn, Provo, UT 84602 USA; [Thomas, David L.] UCL, Inst Neurol, London, England; [Yacoub, Essa] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN USA; [Xu, Jungian] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Bartsch, Andreas J.] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Weale, Peter; Dragonu, Julius] Siemens Healthcare UK, Frimley, England; [Garratt, Steve; Hudson, Sarah; Collins, Rory] UK Biobank, Stockport, Lancs, England; [Collins, Rory] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Matthews, Paul M.] Imperial Coll London, Dept Med, Div Brain Sci, London, England	University of Oxford; Brigham Young University; University of London; University College London; University of Minnesota System; University of Minnesota Twin Cities; Icahn School of Medicine at Mount Sinai; Ruprecht Karls University Heidelberg; Siemens AG; University of Oxford; Imperial College London	Miller, KL (corresponding author), Univ Oxford, Oxford Ctr Funct MRI Brain FMRIB, Oxford, England.	karla@fmrib.ox.ac.uk	Yacoub, Essa/AAS-7757-2021; Jenkinson, Mark/AAC-8861-2019; Xu, Junqian/D-2247-2009; Sotiropoulos, Stamatios/I-1163-2019	Jenkinson, Mark/0000-0001-6043-0166; Xu, Junqian/0000-0001-8438-2066; Sotiropoulos, Stamatios/0000-0003-4735-5776; Smith, Stephen/0000-0001-8166-069X; Jbabdi, Saad/0000-0003-3234-5639; Okell, Thomas/0000-0001-8258-0659; Miller, Karla/0000-0002-2511-3189; Thomas, David/0000-0003-1491-1641; Alfaro-Almagro, Fidel/0000-0002-9133-5951; Garratt, Steve/0000-0001-9638-4173; Dichgans, Martin/0000-0002-0654-387X	UK Medical Research Council; Wellcome Trust; Edmund J Safra Foundation; Imperial College Healthcare Trust Biomedical Research Centre; Medical Research Council; EPSRC [EP/N014529/1, EP/L023067/1] Funding Source: UKRI; MRC [MR/K006673/1, MC_PC_15067, MR/M024903/1, MR/L009013/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L023067/1, EP/N014529/1] Funding Source: researchfish; Medical Research Council [MR/L009013/1, MC_PC_15067, MR/M024903/1, MR/K006673/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10022] Funding Source: researchfish; Parkinson&quot;s UK [J-1403] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Edmund J Safra Foundation; Imperial College Healthcare Trust Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK)	We would like to acknowledge the valuable contributions of members of the UK Biobank Imaging Working Group and the UK Biobank coordinating center. We are very grateful for additional input into the imaging protocol and image processing pipelines from M. Chappell, S. Clare, E. Duff, D. Flitney, M. Hernandez Fernandez, H. Johansen-Berg, P. McCarthy, J. Miller, D. Mortimer, J. Price, G. Salimi-Khorshidi, E. Vallee, D. Vidaurre, M. Webster, A. Winkler, A. Young, E. Auerbach, S. Moeller, K. Ugurbil, D. Alexander, N. Fox, E. Kaden, S. Ourselin, G. Zhang, A. Daducci, T. Stoecker, D. Barch, N. Bloom, G. Burgess, M. Glasser, M. Harms, D. Nolan, B. Fischl, D. Greve, J. Polimeni, T. Nichols, A. Murphy, G. Parker, E Barkhof, C. Beckmann, M. Mennes, M. Vernooij, N. Weiskopf, C. Rorden and J. Wardlaw. We are grateful for the provision of simultaneous multi-slice (multiband) pulse sequence and reconstruction algorithms from the Center for Magnetic Resonance Research, University of Minnesota. Finally, we are extremely grateful to all UK Biobank study participants, who generously donated their time to make this resource possible. UK Biobank (including the imaging enhancement) has been generously supported by the UK Medical Research Council and the Wellcome Trust. K.L.M. and S.M.S. receive further support from the Wellcome Trust. P.M.M. acknowledges support from the Edmund J Safra Foundation and Lily Safra, the Imperial College Healthcare Trust Biomedical Research Centre, and the Medical Research Council.	Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BERKSON J, 1946, BIOMETRICS BULL, V2, P47, DOI 10.2307/3002000; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; de Groot M, 2013, NEUROIMAGE, V76, P400, DOI 10.1016/j.neuroimage.2013.03.015; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Douaud G, 2013, J NEUROSCI, V33, P2147, DOI 10.1523/JNEUROSCI.4437-12.2013; Douaud G, 2011, NEUROIMAGE, V55, P880, DOI 10.1016/j.neuroimage.2010.12.008; Duff EP, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3008438; Duyn J, 2013, J MAGN RESON, V229, P198, DOI 10.1016/j.jmr.2012.11.013; Ennis DB, 2006, MAGN RESON MED, V55, P136, DOI 10.1002/mrm.20741; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fjell AM, 2010, REV NEUROSCIENCE, V21, P187, DOI 10.1515/revneuro.2010.21.3.187; Gage SH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005765; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greiser KH, 2014, EUR J EPIDEMIOL, V29, P371, DOI 10.1007/s10654-014-9890-7; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hamidi M, 2004, BIOL PSYCHIAT, V55, P563, DOI 10.1016/j.biopsych.2003.11.006; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Jbabdi S, 2012, MAGN RESON MED, V68, P1846, DOI 10.1002/mrm.24204; Karas GB, 2003, NEUROIMAGE, V18, P895, DOI 10.1016/S1053-8119(03)00041-7; Kirk RE, 1996, EDUC PSYCHOL MEAS, V56, P746, DOI 10.1177/0013164496056005002; Kuznetsova KA, 2016, BRAIN STRUCT FUNCT, V221, P3223, DOI 10.1007/s00429-015-1097-5; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; Pearl J, 2009, CAUSALITY MODELS REA; Petersen SE, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-46; Pirpamer L, 2016, NEUROBIOL AGING, V43, P149, DOI 10.1016/j.neurobiolaging.2016.04.002; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reichle ED, 2000, COGNITIVE PSYCHOL, V40, P261, DOI 10.1006/cogp.2000.0733; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Schram MT, 2014, EUR J EPIDEMIOL, V29, P439, DOI 10.1007/s10654-014-9889-0; SIMPSON EH, 1951, J ROY STAT SOC B, V13, P238; Smith SM, 2015, NAT NEUROSCI, V18, P1565, DOI 10.1038/nn.4125; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stanek KM, 2011, OBESITY, V19, P500, DOI 10.1038/oby.2010.312; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Swanson JM, 2012, LANCET, V380, P110, DOI 10.1016/S0140-6736(12)61179-9; Tan ZS, 2005, ARCH NEUROL-CHICAGO, V62, P107, DOI 10.1001/archneur.62.1.107; Van der Werf YD, 2001, COGNITIVE BRAIN RES, V11, P377, DOI 10.1016/S0926-6410(01)00010-6; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wick Jeannette Y, 2011, Consult Pharm, V26, P634, DOI 10.4140/TCP.n.2011.634; Yaffe K, 1999, J AM GERIATR SOC, V47, P1176, DOI 10.1111/j.1532-5415.1999.tb05196.x; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	50	645	649	4	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2016	19	11					1523	1536		10.1038/nn.4393	http://dx.doi.org/10.1038/nn.4393			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EA3WL	27643430	Green Accepted, Green Submitted			2022-12-17	WOS:000386539900022
J	Weiss, Y; Simoncelli, EP; Adelson, EH				Weiss, Y; Simoncelli, EP; Adelson, EH			Motion illusions as optimal percepts	NATURE NEUROSCIENCE			English	Article								The pattern of local image velocities on the retina encodes important environmental information. Although humans are generally able to extract this information, they can easily be deceived into seeing incorrect velocities. We show that these 'illusions' arise naturally in a system that attempts to estimate local image velocity. We formulated a model of visual motion perception using standard estimation theory, under the assumptions that (i) there is noise in the initial measurements and (ii) slower motions are more likely to occur than faster ones. We found that specific instantiation of such a velocity estimator can account for a wide variety of psychophysical phenomena.	Hebrew Univ Jerusalem, Sch Engn & Comp Sci, IL-91904 Jerusalem, Israel; NYU, Howard Hughes Med Inst, Ctr Neural Sci, New York, NY 10003 USA; NYU, Courant Inst Math Sci, New York, NY 10003 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Hebrew University of Jerusalem; Howard Hughes Medical Institute; New York University; New York University; Massachusetts Institute of Technology (MIT)	Weiss, Y (corresponding author), Hebrew Univ Jerusalem, Sch Engn & Comp Sci, Givat Ram Campus, IL-91904 Jerusalem, Israel.			Simoncelli, Eero/0000-0002-1206-527X	NATIONAL EYE INSTITUTE [R01EY011005] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY11005] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Lucas B.D., 1981, ITERATIVE IMAGE REGI, P674; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; MORGAN MJ, 1992, NATURE, V355, P344, DOI 10.1038/355344a0; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; NAKAYAMA K, 1985, VISION RES, V25, P625, DOI 10.1016/0042-6989(85)90171-3; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; Schrater PR, 2000, NAT NEUROSCI, V3, P64, DOI 10.1038/71134; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; WELCH L, 1989, NATURE, V337, P734, DOI 10.1038/337734a0; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317	12	644	645	0	50	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					598	604		10.1038/nn858	http://dx.doi.org/10.1038/nn858			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12021763	Green Submitted			2022-12-17	WOS:000175874600021
J	Koob, GF; Le Moal, M				Koob, GF; Le Moal, M			Plasticity of reward neurocircuitry and the 'dark side' of drug addiction	NATURE NEUROSCIENCE			English	Editorial Material							DYSREGULATION; ALLOSTASIS; WITHDRAWAL; STRESS; DEPENDENCE; BEHAVIOR; ETHANOL; RELAPSE; SEEKING; BRAIN	Drug seeking is associated with activation of reward neural circuitry. Here we argue that drug addiction also involves a 'dark side'-a decrease in the function of normal reward-related neurocircuitry and persistent recruitment of anti-reward systems. Understanding the neuroplasticity of the dark side of this circuitry is the key to understanding vulnerability to addiction.	Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; Univ Bordeaux 2, Lab Physiopathol Comportements, INSERM, U588, F-33076 Bordeaux, France	Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Koob, GF (corresponding author), Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA.	gkoob@scripps.edu	LE MOAL, Michel/B-5125-2008					Ahmed SH, 2002, NAT NEUROSCI, V5, P625, DOI 10.1038/nn872; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Aston-Jones G, 1999, ANN NY ACAD SCI, V877, P486, DOI 10.1111/j.1749-6632.1999.tb09284.x; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kreek MJ, 1998, DRUG ALCOHOL DEPEN, V51, P23, DOI 10.1016/S0376-8716(98)00064-7; Le Moal Michel, 1995, P283; MARTIN WR, 1968, ADDICT STATES, P206; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Piazza PV, 1996, ANNU REV PHARMACOL, V36, P359, DOI 10.1146/annurev.pa.36.040196.002043; Rasmussen DD, 2000, ALCOHOL CLIN EXP RES, V24, P1836, DOI 10.1097/00000374-200012000-00013; See RE, 2003, ANN NY ACAD SCI, V985, P294; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Shippenberg TS, 2002, NEUROPSYCHOPHARMACOL, P1381; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Valdez GR, 2002, ALCOHOL CLIN EXP RES, V26, P1494, DOI 10.1097/01.ALC.0000033120.51856.F0; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; World Health Organization, 2010, ICD 10 INT STAT CLAS	22	643	656	2	65	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1442	1444		10.1038/nn1105-1442	http://dx.doi.org/10.1038/nn1105-1442			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16251985				2022-12-17	WOS:000232966600013
J	Schoenbaum, G; Chiba, AA; Gallagher, M				Schoenbaum, G; Chiba, AA; Gallagher, M			Orbitofrontal cortex and basolateral amygdala encode expected outcomes during learning	NATURE NEUROSCIENCE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; FRONTAL-CORTEX; INFORMATION; LESIONS; RAT; REINFORCEMENT; PROJECTIONS; MONKEYS; MEMORY	Reciprocal connections between the orbitofrontal cortex and the basolateral nucleus of the amygdala may provide a critical circuit for the learning that underlies goal-directed behavior. We examined neural activity in rat orbitofrontal cortex and basolateral amygdala during instrumental learning in an olfactory discrimination task. Neurons in both regions fired selectively during the anticipation of rewarding or aversive outcomes. This selective activity emerged early in training, before the rats had learned reliably to avoid the aversive outcome. The results support the concept that the basolateral amygdala and orbitofrontal cortex cooperate to encode information that may be used to guide goal-directed behavior.	Johns Hopkins Univ, Dept Psychol, Baltimore, MD 21218 USA; Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA	Johns Hopkins University; University of California System; University of California San Diego	Schoenbaum, G (corresponding author), Johns Hopkins Univ, Dept Psychol, 3400 N Charles St,25 Ames Hall, Baltimore, MD 21218 USA.	schoenbg@jhu.edu						Balleine B. W., 1997, Society for Neuroscience Abstracts, V23, P786; Bechara A, 1998, J NEUROSCI, V18, P428; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Brown S., 1888, PHILOS T R SOC LON B, V179, P303; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1659, DOI 10.1152/jn.1996.75.4.1659; Damasio A. R., 1994, DECARTES ERROR; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J.M., 1985, CEREB CORTEX, V4, P151; FUSTER JM, 1982, EXP NEUROL, V77, P679, DOI 10.1016/0014-4886(82)90238-2; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Hatfield T, 1996, J NEUROSCI, V16, P5256; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; KLING A, 1972, NEUROBIOLOGY AMYGDAL, P611; Kluver H, 1939, ARCH NEURO PSYCHIATR, V42, P979; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; Kolb B., 1990, CEREBRAL CORTEX RAT, P437; KRETTEK JE, 1977, J COMP NEUROL, V172, P687, DOI 10.1002/cne.901720408; Malkova L, 1997, J NEUROSCI, V17, P6011; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; Miller EK, 1996, J NEUROSCI, V16, P5154; NIKI H, 1974, BRAIN RES, V70, P346, DOI 10.1016/0006-8993(74)90324-2; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; PRICE JL, 1987, HDB CHEM NEUROANATOM, V5, P279; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P751, DOI 10.1152/jn.1995.74.2.751; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0	30	643	649	3	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					155	159		10.1038/407	http://dx.doi.org/10.1038/407			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195132				2022-12-17	WOS:000076361100018
J	Liu, K; Lu, Y; Lee, JK; Samara, R; Willenberg, R; Sears-Kraxberger, I; Tedeschi, A; Park, KK; Jin, D; Cai, B; Xu, BG; Connolly, L; Steward, O; Zheng, BH; He, ZG				Liu, Kai; Lu, Yi; Lee, Jae K.; Samara, Ramsey; Willenberg, Rafer; Sears-Kraxberger, Ilse; Tedeschi, Andrea; Park, Kevin Kyungsuk; Jin, Duo; Cai, Bin; Xu, Bengang; Connolly, Lauren; Steward, Oswald; Zheng, Binhai; He, Zhigang			PTEN deletion enhances the regenerative ability of adult corticospinal neurons	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; NEURITE GROWTH-INHIBITORS; NOGO-DEFICIENT MICE; AXON REGENERATION; FUNCTIONAL RECOVERY; TRACT AXONS; IN-VIVO; RAT; PLASTICITY	Despite the essential role of the corticospinal tract (CST) in controlling voluntary movements, successful regeneration of large numbers of injured CST axons beyond a spinal cord lesion has never been achieved. We found that PTEN/mTOR are critical for controlling the regenerative capacity of mouse corticospinal neurons. After development, the regrowth potential of CST axons was lost and this was accompanied by a downregulation of mTOR activity in corticospinal neurons. Axonal injury further diminished neuronal mTOR activity in these neurons. Forced upregulation of mTOR activity in corticospinal neurons by conditional deletion of Pten, a negative regulator of mTOR, enhanced compensatory sprouting of uninjured CST axons and enabled successful regeneration of a cohort of injured CST axons past a spinal cord lesion. Furthermore, these regenerating CST axons possessed the ability to reform synapses in spinal segments distal to the injury. Thus, modulating neuronal intrinsic PTEN/mTOR activity represents a potential therapeutic strategy for promoting axon regeneration and functional repair after adult spinal cord injury.	[Liu, Kai; Lu, Yi; Tedeschi, Andrea; Park, Kevin Kyungsuk; Jin, Duo; Cai, Bin; Xu, Bengang; Connolly, Lauren; He, Zhigang] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Liu, Kai; Lu, Yi; Tedeschi, Andrea; Park, Kevin Kyungsuk; Jin, Duo; Cai, Bin; Xu, Bengang; Connolly, Lauren; He, Zhigang] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Lee, Jae K.; Samara, Ramsey; Zheng, Binhai] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Willenberg, Rafer; Sears-Kraxberger, Ilse; Steward, Oswald] Univ Calif Irvine, Coll Med, Reeve Irvine Res Ctr, Irvine, CA 92717 USA; [Willenberg, Rafer; Sears-Kraxberger, Ilse; Steward, Oswald] Univ Calif Irvine, Coll Med, Dept Anat & Neurobiol Neurobiol & Behav & Neurosu, Irvine, CA 92717 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California Irvine	He, ZG (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	zhigang.he@childrens.harvard.edu	Lu, Yi/AEV-5561-2022	Liu, Kai/0000-0001-9351-1640; Steward, Oswald/0000-0001-7069-8756	Wings for Life; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Craig H. Neilson Foundation; National Institute of Neurological Disorders and Stroke; International Spinal Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054734, F31NS070558, R01NS068128] Funding Source: NIH RePORTER	Wings for Life; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Craig H. Neilson Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); International Spinal Research Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Wang for providing Rosa-stop-PLAP mice and M. Greenberg, M. Tessier-Lavigne and C. Woolf for reading the manuscript. This work was supported by grants from Wings for Life (K.L. and Z.H.), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (Z.H.), the Craig H. Neilson Foundation (Y.L. and K.K.P.), the National Institute of Neurological Disorders and Stroke (Z.H., B.Z. and O.S.), the International Spinal Research Trust (Z.H.) and a private contribution to the Reeve-Irvine Research Center (O.S.). R.W. is the recipient of a predoctoral fellowship from the National Institute of Neurological Disorders and Stroke.	Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bareyre FM, 2005, NAT MED, V11, P1355, DOI 10.1038/nm1331; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Berger W, 1998, NEUROSCI BIOBEHAV R, V22, P579, DOI 10.1016/S0149-7634(97)00047-X; BERNSTEI.JJ, 1973, EXP NEUROL, V41, P402, DOI 10.1016/0014-4886(73)90282-3; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; BREGMAN BS, 1989, J COMP NEUROL, V282, P355, DOI 10.1002/cne.902820304; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; Fujiki M, 1996, J COMP NEUROL, V371, P469; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hasegawa H, 2008, J COMP NEUROL, V511, P543, DOI 10.1002/cne.21862; Hiebert GW, 2002, J NEUROSCI RES, V69, P160, DOI 10.1002/jnr.10275; Hollis ER, 2009, EXP NEUROL, V215, P53, DOI 10.1016/j.expneurol.2008.09.014; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Inman DM, 2003, J COMP NEUROL, V462, P431, DOI 10.1002/cne.10768; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Lee JK, 2009, J NEUROSCI, V29, P8649, DOI 10.1523/JNEUROSCI.1864-09.2009; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Persson S, 2006, J COMP NEUROL, V497, P683, DOI 10.1002/cne.20987; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; RICHARDSON PM, 1984, J NEUROCYTOL, V13, P165, DOI 10.1007/BF01148324; SAVIO T, 1990, P NATL ACAD SCI USA, V87, P4130, DOI 10.1073/pnas.87.11.4130; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Steward O, 2008, J NEUROSCI, V28, P6836, DOI 10.1523/JNEUROSCI.5372-07.2008; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; YIN HS, 1983, J NEUROSCI, V3, P1135; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; Zheng BH, 2006, TRENDS NEUROSCI, V29, P640, DOI 10.1016/j.tins.2006.09.005; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	48	642	678	5	117	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1075	U64		10.1038/nn.2603	http://dx.doi.org/10.1038/nn.2603			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20694004	Green Accepted, Green Submitted			2022-12-17	WOS:000281332600012
J	Maness, PF; Schachner, M				Maness, Patricia F.; Schachner, Melitta			Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration	NATURE NEUROSCIENCE			English	Review							CELL-ADHESION MOLECULE; NEURITE OUTGROWTH; CLOSE HOMOLOG; MICE DEFICIENT; CYTOPLASMIC DOMAIN; POLYSIALIC ACID; LIPID RAFTS; HOMOPHILIC BINDING; ANKYRIN BINDING; FGF RECEPTOR	Recognition molecules of the immunoglobulin superfamily have important roles in neuronal interactions during ontogeny, including migration, survival, axon guidance and synaptic targeting. Their downstream signal transduction events specify whether a cell changes its place of residence or projects axons and dendrites to targets in the brain, allowing the construction of a dynamic neural network. A wealth of recent discoveries shows that cell adhesion molecules interact with attractant and repellent guidance receptors to control growth cone and cell motility in a coordinate fashion. We focus on the best-studied subclasses, the neural cell adhesion molecule NCAM and the L1 family of adhesion molecules, which share important structural and functional features. We have chosen these paradigmatic molecules and their interactions with other recognition molecules as instructive for elucidating the mechanisms by which other recognition molecules may guide cell interactions during development or modify their function as a result of injury, learning and memory.	Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Neurosci Res Ctr, Chapel Hill, NC 27599 USA; Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; Rutgers State Univ, Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; Dalian Med Univ, Sino German Ctr Neurosci, Dalian 116011, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick; Dalian Medical University	Maness, PF (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	srclab@med.unc.edu			NIMH NIH HHS [MH064056] Funding Source: Medline; NINDS NIH HHS [NS049109] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049109] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson AA, 2005, J NEUROCHEM, V95, P570, DOI 10.1111/j.1471-4159.2005.03417.x; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; BEGGS HE, 1994, J CELL BIOL, V127, P825, DOI 10.1083/jcb.127.3.825; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Castellani V, 2004, MOL CELL NEUROSCI, V26, P89, DOI 10.1016/j.mcn.2004.01.010; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; Cheng L, 2005, J NEUROSCI, V25, P395, DOI 10.1523/JNEUROSCI.4097-04.2005; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; DahlinHuppe K, 1997, MOL CELL NEUROSCI, V9, P144, DOI 10.1006/mcne.1997.0608; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; Demyanenko GP, 2003, J NEUROSCI, V23, P530, DOI 10.1523/JNEUROSCI.23-02-00530.2003; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Diestel S, 2005, J NEUROCHEM, V95, P1777, DOI 10.1111/j.1471-4159.2005.03475.x; Doherty P, 2000, MOL CELL NEUROSCI, V16, P283, DOI 10.1006/mcne.2000.0907; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Falk J, 2004, MOL BIOL CELL, V15, P4695, DOI 10.1091/mbc.E04-03-0171; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Felding-Habermann B, 1997, J CELL BIOL, V139, P1567, DOI 10.1083/jcb.139.6.1567; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Garver TD, 1997, J CELL BIOL, V137, P703, DOI 10.1083/jcb.137.3.703; Gil OD, 2003, J CELL BIOL, V162, P719, DOI 10.1083/jcb.200211011; Gutwein P, 2000, J BIOL CHEM, V275, P15490, DOI 10.1074/jbc.275.20.15490; Heiz M, 2004, J BIOL CHEM, V279, P31149, DOI 10.1074/jbc.M403587200; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Hinkle CL, 2006, J NEUROBIOL, V66, P1378, DOI 10.1002/neu.20257; Huang ZJ, 2006, NAT NEUROSCI, V9, P163, DOI 10.1038/nn1638; Hubschmann MV, 2005, J NEUROSCI RES, V80, P826, DOI 10.1002/jnr.20530; Irintchev A, 2004, BRAIN RES, V1029, P131, DOI 10.1016/j.brainres.2004.09.042; Jacob J, 2002, J NEUROBIOL, V51, P177, DOI 10.1002/neu.10052; Jessen U, 2001, J NEUROCHEM, V79, P1149, DOI 10.1046/j.1471-4159.2001.00636.x; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Johnson CP, 2004, P NATL ACAD SCI USA, V101, P6963, DOI 10.1073/pnas.0307567100; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kalus I, 2006, J NEUROCHEM, V98, P78, DOI 10.1111/j.1471-4159.2006.03847.x; Kamiguchi H, 1998, J NEUROSCI, V18, P5311, DOI 10.1523/JNEUROSCI.18-14-05311.1998; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Kizhatil K, 2002, J NEUROSCI, V22, P7948; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kolkova K, 2000, J NEUROSCI, V20, P2238; Krushel LA, 1999, J BIOL CHEM, V274, P2432, DOI 10.1074/jbc.274.4.2432; Kurumaji A, 2001, AM J MED GENET, V105, P99; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Mintz CD, 2003, J COMP NEUROL, V464, P438, DOI 10.1002/cne.10809; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Nakai Y, 2002, J CELL BIOL, V159, P1097, DOI 10.1083/jcb.200209077; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; Needham LK, 2001, J NEUROSCI, V21, P1490, DOI 10.1523/JNEUROSCI.21-05-01490.2001; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Nishimura K, 2003, J CELL BIOL, V163, P1077, DOI 10.1083/jcb.200303060; Panicker AK, 2006, EXP CELL RES, V312, P299, DOI 10.1016/j.yexcr.2005.10.031; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; PERSOHN E, 1989, J COMP NEUROL, V288, P92, DOI 10.1002/cne.902880108; Petridis AK, 2004, DEV DYNAM, V230, P675, DOI 10.1002/dvdy.20094; Pillai-Nair N, 2005, J NEUROSCI, V25, P4659, DOI 10.1523/JNEUROSCI.0565-05.2005; Polo-Parada L, 2005, NEURON, V46, P917, DOI 10.1016/j.neuron.2005.05.018; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Pratte M, 2003, BEHAV BRAIN RES, V147, P31, DOI 10.1016/S0166-4328(03)00114-1; RAO Y, 1994, J BIOL CHEM, V269, P27540; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rolf B, 2002, J NEUROSCI, V22, P8357; Saffell JL, 1997, NEURON, V18, P231, DOI 10.1016/S0896-6273(00)80264-0; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Sakurai T, 2001, J CELL BIOL, V154, P1259, DOI 10.1083/jcb.200104122; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schafer DP, 2004, J NEUROSCI, V24, P3176, DOI 10.1523/JNEUROSCI.5427-03.2004; SCHAGEN P, 1974, ADV IMAGE PICKUP DIS, V1, P1; Schmid RS, 2000, J NEUROSCI, V20, P4177; Schmid RS, 2004, NEUROREPORT, V15, P2791; Schmid RS, 1999, J NEUROBIOL, V38, P542, DOI 10.1002/(SICI)1097-4695(199903)38:4<542::AID-NEU9>3.3.CO;2-T; SCHUCH U, 1989, NEURON, V3, P13, DOI 10.1016/0896-6273(89)90111-6; Silletti S, 2004, J BIOL CHEM, V279, P28880, DOI 10.1074/jbc.M404075200; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Stork O, 1999, J NEUROBIOL, V40, P343, DOI 10.1002/(SICI)1097-4695(19990905)40:3<343::AID-NEU6>3.0.CO;2-S; Stork O, 1997, EUR J NEUROSCI, V9, P1117, DOI 10.1111/j.1460-9568.1997.tb01464.x; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Whittard JD, 2006, MOL BIOL CELL, V17, P2696, DOI 10.1091/mbc.E06-01-0090; Wiencken-Barger AE, 2004, CEREB CORTEX, V14, P121, DOI 10.1093/cercor/bhg110; Williams SE, 2006, NEURON, V50, P535, DOI 10.1016/j.neuron.2006.03.037; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017	100	642	657	1	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2007	10	1					19	26		10.1038/nn1827	http://dx.doi.org/10.1038/nn1827			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120PC	17189949				2022-12-17	WOS:000243096100010
J	Rao, SM; Mayer, AR; Harrington, DL				Rao, SM; Mayer, AR; Harrington, DL			The evolution of brain activation during temporal processing	NATURE NEUROSCIENCE			English	Article							TIME-ESTIMATION; WORKING-MEMORY; MOTOR; CEREBELLUM; ATTENTION; MOVEMENT; DISCRIMINATION; REPRESENTATION; INFORMATION; PERCEPTION	Timing is crucial to many aspects of human performance. To better understand its neural underpinnings, we used event-related fMRI to examine the time course of activation associated with different components of a time perception task. We distinguished systems associated with encoding time intervals from those related to comparing intervals and implementing a response. Activation in the basal ganglia occurred early, and was uniquely associated with encoding time intervals, whereas cerebellar activation unfolded late, suggesting an involvement in processes other than explicit timing. Early cortical activation associated with encoding of time intervals was observed in the right inferior parietal cortex and bilateral premotor cortex, implicating these systems in attention and temporary maintenance of intervals. Late activation in the right dorsolateral prefrontal cortex emerged during comparison of time intervals. Our results illustrate a dynamic network of cortical-subcortical activation associated with different components of temporal information processing.	Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Dept Vet Affairs, Albuquerque, NM 87108 USA; Univ New Mexico, Dept Neurol, Albuquerque, NM 87113 USA	Medical College of Wisconsin; University of New Mexico	Harrington, DL (corresponding author), Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA.	dharring@unm.edu	Rao, Stephen M/A-2460-2010	Rao, Stephen M/0000-0002-6463-7460; Harrington, Deborah/0000-0001-9658-9080	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057836, P01MH051358] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00058] Funding Source: Medline; NIMH NIH HHS [R01 MH57836, P01 MH51358] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Awh E, 1995, ANN NY ACAD SCI, V769, P97, DOI 10.1111/j.1749-6632.1995.tb38134.x; Baddeley Alan, 1986, WORKING MEMORY; Bower JM, 1997, PROG BRAIN RES, V114, P463; BRODAL P, 1979, NEUROSCIENCE, V4, P193, DOI 10.1016/0306-4522(79)90082-4; BROWN SW, 1985, PERCEPT PSYCHOPHYS, V38, P115, DOI 10.3758/BF03198848; BRUNIA CHM, 1988, ELECTROEN CLIN NEURO, V69, P234, DOI 10.1016/0013-4694(88)90132-0; Casini L, 1997, MEM COGNITION, V25, P812, DOI 10.3758/BF03211325; Casini L, 1999, NEUROPSYCHOLOGY, V13, P10, DOI 10.1037/0894-4105.13.1.10; CAVADA C, 1991, NEUROSCIENCE, V42, P683, DOI 10.1016/0306-4522(91)90037-O; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Desmond JE, 1997, J NEUROSCI, V17, P9675; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Harrington DL, 1998, J NEUROSCI, V18, P1085; Harrington DL, 1999, REV NEUROSCIENCE, V10, P91, DOI 10.1515/REVNEURO.1999.10.2.91; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; JUEPTNER M, 1995, NEUROLOGY, V45, P1540, DOI 10.1212/WNL.45.8.1540; Larsson J, 1996, NEUROREPORT, V7, P463, DOI 10.1097/00001756-199601310-00021; Lejeune H, 1997, NEUROSCI LETT, V235, P21, DOI 10.1016/S0304-3940(97)00698-8; Malapani C, 1998, J COGNITIVE NEUROSCI, V10, P316, DOI 10.1162/089892998562762; Malapani C, 1998, NEUROREPORT, V9, P3907, DOI 10.1097/00001756-199812010-00026; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Manto M, 1996, EUR NEUROL, V36, P333, DOI 10.1159/000117289; Maquet P, 1996, NEUROIMAGE, V3, P119, DOI 10.1006/nimg.1996.0014; MARICQ AV, 1983, PSYCHOPHARMACOLOGY, V79, P10, DOI 10.1007/BF00433008; Matell MS, 2000, BIOESSAYS, V22, P94, DOI 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E; MECK WH, 1987, J NEUROSCI, V7, P3505; MECK WH, 1986, PHARMACOL BIOCHEM BE, V25, P1185, DOI 10.1016/0091-3057(86)90109-7; MOHL W, 1991, NEUROREPORT, V2, P309, DOI 10.1097/00001756-199106000-00002; NARABAYASHI H, 1985, CLIN NEUROPHYSIOL, P45; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; PASTOR MA, 1992, BRAIN, V115, P875, DOI 10.1093/brain/115.3.875; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; POSNER MI, 1984, J NEUROSCI, V4, P1863; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Rao SM, 1997, J NEUROSCI, V17, P5528; Schmahmann J. D., 1997, CEREBELLUM COGNITION; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Talairach J., 1988, COPLANAR STEREOTAXIC; Wearden JH, 1999, BEHAV PROCESS, V45, P3, DOI 10.1016/S0376-6357(99)00006-6; Zakay D., 1996, ADV PSYCHOL, V115, P143, DOI [10.1016/S0166-4115(96)80057-4, DOI 10.1016/S0166-4115(96)80057-4]	50	642	647	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					317	323		10.1038/85191	http://dx.doi.org/10.1038/85191			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405UE	11224550	Green Published			2022-12-17	WOS:000167178300021
J	Akopian, AN; Souslova, V; England, S; Okuse, K; Ogata, N; Ure, J; Smith, A; Kerr, BJ; McMahon, SB; Boyce, S; Hill, R; Stanfa, LC; Dickenson, AH; Wood, JN				Akopian, AN; Souslova, V; England, S; Okuse, K; Ogata, N; Ure, J; Smith, A; Kerr, BJ; McMahon, SB; Boyce, S; Hill, R; Stanfa, LC; Dickenson, AH; Wood, JN			The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways	NATURE NEUROSCIENCE			English	Article							ROOT GANGLION NEURONS; PRIMARY SENSORY NEURONS; TTX-RESISTANT; NERVE INJURY; NA+ CURRENTS; SMALL-CELLS; RAT; EXPRESSION; DISRUPTION; POTENTIALS	Many damage-sensing neurons express tetrodotoxin (TTX)-resistant voltage-gated sodium channels. Here we examined the role of the sensory-neuron-specific (SNS) TTX-resistant sodium channel a subunit in nociception and pain by constructing sns-null mutant mice. These mice expressed only TTX-sensitive sodium currents on step depolarizations from normal resting potentials, showing that all slow TTX-resistant currents are encoded by the sns gene. Null mutants were viable, fertile and apparently normal, although lowered thresholds of electrical activation of C-fibers and increased current densities of TTX-sensitive channels demonstrated compensatory upregulation of TTX-sensitive currents in sensory neurons. Behavioral studies demonstrated a pronounced analgesia to noxious mechanical stimuli, small deficits in noxious thermoreception and delayed development of inflammatory hyperalgesia. These data show that SNS is involved in pain pathways and suggest that blockade of SNS expression or function may produce analgesia without side effects.	UCL, Dept Biol, Mol Nocicept Grp, London WC1E 6BT, England; Hiroshima Univ, Fac Med, Dept Physiol 2, Hiroshima 734, Japan; Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland; United Med & Dent Sch Guys & St Thomas Hosp, St Thomas Hosp, Sch Med, Dept Physiol, London SE1 7EH, England; Merck Sharp & Dohme Res Labs, Harlow CM20 2QR, Essex, England; UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London; Hiroshima University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Merck & Company; University of London; University College London	Wood, JN (corresponding author), UCL, Dept Biol, Mol Nocicept Grp, Medawar Bldg, London WC1E 6BT, England.	j.wood@ucl.ac.uk		McMahon, Stephen/0000-0003-4656-5536	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akopian AN, 1997, FEBS LETT, V400, P183, DOI 10.1016/S0014-5793(96)01389-0; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Boyce S, 1999, EXP NEUROL, V155, P49, DOI 10.1006/exnr.1998.6873; Brau ME, 1998, EUR J ANAESTH, V15, P80; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Cummins TR, 1997, J NEUROSCI, V17, P3503; Dib-Hajj SD, 1998, P NATL ACAD SCI USA, V95, P8963, DOI 10.1073/pnas.95.15.8963; ELLIOTT AA, 1993, J PHYSIOL-LONDON, V463, P39, DOI 10.1113/jphysiol.1993.sp019583; England S, 1996, J PHYSIOL-LONDON, V495, P429, DOI 10.1113/jphysiol.1996.sp021604; FUKUDA J, 1980, BRAIN RES, V182, P191, DOI 10.1016/0006-8993(80)90844-6; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gold MS, 1996, J NEUROPHYSIOL, V75, P2629, DOI 10.1152/jn.1996.75.6.2629; Gold MS, 1996, P NATL ACAD SCI USA, V93, P1108, DOI 10.1073/pnas.93.3.1108; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; JEFTINIJA S, 1994, BRAIN RES, V665, P69, DOI 10.1016/0006-8993(94)91153-3; Khasar SG, 1998, NEUROSCI LETT, V256, P17, DOI 10.1016/S0304-3940(98)00738-1; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MATSUDA Y, 1978, BRAIN RES, V154, P69, DOI 10.1016/0006-8993(78)91052-1; OGATA N, 1993, J PHYSIOL-LONDON, V466, P9; OGATA N, 1992, DEV BRAIN RES, V65, P93, DOI 10.1016/0165-3806(92)90012-L; Okuse K, 1997, PROG PAIN RES MANAG, V9, P239; PEARCE RJ, 1994, NEUROSCIENCE, V63, P1041, DOI 10.1016/0306-4522(94)90571-1; QUASTHOFF S, 1995, NEUROSCIENCE, V69, P955, DOI 10.1016/0306-4522(95)00307-5; RIZZO MA, 1994, J NEUROPHYSIOL, V72, P2796, DOI 10.1152/jn.1994.72.6.2796; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; ROY ML, 1992, J NEUROSCI, V12, P2104; Rupniak NMJ, 1997, PAIN, V71, P89, DOI 10.1016/S0304-3959(97)03343-5; Rush AM, 1998, J PHYSIOL-LONDON, V511, P771, DOI 10.1111/j.1469-7793.1998.771bg.x; Sangameswaran L, 1996, J BIOL CHEM, V271, P5953, DOI 10.1074/jbc.271.11.5953; Scholz A, 1998, EUR J NEUROSCI, V10, P2547, DOI 10.1046/j.1460-9568.1998.t01-1-00268.x; Scholz A, 1998, J NEUROPHYSIOL, V79, P1746, DOI 10.1152/jn.1998.79.4.1746; Souslova VA, 1997, GENOMICS, V41, P201, DOI 10.1006/geno.1997.4669; Stanfa LC, 1996, BRAIN RES, V737, P92, DOI 10.1016/0006-8993(96)00629-4; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Tate S, 1998, NAT NEUROSCI, V1, P653, DOI 10.1038/3652; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	39	642	676	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					541	548		10.1038/9195	http://dx.doi.org/10.1038/9195			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448219				2022-12-17	WOS:000084735900014
J	Diano, S; Farr, SA; Benoit, SC; McNay, EC; da Silva, I; Horvath, B; Gaskin, FS; Nonaka, N; Jaeger, LB; Banks, WA; Morley, JE; Pinto, S; Sherwin, RS; Xu, L; Yamada, KA; Sleeman, MW; Tschop, MH; Horvath, TL				Diano, S; Farr, SA; Benoit, SC; McNay, EC; da Silva, I; Horvath, B; Gaskin, FS; Nonaka, N; Jaeger, LB; Banks, WA; Morley, JE; Pinto, S; Sherwin, RS; Xu, L; Yamada, KA; Sleeman, MW; Tschop, MH; Horvath, TL			Ghrelin controls hippocampal spine synapse density and memory performance	NATURE NEUROSCIENCE			English	Article							SPONTANEOUS-ALTERNATION; GLUCOSE-CONCENTRATION; INTRASEPTAL MORPHINE; GROWTH-HORMONE; ACETYLCHOLINE OUTPUT; SPATIAL MEMORY; MEDIAL SEPTUM; BRAIN; ATTENUATION; INFUSIONS	The gut hormone and neuropeptide ghrelin affects energy balance and growth hormone release through hypothalamic action that involves synaptic plasticity in the melanocortin system. Ghrelin binding is also present in other brain areas, including the telencephalon, where its function remains elusive. Here we report that circulating ghrelin enters the hippocampus and binds to neurons of the hippocampal formation, where it promotes dendritic spine synapse formation and generation of long-term potentiation. These ghrelin-induced synaptic changes are paralleled by enhanced spatial learning and memory. Targeted disruption of the gene that encodes ghrelin resulted in decreased numbers of spine synapses in the CA1 region and impaired performance of mice in behavioral memory testing, both of which were rapidly reversed by ghrelin administration. Our observations reveal an endogenous function of ghrelin that links metabolic control with higher brain functions and suggest novel therapeutic strategies to enhance learning and memory processes.	Yale Univ, Sch Med, Dept Obstet & Gynecol & Reprod Sci, New Haven, CT 06520 USA; VA Med Ctr, GRECC, St Louis, MO 63106 USA; St Louis Univ, Sch Med, Div Geriatr Med, Dept Internal Med, St Louis, MO 63103 USA; Univ Cincinnati, Dept Psychiat, Cincinnati, OH 45237 USA; Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Rockefeller Univ, Howard Hughes Med Inst, Dept Mol Genet, New York, NY 10021 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA	Yale University; Geriatric Research Education & Clinical Center; Saint Louis University; University System of Ohio; University of Cincinnati; Yale University; Howard Hughes Medical Institute; Rockefeller University; Regeneron; Washington University (WUSTL); Yale University; Yale University	Horvath, TL (corresponding author), Yale Univ, Sch Med, Dept Obstet & Gynecol & Reprod Sci, 333 Cedar St, New Haven, CT 06520 USA.	tamas.horvath@yale.edu	Banks, William A/K-1330-2017; Silva, Ivaldo/E-4143-2012; Morley, John Edward/K-1570-2019; Tschoep, Matthias H/I-5443-2014; Horvath, Balazs/GQH-5692-2022; morley, john e/F-9177-2011; Xu, Lin/C-4662-2011	Banks, William A/0000-0002-0496-3619; Silva, Ivaldo/0000-0002-2370-943X; morley, john e/0000-0001-6444-2965; Farr, Susan/0000-0002-0481-2570; Horvath, Balazs/0000-0002-1566-6564; Tschoep, Matthias/0000-0002-4744-371X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061619, R01DK060711, R01DK070039, T35DK007386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041725, R01NS040525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012743] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA12743] Funding Source: Medline; NIA NIH HHS [AG22880] Funding Source: Medline; NIDDK NIH HHS [DK7386, DK61619, DK70039, DK60711] Funding Source: Medline; NINDS NIH HHS [NS40525, NS41725] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; BOSTOCK E, 1988, BEHAV NEUROSCI, V102, P643, DOI 10.1037/0735-7044.102.5.643; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Farr SA, 2000, BRAIN RES, V872, P242, DOI 10.1016/S0006-8993(00)02495-1; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Grove KL, 2005, J CLIN INVEST, V115, P3393, DOI 10.1172/JCI27211; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Horvath TL, 2003, CURR PHARM DESIGN, V9, P1383, DOI 10.2174/1381612033454748; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Li CJ, 2004, P NATL ACAD SCI USA, V101, P2185, DOI 10.1073/pnas.0307313101; McNay EC, 2001, J GERONTOL A-BIOL, V56, pB66, DOI 10.1093/gerona/56.2.B66; McNay EC, 2001, NEUROBIOL LEARN MEM, V75, P325, DOI 10.1006/nlme.2000.3976; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; McNay EC, 1998, J NEUROSCI, V18, P3853; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; Morley JE, 2000, PEPTIDES, V21, P1761, DOI 10.1016/S0196-9781(00)00342-9; MYHRER T, 1988, BEHAV NEUROSCI, V102, P356, DOI 10.1037/0735-7044.102.3.356; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; RAGOZZINO ME, 1995, NEUROSCIENCE, V68, P981, DOI 10.1016/0306-4522(95)00204-V; RAGOZZINO ME, 1994, BRAIN RES, V655, P77, DOI 10.1016/0006-8993(94)91599-7; Ragozzino ME, 1995, BEHAV NEUROSCI, V109, P1074; RAGOZZINO ME, 1992, BRAIN RES, V597, P241, DOI 10.1016/0006-8993(92)91480-3; Reed JM, 1997, BEHAV NEUROSCI, V111, P667, DOI 10.1037/0735-7044.111.4.667; Rigamonti AE, 2002, J ENDOCRINOL, V175, pR1, DOI 10.1677/joe.0.175R001; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; Seyler DE, 2000, DRUG DEVELOP RES, V49, P260, DOI 10.1002/1098-2299(200004)49:4<260::AID-DDR5>3.0.CO;2-6; Talley CP, 1999, NEUROBIOL LEARN MEM, V71, P62, DOI 10.1006/nlme.1998.3861; Thio LL, 2000, NEUROLOGY, V54, P325, DOI 10.1212/WNL.54.2.325; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; WAN RQ, 1995, NEUROBIOL LEARN MEM, V63, P74, DOI 10.1006/nlme.1995.1007; Wortley KE, 2004, P NATL ACAD SCI USA, V101, P8227, DOI 10.1073/pnas.0402763101; Wortley KE, 2005, J CLIN INVEST, V115, P3573, DOI 10.1172/JCI26003; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	42	641	671	0	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					381	388		10.1038/nn1656	http://dx.doi.org/10.1038/nn1656			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16491079				2022-12-17	WOS:000235645600018
J	Koos, T; Tepper, JM				Koos, T; Tepper, JM			Inhibitory control of neostriatal projection neurons by GABAergic interneurons	NATURE NEUROSCIENCE			English	Article							PARVALBUMIN-IMMUNOREACTIVE NEURONS; JUNCTION POTENTIAL CORRECTIONS; INVITRO SLICE PREPARATION; MEDIUM SPINY NEURONS; RAT NEOSTRIATUM; MEMBRANE-PROPERTIES; STRIATAL NEURONS; POSTNATAL-DEVELOPMENT; SYNAPTIC CONNECTIONS; NUCLEUS-ACCUMBENS	The basal ganglia are a highly interconnected network of nuclei essential for the modulation and execution of voluntary behavior. The neostriatum is the principal input and one of the principal controllers of the output of the basal ganglia. Neostriatal projection neurons seem to be dynamically and powerfully controlled by GABAergic inputs, but the source(s) and physiological properties of these inputs remain unclear. Here we use paired whole-cell recordings to show that this inhibition derives from small populations of GABAergic interneurons that are themselves interconnected through functional electrotonic synapses. Inhibitory synaptic potentials generated from single interneurons are sufficiently powerful to delay or entirely block the generation of action potentials in a large number of projection neurons simultaneously.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Rutgers State Univ, Program Cellular & Mol Biodynam, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick	Tepper, JM (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.		Tepper, James/AAA-3828-2019	Tepper, James/0000-0002-8643-4082	NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH058885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034865] Funding Source: NIH RePORTER; NIMH NIH HHS [MH58885] Funding Source: Medline; NINDS NIH HHS [NS34865] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BENNETT BD, 1994, NEUROSCIENCE, V62, P707, DOI 10.1016/0306-4522(94)90471-5; Bevan MD, 1998, J NEUROSCI, V18, P9438; BOLAM JP, 1993, MOL CELLULAR MECH NE, P1; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P651, DOI 10.1152/jn.1990.63.4.651; CHANG HT, 1992, BRAIN RES, V574, P307, DOI 10.1016/0006-8993(92)90830-3; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; DODT HU, 1990, BRAIN RES, V537, P333, DOI 10.1016/0006-8993(90)90380-T; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gerfen C.R., 1996, HDB CHEM NEUROANAT, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; GROVES PM, 1983, BRAIN RES REV, V5, P109, DOI 10.1016/0165-0173(83)90011-5; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; JAEER D, 1994, J NEUROPHYSIOL, V72, P1; JIANG ZG, 1991, J PHYSIOL-LONDON, V443, P533, DOI 10.1113/jphysiol.1991.sp018850; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Kincaid AE, 1998, J NEUROSCI, V18, P4722, DOI 10.1523/jneurosci.18-12-04722.1998; KITA H, 1985, EXP BRAIN RES, V60, P54; KITA H, 1993, PROG BRAIN RES, V99, P51; Kita H, 1996, NEUROSCIENCE, V70, P925, DOI 10.1016/0306-4522(95)00410-6; KITA H, 1990, BRAIN RES, V536, P1, DOI 10.1016/0006-8993(90)90002-S; KITA T, 1984, BRAIN RES, V300, P129, DOI 10.1016/0006-8993(84)91347-7; LENZ S, 1994, SYNAPSE, V18, P55, DOI 10.1002/syn.890180108; LIGHTHALL JW, 1981, BRAIN RES, V212, P182, DOI 10.1016/0006-8993(81)90048-2; LIGHTHALL JW, 1983, BRAIN RES BULL, V11, P103, DOI 10.1016/0361-9230(83)90058-8; Miles R, 1996, CURR OPIN NEUROBIOL, V6, P387, DOI 10.1016/S0959-4388(96)80124-3; NG B, 1995, J NEUROSCI METH, V56, P37, DOI 10.1016/0165-0270(94)00087-W; Nicola SM, 1997, J NEUROSCI, V17, P5697; NISENBAUM ES, 1994, J NEUROPHYSIOL, V71, P1174, DOI 10.1152/jn.1994.71.3.1174; NISENBAUM ES, 1992, NEUROSCIENCE, V48, P561, DOI 10.1016/0306-4522(92)90402-N; Oorschot DE, 1996, J COMP NEUROL, V366, P580, DOI 10.1002/(SICI)1096-9861(19960318)366:4<580::AID-CNE3>3.0.CO;2-0; Parthasarathy HB, 1997, J NEUROSCI, V17, P2477; PENNARTZ CMA, 1992, J NEUROPHYSIOL, V67, P1325, DOI 10.1152/jn.1992.67.5.1325; Plenz D, 1998, J NEUROSCI, V18, P266; Rinzel J, 1998, SCIENCE, V279, P1351, DOI 10.1126/science.279.5355.1351; TEPPER JM, 1993, PROG BRAIN RES, V99, P35; Tepper JM, 1998, DEV NEUROSCI-BASEL, V20, P125, DOI 10.1159/000017308; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; WICKENS JR, 1995, SYNAPSE, V20, P281, DOI 10.1002/syn.890200402; Wilson C. J., 1992, SINGLE NEURON COMPUT, P141, DOI [10.1016/B978-0-12-484815-3.50012-8, DOI 10.1016/B978-0-12-484815-3.50012-8]; WILSON CJ, 1983, EXP BRAIN RES, V51, P217; Wilson CJ, 1996, J NEUROSCI, V16, P2397; WILSON CJ, 1980, J COMP NEUROL, V194, P599, DOI 10.1002/cne.901940308; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; YAMADA H, 1995, BRAIN RES, V677, P333, DOI 10.1016/0006-8993(95)00190-2; YOSHIDA M, 1991, NEUROSCI RES, V10, P34, DOI 10.1016/0168-0102(91)90018-T	48	641	651	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					467	472		10.1038/8138	http://dx.doi.org/10.1038/8138			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321252				2022-12-17	WOS:000084609400018
J	Kang, J; Jiang, L; Goldman, SA; Nedergaard, M				Kang, J; Jiang, L; Goldman, SA; Nedergaard, M			Astrocyte-mediated potentiation of inhibitory synaptic transmission	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CULTURED ASTROCYTES; HIPPOCAMPUS INVITRO; CALCIUM WAVES; IN-SITU; NEURONS; CELLS; STIMULATION; SYNAPSES	We investigated the role of astrocytes in activity-dependent modulation of inhibitory synaptic transmission in hippocampal slices. Repetitive firing of an interneuron decreased the probability of synaptic failures in spike-evoked inhibitory postsynaptic currents (unitary IPSCs) in CA1 pyramidal neurons. The GABA(B)-receptor antagonist CCP55845A abolished this effect. Direct stimulation of astrocytes, or application of the GABA(B)-receptor agonist baclofen, potentiated miniature inhibitory postsynaptic currents (mIPSCs) in pyramidal neurons. These effects were blocked by inhibition of astrocytic calcium signaling with the calcium chelator BAPTA or by antagonists of the ionotropic glutamate receptors. These observations suggest that interneuronal firing elicits a GABA(B)-receptor-mediated elevation of calcium in surrounding astrocytes, which in turn potentiates inhibitory transmission. Astrocytes may therefore be a necessary intermediary in activity-dependent modulation of inhibitory synapses in the hippocampus.	New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA; Cornell Univ, Coll Med, Dept Neurol & Neurosci, New York, NY 10021 USA	New York Medical College; Cornell University	Kang, J (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Basic Sci Bldg,Room 204, Valhalla, NY 10595 USA.	jian_kang@NYMC.edu		Goldman, Steven/0000-0002-5498-4303	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS037349, R01NS035011, R01NS030007] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS30007, IR29NS37349-01, R01NS35011] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina ML, 1998, J NEUROSCI, V18, P2520; Cox CL, 1997, P NATL ACAD SCI USA, V94, P8854, DOI 10.1073/pnas.94.16.8854; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DAVIES CH, 1993, J PHYSIOL-LONDON, V472, P245, DOI 10.1113/jphysiol.1993.sp019945; FLEIDERVISH IA, 1995, J NEUROPHYSIOL, V73, P2591, DOI 10.1152/jn.1995.73.6.2591; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Jeftinija SD, 1996, J NEUROCHEM, V66, P676; Kang J, 1996, J NEUROPHYSIOL, V76, P188, DOI 10.1152/jn.1996.76.1.188; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; KOMATSU Y, 1994, J NEUROSCI, V14, P6488; KORN H, 1992, P NATL ACAD SCI USA, V89, P440, DOI 10.1073/pnas.89.1.440; KORN SJ, 1987, J NEUROPHYSIOL, V57, P325, DOI 10.1152/jn.1987.57.1.325; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MCCARREN M, 1985, J NEUROPHYSIOL, V53, P557, DOI 10.1152/jn.1985.53.2.557; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MILES R, 1991, J PHYSIOL-LONDON, V443, P669, DOI 10.1113/jphysiol.1991.sp018857; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Newman EA, 1998, J NEUROSCI, V18, P4022; NILSSON M, 1993, NEUROSCIENCE, V54, P605, DOI 10.1016/0306-4522(93)90232-5; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pasti L, 1997, J NEUROSCI, V17, P7817; Porter JT, 1996, J NEUROSCI, V16, P5073; Pouzat C, 1997, J NEUROSCI, V17, P9104; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; THOMPSON SM, 1985, J NEUROSCI, V5, P817; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; WONG RKS, 1982, J NEUROPHYSIOL, V48, P938, DOI 10.1152/jn.1982.48.4.938; Xie Z, 1995, CAN J PHYSIOL PHARM, V73, P1706, DOI 10.1139/y95-734	35	641	660	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1998	1	8					683	692		10.1038/3684	http://dx.doi.org/10.1038/3684			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	144PR	10196584				2022-12-17	WOS:000077323400012
J	Mi, S; Lee, X; Shao, ZH; Thill, G; Ji, BX; Relton, J; Levesque, M; Allaire, N; Perrin, S; Sands, B; Crowell, T; Cate, RL; McCoy, JM; Pepinsky, RB				Mi, S; Lee, X; Shao, ZH; Thill, G; Ji, BX; Relton, J; Levesque, M; Allaire, N; Perrin, S; Sands, B; Crowell, T; Cate, RL; McCoy, JM; Pepinsky, RB			LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex	NATURE NEUROSCIENCE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; OUTGROWTH INHIBITOR; NEURITE OUTGROWTH; AXON REGENERATION; RHO GTPASES; GROWTH; PROTEINS; PROMOTES; GUIDANCE; BINDING	Axon regeneration in the adult CNS is prevented by inhibitors in myelin. These inhibitors seem to modulate RhoA activity by binding to a receptor complex comprising a ligand-binding subunit (the Nogo-66 receptor NgR1) and a signal transducing subunit (the neurotrophin receptor p75). However, in reconstituted non-neuronal systems, NgR1 and p75 together are unable to activate RhoA, suggesting that additional components of the receptor may exist. Here we describe LINGO-1, a nervous system-specific transmembrane protein that binds NgR1 and p75 and that is an additional functional component of the NgR1/p75 signaling complex. In non-neuronal cells, coexpression of human NgR1, p75 and LINGO-1 conferred responsiveness to oligodendrocyte myelin glycoprotein, as measured by RhoA activation. A dominant-negative human LINGO-1 construct attenuated myelin inhibition in transfected primary neuronal cultures. This effect on neurons was mimicked using an exogenously added human LINGO-1-Fc fusion protein. Together these observations suggest that LINGO-1 has an important role in CNS biology.	Biogen Idec Inc, Dept Discovery Biol, Cambridge, MA 02142 USA	Biogen	Mi, S (corresponding author), Biogen Idec Inc, Dept Discovery Biol, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	sha.mi@biogenidec.com	Sands, Bruce/R-7887-2019	Sands, Bruce/0000-0001-5762-5042				AGUAYO AJ, 1981, J EXP BIOL, V95, P231; Arcaro A, 1998, J BIOL CHEM, V273, P805, DOI 10.1074/jbc.273.2.805; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Chauhan NB, 2003, NEUROCHEM INT, V43, P225, DOI 10.1016/S0197-0186(03)00006-8; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chisholm A, 1999, CURR OPIN NEUROBIOL, V9, P603, DOI 10.1016/S0959-4388(99)00021-5; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hunt D, 2002, J NEUROCYTOL, V31, P93, DOI 10.1023/A:1023941421781; Ivanisevic L, 2003, ONCOGENE, V22, P5677, DOI 10.1038/sj.onc.1206864; KULAPANULA J, 2003, J CELL BIOL, V160, P963; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Liu BP, 2001, CURR OPIN CELL BIOL, V13, P619, DOI 10.1016/S0955-0674(00)00260-X; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Nguyen-Ba-Charvet KT, 2002, J PHYSIOL-PARIS, V96, P91, DOI 10.1016/S0928-4257(01)00084-5; Ono T, 2003, J NEUROSCI, V23, P5887; Pignot V, 2003, J NEUROCHEM, V85, P717, DOI 10.1046/j.1471-4159.2003.01710.x; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ricci A, 2004, AM J RESP CELL MOL, V30, P12, DOI 10.1165/rcmb.2002-0110OC; Robinson LLL, 2003, J CLIN ENDOCR METAB, V88, P3943, DOI 10.1210/jc.2003-030196; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010	38	640	717	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2004	7	3					221	228		10.1038/nn1188	http://dx.doi.org/10.1038/nn1188			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	777UU	14966521				2022-12-17	WOS:000189197900011
J	Alexander, WH; Brown, JW				Alexander, William H.; Brown, Joshua W.			Medial prefrontal cortex as an action-outcome predictor	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; SUPPLEMENTARY EYE FIELD; TIME-ESTIMATION TASK; ERROR LIKELIHOOD; NEURONAL-ACTIVITY; COGNITIVE CONTROL; DECISION-MAKING; CONFLICT; PERFORMANCE; REWARD	The medial prefrontal cortex (mPFC) and especially anterior cingulate cortex is central to higher cognitive function and many clinical disorders, yet its basic function remains in dispute. Various competing theories of mPFC have treated effects of errors, conflict, error likelihood, volatility and reward, using findings from neuroimaging and neurophysiology in humans and monkeys. No single theory has been able to reconcile and account for the variety of findings. Here we show that a simple model based on standard learning rules can simulate and unify an unprecedented range of known effects in mPFC. The model reinterprets many known effects and suggests a new view of mPFC, as a region concerned with learning and predicting the likely outcomes of actions, whether good or bad. Cognitive control at the neural level is then seen as a result of evaluating the probable and actual outcomes of one's actions.	[Alexander, William H.; Brown, Joshua W.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Brown, JW (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	jwmbrown@indiana.edu	Brown, Joshua/G-2867-2011		Air Force Office of Scientific Research [FA9550-07-1-0454, R03 DA023462, R01 DA026457]; NARSAD; Sidney R. Baer Jr. Foundation; Department of the Interior (DOI) [D10PC20023]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA023462, R01DA026457] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NARSAD(NARSAD); Sidney R. Baer Jr. Foundation; Department of the Interior (DOI); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Pessoa, S. Padmala, T. Braver, V. Stuphorn, A. Krawitz, D. Nee and the J. Schall laboratory for critical feedback. Supported in part by Air Force Office of Scientific Research FA9550-07-1-0454 (J. W. B.), R03 DA023462 (J. W. B.), R01 DA026457 (J. W. B.), a NARSAD Young Investigator Award (J. W. B.) and the Sidney R. Baer Jr. Foundation (J. W. B.). Supported by the Intelligence Advanced Research Projects Activity (IARPA) through Department of the Interior (DOI) contract D10PC20023. The US Government is authorized to reproduce and distribute reprints for Governmental purposes notwithstanding any copyright annotation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of IARPA, DOI or the US Government.	Aarts E, 2008, J NEUROSCI, V28, P4671, DOI 10.1523/JNEUROSCI.4400-07.2008; Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Brown JW, 2007, COGN AFFECT BEHAV NE, V7, P266, DOI 10.3758/CABN.7.4.266; Brown JW, 2009, PSYCHOL RES-PSYCH FO, V73, P744, DOI 10.1007/s00426-008-0198-7; Brown JW, 2009, NEUROIMAGE, V47, P334, DOI 10.1016/j.neuroimage.2009.04.034; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Burle B, 2008, J COGNITIVE NEUROSCI, V20, P1637, DOI 10.1162/jocn.2008.20110; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Cole MW, 2009, TRENDS NEUROSCI, V32, P566, DOI 10.1016/j.tins.2009.07.001; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; Ford KA, 2009, NEUROIMAGE, V45, P470, DOI 10.1016/j.neuroimage.2008.12.009; GEHRING WJ, 1990, PSYCHOPHYSIOLOGY, V27, P34; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Haggard P, 2008, NAT REV NEUROSCI, V9, P934, DOI 10.1038/nrn2497; Holroyd CB, 2005, J EXP PSYCHOL GEN, V134, P163, DOI 10.1037/0096-3445.134.2.163; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Holroyd CB, 2007, PSYCHOPHYSIOLOGY, V44, P913, DOI 10.1111/j.1469-8986.2007.00561.x; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jessup RK, 2010, J NEUROSCI, V30, P3467, DOI 10.1523/JNEUROSCI.4130-09.2010; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; Nee DE, 2011, NEUROIMAGE, V54, P528, DOI 10.1016/j.neuroimage.2010.08.027; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Olson CR, 2002, PHYSIOL BEHAV, V77, P663, DOI 10.1016/S0031-9384(02)00945-9; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Sallet J, 2007, COGN AFFECT BEHAV NE, V7, P327, DOI 10.3758/CABN.7.4.327; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Singh SP, 1996, MACH LEARN, V22, P123, DOI 10.1007/BF00114726; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Yeung N, 2009, J NEUROSCI, V29, P14506, DOI 10.1523/JNEUROSCI.3615-09.2009; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	638	644	5	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1338	U163		10.1038/nn.2921	http://dx.doi.org/10.1038/nn.2921			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	825EQ	21926982	Green Accepted			2022-12-17	WOS:000295254200024
J	Grabert, K; Michoel, T; Karavolos, MH; Clohisey, S; Baillie, JK; Stevens, MP; Freeman, TC; Summers, KM; McColl, BW				Grabert, Kathleen; Michoel, Tom; Karavolos, Michail H.; Clohisey, Sara; Baillie, J. Kenneth; Stevens, Mark P.; Freeman, Tom C.; Summers, Kim M.; McColl, Barry W.			Microglial brain region-dependent diversity and selective regional sensitivities to aging	NATURE NEUROSCIENCE			English	Article							GENE-EXPRESSION; ENDOGENOUS RETROVIRUS; LANGERHANS CELLS; AGE; CNS; RECEPTOR; NETWORKS; NEURODEGENERATION; DEDIFFERENTIATION; VISUALIZATION	Microglia have critical roles in neural development, homeostasis and neuroinflammation and are increasingly implicated in age-related neurological dysfunction. Neurodegeneration often occurs in disease-specific, spatially restricted patterns, the origins of which are unknown. We performed to our knowledge the first genome-wide analysis of microglia from discrete brain regions across the adult lifespan of the mouse, and found that microglia have distinct region-dependent transcriptional identities and age in a regionally variable manner. In the young adult brain, differences in bioenergetic and immunoregulatory pathways were the major sources of heterogeneity and suggested that cerebellar and hippocampal microglia exist in a more immune-vigilant state. Immune function correlated with regional transcriptional patterns. Augmentation of the distinct cerebellar immunophenotype and a contrasting loss in distinction of the hippocampal phenotype among forebrain regions were key features during aging. Microglial diversity may enable regionally localized homeostatic functions but could also underlie region-specific sensitivities to microglial dysregulation and involvement in age-related neurodegeneration.	[Grabert, Kathleen; Michoel, Tom; Karavolos, Michail H.; Clohisey, Sara; Baillie, J. Kenneth; Stevens, Mark P.; Freeman, Tom C.; Summers, Kim M.; McColl, Barry W.] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	McColl, BW (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland.	barry.mccoll@roslin.ed.ac.uk	Baillie, Kenneth/AEK-6650-2022; Clohisey, Sara/AAB-9321-2021; Baillie, John Kenneth/F-3124-2011; Summers, Kim M/M-4086-2015	Baillie, Kenneth/0000-0001-5258-793X; Clohisey, Sara/0000-0001-7489-9846; Baillie, John Kenneth/0000-0001-5258-793X; Summers, Kim M/0000-0002-7084-4386; McColl, Barry W/0000-0002-0521-9656; Michoel, Tom/0000-0003-4749-4725; Freeman, Thomas/0000-0001-5235-8483; Stevens, Mark/0000-0003-2174-5039	Darwin Trust of Edinburgh; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J004332/1]; Medical Research Council (MRC) [MR/L003384/1]; Natural Environment Research Council [R8/H10/56]; MRC [MR/K001744/1]; BBSRC [BB/J004332/1, BB/J004243/1]; BBSRC [BBS/E/D/20251969, BBS/E/D/20211551, BBS/E/D/20211552, BBS/E/D/20241863, BBS/E/D/20310000, BB/I001107/1, BBS/E/D/20241864, BBS/E/D/05191131] Funding Source: UKRI; MRC [G0900740, MR/L003384/1] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191131, BBS/E/D/20211551, BBS/E/D/20251969, BBS/E/D/20211552, BBS/E/D/20310000, BBS/E/D/20241863, BBS/E/D/20241864, BB/I001107/1] Funding Source: researchfish; Medical Research Council [G0900740, MR/K001744/1, MR/L003384/1] Funding Source: researchfish; Natural Environment Research Council [NBAF010003] Funding Source: researchfish; Wellcome Trust [103258/Z/13/Z] Funding Source: researchfish	Darwin Trust of Edinburgh; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank members of Edinburgh Genomics, The University of Edinburgh, for performing microarray assays, B. Fleming for technical assistance with microglial purification and Y.-T. Lai for help optimizing regional brain dissection. This work was funded by a PhD scholarship from the Darwin Trust of Edinburgh to K Grabert and grants from the Biotechnology and Biological Sciences Research Council (BBSRC; BB/J004332/1) and the Medical Research Council (MRC; MR/L003384/1). The Roslin Institute and Edinburgh Genomics are partly supported through core grants from the Natural Environment Research Council (R8/H10/56), MRC (MR/K001744/1) and BBSRC (BB/J004243/1, BB/J004332/1).	Archer Michael C, 2011, Genes Cancer, V2, P712, DOI 10.1177/1947601911423029; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Bernhart E, 2010, PROTEOMICS, V10, P141, DOI 10.1002/pmic.200900195; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chen BS, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-46; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Damani MR, 2011, AGING CELL, V10, P263, DOI 10.1111/j.1474-9726.2010.00660.x; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; De Haas AH, 2008, GLIA, V56, P888, DOI 10.1002/glia.20663; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; Goh JOS, 2011, AGING DIS, V2, P30; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Griffin MJ, 2013, J BIOL CHEM, V288, P35925, DOI 10.1074/jbc.M113.491936; Hart AD, 2012, BRAIN BEHAV IMMUN, V26, P754, DOI 10.1016/j.bbi.2011.11.006; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hume DA, 2010, GENOMICS, V95, P328, DOI 10.1016/j.ygeno.2010.03.002; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Karch CM, 2015, BIOL PSYCHIAT, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee KH, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-82; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Linnartz Bettina, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/587463; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Sleimen-Malkoun R, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00140; Stocking C, 2008, CELL MOL LIFE SCI, V65, P3383, DOI 10.1007/s00018-008-8497-0; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Yao P, 2015, NAT NEUROSCI, V18, P1168, DOI 10.1038/nn.4063; Yu P, 2012, IMMUNITY, V37, P867, DOI 10.1016/j.immuni.2012.07.018	55	637	640	6	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2016	19	3					504	+		10.1038/nn.4222	http://dx.doi.org/10.1038/nn.4222			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE7MU	26780511	Green Accepted			2022-12-17	WOS:000370822200023
J	Noble, KG; Houston, SM; Brito, NH; Bartsch, H; Kan, E; Kuperman, JM; Akshoomoff, N; Amaral, DG; Bloss, CS; Libiger, O; Schork, NJ; Murray, SS; Casey, BJ; Chang, LD; Ernst, TM; Frazier, JA; Gruen, JR; Kennedy, DN; Van Zijl, P; Mostofsky, S; Kaufmann, WE; Kenet, T; Dale, AM; Jernigan, TL; Sowell, ER				Noble, Kimberly G.; Houston, Suzanne M.; Brito, Natalie H.; Bartsch, Hauke; Kan, Eric; Kuperman, Joshua M.; Akshoomoff, Natacha; Amaral, David G.; Bloss, Cinnamon S.; Libiger, Ondrej; Schork, Nicholas J.; Murray, Sarah S.; Casey, B. J.; Chang, Linda; Ernst, Thomas M.; Frazier, Jean A.; Gruen, Jeffrey R.; Kennedy, David N.; Van Zijl, Peter; Mostofsky, Stewart; Kaufmann, Walter E.; Kenet, Tal; Dale, Anders M.; Jernigan, Terry L.; Sowell, Elizabeth R.			Family income, parental education and brain structure in children and adolescents	NATURE NEUROSCIENCE			English	Article							SOCIOECONOMIC-STATUS; CORTICAL THICKNESS; CHILDHOOD POVERTY; ASSOCIATIONS; CORTEX; NETWORKS	Socioeconomic disparities are associated with differences in cognitive development. The extent to which this translates to disparities in brain structure is unclear. We investigated relationships between socioeconomic factors and brain morphometry, independently of genetic ancestry, among a cohort of 1,099 typically developing individuals between 3 and 20 years of age. Income was logarithmically associated with brain surface area. Among children from lower income families, small differences in income were associated with relatively large differences in surface area, whereas, among children from higher income families, similar income increments were associated with smaller differences in surface area. These relationships were most prominent in regions supporting language, reading, executive functions and spatial skills; surface area mediated socioeconomic differences in certain neurocognitive abilities. These data imply that income relates most strongly to brain structure among the most disadvantaged children.	[Noble, Kimberly G.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Noble, Kimberly G.] Columbia Univ, Teachers Coll, New York, NY 10027 USA; [Houston, Suzanne M.] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Houston, Suzanne M.; Kan, Eric; Sowell, Elizabeth R.] Childrens Hosp, Saban Res Inst, Los Angeles, CA 90027 USA; [Houston, Suzanne M.; Kan, Eric; Sowell, Elizabeth R.] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Brito, Natalie H.] Columbia Univ, Robert Wood Johnson Hlth & Soc Scholar Program, New York, NY 10027 USA; [Bartsch, Hauke] Univ Calif San Diego, Stein Inst Res Aging, San Diego, CA 92103 USA; [Kuperman, Joshua M.; Dale, Anders M.] Univ Calif San Diego, Multimodal Imaging Lab, San Diego, CA 92103 USA; [Kuperman, Joshua M.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Kuperman, Joshua M.; Akshoomoff, Natacha; Amaral, David G.; Bloss, Cinnamon S.; Murray, Sarah S.; Casey, B. J.; Chang, Linda; Ernst, Thomas M.; Frazier, Jean A.; Gruen, Jeffrey R.; Kennedy, David N.; Van Zijl, Peter; Mostofsky, Stewart; Kaufmann, Walter E.; Kenet, Tal; Dale, Anders M.; Jernigan, Terry L.; Sowell, Elizabeth R.] Pediat Imaging Neurocognit & Genet Study, San Diego, CA USA; [Akshoomoff, Natacha; Jernigan, Terry L.] Univ Calif San Diego, Ctr Human Dev, San Diego, CA 92103 USA; [Akshoomoff, Natacha; Jernigan, Terry L.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Amaral, David G.] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA; [Bloss, Cinnamon S.] Univ Calif San Diego, Qualcomm Inst, San Diego, CA 92103 USA; [Libiger, Ondrej] MD Revolut Inc, La Jolla, CA USA; [Schork, Nicholas J.] Univ Calif San Diego, J Craig Venter Inst, Human Biol, San Diego, CA 92103 USA; [Murray, Sarah S.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Casey, B. J.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Chang, Linda; Ernst, Thomas M.] Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA; [Frazier, Jean A.; Kennedy, David N.] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Gruen, Jeffrey R.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Gruen, Jeffrey R.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Gruen, Jeffrey R.] Yale Univ, Sch Med, Dept Investigat Med, New Haven, CT 06510 USA; [Van Zijl, Peter] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Van Zijl, Peter; Mostofsky, Stewart] Kennedy Krieger Inst, Baltimore, MD USA; [Kaufmann, Walter E.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Kaufmann, Walter E.; Kenet, Tal] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kenet, Tal] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Dale, Anders M.; Jernigan, Terry L.] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, Dept Neurol, San Diego, CA 92103 USA; [Dale, Anders M.] Univ Calif San Diego, Ctr Translat Imaging & Personalized Med, La Jolla, CA 92093 USA	Columbia University; Columbia University; Columbia University Teachers College; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Columbia University; Robert Wood Johnson Foundation (RWJF); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis; University of California System; University of California San Diego; J. Craig Venter Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Cornell University; University of Hawaii System; University of Massachusetts System; University of Massachusetts Worcester; Yale University; Yale University; Yale University; Johns Hopkins University; Kennedy Krieger Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Sowell, ER (corresponding author), Childrens Hosp, Saban Res Inst, Los Angeles, CA 90027 USA.	kgn2106@columbia.edu; esowell@chla.usc.edu	Van Zijl, Peter C/ABF-3732-2020	Brito, Natalie/0000-0003-1016-0094; Bloss, Cinnamon/0000-0003-1315-8387; Noble, Kimberly/0000-0003-1496-5113; Bartsch, Hauke/0000-0003-1486-4128; Schork, Nicholas/0000-0003-0920-5013	Annie E. Casey Foundation; GH Sergievsky Center;  [RC2 DA029475];  [R01 HD053893];  [R01 MH087563];  [R01 HD061414]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079123, R01HD075865, R01HD053893, R01HD061414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087563, R01MH083320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA029475] Funding Source: NIH RePORTER	Annie E. Casey Foundation; GH Sergievsky Center; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the Annie E. Casey Foundation and the GH Sergievsky Center (K.G.N.) and by the following grants: RC2 DA029475 to T.L.J., L.C., T.M.E., A.M.D. and S.S.M. R01 HD053893 to E.R.S., R01 MH087563 to E.R.S. and R01 HD061414 to T.L.J.	Akshoomoff N, 2014, NEUROPSYCHOLOGY, V28, P1, DOI 10.1037/neu0000001; Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Bakken TE, 2012, P NATL ACAD SCI USA, V109, P3985, DOI 10.1073/pnas.1105829109; BrooksGunn J, 1997, FUTURE CHILD, V7, P55, DOI 10.2307/1602387; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Chiang MC, 2011, NEUROIMAGE, V54, P2308, DOI 10.1016/j.neuroimage.2010.10.015; Duncan GJ, 2005, FUTURE CHILD, V15, P35, DOI 10.1353/foc.2005.0004; Duncan GJ, 2012, WIRES COGN SCI, V3, P377, DOI 10.1002/wcs.1176; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2012, P NATL ACAD SCI USA, V109, P19620, DOI 10.1073/pnas.1208243109; Gianaros PJ, 2007, SOC COGN AFFECT NEUR, V2, P161, DOI 10.1093/scan/nsm013; Grieve SM, 2011, NEUROIMAGE, V55, P868, DOI 10.1016/j.neuroimage.2010.12.087; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hanson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080954; Hanson JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018712; Jednorog K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042486; Kim P, 2013, P NATL ACAD SCI USA, V110, P18442, DOI 10.1073/pnas.1308240110; Kitzman HJ, 2010, ARCH PEDIAT ADOL MED, V164, P412, DOI 10.1001/archpediatrics.2010.76; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Lange N, 2010, DEV NEUROPSYCHOL, V35, P296, DOI 10.1080/87565641003696833; Lawson GM, 2013, DEVELOPMENTAL SCI, V16, P641, DOI 10.1111/desc.12096; Luby J, 2013, JAMA PEDIATR, V167, P1135, DOI 10.1001/jamapediatrics.2013.3139; McCandliss BD, 2003, MENT RETARD DEV D R, V9, P196, DOI 10.1002/mrdd.10080; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Noble KG, 2006, DEVELOPMENTAL SCI, V9, P642; Noble KG, 2013, DEVELOPMENTAL SCI, V16, P653, DOI 10.1111/desc.12077; Noble KG, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00307; Noble KG, 2012, DEVELOPMENTAL SCI, V15, P516, DOI 10.1111/j.1467-7687.2012.01147.x; Raizada RDS, 2008, NEUROIMAGE, V40, P1392, DOI 10.1016/j.neuroimage.2008.01.021; Raver CC, 2011, CHILD DEV, V82, P362, DOI 10.1111/j.1467-8624.2010.01561.x; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Rosenzweig MR, 2003, DEV NEUROPSYCHOL, V24, P523, DOI 10.1207/S15326942DN242&3_02; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Schnack HG, 2015, CEREB CORTEX, V25, P1608, DOI 10.1093/cercor/bht357; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Sheridan MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035744; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Staff RT, 2012, ANN NEUROL, V71, P653, DOI 10.1002/ana.22631; Stevens C, 2009, DEVELOPMENTAL SCI, V12, P634, DOI 10.1111/j.1467-7687.2009.00807.x; Tomalski P, 2013, DEVELOPMENTAL SCI, V16, P676, DOI 10.1111/desc.12079; Trzaskowski M, 2014, INTELLIGENCE, V42, P83, DOI 10.1016/j.intell.2013.11.002; Tulsky DS, 2013, MONOGR SOC RES CHILD, V78, P70, DOI 10.1111/mono.12035; Vannest J, 2009, AM J ROENTGENOL, V192, P1190, DOI 10.2214/AJR.08.2246; Ziol-Guest KM, 2012, P NATL ACAD SCI USA, V109, P17289, DOI 10.1073/pnas.1203167109	49	633	655	25	357	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2015	18	5					773	+		10.1038/nn.3983	http://dx.doi.org/10.1038/nn.3983			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CG9LN	25821911	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000353636900026
J	Esteban, JA; Shi, SH; Wilson, C; Nuriya, M; Huganir, RL; Malinow, R				Esteban, JA; Shi, SH; Wilson, C; Nuriya, M; Huganir, RL; Malinow, R			PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; FREQUENCY STIMULATION; ACTIVATION INCREASES; HIPPOCAMPAL SYNAPSES; GLUTAMATE RECEPTORS; LATE-PHASE; AREA CA1; LTP	The regulated incorporation of AMPA receptors into synapses is important for synaptic plasticity. Here we examine the role of protein kinase A (PKA) in this process. We found that PKA phosphorylation of the AMPA receptor subunits GluR4 and GluR1 directly controlled the synaptic incorporation of AMPA receptors in organotypic slices from rat hippocampus. Activity-driven PKA phosphorylation of GluR4 was necessary and sufficient to relieve a retention interaction and drive receptors into synapses. In contrast, PKA phosphorylation of GluR1 and the activity of calcium/calmodulin-dependent kinase II (CaMKII) were both necessary for receptor incorporation. Thus, PKA phosphorylation of AMPA receptor subunits contributes to diverse mechanisms underlying synaptic plasticity.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Johns Hopkins University; Cold Spring Harbor Laboratory	Esteban, JA (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	estebanj@umich.edu; malinow@cshl.org	Esteban, Jose/L-4944-2014; Nuriya, Mutsuo/J-5928-2013	Esteban, Jose/0000-0002-3759-3300; Nuriya, Mutsuo/0000-0002-5689-8222	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032827, R01NS036715] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS036715, NS36715, NS32827] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Brandon EP, 1997, CURR OPIN NEUROBIOL, V7, P397, DOI 10.1016/S0959-4388(97)80069-4; Brown GP, 2000, J NEUROSCI, V20, P7880; Carvalho AL, 1999, J NEUROSCI, V19, P4748; Chao SZ, 2002, J NEUROCHEM, V81, P984, DOI 10.1046/j.1471-4159.2002.00877.x; CHETKOVICH DM, 1993, J NEUROCHEM, V61, P1933, DOI 10.1111/j.1471-4159.1993.tb09836.x; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Jordan JD, 1998, BIOCHEM PHARMACOL, V55, P1347; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1999, IMAGING LIVING CELLS; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Moita MAP, 2002, NAT NEUROSCI, V5, P837, DOI 10.1038/nn901; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Price CJ, 1999, J NEUROCHEM, V73, P2441, DOI 10.1046/j.1471-4159.1999.0732441.x; Reed TM, 2002, J NEUROSCI, V22, P5188, DOI 10.1523/JNEUROSCI.22-12-05188.2002; Roberson ED, 1996, J BIOL CHEM, V271, P30436, DOI 10.1074/jbc.271.48.30436; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Zhu JJ, 2002, NAT NEUROSCI, V5, P513, DOI 10.1038/nn0602-850; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	48	633	656	3	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2003	6	2					136	143		10.1038/nn997	http://dx.doi.org/10.1038/nn997			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	640CL	12536214				2022-12-17	WOS:000180669100013
J	Kennerley, SW; Walton, ME; Behrens, TEJ; Buckley, MJ; Rushworth, MFS				Kennerley, Steven W.; Walton, Mark E.; Behrens, Timothy E. J.; Buckley, Mark J.; Rushworth, Matthew F. S.			Optimal decision making and the anterior cingulate cortex	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; FRONTAL-CORTEX; NEURONAL-ACTIVITY; DOPAMINE NEURONS; RHESUS-MONKEY; MATCHING BEHAVIOR; PREDICTION ERROR; PARIETAL CORTEX; MOTOR AREAS; REWARD	Learning the value of options in an uncertain environment is central to optimal decision making. The anterior cingulate cortex ( ACC) has been implicated in using reinforcement information to control behavior. Here we demonstrate that the ACC's critical role in reinforcement-guided behavior is neither in detecting nor in correcting errors, but in guiding voluntary choices based on the history of actions and outcomes. ACC lesions did not impair the performance of monkeys ( Macaca mulatta) immediately after errors, but made them unable to sustain rewarded responses in a reinforcement-guided choice task and to integrate risk and payoff in a dynamic foraging task. These data suggest that the ACC is essential for learning the value of actions.	Dept Expt Psychol, Oxford OX1 3UD, England; John Radcliffe Hosp, Oxford Ctr FMRIB, Oxford OX3 9DU, England	University of Oxford	Kennerley, SW (corresponding author), Dept Expt Psychol, S Pk Rd, Oxford OX1 3UD, England.	skennerley@berkeley.edu	Kennerley, Steven W/E-3330-2018	Kennerley, Steven W/0000-0002-5696-7507; Rushworth, Matthew/0000-0002-5578-9884; Behrens, Timothy/0000-0003-0048-1177	Medical Research Council [G0300665, G0501316] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0501316, G0300665] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; AMIEZ C, 2005, CEREB CORTEX; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Fellows LK, 2005, BRAIN, V128, P788, DOI 10.1093/brain/awh405; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; Hadland KA, 2003, J NEUROPHYSIOL, V89, P1161, DOI 10.1152/jn.00634.2002; HE SQ, 1995, J NEUROSCI, V15, P3284; Herrnstein R. J., 1997, MATCHING LAW PAPERS; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lee D, 2004, COGNITIVE BRAIN RES, V22, P45, DOI 10.1016/j.cogbrainres.2004.07.007; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; Morecraft RJ, 1998, BRAIN RES BULL, V45, P209, DOI 10.1016/S0361-9230(97)00344-4; Morris R, 1999, J COMP NEUROL, V407, P183, DOI 10.1002/(SICI)1096-9861(19990503)407:2<183::AID-CNE3>3.0.CO;2-N; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; MURRAY EA, 1989, EXP BRAIN RES, V74, P173; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Paxinos G., 1999, RHESUS MONKEY BRAIN, DOI DOI 10.1016/J.CEJA.2021.100223; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Roberts AC, 2000, CEREB CORTEX, V10, P252, DOI 10.1093/cercor/10.3.252; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Satoh T, 2003, J NEUROSCI, V23, P9913; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Swick D, 2002, P NATL ACAD SCI USA, V99, P16354, DOI 10.1073/pnas.252521499; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026	50	630	638	1	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2006	9	7					940	947		10.1038/nn1724	http://dx.doi.org/10.1038/nn1724			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IZ	16783368				2022-12-17	WOS:000238590800021
J	Desmurget, M; Epstein, CM; Turner, RS; Prablanc, C; Alexander, GE; Grafton, ST				Desmurget, M; Epstein, CM; Turner, RS; Prablanc, C; Alexander, GE; Grafton, ST			Role of the posterior parietal cortex in updating reaching movements to a visual target	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MEMORY-GUIDED SACCADES; HAND POSITION; OPTIC ATAXIA; ARM; HUMANS; SUPPRESSION; PERCEPTION; REPRESENTATION; COMPUTATIONS	The exact role of posterior parietal cortex (PPC) in visually directed reaching is unknown. We propose that, by building an internal representation of instantaneous hand location, PPC computes a dynamic motor error used by motor centers to correct the ongoing trajectory. With unseen right hands, five subjects pointed to visual targets that either remained stationary or moved during saccadic eye movements. Transcranial magnetic stimulation (TMS) was applied over the left PPC during target presentation. Stimulation disrupted path corrections that normally occur in response to target jumps, but had no effect on those directed at stationary targets. Furthermore, left-hand movement corrections were not blocked, ruling out visual or oculomotor effects of stimulation.	Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; INSERM, U94, F-69500 Bron, France	Emory University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Grafton, ST (corresponding author), Emory Univ, Sch Med, Dept Neurol, Woodruff Mem Bldg,Suite 6000,PO Drawer V, Atlanta, GA 30322 USA.		Turner, Robert S/A-9695-2008; Desmurget, Michel/L-2401-2017	Turner, Robert S/0000-0002-6074-4365; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033504] Funding Source: NIH RePORTER; NINDS NIH HHS [NS33504] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS JA, 1971, J MOTOR BEHAV, V3, P111; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Arbib M. A., 2011, HDB PHYSL NERVOUS SY, P1449, DOI [10.1002/cphy.cp010233, DOI 10.1016/J.JPHYSPARIS.2008.03.001]; AUERBACH SH, 1981, J NEUROL NEUROSUR PS, V44, P430, DOI 10.1136/jnnp.44.5.430; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Desmurget M, 1998, NEUROSCI BIOBEHAV R, V22, P761, DOI 10.1016/S0149-7634(98)00004-9; Desmurget M, 1997, J NEUROPHYSIOL, V77, P1644, DOI 10.1152/jn.1997.77.3.1644; DESMURGET M, 1995, CAN J PHYSIOL PHARM, V73, P262, DOI 10.1139/y95-037; DESMURGET M, IN PRESS Q J EXP PSY; Epstein CM, 1996, NEUROLOGY, V47, P1590, DOI 10.1212/WNL.47.6.1590; Epstein CM, 1996, J CLIN NEUROPHYSIOL, V13, P242, DOI 10.1097/00004691-199605000-00008; FAUGIERGRIMAUD S, 1985, EXP BRAIN RES, V59, P125; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; GRAFTON ST, 1992, BRAIN, V115, P565, DOI 10.1093/brain/115.2.565; GRAFTON ST, 1993, EXP BRAIN RES, V95, P172; HINTON G, 1984, J MOTOR BEHAV, V16, P171; Hoff B., 1992, EXP BRAIN RES, V22, P285; HOLLERBACH JM, 1982, TRENDS NEUROSCI, V5, P189, DOI 10.1016/0166-2236(82)90111-4; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; Keele S. W., 1981, HDB PHYSL 1, P1391, DOI DOI 10.1002/CPHY.CP010231; Kertzman C, 1997, EXP BRAIN RES, V114, P170, DOI 10.1007/PL00005617; MATIN E, 1974, PSYCHOL BULL, V81, P899, DOI 10.1037/h0037368; MCKAY WA, 1992, J NEUROPHYSIOL, V67, P1335; Muri RM, 1996, J NEUROPHYSIOL, V76, P2102, DOI 10.1152/jn.1996.76.3.2102; OYACHI H, 1995, INVEST OPHTH VIS SCI, V36, P1441; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; PRABLANC C, 1979, BIOL CYBERN, V35, P113, DOI 10.1007/BF00337436; Rushworth MFS, 1998, J NEUROPHYSIOL, V79, P478, DOI 10.1152/jn.1998.79.1.478; SEAL J, 1982, BRAIN RES, V250, P229, DOI 10.1016/0006-8993(82)90417-6; Vindras P, 1998, J NEUROPHYSIOL, V79, P3290, DOI 10.1152/jn.1998.79.6.3290; Wang XG, 1998, J VISUAL COMP ANIMAT, V9, P33, DOI 10.1002/(SICI)1099-1778(199801/03)9:1<33::AID-VIS174>3.0.CO;2-Q; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245	39	628	631	1	47	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					563	567		10.1038/9219	http://dx.doi.org/10.1038/9219			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448222				2022-12-17	WOS:000084735900017
J	Puglielli, L; Tanzi, RE; Kovacs, DM				Puglielli, L; Tanzi, RE; Kovacs, DM			Alzheimer's disease: the cholesterol connection	NATURE NEUROSCIENCE			English	Review							AMYLOID PRECURSOR PROTEIN; LOW-DENSITY-LIPOPROTEIN; TRANSGENIC MOUSE MODEL; APOLIPOPROTEIN-E POLYMORPHISM; RECEPTOR-RELATED PROTEIN; BETA-PEPTIDE; A-BETA; CEREBROTENDINOUS XANTHOMATOSIS; CEREBROSPINAL-FLUID; PLAQUE-FORMATION	A hallmark of all forms of Alzheimer's disease (AD) is an abnormal accumulation of the beta-amyloid protein (AD) in specific brain regions. Both the generation and clearance of A-beta are regulated by cholesterol. Elevated cholesterol levels increase A-beta in cellular and most animals models of AD, and drugs that inhibit cholesterol synthesis lower A-beta in these models. Recent studies show that not only the total amount, but also the distribution of cholesterol within neurons, impacts A-beta biogenesis. The identification of a variant of the apolipoprotein E (APOE) gene as a major genetic risk factor for AD is also consistent with a role for cholesterol in the pathogenesis of AD. Clinical trials have recently been initiated to test whether lowering plasma and/or neuronal cholesterol levels is a viable strategy for treating and preventing AD. In this review, we describe recent findings concerning the molecular mechanisms underlying the cholesterol-AD connection.	Harvard Univ, Sch Med, Neurobiol Dis Lab, CAGN,Massachusetts Gen Hosp, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Genet & Aging Res Unit, CAGN,Massachusetts Gen Hosp, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Kovacs, DM (corresponding author), Harvard Univ, Sch Med, Neurobiol Dis Lab, CAGN,Massachusetts Gen Hosp, Charlestown, MA 02129 USA.	kovacs@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454				Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Bales KR, 1999, P NATL ACAD SCI USA, V96, P15233, DOI 10.1073/pnas.96.26.15233; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bjorkhem I., 1995, METABOLIC MOL BASES, P2073; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; BOERWINKLE E, 1987, AM J MED GENET, V27, P567, DOI 10.1002/ajmg.1320270310; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chang TY, 2001, J LIPID RES, V42, P1933; Chang TY, 2001, CURR OPIN LIPIDOL, V12, P289, DOI 10.1097/00041433-200106000-00008; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Corsini Alberto, 2000, Journal of Cardiovascular Pharmacology and Therapeutics, V5, P161, DOI 10.1177/107424840000500304; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; EHNHOLM C, 1986, J LIPID RES, V27, P227; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Fernandes MAS, 1999, BBA-MOL BASIS DIS, V1454, P89, DOI 10.1016/S0925-4439(99)00030-7; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; Fukumoto H, 2002, J BIOL CHEM, V277, P48508, DOI 10.1074/jbc.M209085200; Haley RW, 2000, ARCH NEUROL-CHICAGO, V57, P1410, DOI 10.1001/archneur.57.10.1410; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Holtzman DM, 2001, J MOL NEUROSCI, V17, P147, DOI 10.1385/JMN:17:2:147; Howland DS, 1998, J BIOL CHEM, V273, P16576, DOI 10.1074/jbc.273.26.16576; JARVIK GP, 1995, NEUROLOGY, V45, P1092, DOI 10.1212/WNL.45.6.1092; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; KNEBL J, 1994, MECH AGEING DEV, V73, P69, DOI 10.1016/0047-6374(94)90039-6; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kuo YM, 1998, BIOCHEM BIOPH RES CO, V252, P711, DOI 10.1006/bbrc.1998.9652; LADU MJ, 1994, J BIOL CHEM, V269, P23403; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; Mori T, 2001, J NEUROPATH EXP NEUR, V60, P778, DOI 10.1093/jnen/60.8.778; NASLUND J, 1995, NEURON, V15, P219, DOI 10.1016/0896-6273(95)90079-9; Papassotiropoulos A, 2002, J PSYCHIAT RES, V36, P27, DOI 10.1016/S0022-3956(01)00050-4; PETANCESKA S, 2003, CURR MED CHEM IMUN E, V3, P233; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; Racchi M, 1997, BIOCHEM J, V322, P893, DOI 10.1042/bj3220893; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; REFOLO LM, 1991, J NEUROSCI, V11, P3888; Rockwood K, 2002, ARCH NEUROL-CHICAGO, V59, P223, DOI 10.1001/archneur.59.2.223; Runz H, 2002, J NEUROSCI, V22, P1679, DOI 10.1523/JNEUROSCI.22-05-01679.2002; SALEN G, 1973, J CLIN INVEST, V52, P2822, DOI 10.1172/JCI107478; SALEN G, 1987, NEW ENGL J MED, V316, P1233, DOI 10.1056/NEJM198705143162002; SANAN DA, 1994, J CLIN INVEST, V94, P860, DOI 10.1172/JCI117407; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Snipes G J, 1997, Subcell Biochem, V28, P173; SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044; Sparks DL, 2000, ANN NY ACAD SCI, V903, P335, DOI 10.1111/j.1749-6632.2000.tb06384.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Thinakaran G, 1999, J CLIN INVEST, V104, P1321, DOI 10.1172/JCI8728; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Van Uden E, 2000, J BIOL CHEM, V275, P30525, DOI 10.1074/jbc.M001151200; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P793, DOI 10.1001/archneur.57.6.793; Yaffe K, 2002, ARCH NEUROL-CHICAGO, V59, P378, DOI 10.1001/archneur.59.3.378; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 1997, FEBS LETT, V420, P43, DOI 10.1016/S0014-5793(97)01484-1; Yang DS, 1999, NEUROSCIENCE, V90, P1217, DOI 10.1016/S0306-4522(98)00561-2	70	626	671	1	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2003	6	4					345	351		10.1038/nn0403-345	http://dx.doi.org/10.1038/nn0403-345			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	660KV	12658281				2022-12-17	WOS:000181833100011
J	Zhang, XM; Firestein, S				Zhang, XM; Firestein, S			The olfactory receptor gene superfamily of the mouse	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; ODORANT RECEPTOR; SEQUENCE; CLUSTER; FAMILY; IDENTIFICATION; VERTEBRATES; EXPRESSION; NEURONS; ANOSMIA	Olfactory receptor (OR) genes are the largest gene superfamily in vertebrates. We have identified the mouse OR genes from the nearly complete Celera mouse genome by a comprehensive data mining strategy. We found 1,296 mouse OR genes (including similar to20% pseudogenes), which can be classified into 228 families. OR genes are distributed in 27 clusters on all mouse chromosomes except 12 and Y. One OR gene cluster matches a known locus mediating a specific anosmia, indicating the anosmia may be due directly to the loss of receptors. A large number of apparently functional 'fish-like' Class I OR genes in the mouse genome may have important roles in mammalian olfaction. Human ORs cover a similar 'receptor space' as the mouse ORs, suggesting that the human olfactory system has retained the ability to recognize a broad spectrum of chemicals even though humans have lost nearly two-thirds of the OR genes as compared to mice.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Firestein, S (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	sjf24@columbia.edu						Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; Brosius J, 1999, TRENDS GENET, V15, P304, DOI 10.1016/S0168-9525(99)01783-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Bulger M, 1999, P NATL ACAD SCI USA, V96, P5129, DOI 10.1073/pnas.96.9.5129; Carver EA, 1998, MAMM GENOME, V9, P349, DOI 10.1007/s003359900768; Conzelmann S, 2000, EUR J NEUROSCI, V12, P3926, DOI 10.1046/j.1460-9568.2000.00286.x; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; Ehlers A, 2000, GENOME RES, V10, P1968, DOI 10.1101/gr.10.12.1968; Freitag J, 1998, J COMP PHYSIOL A, V183, P635, DOI 10.1007/s003590050287; Freitag J, 1995, NEURON, V15, P1383, DOI 10.1016/0896-6273(95)90016-0; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; Gibson AD, 2000, ANNU REV NEUROSCI, V23, P417, DOI 10.1146/annurev.neuro.23.1.417; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Glusman G, 2000, GENOMICS, V63, P227, DOI 10.1006/geno.1999.6030; Glusman G, 1996, GENOMICS, V37, P147, DOI 10.1006/geno.1996.0536; GRIFF IC, 1995, CELL, V83, P407, DOI 10.1016/0092-8674(95)90118-3; Hoppe R, 2000, GENOMICS, V66, P284, DOI 10.1006/geno.2000.6205; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; Lapidot M, 2001, GENOMICS, V71, P296, DOI 10.1006/geno.2000.6431; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mezler M, 2001, J EXP BIOL, V204, P2987; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; Pilpel Y, 1999, PROTEIN SCI, V8, P969, DOI 10.1110/ps.8.5.969; Raming K, 1998, RECEPTOR CHANNEL, V6, P141; Skoufos E, 1999, NUCLEIC ACIDS RES, V27, P343, DOI 10.1093/nar/27.1.343; Strotmann J, 1999, GENE, V236, P281, DOI 10.1016/S0378-1119(99)00275-9; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; WYSOCKI CJ, 1977, BEHAV GENET, V7, P171, DOI 10.1007/BF01066005; Xie SY, 2000, MAMM GENOME, V11, P1070, DOI 10.1007/s003350010217; Younger RM, 2001, GENOME RES, V11, P519, DOI 10.1101/gr.GR-1603R; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zozulya S, 2001, GENOME BIOL, V2	40	626	735	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					124	133		10.1038/nn800	http://dx.doi.org/10.1038/nn800			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802173				2022-12-17	WOS:000173558400014
J	Petreanu, L; Huber, D; Sobczyk, A; Svoboda, K				Petreanu, Leopoldo; Huber, Daniel; Sobczyk, Aleksander; Svoboda, Karel			Channelrhodopsin-2-assisted circuit mapping of long-range callosal projections	NATURE NEUROSCIENCE			English	Article							SYNAPTIC CONNECTIONS; CORPUS-CALLOSUM; OPTICAL CONTROL; NEURONS; RAT; ORGANIZATION; SYNAPSES; PHOTOSTIMULATION; INTERNEURONS; RESPONSES	The functions of cortical areas depend on their inputs and outputs, but the detailed circuits made by long- range projections are unknown. We show that the light- gated channel channelrhodopsin- 2 ( ChR2) is delivered to axons in pyramidal neurons in vivo. In brain slices from ChR2- expressing mice, photostimulation of ChR2- positive axons can be transduced reliably into single action potentials. Combining photostimulation with whole- cell recordings of synaptic currents makes it possible to map circuits between presynaptic neurons, defined by ChR2 expression, and postsynaptic neurons, defined by targeted patching. We applied this technique, ChR2- assisted circuit mapping ( CRACM), to map long- range callosal projections from layer ( L) 2/3 of the somatosensory cortex. L2/3 axons connect with neurons in L5, L2/3 and L6, but not L4, in both ipsilateral and contralateral cortex. In both hemispheres the L2/3- to- L5 projection is stronger than the L2/3- to- L2/3 projection. Our results suggest that laminar specificity may be identical for local and longrange cortical projections.	Howard Hughes Med Inst, Ashburn, VA 20147 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Huber, Daniel/C-2932-2013	Petreanu, Leopoldo/0000-0003-1434-4691; Huber, Daniel/0000-0002-0744-7679				Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bureau I, 2006, PLOS BIOL, V4, P2361, DOI 10.1371/journal.pbio.0040382; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; CZEIGER D, 1993, J COMP NEUROL, V330, P502, DOI 10.1002/cne.903300406; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Dantzker JL, 1998, J NEUROSCI, V18, P4145; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; IVY GO, 1979, BRAIN RES, V173, P532, DOI 10.1016/0006-8993(79)90247-6; Karayannis T, 2007, CEREB CORTEX, V17, P1213, DOI 10.1093/cercor/bhl035; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; Kumar SS, 2001, J NEUROPHYSIOL, V86, P2973, DOI 10.1152/jn.2001.86.6.2973; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; OLAVARRIA J, 1984, BRAIN RES, V291, P364, DOI 10.1016/0006-8993(84)91270-8; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; VOGT BA, 1982, J NEUROPHYSIOL, V48, P1257, DOI 10.1152/jn.1982.48.6.1257; WHITE EL, 1991, J COMP NEUROL, V303, P233, DOI 10.1002/cne.903030206; WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302; Zarrinpar A, 2006, J NEUROPHYSIOL, V95, P1751, DOI 10.1152/jn.00974.2005; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	45	625	635	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					663	668		10.1038/nn1891	http://dx.doi.org/10.1038/nn1891			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17435752				2022-12-17	WOS:000245948000024
J	Lai, K; Kaspar, BK; Gage, FH; Schaffer, DV				Lai, K; Kaspar, BK; Gage, FH; Schaffer, DV			Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo	NATURE NEUROSCIENCE			English	Article							CNS STEM-CELLS; SUBVENTRICULAR ZONE; DENTATE GYRUS; MAMMALIAN FOREBRAIN; RAT HIPPOCAMPUS; NERVOUS-SYSTEM; SPINAL-CORD; NEURONS; NEUROGENESIS; SIGNALS	Neural stem cells exist in the developing and adult nervous systems of all mammals, but the basic mechanisms that control their behavior are not yet well understood. Here, we investigated the role of Sonic hedgehog (Shh), a factor vital for neural development, in regulating adult hippocampal neural stem cells. We found high expression of the Shh receptor Patched in both the adult rat hippocampus and neural progenitor cells isolated from this region. In addition, Shh elicited a strong, dose-dependent proliferative response in progenitors in vitro. Furthermore, adeno-associated viral vector delivery of shh cDNA to the hippocampus elicited a 3.3-fold increase in cell proliferation. Finally, the pharmacological inhibitor of Shh signaling cyclopamine reduced hippocampal neural progenitor proliferation in vivo. This work identifies Shh as a regulator of adult hippocampal neural stem cells.	Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Salk Inst Biol Studies, Genet Lab, San Diego, CA 92186 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Salk Institute	Schaffer, DV (corresponding author), Univ Calif Berkeley, Dept Chem Engn, 201 Gilman Hall, Berkeley, CA 94720 USA.		Kaspar, Brian/E-6490-2010; Kaspar, Brian/E-3349-2011					Aberg MAI, 2000, J NEUROSCI, V20, P2896; Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; AMARAL DG, 1985, J COMP NEUROL, V240, P37, DOI 10.1002/cne.902400104; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Britto J, 2002, NAT NEUROSCI, V5, P103, DOI 10.1038/nn797; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gould E, 1997, J NEUROSCI, V17, P2492; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Hitoshi S, 2002, DEVELOPMENT, V129, P233; Huang Z, 1998, DEVELOPMENT, V125, P3753; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jin KL, 2002, J NEUROSCI, V22, P5365; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kaspar BK, 2002, P NATL ACAD SCI USA, V99, P2320, DOI 10.1073/pnas.042678699; Kaspar BK, 2002, MOL THER, V5, P50, DOI 10.1006/mthe.2001.0520; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Poncet C, 1996, MECH DEVELOP, V60, P13, DOI 10.1016/S0925-4773(96)00595-3; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; RUIZ IAA, 2002, NAT REV NEUROSCI, V3, P24, DOI DOI 10.1038/NRN704; Sakurada K, 1999, DEVELOPMENT, V126, P4017; SAMULSKI RJ, 1989, J VIROL, V63, P3822, DOI 10.1128/JVI.63.9.3822-3828.1989; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Tanigaki K, 2001, NEURON, V29, P45, DOI 10.1016/S0896-6273(01)00179-9; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Traiffort E, 2001, EUR J NEUROSCI, V14, P839, DOI 10.1046/j.0953-816x.2001.01708.x; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weiss S, 1996, J NEUROSCI, V16, P7599; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	50	624	677	2	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2003	6	1					21	27		10.1038/nn983	http://dx.doi.org/10.1038/nn983			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630CE	12469128				2022-12-17	WOS:000180089300011
J	Kanwisher, N				Kanwisher, N			Domain specificity in face perception	NATURE NEUROSCIENCE			English	Editorial Material							HUMAN EXTRASTRIATE CORTEX; INFEROTEMPORAL CORTEX; RESPONSE PROPERTIES; RECOGNITION; AREA; PROSOPAGNOSIA; EXPERTISE; CATEGORIZATION; REPRESENTATION; ORGANIZATION	Is face perception carried out by modules specialized only for processing faces? Or are faces perceived by domain-general mechanisms that can also operate on non-face stimuli? Considerable evidence supports the domain-specific view.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Kanwisher, N (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	ngk@psyche.mit.edu			PHS HHS [56037] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; ASSAL G, 1984, REV NEUROL, V140, P580; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DeRenzi E., 1986, ASPECTS FACE PROCESS, P243, DOI DOI 10.1007/978-94-009-4420-6; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Duchaine BC, 2000, NEUROREPORT, V11, P79, DOI 10.1097/00001756-200001170-00016; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; FAUST C, 1955, ZEREBRALEN HERSTORUN; Fodor J.A., 1983, MODULARITY MIND; Gauthier I, 2000, COGNITIVE NEUROPSYCH, V17, P143, DOI 10.1080/026432900380544; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HAXBY JV, 1994, J NEUROSCI, V14, P6336; Henke K, 1998, CORTEX, V34, P289, DOI 10.1016/S0010-9452(08)70756-1; Hirschfeld L., 1994, MAPPING MIND DOMAIN, P85; Jacobs RA, 1999, TRENDS COGN SCI, V3, P31, DOI 10.1016/S1364-6613(98)01260-1; Kanwisher N, 1999, NEUROREPORT, V10, P183, DOI 10.1097/00001756-199901180-00035; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KANWISHER N, IN PRESS HDB FUNCTIO; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; MCNEIL JE, 1993, Q J EXP PSYCHOL-A, V46, P1, DOI 10.1080/14640749308401064; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Moscovitch M, 2000, COGNITIVE NEUROPSYCH, V17, P201, DOI 10.1080/026432900380571; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; PINKER S, 1997, HOW MIND WORKS; Polk TA, 1998, P NATL ACAD SCI USA, V95, P847, DOI 10.1073/pnas.95.3.847; Puce A, 1996, J NEUROSCI, V16, P5205; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; RHODES G, 1990, PERCEPTION, V19, P773, DOI 10.1068/p190773; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SERGENT J, 1992, CEREB CORTEX, V2, P375, DOI 10.1093/cercor/2.5.375; SPERBER D, 1994, MAPPING MIND DOMAIN, P37; Tanaka JW, 1997, MEM COGNITION, V25, P583, DOI 10.3758/BF03211301; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; Wagner AD, 1999, NEURON, V22, P19, DOI 10.1016/S0896-6273(00)80674-1; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	53	624	636	2	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					759	763		10.1038/77664	http://dx.doi.org/10.1038/77664			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903567				2022-12-17	WOS:000167177300009
J	Winkler, EA; Bell, RD; Zlokovic, BV				Winkler, Ethan A.; Bell, Robert D.; Zlokovic, Berislav V.			Central nervous system pericytes in health and disease	NATURE NEUROSCIENCE			English	Review							BLOOD-BRAIN-BARRIER; SMOOTH-MUSCLE-CELLS; PDGF BETA-RECEPTOR; ALZHEIMERS-DISEASE; DIABETIC-RETINOPATHY; TGF-BETA; BONE-MARROW; N-CADHERIN; ENDOTHELIAL SURVIVAL; FUNCTIONAL HYPEREMIA	Pericytes are uniquely positioned within the neurovascular unit to serve as vital integrators, coordinators and effectors of many neurovascular functions, including angiogenesis, blood-brain barrier (BBB) formation and maintenance, vascular stability and angioarchitecture, regulation of capillary blood flow and clearance of toxic cellular byproducts necessary for proper CNS homeostasis and neuronal function. New studies have revealed that pericyte deficiency in the CNS leads to BBB breakdown and brain hypoperfusion resulting in secondary neurodegenerative changes. Here we review recent progress in understanding the biology of CNS pericytes and their role in health and disease.	[Winkler, Ethan A.; Bell, Robert D.; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Dept Neurol & Neurosurg, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA	University of Rochester	Zlokovic, BV (corresponding author), Univ Rochester, Med Ctr, Dept Neurol & Neurosurg, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA.	berislav_zlokovic@urmc.rochester.edu			US National Institutes of Health [R37 AG023084, R37 NS34467, HL63290]; Zilkha family; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034467, R37NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG023084] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zilkha family; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the US National Institutes of Health (grants R37 AG023084, R37 NS34467 and HL63290) and the Zilkha family for the research support.	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Bautch VL, 2009, CELL ADHES MIGR, V3, P199, DOI 10.4161/cam.3.2.8397; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Bobbie MW, 2010, INVEST OPHTH VIS SCI, V51, P3758, DOI 10.1167/iovs.09-4489; Braun A, 2007, J NEUROSCI, V27, P12012, DOI 10.1523/JNEUROSCI.3281-07.2007; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Carvalho RLC, 2007, J CELL SCI, V120, P4269, DOI 10.1242/jcs.013169; Chen B, 2010, STROKE, V41, P2348, DOI 10.1161/STROKEAHA.110.584920; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Chew SSL, 2010, EXP NEUROL, V225, P250, DOI 10.1016/j.expneurol.2010.07.014; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; FLORES LD, 2009, HISTOL HISTOPATHOL, V24, P909; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gerhardt H, 2000, DEV DYNAM, V218, P472, DOI 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hamilton Nicola B, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00005; Hammes HP, 2011, DIABETES, V60, P9, DOI 10.2337/db10-0454; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hirase H, 2004, GLIA, V46, P95, DOI 10.1002/glia.10295; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Jeansson M, 2011, J CLIN INVEST, V121, P2278, DOI 10.1172/JCI46322; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Kamouchi M, 2004, MOL BRAIN RES, V126, P114, DOI 10.1016/j.molbrainres.2004.03.008; Kokovay E, 2006, J CEREBR BLOOD F MET, V26, P545, DOI 10.1038/sj.jcbfm.9600214; Korn J, 2002, J COMP NEUROL, V442, P78, DOI 10.1002/cne.1423; Kurz H, 2009, CELL ADHES MIGR, V3, P205, DOI 10.4161/cam.3.2.7855; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P677, DOI 10.1189/jlb.0506309; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Li FF, 2011, DEV CELL, V20, P291, DOI 10.1016/j.devcel.2011.01.011; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Mhatre M, 2004, NEUROBIOL AGING, V25, P783, DOI 10.1016/j.neurobiolaging.2003.07.007; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Niwa K, 2000, P NATL ACAD SCI USA, V97, P9735, DOI 10.1073/pnas.97.17.9735; Ozerdem Ugur, 2004, Angiogenesis, V7, P269, DOI 10.1007/s10456-004-4182-6; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pfister F, 2010, ACTA DIABETOL, V47, P59, DOI 10.1007/s00592-009-0099-2; Piquer-Gil M, 2009, J CEREBR BLOOD F MET, V29, P480, DOI 10.1038/jcbfm.2008.150; Quaegebeur A, 2010, NEURON, V68, P321, DOI 10.1016/j.neuron.2010.10.024; Regan JN, 2009, CIRC RES, V104, P419, DOI 10.1161/CIRCRESAHA.109.194233; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Sieczkiewicz GJ, 2003, MICROVASC RES, V66, P190, DOI 10.1016/S0026-2862(03)00055-4; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Stenzel D, 2009, BLOOD, V114, P915, DOI 10.1182/blood-2008-10-186239; Stewart KS, 2011, BLOOD, V117, P719, DOI 10.1182/blood-2010-05-284869; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Van Geest RJ, 2010, INVEST OPHTH VIS SCI, V51, P1857, DOI 10.1167/iovs.09-4181; VERBEEK MM, 1995, J IMMUNOL, V154, P5876; VINTERS HV, 1994, ULTRASTRUCT PATHOL, V18, P333, DOI 10.3109/01913129409023202; Vinukonda G, 2010, STROKE, V41, P1766, DOI 10.1161/STROKEAHA.110.588400; Virgintino Daniela, 2007, Angiogenesis, V10, P35, DOI 10.1007/s10456-006-9061-x; Wakui S, 2006, LAB INVEST, V86, P1172, DOI 10.1038/labinvest.3700476; Walshe TE, 2011, INVEST OPHTH VIS SCI, V52, P4472, DOI 10.1167/iovs.10-7061; Walshe TE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005149; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wilhelmus MMM, 2007, AM J PATHOL, V171, P1989, DOI 10.2353/ajpath.2007.070050; Winkler EA, 2011, DEV CELL, V20, P279, DOI 10.1016/j.devcel.2011.03.002; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; WISNIEWSKI HM, 1992, ACTA NEUROPATHOL, V84, P117, DOI 10.1007/BF00311383; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zlokovic BV, 2008, NEUROTHERAPEUTICS, V5, P409, DOI 10.1016/j.nurt.2008.05.011; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	100	621	646	6	121	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2011	14	11					1398	1405		10.1038/nn.2946	http://dx.doi.org/10.1038/nn.2946			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841NI	22030551	Green Accepted			2022-12-17	WOS:000296518600012
J	Giuffrida, A; Parsons, LH; Kerr, TM; de Fonseca, FR; Navarro, M; Piomelli, D				Giuffrida, A; Parsons, LH; Kerr, TM; de Fonseca, FR; Navarro, M; Piomelli, D			Dopamine activation of endogenous cannabinoid signaling in dorsal striatum	NATURE NEUROSCIENCE			English	Article							RAT-BRAIN MICROSOMES; RECEPTOR-LIGAND; TOURETTES-SYNDROME; BASAL GANGLIA; ANANDAMIDE; AGONIST; IDENTIFICATION; INHIBITION; SR141716A; NEURONS	We measured endogenous cannabinoid release in dorsal striatum of freely moving rats by microdialysis and gas chromatography/mass spectrometry. Neural activity stimulated the release of anandamide, but not of other endogenous cannabinoids such as 2-arachidonylglycerol. Moreover, anandamide release was increased eightfold over baseline after local administration of the D-2-like (D-2, D-3, D-4) dopamine receptor agonist quinpirole, a response that was prevented by the D-2-like receptor antagonist raclopride. Administration of the D-1-like (D-1, D-5) receptor agonist SKF38393 had no such effect. These results suggest that functional interactions between endocannabinoid and dopaminergic systems may contribute to striatal signaling. In agreement with this hypothesis, pretreatment with the cannabinoid antagonist SR141716A enhanced the stimulation of motor behavior elicited by systemic administration of quinpirole. The endocannabinoid system therefore may act as an inhibitory feedback mechanism countering dopamine-induced facilitation of motor activity.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Univ Complutense, Dept Psychobiol, Madrid 28233, Spain	University of California System; University of California Irvine; Scripps Research Institute; Complutense University of Madrid	Piomelli, D (corresponding author), Univ Calif Irvine, Dept Pharmacol, 360 Med Surge 2, Irvine, CA 92697 USA.	poimelli@uci.edu	Giuffrida, Andrea/H-3770-2013; DE FONSECA, FERNANDO RODRIGUEZ/E-9767-2012	Giuffrida, Andrea/0000-0002-3773-0694; 	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012447, R01DA012413] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Cadas H, 1996, J NEUROSCI, V16, P3934; Cadas H, 1997, J NEUROSCI, V17, P1226; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Chase TN, 1996, ADV NEUROL, V69, P497; Civelli Olivier, 1995, P155; Compton DR, 1996, J PHARMACOL EXP THER, V277, P586; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DESARNAUD F, 1995, J BIOL CHEM, V270, P6030, DOI 10.1074/jbc.270.11.6030; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Eidelberg D, 1997, NEUROLOGY, V48, P927, DOI 10.1212/WNL.48.4.927; EILAM D, 1989, EUR J PHARMACOL, V161, P151, DOI 10.1016/0014-2999(89)90837-6; FACCI L, 1995, P NATL ACAD SCI USA, V92, P3376, DOI 10.1073/pnas.92.8.3376; FRIDE E, 1993, EUR J PHARMACOL, V231, P313, DOI 10.1016/0014-2999(93)90468-W; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Giuffrida A, 1998, FEBS LETT, V422, P373, DOI 10.1016/S0014-5793(98)00046-5; GOUGH AL, 1978, NEUROPHARMACOLOGY, V17, P137, DOI 10.1016/0028-3908(78)90126-0; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HEMMING M, 1993, J PSYCHOPHARMACOL, V7, P389, DOI 10.1177/026988119300700411; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; HILLARD CJ, 1995, BBA-LIPID LIPID MET, V1257, P249, DOI 10.1016/0005-2760(95)00087-S; Kondo S, 1998, FEBS LETT, V429, P152, DOI 10.1016/S0014-5793(98)00581-X; Landsman RS, 1997, EUR J PHARMACOL, V334, pR1, DOI 10.1016/S0014-2999(97)01160-6; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Matsuda LA, 1997, CRIT REV NEUROBIOL, V11, P143, DOI 10.1615/CritRevNeurobiol.v11.i2-3.30; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; MULLERVAHL KR, IN PRESS AM J PSYCHI; NAVARRO M, 1993, PHARMACOL BIOCHEM BE, V45, P291, DOI 10.1016/0091-3057(93)90241-K; PARSONS LH, 1994, CRIT REV NEUROBIOL, V8, P189; Parsons LH, 1996, J NEUROCHEM, V67, P1078; Piomelli Daniele, 1995, P595; PRYOR GT, 1978, PHARMACOL BIOCHEM BE, V8, P295, DOI 10.1016/0091-3057(78)90320-9; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; SanudoPena MC, 1996, NEUROSCI LETT, V206, P21, DOI 10.1016/0304-3940(96)12436-8; Schmid HHO, 1996, CHEM PHYS LIPIDS, V80, P133, DOI 10.1016/0009-3084(96)02554-6; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; Sim LJ, 1996, EUR J PHARMACOL, V307, P97, DOI 10.1016/0014-2999(96)00211-7; SOUILHAC J, 1995, PHARMACOL BIOCHEM BE, V51, P3, DOI 10.1016/0091-3057(94)00396-Z; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sugiura T, 1996, EUR J BIOCHEM, V240, P53, DOI 10.1111/j.1432-1033.1996.0053h.x; Sugiura T, 1996, BIOCHEM BIOPH RES CO, V218, P113, DOI 10.1006/bbrc.1996.0020; Surmeier D J, 1998, Adv Pharmacol, V42, P1020; Szabo B, 1998, NEUROSCIENCE, V85, P395, DOI 10.1016/S0306-4522(97)00597-6; Thorn L, 1997, NEUROPHARMACOLOGY, V36, P787, DOI 10.1016/S0028-3908(97)00033-6; UEDA N, 1995, J BIOL CHEM, V270, P23823, DOI 10.1074/jbc.270.40.23823; WADDINGTON JL, 1990, NEUROBIOLOGY STEREOT, P64; Wolf SS, 1996, SCIENCE, V273, P1225, DOI 10.1126/science.273.5279.1225	50	620	636	1	23	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					358	363		10.1038/7268	http://dx.doi.org/10.1038/7268			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204543	Green Submitted			2022-12-17	WOS:000080532000015
J	Diba, K; Buzsaki, G				Diba, Kamran; Buzsaki, Gyoergy			Forward and reverse hippocampal place-cell sequences during ripples	NATURE NEUROSCIENCE			English	Article							MEMORY; EXPERIENCE; SLEEP; ENSEMBLE; REPLAY; MODEL; RAT	We report that temporal spike sequences from hippocampal place neurons of rats on an elevated track recurred in reverse order at the end of a run, but in forward order in anticipation of the run, coinciding with sharp waves. Vector distances between the place fields were reflected in the temporal structure of these sequences. This bidirectional re-enactment of temporal sequences may contribute to the establishment of higher-order associations in episodic memory.	Rutgers State Univ, Ctr Mol & Behav Neurobiol, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Diba, K (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurobiol, 197 Univ Ave, Newark, NJ 07102 USA.	diba@andromeda.rutgers.edu; buzsaki@axon.rutgers.edu		Diba, Kamran/0000-0001-5128-4478; Buzsaki, Gyorgy/0000-0002-3100-4800	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH054671-09, R01 MH054671-06, MH54671, R01 MH054671-08, R01 MH054671-07, R01 MH054671, R01 MH054671-04, R01 MH054671-03, R01 MH054671-05] Funding Source: Medline; NINDS NIH HHS [R01 NS034994-07S1, R01 NS034994-06, R01 NS034994-08, R01 NS034994-09, R01 NS034994-07, R01 NS034994, R01 NS034994-11, NS34994, R01 NS034994-10, R01 NS034994-05, R01 NS034994-05S1, R01 NS034994-04] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Drosopoulos S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000376; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kahana MJ, 1996, MEM COGNITION, V24, P103, DOI 10.3758/BF03197276; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	15	619	626	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2007	10	10					1241	1242		10.1038/nn1961	http://dx.doi.org/10.1038/nn1961			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	214FG	17828259	Green Accepted			2022-12-17	WOS:000249720800008
J	Russo, SJ; Murroughl, JW; Han, MH; Charney, DS; Nestler, EJ				Russo, Scott J.; Murroughl, James W.; Han, Ming-Hu; Charney, Dennis S.; Nestler, Eric J.			Neurobiology of resilience	NATURE NEUROSCIENCE			English	Review							POSTTRAUMATIC-STRESS-DISORDER; SOCIAL DEFEAT STRESS; MOUSE NUCLEUS-ACCUMBENS; SEX-DIFFERENCES; ENVIRONMENTAL ENRICHMENT; CHROMATIN REGULATION; GENETIC-VARIATION; ADULT DEPRESSION; DOPAMINE NEURONS; FEAR EXTINCTION	Humans exhibit a remarkable degree of resilience in the face of extreme stress, with most resisting the development of neuropsychiatric disorders. Over the past 5 years, there has been increasing interest in the active, adaptive coping mechanisms of resilience; however, in humans, most published work focuses on correlative neuroendocrine markers that are associated with a resilient phenotype. In this review, we highlight a growing literature in rodents that is starting to complement the human work by identifying the active behavioral, neural, molecular and hormonal basis of resilience. The therapeutic implications of these findings are important and can pave the way for an innovative approach to drug development for a range of stress-related syndromes.	[Russo, Scott J.; Murroughl, James W.; Han, Ming-Hu; Charney, Dennis S.; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, Dept Neurosci, New York, NY USA; [Murroughl, James W.; Charney, Dennis S.; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, Dept Psychiat, New York, NY USA; [Han, Ming-Hu; Charney, Dennis S.; Nestler, Eric J.] Mt Sinai Sch Med, Friedman Brain Inst, Dept Pharmacol & Syst Therapeut, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Russo, SJ (corresponding author), Mt Sinai Sch Med, Friedman Brain Inst, Dept Neurosci, New York, NY USA.	scott.russo@mssm.edu	Russo, Scott/R-7107-2019; Han, Ming-Hu/G-8836-2012; Murrough, James/J-7129-2013	Russo, Scott/0000-0002-6470-1805; Murrough, James/0000-0001-6286-1242	US National Institute of Mental Health [R01 MH090264, K23 MH094707, R01 MH092306, R01 MH51399, P50 MH66172, P50 MH96890]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066172, R01MH092306, R01MH090264, K23MH094707, R01MH051399, P50MH096890] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Preparation of this review was supported by grants from the US National Institute of Mental Health: R01 MH090264 (S.J.R.); K23 MH094707 (J.W.M.); R01 MH092306 (M.-H.H.); and R01 MH51399, P50 MH66172 and P50 MH96890 (E.J.N.).	Adamec R, 2012, PHYSIOL BEHAV, V105, P628, DOI 10.1016/j.physbeh.2011.09.016; Andrus BM, 2012, MOL PSYCHIATR, V17, P49, DOI 10.1038/mp.2010.119; Autry AE, 2009, BIOL PSYCHIAT, V66, P84, DOI 10.1016/j.biopsych.2009.02.007; Balana B, 2011, P NATL ACAD SCI USA, V108, P5831, DOI 10.1073/pnas.1018645108; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Berton O, 2007, NEURON, V55, P289, DOI 10.1016/j.neuron.2007.06.033; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bowman RE, 2003, HORM BEHAV, V43, P48, DOI 10.1016/S0018-506X(02)00022-3; Bowman RE, 2002, NEUROSCIENCE, V113, P401, DOI 10.1016/S0306-4522(02)00156-2; Bradley RG, 2008, ARCH GEN PSYCHIAT, V65, P190, DOI 10.1001/archgenpsychiatry.2007.26; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Butterfield MI, 2005, AM J PSYCHIAT, V162, P380, DOI 10.1176/appi.ajp.162.2.380; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; Christoffel DJ, 2012, NEUROPSYCHOPHARMACOL, V37, P2615, DOI 10.1038/npp.2012.121; Christoffel DJ, 2011, REV NEUROSCIENCE, V22, P535, DOI 10.1515/RNS.2011.044; Christoffel DJ, 2011, J NEUROSCI, V31, P314, DOI 10.1523/JNEUROSCI.4763-10.2011; Cohen H, 2012, NEUROPSYCHOPHARMACOL, V37, P350, DOI 10.1038/npp.2011.230; Conrad CD, 2003, NEUROBIOL LEARN MEM, V79, P32, DOI 10.1016/S1074-7427(02)00018-7; Covington HE, 2011, NEUROSCI LETT, V493, P122, DOI 10.1016/j.neulet.2011.02.022; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Palacios RDY, 2011, BIOL PSYCHIAT, V70, P449, DOI 10.1016/j.biopsych.2011.05.014; Domschke K, 2010, EUR NEUROPSYCHOPHARM, V20, P301, DOI 10.1016/j.euroneuro.2009.09.006; Douglas AJ, 2003, ENDOCRINOLOGY, V144, P5268, DOI 10.1210/en.2003-0461; Edwards DA, 2006, PHYSIOL BEHAV, V87, P135, DOI 10.1016/j.physbeh.2005.09.007; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Fleshner M, 2011, STRESS, V14, P498, DOI 10.3109/10253890.2011.596865; Galea LAM, 1997, NEUROSCIENCE, V81, P689, DOI 10.1016/S0306-4522(97)00233-9; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P2322; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Katz M, 2009, DEV NEUROSCI-BASEL, V31, P293, DOI 10.1159/000216540; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lammel S, 2011, NEURON, V70, P855, DOI 10.1016/j.neuron.2011.03.025; LaPlant Q, 2009, BIOL PSYCHIAT, V65, P874, DOI 10.1016/j.biopsych.2009.01.024; Lehmann ML, 2011, J NEUROSCI, V31, P6159, DOI 10.1523/JNEUROSCI.0577-11.2011; LEVINE S, 1962, SCIENCE, V135, P795, DOI 10.1126/science.135.3506.795-a; Linden DEJ, 2006, MOL PSYCHIATR, V11, P528, DOI 10.1038/sj.mp.4001816; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Luine V, 2002, STRESS, V5, P205, DOI 10.1080/1025389021000010549; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Lyons DM, 2010, DEV PSYCHOBIOL, V52, P616, DOI 10.1002/dev.20500; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Meewisse ML, 2007, BRIT J PSYCHIAT, V191, P387, DOI 10.1192/bjp.bp.106.024877; Mickey BJ, 2011, ARCH GEN PSYCHIAT, V68, P158, DOI 10.1001/archgenpsychiatry.2010.197; Milad MR, 2005, PSYCHOPHYSIOLOGY, V42, P456, DOI 10.1111/j.1469-8986.2005.00302.x; Moncek F, 2004, J NEUROENDOCRINOL, V16, P423, DOI 10.1111/j.1365-2826.2004.01173.x; Morgan CA, 2002, BIOL PSYCHIAT, V52, P136, DOI 10.1016/S0006-3223(02)01319-7; Morgan CA, 2000, BIOL PSYCHIAT, V47, P902, DOI 10.1016/S0006-3223(99)00239-5; Morgan CA, 2000, BIOL PSYCHIAT, V47, P891, DOI 10.1016/S0006-3223(99)00307-8; Mozhui K, 2010, J NEUROSCI, V30, P5357, DOI 10.1523/JNEUROSCI.5017-09.2010; Mulchahey JJ, 2001, PSYCHONEUROENDOCRINO, V26, P273, DOI 10.1016/S0306-4530(00)00052-4; Murrough JW, 2011, NEUROBIOL LEARN MEM, V96, P553, DOI 10.1016/j.nlm.2011.06.006; Murrough JW, 2011, BIOL PSYCHIAT, V69, P510, DOI 10.1016/j.biopsych.2011.01.019; Nesse RM, 2000, ARCH GEN PSYCHIAT, V57, P14, DOI 10.1001/archpsyc.57.1.14; Oliveira T, 2009, PSYCHONEUROENDOCRINO, V34, P1056, DOI 10.1016/j.psyneuen.2009.02.006; Ono Y, 2012, STRESS, V15, P207, DOI 10.3109/10253890.2011.614296; Parker KJ, 2005, BIOL PSYCHIAT, V57, P848, DOI 10.1016/j.biopsych.2004.12.024; Parker KJ, 2004, ARCH GEN PSYCHIAT, V61, P933, DOI 10.1001/archpsyc.61.9.933; Polanczyk G, 2009, ARCH GEN PSYCHIAT, V66, P978, DOI 10.1001/archgenpsychiatry.2009.114; Pope HG, 2003, AM J PSYCHIAT, V160, P105, DOI 10.1176/appi.ajp.160.1.105; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Rasmusson AM, 2003, CNS SPECTRUMS, V8, P651, DOI 10.1017/S1092852900008841; Rauch SL, 2005, NEUROREPORT, V16, P1909, DOI 10.1097/01.wnr.0000186599.66243.50; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Ricon T, 2012, STRESS, V15, P11, DOI 10.3109/10253890.2011.572207; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; Stein MB, 2009, AM J MED GENET B, V150B, P900, DOI 10.1002/ajmg.b.30916; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Taliaz D, 2011, J NEUROSCI, V31, P4475, DOI 10.1523/JNEUROSCI.5725-10.2011; Taylor MK, 2012, STRESS, V15, P85, DOI 10.3109/10253890.2011.585189; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; van Tol MJ, 2012, BIOL PSYCHIAT, V71, P593, DOI 10.1016/j.biopsych.2011.11.016; Vialou V, 2010, J NEUROSCI, V30, P14585, DOI 10.1523/JNEUROSCI.2496-10.2010; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Vidal J, 2011, BEHAV PROCESS, V88, P76, DOI 10.1016/j.beproc.2011.08.005; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009; Wood GE, 1998, P NATL ACAD SCI USA, V95, P4066, DOI 10.1073/pnas.95.7.4066; Wood GE, 2001, BEHAV NEUROSCI, V115, P175, DOI 10.1037//0735-7044.115.1.175; Wood SK, 2010, ENDOCRINOLOGY, V151, P1795, DOI 10.1210/en.2009-1026; Yehuda R, 2006, ACTA PSYCHIAT SCAND, V114, P187, DOI 10.1111/j.1600-0447.2006.00801.x; Yehuda R, 2005, AM J PSYCHIAT, V162, P998, DOI 10.1176/appi.ajp.162.5.998; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858	100	618	626	13	224	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1475	1484		10.1038/nn.3234	http://dx.doi.org/10.1038/nn.3234			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23064380	Green Accepted			2022-12-17	WOS:000310424900006
J	Carleton, A; Petreanu, LT; Lansford, R; Alvarez-Buylla, A; Lledo, PM				Carleton, A; Petreanu, LT; Lansford, R; Alvarez-Buylla, A; Lledo, PM			Becoming a new neuron in the adult olfactory bulb	NATURE NEUROSCIENCE			English	Article							ANTERIOR SUBVENTRICULAR ZONE; POSTNATAL-DEVELOPMENT; PROGENITOR CELLS; PRECURSOR CELLS; DENTATE GYRUS; STEM-CELLS; IN-VITRO; NEUROGENESIS; MIGRATION; HIPPOCAMPUS	New neurons are continually recruited throughout adulthood in certain regions of the adult mammalian brain. How these cells mature and integrate into preexisting functional circuits remains unknown. Here we describe the physiological properties of newborn olfactory bulb interneurons at five different stages of their maturation in adult mice. Patch-clamp recordings were obtained from tangentially and radially migrating young neurons and from neurons in three subsequent maturation stages. Tangentially migrating neurons expressed extrasynaptic GABA(A) receptors and then AMPA receptors, before NMDA receptors appeared in radially migrating neurons. Spontaneous synaptic activity emerged soon after migration was complete, and spiking activity was the last characteristic to be acquired. This delayed excitability is unique to cells born in the adult and may protect circuits from uncontrolled neurotransmitter release and neural network disruption. Our results show that newly born cells recruited into the olfactory bulb become neurons, and a unique sequence of events leads to their functional integration.	Inst Pasteur, Lab Percept & Memory, CNRS UMR 2182, F-75015 Paris, France; Rockefeller Univ, New York, NY 10021 USA; CALTECH, Beckman Inst, Div Biol, Biol Imaging Ctr, Pasadena, CA 91125 USA; UCSF, San Francisco, CA 94134 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Rockefeller University; California Institute of Technology; University of California System; University of California San Francisco	Lledo, PM (corresponding author), Inst Pasteur, Lab Percept & Memory, CNRS UMR 2182, 25 Rue Dr Roux, F-75015 Paris, France.	pmlledo@pasteur.fr	Lansford, Rusty/C-6956-2014; Carleton, Alan/C-9721-2010	Carleton, Alan/0000-0001-5633-9159; Petreanu, Leopoldo/0000-0003-1434-4691; Lansford, Rusty/0000-0002-2159-3699; Alvarez-Buylla, Arturo/0000-0003-4426-8925	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NICHD NIH HHS [HD32116] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alonso G, 1999, J COMP NEUROL, V405, P508, DOI 10.1002/(SICI)1096-9861(19990322)405:4<508::AID-CNE5>3.0.CO;2-5; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Carlen M, 2002, CURR BIOL, V12, P606, DOI 10.1016/S0960-9822(02)00771-6; Castillo PE, 1999, J NEUROSCI, V19, P9180; Cecchi GA, 2001, J COMPUT NEUROSCI, V11, P175, DOI 10.1023/A:1012849801892; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; De Marchis S, 2001, J NEUROBIOL, V49, P326, DOI 10.1002/neu.10012; Didier A, 2001, P NATL ACAD SCI USA, V98, P6441, DOI 10.1073/pnas.101126398; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gutierrez R, 2002, J NEUROPHYSIOL, V87, P2562, DOI 10.1152/jn.2002.87.5.2562; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; Koester J., 1991, PRINCIPLES NEURAL SC, V3, P81; Komuro H, 1998, J NEUROBIOL, V37, P110, DOI 10.1002/(SICI)1097-4695(199810)37:1<110::AID-NEU9>3.3.CO;2-Q; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Liu RH, 1999, EXP NEUROL, V158, P143, DOI 10.1006/exnr.1999.7078; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Nottebohm F, 2002, J NEUROSCI, V22, P624, DOI 10.1523/JNEUROSCI.22-03-00624.2002; Nusser Z, 2001, J NEUROPHYSIOL, V86, P2823, DOI 10.1152/jn.2001.86.6.2823; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pirchio M, 1997, J NEUROSCI, V17, P5428; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Roy NS, 2000, NAT MED, V6, P271; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; SPIGELMAN I, 1992, J NEUROPHYSIOL, V68, P55, DOI 10.1152/jn.1992.68.1.55; Stewart RR, 1999, J NEUROPHYSIOL, V81, P95, DOI 10.1152/jn.1999.81.1.95; Stewart RR, 2002, J NEUROBIOL, V50, P305, DOI 10.1002/neu.10038; Tyzio R, 1999, J NEUROSCI, V19, P10372; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	47	618	641	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					507	518		10.1038/nn1048	http://dx.doi.org/10.1038/nn1048			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672ZD	12704391				2022-12-17	WOS:000182553200018
J	Ji, RR; Baba, H; Brenner, GJ; Woolf, CJ				Ji, RR; Baba, H; Brenner, GJ; Woolf, CJ			Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity	NATURE NEUROSCIENCE			English	Article							DORSAL HORN NEURONS; FORMALIN-INDUCED ACTIVITY; LONG-TERM POTENTIATION; RECEPTOR MESSENGER-RNA; PROTEIN-KINASE; CENTRAL SENSITIZATION; TISSUE-INJURY; IN-VIVO; RAT; STIMULATION	We investigated the involvement of extracellular signal-regulated protein kinases (ERK) within spinal neurons in producing pain hypersensitivity. Within a minute of an intense noxious peripheral or C-fiber electrical stimulus, many phosphoERK-positive neurons were observed, most predominantly in lamina I and IIo of the ipsilateral dorsal horn. This staining was intensity and NMDA receptor dependent. Low-intensity stimuli or A-fiber input had no effect. Inhibition of ERK phosphorylation by a MEK inhibitor reduced the second phase of formalin-induced pain behavior, a measure of spinal neuron sensitization. ERK signaling within the spinal cord is therefore involved in generating pain hypersensitivity. Because of its rapid activation, this effect probably involves regulation of neuronal excitability without changes in transcription.	Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ji, RR (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neural Plast Res Grp, 149 13th St,Rm 4309, Boston, MA 02129 USA.	ji@helix.mgh.harvard.edu	Ji, Ru-Rong/L-7070-2017; Woolf, Clifford/A-9784-2010; Brenner, Gary/AAI-1293-2019	Ji, Ru-Rong/0000-0002-9355-3688; Brenner, Gary/0000-0002-4586-1723	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 38253-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Baba H, 1999, J NEUROSCI, V19, P859; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BARABAN JM, 1993, J NEUROCHEM, V60, P330, DOI 10.1111/j.1471-4159.1993.tb05855.x; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CODERRE TJ, 1992, J NEUROSCI, V12, P3665; CODERRE TJ, 1990, BRAIN RES, V535, P155, DOI 10.1016/0006-8993(90)91835-5; DICKENSON AH, 1987, PAIN, V30, P349, DOI 10.1016/0304-3959(87)90023-6; DICKENSON AH, 1987, NEUROSCI LETT, V83, P207, DOI 10.1016/0304-3940(87)90242-4; DUBNER R, 1992, TRENDS NEUROSCI, V15, P96, DOI 10.1016/0166-2236(92)90019-5; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x; Henry JL, 1999, J NEUROSCI, V19, P6588; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; JI RR, 1995, NEUROSCIENCE, V68, P563, DOI 10.1016/0306-4522(95)94333-T; JI RR, 1994, J NEUROSCI, V14, P6423; Ji RR, 1997, J NEUROSCI, V17, P1776; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; McCall WD, 1996, NEUROSCI LETT, V208, P45, DOI 10.1016/0304-3940(96)12552-0; MCCARSON KE, 1994, J NEUROSCI, V14, P712; Messersmith DJ, 1998, MOL BRAIN RES, V53, P259, DOI 10.1016/S0169-328X(97)00308-2; Michael GJ, 1997, J NEUROSCI, V17, P8476; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sgambato V, 1998, J NEUROSCI, V18, P8814; SIMONE DA, 1989, BRAIN RES, V486, P185, DOI 10.1016/0006-8993(89)91293-6; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; SWETT JE, 1985, J COMP NEUROL, V231, P66, DOI 10.1002/cne.902310106; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; Woolf CJ, 1998, NEURON, V20, P1063, DOI 10.1016/S0896-6273(00)80487-0; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 1999, P NATL ACAD SCI USA, V96, P7723, DOI 10.1073/pnas.96.14.7723; WOOLF CJ, 1991, PAIN, V44, P293, DOI 10.1016/0304-3959(91)90100-C; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; YAMAMOTO T, 1992, ANESTHESIOLOGY, V77, P757, DOI 10.1097/00000542-199210000-00021; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	50	615	668	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1114	1119		10.1038/16040	http://dx.doi.org/10.1038/16040			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570489				2022-12-17	WOS:000085810100016
J	Baliki, MN; Petre, B; Torbey, S; Herrmann, KM; Huang, LJ; Schnitzer, TJ; Fields, HL; Apkarian, AV				Baliki, Marwan N.; Petre, Bogdan; Torbey, Souraya; Herrmann, Kristina M.; Huang, Lejian; Schnitzer, Thomas J.; Fields, Howard L.; Apkarian, A. Vania			Corticostriatal functional connectivity predicts transition to chronic back pain	NATURE NEUROSCIENCE			English	Article							BRAIN	The mechanism of brain reorganization in pain chronification is unknown. In a longitudinal brain imaging study, subacute back pain (SBP) patients were followed over the course of 1 year. When pain persisted (SBPp, in contrast to recovering SBP and healthy controls), brain gray matter density decreased. Initially greater functional connectivity of nucleus accumbens with prefrontal cortex predicted pain persistence, implying that corticostriatal circuitry is causally involved in the transition from acute to chronic pain.	[Baliki, Marwan N.; Petre, Bogdan; Torbey, Souraya; Herrmann, Kristina M.; Huang, Lejian; Apkarian, A. Vania] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Schnitzer, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Rheumatol, Chicago, IL 60611 USA; [Fields, Howard L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Fields, Howard L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA; [Apkarian, A. Vania] Northwestern Univ, Feinberg Sch Med, Dept Anesthesia, Chicago, IL 60611 USA; [Apkarian, A. Vania] Northwestern Univ, Feinberg Sch Med, Dept Surg, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Apkarian, AV (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	a-apkarian@northwestern.edu	Fields, Howard/ABG-9073-2020; Petre, Bogdan/L-5927-2019	Apkarian, A. Vania/0000-0002-9788-7458	National Institute of Neurological Disorders and Stroke [NS35115]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035115] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all of the patients and healthy volunteers that participated in the study. The study was funded by the National Institute of Neurological Disorders and Stroke (NS35115). M.N.B. was funded by an anonymous foundation.	Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Baliki MN, 2006, J NEUROSCI, V26, P12165, DOI 10.1523/JNEUROSCI.3576-06.2006; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Chanda ML, 2011, J PAIN, V12, P792, DOI 10.1016/j.jpain.2011.01.008; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Isnard J, 2011, PAIN, V152, P946, DOI 10.1016/j.pain.2010.12.025; Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005	18	614	635	3	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2012	15	8					1117	+		10.1038/nn.3153	http://dx.doi.org/10.1038/nn.3153			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979UE	22751038	Green Accepted, Green Submitted			2022-12-17	WOS:000306844500017
J	Di Giorgio, FP; Carrasco, MA; Siao, MC; Maniatis, T; Eggan, K				Di Giorgio, Francesco Paolo; Carrasco, Monica A.; Siao, Michelle C.; Maniatis, Tom; Eggan, Kevin			Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; EXTEND SURVIVAL; MOUSE EMBRYOS; DISEASE; DEGENERATION; MUTATIONS; GENE; DIFFERENTIATION	Here we report an in vitro model system for studying the molecular and cellular mechanisms that underlie the neurodegenerative disease amyotrophic lateral sclerosis ( ALS). Embryonic stem cells ( ESCs) derived from mice carrying normal or mutant transgenic alleles of the human SOD1 gene were used to generate motor neurons by in vitro differentiation. These motor neurons could be maintained in long-term coculture either with additional cells that arose during differentiation or with primary glial cells. Motor neurons carrying either the nonpathological human SOD1 transgene or the mutant SOD1G93A allele showed neurodegenerative properties when cocultured with SOD1G93A glial cells. Thus, our studies demonstrate that glial cells carrying a human SOD1G93A mutation have a direct, non - cell autonomous effect on motor neuron survival. More generally, our results show that ESC- based models of disease provide a powerful tool for studying the mechanisms of neural degeneration. These phenotypes displayed in culture could provide cell- based assays for the identification of new ALS drugs.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Stem Cell Inst, Stowers Med Inst, Cambridge, MA 02138 USA; Univ Perugia, I-06100 Perugia, Italy	Harvard University; Harvard University; Stowers Institute for Medical Research; University of Perugia	Maniatis, T (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	maniatis@mcb.harvard.edu; eggan@mcb.harvard.edu	Eggan, Kevin/P-7119-2018	Siao, Michelle/0000-0002-3600-9483	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043915] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD046732, R01 HD046732-01A1] Funding Source: Medline; NINDS NIH HHS [R01 NS043915, R01 NS043915-27] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Banker G., 1998, CULTURING NERVE CELL; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Ben-Nun IF, 2006, MOL CELL ENDOCRINOL, V252, P154, DOI 10.1016/j.mce.2006.03.034; BIGNAMI A, 1974, J COMP NEUROL, V153, P27, DOI 10.1002/cne.901530104; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brown RH, 1997, ARCH NEUROL-CHICAGO, V54, P1246, DOI 10.1001/archneur.1997.00550220050013; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cole N, 1999, SEMIN NEUROL, V19, P407, DOI 10.1055/s-2008-1040855; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HOGAN B, 1994, MANIPULATING MOUSE E; Ince PG, 1998, J NEUROPATH EXP NEUR, V57, P895, DOI 10.1097/00005072-199810000-00002; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2004, MOL CELL NEUROSCI, V25, P241, DOI 10.1016/j.mcn.2003.10.011; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	32	613	647	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2007	10	5					608	614		10.1038/nn1885	http://dx.doi.org/10.1038/nn1885			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160NB	17435754	Green Accepted			2022-12-17	WOS:000245948000017
J	Tsuchiya, N; Koch, C				Tsuchiya, N; Koch, C			Continuous flash suppression reduces negative afterimages	NATURE NEUROSCIENCE			English	Article							MOTION-INDUCED BLINDNESS; PRIMARY VISUAL-CORTEX; BINOCULAR-RIVALRY; AFTER-IMAGES; COMPLEMENTARY AFTERIMAGES; INTEROCULAR SUPPRESSION; ADAPTATION; PERCEPTION; AWARENESS; ATTENTION	Illusions that produce perceptual suppression despite constant retinal input are used to manipulate visual consciousness. Here we report on a powerful variant of existing techniques, continuous flash suppression. Distinct images flashed successively at similar to 10 Hz into one eye reliably suppress an image presented to the other eye. The duration of perceptual suppression is at least ten times greater than that produced by binocular rivalry. Using this tool we show that the strength of the negative afterimage of an adaptor was reduced by half when it was perceptually suppressed by input from the other eye. The more completely the adaptor was suppressed, the more strongly the afterimage intensity was reduced. Paradoxically, trial-to-trial visibility of the adaptor did not correlate with the degree of reduction. Our results imply that formation of afterimages involves neuronal structures that access input from both eyes but that do not correspond directly to the neuronal correlates of perceptual awareness.	CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA	California Institute of Technology	Tsuchiya, N (corresponding author), CALTECH, Computat & Neural Syst Program, M-S 139-74,1200 E Calif Blvd, Pasadena, CA 91125 USA.	naotsu@klab.caltech.edu	Tsuchiya, Naotsugu/N-8153-2014	Tsuchiya, Naotsugu/0000-0003-4216-8701; Koch, Christof/0000-0001-6482-8067				ALPERN M, 1962, J OPT SOC AM, V52, P219, DOI 10.1364/JOSA.52.000219; ANSTIS S, 1978, VISION RES, V18, P899, DOI 10.1016/0042-6989(78)90016-0; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; Blake Randolph, 1995, P17; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; BOSSINK CJH, 1993, VISION RES, V33, P1413, DOI 10.1016/0042-6989(93)90047-Z; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Breese BB., 1899, PSYCHOL REV-MONOGR S, V3, DOI [10.1037/h0092990, DOI 10.1037/H0092990]; BRINDLEY GS, 1962, J PHYSIOL-LONDON, V164, P168, DOI 10.1113/jphysiol.1962.sp007011; Chan D, 2001, J NEUROL NEUROSUR PS, V71, P515, DOI 10.1136/jnnp.71.4.515; Craik KJW, 1940, NATURE, V145, P512, DOI 10.1038/145512a0; FOX R, 1969, PERCEPT PSYCHOPHYS, V5, P215, DOI 10.3758/BF03210542; HAYHOE MM, 1984, PERCEPTION, V13, P455, DOI 10.1068/p130455; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hofstoetter C, 2004, CONSCIOUS COGN, V13, P691, DOI 10.1016/j.concog.2004.06.007; KELLY DH, 1993, J OPT SOC AM A, V10, P29, DOI 10.1364/JOSAA.10.000029; Koch C., 2004, QUEST CONSCIOUSNESS, P260; Kreiman G, 2002, P NATL ACAD SCI USA, V99, P8378, DOI 10.1073/pnas.072194099; LACK LC, 1978, SELECTIVE ATTENTION, P117; Lamme VAF, 2003, TRENDS COGN SCI, V7, P12, DOI 10.1016/S1364-6613(02)00013-X; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; LEVELT WJM, 1965, BINOCULAR RIVALTY; LOGOTHETIS NK, 1989, SCIENCE, V245, P761, DOI 10.1126/science.2772635; LOOMIS JM, 1978, J OPT SOC AM, V68, P411, DOI 10.1364/JOSA.68.000411; LOOMIS JM, 1972, VISION RES, V12, P1587, DOI 10.1016/0042-6989(72)90031-4; Lou L, 2001, PERCEPTION, V30, P1439, DOI 10.1068/p3127; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Macknik SL, 2004, J COGNITIVE NEUROSCI, V16, P1049, DOI 10.1162/0898929041502788; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Rajimehr R, 2004, NEURON, V41, P663, DOI 10.1016/S0896-6273(04)00041-8; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; SAKITT B, 1976, VISION RES, V16, P129, DOI 10.1016/0042-6989(76)90089-4; SCHILLER PH, 1994, VISUAL NEUROSCI, V11, P643, DOI 10.1017/S0952523800002960; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; Shenberg DL, 1997, P NATL ACAD SCI USA, V94, P3408, DOI 10.1073/pnas.94.7.3408; Shimojo S, 2001, SCIENCE, V293, P1677, DOI 10.1126/science.1060161; Suzuki S, 2003, J EXP PSYCHOL HUMAN, V29, P793, DOI 10.1037/0096-1523.29.4.793; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; VIRSU V, 1977, VISION RES, V17, P853, DOI 10.1016/0042-6989(77)90129-8; Weiskrantz L, 1950, Q J EXP PSYCHOL, V2, P170, DOI 10.1080/17470215008416594; Weiskrantz L, 2002, CONSCIOUS COGN, V11, P568, DOI 10.1016/S1053-8100(02)00015-6; WIESENFELDER H, 1990, J NEUROSCI, V10, P3880, DOI 10.1523/JNEUROSCI.10-12-03880.1990; Wilke M, 2003, NEURON, V39, P1043, DOI 10.1016/j.neuron.2003.08.003; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Wilson HR, 1997, VISUAL NEUROSCI, V14, P403, DOI 10.1017/S0952523800012098; WOLFE JM, 1984, VISION RES, V24, P471, DOI 10.1016/0042-6989(84)90044-0	50	613	628	3	132	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1096	1101		10.1038/nn1500	http://dx.doi.org/10.1038/nn1500			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	949BP	15995700				2022-12-17	WOS:000230760200022
J	Hipp, JF; Hawellek, DJ; Corbetta, M; Siegel, M; Engel, AK				Hipp, Joerg F.; Hawellek, David J.; Corbetta, Maurizio; Siegel, Markus; Engel, Andreas K.			Large-scale cortical correlation structure of spontaneous oscillatory activity	NATURE NEUROSCIENCE			English	Article							RESTING STATE NETWORKS; FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; ACTIVITY FLUCTUATIONS; CORTEX; SYNCHRONIZATION; ORGANIZATION; SPECIFICITY; SIGNATURES; STABILITY	Little is known about the brain-wide correlation of electrophysiological signals. We found that spontaneous oscillatory neuronal activity exhibited frequency-specific spatial correlation structure in the human brain. We developed an analysis approach that discounts spurious correlation of signal power caused by the limited spatial resolution of electrophysiological measures. We applied this approach to source estimates of spontaneous neuronal activity reconstructed from magnetoencephalography. Overall, correlation of power across cortical regions was strongest in the alpha to beta frequency range (8-32 Hz) and correlation patterns depended on the underlying oscillation frequency. Global hubs resided in the medial temporal lobe in the theta frequency range (4-6 Hz), in lateral parietal areas in the alpha to beta frequency range (8-23 Hz) and in sensorimotor areas for higher frequencies (32-45 Hz). Our data suggest that interactions in various large-scale cortical networks may be reflected in frequency-specific power envelope correlations.	[Hipp, Joerg F.; Hawellek, David J.; Engel, Andreas K.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany; [Hipp, Joerg F.; Corbetta, Maurizio] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany; [Corbetta, Maurizio] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Corbetta, Maurizio] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Corbetta, Maurizio] Washington Univ, Sch Med, Dept Anat, St Louis, MO 63110 USA; [Corbetta, Maurizio] Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hipp, JF (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany.	joerg.hipp@cin.uni-tuebingen.de	Corbetta, Maurizio/AAZ-5219-2020; Siegel, Markus/H-5225-2012; Engel, Andreas K./AAH-6384-2019; Hipp, Joerg F/D-8936-2014; Engel, Andreas K/C-7781-2012	Siegel, Markus/0000-0001-5115-936X; Engel, Andreas K./0000-0003-4899-8466; Hipp, Joerg F/0000-0002-7875-2988; Engel, Andreas K/0000-0003-4899-8466; Hawellek, David J/0000-0002-2529-3351; CORBETTA, MAURIZIO/0000-0001-8295-3304	European Union [NEST-PATH-043457, HEALTH-F2-2008-200728]; National Institute of Mental Health [R01 MH096482-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096482] Funding Source: NIH RePORTER	European Union(European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Hipp for helpful discussions and comments on the manuscript, and the bwGRiD project (http://www.bw-grid.de) for the computational resources. This work was supported by grants from the European Union (NEST-PATH-043457 to A. K. E. and HEALTH-F2-2008-200728 to M. C. and A. K. E.) and the National Institute of Mental Health (R01 MH096482-01 to M.C.).	Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Bruns A, 2000, NEUROREPORT, V11, P1509, DOI 10.1097/00001756-200005150-00028; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Kahn I, 2008, J NEUROPHYSIOL, V100, P129, DOI 10.1152/jn.00077.2008; Laird Angela R, 2009, Front Neuroinform, V3, P23, DOI 10.3389/neuro.11.023.2009; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liu ZM, 2010, NEUROIMAGE, V51, P102, DOI 10.1016/j.neuroimage.2010.01.092; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Magri C, 2012, J NEUROSCI, V32, P1395, DOI 10.1523/JNEUROSCI.3985-11.2012; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Miller KJ, 2009, P NATL ACAD SCI USA, V106, P12174, DOI 10.1073/pnas.0902071106; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nolte G, 2003, PHYS MED BIOL, V48, P3637, DOI 10.1088/0031-9155/48/22/002; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scheeringa R, 2011, NEURON, V69, P572, DOI 10.1016/j.neuron.2010.11.044; Schepers IM, 2012, BRAIN, V135, P922, DOI 10.1093/brain/aws014; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Siegel M, 2008, NEURON, V60, P709, DOI 10.1016/j.neuron.2008.09.010; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	60	611	612	6	118	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					884	U110		10.1038/nn.3101	http://dx.doi.org/10.1038/nn.3101			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22561454	Green Accepted			2022-12-17	WOS:000304546700016
J	Bylund, M; Andersson, E; Novitch, BG; Muhr, J				Bylund, M; Andersson, E; Novitch, BG; Muhr, J			Vertebrate neurogenesis is counteracted by Sox1-3 activity	NATURE NEUROSCIENCE			English	Article							VENTRAL NEURAL-TUBE; NEURONAL DIFFERENTIATION; NERVOUS-SYSTEM; STEM-CELLS; GENE-EXPRESSION; ACHAETE-SCUTE; CHICK-EMBRYO; BHLH PROTEIN; SOX2; FATE	The generation of neurons from stem cells involves the activity of proneural basic helix-loop-helix (bHLH) proteins, but the mechanism by which these proteins irreversibly commit stem cells to neuronal differentiation is not known. Here we report that expression of the transcription factors Sox1, Sox2 and Sox3 (Sox1-3) is a critical determinant of neurogenesis. Using chick in ovo electroporation, we found that Sox1-3 transcription factors keep neural cells undifferentiated by counteracting the activity of proneural proteins. Conversely, the capacity of proneural bHLH proteins to direct neuronal differentiation critically depends on their ability to suppress Sox1-3 expression in CNS progenitors. These data suggest that the generation of neurons from stem cells depends on the inhibition of Sox1-3 expression by proneural proteins.	Karolinska Inst, Ludwig Inst Canc Res, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Karolinska Institutet; Ludwig Institute for Cancer Research; Karolinska Institutet; Columbia University; Howard Hughes Medical Institute	Muhr, J (corresponding author), Karolinska Inst, Ludwig Inst Canc Res, Box 240, SE-17177 Stockholm, Sweden.			Novitch, Bennett/0000-0002-2696-3708; andersson, elisabet/0000-0003-3095-465X				Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Berk AJ, 1998, COLD SPRING HARB SYM, V63, P243, DOI 10.1101/sqb.1998.63.243; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Buescher M, 2002, DEVELOPMENT, V129, P4193; CACCAMO D, 1989, LAB INVEST, V60, P390; Collignon J, 1996, DEVELOPMENT, V122, P509; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; JASONI CL, 1994, DEVELOPMENT, V120, P769; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kamachi Y, 1998, DEVELOPMENT, V125, P2521; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kintner C, 2002, J NEUROSCI, V22, P639, DOI 10.1523/JNEUROSCI.22-03-00639.2002; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; Lo LC, 2002, DEVELOPMENT, V129, P1553; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Morrow EM, 1999, DEVELOPMENT, V126, P23; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Overton PM, 2002, DEVELOPMENT, V129, P4219; Perez SE, 1999, DEVELOPMENT, V126, P1715; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Roztocil T, 1997, DEVELOPMENT, V124, P3263; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Smith ST, 1996, DEVELOPMENT, V122, P3141; STEVANOVIC M, 1993, HUM MOL GENET, V3, P2013; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zappone MV, 2000, DEVELOPMENT, V127, P2367	50	611	635	1	31	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1162	1168		10.1038/nn1131	http://dx.doi.org/10.1038/nn1131			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14517545				2022-12-17	WOS:000186229200015
J	Rampon, C; Tang, YP; Goodhouse, J; Shimizu, E; Kyin, M; Tsien, JZ				Rampon, C; Tang, YP; Goodhouse, J; Shimizu, E; Kyin, M; Tsien, JZ			Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINE DENSITY; LONG-TERM POTENTIATION; NMDAR1 KNOCKOUT MICE; SYNAPTIC PLASTICITY; NUMERICAL DENSITY; RATS; HIPPOCAMPUS; SYNAPSES; PATTERNS; RECEPTOR	We produced CA1-specific NMDA receptor 1 subunit-knockout (CA1-KO) mice to determine the NMDA receptor dependence of nonspatial memory formation and of experience-induced structural plasticity in the CA1 region. CA1-KO mice were profoundly impaired in object recognition, olfactory discrimination and contextual fear memories. Surprisingly, these deficits could be rescued by enriching experience. Using stereological electron microscopy, we found that enrichment induced an increase of the synapse density in the CA1 region in knockouts as well as control littermates. Therefore, our data indicate that CA1 NMDA receptor activity is critical in hippocampus-dependent nonspatial memory, but is not essential for experience-induced synaptic structural changes.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08540 USA	Princeton University	Tsien, JZ (corresponding author), Princeton Univ, Dept Mol Biol, Washington Rd, Princeton, NJ 08540 USA.	jtsien@molbio.princeton.edu	Tang, Ya-Ping/A-1035-2011; Shimizu, Eiji/K-4637-2017	Shimizu, Eiji/0000-0002-6741-9338; Tang, Ya-Ping/0000-0002-0445-4072; rampon, claire/0000-0001-8551-8682				BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bunsey M, 1995, HIPPOCAMPUS, V5, P546, DOI 10.1002/hipo.450050606; DALRYMPLEALFORD JC, 1984, BEHAV NEUROSCI, V98, P23, DOI 10.1037/0735-7044.98.1.23; DEGROOT DMG, 1986, J NEUROSCI METH, V18, P79, DOI 10.1016/0165-0270(86)90113-5; Diamond M.C., 1988, ENRICHING HEREDITY; FIALA BA, 1978, EXP NEUROL, V59, P372, DOI 10.1016/0014-4886(78)90229-7; GABBOTT PL, 1984, J NEUROSCI METH, V11, P221, DOI 10.1016/0165-0270(84)90084-0; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GRAY EG, 1959, J ANAT, V93, P420; GREENOUGH WT, 1990, SYMP MED H, V23, P159; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; KOGAN JH, 1996, CURR BIOL, V7, P1; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Mumby DG, 1996, BEHAV NEUROSCI, V110, P266, DOI 10.1037/0735-7044.110.2.266; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Paxinos G., 1997, MOUSE BRAIN STEREOTA; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rosene D. L., 1987, CEREB CORTEX, V6, P345, DOI DOI 10.1007/978-1-4615-6616-8_9; ROSENZWE.MR, 1966, AM PSYCHOL, V21, P321, DOI 10.1037/h0023555; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sorra KE, 1998, J COMP NEUROL, V398, P225; Sorra KE, 1998, J NEUROSCI, V18, P658; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Stevens CF, 1998, CURR BIOL, V8, pR151, DOI 10.1016/S0960-9822(98)70097-1; STRUPP BJ, 1984, J COMP PSYCHOL, V98, P257, DOI 10.1037/0735-7036.98.3.257; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Woolf NJ, 1998, PROG NEUROBIOL, V55, P59, DOI 10.1016/S0301-0082(97)00094-4; WOOLLEY CS, 1990, J NEUROSCI, V10, P4035, DOI 10.1523/JNEUROSCI.10-12-04035.1990; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	41	611	629	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2000	3	3					238	244		10.1038/72945	http://dx.doi.org/10.1038/72945			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	292TE	10700255				2022-12-17	WOS:000085810500012
J	Fang, EF; Hou, YJ; Palikaras, K; Adriaanse, BA; Kerr, JS; Yang, BM; Lautrup, S; Hasan-Olive, MM; Caponio, D; Dan, XL; Rocktaschel, P; Croteau, DL; Akbari, M; Greig, NH; Fladby, T; Nilsen, H; Cader, MZ; Mattson, MP; Tavernarakis, N; Bohr, VA				Fang, Evandro F.; Hou, Yujun; Palikaras, Konstantinos; Adriaanse, Bryan A.; Kerr, Jesse S.; Yang, Beimeng; Lautrup, Sofie; Hasan-Olive, Md Mahdi; Caponio, Domenica; Dan, Xiuli; Rocktaschel, Paula; Croteau, Deborah L.; Akbari, Mansour; Greig, Nigel H.; Fladby, Tormod; Nilsen, Hilde; Cader, M. Zameel; Mattson, Mark P.; Tavernarakis, Nektarios; Bohr, Vilhelm A.			Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							A-BETA; LIFE-SPAN; NEURONS; MICROGLIA; AUTOPHAGY; PROTEIN; ELEGANS; PHOSPHORYLATION; FEATURES; BRAIN	Accumulation of damaged mitochondria is a hallmark of aging and age-related neurodegeneration, including Alzheimer's disease (AD). The molecular mechanisms of impaired mitochondrial homeostasis in AD are being investigated. Here we provide evidence that mitophagy is impaired in the hippocampus of AD patients, in induced pluripotent stem cell-derived human AD neurons, and in animal AD models. In both amyloid-beta (A beta) and tau Caenorhabditis elegans models of AD, mitophagy stimulation (through NAD(+) supplementation, urolithin A, and actinonin) reverses memory impairment through PINK-1 (PTEN-induced kinase-1)-, PDR-1 (Parkinson's disease-related-1; parkin)-, or DCT-1 (DAF-16/FOXO-controlled germline-tumor affecting-1)-dependent pathways. Mitophagy diminishes insoluble A beta(1-42) and A beta(1-40) and prevents cognitive impairment in an APP/PS1 mouse model through microglial phagocytosis of extracellular A beta plaques and suppression of neuroinflammation. Mitophagy enhancement abolishes AD-related tau hyperphosphorylation in human neuronal cells and reverses memory impairment in transgenic tau nematodes and mice. Our findings suggest that impaired removal of defective mitochondria is a pivotal event in AD pathogenesis and that mitophagy represents a potential therapeutic intervention.	[Fang, Evandro F.; Hou, Yujun; Kerr, Jesse S.; Yang, Beimeng; Lautrup, Sofie; Dan, Xiuli; Croteau, Deborah L.; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Fang, Evandro F.; Hasan-Olive, Md Mahdi; Caponio, Domenica; Nilsen, Hilde] Univ Oslo, Dept Clin Mol Biol, Lorenskog, Norway; [Fang, Evandro F.; Hasan-Olive, Md Mahdi; Caponio, Domenica; Nilsen, Hilde] Akershus Univ Hosp, Lorenskog, Norway; [Palikaras, Konstantinos; Tavernarakis, Nektarios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Palikaras, Konstantinos; Tavernarakis, Nektarios] Univ Crete, Dept Basic Sci, Fac Med, Iraklion, Greece; [Adriaanse, Bryan A.; Rocktaschel, Paula; Cader, M. Zameel] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Akbari, Mansour; Bohr, Vilhelm A.] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Greig, Nigel H.] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA; [Fladby, Tormod] Univ Oslo, Inst Clin Med, Div Med & Lab Sci, Fac Med, Oslo, Norway; [Fladby, Tormod] Akershus Univ Hosp, Dept Neurol, Lorenskog, Norway; [Mattson, Mark P.] NIA, Lab Neurosci, NIH, Baltimore, MD 21224 USA; [Fang, Evandro F.; Mattson, Mark P.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Oslo; University of Oslo; Foundation for Research & Technology - Hellas (FORTH); University of Crete; University of Oxford; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Oslo; University of Oslo; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Fang, EF; Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.; Fang, EF (corresponding author), Univ Oslo, Dept Clin Mol Biol, Lorenskog, Norway.; Fang, EF (corresponding author), Akershus Univ Hosp, Lorenskog, Norway.; Bohr, VA (corresponding author), Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark.; Fang, EF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	e.f.fang@medisin.uio.no; bohrv@grc.nia.nih.gov	Fang, Evandro Fei/AAV-4653-2020; Bohr, Vilhelm/AAP-5931-2020; Tavernarakis, Nektarios/B-9684-2013; Croteau, Deb/AAP-5933-2020; Hou, Yujun/AFX-2626-2022; Fang, Evandro Fei/AAC-5511-2019; Palikaras, Konstantinos/AAI-1300-2020	Tavernarakis, Nektarios/0000-0002-5253-1466; Fang, Evandro Fei/0000-0003-0355-7202; Croteau, Deborah/0000-0002-6094-4084; Fladby, Tormod/0000-0002-9984-9797; Hou, Yujun/0000-0003-1778-1176; Cader, Zameel/0000-0002-6952-406X; Caponio, Domenica/0000-0002-3827-8943; Dan, Xiuli/0000-0002-8417-9639; Akbari, Mansour/0000-0002-6490-7766; Palikaras, Konstantinos/0000-0001-6992-5560	National Center for Research Resources of the National Institutes of Health; Intramural Research Program of the NIH; NIA; Helse Sor-Ost RHF [2017056, 275911]; Research Council of Norway [262175, 277813]; Center for Healthy Aging, University of Copenhagen; European Research Council [ERC-GA695190-MANNA, ERC-GA737599-NeuronAgeScreen]; European Commission; MRC [1826685, MC_PC_16034, 1826429] Funding Source: UKRI	National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Helse Sor-Ost RHF; Research Council of Norway(Research Council of Norway); Center for Healthy Aging, University of Copenhagen; European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Legouis (Institut de Biologie Integrative de la Cellule) for the C. elegans strain expressing GFP:: LGG-2. Some of the nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Center for Research Resources of the National Institutes of Health, and S. Mitani (National Bioresource Project) in Japan. We thank A. Fire for the plasmid vectors. We thank S. Cordonnier, H. Kassahun, J. Tian, W.B. Iser, M.A. Wilson, D. Figueroa, E. Fivenson, and Q.P. Lu for the experiments involving C. elegans and mice; K. Marosi and T.G. Demarest for the Seahorse studies; M. Kang, Y.Q. Zhang, E. Lehrmann, and K. Becker for the array data analysis; and A. Pasparaki for the technical support with the experiments. We thank N.F. Borhan for reading the paper. This research was supported by the Intramural Research Program of the NIH; the NIA (V.A.B.); the Helse Sor-Ost RHF (E.F.F., grant no. 2017056 and H.N., grant no. 275911); The Research Council of Norway (E.F.F., grant nos. 262175 and 277813); Center for Healthy Aging, University of Copenhagen; the European Research Council (ERC-GA695190-MANNA, ERC-GA737599-NeuronAgeScreen); the European Commission Framework Programmes;	Aman Y., 2018, TRANSL MED AGING, V2, P30, DOI [DOI 10.1016/J.TMA.2018.08.003, 10.1016/j.tma.2018.08.003]; Babcock AA, 2015, BRAIN BEHAV IMMUN, V48, P86, DOI 10.1016/j.bbi.2015.03.006; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BRENNER S, 1974, GENETICS, V77, P71; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Bu XL, 2018, MOL PSYCHIATR, V23, DOI 10.1038/mp.2017.204; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Du F, 2017, BRAIN, V140, P3233, DOI 10.1093/brain/awx258; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fang EF, 2017, JOVE-J VIS EXP, DOI 10.3791/56301; Fang EF, 2017, TRENDS MOL MED, V23, P899, DOI 10.1016/j.molmed.2017.08.001; Fang EF, 2017, SCI REP-UK, V7, DOI 10.1038/srep46208; Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Fatouros C, 2012, HUM MOL GENET, V21, P3587, DOI 10.1093/hmg/dds190; Fivenson EM, 2017, NEUROCHEM INT, V109, P202, DOI 10.1016/j.neuint.2017.02.007; Forester CM, 2018, P NATL ACAD SCI USA, V115, P2353, DOI 10.1073/pnas.1707514115; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Handel AE, 2016, HUM MOL GENET, V25, P989, DOI 10.1093/hmg/ddv637; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hou YJ, 2018, P NATL ACAD SCI USA, V115, pE1876, DOI 10.1073/pnas.1718819115; Hou YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111215; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kerr JS, 2017, TRENDS NEUROSCI, V40, P151, DOI 10.1016/j.tins.2017.01.002; Khandelwal PJ, 2011, HUM MOL GENET, V20, P2091, DOI 10.1093/hmg/ddr091; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Koopman M, 2016, NAT PROTOC, V11, P1798, DOI 10.1038/nprot.2016.106; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lublin A L, 2013, Drug Discov Today Technol, V10, pe115, DOI 10.1016/j.ddtec.2012.02.002; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Martin-Maestro P, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00291; Mazure CM, 2016, LANCET NEUROL, V15, P451, DOI 10.1016/S1474-4422(16)00067-3; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Palikaras K, 2017, METHODS MOL BIOL, V1567, P349, DOI 10.1007/978-1-4939-6824-4_21; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Sarlus H, 2017, J CLIN INVEST, V127, P3240, DOI 10.1172/JCI90606; Scheibye-Knudsen M, 2015, TRENDS CELL BIOL, V25, P158, DOI 10.1016/j.tcb.2014.11.002; Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Skamagki M, 2017, NAT CELL BIOL, V19, P1037, DOI 10.1038/ncb3598; Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009; Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010; Thornton C, 2011, BIOCHEM J, V434, P503, DOI 10.1042/BJ20101485; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Voglis G, 2008, EMBO J, V27, P3288, DOI 10.1038/emboj.2008.252; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Ye X, 2015, HUM MOL GENET, V24, P2938, DOI 10.1093/hmg/ddv056; Yoon SO, 2012, NEURON, V75, P824, DOI 10.1016/j.neuron.2012.06.024; Yuan HS, 2018, NAT PROTOC, V13, P392, DOI 10.1038/nprot.2017.133; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	65	610	637	63	717	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2019	22	3					401	+		10.1038/s41593-018-0332-9	http://dx.doi.org/10.1038/s41593-018-0332-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HM4DL	30742114	Green Submitted, Green Accepted			2022-12-17	WOS:000459423800011
J	Khakh, BS; Sofroniew, MV				Khakh, Baljit S.; Sofroniew, Michael V.			Diversity of astrocyte functions and phenotypes in neural circuits	NATURE NEUROSCIENCE			English	Review							GRAY-MATTER ASTROCYTES; LONG-TERM POTENTIATION; REACTIVE ASTROCYTES; IN-VIVO; PROTOPLASMIC ASTROCYTES; HIPPOCAMPAL ASTROCYTES; GLUTAMATE TRANSPORTERS; STRUCTURAL PLASTICITY; CORTICAL ASTROCYTES; NEURONAL-ACTIVITY	Astrocytes tile the entire CNS. They are vital for neural circuit function, but have traditionally been viewed as simple, homogenous cells that serve the same essential supportive roles everywhere. Here, we summarize breakthroughs that instead indicate that astrocytes represent a population of complex and functionally diverse cells. Physiological diversity of astrocytes is apparent between different brain circuits and microcircuits, and individual astrocytes display diverse signaling in subcellular compartments. With respect to injury and disease, astrocytes undergo diverse phenotypic changes that may be protective or causative with regard to pathology in a context-dependent manner. These new insights herald the concept that astrocytes represent a diverse population of genetically tractable cells that mediate neural circuit-specific roles in health and disease.	[Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychol, Los Angeles, CA 90095 USA; [Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khakh, BS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychol, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu; sofroniew@mednet.ucla.edu	Sofroniew, Michael/ABE-8857-2020		US National Institutes of Health (NIH) [NS060677, MH099559A, MH104069]; CHDI Foundation; NIH [NS084030]; NIH from NCRR [RR04050, RR RR08605]; National Institute on Drug Abuse [DA016602]; National Institute of Biomedical Imaging and Bioengineering; National Institute of Mental Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008605, P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099559, DP1MH104069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057624, R01NS060677, R01NS084030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016602] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH from NCRR; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	B.S.K. is supported by the US National Institutes of Health (NIH; NS060677, MH099559A, MH104069) and the CHDI Foundation. M.V.S. is supported by NIH (NS084030), Wings for Life, Hilton Foundation, CHDI, and the Dr. Miriam and Sheldon B. Adelson Medical Research Foundation. The images shown in Figure 1 are from the The Cell Centered Database, which is supported by NIH grants from NCRR RR04050, RR RR08605, and the Human Brain Project DA016602 from the National Institute on Drug Abuse, the National Institute of Biomedical Imaging and Bioengineering, and the National Institute of Mental Health.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Agulhon C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00139; Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Allen NJ, 2014, ANNU REV CELL DEV BI, V30, P439, DOI 10.1146/annurev-cellbio-100913-013053; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Atkin SD, 2009, J NEUROSCI METH, V181, P212, DOI 10.1016/j.jneumeth.2009.05.006; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Bayraktar OA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020362; Bekar LK, 2008, CEREB CORTEX, V18, P2789, DOI 10.1093/cercor/bhn040; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Bernardinelli Y, 2014, CURR BIOL, V24, P1679, DOI 10.1016/j.cub.2014.06.025; Bernardinelli Y, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/232105; Bonder DE, 2014, J NEUROSCI, V34, P13139, DOI 10.1523/JNEUROSCI.2591-14.2014; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bush TG, 1998, CELL, V93, P189, DOI 10.1016/S0092-8674(00)81571-8; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cepeda C, 2010, ASN NEURO, V2, DOI 10.1042/AN20090058; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Christian CA, 2013, P NATL ACAD SCI USA, V110, P20278, DOI 10.1073/pnas.1318031110; Christian CA, 2013, NEURON, V78, P1063, DOI 10.1016/j.neuron.2013.04.026; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; CORNELLBELL AH, 1990, GLIA, V3, P322, DOI 10.1002/glia.440030503; DeFelipe J., 2010, CAJALS BUTTERFLIES S, DOI [10.1093/acprof:oso/9780195392708.001.0001, DOI 10.1093/ACPROF:OSO/9780195392708.001.0001]; Delekate A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6422; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Ding FF, 2013, CELL CALCIUM, V54, P387, DOI 10.1016/j.ceca.2013.09.001; Dunn KM, 2013, P NATL ACAD SCI USA, V110, P6157, DOI 10.1073/pnas.1216514110; Eng F.L., 1970, T AM SOC NEUROCHEM, V1, P42; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Estrada-Sanchez AM, 2012, BASAL GANGLIA, V2, P57, DOI 10.1016/j.baga.2012.04.029; FATATIS A, 1994, P NATL ACAD SCI USA, V91, P2036, DOI 10.1073/pnas.91.6.2036; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Freeman MR, 2013, NEURON, V80, P613, DOI 10.1016/j.neuron.2013.10.034; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Gee JM, 2014, NEURON, V83, P1058, DOI 10.1016/j.neuron.2014.07.024; Genoud C, 2006, PLOS BIOL, V4, P2057, DOI 10.1371/journal.pbio.0040343; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Haustein MD, 2014, NEURON, V82, P413, DOI 10.1016/j.neuron.2014.02.041; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Herculano-Houzel S, 2014, GLIA, V62, P1377, DOI 10.1002/glia.22683; Hires SA, 2008, BRAIN CELL BIOL, V36, P69, DOI 10.1007/s11068-008-9029-4; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Insel TR, 2013, SCIENCE, V340, P687, DOI 10.1126/science.1239276; Jiang R, 2014, JOVE-J VIS EXP, DOI 10.3791/51972; Kanemaru K, 2014, CELL REP, V8, P311, DOI 10.1016/j.celrep.2014.05.056; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kerr JND, 2012, CURR OPIN NEUROBIOL, V22, P45, DOI 10.1016/j.conb.2011.12.002; Khakh BS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020404; Kimelberg HK, 2010, NEUROSCIENTIST, V16, P79, DOI 10.1177/1073858409342593; Kofuji P, 2004, NEUROSCIENCE, V129, P1045, DOI 10.1016/j.neurscience.2004.06.008; KOSAKA T, 1986, J COMP NEUROL, V249, P242, DOI 10.1002/cne.902490209; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; KUFFLER SW, 1967, PROC R SOC SER B-BIO, V168, P1, DOI 10.1098/rspb.1967.0047; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Lavialle M, 2011, P NATL ACAD SCI USA, V108, P12915, DOI 10.1073/pnas.1100957108; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Lushnikova I, 2009, HIPPOCAMPUS, V19, P753, DOI 10.1002/hipo.20551; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Martone ME, 2002, J STRUCT BIOL, V138, P145, DOI 10.1016/S1047-8477(02)00006-0; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; MILLER RH, 1984, J NEUROSCI, V4, P585; Mishima T, 2010, J NEUROSCI, V30, P3093, DOI 10.1523/JNEUROSCI.5065-09.2010; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Molotkov D, 2013, CELL CALCIUM, V53, P338, DOI 10.1016/j.ceca.2013.03.001; Morel L, 2014, J NEUROSCI, V34, P10950, DOI 10.1523/JNEUROSCI.1167-14.2014; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Navarrete M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001259; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nimmerjahn A, 2015, CURR OPIN NEUROBIOL, V32, P95, DOI 10.1016/j.conb.2015.01.015; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Oliet SHR, 2010, EUR J NEUROSCI, V32, P1989, DOI 10.1111/j.1460-9568.2010.07514.x; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; ORKAND RK, 1966, J NEUROPHYSIOL, V29, P788, DOI 10.1152/jn.1966.29.4.788; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Pannasch U, 2014, NAT NEUROSCI, V17, P549, DOI 10.1038/nn.3662; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Perez-Alvarez A, 2014, J NEUROSCI, V34, P12738, DOI 10.1523/JNEUROSCI.2401-14.2014; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Poopalasundaram S, 2000, GLIA, V30, P362, DOI 10.1002/(SICI)1098-1136(200006)30:4<362::AID-GLIA50>3.0.CO;2-4; Poskanzer KE, 2011, P NATL ACAD SCI USA, V108, P18453, DOI 10.1073/pnas.1112378108; Rao VLR, 2001, NEUROCHEM RES, V26, P497; Reeves AMB, 2011, J NEUROSCI, V31, P9353, DOI 10.1523/JNEUROSCI.0127-11.2011; Reichenbach A., 2013, NEUROGLIA; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; Sasaki T, 2014, J PHYSIOL-LONDON, V592, P2771, DOI 10.1113/jphysiol.2014.272864; Sasaki T, 2011, SCIENCE, V331, P599, DOI 10.1126/science.1197598; Shepherd G.M., 2010, HDB BRAIN MICROCIRCU; Shigetomi E, 2013, J NEUROSCI, V33, P10143, DOI 10.1523/JNEUROSCI.5779-12.2013; Shigetomi E, 2013, J GEN PHYSIOL, V141, P633, DOI 10.1085/jgp.201210949; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; Shigetomi E, 2010, NEURON GLIA BIOL, V6, P183, DOI 10.1017/S1740925X10000219; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; SMITH SJ, 1992, PROG BRAIN RES, V94, P119; SMITH SJ, 1994, CURR BIOL, V4, P807, DOI 10.1016/S0960-9822(00)00178-0; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sosunov AA, 2014, J NEUROSCI, V34, P2285, DOI 10.1523/JNEUROSCI.4037-13.2014; Srinivasan R, 2015, NAT NEUROSCI, V18, P708, DOI 10.1038/nn.4001; Stork T, 2014, NEURON, V83, P388, DOI 10.1016/j.neuron.2014.06.026; Straub SV, 2006, J GEN PHYSIOL, V128, P659, DOI 10.1085/jgp.200609650; Sun D, 2012, NEUROSCIENTIST, V18, P567, DOI 10.1177/1073858411423441; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	145	610	624	22	171	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2015	18	7					942	952		10.1038/nn.4043	http://dx.doi.org/10.1038/nn.4043			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CL3QU	26108722	Green Accepted			2022-12-17	WOS:000356866200007
J	Churchland, MM; Yu, BM; Cunningham, JP; Sugrue, LP; Cohen, MR; Corrado, GS; Newsome, WT; Clark, AM; Hosseini, P; Scott, BB; Bradley, DC; Smith, MA; Kohn, A; Movshon, JA; Armstrong, KM; Moore, T; Chang, SW; Snyder, LH; Lisberger, SG; Priebe, NJ; Finn, IM; Ferster, D; Ryu, SI; Santhanam, G; Sahani, M; Shenoy, KV				Churchland, Mark M.; Yu, Byron M.; Cunningham, John P.; Sugrue, Leo P.; Cohen, Marlene R.; Corrado, Greg S.; Newsome, William T.; Clark, Andrew M.; Hosseini, Paymon; Scott, Benjamin B.; Bradley, David C.; Smith, Matthew A.; Kohn, Adam; Movshon, J. Anthony; Armstrong, Katherine M.; Moore, Tirin; Chang, Steve W.; Snyder, Lawrence H.; Lisberger, Stephen G.; Priebe, Nicholas J.; Finn, Ian M.; Ferster, David; Ryu, Stephen I.; Santhanam, Gopal; Sahani, Maneesh; Shenoy, Krishna V.			Stimulus onset quenches neural variability: a widespread cortical phenomenon	NATURE NEUROSCIENCE			English	Article							TO-TRIAL VARIABILITY; RESPONSE VARIABILITY; AREA MT; NEURONS; DIRECTION; CORTEX; MODULATION; DYNAMICS; INFORMATION; MICROSTIMULATION	Neural responses are typically characterized by computing the mean firing rate, but response variability can exist across trials. Many studies have examined the effect of a stimulus on the mean response, but few have examined the effect on response variability. We measured neural variability in 13 extracellularly recorded datasets and one intracellularly recorded dataset from seven areas spanning the four cortical lobes in monkeys and cats. In every case, stimulus onset caused a decline in neural variability. This occurred even when the stimulus produced little change in mean firing rate. The variability decline was observed in membrane potential recordings, in the spiking of individual neurons and in correlated spiking variability measured with implanted 96-electrode arrays. The variability decline was observed for all stimuli tested, regardless of whether the animal was awake, behaving or anaesthetized. This widespread variability decline suggests a rather general property of cortex, that its state is stabilized by an input.	[Churchland, Mark M.; Yu, Byron M.; Cunningham, John P.; Ryu, Stephen I.; Santhanam, Gopal; Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Sch Med, Stanford, CA 94305 USA; [Churchland, Mark M.; Yu, Byron M.; Sugrue, Leo P.; Cohen, Marlene R.; Corrado, Greg S.; Newsome, William T.; Armstrong, Katherine M.; Moore, Tirin; Shenoy, Krishna V.] Stanford Univ, Neurosci Program, Sch Med, Stanford, CA 94305 USA; [Yu, Byron M.; Sahani, Maneesh] UCL, Gatsby Computat Neurosci Unit, London, England; [Sugrue, Leo P.; Cohen, Marlene R.; Corrado, Greg S.; Newsome, William T.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Newsome, William T.; Armstrong, Katherine M.; Moore, Tirin] Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA; [Clark, Andrew M.; Hosseini, Paymon; Scott, Benjamin B.; Bradley, David C.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Clark, Andrew M.; Hosseini, Paymon; Scott, Benjamin B.; Bradley, David C.] Univ Chicago, Comm Computat Neurosci, Chicago, IL 60637 USA; [Smith, Matthew A.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Smith, Matthew A.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Kohn, Adam] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Kohn, Adam; Movshon, J. Anthony] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Chang, Steve W.; Snyder, Lawrence H.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Lisberger, Stephen G.] Univ Calif San Francisco, Howard Hughes Med Inst, WM Keck Fdn, Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Lisberger, Stephen G.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA; [Priebe, Nicholas J.] Univ Texas Austin, Neurobiol Sect, Sch Biol Sci, Austin, TX 78712 USA; [Finn, Ian M.; Ferster, David] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Ryu, Stephen I.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University; University of London; University College London; Howard Hughes Medical Institute; Stanford University; Stanford University; University of Chicago; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yeshiva University; Albert Einstein College of Medicine; New York University; Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Austin; Northwestern University; Stanford University; Stanford University	Churchland, MM (corresponding author), Stanford Univ, Dept Elect Engn, Sch Med, Stanford, CA 94305 USA.	church@stanford.edu	Snyder, Lawrence H/A-4593-2017; Newsome, William T./W-7171-2019	Chang, Steve Wohn Chul/0000-0003-4160-7549; Smith, Matthew A/0000-0003-1192-9942	Helen Hay Whitney; Burroughs Welcome Fund Career Awards in the Biomedical Sciences; US National Institutes of Health (NIH) [EY05603, EY014924, EY015958, EY018894, EY02017, EY04440, EY016774, 1 EY13138-01, EY019288]; National Institute of Neurological Disorders and Stroke Collaborative Research in Computational Neuroscience [R01-NS054283]; Michael Flynn Stanford Graduate Fellowship; Howard Hughes Medical Institute; Sloan FoundationPew Charitable Trust; US National Defense Science and Engineering Graduate Fellowships; National Science Foundation Graduate Research Fellowships; Christopher and Dana Reeve Foundation; Stanford Center for Integrated Systems; National Science Foundation Center for Neuromorphic Systems Engineering at Caltech; Office of Naval Research; NIH Director's Pioneer Award [1DP1OD006409]; Whitaker Foundation; NATIONAL EYE INSTITUTE [R01EY013138, K99EY018894, R01EY019288, R01EY016774, R01EY005603, R01EY004726, R37EY004440, R01EY003878, R56EY014924, R01EY012135, F32EY015958, R01EY004440, R01EY002017, R00EY018894, R01EY014924, R37EY005603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054283] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006409] Funding Source: NIH RePORTER	Helen Hay Whitney; Burroughs Welcome Fund Career Awards in the Biomedical Sciences(Burroughs Wellcome Fund); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke Collaborative Research in Computational Neuroscience(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael Flynn Stanford Graduate Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sloan FoundationPew Charitable Trust; US National Defense Science and Engineering Graduate Fellowships; National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); Christopher and Dana Reeve Foundation; Stanford Center for Integrated Systems; National Science Foundation Center for Neuromorphic Systems Engineering at Caltech; Office of Naval Research(Office of Naval Research); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitaker Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Helen Hay Whitney postdoctoral fellowship (M. M. C.), Burroughs Welcome Fund Career Awards in the Biomedical Sciences (M. M. C. and K. V. S.), Gatsby Charitable Foundation (M. S. and B.M.Y.), US National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke Collaborative Research in Computational Neuroscience grant R01-NS054283 (K. V. S. and M. S.), the Michael Flynn Stanford Graduate Fellowship (J.P.C.), the Howard Hughes Medical Institute and NIH grant EY05603 (W.T.N., L. P. S., M. R. C. and G. S. C.), a Howard Hughes Medical Institute predoctoral fellowship (M. R. C.), NIH grant EY014924 (T. M. and K. M. A.), Sloan Foundation (T. M. and K. V. S.), Pew Charitable Trust (T. M.), NIH EY015958 and EY018894 (M. A. S.), NIH EY02017 and EY04440 (J.A.M.), NIH EY016774 (A. K.), NIH 1 EY13138-01 (D. C. B., A. M. C., P. H. and B. B. S.), NIH EY019288 (N.J.P.), the Pew Charitable Trust (N.J.P.), EY04726 (D. F.), US National Defense Science and Engineering Graduate Fellowships (B.M.Y. and G. S.), National Science Foundation Graduate Research Fellowships (B.M.Y. and G. S.), the Christopher and Dana Reeve Foundation (K. V. S. and S. I. R.), and the awards from Stanford Center for Integrated Systems, National Science Foundation Center for Neuromorphic Systems Engineering at Caltech, Office of Naval Research, NIH Director's Pioneer Award 1DP1OD006409 and Whitaker Foundation (K. V. S.).	ABBOTT LF, NEURONAL VA IN PRESS; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Armstrong KM, 2007, P NATL ACAD SCI USA, V104, P9499, DOI 10.1073/pnas.0701104104; Armstrong KM, 2006, NEURON, V50, P791, DOI 10.1016/j.neuron.2006.05.010; Azouz R, 1999, J NEUROSCI, V19, P2209; BOCH R, 1983, EXP BRAIN RES, V50, P201; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Chang SWC, 2008, J NEUROSCI, V28, P6128, DOI 10.1523/JNEUROSCI.1442-08.2008; Churchland MM, 2007, CURR OPIN NEUROBIOL, V17, P609, DOI 10.1016/j.conb.2007.11.001; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cohen JY, 2007, J NEUROPHYSIOL, V98, P2580, DOI 10.1152/jn.00522.2007; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Everitt B., 1984, INTRO LATENT VARIABL; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; FORTIER PA, 1993, J NEUROPHYSIOL, V69, P1136, DOI 10.1152/jn.1993.69.4.1136; Gur M, 1997, J NEUROSCI, V17, P2914; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; KIHLBERG JK, 1972, APPL STAT, V21, P76; Kisley MA, 1999, J NEUROSCI, V19, P10451; Kohn A, 2009, CURR OPIN NEUROBIOL, V19, P434, DOI 10.1016/j.conb.2009.06.007; LEE D, NEURONAL VA IN PRESS; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mandelblat-Cerf Y, 2009, J NEUROSCI, V29, P15053, DOI 10.1523/JNEUROSCI.3011-09.2009; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Nawrot MP, 2008, J NEUROSCI METH, V169, P374, DOI 10.1016/j.jneumeth.2007.10.013; Oram MW, 2001, J NEUROPHYSIOL, V86, P1700, DOI 10.1152/jn.2001.86.4.1700; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Priebe NJ, 2002, J NEUROPHYSIOL, V88, P354, DOI 10.1152/jn.00852.2001; Rickert J, 2009, J NEUROSCI, V29, P13870, DOI 10.1523/JNEUROSCI.5441-08.2009; Roweis S, 1999, NEURAL COMPUT, V11, P305, DOI 10.1162/089976699300016674; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; WERNER G, 1963, J NEUROPHYSIOL, V26, P958, DOI 10.1152/jn.1963.26.6.958; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008	50	609	614	1	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					369	U25		10.1038/nn.2501	http://dx.doi.org/10.1038/nn.2501			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20173745	Green Accepted, Green Submitted			2022-12-17	WOS:000274860100020
J	Wong, PCM; Skoe, E; Russo, NM; Dees, T; Kraus, N				Wong, Patrick C. M.; Skoe, Erika; Russo, Nicole M.; Dees, Tasha; Kraus, Nina			Musical experience shapes human brainstem encoding of linguistic pitch patterns	NATURE NEUROSCIENCE			English	Article							LANGUAGE; SPEECH; CORTEX	Music and speech are very cognitively demanding auditory phenomena generally attributed to cortical rather than subcortical circuitry. We examined brainstem encoding of linguistic pitch and found that musicians show more robust and faithful encoding compared with nonmusicians. These results not only implicate a common subcortical manifestation for two presumed cortical functions, but also a possible reciprocity of corticofugal speech and music tuning, providing neurophysiological explanations for musicians' higher language-learning ability.	Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA; Northwestern Univ, Interdepartmental Neurosci Program, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Dept Otolaryngol, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Wong, PCM (corresponding author), Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, 2240 Campus Dr, Evanston, IL 60208 USA.	pwong@northwestern.edu	Wong, Patrick/A-8102-2012	Russo-Ponsaran, Nicole/0000-0002-9430-152X; Wong, Patrick/0000-0002-6105-5027	NICHD NIH HHS [R03HD051827, R03 HD051827] Funding Source: Medline; NIDCD NIH HHS [R01DC001510, R21DC007468, R01 DC001510, R21 DC007468] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD051827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001510, R21DC007468] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Gordon M, 2000, J COMP NEUROL, V426, P165, DOI 10.1002/1096-9861(20001016)426:2<165::AID-CNE1>3.0.CO;2-I; GREENBERG S, 1987, HEARING RES, V25, P91, DOI 10.1016/0378-5955(87)90083-9; Johnson KL, 2005, EAR HEARING, V26, P424, DOI 10.1097/01.aud.0000179687.71662.6e; Krishnan A, 2005, COGNITIVE BRAIN RES, V25, P161, DOI 10.1016/j.cogbrainres.2005.05.004; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Rauschecker JP, 1998, CURR OPIN NEUROBIOL, V8, P516, DOI 10.1016/S0959-4388(98)80040-8; Russo NM, 2005, BEHAV BRAIN RES, V156, P95, DOI 10.1016/j.bbr.2004.05.012; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Suga N, 2000, P NATL ACAD SCI USA, V97, P11807, DOI 10.1073/pnas.97.22.11807; Wong PCM, 2004, J NEUROSCI, V24, P9153, DOI 10.1523/JNEUROSCI.2225-04.2004; WONG PCM, IN PRESS HUM BRAIN M	15	607	625	1	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2007	10	4					420	422		10.1038/nn1872	http://dx.doi.org/10.1038/nn1872			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	150PL	17351633	Green Accepted			2022-12-17	WOS:000245228600011
J	Happe, F; Ronald, A; Plomin, R				Happe, Francesca; Ronald, Angelica; Plomin, Robert			Time to give up on a single explanation for autism	NATURE NEUROSCIENCE			English	Article							WEAK CENTRAL COHERENCE; GENETIC-HETEROGENEITY; SPECTRUM DISORDERS; CHILDREN; PHENOTYPE; TRAITS; DYSFUNCTION; BEHAVIORS; TWIN; MIND	We argue that there will be no single ( genetic or cognitive) cause for the diverse symptoms defining autism. We present recent evidence of behavioral fractionation of social impairment, communication difficulties and rigid and repetitive behaviors. Twin data suggest largely nonoverlapping genes acting on each of these traits. At the cognitive level, too, attempts at a single explanation for the symptoms of autism have failed. Implications for research and treatment are discussed.	Kings Coll London, Inst Psychiat, London SE5 8AF, England	University of London; King's College London	Happe, F (corresponding author), Kings Coll London, Inst Psychiat, De Crispigny Pk, London SE5 8AF, England.	spjgarr@iop.kcl.ac.uk	Plomin, Robert/B-8911-2008; Ronald, Angelica/C-7812-2009	Ronald, Angelica/0000-0002-9576-2176; Plomin, Robert/0000-0002-0756-3629; Happe, Francesca/0000-0001-9226-4000	Medical Research Council [G0500079(73692), G0500079] Funding Source: Medline; Medical Research Council [G9817803B] Funding Source: researchfish; MRC [G0500079] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aldred C, 2004, J CHILD PSYCHOL PSYC, V45, P1420, DOI 10.1111/j.1469-7610.2004.00338.x; American Psychiatric Association, 1994, DIAGNOSTIC STAT MANU, V4th; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S., 2000, UNDERSTANDING OTHER; Belmonte MK, 2003, COGNITIVE BRAIN RES, V17, P651, DOI 10.1016/S0926-6410(03)00189-7; Bishop DVM, 2003, NOVART FDN SYMP, V251, P213; BISHOP DVM, 1989, BRIT J DISORD COMMUN, V24, P107; Briskman J, 2001, J CHILD PSYCHOL PSYC, V42, P309, DOI 10.1111/1469-7610.00724; Buxbaum JD, 2001, AM J HUM GENET, V68, P1514, DOI 10.1086/320588; Charman T, 2001, DEVELOPMENT OF AUTISM: PERSPECTIVES FROM THEORY AND RESEARCH, P325; Charman T, 2003, INT J LANG COMM DIS, V38, P265, DOI 10.1080/136820310000104830; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Constantino JN, 2000, J DEV BEHAV PEDIATR, V21, P2, DOI 10.1097/00004703-200002000-00002; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; GOODMAN R, 1989, J AUTISM DEV DISORD, V19, P409, DOI 10.1007/BF02212939; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; HAPPE F, 2003, J AUTISM DEV DISORD, V251, P198; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Kanner L, 1943, NERV CHILD, V2, P217; KLIN A, 1992, J CHILD PSYCHOL PSYC, V33, P861, DOI 10.1111/j.1469-7610.1992.tb01961.x; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Lopez BR, 2005, J AUTISM DEV DISORD, V35, P445, DOI 10.1007/s10803-005-5035-x; Lord C, 1996, J AM ACAD CHILD PSY, V35, P1542, DOI 10.1097/00004583-199611000-00024; MOLIN SO, 2006, UNDERSTANDING AUTISM; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Newschaffer CJ, 2002, EPIDEMIOL REV, V24, P137, DOI 10.1093/epirev/mxf010; Pellicano E, 2006, DEV PSYCHOPATHOL, V18, P77, DOI 10.1017/S0954579406060056; Pickles A, 2000, J CHILD PSYCHOL PSYC, V41, P491, DOI 10.1017/S0021963099005557; Piven J, 1997, AM J PSYCHIAT, V154, P185; Ronald A, 2005, DEVELOPMENTAL SCI, V8, P444, DOI 10.1111/j.1467-7687.2005.00433.x; RONALD A, IN PRESS J AM ACAD C; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Shao YJ, 2003, AM J HUM GENET, V72, P539, DOI 10.1086/367846; Skuse DH, 2005, BRIT J PSYCHIAT, V187, P568, DOI 10.1192/bjp.187.6.568; Turner M, 1999, J CHILD PSYCHOL PSYC, V40, P839, DOI 10.1111/1469-7610.00502; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288	39	607	654	4	198	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1218	1220		10.1038/nn1770	http://dx.doi.org/10.1038/nn1770			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	098BB	17001340				2022-12-17	WOS:000241493900010
J	Mayr, U; Awh, E; Laurey, P				Mayr, U; Awh, E; Laurey, P			Conflict adaptation effects in the absence of executive control	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL		Univ Oregon, Dept Psychol, Eugene, OR 97403 USA	University of Oregon	Mayr, U (corresponding author), Univ Oregon, Dept Psychol, Eugene, OR 97403 USA.			Awh, Edward/0000-0002-5211-5278	NIA NIH HHS [R01 AG19296-01A1] Funding Source: Medline; NIMH NIH HHS [R01 MH64119] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019296] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cohen A, 1997, COGNITIVE PSYCHOL, V32, P128, DOI 10.1006/cogp.1997.0648; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; Logan GD, 2002, PSYCHOL REV, V109, P376, DOI 10.1037//0033-295X.109.2.376; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; PASHLER H, 1991, J EXP PSYCHOL LEARN, V17, P33, DOI 10.1037/0278-7393.17.1.33; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7	12	607	619	1	46	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2003	6	5					450	452		10.1038/nn1051	http://dx.doi.org/10.1038/nn1051			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	672ZD	12704394				2022-12-17	WOS:000182553200010
J	Olausson, H; Lamarre, Y; Backlund, H; Morin, C; Wallin, BG; Starck, G; Ekholm, S; Strigo, I; Worsley, K; Vallbo, AB; Bushnell, MC				Olausson, H; Lamarre, Y; Backlund, H; Morin, C; Wallin, BG; Starck, G; Ekholm, S; Strigo, I; Worsley, K; Vallbo, AB; Bushnell, MC			Unmyelinated tactile afferents signal touch and project to insular cortex	NATURE NEUROSCIENCE			English	Article							HAIRY SKIN; PAIN MECHANISMS; UNITS; FIBERS; MECHANORECEPTORS; NEURONS; SENSIBILITY; ACTIVATION; STIMULI; FIELDS	There is dual tactile innervation of the human hairy skin: in addition to fast-conducting myelinated afferent fibers, there is a system of slow-conducting unmyelinated (C) afferents that respond to light touch. In a unique patient lacking large myelinated afferents, we found that activation of C tactile (CT) afferents produced a faint sensation of pleasant touch. Functional magnetic resonance imaging (fMRI) analysis during CT stimulation showed activation of the insular region, but not of somatosensory areas S1 and S2. These findings identify CT as a system for limbic touch that may underlie emotional, hormonal and affiliative responses to caress-like, skin-to-skin contact between individuals.	Sahlgrens Univ Hosp, Dept Clin Neurophysiol, S-41345 Gothenburg, Sweden; Univ Montreal, Dept Physiol, Montreal, PQ H3C 3J7, Canada; Gothenburg Univ, Dept Physiol, S-41345 Gothenburg, Sweden; McGill Univ, Dept Anesthesia, Montreal, PQ H3G 1Y6, Canada; Sahlgrens Univ Hosp, Dept Radiat Phys, S-41345 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Radiol, S-41345 Gothenburg, Sweden; McGill Univ, Dept Math & Stat, Montreal, PQ H3G 1Y6, Canada	Sahlgrenska University Hospital; Universite de Montreal; University of Gothenburg; McGill University; Sahlgrenska University Hospital; Sahlgrenska University Hospital; McGill University	Olausson, H (corresponding author), Sahlgrens Univ Hosp, Dept Clin Neurophysiol, S-41345 Gothenburg, Sweden.	olausson@physiol.gu.se	strigo, irina A/L-9882-2016	strigo, irina A/0000-0002-8799-716X; Starck, Goran/0000-0002-7917-012X				Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; BESSOU P, 1971, J NEUROPHYSIOL, V34, P116, DOI 10.1152/jn.1971.34.1.116; Brooks JCW, 2002, NEUROIMAGE, V15, P293, DOI 10.1006/nimg.2001.0974; BURGESS PR, 1968, J NEUROPHYSIOL, V31, P833, DOI 10.1152/jn.1968.31.6.833; COGHILL RC, 1994, J NEUROSCI, V14, P4095; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Craig AD, 1996, PROG BRAIN RES, V107, P225; Craig AD, 2002, J NEUROPHYSIOL, V87, P1902, DOI 10.1152/jn.00578.2001; Craig AD, 2000, J PAIN, V1, P33, DOI 10.1016/S1526-5900(00)90086-5; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; Damasio A.R., 1999, FEELING WHAT HAPPENS; Disbrow E, 1998, HUM BRAIN MAPP, V6, P150, DOI 10.1002/(SICI)1097-0193(1998)6:3<150::AID-HBM4>3.0.CO;2-2; DOUGLAS WW, 1957, J PHYSIOL-LONDON, V139, P385, DOI 10.1113/jphysiol.1957.sp005899; Drzezga A, 2001, PAIN, V92, P295, DOI 10.1016/S0304-3959(01)00271-8; Edin BB, 2001, J PHYSIOL-LONDON, V531, P289, DOI 10.1111/j.1469-7793.2001.0289j.x; Essick GK, 1999, NEUROREPORT, V10, P2083, DOI 10.1097/00001756-199907130-00017; FORGET R, 1995, CAN J PHYSIOL PHARM, V73, P285, DOI 10.1139/y95-039; FRIEDMAN DP, 1986, J COMP NEUROL, V252, P323, DOI 10.1002/cne.902520304; GEORGOPOULOS AP, 1976, J NEUROPHYSIOL, V39, P71, DOI 10.1152/jn.1976.39.1.71; HARLOW HF, 1958, AM PSYCHOL, V13, P673, DOI 10.1037/h0047884; IGGO A, 1960, J PHYSIOL-LONDON, V152, P337, DOI 10.1113/jphysiol.1960.sp006491; JARVILEHTO T, 1976, EXP BRAIN RES, V25, P45; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; KAKUDA N, 1992, NEUROSCI RES, V15, P179, DOI 10.1016/0168-0102(92)90003-U; Kandel E.R., 2000, PRINCIPLES NEURAL SC; KONIETZNY F, 1977, PFLUG ARCH EUR J PHY, V368, P39, DOI 10.1007/BF01063452; KUMAZAWA T, 1977, J NEUROPHYSIOL, V40, P1325, DOI 10.1152/jn.1977.40.6.1325; KUMAZAWA T, 1977, J PHYSIOLOGY PARIS, V73, P287; Light AR, 1999, J NEUROPHYSIOL, V82, P3316, DOI 10.1152/jn.1999.82.6.3316; LIGHT AR, 1979, J COMP NEUROL, V186, P151, DOI 10.1002/cne.901860204; MACKENZIE RA, 1975, J NEUROL NEUROSUR PS, V38, P865, DOI 10.1136/jnnp.38.9.865; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; NORDIN M, 1990, J PHYSIOL-LONDON, V426, P229, DOI 10.1113/jphysiol.1990.sp018135; Olausson H, 2001, BRAIN, V124, P916, DOI 10.1093/brain/124.5.916; Olausson H, 1997, MUSCLE NERVE, V20, P1414, DOI 10.1002/(SICI)1097-4598(199711)20:11<1414::AID-MUS9>3.0.CO;2-D; PERL ER, 1968, J PHYSIOL-LONDON, V197, P593, DOI 10.1113/jphysiol.1968.sp008576; ROBINSON CJ, 1980, J COMP NEUROL, V192, P69, DOI 10.1002/cne.901920105; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; SUGIURA Y, 1986, SCIENCE, V234, P358, DOI 10.1126/science.3764416; TALAIRACH Y, 1988, COPLANAR STEREOTAXIC; Uvnas-Moberg K, 1998, PSYCHONEUROENDOCRINO, V23, P819, DOI 10.1016/S0306-4530(98)00056-0; VALLBO A, 1993, BRAIN RES, V628, P301, DOI 10.1016/0006-8993(93)90968-S; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753; VALLBO AB, 1995, J PHYSIOL-LONDON, V483, P783, DOI 10.1113/jphysiol.1995.sp020622; White JC, 1969, PAIN NEUROSURGEON 40; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933; YARNITSKY D, 1995, PAIN, V60, P329, DOI 10.1016/0304-3959(94)00132-X; Zotterman Y, 1939, J PHYSIOL-LONDON, V95, P1	49	606	622	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					900	904		10.1038/nn896	http://dx.doi.org/10.1038/nn896			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12145636				2022-12-17	WOS:000177656300021
J	Corbetta, M; Kincade, MJ; Lewis, C; Snyder, AZ; Sapir, A				Corbetta, M; Kincade, MJ; Lewis, C; Snyder, AZ; Sapir, A			Neural basis and recovery of spatial attention deficits in spatial neglect	NATURE NEUROSCIENCE			English	Article							HEMISPATIAL NEGLECT; SUBCORTICAL STROKE; UNILATERAL NEGLECT; VISUAL-ATTENTION; PARIETAL CORTEX; APHASIA; ANATOMY; MECHANISMS; HUMANS; VOLUNTARY	The syndrome of spatial neglect is typically associated with focal injury to the temporoparietal or ventral frontal cortex. This syndrome shows spontaneous partial recovery, but the neural basis of both spatial neglect and its recovery is largely unknown. We show that spatial attention deficits in neglect (rightward bias and reorienting) after right frontal damage correlate with abnormal activation of structurally intact dorsal and ventral parietal regions that mediate related attentional operations in the normal brain. Furthermore, recovery of these attention deficits correlates with the restoration and rebalancing of activity within these regions. These results support a model of recovery based on the re-weighting of activity within a distributed neuronal architecture, and they show that behavioral deficits depend not only on structural changes at the locus of injury, but also on physiological changes in distant but functionally related brain areas.	Washington Univ, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Rehabil Inst St Louis, St Louis, MO 63108 USA; Washington Univ, Dept Psychol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Dept Neurol, 660 S Euclid Ave, St Louis, MO 63110 USA.	mau@npg.wustl.edu	Lewis, Chris M/F-6665-2010; Corbetta, Maurizio/AAZ-5219-2020; Lewis, Christopher/AAP-5035-2021	Lewis, Christopher/0000-0001-8362-1248; CORBETTA, MAURIZIO/0000-0001-8295-3304				Appelros P, 2002, J REHABIL MED, V34, P215, DOI 10.1080/165019702760279206; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Binkofski F, 2004, NEUROLOGY, V63, P1223, DOI 10.1212/01.WNL.0000140468.92212.BE; Brighina F, 2003, NEUROSCI LETT, V336, P131, DOI 10.1016/S0304-3940(02)01283-1; CARAMAZZA A, 1988, ANNU REV NEUROSCI, V11, P395, DOI 10.1146/annurev.neuro.11.1.395; Connolly JD, 2002, NAT NEUROSCI, V5, P1345, DOI 10.1038/nn969; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DEUEL RK, 1984, ANN NEUROL, V15, P521, DOI 10.1002/ana.410150603; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; HALLIGAN PW, 1994, COGNITIVE NEUROPSYCH, V11, P167, DOI 10.1080/02643299408251973; Heilman K. M., 1987, NEUROPHYSIOLOGICAL N, V45, P115, DOI [DOI 10.1016/S0166-4115(08)61711-2, 10.1016/S0166-4115(08)61711-2]; Heiss WD, 1999, ANN NEUROL, V45, P430, DOI 10.1002/1531-8249(199904)45:4<430::AID-ANA3>3.0.CO;2-P; Hillis AE, 2005, J NEUROSCI, V25, P3161, DOI 10.1523/JNEUROSCI.4468-04.2005; HORNAK J, 1992, NEUROPSYCHOLOGIA, V30, P547, DOI 10.1016/0028-3932(92)90057-S; Husain M, 2003, NAT REV NEUROSCI, V4, P26, DOI 10.1038/nrn1005; Jackson J H, 1884, Br Med J, V1, P591; Jackson J. H., 1884, BMJ-BRIT MED J, V1, P660, DOI [DOI 10.1136/BMJ.1.1214.660, 10.1136/bmj.1.1214.660]; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; KINSBOURNE M, 1977, HEMIINATTENTION HEMI, P41; LUCK SJ, 1989, NATURE, V342, P543, DOI 10.1038/342543a0; LYNCH JC, 1989, J NEUROPHYSIOL, V61, P74, DOI 10.1152/jn.1989.61.1.74; Macaluso E, 2002, J COGNITIVE NEUROSCI, V14, P389, DOI 10.1162/089892902317361912; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; MORROW LA, 1988, PSYCHOBIOLOGY, V16, P261; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Naeser MA, 2005, BRAIN LANG, V93, P95, DOI 10.1016/j.bandl.2004.08.004; Pedersen PM, 1997, AM J PHYS MED REHAB, V76, P122, DOI 10.1097/00002060-199703000-00007; PEERS PV, 2005, CEREB CORTEX; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Pineiro R, 2002, STROKE, V33, P103, DOI 10.1161/hs0102.100482; Pizzamiglio L, 1998, ARCH NEUROL-CHICAGO, V55, P561, DOI 10.1001/archneur.55.4.561; POSNER MI, 1984, J NEUROSCI, V4, P1863; Pouget A, 2000, CURR OPIN NEUROBIOL, V10, P242, DOI 10.1016/S0959-4388(00)00077-5; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Rossini PM, 2004, BRAIN, V127, P99, DOI 10.1093/brain/awh012; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; VALLAR G, 1988, J NEUROL NEUROSUR PS, V51, P1269, DOI 10.1136/jnnp.51.10.1269; Vallar G., 1987, NEUROPHYSIOLOGICAL N, V45, P235; Von Monakov C., 1911, J PSYCHOL NEUROL, V17, P185	46	605	616	2	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1603	1610		10.1038/nn1574	http://dx.doi.org/10.1038/nn1574			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16234807	Green Published			2022-12-17	WOS:000232966600036
J	Okamoto, KI; Nagai, T; Miyawaki, A; Hayashi, Y				Okamoto, KI; Nagai, T; Miyawaki, A; Hayashi, Y			Rapid and persistent modulation of actin dynamics regulates postsynaptic reorganization underlying bidirectional plasticity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; DENDRITIC SPINES; AMPA RECEPTORS; F-ACTIN; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS; NMDA RECEPTORS; LTP	The synapse is a highly organized cellular specialization whose structure and composition are reorganized, both positively and negatively, depending on the strength of input signals. The mechanisms orchestrating these changes are not well understood. A plausible locus for the reorganization of synapse components and structure is actin, because it serves as both cytoskeleton and scaffold for synapses and exists in a dynamic equilibrium between F-actin and G-actin that is modulated bidirectionally by cellular signaling. Using a new FRET-based imaging technique to monitor F-actin/G-actin equilibrium, we show here that tetanic stimulation causes a rapid, persistent shift of actin equilibrium toward F-actin in the dendritic spines of rat hippocampal neurons. This enlarges the spines and increases postsynaptic binding capacity. In contrast, prolonged low-frequency stimulation shifts the equilibrium toward G-actin, resulting in a loss of postsynaptic actin and of structure. This bidirectional regulation of actin is actively involved in protein assembly and disassembly and provides a substrate for bidirectional synaptic plasticity.	MIT, Dept Brain & Cognit Sci, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, Cambridge, MA 02139 USA; RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct Dynam, Saitama 3510198, Japan	Massachusetts Institute of Technology (MIT); RIKEN; RIKEN	Hayashi, Y (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Ctr Learning & Memory, RIKEN MIT Neurosci Res Ctr, E25-618, Cambridge, MA 02139 USA.	yhayashi@mit.edu	Hayashi, Yasunori/AAF-1408-2019; Miyawaki, Atsushi/K-3569-2014; Hayashi, Yasunori/C-2249-2008; Okamoto, Kenichi/E-4582-2013	Hayashi, Yasunori/0000-0002-7560-3004; Miyawaki, Atsushi/0000-0002-2329-3235; Hayashi, Yasunori/0000-0002-7560-3004; Nagai, Takeharu/0000-0003-2650-9895; Okamoto, Kenichi/0000-0001-9527-2444				Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Allison DW, 1998, J NEUROSCI, V18, P2423; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; FIFKOVA E, 1992, INT REV CYTOL, V139, P267, DOI 10.1016/S0074-7696(08)61414-X; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Furuyashiki T, 2002, P NATL ACAD SCI USA, V99, P14458, DOI 10.1073/pnas.212148999; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Halpain S, 1998, J NEUROSCI, V18, P9835; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hering H, 2003, J NEUROSCI, V23, P11759; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; KAUER JA, 1988, NATURE, V334, P250, DOI 10.1038/334250a0; Kim CH, 1999, J NEUROSCI, V19, P4314; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; LISMAN J, 1988, J PHYSIOL-PARIS, V83, P187; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Piccini A, 2002, J NEUROSCI, V22, P5387; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; WANG YL, 1981, CELL, V27, P429, DOI 10.1016/0092-8674(81)90384-6; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	51	605	620	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1104	1112		10.1038/nn1311	http://dx.doi.org/10.1038/nn1311			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15361876				2022-12-17	WOS:000224156900020
J	Prinz, AA; Bucher, D; Marder, E				Prinz, AA; Bucher, D; Marder, E			Similar network activity from disparate circuit parameters	NATURE NEUROSCIENCE			English	Article							LOBSTER STOMATOGASTRIC GANGLION; UNDERLYING PATTERN GENERATION; ACTIVITY-DEPENDENT REGULATION; SELECTIVE INACTIVATION; IDENTIFIED NEURONS; DOPAMINE MODULATION; QUANTAL AMPLITUDE; PYLORIC NEURON; PHASE-SHIFTS; CURRENTS	It is often assumed that cellular and synaptic properties need to be regulated to specific values to allow a neuronal network to function properly. To determine how tightly neuronal properties and synaptic strengths need to be tuned to produce a given network output, we simulated more than 20 million versions of a three-cell model of the pyloric network of the crustacean stomatogastric ganglion using different combinations of synapse strengths and neuron properties. We found that virtually indistinguishable network activity can arise from widely disparate sets of underlying mechanisms, suggesting that there could be considerable animal-to-animal variability in many of the parameters that control network activity, and that many different combinations of synaptic strengths and intrinsic membrane properties can be consistent with appropriate network performance.	Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Prinz, AA (corresponding author), Brandeis Univ, Volen Ctr, Mail Stop 013,415 South St, Waltham, MA 02454 USA.	prinz@brandeis.edu	Prinz, Astrid/GPX-8509-2022	Bucher, Dirk/0000-0003-4144-2895	NIMH NIH HHS [MH-46742] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046742, R37MH046742] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 1998, METHODS NEURONAL MOD, P361; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BELL AJ, 1992, ADV NEURAL INFORMATI, P59; Bhalla US, 2001, CHAOS, V11, P221, DOI 10.1063/1.1350440; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Brezina V, 1996, SCIENCE, V273, P806, DOI 10.1126/science.273.5276.806; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Dayan P., 2001, THEORETICAL NEUROSCI; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; EISEN JS, 1982, J NEUROPHYSIOL, V48, P1392, DOI 10.1152/jn.1982.48.6.1392; FOSTER WR, 1993, J NEUROPHYSIOL, V70, P2502, DOI 10.1152/jn.1993.70.6.2502; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; Golowasch J, 2002, J NEUROPHYSIOL, V87, P1129, DOI 10.1152/jn.00412.2001; GOLOWASCH J, 1992, J NEUROPHYSIOL, V67, P318, DOI 10.1152/jn.1992.67.2.318; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Harris -Warrick R.M., 1992, DYNAMIC BIOL NETWORK; HARRISWARRICK RM, 1995, J NEUROSCI, V15, P342; HARRISWARRICK RM, 1995, J NEUROPHYSIOL, V74, P1404, DOI 10.1152/jn.1995.74.4.1404; HARTLINE DK, 1979, BIOL CYBERN, V33, P209, DOI 10.1007/BF00337410; Hartline DK, 1987, CRUSTACEAN STOMATOGA, P75; Hong SJ, 1997, J NEUROPHYSIOL, V77, P76, DOI 10.1152/jn.1997.77.1.76; Huerta R, 2001, BIOL CYBERN, V84, pL1, DOI 10.1007/PL00007976; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Li MX, 1996, J NEUROPHYSIOL, V76, P2595, DOI 10.1152/jn.1996.76.4.2595; Liu Z, 1998, J NEUROSCI, V18, P2309; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Marder E, 2002, NEURAL NETWORKS, V15, P479, DOI 10.1016/S0893-6080(02)00043-6; MARDER E, 1984, J NEUROPHYSIOL, V51, P1345, DOI 10.1152/jn.1984.51.6.1345; MARDER E, 1976, J PHYSIOL-LONDON, V257, P63, DOI 10.1113/jphysiol.1976.sp011356; MAYNARD DM, 1972, ANN NY ACAD SCI, V193, P59, DOI 10.1111/j.1749-6632.1972.tb27823.x; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1416, DOI 10.1152/jn.1982.48.6.1416; Mutalik VK, 2004, FEBS LETT, V558, P79, DOI 10.1016/S0014-5793(04)00021-3; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Pulver SR, 2005, J NEUROBIOL, V62, P47, DOI 10.1002/neu.20066; Selverston A I, 1976, Prog Neurobiol, V7, P215, DOI 10.1016/0301-0082(76)90008-3; SELVERSTON AI, 1980, J NEUROPHYSIOL, V44, P1102, DOI 10.1152/jn.1980.44.6.1102; SIEGEL M, 1994, P NATL ACAD SCI USA, V91, P11308, DOI 10.1073/pnas.91.24.11308; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Thoby-Brisson M, 2002, J NEUROPHYSIOL, V88, P2942, DOI 10.1152/jn.00482.2001; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92	50	604	610	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1345	1352		10.1038/nn1352	http://dx.doi.org/10.1038/nn1352			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15558066				2022-12-17	WOS:000225353900015
J	Haynes, JD; Rees, G				Haynes, JD; Rees, G			Predicting the orientation of invisible stimuli from activity in human primary visual cortex	NATURE NEUROSCIENCE			English	Article							OCULAR-DOMINANCE COLUMNS; CORTICAL ACTIVATION; BINOCULAR-RIVALRY; STRIATE CORTEX; FUNCTIONAL MRI; PERCEPTION; REPRESENTATIONS; AWARENESS; VISUALIZATION; ADAPTATION	Humans can experience aftereffects from oriented stimuli that are not consciously perceived, suggesting that such stimuli receive cortical processing. Determining the physiological substrate of such effects has proven elusive owing to the low spatial resolution of conventional human neuroimaging techniques compared to the size of orientation columns in visual cortex. Here we show that even at conventional resolutions it is possible to use fMRI to obtain a direct measure of orientation-selective processing in V1. We found that many parts of V1 show subtle but reproducible biases to oriented stimuli, and that we could accumulate this information across the whole of V1 using multivariate pattern recognition. Using this information, we could then successfully predict which one of two oriented stimuli a participant was viewing, even when masking rendered that stimulus invisible. Our findings show that conventional fMRI can be used to reveal feature-selective processing in human cortex, even for invisible stimuli.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Haynes, JD (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	haynes@fil.ion.ucl.ac.uk	Haynes, John-Dylan/Q-1148-2016; Rees, Geraint/C-1493-2008	Haynes, John-Dylan/0000-0003-1786-6954; Rees, Geraint/0000-0002-9623-7007	Wellcome Trust [067453] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; Boynton GM, 2003, J NEUROSCI, V23, P8781; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; COX AN, 1970, ASTROPHYS J SUPPL S, V19, P261, DOI 10.1086/190208; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Dehaene S, 1998, NAT NEUROSCI, V1, P549, DOI 10.1038/2785; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; DUDA OR, 2001, PATTERN CLASSIFICATI; Everitt B. S., 1991, APPL MULTIVARIATE DA; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; Gur M, 1997, VISION RES, V37, P377, DOI 10.1016/S0042-6989(96)00183-6; Hannula DE, 2005, NAT REV NEUROSCI, V6, P247, DOI 10.1038/nrn1630; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; He S, 2001, NATURE, V411, P473, DOI 10.1038/35078072; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Rajimehr R, 2004, NEURON, V41, P663, DOI 10.1016/S0896-6273(04)00041-8; Rees G, 2000, BRAIN, V123, P1624, DOI 10.1093/brain/123.8.1624; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Teo PC, 1997, IEEE T MED IMAGING, V16, P852, DOI 10.1109/42.650881; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; Vuilleumier P, 2001, P NATL ACAD SCI USA, V98, P3495, DOI 10.1073/pnas.051436898; Wandell BA, 2000, J COGNITIVE NEUROSCI, V12, P739, DOI 10.1162/089892900562561; Westheimer G, 2003, VISION RES, V43, P53, DOI 10.1016/S0042-6989(02)00398-X; Wilkinson F, 2000, CURR BIOL, V10, P1455, DOI 10.1016/S0960-9822(00)00800-9; YUKIE M, 1981, J COMP NEUROL, V201, P81, DOI 10.1002/cne.902010107	37	603	611	1	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					686	691		10.1038/nn1445	http://dx.doi.org/10.1038/nn1445			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852013				2022-12-17	WOS:000228895100031
J	Kravitz, AV; Tye, LD; Kreitzer, AC				Kravitz, Alexxai V.; Tye, Lynne D.; Kreitzer, Anatol C.			Distinct roles for direct and indirect pathway striatal neurons in reinforcement	NATURE NEUROSCIENCE			English	Article							OPTOGENETIC CONTROL; REWARD; DOPAMINE	Dopamine signaling is implicated in reinforcement learning, but the neural substrates targeted by dopamine are poorly understood. We bypassed dopamine signaling itself and tested how optogenetic activation of dopamine D1 or D2 receptor-expressing striatal projection neurons influenced reinforcement learning in mice. Stimulating D1 receptor-expressing neurons induced persistent reinforcement, whereas stimulating D2 receptor-expressing neurons induced transient punishment, indicating that activation of these circuits is sufficient to modify the probability of performing future actions.	[Kravitz, Alexxai V.; Tye, Lynne D.; Kreitzer, Anatol C.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA; [Tye, Lynne D.; Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Tye, Lynne D.; Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kreitzer, AC (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA.	akreitzer@gladstone.ucsf.edu	Core, Vector/CAF-4832-2022	Kravitz, Alexxai/0000-0001-5983-0218	W.M. Keck Foundation; Pew Biomedical Scholars Program; McKnight Foundation; US National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075099, ZIADK075096, ZIADK075101, ZIADK075103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078435, R01NS064984] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); Pew Biomedical Scholars Program; McKnight Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the Nikon Imaging Center at the University of California San Francisco for assistance with image acquisition, K. Deisseroth for optogenetic constructs and K. Tye for helpful comments on the manuscript. A.C.K. and co-workers are funded by the W.M. Keck Foundation, the Pew Biomedical Scholars Program, the McKnight Foundation and the US National Institutes of Health.	Abe M, 2011, CURR BIOL, V21, P557, DOI 10.1016/j.cub.2011.02.030; Azrin N. H., 1966, OPERANT BEHAVIOR ARE, P380; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Eshel N, 2010, BIOL PSYCHIAT, V68, P118, DOI 10.1016/j.biopsych.2010.01.027; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Nakatani Y, 2009, NEUROBIOL LEARN MEM, V92, P370, DOI 10.1016/j.nlm.2009.05.003; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Skinner B. F, 1953, SCI HUMAN BEHAV; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991	16	600	603	10	109	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					816	U23		10.1038/nn.3100	http://dx.doi.org/10.1038/nn.3100			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22544310	Green Submitted, Green Accepted			2022-12-17	WOS:000304546700007
J	Scholz, J; Woolf, CJ				Scholz, J; Woolf, CJ			Can we conquer pain?	NATURE NEUROSCIENCE			English	Review							MOLECULAR MECHANISMS; NEUROPATHIC PAIN; ACTIVATION; MANAGEMENT; INHIBITION; ANALGESIA; THERAPY	Pain can be an adaptive sensation, an early warning to protect the body from tissue injury. By the introduction of hypersensitivity to normally innocuous stimuli, pain may also aid in repair after tissue damage. Pain can also be maladaptive, reflecting pathological function of the nervous system. Multiple molecular and cellular mechanisms operate alone and in combination within the peripheral and central nervous systems to produce the different forms of pain. Elucidation of these mechanisms is key to the development of treatments that specifically target underlying causes rather than just symptoms. This new approach promises to revolutionize pain diagnosis and management.	Massachusetts Gen Hosp, Dept Anesthesia, Neural Plast Res Grp, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Woolf, CJ (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia, Neural Plast Res Grp, Boston, MA 02129 USA.		Woolf, Clifford/A-9784-2010					Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Boddeke EWGM, 2001, EUR J PHARMACOL, V429, P115, DOI 10.1016/S0014-2999(01)01311-5; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.3.CO;2-E; Desmeules JA, 1999, J PHARMACOL EXP THER, V288, P607; Fields HL, 2000, PROG BRAIN RES, V122, P245; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Flores CM, 2001, PHARMACOGENOMICS, V2, P177, DOI 10.1517/14622416.2.3.177; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Lynch D, 2000, PRACTICAL MANAGEMENT, P270; Mantyh PW, 2002, NAT REV CANCER, V2, P201, DOI 10.1038/nrc747; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Rittner HL, 2001, ANESTHESIOLOGY, V95, P500, DOI 10.1097/00000542-200108000-00036; Rose MA, 2002, ANAESTHESIA, V57, P451, DOI 10.1046/j.0003-2409.2001.02399.x; Sarkar S, 2000, LANCET, V356, P1154, DOI 10.1016/S0140-6736(00)02758-6; Sindrup SH, 1999, PAIN, V83, P389, DOI 10.1016/S0304-3959(99)00154-2; Svensson CI, 2002, ANNU REV PHARMACOL, V42, P553, DOI 10.1146/annurev.pharmtox.42.092401.143905; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Wood JN, 2000, AM J PHYSIOL-GASTR L, V278, pG507, DOI 10.1152/ajpgi.2000.278.4.G507; Woolf CJ, 2001, ANESTHESIOLOGY, V95, P241, DOI 10.1097/00000542-200107000-00034; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765	24	596	626	1	81	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1062	1067		10.1038/nn942	http://dx.doi.org/10.1038/nn942			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403987				2022-12-17	WOS:000179041300015
J	Woo, NH; Teng, HK; Siao, CJ; Chiaruttini, C; Pang, PT; Milner, TA; Hempstead, BL; Lu, B				Woo, NH; Teng, HK; Siao, CJ; Chiaruttini, C; Pang, PT; Milner, TA; Hempstead, BL; Lu, B			Activation of p75(NTR) by proBDNF facilitates hippocampal long-term depression	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIN RECEPTOR P75(NTR); ACTIVITY-DEPENDENT SECRETION; NERVE GROWTH-FACTOR; RAT DENTATE GYRUS; SIGNAL-TRANSDUCTION; SYNAPTIC PLASTICITY; AREA CA1; BDNF; MICE; NEURONS	Pro- and mature brain-derived neurotrophic factor (BDNF) activate two distinct receptors: p75 neurotrophin receptor (p75(NTR)) and TrkB. Mature BDNF facilitates hippocampal synaptic potentiation through TrkB. Here we report that proBDNF, by activating p75(NTR), facilitates hippocampal long-term depression (LTD). Electron microscopy showed that p75(NTR) localized in dendritic spines, in addition to afferent terminals, of CA1 neurons. Deletion of p75(NTR) in mice selectively impaired the NMDA receptor - dependent LTD, without affecting other forms of synaptic plasticity. p75(NTR-/-) mice also showed a decrease in the expression of NR2B, an NMDA receptor subunit uniquely involved in LTD. Activation of p75(NTR) by proBDNF enhanced NR2B-dependent LTD and NR2B-mediated synaptic currents. These results show a crucial role for proBDNF-p75(NTR) signaling in LTD and its potential mechanism, and together with the finding that mature BDNF promotes synaptic potentiation, suggest a bidirectional regulation of synaptic plasticity by proBDNF and mature BDNF.	NICHD, Sect Neural Dev & Plast, LCSN, Porter Neurosci Res Ctr, Bethesda, MD 20892 USA; Cornell Univ, Weill Med coll, Dept Med, Div Hematol, New York, NY 10021 USA; Cornell Univ, Weill Med coll, Dept Neurol & Neurosci, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cornell University; Cornell University	Lu, B (corresponding author), NICHD, Sect Neural Dev & Plast, LCSN, Porter Neurosci Res Ctr, 35 Lincoln Dr, Bethesda, MD 20892 USA.	bailu@mail.nih.gov	Lu, Bai/A-4018-2012	Lu, Bai/0000-0001-5418-9759	NHLBI NIH HHS [HL18974] Funding Source: Medline; NINDS NIH HHS [NS30658] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000714] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018974] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BANDTLOW C, 2004, SCI STKE, pPE24, DOI DOI 10.1126/STKE.2352004PE24; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chao MV, 2002, NEURON, V33, P9, DOI 10.1016/S0896-6273(01)00573-6; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Dougherty KD, 1999, J COMP NEUROL, V407, P77, DOI 10.1002/(SICI)1096-9861(19990428)407:1<77::AID-CNE6>3.0.CO;2-S; Dougherty KD, 1999, J NEUROSCI, V19, P10140; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ibanez CF, 2002, TRENDS NEUROSCI, V25, P284, DOI 10.1016/S0166-2236(02)02169-0; Ikegaya Y, 2002, EUR J NEUROSCI, V16, P145, DOI 10.1046/j.1460-9568.2002.02051.x; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kemp N, 1999, NEUROPHARMACOLOGY, V38, P495, DOI 10.1016/S0028-3908(98)00222-6; Kirkwood A, 1999, J NEUROSCI, V19, P1599; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu B, 2003, NEURON, V39, P735, DOI 10.1016/S0896-6273(03)00538-5; LU B, IN PRESS NAT REV NEU; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Mischel PS, 2001, J BIOL CHEM, V276, P11294, DOI 10.1074/jbc.M005132200; Mowla SJ, 1999, J NEUROSCI, V19, P2069; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peters A, 1991, FINE STRUCTURE NERVO; Peters I, 2001, WORLD LITERATURE TOD, V75, P404, DOI 10.2307/40156724; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; VanderZee CEEM, 1996, SCIENCE, V274, P1729, DOI 10.1126/science.274.5293.1729; Wright JW, 2004, BEHAV BRAIN RES, V153, P453, DOI 10.1016/j.bbr.2004.01.001; YAN Q, 1988, J NEUROSCI, V8, P3481	50	595	620	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2005	8	8					1069	1077		10.1038/nn1510	http://dx.doi.org/10.1038/nn1510			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949BP	16025106				2022-12-17	WOS:000230760200019
J	Fortin, NJ; Agster, KL; Eichenbaum, HB				Fortin, NJ; Agster, KL; Eichenbaum, HB			Critical role of the hippocampus in memory for sequences of events	NATURE NEUROSCIENCE			English	Article							RECOGNITION MEMORY; OBJECT-RECOGNITION; EPISODIC MEMORY; MONKEYS; DAMAGE; RATS; IMPAIRMENT; ASSOCIATOR; ABLATION; LOCATION	Recent models of hippocampal function emphasize the potential role of this brain structure in encoding and retrieving sequences of events that compose episodic memories. Here we show that hippocampal lesions produce a severe and selective impairment in the capacity of rats to remember the sequential ordering of a series of odors, despite an intact capacity to recognize odors that recently occurred. These findings support the hypothesis that hippocampal networks mediate associations between sequential events that constitute elements of an episodic memory.	Boston Univ, Dept Psychol, Lab Cognit Neurobiol, Boston, MA 02215 USA	Boston University	Eichenbaum, HB (corresponding author), Boston Univ, Dept Psychol, Lab Cognit Neurobiol, 64 Cummington St, Boston, MA 02215 USA.	hbe@bu.edu		Fortin, Norbert/0000-0002-6793-6984	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009973] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG009973-070005, AG09973, P01 AG009973] Funding Source: Medline; NIMH NIH HHS [MH52090, R01 MH052090, R01 MH052090-05] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; CHIBA AA, 1994, BEHAV NEURAL BIOL, V61, P123, DOI 10.1016/S0163-1047(05)80065-2; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; Dudchenko PA, 2000, J NEUROSCI, V20, P2964; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; GAFFAN D, 1994, EXP BRAIN RES, V99, P411; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; JARRARD LE, 1986, HIPPOCAMPUS, V4, P93; KESNER RP, 1982, SCIENCE, V218, P173, DOI 10.1126/science.7123228; Kesner RP, 1990, NEUROBIOLOGY COMP CO, P179; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Murray EA, 1999, TRENDS COGN SCI, V3, P142, DOI 10.1016/S1364-6613(99)01303-0; Murray EA, 1996, SEMIN NEUROSCI, V8, P13, DOI 10.1006/smns.1996.0003; Murray EA, 1998, J NEUROSCI, V18, P6568; RAWLINS JNP, 1985, BEHAV BRAIN SCI, V8, P479, DOI 10.1017/S0140525X00001291; Shapiro Matthew L., 1994, P87; Sohal VS, 1998, NEURAL COMPUT, V10, P869, DOI 10.1162/089976698300017539; Swanson L., 1992, BRAIN MAPS STRUCTURE; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000; ZOLAMORGAN S, 1994, HIPPOCAMPUS, V4, P483, DOI 10.1002/hipo.450040410	32	595	603	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					458	462		10.1038/nn834	http://dx.doi.org/10.1038/nn834			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11976705	Green Accepted			2022-12-17	WOS:000175272000017
J	Maess, B; Koelsch, S; Gunter, TC; Friederici, AD				Maess, B; Koelsch, S; Gunter, TC; Friederici, AD			Musical syntax is processed in Broca's area: an MEG study	NATURE NEUROSCIENCE			English	Article							PERCEIVED HARMONIC STRUCTURE; AUDITORY-CORTEX; SENTENCE COMPREHENSION; PITCH DISCRIMINATION; MAGNETIC-FIELDS; BRAIN; REPRESENTATION; LOCALIZATION; ORGANIZATION; GENERATORS	The present experiment was designed to localize the neural substrates that process music-syntactic incongruities, using magnetoencephalography (MEG). Electrically, such processing has been proposed to be indicated by early right-anterior negativity (ERAN), which is elicited by harmonically inappropriate chords occurring within a major-minor tonal context. In the present experiment, such chords elicited an early effect, taken as the magnetic equivalent of the ERAN (termed mERAN). The source of mERAN activity was localized in Broca's area and its right-hemisphere homologue, areas involved in syntactic analysis during auditory language comprehension. We find that these areas are also responsible for an analysis of incoming harmonic sequences, indicating that these regions process syntactic information that is less language-specific than previously believed.	Max Planck Inst Cognit Neurosci, D-04303 Leipzig, Germany	Max Planck Society	Maess, B (corresponding author), Max Planck Inst Cognit Neurosci, POB 500 355, D-04303 Leipzig, Germany.		Koelsch, Stefan/AAV-1556-2020	Maess, Burkhard/0000-0002-7857-291X				Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; AUZOU P, 1995, NEUROPSYCHOLOGIA, V33, P25, DOI 10.1016/0028-3932(94)00100-4; BERENT I, 1993, COGNITION, V46, P203, DOI 10.1016/0010-0277(93)90010-S; BHARUCHA J, 1983, COGNITION, V13, P63, DOI 10.1016/0010-0277(83)90003-3; BHARUCHA JJ, 1984, COGNITIVE PSYCHOL, V16, P485, DOI 10.1016/0010-0285(84)90018-5; BHARUCHA JJ, 1986, J EXP PSYCHOL HUMAN, V12, P403, DOI 10.1037/0096-1523.12.4.403; BHARUCHA JJ, 1987, PERCEPT PSYCHOPHYS, V41, P519, DOI 10.3758/BF03210486; Caplan D, 1999, NEUROIMAGE, V9, P343, DOI 10.1006/nimg.1998.0412; Caplan D, 1998, J COGNITIVE NEUROSCI, V10, P541, DOI 10.1162/089892998562843; Caplan D, 2000, HUM BRAIN MAPP, V9, P65; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; CLYNES M, 1969, AVERAGED EVOKED POTE, P363; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; Douglas S., 1994, J RES READ, V17, p99?107, DOI [DOI 10.1111/J.1467-9817.1994.TB00057.X, 10.1111/j.1467-9817.1994.tb00057.x]; Friederici AD, 2000, HUM BRAIN MAPP, V11, P1, DOI 10.1002/1097-0193(200009)11:1<1::AID-HBM10>3.0.CO;2-B; FRIEDERICI AD, 1998, LANGUAGE COMPREHENSI; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; HARI R, 1980, EXP BRAIN RES, V40, P237, DOI 10.1007/BF00237543; Hindemith P., 1940, UNTERWEISUNG TONSATZ, V1; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; KOELSCH S, IN PRESS NEUROREPORT; KRUMHANSL CL, 1982, PERCEPT PSYCHOPHYS, V32, P96, DOI 10.3758/BF03204269; KRUMHANSL CL, 1982, PSYCHOL REV, V89, P334, DOI 10.1037/0033-295X.89.4.334; KRUMHANSL CL, 1982, J EXP PSYCHOL HUMAN, V8, P24, DOI 10.1037/0096-1523.8.1.24; Lerdahl, 1999, GENERATIVE THEORY MU; Levanen S, 1996, CEREB CORTEX, V6, P288, DOI 10.1093/cercor/6.2.288; LIEGEOISCHAUVEL C, 1994, ELECTROEN CLIN NEURO, V92, P204, DOI 10.1016/0168-5597(94)90064-7; MAKELA JP, 1994, ELECTROEN CLIN NEURO, V92, P414, DOI 10.1016/0168-5597(94)90018-3; Meyer M, 2000, COGNITIVE BRAIN RES, V9, P19, DOI 10.1016/S0926-6410(99)00039-7; Naatanen R., 1992, ATTENTION BRAIN FUNC; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; Opitz B, 1999, PSYCHOPHYSIOLOGY, V36, P142, DOI 10.1017/S0048577299980848; PANTEV C, 1990, ELECTROEN CLIN NEURO, V75, P173, DOI 10.1016/0013-4694(90)90171-F; PANTEV C, 1989, SCIENCE, V246, P486, DOI 10.1126/science.2814476; PANTEV C, 1995, ELECTROEN CLIN NEURO, V94, P26, DOI 10.1016/0013-4694(94)00209-4; Patel AD, 1998, J COGNITIVE NEUROSCI, V10, P717, DOI 10.1162/089892998563121; RAFFMANN D, 1993, LANGUAGE MUSIC MIND; Rinne T, 2000, NEUROIMAGE, V12, P14, DOI 10.1006/nimg.2000.0591; SHAYWITZ BA, 1995, NATURE, V373, P607, DOI 10.1038/373607a0; Sloboda JA, 1986, MUSICAL MIND COGNITI; SWAIN J, 1997, MUSICAL LANGUAGE; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	46	593	610	1	88	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					540	545		10.1038/87502	http://dx.doi.org/10.1038/87502			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	427NN	11319564				2022-12-17	WOS:000168412600019
J	Ke, MT; Fujimoto, S; Imai, T				Ke, Meng-Tsen; Fujimoto, Satoshi; Imai, Takeshi			SeeDB: a simple and morphology-preserving optical clearing agent for neuronal circuit reconstruction	NATURE NEUROSCIENCE			English	Article							RAT OLFACTORY-BULB; MITRAL CELLS; IN-VIVO; NERVOUS-SYSTEM; TUFTED CELLS; MOUSE-BRAIN; CORTEX; EXPRESSION; PATHWAYS; VISUALIZATION	We report a water-based optical clearing agent, SeeDB, which clears fixed brain samples in a few days without quenching many types of fluorescent dyes, including fluorescent proteins and lipophilic neuronal tracers. Our method maintained a constant sample volume during the clearing procedure, an important factor for keeping cellular morphology intact, and facilitated the quantitative reconstruction of neuronal circuits. Combined with two-photon microscopy and an optimized objective lens, we were able to image the mouse brain from the dorsal to the ventral side. We used SeeDB to describe the near-complete wiring diagram of sister mitral cells associated with a common glomerulus in the mouse olfactory bulb. We found the diversity of dendrite wiring patterns among sister mitral cells, and our results provide an anatomical basis for non-redundant odor coding by these neurons. Our simple and efficient method is useful for imaging intact morphological architecture at large scales in both the adult and developing brains.	[Ke, Meng-Tsen; Fujimoto, Satoshi; Imai, Takeshi] RIKEN Ctr Dev Biol, Lab Sensory Circuit Format, Kobe, Hyogo, Japan; [Ke, Meng-Tsen; Imai, Takeshi] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Imai, Takeshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	RIKEN; Kyoto University; Japan Science & Technology Agency (JST)	Imai, T (corresponding author), RIKEN Ctr Dev Biol, Lab Sensory Circuit Format, Kobe, Hyogo, Japan.	imai@cdb.riken.jp	Fujimoto, Satoshi/C-9221-2017; Imai, Takeshi/L-2201-2013	Fujimoto, Satoshi/0000-0002-7618-5502; Imai, Takeshi/0000-0002-8449-0080; Ke, Meng-Tsen/0000-0002-4444-0804	PRESTO program of the Japan Science and Technology Agency; Sumitomo Foundation; Nakajima Foundation; Mitsubishi Foundation; Strategic Programs for R&D (President's Discretionary Fund) of RIKEN; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [23680038] Funding Source: KAKEN	PRESTO program of the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Sumitomo Foundation; Nakajima Foundation; Mitsubishi Foundation; Strategic Programs for R&D (President's Discretionary Fund) of RIKEN; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank J.R. Sanes (Harvard) (Thy1-YFP-G, H) and P. Mombaerts (Max Planck Institute) (OMP-GFP) for providing mouse strains. We are also grateful to M. Eiraku and K. Muguruma for assistance with two-photon microscopy setup, Olympus for the customized objective lens, Y. Mimori-Kiyosue for equipment, J. Nabekura and T. Nemoto for instructions on in vivo two-photon imaging, and R. Iwata and H. Hiraga for valuable comments on the manuscript. This work was supported by grants from the PRESTO program of the Japan Science and Technology Agency, the Sumitomo Foundation, the Nakajima Foundation, the Mitsubishi Foundation, the Strategic Programs for R&D (President's Discretionary Fund) of RIKEN, and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to T.I.). The imaging experiments were supported by the RIKEN Center for Developmental Biology Imaging Facility and the Four-dimensional Tissue Analysis Unit. Animal experiments were supported by the Laboratory for Animal Resources and Genetic Engineering at the RIKEN Center for Developmental Biology.	Bancroft J., 2007, THEORY PRACTICE HIST, V6 ed; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; DENT JA, 1989, DEVELOPMENT, V105, P61; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; DILLS WL, 1993, AM J CLIN NUTR, V58, P779, DOI 10.1093/ajcn/58.5.779S; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Fantana AL, 2008, NEURON, V59, P802, DOI 10.1016/j.neuron.2008.07.039; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Gonzalez-Bellido P. T., 2012, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.PR0T069625; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; HINDS JW, 1977, J COMP NEUROL, V171, P345, DOI 10.1002/cne.901710304; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; KAPLAN MS, 1985, J COMP NEUROL, V239, P117, DOI 10.1002/cne.902390110; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Kikuta S, 2013, NEURON, V77, P1122, DOI 10.1016/j.neuron.2013.01.022; Kim DH, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00005; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/nmeth.1784, 10.1038/NMETH.1784]; KLYMKOWSKY MW, 1991, METHOD CELL BIOL, V36, P419; Li Y, 2012, NATURE, V486, P118, DOI 10.1038/nature11110; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lo LC, 2011, NEURON, V72, P938, DOI 10.1016/j.neuron.2011.12.002; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Miyasaka N, 2009, J NEUROSCI, V29, P4756, DOI 10.1523/JNEUROSCI.0118-09.2009; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; Murthy VN, 2011, ANNU REV NEUROSCI, V34, P233, DOI 10.1146/annurev-neuro-061010-113738; Nagayama S, 2007, NEURON, V53, P789, DOI 10.1016/j.neuron.2007.02.018; Nagayama S, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00120; Nishikimi M, 2011, J NEUROSCI, V31, P16251, DOI 10.1523/JNEUROSCI.3303-11.2011; Ohtsuki G, 2012, NEURON, V75, P65, DOI 10.1016/j.neuron.2012.05.023; ORONA E, 1983, J COMP NEUROL, V217, P227, DOI 10.1002/cne.902170209; ORONA E, 1984, J COMP NEUROL, V226, P346, DOI 10.1002/cne.902260305; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Taylor W. R., 1967, Proceedings of the United States National Museum, V122, P1; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Tuchin V. V., 2007, TISSUE OPTICS LIGHT; Yu YC, 2012, NATURE, V486, P113, DOI 10.1038/nature10958	50	592	612	7	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2013	16	8					1154	U246		10.1038/nn.3447	http://dx.doi.org/10.1038/nn.3447			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	190EV	23792946				2022-12-17	WOS:000322323000028
J	Hickman, S; Izzy, S; Sen, P; Morsett, L; El Khoury, J				Hickman, Suzanne; Izzy, Saef; Sen, Pritha; Morsett, Liza; El Khoury, Joseph			Microglia in neurodegeneration	NATURE NEUROSCIENCE			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; ALZHEIMERS-DISEASE; MOUSE MODEL; AMYLOID-BETA; TAU PATHOLOGY; REACTIVE MICROGLIA; SCAVENGER RECEPTOR; CEREBROSPINAL-FLUID; HUNTINGTON-DISEASE	The neuroimmune system is involved in development, normal functioning, aging, and injury of the central nervous system. Microglia, first described a century ago, are the main neuroimmune cells and have three essential functions: a sentinel function involved in constant sensing of changes in their environment, a housekeeping function that promotes neuronal well-being and normal operation, and a defense function necessary for responding to such changes and providing neuroprotection. Microglia use a defined armamentarium of genes to perform these tasks. In response to specific stimuli, or with neuroinflammation, microglia also have the capacity to damage and kill neurons. Injury to neurons in Alzheimer's, Parkinson's, Huntington's, and prion diseases, as well as in amyotrophic lateral sclerosis, frontotemporal dementia, and chronic traumatic encephalopathy, results from disruption of the sentinel or housekeeping functions and dysregulation of the defense function and neuroinflammation. Pathways associated with such injury include several sensing and housekeeping pathways, such as the Trem2, Cx3cr1 and progranulin pathways, which act as immune checkpoints to keep the microglial inflammatory response under control, and the scavenger receptor pathways, which promote clearance of injurious stimuli. Peripheral interference from systemic inflammation or the gut microbiome can also alter progression of such injury. Initiation or exacerbation of neurodegeneration results from an imbalance between these microglial functions; correcting such imbalance may be a potential mode for therapy.	[El Khoury, Joseph] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	El Khoury, J (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA.	jelkhoury@mgh.harvard.edu		El Khoury, Joseph/0000-0003-1498-1703	NIH [RF1 AG051506]; NATIONAL INSTITUTE ON AGING [RF1AG051506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grant RF1 AG051506 to J.E.K.	Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042; Aguzzi A, 2017, J CLIN INVEST, V127, P3230, DOI 10.1172/JCI90605; Apolloni S, 2013, HUM MOL GENET, V22, P4102, DOI 10.1093/hmg/ddt259; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Bemiller SM, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0216-6; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bisht K, 2016, GLIA, V64, P826, DOI 10.1002/glia.22966; Bolos M, 2016, J ALZHEIMERS DIS, V50, P77, DOI 10.3233/JAD-150704; Brown GC, 2015, BRAIN RES, V1628, P288, DOI 10.1016/j.brainres.2015.08.031; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Calvo A, 2018, MUSCLE NERVE, V57, P212, DOI 10.1002/mus.25653; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chen YD, 2015, J NEUROL, V262, P814, DOI 10.1007/s00415-014-7630-2; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Chitramuthu BP, 2017, BRAIN, V140, P3081, DOI 10.1093/brain/awx198; Condello C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7176; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Cornejo F, 2018, BRAIN BEHAV IMMUN, V69, P336, DOI 10.1016/j.bbi.2017.12.007; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; Crotti A, 2014, NAT NEUROSCI, V17, P513, DOI 10.1038/nn.3668; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; Deng H, 2018, AGEING RES REV, V42, P72, DOI 10.1016/j.arr.2017.12.007; Dickson DW, 2018, PARKINSONISM RELAT D, V46, pS30, DOI 10.1016/j.parkreldis.2017.07.033; El Khoury JB, 2003, J EXP MED, V197, P1657, DOI 10.1084/jem.20021546; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; El Khoury J, 2009, RES PROG ALZHEIM DEM, V4, P37; El Khoury J, 2010, NAT MED, V16, P1369, DOI 10.1038/nm1210-1369; ElKhoury J, 1996, NATURE, V382, P716; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Falsig J, 2008, NAT NEUROSCI, V11, P109, DOI 10.1038/nn2028; Ferrer I, 2014, J NEUROPATH EXP NEUR, V73, P81, DOI 10.1097/NEN.0000000000000030; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Frautschy SA, 1998, AM J PATHOL, V152, P307; Frenkel D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3030; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Gan L, 2004, J BIOL CHEM, V279, P5565, DOI 10.1074/jbc.M306183200; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Ghosh Rhia, 2018, Handb Clin Neurol, V147, P255, DOI 10.1016/B978-0-444-63233-3.00017-8; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Gold M, 2015, SEMIN IMMUNOPATHOL, V37, P607, DOI 10.1007/s00281-015-0518-0; Gong Y, 2017, ANN NEUROL, V82, P813, DOI 10.1002/ana.25085; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Grizenkova J, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-44; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hafner-Bratkovic I, 2012, CELL MOL LIFE SCI, V69, P4215, DOI 10.1007/s00018-012-1140-0; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/mds.23455; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Healy LM, 2016, J IMMUNOL, V196, P3375, DOI 10.4049/jimmunol.1502562; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hickman SE, 2014, BIOCHEM PHARMACOL, V88, P495, DOI 10.1016/j.bcp.2013.11.021; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hickman SE, 2013, J ALZHEIMERS DIS, V33, pS295, DOI 10.3233/JAD-2012-129027; Hickman SE, 2010, CNS NEUROL DISORD-DR, V9, P168, DOI 10.2174/187152710791011982; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hortega Rio, 1918, TRAB LAB INVEST BIOL, V15, P367; Hughes MM, 2010, GLIA, V58, P2017, DOI 10.1002/glia.21070; Iaccarino L, 2018, MOL NEUROBIOL, V55, P2856, DOI 10.1007/s12035-017-0522-6; Jay TR, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0197-5; Jiang T, 2015, NEUROBIOL AGING, V36, P3176, DOI 10.1016/j.neurobiolaging.2015.08.019; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kim C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2534; Kouadir M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030756; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kuhlmann T, 2017, ACTA NEUROPATHOL, V133, P13, DOI 10.1007/s00401-016-1653-y; Lall D, 2017, J CLIN INVEST, V127, P3250, DOI 10.1172/JCI90607; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Leonardo CC, 2009, NEUROSCIENCE, V160, P755, DOI 10.1016/j.neuroscience.2009.02.080; Leyns CEG, 2017, P NATL ACAD SCI USA, V114, P11524, DOI 10.1073/pnas.1710311114; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lill CM, 2015, ALZHEIMERS DEMENT, V11, P1407, DOI 10.1016/j.jalz.2014.12.009; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Lopez-Lopez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096528; Lue LF, 2015, BRAIN PATHOL, V25, P469, DOI 10.1111/bpa.12190; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Martin E, 2017, AGING CELL, V16, P27, DOI 10.1111/acel.12522; Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Meissner F, 2010, P NATL ACAD SCI USA, V107, P13046, DOI 10.1073/pnas.1002396107; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Minter MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30028; Morganti JM, 2012, J NEUROSCI, V32, P14592, DOI 10.1523/JNEUROSCI.0539-12.2012; Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189; Nash KR, 2013, NEUROBIOL AGING, V34, P1540, DOI 10.1016/j.neurobiolaging.2012.12.011; O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064; O'Rourke JG, 2015, NEURON, V88, P892, DOI 10.1016/j.neuron.2015.10.027; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Origlia N, 2010, J NEUROSCI, V30, P11414, DOI 10.1523/JNEUROSCI.2127-10.2010; Paloneva J, 2003, J EXP MED, V198, P669, DOI 10.1084/jem.20030027; Paolicelli RC, 2017, NEURON, V95, P297, DOI 10.1016/j.neuron.2017.05.037; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; PrabhuDas MR, 2017, J IMMUNOL, V198, P3775, DOI 10.4049/jimmunol.1700373; Ransohoff RM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020560; Ryan KJ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7635; Sakai K, 2013, J VIROL, V87, P13433, DOI 10.1128/JVI.02072-13; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Satoh J, 2011, NEUROPATHOLOGY, V31, P363, DOI 10.1111/j.1440-1789.2010.01174.x; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sery O, 2017, BIOCHIMIE, V135, P46, DOI 10.1016/j.biochi.2017.01.009; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; Sleegers K, 2008, NEUROLOGY, V71, P253, DOI 10.1212/01.wnl.0000289191.54852.75; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Sorce S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004531; Spiller KJ, 2018, NAT NEUROSCI, V21, P329, DOI 10.1038/s41593-018-0083-7; Striebel JF, 2016, J GEN VIROL, V97, P1481, DOI 10.1099/jgv.0.000442; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Suarez-Calvet M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1767; Suarez-Calvet M, 2016, EMBO MOL MED, V8, P466, DOI 10.15252/emmm.201506123; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Thome AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140566; TOOYAMA I, 1990, BRAIN RES, V523, P273, DOI 10.1016/0006-8993(90)91496-4; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Van Kampen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097032; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Villemagne VL, 2017, SEMIN NUCL MED, V47, P75, DOI 10.1053/j.semnuclmed.2016.09.006; Vodopivec I, 2009, NEURODEGENER DIS, V6, P270, DOI 10.1159/000261723; Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wilkinson K, 2011, J BIOL CHEM, V286, P34914, DOI 10.1074/jbc.M111.232116; Xie WL, 2013, J MOL NEUROSCI, V51, P919, DOI 10.1007/s12031-013-0002-z; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yamasaki T, 2018, J VIROL, V92, DOI 10.1128/JVI.01457-17; Yang G, 2013, P NATL ACAD SCI USA, V110, P10306, DOI 10.1073/pnas.1222895110; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031; Zrzavy T, 2017, BRAIN, V140, P1900, DOI 10.1093/brain/awx113; Zujovic V, 2001, J NEUROIMMUNOL, V115, P135, DOI 10.1016/S0165-5728(01)00259-4	150	591	612	26	369	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2018	21	10					1359	1369		10.1038/s41593-018-0242-x	http://dx.doi.org/10.1038/s41593-018-0242-x			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU9FY	30258234	Green Accepted			2022-12-17	WOS:000445651600011
J	Cohen, MR; Kohn, A				Cohen, Marlene R.; Kohn, Adam			Measuring and interpreting neuronal correlations	NATURE NEUROSCIENCE			English	Review							PRIMARY VISUAL-CORTEX; LATERAL INTRAPARIETAL AREA; DECISION-RELATED ACTIVITY; SPIKE-TIME CORRELATIONS; EYE FIELD NEURONS; NOISE CORRELATIONS; SINGLE NEURONS; FUNCTIONAL CONNECTIVITY; SENSORY NEURONS; NEURAL ACTIVITY	Mounting evidence suggests that understanding how the brain encodes information and performs computations will require studying the correlations between neurons. The recent advent of recording techniques such as multielectrode arrays and two-photon imaging has made it easier to measure correlations, opening the door for detailed exploration of their properties and contributions to cortical processing. However, studies have reported discrepant findings, providing a confusing picture. Here we briefly review these studies and conduct simulations to explore the influence of several experimental and physiological factors on correlation measurements. Differences in response strength, the time window over which spikes are counted, spike sorting conventions and internal states can all markedly affect measured correlations and systematically bias estimates. Given these complicating factors, we offer guidelines for interpreting correlation data and a discussion of how best to evaluate the effect of correlations on cortical processing.	[Cohen, Marlene R.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Kohn, Adam] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Kohn, Adam] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, Bronx, NY 10467 USA	Harvard University; Harvard Medical School; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cohen, MR (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cohenm@pitt.edu; adam.kohn@einstein.yu.edu			US National Institutes of Health [R01 EY016774, K99 EY020844-01]; NATIONAL EYE INSTITUTE [R01EY016774, K99EY020844] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We are grateful to P. Latham for analytical descriptions for our simulations and for the derivation of the relationship between measurement window and correlations that are not based on common spikes and to R. Coen-Cagli for the derivation relating correlation to the proportion of spikes discarded during spike sorting. We thank R. Coen-Cagli, B. Cumming, M. Histed, X. Jia, K. Josic, J. Maunsell, A. Ni, H. Nienborg, A. Pouget, O. Schwartz, S. Tanabe, and J. A. Movshon and E. Simoncelli and members of their laboratories for helpful discussions and comments on an earlier version of the manuscript. This work was supported by US National Institutes of Health grants R01 EY016774 (A. K.) and K99 EY020844-01 (M. R. C.).	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Amari S, 2009, NEURAL COMPUT, V21, P960, DOI 10.1162/neco.2008.03-08-729; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Averbeck BB, 2003, J NEUROSCI, V23, P7630; Averbeck BB, 2006, J NEUROPHYSIOL, V95, P3633, DOI 10.1152/jn.00919.2005; Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; BARLOW HB, 1989, COMPUTING NEURON; Beck JM, 2008, NEURON, V60, P1142, DOI 10.1016/j.neuron.2008.09.021; Bedenbaugh P, 1997, NEURAL COMPUT, V9, P1265, DOI 10.1162/neco.1997.9.6.1265; Berens P, 2008, FRONT NEUROSCI-SWITZ, V2, P199, DOI 10.3389/neuro.01.037.2008; Bichot NP, 2001, J NEUROSCI, V21, P713, DOI 10.1523/JNEUROSCI.21-02-00713.2001; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; CHEAL ML, 1991, Q J EXP PSYCHOL-A, V43, P859, DOI 10.1080/14640749108400960; Cohen JY, 2010, J NEUROSCI, V30, P3227, DOI 10.1523/JNEUROSCI.4600-09.2010; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Cohen MR, 2009, J NEUROSCI, V29, P6635, DOI 10.1523/JNEUROSCI.5179-08.2009; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Dorn JD, 2003, J NEUROPHYSIOL, V89, P2271, DOI 10.1152/jn.000889.2002; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Erickson CA, 2000, NAT NEUROSCI, V3, P1143, DOI 10.1038/80664; ESPINOSA IE, 1988, BRAIN RES, V450, P39, DOI 10.1016/0006-8993(88)91542-9; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Greschner M, 2011, J PHYSIOL-LONDON, V589, P75, DOI 10.1113/jphysiol.2010.193888; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Herrington TM, 2009, J NEUROSCI, V29, P14160, DOI 10.1523/JNEUROSCI.1916-09.2009; Huang X, 2009, J NEUROPHYSIOL, V101, P3012, DOI 10.1152/jn.00010.2009; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Jermakowicz WJ, 2009, J NEUROPHYSIOL, V101, P2279, DOI 10.1152/jn.91207.2008; Kass RE, 2005, J NEUROPHYSIOL, V94, P8, DOI 10.1152/jn.00648.2004; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Kohn A, 2009, CURR OPIN NEUROBIOL, V19, P434, DOI 10.1016/j.conb.2009.06.007; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; KROSE BJA, 1989, VISION RES, V29, P1607, DOI 10.1016/0042-6989(89)90142-9; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Leber AB, 2010, J NEUROSCI, V30, P11458, DOI 10.1523/JNEUROSCI.0809-10.2010; Lee D, 1998, J NEUROSCI, V18, P1161; Maynard EM, 1999, J NEUROSCI, V19, P8083; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Mazurek ME, 2002, NAT NEUROSCI, V5, P463, DOI 10.1038/nn836; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Muller MM, 1998, NAT NEUROSCI, V1, P631, DOI 10.1038/2865; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Nevet A, 2007, J NEUROPHYSIOL, V98, P2232, DOI 10.1152/jn.00190.2007; Nienborg H, 2010, CURR OPIN NEUROBIOL, V20, P376, DOI 10.1016/j.conb.2010.05.002; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Nirenberg S, 2003, P NATL ACAD SCI USA, V100, P7348, DOI 10.1073/pnas.1131895100; Okatan M, 2005, NEURAL COMPUT, V17, P1927, DOI 10.1162/0899766054322973; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Palmer C, 2007, J NEUROSCI, V27, P8122, DOI 10.1523/JNEUROSCI.1940-07.2007; Paninski L, 2010, J COMPUT NEUROSCI, V29, P107, DOI 10.1007/s10827-009-0179-x; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Poort J, 2009, CEREB CORTEX, V19, P543, DOI 10.1093/cercor/bhn103; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Price NSC, 2010, J NEUROSCI, V30, P14036, DOI 10.1523/JNEUROSCI.2336-10.2010; Rasch MJ, 2011, J NEUROPHYSIOL, V105, P757, DOI 10.1152/jn.00845.2009; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rosenbaum RJ, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00009; Samonds JM, 2009, J NEUROSCI, V29, P15780, DOI 10.1523/JNEUROSCI.2305-09.2009; Sapir A, 2005, P NATL ACAD SCI USA, V102, P17810, DOI 10.1073/pnas.0504678102; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Stark E, 2008, J NEUROSCI, V28, P10618, DOI 10.1523/JNEUROSCI.3418-08.2008; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2007, FRONT COMPUT NEUROSC, V1, DOI 10.3389/neuro.10.006.2007; Zhang ML, 2004, J NEUROPHYSIOL, V92, P1464, DOI 10.1152/jn.01272.2003; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	92	590	593	3	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2011	14	7					811	819		10.1038/nn.2842	http://dx.doi.org/10.1038/nn.2842			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783KR	21709677	Green Accepted			2022-12-17	WOS:000292081700005
J	Sergent, C; Baillet, S; Dehaene, S				Sergent, C; Baillet, S; Dehaene, S			Timing of the brain events underlying access to consciousness during the attentional blink	NATURE NEUROSCIENCE			English	Article							SERIAL VISUAL PRESENTATION; INATTENTIONAL BLINDNESS; NEURONAL MODEL; NETWORK MODEL; NEURAL FATE; PERCEPTION; RECOGNITION; HUMANS; TASKS; IDENTIFICATION	In the phenomenon of attentional blink, identical visual stimuli are sometimes fully perceived and sometimes not detected at all. This phenomenon thus provides an optimal situation to study the fate of stimuli not consciously perceived and the differences between conscious and nonconscious processing. We correlated behavioral visibility ratings and recordings of event-related potentials to study the temporal dynamics of access to consciousness. Intact early potentials (P1 and N1) were evoked by unseen words, suggesting that these brain events are not the primary correlates of conscious perception. However, we observed a rapid divergence around 270 ms, after which several brain events were evoked solely by seen words. Thus, we suggest that the transition toward access to consciousness relates to the optional triggering of a late wave of activation that spreads through a distributed network of cortical association areas.	CEA, Serv Hosp Frederic Joliot, INSERM, U562, F-91401 Orsay, France; Hop La Pitie Salpetriere, CNRS, UPR LENA 640, Cognit Neurosci & Brain Imaging Lab, F-75651 Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Sergent, C (corresponding author), CEA, Serv Hosp Frederic Joliot, INSERM, U562, 4 Pl Gen Leclerc, F-91401 Orsay, France.	sergent@shfj.cea.fr	Baillet, Sylvain/AAF-6512-2019	Baillet, Sylvain/0000-0002-6762-5713				Baars B., 1989, COGNITIVE THEORY CON; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Beck DM, 2001, NAT NEUROSCI, V4, P645, DOI 10.1038/88477; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Darvas F, 2006, HUM BRAIN MAPP, V27, P129, DOI 10.1002/hbm.20171; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Dehaene S, 2005, PLOS BIOL, V3, P910, DOI 10.1371/journal.pbio.0030141; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Devlin JT, 2004, P NATL ACAD SCI USA, V101, P14984, DOI 10.1073/pnas.0403766101; Feinstein JS, 2004, CONSCIOUS COGN, V13, P323, DOI 10.1016/j.concog.2003.10.004; FRAGOPANAGOS NF, IN PRESS BRAIN RES C; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Gross J, 2004, P NATL ACAD SCI USA, V101, P13050, DOI 10.1073/pnas.0404944101; Halgren E, 1998, ELECTROEN CLIN NEURO, V106, P156, DOI 10.1016/S0013-4694(97)00119-3; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Kranczioch C, 2005, NEUROIMAGE, V24, P704, DOI 10.1016/j.neuroimage.2004.09.024; Kranczioch C, 2003, COGNITIVE BRAIN RES, V17, P177, DOI 10.1016/S0926-6410(03)00092-2; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Marois R, 2000, NEURON, V28, P299, DOI 10.1016/S0896-6273(00)00104-5; Marois R, 2004, NEURON, V41, P465, DOI 10.1016/S0896-6273(04)00012-1; McArthur G, 1999, NEUROREPORT, V10, P3691, DOI 10.1097/00001756-199911260-00042; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; Pallaro Anabel N., 1997, Journal of Nutritional Immunology, V5, P29; Pammer K, 2004, NEUROIMAGE, V22, P1819, DOI 10.1016/j.neuroimage.2004.05.004; Pins D, 2003, CEREB CORTEX, V13, P461, DOI 10.1093/cercor/13.5.461; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Saunders P. T., 1980, INTRO CATASTROPHE TH; Sergent C, 2004, PSYCHOL SCI, V15, P720, DOI 10.1111/j.0956-7976.2004.00748.x; Shapiro KL, 1997, J EXP PSYCHOL HUMAN, V23, P504, DOI 10.1037/0096-1523.23.2.504; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Taylor JG, 1996, BIOL CYBERN, V75, P59, DOI 10.1007/BF00238740; Thom R, 1972, STABILITE STRUCTUREL; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Vuilleumier P, 2001, P NATL ACAD SCI USA, V98, P3495, DOI 10.1073/pnas.051436898; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207	47	587	598	2	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1391	1400		10.1038/nn1549	http://dx.doi.org/10.1038/nn1549			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	968EY	16158062				2022-12-17	WOS:000232145900025
J	Wilson, SM; Saygin, AP; Sereno, MI; Iacoboni, M				Wilson, SM; Saygin, AP; Sereno, MI; Iacoboni, M			Listening to speech activates motor areas involved in speech production	NATURE NEUROSCIENCE			English	Article							PREMOTOR CORTEX; PERCEPTION	To examine the role of motor areas in speech perception, we carried out a functional magnetic resonance imaging (fMRI) study in which subjects listened passively to monosyllables and produced the same speech sounds. Listening to speech activated bilaterally a superior portion of ventral premotor cortex that largely overlapped a speech production motor area centered just posteriorly on the border of Brodmann areas 4a and 6, which we distinguished from a more ventral speech production area centered in area 4p. Our findings support the view that the motor system is recruited in mapping acoustic inputs to a phonetic code.	Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Wilson, SM (corresponding author), Univ Calif Los Angeles, Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA.	stephenw@ucla.edu	Sereno, Martin I/F-7657-2012; Galantucci, Bruno/E-5770-2010; Saygin, Ayse Pinar/B-1494-2010; Saygin, Ayse Pinar/A-7126-2009	Sereno, Martin I/0000-0002-7598-7829; Saygin, Ayse Pinar/0000-0002-0859-9500; Wilson, Stephen/0000-0001-9884-2852				Benson RR, 2001, BRAIN LANG, V78, P364, DOI 10.1006/brln.2001.2484; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; BLUMSTEIN SE, 1977, NEUROPSYCHOLOGIA, V15, P19, DOI 10.1016/0028-3932(77)90111-7; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Callan DE, 2003, NEUROREPORT, V14, P2213, DOI 10.1097/00001756-200312020-00016; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Fox PT, 2001, NEUROIMAGE, V13, P196, DOI 10.1006/nimg.2000.0659; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Geyer S., 2004, MICROSTRUCTURAL BORD; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Watkins KE, 2003, NEUROPSYCHOLOGIA, V41, P989, DOI 10.1016/S0028-3932(02)00316-0	15	584	593	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2004	7	7					701	702		10.1038/nn1263	http://dx.doi.org/10.1038/nn1263			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	832NO	15184903				2022-12-17	WOS:000222274400009
J	Zaki, J; Ochsner, K				Zaki, Jamil; Ochsner, Kevin			The neuroscience of empathy: progress, pitfalls and promise	NATURE NEUROSCIENCE			English	Article							AUTISM SPECTRUM DISORDERS; SOCIAL COGNITION; INDIVIDUAL-DIFFERENCES; NEURAL RESPONSES; MIRROR; OTHERS; SYSTEMS; PAIN; SELF; SIMULATION	The last decade has witnessed enormous growth in the neuroscience of empathy. Here, we survey research in this domain with an eye toward evaluating its strengths and weaknesses. First, we take stock of the notable progress made by early research in characterizing the neural systems supporting two empathic sub-processes: sharing others' internal states and explicitly considering those states. Second, we describe methodological and conceptual pitfalls into which this work has sometimes fallen, which can limit its validity. These include the use of relatively artificial stimuli that differ qualitatively from the social cues people typically encounter and a lack of focus on the relationship between brain activity and social behavior. Finally, we describe current research trends that are overcoming these pitfalls through simple but important adjustments in focus, and the future promise of empathy research if these trends continue and expand.	[Zaki, Jamil] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Ochsner, Kevin] Columbia Univ, Dept Psychol, New York, NY 10027 USA	Harvard University; Columbia University	Zaki, J (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	zaki@wjh.harvard.edu; ochsner@psych.columbia.edu	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378	Templeton Positive Neuroscience Award; National Institute on Drug Abuse [1R01 DA022541-01]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022541] Funding Source: NIH RePORTER	Templeton Positive Neuroscience Award; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Writing of this paper was supported by a Templeton Positive Neuroscience Award (to J.Z.) and National Institute on Drug Abuse Grant 1R01 DA022541-01 (to K.O.).	Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Bartz JA, 2011, TRENDS COGN SCI, V15, P301, DOI 10.1016/j.tics.2011.05.002; Batson C. D., 2011, ALTRUISM HUMANS, DOI DOI 10.1093/ACPROF:OSO/9780195341065.001.0001; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Fan Y, 2008, NEUROPSYCHOLOGIA, V46, P160, DOI 10.1016/j.neuropsychologia.2007.07.023; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Golan O, 2006, DEV PSYCHOPATHOL, V18, P591, DOI 10.1017/S0954579406060305; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Harris LT, 2006, PSYCHOL SCI, V17, P847, DOI 10.1111/j.1467-9280.2006.01793.x; Harvey P.O., SCHIZOPHR B IN PRESS; Hein G, 2010, NEURON, V68, P149, DOI 10.1016/j.neuron.2010.09.003; Henson R, 2006, TRENDS COGN SCI, V10, P64, DOI 10.1016/j.tics.2005.12.005; Ickes W.J., 1997, EMPATHIC ACCURACY; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Lamm C, 2010, BRAIN STRUCT FUNCT, V214, P579, DOI 10.1007/s00429-010-0251-3; Leslie AM, 2004, TRENDS COGN SCI, V8, P528, DOI 10.1016/j.tics.2004.10.001; Lombardo MV, 2010, J COGNITIVE NEUROSCI, V22, P1623, DOI 10.1162/jocn.2009.21287; Masten CL, 2011, NEUROIMAGE, V55, P381, DOI 10.1016/j.neuroimage.2010.11.060; Neisser U., 1976, COGNITION REALITY PR; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Philip RCM, 2012, NEUROSCI BIOBEHAV R, V36, P901, DOI 10.1016/j.neubiorev.2011.10.008; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Preston S. D., 2002, BEHAV BRAIN SCI, V25, P20, DOI [10.1017/S0140525X02380014, DOI 10.1017/S0140525X023]; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Redcay E, 2010, NEUROIMAGE, V50, P1639, DOI 10.1016/j.neuroimage.2010.01.052; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Saxe R, 2005, TRENDS COGN SCI, V9, P174, DOI 10.1016/j.tics.2005.01.012; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Spunt RP, 2012, NEUROIMAGE, V59, P3050, DOI 10.1016/j.neuroimage.2011.10.005; Tomasello M, 2000, CULTURAL ORIGIN HUMA; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Wagner D.D., 2011, CEREB CORTEX; Wheatley T, 2007, PSYCHOL SCI, V18, P469, DOI 10.1111/j.1467-9280.2007.01923.x; WISPE L, 1986, J PERS SOC PSYCHOL, V50, P314, DOI 10.1037/0022-3514.50.2.314; Wolf I, 2010, NEUROIMAGE, V49, P894, DOI 10.1016/j.neuroimage.2009.08.060; Zaki J, 2007, SOC NEUROSCI-UK, V2, P276, DOI 10.1080/17470910701401973; Zaki J, 2011, PSYCHOL INQ, V22, P159, DOI 10.1080/1047840X.2011.551743; Zaki J, 2011, P NATL ACAD SCI USA, V108, P19761, DOI 10.1073/pnas.1112324108; Zaki J, 2010, J NEUROSCI, V30, P8481, DOI 10.1523/JNEUROSCI.0382-10.2010; Zaki J, 2009, ANN NY ACAD SCI, V1167, P16, DOI 10.1111/j.1749-6632.2009.04601.x; Zaki J, 2009, P NATL ACAD SCI USA, V106, P11382, DOI 10.1073/pnas.0902666106	51	583	589	10	165	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					675	680		10.1038/nn.3085	http://dx.doi.org/10.1038/nn.3085			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	932DI	22504346				2022-12-17	WOS:000303270200009
J	Szulwach, KE; Li, XK; Li, YJ; Song, CX; Wu, H; Dai, Q; Irier, H; Upadhyay, AK; Gearing, M; Levey, AI; Vasanthakumar, A; Godley, LA; Chang, Q; Cheng, XD; He, C; Jin, P				Szulwach, Keith E.; Li, Xuekun; Li, Yujing; Song, Chun-Xiao; Wu, Hao; Dai, Qing; Irier, Hasan; Upadhyay, Anup K.; Gearing, Marla; Levey, Allan I.; Vasanthakumar, Aparna; Godley, Lucy A.; Chang, Qiang; Cheng, Xiaodong; He, Chuan; Jin, Peng			5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging	NATURE NEUROSCIENCE			English	Article							EMBRYONIC STEM-CELLS; CPG-BINDING PROTEIN-2; DNA METHYLATION; L1 RETROTRANSPOSITION; RETT-SYNDROME; ADULT NEUROGENESIS; BDNF TRANSCRIPTION; MEMORY FORMATION; MECP2; 5-HYDROXYMETHYLCYTOSINE	DNA methylation dynamics influence brain function and are altered in neurological disorders. 5-hydroxymethylcytosine (5-hmC), a DNA base that is derived from 5-methylcytosine, accounts for similar to 40% of modified cytosine in the brain and has been implicated in DNA methylation-related plasticity. We mapped 5-hmC genome-wide in mouse hippocampus and cerebellum at three different ages, which allowed us to assess its stability and dynamic regulation during postnatal neurodevelopment through adulthood. We found developmentally programmed acquisition of 5-hmC in neuronal cells. Epigenomic localization of 5-hmC-regulated regions revealed stable and dynamically modified loci during neurodevelopment and aging. By profiling 5-hmC in human cerebellum, we found conserved genomic features of 5-hmC. Finally, we found that 5-hmC levels were inversely correlated with methyl-CpG-binding protein 2 dosage, a protein encoded by a gene in which mutations cause Rett syndrome. These data suggest that 5-hmC-mediated epigenetic modification is critical in neurodevelopment and diseases.	[Szulwach, Keith E.; Li, Xuekun; Li, Yujing; Irier, Hasan; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Song, Chun-Xiao; Dai, Qing; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Song, Chun-Xiao; Dai, Qing; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Wu, Hao] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Upadhyay, Anup K.; Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Gearing, Marla; Levey, Allan I.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Vasanthakumar, Aparna; Godley, Lucy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Chang, Qiang] Univ Wisconsin, Waisman Ctr, Dept Genet & Neurol, Madison, WI 53705 USA	Emory University; University of Chicago; University of Chicago; Emory University; Rollins School Public Health; Emory University; Emory University; University of Chicago; University of Wisconsin System; University of Wisconsin Madison	Jin, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	peng.jin@emory.edu	Li, yujing/GQA-4109-2022; Wu, Hao/H-3899-2017; Li, Yujing/AAJ-1411-2020; Levey, Allan/F-2104-2011; Dai, Qing/ABD-8444-2021; Jin, Peng/B-5977-2012	Wu, Hao/0000-0003-1269-7354; Li, Yujing/0000-0002-4363-2484; Levey, Allan/0000-0002-3153-502X; Jin, Peng/0000-0001-6137-6659; Song, Chun-Xiao/0000-0002-7781-6521	US National Institutes of Health (NIH) [T32MH087977]; NIH [CA129831, CA129831-03S1, GM071440, GM049245, NS051630, MH076090, P50AG025688]; Emory Alzheimer's Disease Center [P50AG025688]; Simons Foundation Autism Research Initiative; Beckman Young Investigator Award; Basil O'Connor Scholar Research Award; Emory Genetics Discovery Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064743, P30HD003352] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA129831] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049245, R01GM071440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH076090, R01MH076090, T32MH087977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051630, R21NS067461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Alzheimer's Disease Center; Simons Foundation Autism Research Initiative; Beckman Young Investigator Award; Basil O'Connor Scholar Research Award(March of Dimes); Emory Genetics Discovery Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank the members of the Jin laboratory for their assistance, and S.T. Warren and C. Strauss for critical reading of the manuscript. H.I. is supported by the Training Program in Human Disease Genetics funded by the US National Institutes of Health (NIH, T32MH087977). L.A.G. is supported by NIH grants CA129831 and CA129831-03S1. C.H. was partially supported by NIH grant GM071440. X.C. was supported by NIH grant GM049245 and is a Georgia Research Alliance Eminent Scholar. M.G. and A.I.L. are partially supported by Emory Alzheimer's Disease Center (P50AG025688). P.J. is supported by NIH grants (NS051630, MH076090 and P50AG025688) and Simons Foundation Autism Research Initiative. P.J. is also the recipient of a Beckman Young Investigator Award, Basil O'Connor Scholar Research Award and Alfred P. Sloan Research Fellow in Neuroscience. This work was supported, in part, by the Emory Genetics Discovery Fund.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kuemerle B, 1997, J NEUROSCI, V17, P7881; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Song DL, 1996, DEVELOPMENT, V122, P627; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	50	579	602	1	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2011	14	12					1607	U150		10.1038/nn.2959	http://dx.doi.org/10.1038/nn.2959			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	855EJ	22037496	Green Accepted			2022-12-17	WOS:000297546300022
J	Martinez-Vicente, M; Talloczy, Z; Wong, E; Tang, GM; Koga, H; Kaushik, S; de Vries, R; Arias, E; Harris, S; Sulzer, D; Cuervo, AM				Martinez-Vicente, Marta; Talloczy, Zsolt; Wong, Esther; Tang, Guomei; Koga, Hiroshi; Kaushik, Susmita; de Vries, Rosa; Arias, Esperanza; Harris, Spike; Sulzer, David; Cuervo, Ana Maria			Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease	NATURE NEUROSCIENCE			English	Article							MUTANT HUNTINGTIN; MONITORING AUTOPHAGY; ALPHA-SYNUCLEIN; DEGRADATION; POLYGLUTAMINE; AGGREGATION; CLEARANCE; PROTEINS; MODELS; CELL	Continuous turnover of intracellular components by autophagy is necessary to preserve cellular homeostasis in all tissues. Alterations in macroautophagy, the main process responsible for bulk autophagic degradation, have been proposed to contribute to pathogenesis in Huntington's disease (HD), a genetic neurodegenerative disorder caused by an expanded polyglutamine tract in the huntingtin protein. However, the precise mechanism behind macroautophagy malfunction in HD is poorly understood. In this work, using cellular and mouse models of HD and cells from humans with HD, we have identified a primary defect in the ability of autophagic vacuoles to recognize cytosolic cargo in HD cells. Autophagic vacuoles form at normal or even enhanced rates in HD cells and are adequately eliminated by lysosomes, but they fail to efficiently trap cytosolic cargo in their lumen. We propose that inefficient engulfment of cytosolic components by autophagosomes is responsible for their slower turnover, functional decay and accumulation inside HD cells.	[Martinez-Vicente, Marta; Wong, Esther; Koga, Hiroshi; Kaushik, Susmita; Arias, Esperanza; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Inst Aging Studies, Bronx, NY 10467 USA; [Talloczy, Zsolt; Tang, Guomei; de Vries, Rosa; Harris, Spike; Sulzer, David] Columbia Univ, Dept Neurol, Sch Med, New York, NY USA; [Talloczy, Zsolt; Tang, Guomei; de Vries, Rosa; Harris, Spike; Sulzer, David] Columbia Univ, Dept Psychiat, Sch Med, New York, NY USA; [Talloczy, Zsolt; Tang, Guomei; de Vries, Rosa; Harris, Spike; Sulzer, David] Columbia Univ, Dept Pharmacol, Sch Med, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Columbia University; Columbia University; Columbia University	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Inst Aging Studies, Bronx, NY 10467 USA.	ds43@columbia.edu; ana-maria.cuervo@einstein.yu.edu	Kaushik, Susmita/GVS-3186-2022; Martinez-Vicente, Marta/K-4312-2014; Wong, Esther/E-1344-2011	Kaushik, Susmita/0000-0002-6096-5387; Martinez-Vicente, Marta/0000-0001-7053-2625; Cuervo, Ana Maria/0000-0002-0771-700X; Arias, Esperanza/0000-0002-7836-5072; Wong, Esther/0000-0003-2421-7346	Huntington Disease Society of America; US National Institutes of Health National Institute on Aging [AG021904, AG031782, DK041918, T32AG023475]; National Institute of Neurological Disorders and Stroke Udall Center of Excellence; Glenn Foundation; Picower and Simons foundation; Hereditary Disease Foundation; Fulbright fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG021904, T32AG023475, R01AG021904, P01AG031782] Funding Source: NIH RePORTER	Huntington Disease Society of America; US National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke Udall Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Glenn Foundation; Picower and Simons foundation; Hereditary Disease Foundation; Fulbright fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Singh and B. Patel for technical assistance. Mouse fibroblasts expressing <SUP>146</SUP>Q-htt exon 1 and human lymphoblasts from unaffected controls and individuals with HD were gifts from N. Wexler (Hereditary Disease Foundation), M. Andresen (Massachusetts Institute of Technology) and J. Gusella (Massachusetts General Hospital). The antibodies to mannose-6-phosphate receptor and Rab5 were a gift from A. Wolkoff (Albert Einstein College of Medicine). This work was supported by a Huntington Disease Society of America grant (D. S., A. M. C.); US National Institutes of Health National Institute on Aging grants AG021904, AG031782, DK041918 (A. M. C.) and National Institute of Neurological Disorders and Stroke Udall Center of Excellence grant (D. S.); and the Glenn Foundation (A. M. C.), and Picower and Simons foundation (D. S.). E. W. is supported by the Hereditary Disease Foundation. E. A. is supported by a Fulbright fellowship. S. K. is supported by US National Institutes of Health National Institute on Aging grant T32AG023475.	Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bae Y, 2006, P NATL ACAD SCI USA, V103, P3405, DOI 10.1073/pnas.0511316103; Browne SE, 1999, BRAIN PATHOL, V9, P147; Browne SE, 2008, ANN NY ACAD SCI, V1147, P358, DOI 10.1196/annals.1427.018; Chu CT, 2009, METHOD ENZYMOL, V453, P217, DOI 10.1016/S0076-6879(08)04011-1; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Garfield AS, 2010, METHODS MOL BIOL, V633, P19, DOI 10.1007/978-1-59745-019-5_2; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Larsen KE, 2002, J NEUROSCI, V22, P8951; Martin-Aparicio E, 2001, J NEUROSCI, V21, P8772, DOI 10.1523/JNEUROSCI.21-22-08772.2001; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nagata E, 2004, NEUROREPORT, V15, P1325, DOI 10.1097/01.wnr.0000127073.66692.8f; OHSUMI Y, 1983, J BIOCHEM, V93, P547; Petersen A, 2001, HUM MOL GENET, V10, P1243, DOI 10.1093/hmg/10.12.1243; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Rubinszfein DC, 2005, AUTOPHAGY, V1, P11, DOI 10.4161/auto.1.1.1513; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Sulzer D, 2000, P NATL ACAD SCI USA, V97, P11869, DOI 10.1073/pnas.97.22.11869; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082	45	579	591	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					567	U74		10.1038/nn.2528	http://dx.doi.org/10.1038/nn.2528			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20383138	Green Accepted			2022-12-17	WOS:000277065700014
J	Heins, N; Malatesta, P; Cecconi, F; Nakafuku, M; Tucker, KL; Hack, MA; Chapouton, P; Barde, YA; Gotz, M				Heins, N; Malatesta, P; Cecconi, F; Nakafuku, M; Tucker, KL; Hack, MA; Chapouton, P; Barde, YA; Gotz, M			Glial cells generate neurons: the role of the transcription factor Pax6	NATURE NEUROSCIENCE			English	Article							SUBVENTRICULAR ZONE; MOUSE; EXPRESSION; DIFFERENTIATION; ASTROCYTES; IDENTITY; GENES; IDENTIFICATION; RETROVIRUSES; NEUROGENIN2	Radial glial cells, ubiquitous throughout the developing CNS, guide radially migrating neurons and are the precursors of astrocytes. Recent evidence indicates that radial glial cells also generate neurons in the developing cerebral cortex. Here we investigated the role of the transcription factor Pax6 expressed in cortical radial glia. We showed that radial glial cells isolated from the cortex of Pax6 mutant mice have a reduced neurogenic potential, whereas the neurogenic potential of non-radial glial precursors is not affected. Consistent with defects in only one neurogenic lineage, the number of neurons in the Pax6 mutant cortex in vivo is reduced by half. Conversely, retrovirally mediated Pax6 expression instructs neurogenesis even in astrocytes from postnatal cortex in vitro. These results demonstrated an important role of Pax6 as intrinsic fate determinant of the neurogenic potential of glial cells.	Max Planck Inst Neurobiol, D-82152 Munich, Germany; Univ Roma Tor Vergata, Dipartimento Biol, I-00133 Rome, Italy; Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Max Planck Society; University of Rome Tor Vergata; University of Tokyo; Friedrich Miescher Institute for Biomedical Research	Gotz, M (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Munich, Germany.	mgoetz@neuro.mpg.de	Nakafuku, Masato/J-3068-2013; Malatesta, Paolo/J-3570-2012; Barde, Yves/F-6019-2011; Cecconi, Francesco/K-3969-2016	Malatesta, Paolo/0000-0003-3045-3361; Cecconi, Francesco/0000-0002-5614-4359; Barde, Yves/0000-0002-7627-461X; Nakafuku, Masato/0000-0001-7783-9005	Telethon [TCP99038] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; Caric D, 1997, DEVELOPMENT, V124, P5087; Chapouton P, 1999, DEVELOPMENT, V126, P5569; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Estivill-Torrus G, 2002, DEVELOPMENT, V129, P455; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; GHATTAS IR, 1991, MOL CELL BIOL, V11, P5848, DOI 10.1128/MCB.11.12.5848; Goetz M, 1998, TRENDS NEUROSCI, V21, P135, DOI 10.1016/S0166-2236(98)01228-4; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; GROVE EA, 1993, DEVELOPMENT, V117, P553; HAJIHOSSEINI M, 1993, EMBO J, V12, P4969, DOI 10.1002/j.1460-2075.1993.tb06190.x; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Heins N, 2001, MOL CELL NEUROSCI, V18, P485, DOI 10.1006/mcne.2001.1046; Hildebrand B, 1997, NEUROSCIENCE, V78, P957, DOI 10.1016/S0306-4522(96)00676-8; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Lillien L, 1997, CURR BIOL, V7, pR168, DOI 10.1016/S0960-9822(97)70080-0; Lo LC, 1998, DEVELOPMENT, V125, P609; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Skogh C, 2001, MOL CELL NEUROSCI, V17, P811, DOI 10.1006/mcne.2001.0973; Stoykova A, 2000, J NEUROSCI, V20, P8042; Stoykova A, 1997, DEVELOPMENT, V124, P3765; Stoykova A, 1996, DEVELOPMENT, V122, P3453; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Toresson H, 2000, DEVELOPMENT, V127, P4361; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	48	579	601	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					308	315		10.1038/nn828	http://dx.doi.org/10.1038/nn828			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11896398				2022-12-17	WOS:000174606900010
J	Rushworth, MFS; Behrens, TEJ				Rushworth, Matthew F. S.; Behrens, Timothy E. J.			Choice, uncertainty and value in prefrontal and cingulate cortex	NATURE NEUROSCIENCE			English	Review							PRIMATE ORBITOFRONTAL CORTEX; MEDIAL FRONTAL-CORTEX; DOPAMINE NEURONS ENCODE; ANTERIOR CINGULATE; DECISION-MAKING; REWARD VALUE; PREDICTED REWARD; MACAQUE MONKEYS; CAUDATE-NUCLEUS; PARIETAL CORTEX	Reinforcement learning models that focus on the striatum and dopamine can predict the choices of animals and people. Representations of reward expectation and of reward prediction errors that are pertinent to decision making, however, are not confined to these regions but are also found in prefrontal and cingulate cortex. Moreover, decisions are not guided solely by the magnitude of the reward that is expected. Uncertainty in the estimate of the reward expectation, the value of information that might be gained by taking a course of action and the cost of an action all influence the manner in which decisions are made through prefrontal and cingulate cortex.	[Rushworth, Matthew F. S.] Univ Oxford, Dept Expt Psychol, John Radcliffe Hosp, Oxford OX1 3UD, England; Univ Oxford, Ctr Funct MRI, John Radcliffe Hosp, Oxford OX1 3UD, England	University of Oxford; University of Oxford	Rushworth, MFS (corresponding author), Univ Oxford, Dept Expt Psychol, John Radcliffe Hosp, S Parks Rd, Oxford OX1 3UD, England.	matthew.rushworth@psy.ox.ac.uk; behrens@fmrib.ox.lac.uk		Rushworth, Matthew/0000-0002-5578-9884; Behrens, Timothy/0000-0003-0048-1177	MRC [G0501316, G0600994] Funding Source: UKRI; Medical Research Council [G0501316, G0600994] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akkal D, 2002, EUR J NEUROSCI, V15, P887, DOI 10.1046/j.1460-9568.2002.01920.x; Amiez C, 2005, EUR J NEUROSCI, V21, P3447, DOI 10.1111/j.1460-9568.2005.04170.x; Amiez C, 2006, CEREB CORTEX, V16, P1040, DOI 10.1093/cercor/bhj046; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Averbeck BB, 2006, NAT NEUROSCI, V9, P276, DOI 10.1038/nn1634; Baxter MG, 2000, J NEUROSCI, V20, P4311; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Cohen MX, 2007, J NEUROSCI, V27, P371, DOI 10.1523/JNEUROSCI.4421-06.2007; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; DEIBER MP, 1991, EXP BRAIN RES, V84, P393; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Dum RP, 1996, J NEUROSCI, V16, P6513; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Forstmann BU, 2006, J COGNITIVE NEUROSCI, V18, P388, DOI 10.1162/089892906775990589; Gallagher M, 1999, J NEUROSCI, V19, P6610; Genovesio A, 2006, J NEUROSCI, V26, P7305, DOI 10.1523/JNEUROSCI.0699-06.2006; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Haruno M, 2006, J NEUROPHYSIOL, V95, P948, DOI 10.1152/jn.00382.2005; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Haruno M, 2006, NEURAL NETWORKS, V19, P1242, DOI 10.1016/j.neunet.2006.06.007; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Hoshi E, 2005, J NEUROPHYSIOL, V94, P640, DOI 10.1152/jn.01201.2004; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kheramin S, 2002, PSYCHOPHARMACOLOGY, V165, P9, DOI 10.1007/s00213-002-1228-6; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Kobayashi S, 2006, NEURON, V51, P861, DOI 10.1016/j.neuron.2006.08.031; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Matsumoto M, 2007, NAT NEUROSCI, V10, P647, DOI 10.1038/nn1890; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Mushiake H, 2006, NEURON, V50, P631, DOI 10.1016/j.neuron.2006.03.045; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Ostlund SB, 2007, ANN NY ACAD SCI, V1121, P174, DOI 10.1196/annals.1401.033; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Preuschoff K, 2006, NEURON, V51, P381, DOI 10.1016/j.neuron.2006.06.024; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2005, J NEUROPHYSIOL, V94, P2457, DOI 10.1152/jn.00373.2005; Rolls ET, 1999, J NEUROSCI, V19, P1532; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; ROLLS ET, 1994, J NEUROSCI, V14, P5437; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2007, EUR J NEUROSCI, V26, P2315, DOI 10.1111/j.1460-9568.2007.05844.x; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Rushworth MFS, 2007, TRENDS COGN SCI, V11, P168, DOI 10.1016/j.tics.2007.01.004; Saito N, 2005, CEREB CORTEX, V15, P1535, DOI 10.1093/cercor/bhi032; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Satoh T, 2003, J NEUROSCI, V23, P9913; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tobler PN, 2007, J NEUROPHYSIOL, V97, P1621, DOI 10.1152/jn.00745.2006; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tobler PN, 2003, J NEUROSCI, V23, P10402; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Ullsperger M, 2007, NEUROIMAGE, V35, P1356, DOI 10.1016/j.neuroimage.2007.01.026; Van Hoesen G. W. M., 1993, NEUROBIOLOGY CINGULA, P249, DOI DOI 10.1007/978-1-4899-6704-6_9; Vogt BA, 2005, J COMP NEUROL, V485, P218, DOI 10.1002/cne.20512; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Walton ME, 2006, NEURAL NETWORKS, V19, P1302, DOI 10.1016/j.neunet.2006.03.005; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Walton ME, 2003, J NEUROSCI, V23, P6475; Walton ME, 2002, J NEUROSCI, V22, P10996; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Watanabe M, 2007, CEREB CORTEX, V17, pI101, DOI 10.1093/cercor/bhm067; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Wise SP, 2000, TRENDS NEUROSCI, V23, P271, DOI 10.1016/S0166-2236(00)01570-8; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006	100	577	578	2	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					389	397		10.1038/nn2066	http://dx.doi.org/10.1038/nn2066			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18368045				2022-12-17	WOS:000254359300007
J	Bero, AW; Yan, P; Roh, JH; Cirrito, JR; Stewart, FR; Raichle, ME; Lee, JM; Holtzman, DM				Bero, Adam W.; Yan, Ping; Roh, Jee Hoon; Cirrito, John R.; Stewart, Floy R.; Raichle, Marcus E.; Lee, Jin-Moo; Holtzman, David M.			Neuronal activity regulates the regional vulnerability to amyloid-beta deposition	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MICE; MESSENGER-RNA; IN-VIVO; AEROBIC GLYCOLYSIS; FUNCTIONAL CONNECTIVITY; INTERSTITIAL FLUID; DEFAULT NETWORK; GAMMA-SECRETASE; HUMAN-BRAIN	Amyloid-beta (A beta) plaque deposition in specific brain regions is a pathological hallmark of Alzheimer's disease. However, the mechanism underlying the regional vulnerability to A beta deposition in Alzheimer's disease is unknown. Herein, we provide evidence that endogenous neuronal activity regulates the regional concentration of interstitial fluid (ISF) A beta, which drives local A beta aggregation. Using in vivo microdialysis, we show that ISF A beta concentrations in several brain regions of APP transgenic mice before plaque deposition were commensurate with the degree of subsequent plaque deposition and with the concentration of lactate, a marker of neuronal activity. Furthermore, unilateral vibrissal stimulation increased ISF A beta, and unilateral vibrissal deprivation decreased ISF A beta and lactate, in contralateral barrel cortex. Long-term unilateral vibrissal deprivation decreased amyloid plaque formation and growth. Our results suggest a mechanism to account for the vulnerability of specific brain regions to A beta deposition in Alzheimer's disease.	[Bero, Adam W.; Yan, Ping; Roh, Jee Hoon; Cirrito, John R.; Stewart, Floy R.; Raichle, Marcus E.; Lee, Jin-Moo; Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Bero, Adam W.; Roh, Jee Hoon; Stewart, Floy R.; Holtzman, David M.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Bero, Adam W.; Yan, Ping; Roh, Jee Hoon; Cirrito, John R.; Stewart, Floy R.; Lee, Jin-Moo; Holtzman, David M.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Bero, Adam W.; Yan, Ping; Roh, Jee Hoon; Cirrito, John R.; Stewart, Floy R.; Lee, Jin-Moo; Holtzman, David M.] Washington Univ, Sch Med, Charles F & Joanne Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Raichle, Marcus E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Raichle, Marcus E.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Holtzman, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	holtzman@neuro.wustl.edu	JH, Roh/F-4078-2014; Lee, Jin-Moo/K-2024-2015	JH, Roh/0000-0002-3243-0529; Lee, Jin-Moo/0000-0002-3979-0906	US National Institutes of Health [AG033452, AG029524, AG568127, NS06833, NS67905, NS32636, AG13956, P30NS057105]; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS006833, R01NS067905, P01NS006833, P01NS032636, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG029524, R37AG013956, F31AG033452, R01AG013956] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R.H. Mach (Washington University School of Medicine, St. Louis) for generously providing methoxy-X04 and X-34. We thank K.H. Ashe (University of Minnesota) for generously providing Tg2576 mice. We thank Eli Lilly and Co. for generously providing m266 and biotinylated 3D6 anti-A beta antibodies. This work was supported by US National Institutes of Health grants AG033452 (A.W.B.), AG029524 (J.R.C.), AG568127 (J.R.C.), NS06833 (M.E.R.), NS67905 (J.-M.L.), NS32636 (J.-M.L.), AG13956 (D.M.H.), P30NS057105 (D.M.H.) and the Cure Alzheimer's Fund (D.M.H.).	BAHMANYAR S, 1987, SCIENCE, V237, P77, DOI 10.1126/science.3299701; Bigl M, 2000, NEUROSCI LETT, V292, P107, DOI 10.1016/S0304-3940(00)01452-X; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2003, J NEUROSCI, V23, P8844; DURHAM D, 1978, J COMP NEUROL, V178, P629, DOI 10.1002/cne.901780403; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Flicker L, 2010, J ALZHEIMERS DIS, V20, P803, DOI 10.3233/JAD-2010-091624; Franklin K. B. J., 1996, MOUSE BRAIN STEREOTA; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; GOEDERT M, 1987, EMBO J, V6, P3627, DOI 10.1002/j.1460-2075.1987.tb02694.x; Goldstein ME, 2007, J PHARMACOL EXP THER, V323, P102, DOI 10.1124/jpet.107.125492; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Irizarry MC, 2001, AM J PATHOL, V158, P173, DOI 10.1016/S0002-9440(10)63955-7; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kim J, 2009, NEURON, V64, P632, DOI 10.1016/j.neuron.2009.11.013; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Klunk WE, 2002, J NEUROPATH EXP NEUR, V61, P797, DOI 10.1093/jnen/61.9.797; Lazarov O, 2002, J NEUROSCI, V22, P9785; MELZER P, 1985, BRAIN RES, V348, P229, DOI 10.1016/0006-8993(85)90441-X; Meyer-Luehmann M, 2003, NAT NEUROSCI, V6, P370, DOI 10.1038/nn1022; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Olney JW, 1997, ARCH NEUROL-CHICAGO, V54, P1234, DOI 10.1001/archneur.1997.00550220042012; Page K, 1996, P NATL ACAD SCI USA, V93, P14020, DOI 10.1073/pnas.93.24.14020; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rojas MJ, 2006, AM J PHYSIOL-REG I, V291, pR189, DOI 10.1152/ajpregu.00409.2005; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Uehara T, 2008, PHARMACOL BIOCHEM BE, V90, P273, DOI 10.1016/j.pbb.2008.04.001; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009	49	575	589	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					750	U353		10.1038/nn.2801	http://dx.doi.org/10.1038/nn.2801			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21532579	Green Accepted			2022-12-17	WOS:000290958000018
J	Jourdain, P; Bergersen, LH; Bhaukaurally, K; Bezzi, P; Santello, M; Domercq, M; Matute, C; Tonello, F; Gundersen, V; Volterra, A				Jourdain, Pascal; Bergersen, Linda H.; Bhaukaurally, Khaleel; Bezzi, Paola; Santello, Mirko; Domercq, Maria; Matute, Carlos; Tonello, Fiorella; Gundersen, Vidar; Volterra, Andrea			Glutamate exocytosis from astrocytes controls synaptic strength	NATURE NEUROSCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; GYRUS GRANULE CELLS; RAT HIPPOCAMPUS; NMDA RECEPTORS; DENTATE GYRUS; CALCIUM OSCILLATIONS; ENTORHINAL CORTEX; GLIAL-CELLS; IN-SITU; RELEASE	The release of transmitters from glia influences synaptic functions. The modalities and physiological functions of glial release are poorly understood. Here we show that glutamate exocytosis from astrocytes of the rat hippocampal dentate molecular layer enhances synaptic strength at excitatory synapses between perforant path afferents and granule cells. The effect is mediated by ifenprodil-sensitive NMDA ionotropic glutamate receptors and involves an increase of transmitter release at the synapse. Correspondingly, we identify NMDA receptor 2B subunits on the extrasynaptic portion of excitatory nerve terminals. The receptor distribution is spatially related to glutamate-containing synaptic-like microvesicles in the apposed astrocytic processes. This glial regulatory pathway is endogenously activated by neuronal activity-dependent stimulation of purinergic P2Y1 receptors on the astrocytes. Thus, we provide the first combined functional and ultrastructural evidence for a physiological control of synaptic activity via exocytosis of glutamate from astrocytes.	Univ Lausanne, Dept Cell Biol & Morphol, CH-1005 Lausanne, Switzerland; Univ Oslo, Dept Anat, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway; Univ Basque Country, Dept Neurosci, Vizcaya 48640, Spain; Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; Univ Hosp, Dept Neurol, Rikshosp, N-0023 Oslo, Norway	University of Lausanne; University of Oslo; University of Oslo; University of Basque Country; University of Padua; University of Oslo; National Hospital Norway	Volterra, A (corresponding author), Univ Lausanne, Dept Cell Biol & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.	andrea.volterra@unil.ch	Santello, Mirko/F-9007-2014; Bezzi, Paola/AAP-2440-2020; Tonello, Fiorella/AAM-6737-2021; Domercq, Maria/Z-2274-2019; Tonello, Fiorella/G-8957-2013; Matute, Carlos/N-5559-2014	Santello, Mirko/0000-0002-7709-4127; Tonello, Fiorella/0000-0001-8935-8938; Domercq, Maria/0000-0002-4918-9276; Tonello, Fiorella/0000-0001-8935-8938; Matute, Carlos/0000-0001-8672-711X; Volterra, Andrea/0000-0003-1069-1602; Bergersen, Linda Hildegard/0000-0002-9964-9744				Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bowser DN, 2004, J NEUROSCI, V24, P8606, DOI 10.1523/JNEUROSCI.2660-04.2004; Boyer JL, 1996, MOL PHARMACOL, V50, P1323; Bushong EA, 2003, J COMP NEUROL, V462, P241, DOI 10.1002/cne.10728; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Crippa D, 2006, J PHYSIOL-LONDON, V570, P567, DOI 10.1113/jphysiol.2005.094052; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dalby NO, 2003, J NEUROPHYSIOL, V90, P786, DOI 10.1152/jn.00118.2003; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fellin T, 2006, J NEUROSCI, V26, P9312, DOI 10.1523/JNEUROSCI.2836-06.2006; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gundersen V, 1998, J NEUROSCI, V18, P6059; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; MITCHELL JB, 1993, J NEUROSCI, V13, P3439; Moran-Jimenez MJ, 2000, MOL BRAIN RES, V78, P50, DOI 10.1016/S0169-328X(00)00067-X; Mori M, 2001, J PHYSIOL-LONDON, V535, P115, DOI 10.1111/j.1469-7793.2001.t01-1-00115.x; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pasti L, 1997, J NEUROSCI, V17, P7817; Rossetto O, 2001, TOXICON, V39, P1151, DOI 10.1016/S0041-0101(00)00252-X; Rossi D, 2005, J BIOL CHEM, V280, P42088, DOI 10.1074/jbc.M504124200; Rusakov DA, 2002, TRENDS NEUROSCI, V25, P492, DOI 10.1016/S0166-2236(02)02230-0; RUTECKI PA, 1989, J NEUROSURG, V70, P667, DOI 10.3171/jns.1989.70.5.0667; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; STALEY KJ, 1991, SYNAPSE, V9, P219, DOI 10.1002/syn.890090308; STEINHAUSER C, 1992, EUR J NEUROSCI, V4, P472, DOI 10.1111/j.1460-9568.1992.tb00897.x; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; VONKUGELGEN I, 2000, N-S ARCH PHARMACOL, V352, P310; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zhang Q, 2004, J BIOL CHEM, V279, P12724, DOI 10.1074/jbc.M312845200; Zhang Q, 2004, P NATL ACAD SCI USA, V101, P9441, DOI 10.1073/pnas.0401960101	50	573	592	0	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2007	10	3					331	339		10.1038/nn1849	http://dx.doi.org/10.1038/nn1849			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	140CM	17310248				2022-12-17	WOS:000244480300015
J	Day, M; Wang, ZF; Ding, J; An, XH; Ingham, CA; Shering, AF; Wokosin, D; Ilijic, E; Sun, ZX; Sampson, AR; Mugnaini, E; Deutch, AY; Sesack, SR; Arbuthnott, GW; Surmeier, DJ				Day, M; Wang, ZF; Ding, J; An, XH; Ingham, CA; Shering, AF; Wokosin, D; Ilijic, E; Sun, ZX; Sampson, AR; Mugnaini, E; Deutch, AY; Sesack, SR; Arbuthnott, GW; Surmeier, DJ			Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models	NATURE NEUROSCIENCE			English	Article							MEDIUM SPINY NEURONS; BASAL GANGLIA; DOPAMINE-RECEPTORS; DENDRITIC SPINES; STRIATAL NEURONS; CA2+ CHANNELS; SYNAPTIC-TRANSMISSION; NEOSTRIATAL NEURONS; RAT NEOSTRIATUM; GENE-EXPRESSION	Parkinson disease is a common neurodegenerative disorder that leads to difficulty in effectively translating thought into action. Although it is known that dopaminergic neurons that innervate the striatum die in Parkinson disease, it is not clear how this loss leads to symptoms. Recent work has implicated striatopallidal medium spiny neurons ( MSNs) in this process, but how and precisely why these neurons change is not clear. Using multiphoton imaging, we show that dopamine depletion leads to a rapid and profound loss of spines and glutamatergic synapses on striatopallidal MSNs but not on neighboring striatonigral MSNs. This loss of connectivity is triggered by a new mechanism-dysregulation of intraspine Cav1.3 L-type Ca2+ channels. The disconnection of striatopallidal neurons from motor command structures is likely to be a key step in the emergence of pathological activity that is responsible for symptoms in Parkinson disease.	Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Edinburgh, Div Neurosci & Vet Biomed Sci, Edinburgh EH9 1QH, Midlothian, Scotland; Univ Pittsburgh, Dept Stat, Pittsburgh, PA 15260 USA; Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Vanderbilt Univ, Med Ctr, Dept Psychiat, Nashville, TN 37212 USA; Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37212 USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Edinburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Feinberg School of Medicine; Vanderbilt University; Vanderbilt University	Surmeier, DJ (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Sesack, Susan R/H-8013-2018; Ding, Jun/B-2513-2009; Tuluc, Petronel/C-2527-2011; Arbuthnott, Gordon W/A-4606-2015	Sesack, Susan R/0000-0002-2852-7440; Ding, Jun/0000-0003-0690-1312; Arbuthnott, Gordon W/0000-0002-3386-8362	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS019608, R37NS034696, P01NS019608, P50NS047085, P01NS044282, R01NS034696] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 047085, NS 19608, NS 34696, NS 44282] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Calabresi P, 2000, PROG NEUROBIOL, V61, P231, DOI 10.1016/S0301-0082(99)00030-1; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Cepeda C, 2001, J NEUROPHYSIOL, V85, P659, DOI 10.1152/jn.2001.85.2.659; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dunah AW, 2000, MOL PHARMACOL, V57, P342; GALARRAGA E, 1987, NEUROSCI LETT, V81, P351, DOI 10.1016/0304-3940(87)90409-5; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gross CE, 1999, PROG NEUROBIOL, V59, P509, DOI 10.1016/S0301-0082(99)00015-5; Gubellini P, 2002, J NEUROSCI, V22, P6900; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; Hutchison WD, 2004, J NEUROSCI, V24, P9240, DOI 10.1523/JNEUROSCI.3366-04.2004; INGHAM CA, 1993, EXP BRAIN RES, V93, P17, DOI 10.1007/BF00227776; Ingham CA, 1998, J NEUROSCI, V18, P4732; LAHOSTE GJ, 1993, P NATL ACAD SCI USA, V90, P7451, DOI 10.1073/pnas.90.16.7451; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; Lovinger DM, 2003, ANN NY ACAD SCI, V1003, P226, DOI 10.1196/annals.1300.014; MCNEILL TH, 1988, BRAIN RES, V455, P148, DOI 10.1016/0006-8993(88)90124-2; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; NISENBAUM ES, 1986, BRAIN RES, V398, P221, DOI 10.1016/0006-8993(86)91481-2; Oertner TG, 2005, CELL CALCIUM, V37, P477, DOI 10.1016/j.ceca.2005.01.016; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pang ZP, 2001, NEUROSCI LETT, V308, P201, DOI 10.1016/S0304-3940(01)02031-6; Picconi B, 2004, BRAIN, V127, P1661, DOI 10.1093/brain/awh190; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Raz A, 2000, J NEUROSCI, V20, P8559, DOI 10.1523/JNEUROSCI.20-22-08559.2000; Segal M, 2001, PROG NEUROBIOL, V63, P61, DOI 10.1016/S0301-0082(00)00021-6; SHOLL DA, 1953, J ANAT, V87, P387; Stephens B, 2005, NEUROSCIENCE, V132, P741, DOI 10.1016/j.neuroscience.2005.01.007; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Tkatch T, 1998, NEUROREPORT, V9, P1935, DOI 10.1097/00001756-199806220-00004; Tseng KY, 2001, J NEUROSCI, V21, P6430, DOI 10.1523/JNEUROSCI.21-16-06430.2001; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Wichmann T, 2003, ADV NEUROL, V91, P9; WILSON CJ, 1994, MICROSC RES TECHNIQ, V29, P368, DOI 10.1002/jemt.1070290507; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	50	572	589	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2006	9	2					251	259		10.1038/nn1632	http://dx.doi.org/10.1038/nn1632			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	007SN	16415865				2022-12-17	WOS:000234990100021
J	Ma, WJ; Husain, M; Bays, PM				Ma, Wei Ji; Husain, Masud; Bays, Paul M.			Changing concepts of working memory	NATURE NEUROSCIENCE			English	Review							SHORT-TERM-MEMORY; PREDICTS INDIVIDUAL-DIFFERENCES; POSTERIOR PARIETAL CORTEX; VISUAL INFORMATION; NEURAL MECHANISMS; BINDING DEFICITS; POPULATION CODES; DECISION-MAKING; CAPACITY LIMIT; PRECISION	Working memory is widely considered to be limited in capacity, holding a fixed, small number of items, such as Miller's 'magical number' seven or Cowan's four. It has recently been proposed that working memory might better be conceptualized as a limited resource that is distributed flexibly among all items to be maintained in memory. According to this view, the quality rather than the quantity of working memory representations determines performance. Here we consider behavioral and emerging neural evidence for this proposal.	[Ma, Wei Ji] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Ma, Wei Ji] NYU, Dept Psychol, New York, NY 10003 USA; [Husain, Masud] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Husain, Masud] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Bays, Paul M.] UCL, Inst Neurol, London, England; [Bays, Paul M.] Univ Calif Berkeley, Inst Cognit & Brain Sci, Berkeley, CA 94720 USA	New York University; New York University; University of Oxford; University of Oxford; University of London; University College London; University of California System; University of California Berkeley	Ma, WJ (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	weijima@nyu.edu	Husain, Masud/C-2074-2008	Husain, Masud/0000-0002-6850-9255; Bays, Paul/0000-0003-4684-4893; Ma, Wei Ji/0000-0002-9835-9083	National Eye Institute [R01EY020958]; Army Research Office [W911NF-12-1-0262]; Wellcome Trust; NATIONAL EYE INSTITUTE [R01EY020958] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Army Research Office; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank R. van den Berg for useful discussions and assistance with Figure 5. W.J.M. is supported by award number R01EY020958 from the National Eye Institute and award number W911NF-12-1-0262 from the Army Research Office. P. M. B. and M. H. are supported by the Wellcome Trust.	Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; Anderson DE, 2011, J NEUROSCI, V31, P1128, DOI 10.1523/JNEUROSCI.4125-10.2011; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Awh E, 2007, PSYCHOL SCI, V18, P622, DOI 10.1111/j.1467-9280.2007.01949.x; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bays P.M., J NEUROSCI IN PRESS; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bays PM, 2011, J VISION, V11, DOI 10.1167/11.10.6; Bays PM, 2011, NEUROPSYCHOLOGIA, V49, P1622, DOI 10.1016/j.neuropsychologia.2010.12.023; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Brady TF, 2013, PSYCHOL SCI, V24, P981, DOI 10.1177/0956797612465439; Brady TF, 2013, PSYCHOL REV, V120, P85, DOI 10.1037/a0030779; Brady TF, 2011, PSYCHOL SCI, V22, P384, DOI 10.1177/0956797610397956; Brockmole JR, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00012; Bundesen C, 2005, PSYCHOL REV, V112, P291, DOI 10.1037/0033-295X.112.2.291; Buschman TJ, 2011, P NATL ACAD SCI USA, V108, P11252, DOI 10.1073/pnas.1104666108; Chesney DL, 2011, ATTEN PERCEPT PSYCHO, V73, P2457, DOI 10.3758/s13414-011-0204-9; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; Churchland AK, 2011, NEURON, V69, P818, DOI 10.1016/j.neuron.2010.12.037; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Dyrholm M, 2011, J MATH PSYCHOL, V55, P416, DOI 10.1016/j.jmp.2011.08.005; Elmore LC, 2011, CURR BIOL, V21, P975, DOI 10.1016/j.cub.2011.04.031; Emrich SM, 2013, J NEUROSCI, V33, P6516, DOI 10.1523/JNEUROSCI.5732-12.2013; Emrich SM, 2012, J VISION, V12, DOI 10.1167/12.4.12; Eng HY, 2005, PSYCHON B REV, V12, P1127, DOI 10.3758/BF03206454; Ester EF, 2013, J COGNITIVE NEUROSCI, V25, P754, DOI 10.1162/jocn_a_00357; Fougnie D, 2013, J EXP PSYCHOL GEN, V142, P621, DOI 10.1037/a0030300; Fougnie D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2237; Fougnie D, 2010, J VISION, V10, DOI 10.1167/10.12.27; Franconeri SL, 2013, TRENDS COGN SCI, V17, P134, DOI 10.1016/j.tics.2013.01.010; Freeman J, 2011, J NEUROSCI, V31, P4792, DOI 10.1523/JNEUROSCI.5160-10.2011; Fuster J. M., 1999, MEMORY CEREBRAL CORT; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Gorgoraptis N, 2011, J NEUROSCI, V31, P8502, DOI 10.1523/JNEUROSCI.0208-11.2011; Harrison SA, 2009, NATURE, V458, P632, DOI 10.1038/nature07832; Heyes SB, 2012, DEVELOPMENTAL SCI, V15, P528, DOI 10.1111/j.1467-7687.2012.01148.x; Heyselaar E, 2011, J VISION, V11, DOI 10.1167/11.3.11; Holcombe AO, 2012, COGNITION, V123, P218, DOI 10.1016/j.cognition.2011.10.003; Keshvari S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002927; Keshvari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040216; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Kumar S, 2013, COGN NEUROSCI-UK, V4, P12, DOI 10.1080/17588928.2012.716416; Lara AH, 2012, J VISION, V12, DOI 10.1167/12.3.13; Leung Hoi-Chung, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P553, DOI 10.3758/CABN.4.4.553; Lewis-Peacock JA, 2012, J COGNITIVE NEUROSCI, V24, P61, DOI 10.1162/jocn_a_00140; Linden DEJ, 2003, NEUROIMAGE, V20, P1518, DOI 10.1016/j.neuroimage.2003.07.021; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Luck SJ, 2013, TRENDS COGN SCI, V17, P391, DOI 10.1016/j.tics.2013.06.006; Luria R, 2010, J COGNITIVE NEUROSCI, V22, P496, DOI 10.1162/jocn.2009.21214; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Ma WJ, 2011, NAT NEUROSCI, V14, P783, DOI 10.1038/nn.2814; Ma WJ, 2009, J VISION, V9, DOI 10.1167/9.11.3; Machizawa MG, 2012, PSYCHOL SCI, V23, P554, DOI 10.1177/0956797611431988; Marshall L, 2013, J VISION, V13, DOI 10.1167/13.2.21; Mazyar H, 2012, J VISION, V12, DOI 10.1167/12.6.10; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Melcher D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029296; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/0033-295X.101.2.343; Noack H, 2012, PSYCHOL AGING, V27, P627, DOI 10.1037/a0027251; Olson IR, 2002, PERCEPT PSYCHOPHYS, V64, P1055, DOI 10.3758/BF03194756; Orhan AE, 2013, PSYCHOL REV, V120, P297, DOI 10.1037/a0031541; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; PALMER J, 1990, J EXP PSYCHOL HUMAN, V16, P332, DOI 10.1037/0096-1523.16.2.332; Parra MA, 2009, BRAIN, V132, P1057, DOI 10.1093/brain/awp036; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; Peich MC, 2013, PSYCHOL AGING, V28, P729, DOI 10.1037/a0033236; Pertzov Y, 2013, J EXP PSYCHOL HUMAN, V39, P1224, DOI 10.1037/a0030947; Pertzov Y, 2013, BRAIN, V136, P2474, DOI 10.1093/brain/awt129; Rademaker RL, 2012, J VISION, V12, DOI 10.1167/12.13.21; Raffone A, 2001, J COGNITIVE NEUROSCI, V13, P766, DOI 10.1162/08989290152541430; Reinhart RMG, 2012, J NEUROSCI, V32, P7711, DOI 10.1523/JNEUROSCI.0215-12.2012; Riggall AC, 2012, J NEUROSCI, V32, P12990, DOI 10.1523/JNEUROSCI.1892-12.2012; Rouder J.N., 2008, NATL ACAD SCI US, V105, P5975; Serences JT, 2009, PSYCHOL SCI, V20, P207, DOI 10.1111/j.1467-9280.2009.02276.x; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Shao N, 2010, MEM COGNITION, V38, P629, DOI 10.3758/MC.38.5.629; SHIBUYA H, 1988, J EXP PSYCHOL HUMAN, V14, P591, DOI 10.1037/0096-1523.14.4.591; Sims CR, 2012, PSYCHOL REV, V119, P807, DOI 10.1037/a0029856; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Umemoto A, 2010, COGNITION, V117, P69, DOI 10.1016/j.cognition.2010.07.001; van den Berg R., ATTEN PERCE IN PRESS; van den Berg R., PSYCHOL REV IN PRESS; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P8780, DOI 10.1073/pnas.1117465109; van Dijk H, 2010, P NATL ACAD SCI USA, V107, P900, DOI 10.1073/pnas.0908821107; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; VUL E, 2009, ADV NEURAL INFORM PR, V22, P1955; Wei ZQ, 2012, J NEUROSCI, V32, P11228, DOI 10.1523/JNEUROSCI.0735-12.2012; Wheeler ME, 2002, J EXP PSYCHOL GEN, V131, P48, DOI 10.1037//0096-3445.131.1.48; Wilken P, 2004, J VISION, V4, P1120, DOI 10.1167/4.12.11; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Xu YD, 2002, J EXP PSYCHOL HUMAN, V28, P458, DOI 10.1037//0096-1523.28.2.458; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860; Zokaei N, 2011, J VISION, V11, DOI 10.1167/11.14.2	99	571	585	18	242	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2014	17	3					347	356		10.1038/nn.3655	http://dx.doi.org/10.1038/nn.3655			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8CA	24569831	Green Accepted			2022-12-17	WOS:000332016500007
J	Buckner, RL; Krienen, FM; Yeo, BTT				Buckner, Randy L.; Krienen, Fenna M.; Yeo, B. T. Thomas			Opportunities and limitations of intrinsic functional connectivity MRI	NATURE NEUROSCIENCE			English	Review							RESTING-STATE NETWORKS; GLOBAL SIGNAL REGRESSION; DEFAULT MODE NETWORK; HUMAN BRAIN; STRUCTURAL CONNECTIVITY; CORPUS-CALLOSUM; CORTEX; ORGANIZATION; ARCHITECTURE; DISTINCT	Intrinsic functional connectivity magnetic resonance imaging (fcMRI) has emerged as a powerful tool for mapping large-scale networks in the human brain. Robust and reliable functionally coupled networks can be detected in individuals that echo many known features of anatomical organization. Features of brain organization have been discovered, including descriptions of distributed large-scale networks interwoven throughout association cortex, interactions (including anticorrelations) between brain networks and insights into the topography of subcortical structures. But interpreting fcMRI is complicated by several factors. Functional coupling changes dynamically, suggesting that it is constrained by, but not fully dictated by, anatomic connectivity. Critically to study of between-group differences, fcMRI is sensitive to head motion and to differences in the mental states of participants during the scans. We discuss the potential of fcMRI in the context of its limitations.	[Buckner, Randy L.; Krienen, Fenna M.] Harvard Univ, Dept Psychol, Ctr Brain Sci, Cambridge, MA 02138 USA; [Buckner, Randy L.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Buckner, Randy L.; Krienen, Fenna M.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Yeo, B. T. Thomas] Duke NUS Grad Med Sch, Ctr Cognit Neurosci, Singapore, Singapore	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; National University of Singapore	Buckner, RL (corresponding author), Harvard Univ, Dept Psychol, Ctr Brain Sci, 33 Kirkland St, Cambridge, MA 02138 USA.	randy_buckner@harvard.edu	Yeo, B.T. Thomas/X-2860-2019	Yeo, B.T. Thomas/0000-0002-0119-3276	Medical Research Council [G0600717B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Andrews-Hanna JR, 2012, NEUROSCIENTIST, V18, P251, DOI 10.1177/1073858411403316; Birn RM, 2008, NEUROIMAGE, V40, P644, DOI 10.1016/j.neuroimage.2007.11.059; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Deco G, 2011, NEUROSCIENTIST, V17, P107, DOI 10.1177/1073858409354384; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Handwerker DA, 2012, NEUROIMAGE, V62, P1017, DOI 10.1016/j.neuroimage.2012.02.015; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Hill J, 2010, P NATL ACAD SCI USA, V107, P13135, DOI 10.1073/pnas.1001229107; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; HUTCHISON RM, 2012, HUM BRAIN MAPP, V34, P2154, DOI DOI 10.1002/HBM.22058; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; KAAS JH, 1987, ANNU REV PSYCHOL, V38, P129, DOI 10.1146/annurev.ps.38.020187.001021; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Lu J, 2011, J NEUROSCI, V31, P15065, DOI 10.1523/JNEUROSCI.2364-11.2011; Manni E, 2004, NAT REV NEUROSCI, V5, P241, DOI 10.1038/nrn1347; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; Mesulam M, 2012, NEUROIMAGE, V62, P2182, DOI 10.1016/j.neuroimage.2011.12.033; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rosa MGP, 2005, PHILOS T R SOC B, V360, P665, DOI 10.1098/rstb.2005.1626; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wang L, 2012, NEURON, V76, P1010, DOI 10.1016/j.neuron.2012.09.033; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zinkin J., 1950, DEMENTIA PRAECOX GRO	58	571	587	4	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					832	837		10.1038/nn.3423	http://dx.doi.org/10.1038/nn.3423			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23799476				2022-12-17	WOS:000321180900013
J	Belforte, JE; Zsiros, V; Sklar, ER; Jiang, ZH; Yu, G; Li, YQ; Quinlan, EM; Nakazawa, K				Belforte, Juan E.; Zsiros, Veronika; Sklar, Elyse R.; Jiang, Zhihong; Yu, Gu; Li, Yuqing; Quinlan, Elizabeth M.; Nakazawa, Kazu			Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes	NATURE NEUROSCIENCE			English	Article							SPATIAL WORKING-MEMORY; PREFRONTAL CORTEX; MICE LACKING; PREPULSE INHIBITION; SYNAPTIC PLASTICITY; BIPOLAR DISORDER; ANIMAL-MODELS; KETAMINE; PSYCHOSIS; PHENCYCLIDINE	Cortical GABAergic dysfunction may underlie the pathophysiology of psychiatric disorders, including schizophrenia. Here, we characterized a mouse strain in which the essential NR1 subunit of the NMDA receptor (NMDAR) was selectively eliminated in 40-50% of cortical and hippocampal interneurons in early postnatal development. Consistent with the NMDAR hypofunction theory of schizophrenia, distinct schizophrenia-related symptoms emerged after adolescence, including novelty-induced hyperlocomotion, mating and nest-building deficits, as well as anhedonia-like and anxiety-like behaviors. Many of these behaviors were exacerbated by social isolation stress. Social memory, spatial working memory and prepulse inhibition were also impaired. Reduced expression of glutamic acid decarboxylase 67 and parvalbumin was accompanied by disinhibition of cortical excitatory neurons and reduced neuronal synchrony. Postadolescent deletion of NR1 did not result in such abnormalities. These findings suggest that early postnatal inhibition of NMDAR activity in corticolimbic GABAergic interneurons contributes to the pathophysiology of schizophrenia-related disorders.	[Belforte, Juan E.; Zsiros, Veronika; Sklar, Elyse R.; Jiang, Zhihong; Nakazawa, Kazu] NIMH, Unit Genet Cognit & Behav, Mood & Anxiety Disorders Program, Intramural Res Program, Bethesda, MD 20892 USA; [Belforte, Juan E.] NIAAA, Intramural Res Program, NIH, US Dept HHS, Bethesda, MD USA; [Yu, Gu; Quinlan, Elizabeth M.] Univ Maryland, Dept Biol, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA; [Li, Yuqing] Univ Alabama, Med Sch Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University System of Maryland; University of Maryland College Park; University of Alabama System; University of Alabama Birmingham	Nakazawa, K (corresponding author), NIMH, Unit Genet Cognit & Behav, Mood & Anxiety Disorders Program, Intramural Res Program, Bethesda, MD 20892 USA.	nakazawk@mail.nih.gov	Li, Yuqing/G-1596-2011; Nakazawa, Kazutoshi/J-6195-2015; Li, Yuqing/AAR-9383-2021; Belforte, Juan/Q-6633-2019	Li, Yuqing/0000-0003-1211-5529; Nakazawa, Kazutoshi/0000-0001-5699-9093; Li, Yuqing/0000-0003-1211-5529; Belforte, Juan/0000-0002-6300-5314; Gu, Yu/0000-0001-7882-5422	US National Institute of Mental Health; US National Institute on Alcohol Abuse and Addiction; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002895, ZICMH002901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS065273] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Institute on Alcohol Abuse and Addiction; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We also acknowledge the CURE/Digestive diseases research center at the University of California Los Angeles and the US National Institute of Mental Health Chemical Synthesis and Drug Supply Program for antibodies and risperidone, respectively. This work was supported by the Intramural Research Program of the US National Institute of Mental Health and of the US National Institute on Alcohol Abuse and Addiction.	Agid O, 2000, BIOMED PHARMACOTHER, V54, P135, DOI 10.1016/S0753-3322(00)89046-0; Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; BRAUTIGAN DL, 1990, NATURE, V344, P74, DOI 10.1038/344074a0; Breier A, 1997, AM J PSYCHIAT, V154, P805; Bubenikova-Valesova V, 2008, NEUROSCI BIOBEHAV R, V32, P1014, DOI 10.1016/j.neubiorev.2008.03.012; Cannon M, 1997, AM J PSYCHIAT, V154, P1544; Carter CJ, 2006, SCHIZOPHR RES, V86, P1, DOI 10.1016/j.schres.2006.05.023; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cochran SM, 2003, NEUROPSYCHOPHARMACOL, V28, P265, DOI 10.1038/sj.npp.1300031; Coyle JT, 1996, HARVARD REV PSYCHIAT, V3, P241, DOI 10.3109/10673229609017192; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; DEUTSCH SI, 1989, CLIN NEUROPHARMACOL, V12, P1, DOI 10.1097/00002826-198902000-00001; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Gainetdinov RR, 2001, TRENDS NEUROSCI, V24, P527, DOI 10.1016/S0166-2236(00)01886-5; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Grunze HCR, 1996, J NEUROSCI, V16, P2034; Hagberg H, 2002, DEV NEUROSCI-BASEL, V24, P364, DOI 10.1159/000069040; HASEGAWA M, 1993, NEUROSCI LETT, V150, P53, DOI 10.1016/0304-3940(93)90106-U; Houthoofd SAMK, 2008, CLIN THER, V30, P1565, DOI 10.1016/j.clinthera.2008.09.014; Huang ZJ, 2009, J PHYSIOL-LONDON, V587, P1881, DOI 10.1113/jphysiol.2008.168211; Ikegaya Y, 2000, NEUROSCIENCE, V98, P647, DOI 10.1016/S0306-4522(00)00188-3; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; JAVITT D C, 1987, Hillside Journal of Clinical Psychiatry, V9, P12; Jinde S, 2009, EUR J NEUROSCI, V30, P1036, DOI 10.1111/j.1460-9568.2009.06896.x; Keilhoff G, 2004, NEUROSCIENCE, V126, P591, DOI 10.1016/j.neuroscience.2004.03.039; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Labrie V, 2008, PSYCHOPHARMACOLOGY, V200, P217, DOI 10.1007/s00213-008-1196-6; LAHTI AC, 1995, NEUROPSYCHOPHARMACOL, V13, P9, DOI 10.1016/0893-133X(94)00131-I; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Li Q, 2002, J NEUROSCI, V22, P3070, DOI 10.1523/JNEUROSCI.22-08-03070.2002; Lim EP, 2007, PSYCHOPHARMACOLOGY, V191, P297, DOI 10.1007/s00213-006-0664-0; LODGE D, 1982, EUR J PHARMACOL, V77, P203, DOI 10.1016/0014-2999(82)90022-X; Martucci L, 2003, AM J MED GENET B, V119B, P24, DOI 10.1002/ajmg.b.20014; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Morrow BA, 2007, PSYCHOPHARMACOLOGY, V192, P283, DOI 10.1007/s00213-007-0708-0; OLNEY JW, 1995, ARCH GEN PSYCHIAT, V52, P998; OLNEY JW, 1988, EXCITATORY AMINO ACI, P337; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; Piskulic D, 2007, PSYCHIAT RES, V150, P111, DOI 10.1016/j.psychres.2006.03.018; Reilly JL, 2006, ARCH GEN PSYCHIAT, V63, P1189, DOI 10.1001/archpsyc.63.11.1189; Rujescu D, 2006, BIOL PSYCHIAT, V59, P721, DOI 10.1016/j.biopsych.2005.08.029; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Vollenweider FX, 1997, EUR NEUROPSYCHOPHARM, V7, P9, DOI 10.1016/S0924-977X(96)00039-9; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106	50	571	580	2	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2010	13	1					76	U240		10.1038/nn.2447	http://dx.doi.org/10.1038/nn.2447			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	536PM	19915563	Green Accepted			2022-12-17	WOS:000273056300016
J	Cameron, HA; McKay, RDG				Cameron, HA; McKay, RDG			Restoring production of hippocampal neurons in old age	NATURE NEUROSCIENCE			English	Article							RAT DENTATE GYRUS; ADULT-RAT; PYRAMIDAL NEURONS; ADRENAL-STEROIDS; CORTISOL-LEVELS; INDUCED ATROPHY; GRANULE CELLS; NEUROGENESIS; STRESS; PROLIFERATION	The production of hippocampal granule neurons continues throughout adulthood but dramatically decreases in old age. Here we show that reducing corticosteroid levels in aged rats restored the rate of cell proliferation, resulting in increased numbers of new granule neurons. This result indicates that the neuronal precursor population in the dentate gyrus remains stable into old age, but that neurogenesis is normally slowed by high levels of corticosteroids. The findings further suggest that decreased neurogenesis may contribute to age-related memory deficits associated with high corticosteroids, and that these deficits may be reversible.	NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Cameron, HA (corresponding author), NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.		Cameron, Heather/E-6221-2011	Cameron, Heather/0000-0002-3245-5777				Bye N, 1998, NEUROREPORT, V9, P1179, DOI 10.1097/00001756-199804200-00040; Cameron H, 1996, J COMP NEUROL, V369, P56, DOI 10.1002/(SICI)1096-9861(19960520)369:1<56::AID-CNE4>3.0.CO;2-J; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; GOULD E, 1991, J COMP NEUROL, V313, P486, DOI 10.1002/cne.903130309; GOULD E, 1990, NEUROSCIENCE, V37, P367, DOI 10.1016/0306-4522(90)90407-U; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Guillery RW, 1997, J COMP NEUROL, V386, P2, DOI 10.1002/(SICI)1096-9861(19970915)386:1<2::AID-CNE2>3.0.CO;2-6; Kempermann G, 1998, J NEUROSCI, V18, P3206; KOSAKA T, 1986, J COMP NEUROL, V249, P242, DOI 10.1002/cne.902490209; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LANDFIELD PW, 1994, ANN NY ACAD SCI, V746, P308; Liu YB, 1996, J NEUROPHYSIOL, V76, P1074, DOI 10.1152/jn.1996.76.2.1074; LUPIEN S, 1994, J NEUROSCI, V14, P2893, DOI 10.1523/jneurosci.14-05-02893.1994; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Magarinos AM, 1999, EUR J PHARMACOL, V371, P113, DOI 10.1016/S0014-2999(99)00163-6; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; MINTURN JE, 1995, J COMP NEUROL, V355, P369, DOI 10.1002/cne.903550304; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Porter NM, 1998, NAT NEUROSCI, V1, P3, DOI 10.1038/196; Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926; SAPOLSKY RM, 1992, NEUROBIOL AGING, V13, P171, DOI 10.1016/0197-4580(92)90025-S; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; SERESS L, 1981, J ANAT, V133, P181; SLOVITER RS, 1993, J COMP NEUROL, V330, P337, DOI 10.1002/cne.903300305; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; WATANABE Y, 1992, HIPPOCAMPUS, V2, P431, DOI 10.1002/hipo.450020410; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WEST MJ, 1993, NEUROBIOL AGING, V14, P287, DOI 10.1016/0197-4580(93)90113-P; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A	38	571	592	0	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1999	2	10					894	897		10.1038/13197	http://dx.doi.org/10.1038/13197			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FE	10491610				2022-12-17	WOS:000083883200015
J	Brown, EN; Kass, RE; Mitra, PP				Brown, EN; Kass, RE; Mitra, PP			Multiple neural spike train data analysis: state-of-the-art and future challenges	NATURE NEUROSCIENCE			English	Article							CORTICAL-NEURONS; FIRING PATTERNS; INFORMATION; POPULATION; QUANTIFICATION; CLASSIFICATION; RECONSTRUCTION; IDENTIFICATION; PREDICTION; DISCHARGE	Multiple electrodes are now a standard tool in neuroscience research that make it possible to study the simultaneous activity of several neurons in a given brain region or across different regions. The data from multi-electrode studies present important analysis challenges that must be resolved for optimal use of these neurophysiological measurements to answer questions about how the brain works. Here we review statistical methods for the analysis of multiple neural spike-train data and discuss future challenges for methodology research.	Harvard Univ, Sch Med, MIT, Div Hlth Sci & Technol, Boston, MA 02114 USA; Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15208 USA; Ctr Neural Basis Cognit, Dept Stat, Pittsburgh, PA 15208 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cold Spring Harbor Laboratory	Brown, EN (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, Neurosci Stat Res Lab, Boston, MA 02114 USA.	brown@neurostat.mgh.harvard.edu		Mitra, Partha/0000-0001-8818-6804	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064537, R01MH059733, R01MH062528, K02MH061637, R25MH066410] Funding Source: NIH RePORTER; NIDA NIH HHS [DA015664] Funding Source: Medline; NIMH NIH HHS [MH66410, MH59733, MH61637, MH64537, MH62528] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abdallahi LMOM, 2003, BIOL CYBERN, V89, P170, DOI 10.1007/s00422-003-0416-8; ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Aksay E, 2003, J NEUROSCI, V23, P10852; AMARASINGHAM A, 2002, TEMPORAL STRUCTURE N; [Anonymous], 1978, DEV STAT; Baker SN, 2001, NEURAL COMPUT, V13, P1351, DOI 10.1162/08997660152002889; Bar-Gad I, 2001, J NEUROSCI METH, V107, P1, DOI 10.1016/S0165-0270(01)00339-9; Barbieri R, 2004, NEURAL COMPUT, V16, P277, DOI 10.1162/089976604322742038; Barbieri R, 2001, J NEUROSCI METH, V105, P25, DOI 10.1016/S0165-0270(00)00344-7; BERGER T, 2003, IEEE INF THEORY SOC, V53, P1; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brillinger D.R., 1981, TIME SERIES; BRILLINGER DR, 1992, J AM STAT ASSOC, V87, P260, DOI 10.2307/2290256; BRILLINGER DR, 1988, BIOL CYBERN, V59, P189, DOI 10.1007/BF00318010; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; Brown EN, 2004, MATH COMP BIOL SER, P253; Brown EN, 2001, P NATL ACAD SCI USA, V98, P12261, DOI 10.1073/pnas.201409398; Brown EN, 1998, J NEUROSCI, V18, P7411; CHORNOBOY ES, 1988, BIOL CYBERN, V59, P265, DOI 10.1007/BF00332915; Daley D., 2003, INTRO THEORY POINT P, V1; Dayan P., 2001, THEORETICAL NEUROSCI; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gao Y, 2003, I IEEE EMBS C NEUR E, P189; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GERSTEIN GL, 1969, SCIENCE, V164, P828, DOI 10.1126/science.164.3881.828; Grun S, 2002, NEURAL COMPUT, V14, P81, DOI 10.1162/089976602753284464; Gutig R, 2002, NEURAL COMPUT, V14, P121, DOI 10.1162/089976602753284473; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Ito H, 2000, NEURAL COMPUT, V12, P195, DOI 10.1162/089976600300015952; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; Kass RE, 2003, NETWORK-COMP NEURAL, V14, P5, DOI 10.1088/0954-898X/14/1/301; Kass RE, 2001, NEURAL COMPUT, V13, P1713, DOI 10.1162/08997660152469314; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Martignon L, 2000, NEURAL COMPUT, V12, P2621, DOI 10.1162/089976600300014872; Nguyen DP, 2003, NETWORK-COMP NEURAL, V14, P61, DOI 10.1088/0954-898X/14/1/304; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Pawitan Y., 2001, ALL LIKELIHOOD STAT; Percival D., 2000, CA ST PR MA; PERCIVAL DB, 2002, SPECTRAL ANAL PHYS A; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pipa G, 2003, NEUROCOMPUTING, V52-4, P31, DOI 10.1016/S0925-2312(02)00823-8; Qaqish BF, 2003, BIOMETRIKA, V90, P455, DOI 10.1093/biomet/90.2.455; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Rieke F., 1997, SPIKES EXPLORING NEU; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHIKRI O, 2003, NEURAL COMPUT, V5, P1803; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Stuart L, 2002, BIOSYSTEMS, V67, P265, DOI 10.1016/S0303-2647(02)00084-9; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Thomson D. J, 1991, ADV SPECTRUM ANAL AR, VI, P58; Victor JD, 2003, NETWORK-COMP NEURAL, V14, P1, DOI 10.1088/0954-898X/14/1/001; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wiener MC, 2003, J NEUROSCI, V23, P2394; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	65	570	586	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					456	461		10.1038/nn1228	http://dx.doi.org/10.1038/nn1228			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15114358				2022-12-17	WOS:000221101300013
J	Di Marzo, V; Matias, I				Di Marzo, V; Matias, I			Endocannabinoid control of food intake and energy balance	NATURE NEUROSCIENCE			English	Review							CB1 RECEPTOR ANTAGONIST; MESSENGER-RNA EXPRESSION; CANNABINOID RECEPTOR; MOLECULAR CHARACTERIZATION; SELECTIVE ANTAGONIST; BODY-WEIGHT; BRAIN; ANANDAMIDE; SR141716; DIET	Marijuana and its major psychotropic component, Delta(9)-tetrahydrocannabinol, stimulate appetite and increase body weight in wasting syndromes, suggesting that the CB1 cannabinoid receptor and its endogenous ligands, the endocannabinoids, are involved in controlling energy balance. The endocannabinoid system controls food intake via both central and peripheral mechanisms, and it may also stimulate lipogenesis and fat accumulation. Here we discuss the multifaceted regulation of energy homeostasis by endocannabinoids, together with its applications to the treatment of eating disorders and metabolic syndromes.	CNR, Endocannnabinoid Res Grp, Inst Biomol Chem, I-80078 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR)	Di Marzo, V (corresponding author), CNR, Endocannnabinoid Res Grp, Inst Biomol Chem, Via Campi Flegrei 34, I-80078 Naples, Italy.	vdimarzo@icmib.na.cnr.it	Di Marzo, Vincenzo/AAD-7742-2019	Di Marzo, Vincenzo/0000-0002-1490-3070				Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Berger A, 2001, P NATL ACAD SCI USA, V98, P6402, DOI 10.1073/pnas.101119098; Berrendero F, 1999, SYNAPSE, V33, P181, DOI 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Black Shawn C, 2004, Curr Opin Investig Drugs, V5, P389; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Carai MAM, 2004, EUR J PHARMACOL, V494, P221, DOI 10.1016/j.ejphar.2004.05.005; Chambers AP, 2004, PHYSIOL BEHAV, V82, P863, DOI [10.1016/S0031-9384(04)00302-6, 10.1016/j.physbeh.2004.07.004]; Chen RZ, 2004, BRAIN RES, V999, P227, DOI 10.1016/j.brainres.2003.12.004; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; De Vry J, 2004, EUR J PHARMACOL, V483, P55, DOI 10.1016/j.ejphar.2003.10.012; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 1998, NATURE, V396, P636, DOI 10.1038/25267; Di S, 2003, J NEUROSCI, V23, P4850; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Duarte C, 2004, NEUROPSYCHOPHARMACOL, V29, P911, DOI 10.1038/sj.npp.1300370; Fride E, 2004, EUR J PHARMACOL, V500, P289, DOI 10.1016/j.ejphar.2004.07.033; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; GOMEZOCANA J, 1912, ARXIUS I CIENCES, V1, P22; Hanus L, 2003, BRAIN RES, V983, P144, DOI 10.1016/S0006-8993(03)03046-4; Hao SZ, 2000, EUR J PHARMACOL, V392, P147, DOI 10.1016/S0014-2999(00)00059-5; Higgs S, 2003, PSYCHOPHARMACOLOGY, V165, P370, DOI 10.1007/s00213-002-1263-3; Hilairet S, 2003, J BIOL CHEM, V278, P23731, DOI 10.1074/jbc.M212369200; Hildebrandt AL, 2003, EUR J PHARMACOL, V462, P125, DOI 10.1016/S0014-2999(03)01343-8; Horvath TL, 2003, J CLIN INVEST, V112, P323, DOI [10.1172/JCI19376, 10.1172/JCI200319376]; Howlett AC, 2002, PROSTAG OTH LIPID M, V68-9, P619, DOI 10.1016/S0090-6980(02)00060-6; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kirkham TC, 2001, PSYCHOPHARMACOLOGY, V153, P267, DOI 10.1007/s002130000596; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Maccarrone M, 2003, J BIOL CHEM, V278, P13318, DOI 10.1074/jbc.M211248200; Matias I, 2003, CELL MOL LIFE SCI, V60, P382, DOI 10.1007/s000180300031; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McLaughlin PJ, 2003, BEHAV PHARMACOL, V14, P583, DOI 10.1097/00008877-200312000-00002; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; MONTELEONE P, IN PRESS NEUROPSYCHO; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; OSEIHYIAMAN D, IN PRESS J CLIN INVE; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Poirier B, 2005, DIABETES OBES METAB, V7, P65, DOI 10.1111/j.1463-1326.2004.00374.x; Poncelet M, 2003, NEUROSCI LETT, V343, P216, DOI 10.1016/S0304-3940(03)00397-5; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Rinaldi-Carmona M, 2004, J PHARMACOL EXP THER, V310, P905, DOI 10.1124/jpet.104.067884; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Rowland NE, 2001, PSYCHOPHARMACOLOGY, V159, P111, DOI 10.1007/s002130100910; Simiand J, 1998, BEHAV PHARMACOL, V9, P179; Sipe JC, 2005, INT J OBESITY, V29, P755, DOI 10.1038/sj.ijo.0802954; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; THORNTONJONES ZD, 2005, PSYCHOPHARMACOLO JAN, DOI DOI 10.1007/S00213-004-2047-8; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Tucci SA, 2004, BRIT J PHARMACOL, V143, P520, DOI 10.1038/sj.bjp.0705968; Verty ANA, 2004, BRAIN RES, V1020, P188, DOI 10.1016/j.brainres.2004.06.033; Verty ANA, 2004, ENDOCRINOLOGY, V145, P3224, DOI 10.1210/en.2004-0059; Verty ANA, 2003, PSYCHOPHARMACOLOGY, V168, P314, DOI 10.1007/s00213-003-1451-9; Vickers SP, 2003, PSYCHOPHARMACOLOGY, V167, P103, DOI 10.1007/s00213-002-1384-8; Watanabe S, 2003, PROSTAG LEUKOTR ESS, V69, P51, DOI 10.1016/S0952-3278(03)00056-5; Werner NA, 2003, BRAIN RES, V967, P290, DOI 10.1016/S0006-8993(02)04274-9; Williams CM, 1998, PHYSIOL BEHAV, V65, P343, DOI 10.1016/S0031-9384(98)00170-X; Williams CM, 2002, PHARMACOL BIOCHEM BE, V71, P333, DOI 10.1016/S0091-3057(01)00694-3; WILLIAMS SK, 1999, TIS ENGN INTELL UNIT, V1, P143	65	569	585	0	45	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					585	589		10.1038/nn1457	http://dx.doi.org/10.1038/nn1457			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15856067				2022-12-17	WOS:000228895100017
J	Fritz, J; Shamma, S; Elhilali, M; Klein, D				Fritz, J; Shamma, S; Elhilali, M; Klein, D			Rapid task-related plasticity of spectrotemporal receptive fields in primary auditory cortex	NATURE NEUROSCIENCE			English	Article							PHYSIOLOGICAL PLASTICITY; DEPENDENT PLASTICITY; REORGANIZATION; SYSTEM; REPRESENTATION; EXPERIENCE; MICROSTIMULATION; STIMULATION; NEURONS; CAT	We investigated the hypothesis that task performance can rapidly and adaptively reshape cortical receptive field properties in accord with specific task demands and salient sensory cues. We recorded neuronal responses in the primary auditory cortex of behaving ferrets that were trained to detect a target tone of any frequency. Cortical plasticity was quantified by measuring focal changes in each cell's spectrotemporal response field (STRF) in a series of passive and active behavioral conditions. STRF measurements were made simultaneously with task performance, providing multiple snapshots of the dynamic STRF during ongoing behavior. Attending to a specific target frequency during the detection task consistently induced localized facilitative changes in STRF shape, which were swift in onset. Such modulatory changes may enhance overall cortical responsiveness to the target tone and increase the likelihood of 'capturing' the attended target during the detection task. Some receptive field changes persisted for hours after the task was over and hence may contribute to long-term sensory memory.	Univ Maryland, Inst Syst Res Elect & Comp Engn, Ctr Auditory & Acoust Res, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Fritz, J (corresponding author), Univ Maryland, Inst Syst Res Elect & Comp Engn, Ctr Auditory & Acoust Res, College Pk, MD 20742 USA.	ripple@isr.umd.edu	Fritz, Jonathan/AAK-4863-2020; Shamma, Shihab A/F-9852-2012; Elhilali, Mounya/A-3396-2010	Elhilali, Mounya/0000-0003-2597-738X; Fritz, Jonathan/0000-0002-0625-172X				Ahissar E, 1998, NEUROPHARMACOLOGY, V37, P633, DOI 10.1016/S0028-3908(98)00068-9; BAKIN JS, 1990, BRAIN RES, V536, P271, DOI 10.1016/0006-8993(90)90035-A; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Blake DT, 2002, P NATL ACAD SCI USA, V99, P10114, DOI 10.1073/pnas.092278099; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Dorris MC, 2000, J NEUROSCI, V20; Edeline JM, 1999, PROG NEUROBIOL, V57, P165, DOI 10.1016/S0301-0082(98)00042-2; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P539, DOI 10.1037/0735-7044.107.4.539; Efron B, 1998, INTRO BOOTSTRAP; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Fu KMG, 2003, J NEUROSCI, V23, P7510; Fuster JM, 1995, MEMORY CEREBRAL CORT; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Harris JA, 2001, NEURON, V30, P315, DOI 10.1016/S0896-6273(01)00300-2; Heffner H.E., 1995, METHODS COMP PSYCHOA, P79; Huntley GW, 1997, CEREB CORTEX, V7, P143, DOI 10.1093/cercor/7.2.143; Kilgard MP, 2002, BIOL CYBERN, V87, P333, DOI 10.1007/s00422-002-0352-z; Kilgard MP, 2002, P NATL ACAD SCI USA, V99, P3205, DOI 10.1073/pnas.261705198; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kilgard MP, 2001, J NEUROPHYSIOL, V86, P326, DOI 10.1152/jn.2001.86.1.326; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; Li CSR, 2001, NEURON, V30, P593, DOI 10.1016/S0896-6273(01)00301-4; Ma XF, 2003, J NEUROPHYSIOL, V89, P90, DOI 10.1152/jn.00968.2001; Ma XF, 2001, J NEUROPHYSIOL, V85, P1078, DOI 10.1152/jn.2001.85.3.1078; Maldonado PE, 1996, EXP BRAIN RES, V112, P420; METHERATE R, 1998, FRONT BIOSCI, V6, P494; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Ohl FW, 1996, EUR J NEUROSCI, V8, P1001, DOI 10.1111/j.1460-9568.1996.tb01587.x; PADOASCHIOPPA C, 2003, J NEUROPHYSIOL  0910; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Schulze H, 2002, ACTA ACUST UNITED AC, V88, P399; SHAMMA SA, 1993, J NEUROPHYSIOL, V69, P367, DOI 10.1152/jn.1993.69.2.367; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Talwar SK, 2001, J NEUROPHYSIOL, V86, P1555, DOI 10.1152/jn.2001.86.4.1555; Talwar SK, 2001, J NEUROPHYSIOL, V85, P2350, DOI 10.1152/jn.2001.85.6.2350; Thiel CM, 2002, NEURON, V35, P567, DOI 10.1016/S0896-6273(02)00801-2; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Weinberger NM, 2001, MODEL SYSTEMS AND THE NEUROBIOLOGY OF ASSOCIATIVE LEARNING: A FESTSCHRIFT IN HONOR OF RICHARD F. THOMPSON, P187; WEINBERGER NM, 1984, BEHAV NEUROSCI, V98, P171, DOI 10.1037/0735-7044.98.2.171; WEINBERGER NM, 1995, ANNU REV NEUROSCI, V18, P129; Xiao ZJ, 2002, P NATL ACAD SCI USA, V99, P15743, DOI 10.1073/pnas.242606699	50	567	571	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1216	1223		10.1038/nn1141	http://dx.doi.org/10.1038/nn1141			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14583754				2022-12-17	WOS:000186229200022
J	Beattie, EC; Carroll, RC; Yu, X; Morishita, W; Yasuda, H; von Zastrow, M; Malenka, RC				Beattie, EC; Carroll, RC; Yu, X; Morishita, W; Yasuda, H; von Zastrow, M; Malenka, RC			Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; SYNAPTIC VESICLE ENDOCYTOSIS; STIMULATION-DEPENDENT DEPHOSPHORYLATION; IONOTROPIC GLUTAMATE RECEPTORS; HIPPOCAMPAL PYRAMIDAL CELLS; SILENT SYNAPSES; NERVE-TERMINALS; NMDA RECEPTOR; PROTEIN PHOSPHATASES; EXPRESSION	The endocytosis of AMPA receptors is thought to be important in the expression of long-term depression (LTD) triggered by NMDA receptor activation. Although signaling pathways necessary for LTD induction have been identified, those responsible for the regulated internalization of AMPA receptors are unknown. Here we show that activation of NMDA receptors alone can trigger AMPA receptor endocytosis through calcium influx and activation of the calcium-dependent protein phosphatase calcineurin. A distinct signaling mechanism mediates the AMPA receptor endocytosis stimulated by insulin. These results demonstrate that although multiple signaling pathways can induce AMPA receptor internalization, NMDA receptor activation enhances AMPA receptor endocytosis via a signaling mechanism required for the induction of LTD.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.			Yasuda, Hiroki/0000-0001-5911-609X				Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chen H, 1999, J BIOL CHEM, V274, P3257, DOI 10.1074/jbc.274.6.3257; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; ENAN E, 1992, BIOCHEM PHARMACOL, V43, P1777, DOI 10.1016/0006-2952(92)90710-Z; Feldman DE, 1998, NEURON, V20, P1067, DOI 10.1016/S0896-6273(00)80488-2; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Halpain S, 1998, J NEUROSCI, V18, P9835; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HEIDENREICH KA, 1993, ANN NY ACAD SCI, V692, P72; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LIN JW, 2000, NAT NEUROSCI, V3; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lissin DV, 1999, J NEUROSCI, V19, P1263; LIU J, 1993, TRENDS PHARMACOL SCI, V14, P182, DOI 10.1016/0165-6147(93)90206-Y; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; O'Dell T J, 1994, Learn Mem, V1, P129; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1	50	567	582	1	33	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1291	1300		10.1038/81823	http://dx.doi.org/10.1038/81823			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100150	Bronze			2022-12-17	WOS:000167177900015
J	Kindt, M; Soeter, M; Vervliet, B				Kindt, Merel; Soeter, Marieke; Vervliet, Bram			Beyond extinction: erasing human fear responses and preventing the return of fear	NATURE NEUROSCIENCE			English	Article							POTENTIATED STARTLE; AMYGDALA; RECONSOLIDATION; CONSOLIDATION; RETRIEVAL; MEMORIES	Animal studies have shown that fear memories can change when recalled, a process referred to as reconsolidation. We found that oral administration of the beta-adrenergic receptor antagonist propranolol before memory reactivation in humans erased the behavioral expression of the fear memory 24 h later and prevented the return of fear. Disrupting the reconsolidation of fear memory opens up new avenues for providing a long-term cure for patients with emotional disorders.	[Kindt, Merel; Soeter, Marieke; Vervliet, Bram] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands	University of Amsterdam	Kindt, M (corresponding author), Univ Amsterdam, Dept Clin Psychol, Roetersstr 15, NL-1018 WB Amsterdam, Netherlands.	m.kindt@uva.nl	Vervliet, Bram/AAE-6276-2019	Vervliet, Bram/0000-0002-5904-4257	The Netherlands Organization for Scientific Research	The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank B. Molenkamp for technical help. This work was supported by a Vici grant (M. K.) from The Netherlands Organization for Scientific Research.	Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Canal CE, 2007, BEHAV NEUROSCI, V121, P732, DOI 10.1037/0735-7044.121.4.732; Craske MG., 1999, ANXIETY DISORDERS PS; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; Debiec J, 2004, NEUROSCIENCE, V129, P267, DOI 10.1016/j.neuroscience.2004.08.018; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mineka S, 2002, BIOL PSYCHIAT, V52, P927, DOI 10.1016/S0006-3223(02)01669-4; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2006, LEARN MEMORY, V13, P530, DOI 10.1101/lm.350906; Norrholm SD, 2006, LEARN MEMORY, V13, P681, DOI 10.1101/lm.393906; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; van Stegeren AH, 2005, NEUROIMAGE, V24, P898, DOI 10.1016/j.neuroimage.2004.09.011	15	566	577	3	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2009	12	3					256	258		10.1038/nn.2271	http://dx.doi.org/10.1038/nn.2271			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	410LF	19219038				2022-12-17	WOS:000263577900009
J	Doetsch, F				Doetsch, F			The glial identity of neural stem cells	NATURE NEUROSCIENCE			English	Review							ADULT MAMMALIAN BRAIN; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; RADIAL GLIA; SUBVENTRICULAR ZONE; PROGENITOR CELLS; VENTRICULAR ZONE; PRECURSOR CELLS; CEREBRAL-CORTEX; SPINAL-CORD	Glia are the most numerous cells in the brain, and their many diverse functions highlight their essential role in the nervous system. Recent studies have revealed an unexpected new role for glia in a wide variety of species, that of stem cells/progenitors in the adult and embryonic brain. Differentiation along the glial lineage may be a default state of development reflected in the progression of stem cells along the neuroepithelial radial glia astrocyte lineage.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Doetsch, F (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, 630 W 168th St, New York, NY 10032 USA.	fkd2101@columbia.edu						Alvarez-Buylla A, 1998, J NEUROSCI, V18, P1020; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; Alves JAJ, 2002, J NEUROBIOL, V52, P251, DOI 10.1002/neu.10087; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; BIGNAMI A, 1974, NATURE, V252, P55, DOI 10.1038/252055a0; CAJAL RY, 1995, HISTOLOGY NERVOUS SY, V1; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; CHOI BH, 1978, BRAIN RES, V148, P295, DOI 10.1016/0006-8993(78)90721-7; COHEN E, 1987, INT J DEV NEUROSCI, V5, P43, DOI 10.1016/0736-5748(87)90047-5; D'Ambrosio R, 1998, J NEUROSCI, V18, P4425; Delaney CL, 1996, J NEUROSCI, V16, P6908; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Doetsch F, 2001, BRAIN BEHAV EVOLUT, V58, P306, DOI 10.1159/000057572; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; ECKENHOFF MF, 1988, J NEUROSCI, V8, P2729; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Font E, 1997, BRAIN RES, V754, P245, DOI 10.1016/S0006-8993(97)00085-1; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; GOMEZPINILLA F, 1995, J NEUROSCI, V15, P2021, DOI 10.1523/JNEUROSCI.15-03-02021.1995; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; GRAY GE, 1992, DEVELOPMENT, V114, P271; Gritti A, 1999, J NEUROSCI, V19, P3287; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Imura T, 2003, J NEUROSCI, V23, P2824; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Koketsu D, 2003, J NEUROSCI, V23, P937; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Lie DC, 2002, J NEUROSCI, V22, P6639; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marino S, 2000, GENE DEV, V14, P994; Marshall CAG, 2002, J NEUROSCI, V22, P9821; Matthias K, 2003, J NEUROSCI, V23, P1750; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Morshead CM, 2003, EUR J NEUROSCI, V18, P76, DOI 10.1046/j.1460-9568.2003.02727.x; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Palmer TD, 1999, J NEUROSCI, V19, P8487; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; Peters A, 1991, FINE STRUCTURE NERVO; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Sakakibara S, 1997, J NEUROSCI, V17, P8300; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shibata T, 1997, J NEUROSCI, V17, P9212; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Skogh C, 2001, MOL CELL NEUROSCI, V17, P811, DOI 10.1006/mcne.2001.0973; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tamamaki N, 2001, NEUROSCI RES, V41, P51, DOI 10.1016/S0168-0102(01)00259-0; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Terskikh AV, 2001, P NATL ACAD SCI USA, V98, P7934, DOI 10.1073/pnas.131200898; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Weiss S, 1996, J NEUROSCI, V16, P7599; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; YAZAKI N, 1994, J NEUROSCI RES, V37, P445, DOI 10.1002/jnr.490370403; Yuasa S, 2001, ARCH HISTOL CYTOL, V64, P119, DOI 10.1679/aohc.64.119; Zhou M, 2001, J NEUROSCI, V21, P7901, DOI 10.1523/JNEUROSCI.21-20-07901.2001; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	100	564	583	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1127	1134		10.1038/nn1144	http://dx.doi.org/10.1038/nn1144			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14583753				2022-12-17	WOS:000186229200008
J	Baker, DA; McFarland, K; Lake, RW; Shen, H; Tang, XC; Toda, S; Kalivas, PW				Baker, DA; McFarland, K; Lake, RW; Shen, H; Tang, XC; Toda, S; Kalivas, PW			Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse	NATURE NEUROSCIENCE			English	Article							NUCLEUS-ACCUMBENS; BEHAVIORAL SENSITIZATION; SYSTEM X(C)(-); INDUCED REINSTATEMENT; DRUG-ADDICTION; SEEKING; TRANSMISSION; TRANSPORT; EXPRESSION; RECEPTORS	Repeated cocaine treatment and withdrawal produces changes in brain function thought to be involved in relapse to drug use. Withdrawal from repeated cocaine reduced in vivo extracellular glutamate in the nucleus accumbens of rats by decreasing the exchange of extracellular cystine for intracellular glutamate. In vivo restoration of cystine/glutamate exchange by intracranial perfusion of cystine or systemically administered N-acetylcysteine normalized the levels of glutamate in cocaine-treated subjects. To determine if the reduction in nonvesicular glutamate release is a mediator of relapse, we examined cocaine-primed reinstatement of drug seeking after cocaine self-administration was stopped. Reinstatement was prevented by stimulating cystine/glutamate exchange with N-acetylcysteine and restoring extracellular glutamate. Thus, withdrawal from repeated cocaine increases susceptibility to relapse in part by reducing cystine/glutamate exchange, and restoring exchanger activity prevents cocaine-primed drug seeking.	Med Univ S Carolina, Dept Physiol & Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina	Kalivas, PW (corresponding author), Med Univ S Carolina, Dept Physiol & Neurosci, Charleston, SC 29425 USA.	kalivasp@musc.edu	Jansen, Heiko T./A-5770-2008; baker, david/I-6955-2013	Jansen, Heiko T./0000-0003-0178-396X; baker, david/0000-0002-0664-6780	NIDA NIH HHS [DA-07288, DA-06074, DA-03960] Funding Source: Medline; NIMH NIH HHS [MH-40817] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040817] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Baker DA, 2002, J NEUROSCI, V22, P9134; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; COTGREAVE IA, 1994, BBA-MOL CELL RES, V1222, P375, DOI 10.1016/0167-4889(94)90043-4; Di Ciano P, 2001, NEUROPSYCHOPHARMACOL, V25, P341, DOI 10.1016/S0893-133X(01)00235-4; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Gochenauer GE, 2001, J NEUROCHEM, V78, P276, DOI 10.1046/j.1471-4159.2001.00385.x; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Hotsenpiller G, 2001, EUR J NEUROSCI, V14, P1843, DOI 10.1046/j.0953-816x.2001.01804.x; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Keys AS, 1998, SYNAPSE, V30, P393, DOI 10.1002/(SICI)1098-2396(199812)30:4<393::AID-SYN6>3.0.CO;2-H; Knickelbein RG, 1997, AM J PHYSIOL-LUNG C, V273, pL1147, DOI 10.1152/ajplung.1997.273.6.L1147; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Manzoni O, 1997, EUR J NEUROSCI, V9, P1514, DOI 10.1111/j.1460-9568.1997.tb01506.x; McFarland K, 2003, J NEUROSCI, V23, P3531; McFarland K, 2001, J NEUROSCI, V21, P8655; MEISTER A, 1985, METHOD ENZYMOL, V113, P571; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; ODONNELL P, 1995, J NEUROSCI, V15, P3622; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Pierce RC, 1996, J NEUROSCI, V16, P1550; Reid MS, 1997, SYNAPSE, V27, P95, DOI 10.1002/(SICI)1098-2396(199710)27:2<95::AID-SYN1>3.3.CO;2-L; Sasaki H, 2002, J BIOL CHEM, V277, P44765, DOI 10.1074/jbc.M208704200; Sato H, 2002, J NEUROSCI, V22, P8028; Sato H, 1998, BBA-BIOMEMBRANES, V1414, P85, DOI 10.1016/S0005-2736(98)00159-X; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Shih AY, 2001, BIOCHEM BIOPH RES CO, V282, P1132, DOI 10.1006/bbrc.2001.4703; SMITH JA, 1995, BRAIN RES, V683, P264, DOI 10.1016/0006-8993(95)00383-2; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Timmerman W, 1997, SYNAPSE, V27, P242, DOI 10.1002/(SICI)1098-2396(199711)27:3<242::AID-SYN9>3.0.CO;2-D; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Warr O, 1999, J PHYSIOL-LONDON, V514, P783, DOI 10.1111/j.1469-7793.1999.783ad.x; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999	41	564	580	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					743	749		10.1038/nn1069	http://dx.doi.org/10.1038/nn1069			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12778052				2022-12-17	WOS:000183780400023
J	Watanabe, K; Kamiya, D; Nishiyama, A; Katayama, T; Nozaki, S; Kawasaki, H; Watanabe, Y; Mizuseki, K; Sasai, Y				Watanabe, K; Kamiya, D; Nishiyama, A; Katayama, T; Nozaki, S; Kawasaki, H; Watanabe, Y; Mizuseki, K; Sasai, Y			Directed differentiation of telencephalic precursors from embryonic stem cells	NATURE NEUROSCIENCE			English	Article							NEURAL DIFFERENTIATION; HEAD INDUCTION; MOUSE EMBRYOS; GENE; EXPRESSION; NEURONS; BRAIN; WNT; SPECIFICATION; GASTRULATION	We demonstrate directed differentiation of telencephalic precursors from mouse embryonic stem (ES) cells using optimized serum-free suspension culture (SFEB culture). Treatment with Wnt and Nodal antagonists (Dkk1 and LeftyA) during the first 5 d of SFEB culture causes nearly selective neural differentiation in ES cells (similar to90%). In the presence of Dkkl, with or without LeftyA, SFEB induces efficient generation (similar to35%) of cells expressing telencephalic marker Bf1. Wnt3a treatment during the late culture period increases the pallial telencephalic population (Pax6(+) cells yield up to 75% of Bf1(+) cells), whereas Shh promotes basal telencephalic differentiation (into Nkx2.1(+) and/or lslet1/2(+) cells) at the cost of pallial telencephalic differentiation. Thus, in the absence of caudalizing signals, floating aggregates of ES cells generate naive telencephalic precursors that acquire subregional identities by responding to extracellular patterning signals.	RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; Kyoto Univ, Grad Sch Med, Dept Med Embryol, Kyoto 6068501, Japan; Osaka City Univ, Grad Sch Med, Dept Physiol, Osaka 5458585, Japan; Univ Tokyo, Grad Sch Med, Dept Mol & Syst Neurobiol, Tokyo 1130033, Japan	RIKEN; Kyoto University; Osaka Metropolitan University; University of Tokyo	Sasai, Y (corresponding author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	sasaicdb@mub.biglobe.ne.jp	KAWASAKI, Hiroshi/L-3736-2015; Mizuseki, Kenji/A-9214-2011; Nozaki, Satoshi/E-3052-2010; Kawasaki, Hiroshi/C-4404-2015; Watanabe, Kiichi/ABA-4854-2020	Mizuseki, Kenji/0000-0002-1456-2149; Nozaki, Satoshi/0000-0002-9526-1902; Kawasaki, Hiroshi/0000-0002-2514-1497				Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Chang CW, 2004, P NATL ACAD SCI USA, V101, P2613, DOI 10.1073/pnas.0308645100; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Duncan SA, 1997, DEVELOPMENT, V124, P279; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Finley MFA, 1999, J NEUROBIOL, V40, P271, DOI 10.1002/(SICI)1097-4695(19990905)40:3<271::AID-NEU1>3.0.CO;2-C; Galceran J, 2000, DEVELOPMENT, V127, P469; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gunhaga L, 2003, NAT NEUROSCI, V6, P701, DOI 10.1038/nn1068; HAUB O, 1991, DEVELOPMENT, V112, P397; HEBERT JM, 1991, DEVELOPMENT, V112, P407; Hirase H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0003.2001; HSIEHLI HM, 1995, MECH DEVELOP, V50, P177, DOI 10.1016/0925-4773(94)00334-J; JOHANSSON MW, 1995, TECHNIQUES FISH IMMU, V4, P141; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lee SMK, 2000, DEVELOPMENT, V127, P457; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P1, DOI 10.1002/jez.1401200102; Nordstrom U, 2002, NAT NEUROSCI, V5, P525, DOI 10.1038/nn854; Oliver G, 1995, DEVELOPMENT, V121, P4045; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Rallu M, 2002, DEVELOPMENT, V129, P4963; Sakuma R, 2002, GENES CELLS, V7, P401, DOI 10.1046/j.1365-2443.2002.00528.x; SHIRAYOSHI Y, 1983, CELL, V35, P631, DOI 10.1016/0092-8674(83)90095-8; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Takahashi K, 2003, J NEUROSCI RES, V73, P61, DOI 10.1002/jnr.10638; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Wang HF, 2001, NEUROSCIENCE, V103, P999, DOI 10.1016/S0306-4522(00)00590-X; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	48	563	609	5	51	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					288	296		10.1038/nn1402	http://dx.doi.org/10.1038/nn1402			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15696161	Green Submitted			2022-12-17	WOS:000227354600013
J	Tanaka, SC; Doya, K; Okada, G; Ueda, K; Okamoto, Y; Yamawaki, S				Tanaka, SC; Doya, K; Okada, G; Ueda, K; Okamoto, Y; Yamawaki, S			Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops	NATURE NEUROSCIENCE			English	Article							MEDIAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; NUCLEUS-ACCUMBENS; NEURAL RESPONSES; HUMAN BRAIN; PROBABILISTIC REINFORCEMENT; SEROTONERGIC NEURONS; DECISION-MAKING; LESIONS; MOTOR	Evaluation of both immediate and future outcomes of one's actions is a critical requirement for intelligent behavior. Using functional magnetic resonance imaging (fMRI), we investigated brain mechanisms for reward prediction at different time scales in a Markov decision task. When human subjects learned actions on the basis of immediate rewards, significant activity was seen in the lateral orbitofrontal cortex and the striatum. When subjects learned to act in order to obtain large future rewards while incurring small immediate losses, the dorsolateral prefrontal cortex, inferior parietal cortex, dorsal raphe nucleus and cerebellum were also activated. Computational model-based regression analysis using the predicted future rewards and prediction errors estimated from subjects' performance data revealed graded maps of time scale within the insula and the striatum: ventroanterior regions were involved in predicting immediate rewards and dorsoposterior regions were involved in predicting future rewards. These results suggest differential involvement of the cortico-basal ganglia loops in reward prediction at different time scales.	Nara Inst Sci & Technol, Dept Bioinformat & Genom, Nara 6300101, Japan; ATR Computat Neurosci Labs, Dept Computat Neurobiol, Kyoto 6190288, Japan; Japan Sci & Techol Agcy, CREST, Kyoto 6190288, Japan; Hiroshima Univ, Dept Psychiat & Neurosci, Minami Ku, Hiroshima 7348551, Japan	Nara Institute of Science & Technology; Japan Science & Technology Agency (JST); Hiroshima University	Doya, K (corresponding author), Nara Inst Sci & Technol, Dept Bioinformat & Genom, 8916-5 Takayama, Nara 6300101, Japan.	doya@atr.jp	Doya, Kenji/B-5841-2015	Doya, Kenji/0000-0002-2446-6820; Tanaka, Saori/0000-0002-7001-5051				Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Balleine BW, 2000, J NEUROSCI, V20, P8954; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Chikama M, 1997, J NEUROSCI, V17, P9686; Compan V, 1998, BRAIN RES, V793, P103, DOI 10.1016/S0006-8993(98)00168-1; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Eagle DM, 1999, BEHAV NEUROSCI, V113, P718, DOI 10.1037/0735-7044.113.4.718; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Evenden JL, 1996, PSYCHOPHARMACOLOGY, V128, P161, DOI 10.1007/s002130050121; HABER SN, 1995, J NEUROSCI, V15, P4851; Hanakawa T, 2002, CEREB CORTEX, V12, P1157, DOI 10.1093/cercor/12.11.1157; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Houk JC, 1995, MODELS INFORM PROCES, P249; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Martens LC, 2001, EUR J PAEDIATR DENT, V2, P21; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Mijnster MJ, 1997, J COMP NEUROL, V389, P1; Mobini S, 2000, PSYCHOPHARMACOLOGY, V152, P390, DOI 10.1007/s002130000542; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Owen AM, 1996, EUR J NEUROSCI, V8, P353, DOI 10.1111/j.1460-9568.1996.tb01219.x; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Pears A, 2003, J NEUROSCI, V23, P11189; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003	49	561	577	3	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					887	893		10.1038/nn1279	http://dx.doi.org/10.1038/nn1279			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15235607				2022-12-17	WOS:000222930800020
J	Yamins, DLK; DiCarlo, JJ				Yamins, Daniel L. K.; DiCarlo, James J.			Using goal-driven deep learning models to understand sensory cortex	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELD PROPERTIES; OBJECT RECOGNITION; HIERARCHICAL-MODELS; NEURAL RESPONSES; TRADE-OFF; SHAPE; REPRESENTATION; SELECTIVITY; CELLS; CODE	Fueled by innovation in the computer vision and artificial intelligence communities, recent developments in computational neuroscience have used goal-driven hierarchical convolutional neural networks (HCNNs) to make strides in modeling neural single-unit and population responses in higher visual cortical areas. In this Perspective, we review the recent progress in a broader modeling context and describe some of the key technical innovations that have supported it. We then outline how the goal- driven HCNN approach can be used to delve even more deeply into understanding the development and organization of sensory cortical processing.	[Yamins, Daniel L. K.; DiCarlo, James J.] MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Yamins, Daniel L. K.; DiCarlo, James J.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Yamins, DLK (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Yamins, DLK (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	yamins@mit.edu						Afraz A, 2015, P NATL ACAD SCI USA, V112, P6730, DOI 10.1073/pnas.1423328112; Barlow H., 1961, SENSORY COMMUNICATIO, P217; Bengio Y., 2013, UNSUPERVISED TRANSFE, V7, P29; Bengio YJF, 2009, LEARNING DEEP ARCHIT; Bergstra J, 2013, P 30 INT C INT C MAC, V28; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; Cadieu CF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003963; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Choudhary Swadesh, 2012, Artificial Neural Networks and Machine Learning - ICANN 2012. Proceedings of the 22nd International Conference on Artificial Neural Networks, P121, DOI 10.1007/978-3-642-33269-2_16; David SV, 2006, J NEUROPHYSIOL, V96, P3492, DOI 10.1152/jn.00575.2006; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; DEVALOIS KK, 1979, J PHYSIOL-LONDON, V291, P483, DOI 10.1113/jphysiol.1979.sp012827; DiCarlo JJ, 2007, TRENDS COGN SCI, V11, P333, DOI 10.1016/j.tics.2007.06.010; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; Gallant JL, 1996, J NEUROPHYSIOL, V76, P2718, DOI 10.1152/jn.1996.76.4.2718; Gatys L.A., 2015, PREPRINT; Goodfellow I. J., 2014, PREPRINT; Griffin G., 2007, 120 CAL I TECHN; Guclu U, 2015, J NEUROSCI, V35, P10005, DOI 10.1523/JNEUROSCI.5023-14.2015; Halevy A, 2009, IEEE INTELL SYST, V24, P8, DOI 10.1109/MIS.2009.36; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; HINTON GE, 1995, SCIENCE, V268, P1158, DOI 10.1126/science.7761831; HOYLE G, 1984, BEHAV BRAIN SCI, V7, P367, DOI 10.1017/S0140525X0001863X; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Hulbert JC, 2015, CEREB CORTEX, V25, P3994, DOI 10.1093/cercor/bhu284; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kell A., 2015, SOC NEUR ABSTR; Khaligh-Razavi SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003915; Khorrami P., 2015, PREPRINT; Klein DJ, 2006, J COMPUT NEUROSCI, V20, P111, DOI 10.1007/s10827-005-3589-4; Kriegeskorte N, 2009, FRONT NEUROSCI-SWITZ, V3, P363, DOI 10.3389/neuro.01.035.2009; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; LeCun Y, 1995, HDB BRAIN THEORY NEU, V3361, P1995, DOI DOI 10.1109/IJCNN.2004.1381049; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Majaj NJ, 2015, J NEUROSCI, V35, P13402, DOI 10.1523/JNEUROSCI.5181-14.2015; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Marder E, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002147; Marr D., 2010, VISION COMPUTATIONAL; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Olshausen BA, 2001, ADV NEUR IN, V13, P887; Pagan M, 2013, NAT NEUROSCI, V16, P1132, DOI 10.1038/nn.3433; Pasupathy A, 2002, NAT NEUROSCI, V5, P1332, DOI 10.1038/nn972; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Pinto N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040027; Pinto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000579; Razavian AS, 2014, IEEE COMPUT SOC CONF, P512, DOI 10.1109/CVPRW.2014.131; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Rust NC, 2010, J NEUROSCI, V30, P12978, DOI 10.1523/JNEUROSCI.0179-10.2010; Serre T, 2007, P NATL ACAD SCI USA, V104, P6424, DOI 10.1073/pnas.0700622104; Sharpee TO, 2013, P NATL ACAD SCI USA, V110, P11618, DOI 10.1073/pnas.1217479110; Simonyan K., 2014, PREPRINT; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Snoek J., 2012, P 25 INT C NEUR INF, P2951, DOI DOI 10.48550/ARXIV.1206.2944; Stadie B. C., 2015, PREPRINT; Szegedy C., 2014, PREPRINT; Szegedy C, 2013, PREPRINT; ULLMAN S, 1984, COGNITION, V18, P97, DOI 10.1016/0010-0277(84)90023-4; Yamane Y, 2008, NAT NEUROSCI, V11, P1352, DOI 10.1038/nn.2202; Yamins D.L., 2013, ADV NEURAL INFORM PR, V26, P3093, DOI [DOI 10.5555/2999792.2999957, 10.5555/2999792.2999957]; Yamins DLK, 2014, P NATL ACAD SCI USA, V111, P8619, DOI 10.1073/pnas.1403112111; Yau JM, 2013, CEREB CORTEX, V23, P198, DOI 10.1093/cercor/bhs004; Zhu L, 2008, LECT NOTES COMPUT SC, V5303, P759; Zoccolan D, 2007, J NEUROSCI, V27, P12292, DOI 10.1523/JNEUROSCI.1897-07.2007	74	559	567	23	295	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2016	19	3					356	365		10.1038/nn.4244	http://dx.doi.org/10.1038/nn.4244			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE7MU	26906502				2022-12-17	WOS:000370822200004
J	Heinz, A; Braus, DF; Smolka, MN; Wrase, J; Puls, I; Hermann, D; Klein, S; Grusser, SM; Flor, H; Schumann, G; Mann, K; Buchel, C				Heinz, A; Braus, DF; Smolka, MN; Wrase, J; Puls, I; Hermann, D; Klein, S; Grusser, SM; Flor, H; Schumann, G; Mann, K; Buchel, C			Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter	NATURE NEUROSCIENCE			English	Article							POLYMORPHISM; PROJECTIONS; STIMULI	Major depression is conditionally linked to a polymorphism of the human serotonin transporter gene (SLC6A4). During the presentation of aversive, but not pleasant, pictures, healthy carriers of the SLC6A4 short (s) allele showed stronger activation of the amygdala on functional magnetic resonance imaging. s carriers also showed greater coupling between the amygdala and the ventromedial prefrontal cortex, which may contribute to the abnormally high activity in the amygdala and medial prefrontal cortex seen in major depression.	Charite Univ Med Berlin, Dept Psychiat, D-10117 Berlin, Germany; Univ Med Ctr, Dept Psychiat, NeuroImage Nord, D-20246 Hamburg, Germany; Cent Inst Mental Hlth, D-68159 Mannheim, Germany; Charite Univ Med Berlin, Dept Med Psychol, D-10117 Berlin, Germany; Univ Med Ctr, Dept Neurol, NeuroImage Nord, D-20246 Hamburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Central Institute of Mental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Heinz, A (corresponding author), Charite Univ Med Berlin, Dept Psychiat, Campus Charite Mitte,Schumannstr 20-21, D-10117 Berlin, Germany.	andreas.heinz@charite.de	Heinz, Andreas/ABB-7736-2020; anand, amit/A-7222-2009; Schumann, Gunter/H-1013-2013; Vollstädt-Klein, Sabine/C-6744-2012; Smolka, Michael/B-4865-2011	Heinz, Andreas/0000-0001-5405-9065; Vollstädt-Klein, Sabine/0000-0002-6210-672X; Smolka, Michael/0000-0001-5398-5569; Flor, Herta/0000-0003-4809-5398; Hermann, Derik/0000-0003-4434-1221				AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Drevets WC, 2003, ANN NY ACAD SCI, V985, P420, DOI 10.1111/j.1749-6632.2003.tb07098.x; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Garpenstrand H, 2001, BEHAV NEUROSCI, V115, P358, DOI 10.1037//0735-7044.115.2.358; Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Irwin W, 2004, NEUROIMAGE, V21, P674, DOI 10.1016/j.neuroimage.2003.09.057; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; *NAT I MENT HLTH C, 1999, PHOT SLID; Pinto AO, 2003, ANN NY ACAD SCI, V985, P542; Taylor SF, 2003, NEUROIMAGE, V18, P650, DOI 10.1016/S1053-8119(02)00051-4; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3	14	554	573	0	47	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2005	8	1					20	21		10.1038/nn1366	http://dx.doi.org/10.1038/nn1366			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	882VO	15592465				2022-12-17	WOS:000225967600009
J	Desai, NS; Rutherford, LC; Turrigiano, GG				Desai, NS; Rutherford, LC; Turrigiano, GG			Plasticity in the intrinsic excitability of cortical pyramidal neurons	NATURE NEUROSCIENCE			English	Article							ACTIVITY-DEPENDENT REGULATION; RAT NEOCORTICAL NEURONS; ELECTRICAL-ACTIVITY; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; DEVELOPMENTAL-CHANGES; POTASSIUM CURRENTS; QUANTAL AMPLITUDE; CALCIUM CURRENTS; CULTURED NEURONS	During learning and development, the level of synaptic input received by cortical neurons may change dramatically. Given a limited range of possible firing rates, how do neurons maintain responsiveness to both small and large synaptic inputs? We demonstrate that in response to changes in activity, cultured cortical pyramidal neurons regulate intrinsic excitability to promote stability in firing. Depriving pyramidal neurons of activity for two days increased sensitivity to current injection by selectively regulating voltage-dependent conductances. This suggests that one mechanism by which neurons maintain sensitivity to different levels of synaptic input is by altering the function relating current to firing rate.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, GG (corresponding author), Brandeis Univ, Dept Biol, 415 South St, Waltham, MA 02454 USA.	turrigiano@binah.cc.brandeis.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036853, K02NS001893] Funding Source: NIH RePORTER; NINDS NIH HHS [K02 NS01893, R01 NS36853] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BEAR MF, 1995, NEURON, V15, P1, DOI 10.1016/0896-6273(95)90056-X; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BRODIE C, 1989, BRAIN RES, V488, P186, DOI 10.1016/0006-8993(89)90708-7; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; DESARMENIEN MG, 1991, NEURON, V7, P797, DOI 10.1016/0896-6273(91)90282-5; FRANKLIN JL, 1992, J NEUROSCI, V12, P1726; Hamill OP, 1991, CEREB CORTEX, V1, P48, DOI 10.1093/cercor/1.1.48; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; HUGUENARD JR, 1988, J NEUROPHYSIOL, V59, P778, DOI 10.1152/jn.1988.59.3.778; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KLEE R, 1995, J NEUROPHYSIOL, V74, P1982, DOI 10.1152/jn.1995.74.5.1982; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; LI M, 1992, NEURON, V8, P1151, DOI 10.1016/0896-6273(92)90135-Z; Li MX, 1996, J NEUROPHYSIOL, V76, P2595, DOI 10.1152/jn.1996.76.4.2595; LINSDELL P, 1995, J NEUROSCI, V15, P4507; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Moody WJ, 1998, J NEUROBIOL, V37, P97, DOI 10.1002/(SICI)1097-4695(199810)37:1<97::AID-NEU8>3.0.CO;2-3; Moody WJ, 1998, CURR TOP DEV BIOL, V39, P159, DOI 10.1016/S0070-2153(08)60455-X; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; OFFORD J, 1989, NEURON, V2, P1447, DOI 10.1016/0896-6273(89)90190-6; RAMAKERS GJA, 1990, EXP BRAIN RES, V79, P157; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Rutherford LC, 1997, J NEUROSCI, V17, P4527; SIEGEL M, 1994, P NATL ACAD SCI USA, V91, P11308, DOI 10.1073/pnas.91.24.11308; SPIGELMAN I, 1992, J NEUROPHYSIOL, V68, P55, DOI 10.1152/jn.1992.68.1.55; SPITZER NC, 1991, J NEUROBIOL, V22, P659, DOI 10.1002/neu.480220702; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Tarasenko AN, 1998, J PHYSIOL-LONDON, V509, P385, DOI 10.1111/j.1469-7793.1998.385bn.x; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; TURRIGIANO GG, IN PRESS TRENDS NEUR; YAARI Y, 1987, SCIENCE, V235, P680, DOI 10.1126/science.2433765; ZONA C, 1988, NEUROSCI LETT, V94, P285, DOI 10.1016/0304-3940(88)90032-8	42	554	558	4	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					515	520		10.1038/9165	http://dx.doi.org/10.1038/9165			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10448215				2022-12-17	WOS:000084735900010
J	Fromer, M; Roussos, P; Sieberts, SK; Johnson, JS; Kavanagh, DH; Perumal, TM; Ruderfer, DM; Oh, EC; Topol, A; Shah, HR; Klei, LL; Kramer, R; Pinto, D; Gumus, ZH; Cicek, AE; Dang, KK; Browne, A; Lu, C; Xie, L; Readhead, B; Stahl, EA; Xiao, JQ; Parvizi, M; Hamamsy, T; Fullard, JF; Wang, YC; Mahajan, MC; Derry, JMJ; Dudley, JT; Hemby, SE; Logsdon, BA; Talbot, K; Raj, T; Bennett, DA; De Jager, PL; Zhu, J; Zhang, B; Sullivan, PF; Chess, A; Purcell, SM; Shinobu, LA; Mangravite, LM; Toyoshiba, H; Gur, RE; Hahn, CG; Lewis, DA; Haroutunian, V; Peters, MA; Lipska, BK; Buxbaum, JD; Schadt, EE; Hirai, K; Roeder, K; Brennand, KJ; Katsanis, N; Domenici, E; Devlin, B; Sklar, P				Fromer, Menachem; Roussos, Panos; Sieberts, Solveig K.; Johnson, Jessica S.; Kavanagh, David H.; Perumal, Thanneer M.; Ruderfer, Douglas M.; Oh, Edwin C.; Topol, Aaron; Shah, Hardik R.; Klei, Lambertus L.; Kramer, Robin; Pinto, Dalila; Gumus, Zeynep H.; Cicek, A. Ercument; Dang, Kristen K.; Browne, Andrew; Lu, Cong; Xie, Lu; Readhead, Ben; Stahl, Eli A.; Xiao, Jianqiu; Parvizi, Mahsa; Hamamsy, Tymor; Fullard, John F.; Wang, Ying-Chih; Mahajan, Milind C.; Derry, Jonathan M. J.; Dudley, Joel T.; Hemby, Scott E.; Logsdon, Benjamin A.; Talbot, Konrad; Raj, Towfique; Bennett, David A.; De Jager, Philip L.; Zhu, Jun; Zhang, Bin; Sullivan, Patrick F.; Chess, Andrew; Purcell, Shaun M.; Shinobu, Leslie A.; Mangravite, Lara M.; Toyoshiba, Hiroyoshi; Gur, Raquel E.; Hahn, Chang-Gyu; Lewis, David A.; Haroutunian, Vahram; Peters, Mette A.; Lipska, Barbara K.; Buxbaum, Joseph D.; Schadt, Eric E.; Hirai, Keisuke; Roeder, Kathryn; Brennand, Kristen J.; Katsanis, Nicholas; Domenici, Enrico; Devlin, Bernie; Sklar, Pamela			Gene expression elucidates functional impact of polygenic risk for schizophrenia	NATURE NEUROSCIENCE			English	Article							NEURAL PROGENITOR CELLS; PREFRONTAL CORTEX; TRANSCRIPTOMIC ANALYSIS; ALZHEIMERS-DISEASE; MULTIPLE GENES; HUMAN BRAIN; MUTATIONS; VARIANTS; NETWORKS; METAANALYSIS	Over 100 genetic loci harbor schizophrenia-associated variants, yet how these variants confer liability is uncertain. The CommonMind Consortium sequenced RNA from dorsolateral prefrontal cortex of people with schizophrenia (N = 258) and control subjects (N = 279), creating a resource of gene expression and its genetic regulation. Using this resource,similar to 20% of schizophrenia loci have variants that could contribute to altered gene expression and liability. In five loci, only a single gene was involved: FURIN, TSNARE1, CNTN4, CLCN3 or SNAP91. Altering expression of FURIN, TSNARE1 or CNTN4 changed neurodevelopment in zebrafish; knockdown of FURIN in human neural progenitor cells yielded abnormal migration. Of 693 genes showing significant case-versus-control differential expression, their fold changes were <= 1.33, and an independent cohort yielded similar results. Gene co-expression implicates a network relevant for schizophrenia. Our findings show that schizophrenia is polygenic and highlight the utility of this resource for mechanistic interpretations of genetic liability for brain diseases.	[Fromer, Menachem; Roussos, Panos; Johnson, Jessica S.; Kavanagh, David H.; Ruderfer, Douglas M.; Topol, Aaron; Pinto, Dalila; Browne, Andrew; Stahl, Eli A.; Hamamsy, Tymor; Fullard, John F.; Purcell, Shaun M.; Haroutunian, Vahram; Buxbaum, Joseph D.; Brennand, Kristen J.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY 10029 USA; [Fromer, Menachem; Roussos, Panos; Kavanagh, David H.; Ruderfer, Douglas M.; Shah, Hardik R.; Pinto, Dalila; Gumus, Zeynep H.; Browne, Andrew; Readhead, Ben; Stahl, Eli A.; Hamamsy, Tymor; Wang, Ying-Chih; Mahajan, Milind C.; Dudley, Joel T.; Raj, Towfique; Zhu, Jun; Zhang, Bin; Chess, Andrew; Purcell, Shaun M.; Schadt, Eric E.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA; [Roussos, Panos; Chess, Andrew; Buxbaum, Joseph D.; Brennand, Kristen J.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Roussos, Panos; Haroutunian, Vahram] JJ Peters Virginia Med Ctr, Psychiat, Bronx, NY USA; [Sieberts, Solveig K.; Perumal, Thanneer M.; Dang, Kristen K.; Derry, Jonathan M. J.; Logsdon, Benjamin A.; Mangravite, Lara M.; Peters, Mette A.] Sage Bionetworks, Syst Biol, Seattle, WA USA; [Oh, Edwin C.; Parvizi, Mahsa; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC USA; [Oh, Edwin C.] Duke Univ, Dept Neurol, Durham, NC USA; [Klei, Lambertus L.; Xie, Lu; Lewis, David A.; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Kramer, Robin; Lipska, Barbara K.] NIMH, Human Brain Collect Core, NIH, Bethesda, MD 20892 USA; [Pinto, Dalila; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Cicek, A. Ercument] Carnegie Mellon Univ, Sch Comp Sci, Dept Computat Biol, Pittsburgh, PA 15213 USA; [Lu, Cong] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Hemby, Scott E.] High Point Univ, Fred Wilson Sch Pharm, Dept Basic Pharmaceut Sci, High Point, NC USA; [Talbot, Konrad] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Raj, Towfique; Haroutunian, Vahram; Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Raj, Towfique; De Jager, Philip L.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Chess, Andrew] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Shinobu, Leslie A.; Hirai, Keisuke] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, CNS Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Toyoshiba, Hiroyoshi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Integrated Technol Res Labs, Fujisawa, Kanagawa, Japan; [Gur, Raquel E.] Univ Penn, Dept Psychiat, Perelman Sch Med, Neuropsychiat Sect, Philadelphia, PA 19104 USA; [Hahn, Chang-Gyu] Univ Penn, Dept Psychiat, Perelman Sch Med, Neuropsychiat Signaling Program, Philadelphia, PA 19104 USA; [Katsanis, Nicholas] Duke Univ, Dept Cell Biol & Pediat, Durham, NC USA; [Domenici, Enrico] Univ Trento, Ctr Integrat Biol CIBIO, Lab Neurogen Biomarkers, Trento, Italy; [Roeder, Kathryn; Devlin, Bernie] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Duke University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Icahn School of Medicine at Mount Sinai; Carnegie Mellon University; Carnegie Mellon University; Cedars Sinai Medical Center; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rush University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet; Icahn School of Medicine at Mount Sinai; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Duke University; University of Trento; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sklar, P (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Genom, New York, NY 10029 USA.; Sklar, P (corresponding author), Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA.; Sklar, P (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.	pamela.sklar@mssm.edu	Gur, Ruben/K-1999-2019; Pinto, Dalila/C-4218-2016; Buxbaum, Joseph D/G-6001-2010; Brennand, Kristen J/J-8704-2012; Xiao, Jianqiu/AAB-7860-2021; Brennand, Kristen J/U-5470-2019; Raj, Towfique/ABD-7620-2021; Lipska, Barbara K/E-4569-2017; Lewis, David A/G-4053-2014; Domenici, Enrico/K-8194-2016; Fromer, Menachem/G-2116-2012	Gur, Ruben/0000-0002-9657-1996; Pinto, Dalila/0000-0002-8769-0846; Brennand, Kristen J/0000-0003-0993-5956; Lewis, David A/0000-0002-3225-6778; Domenici, Enrico/0000-0001-7436-6919; Johnson, Jessica/0000-0002-4519-3120; Dang, Kristen/0000-0002-7512-4476; Talbot, Konrad/0000-0003-4549-0835; Fromer, Menachem/0000-0003-3749-4342; Cicek, A. Ercument/0000-0001-8613-6619; Buxbaum, Joseph/0000-0001-8898-8313; Hemby, Scott/0000-0002-6987-1133; Perumal, Thanneer Malai/0000-0003-1168-8982; Xiao, Jianqiu/0000-0002-8896-9187; Roeder, Kathryn/0000-0002-8869-6254	Takeda Pharmaceuticals Company Limited; F. Hoffman-La Roche Ltd; VA VISN3 MIRECC; NIMH Intramural program; New York Stem Cell Foundation; Silvio O Conte Center grant [P50MH094268]; NARSAD; Stanley Medical Research Institute; NIMH [R01MH074313, R01AG036836, U01AG046152, R01AG017917, R01AG046170, R01MH109706];  [R01MH093725-02S1];  [P50MH066392];  [R01MH097276];  [R01MH075916];  [P50MH096891];  [P50MH084053-S1];  [R37MH057881];  [R37MH057881S1];  [R01MH085542-S1];  [U01MH096296-S2];  [HHSN271201300031C];  [R01MH101454];  [R01MH109677];  [R01AG050986];  [VA Merit BX002395];  [R01 AG036836]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG008451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097276, R01MH074313, P50MH094268, R01MH075916, R01MH109677, R01MH085542, P50MH096891, R37MH057881, U01MH096296, R01MH093725, R01MH109706, T32MH087004, R01MH101454, R01MH095034, P50MH084053, P50MH066392, R01MH110555, ZICMH002903, R21MH105881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010161, R01AG017917, R01AG050986, U01AG046152, RF1AG015819, R01AG036836] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002395] Funding Source: NIH RePORTER	Takeda Pharmaceuticals Company Limited; F. Hoffman-La Roche Ltd; VA VISN3 MIRECC; NIMH Intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); New York Stem Cell Foundation; Silvio O Conte Center grant; NARSAD(NARSAD); Stanley Medical Research Institute; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	We thank the patients and families who donated material for these studies. We thank T. Lehner for his early and inspirational ideas about this project, as well as organizational and intellectual support. We thank X. He for discussions regarding Sherlock, J. Scarpa for help running and interpreting WGCNA, L. Essioux for support in establishing and managing interactions with the Consortium, and A. Bertolino and A. Ghosh for continuous encouragement. Data and results were generated as part of the CommonMind Consortium supported by funding from Takeda Pharmaceuticals Company Limited, F. Hoffman-La Roche Ltd; grants R01MH093725-02S1 (J.D.B.), P50MH066392 (J.D.B.), R01MH097276 (P.S., E.E.S.), R01MH075916 (C.-G.H.), P50MH096891 C.-G.H., REG, P50MH084053-S1 (D.A.L.), R37MH057881 (B.D.), R37MH057881S1 (B.D.), R01MH085542-S1 (P.S.), U01MH096296-S2 (P.S.), HHSN271201300031C (V.H.), VA VISN3 MIRECC (V.H.), P50MH066392 (J.D.B.), NIMH Intramural program (B.K.L.), R01MH101454 (K.J.B.), R01MH109677 (P.R.), R01AG050986 (P.R.), VA Merit BX002395 (P.R.) and R01 AG036836 (P.D.H.); New York Stem Cell Foundation (K.J.B.); the Silvio O Conte Center grant P50MH094268 (N.K.); NARSAD (E.C.O.) and NARSAD Young Investigator (D.M.R., P.R., E.A.S.); the Stanley Medical Research Institute for Funding for Non-Human Primate Research; and NIMH grants R01MH074313 (S.E.H.); R01AG036836, U01AG046152 and R01AG017917 (D.A.B. and P.I.D.J.); R01AG046170 (E.S.S., B.Z., J.Z., and P.R.); and R01MH109706 (E.C.O.). Brain tissues for the study were obtained from the following brain bank collections: the Mount Sinai NIH Brain and Tissue Repository, the University of Pennsylvania Alzheimer's Disease Core Center, the University of Pittsburgh Brain Tissue Donation Program, the NIMH Human Brain Collection Core and Wake Forest University. CMC Leadership: P. Sklar and J.D. Buxbaum (Icahn School of Medicine at Mount Sinai), B. Devlin and D.A. Lewis (University of Pittsburgh), R.E. Gur and C.-G. Hahn (University of Pennsylvania), K. Hirai and H. Toyoshiba (Takeda Pharmaceuticals Company Limited), E. Domenici and L. Essioux (F. Hoffman-La Roche Ltd), L.M. Mangravite and M.A. Peters (Sage Bionetworks), and T. Lehner and B.K. Lipska (NIMH).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bharadwaj R, 2014, NEURON, V84, P997, DOI 10.1016/j.neuron.2014.10.032; Borck G, 2015, GENOME RES, V25, P155, DOI 10.1101/gr.176925.114; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Carboni L, 2016, PROTEOM CLIN APPL, V10, P430, DOI 10.1002/prca.201500087; Carvalho CMB, 2014, AM J HUM GENET, V95, P565, DOI 10.1016/j.ajhg.2014.10.006; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Dawson LA, 2013, FUTURE MED CHEM, V5, P1525, DOI 10.4155/fmc.13.122; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Delaloy C, 2010, CELL CYCLE, V9, P2913, DOI 10.4161/cc.9.15.12699; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Guzman RE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00143; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Hitzemann R, 2014, INT REV NEUROBIOL, V116, P1, DOI 10.1016/B978-0-12-801105-8.00001-1; Horvath S, 2011, BIOL PSYCHIAT, V69, P157, DOI 10.1016/j.biopsych.2010.07.017; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Kim Y, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.96; Kirov G, 2015, HUM MOL GENET, V24, pR45, DOI 10.1093/hmg/ddv253; Lee IS, 2015, NPJ SCHIZOPHR, V1, DOI 10.1038/npjschz.2015.19; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Mishra-Gorur K, 2014, NEURON, V84, P1226, DOI 10.1016/j.neuron.2014.12.014; Mistry M, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-105; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Ouchi Y, 2013, J NEUROSCI, V33, P9408, DOI 10.1523/JNEUROSCI.2700-12.2013; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Roussos P, 2014, CELL REP, V9, P1417, DOI 10.1016/j.celrep.2014.10.015; Roussos P, 2012, ARCH GEN PSYCHIAT, V69, P1205, DOI 10.1001/archgenpsychiatry.2012.704; Sakai T, 2008, NEUROPATHOLOGY, V28, P143, DOI 10.1111/j.1440-1789.2007.00867.x; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shimoda Y, 2009, CELL ADHES MIGR, V3, P64, DOI 10.4161/cam.3.1.7764; Silva MAD, 2013, P NATL ACAD SCI USA, V110, P15097, DOI 10.1073/pnas.1306884110; Topol A, 2015, BIOL PSYCHIAT, V78, pE29, DOI 10.1016/j.biopsych.2014.12.028; Torkamani A, 2010, GENOME RES, V20, P403, DOI 10.1101/gr.101956.109; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Xiao R, 2009, GENET EPIDEMIOL, V33, P453, DOI 10.1002/gepi.20398; Yuan Q, 2016, BIOL PSYCHIAT, V80, P312, DOI 10.1016/j.biopsych.2015.08.019; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	51	552	556	6	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2016	19	11					1442	1453		10.1038/nn.4399	http://dx.doi.org/10.1038/nn.4399			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA3WL	27668389	Green Submitted, Green Accepted			2022-12-17	WOS:000386539900014
J	Aton, SJ; Colwell, CS; Harmar, AJ; Waschek, J; Herzog, ED				Aton, SJ; Colwell, CS; Harmar, AJ; Waschek, J; Herzog, ED			Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons	NATURE NEUROSCIENCE			English	Article							INHIBITORY SYNAPTIC-TRANSMISSION; MOUSE SUPRACHIASMATIC NUCLEUS; FREE-RUNNING RHYTHMS; VPAC(2) RECEPTOR; MESSENGER-RNA; EXPRESSION; PEPTIDE; CELLS; VIP; NEUROPEPTIDES	The mammalian suprachiasmatic nucleus (SCN) is a master circadian pacemaker. It is not known which SCN neurons are autonomous pacemakers or how they synchronize their daily firing rhythms to coordinate circadian behavior. Vasoactive intestinal polypeptide ( VIP) and the VIP receptor VPAC2 ( encoded by the gene Vipr2) may mediate rhythms in individual SCN neurons, synchrony between neurons, or both. We found that Vip(-/-) and Vipr2(-/-) mice showed two daily bouts of activity in a skeleton photoperiod and multiple circadian periods in constant darkness. Loss of VIP or VPAC2 also abolished circadian firing rhythms in approximately half of all SCN neurons and disrupted synchrony between rhythmic neurons. Critically, daily application of a VPAC2 agonist restored rhythmicity and synchrony to VIP-/- SCN neurons, but not to Vipr2(-/-) neurons. We conclude that VIP coordinates daily rhythms in the SCN and behavior by synchronizing a small population of pacemaking neurons and maintaining rhythmicity in a larger subset of neurons.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; Univ Edinburgh, Div Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH8 9JZ, Midlothian, Scotland	Washington University (WUSTL); University of California System; University of California Los Angeles; University of Edinburgh; University of Edinburgh	Herzog, ED (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.	herzog@wustl.edu	Colwell, Chris/AAM-6111-2020	Aton, Sara/0000-0002-2921-0509; Colwell, Christopher/0000-0002-1059-184X; Harmar, Anthony/0000-0002-3838-9264; Herzog, Erik/0000-0001-7209-5174	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062517, F31MH073302, R01MH063104] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH063104, MH073302, MH62517, MH63104, R01 MH062517, F31 MH073302] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Akiyama M, 2001, J NEUROCHEM, V78, P499, DOI 10.1046/j.1471-4159.2001.00452.x; Ban Y, 1997, J NEUROSCI, V17, P3920; BANKER G, 1991, CULTURING NERVE CELL, P75; BATSCHELET E, 1981, MATH BIOL, P31; Cagampang FRA, 1998, MOL BRAIN RES, V54, P108, DOI 10.1016/S0169-328X(97)00327-6; Colwell CS, 2000, J NEUROBIOL, V43, P379, DOI 10.1002/1097-4695(20000615)43:4<379::AID-NEU6>3.0.CO;2-0; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; DAIKOKU S, 1992, J COMP NEUROL, V325, P559, DOI 10.1002/cne.903250408; Dardente H, 2004, MOL BRAIN RES, V124, P143, DOI 10.1016/j.molbrainres.2004.01.010; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; Honma S, 2004, NEUROSCI LETT, V358, P173, DOI 10.1016/j.neulet.2004.01.022; Hughes AT, 2004, J NEUROSCI, V24, P3522, DOI 10.1523/JNEUROSCI.5345-03.2004; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Itri J, 2004, J NEUROPHYSIOL, V92, P311, DOI 10.1152/jn.01078.2003; Itri J, 2003, J NEUROPHYSIOL, V90, P1589, DOI 10.1152/jn.00332.2003; Jiang ZG, 1997, NEUROSCIENCE, V77, P1059, DOI 10.1016/S0306-4522(96)00539-8; Kallo I, 2004, EUR J NEUROSCI, V19, P2201, DOI 10.1111/j.0953-816X.2004.03335.x; Kalsbeek A, 2002, CELL TISSUE RES, V309, P109, DOI 10.1007/s00441-002-0577-0; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Long MA, 2005, NAT NEUROSCI, V8, P61, DOI 10.1038/nn1361; MISTLBERGER RE, 1991, J BIOL RHYTHM, V6, P71, DOI 10.1177/074873049100600108; Moody TW, 2003, PEPTIDES, V24, P163, DOI 10.1016/S0196-9781(02)00290-5; Nakamura W, 2001, EUR J NEUROSCI, V14, P666, DOI 10.1046/j.0953-816x.2001.01684.x; Nielsen HS, 2002, EUR J NEUROSCI, V15, P570, DOI 10.1046/j.0953-816x.2001.01882.x; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; PIGGINS HD, 1995, J NEUROSCI, V15, P5612; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Quintero JE, 2003, J NEUROSCI, V23, P8070; Reed HE, 2001, EUR J NEUROSCI, V13, P839, DOI 10.1046/j.0953-816x.2000.01437.x; Reed HE, 2002, J NEUROENDOCRINOL, V14, P639, DOI 10.1046/j.1365-2826.2002.00826.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; Shen SB, 2000, P NATL ACAD SCI USA, V97, P11575, DOI 10.1073/pnas.97.21.11575; SHINOHARA K, 1995, P NATL ACAD SCI USA, V92, P7396, DOI 10.1073/pnas.92.16.7396; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Van Gelder RN, 2003, SCIENCE, V300, P1534, DOI 10.1126/science.1085446; VANDENPOL AN, 1986, J COMP NEUROL, V252, P507, DOI 10.1002/cne.902520407; Watanabe K, 2000, BRAIN RES, V877, P361, DOI 10.1016/S0006-8993(00)02724-4; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	50	552	566	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					476	483		10.1038/nn1419	http://dx.doi.org/10.1038/nn1419			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15750589	Green Accepted			2022-12-17	WOS:000228040400018
J	Calder, AJ; Keane, J; Manes, F; Antoun, N; Young, AW				Calder, AJ; Keane, J; Manes, F; Antoun, N; Young, AW			Impaired recognition and experience of disgust following brain injury	NATURE NEUROSCIENCE			English	Article							FACIAL EXPRESSIONS; HUNTINGTONS-DISEASE; AMYGDALA; FEAR; EMOTIONS; DAMAGE		MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; Addenbrookes Hosp, Dept Radiol, Cambridge CB2 2QQ, England; Univ York, Dept Psychol, York YO1 5DD, N Yorkshire, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of York - UK	Calder, AJ (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.		Young, Andy/G-2189-2011	Young, Andy/0000-0002-1202-6297				ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Chikama M, 1997, J NEUROSCI, V17, P9686; Ekman P., 1976, PICTURES FACIAL AFFE; Gray JM, 1997, BRAIN, V120, P2029, DOI 10.1093/brain/120.11.2029; Lang PJ, 1995, INT AFFECTIVE PICTUR; Matsumoto D., 1988, JAPANESE CAUCASIAN F; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Rozin P., 1993, HDB EMOTIONS, P575; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Small DM, 1999, NEUROREPORT, V10, P7, DOI 10.1097/00001756-199901180-00002; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522	15	551	569	1	60	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11					1077	1078		10.1038/80586	http://dx.doi.org/10.1038/80586			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TX	11036262				2022-12-17	WOS:000167177600010
J	Brefczynski, JA; DeYoe, EA				Brefczynski, JA; DeYoe, EA			A physiological correlate of the 'spotlight' of visual attention	NATURE NEUROSCIENCE			English	Article							SELECTIVE ATTENTION; FUNCTIONAL MRI; RETINOTOPIC ORGANIZATION; CEREBRAL-CORTEX; BRAIN ACTIVITY; AREA V4; COLOR; PET; MT; SENSITIVITY	Here we identify a neural correlate of the ability to precisely direct visual attention to locations other than the center of gaze. Human subjects performed a task requiring shifts of visual attention (but not of gaze) from one location to the next within a dense array of targets and distracters while functional MRI was used to map corresponding displacements of neural activation within visual cortex. The cortical topography of the purely attention-driven activity precisely matched the topography of activity evoked by the cued targets when presented in isolation. Such retinotopic mapping of attention-related activation was found in primary visual cortex, as well as in dorsomedial and ventral occipital visual areas previously implicated in processing the attended target features. These results identify a physiological basis for the effects of spatially directed visual attention.	Med Coll Wisconsin, Dept Cellular Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	DeYoe, EA (corresponding author), Med Coll Wisconsin, Dept Cellular Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.				NEI NIH HHS [EY10244] Funding Source: Medline; NIMH NIH HHS [MH51358] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH051358] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Beauchamp MS, 1997, J NEUROPHYSIOL, V78, P516, DOI 10.1152/jn.1997.78.1.516; BEAUCHAMP MS, IN PRESS CEREB CORTE; CORBETTA M, 1991, J NEUROSCI, V11, P2383; CORBETTA M, 1993, J NEUROSCI, V13, P1202; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Crick F., 1995, ASTONISHING HYPOTHES; DESIMONE R, 1990, COLD SH Q B, V55, P963; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DEYOE EA, 1993, P SOC MAGN RESON MED, V3, P1394; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1997, HUM BRAIN MAPP, V5, P287, DOI 10.1002/(SICI)1097-0193(1997)5:4<287::AID-HBM14>3.0.CO;2-B; James W, 1890, PRINCIPLES PSYCHOL, V1; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; LABERGE D, 1983, J EXP PSYCHOL HUMAN, V9, P371, DOI 10.1037/0096-1523.9.3.371; LUCK SJ, 1995, INT J NEUROSCI, V80, P281, DOI 10.3109/00207459508986105; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MOTTER BC, 1994, J NEUROSCI, V14, P2178; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Saad Z. S., 1997, Proceedings of the 19th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. `Magnificent Milestones and Emerging Opportunities in Medical Engineering' (Cat. No.97CH36136), P460, DOI 10.1109/IEMBS.1997.754579; SCHEIN SJ, 1990, J NEUROSCI, V10, P3369; SCHNEIDER W, 1993, NATURE, V365, P150, DOI 10.1038/365150a0; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; von Helmholtz H., 1910, TREATISE PHYSL OPTIC, V3; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I	37	551	554	2	47	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					370	374		10.1038/7280	http://dx.doi.org/10.1038/7280			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204545				2022-12-17	WOS:000080532000017
J	Ziv, Y; Burns, LD; Cocker, ED; Hamel, EO; Ghosh, KK; Kitch, LJ; El Gamal, A; Schnitzer, MJ				Ziv, Yaniv; Burns, Laurie D.; Cocker, Eric D.; Hamel, Elizabeth O.; Ghosh, Kunal K.; Kitch, Lacey J.; El Gamal, Abbas; Schnitzer, Mark J.			Long-term dynamics of CA1 hippocampal place codes	NATURE NEUROSCIENCE			English	Article							SPATIAL INFORMATION; STABILITY; MEMORY; CELLS; MICE; REPRESENTATION; EXPERIENCE	Using Ca2+ imaging in freely behaving mice that repeatedly explored a familiar environment, we tracked thousands of CA1 pyramidal cells' place fields over weeks. Place coding was dynamic, as each day the ensemble representation of this environment involved a unique subset of cells. However, cells in the similar to 15-25% overlap between any two of these subsets retained the same place fields, which sufficed to preserve an accurate spatial representation across weeks.	[Ziv, Yaniv; Burns, Laurie D.; Cocker, Eric D.; Hamel, Elizabeth O.; Kitch, Lacey J.; Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA; [Ghosh, Kunal K.; El Gamal, Abbas] Stanford Univ, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Schnitzer, MJ (corresponding author), Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA.	yziv@stanford.edu; mschnitz@stanford.edu	Core, Vector/CAF-4832-2022		US National Science Foundation; Simons Foundation; Machiah Foundation; Paul G. Allen Family Foundation; US National Institutes of Health [DP1OD003560, R21AG038771, R21MH099469]; Div Of Biological Infrastructure [1063292] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH099469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG038771] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003560] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); Simons Foundation; Machiah Foundation; Paul G. Allen Family Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Looger (Janelia Farm Research Campus) for GCaMP3 plasmid, and A. Attardo, T. Davidson, J. Fitzgerald, J. Li, J.Z. Li, A. Lui, C. Ramachandran, O. Yizhar and T. Zhang for conversations and assistance. We appreciate fellowships from the US National Science Foundation (L.D.B., L.J.K.), the Simons (L.J.K.) and Machiah (Y.Z.) Foundations and research funding to M.J.S. from the Paul G. Allen Family Foundation and the US National Institutes of Health (grants DP1OD003560, R21AG038771 and R21MH099469).	Barretto RPJ, 2011, NAT MED, V17, P223, DOI 10.1038/nm.2292; Cacucci F, 2007, J NEUROSCI, V27, P7854, DOI 10.1523/JNEUROSCI.1704-07.2007; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kentros CG, 2004, NEURON, V42, P283, DOI 10.1016/S0896-6273(04)00192-8; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; MARKUS EJ, 1994, HIPPOCAMPUS, V4, P410, DOI 10.1002/hipo.450040404; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; MULLER RU, 1987, J NEUROSCI, V7, P1935; Muzzio IA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000140; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Rotenberg A, 1996, CELL, V87, P1351, DOI 10.1016/S0092-8674(00)81829-2; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398	19	549	554	1	76	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2013	16	3					264	266		10.1038/nn.3329	http://dx.doi.org/10.1038/nn.3329			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LE	23396101	Green Accepted			2022-12-17	WOS:000315474800006
J	De Jager, PL; Srivastava, G; Lunnon, K; Burgess, J; Schalkwyk, LC; Yu, L; Eaton, ML; Keenan, BT; Ernst, J; McCabe, C; Tang, AN; Raj, T; Replogle, J; Brodeur, W; Gabriel, S; Chai, HS; Younkin, C; Younkin, SG; Zou, FG; Szyf, M; Epstein, CB; Schneider, JA; Bernstein, BE; Meissner, A; Ertekin-Taner, N; Chibnik, LB; Kellis, M; Mill, J; Bennett, DA				De Jager, Philip L.; Srivastava, Gyan; Lunnon, Katie; Burgess, Jeremy; Schalkwyk, Leonard C.; Yu, Lei; Eaton, Matthew L.; Keenan, Brendan T.; Ernst, Jason; McCabe, Cristin; Tang, Anna; Raj, Towfique; Replogle, Joseph; Brodeur, Wendy; Gabriel, Stacey; Chai, High S.; Younkin, Curtis; Younkin, Steven G.; Zou, Fanggeng; Szyf, Moshe; Epstein, Charles B.; Schneider, Julie A.; Bernstein, Bradley E.; Meissner, Alex; Ertekin-Taner, Nilufer; Chibnik, Lori B.; Kellis, Manolis; Mill, Jonathan; Bennett, David A.			Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci	NATURE NEUROSCIENCE			English	Article							SUSCEPTIBILITY LOCI; RELIGIOUS ORDERS; WIDE ASSOCIATION; COMMON VARIANTS; GENETIC RISK; RUSH MEMORY; NEUROPATHOLOGY; ACTIVATION; EXPRESSION; IRHOM2	We used a collection of 708 prospectively collected autopsied brains to assess the methylation state of the brain's DNA in relation to Alzheimer's disease (AD). We found that the level of methylation at 71 of the 415,848 interrogated CpGs was significantly associated with the burden of AD pathology, including CpGs in the ABCA7 and BIN1 regions, which harbor known AD susceptibility variants. We validated 11 of the differentially methylated regions in an independent set of 117 subjects. Furthermore, we functionally validated these CpG associations and identified the nearby genes whose RNA expression was altered in AD: ANK1, CDH23, DIP2A, RHBDF2, RPL13, SERPINF1 and SERPINF2. Our analyses suggest that these DNA methylation changes may have a role in the onset of AD given that we observed them in presymptomatic subjects and that six of the validated genes connect to a known AD susceptibility gene network.	[De Jager, Philip L.; Srivastava, Gyan; Keenan, Brendan T.; Tang, Anna; Raj, Towfique; Replogle, Joseph; Chibnik, Lori B.] Brigham & Womens Hosp, Dept Neurol, Inst Neurosci, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [De Jager, Philip L.; Srivastava, Gyan; Keenan, Brendan T.; Tang, Anna; Raj, Towfique; Replogle, Joseph; Chibnik, Lori B.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [De Jager, Philip L.; Srivastava, Gyan; Raj, Towfique; Replogle, Joseph; Bernstein, Bradley E.; Chibnik, Lori B.] Harvard Univ, Sch Med, Boston, MA USA; [De Jager, Philip L.; Srivastava, Gyan; Eaton, Matthew L.; Keenan, Brendan T.; Ernst, Jason; McCabe, Cristin; Raj, Towfique; Replogle, Joseph; Chibnik, Lori B.; Kellis, Manolis] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Lunnon, Katie; Schalkwyk, Leonard C.; Mill, Jonathan] Univ Exeter, Sch Med, Exeter, Devon, England; [Lunnon, Katie; Schalkwyk, Leonard C.; Mill, Jonathan] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Burgess, Jeremy; Chai, High S.; Younkin, Curtis; Younkin, Steven G.; Zou, Fanggeng; Ertekin-Taner, Nilufer] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Burgess, Jeremy; Chai, High S.; Ertekin-Taner, Nilufer] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Yu, Lei; Schneider, Julie A.; Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Eaton, Matthew L.; Ernst, Jason; Meissner, Alex; Kellis, Manolis] MIT, CSAIL, Cambridge, MA 02139 USA; [Brodeur, Wendy; Gabriel, Stacey] Broad Inst, Genet Anal Platform, Cambridge, MA USA; [Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Epstein, Charles B.; Bernstein, Bradley E.; Meissner, Alex] Broad Inst, Epigen Program, Cambridge, MA USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Meissner, Alex] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Exeter; University of London; King's College London; Mayo Clinic; Mayo Clinic; Rush University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; McGill University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University	De Jager, PL (corresponding author), Brigham & Womens Hosp, Dept Neurol, Inst Neurosci, Program Translat NeuroPsychiat Genom, 75 Francis St, Boston, MA 02115 USA.	pdejager@partners.org; david_a_bennett@rush.edu	Mill, Jonathan S/B-3276-2010; Mill, Jonathan/B-5678-2014; Lunnon, Katie/C-4638-2012; Kellis, Manolis/ABE-7385-2020; Schalkwyk, Leonard C/A-2150-2010; Yu, Lei/AAT-3685-2020; Raj, Towfique/ABD-7620-2021	Mill, Jonathan S/0000-0003-1115-3224; Mill, Jonathan/0000-0003-1115-3224; Lunnon, Katie/0000-0001-7570-6065; Kellis, Manolis/0000-0001-7113-9630; Schalkwyk, Leonard C/0000-0001-7030-5756; Epstein, Charles B./0000-0001-8358-8345; Burgess, Jeremy/0000-0001-9454-3070; Replogle, Joseph/0000-0003-1832-919X; Chibnik, Lori/0000-0001-6293-806X	US National Institutes of Health [R01 AG036042, R01AG036836, R01 AG17917, R01AG15819, R01 AG032990, R01 AG18023, RC2 AG036547, P30 AG10161, P50 AG016574, U01 ES017155, KL2 RR024151, K25 AG041906-01, AG036039]; Siragusa Foundation; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Alzheimer's Research UK; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG046152, R01AG017917, R01AG036836, R01AG018023, R01AG032990, P50AG016574, RF1AG015819, R01AG036042, R01AG036039, P30AG010161, K25AG041906, RC2AG036547, U01AG046139, R01AG015819] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siragusa Foundation; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the National Institute for Health (NIHR) Biomedical Research Unit in Dementia in the South London and Maudsley NHS Foundation Trust (SLaM), Brains for Dementia Research (Alzheimer Brain Bank UK) and the donors and families who made this research possible. We also would like to thank the participants of the ROS and MAP studies for their participation in these studies. Support for this research was provided by grants from the US National Institutes of Health (R01 AG036042, R01AG036836, R01 AG17917,R01AG15819, R01 AG032990, R01 AG18023, RC2 AG036547, P30 AG10161, P50 AG016574, U01 ES017155, KL2 RR024151, K25 AG041906-01). Support was also provided by the Siragusa Foundation to N.E.-T., and the Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program to N.E.-T., S.G.Y. and F.Z. This work was funded by US National Institutes of Health grant AG036039 to J.M. and an Equipment Grant from Alzheimer's Research UK.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Akbarian S, 2013, JAMA NEUROL, V70, P711, DOI 10.1001/jamaneurol.2013.1459; Bakulski KM, 2012, J ALZHEIMERS DIS, V29, P571, DOI 10.3233/JAD-2012-111223; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bennett DA, 2013, J ALZHEIMERS DIS, V33, pS397, DOI 10.3233/JAD-2012-129007; Bennett DA, 2012, ANN NEUROL, V72, P599, DOI 10.1002/ana.23654; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Chibnik LB, 2011, ANN NEUROL, V69, P560, DOI 10.1002/ana.22277; Chouliaras L, 2013, NEUROBIOL AGING, V34, P2091, DOI 10.1016/j.neurobiolaging.2013.02.021; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Linnertz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007480; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Lunnon K., 2014, NAT NEUROSCI, V17, pXXX; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Negash S, 2011, CURR ALZHEIMER RES, V8, P336, DOI 10.2174/156720511795745302; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Raj T, 2012, AM J HUM GENET, V90, P720, DOI 10.1016/j.ajhg.2012.02.022; Renner NA, 2013, J CELL PHYSIOL, V228, P1284, DOI 10.1002/jcp.24283; Roet KCD, 2013, J NEUROSCI, V33, P11116, DOI 10.1523/JNEUROSCI.1002-13.2013; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shulman JM, 2013, JAMA NEUROL, V70, P1150, DOI 10.1001/jamaneurol.2013.2815; Siggs OM, 2012, BLOOD, V119, P5769, DOI 10.1182/blood-2012-03-417949; Simpson JE, 2011, NEUROBIOL AGING, V32, P1795, DOI 10.1016/j.neurobiolaging.2011.04.013; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tanaka M, 2010, FEBS J, V277, P4278, DOI 10.1111/j.1742-4658.2010.07816.x; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698	41	548	549	3	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2014	17	9					1156	1163		10.1038/nn.3786	http://dx.doi.org/10.1038/nn.3786			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AO2DJ	25129075	Green Submitted, Green Accepted			2022-12-17	WOS:000341125400008
J	Rilling, JK; Glasser, MF; Preuss, TM; Ma, XY; Zhao, TJ; Hu, XP; Behrens, TEJ				Rilling, James K.; Glasser, Matthew F.; Preuss, Todd M.; Ma, Xiangyang; Zhao, Tiejun; Hu, Xiaoping; Behrens, Timothy E. J.			The evolution of the arcuate fasciculus revealed with comparative DTI	NATURE NEUROSCIENCE			English	Article							PROBABILISTIC DIFFUSION TRACTOGRAPHY; LANGUAGE; BRAIN; TOOL	The arcuate fasciculus is a white-matter fiber tract that is involved in human language. Here we compared cortical connectivity in humans, chimpanzees and macaques (Macaca mulatta) and found a prominent temporal lobe projection of the human arcuate fasciculus that is much smaller or absent in nonhuman primates. This human specialization may be relevant to the evolution of language.	[Rilling, James K.; Glasser, Matthew F.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Rilling, James K.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Rilling, James K.; Preuss, Todd M.] Emory Univ, Ctr Behav Neurosci, Atlanta, GA 30302 USA; [Rilling, James K.] Yerkes Natl Primate Res Ctr, Div Psychobiol, Atlanta, GA 30329 USA; [Preuss, Todd M.] Yerkes Natl Primate Res Ctr, Div Neurosci, Atlanta, GA 30329 USA; [Preuss, Todd M.] Emory Univ, Sch Med, Emory Univ Hosp, Pathol & Lab Med, Atlanta, GA 30322 USA; [Ma, Xiangyang; Zhao, Tiejun; Hu, Xiaoping] Emory Univ, Biomed Imaging Technol Ctr, Atlanta, GA 30322 USA; [Behrens, Timothy E. J.] Univ Oxford, John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England; [Behrens, Timothy E. J.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	Emory University; Emory University; Emory University; Emory University; Emory University; University of Oxford; University of Oxford	Rilling, JK (corresponding author), Emory Univ, Dept Anthropol, 207 Anthropol Bldg,1557 Dickey Dr, Atlanta, GA 30322 USA.	jrillin@emory.edu	Preuss, Todd/GSI-6571-2022; Glasser, Matthew F./AAE-7291-2019; Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026; Behrens, Timothy/0000-0003-0048-1177; Hu, Xiaoping/0000-0001-7014-5983	Medical Research Council [G0501316] Funding Source: Medline; NCRR NIH HHS [RR-00165] Funding Source: Medline; NIBIB NIH HHS [R01EB002009] Funding Source: Medline; MRC [G0501316] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002009] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Croxson PL, 2005, J NEUROSCI, V25, P8854, DOI 10.1523/JNEUROSCI.1311-05.2005; Deacon T., 1997, SYMBOLIC SPECIES; Dejerine J., 1895, ANATOMIE CENTRES NER; GESCHWIN.N, 1970, SCIENCE, V170, P940, DOI 10.1126/science.170.3961.940; GLASSER MF, 2008, CEREB CORTEX, P14, DOI DOI 10.1093/CERC0R/BHN011; GOULD SJ, 1991, J SOC ISSUES, V47, P43, DOI 10.1111/j.1540-4560.1991.tb01822.x; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; PETRIDES M, 2002, PRINCIPLES FRONTAL L, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; Preuss T.M., 2004, COGNITIVE NEUROSCIEN, V3rd, P5; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Rilling JK, 2002, J HUM EVOL, V42, P505, DOI 10.1006/jhev.2001.0537; Sakai KL, 2005, SCIENCE, V310, P815, DOI 10.1126/science.1113530; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394	15	548	554	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2008	11	4					426	428		10.1038/nn2072	http://dx.doi.org/10.1038/nn2072			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	279MM	18344993				2022-12-17	WOS:000254359300014
J	Krakauer, JW; Ghilardi, MF; Ghez, C				Krakauer, JW; Ghilardi, MF; Ghez, C			Independent learning of internal models for kinematic and dynamic control of reaching	NATURE NEUROSCIENCE			English	Article							VISUOMOTOR TRANSFORMATION; ARM TRAJECTORIES; MOTOR CORTEX; MOVEMENTS; MEMORY; ADAPTATION; ACCURACY; INPUT; SPACE	Psychophysical studies of reaching movements suggest that hand kinematics are learned from errors in extent and direction in an extrinsic coordinate system, whereas dynamics are learned from proprioceptive errors in an intrinsic coordinate system. We examined consolidation and interference to determine if these two forms of learning were independent. Learning and consolidation of two novel transformations, a rotated spatial reference frame and altered intersegmental dynamics, did not interfere with each other and consolidated in parallel. Thus separate kinematic and dynamic models were constructed simultaneously based on errors computed in different coordinate frames, and possibly, in different sensory modalities, using separate working-memory systems. These results suggest that computational approaches to motor learning should include two separate performance errors rather than one.	Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; CNR, INB, I-20133 Milan, Italy	Columbia University; New York State Psychiatry Institute; Columbia University; Consiglio Nazionale delle Ricerche (CNR)	Ghez, C (corresponding author), Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.	cpg1@columbia.edu			NINDS NIH HHS [NS 22713, NS 01961] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001961] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASANUMA H, 1981, PROG NEUROBIOL, V16, P241, DOI 10.1016/0301-0082(81)90015-0; ASANUMA H, 1989, JPN J PHYSIOL, V39, P1, DOI 10.2170/jjphysiol.39.1; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baddeley Alan, 1986, WORKING MEMORY; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Desmurget M, 1998, NEUROSCI BIOBEHAV R, V22, P761, DOI 10.1016/S0149-7634(98)00004-9; FLANAGAN JR, 1995, J NEUROPHYSIOL, V74, P2174, DOI 10.1152/jn.1995.74.5.2174; FLANDERS M, 1992, BEHAV BRAIN SCI, V15, P309, DOI 10.1017/S0140525X00068813; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; GHEZ C, 1990, COLD SH Q B, V55, P837; GHEZ C, IN PRESS COGNITIVE N, P501; GHILARDI MF, 1995, J NEUROPHYSIOL, V73, P2535, DOI 10.1152/jn.1995.73.6.2535; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; GORDON J, 1995, J NEUROPHYSIOL; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; HOY MG, 1986, J BIOMECH, V19, P867, DOI 10.1016/0021-9290(86)90137-5; Jordan M. I., 1996, HDB PERCEPTION ACTIO, V2, P71, DOI DOI 10.1016/S1874-5822(06)80005-8; LAJOIE Y, 1992, NEUROLOGY, V42, P1104, DOI 10.1212/WNL.42.5.1104; Moeller JR, 1998, QUANTITATIVE FUNCTIONAL BRAIN IMAGING WITH POSITRON EMISSION TOMOGRAPHY, P165, DOI 10.1016/B978-012161340-2/50026-3; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Pine ZM, 1996, NEUROREPORT, V7, P2357, DOI 10.1097/00001756-199610020-00016; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; VINDRAS P, 1998, J EXP PSYCHOL, V24, P1; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; WOLPERT DM, 1995, EXP BRAIN RES, V103, P460	30	548	548	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1999	2	11					1026	1031		10.1038/14826	http://dx.doi.org/10.1038/14826			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FF	10526344				2022-12-17	WOS:000083883300022
J	Schwartz, O; Simoncelli, EP				Schwartz, O; Simoncelli, EP			Natural signal statistics and sensory gain control	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; SIMPLE CELLS; ORIENTATION SELECTIVITY; SPATIAL SUMMATION; RECEPTIVE-FIELDS; CORTICAL-NEURONS; AUDITORY-NERVE; PATTERN-VISION; V1 NEURONS	We describe a form of nonlinear decomposition that is well-suited for efficient encoding of natural signals. Signals are initially decomposed using a bank of linear filters. Each filter response is then rectified and divided by a weighted sum of rectified responses of neighboring filters. We show that this decomposition, with parameters optimized for the statistics of a generic ensemble of natural images or sounds, provides a good characterization of the nonlinear response properties of typical neurons in primary visual cortex or auditory nerve, respectively. These results suggest that nonlinear response properties of sensory neurons are not an accident of biological implementation, but have an important functional role.	NYU, Ctr Neural Sci, Howard Hughes Med Inst, New York, NY 10003 USA; NYU, Courant Inst Math Sci, New York, NY 10003 USA	Howard Hughes Medical Institute; New York University; New York University	Simoncelli, EP (corresponding author), NYU, Ctr Neural Sci, Howard Hughes Med Inst, New York, NY 10003 USA.	eero.simoncelli@nyu.edu						Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; BARLOW H, 1989, COMP NEUR S, P54; Barlow H., 1961, SENSORY COMMUNICATIO, P217; Bell AJ, 1996, NETWORK-COMP NEURAL, V7, P261, DOI 10.1088/0954-898X/7/2/005; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Carandini M, 1997, J NEUROSCI, V17, P8621; CAVANAUGH JR, 2000, THESIS NEW YORK U; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; Delgutte B., 1996, AUDITORY COMPUTATION, P157, DOI DOI 10.1007/978-1-4612-4070-9_5; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; GEISLER DC, 1998, SOUND SYNAPSE PHYSL; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Graham N, 2000, VISION RES, V40, P2737, DOI 10.1016/S0042-6989(00)00123-1; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hirsch JA, 1998, J NEUROSCI, V18, P9517; JAVEL E, 1978, J ACOUST SOC AM, V63, P1093, DOI 10.1121/1.381817; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; LYON RF, 1990, LECT NOTES BIOMATH, V87, P395; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; NELSON JI, 1985, EXP BRAIN RES, V61, P54; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; ROSE JE, 1971, J NEUROPHYSIOL, V34, P685, DOI 10.1152/jn.1971.34.4.685; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Shapley R., 1984, PROG RETIN RES, V3, P263, DOI [10.1016/0278-4327(84)90011-7, DOI 10.1016/0278-4327(84)90011-7]; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SIMONCELLI EP, 1992, IEEE T INFORM THEORY, V38, P587, DOI 10.1109/18.119725; Simoncelli EP, 1999, ADV NEUR IN, V11, P153; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SLANEY M, 1993, 35 PATT HOLDW AUD FI; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; WAINWRIGHT MJ, IN PRESS APPL COMPUT; WAINWRIGHT MJ, 2001, IN PRESS PROBABILIST; Wang KS, 1994, IEEE T SPEECH AUDI P, V2, P421, DOI 10.1109/89.294356; Zhao HB, 1999, NATURE, V399, P359, DOI 10.1038/20686	50	547	550	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					819	825		10.1038/90526	http://dx.doi.org/10.1038/90526			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477428				2022-12-17	WOS:000170137300015
J	de Quervain, DJF; Roozendaal, B; Nitsch, RM; McGaugh, JL; Hock, C				de Quervain, DJF; Roozendaal, B; Nitsch, RM; McGaugh, JL; Hock, C			Acute cortisone administration impairs retrieval of long-term declarative memory in humans	NATURE NEUROSCIENCE			English	Article							BASOLATERAL AMYGDALA; STRESS; CORTICOSTEROIDS; ENHANCEMENT; ACTIVATION; COGNITION		Univ Zurich, Dept Psychiat Res, CH-8029 Zurich, Switzerland; Univ Basel, Dept Psychiat, CH-4025 Basel, Switzerland; Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of Zurich; University of Basel; University of California System; University of California Irvine; University of California System; University of California Irvine	de Quervain, DJF (corresponding author), Univ Zurich, Dept Psychiat Res, Lenggstr 31, CH-8029 Zurich, Switzerland.		Roozendaal, Benno/B-8403-2013	de Quervain, Dominique/0000-0001-7131-2464				de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Keenan PA, 1996, NEUROLOGY, V47, P1396, DOI 10.1212/WNL.47.6.1396; Kirschbaum C, 1996, LIFE SCI, V58, P1475, DOI 10.1016/0024-3205(96)00118-X; LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Lupien SJ, 1999, BEHAV NEUROSCI, V113, P420, DOI 10.1037/0735-7044.113.3.420; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Newcomer JW, 1999, ARCH GEN PSYCHIAT, V56, P527, DOI 10.1001/archpsyc.56.6.527; Quirarte GL, 1997, P NATL ACAD SCI USA, V94, P14048, DOI 10.1073/pnas.94.25.14048; Roozendaal B, 1996, NEUROBIOL LEARN MEM, V65, P1, DOI 10.1006/nlme.1996.0001; Roozendaal B, 1999, P NATL ACAD SCI USA, V96, P11642, DOI 10.1073/pnas.96.20.11642; RUBINOW DR, 1984, ARCH GEN PSYCHIAT, V41, P279; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; WHELAN TB, 1980, J NERV MENT DIS, V168, P753, DOI 10.1097/00005053-198012000-00008	15	547	556	2	43	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					313	314		10.1038/73873	http://dx.doi.org/10.1038/73873			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725918				2022-12-17	WOS:000087945400009
J	Reyes, A; Lujan, R; Rozov, A; Burnashev, N; Somogyi, P; Sakmann, B				Reyes, A; Lujan, R; Rozov, A; Burnashev, N; Somogyi, P; Sakmann, B			Target-cell-specific facilitation and depression in neocortical circuits	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; SYNAPTIC TRANSMISSION; TRANSMITTER RELEASE; PYRAMIDAL NEURONS; STRATUM-ORIENS; IN-VITRO; SYNAPSES; CONNECTIONS; INTERNEURONS; PLASTICITY	In neocortical circuits, repetitively active neurons evoke unitary postsynaptic potentials (PSPs) whose peak amplitudes either increase (facilitate) or decrease (depress) progressively. To examine the basis for these different synaptic responses, we made simultaneous recordings from three classes of neurons in cortical layer 2/3. We induced repetitive action potentials in pyramidal cells and recorded the evoked unitary excitatory (E)PSPs in two classes of GABAergic neurons. We observed facilitation of EPSPs in bitufted GABAergic interneurons, many of which expressed somatostatin immunoreactivity. EPSPs recorded from multipolar interneurons, however, showed depression. Some of these neurons were immunopositive for parvalbumin. Unitary inhibitory (I)PSPs evoked by repetitive stimulation of a bitufted neuron also showed a less pronounced but significant difference between the two target neurons. Facilitation and depression involve presynaptic mechanisms, and because a single neuron can express both behaviors simultaneously, we infer that local differences in the molecular structure of presynaptic nerve terminals are induced by retrograde signals from different classes of target neurons. Because bitufted and multipolar neurons both formed reciprocal inhibitory connections with pyramidal cells, the results imply that the balance of activation between two recurrent inhibitory pathways in the neocortex depends on the frequency of action potentials in pyramidal cells.	Max Planck Inst Med Forsch, Zellphysiol Abt, D-69120 Heidelberg, Germany; Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford, England	Max Planck Society; University of Oxford	Sakmann, B (corresponding author), Max Planck Inst Med Forsch, Zellphysiol Abt, Jahnstr 29, D-69120 Heidelberg, Germany.	zpsecr@sunny.mpimf-heidelberg.mpg.de	Lujan, Rafael/G-2555-2015; Burnashev, Nail/G-4056-2013; Rozov, Andrei/C-1997-2015	Lujan Miras, Rafael/0000-0003-2001-9545				Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1997, J PHYSIOL-LONDON, V501P, pP9; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Atluri PP, 1996, J NEUROSCI, V16, P5661; ATWOOD HL, 1971, J NEUROPHYSIOL, V34, P157, DOI 10.1152/jn.1971.34.1.157; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; BLASCOIBANEZ JM, 1995, EUR J NEUROSCI, V7, P2170, DOI 10.1111/j.1460-9568.1995.tb00638.x; BOWER JM, 1986, P NATL ACAD SCI USA, V83, P1115, DOI 10.1073/pnas.83.4.1115; BRODIN L, 1994, J NEUROPHYSIOL, V72, P592, DOI 10.1152/jn.1994.72.2.592; Buhl EH, 1997, J PHYSIOL-LONDON, V500, P689, DOI 10.1113/jphysiol.1997.sp022053; DAVIS GW, 1993, J NEUROSCI, V13, P3827; DAVIS GW, 1994, TRENDS NEUROSCI, V17, P9, DOI 10.1016/0166-2236(94)90028-0; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; FRANK E, 1973, J PHYSIOL-LONDON, V233, P635, DOI 10.1113/jphysiol.1973.sp010327; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; KATZ PS, 1993, J NEUROSCI, V13, P3075; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KOERBER HR, 1991, J NEUROPHYSIOL, V65, P590, DOI 10.1152/jn.1991.65.3.590; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; MASON A, 1991, J NEUROSCI, V11, P72; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; MULLER KJ, 1974, J PHYSIOL-LONDON, V238, P357, DOI 10.1113/jphysiol.1974.sp010529; RAHAMIMOFF R, 1968, J PHYSIOL-LONDON, V195, P471, DOI 10.1113/jphysiol.1968.sp008468; Schroder R, 1997, EUR J NEUROSCI, V9, P163, DOI 10.1111/j.1460-9568.1997.tb01364.x; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SOMOGYI P, 1984, J NEUROSCI, V4, P2590; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; THOMSON AM, 1993, NEUROSCIENCE, V54, P347, DOI 10.1016/0306-4522(93)90257-G; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; VINCENT SR, 1985, J COMP NEUROL, V238, P169, DOI 10.1002/cne.902380205; WINSLOW JL, 1994, J NEUROPHYSIOL, V72, P1769, DOI 10.1152/jn.1994.72.4.1769; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	43	546	552	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					279	285		10.1038/1092	http://dx.doi.org/10.1038/1092			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195160				2022-12-17	WOS:000076361300010
J	Loken, LS; Wessberg, J; Morrison, I; McGlone, F; Olausson, H				Loken, Line S.; Wessberg, Johan; Morrison, India; McGlone, Francis; Olausson, Hakan			Coding of pleasant touch by unmyelinated afferents in humans	NATURE NEUROSCIENCE			English	Article							HUMAN HAIRY SKIN; TACTILE AFFERENTS; PAIN; PSYCHOPHYSICS; PLEASURE	Pleasant touch sensations may begin with neural coding in the periphery by specific afferents. We found that during soft brush stroking, low-threshold unmyelinated mechanoreceptors (C-tactile), but not myelinated afferents, responded most vigorously at intermediate brushing velocities (1-10 cm s(-1)), which were perceived by subjects as being the most pleasant. Our results indicate that C-tactile afferents constitute a privileged peripheral pathway for pleasant tactile stimulation that is likely to signal affiliative social body contact.	[Loken, Line S.; Wessberg, Johan; Morrison, India; Olausson, Hakan] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Loken, Line S.; Morrison, India; Olausson, Hakan] Sahlgrens Univ Hosp, Dept Clin Neurophysiol, S-41345 Gothenburg, Sweden; [McGlone, Francis] Univ Liverpool, Dept Neurol Sci, Liverpool L69 3BX, Merseyside, England; [McGlone, Francis] Unilever R&D, Sensat Percept & Behav Grp, Wirral, Cheshire, England	University of Gothenburg; Sahlgrenska University Hospital; University of Liverpool; Unilever	Loken, LS (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden.	line.loken@neuro.gu.se; olausson@physiol.gu.se	McGlone, Francis Philip/AAA-5058-2022; McGlone, Francis/F-8349-2011	McGlone, Francis/0000-0002-0881-635X; Ruiz de castilla, Nicolas/0000-0002-7173-5376; Loken, Line/0000-0001-6762-9717	Swedish Research Council; Sahlgrenska University Hospital; Unilever; Wenner-Gren foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Sahlgrenska University Hospital; Unilever(Unilever); Wenner-Gren foundation	We thank A. Vallbo, U. Norrsell and M. C. Bushnell for kindly reading the manuscript and offering advice. We also thank K. Gothner, M. Evert and J. Lindholm for technical assistance. This work was supported by the Swedish Research Council, Sahlgrenska University Hospital, Unilever and the Wenner-Gren foundation.	Andrew D, 1999, J NEUROPHYSIOL, V82, P2641, DOI 10.1152/jn.1999.82.5.2641; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; BESSOU P, 1971, J NEUROPHYSIOL, V34, P116, DOI 10.1152/jn.1971.34.1.116; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Gallace A, 2010, NEUROSCI BIOBEHAV R, V34, P246, DOI 10.1016/j.neubiorev.2008.10.004; Hertenstein MJ, 2006, EMOTION, V6, P528, DOI 10.1037/1528-3542.6.3.528; Johnson KO, 2002, NEUROSCIENTIST, V8, P111, DOI 10.1177/107385840200800207; KOLTZENBURG M, 1994, J NEUROSCI, V14, P1756, DOI 10.1523/JNEUROSCI.14-03-01756.1994; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Olausson H, 2008, EXP BRAIN RES, V184, P135, DOI 10.1007/s00221-007-1175-x; Olausson H, 2010, NEUROSCI BIOBEHAV R, V34, P185, DOI 10.1016/j.neubiorev.2008.09.011; Vallbo AB, 1999, J NEUROPHYSIOL, V81, P2753, DOI 10.1152/jn.1999.81.6.2753	15	545	555	4	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2009	12	5					547	548		10.1038/nn.2312	http://dx.doi.org/10.1038/nn.2312			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438SJ	19363489				2022-12-17	WOS:000265575400009
J	Gropp, E; Shanabrough, M; Borok, E; Xu, AW; Janoschek, R; Buch, T; Plum, L; Balthasar, N; Hampel, B; Waisman, A; Barsh, GS; Horvath, TL; Bruning, JC				Gropp, E; Shanabrough, M; Borok, E; Xu, AW; Janoschek, R; Buch, T; Plum, L; Balthasar, N; Hampel, B; Waisman, A; Barsh, GS; Horvath, TL; Bruning, JC			Agouti-related peptide-expressing neurons are mandatory for feeding	NATURE NEUROSCIENCE			English	Article							NEUROPEPTIDE-Y; ARCUATE NUCLEUS; ENERGY HOMEOSTASIS; MELANOCORTIN; PROTEIN; OBESITY; INSULIN; RATS; MICE	Multiple hormones controlling energy homeostasis regulate the expression of neuropeptide Y (NPY) and agouti-related peptide ( AgRP) in the arcuate nucleus of the hypothalamus. Nevertheless, inactivation of the genes encoding NPY and/or AgRP has no impact on food intake in mice. Here we demonstrate that induced selective ablation of AgRP-expressing neurons in adult mice results in acute reduction of feeding, demonstrating direct evidence for a critical role of these neurons in the regulation of energy homeostasis.	Univ Cologne, Inst Genet, D-50674 Cologne, Germany; Univ Cologne, Ctr Mol Med CMMC, Dept Mouse Genet & Metab, D-50674 Cologne, Germany; Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; Stanford Univ, Sch Med, Dept Genet & Pediat, Stanford, CA 94305 USA; Univ Cologne, Dept Internal Med 2, D-50924 Cologne, Germany; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Endocrinol, Boston, MA 02215 USA; Johannes Gutenberg Univ Mainz, Med Klin & Poliklin 1, Unit Pathophysiol, D-55131 Mainz, Germany	University of Cologne; University of Cologne; Yale University; Yale University; Yale University; Stanford University; University of Cologne; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johannes Gutenberg University of Mainz	Horvath, TL (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.	tamas.horvath@yale.edu; jens.bruening@uni-koelin.de	Waisman, Ari/C-7383-2015; Buch, Thorsten/P-1659-2019; Plum-Mörschel, Leona/W-9413-2019	Waisman, Ari/0000-0003-4304-8234; Buch, Thorsten/0000-0002-2236-9074; Plum-Mörschel, Leona/0000-0002-1907-761X; Janoschek, Ruth/0000-0002-1332-9353	NIDDK NIH HHS [DK-07386, DK-060711] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK007386, R01DK060711] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Cone RD, 1999, TRENDS ENDOCRIN MET, V10, P211, DOI 10.1016/S1043-2760(99)00153-8; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Gardiner JV, 2005, BIOCHEM BIOPH RES CO, V327, P1088, DOI 10.1016/j.bbrc.2004.12.113; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pierroz DD, 1996, ENDOCRINOLOGY, V137, P3, DOI 10.1210/en.137.1.3; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Schwartz MW, 1996, J CLIN INVEST, V98, P1101, DOI 10.1172/JCI118891; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506	14	545	549	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2005	8	10					1289	1291		10.1038/nn1548	http://dx.doi.org/10.1038/nn1548			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	968EY	16158063				2022-12-17	WOS:000232145900009
J	Oldham, MC; Konopka, G; Iwamoto, K; Langfelder, P; Kato, T; Horvath, S; Geschwind, DH				Oldham, Michael C.; Konopka, Genevieve; Iwamoto, Kazuya; Langfelder, Peter; Kato, Tadafumi; Horvath, Steve; Geschwind, Daniel H.			Functional organization of the transcriptome in human brain	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; GENE-COEXPRESSION NETWORK; BIPOLAR DISORDER; EXPRESSION ANALYSES; CHIMPANZEE BRAINS; POSTMORTEM BRAINS; ADULT; MODULES; CONSERVATION; ASTROCYTES	The enormous complexity of the human brain ultimately derives from a finite set of molecular instructions encoded in the human genome. These instructions can be directly studied by exploring the organization of the brain's transcriptome through systematic analysis of gene coexpression relationships. We analyzed gene coexpression relationships in microarray data generated from specific human brain regions and identified modules of coexpressed genes that correspond to neurons, oligodendrocytes, astrocytes and microglia. These modules provide an initial description of the transcriptional programs that distinguish the major cell classes of the human brain and indicate that cell type-specific information can be obtained from whole brain tissue without isolating homogeneous populations of cells. Other modules corresponded to additional cell types, organelles, synaptic function, gender differences and the subventricular neurogenic niche. We found that subventricular zone astrocytes, which are thought to function as neural stem cells in adults, have a distinct gene expression pattern relative to protoplasmic astrocytes. Our findings provide a new foundation for neurogenetic inquiries by revealing a robust and previously unrecognized organization to the human brain transcriptome.	[Oldham, Michael C.] Univ Calif Los Angeles, Interdepartmental Program Neurosci, Los Angeles, CA 90095 USA; [Oldham, Michael C.; Konopka, Genevieve; Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; [Oldham, Michael C.; Konopka, Genevieve; Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Iwamoto, Kazuya; Kato, Tadafumi] RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama 3510198, Japan; [Langfelder, Peter; Horvath, Steve; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, Dept Biostat, Sch Publ Hlth, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RIKEN; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Oldham, MC (corresponding author), Univ Calif Los Angeles, Interdepartmental Program Neurosci, 695 Charles Young Dr S,Gonda Room 1506D, Los Angeles, CA 90095 USA.	oldham@ucla.edu; dhg@ucla.edu	Kato, Tadafumi/J-3583-2014	Kato, Tadafumi/0000-0001-7856-3952; Konopka, Genevieve/0000-0002-3363-7302	James S. McDonnell Foundation; Method to Extend Research in Time (MERIT) [5R37MH060233]; US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060233] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Method to Extend Research in Time (MERIT); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to express their gratitude to the individuals who produced and made available to the scientific community the raw data analyzed in this study. Post mortem brain tissue was donated by The Stanley Research Institute's brain collection courtesy of M. B. Knable, E. F. Torrey, M. J. Webster, S. Weis and R. H. Yolken. We are grateful to our colleagues N. Khanlou, J. Pomakian and H. Vinters for their help in obtaining additional post mortem human brain tissue. We also thank C. Wiita for technical support and L. Kawaguchi for administrative support and lab management. This work was supported by the James S. McDonnell Foundation and a Method to Extend Research in Time (MERIT) Award 5R37MH060233 (D. H. G.), funded by the US National Institute of Mental Health.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang Y, 2007, BIOINFORMATICS, V23, pI222, DOI 10.1093/bioinformatics/btm222; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Khaitovich P, 2004, GENOME RES, V14, P1462, DOI 10.1101/gr.2538704; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li JZ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-336; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Morciano M, 2005, J NEUROCHEM, V95, P1732, DOI 10.1111/j.1471-4159.2005.03506.x; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nagata T, 2004, MOL BRAIN RES, V121, P1, DOI 10.1016/j.molbrainres.2003.10.023; Nelson SB, 2006, CURR OPIN NEUROBIOL, V16, P571, DOI 10.1016/j.conb.2006.08.006; Nielsen JA, 2006, J NEUROSCI, V26, P9881, DOI 10.1523/JNEUROSCI.2246-06.2006; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.3.CO;2-S; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rong YQ, 2004, MOL BRAIN RES, V132, P128, DOI 10.1016/j.molbrainres.2004.10.015; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Ryan MM, 2006, MOL PSYCHIATR, V11, P965, DOI 10.1038/sj.mp.4001875; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Snel B, 2004, NUCLEIC ACIDS RES, V32, P4725, DOI 10.1093/nar/gkh815; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang JH, 2005, GENOMICS, V85, P297, DOI 10.1016/j.ygeno.2004.11.004	50	543	552	5	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2008	11	11					1271	1282		10.1038/nn.2207	http://dx.doi.org/10.1038/nn.2207			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	366HZ	18849986	Green Accepted			2022-12-17	WOS:000260472700016
J	Gerdeman, GL; Ronesi, J; Lovinger, DM				Gerdeman, GL; Ronesi, J; Lovinger, DM			Postsynaptic endocannabinoid release is critical to long-term depression in the striatum	NATURE NEUROSCIENCE			English	Article							CB1 CANNABINOID RECEPTOR; EXCITATORY SYNAPTIC TRANSMISSION; ACID AMIDE HYDROLASE; ENDOGENOUS CANNABINOIDS; KNOCKOUT MICE; DORSAL STRIATUM; PURKINJE-CELLS; BASAL GANGLIA; RAT; NEURONS	The striatum functions critically in movement control and habit formation. The development and function of cortical input to the striatum are thought to be regulated by activity-dependent plasticity of corticostriatal glutamatergic synapses. Here we show that the induction of a form of striatal synaptic plasticity, long-term depression (LTD), is dependent on activation of the CB1 cannabinoid receptor. LTD was facilitated by blocking cellular endocannabinoid uptake, and postsynaptic loading of anandamide (AEA) produced presynaptic depression. The endocannabinoid necessary for striatal LTD is thus likely to be released postsynaptically as a retrograde messenger. These findings demonstrate a new role for endocannabinoids in the induction of long-term synaptic plasticity in a circuit necessary for habit formation and motor control.	Vanderbilt Univ, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Lovinger, DM (corresponding author), NIAAA, Lab Integrat Neurosci, 158H Pk 5 Bldg, Rockville, MD 20852 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA005923] Funding Source: NIH RePORTER; NIDA NIH HHS [DA05923] Funding Source: Medline; NINDS NIH HHS [NS30470] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auclair N, 2000, J NEUROPHYSIOL, V83, P3287, DOI 10.1152/jn.2000.83.6.3287; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Cadas H, 1996, J NEUROSCI, V16, P3934; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1999, J NEUROSCI, V19, P2489; Calabresi P, 1997, J NEUROSCI, V17, P4536; Calabresi P, 1996, TRENDS NEUROSCI, V19, P19, DOI 10.1016/0166-2236(96)81862-5; Choi S, 1997, P NATL ACAD SCI USA, V94, P2665, DOI 10.1073/pnas.94.6.2665; Choi SK, 1997, J NEUROSCI, V17, P8613; Day TA, 2001, MOL PHARMACOL, V59, P1369, DOI 10.1124/mol.59.6.1369; Deutsch DG, 2001, J BIOL CHEM, V276, P6967, DOI 10.1074/jbc.M003161200; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Gerdeman G, 2001, J NEUROPHYSIOL, V85, P468, DOI 10.1152/jn.2001.85.1.468; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; GOUGH AL, 1978, NEUROPHARMACOLOGY, V17, P137, DOI 10.1016/0028-3908(78)90126-0; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Gubellini P, 2001, NEUROPHARMACOLOGY, V40, P839, DOI 10.1016/S0028-3908(01)00021-1; HERKENHAM M, 1991, BRAIN RES, V547, P267, DOI 10.1016/0006-8993(91)90970-7; Hillard CJ, 2000, CHEM PHYS LIPIDS, V108, P123, DOI 10.1016/S0009-3084(00)00191-2; Huang CC, 2001, J PHYSIOL-LONDON, V532, P731, DOI 10.1111/j.1469-7793.2001.0731e.x; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Leckman JF, 2000, NEURON, V28, P349, DOI 10.1016/S0896-6273(00)00114-8; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; LOVINGER DM, 1993, J NEUROPHYSIOL, V70, P1937, DOI 10.1152/jn.1993.70.5.1937; Maccarrone M, 2000, J BIOL CHEM, V275, P13484, DOI 10.1074/jbc.275.18.13484; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Partridge JG, 2000, J NEUROPHYSIOL, V84, P1422, DOI 10.1152/jn.2000.84.3.1422; Rodriguez JJ, 2001, J NEUROSCI, V21, P823, DOI 10.1523/JNEUROSCI.21-03-00823.2001; Steiner H, 1999, P NATL ACAD SCI USA, V96, P5786, DOI 10.1073/pnas.96.10.5786; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sung KW, 2001, J NEUROPHYSIOL, V86, P2405, DOI 10.1152/jn.2001.86.5.2405; Tang KC, 2001, P NATL ACAD SCI USA, V98, P1255, DOI 10.1073/pnas.031374698; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; WALSH JP, 1993, BRAIN RES, V608, P123, DOI 10.1016/0006-8993(93)90782-I; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	48	542	557	0	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					446	451		10.1038/nn832	http://dx.doi.org/10.1038/nn832			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11976704				2022-12-17	WOS:000175272000015
J	Hoshi, E; Tremblay, L; Feger, J; Carras, PL; Strick, PL				Hoshi, E; Tremblay, L; Feger, J; Carras, PL; Strick, PL			The cerebellum communicates with the basal ganglia	NATURE NEUROSCIENCE			English	Article							CIRCUITS; MOTOR; THALAMUS; PRIMATE; SYSTEM; CORTEX	The cerebral cortex is interconnected with two major subcortical structures: the basal ganglia and the cerebellum. How and where cerebellar circuits interact with basal ganglia circuits has been a longstanding question. Using transneuronal transport of rabies virus in macaques, we found that a disynaptic pathway links an output stage of cerebellar processing, the dentate nucleus, with an input stage of basal ganglia processing, the striatum.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Ctr Neural Basis Cognit, Pittsburgh, PA 15261 USA; Tamagawa Univ Res Inst, Tokyo 1948610, Japan; Hop La Pitie Salpetriere, INSERM, U679, F-75651 Paris, France; Pittsburgh Vet Affairs Med Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Strick, PL (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA.	strickp@pitt.edu	Tremblay, Leon/H-1559-2017	Tremblay, Leon/0000-0001-8370-6903	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS047126] Funding Source: NIH RePORTER; NCRR NIH HHS [RR018604] Funding Source: Medline; NIMH NIH HHS [MH56661] Funding Source: Medline; NINDS NIH HHS [NS047126] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Clower DM, 2005, CEREB CORTEX, V15, P913, DOI 10.1093/cercor/bhh190; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Dum RP, 2002, ANN NY ACAD SCI, V978, P289, DOI 10.1111/j.1749-6632.2002.tb07575.x; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Ichinohe N, 2000, BRAIN RES, V880, P191, DOI 10.1016/S0006-8993(00)02744-X; Jones EG, 1985, THALAMUS; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; Masterman DL, 1997, J PSYCHOPHARMACOL, V11, P107, DOI 10.1177/026988119701100203; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Percheron G, 1996, BRAIN RES REV, V22, P93; Schmahmann J. D., 1997, CEREBELLUM COGNITION; Smith Y, 2004, TRENDS NEUROSCI, V27, P520, DOI 10.1016/j.tins.2004.07.004; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9	15	539	549	4	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1491	1493		10.1038/nn1544	http://dx.doi.org/10.1038/nn1544			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	979TB	16205719				2022-12-17	WOS:000232966600020
J	Yantis, S; Schwarzbach, J; Serences, JT; Carlson, RL; Steinmetz, MA; Pekar, JJ; Courtney, SM				Yantis, S; Schwarzbach, J; Serences, JT; Carlson, RL; Steinmetz, MA; Pekar, JJ; Courtney, SM			Transient neural activity in human parietal cortex during spatial attention shifts	NATURE NEUROSCIENCE			English	Article							MULTIPLE-STIMULUS DISPLAYS; VISUAL-ATTENTION; BRAIN ACTIVITY; AREA 7A; SELECTIVE ATTENTION; NEURONAL RESPONSES; DIRECTED ATTENTION; MECHANISMS; MODULATION; SYSTEMS	Observers viewing a complex visual scene selectively attend to relevant locations or objects and ignore irrelevant ones. Selective attention to an object enhances its neural representation in extrastriate cortex, compared with those of unattended objects, via top-down attentional control signals. The posterior parietal cortex is centrally involved in this control of spatial attention. We examined brain activity during attention shifts using rapid, event-related fMRI of human observers as they covertly shifted attention between two peripheral spatial locations. Activation in extrastriate cortex increased after a shift of attention to the contralateral visual field and remained high during sustained contralateral attention. The time course of activity was substantially different in posterior parietal cortex, where transient increases in activation accompanied shifts of attention in either direction. This result suggests that activation of the parietal cortex is associated with a discrete signal to shift spatial attention, and is not the source of a signal to continuously maintain the current attentive state.	Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA; Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University	Yantis, S (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	yantis@jhu.edu	Yantis, Steven/A-7488-2009; Schwarzbach, Jens/D-1776-2010	Pekar, James/0000-0002-9830-0655	NCRR NIH HHS [P41-RR15241] Funding Source: Medline; NIDA NIH HHS [R01-DA13165] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013165] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Conner CE, 1997, J NEUROSCI, V17, P3201; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; Constantinidis C, 2001, CEREB CORTEX, V11, P592, DOI 10.1093/cercor/11.7.592; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, J NEUROSCI, V18, P7426; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DESIMONE R, 1990, COLD SH Q B, V55, P963; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Goebel R, 1993, ADV NEURAL INFORMATI, V5, P903; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; LABERGE D, 1990, J NEUROSCI, V10, P613; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; POSNER MI, 1984, J NEUROSCI, V4, P1863; REEVES A, 1986, PSYCHOL REV, V93, P180, DOI 10.1037/0033-295X.93.2.180; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sperling G., 1980, ATTENTION PERFORM, P347; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Yantis S., 1998, ATTENTION, V1, P223, DOI DOI 10.1037/0096-1523.16.4.812	46	538	547	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					995	1002		10.1038/nn921	http://dx.doi.org/10.1038/nn921			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12219097				2022-12-17	WOS:000178242200019
J	Banghart, M; Borges, K; Isacoff, E; Trauner, D; Kramer, RH				Banghart, M; Borges, K; Isacoff, E; Trauner, D; Kramer, RH			Light-activated ion channels for remote control of neuronal firing	NATURE NEUROSCIENCE			English	Article							GATED POTASSIUM CHANNELS; K+-CHANNELS; MAMMALIAN NEURONS; INACTIVATION; MUTATIONS; PHOTOSTIMULATION; MECHANISMS; EXPRESSION; CIRCUITS; BLOCKADE	Neurons have ion channels that are directly gated by voltage, ligands and temperature but not by light. Using structure-based design, we have developed a new chemical gate that confers light sensitivity to an ion channel. The gate includes a functional group for selective conjugation to an engineered K+ channel, a pore blocker and a photoisomerizable azobenzene. Long-wavelength light drives the azobenzene moiety into its extended trans configuration, allowing the blocker to reach the pore. Short-wavelength light generates the shorter cis configuration, retracting the blocker and allowing conduction. Exogenous expression of these channels in rat hippocampal neurons, followed by chemical modification with the photoswitchable gate, enables different wavelengths of light to switch action potential firing on and off. These synthetic photoisomerizable azobenzene-regulated K+ (SPARK) channels allow rapid, precise and reversible control over neuronal firing, with potential applications for dissecting neural circuits and controlling activity downstream from sites of neural damage or degeneration.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Trauner, D (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	trauner@cchem.berkeley.edu; rhkramer@berkeley.edu	isacoff, ehud/AAP-1459-2020	Banghart, Matthew/0000-0001-7248-2932; Isacoff, Ehud Y./0000-0003-4775-9359	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060711] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH060711] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Blaustein RO, 2000, NAT STRUCT BIOL, V7, P309; Blaustein RO, 2002, J GEN PHYSIOL, V120, P203, DOI 10.1085/jgp.20028613; CALLAWAY EM, 1994, CURR BIOL, V4, P1010, DOI 10.1016/S0960-9822(00)00228-1; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Djurisic M, 2003, METHOD ENZYMOL, V361, P423; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Flint DG, 2002, CHEM BIOL, V9, P391, DOI 10.1016/S1074-5521(02)00109-6; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; James DA, 2001, PROTEIN ENG, V14, P983, DOI 10.1093/protein/14.12.983; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Johns DC, 1999, J NEUROSCI, V19, P1691; KARSCHIN A, 1991, FEBS LETT, V278, P229, DOI 10.1016/0014-5793(91)80123-K; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; KNOLL H, 2004, CRC HDB ORGANIC PHOT, V2; Lechner HAE, 2002, J NEUROSCI, V22, P5287; LESTER HA, 1980, J GEN PHYSIOL, V75, P207, DOI 10.1085/jgp.75.2.207; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Nerbonne JM, 1996, CURR OPIN NEUROBIOL, V6, P379, DOI 10.1016/S0959-4388(96)80123-1; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Slimko EM, 2002, J NEUROSCI, V22, P7373; Sutherland ML, 1999, P NATL ACAD SCI USA, V96, P2451, DOI 10.1073/pnas.96.5.2451; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	31	536	615	7	186	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1381	1386		10.1038/nn1356	http://dx.doi.org/10.1038/nn1356			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15558062	Green Accepted			2022-12-17	WOS:000225353900020
J	Bezzi, P; Gundersen, V; Galbete, JL; Seifert, G; Steinhauser, C; Pilati, E; Volterra, A				Bezzi, P; Gundersen, V; Galbete, JL; Seifert, G; Steinhauser, C; Pilati, E; Volterra, A			Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate	NATURE NEUROSCIENCE			English	Article							CALCIUM OSCILLATIONS; SYNAPTIC VESICLES; RELEASE; TRANSPORTERS; MEMBRANE; CA2+; LOCALIZATION; EXPRESSION; RECEPTORS; SUGGESTS	Astrocytes establish rapid cell-to-cell communication through the release of chemical transmitters. The underlying mechanisms and functional significance of this release are, however, not well understood. Here we identify an astrocytic vesicular compartment that is competent for glutamate exocytosis. Using postembedding immunogold labeling of the rat hippocampus, we show that vesicular glutamate transporters (VGLUT1/2) and the vesicular SNARE protein, cellubrevin, are both expressed in small vesicular organelles that resemble synaptic vesicles of glutamatergic terminals. Astrocytic vesicles, which are not as densely packed as their neuronal counterparts, can be observed in small groups at sites adjacent to neuronal structures bearing glutamate receptors. Fluorescently tagged VGLUT-containing vesicles were studied dynamically in living astrocytes by total internal reflection fluorescence (TIRF) microscopy. After activation of metabotropic glutamate receptors, astrocytic vesicles underwent rapid (milliseconds) Ca2+- and SNARE-dependent exocytic fusion that was accompanied by glutamate release. These data document the existence of a Ca2+-dependent quantal glutamate release activity in glia that was previously considered to be specific to synapses.	Univ Lausanne, Dept Cell Biol & Morphol, CH-1005 Lausanne, Switzerland; UNIL CHUV Technol Dev Unit, Cellular Imaging Facil, CH-1005 Lausanne, Switzerland; Univ Oslo, Inst Anat, N-0317 Oslo, Norway; Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway; Univ Bonn, Dept Expt Neurobiol, D-53105 Bonn, Germany; Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Oslo; University of Oslo; University of Bonn; University of Milan; University of Milan	Volterra, A (corresponding author), Univ Lausanne, Dept Cell Biol & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.	Andrea.Volterra@ibcm.unil.ch	Bezzi, Paola/AAP-2440-2020	Volterra, Andrea/0000-0003-1069-1602				Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Avery J, 2000, J CELL BIOL, V148, P317, DOI 10.1083/jcb.148.2.317; Becherer U, 2003, NAT NEUROSCI, V6, P846, DOI 10.1038/nn1087; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bergersen L, 2003, EUR J NEUROSCI, V18, P931, DOI 10.1046/j.1460-9568.2003.02828.x; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; CHILTON BJ, 1995, CIVIL ENG SYST, V12, P219, DOI 10.1080/02630259508970172; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2002, P NATL ACAD SCI USA, V99, P14488, DOI 10.1073/pnas.222546799; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Gundersen V, 1998, J NEUROSCI, V18, P6059; Humeau Y, 2000, BIOCHIMIE, V82, P427, DOI 10.1016/S0300-9084(00)00216-9; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Matthias K, 2003, J NEUROSCI, V23, P1750; Muyderman H, 2001, J BIOL CHEM, V276, P46504, DOI 10.1074/jbc.M103849200; Nedergaard M, 2002, NAT REV NEUROSCI, V3, P748, DOI 10.1038/nrn916; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pasti L, 1997, J NEUROSCI, V17, P7817; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; ROSENTHAL L, 1989, PHARMACOL THERAPEUT, V42, P115, DOI 10.1016/0163-7258(89)90024-7; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Schroder W, 1999, GLIA, V28, P166, DOI 10.1002/(SICI)1098-1136(199911)28:2<166::AID-GLIA8>3.0.CO;2-T; SEIFERT G, 2002, NEUROMETHODS PATCH C, V35, P301; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; STOUT AL, 1989, APPL OPTICS, V28, P5237, DOI 10.1364/AO.28.005237; Tse FT, 1999, BIOESSAYS, V21, P861, DOI 10.1002/(SICI)1521-1878(199910)21:10<861::AID-BIES8>3.0.CO;2-9; Tse FW, 1997, NEURON, V18, P121, DOI 10.1016/S0896-6273(01)80051-9; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Valtorta F, 2001, TRENDS CELL BIOL, V11, P324, DOI 10.1016/S0962-8924(01)02058-X; VOLTERRA A, 2004, NEUROGLIA, P190; Volterra A., 2002, TRIPARTITE SYNAPSE G, P164; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	47	535	556	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					613	620		10.1038/nn1246	http://dx.doi.org/10.1038/nn1246			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15156145				2022-12-17	WOS:000221640300015
J	Bishop, SJ				Bishop, Sonia J.			Trait anxiety and impoverished prefrontal control of attention	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY CAPACITY; PERCEPTUAL LOAD; INDIVIDUAL-DIFFERENCES; SELECTIVE ATTENTION; NEURAL BASIS; CONFLICT; CORTEX; INTERFERENCE; PERFORMANCE; DISORDERS	Many neurocognitive models of anxiety emphasize the importance of a hyper-responsive threat-detection system centered on the amygdala, with recent accounts incorporating a role for prefrontal mechanisms in regulating attention to threat. Here we investigated whether trait anxiety is associated with a much broader dysregulation of attentional control. Volunteers performed a response-conflict task under conditions that posed high or low demands on attention. High trait-anxious individuals showed reduced prefrontal activity and slower target identification in response to processing competition when the task did not fully occupy attentional resources. The relationship between trait anxiety and prefrontal recruitment remained after controlling for state anxiety. These findings indicate that trait anxiety is linked to impoverished recruitment of prefrontal attentional control mechanisms to inhibit distractor processing even when threat-related stimuli are absent. Notably, this deficit was observed when ongoing task-related demands on attention were low, potentially explaining the day-to-day difficulties in concentration that are associated with clinical anxiety.	[Bishop, Sonia J.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Bishop, Sonia J.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Bishop, Sonia J.] Univ Cambridge, Dept Expt Psychol, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Bishop, Sonia J.] MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Cambridge	Bishop, SJ (corresponding author), Univ Calif Berkeley, Dept Psychol, Tolman Hall 1650, Berkeley, CA 94720 USA.	sbishop@berkeley.edu	Bishop, Sonia J/I-7729-2012		UK Medical Research Council [G120/919]; University of Cambridge Behavioral and Clinical Neuroscience Institute; MRC [G120/919] Funding Source: UKRI; Medical Research Council [G120/919] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cambridge Behavioral and Clinical Neuroscience Institute(University of Cambridge); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Thanks go to J. Duncan for comments on a draft manuscript, radiographers H. Lloyd and S. Eldridge for assistance with fMRI data collection, and to S. Strangeways for assistance with figure preparation. This work was funded by the UK Medical Research Council through a Medical Research Council Career Development Award (G120/919) held at the University of Cambridge Behavioral and Clinical Neuroscience Institute, with additional resources being provided by the Medical Research Council Cognition and Brain Sciences Unit.	Barrett LF, 2004, PSYCHOL BULL, V130, P553, DOI 10.1037/0033-2909.130.4.553; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Bishop SJ, 2007, CEREB CORTEX, V17, P1595, DOI 10.1093/cercor/bhl070; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chen Z, 2007, PSYCHON B REV, V14, P306, DOI 10.3758/BF03194069; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Derakshan N, 1998, COGNITION EMOTION, V12, P697; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Duncan J, 2006, Q J EXP PSYCHOL, V59, P2, DOI 10.1080/17470210500260674; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Durston S, 2003, NEUROIMAGE, V20, P2135, DOI 10.1016/j.neuroimage.2003.08.004; Elia Josephine, 2008, Child Adolesc Psychiatry Ment Health, V2, P15, DOI 10.1186/1753-2000-2-15; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; EYSENCK MW, 1992, COGNITION EMOTION, V6, P409, DOI 10.1080/02699939208409696; Forster S, 2007, PSYCHOL SCI, V18, P377, DOI 10.1111/j.1467-9280.2007.01908.x; FOX E, 1993, BEHAV RES THER, V31, P487, DOI 10.1016/0005-7967(93)90129-I; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Huang-Pollock CL, 2002, DEV PSYCHOL, V38, P363, DOI 10.1037//0012-1649.38.3.363; Jenkins R, 2005, PSYCHON B REV, V12, P314, DOI 10.3758/BF03196378; Kane MJ, 2000, J EXP PSYCHOL LEARN, V26, P336, DOI 10.1037//0278-7393.26.2.336; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Lang PJ, 2000, J AFFECT DISORDERS, V61, P137, DOI 10.1016/S0165-0327(00)00343-8; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Lavie N, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P175; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MANDLER G, 1952, J ABNORM SOC PSYCH, V47, P166, DOI 10.1037/h0062855; Mathews A, 1997, TRENDS COGN SCI, V1, P340, DOI 10.1016/S1364-6613(97)01092-9; Maylor EA, 1998, PSYCHOL AGING, V13, P563, DOI 10.1037/0882-7974.13.4.563; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; Spielberger CD, 1989, STATE TRAIT ANXIETY; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3	42	534	548	2	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2009	12	1					92	98		10.1038/nn.2242	http://dx.doi.org/10.1038/nn.2242			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	388HL	19079249				2022-12-17	WOS:000262010800020
J	Vyazovskiy, VV; Cirelli, C; Pfister-Genskow, M; Faraguna, U; Tononi, G				Vyazovskiy, Vladyslav V.; Cirelli, Chiara; Pfister-Genskow, Martha; Faraguna, Ugo; Tononi, Giulio			Molecular and electrophysiological evidence for net synaptic potentiation in wake and depression in sleep	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPUS IN-VIVO; CORTICAL SYNCHRONIZATION; RECEPTOR TRAFFICKING; SLOW WAVES; BRAIN TEMPERATURE; AMPA RECEPTORS; PLASTICITY; RAT; HOMEOSTASIS	Plastic changes occurring during wakefulness aid in the acquisition and consolidation of memories. For some memories, further consolidation requires sleep, but whether plastic processes during wakefulness and sleep differ is unclear. We show that, in rat cortex and hippocampus, GluR1-containing AMPA receptor ( AMPAR) levels are high during wakefulness and low during sleep, and changes in the phosphorylation states of AMPARs, CamKII and GSK3 beta are consistent with synaptic potentiation during wakefulness and depression during sleep. Furthermore, slope and amplitude of cortical evoked responses increase after wakefulness, decrease after sleep and correlate with changes in slow-wave activity, a marker of sleep pressure. Changes in molecular and electrophysiological indicators of synaptic strength are largely independent of the time of day. Finally, cortical long-term potentiation can be easily induced after sleep, but not after wakefulness. Thus, wakefulness appears to be associated with net synaptic potentiation, whereas sleep may favor global synaptic depression, thereby preserving an overall balance of synaptic strength.	[Vyazovskiy, Vladyslav V.; Cirelli, Chiara; Pfister-Genskow, Martha; Faraguna, Ugo; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA; [Faraguna, Ugo] Scuola Normale S Anna, I-56127 Pisa, Italy	University of Wisconsin System; University of Wisconsin Madison	Cirelli, C (corresponding author), Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA.	ccirelli@wisc.edu; gtononi@wisc.edu	Faraguna, Ugo/J-6805-2012; Tononi, Giulio/B-8387-2009	Faraguna, Ugo/0000-0002-4814-7218; Vyazovskiy, Vladyslav/0000-0002-4336-6681	NIH HHS [DP1 OD000579] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Borbely A.A., 2005, PRINCIPLES PRACTICE; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; CAIN DP, 1994, BRAIN RES, V658, P135, DOI 10.1016/S0006-8993(09)90019-1; Campbell IG, 2002, J NEUROPHYSIOL, V88, P1073, DOI 10.1152/jn.2002.88.2.1073; Cirelli C, 2000, J NEUROSCI, V20, P9187; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; CZAMECKI A, 2007, J PHYSIOL-LONDON, V578, P471; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Fox CJ, 2006, HIPPOCAMPUS, V16, P907, DOI 10.1002/hipo.20230; GEOL A, 2006, NAT NEUROSCI, V9, P1001; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, P157, DOI 10.1016/0166-4328(95)00012-I; Glazewski S, 1998, NEUROPHARMACOLOGY, V37, P581, DOI 10.1016/S0028-3908(98)00039-2; HALL RD, 1970, EXP BRAIN RES, V11, P93; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Kauer JA, 2006, NAT NEUROSCI, V9, P593, DOI 10.1038/nn0506-593; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kopp C, 2006, J NEUROSCI, V26, P12456, DOI 10.1523/JNEUROSCI.2702-06.2006; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McDermott CM, 2003, J NEUROSCI, V23, P9687; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; RACINE RJ, 1995, BRAIN RES, V702, P87, DOI 10.1016/0006-8993(95)01025-0; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Steriade M, 1976, Prog Neurobiol, V6, P155; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 2005, BRAINSTEM CONTROL WA, P728; Tartar JL, 2006, EUR J NEUROSCI, V23, P2739, DOI 10.1111/j.1460-9568.2006.04808.x; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2007, SLEEP, V30, P1631, DOI 10.1093/sleep/30.12.1631; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	50	534	545	2	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					200	208		10.1038/nn2035	http://dx.doi.org/10.1038/nn2035			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204445				2022-12-17	WOS:000252712100014
J	Meffert, MK; Chang, JM; Wiltgen, BJ; Fanselow, MS; Baltimore, D				Meffert, MK; Chang, JM; Wiltgen, BJ; Fanselow, MS; Baltimore, D			NF-kappa B functions in synaptic signaling and behavior	NATURE NEUROSCIENCE			English	Article							CALMODULIN KINASE-II; TRANSCRIPTION FACTOR; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; NUCLEAR TRANSLOCATION; CREB PHOSPHORYLATION; INHIBITOR PROTEIN; MICE LACKING; CALCIUM; BRAIN	Ca2+-regulated gene transcription is essential to diverse physiological processes, including the adaptive plasticity associated with learning. We found that basal synaptic input activates the NF-kappaB transcription factor by a pathway requiring the Ca2+ /calmodulin-dependent kinase CaMKII and local submembranous Ca2+ elevation. The p65: p50 NF-kappaB form is selectively localized at synapses; p65-deficient mice have no detectable synaptic NF-kappaB. Activated NF-kappaB moves to the nucleus and could directly transmute synaptic signals into altered gene expression. Mice lacking p65 show a selective learning deficit in the spatial version of the radial arm maze. These observations suggest that long-term changes to adult neuronal function caused by synaptic stimulation can be regulated by NF-kappaB nuclear translocation and gene activation.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles	Baltimore, D (corresponding author), CALTECH, Div Biol, MC204-31, Pasadena, CA 91125 USA.			Rudell, Jolene/0000-0003-3022-4649				Albensi BC, 2000, SYNAPSE, V35, P151; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Brown JR, 1996, CELL, V86, P297, DOI 10.1016/S0092-8674(00)80101-4; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; FINK CC, IN PRESS NEURON; Freudenthal R, 2000, BRAIN RES, V855, P274, DOI 10.1016/S0006-8993(99)02358-6; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Goslin K., 1990, CULTURING NERVE CELL; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Guerrini L, 1997, J NEUROSCI, V17, P6057; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Lerant A, 2001, BRAIN RES, V904, P259, DOI 10.1016/S0006-8993(01)02470-2; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu D, 1998, J NEUROSCI, V18, P1329; Maldonado R, 1999, P NATL ACAD SCI USA, V96, P14094, DOI 10.1073/pnas.96.24.14094; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; Meberg PJ, 1996, MOL BRAIN RES, V38, P179, DOI 10.1016/0169-328X(95)00229-L; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; Nelson G, 2002, J CELL SCI, V115, P1137; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; PAYLOR R, 1994, BRAIN RES, V651, P275, DOI 10.1016/0006-8993(94)90707-2; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Sage JR, 2000, BEHAV NEUROSCI, V114, P295, DOI 10.1037/0735-7044.114.2.295; SchmidtUllrich R, 1996, DEVELOPMENT, V122, P2117; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; VAN AD, 1996, SCIENCE, V274, P787; WALDMANN R, 1990, BIOCHEMISTRY-US, V29, P1679, DOI 10.1021/bi00459a002; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987	47	534	552	1	41	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2003	6	10					1072	1078		10.1038/nn1110	http://dx.doi.org/10.1038/nn1110			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	727AK	12947408				2022-12-17	WOS:000185633600019
J	Shi, YC; Kirwan, P; Smith, J; Robinson, HPC; Livesey, FJ				Shi, Yichen; Kirwan, Peter; Smith, James; Robinson, Hugh P. C.; Livesey, Frederick J.			Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL NEURONOGENESIS; SUBVENTRICULAR ZONE; HUMAN ES; NEURONS; SPECIFICATION; SUBTYPE; DIFFERENTIATION; NEUROGENESIS; EVOLUTION; MODEL	Efforts to study the development and function of the human cerebral cortex in health and disease have been limited by the availability of model systems. Extrapolating from our understanding of rodent cortical development, we have developed a robust, multistep process for human cortical development from pluripotent stem cells: directed differentiation of human embryonic stem (ES) and induced pluripotent stem (iPS) cells to cortical stem and progenitor cells, followed by an extended period of cortical neurogenesis, neuronal terminal differentiation to acquire mature electrophysiological properties, and functional excitatory synaptic network formation. We found that induction of cortical neuroepithelial stem cells from human ES cells and human iPS cells was dependent on retinoid signaling. Furthermore, human ES cell and iPS cell differentiation to cerebral cortex recapitulated in vivo development to generate all classes of cortical projection neurons in a fixed temporal order. This system enables functional studies of human cerebral cortex development and the generation of individual-specific cortical networks ex vivo for disease modeling and therapeutic purposes.	[Shi, Yichen; Kirwan, Peter; Smith, James; Livesey, Frederick J.] Univ Cambridge, Gurdon Inst, Cambridge, England; [Shi, Yichen; Kirwan, Peter; Smith, James; Livesey, Frederick J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Robinson, Hugh P. C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Livesey, FJ (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge, England.	rick@gurdon.cam.ac.uk		Robinson, Hugh/0000-0002-5048-9954; Livesey, Rick/0000-0001-6128-3372; Kirwan, Peter/0000-0003-1446-7544; Smith, James/0000-0001-9131-5849	Biotechnology and Biological Sciences Research Council; University of Cambridge/Wellcome Trust; Wellcome Trust; Alzheimer's Research UK; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Cambridge/Wellcome Trust; Wellcome Trust(Wellcome TrustEuropean Commission); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Vallier (Cambridge) and Y. Takashima for kindly providing human iPS cell lines and J. Nichols (Cambridge Centre for Stem Cell Research, Cambridge) for providing the Edi2 human ES cell line. We also thank the members of the Livesey laboratory for their contributions, comments and input to this research. Y. S. was supported by a Biotechnology and Biological Sciences Research Council Dorothy Hodgkin Studentship. P. K. was supported by the University of Cambridge/Wellcome Trust PhD Programme in Developmental Biology. This research benefits from core support to the Gurdon Institute from the Wellcome Trust and Cancer Research UK and grants to F. J. L. from the Wellcome Trust and Alzheimer's Research UK.	Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Au E, 2008, CELL STEM CELL, V3, P472, DOI 10.1016/j.stem.2008.10.013; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Hu BY, 2010, METHODS MOL BIOL, V636, P123, DOI 10.1007/978-1-60761-691-7_8; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Maden M, 1996, CURR BIOL, V6, P417, DOI 10.1016/S0960-9822(02)00509-2; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V393, P743, DOI 10.1113/jphysiol.1987.sp016851; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mountcastle V. B., 1998, CEREBRAL CORTEX; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; POLLEUX F, 2002, SCI STKE, V136, pPL9; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Takahashi T, 1996, J NEUROSCI, V16, P6183; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	46	533	551	10	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2012	15	3					477	U180		10.1038/nn.3041	http://dx.doi.org/10.1038/nn.3041			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	899CY	22306606	Green Accepted			2022-12-17	WOS:000300793100023
J	Piccini, P; Brooks, DJ; Bjorklund, A; Gunn, RN; Grasby, PM; Rimoldi, O; Brundin, P; Hagell, P; Rehncrona, S; Widner, H; Lindvall, O				Piccini, P; Brooks, DJ; Bjorklund, A; Gunn, RN; Grasby, PM; Rimoldi, O; Brundin, P; Hagell, P; Rehncrona, S; Widner, H; Lindvall, O			Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; LONG-TERM SURVIVAL; C-11 RACLOPRIDE; DISEASE; GRAFTS; RECEPTORS; PRIMATES; THERAPY; BINDING	Synaptic dopamine release from embryonic nigral transplants has been monitored in the striatum of a patient with Parkinson's disease using [C-11]-raclopride positron emission tomography to measure dopamine D-2 receptor occupancy by the endogenous transmitter. In this patient, who had received a transplant in the right putamen 10 years earlier, grafts had restored both basal and drug-induced dopamine release to normal levels. This was associated with sustained, marked clinical benefit and normalized levels of dopamine storage in the grafted putamen. Despite an ongoing disease process, grafted neurons can thus continue for a decade to store and release dopamine and give rise to substantial symptomatic relief.	Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, MRC,Cyclotron Unit, London W12 0NN, England; Wallenberg Neurosci Ctr, Neurobiol Sect, SE-22362 Lund, Sweden; Wallenberg Neurosci Ctr, Sect Neuronal Survival, SE-22362 Lund, Sweden; Wallenberg Neurosci Ctr, Sect Restorat Neurol, SE-22362 Lund, Sweden; Univ Lund Hosp, Dept Clin Neurosci, Div Neurol, SE-22185 Lund, Sweden; Univ Lund Hosp, Dept Clin Neurosci, Div Neurosurg, SE-22185 Lund, Sweden	Imperial College London; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Piccini, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sch Med, MRC,Cyclotron Unit, Du Cane Rd, London W12 0NN, England.		Rimoldi, Ornella/ABH-5358-2020; Björklund, Anders/ABA-1326-2020; Hagell, Peter/F-5915-2010; Hagell, Peter/G-9559-2014; Gunn, Roger/H-1666-2012	Hagell, Peter/0000-0003-2174-372X; Hagell, Peter/0000-0003-2174-372X; Gunn, Roger/0000-0003-1181-5769; Piccini, Paola/0000-0003-4162-6141; Bjorklund, Anders/0000-0002-5676-6203; Brooks, David/0000-0003-2602-2518				ANNETT LE, 1994, ADV NEUROSC, V2, P71; ANTONINI A, 1994, NEUROLOGY, V44, P1325, DOI 10.1212/WNL.44.7.1325; BROOKS DJ, 1990, ANN NEUROL, V28, P547, DOI 10.1002/ana.410280412; Brundin P, 1994, FUNCTIONAL NEURAL TR, V2, P9; Carson RE, 1997, J CEREBR BLOOD F MET, V17, P437, DOI 10.1097/00004647-199704000-00009; Elsworth JD, 1998, BRAIN RES, V795, P55, DOI 10.1016/S0006-8993(98)00252-2; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; Kordower JH, 1998, MOVEMENT DISORD, V13, P383, DOI 10.1002/mds.870130303; Laruelle M, 1997, SYNAPSE, V25, P1, DOI 10.1002/(SICI)1098-2396(199701)25:1<1::AID-SYN1>3.0.CO;2-H; Lindvall O, 1999, MOVEMENT DISORD, V14, P201, DOI 10.1002/1531-8257(199903)14:2<201::AID-MDS1001>3.3.CO;2-H; LINDVALL O, 1992, ANN NEUROL, V31, P155, DOI 10.1002/ana.410310206; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; Olanow CW, 1996, TRENDS NEUROSCI, V19, P102, DOI 10.1016/S0166-2236(96)80038-5; RINNE UK, 1990, MOVEMENT DISORD, V5, P55, DOI 10.1002/mds.870050114; SAWLE GV, 1993, BRAIN, V116, P853, DOI 10.1093/brain/116.4.853; SEEMAN P, 1987, NEUROPSYCHOPHARMACOL, V1, P5, DOI 10.1016/0893-133X(87)90004-2; Studholme C, 1997, MED PHYS, V24, P25, DOI 10.1118/1.598130; Wenning GK, 1997, ANN NEUROL, V42, P95, DOI 10.1002/ana.410420115	20	531	564	0	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	1999	2	12					1137	1140		10.1038/16060	http://dx.doi.org/10.1038/16060			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TA	10570493				2022-12-17	WOS:000085810100020
J	Obici, S; Feng, ZH; Karkanias, G; Baskin, DG; Rossetti, L				Obici, S; Feng, ZH; Karkanias, G; Baskin, DG; Rossetti, L			Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; Y MESSENGER-RNA; GENE-EXPRESSION; FOOD-INTAKE; VISCERAL ADIPOSITY; ARCUATE NUCLEUS; DIABETIC RATS; BODY-WEIGHT; LEPTIN; BRAIN	We investigated the role of hypothalamic insulin signaling in the regulation of energy balance and insulin action in rats through selective decreases in insulin receptor expression in discrete hypothalamic nuclei. We generated an antisense oligodeoxynucleotide directed against the insulin receptor precursor protein and administered this directly into the third cerebral ventricle. Immunostaining of rat brains after 7-day administration of the oligodeoxynucleotide showed a selective decrease of insulin receptor protein within cells in the medial portion of the arcuate nucleus (decreased by similar to80% as compared to rats treated with a control oligodeoxynucleotide). Insulin receptors in other hypothalamic and extra-hypothalamic areas were not affected. This selective decrease in hypothalamic insulin receptor protein was accompanied by rapid onset of hyperphagia and increased fat mass. During insulin-clamp studies, physiological hyperinsulinemia decreased glucose production by 55% in rats treated with control oligodeoxynucleotides but by only 25% in rats treated with insulin receptor antisense oligodeoxynucleotides. Thus, insulin receptors in discrete areas of the hypothalamus have a physiological role in the control of food intake, fat mass and hepatic action of insulin.	Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA; VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; Univ Washington, Seattle, WA 98108 USA	Yeshiva University; Albert Einstein College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Rossetti, L (corresponding author), Yeshiva Univ Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045024, R01DK045024, R01DK048321, R37DK048321, P60DK020541, P30DK017047] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 20541, DK 48321, DK 17047, DK 45024] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Air EL, 2002, NAT MED, V8, P179, DOI 10.1038/nm0202-179; Barzilai N, 1999, AM J PHYSIOL-ENDOC M, V277, pE291, DOI 10.1152/ajpendo.1999.277.2.E291; Barzilai N, 1997, J CLIN INVEST, V100, P3105, DOI 10.1172/JCI119865; BASKIN DG, 1987, ANNU REV PHYSIOL, V49, P335, DOI 10.1146/annurev.ph.49.030187.002003; Baskin DG, 1999, J HISTOCHEM CYTOCHEM, V47, P353, DOI 10.1177/002215549904700309; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Burry RW, 2000, J HISTOCHEM CYTOCHEM, V48, P163, DOI 10.1177/002215540004800201; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CHIANG MY, 1991, J BIOL CHEM, V266, P18162; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; DAVIS SN, 1995, J CLIN INVEST, V95, P593, DOI 10.1172/JCI117703; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; HEIDENREICH KA, 1993, ANN NY ACAD SCI, V692, P72; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; LUZI L, 1992, DIABETES, V41, P1632, DOI 10.2337/diabetes.41.12.1632; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Paxinos G., 1998, RAT BRAIN STEROTAXIC; ROBINSON LJ, 1994, ENDOCRINOLOGY, V135, P2568, DOI 10.1210/en.135.6.2568; ROSSETTI L, 1990, J CLIN INVEST, V85, P1785, DOI 10.1172/JCI114636; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; SCHWARTZ MW, 1991, ENDOCRINOLOGY, V128, P2645, DOI 10.1210/endo-128-5-2645; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; SIPOLS AJ, 1995, DIABETES, V44, P147, DOI 10.2337/diabetes.44.2.147; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wang JL, 1999, NAT MED, V5, P895, DOI 10.1038/11335; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; WOODS SC, 1984, AM J PHYSIOL, V247, pR393, DOI 10.1152/ajpregu.1984.247.2.R393; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	36	529	545	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2002	5	6					566	572		10.1038/nn861	http://dx.doi.org/10.1038/nn861			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556XQ	12021765				2022-12-17	WOS:000175874600017
J	Meinhardt, J; Radke, J; Dittmayer, C; Franz, J; Thomas, C; Mothes, R; Laue, M; Schneider, J; Brunink, S; Greuel, S; Lehmann, M; Hassan, O; Aschman, T; Schumann, E; Chua, RL; Conrad, C; Eils, R; Stenzel, W; Windgassen, M; Rossler, L; Goebel, HH; Gelderblom, HR; Martin, H; Nitsche, A; Schulz-Schaeffer, WJ; Hakroush, S; Winkler, MS; Tampe, B; Scheibe, F; Kortvelyessy, P; Reinhold, D; Siegmund, B; Kuhl, AA; Elezkurtaj, S; Horst, D; Oesterhelweg, L; Tsokos, M; Ingold-Heppner, B; Stadelmann, C; Drosten, C; Corman, VM; Radbruch, H; Heppner, FL				Meinhardt, Jenny; Radke, Josefine; Dittmayer, Carsten; Franz, Jonas; Thomas, Carolina; Mothes, Ronja; Laue, Michael; Schneider, Julia; Bruenink, Sebastian; Greuel, Selina; Lehmann, Malte; Hassan, Olga; Aschman, Tom; Schumann, Elisa; Chua, Robert Lorenz; Conrad, Christian; Eils, Roland; Stenzel, Werner; Windgassen, Marc; Roessler, Larissa; Goebel, Hans-Hilmar; Gelderblom, Hans R.; Martin, Hubert; Nitsche, Andreas; Schulz-Schaeffer, Walter J.; Hakroush, Samy; Winkler, Martin S.; Tampe, Bjoern; Scheibe, Franziska; Koertvelyessy, Peter; Reinhold, Dirk; Siegmund, Britta; Kuehl, Anja A.; Elezkurtaj, Sefer; Horst, David; Oesterhelweg, Lars; Tsokos, Michael; Ingold-Heppner, Barbara; Stadelmann, Christine; Drosten, Christian; Corman, Victor Max; Radbruch, Helena; Heppner, Frank L.			Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19	NATURE NEUROSCIENCE			English	Article							ELECTRON-MICROSCOPY; INFECTION; MICE; ACE2	The newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a pandemic respiratory disease. Moreover, thromboembolic events throughout the body, including in the CNS, have been described. Given the neurological symptoms observed in a large majority of individuals with COVID-19, SARS-CoV-2 penetrance of the CNS is likely. By various means, we demonstrate the presence of SARS-CoV-2 RNA and protein in anatomically distinct regions of the nasopharynx and brain. Furthermore, we describe the morphological changes associated with infection such as thromboembolic ischemic infarction of the CNS and present evidence of SARS-CoV-2 neurotropism. SARS-CoV-2 can enter the nervous system by crossing the neural-mucosal interface in olfactory mucosa, exploiting the close vicinity of olfactory mucosal, endothelial and nervous tissue, including delicate olfactory and sensory nerve endings. Subsequently, SARS-CoV-2 appears to follow neuroanatomical structures, penetrating defined neuroanatomical areas including the primary respiratory and cardiovascular control center in the medulla oblongata. The authors demonstrate the presence of SARS-CoV-2 in the nasopharynx and brain, suggesting that the virus is present in the CNS and may enter through the olfactory mucosa, exploiting the close vicinity of olfactory mucosal, endothelial and nervous tissue.	[Meinhardt, Jenny; Radke, Josefine; Dittmayer, Carsten; Mothes, Ronja; Hassan, Olga; Aschman, Tom; Schumann, Elisa; Stenzel, Werner; Goebel, Hans-Hilmar; Martin, Hubert; Radbruch, Helena; Heppner, Frank L.] Charite Univ Med Berlin, Dept Neuropathol, Berlin, Germany; [Meinhardt, Jenny; Radke, Josefine; Dittmayer, Carsten; Mothes, Ronja; Schneider, Julia; Bruenink, Sebastian; Greuel, Selina; Lehmann, Malte; Hassan, Olga; Aschman, Tom; Schumann, Elisa; Chua, Robert Lorenz; Conrad, Christian; Eils, Roland; Stenzel, Werner; Windgassen, Marc; Roessler, Larissa; Goebel, Hans-Hilmar; Martin, Hubert; Scheibe, Franziska; Koertvelyessy, Peter; Siegmund, Britta; Kuehl, Anja A.; Elezkurtaj, Sefer; Horst, David; Oesterhelweg, Lars; Tsokos, Michael; Drosten, Christian; Corman, Victor Max; Radbruch, Helena; Heppner, Frank L.] Free Univ Berlin, Berlin, Germany; [Meinhardt, Jenny; Radke, Josefine; Dittmayer, Carsten; Mothes, Ronja; Schneider, Julia; Bruenink, Sebastian; Greuel, Selina; Lehmann, Malte; Hassan, Olga; Aschman, Tom; Schumann, Elisa; Chua, Robert Lorenz; Conrad, Christian; Eils, Roland; Stenzel, Werner; Windgassen, Marc; Roessler, Larissa; Goebel, Hans-Hilmar; Martin, Hubert; Scheibe, Franziska; Koertvelyessy, Peter; Siegmund, Britta; Kuehl, Anja A.; Elezkurtaj, Sefer; Horst, David; Oesterhelweg, Lars; Tsokos, Michael; Drosten, Christian; Corman, Victor Max; Radbruch, Helena; Heppner, Frank L.] Humboldt Univ, Berlin, Germany; [Meinhardt, Jenny; Radke, Josefine; Dittmayer, Carsten; Mothes, Ronja; Schneider, Julia; Bruenink, Sebastian; Greuel, Selina; Lehmann, Malte; Hassan, Olga; Aschman, Tom; Schumann, Elisa; Stenzel, Werner; Windgassen, Marc; Roessler, Larissa; Goebel, Hans-Hilmar; Martin, Hubert; Scheibe, Franziska; Koertvelyessy, Peter; Siegmund, Britta; Kuehl, Anja A.; Elezkurtaj, Sefer; Horst, David; Oesterhelweg, Lars; Tsokos, Michael; Drosten, Christian; Corman, Victor Max; Radbruch, Helena; Heppner, Frank L.] Berlin Inst Hlth, Berlin, Germany; [Radke, Josefine; Heppner, Frank L.] Berlin Inst Hlth BIH, Berlin, Germany; [Radke, Josefine; Schumann, Elisa] German Canc Consortium DKTK, Partner Site Berlin, CCCC Campus Mitte, Berlin, Germany; [Franz, Jonas; Thomas, Carolina; Stadelmann, Christine] Univ Med Ctr, Inst Neuropathol, Gottingen, Germany; [Franz, Jonas] Univ Gottingen, Campus Inst Dynam Biol Networks, Gottingen, Germany; [Franz, Jonas; Thomas, Carolina] Max Planck Inst Expt Med, Gottingen, Germany; [Laue, Michael; Gelderblom, Hans R.; Nitsche, Andreas] Robert Koch Inst, Ctr Biol Threats & Special Pathogens ZBS, Berlin, Germany; [Schneider, Julia; Bruenink, Sebastian; Drosten, Christian; Corman, Victor Max] Charite Univ Med Berlin, Inst Virol, Berlin, Germany; [Schneider, Julia; Bruenink, Sebastian; Drosten, Christian; Corman, Victor Max] German Ctr Infect Res, Berlin, Germany; [Greuel, Selina; Elezkurtaj, Sefer; Horst, David] Charite Univ Med Berlin, Inst Pathol, Berlin, Germany; [Lehmann, Malte; Siegmund, Britta] Charite Univ Med Berlin, Div Gastroenterol Infectiol & Rheumatol, Med Dept, Berlin, Germany; [Chua, Robert Lorenz; Conrad, Christian; Eils, Roland] Berlin Inst Hlth BIH, Ctr Digital Hlth, Berlin, Germany; [Eils, Roland] Heidelberg Univ, Fac Med, Hlth Data Sci Unit, Heidelberg, Germany; [Windgassen, Marc; Roessler, Larissa; Oesterhelweg, Lars; Tsokos, Michael] Charite Univ Med Berlin, Inst Legal Med & Forens Sci, Berlin, Germany; [Schulz-Schaeffer, Walter J.] Univ Saarland, Inst Neuropathol, Homburg, Germany; [Hakroush, Samy] Univ Med Ctr Gottingen, Inst Pathol, Gottingen, Germany; [Winkler, Martin S.] Univ Med Ctr Gottingen, Dept Anaesthesiol & Intens Care Med, Gottingen, Germany; [Tampe, Bjoern] Univ Med Ctr Gottingen, Dept Nephrol & Rheumatol, Gottingen, Germany; [Scheibe, Franziska; Koertvelyessy, Peter] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Scheibe, Franziska; Heppner, Frank L.] NeuroCure, Cluster Excellence, Berlin, Germany; [Koertvelyessy, Peter] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany; [Reinhold, Dirk] Otto von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany; [Kuehl, Anja A.] Charite Univ Med Berlin, Berlin, Germany; [Kuehl, Anja A.] iPATH Berlin, Berlin, Germany; [Ingold-Heppner, Barbara] DRK Klin Berlin, Inst Pathol, Berlin, Germany; [Heppner, Frank L.] German Ctr Neurodegenerat Dis DZNE Berlin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Berlin Institute of Health; Helmholtz Association; German Cancer Research Center (DKFZ); University of Gottingen; University of Gottingen; Max Planck Society; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Center for Infection Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Saarland University; University of Gottingen; University of Gottingen; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Otto von Guericke University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Heppner, FL (corresponding author), Charite Univ Med Berlin, Dept Neuropathol, Berlin, Germany.; Heppner, FL (corresponding author), Free Univ Berlin, Berlin, Germany.; Heppner, FL (corresponding author), Humboldt Univ, Berlin, Germany.; Heppner, FL (corresponding author), Berlin Inst Hlth, Berlin, Germany.; Heppner, FL (corresponding author), Berlin Inst Hlth BIH, Berlin, Germany.; Heppner, FL (corresponding author), NeuroCure, Cluster Excellence, Berlin, Germany.; Heppner, FL (corresponding author), German Ctr Neurodegenerat Dis DZNE Berlin, Berlin, Germany.	frank.heppner@charite.de	Radke, Josefine/GQH-8274-2022; Tampe, Björn/ABA-6091-2021; Winkler, Martin Sebastian/AGZ-1086-2022; Eils, Roland/B-6121-2009; Elezkurtaj, Sefer/AGE-2331-2022; Corman, Victor M/K-1319-2019; Radke, Josefine/AAB-9873-2022; Heppner, Frank/ABH-8393-2020; Siegmund, Britta/E-6929-2018	Radke, Josefine/0000-0001-9860-2007; Tampe, Björn/0000-0002-4357-9863; Eils, Roland/0000-0002-0034-4036; Elezkurtaj, Sefer/0000-0002-1699-1270; Corman, Victor M/0000-0002-3605-0136; Radke, Josefine/0000-0001-9860-2007; Heppner, Frank/0000-0001-9816-8917; Kuhl, Anja/0000-0003-2293-5387; Meinhardt, Jenny/0000-0003-0366-2416; Radbruch, Helena/0000-0001-6941-3397; Chua, Robert Lorenz/0000-0001-5945-9957; Schneider, Julia/0000-0002-0494-1022; Aschman, Tom/0000-0002-2101-6146; Conrad, Christian/0000-0001-7036-342X; Hakroush, Samy/0000-0002-2843-3567; Lehmann, Malte/0000-0002-3786-7375; Franz, Jonas/0000-0001-7523-6622; Siegmund, Britta/0000-0002-0055-958X; Stadelmann, Christine/0000-0003-1766-5458; Thomas, Carolina/0000-0002-7386-1181; Nitsche, Andreas/0000-0001-8185-3176; Stenzel, Werner/0000-0002-1143-2103	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy [EXC-2049-390688087, SFB TRR 167, HE 3130/6-1, SFB 958/Z02, SFB TRR 130 TP17, EXC 2067/1-390729940, SFB TRR 274, STA 1389/5-1, SFB TRR 241]; German Center for Neurodegenerative Diseases (DZNE) Berlin; European Union (PHAGO, Innovative Medicines Initiative-2; FP7-PEOPLE-2012-ITN: NeuroKine) [115976]; Ministry for Science and Education of Lower Saxony through the program 'Niedersachsisches Vorab'; Charite Foundation; Institute of Pathology of the University Medical Center, Gottingen	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy(German Research Foundation (DFG)); German Center for Neurodegenerative Diseases (DZNE) Berlin; European Union (PHAGO, Innovative Medicines Initiative-2; FP7-PEOPLE-2012-ITN: NeuroKine); Ministry for Science and Education of Lower Saxony through the program 'Niedersachsisches Vorab'; Charite Foundation; Institute of Pathology of the University Medical Center, Gottingen	We are indebted to F. Egelhofer, R. Koll, P. Matylewski, K. Permien, V. Wolf, S. Meier, R. Muller, U. Scheidt, K. Guttek, F. Paap, B. Maruschak and K. Schulz for excellent technical assistance and advice. We thank the Core Facility for Electron Microscopy of the Charite for support in acquisition of the data. We also thank H. Bohnenberger, S. Kuffer and the Institute of Pathology of the University Medical Center, Gottingen, for their support. The authors are most grateful to the individuals with COVD-19 and their relatives for consenting to autopsy and subsequent research, which were facilitated by the Biobank of the Department of Neuropathology, Charite-Universitatsmedizin Berlin. Cartoon images were partially created with Biorender.com. This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy EXC-2049-390688087, as well as SFB TRR 167 and HE 3130/6-1 to F.L.H., SFB 958/Z02 to J.S., SFB TRR 130 TP17 to H.R., EXC 2067/1-390729940, SFB TRR 274 and STA 1389/5-1 to C.S. and SFB TRR 241 to B.S. and A.A.K., by the German Center for Neurodegenerative Diseases (DZNE) Berlin, by the European Union (PHAGO, 115976; Innovative Medicines Initiative-2; FP7-PEOPLE-2012-ITN: NeuroKine) and by the Ministry for Science and Education of Lower Saxony through the program 'Niedersachsisches Vorab' to J.F. Furthermore, we thank the Charite Foundation (Max Rubner Preis 2016) for financial support to C. Dittmayer.	[Anonymous], 2020, FREE NEUROPATHOLOGY, DOI DOI 10.17879/FREENEUROPATHOLOGY-2020-2736; Arbour N, 2000, J VIROL, V74, P8913, DOI 10.1128/JVI.74.19.8913-8921.2000; Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122; Besson Sebastien, 2019, Digit Pathol (2019), V2019, P3, DOI 10.1007/978-3-030-23937-4_1; Blanchard E, 2015, CELL MICROBIOL, V17, P45, DOI 10.1111/cmi.12372; Brann DH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5801; Butowt R, 2020, ACS CHEM NEUROSCI, V11, P1200, DOI 10.1021/acschemneuro.0c00172; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Cardona GC, 2020, J NEUROL SCI, V412, DOI 10.1016/j.jns.2020.116824; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Cyranoski D, 2020, NATURE, V581, P22, DOI 10.1038/d41586-020-01315-7; Deigendesch N, 2020, ACTA NEUROPATHOL, V140, P583, DOI 10.1007/s00401-020-02213-y; Desforges M, 2014, ADV EXP MED BIOL, V807, P75, DOI 10.1007/978-81-322-1777-0_6; Dittmayer C, 2020, LANCET, V396, pE64, DOI 10.1016/S0140-6736(20)32079-1; Doobay MF, 2007, AM J PHYSIOL-REG I, V292, pR373, DOI 10.1152/ajpregu.00292.2006; Glass WG, 2004, J IMMUNOL, V173, P4030, DOI 10.4049/jimmunol.173.6.4030; Goldsmith CS, 2004, EMERG INFECT DIS, V10, P320, DOI 10.3201/eid1002.030913; Goldsmith CS, 2020, LANCET, V395, pE99, DOI 10.1016/S0140-6736(20)31188-0; Goldsmith CS, 2009, CLIN MICROBIOL REV, V22, P552, DOI 10.1128/CMR.00027-09; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Holbrook EH, 2011, LARYNGOSCOPE, V121, P1687, DOI 10.1002/lary.21856; Jensen MP, 2021, NEUROPATH APPL NEURO, V47, P17, DOI 10.1111/nan.12662; Khan S, 2020, ELIFE, V9, DOI 10.7554/eLife.59136; Kortvelyessy P, 2020, CYTOKINE, V135, DOI 10.1016/j.cyto.2020.155226; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Laue M, 2010, METHOD CELL BIOL, V96, P1, DOI 10.1016/S0091-679X(10)96001-9; Li K, 2016, J INFECT DIS, V213, P712, DOI 10.1093/infdis/jiv499; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2; Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062; Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08; Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787; Paniz-Mondolfi A, 2020, J MED VIROL, V92, P699, DOI 10.1002/jmv.25915; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2011400, 10.1056/NEJMc2013400]; Reichard RR, 2020, ACTA NEUROPATHOL, V140, P1, DOI 10.1007/s00401-020-02166-2; Schaller T, 2020, JAMA-J AM MED ASSOC, V323, P2518, DOI 10.1001/jama.2020.8907; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schurink B, 2020, LANCET MICROBE, V1, pE290, DOI 10.1016/S2666-5247(20)30144-0; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Solomon IH, 2020, NEW ENGL J MED, V383, P989, DOI 10.1056/NEJMc2019373; Tsai SY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003848; van Riel D, 2015, J PATHOL, V235, P277, DOI 10.1002/path.4461; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; von Weyhern CH, 2020, LANCET, V395, pE109, DOI 10.1016/S0140-6736(20)31282-4; Wang YZ, 2020, CELL MOL LIFE SCI, V77, P3597, DOI 10.1007/s00018-019-03385-x; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Zubair AS, 2020, JAMA NEUROL, V77, P1018, DOI 10.1001/jamaneurol.2020.2065	49	527	538	14	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2021	24	2					168	175		10.1038/s41593-020-00758-5	http://dx.doi.org/10.1038/s41593-020-00758-5		NOV 2020	8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QB1EW	33257876	Bronze			2022-12-17	WOS:000594824500002
J	Toni, N; Laplagne, DA; Zhao, C; Lombardi, G; Ribak, CE; Gage, FH; Schinder, AF				Toni, Nicolas; Laplagne, Diego A.; Zhao, Chunmei; Lombardi, Gabriela; Ribak, Charles E.; Gage, Fred H.; Schinder, Alejandro F.			Neurons born in the adult dentate gyrus form functional synapses with target cells	NATURE NEUROSCIENCE			English	Article							MOSSY FIBER SYNAPSES; ENHANCED SYNAPTIC PLASTICITY; NEWLY GENERATED NEURONS; CA3 PYRAMIDAL CELLS; GRANULE CELLS; RAT HIPPOCAMPUS; INTRACELLULAR-RECORDINGS; NEUROGENESIS; INHIBITION; ACTIVATION	Adult neurogenesis occurs in the hippocampus and the olfactory bulb of the mammalian CNS. Recent studies have demonstrated that newborn granule cells of the adult hippocampus are postsynaptic targets of excitatory and inhibitory neurons, but evidence of synapse formation by the axons of these cells is still lacking. By combining retroviral expression of green fluorescent protein in adult-born neurons of the mouse dentate gyrus with immuno-electron microscopy, we found output synapses that were formed by labeled terminals on appropriate target cells in the CA3 area and the hilus. Furthermore, retroviral expression of channelrhodopsin-2 allowed us to light-stimulate newborn granule cells and identify postsynaptic target neurons by whole-cell recordings in acute slices. Our structural and functional evidence indicates that axons of adult-born granule cells establish synapses with hilar interneurons, mossy cells and CA3 pyramidal cells and release glutamate as their main neurotransmitter.	[Toni, Nicolas; Zhao, Chunmei; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Laplagne, Diego A.; Lombardi, Gabriela; Schinder, Alejandro F.] Consejo Nacl Invest Cient & Tecn, Leloir Inst, Lab Neuronal Plast, RA-1405 Buenos Aires, DF, Argentina; [Ribak, Charles E.] Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92697 USA	Salk Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of California System; University of California Irvine	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu; aschinder@leloir.org.ar	Laplagne, Diego A/I-4462-2014; Toni, Nicolas/M-2057-2014	Laplagne, Diego A/0000-0001-5860-1667; Toni, Nicolas/0000-0001-5585-268X; Schinder, Alejandro/0000-0003-4863-8348	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050217, R01NS038331] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS050217, R01 NS050217-04, R01 NS038331, NS038331, NS050217] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acsady L, 1998, J NEUROSCI, V18, P3386; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; AMARAL DG, 1979, ANAT EMBRYOL, V155, P241, DOI 10.1007/BF00317638; AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; FROTSCHER M, 1989, EXP BRAIN RES, V75, P441; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gutierrez R, 2005, TRENDS NEUROSCI, V28, P297, DOI 10.1016/j.tins.2005.04.005; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; KNEISLER TB, 1995, HIPPOCAMPUS, V5, P151, DOI 10.1002/hipo.450050302; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; SCHARFMAN HE, 1990, NEUROSCIENCE, V37, P693, DOI 10.1016/0306-4522(90)90100-I; SCHARFMAN HE, 1995, J NEUROPHYSIOL, V74, P179, DOI 10.1152/jn.1995.74.1.179; SCHARFMAN HE, 1994, J NEUROPHYSIOL, V72, P2167, DOI 10.1152/jn.1994.72.5.2167; Schinder AF, 2004, PHYSIOLOGY, V19, P253, DOI 10.1152/physiol.00012.2004; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; SERESS L, 1995, HIPPOCAMPUS, V5, P217, DOI 10.1002/hipo.450050308; Shapiro LA, 2007, BRAIN RES, V1149, P30, DOI 10.1016/j.brainres.2006.07.032; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; SORIANO E, 1993, J COMP NEUROL, V333, P435, DOI 10.1002/cne.903330309; STANDEN NB, 1978, J PHYSIOL-LONDON, V280, P169, DOI 10.1113/jphysiol.1978.sp012379; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	37	527	550	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2008	11	8					901	907		10.1038/nn.2156	http://dx.doi.org/10.1038/nn.2156			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330UU	18622400	Green Submitted, Green Accepted, Green Published			2022-12-17	WOS:000257969100015
J	Fietz, SA; Kelava, I; Vogt, J; Wilsch-Brauninger, M; Stenzel, D; Fish, JL; Corbeil, D; Riehn, A; Distler, W; Nitsch, R; Huttner, WB				Fietz, Simone A.; Kelava, Iva; Vogt, Johannes; Wilsch-Braeuninger, Michaela; Stenzel, Denise; Fish, Jennifer L.; Corbeil, Denis; Riehn, Axel; Distler, Wolfgang; Nitsch, Robert; Huttner, Wieland B.			OSVZ progenitors of human and ferret neocortex are epithelial-like and expand by integrin signaling	NATURE NEUROSCIENCE			English	Article							MAMMALIAN NEUROEPITHELIAL CELLS; MOUSE CEREBRAL-CORTEX; RADIAL GLIA; NEURAL STEM; CORTICAL NEUROGENESIS; SUBVENTRICULAR ZONE; DIVISIONS; DIFFERENTIATION; EVOLUTION; BRAIN	A major cause of the cerebral cortex expansion that occurred during evolution is the increase in subventricular zone (SVZ) progenitors. We found that progenitors in the outer SVZ (OSVZ) of developing human neocortex retain features of radial glia, in contrast to rodent SVZ progenitors, which have limited proliferation potential. Although delaminating from apical adherens junctions, OSVZ progenitors maintained a basal process contacting the basal lamina, a canonical epithelial property. OSVZ progenitor divisions resulted in asymmetric inheritance of their basal process. Notably, OSVZ progenitors are also found in the ferret, a gyrencephalic nonprimate. Functional disruption of integrins, expressed on the basal process of ferret OSVZ progenitors, markedly decreased the OSVZ progenitor population size, but not that of other, process-lacking SVZ progenitors, in slice cultures of ferret neocortex. Our findings suggest that maintenance of this epithelial property allows integrin-mediated, repeated asymmetric divisions of OSVZ progenitors, providing a basis for neocortical expansion.	[Fietz, Simone A.; Kelava, Iva; Wilsch-Braeuninger, Michaela; Stenzel, Denise; Fish, Jennifer L.; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Vogt, Johannes; Nitsch, Robert] Charite, Ctr Anat, Inst Cell Biol & Neurobiol, Berlin, Germany; [Corbeil, Denis] Tech Univ Dresden, BIOTEC, Dresden, Germany; [Riehn, Axel; Distler, Wolfgang] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Klin & Poliklin Frauenheilkunde & Geburtshilfe, Dresden, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Huttner, WB (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	huttner@mpi-cbg.de	Corbeil, Denis/A-6519-2010; Huttner, Wieland B./P-4080-2018; Nitsch, Robert/AAI-9129-2021; Corbeil, Denis/AFL-1008-2022; Vogt, Johannes/O-4289-2019; Corbeil, Denis/L-2340-2019; Vogt, Johannes/K-2278-2015	Corbeil, Denis/0000-0003-1181-3659; Fish, Jennifer/0000-0002-2654-2583; Vogt, Johannes/0000-0003-2439-8247	Deutsche Forschungsgemeinschaft (DFG) [SFB 655, A2]; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	We thank J. Helppi and other members of the animal facility, and the light microscopy facility, of the Max Planck Institute of Molecular Cell Biology and Genetics for excellent support, A.-M. Marzesco and E. Taverna for experimental advice, C. Haffner for excellent technical assistance, S. Preibisch for developing the Fiji plug-in, and J. Pulvers for his helpful comments on the manuscript. We are grateful to the Bundesinstitut fur Risikobewertung and Biotie Therapies for ferret housing. S.A.F., I.K. and J.L.F. were members of the International Max Planck Research School for Molecular Cell Biology and Bioengineering. W.B.H. was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) (SFB 655, A2) and by the DFG-funded Center for Regenerative Therapies Dresden and by the Fonds der Chemischen Industrie.	AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Abdel-Mannan O, 2008, BRAIN RES BULL, V75, P398, DOI 10.1016/j.brainresbull.2007.10.047; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Bayatti N, 2008, CEREB CORTEX, V18, P1536, DOI 10.1093/cercor/bhm184; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Carney RSE, 2007, BRAIN STRUCT FUNCT, V212, P37, DOI 10.1007/s00429-007-0142-4; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778; Fuchs E, 2009, CELL STEM CELL, V4, P499, DOI 10.1016/j.stem.2009.05.001; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; HIRSCH E, 1994, DEV DYNAM, V201, P108, DOI 10.1002/aja.1002010203; Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; Konno D, 2008, NAT CELL BIOL, V10, P93, DOI 10.1038/ncb1673; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kosodo Y, 2008, EMBO J, V27, P3151, DOI 10.1038/emboj.2008.227; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kriegstein AR, 2003, GLIA, V43, P37, DOI 10.1002/glia.10250; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lathia JD, 2007, DEV DYNAM, V236, P3267, DOI 10.1002/dvdy.21319; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mo ZC, 2008, CEREB CORTEX, V18, P1455, DOI 10.1093/cercor/bhm181; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Neal J, 2007, J ANAT, V210, P66, DOI 10.1111/j.1469-7580.2006.00674.x; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Radakovits R, 2009, J NEUROSCI, V29, P7694, DOI 10.1523/JNEUROSCI.5537-08.2009; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; SMART IHM, 1986, J ANAT, V146, P141; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wierzbicka-Patynowski I, 1999, J BIOL CHEM, V274, P37809, DOI 10.1074/jbc.274.53.37809; WOODHAMS PL, 1981, ANAT EMBRYOL, V163, P331, DOI 10.1007/BF00315709; Yoshida N, 2003, EXP CELL RES, V287, P262, DOI 10.1016/S0014-4827(03)00158-7	50	526	533	4	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2010	13	6					690	U62		10.1038/nn.2553	http://dx.doi.org/10.1038/nn.2553			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	600QY	20436478				2022-12-17	WOS:000278003300013
J	Sweeney, MD; Ayyadurai, S; Zlokovic, BV				Sweeney, Melanie D.; Ayyadurai, Shiva; Zlokovic, Berislav V.			Pericytes of the neurovascular unit: key functions and signaling pathways	NATURE NEUROSCIENCE			English	Review							BLOOD-BRAIN-BARRIER; ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; CEREBRAL CAVERNOUS MALFORMATIONS; FAMILIAL ALZHEIMERS-DISEASE; BASAL GANGLIA CALCIFICATION; MOTOR-NEURON DEGENERATION; CENTRAL-NERVOUS-SYSTEM; SENSITIVE K+ CURRENTS; FACTOR-RECEPTOR-BETA	Pericytes are vascular mural cells embedded in the basement membrane of blood microvessels. They extend their processes along capillaries, pre-capillary arterioles and post-capillary venules. CNS pericytes are uniquely positioned in the neurovascular unit between endothelial cells, astrocytes and neurons. They integrate, coordinate and process signals from their neighboring cells to generate diverse functional responses that are critical for CNS functions in health and disease, including regulation of the blood-brain barrier permeability, angiogenesis, clearance of toxic metabolites, capillary hemodynamic responses, neuroinflammation and stem cell activity. Here we examine the key signaling pathways between pericytes and their neighboring endothelial cells, astrocytes and neurons that control neurovascular functions. We also review the role of pericytes in CNS disorders including rare monogenic diseases and complex neurological disorders such as Alzheimer's disease and brain tumors. Finally, we discuss directions for future studies.	[Sweeney, Melanie D.; Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Sweeney, Melanie D.; Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Ayyadurai, Shiva] CytoSolve Res Div, Syst Biol Grp, Cambridge, MA USA	University of Southern California; University of Southern California	Zlokovic, BV (corresponding author), Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.; Zlokovic, BV (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	zlokovic@usc.edu	Zlokovic, Berislav/ABE-7362-2020	Zlokovic, Berislav/0000-0002-6802-8232; Sweeney, Melanie/0000-0001-9009-6488	National Institutes of Health [R01AG023084, R01NS090904, R01NS034467, R01AG039452]; Cure for Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS090904, R01NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG039452, R01AG023084, R01AG039452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure for Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	B.V.Z. is supported by the National Institutes of Health grants R01AG023084, R01NS090904, R01NS034467 and R01AG039452 and the Cure for Alzheimer's Fund.	Al Ahmad A, 2009, J CELL PHYSIOL, V218, P612, DOI 10.1002/jcp.21638; Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313; Alata W, 2015, J CEREBR BLOOD F MET, V35, P86, DOI 10.1038/jcbfm.2014.172; Alcendor DJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt379; Alikhani M, 2010, MOL VIS, V16, P408; Armstrong RA, 2008, FOLIA NEUROPATHOL, V46, P241; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arnold TD, 2014, DEVELOPMENT, V141, P4489, DOI 10.1242/dev.107193; Attwell D, 2016, J CEREBR BLOOD F MET, V36, P451, DOI 10.1177/0271678X15610340; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Augustin HG, 2003, CELL TISSUE RES, V314, P25, DOI 10.1007/s00441-003-0770-9; Ayyadurai VAS, 2011, CELL MOL BIOENG, V4, P28, DOI 10.1007/s12195-010-0143-x; Baloyannis SJ, 2012, J NEUROL SCI, V322, P117, DOI 10.1016/j.jns.2012.07.010; Behl Y, 2009, DIABETES, V58, P917, DOI 10.2337/db08-0537; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Benest AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070459; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bjorkqvist M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029868; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Bondjers C, 2006, FASEB J, V20, P1703, DOI 10.1096/fj.05-4944fje; Bottner M, 2000, J NEUROCHEM, V75, P2227, DOI 10.1046/j.1471-4159.2000.0752227.x; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Christian S, 2008, AM J PATHOL, V172, P486, DOI 10.2353/ajpath.2008.070623; Cui X, 2011, NEUROBIOL DIS, V43, P285, DOI 10.1016/j.nbd.2011.04.005; Dai M, 2009, HEARING RES, V254, P100, DOI 10.1016/j.heares.2009.04.018; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dieterich LC, 2012, J PATHOL, V228, P378, DOI 10.1002/path.4072; Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469; Dore-Duffy P, 2007, NEUROL RES, V29, P395, DOI 10.1179/016164107X204729; Engelhardt S, 2014, BRIT J PHARMACOL, V171, P1210, DOI 10.1111/bph.12489; Erber R, 2006, EMBO J, V25, P628, DOI 10.1038/sj.emboj.7600949; Farkas E, 2001, PROG NEUROBIOL, V64, P575, DOI 10.1016/S0301-0082(00)00068-X; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Feng YX, 2007, THROMB HAEMOSTASIS, V97, P99, DOI 10.1160/TH06-05-0277; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Garmy-Susini B, 2005, J CLIN INVEST, V115, P1542, DOI 10.1172/JCI23445; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052; Gerhardt H, 2000, DEV DYNAM, V218, P472, DOI 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghosh M, 2015, ANN NEUROL, V78, P887, DOI 10.1002/ana.24512; Gliemann J, 2004, BIOCHEM J, V381, P203, DOI 10.1042/BJ20040149; Gonul E, 2002, MICROVASC RES, V64, P116, DOI 10.1006/mvre.2002.2413; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; Guichet PO, 2015, STEM CELLS, V33, P21, DOI 10.1002/stem.1767; Hall CN, 2014, NATURE, V508, P55, DOI 10.1038/nature13165; Halliday M. R., 2015, J CEREB BLOOD FLOW M; Halliday MR, 2013, JAMA NEUROL, V70, P1198, DOI 10.1001/jamaneurol.2013.3841; Hamel E, 2004, PROG BRAIN RES, V145, P171, DOI 10.1016/S0079-6123(02)45012-7; Hamilton NB, 2010, FRONT NEUROENERGETIC; Hartmann DA, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.4.041402; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; HELBIG H, 1992, INVEST OPHTH VIS SCI, V33, P2105; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Henshall TL, 2015, ARTERIOSCL THROM VAS, V35, P409, DOI 10.1161/ATVBAHA.114.304849; Hermey G, 2006, BIOCHEM J, V395, P285, DOI 10.1042/BJ20051364; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; Hirschi KK, 2003, CIRC RES, V93, P429, DOI 10.1161/01.RES.0000091259.84556.D5; Hultman K, 2013, J CEREBR BLOOD F MET, V33, P1251, DOI 10.1038/jcbfm.2013.76; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jansson D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-104; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Jurek A, 2011, CELL SIGNAL, V23, P280, DOI 10.1016/j.cellsig.2010.09.013; Kamouchi M, 2004, MOL BRAIN RES, V126, P114, DOI 10.1016/j.molbrainres.2004.03.008; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; Kickingereder P, 2016, RADIOLOGY, V279, P542, DOI 10.1148/radiol.2015151172; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Kim KT, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0692-3; Kleinstreuer N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002996; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Lemos RR, 2015, HUM MUTAT, V36, P489, DOI 10.1002/humu.22778; Li FF, 2011, DEV CELL, V20, P291, DOI 10.1016/j.devcel.2011.01.011; Li Q, 2001, BRAIN RES, V907, P93, DOI 10.1016/S0006-8993(01)02607-5; Li XF, 2011, J BIOL CHEM, V286, P26138, DOI 10.1074/jbc.M110.211250; Liebner S, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-1; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lovick TA, 1999, NEUROSCIENCE, V92, P47, DOI 10.1016/S0306-4522(98)00737-4; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; MacFadyen J, 2007, GENE EXPR PATTERNS, V7, P363, DOI 10.1016/j.modgep.2006.07.006; MacVicar BA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020388; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Marchi N, 2013, NEUROSCIENTIST, V19, P304, DOI 10.1177/1073858412462747; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Mufti RE, 2010, J PHYSIOL-LONDON, V588, P3983, DOI 10.1113/jphysiol.2010.193300; Nakagomi T, 2015, STEM CELLS, V33, P1962, DOI 10.1002/stem.1977; Nakamura K, 2009, MICROVASC RES, V77, P327, DOI 10.1016/j.mvr.2008.12.001; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Niu F, 2014, J NEUROSCI, V34, P11812, DOI 10.1523/JNEUROSCI.1139-14.2014; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Park L, 2013, P NATL ACAD SCI USA, V110, P3089, DOI 10.1073/pnas.1300021110; Peppiatt CM, 2006, NATURE, V443, P700, DOI 10.1038/nature05193; Pieper C, 2014, BRAIN RES, V1550, P1, DOI 10.1016/j.brainres.2014.01.004; Reis M, 2013, EXP CELL RES, V319, P1317, DOI 10.1016/j.yexcr.2012.12.023; Reitz C, 2012, FUTUR NEUROL, V7, P423, DOI 10.2217/FNL.12.31; Reitz C, 2011, ARCH NEUROL-CHICAGO, V68, P99, DOI 10.1001/archneurol.2010.346; Reyahi A, 2015, DEV CELL, V34, P19, DOI 10.1016/j.devcel.2015.05.008; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Ruck T, 2015, NEURAL REGEN RES, V10, P889, DOI 10.4103/1673-5374.158342; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sagare AP, 2015, NEUROSCI LETT, V607, P97, DOI 10.1016/j.neulet.2015.09.025; Sagare AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3932; Sakagami K, 2001, MICROVASC RES, V62, P196, DOI 10.1006/mvre.2001.2343; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; SATO Y, 1989, J CELL BIOL, V109, P309, DOI 10.1083/jcb.109.1.309; Schulz GB, 2015, STROKE, V46, P1337, DOI 10.1161/STROKEAHA.114.007512; Sengillo JD, 2013, BRAIN PATHOL, V23, P303, DOI 10.1111/bpa.12004; Shaheen RM, 2001, CANCER RES, V61, P1464; Shimizu F, 2012, NEUROCHEM RES, V37, P401, DOI 10.1007/s11064-011-0626-8; Simonavicius N, 2008, MODERN PATHOL, V21, P308, DOI 10.1038/modpathol.3801006; Slevin M, 2000, STROKE, V31, P1863, DOI 10.1161/01.STR.31.8.1863; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Sosa MAG, 2010, AM J PATHOL, V176, P353, DOI 10.2353/ajpath.2010.090482; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Svensson A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123553; Sweeney MD, 2015, J CEREBR BLOOD F MET, V35, P1055, DOI 10.1038/jcbfm.2015.76; Takahashi H, 2015, BIOCHEM BIOPH RES CO, V457, P532, DOI 10.1016/j.bbrc.2015.01.016; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Tillet E, 2005, EXP CELL RES, V310, P392, DOI 10.1016/j.yexcr.2005.08.021; Uemura A, 2002, J CLIN INVEST, V110, P1619, DOI 10.1172/JCI200215621; van Dijk CGM, 2015, INT J CARDIOL, V190, P75, DOI 10.1016/j.ijcard.2015.03.258; Van Geest RJ, 2010, INVEST OPHTH VIS SCI, V51, P1857, DOI 10.1167/iovs.09-4181; Vinukonda G, 2010, STROKE, V41, P1766, DOI 10.1161/STROKEAHA.110.588400; Voisin MB, 2010, AM J PATHOL, V176, P482, DOI 10.2353/ajpath.2010.090510; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077; Wang FF, 2015, ONCOTARGET, V6, P2709, DOI 10.18632/oncotarget.2779; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Winkler EA, 2014, P NATL ACAD SCI USA, V111, pE1035, DOI 10.1073/pnas.1401595111; Winkler EA, 2013, ACTA NEUROPATHOL, V125, P111, DOI 10.1007/s00401-012-1039-8; Winkler EA, 2012, J CEREBR BLOOD F MET, V32, P1841, DOI 10.1038/jcbfm.2012.113; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; Wu DM, 2001, VISUAL NEUROSCI, V18, P935, DOI 10.1017/S0952523801186104; Yamanishi S, 2006, AM J PHYSIOL-HEART C, V290, pH925, DOI 10.1152/ajpheart.01012.2005; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang L, 2003, CANCER RES, V63, P3403; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zlokovic BV, 2010, NAT MED, V16, P1370, DOI 10.1038/nm1210-1370; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x; ZLOKOVIC BV, 1987, J NEUROCHEM, V49, P310, DOI 10.1111/j.1471-4159.1987.tb03431.x; ZLOKOVIC BV, 1995, PHARM RES-DORDR, V12, P1395, DOI 10.1023/A:1016254514167; ZLOKOVIC BV, 1985, BRAIN RES, V336, P125, DOI 10.1016/0006-8993(85)90423-8; ZLOKOVIC BV, 1985, BRAIN RES, V358, P191, DOI 10.1016/0006-8993(85)90963-1	174	524	543	7	153	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2016	19	6					771	783		10.1038/nn.4288	http://dx.doi.org/10.1038/nn.4288			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DN0HI	27227366	Green Accepted			2022-12-17	WOS:000376744600005
J	Pisella, L; Grea, H; Tilikete, C; Vighetto, A; Desmurget, M; Rode, G; Boisson, D; Rossetti, Y				Pisella, L; Grea, H; Tilikete, C; Vighetto, A; Desmurget, M; Rode, G; Boisson, D; Rossetti, Y			An 'automatic pilot' for the hand in human posterior parietal cortex: toward reinterpreting optic ataxia	NATURE NEUROSCIENCE			English	Article							REACHING MOVEMENTS; PREHENSION MOVEMENTS; UTILIZATION BEHAVIOR; GRASPING MOVEMENTS; UNILATERAL NEGLECT; MOTOR-RESPONSES; VISUAL CONTROL; FRONTAL LOBES; TARGET; MECHANISMS	We designed a protocol distinguishing between automatic and intentional motor reactions to changes in target location triggered at movement onset. In response to target jumps, but not to a similar change cued by a color switch, normal subjects often could not avoid automatically correcting fast aiming movements. This suggests that an 'automatic pilot' relying on spatial vision drives fast corrective arm movements that can escape intentional control. in a patient with a bilateral posterior parietal cortex (PPC) lesion, motor corrections could only be stow and deliberate. We propose that 'on-line' control is the most specific function of the PPC and that optic ataxia could result from a disruption of automatic hand guidance.	Espace & Act, INSERM, U534, D-69676 Bonn, Germany; Univ Lyon 1, F-69365 Lyon, France; Hospices Civils Lyon, F-69003 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Rossetti, Y (corresponding author), Espace & Act, INSERM, U534, 16 Ave Lepine,CP 13, D-69676 Bonn, Germany.		Rode, Gilles/J-8933-2017; Desmurget, Michel/L-2401-2017; Tilikete, Caroline/H-5996-2017; Pisella, Laure/H-6072-2017; Rossetti, Yves/H-3693-2017	Tilikete, Caroline/0000-0002-1452-1398; Pisella, Laure/0000-0001-6550-3774; Rossetti, Yves/0000-0001-8867-4496				Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; CASTIELLO U, 1991, BRAIN, V114, P2639, DOI 10.1093/brain/114.6.2639; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; DEJONG R, 1995, J EXP PSYCHOL HUMAN, V21, P498, DOI 10.1037/0096-1523.21.3.498; DELLASALA S, 1994, HDB NEUROPSYCHOLOGY, V9, P233; Desmurget M, 1998, NEUROSCI BIOBEHAV R, V22, P761, DOI 10.1016/S0149-7634(98)00004-9; DESMURGET M, 1995, J NEUROPHYSIOL, V74, P905, DOI 10.1152/jn.1995.74.2.905; Desmurget M, 1996, EXP BRAIN RES, V110, P265; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; FAUGIERGRIMAUD S, 1985, EXP BRAIN RES, V59, P125; Gentilucci M, 1996, NEUROPSYCHOLOGIA, V34, P369, DOI 10.1016/0028-3932(95)00128-X; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; GRAFTON ST, 1992, BRAIN, V115, P565, DOI 10.1093/brain/115.2.565; HAFFENDEN AM, IN PRESS COGN NEUROS; JAKOBSON LS, 1991, NEUROPSYCHOLOGIA, V29, P803, DOI 10.1016/0028-3932(91)90073-H; JEANNEROD M, 1986, NEUROPSYCHOLOGIA, V24, P41, DOI 10.1016/0028-3932(86)90042-4; JEANNEROD M, 1994, NEUROPSYCHOLOGIA, V32, P369, DOI 10.1016/0028-3932(94)90084-1; JENNINGS JR, 1992, J EXP PSYCHOL HUMAN, V18, P422, DOI 10.1037/0096-1523.18.2.422; KOMILIS E, 1993, J MOTOR BEHAV, V25, P299, DOI 10.1080/00222895.1993.9941651; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; LHERMITTE F, 1983, BRAIN, V106, P237, DOI 10.1093/brain/106.2.237; Li WX, 1997, VISION RES, V37, P1779, DOI 10.1016/S0042-6989(96)00301-X; Logan G.D., 1994, INHIBITORY PROCESSES, P214; Logan G. D., 1981, ATTENTION PERFORM, VIX, P205; Mattingley JB, 1998, EXP BRAIN RES, V120, P243, DOI 10.1007/s002210050398; Mattingley JB, 1998, NATURE, V392, P179, DOI 10.1038/32413; MCKAY WA, 1992, J NEUROPHYSIOL, V67, P1331; Milner A. D., 1995, VISUAL BRAIN ACTION; Milner AD, 1999, P ROY SOC B-BIOL SCI, V266, P2225, DOI 10.1098/rspb.1999.0912; NOWAK LG, 1997, EXTRASTRIATE VISUAL, P205; PAULIGNAN Y, 1991, EXP BRAIN RES, V83, P502; PELISSON D, 1986, EXP BRAIN RES, V62, P303; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Pisella L, 1998, EXP BRAIN RES, V121, P270, DOI 10.1007/s002210050460; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; RIDDOCH J, IN PRESS ATTENTION P, V18; Riddoch MJ, 1998, COGNITIVE NEUROPSYCH, V15, P645, DOI 10.1080/026432998381041; Rossetti Y, 1998, CONSCIOUS COGN, V7, P520, DOI 10.1006/ccog.1998.0370; ROSSETTI Y, IN PRESS VIS COGNIT; Rossetti Y., 2000, DISSOCIATION INTERAC, P129; Rushworth MFS, 1997, EXP BRAIN RES, V117, P292, DOI 10.1007/s002210050224; Rushworth MFS, 1998, J NEUROPHYSIOL, V79, P478, DOI 10.1152/jn.1998.79.1.478; Sakata Hideo, 1994, Current Opinion in Neurobiology, V4, P847, DOI 10.1016/0959-4388(94)90133-3; Schwartz Andrew B., 1994, Current Opinion in Neurobiology, V4, P840, DOI 10.1016/0959-4388(94)90132-5; SLATERHAMMEL AT, 1960, RES QUART, V31, P217, DOI 10.1080/10671188.1960.10613098; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanne J, 1995, NEUROREPORT, V7, P267, DOI 10.1097/00001756-199512000-00064; UNGERLEIDER LG, 1982, 2 CORTICAL VISUAL SY, P549; VIGHETTO A, 1980, THESIS U C BERNARD L	50	522	528	0	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					729	736		10.1038/76694	http://dx.doi.org/10.1038/76694			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862707				2022-12-17	WOS:000167177200021
J	Carter, ME; Yizhar, O; Chikahisa, S; Nguyen, H; Adamantidis, A; Nishino, S; Deisseroth, K; de Lecea, L				Carter, Matthew E.; Yizhar, Ofer; Chikahisa, Sachiko; Nguyen, Hieu; Adamantidis, Antoine; Nishino, Seiji; Deisseroth, Karl; de Lecea, Luis			Tuning arousal with optogenetic modulation of locus coeruleus neurons	NATURE NEUROSCIENCE			English	Article							IN-VIVO MICRODIALYSIS; SLEEP-WAKING CYCLE; PREFRONTAL CORTEX; NORADRENERGIC SYSTEM; NOREPINEPHRINE; RATS; WAKE; ACTIVATION; CATAPLEXY; CERULEUS	Neural activity in the noradrenergic locus coeruleus correlates with periods of wakefulness and arousal. However, it is unclear whether tonic or phasic activity in these neurons is necessary or sufficient to induce transitions between behavioral states and to promote long-term arousal. Using optogenetic tools in mice, we found that there is a frequency-dependent, causal relationship among locus coeruleus firing, cortical activity, sleep-to-wake transitions and general locomotor arousal. We also found that sustained, high-frequency stimulation of the locus coeruleus at frequencies of 5 Hz and above caused reversible behavioral arrests. These results suggest that the locus coeruleus is finely tuned to regulate organismal arousal and that bursts of noradrenergic overexcitation cause behavioral attacks that resemble those seen in people with neuropsychiatric disorders.	[Carter, Matthew E.; Deisseroth, Karl; de Lecea, Luis] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Carter, Matthew E.; Nguyen, Hieu; Adamantidis, Antoine; de Lecea, Luis] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Yizhar, Ofer; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Chikahisa, Sachiko; Nishino, Seiji] Stanford Univ, Sleep & Circadian Neurobiol Lab, Stanford, CA 94305 USA; [Chikahisa, Sachiko] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Integrat Physiol, Tokushima 770, Japan	Stanford University; Stanford University; Stanford University; Stanford University; Tokushima University	de Lecea, L (corresponding author), Stanford Univ, Neurosci Program, Stanford, CA 94305 USA.	llecea@stanford.edu	YIZHAR, OFER/AAV-8497-2021; de Lecea, Luis/B-3171-2009; Core, Vector/CAF-4832-2022; de Lecea, Luis/ABE-4005-2021	de Lecea, Luis/0000-0002-8921-5942; de Lecea, Luis/0000-0002-8921-5942; Yizhar, Ofer/0000-0003-4228-1448; Carter, Matthew/0000-0003-1802-090X; Adamantidis, Antoine/0000-0003-2531-5175	NSF; US National Institutes of Health (NIH) [F31MH83439]; European Molecular Biology Organization; Japan Society for the Promotion of Science [21-8162]; Fonds National de la Recherche Scientifique; NIH [K99, R01MH072525, MH83702, MH87592, DA21880]; NARSAD; National Institute of Mental Health; National Institute on Drug Abuse; McKnight Foundation; Coulter Foundation; Snyder Foundation; Albert Yu Foundation; Mary Bechmann and Keck Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH083439, R01MH087592, R01MH083702, R01MH072525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021880] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); McKnight Foundation; Coulter Foundation; Snyder Foundation; Albert Yu Foundation; Mary Bechmann and Keck Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the de Lecea laboratory for helpful advice and feedback, J. Shieh for assistance with confocal images, A. Hilgendorff for assistance with mouse cardiovascular measurements and S. Xie for access to custom-built SmartCages. M.E.C. received financial support from an NSF Graduate Research Fellowship and the US National Institutes of Health (NIH) National Research Service Award (F31MH83439). O.Y. is supported by a European Molecular Biology Organization long-term postdoctoral fellowship. S.C. is supported by the Excellent Young Researcher Overseas Visit Program (21-8162) of the Japan Society for the Promotion of Science. A.A. is supported by fellowships from the Fonds National de la Recherche Scientifique ('Charge de Recherche'), NIH (K99) and NARSAD. S.N. is supported by NIH grant R01MH072525. K.D. is supported by the National Science Foundation, National Institute of Mental Health, National Institute on Drug Abuse, and the McKnight, Coulter, Snyder, Albert Yu and Mary Bechmann, and Keck Foundations. L.d.L. is supported by the NIH (MH83702, MH87592, DA21880) and NARSAD.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; ASTONJONES G, 1981, J NEUROSCI, V1, P887; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; BERRIDGE CW, 1991, J NEUROSCI, V11, P3135; Berridge CW, 2000, NEUROSCIENCE, V99, P495, DOI 10.1016/S0306-4522(00)00215-3; Blanco-Centurion C, 2007, J NEUROSCI, V27, P14041, DOI 10.1523/JNEUROSCI.3217-07.2007; Boucetta S, 2009, J NEUROSCI, V29, P4664, DOI 10.1523/JNEUROSCI.5502-08.2009; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Bourgin P, 2000, J NEUROSCI, V20, P7760; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Carter ME, 2009, J NEUROSCI, V29, P10939, DOI 10.1523/JNEUROSCI.1205-09.2009; DESARRO GB, 1987, BRIT J PHARMACOL, V90, P675; FLICKER C, 1982, BEHAV NEURAL BIOL, V34, P421, DOI 10.1016/S0163-1047(82)91843-X; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Hassani OK, 2009, J NEUROSCI, V29, P11828, DOI 10.1523/JNEUROSCI.1259-09.2009; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Hunsley MS, 2003, SLEEP, V26, pA174; Jodo E, 1998, NEUROSCIENCE, V83, P63, DOI 10.1016/S0306-4522(97)00372-2; JONES BE, 1977, BRAIN RES, V124, P473, DOI 10.1016/0006-8993(77)90948-9; Kodama T, 2003, J NEUROSCI, V23, P1548, DOI 10.1523/JNEUROSCI.23-04-01548.2003; Lai YY, 2001, J NEUROSCI, V21, P7384, DOI 10.1523/JNEUROSCI.21-18-07384.2001; LIDBRINK P, 1974, BRAIN RES, V74, P19, DOI 10.1016/0006-8993(74)90109-7; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; Parmentier R, 2002, J NEUROSCI, V22, P7695; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Scammell TE, 2009, SLEEP, V32, P111; SEGAL DS, 1970, P NATL ACAD SCI USA, V66, P289, DOI 10.1073/pnas.66.2.289; Shipley MT, 1996, J COMP NEUROL, V365, P56, DOI 10.1002/(SICI)1096-9861(19960129)365:1<56::AID-CNE5>3.0.CO;2-I; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; Szot P, 2010, NEUROSCIENCE, V166, P279, DOI 10.1016/j.neuroscience.2009.12.027; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; VALENTINO RJ, 1992, NEUROSCIENCE, V48, P689, DOI 10.1016/0306-4522(92)90412-U; Van Bockstaele EJ, 1999, BIOL PSYCHIAT, V46, P1352, DOI 10.1016/S0006-3223(99)00213-9; Wu MF, 1999, NEUROSCIENCE, V91, P1389, DOI 10.1016/S0306-4522(98)00600-9; Wu MF, 2004, J PHYSIOL-LONDON, V554, P202, DOI 10.1113/jphysiol.2003.052134; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	50	518	544	7	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2010	13	12					1526	U117		10.1038/nn.2682	http://dx.doi.org/10.1038/nn.2682			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	684CW	21037585	Green Accepted			2022-12-17	WOS:000284525800018
J	Fell, J; Klaver, P; Lehnertz, K; Grunwald, T; Schaller, C; Elger, CE; Fernandez, G				Fell, J; Klaver, P; Lehnertz, K; Grunwald, T; Schaller, C; Elger, CE; Fernandez, G			Human memory formation is accompanied by rhinal-hippocampal coupling and decoupling	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; BRAIN ACTIVITY; SUBSEQUENT MEMORY; POTENTIALS; OSCILLATIONS; CORTEX; COHERENCE; ATTENTION; FREQUENCY; STIMULATION	In humans, distinct processes within the hippocampus and rhinal cortex support declarative memory formation. But do these medial temporal lobe (MTL) substructures directly cooperate in encoding new memories? Phase synchronization of gamma-band electroencephalogram (EEG) oscillations (around 40 Hz) is a general mechanism of transiently connecting neural assemblies. We recorded depth-EEG from within the MTL of epilepsy patients performing a memorization task. Successful as opposed to unsuccessful memory formation was accompanied by an initial elevation of rhinal-hippocampal gamma synchronization followed by a later desynchronization, suggesting that effective declarative memory formation is accompanied by a direct and temporarily limited cooperation between both MTL substructures.	Univ Bonn, Dept Epileptol, D-53105 Bonn, Germany; Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany	University of Bonn; University of Bonn	Fell, J (corresponding author), Univ Bonn, Dept Epileptol, Sigmund Freud Str 25, D-53105 Bonn, Germany.		Klaver, Peter/M-9506-2019; Klaver, Peter/G-7988-2011; Fernandez, Guillen/B-3771-2009	Klaver, Peter/0000-0002-6541-9975; Klaver, Peter/0000-0002-6541-9975; Fernandez, Guillen/0000-0002-5522-0604; Lehnertz, Klaus/0000-0002-5529-8559				Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; Baayen R. H., 1993, CELEX LEXICAL DATABA; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; BULLOCK TH, 1995, ELECTROEN CLIN NEURO, V95, P161, DOI 10.1016/0013-4694(95)93347-A; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; DESMEDT JE, 1994, NEUROSCI LETT, V168, P126, DOI 10.1016/0304-3940(94)90432-4; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Elger CE, 1997, NEUROPSYCHOLOGIA, V35, P657, DOI 10.1016/S0028-3932(96)00110-8; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fernandez G, 1998, PSYCHOPHYSIOLOGY, V35, P709, DOI 10.1017/S0048577298970500; Fernandez G, 1999, HIPPOCAMPUS, V9, P35, DOI 10.1002/(SICI)1098-1063(1999)9:1<35::AID-HIPO4>3.0.CO;2-Z; Fernandez G, 1999, SCIENCE, V285, P1582, DOI 10.1126/science.285.5433.1582; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; Hermann BP, 1997, ARCH NEUROL-CHICAGO, V54, P369, DOI 10.1001/archneur.1997.00550160019010; Hirai N, 1999, NEUROSCIENCE, V90, P1149, DOI 10.1016/S0306-4522(98)00513-2; Huynh H., 1976, J EDUC STATIST, V1, P69, DOI [DOI 10.3102/10769986001001069, 10.3102/10769986001001069]; JACKSON GD, 1996, MRI NEUROANATOMY; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; KLEE M, 1977, J NEUROPHYSIOL, V40, P647, DOI 10.1152/jn.1977.40.3.647; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; LaBerge D, 1997, CONSCIOUS COGN, V6, P149, DOI 10.1006/ccog.1997.0305; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.0.CO;2-5; Mardia KV, 1972, PROBABILITY MATH STA; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; Menon V, 1996, ELECTROEN CLIN NEURO, V98, P89, DOI 10.1016/0013-4694(95)00206-5; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Morris H H 3rd, 1985, Electroencephalogr Clin Neurophysiol Suppl, V37, P3; Muller MM, 2000, INT J PSYCHOPHYSIOL, V38, P283, DOI 10.1016/s0167-8760(00)00171-9; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; PALLER KA, 1992, ELECTROEN CLIN NEURO, V84, P269, DOI 10.1016/0168-5597(92)90008-Y; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sauve K, 1999, CONSCIOUS COGN, V8, P213, DOI 10.1006/ccog.1999.0383; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Singer W, 1999, NATURE, V397, P391, DOI 10.1038/17021; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Traub RD, 1999, J NEUROSCI, V19, P1088; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Van Roost D, 1998, NEUROSURGERY, V43, P819, DOI 10.1097/00006123-199810000-00058; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	49	518	529	3	35	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1259	1264		10.1038/nn759	http://dx.doi.org/10.1038/nn759			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	498RV	11694886				2022-12-17	WOS:000172525000024
J	Takumi, Y; Ramirez-Leon, V; Laake, P; Rinvik, E; Ottersen, OP				Takumi, Y; Ramirez-Leon, V; Laake, P; Rinvik, E; Ottersen, OP			Different modes of expression of AMPA and NMDA receptors in hippocampal synapses	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT HIPPOCAMPUS; EXCITATORY SYNAPSES; SYNAPTIC TRANSMISSION; GLUTAMATE RECEPTORS; KAINATE RECEPTORS; SILENT SYNAPSES; PYRAMIDAL CELLS; SUBUNITS; LTP	Postembedding immunogold labeling was used to determine the relationship between AMPA and NMDA receptor density and size of Schaffer collateral-commissural (SCC) synapses of the adult rat. All SCC synapses expressed NMDA receptors. AMPA and NMDA receptors were colocalized in at least 75% of SCC synapses; the ratio of AMPA to NMDA receptors was a linear function of postsynaptic density (PSD) diameter, with AMPA receptor number dropping to zero at a PSD diameter of similar to 180 nm. These findings indicate that 'silent' SCC synapses are smaller than the majority of SCC synapses at which AMPA and NMDA receptors are colocalized. Thus synapse size may determine important properties of SCC synapses.	Univ Oslo, Inst Basic Med Sci, Dept Anat, N-0317 Oslo, Norway; Hirosaki Univ, Sch Med, Dept Otorhinolaryngol, Hirosaki, Aomori 0368562, Japan; Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Univ Oslo, Sect Med Stat, N-0317 Oslo, Norway	University of Oslo; Hirosaki University; Karolinska Institutet; University of Oslo	Ottersen, OP (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Anat, POB 1105 Blindern, N-0317 Oslo, Norway.							Andersen P, 1998, BRAIN RES REV, V26, P353, DOI 10.1016/S0165-0173(97)00042-8; BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BRAMHAM CR, 1990, NEUROSCIENCE, V39, P405, DOI 10.1016/0306-4522(90)90277-B; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; DESMOND NL, 1988, BRAIN RES, V453, P308, DOI 10.1016/0006-8993(88)90171-0; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Fritschy JM, 1998, J COMP NEUROL, V390, P194; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P435, DOI 10.1002/hipo.450030405; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; HARRIS KM, 1992, J NEUROSCI, V12, P2685; He Y, 1998, J NEUROSCI RES, V54, P444, DOI 10.1002/(SICI)1097-4547(19981115)54:4<444::AID-JNR2>3.0.CO;2-3; HJELLE OP, 1994, EUR J NEUROSCI, V6, P793, DOI 10.1111/j.1460-9568.1994.tb00990.x; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KELLENBERGER E, 1987, J HISTOCHEM CYTOCHEM, V35, P959, DOI 10.1177/35.9.3302020; Kharazia VN, 1996, NEUROSCI LETT, V210, P37, DOI 10.1016/0304-3940(96)12658-6; KHARAZIA VN, IN PRESS J COMP NEUR; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MAREN S, 1993, P NATL ACAD SCI USA, V90, P9654, DOI 10.1073/pnas.90.20.9654; Matsubara A, 1996, J NEUROSCI, V16, P4457; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Ottersen OP, 1997, EUR J NEUROSCI, V9, P2219, DOI 10.1111/j.1460-9568.1997.tb01640.x; OTTERSEN OP, 1992, NEUROSCIENCE, V46, P519, DOI 10.1016/0306-4522(92)90141-N; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; PETRALIA RS, 1994, J NEUROSCI, V14, P667; Popratiloff A, 1996, J NEUROSCI, V16, P3363; Schikorski T, 1997, J NEUROSCI, V17, P5858; SEEBURG PH, 1993, TRENDS PHARMACOL SCI, V14, P297, DOI 10.1016/0165-6147(93)90047-N; Shirke AM, 1997, J NEUROPHYSIOL, V78, P2682, DOI 10.1152/jn.1997.78.5.2682; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wang YX, 1998, J NEUROSCI, V18, P1148; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501	48	518	531	1	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					618	624		10.1038/10172	http://dx.doi.org/10.1038/10172			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10409387				2022-12-17	WOS:000083882600012
J	Patel, AJ; Honore, E; Lesage, F; Fink, M; Romey, G; Lazdunski, M				Patel, AJ; Honore, E; Lesage, F; Fink, M; Romey, G; Lazdunski, M			Inhalational anesthetics activate two-pore-domain background K+ channels	NATURE NEUROSCIENCE			English	Article							GENERAL-ANESTHETICS; ION CHANNELS; VOLATILE ANESTHETICS; ARACHIDONIC-ACID; NEURONS; MEMBRANE; MECHANISMS; TWIK-1; YEAST; RAT	Volatile anesthetics produce safe, reversible unconsciousness, amnesia and analgesia via hyperpolarization of mammalian neurons. In molluscan pacemaker neurons, they activate an inhibitory synaptic K+ current (I-KAn), proposed to be important in general anesthesia. Here we show that TASK and TREK-1, two recently cloned mammalian two-P-domain K+ channels similar to I-KAn in biophysical properties, are activated by volatile general anesthetics. Chloroform, diethyl ether, halothane and isoflurane activated TREK-1, whereas only halothane and isoflurane activated TASK. Carboxy (C)-terminal regions were critical for anesthetic activation in both channels. Thus both TREK-1 and TASK are possibly important target sites for these agents.	CNRS, Inst Pharmacol Mol & Cellulaire, UPR 411, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Lazdunski, M (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UPR 411, 660 Route Lucioles, F-06560 Valbonne, France.		Lesage, Florian/P-9780-2019; Lesage, Florian/D-5097-2011	Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106; HONORE, Eric/0000-0002-8007-0919				BERGJOHNSEN J, 1987, ACTA PHYSIOL SCAND, V130, P679, DOI 10.1111/j.1748-1716.1987.tb08192.x; Duprat F, 1997, EMBO J, V16, P5464, DOI 10.1093/emboj/16.17.5464; Felisberti F, 1997, BRAIN RES, V766, P56, DOI 10.1016/S0006-8993(97)00554-4; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; FRANKS NP, 1991, SCIENCE, V254, P427, DOI 10.1126/science.1925602; FRANKS NP, 1988, NATURE, V333, P662, DOI 10.1038/333662a0; Gray AT, 1998, ANESTHESIOLOGY, V88, P1076, DOI 10.1097/00000542-199804000-00029; HARRIS RA, 1995, FASEB J, V9, P1454, DOI 10.1096/fasebj.9.14.7589987; KETCHUM KA, 1995, NATURE, V376, P69; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Lesage F, 1996, J BIOL CHEM, V271, P4183; Lopes CMB, 1998, BRIT J PHARMACOL, V125, P309, DOI 10.1038/sj.bjp.0702069; MACIVER MB, 1991, ANESTHESIOLOGY, V74, P83; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; NICOLL RA, 1982, SCIENCE, V217, P1055, DOI 10.1126/science.7112112; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; Reid JD, 1996, RECEPTOR CHANNEL, V4, P51; Sirois JE, 1998, J PHYSIOL-LONDON, V512, P851, DOI 10.1111/j.1469-7793.1998.851bd.x; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; ZHOU XL, 1995, FEBS LETT, V373, P170, DOI 10.1016/0014-5793(95)01035-D	24	516	545	1	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					422	426		10.1038/8084	http://dx.doi.org/10.1038/8084			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321245				2022-12-17	WOS:000084609400011
J	Freischmidt, A; Wieland, T; Richter, B; Ruf, W; Schaeffer, V; Muller, K; Marroquin, N; Nordin, F; Hubers, A; Weydt, P; Pinto, S; Press, R; Millecamps, S; Molko, N; Bernard, E; Desnuelle, C; Soriani, MH; Dorst, J; Graf, E; Nordstrom, U; Feiler, MS; Putz, S; Boeckers, TM; Meyer, T; Winkler, AS; Winkelman, J; de Carvalho, M; Thal, DR; Otto, M; Brannstrom, T; Volk, AE; Kursula, P; Danzer, KM; Lichtner, P; Dikic, I; Meitinger, T; Ludolph, AC; Strom, TM; Andersen, PM; Weishaupt, JH				Freischmidt, Axel; Wieland, Thomas; Richter, Benjamin; Ruf, Wolfgang; Schaeffer, Veronique; Mueller, Kathrin; Marroquin, Nicolai; Nordin, Frida; Huebers, Annemarie; Weydt, Patrick; Pinto, Susana; Press, Rayomond; Millecamps, Stephanie; Molko, Nicolas; Bernard, Emilien; Desnuelle, Claude; Soriani, Marie-Helene; Dorst, Johannes; Graf, Elisabeth; Nordstrom, Ulrika; Feiler, Marisa S.; Putz, Stefan; Boeckers, Tobias M.; Meyer, Thomas; Winkler, Andrea S.; Winkelman, Juliane; de Carvalho, Mamede; Thal, Dietmar R.; Otto, Markus; Brannstrom, Thomas; Volk, Alexander E.; Kursula, Petri; Danzer, Karin M.; Lichtner, Peter; Dikic, Ivan; Meitinger, Thomas; Ludolph, Albert C.; Strom, Tim M.; Andersen, Peter M.; Weishaupt, Jochen H.			Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; AUTOPHAGY RECEPTOR; OPTINEURIN; MUTATIONS; ACTIVATION; GLAUCOMA; BINDING; KINASE; TANK	Amyotrophic lateral sclerosis (ALS) is a genetically heterogeneous neurodegenerative syndrome hallmarked by adult-onset loss of motor neurons. We performed exome sequencing of 252 familial ALS (fALS) and 827 control individuals. Gene-based rare variant analysis identified an exome-wide significant enrichment of eight loss-of-function (LoF) mutations in TBK1 (encoding TANK-binding kinase 1) in 13 fALS pedigrees. No enrichment of LoF mutations was observed in a targeted mutation screen of 1,010 sporadic ALS and 650 additional control individuals. Linkage analysis in four families gave an aggregate LOD score of 4.6. In vitro experiments confirmed the loss of expression of TBK1 LoF mutant alleles, or loss of interaction of the C-terminal TBK1 coiled-coil domain (CCD2) mutants with the TBK1 adaptor protein optineurin, which has been shown to be involved in ALS pathogenesis. We conclude that haploinsufficiency of TBK1 causes ALS and fronto-temporal dementia.	[Freischmidt, Axel; Ruf, Wolfgang; Mueller, Kathrin; Marroquin, Nicolai; Huebers, Annemarie; Weydt, Patrick; Dorst, Johannes; Feiler, Marisa S.; Otto, Markus; Danzer, Karin M.; Ludolph, Albert C.; Andersen, Peter M.; Weishaupt, Jochen H.] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Wieland, Thomas; Graf, Elisabeth; Lichtner, Peter; Meitinger, Thomas; Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Richter, Benjamin; Schaeffer, Veronique; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 3, D-60054 Frankfurt, Germany; [Nordin, Frida; Nordstrom, Ulrika; Andersen, Peter M.] Umea Univ, Dept Pharmacol & Clin Neurosience, Umea, Sweden; [Pinto, Susana; de Carvalho, Mamede] Univ Lisbon, Inst Physiol, P-1699 Lisbon, Portugal; [Press, Rayomond] Univ Lisbon, Inst Mol Med, P-1699 Lisbon, Portugal; [Millecamps, Stephanie] Karolinska Hosp Huddinge, Dept Neurol, Stockholm, Sweden; [Molko, Nicolas] Univ Paris 06, Sorbonne Univ, Inserm U1127, CNRS UMR7225,Inst Cerveau & Moelle Epiniere ICM,U, Paris, France; [Bernard, Emilien] Ctr Hosp Territorial Gaston Bourret, Noumea, New Caledonia; [Desnuelle, Claude; Soriani, Marie-Helene] CHU Lyon, Hop Neurol Pierre Wertheimer, Ctr Reference SLA, Bron, France; [Putz, Stefan; Boeckers, Tobias M.] CHU Nice, Hop Archet, Ctr Reference Malad Neuromusculaires & SLA, F-06202 Nice, France; [Meyer, Thomas] Univ Ulm, Fac Med, Inst Anat & Cell Biol, D-89069 Ulm, Germany; [Winkler, Andrea S.; Winkelman, Juliane] Humboldt Univ, Charite Univ Hosp, D-10099 Berlin, Germany; [de Carvalho, Mamede] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany; [Thal, Dietmar R.] Hosp Santa Maria CHLN, Dept Neurosci, Lisbon, Portugal; [Brannstrom, Thomas] Univ Ulm, Inst Pathol, Neuropathol Lab, D-89069 Ulm, Germany; [Marroquin, Nicolai; Volk, Alexander E.] Umea Univ, Dept Med Biosci, Umea, Sweden; [Volk, Alexander E.] Univ Ulm, Inst Human Genet, D-89069 Ulm, Germany; [Kursula, Petri] Univ Clin Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Kursula, Petri] Univ Oulu, Bioctr, Fac Biochem & Mol Med, Oulu, Finland; [Meitinger, Thomas; Strom, Tim M.] Univ Bergen, Dept Biomed, Bergen, Norway; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Freischmidt, Axel; Wieland, Thomas; Richter, Benjamin; Ruf, Wolfgang] Univ Munich, SyNergy, Munich Cluster Syst Neurol, Munich, Germany	Ulm University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Goethe University Frankfurt; Umea University; Universidade de Lisboa; Universidade de Lisboa; Karolinska Institutet; Karolinska University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; CHU Nice; Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich; Universidade de Lisboa; Hospital Santa Maria; Ulm University; Umea University; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Oulu; University of Bergen; Technical University of Munich; University of Munich	Weishaupt, JH (corresponding author), Univ Ulm, Dept Neurol, D-89069 Ulm, Germany.	peter.andersen@umu.se; jochen.weishaupt@uni-ulm.de	Otto, Markus/F-4304-2015; Press, Rayomand/AAW-8142-2020; Dorst, Johannes/AAL-5984-2021; Dikic, Ivan/O-4650-2015; BERNARD, Emilien/AAN-4050-2020; Pinto, Susana C/K-9435-2014; Weydt, Patrick/F-5114-2015; Pinto, Susana/L-8394-2019; Meitinger, Thomas/O-1318-2015; Kursula, Petri/AAF-4563-2020; Thal, Dietmar R/O-7483-2018; Millecamps, Stéphanie/W-7184-2018; de Carvalho, Mamede/I-6295-2019	Otto, Markus/0000-0003-4273-4267; Dikic, Ivan/0000-0001-8156-9511; BERNARD, Emilien/0000-0002-3952-9265; Pinto, Susana C/0000-0002-0727-5897; Weydt, Patrick/0000-0003-2344-5662; Pinto, Susana/0000-0002-0727-5897; Kursula, Petri/0000-0001-8529-3751; Thal, Dietmar R/0000-0002-1036-1075; Millecamps, Stéphanie/0000-0002-0745-6735; de Carvalho, Mamede/0000-0001-7556-0158; Ruf, Wolfgang/0000-0002-8105-6123; Schaeffer, Veronique/0000-0002-2564-9012; Meitinger, Thomas/0000-0002-8838-8403; Meyer, Thomas/0000-0002-2736-7350	German Federal Ministry of Education and Research [01GI0704, O1GI1007A]; German Research Foundation (SYNERGY excellence cluster); Charcot Foundation; virtual Helmholtz Institute "RNA-Dysmetabolismus in ALS and FTD"; DFG-funded Swabian ALS Registry; LOEWE Centrum; Swedish Research Council; Swedish Brain Power Foundation; Swedish Brain Research Foundation; Ulla-Carin Lindquist Foundation; Hallsten Research Foundation; Swedish Association; Knut and Alice Wallenberg Foundation; Association pour la Recherche sur la Sclerose laterale amyotrophique et autres maladies du motoneurone (ARSla, France) [R13132DD]; Association francaise contre les myopathies (AFM, France) [R11038DD]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (SYNERGY excellence cluster); Charcot Foundation; virtual Helmholtz Institute "RNA-Dysmetabolismus in ALS and FTD"; DFG-funded Swabian ALS Registry; LOEWE Centrum; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power Foundation; Swedish Brain Research Foundation; Ulla-Carin Lindquist Foundation; Hallsten Research Foundation; Swedish Association; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Association pour la Recherche sur la Sclerose laterale amyotrophique et autres maladies du motoneurone (ARSla, France); Association francaise contre les myopathies (AFM, France)(Association Francaise contre les Myopathies)	We are indebted to the patients and their families for their participation in this project. We thank A. Knehr, N. Todt, E. Jasovskaja, B. Schmoll, A.-K. Rikardsson, A. Birve, A.-C. Nilsson and the Ulm Neurology biobank team for technical assistance. We also thank the many physicians who provided samples for this study, particularly L. Brattstrom (Karlskrona Hospital, Sweden), S. Saker (Genethon cell and DNA bank), S. Forlani (ICM DNA and cell bank), and E. LeGuern and C. Cazeneuve (APHP, Hopital Pitie-Salpetriere). We also thank P. Sarvari and D.Y.R. Stainier for early studies on the role of TBK1 in Zebrafish neurodegeneration. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about. This work was supported by grants from the German Federal Ministry of Education and Research (STRENGTH consortium, Sophia and BiomarkAPD and BMBF; 01GI0704, German network for ALS research (MND-NET), O1GI1007A Competence net neurodegenerative dementias/Frontotemporal lobar degeneration consortium (FTLDc)), the German Research Foundation (SYNERGY excellence cluster), the Charcot Foundation for ALS Research (A.C.L., J.H.W.), the virtual Helmholtz Institute "RNA-Dysmetabolismus in ALS and FTD" and the DFG-funded Swabian ALS Registry, the LOEWE Centrum for Gene and Cell therapy and LOEWE Ub-Net (I.D. and B.R.), the Swedish Research Council, the Swedish Brain Power Foundation, the Swedish Brain Research Foundation and the Ulla-Carin Lindquist Foundation, the Hallsten Research Foundation, the Swedish Association for the Neurologically Disabled, the Knut and Alice Wallenberg Foundation, by the Association pour la Recherche sur la Sclerose laterale amyotrophique et autres maladies du motoneurone (ARSla, France, contract R13132DD) and the Association francaise contre les myopathies (AFM, France, contract R11038DD to S.M.).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abhinav K, 2007, NEUROEPIDEMIOLOGY, V29, P44, DOI 10.1159/000108917; Akimoto C, 2014, J MED GENET, V51, P419, DOI 10.1136/jmedgenet-2014-102360; Andersen PM, 2012, EUR J NEUROL, V19, P360, DOI 10.1111/j.1468-1331.2011.03501.x; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cirulli E.T., 2015, EXOME SEQUENCING AMY, DOI [10.1126/science.aaa3650, DOI 10.1126/SCIENCE.AAA3650]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erdmann J, 2013, NATURE, V504, P432, DOI 10.1038/nature12722; Exome Aggregation Consortium, 2014, EXAC BROW BET; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Goncalves A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023971; GUNNARSSON LG, 1991, ACTA NEUROL SCAND, V84, P429, DOI 10.1111/j.1600-0404.1991.tb04983.x; Hubers A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.11.034; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Uenal H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093932; van Blitterswijk M, 2012, HUM MOL GENET, V21, P3776, DOI 10.1093/hmg/dds199; Weidberg H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002355; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111	33	515	523	5	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2015	18	5					631	+		10.1038/nn.4000	http://dx.doi.org/10.1038/nn.4000			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG9LN	25803835	Green Accepted			2022-12-17	WOS:000353636900009
J	Smith, WLW; Pei, Z; Jiang, HB; Dawson, VL; Dawson, TM; Ross, CA				Smith, Wanli W.; Pei, Zhong; Jiang, Haibing; Dawson, Valina L.; Dawson, Ted M.; Ross, Christopher A.			Kinase activity of mutant LRRK2 mediates neuronal toxicity	NATURE NEUROSCIENCE			English	Article							PARKINSONS-DISEASE; MUTATIONS; GENETICS; BINDING; DOMAIN; GTP; ROC	Mutations in the the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal- dominant Parkinson disease and some cases of sporadic Parkinson disease. Here we found that LRRK2 kinase activity was regulated by GTP via the intrinsic GTPase Roc domain, and alterations of LRRK2 protein that reduced kinase activity of mutant LRRK2 correspondingly reduced neuronal toxicity. These data elucidate the pathogenesis of LRRK2-linked Parkinson disease, potentially illuminate mechanisms of sporadic Parkinson disease and suggest therapeutic targets.	Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Smith, WLW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, CMSC 8-121,600 N Wolfe St, Baltimore, MD 21287 USA.	wsmith60@jhmi.edu; caross@jhu.edu	Dawson, Valina/Y-9757-2019; Ross, Christopher A/H-8395-2013	Dawson, Valina/0000-0002-2915-3970	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS055684, P50NS038377] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38377, R21NS055684-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albrecht M, 2005, LANCET, V365, P1230, DOI 10.1016/S0140-6736(05)74810-8; Bosgraaf L, 2003, BBA-MOL CELL RES, V1643, P5, DOI 10.1016/j.bbamcr.2003.08.008; Di Fonzo A, 2005, LANCET, V365, P412; Farrer M, 2005, NEUROLOGY, V65, P738, DOI 10.1212/01.WNL.0000169023.51764.b0; Gasser T, 2005, CURR OPIN NEUROL, V18, P363, DOI 10.1097/01.wco.0000170951.08924.3d; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Korr D, 2006, CELL SIGNAL, V18, P910, DOI 10.1016/j.cellsig.2005.08.015; Morris HR, 2005, ANN MED, V37, P86, DOI 10.1080/07853890510007269; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	15	515	521	3	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2006	9	10					1231	1233		10.1038/nn1776	http://dx.doi.org/10.1038/nn1776			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	098BB	16980962				2022-12-17	WOS:000241493900013
J	Aimone, JB; Wiles, J; Gage, FH				Aimone, James B.; Wiles, Janet; Gage, Fred H.			Potential role for adult neurogenesis in the encoding of time in new memories	NATURE NEUROSCIENCE			English	Article							GENERATED GRANULE CELLS; HIPPOCAMPAL FUNCTION; DENTATE GYRUS; AUTOBIOGRAPHICAL MEMORY; RAT HIPPOCAMPUS; CA3; EVENTS; PROLIFERATION; PLASTICITY; RETRIEVAL		Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld 4072, Australia	Salk Institute; University of Queensland	Aimone, JB (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Aimone, James Bradley/H-4694-2016; Aimone, James B/C-7821-2011; Wiles, Janet/C-1989-2008	Aimone, James Bradley/0000-0002-7361-253X; Wiles, Janet/0000-0002-4051-4116	NIA NIH HHS [AG-020938] Funding Source: Medline; NINDS NIH HHS [NS-05050217, NS-05052842] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG020938] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; BARNES J, 1984, COMPLETE WORK ARTIST, P714; Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Brown NR, 1998, APPL COGNITIVE PSYCH, V12, P305, DOI 10.1002/(SICI)1099-0720(199808)12:4<305::AID-ACP569>3.0.CO;2-5; Burt CDB, 2003, MEM COGNITION, V31, P317, DOI 10.3758/BF03194390; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Erickson CA, 2003, EXP GERONTOL, V38, P61, DOI 10.1016/S0531-5565(02)00160-2; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; FRIEDMAN WJ, 1993, PSYCHOL BULL, V113, P44, DOI 10.1037/0033-2909.113.1.44; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; LOFTUS EF, 1983, MEM COGNITION, V11, P114, DOI 10.3758/BF03213465; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McMahon DBT, 2002, J NEUROPHYSIOL, V88, P528, DOI 10.1152/jn.2002.88.1.528; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Schinder AF, 2004, PHYSIOLOGY, V19, P253, DOI 10.1152/physiol.00012.2004; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shum MS, 1998, PSYCHOL BULL, V124, P423, DOI 10.1037/0033-2909.124.3.423; Song HJ, 2005, J NEUROSCI, V25, P10366, DOI 10.1523/JNEUROSCI.3452-05.2005; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; White AM, 2000, HIPPOCAMPUS, V10, P88, DOI 10.1002/(SICI)1098-1063(2000)10:1<88::AID-HIPO10>3.0.CO;2-L; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	50	513	539	0	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					723	727		10.1038/nn1707	http://dx.doi.org/10.1038/nn1707			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16732202				2022-12-17	WOS:000237895200008
J	Birder, LA; Nakamura, Y; Kiss, S; Nealen, ML; Barrick, S; Kanai, AJ; Wang, E; Ruiz, G; de Groat, WC; Apodaca, G; Watkins, S; Caterina, MJ				Birder, LA; Nakamura, Y; Kiss, S; Nealen, ML; Barrick, S; Kanai, AJ; Wang, E; Ruiz, G; de Groat, WC; Apodaca, G; Watkins, S; Caterina, MJ			Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1	NATURE NEUROSCIENCE			English	Article							INTRAVESICAL CAPSAICIN; PAIN; RESINIFERATOXIN; RELEASE; CHANNEL; REFLEX; CELLS; ATP	In the urinary bladder, the capsaicin-gated ion channel TRPV1 is expressed both within afferent nerve terminals and within the epithelial cells that line the bladder lumen. To determine the significance of this expression pattern, we analyzed bladder function in mice lacking TRPV1. Compared with wild-type littermates, trpv1(-/-) mice had a higher frequency of low-amplitude, nonvoiding bladder contractions. This alteration was accompanied by reductions in both spinal cord signaling and reflex voiding during bladder filling (under anesthesia). In vitro, stretch-evoked ATP release and membrane capacitance changes were diminished in bladders excised from trpv1(-/-) mice, as was hypoosmolality-evoked ATP release from cultured trpv1(-/-) urothelial cells. These findings indicate that TRPV1 participates in normal bladder function and is essential for normal mechanically evoked purinergic signaling by the urothelium.	Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div,Lab Epithelial Cell Biol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Pharmacol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15213 USA; Kanazawa Univ, Sch Med, Dept Urol, Kanazawa, Ishikawa 9208641, Japan; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kanazawa University; Johns Hopkins University; Johns Hopkins University	Birder, LA (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div,Lab Epithelial Cell Biol, Pittsburgh, PA 15213 USA.	lbirder@pitt.edu	Barrick, Stacey/J-1595-2015; Barrick, Stacey/E-7130-2010; Watkins, Simon/ABG-2590-2021; Apodaca, Gerard/HCJ-0048-2022	Watkins, Simon/0000-0003-4092-1552; Barrick, Stacey/0000-0002-4837-3741	NHLBI NIH HHS [R01 HL57985] Funding Source: Medline; NIDDK NIH HHS [R01 DK54425, R01 DK57284, R01 DK54824] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057284, R01DK054425, R01DK054824] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Avelino A, 2002, NEUROSCIENCE, V109, P787, DOI 10.1016/S0306-4522(01)00496-1; Birder LA, 1998, AM J PHYSIOL-RENAL, V275, pF226, DOI 10.1152/ajprenal.1998.275.2.F226; Birder LA, 2001, P NATL ACAD SCI USA, V98, P13396, DOI 10.1073/pnas.231243698; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Burnstock G, 2001, TRENDS PHARMACOL SCI, V22, P182, DOI 10.1016/S0165-6147(00)01643-6; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Chancellor MB, 2000, UROLOGY, V55, P65, DOI 10.1016/S0090-4295(99)00499-9; Cheng CL, 1999, AM J PHYSIOL-REG I, V277, pR786, DOI 10.1152/ajpregu.1999.277.3.R786; Chuang YC, 2001, AM J PHYSIOL-REG I, V281, pR1302, DOI 10.1152/ajpregu.2001.281.4.R1302; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; de Groat WC, 2001, ANNU REV PHARMACOL, V41, P691, DOI 10.1146/annurev.pharmtox.41.1.691; Ferguson DR, 1997, J PHYSIOL-LONDON, V505, P503, DOI 10.1111/j.1469-7793.1997.503bb.x; Fovaeus M, 1998, ACTA PHYSIOL SCAND, V162, P115; Fowler CJ, 2000, UROLOGY, V55, P60, DOI 10.1016/S0090-4295(99)00498-7; Lazzeri M, 1996, J UROLOGY, V156, P947, DOI 10.1016/S0022-5347(01)65669-6; Lecci A, 2001, AUTON NEUROSCI-BASIC, V91, P37, DOI 10.1016/S1566-0702(01)00303-4; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; MAGGI CA, 1984, EUR J PHARMACOL, V103, P41, DOI 10.1016/0014-2999(84)90187-0; MAGGI CA, 1986, J UROLOGY, V136, P696, DOI 10.1016/S0022-5347(17)45030-0; Namasivayam S, 1999, BJU INT, V84, P854; SANTICIOLI P, 1985, J UROLOGY, V133, P700, DOI 10.1016/S0022-5347(17)49164-6; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435; Vlaskovska M, 2001, J NEUROSCI, V21, P5670, DOI 10.1523/JNEUROSCI.21-15-05670.2001	26	512	553	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					856	860		10.1038/nn902	http://dx.doi.org/10.1038/nn902			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12161756				2022-12-17	WOS:000177656300015
J	Rioult-Pedotti, MS; Friedman, D; Hess, G; Donoghue, JP				Rioult-Pedotti, MS; Friedman, D; Hess, G; Donoghue, JP			Strengthening of horizontal cortical connections following skill learning	NATURE NEUROSCIENCE			English	Article							RAT MOTOR CORTEX; LONG-TERM POTENTIATION; LTP INDUCTION; IN-VITRO; PLASTICITY; MAPS; NEURONS; REPRESENTATIONS; DEPENDENCE; CURRENTS	Learning a new motor skill requires an alteration in the spatiotemporal pattern of muscle activation. Motor areas of cerebral neocortex are thought to be involved in this type of learning, possibly by functional reorganization of cortical connections. Here we show that skill learning is accompanied by changes in the strength of connections within adult rat primary motor cortex (M1). Rats were trained for three or five days in a skilled reaching task with one forelimb, after which slices of motor cortex were examined to determine the effect of training on the strength of horizontal intracortical connections in layer II/III. The amplitude of field potentials in the forelimb region contralateral to the trained limb was significantly increased relative to the opposite 'untrained' hemisphere. No differences were seen in the hindlimb region. Moreover, the amount of long-term potentiation (LTP) that could be induced in trained M1 was less than in controls, suggesting that the effect of training was at least partly due to LTP-like mechanisms. These data represent the first direct evidence that plasticity of intracortical connections is associated with learning a new motor skill.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Jagiellonian Univ, Inst Zool, PL-31102 Krakow, Poland	Brown University; Jagiellonian University	Rioult-Pedotti, MS (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	mengia-rioult@brown.edu	Rioult-Pedotti, Mengia-Seraina/AAF-1377-2021; Hess, Grzegorz/HGQ-0966-2022		NINDS NIH HHS [NS22517] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022517] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; ARONIADOU VA, 1995, CEREB CORTEX, V5, P353, DOI 10.1093/cercor/5.4.353; Asanuma H, 1997, NEUROREPORT, V8, pR1; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; Cohen L G, 1993, Adv Neurol, V63, P187; DARIAN SC, 1994, NATURE, V368, P737; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; DONOGHUE JP, 1994, J CLIN NEUROPHYSIOL, V11, P382; Donoghue JP, 1996, ACQUISITION OF MOTOR BEHAVIOR IN VERTEBRATES, P363; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; Donoghue JP, 1997, CEREB CORTEX, V7, P97, DOI 10.1093/cercor/7.2.97; Garraghty P E, 1992, Curr Opin Neurobiol, V2, P522, DOI 10.1016/0959-4388(92)90191-M; Gilbert C D, 1993, Curr Opin Neurobiol, V3, P100, DOI 10.1016/0959-4388(93)90042-W; GRAFTON ST, 1992, J NEUROSCI, V12, P2542; GREENOUGH WT, 1985, BEHAV NEURAL BIOL, V44, P301, DOI 10.1016/S0163-1047(85)90310-3; HESS G, 1994, J NEUROPHYSIOL, V71, P2543, DOI 10.1152/jn.1994.71.6.2543; Hess G, 1996, EUR J NEUROSCI, V8, P658, DOI 10.1111/j.1460-9568.1996.tb01251.x; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; HIRSCH JA, 1993, J PHYSIOL-LONDON, V461, P247, DOI 10.1113/jphysiol.1993.sp019512; Huntley GW, 1997, CEREB CORTEX, V7, P143, DOI 10.1093/cercor/7.2.143; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; KARNI A, 1995, NATURE, V377, P155; Kleim JA, 1996, J NEUROSCI, V16, P4529; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MERZENICH MM, 1988, NEUROBIOLOGY NEOCORT, P41; Morris RGM, 1991, LONG TERM POTENTIATI, P267; Nudo RJ, 1996, J NEUROSCI, V16, P785; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; PRICE AW, 1981, BRAIN RES, V205, P81, DOI 10.1016/0006-8993(81)90721-6; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; WOODY CD, 1991, BRAIN RES, V539, P76, DOI 10.1016/0006-8993(91)90688-R; YOSHIMURA Y, 1994, J NEUROPHYSIOL, V71, P1638, DOI 10.1152/jn.1994.71.5.1638	33	512	517	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	1998	1	3					230	234		10.1038/678	http://dx.doi.org/10.1038/678			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QC	10195148				2022-12-17	WOS:000076361200014
J	Fischer, MH; Castel, AD; Dodd, MD; Pratt, J				Fischer, MH; Castel, AD; Dodd, MD; Pratt, J			Perceiving numbers causes spatial shifts of attention	NATURE NEUROSCIENCE			English	Article								Number symbols are part of our everyday visual world. Here we show that merely looking at numbers causes a shift in covert attention to the left or right side, depending upon the number's magnitude. This observation implies obligatory activation of number meaning and signals a tight coupling of internal and external representations of space.	Univ Dundee, Dept Psychol, Dundee DD1 4HN, Scotland; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada	University of Dundee; University of Toronto	Fischer, MH (corresponding author), Univ Dundee, Dept Psychol, Dundee DD1 4HN, Scotland.	m.h.fischer@dundee.ac.uk	Fischer, Martin H./D-9965-2017	Fischer, Martin H./0000-0003-3818-7272; Pratt, Jay/0000-0002-4902-5095				Bachtold D, 1998, NEUROPSYCHOLOGIA, V36, P731, DOI 10.1016/S0028-3932(98)00002-5; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0096-3445.122.3.371; Dehaene S, 2001, PSYCHOL SCI, V12, P244, DOI 10.1111/1467-9280.00343; DEHAENE S, 2000, NEW COGNITIVE NEUROS, P987; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fischer MH, 2001, NEUROLOGY, V57, P822, DOI 10.1212/WNL.57.5.822; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Hommel B, 2001, PSYCHOL SCI, V12, P360, DOI 10.1111/1467-9280.00367; Pratt J, 1999, J EXP PSYCHOL HUMAN, V25, P730, DOI 10.1037/0096-1523.25.3.730; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	12	511	536	4	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2003	6	6					555	556		10.1038/nn1066	http://dx.doi.org/10.1038/nn1066			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	683GQ	12754517				2022-12-17	WOS:000183140400010
J	Grosche, J; Matyash, V; Moller, T; Verkhratsky, A; Reichenbach, A; Kettenmann, H				Grosche, J; Matyash, V; Moller, T; Verkhratsky, A; Reichenbach, A; Kettenmann, H			Microdomains for neuron-glia interaction: parallel fiber signaling to Bergmann glial cells	NATURE NEUROSCIENCE			English	Article							CEREBELLAR PURKINJE-CELLS; CURRENTS; SPINES; RAT	Astrocytes are considered a reticulate network of cells, through which calcium signals can spread easily. In Bergmann glia, astrocytic cells of the cerebellum, we identified subcellular compartments termed 'glial microdomains'. These elements have a complex surface consisting of thin membrane sheets, contain few mitochondria and wrap around synapses. To test for neuronal interaction with these structures, we electrically stimulated parallel fibers. This stimulation increased intracellular calcium concentration ([Ca2+](i)) in small compartments within Bergmann glial cell processes similar in size to glial microdomains. Thus, a Bergmann glial cell may consist of hundreds of independent compartments capable of autonomous interactions with the particular group of synapses that they ensheath.	Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany; Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Leipzig University	Kettenmann, H (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13122 Berlin, Germany.	hk@nero.glia.mdc-berlin.de	Reichenbach, Andreas/B-2510-2017; Möller, Thomas/W-8974-2019; Verkhratsky, Alexei/J-4527-2013; Kettenmann, Helmut/AAJ-5142-2021	Verkhratsky, Alexei/0000-0003-2592-9898; Kettenmann, Helmut/0000-0001-8208-0291				Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; CHANPALAY V, 1972, Z ANAT ENTWICKLUNGS, V137, P125, DOI 10.1007/BF00538787; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; KIRISCHUK S, 1996, J PHYSIOL-LONDON, V490, P46; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KUFFLER SW, 1966, J NEUROPHYSIOL, V29, P768; Muller T, 1996, GLIA, V17, P274, DOI 10.1002/(SICI)1098-1136(199608)17:4<274::AID-GLIA2>3.0.CO;2-#; MULLER T, 1992, SCIENCE, V256, P1563, DOI 10.1126/science.1317969; RALL W, 1992, PHYSIOL REV, V72, P159; Reichenbach A, 1992, Neuroimage, V1, P69, DOI 10.1016/1053-8119(92)90008-B; ROSENTHAL M, 1992, CAN J PHYSIOL PHARM, V70, P165; SARANTIS M, 1990, BRAIN RES, V516, P322, DOI 10.1016/0006-8993(90)90935-5; Sweadner Kathleen J., 1995, P259; Verkhratsky A, 1996, TRENDS NEUROSCI, V19, P346, DOI 10.1016/0166-2236(96)10048-5; VERKHRATSKY A, 1998, PHYSIOL REV, V78, P1	19	511	528	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					139	143		10.1038/5692	http://dx.doi.org/10.1038/5692			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195197				2022-12-17	WOS:000078231600012
J	Nieuwenhuis, S; Forstmann, BU; Wagenmakers, EJ				Nieuwenhuis, Sander; Forstmann, Birte U.; Wagenmakers, Eric-Jan			Erroneous analyses of interactions in neuroscience: a problem of significance	NATURE NEUROSCIENCE			English	Article								In theory, a comparison of two experimental effects requires a statistical test on their difference. In practice, this comparison is often based on an incorrect procedure involving two separate tests in which researchers conclude that effects differ when one effect is significant (P < 0.05) but the other is not (P > 0.05). We reviewed 513 behavioral, systems and cognitive neuroscience articles in five top-ranking journals (Science, Nature, Nature Neuroscience, Neuron and The Journal of Neuroscience) and found that 78 used the correct procedure and 79 used the incorrect procedure. An additional analysis suggests that incorrect analyses of interactions are even more common in cellular and molecular neuroscience. We discuss scenarios in which the erroneous procedure is particularly beguiling.	[Nieuwenhuis, Sander] Leiden Univ, Dept Psychol, Leiden, Netherlands; [Nieuwenhuis, Sander] Leiden Inst Brain & Cognit, Leiden, Netherlands; [Forstmann, Birte U.; Wagenmakers, Eric-Jan] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); University of Amsterdam	Nieuwenhuis, S (corresponding author), Leiden Univ, Dept Psychol, Leiden, Netherlands.	s.nieuwenhuis@fsw.leidenuiv.nl	Wagenmakers, Eric-Jan/AAH-7065-2019; Forstmann, Birte/AAS-8515-2020	Wagenmakers, Eric-Jan/0000-0003-1596-1034; 				Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Gelman A, 2006, AM STAT, V60, P328, DOI 10.1198/000313006X152649; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; ROSENTHAL R, 1963, J PSYCHOL, V55, P33, DOI 10.1080/00223980.1963.9916596; ROSNOW RL, 1989, AM PSYCHOL, V44, P1276, DOI 10.1037/0003-066X.44.10.1276	7	510	513	1	127	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2011	14	9					1105	1107		10.1038/nn.2886	http://dx.doi.org/10.1038/nn.2886			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	812ID	21878926	Bronze			2022-12-17	WOS:000294284900006
J	Song, HJ; Stevens, CF; Gage, FH				Song, HJ; Stevens, CF; Gage, FH			Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; IN-VITRO; RAT HIPPOCAMPUS; MESSENGER-RNAS; BONE-MARROW; GLIA; DIFFERENTIATION; NEUROGENESIS; EXPRESSION	Neural stem cells are present both in the developing nervous system and in the adult nervous system of all mammals, including humans. Little is known, however, about the extent to which stem cells in adults can give rise to new neurons. We used immunocytochemistry, electron microscopy, fluorescence microscopy (FM imaging) and electrophysiology to demonstrate that progeny of adult rat neural stem cells, when co-cultured with primary neurons and astrocytes from neonatal hippocampus, develop into electrically active neurons and integrate into neuronal networks with functional synaptic transmission. We also found that functional neurogenesis from adult stem cells is possible in co-culture with astrocytes from neonatal and adult hippocampus. These studies show that neural stem cells derived from adult tissues, like those derived from embryonic tissues, retain the potential to differentiate into functional neurons with essential properties of mature CNS neurons.	Salk Inst Biol Studies, Howard Hughes Med Inst, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cfs@salk.edu; gage@salk.edu						ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Auerbach JM, 2000, EUR J NEUROSCI, V12, P1696, DOI 10.1046/j.1460-9568.2000.00067.x; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Blondel O, 2000, J NEUROSCI, V20, P8012; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Clarke D, 2001, CURR OPIN GENET DEV, V11, P575, DOI 10.1016/S0959-437X(00)00235-5; Finley MFA, 1996, J NEUROSCI, V16, P1056; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Goslin K., 1998, CULTURING NERVE CELL, P339; HALES TG, 1994, J NEUROSCI, V14, P5429; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Jessell TM, 2000, CURR OPIN NEUROBIOL, V10, P599, DOI 10.1016/S0959-4388(00)00136-7; Kandel E.R., 2000, PRINCIPLES NEURAL SC; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; NICHOLLS JG, 1992, NEURON BRAIN, P149; NOBEL M, 1998, CULTURING NERVE CELL, P499; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Palmer TD, 1999, J NEUROSCI, V19, P8487; PALMER TD, 1989, BLOOD, V73, P438; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2000, NAT MED, V6, P271; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Sah DWY, 1997, J NEUROBIOL, V32, P95, DOI 10.1002/(SICI)1097-4695(199701)32:1<95::AID-NEU9>3.0.CO;2-9; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; SCHUBERT D, 1974, NATURE, V249, P224, DOI 10.1038/249224a0; SCHWARTZ JP, 1992, GLIA, V5, P75, DOI 10.1002/glia.440050111; SONG HJ, IN PRESS NATURE; SUCHER NJ, 1993, J BIOL CHEM, V268, P22299; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Toda H, 2000, EXP NEUROL, V165, P66, DOI 10.1006/exnr.2000.7473; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vicario-Abejon C, 2000, EUR J NEUROSCI, V12, P677, DOI 10.1046/j.1460-9568.2000.00953.x; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.3.CO;2-3; Ye GL, 2000, DEV BRAIN RES, V124, P33, DOI 10.1016/S0165-3806(00)00103-6; ZAHEER A, 1995, CELL MOL NEUROBIOL, V15, P221, DOI 10.1007/BF02073330	50	510	555	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2002	5	5					438	445		10.1038/nn844	http://dx.doi.org/10.1038/nn844			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	546JY	11953752				2022-12-17	WOS:000175272000014
J	Lehmann, SM; Kruger, C; Park, B; Derkow, K; Rosenberger, K; Baumgart, J; Trimbuch, T; Eom, G; Hinz, M; Kaul, D; Habbel, P; Kalin, R; Franzoni, E; Rybak, A; Nguyen, D; Veh, R; Ninnemann, O; Peters, O; Nitsch, R; Heppner, FL; Golenbock, D; Schott, E; Ploegh, HL; Wulczyn, FG; Lehnardt, S				Lehmann, Sabrina M.; Krueger, Christina; Park, Boyoun; Derkow, Katja; Rosenberger, Karen; Baumgart, Jan; Trimbuch, Thorsten; Eom, Gina; Hinz, Michael; Kaul, David; Habbel, Piet; Kaelin, Roland; Franzoni, Eleonora; Rybak, Agnieszka; Nguyen, Duong; Veh, Ruediger; Ninnemann, Olaf; Peters, Oliver; Nitsch, Robert; Heppner, Frank L.; Golenbock, Douglas; Schott, Eckart; Ploegh, Hidde L.; Wulczyn, F. Gregory; Lehnardt, Seija			An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; IMMUNE-RESPONSES; MICRORNAS; CELLS; IDENTIFICATION; RNA; INFLAMMATION; BIOMARKERS; MICROGLIA; APOPTOSIS	Activation of innate immune receptors by host-derived factors exacerbates CNS damage, but the identity of these factors remains elusive. We uncovered an unconventional role for the microRNA let-7, a highly abundant regulator of gene expression in the CNS, in which extracellular let-7 activates the RNA-sensing Toll-like receptor (TLR) 7 and induces neurodegeneration through neuronal TLR7. Cerebrospinal fluid (CSF) from individuals with Alzheimer's disease contains increased amounts of let-7b, and extracellular introduction of let-7b into the CSF of wild-type mice by intrathecal injection resulted in neurodegeneration. Mice lacking TLR7 were resistant to this neurodegenerative effect, but this susceptibility to let-7 was restored in neurons transfected with TLR7 by intrauterine electroporation of Tlr7(-/-) fetuses. Our results suggest that microRNAs can function as signaling molecules and identify TLR7 as an essential element in a pathway that contributes to the spread of CNS damage.	[Lehmann, Sabrina M.; Krueger, Christina; Derkow, Katja; Rosenberger, Karen; Kaul, David; Habbel, Piet; Lehnardt, Seija] Charite, Dept Neurol, D-13353 Berlin, Germany; [Park, Boyoun] Yonsei Univ, Dept Biol, Seoul 120749, South Korea; [Baumgart, Jan; Nitsch, Robert] Johannes Gutenberg Univ Mainz, Inst Microscop Anat & Neurobiol, Mainz, Germany; [Trimbuch, Thorsten; Heppner, Frank L.; Lehnardt, Seija] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Eom, Gina; Kaelin, Roland; Heppner, Frank L.] Charite, Inst Neuropathol, D-13353 Berlin, Germany; [Hinz, Michael; Rybak, Agnieszka] Max Delbruck Ctr Mol Med, Berlin, Germany; [Franzoni, Eleonora; Nguyen, Duong; Ninnemann, Olaf; Wulczyn, F. Gregory; Lehnardt, Seija] Charite, Inst Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Veh, Ruediger] Charite, Ctr Anat, D-13353 Berlin, Germany; [Peters, Oliver] Charite, Dept Psychiat, D-13353 Berlin, Germany; [Golenbock, Douglas] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Schott, Eckart] Charite, Dept Hepatol & Gastroenterol, D-13353 Berlin, Germany; [Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Yonsei University; Johannes Gutenberg University of Mainz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Massachusetts System; University of Massachusetts Worcester; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lehmann, SM (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	seija.lehnardt@charite.de	Nitsch, Robert/AAI-9129-2021; Lehnardt, Seija/AAA-4113-2022; Kälin, Roland/AAG-9161-2020; Heppner, Frank/ABH-8393-2020; Hinz, Michael/HCI-0550-2022	Heppner, Frank/0000-0001-9816-8917; Baumgart, Jan/0000-0003-1996-4267; Hinz, Michael/0000-0003-2611-4121; Trimbuch, Thorsten/0000-0001-7512-8955; Veh, Rudiger/0000-0002-6253-9808; Peters, Oliver/0000-0003-0568-2998	Deutsche Forschungsgemeinschaft [SFB-TRR43/A1]; NeuroCure Exc 257 [SFB-TRR43/A6];  [SFB665/A2];  [GRK1123]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure Exc 257; ; 	We thank M. Brinkmann (Helmholtz Centre for Infection Research) for providing immortalized bone marrow-derived macrophages. We also thank C. Schipke, A.-M. Rohde, D. Ludecke and J. Schuler for helpful discussions and excellent technical assistance. This work was supported by Deutsche Forschungsgemeinschaft SFB-TRR43/A1 and NeuroCure Exc 257 (to S.L.), SFB-TRR43/A6 (to F.L.H.), and by SFB665/A2 and GRK1123 (to F.G.W.).	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Baraniskin A, 2011, BLOOD, V117, P3140, DOI 10.1182/blood-2010-09-308684; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Butchi NB, 2008, J IMMUNOL, V180, P7604, DOI 10.4049/jimmunol.180.11.7604; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Ghidoni R, 2011, NEURODEGENER DIS, V8, P413, DOI 10.1159/000327756; Ginsberg SD, 1997, ANN NEUROL, V41, P200, DOI 10.1002/ana.410410211; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hinz M, 2007, J BIOL CHEM, V282, P32311, DOI 10.1074/jbc.M705785200; Hoffmann O, 2007, J IMMUNOL, V178, P6476, DOI 10.4049/jimmunol.178.10.6476; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kauppinen S, 2006, HANDB EXP PHARM, V173, P405; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2007, J IMMUNOL, V179, P6134, DOI 10.4049/jimmunol.179.9.6134; Liu T, 2010, NAT NEUROSCI, V13, P1460, DOI 10.1038/nn.2683; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Owens T, 2009, CURR TOP MICROBIOL, V336, P105, DOI 10.1007/978-3-642-00549-7_6; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; ROBERSON SM, 1988, CELL IMMUNOL, V116, P341, DOI 10.1016/0008-8749(88)90236-5; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang SC, 2008, EXP NEUROL, V213, P114, DOI 10.1016/j.expneurol.2008.05.014; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	50	509	538	2	143	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2012	15	6					827	U44		10.1038/nn.3113	http://dx.doi.org/10.1038/nn.3113			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AI	22610069				2022-12-17	WOS:000304546700009
J	Nadarajah, B; Brunstrom, JE; Grutzendler, J; Wong, ROL; Pearlman, AL				Nadarajah, B; Brunstrom, JE; Grutzendler, J; Wong, ROL; Pearlman, AL			Two modes of radial migration in early development of the cerebral cortex	NATURE NEUROSCIENCE			English	Article							GUIDED NEURONAL MIGRATION; CELL-MIGRATION; EXTRACELLULAR-MATRIX; SLICE PREPARATIONS; MAMMALIAN BRAIN; CHICK-EMBRYO; OPTIC TECTUM; NEOCORTEX; REELER; MOUSE	Layer formation in the developing cerebral cortex requires the movement of neurons from their site of origin to their final laminar position. We demonstrate, using time-lapse imaging of acute cortical slices, that two distinct forms of cell movement, locomotion and somal translocation, are responsible for the radial migration of cortical neurons. These modes are distinguished by their dynamic properties and morphological features. Locomotion and translocation are not cell-type specific; although at early ages some cells may move by translocation only, locomoting cells also translocate once their leading process reaches the marginal zone. The existence of two modes of radial migration may account for the differential effects of certain genetic mutations on cortical development.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pearlman, AL (corresponding author), Washington Univ, Sch Med, Dept Neurol, 660 S Euclid Ave, St Louis, MO 63110 USA.	apearl@cellbio.wustl.edu	Grutzendler, Jaime/F-3691-2010					Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Anton ES, 1996, J NEUROSCI, V16, P2283; BOOK KJ, 1990, J COMP NEUROL, V297, P55, DOI 10.1002/cne.902970105; BOOK KJ, 1991, EXP NEUROL, V111, P228, DOI 10.1016/0014-4886(91)90011-Z; BRITTIS PA, 1995, EXP NEUROL, V134, P1, DOI 10.1006/exnr.1995.1031; Brunstrom JE, 1997, NEURON, V18, P505, DOI 10.1016/S0896-6273(00)81250-7; Cameron RS, 1997, J COMP NEUROL, V387, P467; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; FONSECA M, 1995, J COMP NEUROL, V361, P177, DOI 10.1002/cne.903610114; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Gilmore EC, 1998, J NEUROSCI, V18, P6370; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; GOFFINET AM, 1983, J COMP NEUROL, V215, P437, DOI 10.1002/cne.902150408; GRAY GE, 1991, NEURON, V6, P211, DOI 10.1016/0896-6273(91)90357-6; HAGER G, 1995, J NEUROSCI RES, V40, P207, DOI 10.1002/jnr.490400209; HATTEN ME, 1990, TRENDS NEUROSCI, V13, P179, DOI 10.1016/0166-2236(90)90044-B; Hendriks R, 1999, J NEUROSCI RES, V58, P805, DOI 10.1002/(SICI)1097-4547(19991215)58:6<805::AID-JNR7>3.0.CO;2-V; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; KOMURO H, 1995, J NEUROSCI, V15, P1110; Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LUSKIN MB, 1985, J COMP NEUROL, V242, P611, DOI 10.1002/cne.902420409; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MARINPADILLA M, 1971, Z ANAT ENTWICKLUNGS, V134, P117, DOI 10.1007/BF00519296; Meyer G, 1998, J COMP NEUROL, V397, P493; MOREST DK, 1970, Z ANAT ENTWICKLUNGS, V130, P265, DOI 10.1007/BF00520999; Morris NR, 1998, TRENDS CELL BIOL, V8, P467, DOI 10.1016/S0962-8924(98)01389-0; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Pearlman AL, 1998, CURR OPIN NEUROBIOL, V8, P45, DOI 10.1016/S0959-4388(98)80007-X; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; Reinsch S, 1998, J CELL SCI, V111, P2283; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; Sheppard AM, 1995, DEV BIOL, V172, P504, DOI 10.1006/dbio.1995.8034; SNOW RL, 1995, EXP NEUROL, V134, P13, DOI 10.1006/exnr.1995.1032; Takahashi T, 1996, J NEUROSCI, V16, P5762; Wada Y, 1998, J BIOCHEM-TOKYO, V124, P738, DOI 10.1093/oxfordjournals.jbchem.a022174; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2	50	509	521	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					143	150		10.1038/83967	http://dx.doi.org/10.1038/83967			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UC	11175874				2022-12-17	WOS:000167178100012
J	Fox, MD; Snyder, AZ; Zacks, JM; Raichle, ME				Fox, MD; Snyder, AZ; Zacks, JM; Raichle, ME			Coherent spontaneous activity accounts for trial-to-trial variability in human evoked brain responses	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL CONNECTIVITY; DYNAMICS; CORTEX	Trial-to-trial variability in the blood oxygen level-dependent (BOLD) response of functional magnetic resonance imaging has been shown to be relevant to human perception and behavior, but the sources of this variability remain unknown. We demonstrate that coherent spontaneous fluctuations in human brain activity account for a significant fraction of the variability in measured event-related BOLD responses and that spontaneous and task-related activity are linearly superimposed in the human brain.	Washington Univ, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Dept Psychol, St Louis, MO 63110 USA; Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Fox, MD (corresponding author), Washington Univ, Dept Radiol, St Louis, MO 63110 USA.	foxm@npg.wustl.edu	Zacks, Jeffrey M/E-9099-2011; Fox, Michael D./AAZ-3928-2020; anand, amit/A-7222-2009; Bullmore, Ed/C-1706-2012	Zacks, Jeffrey M/0000-0003-1171-3690; Fox, Michael D./0000-0001-8848-6399; Bullmore, Ed/0000-0002-8955-8283	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS006833, P01NS006833] Funding Source: NIH RePORTER; NINDS NIH HHS [NS06833] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Azouz R, 1999, J NEUROSCI, V19, P2209; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Olshausen B. A., 2003, VISUAL NEUROSCIENCES, P1603; Pessoa L, 2005, P NATL ACAD SCI USA, V102, P5612, DOI 10.1073/pnas.0500566102; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486	15	507	512	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					23	25		10.1038/nn1616	http://dx.doi.org/10.1038/nn1616			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16341210				2022-12-17	WOS:000234288000012
J	Luscher, C; Nicoll, RA; Malenka, RC; Muller, D				Luscher, C; Nicoll, RA; Malenka, RC; Muller, D			Synaptic plasticity and dynamic modulation of the portsynaptic membrane	NATURE NEUROSCIENCE			English	Review							LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; DEPENDENT PROTEIN-KINASE; IONOTROPIC GLUTAMATE RECEPTORS; PERFORATED AXOSPINOUS SYNAPSES; RAT DENTATE GYRUS; DENDRITIC SPINES; AMPA RECEPTORS; POSTSYNAPTIC MEMBRANE; TRANSPORTER CURRENTS	The biochemical composition of the postsynaptic membrane and the structure of dendritic spines may be rapidly modulated by synaptic activity. Here we review these findings, discuss their implications for long-term potentiation (LTP) and long-term depression (LTD) and propose a model of sequentially occurring expression mechanisms.	Univ Geneva, Dept Physiol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Neurol, CH-1211 Geneva, Switzerland; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Friend Pritzker Lab, Palo Alto, CA 94304 USA; Univ Geneva, CMU, APSIC, Dept Pharmacol, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of Geneva	Luscher, C (corresponding author), Univ Geneva, CMU, APSIC, Dept Pharmacol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.		Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596				Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; CARLIN RK, 1983, P NATL ACAD SCI-BIOL, V80, P3517, DOI 10.1073/pnas.80.11.3517; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Dailey ME, 1996, J NEUROSCI, V16, P2983; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Desmond NL, 1998, NEUROREPORT, V9, P857, DOI 10.1097/00001756-199803300-00017; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; ENGERT F, NATURE, V66, P99; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; GEINISMAN Y, 1993, HIPPOCAMPUS, V3, P417, DOI 10.1002/hipo.450030404; GEINISMAN Y, 1991, BRAIN RES, V566, P77, DOI 10.1016/0006-8993(91)91683-R; Geinisman Y, 1996, J COMP NEUROL, V368, P413; Halpain S, 1998, J NEUROSCI, V18, P9835; Harris KM, 1999, P NATL ACAD SCI USA, V96, P12213, DOI 10.1073/pnas.96.22.12213; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kaech S, 1999, P NATL ACAD SCI USA, V96, P10433, DOI 10.1073/pnas.96.18.10433; Kennedy MB, 1998, BRAIN RES REV, V26, P243, DOI 10.1016/S0165-0173(97)00043-X; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim CH, 1999, J NEUROSCI, V19, P4314; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Korkotian E, 1999, P NATL ACAD SCI USA, V96, P12068, DOI 10.1073/pnas.96.21.12068; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; Lissin DV, 1999, J NEUROSCI, V19, P1263; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6803; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Muller D, 1997, REV NEUROSCIENCE, V8, P77; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; SCHUSTER T, 1990, BRAIN RES, V523, P171, DOI 10.1016/0006-8993(90)91654-Y; Segal M, 2000, TRENDS NEUROSCI, V23, P53, DOI 10.1016/S0166-2236(99)01499-X; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sorra KE, 1998, J COMP NEUROL, V398, P225; Sorra KE, 1998, J NEUROSCI, V18, P658; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trommald M, 1996, LEARN MEMORY, V3, P218, DOI 10.1101/lm.3.2-3.218; van Rossum D, 1999, TRENDS NEUROSCI, V22, P290, DOI 10.1016/S0166-2236(99)01404-6; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Weeks ACW, 1999, SYNAPSE, V31, P97; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	75	507	516	0	33	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					545	550		10.1038/75714	http://dx.doi.org/10.1038/75714			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816309				2022-12-17	WOS:000087249500009
J	Wolpert, DM; Goodbody, SJ; Husain, M				Wolpert, DM; Goodbody, SJ; Husain, M			Maintaining internal representations the role of the human superior parietal lobe	NATURE NEUROSCIENCE			English	Article							SUSTAINED ATTENTION; CORTEX; MOVEMENTS; SPACE; ANATOMY; MONKEY; PET	In sensorimotor integration, sensory input and motor output signals are combined to provide an internal estimate of the state of both the world and one's own body. Although a single perceptual and motor snapshot can provide information about the current state, computational models show that the state can be optimally estimated by a recursive process in which an internal estimate is maintained and updated by the current sensory and motor signals. These models predict that an internal state estimate is maintained or stored in the brain. Here we report a patient with a lesion of the superior parietal lobe who shows both sensory and motor deficits consistent with an inability to maintain such an internal representation between updates. Our findings suggest that the superior parietal lobe is critical for sensorimotor integration, by maintaining an internal representation of the body's state.	UCL, Inst Neurol, Sobell Dept Neurophysiol, London WC1N 3BG, England; Charing Cross Hosp, Imperial Coll Sch Med, Div Clin Neurosci & Psychol Med, London W6 8RF, England	University of London; University College London; Imperial College London	Wolpert, DM (corresponding author), UCL, Inst Neurol, Sobell Dept Neurophysiol, Queen Sq, London WC1N 3BG, England.	wolpert@hera.ucl.ac.uk	Husain, Masud/C-2074-2008	Husain, Masud/0000-0002-6850-9255; Wolpert, Daniel/0000-0003-2011-2790	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Andersen RA, 1987, HDB PHYSL 1, VV, P483; Balint R, 1909, MON PSYCHIATR NEUROL, V25, P51; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Critchley M., 1953, PARIETAL LOBES; De Renzi E., 1982, DISORDERS SPACE EXPL; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; Goodwin GC., 2014, ADAPTIVE FILTERING P; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; HOLLIDAY IE, 1985, OPHTHAL PHYSL OPT, V5, P149, DOI 10.1016/0275-5408(85)90068-7; Holmes G, 1918, Br J Ophthalmol, V2, P449, DOI 10.1136/bjo.2.9.449; HUSAIN M, 1991, VISION VISUAL DYSFUN, V13, P12; JEANNEROD M, 1984, BRAIN, V107, P899, DOI 10.1093/brain/107.3.899; Jeannerod M., 1997, COGNITIVE NEUROSCIEN; Mattingley JB, 1998, NATURE, V392, P179, DOI 10.1038/32413; MCFIE J, 1950, BRAIN, V73, P167, DOI 10.1093/brain/73.2.167; MENNEMEIER MS, 1994, NEUROPSYCHOLOGIA, V32, P703, DOI 10.1016/0028-3932(94)90030-2; Mesulam M-M, 1985, PRINCIPLES BEHAV NEU; Milner A. D., 1995, VISUAL BRAIN ACTION; Milner AD., 1997, PARIETAL LOBE CONTRI, P3; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; POSNER MI, 1984, J NEUROSCI, V4, P1863; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; WANN JP, 1992, EXP BRAIN RES, V91, P162; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; WOLPERT DM, 1995, EXP BRAIN RES, V103, P460	37	506	508	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	1998	1	6					529	533		10.1038/2245	http://dx.doi.org/10.1038/2245			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	128LE	10196553				2022-12-17	WOS:000076406900020
J	Rosenberg, MD; Finn, ES; Scheinost, D; Papademetris, X; Shen, XL; Constable, RT; Chun, MM				Rosenberg, Monica D.; Finn, Emily S.; Scheinost, Dustin; Papademetris, Xenophon; Shen, Xilin; Constable, R. Todd; Chun, Marvin M.			A neuromarker of sustained attention from whole-brain functional connectivity	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY; FLUID INTELLIGENCE; CHILDREN; NETWORK; FMRI; PARCELLATION; VARIABILITY; PERFORMANCE; CAPACITY; PATTERNS	Although attention plays a ubiquitous role in perception and cognition, researchers lack a simple way to measure a person's overall attentional abilities. Because behavioral measures are diverse and difficult to standardize, we pursued a neuromarker of an important aspect of attention, sustained attention, using functional magnetic resonance imaging. To this end, we identified functional brain networks whose strength during a sustained attention task predicted individual differences in performance. Models based on these networks generalized to previously unseen individuals, even predicting performance from resting-state connectivity alone. Furthermore, these same models predicted a clinical measure of attention-symptoms of attention deficit hyperactivity disorder-from resting-state connectivity in an independent sample of children and adolescents. These results demonstrate that whole-brain functional network strength provides a broadly applicable neuromarker of sustained attention.	[Rosenberg, Monica D.; Chun, Marvin M.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Finn, Emily S.; Constable, R. Todd; Chun, Marvin M.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Scheinost, Dustin; Papademetris, Xenophon; Shen, Xilin; Constable, R. Todd] Yale Univ, Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT USA; [Papademetris, Xenophon] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Constable, R. Todd] Yale Univ, Dept Neurosurg, Sch Med, New Haven, CT USA; [Chun, Marvin M.] Yale Univ, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Rosenberg, MD (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	monica.rosenberg@yale.edu	Finn, Emily S./I-2205-2019; Scheinost, Dustin/Q-2857-2018; Constable, R. Todd/ABE-8038-2021; Rosenberg, Monica D./J-6487-2019	Finn, Emily S./0000-0001-8591-3068; Scheinost, Dustin/0000-0002-6301-1167; Constable, R. Todd/0000-0001-5661-9521; Rosenberg, Monica D./0000-0001-6179-4025; Chun, Marvin/0000-0003-1070-7993; Shen, Xilin/0000-0003-1006-7404	US National Science Foundation; US National Institutes of Health [EB009666, T32 DA022975]; Commonwealth Sciences Foundation, Ministry of Health, China [200802073]; National Foundation, Ministry of Science and Technology, China [2007BAI17B03]; National Natural Sciences Foundation, China [30970802]; Funds for International Cooperation of the National Natural Science Foundation of China [81020108022]; National Natural Science Foundation of China [8100059]; Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH108591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA022975] Funding Source: NIH RePORTER	US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth Sciences Foundation, Ministry of Health, China; National Foundation, Ministry of Science and Technology, China; National Natural Sciences Foundation, China(National Natural Science Foundation of China (NSFC)); Funds for International Cooperation of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	M.D.R. and E.S.F. are supported by US National Science Foundation Graduate Research Fellowships. This work was also supported by US National Institutes of Health EB009666 to R.T.C. and T32 DA022975 to D.S. Data were provided by the ADHD-200 Consortium<SUP>25</SUP>, coordinated by M.P. Milham. Data collection at Peking University was supported by the following funding sources: The Commonwealth Sciences Foundation, Ministry of Health, China (200802073); The National Foundation, Ministry of Science and Technology, China (2007BAI17B03); The National Natural Sciences Foundation, China (30970802); The Funds for International Cooperation of the National Natural Science Foundation of China (81020108022); The National Natural Science Foundation of China (8100059); and the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning.	Acuna C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00062; Baldassarre A, 2012, P NATL ACAD SCI USA, V109, P3516, DOI 10.1073/pnas.1113148109; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Cao QJ, 2006, NEUROREPORT, V17, P1033, DOI 10.1097/01.wnr.0000224769.92454.5d; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Cattell R. B., 1987, INTELLIGENCE ITS STR; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Cocchi L, 2012, J NEUROSCI, V32, P17753, DOI 10.1523/JNEUROSCI.3272-12.2012; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Debettencourt MT, 2015, NAT NEUROSCI, V18, P470, DOI 10.1038/nn.3940; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DuPaul GJ., 1998, ADHD RATING SCALE 4; Engle RW., 1999, INDIVIDUAL DIFFERENC, DOI DOI 10.1017/CBO9781139174909.007; Esterman M, 2013, CEREB CORTEX, V23, P2712, DOI 10.1093/cercor/bhs261; Fair DA, 2010, BIOL PSYCHIAT, V68, P1084, DOI 10.1016/j.biopsych.2010.07.003; Finn ES, 2015, NAT NEUROSCI, V18, P1664, DOI 10.1038/nn.4135; Fortenbaugh FC, 2015, PSYCHOL SCI, V26, P1497, DOI 10.1177/0956797615594896; Friedman L, 2006, NEUROIMAGE, V33, P471, DOI 10.1016/j.neuroimage.2006.07.012; Gabrieli JDE, 2015, NEURON, V85, P11, DOI 10.1016/j.neuron.2014.10.047; Huang LQ, 2012, J EXP PSYCHOL HUMAN, V38, P414, DOI 10.1037/a0026314; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Joshi A, 2011, NEUROINFORMATICS, V9, P69, DOI 10.1007/s12021-010-9092-8; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Krain AL, 2006, CLIN PSYCHOL REV, V26, P433, DOI 10.1016/j.cpr.2006.01.005; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; LI D, 1990, PSYCHOL REP, V67, P531; Luck SJ, 2013, TRENDS COGN SCI, V17, P391, DOI 10.1016/j.tics.2013.06.006; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Qiu MG, 2011, BRAIN TOPOGR, V24, P243, DOI 10.1007/s10548-010-0168-4; Riccio C., 2001, ARCH CLIN NEUROPSYCH, V20, P559; Rosenberg M, 2013, ATTEN PERCEPT PSYCHO, V75, P426, DOI 10.3758/s13414-012-0413-x; Rosenberg MD, 2015, NEUROIMAGE, V114, P249, DOI 10.1016/j.neuroimage.2015.03.032; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scheinost D, 2014, NEUROIMAGE, V95, P13, DOI 10.1016/j.neuroimage.2014.03.035; Shen X, 2013, NEUROIMAGE, V82, P403, DOI 10.1016/j.neuroimage.2013.05.081; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Turk-Browne NB, 2013, SCIENCE, V342, P580, DOI 10.1126/science.1238409; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Unsworth N, 2014, COGNITIVE PSYCHOL, V71, P1, DOI 10.1016/j.cogpsych.2014.01.003; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; Whelan R, 2014, NATURE, V512, P185, DOI 10.1038/nature13402	51	505	517	19	224	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2016	19	1					165	+		10.1038/nn.4179	http://dx.doi.org/10.1038/nn.4179			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7BH	26595653	Green Accepted			2022-12-17	WOS:000367254400027
J	O'Dushlaine, C; Rossin, L; Lee, PH; Duncan, L; Parikshak, NN; Newhouse, S; Ripke, S; Neale, BM; Purcell, SM; Posthuma, D; Nurnberger, JI; Lee, SH; Faraone, SV; Perlis, RH; Mowry, BJ; Thapar, A; Goddard, ME; Witte, JS; Absher, D; Agartz, I; Akil, H; Amin, F; Andreassen, OA; Anjorin, A; Anney, R; Anttila, V; Arking, DE; Asherson, P; Azevedo, MH; Backlund, L; Badner, JA; Bailey, AJ; Banaschewski, T; Barchas, JD; Barnes, MR; Barrett, TB; Bass, N; Battaglia, A; Bauer, M; Bayes, M; Bellivier, F; Bergen, SE; Berrettini, W; Betancur, C; Bettecken, T; Biederman, J; Binder, EB; Black, DW; Blackwood, DHR; Bloss, CS; Boehnke, M; Boomsma, DI; Breuer, R; Bruggeman, R; Cormican, P; Buccola, NG; Buitelaar, JK; Bunney, WE; Buxbaum, JD; Byerley, WF; Byrne, EM; Caesar, S; Cahn, W; Cantor, RM; Casas, M; Chakravarti, A; Chambert, K; Choudhury, K; Cichon, S; Mattheisen, M; Cloninger, CR; Collier, DA; Cook, EH; Coon, H; Cormand, B; Corvin, A; Coryell, WH; Craig, DW; Craig, IW; Crosbie, J; Cuccaro, ML; Curtis, D; Czamara, D; Datta, S; Dawson, G; Day, R; De Geus, EJ; Degenhardt, F; Djurovic, S; Donohoe, GJ; Doyle, AE; Duan, J; Dudbridge, F; Duketis, E; Ebstein, RP; Edenberg, HJ; Elia, J; Ennis, S; Etain, B; Fanous, A; Farmer, AE; Ferrier, IN; Flicldnger, M; Fombonne, E; Foroud, T; Frank, J; Franke, B; Fraser, C; Freedman, R; Freimer, NB; Freitag, CM; Friedl, M; Frisen, L; Gailagher, L; Gejman, PV; Georgieva, L; Gershon, ES; Giegling, I; Gill, M; Gordon, SD; Gordon-Smith, K; Green, EK; Greenwood, TA; Grice, DE; Gross, M; Grozeva, D; Guan, W; Gurling, H; De Haan, L; Haines, JL; Hakonarson, H; Hallmayer, J; Hamilton, SP; Hamshere, ML; Hansen, TF; Hartmann, AM; Hautzinger, M; Heath, AC; Henders, AK; Herms, S; Hickie, IB; Hipolito, M; Hoefels, S; Holsboer, F; Hoogendijk, WJ; Hottenga, JJ; Hultman, CM; Hus, V; Ingason, A; Ising, M; Jamain, S; Jones, EG; Jones, I; Jones, L; Tzeng, JY; Kahler, AK; Kahn, RS; Kandaswamy, R; Keller, MC; Kennedy, JL; Kenny, E; Kent, L; Kim, YJ; Kirov, GK; Klauck, SM; Klei, L; Knowles, JA; Kohli, MA; Koller, DL; Konte, B; Korszun, A; Krabbendam, L; Krasucki, R; Kuntsi, J; Kwan, P; Landen, M; Langstrom, N; Lathrop, M; Lawrence, J; Lawson, WB; Leboyer, M; Ledbetter, DH; Lencz, T; Lesch, KP; Levinson, DF; Lewis, CM; Li, J; Lichtenstein, P; Lieberman, JA; Lin, DY; Linszen, DH; Liu, CY; Lohoff, FW; Loo, SK; Lord, C; Lowe, JK; Lucae, S; MacIntyre, DJ; Madden, PAF; Maestrini, E; Magnusson, PKE; Mahon, PB; Maier, W; Malhotra, AK; Mane, SM; Martin, CL; Martin, NG; Matthews, K; Mattingsdal, M; McCarroll, SA; McGhee, KA; McGough, JJ; McGrath, PJ; McGuffin, P; McInnis, MG; McIntosh, A; McKinney, R; McLean, AW; McMahon, FJ; McMahon, WM; McQuillin, A; Medeiros, H; Medland, SE; Meier, S; Melle, I; Meng, F; Meyer, J; Middeldorp, CM; Middleton, L; Milanova, V; Miranda, A; Monaco, AP; Montgomery, GW; Moran, JL; Moreno-De-Luca, D; Morken, G; Morris, DW; Morrow, EM; Moskvina, V; Muglia, P; Muhleisen, TW; Muir, WJ; Muller-Myhsok, B; Murtha, M; Myers, RM; Myin-Germeys, I; Neale, MC; Nelson, SF; Nievergelt, CM; Nikolov, I; Nimgaonkar, V; Nolen, WA; Nothen, MM; Nwulia, EA; Nyholt, DR; Oades, RD; Olincy, A; Oliveira, G; Olsen, L; Ophoff, RA; Osby, U; Owen, MJ; Palotie, A; Parr, JR; Paterson, AD; Pato, CN; Pato, MT; Penninx, BW; Pergadia, ML; Pericak-Vance, MA; Pickard, BS; Pimm, J; Piven, J; Potash, JB; Poustka, F; Propping, P; Puri, V; Quested, DJ; Quinn, EM; Ramos-Quiroga, JA; Rasmussen, HB; Raychaudhuri, S; Rehnstrom, K; Reif, A; Ribases, M; Rice, JP; Rietschel, M; Roeder, K; Roeyers, H; Rothenberger, A; Rouleau, G; Ruderfer, D; Rujescu, D; Sanders, AR; Sanders, SJ; Santangelo, SL; Sergeant, JA; Schachar, R; Schalling, M; Schatzberg, AF; Scheftner, WA; Schellenberg, GD; Scherer, SW; Schork, NJ; Schulze, TG; Schumacher, J; Schwarz, M; Scolnick, E; Scott, LJ; Shi, JX; Shilling, PD; Shyn, SI; Silverman, JM; Slager, SL; Smalley, SL; Smit, JH; Smith, EN; Sonuga-Barke, EJS; Cair, DS; State, M; Steffens, M; Steinhausen, HC; Strauss, JS; Strohmaier, J; Stroup, TS; Sutdiffe, JS; Szatmari, P; Szelinger, S; Thirumalai, S; Thompson, RC; Todorov, AA; Tozzi, F; Treutlein, J; Uhr, M; Van den Oord, EJCG; Van Grootheest, G; Van Os, J; Vicente, AM; Vieland, VJ; Vincent, JB; Visscher, PM; Walsh, CA; Wassink, TH; Watson, SJ; Weissman, MM; Werge, T; Wienker, TF; Wijsman, EM; Willemsen, G; Williams, N; Willsey, AJ; Witt, SH; Xu, W; Young, AH; Yu, TW; Zammit, S; Zandi, PP; Zhang, P; Zitman, FG; Zollner, S; Devlin, B; Kelsoe, JR; Sklar, P; Daly, MJ; O'Donovan, MC; Craddock, N; Kendler, KS; Weiss, LA; Wray, NR; Zhao, ZM; Geschwind, DH; Sullivan, PF; Smoller, JW; Holmans, PA; Breen, G				O'Dushlaine, Colm; Rossin, Lizzy; Lee, Phil H.; Duncan, Laramie; Parikshak, Neelroop N.; Newhouse, Stephen; Ripke, Stephan; Neale, Benjamin M.; Purcell, Shaun M.; Posthuma, Danielle; Nurnberger, John I.; Lee, S. Hong; Faraone, Stephen V.; Perlis, Roy H.; Mowry, Bryan J.; Thapar, Anita; Goddard, Michael E.; Witte, John S.; Absher, Devin; Agartz, Ingrid; Akil, Huda; Amin, Farooq; Andreassen, Ole A.; Anjorin, Adebayo; Anney, Richard; Anttila, Verneri; Arking, Dan E.; Asherson, Philip; Azevedo, Maria H.; Backlund, Lena; Badner, Judith A.; Bailey, Anthony J.; Banaschewski, Tobias; Barchas, Jack D.; Barnes, Michael R.; Barrett, Thomas B.; Bass, Nicholas; Battaglia, Agatino; Bauer, Michael; Bayes, Monica; Bellivier, Frank; Bergen, Sarah E.; Berrettini, Wade; Betancur, Catalina; Bettecken, Thomas; Biederman, Joseph; Binder, Elisabeth B.; Black, Donald W.; Blackwood, Douglas H. R.; Bloss, Cinnamon S.; Boehnke, Michael; Boomsma, Dorret I.; Breuer, Rene; Bruggeman, Richard; Cormican, Paul; Buccola, Nancy G.; Buitelaar, Jan K.; Bunney, William E.; Buxbaum, Joseph D.; Byerley, William F.; Byrne, Enda M.; Caesar, Sian; Cahn, Wiepke; Cantor, Rita M.; Casas, Miguel; Chakravarti, Aravinda; Chambert, Kimberly; Choudhury, Khalid; Cichon, Sven; Mattheisen, Manuel; Cloninger, C. Robert; Collier, David A.; Cook, Edwin H.; Coon, Hilary; Cormand, Bru; Corvin, Aiden; Coryell, William H.; Craig, David W.; Craig, Ian W.; Crosbie, Jennifer; Cuccaro, Michael L.; Curtis, David; Czamara, Darina; Datta, Susmita; Dawson, Geraldine; Day, Richard; De Geus, Eco J.; Degenhardt, Franziska; Djurovic, Srdjan; Donohoe, Gary J.; Doyle, Alysa E.; Duan, Jubao; Dudbridge, Frank; Duketis, Eftichia; Ebstein, Richard P.; Edenberg, Howard J.; Elia, Josephine; Ennis, Sean; Etain, Bruno; Fanous, Ayman; Farmer, Anne E.; Ferrier, I. Nicol; Flicldnger, Matthew; Fombonne, Eric; Foroud, Tatiana; Frank, Josef; Franke, Barbara; Fraser, Christine; Freedman, Robert; Freimer, Nelson B.; Freitag, Christine M.; Friedl, Marion; Frisen, Louise; Gailagher, Louise; Gejman, Pablo V.; Georgieva, Lyudmila; Gershon, Elliot S.; Giegling, Ina; Gill, Michael; Gordon, Scott D.; Gordon-Smith, Katherine; Green, Elaine K.; Greenwood, Tiffany A.; Grice, Dorothy E.; Gross, Magdalena; Grozeva, Detelina; Guan, Weihua; Gurling, Hugh; De Haan, Lieuwe; Haines, Jonathan L.; Hakonarson, Hakon; Hallmayer, Joachim; Hamilton, Steven P.; Hamshere, Marian L.; Hansen, Thomas F.; Hartmann, Annette M.; Hautzinger, Martin; Heath, Andrew C.; Henders, Anjali K.; Herms, Stefan; Hickie, Ian B.; Hipolito, Maria; Hoefels, Susanne; Holsboer, Florian; Hoogendijk, Witte J.; Hottenga, Jouke-Jan; Hultman, Christina M.; Hus, Vanessa; Ingason, Andres; Ising, Marcus; Jamain, Stephane; Jones, Edward G.; Jones, Ian; Jones, Lisa; Tzeng, Jung-Ying; Kaehler, Anna K.; Kahn, Rene S.; Kandaswamy, Radhika; Keller, Matthew C.; Kennedy, James L.; Kenny, Elaine; Kent, Lindsey; Kim, Yunjung; Kirov, George K.; Klauck, Sabine M.; Klei, Lambertus; Knowles, James A.; Kohli, Martin A.; Koller, Daniel L.; Konte, Bettina; Korszun, Ania; Krabbendam, Lydia; Krasucki, Robert; Kuntsi, Jonna; Kwan, Phoenix; Landen, Mikael; Laengstroem, Niklas; Lathrop, Mark; Lawrence, Jacob; Lawson, William B.; Leboyer, Marion; Ledbetter, David H.; Lencz, Todd; Lesch, Klaus-Peter; Levinson, Douglas F.; Lewis, Cathryn M.; Li, Jun; Lichtenstein, Paul; Lieberman, Jeffrey A.; Lin, Dan-Yu; Linszen, Don H.; Liu, Chunyu; Lohoff, Falk W.; Loo, Sandra K.; Lord, Catherine; Lowe, Jennifer K.; Lucae, Susanne; MacIntyre, Donald J.; Madden, Pamela A. F.; Maestrini, Elena; Magnusson, Patrik K. E.; Mahon, Pamela B.; Maier, Wolfgang; Malhotra, Anil K.; Mane, Shrikant M.; Martin, Christa L.; Martin, Nicholas G.; Matthews, Keith; Mattingsdal, Morten; McCarroll, Steven A.; McGhee, Kevin A.; McGough, James J.; McGrath, Patrick J.; McGuffin, Peter; McInnis, Melvin G.; McIntosh, Andrew; McKinney, Rebecca; McLean, Alan W.; McMahon, Francis J.; McMahon, William M.; McQuillin, Andrew; Medeiros, Helena; Medland, Sarah E.; Meier, Sandra; Melle, Ingrid; Meng, Fan; Meyer, Jobst; Middeldorp, Christel M.; Middleton, Lefkos; Milanova, Vihra; Miranda, Ana; Monaco, Anthony P.; Montgomery, Grant W.; Moran, Jennifer L.; Moreno-De-Luca, Daniel; Morken, Gunnar; Morris, Derek W.; Morrow, Eric M.; Moskvina, Valentina; Muglia, Pierandrea; Muehleisen, Thomas W.; Muir, Walter J.; Mueller-Myhsok, Bertram; Murtha, Michael; Myers, Richard M.; Myin-Germeys, Inez; Neale, Michael C.; Nelson, Stan F.; Nievergelt, Caroline M.; Nikolov, Ivan; Nimgaonkar, Vishwajit; Nolen, Willem A.; Noethen, Markus M.; Nwulia, Evaristus A.; Nyholt, Dale R.; Oades, Robert D.; Olincy, Ann; Oliveira, Guiomar; Olsen, Line; Ophoff, Roel A.; Osby, Urban; Owen, Michael J.; Palotie, Aarno; Parr, Jeremy R.; Paterson, Andrew D.; Pato, Carlos N.; Pato, Michele T.; Penninx, Brenda W.; Pergadia, Michele L.; Pericak-Vance, Margaret A.; Pickard, Benjamin S.; Pimm, Jonathan; Piven, Joseph; Potash, James B.; Poustka, Fritz; Propping, Peter; Puri, Vinay; Quested, Digby J.; Quinn, Emma M.; Ramos-Quiroga, Josep Antoni; Rasmussen, Henrik B.; Raychaudhuri, Soumya; Rehnstroem, Karola; Reif, Andreas; Ribases, Marta; Rice, John P.; Rietschel, Marcella; Roeder, Kathryn; Roeyers, Herbert; Rothenberger, Aribert; Rouleau, Guy; Ruderfer, Douglas; Rujescu, Dan; Sanders, Alan R.; Sanders, Stephan J.; Santangelo, Susan L.; Sergeant, Joseph A.; Schachar, Russell; Schalling, Martin; Schatzberg, Alan F.; Scheftner, William A.; Schellenberg, Gerard D.; Scherer, Stephen W.; Schork, Nicholas J.; Schulze, Thomas G.; Schumacher, Johannes; Schwarz, Markus; Scolnick, Edward; Scott, Laura J.; Shi, Jianxin; Shilling, Paul D.; Shyn, Stanley I.; Silverman, Jeremy M.; Slager, Susan L.; Smalley, Susan L.; Smit, Johannes H.; Smith, Erin N.; Sonuga-Barke, Edmund J. S.; Cair, David St.; State, Matthew; Steffens, Michael; Steinhausen, Hans-Christoph; Strauss, John S.; Strohmaier, Jana; Stroup, T. Scott; Sutdiffe, James S.; Szatmari, Peter; Szelinger, Szabocls; Thirumalai, Srinivasa; Thompson, Robert C.; Todorov, Alexandre A.; Tozzi, Federica; Treutlein, Jens; Uhr, Manfred; Van den Oord, Edwin J. C. G.; Van Grootheest, Gerard; Van Os, Jim; Vicente, Astrid M.; Vieland, Veronica J.; Vincent, John B.; Visscher, Peter M.; Walsh, Christopher A.; Wassink, Thomas H.; Watson, Stanley J.; Weissman, Myrna M.; Werge, Thomas; Wienker, Thomas F.; Wijsman, Ellen M.; Willemsen, Gonneke; Williams, Nigel; Willsey, A. Jeremy; Witt, Stephanie H.; Xu, Wei; Young, Allan H.; Yu, Timothy W.; Zammit, Stanley; Zandi, Peter P.; Zhang, Peng; Zitman, Frans G.; Zoellner, Sebastian; Devlin, Bernie; Kelsoe, John R.; Sklar, Pamela; Daly, Mark J.; O'Donovan, Michael C.; Craddock, Nicholas; Kendler, Kenneth S.; Weiss, Lauren A.; Wray, Naomi R.; Zhao, Zhaoming; Geschwind, Daniel H.; Sullivan, Patrick F.; Smoller, Jordan W.; Holmans, Peter A.; Breen, Gerome		IIBDGC; Network & Pathway Anal Subgrp Psyc	Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways	NATURE NEUROSCIENCE			English	Article							DE-NOVO MUTATIONS; SCHIZOPHRENIA; METHYLATION; DISORDERS; AUTISM; BRAIN; PROMOTERS; BURDEN	Genome-wide association studies (GWAS) of psychiatric disorders have identified multiple genetic associations with such disorders, but better methods are needed to derive the underlying biological mechanisms that these signals indicate. We sought to identify biological pathways in GWAS data from over 60,000 participants from the Psychiatric Genomics Consortium. We developed an analysis framework to rank pathways that requires only summary statistics. We combined this score across disorders to find common pathways across three adult psychiatric disorders: schizophrenia, major depression and bipolar disorder. Histone methylation processes showed the strongest association, and we also found statistically significant evidence for associations with multiple immune and neuronal signaling pathways and with the postsynaptic density. Our study indicates that risk variants for psychiatric disorders aggregate in particular biological pathways and that these pathways are frequently shared between disorders. Our results confirm known mechanisms and suggest several novel insights into the etiology of psychiatric disorders.	[O'Dushlaine, Colm] Regeneron Pharmaceut Inc, Regeneron Genet Ctr, Tarrytown, NY 10591 USA; [O'Dushlaine, Colm; Rossin, Lizzy; Duncan, Laramie; Ripke, Stephan; Neale, Benjamin M.; Purcell, Shaun M.; Perlis, Roy H.; Anttila, Verneri; Raychaudhuri, Soumya; Daly, Mark J.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Lee, Phil H.; Perlis, Roy H.; Bergen, Sarah E.; Smoller, Jordan W.] Massachusetts Gen Hosp, Psychiat & Neurodevelopmental Genet Unit, Boston, MA 02114 USA; [Duncan, Laramie; Ripke, Stephan; Neale, Benjamin M.; Purcell, Shaun M.; Bergen, Sarah E.; Chambert, Kimberly; McCarroll, Steven A.; Moran, Jennifer L.; Raychaudhuri, Soumya; Scolnick, Edward; Daly, Mark J.; Smoller, Jordan W.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Duncan, Laramie; Ripke, Stephan; Neale, Benjamin M.; Purcell, Shaun M.; Bergen, Sarah E.; Chambert, Kimberly; McCarroll, Steven A.; Moran, Jennifer L.; Raychaudhuri, Soumya; Scolnick, Edward; Daly, Mark J.; Smoller, Jordan W.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Parikshak, Neelroop N.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Program Neurobehav Genet, Los Angeles, CA 90095 USA; [Newhouse, Stephen; Asherson, Philip; Collier, David A.; Craig, Ian W.; Farmer, Anne E.; Kuntsi, Jonna; Lewis, Cathryn M.; McGuffin, Peter; Breen, Gerome] Kings Coll London, Inst Psychiat Psychol & Neurosci, Social Genet & Dev Psychiat Ctr, MRC, London, England; [Newhouse, Stephen; Breen, Gerome] NIHR, Biomed Res Ctr Mental Hlth, South London & Maudsley NHS Trust & Inst Psychiat, London, England; [Purcell, Shaun M.; Ruderfer, Douglas] Icahn Sch Med Mt Sinai, Dept Psychiat, Div Psychiat Gen, New York, NY USA; [Posthuma, Danielle] Vrije Univ Amsterdam, Dept Funct Gen, Amsterdam, Netherlands; Vrije Univ Amsterdam, Dept Clin Genet, Amsterdam, Netherlands; [Posthuma, Danielle] Erasmus Univ, Med Ctr, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [Nurnberger, John I.] Indiana Univ, Sch Med, Inst Psychiat Res, Indianapolis, IN 46202 USA; [Nurnberger, John I.] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Lee, S. Hong; Mowry, Bryan J.; Byrne, Enda M.; Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA; [Faraone, Stephen V.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Mowry, Bryan J.] Queensland Ctr Mental Hlth Res, Wacol, Qld, Australia; [Thapar, Anita; Fraser, Christine; Georgieva, Lyudmila; Gordon-Smith, Katherine; Grozeva, Detelina; Jones, Ian; Kirov, George K.; Moskvina, Valentina; Nikolov, Ivan; Owen, Michael J.; Williams, Nigel; Zammit, Stanley; O'Donovan, Michael C.; Craddock, Nicholas; Holmans, Peter A.] Cardiff Univ, Sch Med, MRC, Ctr Neuropsychiat Genet & Gen, Cardiff CF10 3AX, S Glam, Wales; [Thapar, Anita; Fraser, Christine; Georgieva, Lyudmila; Jones, Ian; Kirov, George K.; Nikolov, Ivan; Owen, Michael J.; Williams, Nigel; Zammit, Stanley; Sklar, Pamela; O'Donovan, Michael C.; Craddock, Nicholas] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales; [Goddard, Michael E.] Dept Environm & Primary Ind Victoria, Biosci Res Div, Melbourne, Vic, Australia; [Goddard, Michael E.] Univ Melbourne, Fac Land & Environm, Melbourne, Vic, Australia; [Witte, John S.; Foroud, Tatiana; Koller, Daniel L.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Absher, Devin; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Agartz, Ingrid; Andreassen, Ole A.; Djurovic, Srdjan; Mattingsdal, Morten; Melle, Ingrid] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, Oslo, Norway; [Agartz, Ingrid] Diakonhjemmet Hosp Oslo, Dept Res, Oslo, Norway; [Akil, Huda; Meng, Fan; Thompson, Robert C.; Watson, Stanley J.] Univ Michigan, Mol & Behav Neurosci Inst, Mol Psychiat Lab, Ann Arbor, MI 48109 USA; [Amin, Farooq] Emory Univ, Atlanta Vet Affairs Med Ctr, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Andreassen, Ole A.; Melle, Ingrid] Oslo Univ Hosp, Div Mental Hlth & Addict, N-0450 Oslo, Norway; [Anjorin, Adebayo; Bass, Nicholas; Choudhury, Khalid; Gurling, Hugh; Kandaswamy, Radhika; Krasucki, Robert; Lawrence, Jacob; McQuillin, Andrew; Pimm, Jonathan; Puri, Vinay] UCL, Mental Hlth Sci Unit, London, England; [Anney, Richard; Cormican, Paul; Corvin, Aiden; Donohoe, Gary J.; Gailagher, Louise; Gill, Michael; Kenny, Elaine; Morris, Derek W.; Quinn, Emma M.; Visscher, Peter M.] Trin Coll Dublin, Dept Psychiat, Dublin, Ireland; [Arking, Dan E.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Azevedo, Maria H.; Oliveira, Guiomar] Univ Coimbra, Fac Med, Coimbra, Portugal; [Backlund, Lena; Frisen, Louise; Osby, Urban; Schalling, Martin] Karolinska Inst, Ctr Mol Med, Dept Mol Med & Surg, Stockholm, Sweden; [Badner, Judith A.; Gershon, Elliot S.] Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; [Bailey, Anthony J.] Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; [Banaschewski, Tobias] Heidelberg Univ, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherary, Mannheim, Germany; [Barchas, Jack D.] Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10021 USA; [Barnes, Michael R.] GlaxoSmithKline, London, England; [Barrett, Thomas B.] Portland VA Med Ctr, Portland, OR USA; [Battaglia, Agatino] Stella Maris Inst Child & Adolescent Neuropsychia, Pisa, Italy; [Bauer, Michael] Carl Gustav Carus Univ Hosp, Dept Psychiat & Psychotherapy, Dresden, Germany; [Bayes, Monica] CNAG, PCB, Barcelona, Spain; [Bellivier, Frank; Etain, Bruno; Jamain, Stephane; Leboyer, Marion] INSERM, U955, Creteil, France; Univ Paris 07, Paris, France; Grp Hosp St Louis Lariboisiere, AP HP, Dept Psychiat, Paris, France; [Bellivier, Frank; Etain, Bruno; Jamain, Stephane; Leboyer, Marion] ENBREC Grp, Fdn FondaMental, Creteil, France; [Bergen, Sarah E.; Hultman, Christina M.; Kaehler, Anna K.; Landen, Mikael; Laengstroem, Niklas; Lichtenstein, Paul; Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Berrettini, Wade; Elia, Josephine; Lohoff, Falk W.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Betancur, Catalina] INSERM, U952, Paris, France; CNRS, UMR 7224, Paris, France; [Betancur, Catalina] Univ Paris 06, Paris, France; [Bettecken, Thomas; Binder, Elisabeth B.; Czamara, Darina; Holsboer, Florian; Ising, Marcus; Kohli, Martin A.; Lucae, Susanne; Mueller-Myhsok, Bertram; Uhr, Manfred] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Biederman, Joseph] Massachusetts Gen Hosp, Clin & Res Programs Pediat Psychopharmacol & ADHD, Boston, MA 02114 USA; [Biederman, Joseph] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Black, Donald W.; Coryell, William H.; Potash, James B.; Wassink, Thomas H.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Blackwood, Douglas H. R.; MacIntyre, Donald J.; McGhee, Kevin A.; McIntosh, Andrew; McLean, Alan W.; Muir, Walter J.; Pickard, Benjamin S.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh, Midlothian, Scotland; [Bloss, Cinnamon S.; Schork, Nicholas J.; Smith, Erin N.] Scripps Translat Sci Inst, La Jolla, CA USA; [Bloss, Cinnamon S.] Scripps Hlth, La Jolla, CA USA; [Boehnke, Michael; Flicldnger, Matthew; Guan, Weihua; Kwan, Phoenix; Scott, Laura J.; Zhang, Peng; Zoellner, Sebastian] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Boehnke, Michael; Flicldnger, Matthew; Guan, Weihua; Kwan, Phoenix; Scott, Laura J.; Zhang, Peng; Zoellner, Sebastian] Univ Michigan, Sch Publ Hlth, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Boomsma, Dorret I.; De Geus, Eco J.; Hottenga, Jouke-Jan; Middeldorp, Christel M.; Willemsen, Gonneke] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Penninx, Brenda W.; Smit, Johannes H.; Van Grootheest, Gerard; Willemsen, Gonneke] Inst Hlth & Care Res, EMGO, Amsterdam, Netherlands; [Boomsma, Dorret I.; De Geus, Eco J.; Hottenga, Jouke-Jan; Middeldorp, Christel M.; Penninx, Brenda W.] Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Breuer, Rene; Frank, Josef; Meier, Sandra; Strohmaier, Jana; Treutlein, Jens; Witt, Stephanie H.] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Bruggeman, Richard; Nolen, Willem A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Buccola, Nancy G.] Louisiana State Univ, Hlth Sci Ctr, Sch Nursing, New Orleans, LA USA; [Buitelaar, Jan K.; Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands; [Bunney, William E.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Buxbaum, Joseph D.] Seaver Autism Ctr Res & Treatment, Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Byerley, William F.; Hamilton, Steven P.; Weiss, Lauren A.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Byerley, William F.] NCIRE, San Francisco, CA USA; [Caesar, Sian; Gordon-Smith, Katherine; Jones, Lisa] Univ Birmingham, Dept Psychiat, Birmingham, W Midlands, England; [Cahn, Wiepke; Kahn, Rene S.] Univ Med Ctr, Rudolf Magnus Inst Neurosci, Utrecht Psychiat, Dept Psychiat, Birmingham, W Midlands, England; [Cantor, Rita M.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Casas, Miguel; Ramos-Quiroga, Josep Antoni] Hosp Univ Vail Hebron, CIBERSAM, Ctr Invest Biomed Area Salud Mental, Barcelona, Spain; [Casas, Miguel; Ramos-Quiroga, Josep Antoni] Univ Autonoma Barcelona, Dept Psychiat & Legal Med, E-08193 Barcelona, Spain; [Cichon, Sven; Degenhardt, Franziska; Herms, Stefan; Muehleisen, Thomas W.; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Gen, Bonn, Germany; INM 1, Res Ctr, Julich, Germany; [Mattheisen, Manuel; Degenhardt, Franziska; Muehleisen, Thomas W.; Noethen, Markus M.; Propping, Peter; Ribases, Marta; Schumacher, Johannes] Univ Bonn, Inst Human Genet, Bonn, Germany; [Cichon, Sven; Herms, Stefan] Univ Basel, Dept Biomed, Div Med Genet, Basel, Switzerland; [Mattheisen, Manuel; Hansen, Thomas F.; Ingason, Andres; Jones, Edward G.; Olsen, Line; Rasmussen, Henrik B.; Werge, Thomas] iPSYCH, Lundbeck Initiat Integrat Psychiat Res, Roskilde, Denmark; Aarhus Univ, Dept Biomed, iPSYCH, Aarhus, Denmark; [Mattheisen, Manuel] Univ Bonn, Dept Genom Math, Bonn, Germany; [Cloninger, C. Robert; Heath, Andrew C.; Madden, Pamela A. F.; Pergadia, Michele L.; Todorov, Alexandre A.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Cook, Edwin H.] Univ Illinois, Inst Juvenile Res, Dept Psychiat, Chicago, IL USA; [Coon, Hilary; McMahon, William M.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Cormand, Bru] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; CIBERER, Biomed Network Res Ctr Rare Dis, Barcelona, Spain; [Cormand, Bru] IBUB, Barcelona, Spain; [Craig, David W.; Szelinger, Szabocls] Translat Genom Res Inst, Phoenix, AZ USA; [Crosbie, Jennifer; Schachar, Russell] Univ Toronto, Hosp Sick Children, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, John P Hussman Inst Human Gen, Miami, FL USA; [Curtis, David] Univ London, East London NHS Fdn Trust, London, England; [Czamara, Darina; Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Datta, Susmita] UCL, Genet Inst, London, England; [Dawson, Geraldine] Autism Speaks, New York, NY USA; Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Dawson, Geraldine; Piven, Joseph] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC USA; [Day, Richard; Matthews, Keith] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Neurosci, Dundee DD1 9SY, Scotland; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, N-0450 Oslo, Norway; [Doyle, Alysa E.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Doyle, Alysa E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Duan, Jubao; Gejman, Pablo V.; Sanders, Alan R.] NorthShore Univ Hlth Syst, Dept Psychiat & Behav Sci, Evanston, IL USA; [Duan, Jubao; Gejman, Pablo V.; Sanders, Alan R.] Univ Chicago, Evanston, IL USA; [Dudbridge, Frank] London Sch Hyg & Trop Med, Dept Noncommun Dis Epidemiol, London WC1, England; [Duketis, Eftichia; Freitag, Christine M.; Poustka, Fritz] JW Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat Psychosomat & Ps, Frankfurt, Germany; [Ebstein, Richard P.] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Edenberg, Howard J.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46204 USA; [Elia, Josephine] Univ Penn, AI Dupont Hosp Children, Philadelphia, PA 19104 USA; [Ennis, Sean] Univ Coll Med Sci, Sch Med, Dublin, Ireland; [Etain, Bruno; Jamain, Stephane; Leboyer, Marion] Hop H Mondor A Chenevier, AP HP, Dept Psychiat, Creteil, France; [Fanous, Ayman] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC USA; [Fanous, Ayman; Neale, Michael C.; Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [Ferrier, I. Nicol; Parr, Jeremy R.; Young, Allan H.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Fombonne, Eric] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Fombonne, Eric] Oregon Hlth & Sci Univ, Inst Dev & Disabil, Portland, OR 97201 USA; [Freedman, Robert; Olincy, Ann] Univ Colorado Denver, Dept Psychiat, Aurora, CO USA; [Freimer, Nelson B.; Loo, Sandra K.; Nelson, Stan F.; Ophoff, Roel A.; Smalley, Susan L.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; [Friedl, Marion; Giegling, Ina; Hartmann, Annette M.; Konte, Bettina; Rujescu, Dan] Univ Halle, Dept Psychiat, Halle, Germany; [Gordon, Scott D.; Henders, Anjali K.; Martin, Nicholas G.; Medland, Sarah E.; Montgomery, Grant W.; Nyholt, Dale R.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Green, Elaine K.] Univ Plymouth, Dept Biomed & Biol Sci, Plymouth PL4 8AA, Devon, England; [Greenwood, Tiffany A.; McKinney, Rebecca; Nievergelt, Caroline M.; Shilling, Paul D.; Kelsoe, John R.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Grice, Dorothy E.] Icahn Sch Med Mt Sinai, OCD & Related Disorders, Div Tics, New York, NY 10029 USA; [Grice, Dorothy E.; Silverman, Jeremy M.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Gross, Magdalena; Hoefels, Susanne; Maier, Wolfgang] Univ Bonn, Dept Psychiat, Bonn, Germany; [Guan, Weihua] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [De Haan, Lieuwe] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37235 USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Gen, Div Human, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Hallmayer, Joachim] Stanford Univ, Sch Med, Dept Psychiat, Stanford, CA 94305 USA; [Hamshere, Marian L.; Hautzinger, Martin] Univ Tubingen, Dept Clin & Dev Psychol, Tubingen, Germany; [Hansen, Thomas F.; Ingason, Andres; Jones, Edward G.; Olsen, Line; Rasmussen, Henrik B.; Werge, Thomas] Copenhagen Univ Hosp, Inst Biol Psychiat, iPSYCH, Roskilde, Denmark; [Hickie, Ian B.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Hipolito, Maria; Lawson, William B.; Nwulia, Evaristus A.] Howard Univ, Coll Med, Dept Psychiat & Behav Sci, Washington, DC 20059 USA; [Hoogendijk, Witte J.] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands; [Hus, Vanessa] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Tzeng, Jung-Ying] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Keller, Matthew C.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Kennedy, James L.] Ctr Addict & Mental Hlth, Psychiat Neurogenet Sect, Toronto, ON, Canada; [Kent, Lindsey] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Kim, Yunjung; Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Klauck, Sabine M.] German Canc Res Ctr, DKFZ, Div Mol Genome Anal, Heidelberg, Germany; [Klei, Lambertus; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Knowles, James A.; Medeiros, Helena; Pato, Carlos N.; Pato, Michele T.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Psychiat, Los Angeles, CA 90033 USA; [Korszun, Ania] Queen Mary Univ London, Wolfson Inst Preventat Med, London, England; [Krabbendam, Lydia; Myin-Germeys, Inez; Van Os, Jim] Maastricht Univ Med Ctr, South Limburg Mental Hlth Res & Teaching Network, Dept Psychiat Neuropsychol, Maastricht, Netherlands; [Landen, Mikael] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Ledbetter, David H.; Martin, Christa L.] Autism & Dev Med Inst, Geisinger Hlth Syst, Danville, PA USA; [Lencz, Todd; Malhotra, Anil K.] Zucker Hillside Hosp Div North Shore, Dept Psychiat, Div Res, Glen Oaks, NY USA; Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY USA; [Lencz, Todd; Malhotra, Anil K.] Yeshiva Univ, Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY USA; [Lesch, Klaus-Peter] Univ Wurzburg, ADHD Clin Res Unit, Dept Psychiat Psychosomat & Psychotherapy, Div Mol Psychiat, D-97070 Wurzburg, Germany; [Lesch, Klaus-Peter] Maastricht Univ, Sch Mental Hlth & Neurosci MHENS, Dept Psychiat & Psychol, NL-6200 MD Maastricht, Netherlands; [Levinson, Douglas F.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Li, Jun] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Lieberman, Jeffrey A.; McGrath, Patrick J.] Columbia Univ, New York State Psychiat Inst, New York, NY USA; [Lin, Dan-Yu] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Linszen, Don H.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Liu, Chunyu] Univ Illinois, Inst Human Genet, Dept Psychiat, Chicago, IL USA; [Loo, Sandra K.; Smalley, Susan L.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Lord, Catherine] Weill Cornell Med Coll, Ctr Autism & Developing Brain, White Plains, NY USA; [Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Autism Res & Treatment, Semel Inst, Los Angeles, CA 90095 USA; [Maestrini, Elena] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Mahon, Pamela B.; Schulze, Thomas G.] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Mane, Shrikant M.] Yale Ctr Genome Anal, Orange, CA USA; [Mattingsdal, Morten] Sorlandet Hosp, Kristiansand, Norway; [McGough, James J.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Los Angeles, CA 90095 USA; [McInnis, Melvin G.; Zhang, Peng; Zoellner, Sebastian] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [McIntosh, Andrew; McLean, Alan W.; Muir, Walter J.; Pickard, Benjamin S.] Univ Edinburgh, Mol Med Ctr, Edinburgh, Midlothian, Scotland; [McMahon, Francis J.] US Natl Inst Hlth Bethesda, Nat Inst Mental Hlth, Bethesda, MD USA; [Meyer, Jobst] Univ Trier, Dept Neurobehav Genet, Trier, Germany; [Middleton, Lefkos] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Milanova, Vihra] Alexander Univ Hosp, Psychiat Clin 1, Dept Psychiat, Sofia, Bulgaria; [Miranda, Ana] Univ Valencia, Dept Dev & Educ Psychol, Valencia, Spain; [Monaco, Anthony P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Monaco, Anthony P.] Tufts Univ, Off President, Medford, MA 02155 USA; [Moreno-De-Luca, Daniel; Sanders, Stephan J.; State, Matthew] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Morken, Gunnar] St Olavs Hosp, Dept Psychiat, Trondheim, Norway; [Morken, Gunnar] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Morrow, Eric M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Morrow, Eric M.] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Moskvina, Valentina; Holmans, Peter A.] Cardiff Univ, Biostat & Bioinformat Unit, Cardiff, Wales; [Muglia, Pierandrea; Tozzi, Federica] GlaxoSmithKline Res & Dev Ltd, Neurosci Ctr Excellence Drug Discovery, Verona, Italy; [Muehleisen, Thomas W.] Univ Bonn, Life & Brain Ctr, Bonn, Germany; [Murtha, Michael; State, Matthew; Willsey, A. Jeremy] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Nimgaonkar, Vishwajit; Sanders, Stephan J.] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA; [Nimgaonkar, Vishwajit] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Oades, Robert D.] Univ Duisburg Essen, Clin Child & Adolescent Psychiat & Psychotherapy, Essen, Germany; [Oliveira, Guiomar] Pediat Hosp, Ctr Hosp, Res & Clin Training Dept, Coimbra, Portugal; [Oliveira, Guiomar] Univ Coimbra, Coimbra, Portugal; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands; [Palotie, Aarno; Rehnstroem, Karola] Sanger Inst, Cambridge, England; [Paterson, Andrew D.] Hosp Sick Children, Genet Program, Toronto, ON M5G 1X8, Canada; [Paterson, Andrew D.] Hosp Sick Children, Genom Biol, Toronto, ON M5G 1X8, Canada; [Paterson, Andrew D.; Xu, Wei] Univ Toronto, Dalia Lana Sch Publ Hlth, Toronto, ON, Canada; [Penninx, Brenda W.; Smit, Johannes H.; Van Grootheest, Gerard] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Quested, Digby J.] Univ Oxford, Acad Dept Psychiat, Oxford, England; [Reif, Andreas] Univ Wurzburg, Dept Psychiat, Wurzburg, Germany; [Ribases, Marta] Vall Hebron Res Inst, Psychiat Genet Unit, Barcelona, Spain; [Rice, John P.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Roeyers, Herbert; Sonuga-Barke, Edmund J. S.] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Rothenberger, Aribert] Univ Med Gottingen, Gottingen, Germany; [Rouleau, Guy] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Sanders, Stephan J.; State, Matthew; Willsey, A. Jeremy] Yale Univ, Dept Genet, New Haven, CT USA; [Sanders, Stephan J.] Yale Univ, Program Neurogenet, New Haven, CT USA; [Santangelo, Susan L.] Maine Med Ctr, Dept Psychiat, Portland, ME 04102 USA; [Santangelo, Susan L.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Sergeant, Joseph A.] Vrije Univ Amsterdam, Dept Clin Neurophysiol, Amsterdam, Netherlands; [Schatzberg, Alan F.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Scheftner, William A.] Rush Univ Med Ctr, Chicago, IL USA; [Schellenberg, Gerard D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Gen, Toronto, ON M5G 1X8, Canada; [Schork, Nicholas J.; Smith, Erin N.] Scripps Res Inst, La Jolla, CA 92037 USA; [Schulze, Thomas G.] Univ Gottingen, Dept Psychiat & Psychotherapy, D-37073 Gottingen, Germany; [Schwarz, Markus] Psychiat Ctr Nordbaden, Wiesloch, Germany; [Shi, Jianxin] Natl Canc Inst, Div Canc Epidemiol & Genet, Bethesda, MD USA; [Shyn, Stanley I.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Slager, Susan L.] Mayo Clin, Rochester, MN USA; [Sonuga-Barke, Edmund J. S.] Univ Southampton, Acad Unit Psychol, Developmental Brain & Behav Lab, Southampton, Hants, England; [Cair, David St.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Steffens, Michael] Fed Inst Drugs & Med Devices BfArM, Res Dept, Bonn, Germany; [Steinhausen, Hans-Christoph] Aalborg Univ Hosp, Res Unit Child & Adolescent Psychiat, Aalborg, Denmark; Univ Basel, Clin Psychol & Epidemiol, Basel, Switzerland; [Steinhausen, Hans-Christoph] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Strauss, John S.] Ctr Addict & Mental Hlth, Mol Neuropsychiat & Dev Lab, Toronto, ON, Canada; [Stroup, T. Scott; Vincent, John B.] Columbia Univ, Dept Psychiat, New York, NY USA; [Sutdiffe, James S.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37235 USA; [Szatmari, Peter] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; Hosp Sick Children, Neurosci & Mental Hlth Program, Toronto, ON M5G 1X8, Canada; [Szatmari, Peter] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Thirumalai, Srinivasa] Oxford Hlth NHS Fdn Trust, Marlborough House Secure Unit, Milton Keynes, Bucks, England; [Van den Oord, Edwin J. C. G.] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Richmond, VA USA; Inst Nacl Saude Dr Ricardo Jorge, Lisbon, Portugal; [Vicente, Astrid M.] BioFIG, Ctr Biodivers, Funct & Integrat Gen, Lisbon, Portugal; Inst Gulbenkian Ciencias, Lisbon, Portugal; [Vicente, Astrid M.] Nationwide Childrens Hosp, Battelle Ctr Math Med, Columbus, OH USA; [Vieland, Veronica J.; Walsh, Christopher A.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Life Sci, Dept Neurol, Boston, MA 02115 USA; [Walsh, Christopher A.] Harvard Univ, Sch Med, Ctr Life Sci, Dept Paediat, Boston, MA 02115 USA; [Weissman, Myrna M.] Columbia Univ, Coll Physicians & Surg, New York, NY USA; [Werge, Thomas] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Wienker, Thomas F.] Univ Bonn, Inst Med Biometry, Bonn, Germany; [Wijsman, Ellen M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Wijsman, Ellen M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Young, Allan H.] Kings Coll London, Inst Psychiat, Ctr Affect Disorders, London, England; [Yu, Timothy W.] Harvard Univ, Sch Med, Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Zandi, Peter P.] Johns Hopkins Univ, Dept Mental Hlth, Baltimore, MD USA; [Zitman, Frans G.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Kelsoe, John R.] Vet Affairs San Diego Healthcare Syst, STEP, Dept Psychiat, San Diego, CA USA; Virginia Commonwealth Univ, Dept Human Mol Genet, Richmond, VA USA; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Kendler, Kenneth S.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Zhao, Zhaoming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA	Regeneron; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of London; King's College London; University of London; King's College London; Icahn School of Medicine at Mount Sinai; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Queensland; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Queensland Centre for Mental Health Research; Cardiff University; Cardiff University; University of Melbourne; University of California System; University of California San Francisco; HudsonAlpha Institute for Biotechnology; University of Oslo; Diakonhjemmet Hospital; University of Michigan System; University of Michigan; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Oslo; University of London; University College London; Trinity College Dublin; Johns Hopkins University; Universidade de Coimbra; Karolinska Institutet; University of Chicago; University of British Columbia; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Cornell University; GlaxoSmithKline; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; IRCCS Fondazione Stella Maris; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; University of Pennsylvania; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Iowa; Royal Infirmary of Edinburgh; University of Edinburgh; Scripps Research Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Groningen; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Radboud University Nijmegen; University of California System; University of California Irvine; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; Northern California Institute for Research & Education; University of Birmingham; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Hospital Universitari Vall d'Hebron; University of Barcelona; Autonomous University of Barcelona; University of Bonn; University of Bonn; University of Basel; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Bonn; Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Utah System of Higher Education; University of Utah; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona; Translational Genomics Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Miami; University of London; University of Munich; University of London; University College London; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Dundee; University of Oslo; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; NorthShore University Health System; University of Chicago; University of London; London School of Hygiene & Tropical Medicine; Goethe University Frankfurt; National University of Singapore; Indiana University System; Indiana University-Purdue University Indianapolis; Nemours Alfred I. duPont Hospital for Children; University of Pennsylvania; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Georgetown University; Virginia Commonwealth University; Newcastle University - UK; Oregon Health & Science University; Oregon Health & Science University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; Martin Luther University Halle Wittenberg; QIMR Berghofer Medical Research Institute; University of Plymouth; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Bonn; University of Minnesota System; University of Minnesota Twin Cities; University of Amsterdam; Academic Medical Center Amsterdam; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Stanford University; Eberhard Karls University of Tubingen; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; University of Sydney; Howard University; Erasmus University Rotterdam; Erasmus MC; University of Michigan System; University of Michigan; University of North Carolina; North Carolina State University; University of Colorado System; University of Colorado Boulder; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of St Andrews; University of North Carolina; University of North Carolina Chapel Hill; Helmholtz Association; German Cancer Research Center (DKFZ); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Southern California; University of London; Queen Mary University London; Maastricht University; Maastricht University Medical Centre (MUMC); University of Gothenburg; CEA; UDICE-French Research Universities; Universite Paris Saclay; Geisinger Health System; Northwell Health; Northwell Health; Yeshiva University; Albert Einstein College of Medicine; University of Wurzburg; Maastricht University; Stanford University; University of Michigan System; University of Michigan; Columbia University; New York State Psychiatry Institute; University of North Carolina; University of North Carolina Chapel Hill; University of Amsterdam; Academic Medical Center Amsterdam; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Los Angeles; Cornell University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Bologna; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan; University of Edinburgh; National Institutes of Health (NIH) - USA; Universitat Trier; Imperial College London; Medical University Sofia; University of Valencia; University of Oxford; Wellcome Centre for Human Genetics; Tufts University; Yale University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Brown University; Brown University; Cardiff University; GlaxoSmithKline; University of Bonn; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Duisburg Essen; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Utrecht University; Utrecht University Medical Center; Wellcome Trust Sanger Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Vrije Universiteit Amsterdam; University of Oxford; University of Wurzburg; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Washington University (WUSTL); Carnegie Mellon University; Ghent University; University of Gottingen; McGill University; Yale University; Yale University; Maine Medical Center; Harvard University; Harvard Medical School; Vrije Universiteit Amsterdam; Stanford University; Rush University; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Scripps Research Institute; University of Gottingen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; Mayo Clinic; University of Southampton; University of Aberdeen; Aalborg University; Aalborg University Hospital; University of Basel; University of Zurich; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Columbia University; Vanderbilt University; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Virginia Commonwealth University; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa; Instituto Gulbenkian de Ciencia; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Columbia University; University of Copenhagen; University of Bonn; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of London; King's College London; Harvard University; Boston Children's Hospital; Harvard Medical School; Johns Hopkins University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Virginia Commonwealth University; Virginia Commonwealth University; Vanderbilt University; Vanderbilt University	Breen, G (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Social Genet & Dev Psychiat Ctr, MRC, London, England.	holmanspa@cardiff.ac.uk; gerome.breen@kcl.ac.uk	Andreassen, Ole A./AAY-7531-2020; Scherer, Stephen W./B-3785-2013; Cloninger, Claude/F-5357-2012; Magnusson, Patrik KE/C-4458-2017; Boomsma, Dorret I/AAX-4470-2020; Monaco, Anthony P/A-4495-2010; Mattingsdal, Morten/Q-9367-2016; Mahon, Pamela Belmonte/O-9806-2018; Grice, Dorothy E/X-3372-2019; Donohoe, Gary/J-6481-2013; Medland, Sarah/AAT-7595-2020; Mattheisen, Manuel/B-4949-2012; de Geus, Eco J.C./M-9318-2015; BELLIVIER, FRANK/H-5197-2012; Duncan, Laramie/AAG-6605-2019; Fanous, Ayman H/O-1263-2017; Muglia, Pierandrea/ABD-9235-2020; Herms, Stefan/J-1949-2014; Hickie, Ian B/K-8975-2015; Stroup, Thomas/AAB-7780-2019; Rujescu, Dan/GRS-3875-2022; Jamain, Stéphane/P-3710-2017; Daly, Mark J/B-2453-2017; Giegling, Ina/ABA-3677-2021; Jamain, Stéphane/L-1822-2019; Langstrom, Niklas/C-5615-2009; Lee, Sang Hong/A-2569-2011; Buitelaar, J.K./AAY-7522-2020; Lencz, Todd/J-3418-2014; van Os, Jim/V-8884-2019; Paterson, Andrew D/A-4088-2011; Betancur, Catalina/K-3791-2017; Breen, Gerome/Y-2706-2019; Lieberman, Jeffrey/AAY-8239-2020; Myin-Germeys, Inez/L-5106-2014; Morken, Gunnar/AAX-3373-2020; Melle, Ingrid S/B-4858-2011; Lewis, Cathryn/M-8766-2019; Sanders, Stephan/S-8645-2019; blackwood, douglas/AIB-8874-2022; Haines, Jonathan/C-3374-2012; Konte, Bettina/AAT-1142-2021; Medland, Sarah E/C-7630-2013; McMahon, Francis J/A-7290-2009; McQuillin, Andrew/C-1623-2008; Wray, Naomi/C-8639-2015; Sonuga-Barke, Edmund j/D-9137-2011; Tozzi, Federica/AAP-5462-2021; Doyle, Alysa/GVR-7637-2022; Leboyer, Marion/AAW-3648-2021; Nelson, Stanley F/D-4771-2009; Hartmann, Annette/AAS-6331-2021; Hansen, Thomas/GWZ-2858-2022; van Grootheest, Gerard/C-6942-2014; Lesch, Klaus-Peter/J-4906-2013; Kennedy, James Lowery/AAZ-6947-2020; Collier, David A/D-1649-2011; Liu, Chunyu/G-7561-2012; Lawson, William B/O-9758-2017; Bergen, Sarah/I-8313-2012; McIntosh, Andrew M/B-9379-2008; Paterson, Andrew/AAQ-7511-2020; Cormand, Bru/H-5338-2015; Silverman, Jeremy M./AAO-4268-2020; Jones, Ian R/B-4925-2009; Mattheisen, Manuel/S-3725-2019; Ruderfer, Douglas M/M-5795-2016; Thapar, Anita/AAH-5555-2020; Lohoff, Falk W/M-7951-2016; State, Matthew/W-2256-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Faraone, Stephen/AAE-7334-2019; Etain, Bruno/L-6647-2017; Degenhardt, Franziska/H-4169-2017; Ribasés, Marta/B-5309-2019; Craig, Ian/AAF-9167-2019; Holmans, Peter/F-4518-2015; Schumacher, Johannes/F-4970-2015; Breen, Gerome D/A-5540-2010; Meier, Sandra/AAB-1242-2021; Zhang, Peng/N-2920-2014; Middeldorp, Christel M/L-7728-2017; Craig, David Wesley/K-6961-2019; Lewis, Cathryn M/A-5225-2010; Banaschewski, Tobias/ABE-5985-2020; Battaglia, Agatino/AAG-1406-2020; Yu, Timothy W./AAF-5738-2019; van Os, Jim/C-2113-2014; Landen, Mikael/AAD-7917-2020; Morris, Derek/AAW-8343-2021; Bal, Vanessa Hus/AAN-2381-2020; Visscher, Peter/ABB-6151-2020; /AAD-2060-2020; Vicente, Astrid/F-8692-2014; Hansen, Thomas Folkmann/O-5965-2014; Oliveira, Guiomar/AAF-3911-2021; Franke, Barbara/D-4836-2009; Kendler, Kenneth/AAF-2876-2019; Ripke, Stephan/AAK-5486-2021; Fombonne, Eric/M-4893-2018; Duncan, Laramie/AAW-5306-2021; Kuntsi, Jonna/G-9750-2011; Nyholt, Dale Robert/J-3174-2017; Buxbaum, Joseph D/G-6001-2010; Greenwood, Tiffany/F-6356-2012; Cichon, Sven/B-9618-2014; Mowry, Bryan/G-5046-2010; Morrow, Eric/J-2767-2013; krabbendam, lydia/F-9163-2010	Scherer, Stephen W./0000-0002-8326-1999; Cloninger, Claude/0000-0003-3096-4807; Magnusson, Patrik KE/0000-0002-7315-7899; Monaco, Anthony P/0000-0001-7480-3197; Mattingsdal, Morten/0000-0003-4440-0324; Mahon, Pamela Belmonte/0000-0002-3947-441X; Grice, Dorothy E/0000-0002-8833-2549; Donohoe, Gary/0000-0003-3037-7426; Medland, Sarah/0000-0003-1382-380X; Mattheisen, Manuel/0000-0002-8442-493X; de Geus, Eco J.C./0000-0001-6022-2666; Muglia, Pierandrea/0000-0002-3973-8606; Herms, Stefan/0000-0002-2786-8200; Hickie, Ian B/0000-0001-8832-9895; Stroup, Thomas/0000-0002-3123-0672; Jamain, Stéphane/0000-0002-4321-4100; Daly, Mark J/0000-0002-0949-8752; Langstrom, Niklas/0000-0002-2686-6799; Lee, Sang Hong/0000-0001-9701-2718; Lencz, Todd/0000-0001-8586-338X; van Os, Jim/0000-0002-7245-1586; Paterson, Andrew D/0000-0002-9169-118X; Betancur, Catalina/0000-0002-3327-4804; Breen, Gerome/0000-0003-2053-1792; Morken, Gunnar/0000-0003-1972-5901; Melle, Ingrid S/0000-0002-9783-548X; Lewis, Cathryn/0000-0002-8249-8476; Haines, Jonathan/0000-0002-4351-4728; Konte, Bettina/0000-0001-5287-308X; Medland, Sarah E/0000-0003-1382-380X; McMahon, Francis J/0000-0002-9469-305X; McQuillin, Andrew/0000-0003-1567-2240; Wray, Naomi/0000-0001-7421-3357; Tozzi, Federica/0000-0002-3536-2920; Leboyer, Marion/0000-0001-5473-3697; Nelson, Stanley F/0000-0002-2082-3114; van Grootheest, Gerard/0000-0003-4350-6661; Lesch, Klaus-Peter/0000-0001-8348-153X; Kennedy, James Lowery/0000-0002-8733-3806; Collier, David A/0000-0003-4087-1559; Liu, Chunyu/0000-0002-5986-4415; Lawson, William B/0000-0002-9324-7090; Bergen, Sarah/0000-0002-5888-0034; McIntosh, Andrew M/0000-0002-0198-4588; Paterson, Andrew/0000-0002-9169-118X; Cormand, Bru/0000-0001-5318-4382; Jones, Ian R/0000-0001-5821-5889; Mattheisen, Manuel/0000-0002-8442-493X; Ruderfer, Douglas M/0000-0002-2365-386X; Thapar, Anita/0000-0002-3689-737X; Faraone, Stephen/0000-0002-9217-3982; Etain, Bruno/0000-0002-5377-1488; Ribasés, Marta/0000-0003-1039-1116; Holmans, Peter/0000-0003-0870-9412; Schumacher, Johannes/0000-0001-9217-6457; Breen, Gerome D/0000-0003-2053-1792; Zhang, Peng/0000-0003-1182-1392; Middeldorp, Christel M/0000-0002-6218-0428; Craig, David Wesley/0000-0003-2040-1955; Lewis, Cathryn M/0000-0002-8249-8476; Banaschewski, Tobias/0000-0003-4595-1144; Battaglia, Agatino/0000-0002-7128-7606; Yu, Timothy W./0000-0003-2988-7701; Morris, Derek/0000-0002-3413-570X; Bal, Vanessa Hus/0000-0003-0750-823X; Visscher, Peter/0000-0002-2143-8760; /0000-0003-4651-0084; Vicente, Astrid/0000-0001-7134-8037; Hansen, Thomas Folkmann/0000-0001-6703-7762; Oliveira, Guiomar/0000-0002-7049-1277; Franke, Barbara/0000-0003-4375-6572; Fombonne, Eric/0000-0002-8605-3538; Kuntsi, Jonna/0000-0002-0113-8162; Nyholt, Dale Robert/0000-0001-7159-3040; Greenwood, Tiffany/0000-0002-6080-6503; Grozeva, Detelina/0000-0003-3239-8415; Cichon, Sven/0000-0002-9475-086X; Ennis, Sean/0000-0002-4330-1386; Moran, Jennifer/0000-0002-5664-4716; Nothen, Markus/0000-0002-8770-2464; Anttila, Verneri/0000-0002-0073-4675; Freitag, Christine Margarete/0000-0001-9676-4782; BELLIVIER, FRANK/0000-0002-3660-6640; Dawson, Geraldine/0000-0003-1410-2764; Walters, James/0000-0002-6980-4053; Myin-Germeys, Inez/0000-0002-3731-4930; Parikshak, Neel/0000-0003-2027-1871; Mowry, Bryan/0000-0002-4115-5645; coryell, william/0000-0003-3989-7276; Sonuga-Barke, Edmund/0000-0002-6996-3935; Morrow, Eric/0000-0003-3430-3520; Casas Brugue, Miquel/0000-0003-3496-8522; Zammit, Stanley/0000-0002-2647-9211; Buccola, Nancy/0000-0003-1378-4636; krabbendam, lydia/0000-0003-4074-5149; Freedman, Robert/0000-0002-2181-2898; Backlund, Lena/0000-0001-9399-5024; Raychaudhuri, Soumya/0000-0002-1901-8265; Buxbaum, Joseph/0000-0001-8898-8313; State, Matthew/0000-0003-1624-8302; Kent, Lindsey/0000-0002-5315-3399; MAESTRINI, ELENA/0000-0001-5924-3179; Bass, Nicholas James/0000-0002-4481-778X; Hamilton, Steven/0000-0001-8106-6260; MacIntyre, Donald J/0000-0001-6963-1335; Jones, Lisa/0000-0002-5122-8334; Goddard, Michael/0000-0001-9917-7946; Young, Allan/0000-0003-2291-6952; Middleton, Lefkos/0000-0002-8615-3723; Willemsen, Gonneke/0000-0003-3755-0236; Duncan, Laramie/0000-0003-1131-661X; Quested, Digby/0000-0001-6155-3336; Bruggeman, Richard/0000-0002-3238-8471; Schork, Nicholas/0000-0003-0920-5013; Wassink, Thomas/0000-0002-0952-8333; Djurovic, Srdjan/0000-0002-8140-8061; Posthuma, Danielle/0000-0001-7582-2365; Anney, Richard/0000-0002-6083-407X; Ramos-Quiroga, Josep Antoni/0000-0003-1622-0350; Gallagher, Louise/0000-0001-9462-2836; Black, Donald/0000-0001-8038-1971; Escott-Price, Valentina/0000-0003-1784-5483; Sanders, Stephan/0000-0001-9112-5148; Bloss, Cinnamon/0000-0003-1315-8387; Asherson, Philip/0000-0003-2667-2254	National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London; Maudsley NHS Foundation Trust; King's College London; US National Institute of Mental Health (NIMH) [K99MH101367]; NIMH [U01 MH085520]; Netherlands Scientific Organization (NOW) [480-05-003]; Dutch Brain Foundation; VU University; MRC [G0800509, G1000708, G0300189] Funding Source: UKRI; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [G0800509, G0300189, MR/L010305/1, G9817803B] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R15CA170091, R01CA082659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH101367, K24MH094614, R25MH060482, U01MH094432, R01MH104261, R01MH100027, R01MH094293, R01MH063480] Funding Source: NIH RePORTER	National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London; US National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Netherlands Scientific Organization (NOW); Dutch Brain Foundation; VU University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	G.B. and S.N. acknowledge funding support for this work from the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. P.H.L. is supported by US National Institute of Mental Health (NIMH) grant K99MH101367. The PGC Cross-Disorder Group is supported by NIMH grant U01 MH085520. Statistical analyses were carried out on the Genetic Cluster Computer, which is fmancially supported by the Netherlands Scientific Organization (NOW; 480-05-003; principal investigator D.P.) along with a supplement from the Dutch Brain Foundation and VU University. Numerous (> 100) grants from government agencies along with substantial private and foundation support worldwide enabled the collection of phenotype and genotype data, without which this research would not be possible.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Bauman AL, 2000, J NEUROSCI, V20, P7571; Ben-David E, 2013, MOL PSYCHIATR, V18, P1054, DOI 10.1038/mp.2012.148; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Cruceanu C, 2013, INT J NEUROPSYCHOPH, V16, P289, DOI 10.1017/S1461145712000363; Dieperink E, 2000, AM J PSYCHIAT, V157, P867, DOI 10.1176/appi.ajp.157.6.867; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Heijmans BT, 2009, EPIGENETICS-US, V4, P526, DOI 10.4161/epi.4.8.10265; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Huang HS, 2007, J NEUROSCI, V27, P11254, DOI 10.1523/JNEUROSCI.3272-07.2007; Jarome TJ, 2013, REV NEUROSCIENCE, V24, P375, DOI 10.1515/revneuro-2013-0008; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; PSYCHIATRIC GWA, 2011, NAT GENET, V43, P977, DOI DOI 10.1038/NG.943; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2010, NEURON, V68, P182, DOI 10.1016/j.neuron.2010.10.003; Susser E, 2008, ANN NY ACAD SCI, V1136, P185, DOI 10.1196/annals.1425.024; Ting JT, 2012, ANNU REV NEUROSCI, V35, P49, DOI 10.1146/annurev-neuro-062111-150442; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Xu XX, 2014, J NEUROSCI, V34, P1420, DOI 10.1523/JNEUROSCI.4488-13.2014; Yauch RL, 2012, CURR OPIN GENET DEV, V22, P45, DOI 10.1016/j.gde.2012.01.003	39	505	511	4	285	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2015	18	2					199	209		10.1038/nn.3922	http://dx.doi.org/10.1038/nn.3922			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CA0UM	25599223	Green Published, Green Accepted			2022-12-17	WOS:000348631800010
J	Tamas, G; Buhl, EH; Lorincz, A; Somogyi, P				Tamas, G; Buhl, EH; Lorincz, A; Somogyi, P			Proximally targeted GABAergic synapses and gap junctions synchronize cortical interneurons	NATURE NEUROSCIENCE			English	Article							SYNAPTIC RELEASE SITES; HIPPOCAMPUS IN-VITRO; CAT VISUAL-CORTEX; INHIBITORY INTERNEURONS; SOMATOSENSORY CORTEX; NEOCORTICAL NEURONS; PYRAMIDAL CELLS; NETWORKS; OSCILLATIONS; RAT	Networks of GABAergic interneurons are implicated in synchronizing cortical activity at gamma frequencies (30-70 Hz). Here we demonstrate that the combined electrical and GABAergic synaptic coupling of basket cells instantaneously entrained gamma-frequency postsynaptic firing in layers 2/3 of rat somatosensory cortex. This entrainment was mediated by rapid curtailment of gap junctional coupling potentials by GABA(A) receptor-mediated IPSPs. Electron microscopy revealed spatial proximity of gap junctions and GABAergic synapses on somata and dendrites. Electrical coupling alone entrained postsynaptic firing with a phase lag, whereas unitary GABAergic connections were ineffective in gamma-frequency phasing. These observations demonstrate precise spatiotemporal mechanisms underlying action potential timing in oscillating interneuronal networks.	Univ Szeged, Dept Comparat Physiol, H-6726 Szeged, Hungary; Univ Oxford, Univ Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England	Szeged University; University of Oxford	Tamas, G (corresponding author), Univ Szeged, Dept Comparat Physiol, Kozepfasor 52, H-6726 Szeged, Hungary.	gtamas@sol.cc.u-szeged.hu	Tamas, Gabor/AAG-9305-2020	Tamas, Gabor/0000-0002-7905-6001				Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; CHRISTIE MJ, 1989, J NEUROSCI, V9, P3584; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; CONNORS BW, 1983, J NEUROSCI, V3, P773; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; KOSAKA T, 1985, J COMP NEUROL, V231, P150, DOI 10.1002/cne.902310203; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; NAKAJIMA Y, 1974, J COMP NEUROL, V156, P375, DOI 10.1002/cne.901560402; Niedermayer E., 1993, ELECTROEN CLIN NEURO; PAPPAS GD, 1966, ANN NY ACAD SCI, V137, P495, DOI 10.1111/j.1749-6632.1966.tb50177.x; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Peters A, 1980, Adv Neurol, V27, P21; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SLOPER JJ, 1972, BRAIN RES, V44, P640, DOI 10.1016/0006-8993(72)90327-7; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; Tamas G, 1997, J NEUROSCI, V17, P6352; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110	35	504	507	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					366	371		10.1038/73936	http://dx.doi.org/10.1038/73936			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725926				2022-12-17	WOS:000087945400017
J	Stout, AK; Raphael, HM; Kanterewicz, BI; Klann, E; Reynolds, IJ				Stout, AK; Raphael, HM; Kanterewicz, BI; Klann, E; Reynolds, IJ			Glutamate-induced neuron death requires mitochondrial calcium uptake	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; NMDA RECEPTOR ACTIVATION; CEREBELLAR GRANULE CELLS; NITRIC-OXIDE FORMATION; METHYL-D-ASPARTATE; CYTOCHROME-C; INTRACELLULAR ACIDIFICATION; SUPEROXIDE PRODUCTION; CORTICAL CULTURES; PREVENT GLUTAMATE	We have investigated the role of mitochondrial calcium buffering in excitotoxic cell death. Glutamate acts at NMDA receptors in cultured rat forebrain neurons to increase the intracellular free calcium concentration. Although concurrent inhibition of mitochondrial calcium uptake substantially enhanced this cytoplasmic calcium increase, it significantly reduced glutamate-stimulated neuronal cell death. Mitochondrial inhibition did not affect nitric oxide production or MAP kinase phosphorylation, which have been proposed to mediate excitotoxicity. These results indicate that very high levels of cytoplasmic calcium are not necessarily toxic to forebrain neurons, and that potential-driven uptake of calcium into mitochondria is required to trigger NMDA-receptor-stimulated neuronal death.	Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reynolds, IJ (corresponding author), Univ Pittsburgh, Dept Pharmacol, E1354 Biomed Sci Tower, Pittsburgh, PA 15261 USA.	ijr@prophet.pharm.pitt.edu	Reynolds, Ian Jeffery/ABH-3197-2020	Reynolds, Ian/0000-0003-3028-5070	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034138, R01NS034007, R29NS034007] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 34007, NS 09998, NS 34138] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; ARKLES B, 1975, J BIOL CHEM, V250, P8856; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bindokas VP, 1996, J NEUROSCI, V16, P1324; BREDT DS, 1989, BIOCHEM BIOPH RES CO, V159, P976, DOI 10.1016/0006-291X(89)92204-3; BROCKMANN HJ, 1993, TRENDS ECOL EVOL, V8, P2, DOI 10.1016/0169-5347(93)90120-E; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Budd SL, 1996, J NEUROCHEM, V67, P2282; CHOI DW, 1987, J NEUROSCI, V7, P369; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Dawson VL, 1996, J NEUROSCI, V16, P2479; DEMERLEPALLARDY C, 1991, BIOCHEM BIOPH RES CO, V181, P456, DOI 10.1016/S0006-291X(05)81441-X; DUGAN LL, 1995, J NEUROSCI, V15, P6377; DYKENS JA, 1987, J NEUROCHEM, V49, P1222, DOI 10.1111/j.1471-4159.1987.tb10014.x; DYKENS JA, 1994, J NEUROCHEM, V63, P584; FAVARON M, 1988, P NATL ACAD SCI USA, V85, P7351, DOI 10.1073/pnas.85.19.7351; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; HEWETT SJ, 1993, BRAIN RES, V625, P337, DOI 10.1016/0006-8993(93)91078-7; Hoyt KR, 1998, J PHYSIOL-LONDON, V509, P103, DOI 10.1111/j.1469-7793.1998.103bo.x; HOYT KR, IN PRESS J NEUROCHEM; Hyrc K, 1997, J NEUROSCI, V17, P6669; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kim CN, 1997, CANCER RES, V57, P3115; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; NEWMEYER DD, 1994, CELL, V79, P353, DOI 10.1016/0092-8674(94)90203-8; NICHOLLS D, 1982, BIOCHIM BIOPHYS ACTA, V683, P57, DOI 10.1016/0304-4173(82)90013-1; NICHOLLS DG, 1985, MOL MECH ISCHEMIC BR, P97; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; PAUWELS PJ, 1992, NEUROSCI LETT, V143, P27, DOI 10.1016/0304-3940(92)90225-V; RAJDEV S, 1993, NEUROSCI LETT, V162, P149, DOI 10.1016/0304-3940(93)90582-6; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; Schinder AF, 1996, J NEUROSCI, V16, P6125; SIMAN R, 1989, J NEUROSCI, V9, P1579; STOUT AK, IN PRESS NEUROSCIENC; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; WANG GJ, 1995, NEUROSCI LETT, V186, P139, DOI 10.1016/0304-3940(95)11305-G; WANG GJ, 1994, J NEUROPHYSIOL, V72, P2563, DOI 10.1152/jn.1994.72.6.2563; White RJ, 1997, J PHYSIOL-LONDON, V498, P31, DOI 10.1113/jphysiol.1997.sp021839; WHITE RJ, 1995, J NEUROSCI, V15, P1318; White RJ, 1996, J NEUROSCI, V16, P5688; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	49	504	519	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					366	373		10.1038/1577	http://dx.doi.org/10.1038/1577			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196525				2022-12-17	WOS:000076361400013
J	Goldman, N; Chen, M; Fujita, T; Xu, QW; Peng, WG; Liu, W; Jensen, TK; Pei, Y; Wang, FS; Han, XN; Chen, JF; Schnermann, J; Takano, T; Bekar, L; Tieu, K; Nedergaard, M				Goldman, Nanna; Chen, Michael; Fujita, Takumi; Xu, Qiwu; Peng, Weiguo; Liu, Wei; Jensen, Tina K.; Pei, Yong; Wang, Fushun; Han, Xiaoning; Chen, Jiang-Fan; Schnermann, Jurgen; Takano, Takahiro; Bekar, Lane; Tieu, Kim; Nedergaard, Maiken			Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture	NATURE NEUROSCIENCE			English	Article							PROSTATIC ACID-PHOSPHATASE; ADENOSINE A(1) RECEPTOR; TUBULOGLOMERULAR FEEDBACK; INFLAMMATORY PAIN; CINGULATE CORTEX; DORSAL-HORN; SPINAL-CORD; MICE; RAT; ELECTROACUPUNCTURE	Acupuncture is an invasive procedure commonly used to relieve pain. Acupuncture is practiced worldwide, despite difficulties in reconciling its principles with evidence-based medicine. We found that adenosine, a neuromodulator with anti-nociceptive properties, was released during acupuncture in mice and that its anti-nociceptive actions required adenosine A1 receptor expression. Direct injection of an adenosine A1 receptor agonist replicated the analgesic effect of acupuncture. Inhibition of enzymes involved in adenosine degradation potentiated the acupuncture-elicited increase in adenosine, as well as its anti-nociceptive effect. These observations indicate that adenosine mediates the effects of acupuncture and that interfering with adenosine metabolism may prolong the clinical benefit of acupuncture.	[Goldman, Nanna; Chen, Michael; Fujita, Takumi; Xu, Qiwu; Peng, Weiguo; Liu, Wei; Jensen, Tina K.; Pei, Yong; Wang, Fushun; Han, Xiaoning; Takano, Takahiro; Bekar, Lane; Tieu, Kim; Nedergaard, Maiken] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Chen, Jiang-Fan] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Schnermann, Jurgen] NIDDKD, US Natl Inst Hlth, Bethesda, MD USA	University of Rochester; Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Nedergaard, M (corresponding author), Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA.	nedergaard@urmc.rochester.edu	Tieu, Kim/AAG-7336-2019; Bekar, Lane K./AAI-2645-2021; Tieu, Kim/F-5426-2012	Tieu, Kim/0000-0001-6606-4371; Tieu, Kim/0000-0001-6606-4371; Bekar, Lane/0000-0001-5083-0967; Chen, Jiang-Fan/0000-0002-0446-3956; Takano, Takahiro/0000-0002-6235-6673	US National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017470, R01ES014899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075177] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the US National Institutes of Health to M.N. and K.T.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Bekar L, 2008, NAT MED, V14, P75, DOI 10.1038/nm1693; Bonafede M, 2008, MED CARE, V46, P41, DOI 10.1097/MLR.0b013e3181589b7d; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Burnstock G, 2009, MED HYPOTHESES, V73, P470, DOI 10.1016/j.mehy.2009.05.031; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; CULLITON BJ, 1972, SCIENCE, V177, P592, DOI 10.1126/science.177.4049.592; CUNHA RA, 1991, EUR J PHARMACOL, V197, P83, DOI 10.1016/0014-2999(91)90368-Z; Davis KD, 1997, J NEUROPHYSIOL, V77, P3370, DOI 10.1152/jn.1997.77.6.3370; Eisenach JC, 2004, J PAIN, V5, P64, DOI 10.1016/j.jpain.2003.10.001; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; GOLEMBIOWSKA K, 1995, BRAIN RES, V699, P315, DOI 10.1016/0006-8993(95)00926-H; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Huang C, 2002, BRAIN RES, V945, P20, DOI 10.1016/S0006-8993(02)02503-9; KARLSTEN R, 1992, Pharmacology and Toxicology, V70, P434; Kelly RB, 2009, AM FAM PHYSICIAN, V80, P481; Lamanna Nicole, 2009, Clin Adv Hematol Oncol, V7, P386; Lao LX, 2004, BRAIN RES, V1020, P18, DOI 10.1016/j.brainres.2004.01.092; Li JH, 2005, CIRCULATION, V111, P2748, DOI 10.1161/CIRCULATIONAHA.104.510669; Li JH, 2003, J APPL PHYSIOL, V95, P577, DOI 10.1152/japplphysiol.00185.2003; Li WM, 2005, JPN J PHYSIOL, V55, P339, DOI 10.2170/jjphysiol.RP001505; LOHSE MJ, 1988, N-S ARCH PHARMACOL, V337, P687; Maione S, 2007, PAIN, V131, P281, DOI 10.1016/j.pain.2007.01.013; Martucci C, 2008, PAIN, V137, P81, DOI 10.1016/j.pain.2007.08.017; POORTMANS JR, 2003, PRINCIPLES EXERCISE; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; REEVE AJ, 1995, NEUROSCI LETT, V194, P81, DOI 10.1016/0304-3940(95)11732-C; SALTER MW, 1987, NEUROSCIENCE, V22, P631, DOI 10.1016/0306-4522(87)90359-9; Sawynok J, 1998, EUR J PHARMACOL, V347, P1, DOI 10.1016/S0014-2999(97)01605-1; Sawynok J, 1998, PAIN, V74, P75, DOI 10.1016/S0304-3959(97)00153-X; Sichardt K, 2007, PURINERG SIGNAL, V3, P285, DOI 10.1007/s11302-007-9065-z; Sjolund KF, 1999, ANESTH ANALG, V88, P605, DOI 10.1097/00000539-199903000-00027; Sun DQ, 2001, P NATL ACAD SCI USA, V98, P9983, DOI 10.1073/pnas.171317998; Takakura Nobuari, 2009, Open Med, V3, pe54; Volonte MG, 2004, J PHARMACEUT BIOMED, V35, P647, DOI 10.1016/j.jpba.2004.02.002; Wei F, 2001, J PHYSIOL-LONDON, V532, P823, DOI 10.1111/j.1469-7793.2001.0823e.x; Weidenhammer W, 2007, CLIN J PAIN, V23, P128, DOI 10.1097/01.ajp.0000210952.09127.df; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; Zijlstra FJ, 2003, MEDIAT INFLAMM, V12, P59, DOI 10.1080/0962935031000114943; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024	45	503	578	8	191	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2010	13	7					883	U130		10.1038/nn.2562	http://dx.doi.org/10.1038/nn.2562			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	615YF	20512135	Green Accepted			2022-12-17	WOS:000279173900022
J	Shimojo, S; Simion, C; Shimojo, E; Scheier, C				Shimojo, S; Simion, C; Shimojo, E; Scheier, C			Gaze bias both reflects and influences preference	NATURE NEUROSCIENCE			English	Article							STIMULI; EMOTION; CANNOT	Emotions operate along the dimension of approach and aversion, and it is reasonable to assume that orienting behavior is intrinsically linked to emotionally involved processes such as preference decisions. Here we describe a gaze 'cascade effect' that was present when human observers were shown pairs of human faces and instructed to decide which face was more attractive. Their gaze was initially distributed evenly between the two stimuli, but then gradually shifted toward the face that they eventually chose. Gaze bias was significantly weaker in a face shape discrimination task. In a second series of experiments, manipulation of gaze duration, but not exposure duration alone, biased observers' preference decisions. We thus conclude that gaze is actively involved in preference formation. The gaze cascade effect was also present when participants compared abstract, unfamiliar shapes for attractiveness, suggesting that orienting and preference for objects in general are intrinsically linked in a positive feedback loop leading to the conscious choice.	CALTECH, Div Biol Computat & Neural Syst, Pasadena, CA 91125 USA; NTT Corp, Commun Sci Labs, Human Informat Sci Lab, Kanagawa 2430198, Japan; Bunkyo Gakuin Univ, Dept Human Studies, Oimachi, Saitama 354, Japan	California Institute of Technology; Nippon Telegraph & Telephone Corporation	Shimojo, S (corresponding author), CALTECH, Div Biol Computat & Neural Syst, Pasadena, CA 91125 USA.	sshimojo@its.caltech.edu						BIRCH EE, 1985, INVEST OPHTH VIS SCI, V26, P366; BUTTERWORTH G, 1991, BRIT J DEV PSYCHOL, V9, P55, DOI 10.1111/j.2044-835X.1991.tb00862.x; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; FANTZ RL, 1961, SCI AM, V204, P66, DOI 10.1038/scientificamerican0561-66; James W., 1884, MIND, Vos-IX, P188, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; KUNSTWILSON WR, 1980, SCIENCE, V207, P557, DOI 10.1126/science.7352271; LAIRD JD, 1974, J PERS SOC PSYCHOL, V29, P475, DOI 10.1037/h0036125; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; MANDLER G, 1987, J EXP PSYCHOL LEARN, V13, P646, DOI 10.1037/0278-7393.13.4.646; Nakamura K, 1998, NEUROREPORT, V9, P753, DOI 10.1097/00001756-199803090-00035; PATTERSON ML, 1982, PSYCHOL REV, V89, P231, DOI 10.1037/0033-295X.89.3.231; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; SCHACHTER S, 1964, ADV EXP SOC PSYCHOL, V1, P49, DOI 10.1016/S0065-2601(08)60048-9; Tomkins S.S., 1962, AFFECT IMAGERY CONSC, VI; VESSEL EA, 2002, J VIS, V2, P492, DOI DOI 10.1167/2.7.492; vonGrunau M, 1995, PERCEPTION, V24, P1297, DOI 10.1068/p241297; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; ZAJONC RB, 1985, SCIENCE, V228, P15, DOI 10.1126/science.3883492	19	503	519	5	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1317	1322		10.1038/nn1150	http://dx.doi.org/10.1038/nn1150			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	746BC	14608360				2022-12-17	WOS:000186725600017
J	Khodagholy, D; Gelinas, JN; Thesen, T; Doyle, W; Devinsky, O; Malliaras, GG; Buzsaki, G				Khodagholy, Dion; Gelinas, Jennifer N.; Thesen, Thomas; Doyle, Werner; Devinsky, Orrin; Malliaras, George G.; Buzsaki, Gyoergy			NeuroGrid: recording action potentials from the surface of the brain	NATURE NEUROSCIENCE			English	Article							IN-VIVO RECORDINGS; CONDUCTING POLYMER; ORGANIC BIOELECTRONICS; GAMMA-OSCILLATIONS; NEURAL INTERFACE; ELECTRODE ARRAY; HIPPOCAMPAL; RETINA; CORTEX; CELLS	Recording from neural networks at the resolution of action potentials is critical for understanding how information is processed in the brain. Here, we address this challenge by developing an organic material-based, ultraconformable, biocompatible and scalable neural interface array (the 'NeuroGrid') that can record both local field potentials (LFPs) and action potentials from superficial cortical neurons without penetrating the brain surface. Spikes with features of interneurons and pyramidal cells were simultaneously acquired by multiple neighboring electrodes of the NeuroGrid, allowing for the isolation of putative single neurons in rats. Spiking activity demonstrated consistent phase modulation by ongoing brain oscillations and was stable in recordings exceeding 1 week's duration. We also recorded LFP-modulated spiking activity intraoperatively in patients undergoing epilepsy surgery. The NeuroGrid constitutes an effective method for large-scale, stable recording of neuronal spikes in concert with local population synaptic activity, enhancing comprehension of neural processes across spatiotemporal scales and potentially facilitating diagnosis and therapy for brain disorders.	[Khodagholy, Dion; Gelinas, Jennifer N.; Buzsaki, Gyoergy] NYU, Sch Med, Inst Neurosci, New York, NY 10012 USA; [Thesen, Thomas; Doyle, Werner; Devinsky, Orrin] NYU, Comprehens Epilepsy Ctr, Dept Neurol, New York, NY USA; [Malliaras, George G.] Ecole Natl Super Mines, Microelect Ctr Prov St Etienne Sch Mines CMP EMSE, Dept Bioelect, MOC, Gardanne, France	New York University; New York University; IMT - Institut Mines-Telecom; Mines Saint-Etienne	Buzsaki, G (corresponding author), NYU, Sch Med, Inst Neurosci, New York, NY 10012 USA.	gyorgy.buzsaki@nyumc.org	Malliaras, George/HDM-2006-2022	Malliaras, George/0000-0002-4582-8501; Buzsaki, Gyorgy/0000-0002-3100-4800; Devinsky, Orrin/0000-0003-0044-4632	US National Institutes of Health [NS074015, MH54671, MH102840]; National Science Foundation; Mathers Foundation; James S. McDonnell Foundation; National Science Foundation [ECCS-0335765]; Simons Foundation; Pediatric Scientist Development Program through March of Dimes Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102840, R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994, R01NS074015] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Mathers Foundation; James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF)); Simons Foundation; Pediatric Scientist Development Program through March of Dimes Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health Grants (NS074015, MH54671, MH102840), the National Science Foundation, the Mathers Foundation and the James S. McDonnell Foundation. The device fabrication was performed at Microelectronic Centre of Provence and the Cornell NanoScale Facility (CNF), a member of the National Nanotechnology Infrastructure Network, which is supported by the National Science Foundation (Grant ECCS-0335765). D.K. is supported through the Simons Foundation (junior fellow). J.G. is supported by the Pediatric Scientist Development Program through a grant from the March of Dimes Foundation. We thank M. Sessolo (University of Valencia), J. Rivnay and M. Ferro (Ecole des Mines), and A. Peyrache and G. Girardeau (NYU Langone Medical Center) for fruitful discussion. We thank M. Skvarla, R. Ilic and M. Metzler from the CNF for their technical support during device fabrication. We thank H. McKellar and A. Boomhaur for managing the institutional review board (IRB) protocol of intraoperative epilepsy patient recordings.	Abidian MR, 2008, BIOMATERIALS, V29, P1273, DOI 10.1016/j.biomaterials.2007.11.022; Adrian ED, 1939, J PHYSIOL-LONDON, V97, P153, DOI 10.1113/jphysiol.1939.sp003798; Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Berggren M, 2007, ADV MATER, V19, P3201, DOI 10.1002/adma.200700419; Besson P, 2008, BRAIN, V131, P3246, DOI 10.1093/brain/awn224; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588; Carandini M, 2012, NAT NEUROSCI, V15, P507, DOI 10.1038/nn.3043; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; Contreras D, 1997, J NEUROPHYSIOL, V78, P335, DOI 10.1152/jn.1997.78.1.335; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Einevoll GT, 2007, J NEUROPHYSIOL, V97, P2174, DOI 10.1152/jn.00845.2006; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hatsopoulos NG, 2009, ANNU REV NEUROSCI, V32, P249, DOI 10.1146/annurev.neuro.051508.135241; Jacobs J, 2009, J NEUROSCI, V29, P10203, DOI 10.1523/JNEUROSCI.2187-09.2009; Khodagholy D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2573; Khodagholy D, 2011, ADV MATER, V23, pH268, DOI 10.1002/adma.201102378; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Marre O, 2012, J NEUROSCI, V32, P14859, DOI 10.1523/JNEUROSCI.0723-12.2012; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Owens RM, 2010, MRS BULL, V35, P449, DOI 10.1557/mrs2010.583; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Rivnay J, 2014, CHEM MATER, V26, P679, DOI 10.1021/cm4022003; Robbins AA, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00181; Rubehn B, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/036003; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Stark E, 2013, NEURON, V80, P1263, DOI 10.1016/j.neuron.2013.09.033; Stavrinidou E, 2013, ADV MATER, V25, P4488, DOI 10.1002/adma.201301240; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Thesen T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2220; Viventi J, 2011, NAT NEUROSCI, V14, P1599, DOI 10.1038/nn.2973; Waziri A, 2009, NEUROSURGERY, V64, P540, DOI 10.1227/01.NEU.0000337575.63861.10; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; WISE KD, 1991, SCIENCE, V254, P1335, DOI 10.1126/science.1962192	47	502	508	29	361	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2015	18	2					310	315		10.1038/nn.3905	http://dx.doi.org/10.1038/nn.3905			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CA0UM	25531570	Green Accepted, Green Submitted			2022-12-17	WOS:000348631800022
J	Meyer-Lindenberg, A; Miletich, RS; Kohn, PD; Esposito, G; Carson, RE; Quarantelli, M; Weinberger, DR; Berman, KF				Meyer-Lindenberg, A; Miletich, RS; Kohn, PD; Esposito, G; Carson, RE; Quarantelli, M; Weinberger, DR; Berman, KF			Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; DOPA DECARBOXYLASE ACTIVITY; VENTRAL TEGMENTAL AREA; CEREBRAL BLOOD-FLOW; CORTICAL REGULATION; WORKING-MEMORY; CORTEX; BRAIN; RECEPTORS; RELEASE	Both dopaminergic neurotransmission and prefrontal cortex (PFC) function are known to be abnormal in schizophrenia. To test the hypothesis that these phenomena are related, we measured presynaptic dopaminergic function simultaneously with regional cerebral blood flow during the Wisconsin Card Sorting Test (WCST) and a control task in unmedicated schizophrenic subjects and matched controls. We show that the dopaminergic uptake constant K-i in the striatum was significantly higher for patients than for controls. Patients had significantly less WCST-related activation in PFC. The two parameters were strongly linked in patients, but not controls. The tight within-patient coupling of these values, with decreased PFC activation predicting exaggerated striatal 6-fluorodopa uptake, supports the hypothesis that prefrontal cortex dysfunction may lead to dopaminergic transmission abnormalities.	NIMH, Unit Integrat Neuroimaging, NIH, Bethesda, MD 20892 USA; NINCDS, NIH, Bethesda, MD 20832 USA; NIH, PET Dept, Ctr Clin, Bethesda, MD 20832 USA; NIMH, Clin Brain Disorders Branch, NIH, Bethesda, MD 20832 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Meyer-Lindenberg, A (corresponding author), NIMH, Unit Integrat Neuroimaging, NIH, 10-4C101,9000 Rockville Pike, Bethesda, MD 20892 USA.		Carson, Richard E/H-3250-2011; Quarantelli, Mario/A-6154-2009; Meyer-Lindenberg, Andreas/H-1076-2011	Carson, Richard E/0000-0002-9338-7966; Quarantelli, Mario/0000-0001-7836-454X; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002717, ZIAMH002652, Z01MH002652, ZIAMH002716, Z01MH002716, Z01MH002717] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Bennett MR, 1998, J PSYCHOPHARMACOL, V12, P289, DOI 10.1177/026988119801200310; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; Bertolino A, 2000, NEUROPSYCHOPHARMACOL, V22, P125, DOI 10.1016/S0893-133X(99)00096-2; BROOKS DJ, 1990, ANN NEUROL, V28, P547, DOI 10.1002/ana.410280412; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; CHRISTIE MJ, 1985, BRAIN RES, V333, P169, DOI 10.1016/0006-8993(85)90140-4; CUMMING P, 1995, J NEUROCHEM, V65, P1381; DANIEL DG, 1991, J NEUROSCI, V11, P1907; DaoCastellana MH, 1997, SCHIZOPHR RES, V23, P167, DOI 10.1016/S0920-9964(96)00102-8; DEUTCH AY, 1992, J NEURAL TRANSM-GEN, P61; Elkashef AM, 2000, PSYCHIAT RES-NEUROIM, V100, P1, DOI 10.1016/S0925-4927(00)00064-0; GJEDDE A, 1991, P NATL ACAD SCI USA, V88, P2721, DOI 10.1073/pnas.88.7.2721; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GRACE AA, 1993, J NEURAL TRANSM-GEN, V91, P111, DOI 10.1007/BF01245228; Hietala J, 1999, SCHIZOPHR RES, V35, P41, DOI 10.1016/S0920-9964(98)00113-3; HIETALA J, 1995, LANCET, V346, P1130, DOI 10.1016/S0140-6736(95)91801-9; Jackson ME, 2001, J NEUROCHEM, V78, P920, DOI 10.1046/j.1471-4159.2001.00499.x; JASKIW GE, 1990, BRAIN RES, V534, P321, DOI 10.1016/0006-8993(90)90149-6; Kegeles LS, 2000, BIOL PSYCHIAT, V48, P627, DOI 10.1016/S0006-3223(00)00976-8; Kraepelin E., 1919, CUTTING SHEPHERD, P13; Laruelle M, 1999, J PSYCHOPHARMACOL, V13, P358, DOI 10.1177/026988119901300405; LEWIS DA, 1995, PSYCHOL MED, V25, P887, DOI 10.1017/S0033291700037375; Lindstrom LH, 1999, BIOL PSYCHIAT, V46, P681, DOI 10.1016/S0006-3223(99)00109-2; MILETICH RS, 1993, BRAIN RES, V626, P1, DOI 10.1016/0006-8993(93)90556-3; Muller U, 1998, J NEUROSCI, V18, P2720; MURASE S, 1993, NEUROSCI LETT, V157, P53, DOI 10.1016/0304-3940(93)90641-W; NAPIER TC, 1992, NEUROREPORT, V3, P609, DOI 10.1097/00001756-199207000-00016; Okubo Y, 1997, NATURE, V385, P634, DOI 10.1038/385634a0; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; PYCOCK CJ, 1980, NATURE, V286, P74, DOI 10.1038/286074a0; REITH J, 1994, P NATL ACAD SCI USA, V91, P11651, DOI 10.1073/pnas.91.24.11651; Saunders RC, 1998, NATURE, V393, P169, DOI 10.1038/30245; Swerdlow NR, 1998, SCHIZOPHRENIA BULL, V24, P285, DOI 10.1093/oxfordjournals.schbul.a033326; Talairach J., 1988, COPLANAR STEREOTAXIC; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Weinberger DR, 1996, PHILOS T R SOC B, V351, P1495, DOI 10.1098/rstb.1996.0135; WEINBERGER DR, 1995, SCHIZOPHR RES, V16, P87, DOI 10.1016/0920-9964(95)00013-C; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004	46	502	517	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					267	271		10.1038/nn804	http://dx.doi.org/10.1038/nn804			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11865311				2022-12-17	WOS:000174146000018
J	Durstewitz, D; Seamans, JK; Sejnowski, TJ				Durstewitz, Daniel; Seamans, Jeremy K.; Sejnowski, Terrence J.			Neurocomputational models of working memory	NATURE NEUROSCIENCE			English	Review							PRIMATE PREFRONTAL CORTEX; DELAYED-RESPONSE TASK; ATTRACTOR NEURAL-NETWORK; NEURONS IN-VITRO; LOW SPIKE RATES; FRONTAL-CORTEX; SYNAPTIC CONNECTIONS; DOPAMINE ANTAGONISTS; RECEPTOR ACTIVATION; RECURRENT NETWORK	During working memory tasks, the firing rates of single neurons recorded in behaving monkeys remain elevated without external cues. Modeling studies have explored different mechanisms that could underlie this selective persistent activity, including recurrent excitation within cell assemblies, synfire chains and single-cell bistability. The models show how sustained activity can be stable in the presence of noise and distractors, how different synaptic and voltage-gated conductances contribute to persistent activity, how neuromodulation could influence its robustness, how completely novel items could be maintained, and how continuous attractor states might be achieved. More work is needed to address the full repertoire of neural dynamics observed during working memory tasks.	[Durstewitz, Daniel; Seamans, Jeremy K.; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA; [Sejnowski, Terrence J.] Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego	Sejnowski, TJ (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	terry@salk.edu	Sejnowski, Terrence/AAV-5558-2021		Deutsche Forschungsgemeinschaft [DU 354/1-1]; Howard Hughes Medical Institute	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	D.D. was funded through a research stipend from the Deutsche Forschungsgemeinschaft (DU 354/1-1). J.K.S and T.J.S. were supported by the Howard Hughes Medical Institute. Thanks to Emilio Salinas, Paul Tiesinga, Sabine Windmann and Kechen Zhang for comments on the manuscript.	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P259, DOI 10.1088/0954-898X/2/3/003; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Amit DJ, 1997, NEURAL COMPUT, V9, P1071, DOI 10.1162/neco.1997.9.5.1071; AMIT DJ, 1995, NETWORK-COMP NEURAL, V6, P359, DOI 10.1088/0954-898X/6/3/004; AMIT DJ, 1994, J NEUROSCI, V14, P6435; AMIT DJ, 1991, NETWORK-COMP NEURAL, V2, P275, DOI 10.1088/0954-898X/2/3/004; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Aura J, 1999, NEUROREPORT, V10, P243, DOI 10.1097/00001756-199902050-00008; Baddeley A. D., 1990, HUMAN MEMORY; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P28; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; BROERSEN LM, 1994, BRAIN RES, V645, P113, DOI 10.1016/0006-8993(94)91644-6; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; Dehaene S., 1999, FUNDAMENTAL NEUROSCI, P1543; Diesmann M, 1999, NATURE, V402, P529, DOI 10.1038/990101; DOMJAN M, 1993, PRINCIPLES LEARNING; Dudkin K N, 1997, Neurosci Behav Physiol, V27, P153, DOI 10.1007/BF02461946; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Durstewitz D, 1999, J NEUROSCI, V19, P2807; FUNAHASHI S, 1994, NEUROSCI RES, V21, P1, DOI 10.1016/0168-0102(94)90063-9; Funahashi S, 2000, CEREB CORTEX, V10, P535, DOI 10.1093/cercor/10.6.535; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster J., 2015, PREFRONTAL CORTEX; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; Goldman-Rakic PS, 1995, MODELS INFORMATION P, P131; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Gonzalez-Burgos G, 2000, CEREB CORTEX, V10, P82, DOI 10.1093/cercor/10.1.82; Goodridge JP, 1998, BEHAV NEUROSCI, V112, P749, DOI 10.1037/0735-7044.112.4.749; Gorelova NA, 2000, J NEUROPHYSIOL, V84, P75, DOI 10.1152/jn.2000.84.1.75; GUIGON E, 1995, CEREB CORTEX, V5, P135, DOI 10.1093/cercor/5.2.135; Gulledge AT, 1998, J NEUROSCI, V18, P9139; Haj-Dahmane S, 1998, J NEUROPHYSIOL, V80, P1197, DOI 10.1152/jn.1998.80.3.1197; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MCFARLAND JL, 1992, J NEUROPHYSIOL, V68, P319, DOI 10.1152/jn.1992.68.1.319; Melchitzky DS, 1998, J COMP NEUROL, V390, P211, DOI 10.1002/(SICI)1096-9861(19980112)390:2<211::AID-CNE4>3.0.CO;2-4; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; MILNER B, 1984, TRENDS NEUROSCI, V7, P403, DOI 10.1016/S0166-2236(84)80143-5; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Moody SL, 1998, J NEUROSCI, V18, P399; Muller U, 1998, J NEUROSCI, V18, P2720; OReilly R., 1999, MODELS WORKING MEMOR, P375, DOI [10.1017/cbo9781139174909.014, DOI 10.1017/CBO9781139174909.014]; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rainer G, 1999, J NEUROSCI, V19, P5493; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; ROSENKILDE CE, 1981, BRAIN RES, V210, P129, DOI 10.1016/0006-8993(81)90890-8; SAWAGUCHI T, 1990, J NEUROPHYSIOL, V63, P1401, DOI 10.1152/jn.1990.63.6.1401; SAWAGUCHI T, 1994, J NEUROPHYSIOL, V71, P515, DOI 10.1152/jn.1994.71.2.515; Scherzer CR, 1998, J COMP NEUROL, V390, P75, DOI 10.1002/(SICI)1096-9861(19980105)390:1<75::AID-CNE7>3.0.CO;2-N; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Seamans JK, 1998, J NEUROSCI, V18, P1613; SEAMANS JK, P NATL ACAD IN PRESS; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Wang XJ, 1999, J NEUROSCI, V19, P9587; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WATANABE T, 1985, BRAIN RES, V325, P241, DOI 10.1016/0006-8993(85)90320-8; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Yang CR, 1996, J NEUROSCI, V16, P1922; Zahrt J, 1997, J NEUROSCI, V17, P8528; Zhang K, 1996, J NEUROSCI, V16, P2112; Zheng P, 1999, NEUROSCIENCE, V91, P527, DOI 10.1016/S0306-4522(98)00604-6; ZIPSER D, 1993, J NEUROSCI, V13, P3406	77	502	511	3	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11		S			1184	1191		10.1038/81460	http://dx.doi.org/10.1038/81460			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V18OV	11127836				2022-12-17	WOS:000208015000013
J	Passafaro, M; Piech, V; Sheng, M				Passafaro, M; Piech, V; Sheng, M			Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; DOMAIN-CONTAINING PROTEINS; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; BREFELDIN-A; MEMBRANE; SYNAPSES; GLUR2; LTP; REDISTRIBUTION	Using a thrombin cleavage assay in cultured hippocampal neurons, we studied the kinetics, regulation and site of AMPA receptor surface delivery. Surface insertion of the GluR1 subunit occurs slowly in basal conditions and is stimulated by NMDA receptor activation and insulin, whereas GluR2 exocytosis is constitutively rapid. Although both subunits ultimately concentrate in synapses, GluR1 and GluR2 show different spatial patterns of surface accumulation, consistent with GluR1 being inserted initially at extrasynaptic sites and GluR2 being inserted more directly at synapses. The spatiotemporal pattern of surface accumulation is determined by the cytoplasmic tails of GluR subunits, and in heteromeric receptors, GluR1 acts dominantly over GluR2. We propose that GluR1 controls the exocytosis and GluR2/3, the recycling and endocytosis of AMPA receptors.	Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Sheng, M (corresponding author), MIT, Ctr Learning & Memory, E18-215,77 Massachusetts Ave, Cambridge, MA 02139 USA.			Sheng, Morgan/0000-0002-8703-5366	NINDS NIH HHS [NS 35050] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chung HJ, 2000, J NEUROSCI, V20, P7258; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HEIN L, 1994, J BIOL CHEM, V269, P27719; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MATSUSHIMA Y, 1965, OSAKA J MATH, V2, P1; Nakagawa T, 2000, SCIENCE, V290, P2270; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	43	501	521	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					917	926		10.1038/nn0901-917	http://dx.doi.org/10.1038/nn0901-917			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528423				2022-12-17	WOS:000170698600018
J	Polsky, A; Mel, BW; Schiller, J				Polsky, A; Mel, BW; Schiller, J			Computational subunits in thin dendrites of pyramidal cells	NATURE NEUROSCIENCE			English	Article							SYNAPTIC INPUT; POSTSYNAPTIC POTENTIALS; SUPRALINEAR SUMMATION; BASAL DENDRITES; NEURONS; INTEGRATION; LOCATION; SPIKES; RAT; DISTRIBUTIONS	The thin basal and oblique dendrites of cortical pyramidal neurons receive most of the synaptic inputs from other cells, but their integrative properties remain uncertain. Previous studies have most often reported global linear or sublinear summation. An alternative view, supported by biophysical modeling studies, holds that thin dendrites provide a layer of independent computational `subunits' that sigmoidally modulate their inputs prior to global summation. To distinguish these possibilities, we combined confocal imaging and dual-site focal synaptic stimulation of identified thin dendrites in rat neocortical pyramidal neurons. We found that nearby inputs on the same branch summed sigmoidally, whereas widely separated inputs or inputs to different branches summed linearly. This strong spatial compartmentalization effect is incompatible with a global summation rule and provides the first experimental support for a two-layer 'neural network' model of pyramidal neuron thin-branch integration. Our findings could have important implications for the computing and memory-related functions of cortical tissue.	Technion Israel Inst Technol, Sch Med, Dept Physiol, IL-31096 Haifa, Israel; Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA	Technion Israel Institute of Technology; University of Southern California	Schiller, J (corresponding author), Technion Israel Inst Technol, Sch Med, Dept Physiol, IL-31096 Haifa, Israel.	jackie@tx.technion.ac.il		Poleg-Polsky, Alon/0000-0003-1327-5129				Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; Ariav G, 2003, J NEUROSCI, V23, P7750; BEAULIEU C, 1985, J COMP NEUROL, V231, P180, DOI 10.1002/cne.902310206; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Cook EP, 1999, J NEUROPHYSIOL, V81, P535, DOI 10.1152/jn.1999.81.2.535; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Jones EG, 1999, CEREB CORTEX, V13, P139; Kepecs A, 2002, J NEUROSCI, V22, P9053; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Margulis M, 1998, J NEUROPHYSIOL, V79, P2809, DOI 10.1152/jn.1998.79.5.2809; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; MEL BW, 1992, ADV NEUR IN, V4, P35; Mel BW, 1998, J NEUROSCI, V18, P4325; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Nettleton JS, 2000, J NEUROPHYSIOL, V83, P3310, DOI 10.1152/jn.2000.83.6.3310; Oakley JC, 2001, J NEUROPHYSIOL, V86, P503, DOI 10.1152/jn.2001.86.1.503; Oviedo H, 2002, NAT NEUROSCI, V5, P261, DOI 10.1038/nn807; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Rall W, 1987, SYNAPTIC FUNCTION PP, P605; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; SHEPHERD GM, 1987, NEUROSCIENCE, V21, P151, DOI 10.1016/0306-4522(87)90329-0; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; Tamas G, 2002, J NEUROSCI, V22, P740, DOI 10.1523/JNEUROSCI.22-03-00740.2002; Urban NN, 1998, P NATL ACAD SCI USA, V95, P11450, DOI 10.1073/pnas.95.19.11450; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903	44	497	501	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2004	7	6					621	627		10.1038/nn1253	http://dx.doi.org/10.1038/nn1253			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	823VA	15156147	Green Accepted			2022-12-17	WOS:000221640300016
J	Chan, KY; Jang, MJ; Yoo, BB; Greenbaum, A; Ravi, N; Wu, WL; Sanchez-Guardado, L; Lois, C; Mazmanian, SK; Deverman, BE; Gradinaru, V				Chan, Ken Y.; Jang, Min J.; Yoo, Bryan B.; Greenbaum, Alon; Ravi, Namita; Wu, Wei-Li; Sanchez-Guardado, Luis; Lois, Carlos; Mazmanian, Sarkis K.; Deverman, Benjamin E.; Gradinaru, Viviana			Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems	NATURE NEUROSCIENCE			English	Article							SINGLE-CELL ELECTROPORATION; ADENOASSOCIATED VIRUS; VIRAL VECTORS; NEURONS; EXPRESSION; THERAPY; BRAIN; PROMOTER; TOOLS; GREEN	Adeno-associated viruses (AAVs) are commonly used for in vivo gene transfer. Nevertheless, AAVs that provide efficient transduction across specific organs or cell populations are needed. Here, we describe AAV-PHP.eB and AAV-PHP.S, capsids that efficiently transduce the central and peripheral nervous systems, respectively. In the adult mouse, intravenous administration of 1 x 10(11) vector genomes (vg) of AAV-PHP. eB transduced 69% of cortical and 55% of striatal neurons, while 1 x 10(12) vg of AAV-PHP.S transduced 82% of dorsal root ganglion neurons, as well as cardiac and enteric neurons. The efficiency of these vectors facilitates robust cotransduction and stochastic, multicolor labeling for individual cell morphology studies. To support such efforts, we provide methods for labeling a tunable fraction of cells without compromising color diversity. Furthermore, when used with cell-type-specific promoters and enhancers, these AAVs enable efficient and targetable genetic modification of cells throughout the nervous system of transgenic and non-transgenic animals.	[Chan, Ken Y.; Jang, Min J.; Yoo, Bryan B.; Greenbaum, Alon; Ravi, Namita; Wu, Wei-Li; Sanchez-Guardado, Luis; Lois, Carlos; Mazmanian, Sarkis K.; Deverman, Benjamin E.; Gradinaru, Viviana] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Deverman, BE; Gradinaru, V (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	bd@caltech.edu; viviana@caltech.edu	Jang, Min Jee/AAO-2892-2020; Sanchez-Guardado, Luis/AAB-5254-2019; Wu, Wei-Li/ADY-3311-2022	Sanchez-Guardado, Luis/0000-0001-5598-8608; Chan, Ken/0000-0002-8853-5186	National Institutes of Health (NIH); Director's New Innovator [DP2NS087949]; PECASE; SPARC [OT2OD023848-01]; National Institute on Aging [R01AG047664]; BRAIN [U01NS090577]; National Institute of Mental Health (NIMH) [R21MH103824]; Gordon and Betty Moore Foundation [GBMF2509]; Curd Foundation; Hereditary Disease Foundation; Beckman Institute; Rosen Center at Caltech; NIH [U01 MH109147 02S1, NS085910]; Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office; Friedrich's Ataxia Research Alliance (FARA); FARA Australasia; Heritage Medical Research Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH103824, U01MH109147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085910, U01NS090577, DP2NS087949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047664] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [OT2OD023848] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Director's New Innovator; PECASE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SPARC; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BRAIN; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Curd Foundation; Hereditary Disease Foundation; Beckman Institute; Rosen Center at Caltech; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Friedrich's Ataxia Research Alliance (FARA); FARA Australasia; Heritage Medical Research Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Mackey and K. Beadle for assistance with cloning and viral production, P. Anguiano for administrative assistance, and the entire Gradinaru group for discussions. We thank G. Stevens and V. Anand for their efforts in image analysis; P. Rajendran and S. Kalyanam at University of California, Los Angeles and C. Fowlkes at the University of California, Irvine, for discussions, the University of Pennsylvania vector core for the AAV2/9 Rep-Cap plasmid, and M. Brenner at the University of Alabama for the GIABC1D promoter. pAAV-Efla-DIO EYFP, pAAV-EFla-Cre and pAAVEf1a-fDIO EYFP were gifts from K. Deisseroth (Addgene plasmids 27056, 55636 and 55641). pEN4S2I13 and pEMS2115 were gifts from E. Simpson (Addgene plasmids 49138 and 49140). This work was primarily supported by the National Institutes of Health (NIH) through grants to V.G.: Director's New Innovator DP2NS087949 and PECASE; SPARC OT2OD023848-01; National Institute on Aging R01AG047664; BRAIN U01NS090577; and National Institute of Mental Health (NIMH) R21MH103824. Additional funding included the Gordon and Betty Moore Foundation through grant GBMF2509 to the Caltech Programmable Molecular `Mchnology Initiative (to V.G.), the Curd Foundation (to VG.), the Hereditary Disease Foundation (to V.G. and B.E.D.), the Beckman Institute (to V.G. and B.E.D.) and Rosen Center (to C.L. and VG.) at Caltech, NIH U01 MH109147 02S1 (to C.L. and V.G.), NIH NS085910 (to S.K.M. and VG.), the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO; to V.G. and KED.) and the Friedrich's Ataxia Research Alliance (FARA) and FARA Australasia (to B.E.D.). S.K.M and V.G. are Heritage Principal Investigators supported by the Heritage Medical Research Institute.	Agha-Mohammadi S, 2004, J GENE MED, V6, P817, DOI 10.1002/jgm.566; Allen WE, 2017, NEURON, V94, P891, DOI 10.1016/j.neuron.2017.04.017; Badea TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007859; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; Bennett J, 2016, LANCET, V388, P661, DOI 10.1016/S0140-6736(16)30371-3; Betley JN, 2011, HUM GENE THER, V22, P669, DOI 10.1089/hum.2010.204; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; Chang RB, 2015, CELL, V161, P622, DOI 10.1016/j.cell.2015.03.022; Choudhury SR, 2016, MOL THER, V24, P726, DOI 10.1038/mt.2015.231; de Leeuw CN, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0232-4; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Deverman BE, 2016, NAT BIOTECHNOL, V34, P204, DOI 10.1038/nbt.3440; Dimidschstein J, 2016, NAT NEUROSCI, V19, P1743, DOI 10.1038/nn.4430; Eldridge MAG, 2016, NAT NEUROSCI, V19, P37, DOI 10.1038/nn.4192; Fischer G, 2014, GENE THER, V21, P44, DOI 10.1038/gt.2013.56; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gallia GL, 1998, ONCOGENE, V16, P1879, DOI 10.1038/sj.onc.1201706; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Gombash SE, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00081, 10.3389/fnmol.2014.00081]; GOW A, 1992, J CELL BIOL, V119, P605, DOI 10.1083/jcb.119.3.605; Gray Steven J, 2011, Curr Protoc Neurosci, VChapter 4, DOI 10.1002/0471142301.ns0417s57; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Haddad R, 2013, NAT NEUROSCI, V16, P949, DOI 10.1038/nn.3407; Hama H, 2015, NAT NEUROSCI, V18, P1518, DOI 10.1038/nn.4107; Hastie E, 2015, HUM GENE THER, V26, P257, DOI 10.1089/hum.2015.025; Hillier D, 2017, NAT NEUROSCI, V20, P960, DOI 10.1038/nn.4566; Hocquemiller M, 2016, HUM GENE THER, V27, P478, DOI 10.1089/hum.2016.087; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Iyer SM, 2014, NAT BIOTECHNOL, V32, P274, DOI 10.1038/nbt.2834; Jackson KL, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00116; Kim CK, 2016, NAT METHODS, V13, P325, DOI [10.1038/NMETH.3770, 10.1038/nmeth.3770]; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Lin MZ, 2016, NAT NEUROSCI, V19, P1142, DOI 10.1038/nn.4359; Loulier K, 2014, NEURON, V81, P505, DOI 10.1016/j.neuron.2013.12.016; Marchio S, 2016, EMBO MOL MED, V8, P592, DOI 10.15252/emmm.201606407; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Mikuni T, 2016, CELL, V165, P1803, DOI 10.1016/j.cell.2016.04.044; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Nathanson JL, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.019.2009; Oh MS, 2009, GENE THER, V16, P437, DOI 10.1038/gt.2008.148; Parekh R, 2013, NEURON, V77, P1017, DOI 10.1016/j.neuron.2013.03.008; Pulicherla N, 2011, MOL THER, V19, P1070, DOI 10.1038/mt.2011.22; Rajasethupathy P, 2016, CELL, V165, P524, DOI 10.1016/j.cell.2016.03.047; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Samad OA, 2013, MOL THER, V21, P49, DOI 10.1038/mt.2012.169; Samulski RJ, 2014, ANNU REV VIROL, V1, P427, DOI 10.1146/annurev-virology-031413-085355; Schwarz LA, 2015, NATURE, V524, P88, DOI 10.1038/nature14600; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Sofroniew NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14472; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Urban DJ, 2015, ANNU REV PHARMACOL, V55, P399, DOI 10.1146/annurev-pharmtox-010814-124803; Van der Perren A, 2015, CURR TOP BEHAV NEURO, V22, P271, DOI 10.1007/7854_2014_310; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wertz A, 2015, SCIENCE, V349, P70, DOI 10.1126/science.aab1687; Williams EK, 2016, CELL, V166, P209, DOI 10.1016/j.cell.2016.05.011; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	64	496	522	11	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2017	20	8					1172	+		10.1038/nn.4593	http://dx.doi.org/10.1038/nn.4593			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FB7CO	28671695	Green Accepted			2022-12-17	WOS:000406298900018
J	Steinberg, EE; Keiflin, R; Boivin, JR; Witten, IB; Deisseroth, K; Janak, PH				Steinberg, Elizabeth E.; Keiflin, Ronald; Boivin, Josiah R.; Witten, Ilana B.; Deisseroth, Karl; Janak, Patricia H.			A causal link between prediction errors, dopamine neurons and learning	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; ORBITOFRONTAL CORTEX; OPTICAL CONTROL; REWARD; RESPONSES; RAT; REINFORCEMENT; BEHAVIOR; MODULATION	Situations in which rewards are unexpectedly obtained or withheld represent opportunities for new learning. Often, this learning includes identifying cues that predict reward availability. Unexpected rewards strongly activate midbrain dopamine neurons. This phasic signal is proposed to support learning about antecedent cues by signaling discrepancies between actual and expected outcomes, termed a reward prediction error. However, it is unknown whether dopamine neuron prediction error signaling and cue-reward learning are causally linked. To test this hypothesis, we manipulated dopamine neuron activity in rats in two behavioral procedures, associative blocking and extinction, that illustrate the essential function of prediction errors in learning. We observed that optogenetic activation of dopamine neurons concurrent with reward delivery, mimicking a prediction error, was sufficient to cause long-lasting increases in cue-elicited reward-seeking behavior. Our findings establish a causal role for temporally precise dopamine neuron signaling in cue-reward learning, bridging a critical gap between experimental evidence and influential theoretical frameworks.	[Steinberg, Elizabeth E.; Keiflin, Ronald; Boivin, Josiah R.; Janak, Patricia H.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA; [Steinberg, Elizabeth E.; Boivin, Josiah R.; Janak, Patricia H.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Witten, Ilana B.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Deisseroth, Karl] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Crack Neural Code Program, Stanford, CA 94305 USA; [Janak, Patricia H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Janak, Patricia H.] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; Princeton University; Princeton University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Janak, PH (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94143 USA.	pjanak@gallo.ucsf.edu		Boivin, Josiah/0000-0001-9895-4141; Janak, Patricia/0000-0002-3333-9049; Keiflin, Ronald/0000-0001-5347-7337	US National Institutes of Health [DA015096, AA17072]; State of California for medical research on alcohol and substance abuse through the University of California, San Francisco; National Science Foundation Graduate Research Fellowship; National Institute of Mental Health; National Institute on Drug Abuse; Michael J Fox Foundation; Howard Hughes Medical Institute; Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015096, DP2DA035149] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Michael J Fox Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery Program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful for the technical assistance of M. Olsman, L. Sahuque and R. Reese, and for critical feedback from H. Fields during manuscript preparation. This research was supported by the US National Institutes of Health (grants DA015096 and AA17072 to P.H.J. and a New Innovator award to I.B.W.), funds from the State of California for medical research on alcohol and substance abuse through the University of California, San Francisco (P.H.J.), a National Science Foundation Graduate Research Fellowship (E.E.S.), and grants from the National Institute of Mental Health, the National Institute on Drug Abuse, the Michael J Fox Foundation, the Howard Hughes Medical Institute, and the Defense Advanced Research Projects Agency Reorganization and Plasticity to Accelerate Injury Recovery Program (K.D.).	Adamantidis AR, 2011, J NEUROSCI, V31, P10829, DOI 10.1523/JNEUROSCI.2246-11.2011; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brown MTC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015870; Burke KA, 2008, NATURE, V454, P340, DOI 10.1038/nature06993; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Domingos AI, 2011, NAT NEUROSCI, V14, P1562, DOI 10.1038/nn.2977; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; HOLLAND PC, 1984, J EXP PSYCHOL ANIM B, V10, P476, DOI 10.1037/0097-7403.10.4.476; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Iordanova MD, 2006, EUR J NEUROSCI, V24, P3265, DOI 10.1111/j.1460-9568.2006.05195.x; Kamin L.J., 1969, FUNDAMENTAL ISSUES A, P42; Kamin L. J., 1969, PUNISHMENT AVERSIVE, P279, DOI DOI 10.2105/AJPH.2006.090910; Kamin L. J., 1968, MIAMI S PREDICTION B, P9; Karim BO, 2003, COMPARATIVE MED, V53, P532; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Tuathaigh CMP, 2003, BEHAV PHARMACOL, V14, P315, DOI 10.1097/01.fbp.0000080416.18561.3e; Parker JG, 2010, P NATL ACAD SCI USA, V107, P13491, DOI 10.1073/pnas.1007827107; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI [10.1177/0269881120954052, DOI 10.1101/GR.110528.110, DOI 10.1016/J.COGPSYCH.2004.11.001]; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Suri RE, 2002, NEURAL NETWORKS, V15, P523, DOI 10.1016/S0893-6080(02)00046-1; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Takahashi YK, 2009, NEURON, V62, P269, DOI 10.1016/j.neuron.2009.03.005; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tye KM, 2010, NAT NEUROSCI, V13, P475, DOI 10.1038/nn.2506; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wassum KM, 2011, LEARN MEMORY, V18, P475, DOI 10.1101/lm.2229311; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007; Witten IB, 2011, NEURON, V72, P721, DOI 10.1016/j.neuron.2011.10.028; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zweifel LS, 2009, P NATL ACAD SCI USA, V106, P7281, DOI 10.1073/pnas.0813415106	48	495	500	7	156	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2013	16	7					966	U248		10.1038/nn.3413	http://dx.doi.org/10.1038/nn.3413			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	174UM	23708143	Green Submitted, Green Accepted			2022-12-17	WOS:000321180900032
J	Bosco, DA; Morfini, G; Karabacak, NM; Song, YY; Gros-Louis, F; Pasinelli, P; Goolsby, H; Fontaine, BA; Lemay, N; McKenna-Yasek, D; Frosch, MP; Agar, JN; Julien, JP; Brady, ST; Brown, RH				Bosco, Daryl A.; Morfini, Gerardo; Karabacak, N. Murat; Song, Yuyu; Gros-Louis, Francois; Pasinelli, Piera; Goolsby, Holly; Fontaine, Benjamin A.; Lemay, Nathan; McKenna-Yasek, Diane; Frosch, Matthew P.; Agar, Jeffrey N.; Julien, Jean-Pierre; Brady, Scott T.; Brown, Robert H., Jr.			Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FAST AXONAL-TRANSPORT; HUMAN SUPEROXIDE-DISMUTASE; MOTOR-NEURON DISEASE; NEURODEGENERATIVE DISEASES; PROTEIN AGGREGATION; EXTRUDED AXOPLASM; SPINAL-CORDS; LINKED SOD1; MOUSE MODEL	Many mutations confer one or more toxic function(s) on copper/zinc superoxide dismutase 1 (SOD1) that impair motor neuron viability and cause familial amyotrophic lateral sclerosis (FALS). Using a conformation-specific antibody that detects misfolded SOD1 (C4F6), we found that oxidized wild-type SOD1 and mutant SOD1 share a conformational epitope that is not present in normal wild-type SOD1. In a subset of human sporadic ALS (SALS) cases, motor neurons in the lumbosacral spinal cord were markedly C4F6 immunoreactive, indicating that an aberrant wild-type SOD1 species was present. Recombinant, oxidized wildtype SOD1 and wild-type SOD1 immunopurified from SALS tissues inhibited kinesin-based fast axonal transport in a manner similar to that of FALS-linked mutant SOD1. Our findings suggest that wild-type SOD1 can be pathogenic in SALS and identify an SOD1-dependent pathogenic mechanism common to FALS and SALS.	[Bosco, Daryl A.; Fontaine, Benjamin A.; Lemay, Nathan; McKenna-Yasek, Diane; Brown, Robert H., Jr.] Univ Massachusetts Med Ctr, Dept Neurol, Worcester, MA USA; [Morfini, Gerardo; Song, Yuyu; Brady, Scott T.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Karabacak, N. Murat; Agar, Jeffrey N.] Brandeis Univ, Dept Chem, Waltham, MA 02254 USA; [Gros-Louis, Francois; Julien, Jean-Pierre] Univ Laval, Dept Psychiat & Neurosci, Res Ctr CHUQ, Quebec City, PQ, Canada; [Pasinelli, Piera] Thomas Jefferson Univ, Farber Inst Neurosci, Weinberg Unit ALS Res, Philadelphia, PA 19107 USA; [Goolsby, Holly; Frosch, Matthew P.] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA; [Morfini, Gerardo; Song, Yuyu; Brady, Scott T.] Marine Biol Lab, Woods Hole, MA 02543 USA	University of Massachusetts System; University of Massachusetts Worcester; University Massachusetts Worcester Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Brandeis University; Laval University; Jefferson University; Harvard University; Massachusetts General Hospital; Marine Biological Laboratory - Woods Hole	Bosco, DA (corresponding author), Univ Massachusetts Med Ctr, Dept Neurol, Worcester, MA USA.	daryl.bosco@umassmed.edu; robert.brown@umassmed.edu	Frosch, Matthew P/ABD-7456-2021; Song, Yuyu/J-8939-2019; Karabacak, Murat/AAG-2891-2019; Karabacak, N Murat/D-7227-2013	Frosch, Matthew P/0000-0002-3940-9861; Song, Yuyu/0000-0002-9196-1610; Karabacak, Murat/0000-0003-2761-5593; Karabacak, N Murat/0000-0003-2761-5593; Pasinelli, Piera/0000-0002-3385-2707; Agar, Jeffery/0000-0003-2645-1873	ALS Therapy Alliance-CVS Pharmacy; Marine Biological Laboratory; ALS Association; US National Institutes of Health; National Institute on Neurological Disorders and Stroke [RO1NS067206-01, U01NS05225-03, R01NS050557-05, 1RC1NS068391-01, 1RC2NS070342-01]; Canadian Institutes of Health Research; Angel Fund; ALS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068391, R01NS067206, R01NS065263, R01NS050557, R01NS023868, RC2NS070342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	ALS Therapy Alliance-CVS Pharmacy; Marine Biological Laboratory; ALS Association; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Angel Fund; ALS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to J. Landers and P. Sapp for DNA sequencing analysis of the SALS cases employed in this study, L. Hayward, A. Tiwari and R.-J. Chain for help with expression of recombinant wild-type SOD1, S. Berth, A. Leitman and M. Saparauskaite for help with axoplasm vesicle transport assays, A. Kaminska and L. Molla for help with biochemical experiments in squid axoplasm, M. Prudencio and D. Borchelt for cell lysates containing SOD1 G93 mutants, C. Vanderburg, E. Tamrazian, A. Bialik and the Diabetes and Endocrinology Research Center (University of Massachusetts Medical Center) for assistance with immunohistochemistry, K. Fitch and the Massachusetts Alzheimer Disease Research Center (P50AG005134) for assistance with human tissue samples, J. Zitzewitz for C6A/C111S-SOD1 protein, A. Weiss for assistance with mice, K. Green at the University of Massachusetts Medical Center Proteomics and Mass Spectrometry Facility for analysis of C6A/C111S-SOD1, and G. Petsko for insightful dialogue and support. We acknowledge financial support from the ALS Therapy Alliance-CVS Pharmacy (D. A. B. and G. M.), 2007/2008 Marine Biological Laboratory research fellowships (G. M.), the ALS Association (D. A. B., R. H. B. Jr, G. M. and S. T. B.), the US National Institutes of Health (D. A. B. (National Institute on Neurological Disorders and Stroke, RO1NS067206-01), R. H. B. Jr (National Institute on Neurological Disorders and Stroke, U01NS05225-03, R01NS050557-05, 1RC1NS068391-01 and 1RC2NS070342-01), S. T. B. and J.N.A.), Canadian Institutes of Health Research (J.-P.J.), the Angel Fund (R. H. B. Jr) and Project ALS (R.H.B.Jr).	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Beckman JS, 2001, TRENDS NEUROSCI, V24, pS15, DOI 10.1016/S0166-2236(00)01981-0; BRADY ST, 1982, SCIENCE, V218, P1129, DOI 10.1126/science.6183745; BRADY ST, 1985, CELL MOTIL CYTOSKEL, V5, P81, DOI 10.1002/cm.970050203; Bredesen DE, 1997, ANN NEUROL, V42, P135, DOI 10.1002/ana.410420202; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI 10.1089/ARS.2009.2536; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; DURAZO A, 2009, J BIOL CHEM, V277, P15923; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Gros-Louis F, 2010, J NEUROCHEM, V113, P1188, DOI 10.1111/j.1471-4159.2010.06683.x; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Liu HN, 2009, ANN NEUROL, V66, P75, DOI 10.1002/ana.21704; Molnar KS, 2009, J BIOL CHEM, V284, P30965, DOI 10.1074/jbc.M109.023945; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Strom AL, 2008, J NEUROCHEM, V106, P495, DOI 10.1111/j.1471-4159.2008.05393.x; Svensson AKE, 2006, J MOL BIOL, V364, P1084, DOI 10.1016/j.jmb.2006.09.005; TANDAN R, 1985, ANN NEUROL, V18, P271, DOI 10.1002/ana.410180302; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Valdmanis PN, 2009, CURR NEUROL NEUROSCI, V9, P198, DOI 10.1007/s11910-009-0030-9; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Ve Velde C., 2008, P NATL ACAD SCI USA, V105, P4022, DOI [DOI 10.1073/PNAS.0712209105, 10.1073/pnas.0712209105]; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553	50	493	514	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1396	U133		10.1038/nn.2660	http://dx.doi.org/10.1038/nn.2660			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20953194	Green Accepted, Green Submitted			2022-12-17	WOS:000283658200021
J	Yin, HH; Mulcare, SP; Hilario, MRF; Clouse, E; Holloway, T; Davis, MI; Hansson, AC; Lovinger, DM; Costa, RM				Yin, Henry H.; Mulcare, Shweta Prasad; Hilario, Monica R. F.; Clouse, Emily; Holloway, Terrell; Davis, Margaret I.; Hansson, Anita C.; Lovinger, David M.; Costa, Rui M.			Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TERM SYNAPTIC DEPRESSION; PRIMARY MOTOR CORTEX; PARKINSONS-DISEASE; DORSAL STRIATUM; STRIATOPALLIDAL NEURONS; RAT NEOSTRIATUM; HABIT FORMATION; PLASTICITY; RECEPTORS	The learning of new skills is characterized by an initial phase of rapid improvement in performance and a phase of more gradual improvements as skills are automatized and performance asymptotes. Using in vivo striatal recordings, we observed region-specific changes in neural activity during the different phases of skill learning, with the associative or dorsomedial striatum being preferentially engaged early in training and the sensorimotor or dorsolateral striatum being engaged later in training. Ex vivo recordings from medium spiny striatal neurons in brain slices of trained mice revealed that the changes observed in vivo corresponded to regional- and training-specific changes in excitatory synaptic transmission in the striatum. Furthermore, the potentiation of glutamatergic transmission observed in dorsolateral striatum after extensive training was preferentially expressed in striatopallidal neurons, rather than striatonigral neurons. These findings demonstrate that region- and pathway-specific plasticity sculpts the circuits involved in the performance of the skill as it becomes automatized.	[Yin, Henry H.; Mulcare, Shweta Prasad; Hilario, Monica R. F.; Clouse, Emily; Holloway, Terrell; Davis, Margaret I.; Lovinger, David M.; Costa, Rui M.] NIAAA, Lab Integrat Neurosci, US Natl Inst Hlth, Rockville, MD 20852 USA; [Yin, Henry H.] Duke Univ, Ctr Cognit Neurosci, Dept Psychol & Neurosci, Durham, NC 27708 USA; [Hansson, Anita C.] NIAAA, Lab Clin & Translat Studies, US Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Duke University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Costa, RM (corresponding author), NIAAA, Lab Integrat Neurosci, US Natl Inst Hlth, 5625 Fishers Lane,MSC 9411, Rockville, MD 20852 USA.	costarui@mail.nih.gov	Davis, Margaret/F-4165-2010; Hansson, Anita C/K-8146-2013	Costa, Rui M./0000-0003-0495-8374; Davis, Margaret/0000-0002-0489-8351	Intramural NIH HHS [Z01 AA000407-06] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000407, ZIAAA000416] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Brasted PJ, 2004, EUR J NEUROSCI, V19, P721, DOI 10.1111/j.0953-816X.2003.03181.x; Briand KA, 1999, EXP BRAIN RES, V129, P38, DOI 10.1007/s002210050934; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Carelli RM, 1997, J NEUROSCI, V17, P1804; Carrillo-Reid L, 2008, J NEUROPHYSIOL, V99, P1435, DOI 10.1152/jn.01131.2007; Choi WY, 2005, J NEUROSCI, V25, P6729, DOI 10.1523/JNEUROSCI.1498-05.2005; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Doyon J, 1996, EUR J NEUROSCI, V8, P637, DOI 10.1111/j.1460-9568.1996.tb01249.x; Flajolet M, 2008, NAT NEUROSCI, V11, P1402, DOI 10.1038/nn.2216; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Jedynak JP, 2007, EUR J NEUROSCI, V25, P847, DOI 10.1111/j.1460-9568.2007.05316.x; JENKINS IH, 1994, J NEUROSCI, V14, P3775; JOYCE JN, 1985, BRAIN RES, V338, P209, DOI 10.1016/0006-8993(85)90149-0; Kargo WJ, 2004, J NEUROSCI, V24, P5560, DOI 10.1523/JNEUROSCI.0562-04.2004; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kasanetz F, 2008, P NATL ACAD SCI USA, V105, P8124, DOI 10.1073/pnas.0711113105; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; LOVINGER DM, 1993, J NEUROPHYSIOL, V70, P1937, DOI 10.1152/jn.1993.70.5.1937; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; Martin J.P., 1967, BASAL GANGLIA POSTUR; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; SAVASTA M, 1986, BRAIN RES, V375, P291, DOI 10.1016/0006-8993(86)90749-3; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Takahashi Y, 2007, FRONT INTEGR NEUROSC, V1, DOI 10.3389/neuro.07.011.2007; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Wickens JR, 2007, ANN NY ACAD SCI, V1104, P192, DOI 10.1196/annals.1390.016; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yin HH, 2006, BEHAV BRAIN RES, V166, P189, DOI 10.1016/j.bbr.2005.07.012; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	50	493	499	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2009	12	3					333	341		10.1038/nn.2261	http://dx.doi.org/10.1038/nn.2261			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	410LF	19198605	Green Accepted			2022-12-17	WOS:000263577900019
J	Liu, J; Harris, A; Kanwisher, N				Liu, J; Harris, A; Kanwisher, N			Stages of processing in face perception: an MEG study	NATURE NEUROSCIENCE			English	Article							OCCIPITOTEMPORAL CORTEX; VISUAL-CORTEX; TIME-COURSE; RESPONSES; HUMANS; RECOGNITION; CATEGORIES; EXPERTISE; STIMULI; OBJECTS	Here we used magnetoencephalography (MEG) to investigate stages of processing in face perception in humans. We found a face-selective MEG response occurring only 100 ms after stimulus onset (the 'M100'), 70 ms earlier than previously reported. Further, the amplitude of this M100 response was correlated with successful categorization of stimuli as faces, but not with successful recognition of individual faces, whereas the previously-described face-selective 'M170' response was correlated with both processes. These data suggest that face processing proceeds through two stages: an initial stage of face categorization, and a later stage at which the identity of the individual face is extracted.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Charlestown, MA 02129 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Liu, J (corresponding author), MIT, Dept Brain & Cognit Sci, NE20-443, Cambridge, MA 02139 USA.		Liu, Jia/C-5630-2011	Harris, Alison/0000-0002-0559-2821; Liu, Jia/0000-0003-0383-0934	NATIONAL EYE INSTITUTE [R01EY013455] Funding Source: NIH RePORTER; NEI NIH HHS [EY13455] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BENTIN S, IN PRESS ENCY COGNIT; Braeutigam S, 2001, NEUROREPORT, V12, P1531, DOI 10.1097/00001756-200105250-00046; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Farah M.J., 1995, VISUAL COGNITION INV, P101; George N, 1997, NEUROREPORT, V8, P1417, DOI 10.1097/00001756-199704140-00019; Gomez Gonzalez Carlos M., 1994, Brain Topography, V7, P41; GRILLSPECTOR K, 2001, J VISION, V1, pA474; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Jeffreys DA, 1996, VIS COGN, V3, P1, DOI 10.1080/713756729; JOLICOEUR P, 1984, COGNITIVE PSYCHOL, V16, P243, DOI 10.1016/0010-0285(84)90009-4; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Keysers C, 2001, J COGNITIVE NEUROSCI, V13, P90, DOI 10.1162/089892901564199; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; Mouchetant-Rostaing Y, 2000, EUR J NEUROSCI, V12, P303, DOI 10.1046/j.1460-9568.2000.00888.x; ORAM MW, 1992, J NEUROPHYSIOL, V68, P70, DOI 10.1152/jn.1992.68.1.70; Rainer G, 2001, CURR BIOL, V11, P846, DOI 10.1016/S0960-9822(01)00242-1; ROLLS ET, 1984, HUM NEUROBIOL, V3, P209; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; SADR J, IN PRESS COGNIT SCI; SADR J, 2001, 20016 MIT ART INT LA; Sams M, 1997, NEUROSCIENCE, V77, P49, DOI 10.1016/S0306-4522(96)00419-8; Schendan HE, 1998, PSYCHOPHYSIOLOGY, V35, P240, DOI 10.1017/S004857729897010X; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; Streit M, 2000, NEUROSCI LETT, V278, P13, DOI 10.1016/S0304-3940(99)00884-8; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Tanaka JW, 2001, J EXP PSYCHOL GEN, V130, P534, DOI 10.1037/0096-3445.130.3.534; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; THORPE SJ, 1989, CONNECTIONISM IN PERSPECTIVE, P63; Thorpe SJ, 2001, SCIENCE, V291, P260, DOI 10.1126/science.1058249; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828	37	493	499	2	46	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2002	5	9					910	916		10.1038/nn909	http://dx.doi.org/10.1038/nn909			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	587RL	12195430				2022-12-17	WOS:000177656300023
J	Reuter, J; Raedler, T; Rose, M; Hand, I; Glascher, J; Buchel, C				Reuter, J; Raedler, T; Rose, M; Hand, I; Glascher, J; Buchel, C			Pathological gambling is linked to reduced activation of the mesolimbic reward system	NATURE NEUROSCIENCE			English	Article							DRUG-ADDICTION; RESPONSES; STRIATUM; CORTEX; TASK; FMRI	By analogy to drug dependence, it has been speculated that the underlying pathology in pathological gambling is a reduction in the sensitivity of the reward system. Studying pathological gamblers and controls during a guessing game using functional magnetic resonance imaging, we observed a reduction of ventral striatal and ventromedial prefrontal activation in the pathological gamblers that was negatively correlated with gambling severity, linking hypoactivation of these areas to disease severity.	Univ Hamburg, Hosp Eppendorf, Neuroimage Nord, Dept Neurol, D-20246 Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Neuroimage Nord, Dept Psychiat, D-20246 Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Dept Psychiat, Behav Therapy Univ, D-20246 Hamburg, Germany	University of Hamburg; University of Hamburg; University of Hamburg	Buchel, C (corresponding author), Univ Hamburg, Hosp Eppendorf, Neuroimage Nord, Dept Neurol, Martinistr 52, D-20246 Hamburg, Germany.	buechel@uke.uni-hamburg.de	Gläscher, Jan/H-2930-2019; Jansen, Heiko T./A-5770-2008; Winwood, Peter/A-6363-2008	Gläscher, Jan/0000-0002-1020-7115; Jansen, Heiko T./0000-0003-0178-396X; 				Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Blum K, 1996, AM SCI, V84, P132; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Potenza MN, 2003, AM J PSYCHIAT, V160, P1990, DOI 10.1176/appi.ajp.160.11.1990; Potenza MN, 2001, JAMA-J AM MED ASSOC, V286, P141, DOI 10.1001/jama.286.2.141; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; Robbins TW, 2000, EXP BRAIN RES, V133, P130, DOI 10.1007/s002210000407; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Volkow ND, 2002, NEUROBIOL LEARN MEM, V78, P610, DOI 10.1006/nlme.2002.4099; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7; Zink CF, 2003, J NEUROSCI, V23, P8092	15	492	508	1	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2005	8	2					147	148		10.1038/nn1378	http://dx.doi.org/10.1038/nn1378			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	892GN	15643429				2022-12-17	WOS:000226638200012
J	Gron, G; Wunderlich, AP; Spitzer, M; Tomczak, R; Riepe, MW				Gron, G; Wunderlich, AP; Spitzer, M; Tomczak, R; Riepe, MW			Brain activation during human navigation: gender-different neural networks as substrate of performance	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; WORKING-MEMORY; HIPPOCAMPAL-FORMATION; SPATIAL MEMORY; TEMPORAL-LOBE; FRONTAL-LOBE; MAZE; RETRIEVAL; PATTERNS; SPACE	Visuospatial navigation in animals and human subjects is generally studied using maze exploration. We used functional MRI to observe brain activation in male and female subjects as they searched for the way out of a complex, three-dimensional, virtual-reality maze. Navigation activated the medial occipital gyri, lateral and medial parietal regions, posterior cingulate and parahippocampal gyri as well as the right hippocampus proper. Gender-specific group analysis revealed distinct activation of the left hippocampus in males, whereas females consistently recruited right parietal and right prefrontal cortex. Thus we demonstrate a neural substrate of well established human gender differences in spatial-cognition performance.	Univ Ulm, Dept Neurol, D-89075 Ulm, Germany; Univ Ulm, Dept Psychiat, D-89075 Ulm, Germany; Univ Ulm, Dept Radiol, D-89075 Ulm, Germany	Ulm University; Ulm University; Ulm University	Riepe, MW (corresponding author), Univ Ulm, Dept Neurol, Steinhovelstr 1, D-89075 Ulm, Germany.			Gron, Georg/0000-0002-0282-3575				Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Astur RS, 1998, BEHAV BRAIN RES, V93, P185, DOI 10.1016/S0166-4328(98)00019-9; Berthoz A, 1997, PHILOS T R SOC B, V352, P1437, DOI 10.1098/rstb.1997.0130; Brodmann K., 1909, VERGLEICHENDE LOKALI; Burgess N, 1999, HIPPOCAMPAL PARIETAL, P3; Cabeza R, 1997, NEURON, V19, P863, DOI 10.1016/S0896-6273(00)80967-8; Colby C.L., 1999, HIPPOCAMPAL PARIETAL, P104; Corsi PM, 1972, DEP PSYCHOL; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; FEIGENBAUM JD, 1991, PSYCHOBIOLOGY, V19, P21; Fletcher PC, 1996, BRAIN, V119, P1587, DOI 10.1093/brain/119.5.1587; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; Flitman S, 1997, NEUROPSYCHOLOGIA, V35, P409, DOI 10.1016/S0028-3932(96)00086-3; Ghaem O, 1997, NEUROREPORT, V8, P739, DOI 10.1097/00001756-199702100-00032; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Kolb B, 1996, BEHAV NEUROSCI, V110, P1271, DOI 10.1037/0735-7044.110.6.1271; Maguire E. A., 1999, HIPPOCAMPAL PARIETAL; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 1996, P ROY SOC B-BIOL SCI, V263, P1745, DOI 10.1098/rspb.1996.0255; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Maguire EA, 1997, J NEUROSCI, V17, P7103; MILNER B, 1965, NEUROPSYCHOLOGIA, V3, P317, DOI 10.1016/0028-3932(65)90005-9; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Moffat SD, 1998, EVOL HUM BEHAV, V19, P73, DOI 10.1016/S1090-5138(97)00104-9; MULLER RU, 1987, J NEUROSCI, V7, P1935; Nunn JA, 1999, BRAIN, V122, P47, DOI 10.1093/brain/122.1.47; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; PETRIDES M, 1985, NEUROPSYCHOLOGIA, V23, P601, DOI 10.1016/0028-3932(85)90062-4; PIGOTT S, 1993, NEUROPSYCHOLOGIA, V31, P1, DOI 10.1016/0028-3932(93)90076-C; PORTEUS SD, 1915, J PSYCHOASTHENICS, V12, P200; Porteus SD., 1959, MAZE TEST CLIN PSYCH; ROLAND PE, 1995, CEREB CORTEX, V5, P79, DOI 10.1093/cercor/5.1.79; Rolls ET, 1996, HIPPOCAMPUS, V6, P601, DOI 10.1002/(SICI)1098-1063(1996)6:6<601::AID-HIPO5>3.0.CO;2-J; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Salmon E, 1996, BRAIN, V119, P1617, DOI 10.1093/brain/119.5.1617; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; SELTZER B, 1984, EXP BRAIN RES, V55, P301; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; Strange BA, 1999, P NATL ACAD SCI USA, V96, P4034, DOI 10.1073/pnas.96.7.4034; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Talairach J., 1988, COPLANAR STEREOTAXIC; Thier P, 1996, P NATL ACAD SCI USA, V93, P4962, DOI 10.1073/pnas.93.10.4962; Van Horn JD, 1998, BRAIN RES, V793, P29, DOI 10.1016/S0006-8993(98)00051-1; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376	49	492	496	0	82	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					404	408		10.1038/73980	http://dx.doi.org/10.1038/73980			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725932				2022-12-17	WOS:000087945400023
J	Harris, KD; Shepherd, GMG				Harris, Kenneth D.; Shepherd, Gordon M. G.			The neocortical circuit: themes and variations	NATURE NEUROSCIENCE			English	Review							LONG-RANGE; LAYER 6; VISUAL-CORTEX; PYRAMIDAL NEURONS; FUNCTIONAL-ORGANIZATION; PROJECTION NEURONS; MOTOR CORTEX; SOMATOSENSORY CORTEX; STIMULUS SELECTIVITY; LAMINAR ORGANIZATION	Similarities in neocortical circuit organization across areas and species suggest a common strategy to process diverse types of information, including sensation from diverse modalities, motor control and higher cognitive processes. Cortical neurons belong to a small number of main classes. The properties of these classes, including their local and long-range connectivity, developmental history, gene expression, intrinsic physiology and in vivo activity patterns, are remarkably similar across areas. Each class contains subclasses; for a rapidly growing number of these, conserved patterns of input and output connections are also becoming evident. The ensemble of circuit connections constitutes a basic circuit pattern that appears to be repeated across neocortical areas, with area- and species-specific modifications. Such 'serially homologous' organization may adapt individual neocortical regions to the type of information each must process.	[Harris, Kenneth D.] UCL, Inst Neurol, London, England; [Harris, Kenneth D.] UCL, Dept Neurosci Physiol & Pharmacol, London, England; [Shepherd, Gordon M. G.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	University of London; University College London; University of London; University College London; Northwestern University; Feinberg School of Medicine	Harris, KD (corresponding author), UCL, Inst Neurol, London, England.	kenneth.harris@ucl.ac.uk; g-shepherd@northwestern.edu		Harris, Kenneth/0000-0002-5930-6456	Wellcome Trust [095668]; Engineering and Physical Sciences Research Council [1005102, K015141]; Simons Foundation; US National Institutes of Health [NS061963, NS087479, DC013272, EB017695]; Whitehall Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB017695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061963, R21NS087479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R56DC013272] Funding Source: NIH RePORTER; EPSRC [EP/K015141/1, EP/I005102/1, EP/I005102/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K015141/1, EP/I005102/1, EP/I005102/2] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Simons Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank K. Svoboda, N. Steinmetz, N. Yamawaki and M. Carandini for comments. K.D.H. is supported by grants from the Wellcome Trust (095668), Engineering and Physical Sciences Research Council (1005102, K015141) and Simons Foundation. G.M.G.S. is supported by grants from the US National Institutes of Health (NS061963, NS087479, DC013272, EB017695) and the Whitehall Foundation.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Alfano C, 2013, DEV NEUROBIOL, V73, P411, DOI 10.1002/dneu.22067; Anderson CT, 2010, NAT NEUROSCI, V13, P739, DOI 10.1038/nn.2538; Bai WZ, 2004, NEUROSCIENCE, V123, P257, DOI 10.1016/j.neuroscience.2003.08.056; Beloozerova IN, 2003, J NEUROSCI, V23, P7844; Bennett C, 2013, NEURON, V80, P350, DOI 10.1016/j.neuron.2013.08.007; Berezovskii VK, 2011, J COMP NEUROL, V519, P3672, DOI 10.1002/cne.22675; Bortone DS, 2014, NEURON, V82, P474, DOI 10.1016/j.neuron.2014.02.021; Braitenberg VB, 1998, CORTEX STAT GEOMETRY; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Callaway EM, 2011, J NEUROSCI, V31, P7456, DOI 10.1523/JNEUROSCI.5222-10.2011; Catania KC, 2012, P NATL ACAD SCI USA, V109, P10701, DOI 10.1073/pnas.1201885109; Chen JL, 2013, NATURE, V499, P336, DOI 10.1038/nature12236; Chou SJ, 2013, SCIENCE, V340, P1239, DOI 10.1126/science.1232806; Christophe E, 2005, J NEUROPHYSIOL, V94, P3357, DOI 10.1152/jn.00076.2005; Clasca F, 2012, EUR J NEUROSCI, V35, P1524, DOI 10.1111/j.1460-9568.2012.08033.x; Constantinople CM, 2013, SCIENCE, V340, P1591, DOI 10.1126/science.1236425; COOGAN TA, 1993, J NEUROSCI, V13, P3749; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Cruikshank SJ, 2012, J NEUROSCI, V32, P17813, DOI 10.1523/JNEUROSCI.3231-12.2012; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; da Costa NM, 2009, J NEUROSCI, V29, P13919, DOI 10.1523/JNEUROSCI.2785-09.2009; de Kock CPJ, 2008, J PHYSIOL-LONDON, V586, P3353, DOI 10.1113/jphysiol.2008.155580; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; De la Rossa A, 2013, NAT NEUROSCI, V16, P193, DOI 10.1038/nn.3299; Deck M, 2013, NEURON, V77, P472, DOI 10.1016/j.neuron.2012.11.031; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Dembrow N, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00054; Deschenes M, 1998, BRAIN RES REV, V28, P286, DOI 10.1016/S0165-0173(98)00017-4; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglas RJ, 1989, NEURAL COMPUT, V1, P480, DOI 10.1162/neco.1989.1.4.480; Dugas-Ford J, 2012, P NATL ACAD SCI USA, V109, P16974, DOI 10.1073/pnas.1204773109; Erzurumlu RS, 2012, EUR J NEUROSCI, V35, P1540, DOI 10.1111/j.1460-9568.2012.08075.x; Evarts E. V., 1984, NEUROPHYSIOLOGICAL A; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; Fitzpatrick D, 1996, CEREB CORTEX, V6, P329, DOI 10.1093/cercor/6.3.329; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Garcia-Cabezas MA, 2014, EUR J NEUROSCI, V39, P1824, DOI 10.1111/ejn.12585; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gerfen CR, 2013, NEURON, V80, P1368, DOI 10.1016/j.neuron.2013.10.016; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hansen BJ, 2012, NEURON, V76, P590, DOI 10.1016/j.neuron.2012.08.029; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Harwell CC, 2012, NEURON, V73, P1116, DOI 10.1016/j.neuron.2012.02.009; Helmstaedter M, 2008, J NEUROSCI, V28, P8273, DOI 10.1523/JNEUROSCI.5701-07.2008; HERKENHAM M, 1980, SCIENCE, V207, P532, DOI 10.1126/science.7352263; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Hooks BM, 2013, J NEUROSCI, V33, P748, DOI 10.1523/JNEUROSCI.4338-12.2013; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Huang ZJ, 2014, NEURON, V83, P1284, DOI 10.1016/j.neuron.2014.08.041; Hutsler JJ, 2005, BRAIN RES, V1052, P71, DOI 10.1016/j.brainres.2005.06.015; Imai Hideaki, 2012, Kobe J Med Sci, V58, pE86; JENSEN KF, 1984, P NATL ACAD SCI-BIOL, V81, P964, DOI 10.1073/pnas.81.3.964; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Kaneko T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00075; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kim J, 2014, J NEUROSCI, V34, P9656, DOI 10.1523/JNEUROSCI.1325-14.2014; Kimura A, 2003, NEUROSCIENCE, V117, P1003, DOI 10.1016/S0306-4522(02)00949-1; Kiritani T, 2012, J NEUROSCI, V32, P4992, DOI 10.1523/JNEUROSCI.4759-11.2012; Kita T, 2012, J NEUROSCI, V32, P5990, DOI 10.1523/JNEUROSCI.5717-11.2012; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Lee CC, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.003.2009; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lorente De No R., 1938, PHYSL NERVOUS SYST, P288; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Markov NT, 2013, SCIENCE, V342, P578, DOI 10.1126/science.1238406; Markov NT, 2013, CURR OPIN NEUROBIOL, V23, P187, DOI 10.1016/j.conb.2012.12.008; Miller MN, 2008, J NEUROSCI, V28, P13716, DOI 10.1523/JNEUROSCI.2940-08.2008; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Movshon JA, 1996, J NEUROSCI, V16, P7733; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Nelson A, 2013, J NEUROSCI, V33, P14342, DOI 10.1523/JNEUROSCI.2275-13.2013; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Olsen SR, 2012, NATURE, V483, P47, DOI 10.1038/nature10835; Parent M, 2005, J COMP NEUROL, V481, P127, DOI 10.1002/cne.20348; PETERS A, 1985, J COMP NEUROL, V234, P218, DOI 10.1002/cne.902340208; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Phillips C.G., 1977, MONOGR PHYSL SOC, V34; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Pouchelon G, 2014, NATURE, V511, P471, DOI 10.1038/nature13390; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Rowell JJ, 2010, J COMP NEUROL, V518, P3272, DOI 10.1002/cne.22399; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Saleem AB, 2013, NAT NEUROSCI, V16, P1864, DOI 10.1038/nn.3567; Sato TR, 2010, J NEUROSCI, V30, P4256, DOI 10.1523/JNEUROSCI.3774-09.2010; Schneider DM, 2014, NATURE, V513, P189, DOI 10.1038/nature13724; Schubert D, 2003, J NEUROSCI, V23, P2961; Sheets PL, 2011, J NEUROPHYSIOL, V106, P2216, DOI 10.1152/jn.00232.2011; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Shepherd GMG, 2009, FRONT NEUROSCI-SWITZ, V3, P337, DOI 10.3389/neuro.01.030.2009; Sirota MG, 2005, J NEUROSCI, V25, P5915, DOI 10.1523/JNEUROSCI.0489-05.2005; Smith MA, 2013, J NEUROPHYSIOL, V109, P940, DOI 10.1152/jn.00846.2012; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; Smith PH, 2012, J COMP NEUROL, V520, P34, DOI 10.1002/cne.22682; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; Staiger JF, 2015, BRAIN STRUCT FUNCT, V220, P1317, DOI 10.1007/s00429-014-0726-8; Stepanyants A, 2009, P NATL ACAD SCI USA, V106, P3555, DOI 10.1073/pnas.0810390106; Suter BA, 2013, CEREB CORTEX, V23, P1965, DOI 10.1093/cercor/bhs184; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; SWADLOW HA, 1989, J NEUROPHYSIOL, V62, P288, DOI 10.1152/jn.1989.62.1.288; Tamamaki N, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00202; Taniguchi H, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00008; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Theyel BB, 2010, NAT NEUROSCI, V13, P84, DOI 10.1038/nn.2449; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Thomson AM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00013; TSENG GF, 1993, J COMP NEUROL, V335, P92, DOI 10.1002/cne.903350107; Ueta Y, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00164; Van Hooser SD, 2013, J NEUROSCI, V33, P11494, DOI 10.1523/JNEUROSCI.1464-13.2013; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; Velez-Fort M, 2014, NEURON, V83, P1431, DOI 10.1016/j.neuron.2014.08.001; von Economo CF, 1929, CYTOARCHITECTONICS H; Watakabe A, 2012, J COMP NEUROL, V520, P3553, DOI 10.1002/cne.23160; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; Wong PY, 2009, BRAIN BEHAV EVOLUT, V73, P206, DOI 10.1159/000225381; Xu H, 2013, NEURON, V77, P155, DOI 10.1016/j.neuron.2012.11.004; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yamashita T, 2013, NEURON, V80, P1477, DOI 10.1016/j.neuron.2013.10.059; Yang WG, 2013, J NEUROSCI, V33, P17373, DOI 10.1523/JNEUROSCI.2515-13.2013; Zhang SY, 2014, SCIENCE, V345, P660, DOI 10.1126/science.1254126; Zhang ZW, 1998, CEREB CORTEX, V8, P428, DOI 10.1093/cercor/8.5.428; Zhang ZW, 1997, J NEUROSCI, V17, P6365; Zhou M, 2014, NAT NEUROSCI, V17, P841, DOI 10.1038/nn.3701; Zingg B, 2014, CELL, V156, P1096, DOI 10.1016/j.cell.2014.02.023	150	491	494	3	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2015	18	2					170	181		10.1038/nn.3917	http://dx.doi.org/10.1038/nn.3917			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CA0UM	25622573	Green Accepted			2022-12-17	WOS:000348631800005
J	Lin, JY; Knutsen, PM; Muller, A; Kleinfeld, D; Tsien, RY				Lin, John Y.; Knutsen, Per Magne; Muller, Arnaud; Kleinfeld, David; Tsien, Roger Y.			ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation	NATURE NEUROSCIENCE			English	Article							MOTOR CORTEX; FACIAL NUCLEUS; IN-VITRO; WHISKER; STIMULATION; MOVEMENTS; ACTIVATION; CHANNEL; CELLS	Channelrhodopsins (ChRs) are used to optogenetically depolarize neurons. We engineered a variant of ChR, denoted red-activatable ChR (ReaChR), that is optimally excited with orange to red light (lambda similar to 590-630 nm) and offers improved membrane trafficking, higher photocurrents and faster kinetics compared to existing red-shifted ChRs. Red light is less scattered by tissue and is absorbed less by blood than the blue to green wavelengths that are required by other ChR variants. We used ReaChR expressed in the vibrissa motor cortex to drive spiking and vibrissa motion in awake mice when excited with red light through intact skull. Precise vibrissa movements were evoked by expressing ReaChR in the facial motor nucleus in the brainstem and illumination with red light through the external auditory canal. Thus, ReaChR enables transcranial optical activation of neurons in deep brain structures without the need to surgically thin the skull, form a transcranial window or implant optical fibers.	[Lin, John Y.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Knutsen, Per Magne; Muller, Arnaud; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Kleinfeld, David] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Howard Hughes Med Inst, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute	Lin, JY (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	j8lin@ucsd.edu		Lin, John/0000-0002-1723-4597	Foundation of Research, Science and Technology New Zealand; Human Frontier Science Program (HFSP); US National Institutes of Health [NS027177, DA029706, OD006831, NS058668]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R37NS027177, R01NS058668, DP1NS082097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029706] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006831] Funding Source: NIH RePORTER	Foundation of Research, Science and Technology New Zealand(New Zealand Foundation for Research, Science and Technology); Human Frontier Science Program (HFSP)(Human Frontier Science Program); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.Y.L. was funded by the Foundation of Research, Science and Technology New Zealand, and P.M.K. was supported by a long-term fellowship from the Human Frontier Science Program (HFSP). The project was supported by grants to R.Y.T. from the US National Institutes of Health (NS027177) and the Howard Hughes Medical Institute and grants to D.K. from the US National Institutes of Health (DA029706, OD006831 and NS058668). We thank P. Tsai for suggesting the name ReaChR. We thank K. Deisseroth (Stanford University) for the hChR2<SUP>H134R</SUP>-eYFP construct, K. Svoboda (Howard Hughes Medical Institute Janelia Farm Research Campus) for the CAG promoter vector, E. Boyden (Massachusetts Institute of Technology) for the lentiviral vector, L. Tian (Howard Hughes Medical Institute Janelia Farm Research Campus) for the AAV2 vector and D. Trono (Ecole Polytechnique Federale De Lausane) for the psPAX2 and pMD2.G lentivirus packaging vectors. AAV2-ReaChR-Citrine and pLenti-ReaChR-Citrine constructs can be requested from http://tsienlab.ucsd.edu/Samples.htm.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; ARMSTRONG CM, 1992, METHOD ENZYMOL, V207, P100; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Berg RW, 2003, J NEUROPHYSIOL, V90, P2950, DOI 10.1152/jn.00511.2003; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Bruegmann T, 2010, NAT METHODS, V7, P897, DOI 10.1038/nmeth.1512; DORFL J, 1982, J ANAT, V135, P147; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Govorunova EG, 2011, MBIO, V2, DOI 10.1128/mBio.00115-11; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Haiss F, 2005, J NEUROSCI, V25, P1579, DOI 10.1523/JNEUROSCI.3760-04.2005; Hauss-Wegrzyniak B, 2002, EXP NEUROL, V176, P336, DOI 10.1006/exnr.2002.7966; Herfst LJ, 2008, J NEUROPHYSIOL, V99, P2821, DOI 10.1152/jn.01014.2007; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kleinlogel S, 2011, NAT NEUROSCI, V14, P513, DOI 10.1038/nn.2776; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; MARTIN MR, 1977, BRAIN RES, V123, P1, DOI 10.1016/0006-8993(77)90639-4; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/NMETH.1808, 10.1038/nmeth.1808]; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; SHICHIDA Y, 1983, BIOCHIM BIOPHYS ACTA, V723, P240, DOI 10.1016/0005-2728(83)90123-8; Sohler TP, 1941, J PHARMACOL EXP THER, V71, P325; Tromberg BJ, 2000, NEOPLASIA, V2, P26, DOI 10.1038/sj.neo.7900082; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Wen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012893; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120	40	491	513	3	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2013	16	10					1499	+		10.1038/nn.3502	http://dx.doi.org/10.1038/nn.3502			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	223HM	23995068	Green Accepted, Green Submitted			2022-12-17	WOS:000324795300024
J	Thomas, MJ; Beurrier, C; Bonci, A; Malenka, RC				Thomas, MJ; Beurrier, C; Bonci, A; Malenka, RC			Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine	NATURE NEUROSCIENCE			English	Article							AMPHETAMINE ADMINISTRATION ALTERS; MEDIAL PREFRONTAL CORTEX; IBOTENIC ACID LESIONS; EXTRACELLULAR DOPAMINE; SYNAPTIC PLASTICITY; SHELL; EXPRESSION; RAT; POTENTIATION; TRANSMISSION	A compelling model of experience-dependent plasticity is the long-lasting sensitization to the locomotor stimulatory effects of drugs of abuse. Adaptations in the nucleus accumbens (NAc), a component of the mesolimbic dopamine system, are thought to contribute to this behavioral change. Here we examine excitatory synaptic transmission in NAc slices prepared from animals displaying sensitization 10-14 days after repeated in vivo cocaine exposure. The ratio of AMPA (alpha -amino-3-hydroxy-5-methyl-4- isoxazole propionic acid) receptor- to NMDA (N-methyl-D-aspartate) receptor-mediated excitatory postsynaptic currents (EPSCs) was decreased at synapses made by prefrontal cortical afferents onto medium spiny neurons in the shell of the NAc. The amplitude of miniature EPSCs at these synapses also was decreased, as was the magnitude of long-term depression. These data suggest that chronic in vivo administration of cocaine elicits a long-lasting depression of excitatory synaptic transmission in the NAc, a change that may contribute to behavioral sensitization and addiction.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA	Stanford University; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.		Thomas, Mark John/HHC-7509-2022; Jansen, Heiko T./A-5770-2008	Thomas, Mark John/0000-0001-5721-5350; Jansen, Heiko T./0000-0003-0178-396X	NIDA NIH HHS [F32 DA005945] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA005945] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Andersen P, 1996, J PHYSIOLOGY-PARIS, V90, P349, DOI 10.1016/S0928-4257(97)87917-X; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; CAINE SB, 1995, BRAIN RES, V692, P47; Carlezon WA, 1996, J NEUROSCI, V16, P3112; CARLEZON WA, 1995, PSYCHOPHARMACOLOGY, V122, P194, DOI 10.1007/BF02246095; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Li Y, 1997, BEHAV BRAIN RES, V84, P285, DOI 10.1016/S0166-4328(96)00158-1; Lu WX, 1997, SYNAPSE, V26, P269, DOI 10.1002/(SICI)1098-2396(199707)26:3<269::AID-SYN8>3.0.CO;2-5; Lu WX, 1999, SYNAPSE, V32, P119, DOI 10.1002/(SICI)1098-2396(199905)32:2<119::AID-SYN5>3.0.CO;2-F; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; MCGINTY JF, 1999, ADV VENTRAL STRIATUM, V877; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; McKinzie DL, 1999, ANN NY ACAD SCI, V877, P788, DOI 10.1111/j.1749-6632.1999.tb09323.x; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nicola SM, 1996, J NEUROSCI, V16, P1591; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Parkinson JA, 1999, J NEUROSCI, V19, P2401; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; PIERCE RC, 1995, J PHARMACOL EXP THER, V275, P1019; Pierce RC, 1998, NEUROSCIENCE, V82, P1103; Pierce RC, 1996, J NEUROSCI, V16, P1550; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; PONTIERI FE, 1994, NEUROREPORT, V5, P2561, DOI 10.1097/00001756-199412000-00039; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 1997, J NEUROSCI, V17, P8491; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; SCHENK S, 1994, BRAIN RES, V659, P17, DOI 10.1016/0006-8993(94)90858-3; Segal D. S., 1983, STIMULANTS NEUROCHEM, P131; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Zahm DS, 1999, ANN NY ACAD SCI, V877, P113, DOI 10.1111/j.1749-6632.1999.tb09264.x; Zhang XF, 1998, J NEUROSCI, V18, P488; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	47	491	501	0	42	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1217	1223		10.1038/nn757	http://dx.doi.org/10.1038/nn757			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11694884				2022-12-17	WOS:000172525000018
J	Turkeltaub, PE; Gareau, L; Flowers, DL; Zeffiro, TA; Eden, GF				Turkeltaub, PE; Gareau, L; Flowers, DL; Zeffiro, TA; Eden, GF			Development of neural mechanisms for reading	NATURE NEUROSCIENCE			English	Article							INFERIOR PREFRONTAL CORTEX; CEREBRAL-BLOOD-FLOW; WORD FORM AREA; WORKING-MEMORY; BRAIN; CHILDREN; FMRI; LANGUAGE; DYSLEXIA; SPECIALIZATION	The complexities of pediatric brain imaging have precluded studies that trace the neural development of cognitive skills acquired during childhood. Using a task that isolates reading-related brain activity and minimizes confounding performance effects, we carried out a cross-sectional functional magnetic resonance imaging (fMRI) study using subjects whose ages ranged from 6 to 22 years. We found that learning to read is associated with two patterns of change in brain activity: increased activity in left-hemisphere middle temporal and inferior frontal gyri and decreased activity in right inferotemporal cortical areas. Activity in the left-posterior superior temporal sulcus of the youngest readers was associated with the maturation of their phonological processing abilities. These findings inform current reading models and provide strong support for Orton's 1925 theory of reading development.	Georgetown Univ, Med Ctr, Washington, DC 20057 USA; Wake Forest Univ, Med Ctr Bowman Gray, Winston Salem, NC 27157 USA	Georgetown University; Wake Forest University	Eden, GF (corresponding author), Georgetown Univ, Med Ctr, 4000 Reservoir Rd,Bldg D,Suite 150, Washington, DC 20057 USA.		Zeffiro, Thomas/AAE-3441-2019	Zeffiro, Thomas/0000-0002-0846-4577; Turkeltaub, Peter/0000-0003-2080-6055	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD040095] Funding Source: NIH RePORTER; NICHD NIH HHS [HD40095] Funding Source: Medline; NIMH NIH HHS [F31 MH6500] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Balsamo LM, 2002, ARCH NEUROL-CHICAGO, V59, P1168, DOI 10.1001/archneur.59.7.1168; Becker JT, 1999, BRAIN COGNITION, V41, P27, DOI 10.1006/brcg.1999.1094; Bookheimer SY, 1995, HUM BRAIN MAPP, V3, P93, DOI 10.1002/hbm.460030206; Brunswick N, 1999, BRAIN, V122, P1901, DOI 10.1093/brain/122.10.1901; Burgund ED, 2002, NEUROIMAGE, V17, P184, DOI 10.1006/nimg.2002.1174; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chall JS., 1983, STAGES READING DEV; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Conel J. L., 1963, POSTNATAL DEV HUMAN; Ehri L.C., 1999, READING DEV TEACHING, P79; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; Flowers L, 2001, ANN DYSLEXIA, V51, P49, DOI 10.1007/s11881-001-0005-2; Friedman RF, 1993, CLIN NEUROPSYCHOLOGY, P37; FRITH U, 1985, SURFACE DYSLEXIA; Gaillard WD, 2003, NEUROLOGY, V60, P94, DOI 10.1212/WNL.60.1.94; Gaillard WD, 2001, NEUROIMAGE, V13, P239, DOI 10.1006/nimg.2000.0681; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jonides J, 1998, J NEUROSCI, V18, P5026; Orton ST., 1937, READING WRITING SPEE; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; PETERSEN SE, 1988, NATURE, V331, P385; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Poldrack Russell A, 2002, Top Magn Reson Imaging, V13, P61, DOI 10.1097/00002142-200202000-00005; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Price CJ, 1996, NEUROIMAGE, V3, P40, DOI 10.1006/nimg.1996.0005; Price CJ, 1997, HUM BRAIN MAPP, V5, P264, DOI 10.1002/(SICI)1097-0193(1997)5:4<264::AID-HBM11>3.0.CO;2-E; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; Pugh KR, 2001, J COMMUN DISORD, V34, P479, DOI 10.1016/S0021-9924(01)00060-0; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Simos PG, 2001, DEV NEUROPSYCHOL, V19, P191, DOI 10.1207/S15326942DN1902_4; SNYDER AZ, 1995, P NATL ACAD SCI USA, V92, P1689, DOI 10.1073/pnas.92.5.1689; STANOVICH KE, 1988, J LEARN DISABIL-US, V21, P590, DOI 10.1177/002221948802101003; Tagamets MA, 2000, J COGNITIVE NEUROSCI, V12, P281, DOI 10.1162/089892900562101; Talairach J., 1988, COPLANAR STEREOTAXIC; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Thomas KM, 1999, NEUROIMAGE, V10, P327, DOI 10.1006/nimg.1999.0466; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Wagner RK, 1997, DEV PSYCHOL, V33, P468, DOI 10.1037/0012-1649.33.3.468; Wolf M, 1999, ANN DYSLEXIA, V49, P3; Yakovlev PL, 1967, REGIONAL DEV BRAIN E, P3	50	490	495	3	115	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					767	773		10.1038/nn1065	http://dx.doi.org/10.1038/nn1065			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	694NJ	12754516				2022-12-17	WOS:000183780400026
J	Carr, MF; Jadhav, SP; Frank, LM				Carr, Margaret F.; Jadhav, Shantanu P.; Frank, Loren M.			Hippocampal replay in the awake state: a potential substrate for memory consolidation and retrieval	NATURE NEUROSCIENCE			English	Review							MEDIAL TEMPORAL-LOBE; CA1 PYRAMIDAL CELLS; SLOW-WAVE SLEEP; SHARP WAVES; RETROGRADE-AMNESIA; SPATIAL MEMORY; PLACE CELLS; SEQUENTIAL EXPERIENCE; THETA OSCILLATIONS; PREFRONTAL CORTEX	The hippocampus is required for the encoding, consolidation and retrieval of event memories. Although the neural mechanisms that underlie these processes are only partially understood, a series of recent papers point to awake memory replay as a potential contributor to both consolidation and retrieval. Replay is the sequential reactivation of hippocampal place cells that represent previously experienced behavioral trajectories and occurs frequently in the awake state, particularly during periods of relative immobility. Awake replay may reflect trajectories through either the current environment or previously visited environments that are spatially remote. The repetition of learned sequences on a compressed time scale is well suited to promote memory consolidation in distributed circuits beyond the hippocampus, suggesting that consolidation occurs in both the awake and sleeping animal. Moreover, sensory information can influence the content of awake replay, suggesting a role for awake replay in memory retrieval.	[Carr, Margaret F.; Jadhav, Shantanu P.; Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Carr, Margaret F.; Jadhav, Shantanu P.; Frank, Loren M.] Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Frank, LM (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.	loren@phy.ucsf.edu	Jadhav, Shantanu/H-6654-2013	Jadhav, Shantanu/0000-0001-5821-0551; Frank, Loren/0000-0002-1752-5677	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080283] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH080283, R01 MH080283-04] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; [Anonymous], 1949, CLIN PSYCHOL-UK, DOI DOI 10.4324/9781410612403; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; CHROBAK JJ, 1994, J NEUROSCI, V14, P6160; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Cohen N.J., 1993, MEMORY AMNESIA HIPPO, DOI DOI 10.1136/JNNP.58.1.128-A; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; de Hoz L, 2006, HIPPOCAMPUS, V16, P704, DOI 10.1002/hipo.20207; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eichenbaum H., 2004, CONDITIONING CONSCIO; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Jackson JC, 2006, J NEUROSCI, V26, P12415, DOI 10.1523/JNEUROSCI.4118-06.2006; Jarrard LE, 2001, HIPPOCAMPUS, V11, P43, DOI 10.1002/1098-1063(2001)11:1<43::AID-HIPO1018>3.0.CO;2-B; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lansink CS, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000173; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Muller RU, 1996, HIPPOCAMPUS, V6, P709, DOI 10.1002/(SICI)1098-1063(1996)6:6<709::AID-HIPO13>3.0.CO;2-4; Nadel L, 2001, TRENDS COGN SCI, V5, P228, DOI 10.1016/S1364-6613(00)01664-8; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Rudy JW, 1995, HIPPOCAMPUS, V5, P375, DOI 10.1002/hipo.450050502; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1982, ANNU REV NEUROSCI, V5, P241, DOI 10.1146/annurev.ne.05.030182.001325; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 2001, HIPPOCAMPUS, V11, P50, DOI 10.1002/1098-1063(2001)11:1<50::AID-HIPO1019>3.0.CO;2-G; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Tulving E, 1998, HIPPOCAMPUS, V8, P198, DOI 10.1002/(SICI)1098-1063(1998)8:3<198::AID-HIPO2>3.0.CO;2-G; van der Meer MAA, 2010, NEURON, V67, P25, DOI 10.1016/j.neuron.2010.06.023; Wierzynski CM, 2009, NEURON, V61, P587, DOI 10.1016/j.neuron.2009.01.011; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110	82	488	496	2	116	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					147	153		10.1038/nn.2732	http://dx.doi.org/10.1038/nn.2732			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	711MJ	21270783	Green Accepted			2022-12-17	WOS:000286595400010
J	Hofstetter, CP; Holmstrom, NAV; Lilja, JA; Schweinhardt, P; Hao, JX; Spenger, C; Wiesenfeld-Hallin, Z; Kurpad, SN; Frisen, J; Olson, L				Hofstetter, CP; Holmstrom, NAV; Lilja, JA; Schweinhardt, P; Hao, JX; Spenger, C; Wiesenfeld-Hallin, Z; Kurpad, SN; Frisen, J; Olson, L			Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD-INJURY; NERVE GROWTH-FACTOR; FUNCTIONAL RECOVERY; INTRACEREBROVENTRICULAR INFUSION; AXONAL GROWTH; BHLH GENES; RAT; TRANSPLANTATION; MYELIN; REPAIR	Several studies have reported functional improvement after transplantation of neural stem cells into injured spinal cord. We now provide evidence that grafting of adult neural stem cells into a rat thoracic spinal cord weight-drop injury improves motor recovery but also causes aberrant axonal sprouting associated with allodynia-like hypersensitivity of forepaws. Transduction of neural stem cells with neurogenin-2 before transplantation suppressed astrocytic differentiation of engrafted cells and prevented graft-induced sprouting and allodynia. Transcluction with neurogenin-2 also improved the positive effects of engrafted stem cells, including increased amounts of myelin in the injured area, recovery of hindlimb locomotor function and hindlimb sensory responses, as determined by functional magnetic resonance imaging. These findings show that stem cell transplantation into injured spinal cord can cause severe side effects and call for caution in the consideration of clinical trials.	Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Karolinska Inst, Div Clin Neurophysiol, S-17177 Stockholm, Sweden; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 1QX, England; Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Oxford; Medical College of Wisconsin	Hofstetter, CP (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.	christoph.hofstetter@neuro.ki.se	Schweinhardt, Petra/AAC-6797-2021; Kurpad, Shekar/V-2188-2019	Schweinhardt, Petra/0000-0003-4837-6595				Akiyama Y, 2001, EXP NEUROL, V167, P27, DOI 10.1006/exnr.2000.7539; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; Bennett AD, 2000, PAIN, V86, P163, DOI 10.1016/S0304-3959(00)00242-6; BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Brown A, 2004, EXP NEUROL, V188, P115, DOI 10.1016/j.expneurol.2004.03.017; Bunge R P, 1997, Adv Neurol, V72, P305; Cairns DM, 1996, ARCH PHYS MED REHAB, V77, P329, DOI 10.1016/S0003-9993(96)90079-9; Cajal S. Ramon, 1928, DEGENERATION REGENER; Christensen MD, 1997, EXP NEUROL, V147, P463, DOI 10.1006/exnr.1997.6608; Christensen MD, 1997, J NEUROTRAUM, V14, P517, DOI 10.1089/neu.1997.14.517; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; Falk A, 2002, EXP CELL RES, V279, P34, DOI 10.1006/excr.2002.5569; Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GRIFFITHS IR, 1983, J NEUROL SCI, V58, P335, DOI 10.1016/0022-510X(83)90093-X; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Hao JX, 2000, NEUROSCI LETT, V286, P208, DOI 10.1016/S0304-3940(00)01107-1; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hofstetter CP, 2003, EUR J NEUROSCI, V18, P3061, DOI 10.1111/j.1460-9568.2003.03062.x; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; HOKFELT T, 1992, ANN NY ACAD SCI, V657, P119; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Jonhagen ME, 1998, DEMENT GERIATR COGN, V9, P246, DOI 10.1159/000017069; Jubran M, 2003, EXP NEUROL, V181, P204, DOI 10.1016/S0014-4886(03)00041-4; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; Mouton PR, 2002, J MICROSC-OXFORD, V206, P54, DOI 10.1046/j.1365-2818.2002.01006.x; Nashmi R, 2001, NEUROSCIENCE, V104, P235, DOI 10.1016/S0306-4522(01)00009-4; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Olson L, 1997, NAT MED, V3, P1329, DOI 10.1038/nm1297-1329; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Spenger C, 2000, EXP NEUROL, V166, P246, DOI 10.1006/exnr.2000.7524; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; UTZSCHNEIDER DA, 1994, P NATL ACAD SCI USA, V91, P53, DOI 10.1073/pnas.91.1.53; Vroemen M, 2003, EUR J NEUROSCI, V18, P743, DOI 10.1046/j.1460-9568.2003.02804.x; WAXMAN SG, 1989, J NEUROL SCI, V91, P1, DOI 10.1016/0022-510X(89)90072-5; Willis Jr W. D., 1991, SENSORY MECH SPINAL; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199	48	488	508	4	46	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2005	8	3					346	353		10.1038/nn1405	http://dx.doi.org/10.1038/nn1405			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	902KL	15711542				2022-12-17	WOS:000227354600020
J	Gunaydin, LA; Yizhar, O; Berndt, A; Sohal, VS; Deisseroth, K; Hegemann, P				Gunaydin, Lisa A.; Yizhar, Ofer; Berndt, Andre; Sohal, Vikaas S.; Deisseroth, Karl; Hegemann, Peter			Ultrafast optogenetic control	NATURE NEUROSCIENCE			English	Article							NEURONS; CHANNELRHODOPSIN-2; OSCILLATIONS; CHANNEL; RESPONSES; CELLS	Channelrhodopsins such as channelrhodopsin-2 (ChR2) can drive spiking with millisecond precision in a wide variety of cells, tissues and animal species. However, several properties of this protein have limited the precision of optogenetic control. First, when ChR2 is expressed at high levels, extra spikes ( for example, doublets) can occur in response to a single light pulse, with potential implications as doublets may be important for neural coding. Second, many cells cannot follow ChR2-driven spiking above the gamma (similar to 40 Hz) range in sustained trains, preventing temporally stationary optogenetic access to a broad and important neural signaling band. Finally, rapid optically driven spike trains can result in plateau potentials of 10 mV or more, causing incidental upstates with information-processing implications. We designed and validated an engineered opsin gene (ChETA) that addresses all of these limitations ( profoundly reducing extra spikes, eliminating plateau potentials and allowing temporally stationary, sustained spike trains up to at least 200 Hz).	[Gunaydin, Lisa A.; Yizhar, Ofer; Sohal, Vikaas S.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Gunaydin, Lisa A.] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Berndt, Andre; Hegemann, Peter] Humboldt Univ, Inst Biol, Berlin, Germany; [Sohal, Vikaas S.; Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Humboldt University of Berlin; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	deissero@stanford.edu; hegemape@rz.hu-berlin.de	Sohal, Vikaas/M-9327-2016; YIZHAR, OFER/AAV-8497-2021	Sohal, Vikaas/0000-0002-2238-4186; Yizhar, Ofer/0000-0003-4228-1448; Berndt, Andre/0000-0003-4758-5598	Stanford University; US National Institutes of Health; Leibniz Graduate School; Deutsche Forschungsgemeinschaft [HE3824/9]; William M. Keck Foundation; Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine; McKnight Foundation; Esther A. and Joseph Klingenstein Fund; National Science Foundation; National Institute of Mental Health; National Institute on Drug Abuse; US National Institutes of Health Pioneer Award	Stanford University(Stanford University); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leibniz Graduate School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); William M. Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Albert Yu and Mary Bechmann Foundation; Wallace Coulter Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); McKnight Foundation; Esther A. and Joseph Klingenstein Fund; National Science Foundation(National Science Foundation (NSF)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); US National Institutes of Health Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	L. A. G. is supported by a BioX fellowship from Stanford University, O.Y. by an Human Frontier Science Program fellowship, and V. S. S. by a K99 Award from the US National Institutes of Health. A. B. is supported by a Leibniz Graduate School fellowship. P. H. is supported by the Deutsche Forschungsgemeinschaft (HE3824/9 and Cluster of Excellence: Unifying concepts in Catalysis). K. D. is supported by the William M. Keck Foundation, the Snyder Foundation, the Albert Yu and Mary Bechmann Foundation, the Wallace Coulter Foundation, the California Institute for Regenerative Medicine, the McKnight Foundation, the Esther A. and Joseph Klingenstein Fund, the National Science Foundation, the National Institute of Mental Health, the National Institute on Drug Abuse, and a US National Institutes of Health Pioneer Award.	Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; BERNDT A, 2010, BIOPHYS J IN PRESS; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Hegemann P, 2005, BIOPHYS J, V89, P3911, DOI 10.1529/biophysj.105.069716; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Levesque M, 2009, NEUROBIOL DIS, V35, P209, DOI 10.1016/j.nbd.2009.04.011; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Ritter E, 2008, J BIOL CHEM, V283, P35033, DOI 10.1074/jbc.M806353200; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; TITTOR J, 1994, BIOPHYS J, V67, P1682, DOI 10.1016/S0006-3495(94)80642-3; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192	25	487	534	2	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2010	13	3					387	U27		10.1038/nn.2495	http://dx.doi.org/10.1038/nn.2495			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	559WW	20081849				2022-12-17	WOS:000274860100022
J	Hall, J; Thomas, KL; Everitt, BJ				Hall, J; Thomas, KL; Everitt, BJ			Rapid and selective induction of BDNF expression in the hippocampus during contextual learning	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION; MEMORY; MICE; LTP; CA1		Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Thomas, KL (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing Site,Tennis Court Rd, Cambridge CB2 3EB, England.		Thomas, Kerrie L/A-6509-2010	Thomas, Kerrie L/0000-0003-3355-9583; Everitt, Barry/0000-0003-4431-6536; Hall, Jeremy/0000-0002-0403-3278	MRC [G9537855] Funding Source: UKRI; Medical Research Council [G9537855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; KIERNAN MJ, 1993, Q J EXP PSYCHOL-B, V46, P271, DOI 10.1080/14640749308401089; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; THOMAS KL, 1996, CORTICAL PLASTICITY, P103; WISDEN W, 1994, IN SITU HYBRIDIZATIO, P9	15	487	514	0	38	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					533	535		10.1038/75698	http://dx.doi.org/10.1038/75698			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	317WG	10816306				2022-12-17	WOS:000087249500006
J	Prinz, M; Priller, J; Sisodia, SS; Ransohoff, RM				Prinz, Marco; Priller, Josef; Sisodia, Sangram S.; Ransohoff, Richard M.			Heterogeneity of CNS myeloid cells and their roles in neurodegeneration	NATURE NEUROSCIENCE			English	Review							CENTRAL-NERVOUS-SYSTEM; AMYOTROPHIC-LATERAL-SCLEROSIS; MARROW-DERIVED MICROGLIA; TUMOR-NECROSIS-FACTOR; BETA-AMYLOID DEPOSITION; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; BONE-MARROW; MOUSE MODEL	The diseased brain hosts a heterogeneous population of myeloid cells, including parenchymal microglia, perivascular cells, meningeal macrophages and blood-borne monocytes. To date, the different types of brain myeloid cells have been discriminated solely on the basis of their localization, morphology and surface epitope expression. However, recent data suggest that resident microglia may be functionally distinct from bone marrow-or blood-derived phagocytes, which invade the CNS under pathological conditions. During the last few years, research on brain myeloid cells has been markedly changed by the advent of new tools in imaging, genetics and immunology. These methodologies have yielded unexpected results, which challenge the traditional view of brain macrophages. On the basis of these new studies, we differentiate brain myeloid subtypes with regard to their origin, function and fate in the brain and illustrate the divergent features of these cells during neurodegeneration.	[Ransohoff, Richard M.] Cleveland Clin, Neuroinflammat Res Ctr, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA; [Ransohoff, Richard M.] Cleveland Clin, Mellen Ctr MS Treatment & Res, Neurol Inst, Cleveland, OH 44106 USA; [Prinz, Marco] Univ Hosp Freiburg, Dept Neuropathol, Freiburg, Germany; [Priller, Josef] Charite, Dept Neuropsychiat, D-13353 Berlin, Germany; [Priller, Josef] Charite, Lab Mol Psychiat, D-13353 Berlin, Germany; [Sisodia, Sangram S.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Sisodia, Sangram S.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Chicago; University of Chicago	Ransohoff, RM (corresponding author), Cleveland Clin, Neuroinflammat Res Ctr, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44106 USA.	marco.prinz@uniklinik-freiburg.de; ransohr@ccf.org	Priller, Josef/ABW-3835-2022	Priller, Josef/0000-0001-7596-0979	BMBF; Competence Network of Multiple Sclerosis (KKNMS); Competence Network of Neurodegenerative Disorders (DZNE); Centre of Chronic Immunodeficiency; Centre for Biological Signaling Studies; DFG [SFB 620, FOR1336]; Hertie-Foundation (Gemeinnutzige Hertie-Stiftung); BMBF (Berlin-Brandenburger Center fur Regenerative Therapien); Deutsche Forschungsgemeinschaft [FOR1336, SFB-TRR43]; National Institutes on Aging; Adler Foundation; Cure Alzheimer's Fund; US National Institutes of Health; National Multiple Sclerosis Society; Williams Family Fund for Multiple Sclerosis Research; Nancy Davis Center Without Walls	BMBF(Federal Ministry of Education & Research (BMBF)); Competence Network of Multiple Sclerosis (KKNMS); Competence Network of Neurodegenerative Disorders (DZNE); Centre of Chronic Immunodeficiency; Centre for Biological Signaling Studies; DFG(German Research Foundation (DFG)); Hertie-Foundation (Gemeinnutzige Hertie-Stiftung); BMBF (Berlin-Brandenburger Center fur Regenerative Therapien)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Adler Foundation; Cure Alzheimer's Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Williams Family Fund for Multiple Sclerosis Research; Nancy Davis Center Without Walls	The authors wish to thank F. F. Klett for Figure 1, K. Bhaskar and B. Lamb for Figure 2, and K. Kierdorf for fruitful discussion. M. P. was supported by the BMBF-funded Competence Network of Multiple Sclerosis (KKNMS), the Competence Network of Neurodegenerative Disorders (DZNE), the Centre of Chronic Immunodeficiency, the Centre for Biological Signaling Studies, the DFG (SFB 620, FOR1336) and the Hertie-Foundation (Gemeinnutzige Hertie-Stiftung). J.P. was supported by the BMBF (Berlin-Brandenburger Center fur Regenerative Therapien) and the Deutsche Forschungsgemeinschaft (SFB-TRR43, FOR1336 and the excellence cluster NeuroCure). Research in the S. S. S. laboratory is supported by the National Institutes on Aging, the Adler Foundation and Cure Alzheimer's Fund. The R. M. R. laboratory is supported by the US National Institutes of Health, the National Multiple Sclerosis Society, the Williams Family Fund for Multiple Sclerosis Research and the Nancy Davis Center Without Walls.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Appel SH, 2008, NEUROLOGY, V71, P1326, DOI 10.1212/01.wnl.0000327668.43541.22; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; ASHWELL K, 1991, DEV BRAIN RES, V58, P1, DOI 10.1016/0165-3806(91)90231-7; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bechmann I, 2001, EXP NEUROL, V168, P242, DOI 10.1006/exnr.2000.7618; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Biju KC, 2010, MOL THER, V18, P1536, DOI 10.1038/mt.2010.107; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chinnery HR, 2010, J NEUROPATH EXP NEUR, V69, P896, DOI 10.1097/NEN.0b013e3181edbc1a; Choi SH, 2008, NEURON, V59, P568, DOI 10.1016/j.neuron.2008.07.033; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Cuadros MA, 1998, PROG NEUROBIOL, V56, P173, DOI 10.1016/S0301-0082(98)00035-5; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Djukic M, 2006, BRAIN, V129, P2394, DOI 10.1093/brain/awl206; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Engelhardt B, 2008, J NEUROL SCI, V274, P23, DOI 10.1016/j.jns.2008.05.019; Firuzi O, 2006, ANN NEUROL, V59, P219, DOI 10.1002/ana.20774; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Gowing G, 2009, EXP NEUROL, V220, P267, DOI 10.1016/j.expneurol.2009.08.021; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Gu XF, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-8; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Holmes C, 2003, J NEUROL NEUROSUR PS, V74, P788, DOI 10.1136/jnnp.74.6.788; Hunot S, 1999, J NEUROSCI, V19, P3440; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Keshet GI, 2007, J COMP NEUROL, V504, P690, DOI 10.1002/cne.21483; Kim WK, 2006, AM J PATHOL, V168, P822, DOI 10.2353/ajpath.2006.050215; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Klunemann HH, 2005, NEUROLOGY, V64, P1502, DOI 10.1212/01.WNL.0000160304.00003.CA; Koenigsknecht-Talboo J, 2008, J NEUROSCI, V28, P14156, DOI 10.1523/JNEUROSCI.4147-08.2008; Kokovay E, 2005, NEUROBIOL DIS, V19, P471, DOI 10.1016/j.nbd.2005.01.023; LaFerla FM, 2010, BIOCHEM SOC T, V38, P993, DOI 10.1042/BST0380993; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Liberatore GT, 1999, NAT MED, V5, P1403; Lichanska AM, 2000, EXP HEMATOL, V28, P601, DOI 10.1016/S0301-472X(00)00157-0; Liu ZQ, 2010, J NEUROSCI, V30, P17091, DOI 10.1523/JNEUROSCI.4403-10.2010; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Massengale M, 2005, J EXP MED, V201, P1579, DOI 10.1084/jem.20050030; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nadeau S, 2000, J NEUROSCI, V20, P3456, DOI 10.1523/JNEUROSCI.20-09-03456.2000; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Price DL, 2000, ANN NY ACAD SCI, V920, P179; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Priller J, 2006, J NEUROSCI, V26, P11753, DOI 10.1523/JNEUROSCI.2275-06.2006; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rodriguez M, 2007, NEUROBIOL DIS, V28, P316, DOI 10.1016/j.nbd.2007.07.024; Roumier A, 2004, J NEUROSCI, V24, P11421, DOI 10.1523/JNEUROSCI.2251-04.2004; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schulz Martina, 2005, Cerebrospinal Fluid Res, V2, P8, DOI 10.1186/1743-8454-2-8; Schwab C, 2010, BBA-MOL BASIS DIS, V1802, P889, DOI 10.1016/j.bbadis.2009.10.013; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; SHOJI H, 1993, J NEUROL, V240, P59, DOI 10.1007/BF00838449; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; Stalder AK, 2005, J NEUROSCI, V25, P11125, DOI 10.1523/JNEUROSCI.2545-05.2005; Stalder M, 2001, NEUROBIOL AGING, V22, P427, DOI 10.1016/S0197-4580(01)00209-3; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Thevandavakkam MA, 2010, CNS NEUROL DISORD-DR, V9, P791; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; UNGER ER, 1993, J NEUROPATH EXP NEUR, V52, P460, DOI 10.1097/00005072-199309000-00004; Wilcock DM, 2004, J NEUROSCI, V24, P6144, DOI 10.1523/JNEUROSCI.1090-04.2004; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	98	486	502	0	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1227	1235		10.1038/nn.2923	http://dx.doi.org/10.1038/nn.2923			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21952260				2022-12-17	WOS:000295254200006
J	Wang, XH; Lou, NH; Xu, QW; Tian, GF; Peng, WG; Han, XN; Kang, J; Takano, T; Nedergaard, M				Wang, Xiaohai; Lou, Nanhong; Xu, Qiwu; Tian, Guo-Feng; Peng, Wei Guo; Han, Xiaoning; Kang, Jian; Takano, Takahiro; Nedergaard, Maiken			Astrocytic Ca2+ signaling evoked by sensory stimulation in vivo	NATURE NEUROSCIENCE			English	Article							CEREBRAL-BLOOD-FLOW; RAT BARREL CORTEX; NEURONAL-ACTIVITY; CALCIUM WAVES; SYNAPTIC-TRANSMISSION; GLUTAMATE; RECEPTORS; BRAIN; SITU; OSCILLATIONS	Although astrocytes are the most abundant cell type in the brain, evidence for their activation during physiological sensory activity is lacking. Here we show that whisker stimulation evokes increases in astrocytic cytosolic calcium (Ca2+) within the barrel cortex of adult mice. Increases in astrocytic Ca2+ were a function of the frequency of stimulation, occurred within several seconds and were inhibited by metabotropic glutamate receptor antagonists. To distinguish between synaptic input and output, local synaptic activity in cortical layer 2 was silenced by iontophoresis of AMPA and NMDA receptor antagonists. The antagonists did not reduce astrocytic Ca2+ responses despite a marked reduction in excitatory postsynaptic currents in response to whisker stimulation. These findings indicate that astrocytes respond to synaptic input, by means of spillover or ectopic release of glutamate, and that increases in astrocytic Ca2+ occur independently of postsynaptic excitatory activity.	Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Aging & Dev Biol, Rochester, NY 14642 USA; New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA	University of Rochester; New York Medical College	Nedergaard, M (corresponding author), Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Aging & Dev Biol, 601 Elmwood Ave, Rochester, NY 14642 USA.	Nedergaard@URMC.Rochester.edu		Wang, Xiaohai/0000-0001-5814-4072; Takano, Takahiro/0000-0002-6235-6673	NINDS NIH HHS [NS30007, NS38073] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038073, R29NS030007, R01NS030007] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1998, J NEUROSCI, V18, P6822; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Battaglia G, 2004, J NEUROSCI, V24, P828, DOI 10.1523/JNEUROSCI.3831-03.2004; Brickley SG, 2001, NEUROPHARMACOLOGY, V41, P730, DOI 10.1016/S0028-3908(01)00135-6; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Cotrina M., 2005, NEUROGLIA, P229; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DUFFY S, 1995, J NEUROSCI, V15, P5535; Dunwiddie TV, 1997, J NEUROSCI, V17, P7673; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Huang YHH, 2004, CURR OPIN NEUROBIOL, V14, P346, DOI 10.1016/j.conb.2004.05.007; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kettenmann H, 1999, Adv Neurol, V79, P565; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Newman EA, 2005, J NEUROSCI, V25, P5502, DOI 10.1523/JNEUROSCI.1354-05.2005; NILSSON M, 1991, DEV BRAIN RES, V63, P33, DOI 10.1016/0165-3806(91)90064-P; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; PORTER T, 1995, IEEE MULTIMEDIA, V2, P101; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Schuchmann S, 2002, NEUROBIOL DIS, V11, P96, DOI 10.1006/nbdi.2002.0533; Stout C, 2003, GLIA, V43, P265, DOI 10.1002/glia.10257; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Venance L, 1997, J NEUROSCI, V17, P1981; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	50	486	500	3	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					816	823		10.1038/nn1703	http://dx.doi.org/10.1038/nn1703			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16699507				2022-12-17	WOS:000237895200022
J	Chen, L; Feany, MB				Chen, L; Feany, MB			alpha-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease	NATURE NEUROSCIENCE			English	Article							COUPLED RECEPTOR KINASES; HUMAN BRAIN; PROTEIN; MUTATIONS; NEURODEGENERATION; LESIONS; GENE; TAU; SUPPRESSION; HUNTINGTIN	alpha-Synuclein is phosphorylated at serine 129 (Ser129) in intracellular protein aggregates called Lewy bodies. These inclusion bodies are the characteristic pathologic lesions of Parkinson disease. Here we define the role of phosphorylation of Ser129 in alpha-synuclein toxicity and inclusion formation using a Drosophila model of Parkinson disease. Mutation of Ser129 to alanine to prevent phosphorylation completely suppresses dopaminergic neuronal loss produced by expression of human alpha-synuclein. In contrast, altering Ser129 to the negatively charged residue aspartate, to mimic phosphorylation, significantly enhances alpha-synuclein toxicity. The G protein-coupled receptor kinase 2 (Gprk2) phosphorylates Ser129 in vivo and enhances alpha-synuclein toxicity. Blocking phosphorylation at Ser129 substantially increases aggregate formation. Thus Ser129 phosphorylation status is crucial in mediating alpha-synuclein neurotoxicity and inclusion formation. Because increased number of inclusion bodies correlates with reduced toxicity, inclusion bodies may protect neurons from alpha-synuclein toxicity.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Feany, MB (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	mel_feany@hms.harvard.edu		Feany, Mel/0000-0003-0315-7970	NIA NIH HHS [AG88001] Funding Source: Medline; NINDS NIH HHS [NS41536] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041536] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; CASSILL JA, 1991, P NATL ACAD SCI USA, V88, P11067, DOI 10.1073/pnas.88.24.11067; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Choi JY, 2002, BIOTECHNOL APPL BIOC, V36, P33, DOI 10.1042/BA20020004; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Ellis CE, 2001, J BIOL CHEM, V276, P3879, DOI 10.1074/jbc.M010316200; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Forloni G, 1996, CURR OPIN NEUROL, V9, P492, DOI 10.1097/00019052-199612000-00017; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee MK, 2002, ANTIVIR RES, V53, P99, DOI 10.1016/S0166-3542(01)00196-6; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; MATSUO ES, 1994, NEURON, V13, P989, DOI 10.1016/0896-6273(94)90264-X; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saito Y, 2003, J NEUROPATH EXP NEUR, V62, P644, DOI 10.1093/jnen/62.6.644; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shulman JM, 2003, GENETICS, V165, P1233; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takahashi M, 2003, NEUROSCI LETT, V336, P155, DOI 10.1016/S0304-3940(02)01258-2; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	43	486	504	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					657	663		10.1038/nn1443	http://dx.doi.org/10.1038/nn1443			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15834418				2022-12-17	WOS:000228895100027
J	Zheng, JL; Gao, WQ				Zheng, JL; Gao, WQ			Overexpression of Math1 induces robust production of extra hair cells in postnatal rat inner ears	NATURE NEUROSCIENCE			English	Article							SENSORY EPITHELIA; MORPHOLOGICAL EVIDENCE; MAMMALIAN COCHLEA; DEVELOPING ORGAN; SUPPORTING CELL; ACOUSTIC TRAUMA; PRONEURAL GENE; NERVOUS-SYSTEM; GROWTH-FACTORS; GUINEA-PIGS	For mammalian cochlear hair cells, fate determination is normally completed by birth. We report here that overexpression of Math1, a mouse homolog of the Drosophila gene atonal, in postnatal rat cochlear explant cultures resulted in extra hair cells. Surprisingly, we found that the source of the ectopic hair cells was columnar epithelial cells located outside the sensory epithelium in the greater epithelial ridge, which normally give rise to inner sulcus cells. Moreover, Math1 expression also facilitated conversion of postnatal utricular supporting cells into hair cells. Thus Math1 was sufficient for the production of hair cells in the ear, and immature postnatal mammalian inner ears retained the competence to generate new hair cells.	Genentech Inc, Dept Neurosci, S San Francisco, CA 94080 USA	Roche Holding; Genentech	Gao, WQ (corresponding author), Genentech Inc, Dept Neurosci, MS 72,1 DNA Way, S San Francisco, CA 94080 USA.							ABDOUH A, 1993, NEUROREPORT, V5, P33, DOI 10.1097/00001756-199310000-00008; AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; BALAK KJ, 1990, J NEUROSCI, V10, P2502; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Chen P, 1999, DEVELOPMENT, V126, P1581; Corwin JT, 1996, CIBA F SYMP, V196, P167; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Corwin JT, 1997, NEURON, V19, P951, DOI 10.1016/S0896-6273(00)80386-4; Cotanche Douglas A., 1994, Current Opinion in Neurobiology, V4, P509, DOI 10.1016/0959-4388(94)90051-5; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Fekete DM, 1998, J NEUROSCI, V18, P7811; Fekete DM, 1999, TRENDS NEUROSCI, V22, P263, DOI 10.1016/S0166-2236(98)01366-6; Fekete DM, 1996, CURR OPIN NEUROBIOL, V6, P533, DOI 10.1016/S0959-4388(96)80061-4; Forge A, 1998, J COMP NEUROL, V397, P69; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Haddon C, 1998, DEVELOPMENT, V125, P4637; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; KELLEY MW, 1993, DEVELOPMENT, V119, P1041; Kim P, 1997, DEV BIOL, V187, P1, DOI 10.1006/dbio.1997.8572; Kuntz AL, 1998, J COMP NEUROL, V399, P413; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Lewis AK, 1998, MECH DEVELOP, V78, P159, DOI 10.1016/S0925-4773(98)00165-8; Li L, 1997, INT J DEV NEUROSCI, V15, P433, DOI 10.1016/S0736-5748(96)00102-5; LIM J, 1992, DEV AUDITORY VESTIBU, P33; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; RUBEL EW, 1995, SCIENCE, V267, P701, DOI 10.1126/science.7839150; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; SOBKOWICZ HM, 1975, J NEUROCYTOL, V4, P543, DOI 10.1007/BF01351537; Stone JS, 1999, DEVELOPMENT, V126, P961; Stone JS, 1998, CURR OPIN NEUROL, V11, P17, DOI 10.1097/00019052-199802000-00004; Sundaresan S, 1998, ENDOCRINOLOGY, V139, P4756, DOI 10.1210/en.139.12.4756; VANDEWATER TR, 1983, DEV AUDITORY VESTIBU, P337; WARCHOL ME, 1995, SCIENCE, V267, P704, DOI 10.1126/science.267.5198.704; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Xiang MQ, 1998, DEVELOPMENT, V125, P3935; Zheng JL, 1999, J NEUROBIOL, V39, P29, DOI 10.1002/(SICI)1097-4695(199904)39:1<29::AID-NEU3>3.0.CO;2-E; Zheng JL, 1996, EUR J NEUROSCI, V8, P1897, DOI 10.1111/j.1460-9568.1996.tb01333.x; Zheng JL, 1999, J NEUROSCI, V19, P2161; Zheng JL, 1997, J NEUROSCI, V17, P8270; Zheng JL, 1997, J NEUROSCI, V17, P216, DOI 10.1523/JNEUROSCI.17-01-00216.1997	45	486	555	0	22	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2000	3	6					580	586		10.1038/75753	http://dx.doi.org/10.1038/75753			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	317WG	10816314				2022-12-17	WOS:000087249500014
J	Guo, JU; Su, YJ; Shin, JH; Shin, JH; Li, HD; Xie, B; Zhong, C; Hu, SH; Le, T; Fan, GP; Zhu, H; Chang, Q; Gao, Y; Ming, GL; Song, HJ				Guo, Junjie U.; Su, Yijing; Shin, Joo Heon; Shin, Jaehoon; Li, Hongda; Xie, Bin; Zhong, Chun; Hu, Shaohui; Le, Thuc; Fan, Guoping; Zhu, Heng; Chang, Qiang; Gao, Yuan; Ming, Guo-li; Song, Hongjun			Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain	NATURE NEUROSCIENCE			English	Article							ACTIVE DNA DEMETHYLATION; EMBRYONIC STEM-CELLS; BASE-RESOLUTION; ENZYMATIC-PROPERTIES; NERVOUS-SYSTEM; DNMT3A; MOUSE; METHYLTRANSFERASE; EPIGENETICS; PATTERNS	DNA methylation has critical roles in the nervous system and has been traditionally considered to be restricted to CpG dinucleotides in metazoan genomes. Here we show that the single base-resolution DNA methylome from adult mouse dentate neurons consists of both CpG (similar to 75%) and CpH (similar to 25%) methylation (H = A/C/T). Neuronal CpH methylation is conserved in human brains, enriched in regions of low CpG density, depleted at protein-DNA interaction sites and anticorrelated with gene expression. Functionally, both methylated CpGs (mCpGs) and mCpHs can repress transcription in vitro and are recognized by methyl-CpG binding protein 2 (MeCP2) in neurons in vivo. Unlike most CpG methylation, CpH methylation is established de novo during neuronal maturation and requires DNA methyltransferase 3A (DNMT3A) for active maintenance in postmitotic neurons. These characteristics of CpH methylation suggest that a substantially expanded proportion of the neuronal genome is under cytosine methylation regulation and provide a new foundation for understanding the role of this key epigenetic modification in the nervous system.	[Guo, Junjie U.; Su, Yijing; Shin, Jaehoon; Zhong, Chun; Gao, Yuan; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Guo, Junjie U.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Guo, Junjie U.; Su, Yijing; Zhong, Chun; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Shin, Joo Heon; Xie, Bin; Gao, Yuan] Johns Hopkins Univ, Sch Med, Lieber Inst Brain Dev, Baltimore, MD USA; [Shin, Jaehoon; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD USA; [Li, Hongda; Chang, Qiang] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Hu, Shaohui; Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Le, Thuc; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.	shongjul@jhmi.edu	Hu, Shaohui/AAE-4433-2020; Li, Hongda/F-3034-2017	Li, Hongda/0000-0001-6754-5150; Ming, Guo-li/0000-0002-2517-6075; Fan, Guoping/0000-0001-5235-6410	US National Institutes of Health (NIH) [NS047344, ES021957, MH087874]; Simons Foundation Autism Research Initiative; NARSAD; NIH [HD069184, NS048271, HD064743, HD066560, NS072924]; Maryland Stem Cell Research Fund (MSCRF); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and NARSAD; Lieber Institute fund; Damon Runyon Cancer Research Foundation; MSCRF postdoctoral fellowships; Samsung Scholarship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184, R01HD064743, P30HD003352] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD066560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087874, R21MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271, R37NS047344, R21NS072924, R56NS047344, R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Fund (MSCRF); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and NARSAD; Lieber Institute fund; Damon Runyon Cancer Research Foundation; MSCRF postdoctoral fellowships; Samsung Scholarship(Samsung); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Baylin, D. Ginty and members of the Song and Ming laboratories for comments and suggestions and Y. Cai and L. Liu for technical support. This work was supported by the US National Institutes of Health (NIH) (NS047344, ES021957 and MH087874), the Simons Foundation Autism Research Initiative and NARSAD to H.S., by the NIH (HD069184 and NS048271), the Maryland Stem Cell Research Fund (MSCRF), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and NARSAD to G.-l.M., by the Lieber Institute fund to Y.G., by NIH (HD064743, HD066560) to Q.C. and by NIH (NS072924) to G.F.; J.U.G. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation. Y.S. and C.Z. were supported by MSCRF postdoctoral fellowships; J.S. was supported by a Samsung Scholarship.	Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Feng J, 2009, INT REV NEUROBIOL, V89, P67, DOI 10.1016/S0074-7742(09)89004-1; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Hu XYV, 2010, P NATL ACAD SCI USA, V107, P15087, DOI 10.1073/pnas.1009025107; Ichiyanagi T, 2013, NUCLEIC ACIDS RES, V41, P738, DOI 10.1093/nar/gks1117; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Nelson ED, 2011, NEUROBIOL LEARN MEM, V96, P53, DOI 10.1016/j.nlm.2011.02.015; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2012, NATURE, V484, P550, DOI 10.1038/nature11086; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Telese F, 2013, NEURON, V77, P606, DOI 10.1016/j.neuron.2013.01.034; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Yokochi T, 2002, J BIOL CHEM, V277, P11735, DOI 10.1074/jbc.M106590200; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang TY, 2010, ANNU REV PSYCHOL, V61, P439, DOI 10.1146/annurev.psych.60.110707.163625; Zheng Y, 2010, NUCLEIC ACIDS RES, V38, P5527, DOI 10.1093/nar/gkq327; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	51	485	492	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2014	17	2					215	222		10.1038/nn.3607	http://dx.doi.org/10.1038/nn.3607			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA2FH	24362762	Green Accepted			2022-12-17	WOS:000330910000015
J	Stickgold, R; James, L; Hobson, JA				Stickgold, R; James, L; Hobson, JA			Visual discrimination learning requires sleep after training	NATURE NEUROSCIENCE			English	Article							MEMORY; IMPROVEMENT; SKILL		Harvard Univ, Sch Med, Dept Psychiat, Neurophysiol Lab, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Stickgold, R (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, Neurophysiol Lab, 74 Fenwood Rd, Boston, MA 02115 USA.				NIMH NIH HHS [MH-48832, MH-13923] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092638, R37MH013923, R01MH013923, T32MH013923] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AJILORE O, 1995, PSYCHOPHYSIOLOGY, V32, P92, DOI 10.1111/j.1469-8986.1995.tb03410.x; Heine R, 1914, Z PSYCHOL PHYSIOL SI, V68, P161; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Pilzecker, 1900, Z PSYCHOL, V1, P1; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; SMITH C, 1985, NEUROSCI BIOBEHAV R, V9, P157, DOI 10.1016/0149-7634(85)90042-9; Squire Larry R., 1994, P203; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Stickgold R, 1998, TRENDS COGN SCI, V2, P484, DOI 10.1016/S1364-6613(98)01258-3	14	484	494	2	62	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1237	1238		10.1038/81756	http://dx.doi.org/10.1038/81756			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UA	11100141	Bronze			2022-12-17	WOS:000167177900008
J	Magee, JC				Magee, JC			Dendritic I-h normalizes temporal summation in hippocampal CA1 neurons	NATURE NEUROSCIENCE			English	Article							ACTION-POTENTIAL INITIATION; PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; PACEMAKER; INTEGRATION; SYNAPSES; EFFICACY; ZD-7288; DISTAL; VITRO	Most mammalian central neurons receive synaptic input over complicated dendritic arbors. Therefore, timing of synaptic information should vary with synapse location. However, I report that temporal summation at CA1 pyramidal somata does not depend on the location of synaptic input. This spatial normalization of temporal integration requires a dendritic hyperpolarization-activated current (I-h). Shaping of synaptic activity by deactivating a nonuniform lh could counterbalance filtering by dendrites and effectively remove location-dependent variability in temporal integration, thus enhancing synchronization of neuronal populations and functional capabilities of the hippocampal CA1 region.	Louisiana State Univ, Med Ctr, Ctr Neurosci, New Orleans, LA 70112 USA	Louisiana State University System	Magee, JC (corresponding author), Louisiana State Univ, Med Ctr, Ctr Neurosci, 2020 Gravier St, New Orleans, LA 70112 USA.				NINDS NIH HHS [NS35865] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035865, R29NS035865] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN P, 1980, J PHYSIOL-LONDON, V307, P273, DOI 10.1113/jphysiol.1980.sp013435; Andreasen M, 1998, J PHYSIOL-LONDON, V507, P441, DOI 10.1111/j.1469-7793.1998.441bt.x; BERNANDER O, 1994, J NEUROPHYSIOL, V72, P2743, DOI 10.1152/jn.1994.72.6.2743; BUZSAKI G, 1982, BRAIN RES, V237, P283, DOI 10.1016/0006-8993(82)90442-5; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Colbert CM, 1996, J NEUROSCI, V16, P6676; Cook EP, 1997, J NEUROPHYSIOL, V78, P2116, DOI 10.1152/jn.1997.78.4.2116; Gasparini S, 1997, PFLUG ARCH EUR J PHY, V435, P99, DOI 10.1007/s004240050488; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; LAURBERG S, 1979, J COMP NEUROL, V184, P685, DOI 10.1002/cne.901840405; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Magee JC, 1998, J NEUROSCI, V18, P7613; Mainen ZF, 1996, J NEUROPHYSIOL, V76, P1904, DOI 10.1152/jn.1996.76.3.1904; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; NICOLL A, 1993, J PHYSIOL-LONDON, V468, P693, DOI 10.1113/jphysiol.1993.sp019795; OKEFFE J, 1993, HIPPOCAMPUS, V3, P317; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299; RALL W, 1967, J NEUROPHYSIOL, V30, P1169, DOI 10.1152/jn.1967.30.5.1169; RALL W, 1964, NEURAL THEORY MODELI, P5; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; SCHWINDT PC, 1988, J NEUROPHYSIOL, V59, P468, DOI 10.1152/jn.1988.59.2.468; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1998, J NEUROSCI, V18, P3501; TSUBAKAWA H, IN PRESS J PHYSL LON; WILSON CJ, 1995, J COMPUT NEUROSCI, V2, P91, DOI 10.1007/BF00961882; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	30	484	489	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	1999	2	6					508	514		10.1038/9158	http://dx.doi.org/10.1038/9158			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	273YA	10461231				2022-12-17	WOS:000084735900009
J	Williamson, TL; Cleveland, DW				Williamson, TL; Cleveland, DW			Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU,ZN SUPEROXIDE-DISMUTASE; NEUROFILAMENT TRANSPORT; TRANSGENIC MICE; RADIAL GROWTH; BETA-TUBULIN; MOUSE MODEL; DISEASE; MUTATION; DAMAGE	Mutations in copper/zinc superoxide dismutase 1 (SOD1), primary causes of human amyotrophic lateral sclerosis (ALS), provoke motor neuron death through an unidentified toxic property. The known neurofilament-dependent slowing of axonal transport, combined with the prominent misaccumulation of neurofilaments in ALS, suggests that an important aspect of toxicity may arise from damage to transport. Here we verify this hypothesis for two SOD1 mutations linked to familial ALS. Reduced transport of selective cargoes of slow transport, especially tubulin, arises months before neurodegeneration. For one mutant, this represents the earliest detectable abnormality. Th:us, damage to the cargoes or machinery of slow transport is an early feature of toxicity mediated by mutant SOD1.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	NINDS NIH HHS [NS 27036] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R01NS027036] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baas PW, 1997, CURR OPIN CELL BIOL, V9, P29, DOI 10.1016/S0955-0674(97)80148-2; BANKER BQ, 1986, MYOLOGY 2, P2031; Borchelt DR, 1998, NEUROBIOL DIS, V5, P27, DOI 10.1006/nbdi.1998.0178; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; CLEVELAND DW, 1995, NATURE, V378, P342, DOI 10.1038/378342a0; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P461, DOI 10.1097/00005072-198409000-00001; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P471, DOI 10.1097/00005072-198409000-00002; Hirokawa N, 1997, CURR OPIN NEUROBIOL, V7, P605, DOI 10.1016/S0959-4388(97)80079-7; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; HOFFMAN PN, 1983, J NEUROSCI, V3, P1694; HOFFMAN PN, 1985, J NEUROSCI, V5, P2920; HOFFMAN PN, 1985, J CELL BIOL, V101, P1332, DOI 10.1083/jcb.101.4.1332; KAWAMURA Y, 1981, J NEUROPATH EXP NEUR, V40, P667, DOI 10.1097/00005072-198111000-00008; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; LEE MK, 1990, P NATL ACAD SCI USA, V87, P7195, DOI 10.1073/pnas.87.18.7195; LOPATA MA, 1987, J CELL BIOL, V105, P1707, DOI 10.1083/jcb.105.4.1707; Marszalek JR, 1996, J CELL BIOL, V135, P711, DOI 10.1083/jcb.135.3.711; MITSUMOTO H, 1993, MUSCLE NERVE, V16, P542, DOI 10.1002/mus.880160517; PARDO CA, 1995, P NATL ACAD SCI USA, V92, P954, DOI 10.1073/pnas.92.4.954; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; WILLARD M, 1983, CELL, V35, P551, DOI 10.1016/0092-8674(83)90189-7; WILLIAMS DB, 1993, PERIPHERAL NEUROPATH, P1028; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Williamson TL, 1996, COLD SPRING HARB SYM, V61, P709; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	43	484	493	0	37	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					50	56		10.1038/4553	http://dx.doi.org/10.1038/4553			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195180				2022-12-17	WOS:000078409300013
J	Saito, T; Matsuba, Y; Mihira, N; Takano, J; Nilsson, P; Itohara, S; Iwata, N; Saido, TC				Saito, Takashi; Matsuba, Yukio; Mihira, Naomi; Takano, Jiro; Nilsson, Per; Itohara, Shigeyoshi; Iwata, Nobuhisa; Saido, Takaomi C.			Single App knock-in mouse models of Alzheimer's disease	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; BETA PEPTIDE; A-BETA; PROTEOLYTIC DEGRADATION; MICE; MUTATION; DEPOSITION; SECRETION; DEFICITS; PLAQUES	Experimental studies of Alzheimer's disease have largely depended on transgenic mice overexpressing amyloid precursor protein (APP). These mice, however, suffer from artificial phenotypes because, in addition to amyloid beta peptide (A beta), they overproduce other APP fragments. We generated knock-in mice that harbor Swedish and Beyreuther/Iberian mutations with and without the Arctic mutation in the APP gene. The mice showed typical A beta pathology, neuroinflammation and memory impairment in an age-dependent manner.	[Saito, Takashi; Matsuba, Yukio; Mihira, Naomi; Takano, Jiro; Nilsson, Per; Iwata, Nobuhisa; Saido, Takaomi C.] RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama, Japan; [Saito, Takashi] Japan Sci & Technol Agcy, Saitama, Japan; [Itohara, Shigeyoshi] RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama, Japan; [Iwata, Nobuhisa] Nagasaki Univ, Grad Sch Biomed Sci, Div Biotechnol, Dept Mol Med Sci, Nagasaki 852, Japan	RIKEN; Japan Science & Technology Agency (JST); RIKEN; Nagasaki University	Saido, TC (corresponding author), RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama, Japan.	saido@brain.riken.jp	Itohara, Shigeyoshi/I-8769-2012; Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015; Saito, Takashi/G-2563-2015	Itohara, Shigeyoshi/0000-0002-2410-9989; Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; Saito, Takashi/0000-0002-9659-9251	research grants from RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health and Welfare; grants-in-aid for the Molecular Imaging Program; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology; Cell Science Research Foundation; Takeda Science Foundation	research grants from RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); grants-in-aid for the Molecular Imaging Program; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology(Japan Science & Technology Agency (JST)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank C.A. Lemere (Brigham and Woman's Hospital) and M. Higuchi (National Institute of Radiological Science) for valuable discussions. We also thank E. Takano, R. Fujioka and Y. Tomita for technical assistance. This work was supported by research grants from RIKEN Brain Science Institute, the Ministry of Education, Culture, Sports, Science and Technology, the Ministry of Health and Welfare, grants-in-aid for the Molecular Imaging Program, Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology, the Cell Science Research Foundation and the Takeda Science Foundation.	Cash DM, 2013, NEUROLOGY, V81, P1425, DOI 10.1212/WNL.0b013e3182a841c6; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Enya M, 1999, AM J PATHOL, V154, P271, DOI 10.1016/S0002-9440(10)65273-X; Forman MS, 1997, J BIOL CHEM, V272, P32247, DOI 10.1074/jbc.272.51.32247; Guardia-Laguarta C, 2010, J NEUROPATH EXP NEUR, V69, P53, DOI 10.1097/NEN.0b013e3181c6b84d; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Hashimoto T, 2011, J BIOL CHEM, V286, P27081, DOI 10.1074/jbc.M111.257378; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kalimo H., 2013, COMMUN, V1, P60; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Nilsson P, 2013, CELL REP, V5, P61, DOI 10.1016/j.celrep.2013.08.042; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sarnyai Z, 2000, P NATL ACAD SCI USA, V97, P14731, DOI 10.1073/pnas.97.26.14731; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6	25	483	490	4	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2014	17	5					661	+		10.1038/nn.3697	http://dx.doi.org/10.1038/nn.3697			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF9DS	24728269				2022-12-17	WOS:000335016200007
J	Sporns, O				Sporns, Olaf			Contributions and challenges for network models in cognitive neuroscience	NATURE NEUROSCIENCE			English	Review							INTERHEMISPHERIC FUNCTIONAL CONNECTIVITY; RESTING-STATE; DEFAULT MODE; BRAIN NETWORKS; STRUCTURAL CONNECTIVITY; COMMUNITY STRUCTURE; HUMAN CONNECTOME; ARCHITECTURE; ORGANIZATION; INTEGRATION	The confluence of new approaches in recording patterns of brain connectivity and quantitative analytic tools from network science has opened new avenues toward understanding the organization and function of brain networks. Descriptive network models of brain structural and functional connectivity have made several important contributions; for example, in the mapping of putative network hubs and network communities. Building on the importance of anatomical and functional interactions, network models have provided insight into the basic structures and mechanisms that enable integrative neural processes. Network models have also been instrumental in understanding the role of structural brain networks in generating spatially and temporally organized brain activity. Despite these contributions, network models are subject to limitations in methodology and interpretation, and they face many challenges as brain connectivity data sets continue to increase in detail and complexity.	Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Sporns, O (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	osporns@indiana.edu	Sporns, Olaf/A-1667-2010	Sporns, Olaf/0000-0001-7265-4036	J.S. McDonnell Foundation	J.S. McDonnell Foundation	The author's work was supported by the J.S. McDonnell Foundation.	Adachi Y, 2012, CEREB CORTEX, V22, P1586, DOI 10.1093/cercor/bhr234; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Anderson ML, 2013, NEUROIMAGE, V73, P50, DOI 10.1016/j.neuroimage.2013.01.071; Bassett DS, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003171; Bassett DS, 2013, CHAOS, V23, DOI 10.1063/1.4790830; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Bellec P, 2010, NEUROIMAGE, V51, P1126, DOI 10.1016/j.neuroimage.2010.02.082; Betzel RF., 2013, NETW SCI, V1, P353, DOI 10.1017/nws.2013.19; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Braga RM, 2013, J NEUROSCI, V33, P14031, DOI 10.1523/JNEUROSCI.0570-13.2013; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Crofts JJ, 2011, NEUROIMAGE, V54, P161, DOI 10.1016/j.neuroimage.2010.08.032; Crossley NA, 2013, P NATL ACAD SCI USA, V110, P11583, DOI 10.1073/pnas.1220826110; de Haan W, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002582; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Doron KW, 2012, P NATL ACAD SCI USA, V109, P18661, DOI 10.1073/pnas.1216402109; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Fornito A, 2012, P NATL ACAD SCI USA, V109, P12788, DOI 10.1073/pnas.1204185109; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Harriger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046497; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hutchison RM, 2013, HUM BRAIN MAPP, V34, P2154, DOI 10.1002/hbm.22058; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kaiser M, 2009, CEREB CORTEX, V19, P3001, DOI 10.1093/cercor/bhp071; Kelly C, 2012, NEUROIMAGE, V61, P1129, DOI 10.1016/j.neuroimage.2012.03.021; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Li LC, 2013, NEUROIMAGE, V80, P462, DOI 10.1016/j.neuroimage.2013.04.024; Lohmann G, 2013, BRAIN CONNECT, V3, P223, DOI 10.1089/brain.2012.0133; Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270; Markova NT, 2013, P NATL ACAD SCI USA, V110, P5187, DOI 10.1073/pnas.1218972110; McIntosh AR, 2013, ANNU REV PSYCHOL, V64, P499, DOI 10.1146/annurev-psych-113011-143804; McIntosh AR, 1999, MEMORY, V7, P523, DOI 10.1080/096582199387733; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Nelson SM, 2010, NEURON, V67, P156, DOI 10.1016/j.neuron.2010.05.025; Nijhuis EHJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065511; O'Reilly JX, 2013, P NATL ACAD SCI USA, V110, P13982, DOI 10.1073/pnas.1305062110; Palva S, 2010, NEUROIMAGE, V49, P3257, DOI 10.1016/j.neuroimage.2009.11.031; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Pernice V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002059; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, NEUROIMAGE, V56, P2068, DOI 10.1016/j.neuroimage.2011.03.069; Schaub MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032210; Seghier ML, 2013, NEUROIMAGE, V68, P181, DOI 10.1016/j.neuroimage.2012.12.005; Sepulcre J, 2012, J NEUROSCI, V32, P10649, DOI 10.1523/JNEUROSCI.0759-12.2012; Shen K, 2012, J NEUROSCI, V32, P17465, DOI 10.1523/JNEUROSCI.2709-12.2012; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2011, NETWORKS BRAIN; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Tomasi D, 2014, CEREB CORTEX, V24, P2619, DOI 10.1093/cercor/bht119; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2013, J NEUROSCI, V33, P14489, DOI 10.1523/JNEUROSCI.2128-13.2013; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Vertes PE, 2012, P NATL ACAD SCI USA, V109, P5868, DOI 10.1073/pnas.1111738109; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wang QX, 2012, J NEUROSCI, V32, P4386, DOI 10.1523/JNEUROSCI.6063-11.2012; Wang Z, 2013, NEURON, V78, P1116, DOI 10.1016/j.neuron.2013.04.023; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zamora-Lopez Gorka, 2010, Front Neuroinform, V4, P1, DOI 10.3389/neuro.11.001.2010	100	482	493	10	200	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2014	17	5					652	660		10.1038/nn.3690	http://dx.doi.org/10.1038/nn.3690			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF9DS	24686784				2022-12-17	WOS:000335016200006
J	Jin, P; Zarnescu, DC; Ceman, S; Nakamoto, M; Mowrey, J; Jongens, TA; Nelson, DL; Moses, K; Warren, ST				Jin, P; Zarnescu, DC; Ceman, S; Nakamoto, M; Mowrey, J; Jongens, TA; Nelson, DL; Moses, K; Warren, ST			Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway	NATURE NEUROSCIENCE			English	Article							RNA INTERFERENCE; MESSENGER-RNA; DENDRITIC SPINES; KNOCKOUT MICE; MOUSE MODEL; TRANSLATION; HOMOLOG; IDENTIFICATION; ARGONAUTE1; DEFICITS	Fragile X syndrome is caused by a loss of expression of the fragile X mental retardation protein (FMRP). FMRP is a selective RNA-binding protein which forms a messenger ribonucleoprotein (mRNP) complex that associates with polyribosomes. Recently, mRNA ligands associated with FMRP have been identified. However, the mechanism by which FMRP regulates the translation of its mRNA ligands remains unclear. MicroRNAs are small noncoding RNAs involved in translational control. Here we show that in vivo mammalian FMRP interacts with microRNAs and the components of the microRNA pathways including Dicer and the mammalian ortholog of Argonaute 1 (AGO1). Using two different Drosophila melanogaster models, we show that AGO1 is critical for FMRP function in neural development and synaptogenesis. Our results suggest that FMRP may regulate neuronal translation via microRNAs and links microRNAs with human disease.	Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Emory University; Emory University; University of Pennsylvania; Baylor College of Medicine	Warren, ST (corresponding author), Emory Univ, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	swarren@emory.edu	Warren, Stephen T/A-2498-2012					Antar LN, 2003, NEURON, V37, P555, DOI 10.1016/S0896-6273(03)00090-4; BAKKER CE, 1994, CELL, V78, P23; Bardoni B, 2002, CURR OPIN GENET DEV, V12, P284, DOI 10.1016/S0959-437X(02)00300-3; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bontekoe CJM, 2002, HUM MOL GENET, V11, P487, DOI 10.1093/hmg/11.5.487; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Cerutti H, 2003, TRENDS GENET, V19, P39, DOI 10.1016/S0168-9525(02)00010-0; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Feng Y, 1997, J NEUROSCI, V17, P1539; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kataoka Y, 2001, GENES CELLS, V6, P313, DOI 10.1046/j.1365-2443.2001.00427.x; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Sung YJ, 2003, J BIOL CHEM, V278, P15669, DOI 10.1074/jbc.M211117200; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	39	479	521	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2004	7	2					113	117		10.1038/nn1174	http://dx.doi.org/10.1038/nn1174			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767TJ	14703574				2022-12-17	WOS:000188468500008
J	Levy, I; Hasson, U; Avidan, G; Hendler, T; Malach, R				Levy, I; Hasson, U; Avidan, G; Hendler, T; Malach, R			Center-periphery organization of human object areas	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; SUPERIOR TEMPORAL SULCUS; FUSIFORM FACE AREA; HUMAN OCCIPITAL LOBE; INFEROTEMPORAL CORTEX; MACAQUE; REPRESENTATION; RECOGNITION; PERCEPTION; SENSITIVITY	The organizing principles that govern the layout of human object-related areas are largely unknown. Here we propose a new organizing principle in which object representations are arranged according to a central versus peripheral visual field bias. The proposal is based on the finding that building-related regions overlap periphery-biased visual field representations, whereas face-related regions are associated with center-biased representations. Furthermore, the eccentricity maps encompass essentially the entire extent of object-related occipito-temporal cortex, indicating that most object representations are organized with respect to retinal eccentricity. A control experiment ruled out the possibility that the results are due exclusively to unequal feature distribution in these images. We hypothesize that brain regions representing object categories that rely on detailed central scrutiny (such as faces) are more strongly associated with processing of central information, compared to representations of objects that may be recognized by more peripheral information (such as buildings or scenes).	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Funct Brain Imaging Lab, IL-64239 Tel Aviv, Israel; Tel Aviv Univ, Fac Med, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University	Malach, R (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.		Avidan, Galia/B-9347-2011; hendler, talma/C-7677-2012	Avidan, Galia/0000-0003-2293-3859; Levy, Ifat/0000-0001-7851-9070; Hasson, Uri/0000-0002-3599-7168				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; BAIZER JS, 1991, J NEUROSCI, V11, P68; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Clark VP, 1996, NEUROIMAGE, V4, P1, DOI 10.1006/nimg.1996.0025; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DESIMONE R, 1980, BRAIN RES, V184, P41, DOI 10.1016/0006-8993(80)90586-7; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; GATTASS R, 1988, J NEUROSCI, V8, P1831; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Hikosaka K, 1998, BEHAV BRAIN RES, V96, P101, DOI 10.1016/S0166-4328(97)00202-7; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Puce A, 1996, J NEUROSCI, V16, P5205; ROSA MG, 1997, EXTRASTRIATE CORTEX, P127; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Yarbus A. L., 1967, EYE MOVEMENTS VISION, P171	41	479	484	0	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					533	539		10.1038/87490	http://dx.doi.org/10.1038/87490			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319563				2022-12-17	WOS:000168412600018
J	Barraclough, DJ; Conroy, ML; Lee, D				Barraclough, DJ; Conroy, ML; Lee, D			Prefrontal cortex and decision making in a mixed-strategy game	NATURE NEUROSCIENCE			English	Article							STRICTLY COMPETITIVE GAMES; SUPPLEMENTARY EYE FIELD; PEOPLE PLAY GAMES; MINIMAX HYPOTHESIS; ANTERIOR CINGULATE; REWARD EXPECTANCY; NEURONAL-ACTIVITY; SIGNALS; CHOICE; RANDOMIZATION	In a multi-agent environment, where the outcomes of one's actions change dynamically because they are related to the behavior of other beings, it becomes difficult to make an optimal decision about how to act. Although game theory provides normative solutions for decision making in groups, how such decision-making strategies are altered by experience is poorly understood. These adaptive processes might resemble reinforcement learning algorithms, which provide a general framework for finding optimal strategies in a dynamic environment. Here we investigated the role of prefrontal cortex (PFC) in dynamic decision making in monkeys. As in reinforcement learning, the animal's choice during a competitive game was biased by its choice and reward history, as well as by the strategies of its opponent. Furthermore, neurons in the dorsolateral prefrontal cortex (DLPFC) encoded the animal's past decisions and payoffs, as well as the conjunction between the two, providing signals necessary to update the estimates of expected reward. Thus, PFC might have a key role in optimizing decision-making strategies.	Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Lee, D (corresponding author), Univ Rochester, Ctr Visual Sci, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	dlee@cvs.rochester.edu	Lee, Daeyeol/A-6794-2008	Lee, Daeyeol/0000-0003-3474-019X	NATIONAL EYE INSTITUTE [P30EY001319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044270] Funding Source: NIH RePORTER; NEI NIH HHS [EY01319] Funding Source: Medline; NINDS NIH HHS [NS44270] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; [Anonymous], 1997, MACHIAVELLIAN INTELL; Binmore K, 2001, ECON J, V111, P445, DOI 10.1111/1468-0297.00645; BROWN JN, 1990, ECONOMETRICA, V58, P1065, DOI 10.2307/2938300; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BUDESCU DV, 1994, J BEHAV DECIS MAKING, V7, P261, DOI 10.1002/bdm.3960070404; Burnham KP, 2002, MODEL SELECTION MULT; Byrne RW., 1988, MACHIAVELLIAN INTELL; Camerer C.F., 2003, BEHAV GAME THEORY; Chen HC, 1997, GAME ECON BEHAV, V18, P32, DOI 10.1006/game.1997.0514; Christensen R, 1997, LOG LINEAR MODELS LO; Dixit A., 1999, GAMES STRATEGY; Erev I, 1998, AM ECON REV, V88, P848; Fudenberg D., 1991, GAME THEORY; Fudenberg D., 1998, THEORY LEARNING GAME; Glimcher PW, 2003, BRADFORD BOOKS, P1; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Kahneman D., 1982, JUDGEMENT UNCERTAINT; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; LITTMAN ML, 1994, MACH LEARN, P157; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; MOOKHERJEE D, 1994, GAME ECON BEHAV, V7, P62, DOI 10.1006/game.1994.1037; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; OCHS J, 1995, GAME ECON BEHAV, V10, P202, DOI 10.1006/game.1995.1030; ONEILL B, 1987, P NATL ACAD SCI USA, V84, P2106, DOI 10.1073/pnas.84.7.2106; ONEILL B, 1991, ECONOMETRICA, V59, P503, DOI 10.2307/2938267; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; RAPOPORT A, 1992, GAME ECON BEHAV, V4, P261, DOI 10.1016/0899-8256(92)90019-O; Rapoport A, 1997, PSYCHOL REV, V104, P603, DOI 10.1037/0033-295X.104.3.603; RAPOPORT A, 1992, J EXP PSYCHOL GEN, V121, P352, DOI 10.1037/0096-3445.121.3.352; ROBINSON J, 1951, ANN MATH, V54, P296, DOI 10.2307/1969530; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; ROLLS ET, 1999, BRAIN EMOTION; Rubinstein A., 1998, MODELING BOUNDED RAT; Sarin R, 2001, GAME ECON BEHAV, V34, P104, DOI 10.1006/game.1999.0783; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shachat JM, 2002, J ECON THEORY, V104, P189, DOI 10.1006/jeth.2001.2915; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Simon H. A., 1957, MODELS MAN; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; TOUHEY JC, 1974, HUM RELAT, V27, P813, DOI 10.1177/001872677402700807; Tsujimoto S, 2004, CEREB CORTEX, V14, P47, DOI 10.1093/cercor/bhg090; Von Neuman J, 1944, THEORY GAMES EC BEHA; Walker M, 2001, AM ECON REV, V91, P1521, DOI 10.1257/aer.91.5.1521; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0	50	478	486	2	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2004	7	4					404	410		10.1038/nn1209	http://dx.doi.org/10.1038/nn1209			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	807DP	15004564				2022-12-17	WOS:000220482500020
J	Land, MF; McLeod, P				Land, MF; McLeod, P			From eye movements to actions: how batsmen hit the ball	NATURE NEUROSCIENCE			English	Article							GAMES; TIME	In cricket, a batsman watches a fast bowler's ball come toward him at a high and unpredictable speed, bouncing off ground of uncertain hardness. Although he views the trajectory for little more than half a second, he can accurately judge where and when the bail will reach him. Batsmen's eye movements monitor the moment when the ball is released, make a predictive saccade to the place where they expect it to hit the ground, wait for it to bounce, and follow its trajectory for 100-200 ms after the bounce. We show how information provided by these fixations may allow precise prediction of the ball's timing and placement. Comparing players with different skill levels, we found that a short latency for the first saccade distinguished good from poor batsmen, and that a cricket player's eye movement strategy contributes to his skill in the game.	Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Sussex; University of Oxford	Land, MF (corresponding author), Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England.							ADAIR R, 1990, PHYSICS BASEBALL; BAHILL AT, 1984, AM SCI, V72, P249; BOOTSMA RJ, 1990, J EXP PSYCHOL HUMAN, V16, P21, DOI 10.1037/0096-1523.16.1.21; Furneaux S, 1999, P ROY SOC B-BIOL SCI, V266, P2435, DOI 10.1098/rspb.1999.0943; HALLETT PE, 1991, LIMITS VISION VISION, V5, P44; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; LAND MF, 1983, IEEE P SMC C TOUQ, V3, P490; LEE DN, 1983, Q J EXP PSYCHOL-A, V35, P333, DOI 10.1080/14640748308402138; LEWES T, 1994, MCC MASTERCLASS NEW; MCLEOD P, 1987, PERCEPTION, V16, P49, DOI 10.1068/p160049; MCLEOD P, 1991, INT J SPORT PSYCHOL, V22, P279; Regan D, 2000, TRENDS COGN SCI, V4, P99, DOI 10.1016/S1364-6613(99)01442-4; REGAN D, 1992, PERCEPTION, V21, P91, DOI 10.1068/p210091; Ripoll H., 1987, EYE MOVEMENTS PHYSL, P616	15	476	482	0	64	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2000	3	12					1340	1345		10.1038/81887	http://dx.doi.org/10.1038/81887			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405UA	11100157	Bronze			2022-12-17	WOS:000167177900022
J	Courtine, G; Gerasimenko, Y; van den Brand, R; Yew, A; Musienko, P; Zhong, H; Song, BB; Ao, Y; Ichiyama, RM; Lavrov, I; Roy, RR; Sofroniew, MV; Edgerton, VR				Courtine, Gregoire; Gerasimenko, Yury; van den Brand, Rubia; Yew, Aileen; Musienko, Pavel; Zhong, Hui; Song, Bingbing; Ao, Yan; Ichiyama, Ronaldo M.; Lavrov, Igor; Roy, Roland R.; Sofroniew, Michael V.; Edgerton, V. Reggie			Transformation of nonfunctional spinal circuits into functional states after the loss of brain input	NATURE NEUROSCIENCE			English	Article							HINDLIMB-STEPPING ABILITY; CENTRAL PATTERN GENERATOR; CORD STIMULATION; INTRASPINAL MICROSTIMULATION; EPIDURAL STIMULATION; ADULT RATS; LOCOMOTION; INJURY; CATS; RECOVERY	After complete spinal cord transections that removed all supraspinal inputs in adult rats, combinations of serotonergic agonists and epidural electrical stimulation were able to acutely transform spinal networks from nonfunctional to highly functional and adaptive states as early as 1 week after injury. Using kinematics, physiological and anatomical analyses, we found that these interventions could recruit specific populations of spinal circuits, refine their control via sensory input and functionally remodel these locomotor pathways when combined with training. The emergence of these new functional states enabled full weight-bearing treadmill locomotion in paralyzed rats that was almost indistinguishable from voluntary stepping. We propose that, in the absence of supraspinal input, spinal locomotion can emerge from a combination of central pattern-generating capability and the ability of these spinal circuits to use sensory afferent input to control stepping. These findings provide a strategy by which individuals with spinal cord injuries could regain substantial levels of motor control.	[Courtine, Gregoire; van den Brand, Rubia; Musienko, Pavel] Univ Zurich, Dept Neurol, Zurich, Switzerland; [Courtine, Gregoire; van den Brand, Rubia; Musienko, Pavel] Ctr Zurich, Rehabil Inst & Technol, Zurich, Switzerland; [Gerasimenko, Yury; Zhong, Hui; Ichiyama, Ronaldo M.; Lavrov, Igor; Roy, Roland R.; Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA USA; [Gerasimenko, Yury; Musienko, Pavel] IP Pavlov Physiol Inst, Motor Physiol Lab, St Petersburg 199034, Russia; [Yew, Aileen; Sofroniew, Michael V.; Edgerton, V. Reggie] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Song, Bingbing; Ao, Yan; Roy, Roland R.; Sofroniew, Michael V.; Edgerton, V. Reggie] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of Zurich; University of California System; University of California Los Angeles; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Courtine, G (corresponding author), Univ Zurich, Dept Neurol, Zurich, Switzerland.	gregoire.courtine@bli.uzh.ch	Gerasimenko, Yury/A-3655-2017; Sofroniew, Michael/ABE-8857-2020; Lavrov, Igor/E-4334-2016; courtine, gregoire/AAJ-1694-2020; Ichiyama, Ronaldo/B-7856-2009; Musienko, Pavel/L-6677-2015	Lavrov, Igor/0000-0002-3885-4509; courtine, gregoire/0000-0002-5744-4142; Musienko, Pavel/0000-0002-7324-9021; Ichiyama, Ronaldo/0000-0002-7640-8032	Craig H. Nielsen Foundation [20062668]; International Paraplegic Foundation [P106]; Swiss National Science Foundation; Christopher and Dana Reeve Foundation [VEC2007]; US National Institute of Neurological Disorders and Stroke [NS16333]; US Civilian Research and Development Foundation [RUB1287207]; Roman Reed Spinal Cord Injury Research Fund of California; Russian Foundation for Basic Research [07-04-00526, 08-04-00688]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016333] Funding Source: NIH RePORTER	Craig H. Nielsen Foundation; International Paraplegic Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Christopher and Dana Reeve Foundation; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US Civilian Research and Development Foundation; Roman Reed Spinal Cord Injury Research Fund of California; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to acknowledge the excellent technical help provided by S. Zdunowski, L. Friedli, J. Heutschi and O. M rzendorfer for data collection and analysis, as well as M. Herrera for his expert assistance and guidance involving the care and handling of the animals. This work was supported by the Craig H. Nielsen Foundation (#20062668), the International Paraplegic Foundation (P106), the National Center of Competence in Research 'Neural Plasticity and Repair' of the Swiss National Science Foundation, the Christopher and Dana Reeve Foundation (VEC2007), the US National Institute of Neurological Disorders and Stroke (NS16333), the US Civilian Research and Development Foundation (RUB1287207), the Roman Reed Spinal Cord Injury Research Fund of California and the Russian Foundation for Basic Research (07-04-00526 and 08-04-00688).	Antri M, 2003, EUR J NEUROSCI, V18, P1963, DOI 10.1046/j.1460-9568.2003.02916.x; Barriere G, 2008, J NEUROSCI, V28, P3976, DOI 10.1523/JNEUROSCI.5692-07.2008; Barthelemy D, 2007, J NEUROPHYSIOL, V97, P1986, DOI 10.1152/jn.00818.2006; Barthelemy D, 2006, J NEUROPHYSIOL, V96, P3273, DOI 10.1152/jn.00203.2006; Beres-Jones JA, 2004, BRAIN, V127, P2232, DOI 10.1093/brain/awh252; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3640, DOI 10.1152/jn.00497.2003; Carhart MR, 2004, IEEE T NEUR SYS REH, V12, P32, DOI 10.1109/TNSRE.2003.822763; Chau C, 1998, J NEUROPHYSIOL, V79, P392, DOI 10.1152/jn.1998.79.1.392; Cote MP, 2004, J NEUROSCI, V24, P11317, DOI 10.1523/JNEUROSCI.1486-04.2004; Courtine G, 2005, BRAIN, V128, P2338, DOI 10.1093/brain/awh604; Courtine G, 2004, J NEUROPHYSIOL, V91, P1524, DOI 10.1152/jn.00817.2003; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; de Leon RD, 1999, J NEUROPHYSIOL, V81, P85, DOI 10.1152/jn.1999.81.1.85; Dietz V, 2004, BRAIN, V127, P2221, DOI 10.1093/brain/awh255; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; Engesser-Cesar C, 2007, EUR J NEUROSCI, V25, P1931, DOI 10.1111/j.1460-9568.2007.05469.x; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; Gaunt RA, 2006, J NEUROPHYSIOL, V96, P2995, DOI 10.1152/jn.00061.2006; Gerasimenko YP, 2007, J NEUROPHYSIOL, V98, P2525, DOI 10.1152/jn.00836.2007; Gerasimenko YP, 2006, J NEUROSCI METH, V157, P253, DOI 10.1016/j.jneumeth.2006.05.004; GISZTER SF, 1993, J NEUROSCI, V13, P467; Grillner S, 2002, BRAIN RES REV, V40, P92, DOI 10.1016/S0165-0173(02)00193-5; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Guevremont L, 2006, IEEE T NEUR SYS REH, V14, P266, DOI 10.1109/TNSRE.2006.881592; Gurfinkel VS, 1998, EUR J NEUROSCI, V10, P1608, DOI 10.1046/j.1460-9568.1998.00179.x; Harkema SJ, 1997, J NEUROPHYSIOL, V77, P797, DOI 10.1152/jn.1997.77.2.797; Harkema SJ, 2008, BRAIN RES REV, V57, P255, DOI 10.1016/j.brainresrev.2007.07.012; Hochman S, 2001, METH NE FRO NEUROSCI, P47; Ichiyama RM, 2005, NEUROSCI LETT, V383, P339, DOI 10.1016/j.neulet.2005.04.049; Ichiyama RM, 2008, J NEUROSCI, V28, P7370, DOI 10.1523/JNEUROSCI.1881-08.2008; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; IWAHARA T, 1992, BRAIN RES BULL, V28, P99, DOI 10.1016/0361-9230(92)90235-P; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kubasak MD, 2008, BRAIN, V131, P264, DOI 10.1093/brain/awm267; Landry ES, 2006, EUR J NEUROSCI, V24, P535, DOI 10.1111/j.1460-9568.2006.04917.x; Lavrov I, 2008, J NEUROSCI, V28, P6022, DOI 10.1523/JNEUROSCI.0080-08.2008; Lavrov I, 2008, J NEUROSCI, V28, P7774, DOI 10.1523/JNEUROSCI.1069-08.2008; Lavrov I, 2006, J NEUROPHYSIOL, V96, P1699, DOI 10.1152/jn.00325.2006; Lemay MA, 2004, J NEUROPHYSIOL, V91, P502, DOI 10.1152/jn.00235.2003; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; Maier IC, 2009, BRAIN, V132, P1426, DOI 10.1093/brain/awp085; Petruska JC, 2007, J NEUROSCI, V27, P4460, DOI 10.1523/JNEUROSCI.2302-06.2007; Rattay F, 2000, SPINAL CORD, V38, P473, DOI 10.1038/sj.sc.3101039; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Rudomin P, 2002, PROG BRAIN RES, V136, P409; Tillakaratne NJK, 2002, J NEUROSCI, V22, P3130, DOI 10.1523/JNEUROSCI.22-08-03130.2002; Tresch MC, 1999, EXP BRAIN RES, V129, P401, DOI 10.1007/s002210050908	50	475	505	4	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2009	12	10					1333	U167		10.1038/nn.2401	http://dx.doi.org/10.1038/nn.2401			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498US	19767747	Green Accepted			2022-12-17	WOS:000270170200023
J	Dombeck, DA; Harvey, CD; Tian, L; Looger, LL; Tank, DW				Dombeck, Daniel A.; Harvey, Christopher D.; Tian, Lin; Looger, Loren L.; Tank, David W.			Functional imaging of hippocampal place cells at cellular resolution during virtual navigation	NATURE NEUROSCIENCE			English	Article							FREELY MOVING ANIMALS; IN-VIVO; NEURAL ACTIVITY; PYRAMIDAL CELLS; UNIT-ACTIVITY; NEURONS; MEMORY; RATS; CA1; INTERNEURONS	Spatial navigation is often used as a behavioral task in studies of the neuronal circuits that underlie cognition, learning and memory in rodents. The combination of in vivo microscopy with genetically encoded indicators has provided an important new tool for studying neuronal circuits, but has been technically difficult to apply during navigation. Here we describe methods for imaging the activity of neurons in the CA1 region of the hippocampus with subcellular resolution in behaving mice. Neurons that expressed the genetically encoded calcium indicator GCaMP3 were imaged through a chronic hippocampal window. Head-restrained mice performed spatial behaviors in a setup combining a virtual reality system and a custom-built two-photon microscope. We optically identified populations of place cells and determined the correlation between the location of their place fields in the virtual environment and their anatomical location in the local circuit. The combination of virtual reality and high-resolution functional imaging should allow a new generation of studies to investigate neuronal circuit dynamics during behavior.	[Dombeck, Daniel A.; Harvey, Christopher D.; Tank, David W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Dombeck, Daniel A.; Harvey, Christopher D.; Tank, David W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Tian, Lin; Looger, Loren L.] Howard Hughes Med Inst, Ashburn, VA USA	Princeton University; Princeton University; Howard Hughes Medical Institute	Tank, DW (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ddombeck@princeton.edu; dwtank@princeton.edu		Dombeck, Daniel/0000-0003-2576-5918; Tian, Lin/0000-0001-7012-6926	Princeton University; National Institutes of Health [5R01MH083686-03]; Howard Hughes Medical Institute; Helen Hay Whitney Foundation; Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083686] Funding Source: NIH RePORTER	Princeton University(Princeton University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen Hay Whitney Foundation; Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Princeton University, the National Institutes of Health (grant 5R01MH083686-03), The Howard Hughes Medical Institute, The Helen Hay Whitney Foundation and The Patterson Trust. We thank F. Collman for the brain motion correction algorithm.	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; Ego-Stengel V, 2007, HIPPOCAMPUS, V17, P161, DOI 10.1002/hipo.20253; EICHENBAUM H, 1989, J NEUROSCI, V9, P2764; Ergorul C, 2004, LEARN MEMORY, V11, P397, DOI 10.1101/lm.73304; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Griffin AL, 2007, J NEUROSCI, V27, P2416, DOI 10.1523/JNEUROSCI.4083-06.2007; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P225, DOI 10.1152/jn.1961.24.3.225; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mizrahi A, 2004, J NEUROSCI, V24, P3147, DOI 10.1523/JNEUROSCI.5218-03.2004; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nakamura NH, 2010, NEUROSCIENCE, V166, P994, DOI 10.1016/j.neuroscience.2009.12.069; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; O'Keefe J, 2007, HIPPOCAMPUS BOOK, P475, DOI DOI 10.1093/ACPROF:OSO/9780195100273.003.0011; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; Reidl J, 2007, NEUROIMAGE, V34, P94, DOI 10.1016/j.neuroimage.2006.08.031; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; SCHNEE A, 2008, RATS VIRTUAL REALITY; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Takahashi S, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.009.2009; THIEL G, 1991, P NATL ACAD SCI USA, V88, P3431, DOI 10.1073/pnas.88.8.3431; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wilent WB, 2007, J NEUROPHYSIOL, V97, P4152, DOI 10.1152/jn.01200.2006; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	50	474	482	4	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2010	13	11					1433	U180		10.1038/nn.2648	http://dx.doi.org/10.1038/nn.2648			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	673KI	20890294	Green Accepted			2022-12-17	WOS:000283658200026
J	Hu, XY; Hicks, CW; He, WX; Wong, P; Macklin, WB; Trapp, BD; Yan, RQ				Hu, Xiangyou; Hicks, Caitlin W.; He, Wanxia; Wong, Philip; Macklin, Wendy B.; Trapp, Bruce D.; Yan, Riqiang			Bace1 modulates myelination in the central and peripheral nervous system	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS BETA-SECRETASE; ASPARTYL PROTEASE; CLEAVING ENZYME; CELL-ADHESION; A-BETA; CLEAVAGE; DISEASE; NEUREGULIN-1; BRAIN	Bace1 is an endopeptidase that cleaves the amyloid precursor protein at the beta-secretase site. Apart from this cleavage, the functional importance of Bace1 in other physiological events is unknown. We show here that Bace1 regulates the process of myelination and myelin sheath thickness in the central and peripheral nerves. In Bace1-null mice, the process of myelination was delayed and myelin thickness was markedly reduced, indicating that genetic deletion of Bace1 causes hypomyelination. Bace1-null mice also showed altered neurological behaviors such as elevated pain sensitivity and reduced grip strength. Further mechanistic studies showed an altered neuregulin-Akt signaling pathway in Bace1-null mice. Full-length neuregulin-1 was increased and its cleavage product was decreased in the CNS of Bace1-null mice. Furthermore, phosphorylated Akt was also reduced. Based upon these and previous studies, we postulate that neuronally enriched Bace1 cleaves neuregulin-1 and that processed neuregulin-1 regulates myelination by means of phosphorylation of Akt in myelin-forming cells.	Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA	Cleveland Clinic Foundation; Johns Hopkins University	Yan, RQ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.	yanr@ccf.org		Yan, Riqiang/0000-0001-7195-7617; Hicks, Caitlin/0000-0001-7638-1936				Bao JX, 2003, J CELL BIOL, V161, P1133, DOI 10.1083/jcb.200212085; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Calaora V, 2001, J NEUROSCI, V21, P4740, DOI 10.1523/JNEUROSCI.21-13-04740.2001; Carteron C, 2006, J CELL SCI, V119, P898, DOI 10.1242/jcs.02799; Cellerino A, 1997, MOL CELL NEUROSCI, V9, P397, DOI 10.1006/mcne.1997.0641; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lemke Greg, 2006, Sci STKE, V2006, ppe11, DOI 10.1126/stke.3252006pe11; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Sussman CR, 2005, J NEUROSCI, V25, P5757, DOI 10.1523/JNEUROSCI.4748-04.2005; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; von Arnim CAF, 2005, J BIOL CHEM, V280, P17777, DOI 10.1074/jbc.M414248200; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Woolf CJ, 2003, NEURON, V38, P153, DOI 10.1016/S0896-6273(03)00233-2; Wrabetz L, 2000, J CELL BIOL, V148, P1021, DOI 10.1083/jcb.148.5.1021; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yin XH, 2006, J CELL BIOL, V172, P469, DOI 10.1083/jcb.200509174	39	474	491	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2006	9	12					1520	1525		10.1038/nn1797	http://dx.doi.org/10.1038/nn1797			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110TP	17099708				2022-12-17	WOS:000242404000016
J	Gutig, R; Sompolinsky, H				Gutig, R; Sompolinsky, H			The tempotron: a neuron that learns spike timing-based decisions	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; RETINAL GANGLION-CELLS; LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; SYNAPTIC PLASTICITY; DEPENDENT PLASTICITY; TEMPORAL INFORMATION; DEPRESSION; NETWORKS; MEMORY	The timing of action potentials in sensory neurons contains substantial information about the eliciting stimuli. Although the computational advantages of spike timing-based neuronal codes have long been recognized, it is unclear whether, and if so how, neurons can learn to read out such representations. We propose a new, biologically plausible supervised synaptic learning rule that enables neurons to efficiently learn a broad range of decision rules, even when information is embedded in the spatiotemporal structure of spike patterns rather than in mean firing rates. The number of categorizations of random spatiotemporal patterns that a neuron can implement is several times larger than the number of its synapses. The underlying nonlinear temporal computation allows neurons to access information beyond single-neuron statistics and to discriminate between inputs on the basis of multineuronal spike statistics. Our work demonstrates the high capacity of neural systems to learn to decode information embedded in distributed patterns of spike synchrony.	Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; Charite Med Fac Berlin, Neurosci Res Ctr, D-10117 Berlin, Germany; Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University	Gutig, R (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	guetig@cc.huji.ac.il; haim@fiz.huji.ac.il	Sompolinsky, Haim/ABB-8398-2021					ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BRESSLOFF PC, 1992, J PHYS A-MATH GEN, V25, P4373, DOI 10.1088/0305-4470/25/16/014; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/S0896-6273(04)00528-8; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Castelo-Branco M, 2000, NATURE, V405, P685, DOI 10.1038/35015079; Centonze D, 2003, REV NEUROSCIENCE, V14, P207; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Foehring RC, 1999, CAN J EXP PSYCHOL, V53, P45, DOI 10.1037/h0087299; GARDNER E, 1988, J PHYS A-MATH GEN, V21, P257, DOI 10.1088/0305-4470/21/1/030; Gutig R, 2003, J NEUROSCI, V23, P3697; Guyonneau R, 2005, NEURAL COMPUT, V17, P859, DOI 10.1162/0899766053429390; Hertz J., 1991, INTRO THEORY NEURAL, DOI DOI 10.1201/9780429499661; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Kuhn A, 2003, NEURAL COMPUT, V15, P67, DOI 10.1162/089976603321043702; Legenstein R, 2005, NEURAL COMPUT, V17, P2337, DOI 10.1162/0899766054796888; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Minsky M., 1969, PERCEPTRONS; Neuenschwander S, 1996, NATURE, V379, P728, DOI 10.1038/379728a0; Ngezahayo A, 2000, J NEUROSCI, V20, P2451; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Perkel D.H., 1968, NEUROSCI RES PROGRAM, V6, P221; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Singer W, 1999, CURR OPIN NEUROBIOL, V9, P189, DOI 10.1016/S0959-4388(99)80026-9; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/s0896-6273(01)00542-6; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wespatat V, 2004, J NEUROSCI, V24, P9067, DOI 10.1523/JNEUROSCI.2221-04.2004; Worgotter F, 2005, NEURAL COMPUT, V17, P245, DOI 10.1162/0899766053011555; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	50	474	484	1	85	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					420	428		10.1038/nn1643	http://dx.doi.org/10.1038/nn1643			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474393				2022-12-17	WOS:000235645600022
J	Rees, G; Friston, KJ; Koch, C				Rees, G; Friston, KJ; Koch, C			A direct quantitative relationship between the functional properties of human and macaque V5	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; ANTERIOR CINGULATE CORTEX; AREA MT; HUMAN BRAIN; MOTION; MONKEY; NEURONS; PERCEPTION; ORGANIZATION; ORIENTATION	The nature of the quantitative relationship between single-neuron recordings in monkeys and functional magnetic resonance imaging (fMRI) measurements in humans is crucial to understanding how experiments in these different species are related, yet it remains undetermined. We measured brain activity in humans attending to moving visual stimuli, using blood oxygenation level-dependent (BOLD) fMRI. Responses in Vs showed a strong and highly linear dependence on increasing strength of motion signal (coherence). These population responses in human Vs had a remarkably simple mathematical relationship to previously observed single-cell responses in macaque Vs. We provided an explicit quantitative estimate for the interspecies comparison of single-neuron activity and BOLD population responses. Our data show previously unknown dissociations between the functional properties of human Vs and other human motion-sensitive areas, thus predicting similar dissociations for the properties of single neurons in homologous areas of macaque cortex.	CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA; UCL, Neurol Inst, Wellcome Dept Cognit Neurol, London WC1N 3BG, England	California Institute of Technology; University of London; University College London	Rees, G (corresponding author), CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA.	geraint@klab.caltech.edu	Rees, Geraint/C-1493-2008; Friston, Karl/D-9230-2011	Rees, Geraint/0000-0002-9623-7007; Friston, Karl/0000-0001-7984-8909; Koch, Christof/0000-0001-6482-8067				ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; ALLMAN JM, 1974, BRAIN RES, V81, P199, DOI 10.1016/0006-8993(74)90936-6; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Britten KH, 1998, J NEUROPHYSIOL, V80, P762, DOI 10.1152/jn.1998.80.2.762; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Buchel C, 1996, NEUROIMAGE, V4, P60, DOI 10.1006/nimg.1996.0029; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Draper N. R., 2014, APPL REGRESSION ANAL; Dupont P, 1997, CEREB CORTEX, V7, P283, DOI 10.1093/cercor/7.3.283; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; MALONEK D, 1994, P ROY SOC B-BIOL SCI, V258, P109, DOI 10.1098/rspb.1994.0150; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; RAYMOND JE, 1994, VISION RES, V34, P1029, DOI 10.1016/0042-6989(94)90007-8; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Scannell JW, 1999, P ROY SOC B-BIOL SCI, V266, P875, DOI 10.1098/rspb.1999.0718; Scase MO, 1996, VISION RES, V36, P2579, DOI 10.1016/0042-6989(95)00325-8; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Talairach J., 1988, COPLANAR STEREOTAXIC; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Turner R, 1998, EXP BRAIN RES, V123, P5, DOI 10.1007/s002210050538; VanOostende S, 1997, CEREB CORTEX, V7, P690, DOI 10.1093/cercor/7.7.690; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1980, PROC R SOC SER B-BIO, V207, P239, DOI 10.1098/rspb.1980.0022; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	40	474	484	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2000	3	7					716	723		10.1038/76673	http://dx.doi.org/10.1038/76673			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TT	10862705				2022-12-17	WOS:000167177200019
J	Ueno, M; Fujita, Y; Tanaka, T; Nakamura, Y; Kikuta, J; Ishii, M; Yamashita, T				Ueno, Masaki; Fujita, Yuki; Tanaka, Tatsuhide; Nakamura, Yuka; Kikuta, Junichi; Ishii, Masaru; Yamashita, Toshihide			Layer V cortical neurons require microglial support for survival during postnatal development	NATURE NEUROSCIENCE			English	Article							PROJECTION NEURONS; CELL-DEATH; MACROPHAGES; ACTIVATION; GROWTH; RECEPTOR; CALLOSAL; PROLIFERATION; DEGENERATION; EXPRESSION	Neurons require trophic support during neural circuit formation; however, how the cellular milieu contributes to neuronal survival remains unclear. We found that layer V cortical neurons require support from microglia for survival during postnatal development. Specifically, we found that microglia accumulated close to the subcerebral and callosal projection axons in the postnatal brain. Inactivation of microglia by minocycline treatment or transient ablation of microglia in CD11b-DTR transgenic mice led to increased apoptosis, specifically in layer V subcerebral and callosal projection neurons. CX3CR1 in microglia was required for the survival of layer V neurons. Microglia consistently promoted the survival of cortical neurons in vitro. In addition, we identified microglia-derived IGF1 as a trophic factor that maintained neuronal survival. Our results highlight a neuron-glia interaction that is indispensable for network formation during a specific period in the developing brain.	[Ueno, Masaki; Fujita, Yuki; Tanaka, Tatsuhide; Nakamura, Yuka; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan; [Ueno, Masaki; Fujita, Yuki; Nakamura, Yuka; Yamashita, Toshihide] Japan Sci & Technol Agcy JST, CREST, Tokyo, Japan; [Tanaka, Tatsuhide] Asahikawa Med Univ, Dept Funct Anat & Neurosci, Sapporo, Hokkaido, Japan; [Kikuta, Junichi; Ishii, Masaru] Osaka Univ, Immunol Frontier Res Ctr, Lab Cellular Dynam, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST); Osaka University	Ueno, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Osaka, Japan.	ms-ueno@umin.ac.jp; yamashita@molneu.med.osaka-u.ac.jp	Ueno, Masaki/J-1216-2019	Ueno, Masaki/0000-0003-1484-9921; Tanaka, Tatsuhide/0000-0002-3373-9093; Yamashita, Toshihide/0000-0003-4559-7018	Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science	Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank H. Ozawa for experimental technical support, M.K. Yamada (University of Tokyo), P. Osten (Cold Spring Harbor Laboratory) and H. Miyoshi (RIKEN) for their kind gift of the lentivirus plasmid and helpful suggestions, and Y. Yoshida (Cincinnati Children's Hospital Medical Center) for critical comments on the manuscript. This work was supported by a grant for Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST) to T.Y. and a Grant-in-Aid for Young Scientists (B) from Japan Society for the Promotion of Science to M.U.	Akazawa H, 2004, J BIOL CHEM, V279, P41095, DOI 10.1074/jbc.M313084200; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Antony JM, 2011, J NEUROSCI RES, V89, P286, DOI 10.1002/jnr.22533; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Canty AJ, 2008, PROG NEUROBIOL, V85, P214, DOI 10.1016/j.pneurobio.2008.02.001; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Catapano LA, 2001, J NEUROSCI, V21, P8863, DOI 10.1523/JNEUROSCI.21-22-08863.2001; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chesik D, 2004, NEUROREPORT, V15, P1033, DOI 10.1097/00001756-200404290-00020; Del Rio P, 2011, GLIA, V59, P821, DOI 10.1002/glia.21155; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hristova M, 2010, GLIA, V58, P11, DOI 10.1002/glia.20896; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kitayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025234; KOESTER SE, 1993, DEV BIOL, V160, P1, DOI 10.1006/dbio.1993.1281; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Ling E A, 2001, Prog Brain Res, V132, P61; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; MILLIGAN CE, 1991, J COMP NEUROL, V314, P125, DOI 10.1002/cne.903140112; Murase S, 1998, J NEUROSCI, V18, P10481; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Oppenheim R. W., 2003, PROGRAMMED CELL DEAT; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Ransohoff RM, 2009, IMMUNITY, V31, P711, DOI 10.1016/j.immuni.2009.09.010; Streit WJ, 2001, NEUROTOXICOLOGY, V22, P619, DOI 10.1016/S0161-813X(01)00033-X; Tanaka T, 2009, J BIOL CHEM, V284, P21626, DOI 10.1074/jbc.M109.005603; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; Ueno Masaki, 2008, Biologics, V2, P253; VALVERDE F, 1995, J NEUROSCI, V15, P5014; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	51	473	483	6	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2013	16	5					543	+		10.1038/nn.3358	http://dx.doi.org/10.1038/nn.3358			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	131WT	23525041				2022-12-17	WOS:000318029300010
J	Kawagoe, R; Takikawa, Y; Hikosaka, O				Kawagoe, R; Takikawa, Y; Hikosaka, O			Expectation of reward modulates cognitive signals in the basal ganglia	NATURE NEUROSCIENCE			English	Article							SELECTIVE VISUAL-ATTENTION; LOCAL DOPAMINE DEPLETION; SACCADIC EYE-MOVEMENTS; MONKEY CAUDATE NEURONS; NIGRA PARS RETICULATA; DELAYED-RESPONSE TASK; FUNCTIONAL-PROPERTIES; OCULOMOTOR FUNCTIONS; PREFRONTAL CORTEX; STRIATUM	Action is controlled by both motivation and cognition. The basal ganglia may be the site where these kinds of information meet. Using a memory-guided saccade task with an asymmetric reward schedule, we show that visual and memory responses of caudate neurons are modulated by expectation of reward so profoundly that a neuron's preferred direction often changed with the change in the rewarded direction. The subsequent saccade to the target was earlier and faster for the rewarded direction. Our results indicate that the caudate contributes to the determination of oculomotor outputs by connecting motivational values (for example, expectation of reward) to visual information.	Juntendo Univ, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1138421, Japan	Juntendo University	Hikosaka, O (corresponding author), Juntendo Univ, Sch Med, Dept Physiol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hikosaka@med.juntendo.ac.jp						ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; AOSAKI T, 1994, J NEUROSCI, V14, P3969; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Calabresi P, 1997, NEUROSCIENCE, V78, P39; CAPLAN LR, 1990, ARCH NEUROL-CHICAGO, V47, P133, DOI 10.1001/archneur.1990.00530020029011; CHEVALIER G, 1990, TRENDS NEUROSCI, V13, P277, DOI 10.1016/0166-2236(90)90109-N; CRAWFORD TJ, 1989, BRAIN, V112, P1573, DOI 10.1093/brain/112.6.1573; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; GROVES PM, 1994, NEUROSCIENCE, V58, P593, DOI 10.1016/0306-4522(94)90084-1; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; HIKOSAKA O, 1985, J NEUROPHYSIOL, V53, P292, DOI 10.1152/jn.1985.53.1.292; HIKOSAKA O, 1993, EXP BRAIN RES, V95, P457; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; HIKOSAKA O, 1992, VESTIBULAR BRAIN STE, P405; HIKOSAKA O, 1994, BASAL GANGLIA, V4, P589; HIKOSAKA O, 1989, NEUROBIOLOGY SACCADI, P257; HILLYARD SA, 1985, TRENDS NEUROSCI, V8, P400, DOI 10.1016/0166-2236(85)90142-0; HOUK IC, 1995, MODELS INFORMATION P, P249; KATO M, 1995, J NEUROSCI, V15, P912; KATO M, 1995, MG NEUR SCI, V14, P178; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Konorski J., 1967, INTEGRATIVE ACTIVITY; KORI A, 1995, J NEUROSCI, V15, P928; MATSUMURA M, 1992, J NEUROPHYSIOL, V67, P1615, DOI 10.1152/jn.1992.67.6.1615; MIYASHITA N, 1995, NEUROREPORT, V6, P1257, DOI 10.1097/00001756-199506090-00007; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; PARTHASARATHY HB, 1992, J NEUROSCI, V12, P4468; PRESTON RJ, 1980, BRAIN RES, V183, P253, DOI 10.1016/0006-8993(80)90462-X; RIBAK CE, 1979, J COMP NEUROL, V187, P261, DOI 10.1002/cne.901870203; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; SAWAGUCHI T, 1990, J NEUROPHYSIOL, V63, P1401, DOI 10.1152/jn.1990.63.6.1401; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WICKENS I, 1995, MODELS INFORMATION P, P187; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; WURTZ RH, 1982, SCI AM, V246, P124, DOI 10.1038/scientificamerican0682-124	45	473	482	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	1998	1	5					411	416		10.1038/1625	http://dx.doi.org/10.1038/1625			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QE	10196532				2022-12-17	WOS:000076361400020
J	Heckers, S; Rauch, SL; Goff, D; Savage, CR; Schacter, DL; Fischman, AJ; Alpert, NM				Heckers, S; Rauch, SL; Goff, D; Savage, CR; Schacter, DL; Fischman, AJ; Alpert, NM			Impaired recruitment of the hippocampus during conscious recollection in schizophrenia	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION TOMOGRAPHY; CEREBRAL BLOOD-FLOW; EPISODIC MEMORY; FUNCTIONAL NEUROANATOMY; RECOGNITION MEMORY; TEMPORAL-LOBE; DYSFUNCTION; BRAIN; MEDICATION; ACTIVATION	Poor attention and impaired memory are enduring and core features of schizophrenia. These impairments have been attributed either to global cortical dysfunction or to perturbations of specific components associated with the dorsolateral prefrontal cortex (DLPFC), hippocampus and cerebellum. Here, we used positron emission tomography (PET) to dissociate activations in DLPFC and hippocampus during verbal episodic memory retrieval. We found reduced hippocampal activation during conscious recollection of studied words, but robust activation of the DLPFC during the effort to retrieve poorly encoded material in schizophrenic patients. This finding provides the first evidence of hippocampal dysfunction during episodic memory retrieval in schizophrenia.	Massachusetts Gen Hosp, Dept Psychiat, Psychot Disorders Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Psychiat, Psychiat Neuroimaging Res Grp, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med, Positron Emiss Tomog Lab, Boston, MA 02114 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Heckers, S (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Psychot Disorders Unit, Boston, MA 02114 USA.		Heckers, Stephan/F-3051-2010	Heckers, Stephan/0000-0003-3601-9910; Schacter, Daniel/0000-0002-2460-6061	NIMH NIH HHS [MH01215, R01MH57915] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057915] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alpert NM, 1996, NEUROIMAGE, V3, P10, DOI 10.1006/nimg.1996.0002; *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P273; Andreasen NC, 1996, NEURON, V16, P697, DOI 10.1016/S0896-6273(00)80090-2; Andreasen NC, 1996, P NATL ACAD SCI USA, V93, P9985, DOI 10.1073/pnas.93.18.9985; Andreasen NC, 1997, SCIENCE, V275, P1586, DOI 10.1126/science.275.5306.1586; Arnold SE, 1997, J NEUROPSYCH CLIN N, V9, P460; Beauregard M, 1996, CAN J PSYCHIAT, V41, P446, DOI 10.1177/070674379604100710; BERMAN KF, 1986, ARCH GEN PSYCHIAT, V43, P126; BUCKNER RL, 1995, J NEUROSCI, V15, P12; DELISI LE, 1989, BIOL PSYCHIAT, V25, P835, DOI 10.1016/0006-3223(89)90263-1; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; DWORK AJ, 1997, SCHIZOPHR B, V23, P403; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; FRISTON KJ, 1992, BRAIN, V115, P367, DOI 10.1093/brain/115.2.367; FRITH CD, 1995, BRIT J PSYCHIAT, V167, P343, DOI 10.1192/bjp.167.3.343; Gilbertson MW, 1997, BIOL PSYCHIAT, V42, P585, DOI 10.1016/S0006-3223(96)00435-0; Goldberg T. E., 1995, P146; Goldberg TE, 1996, J CLIN PSYCHIAT, V57, P62; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; GoldmanRakic PS, 1997, SCHIZOPHRENIA BULL, V23, P437, DOI 10.1093/schbul/23.3.437; Green MF, 1996, AM J PSYCHIAT, V153, P321; HEATON R, 1994, ARCH GEN PSYCHIAT, V51, P469; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; HURON C, 1995, AM J PSYCHIAT, V152, P1737; Kawasaki Y, 1996, PSYCHIAT RES-NEUROIM, V67, P49, DOI 10.1016/0925-4927(96)02685-6; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kraepelin E., 1919, CUTTING SHEPHERD, P13; KRIECKHAUS EE, 1992, BIOL PSYCHIAT, V31, P560, DOI 10.1016/0006-3223(92)90242-R; LIDDLE PF, 1992, BRIT J PSYCHIAT, V160, P179, DOI 10.1192/bjp.160.2.179; Miller DD, 1997, BIOL PSYCHIAT, V41, P550, DOI 10.1016/S0006-3223(96)00110-2; Nyberg L, 1996, NATURE, V380, P715, DOI 10.1038/380715a0; Schacter DL, 1996, NEUROREPORT, V7, P1165, DOI 10.1097/00001756-199604260-00014; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; SILBERSWEIG DA, 1995, NATURE, V378, P176, DOI 10.1038/378176a0; SPITZER M, 1993, BIOL PSYCHIAT, V34, P864, DOI 10.1016/0006-3223(93)90054-H; SPITZER RL, 1991, STRUCTURED CLIN INTE; SQUIRE LR, 1992, P NATL ACAD SCI USA, V89, P1837, DOI 10.1073/pnas.89.5.1837; TAMMINGA CA, 1992, ARCH GEN PSYCHIAT, V49, P522; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; UNGERLEIDER LG, 1995, SCIENCE, V270, P769, DOI 10.1126/science.270.5237.769; VENABLES PH, 1992, ANN NY ACAD SCI, V658, P111, DOI 10.1111/j.1749-6632.1992.tb22841.x; WEINBERGER DR, 1992, AM J PSYCHIAT, V149, P890; Woods RP, 1996, NEUROIMAGE, V4, pS84, DOI 10.1006/nimg.1996.0058	44	473	482	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					318	323		10.1038/1137	http://dx.doi.org/10.1038/1137			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195166				2022-12-17	WOS:000076361300016
J	Mi, S; Miller, RH; Lee, X; Scott, ML; Shulag-Morskaya, S; Shao, ZH; Chang, JF; Thill, G; Levesque, M; Zhang, MD; Hession, C; Sah, D; Trapp, B; He, ZG; Jung, V; McCoy, JM; Pepinsky, RB				Mi, S; Miller, RH; Lee, X; Scott, ML; Shulag-Morskaya, S; Shao, ZH; Chang, JF; Thill, G; Levesque, M; Zhang, MD; Hession, C; Sah, D; Trapp, B; He, ZG; Jung, V; McCoy, JM; Pepinsky, RB			LINGO-1 negatively regulates myelination by oligodendrocytes	NATURE NEUROSCIENCE			English	Article							RECEPTOR FAMILY-MEMBER; FYN TYROSINE KINASE; MORPHOLOGICAL-DIFFERENTIATION; SHEATH THICKNESS; NERVOUS-SYSTEM; SCHWANN-CELLS; ACTIVATION; EXPRESSION; NEUREGULIN; MOLECULES	The control of myelination by oligodendrocytes in the CNS is poorly understood. Here we show that LINGO-1 is an important negative regulator of this critical process. LINGO-1 is expressed in oligodendrocytes. Attenuation of its function by dominant-negative LINGO-1, LINGO-1 RNA-mediated interference (RNAi) or soluble human LINGO-1 (LINGO-1-Fc) leads to differentiation and increased myelination competence. Attenuation of LINGO-1 results in downregulation of RhoA activity, which has been implicated in oligodendrocyte differentiation. Conversely, overexpression of LINGO-1 leads to activation of RhoA and inhibition of oligodendrocyte differentiation and myelination. Treatment of oligodendrocyte and neuron cocultures with LINGO-1-Fc resulted in highly developed myelinated axons that have internodes and well-defined nodes of Ranvier. The contribution of LINGO-1 to myelination was verified in vivo through the analysis of LINGO-1 knockout mice. The ability to recapitulate CNS myelination in vitro using LINGO-1 antagonists and the in vivo effects seen in the LINGO-1 knockout indicate that LINGO-1 signaling may be critical for CNS myelination.	Biogen Idec Inc, Dept Discovery Biol, Cambridge, MA 02142 USA; Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA	Biogen; Case Western Reserve University; Harvard University; Boston Children's Hospital; Harvard Medical School; Cleveland Clinic Foundation	Mi, S (corresponding author), Biogen Idec Inc, Dept Discovery Biol, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	sha.mi@biogenidec.com	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763				Bhat RV, 1996, GLIA, V17, P169; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Edgar JM, 2004, J NEUROSCI RES, V76, P593, DOI 10.1002/jnr.20063; FRIEDE RL, 1986, EXP NEUROL, V92, P234, DOI 10.1016/0014-4886(86)90137-8; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5; Givogri MI, 2002, J NEUROSCI RES, V67, P309, DOI 10.1002/jnr.10128; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Kiewe P, 2003, LEUKEMIA LYMPHOMA, V44, P1815, DOI 10.1080/1042819031000116625; KOLODNY EH, 1993, CURR OPIN NEUROL NEU, V6, P379; Kramer EM, 1999, J BIOL CHEM, V274, P29042, DOI 10.1074/jbc.274.41.29042; Li C, 1998, J NEUROSCI RES, V51, P210, DOI 10.1002/(SICI)1097-4547(19980115)51:2<210::AID-JNR9>3.0.CO;2-G; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Partadiredja G, 2003, J NEUROCYTOL, V32, P1165, DOI 10.1023/B:NEUR.0000021910.65920.41; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Salvati S, 2000, DEV NEUROSCI-BASEL, V22, P481, DOI 10.1159/000017479; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Sperber BR, 2001, J NEUROSCI RES, V63, P303, DOI 10.1002/1097-4547(20010215)63:4<303::AID-JNR1024>3.0.CO;2-A; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Stoffel W, 1997, CURR OPIN NEUROBIOL, V7, P654, DOI 10.1016/S0959-4388(97)80085-2; Svenningsen AF, 2003, J NEUROSCI RES, V72, P565, DOI 10.1002/jnr.10610; Trapp BD, 1999, J NEUROIMMUNOL, V98, P49, DOI 10.1016/S0165-5728(99)00081-8; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Vartanian T, 1997, J CELL BIOL, V137, P211, DOI 10.1083/jcb.137.1.211; Villagra NT, 2004, NEUROBIOL DIS, V16, P158, DOI 10.1016/j.nbd.2004.02.005; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wolf RM, 2001, J NEUROBIOL, V49, P62, DOI 10.1002/neu.1066; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	33	471	517	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					745	751		10.1038/nn1460	http://dx.doi.org/10.1038/nn1460			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895088				2022-12-17	WOS:000229345300014
J	McClung, CA; Nestler, EJ				McClung, CA; Nestler, EJ			Regulation of gene expression and cocaine reward by CREB and Delta FosB	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; NUCLEUS-ACCUMBENS SHELL; MOLECULAR-MECHANISMS; TRANSCRIPTION; BRAIN; DOPAMINE; INDUCTION; STRIATUM; FORM; JUN	DeltaFosB (a truncated form of FosB) and CREB (cAMP response element binding protein) are transcription factors induced in the brain's reward pathways after chronic exposure to drugs of abuse. However, their mechanisms of action and the genes they regulate remain unclear. Using microarray analysis in the nucleus accumbens of inducible transgenic mice, we found that CREB and a dominant-negative CREB have opposite effects on gene expression, as do prolonged expression of DeltaFosB and the activator protein-1 (AP-1) antagonist DeltacJun. However, unlike CREB, short-term and prolonged DeltaFosB induction had opposing effects on gene expression. Gene expression induced by short-term DeltaFosB and by CREB was strikingly similar, and both reduced the rewarding effects of cocaine, whereas prolonged DeltaFosB expression increased drug reward. Gene expression after a short cocaine treatment was more dependent on CREB, whereas gene expression after a longer cocaine treatment became increasingly DeltaFosB dependent. These findings help define the molecular functions of CREB and DeltaFosB and identify clusters of genes that contribute to cocaine addiction.	Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Nestler, EJ (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Eric.Nestler@UTSouthwestern.edu	McClung, Colleen/AAA-5943-2019					Andersson M, 2001, J NEUROSCI, V21, P9930, DOI 10.1523/JNEUROSCI.21-24-09930.2001; Ang E, 2001, J NEUROCHEM, V79, P221, DOI 10.1046/j.1471-4159.2001.00563.x; Bannon MJ, 2002, P NATL ACAD SCI USA, V99, P6382, DOI 10.1073/pnas.092654299; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Beinfeld MC, 2002, J NEUROCHEM, V81, P1021, DOI 10.1046/j.1471-4159.2002.00894.x; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Beurrier C, 2002, J NEUROSCI, V22, P5817; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Brown PH, 1996, CELL GROWTH DIFFER, V7, P1013; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chen JS, 1998, MOL PHARMACOL, V54, P495, DOI 10.1124/mol.54.3.495; Chen JS, 2000, J NEUROSCI, V20, P8965; Chen JS, 1997, J NEUROSCI, V17, P4933; Colby CR, 2003, J NEUROSCI, V23, P2488; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; DOBRZANSKI P, 1991, MOL CELL BIOL, V11, P5470, DOI 10.1128/MCB.11.11.5470; Duman RS, 2002, MOL PSYCHIATR, V7, pS29, DOI 10.1038/sj.mp.4001016; Ehrlich ME, 2002, J NEUROSCI, V22, P9155; Freeman WM, 2001, J NEUROCHEM, V77, P542, DOI 10.1046/j.1471-4159.2001.00252.x; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Josselyn SA, 1996, NEUROSCI LETT, V209, P85, DOI 10.1016/0304-3940(96)12610-0; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Korutla L, 2002, NEUROSCIENCE, V110, P421, DOI 10.1016/S0306-4522(01)00518-8; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; NAKABEPPU Y, 1991, CELL, V64, P751, DOI 10.1016/0092-8674(91)90504-R; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Newton SS, 2002, J NEUROSCI, V22, P10883; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Peakman MC, 2003, BRAIN RES, V970, P73, DOI 10.1016/S0006-8993(03)02230-3; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Sakai N, 2002, MOL PHARMACOL, V61, P1453, DOI 10.1124/mol.61.6.1453; Self DW, 1998, J NEUROSCI, V18, P1848; Shaw-Lutchman TZ, 2003, SYNAPSE, V48, P10, DOI 10.1002/syn.10172; SIMPSON JN, 1995, SYNAPSE, V19, P151, DOI 10.1002/syn.890190302; Tanganelli S, 2001, PEPTIDES, V22, P1229, DOI 10.1016/S0196-9781(01)00446-6; TERWILLIGER RZ, 1991, BRAIN RES, V548, P100, DOI 10.1016/0006-8993(91)91111-D; Turgeon SM, 1997, BRAIN RES, V749, P120, DOI 10.1016/S0006-8993(96)01316-9; UNTERWALD EM, 1993, SYNAPSE, V15, P33, DOI 10.1002/syn.890150104; Walters CL, 2001, J NEUROSCI, V21, P9438, DOI 10.1523/JNEUROSCI.21-23-09438.2001; Wu XL, 2001, J BIOL CHEM, V276, P1735, DOI 10.1074/jbc.M006727200; YEN J, 1991, P NATL ACAD SCI USA, V88, P5077, DOI 10.1073/pnas.88.12.5077; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; Yuferov V, 2003, SYNAPSE, V48, P157, DOI 10.1002/syn.10198	50	470	496	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1208	1215		10.1038/nn1143	http://dx.doi.org/10.1038/nn1143			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14566342				2022-12-17	WOS:000186229200021
J	Uchida, N; Mainen, ZF				Uchida, N; Mainen, ZF			Speed and accuracy of olfactory discrimination in the rat	NATURE NEUROSCIENCE			English	Article							OSCILLATING NEURAL ASSEMBLIES; ODOR DISCRIMINATION; NETWORK DYNAMICS; BULB; INFORMATION; RESPONSES; MAPS; REPRESENTATIONS; PERCEPTION; SIGNALS	The sense of smell is typically thought of as a 'slow' sense, but the true temporal constraints on the accuracy of olfactory perception are not known. It has been proposed that animals make finer odor discriminations at the expense of additional processing time. To test this idea, we measured the relationship between the speed and accuracy of olfactory discrimination in rats. We found that speed of discrimination was independent of odor similarity, as measured by overlap of glomerular activity patterns. Even when pushed to psychophysical limits using mixtures of two odors, rats needed to take only one sniff (< 200 ms at theta frequency) to make a decision of maximum accuracy. These results show that, for the purpose of odor quality discrimination, a fully refined olfactory sensory representation can emerge within a single sensorimotor or theta cycle, suggesting that each sniff can be considered a snapshot of the olfactory world.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Mainen, ZF (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	zach@cshl.org		Mainen, Zachary/0000-0001-7913-9109; Uchida, Naoshige/0000-0002-5755-9409	NIDCD NIH HHS [5R01DC006104-02] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006104] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; AMBROSINGERSON J, 1990, SCIENCE, V247, P1344, DOI 10.1126/science.2315702; ATEMA J, 1995, P NATL ACAD SCI USA, V92, P62, DOI 10.1073/pnas.92.1.62; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Cang JH, 2003, J NEUROSCI, V23, P4108; CHAPUT MA, 1986, PHYSIOL BEHAV, V36, P319, DOI 10.1016/0031-9384(86)90023-5; Chaput MA, 2000, CHEM SENSES, V25, P695, DOI 10.1093/chemse/25.6.695; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; GOLDBERG SJ, 1987, EXP NEUROL, V96, P430, DOI 10.1016/0014-4886(87)90060-4; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; Johnson BN, 2003, J NEUROPHYSIOL, V90, P1084, DOI 10.1152/jn.00115.2003; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; Korsching SI, 2001, CELL MOL LIFE SCI, V58, P520, DOI 10.1007/PL00000877; LAING DG, 1986, PHYSIOL BEHAV, V37, P163, DOI 10.1016/0031-9384(86)90400-2; LAURENT G, 1994, J NEUROSCI, V14, P2993; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leon M, 2003, BRAIN RES REV, V42, P23, DOI 10.1016/S0165-0173(03)00142-5; Linster C, 2002, J NEUROSCI, V22, P6842; Luce RD, 1986, RESPONSE TIMES; MACKAYSIM A, 1994, J NEUROPHYSIOL, V71, P150, DOI 10.1152/jn.1994.71.1.150; MACRIDES F, 1982, J NEUROSCI, V2, P1705; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Meister M, 2001, J NEUROSCI, V21, P1351; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mori K, 2003, BIOCHEM SOC T, V31, P134, DOI 10.1042/bst0310134; NEVITT GA, 1991, J EXP BIOL, V157, P1; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; RABINOVICH M, 2001, PHYS REV LETT, V875; Rubin BD, 2001, NAT NEUROSCI, V4, P355, DOI 10.1038/85997; SKARDA CA, 1987, BEHAV BRAIN SCI, V10, P161, DOI 10.1017/S0140525X00047336; SLOTNICK BM, 1990, COMP PERCEPTION, P155; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; VICKERS NJ, 1994, P NATL ACAD SCI USA, V91, P5756, DOI 10.1073/pnas.91.13.5756; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wise PM, 2000, CHEM SENSES, V25, P247, DOI 10.1093/chemse/25.3.247; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; [No title captured]	47	470	475	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2003	6	11					1224	1229		10.1038/nn1142	http://dx.doi.org/10.1038/nn1142			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KH	14566341				2022-12-17	WOS:000186229200023
J	Amedi, A; Malach, R; Hendler, T; Peled, S; Zohary, E				Amedi, A; Malach, R; Hendler, T; Peled, S; Zohary, E			Visuo-haptic object-related activation in the ventral visual pathway	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL SULCUS; HUMAN OCCIPITAL LOBE; INFEROTEMPORAL CORTEX; SOMATOSENSORY CORTEX; CEREBRAL-CORTEX; MACAQUE MONKEY; PLASTICITY; AREAS; SHAPE; CONNECTIONS	The ventral pathway is involved in primate visual object recognition. In humans, a central stage in this pathway is an occipito-temporal region termed the lateral occipital complex (LOC), which is preferentially activated by visual objects compared to scrambled images or textures. However, objects have characteristic attributes (such as three-dimensional shape) that can be perceived both visually and haptically. Therefore, object-related brain areas may hold a representation of objects in both modalities. Using fMRI to map object-related brain regions, we found robust and consistent somatosensory activation in the occipito-temporal cortex. This region showed clear preference for objects compared to textures in both modalities. Most somatosensory object-selective voxels overlapped a part of the visual object-related region LOG. Thus, we suggest that neuronal populations in the occipito-temporal cortex may constitute a multimodal object-related network.	Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Ctr Neural Computat, IL-91904 Jerusalem, Israel; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Zohary, E (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, IL-91904 Jerusalem, Israel.		hendler, talma/C-7677-2012; Peled, Sharon/ABD-7732-2021; Peled, Sharon/F-8590-2015	Amedi, Amir/0000-0001-5042-2533				ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; KAAS JH, 1983, ANNU REV NEUROSCI, V6, P325, DOI 10.1146/annurev.ne.06.030183.001545; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P3180; NEAL JW, 1990, BRAIN RES, V532, P249, DOI 10.1016/0006-8993(90)91767-B; OSULLIVAN BT, 1994, EUR J NEUROSCI, V6, P137, DOI 10.1111/j.1460-9568.1994.tb00255.x; PONS TP, 1988, P NATL ACAD SCI USA, V85, P5279, DOI 10.1073/pnas.85.14.5279; Pons TP, 1998, NAT MED, V4, P561, DOI 10.1038/nm0598-561; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Roland PE, 1998, P NATL ACAD SCI USA, V95, P3295, DOI 10.1073/pnas.95.6.3295; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Saleem KS, 2000, J NEUROSCI, V20, P5083; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; SERANO SC, 1995, SCIENCE, V268, P889; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9	38	469	477	2	38	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					324	330		10.1038/85201	http://dx.doi.org/10.1038/85201			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224551				2022-12-17	WOS:000167178300022
J	Bazargani, N; Attwell, D				Bazargani, Narges; Attwell, David			Astrocyte calcium signaling: the third wave	NATURE NEUROSCIENCE			English	Article							DEPENDENT GLUTAMATE RELEASE; LONG-TERM POTENTIATION; HIPPOCAMPAL ASTROCYTES; IN-SITU; NEURONAL-ACTIVITY; STRUCTURAL PLASTICITY; RECEPTOR ACTIVATION; VISUAL-CORTEX; CA2+; STIMULATION	The discovery that transient elevations of calcium concentration occur in astrocytes, and release 'gliotransmitters' which act on neurons and vascular smooth muscle, led to the idea that astrocytes are powerful regulators of neuronal spiking, synaptic plasticity and brain blood flow. These findings were challenged by a second wave of reports that astrocyte calcium transients did not mediate functions attributed to gliotransmitters and were too slow to generate blood flow increases. Remarkably, the tide has now turned again: the most important calcium transients occur in fine astrocyte processes not resolved in earlier studies, and new mechanisms have been discovered by which astrocyte [Ca2+](i) is raised and exerts its effects. Here we review how this third wave of discoveries has changed our understanding of astrocyte calcium signaling and its consequences for neuronal function.	[Bazargani, Narges; Attwell, David] UCL, Dept Neurosci Physiol & Pharmacol, London, England	University of London; University College London	Attwell, D (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	d.attwell@ucl.ac.uk	Attwell, David/ABE-6750-2020; Bazargani, Narges/AAL-1559-2020	Attwell, David/0000-0003-3618-0843	Wellcome Trust; European Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	We thank N. Hamilton, R. Jolivet, A. Krasnow and A. Mishra for comments on the manuscript. Supported by the Wellcome Trust and European Research Council.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Araque A, 1998, J NEUROSCI, V18, P6822; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Beppu K, 2014, NEURON, V81, P314, DOI 10.1016/j.neuron.2013.11.011; Bernardinelli Y, 2014, CURR BIOL, V24, P1679, DOI 10.1016/j.cub.2014.06.025; Bernardinelli Y, 2011, J NEUROSCI, V31, P8905, DOI 10.1523/JNEUROSCI.6341-10.2011; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bonder DE, 2014, J NEUROSCI, V34, P13139, DOI 10.1523/JNEUROSCI.2591-14.2014; Bowser DN, 2007, J GEN PHYSIOL, V129, P485, DOI 10.1085/jgp.200709780; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cai ZH, 2000, GLIA, V29, P70, DOI 10.1002/(SICI)1098-1136(20000101)29:1<70::AID-GLIA7>3.0.CO;2-V; Carmignoto G, 2012, GLIA, V60, P1227, DOI 10.1002/glia.22318; Chen NY, 2012, P NATL ACAD SCI USA, V109, pE2832, DOI 10.1073/pnas.1206557109; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; D'Ascenzo M, 2007, P NATL ACAD SCI USA, V104, P1995, DOI 10.1073/pnas.0609408104; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; Devaraju P, 2013, J NEUROPHYSIOL, V109, P2404, DOI 10.1152/jn.00517.2012; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Ding FF, 2013, CELL CALCIUM, V54, P387, DOI 10.1016/j.ceca.2013.09.001; Diniz LP, 2014, GLIA, V62, P1917, DOI 10.1002/glia.22713; Doengi M, 2009, P NATL ACAD SCI USA, V106, P17570, DOI 10.1073/pnas.0809513106; DUFFY S, 1995, J NEUROSCI, V15, P5535; Feldmann A, 2011, J NEUROSCI, V31, P5659, DOI 10.1523/JNEUROSCI.6638-10.2011; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; Filosa JA, 2012, J NEUROENDOCRINOL, V24, P378, DOI 10.1111/j.1365-2826.2011.02243.x; Fujita T, 2014, J NEUROSCI, V34, P16594, DOI 10.1523/JNEUROSCI.2585-14.2014; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hamby ME, 2012, J NEUROSCI, V32, P14489, DOI 10.1523/JNEUROSCI.1256-12.2012; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Haustein MD, 2014, NEURON, V82, P413, DOI 10.1016/j.neuron.2014.02.041; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Holmstrom KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2364; Jimenez-Gonzalez C, 2011, EUR J NEUROSCI, V33, P1471, DOI 10.1111/j.1460-9568.2011.07645.x; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Jurado S, 2013, NEURON, V77, P542, DOI 10.1016/j.neuron.2012.11.029; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; Kanemaru K, 2014, CELL REP, V8, P311, DOI 10.1016/j.celrep.2014.05.056; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kozlov AS, 2006, P NATL ACAD SCI USA, V103, P10058, DOI 10.1073/pnas.0603741103; Lalo U, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001747; Lavialle M, 2011, P NATL ACAD SCI USA, V108, P12915, DOI 10.1073/pnas.1100957108; Lee S, 2010, SCIENCE, V330, P790, DOI 10.1126/science.1184334; Lee W, 2013, NEUROBIOL DIS, V58, P192, DOI 10.1016/j.nbd.2013.06.002; Li DD, 2013, J NEUROSCI, V33, P4434, DOI 10.1523/JNEUROSCI.3667-12.2013; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Lind BL, 2013, P NATL ACAD SCI USA, V110, pE4678, DOI 10.1073/pnas.1310065110; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Liu QY, 2000, J NEUROPHYSIOL, V84, P1392, DOI 10.1152/jn.2000.84.3.1392; Loaiza A, 2003, J NEUROSCI, V23, P7337; Mashimo M, 2010, EUR J NEUROSCI, V32, P1668, DOI 10.1111/j.1460-9568.2010.07452.x; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Moreau K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5998; Morquette P, 2015, NAT NEUROSCI, V18, P844, DOI 10.1038/nn.4013; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Murphy-Royal C, 2015, NAT NEUROSCI, V18, P219, DOI 10.1038/nn.3901; Navarrete M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001259; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Newman EA, 2005, J NEUROSCI, V25, P5502, DOI 10.1523/JNEUROSCI.1354-05.2005; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Newman EA, 2001, J NEUROSCI, V21, P2215, DOI 10.1523/JNEUROSCI.21-07-02215.2001; Newman EA, 1997, SCIENCE, V275, P844, DOI 10.1126/science.275.5301.844; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nimmerjahn A, 2015, CURR OPIN NEUROBIOL, V32, P95, DOI 10.1016/j.conb.2015.01.015; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Nizar K, 2013, J NEUROSCI, V33, P8411, DOI 10.1523/JNEUROSCI.3285-12.2013; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Otsu Y, 2015, NAT NEUROSCI, V18, P210, DOI 10.1038/nn.3906; Palygin O, 2010, CELL CALCIUM, V48, P225, DOI 10.1016/j.ceca.2010.09.004; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Pankratov Y, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00230; Park H, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-54; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Patrushev I, 2013, CELL CALCIUM, V54, P343, DOI 10.1016/j.ceca.2013.08.003; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Petravicz J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00384; Porter JT, 1996, J NEUROSCI, V16, P5073; Pryazhnikov E, 2008, GLIA, V56, P38, DOI 10.1002/glia.20590; Rossi D, 2005, J BIOL CHEM, V280, P42088, DOI 10.1074/jbc.M504124200; Rusakov DA, 2015, NAT REV NEUROSCI, V16, P226, DOI 10.1038/nrn3878; Sahlender DA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0592; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Schulz K, 2012, NAT METHODS, V9, P597, DOI [10.1038/NMETH.2013, 10.1038/nmeth.2013]; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Shelton MK, 2000, J NEUROCHEM, V74, P555, DOI 10.1046/j.1471-4159.2000.740555.x; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Shigetomi E, 2012, NAT NEUROSCI, V15, P70, DOI 10.1038/nn.3000; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Sibille J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00189; Sloan SA, 2014, NEURON, V84, P1112, DOI 10.1016/j.neuron.2014.12.003; Srinivasan R, 2015, NAT NEUROSCI, V18, P708, DOI 10.1038/nn.4001; Su M, 2004, NEUROCHEM RES, V29, P2075, DOI 10.1007/s11064-004-6881-1; Sultan S, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.037; Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takano T, 2005, P NATL ACAD SCI USA, V102, P16466, DOI 10.1073/pnas.0506382102; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Tang WN, 2015, J NEUROSCI, V35, P3016, DOI 10.1523/JNEUROSCI.3319-14.2015; Thrane AS, 2012, P NATL ACAD SCI USA, V109, P18974, DOI 10.1073/pnas.1209448109; Volterra A, 2014, NAT REV NEUROSCI, V15, P327, DOI 10.1038/nrn3725; Wang FS, 2013, J NEUROSCI, V33, P17404, DOI 10.1523/JNEUROSCI.2178-13.2013; Wang FS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002334; Wang HC, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.070; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Winship IR, 2007, J NEUROSCI, V27, P6268, DOI 10.1523/JNEUROSCI.4801-06.2007; Woo DH, 2012, CELL, V151, P25, DOI 10.1016/j.cell.2012.09.005; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	137	468	475	8	202	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2016	19	2					182	189		10.1038/nn.4201	http://dx.doi.org/10.1038/nn.4201			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DC4EG	26814587	Green Submitted			2022-12-17	WOS:000369172600005
J	Hughes, EG; Kang, SH; Fukaya, M; Bergles, DE				Hughes, Ethan G.; Kang, Shin H.; Fukaya, Masahiro; Bergles, Dwight E.			Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain	NATURE NEUROSCIENCE			English	Article							CHONDROITIN-SULFATE PROTEOGLYCAN; NG2-POSITIVE CELLS; GLIAL PROGENITORS; PRECURSOR CELLS; WHITE-MATTER; NG2 CELLS; LONG-TERM; PROLIFERATION; DYNAMICS; ORIGIN	The adult CNS contains an abundant population of oligodendrocyte precursor cells (NG2(+) cells) that generate oligodendrocytes and repair myelin, but how these ubiquitous progenitors maintain their density is unknown. We generated NG2-mEGFP mice and used in vivo two-photon imaging to study their dynamics in the adult brain. Time-lapse imaging revealed that NG2(+) cells in the cortex were highly dynamic; they surveyed their local environment with motile filopodia, extended growth cones and continuously migrated. They maintained unique territories though self-avoidance, and NG2(+) cell loss though death, differentiation or ablation triggered rapid migration and proliferation of adjacent cells to restore their density. NG2(+) cells recruited to sites of focal CNS injury were similarly replaced by a proliferative burst surrounding the injury site. Thus, homeostatic control of NG2(+) cell density through a balance of active growth and self-repulsion ensures that these progenitors are available to replace oligodendrocytes and participate in tissue repair.	[Hughes, Ethan G.; Kang, Shin H.; Fukaya, Masahiro; Bergles, Dwight E.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University	Bergles, DE (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	dbergles@jhmi.edu	Bergles, Dwight/U-8343-2019	Bergles, Dwight/0000-0002-7133-7378; Hughes, Ethan/0000-0003-3243-7429	Kirschstein National Research Service Award grant from the US National Institutes of Health [F32NS076098]; US National Institutes of Health [NS051509, NS050274]; Brain Science Institute at Johns Hopkins University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS076098, P30NS050274, R01NS051509] Funding Source: NIH RePORTER	Kirschstein National Research Service Award grant from the US National Institutes of Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Institute at Johns Hopkins University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Pucak, N. Ye and T. Lee for technical assistance, B. Cudmore (Johns Hopkins University) and S. Wang (Princeton University) for advice on cranial window implantation, W.-B. Gan (New York University) for advice on preparing thinned skull windows, and members of the Bergles laboratory for discussions. E.G.H. was supported by a Kirschstein National Research Service Award grant from the US National Institutes of Health (F32NS076098). Funding was provided by grants from the US National Institutes of Health (NS051509, NS050274) and the Brain Science Institute at Johns Hopkins University.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Chung SH, 2009, APPL PHYS A-MATER, V96, P335, DOI 10.1007/s00339-009-5201-7; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Haber M, 2009, GLIA, V57, P1000, DOI 10.1002/glia.20824; Haberlandt C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017575; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kay JN, 2012, NATURE, V483, P465, DOI 10.1038/nature10877; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Larsen PH, 2003, J NEUROSCI, V23, P11127, DOI 10.1523/jneurosci.23-35-11127.2003; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Magnus T, 2008, GLIA, V56, P200, DOI 10.1002/glia.20604; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; MOORE BR, 1980, BIOMETRIKA, V67, P175; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Spassky N, 2002, J NEUROSCI, V22, P5992; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhang H, 1996, J NEUROSCI, V16, P6886; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	56	468	475	3	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2013	16	6					668	+		10.1038/nn.3390	http://dx.doi.org/10.1038/nn.3390			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	152DE	23624515	Green Accepted			2022-12-17	WOS:000319509600007
J	Um, JW; Nygaard, HB; Heiss, JK; Kostylev, MA; Stagi, M; Vortmeyer, A; Wisniewski, T; Gunther, EC; Strittmatter, SM				Um, Ji Won; Nygaard, Haakon B.; Heiss, Jacqueline K.; Kostylev, Mikhail A.; Stagi, Massimiliano; Vortmeyer, Alexander; Wisniewski, Thomas; Gunther, Erik C.; Strittmatter, Stephen M.			Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; NR2B-CONTAINING NMDA-RECEPTORS; TYROSINE PHOSPHORYLATION; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; TRANSGENIC MICE; MOUSE MODELS	Amyloid-beta (A beta) oligomers are thought to trigger Alzheimer's disease pathophysiology. Cellular prion protein (PrPC) selectively binds oligomeric A beta and can mediate Alzheimer's disease-related phenotypes. We examined the specificity, distribution and signaling of A beta-PrPC complexes, seeking to understand how they might alter the function of NMDA receptors (NMDARs) in neurons. PrPC is enriched in postsynaptic densities, and A beta-PrPC interaction leads to Fyn kinase activation. Soluble A beta assemblies derived from the brains of individuals with Alzheimer's disease interacted with PrPC to activate Fyn. A beta engagement of PrPC-Fyn signaling yielded phosphorylation of the NR2B subunit of NMDARs, which was coupled to an initial increase and then a loss of surface NMDARs. A beta-induced dendritic spine loss and lactate dehydrogenase release required both PrPC and Fyn, and human familial Alzheimer's disease transgene-induced convulsive seizures did not occur in mice lacking PrPC. These results delineate an A beta oligomer signal transduction pathway that requires PrPC and Fyn to alter synaptic function, with deleterious consequences in Alzheimer's disease.	[Um, Ji Won; Nygaard, Haakon B.; Heiss, Jacqueline K.; Kostylev, Mikhail A.; Stagi, Massimiliano; Gunther, Erik C.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06510 USA; [Um, Ji Won; Nygaard, Haakon B.; Heiss, Jacqueline K.; Kostylev, Mikhail A.; Stagi, Massimiliano; Gunther, Erik C.; Strittmatter, Stephen M.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Vortmeyer, Alexander] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Neurol, New York, NY USA	Yale University; Yale University; Yale University; New York University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, Cellular Neurosci Neurodegenerat & Repair Program, New Haven, CT 06510 USA.	stephen.strittmatter@yale.edu	Stagi, Massimiliano/ABF-5894-2020; Wisniewski, Thomas/Q-6525-2019; Strittmatter, Stephen/F-5739-2011	Stagi, Massimiliano/0000-0002-5827-902X; Wisniewski, Thomas/0000-0002-3379-8966; Strittmatter, Stephen/0000-0001-8188-3092; Kostylev, Mikhail/0000-0003-0435-8141	US National Institutes of Health [R01AG034924, R37NS033020, R01NS074319, P30DA018343, R01NS47433, R01NS073502]; Falk Medical Research Trust; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033020, R01NS074319, R01NS073502, R01NS047433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008051, R01AG034924, R01AG020245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Falk Medical Research Trust; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	H.B.N. is an Ellison Medical Foundation American Federation for Aging Research Postdoctoral Fellow and S. M. S. is a member of the Kavli Institute for Neuroscience at Yale University. We acknowledge support from the US National Institutes of Health (R01AG034924, R37NS033020, R01NS074319 and P30DA018343), the Falk Medical Research Trust and the Alzheimer's Association (S. M. S.), and from the US National Institutes of Health (R01NS47433 and R01NS073502; T.W.).	Alier K, 2011, J NEUROSCI, V31, P16292, DOI 10.1523/JNEUROSCI.4367-11.2011; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bate C, 2011, J BIOL CHEM, V286, P37955, DOI 10.1074/jbc.M111.248724; Bizat N, 2010, J NEUROSCI, V30, P5394, DOI 10.1523/JNEUROSCI.5831-09.2010; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cisse M, 2011, J NEUROSCI, V31, P10427, DOI 10.1523/JNEUROSCI.1459-11.2011; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kojima N, 1998, LEARN MEMORY, V5, P429; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mouillet-Richard S, 2007, ANN NY ACAD SCI, V1096, P106, DOI 10.1196/annals.1397.076; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pantera B, 2009, J NEUROCHEM, V110, P194, DOI 10.1111/j.1471-4159.2009.06123.x; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Steinerman JR, 2008, ARCH NEUROL-CHICAGO, V65, P906, DOI 10.1001/archneur.65.7.906; Stuermer CAO, 2004, FASEB J, V18, P1731, DOI 10.1096/fj.04-2150fje; SUZUKI T, 1995, BIOCHEM BIOPH RES CO, V216, P582, DOI 10.1006/bbrc.1995.2662; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Williamson R, 2008, FASEB J, V22, P1552, DOI 10.1096/fj.07-9766com; Yoshimura Y, 2004, J NEUROCHEM, V88, P759, DOI 10.1046/j.1471-4159.2003.02136.x; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhang YF, 2010, P NATL ACAD SCI USA, V107, P19014, DOI 10.1073/pnas.1013543107; Zou WQ, 2011, J BIOL CHEM, V286, P15095, DOI 10.1074/jbc.M110.199356	52	468	489	5	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2012	15	9					1227	U85		10.1038/nn.3178	http://dx.doi.org/10.1038/nn.3178			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	996GJ	22820466	Green Accepted			2022-12-17	WOS:000308072600013
J	Mirescu, C; Peters, JD; Gould, E				Mirescu, C; Peters, JD; Gould, E			Early life experience alters response of adult neurogenesis to stress	NATURE NEUROSCIENCE			English	Article							NEONATAL MATERNAL SEPARATION; GENERATED GRANULE CELLS; RAT DENTATE GYRUS; LONG-EVANS RATS; SYNAPTIC PLASTICITY; HIPPOCAMPAL VOLUME; NEGATIVE FEEDBACK; MAJOR DEPRESSION; MEDIAN-EMINENCE; PROLIFERATION	Maternal deprivation produces persistent abnormalities in behavioral and neuroendocrine functions associated with the hippocampus, a brain region that shows considerable structural change in response to experience throughout life. Here we show that adverse experience early in life affects the regulation of adult neurogenesis in the hippocampus. More specifically, a decrease in cell proliferation and immature neuron production are observed in the dentate gyrus of adult rats that are maternally separated as pups. Although maternally separated rats show normal basal levels of corticosterone, the suppression of cell proliferation in these rats can be reversed by lowering corticosterone below the control value. In addition, normal stress-induced suppression of cell proliferation and neurogenesis, despite normal activation of the hypothalamic pituitary adrenal (HPA) axis, is not observed in maternally separated rats. Our results suggest that early adverse experience inhibits structural plasticity via hypersensitivity to glucocorticoids and diminishes the ability of the hippocampus to respond to stress in adulthood.	Princeton Univ, Dept Physiol, Princeton, NJ 08544 USA	Princeton University	Gould, E (corresponding author), Princeton Univ, Dept Physiol, Princeton, NJ 08544 USA.	goulde@princeton.edu			NIMH NIH HHS [MH58922, MH59740] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059740, P50MH058922] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BANNERMAN DM, 2003, BEHAV NEUROSCI, V116, P884; Bremner JD, 2001, AM J PSYCHIAT, V158, P653, DOI 10.1176/appi.ajp.158.4.653; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Deacon RMJ, 2002, BEHAV NEUROSCI, V116, P494, DOI 10.1037//0735-7044.116.3.494; Dobrossy MD, 2003, MOL PSYCHIATR, V8, P974, DOI 10.1038/sj.mp.4001419; GOULD E, 1990, NEUROSCIENCE, V37, P367, DOI 10.1016/0306-4522(90)90407-U; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; GOULD E, 1992, J NEUROSCI, V12, P3642; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; HERMAN JP, 1995, J NEUROENDOCRINOL, V7, P475, DOI 10.1111/j.1365-2826.1995.tb00784.x; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; Huot RL, 2002, BRAIN RES, V950, P52, DOI 10.1016/S0006-8993(02)02985-2; JANS JE, 1990, DEV PSYCHOBIOL, V23, P519, DOI 10.1002/dev.420230607; Levine S, 2000, EUR J PHARMACOL, V405, P149, DOI 10.1016/S0014-2999(00)00548-3; Liu D, 2000, J NEUROENDOCRINOL, V12, P5; Lovic V, 2001, DEV PSYCHOBIOL, V39, P19, DOI 10.1002/dev.1024; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; MAGARINOS AM, 1987, HORM METAB RES, V19, P105, DOI 10.1055/s-2007-1011753; Malberg JE, 2003, NEUROPSYCHOPHARMACOL, V28, P1562, DOI 10.1038/sj.npp.1300234; MEANEY MJ, 1989, NEUROENDOCRINOLOGY, V50, P597, DOI 10.1159/000125287; Newport DJ, 2002, AM J PSYCHIAT, V159, P1265, DOI 10.1176/appi.ajp.159.8.1265; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SAPOLSKY RM, 1986, BRAIN RES REV, V11, P65, DOI 10.1016/0165-0173(86)90010-X; SAPOLSKY RM, 1989, ENDOCRINOLOGY, V125, P2881, DOI 10.1210/endo-125-6-2881; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Sheline YI, 1996, MOL PSYCHIATR, V1, P298; Sheline YI, 1999, J NEUROSCI, V19, P5034; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; VERNETMAURY E, 1984, J CHEM ECOL, V10, P1007, DOI 10.1007/BF00987509; Viau V, 1996, J NEUROENDOCRINOL, V8, P1, DOI 10.1111/j.1365-2826.1996.tb00680.x; VIAU V, 1993, J NEUROSCI, V13, P1097; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A	44	468	487	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2004	7	8					841	846		10.1038/nn1290	http://dx.doi.org/10.1038/nn1290			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841LH	15273691				2022-12-17	WOS:000222930800014
J	Cunningham, JP; Yu, BM				Cunningham, John P.; Yu, Byron M.			Dimensionality reduction for large-scale neural recordings	NATURE NEUROSCIENCE			English	Review							SINGLE-TRIAL ANALYSIS; CORTICAL ACTIVITY; FIRING PATTERNS; NEURONAL POPULATIONS; NETWORK DYNAMICS; SPIKING ACTIVITY; FRONTAL-CORTEX; ENSEMBLE; STATES; BRAIN	Most sensory, cognitive and motor functions depend on the interactions of many neurons. In recent years, there has been rapid development and increasing use of technologies for recording from large numbers of neurons, either sequentially or simultaneously. A key question is what scientific insight can be gained by studying a population of recorded neurons beyond studying each neuron individually. Here, we examine three important motivations for population studies: single-trial hypotheses requiring statistical power, hypotheses of population response structure and exploratory analyses of large data sets. Many recent studies have adopted dimensionality reduction to analyze these populations and to find features that are not apparent at the level of individual neurons. We describe the dimensionality reduction methods commonly applied to population activity and offer practical advice about selecting methods and interpreting their outputs. This review is intended for experimental and computational researchers who seek to understand the role dimensionality reduction has had and can have in systems neuroscience, and who seek to apply these methods to their own data.	[Cunningham, John P.] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Yu, Byron M.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Dept Biomed Engn, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA; [Yu, Byron M.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Yu, Byron M.] Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Columbia University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cunningham, JP (corresponding author), Columbia Univ, Dept Stat, New York, NY 10027 USA.	jpc2181@columbia.edu; byronyu@cmu.edu			Grossman Center for the Statistics of Mind; Simons Foundation [SCGB-325171, SCGB-325233]; Gatsby Charitable Foundation; US National Institutes of Health National Institute of Child Health and Human Development [R01-HD-071686]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071686] Funding Source: NIH RePORTER	Grossman Center for the Statistics of Mind; Simons Foundation; Gatsby Charitable Foundation; US National Institutes of Health National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to the authors and publishers of the works highlighted in Figure 3 for permission to reuse portions of their figures. We thank C. Chandrasekaran, A. Miri, W. Newsome, B. Raman, and the members of the laboratories of A. Batista, S. Chase and M. Churchland for helpful discussion during the preparation of this manuscript. This work was supported by the Grossman Center for the Statistics of Mind (J.P.C.), the Simons Foundation (SCGB-325171 and SCGB-325233 to J.P.C.), the Gatsby Charitable Foundation (J.P.C.) and the US National Institutes of Health National Institute of Child Health and Human Development (R01-HD-071686 to B.M.Y.).	ABELES M, 1995, P NATL ACAD SCI USA, V92, P8616, DOI 10.1073/pnas.92.19.8616; Afshar A, 2011, NEURON, V71, P555, DOI 10.1016/j.neuron.2011.05.047; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Ames KC, 2014, NEURON, V81, P438, DOI 10.1016/j.neuron.2013.11.003; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Bartho P, 2009, EUR J NEUROSCI, V30, P1767, DOI 10.1111/j.1460-9568.2009.06954.x; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Biljana Petreska, 2011, ADV NEURAL INFORM PR, P756; Bollimunta A, 2012, J NEUROSCI, V32, P12684, DOI 10.1523/JNEUROSCI.5752-11.2012; Boots B, 2012, P 29 INT C MACH LEAR, P623; Bouchard KE, 2013, NATURE, V495, P327, DOI 10.1038/nature11911; Brendel W., 2011, ADV NEURAL INF PROCE, V22, P2654; Briggman KL, 2005, SCIENCE, V307, P896, DOI 10.1126/science.1103736; Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Brown EN, 1998, J NEUROSCI, V18, P7411; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Buesing L., 2012, ADV NEURAL INF PROCE, V25, P1691; Carrillo-Reid L, 2008, J NEUROPHYSIOL, V99, P1435, DOI 10.1152/jn.01131.2007; Churchland MM, 2012, NAT NEUROSCI, V15, P1472, DOI 10.1038/nn.3247; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2010, J NEUROSCI, V30, P15241, DOI 10.1523/JNEUROSCI.2171-10.2010; Cowley BR, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066012; Cox D., 1980, POINT PROCESSES; Cunningham JP, 2009, NEURAL NETWORKS, V22, P1235, DOI 10.1016/j.neunet.2009.02.004; Dan G, 2006, ADV NEURAL INFORM PR, V18, P227, DOI 10. 1. 1. 67. 7313& rep = rep1& type = pdf; DIACONIS P, 1984, ANN STAT, V12, P793, DOI 10.1214/aos/1176346703; Durstewitz D, 2010, NEURON, V66, P438, DOI 10.1016/j.neuron.2010.03.029; Ecker AS, 2014, NEURON, V82, P235, DOI 10.1016/j.neuron.2014.02.006; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; Freeman J, 2014, NAT METHODS, V11, P941, DOI [10.1038/NMETH.3041, 10.1038/nmeth.3041]; Geffen MN, 2009, NEURON, V61, P570, DOI 10.1016/j.neuron.2009.01.021; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GERSTEIN GL, 1969, SCIENCE, V164, P828, DOI 10.1126/science.164.3881.828; Gilja V, 2012, NAT NEUROSCI, V15, P1752, DOI 10.1038/nn.3265; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Horwitz GD, 2001, J NEUROPHYSIOL, V86, P2543, DOI 10.1152/jn.2001.86.5.2543; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Jones LM, 2007, P NATL ACAD SCI USA, V104, P18772, DOI 10.1073/pnas.0705546104; Jun JK, 2010, J NEUROSCI, V30, P916, DOI 10.1523/JNEUROSCI.2062-09.2010; Kaufman MT, 2014, NAT NEUROSCI, V17, P440, DOI 10.1038/nn.3643; Kemere C, 2008, J NEUROPHYSIOL, V100, P2441, DOI 10.1152/jn.00924.2007; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kipke DR, 2008, J NEUROSCI, V28, P11830, DOI 10.1523/JNEUROSCI.3879-08.2008; Kulkarni JE, 2007, NETWORK-COMP NEURAL, V18, P375, DOI 10.1080/09548980701625173; Kumar A, 2010, NAT REV NEUROSCI, V11, P615, DOI 10.1038/nrn2886; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Lawhern V, 2010, J NEUROSCI METH, V189, P267, DOI 10.1016/j.jneumeth.2010.03.024; Levi R, 2005, J NEUROSCI, V25, P9807, DOI 10.1523/JNEUROSCI.2249-05.2005; Lin LN, 2005, P NATL ACAD SCI USA, V102, P6125, DOI 10.1073/pnas.0408233102; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Macke J. H., 2011, ADV NEURAL INFORM PR, V24, P1350; Mante V, 2013, NATURE, V503, P78, DOI 10.1038/nature12742; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; McCullagh P., 1998, GEN LINEAR MODELS, V37; Narayanan NS, 2009, J NEUROPHYSIOL, V101, P2859, DOI 10.1152/jn.90615.2008; Nawrot MP, 2008, J NEUROSCI METH, V169, P374, DOI 10.1016/j.jneumeth.2007.10.013; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; OVERSCHEE PV, 1996, SUBSPACE IDENTIFICAT; Paninski L., 2013, ADV NEURAL INF PROCE, V26, P2391; Paninski L, 2010, J COMPUT NEUROSCI, V29, P107, DOI 10.1007/s10827-009-0179-x; Paz R, 2005, J NEUROSCI, V25, P10941, DOI 10.1523/JNEUROSCI.0164-05.2005; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Ponce-Alvarez A, 2012, J NEUROSCI, V32, P11956, DOI 10.1523/JNEUROSCI.6176-11.2012; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Roweis S, 1999, NEURAL COMPUT, V11, P305, DOI 10.1162/089976699300016674; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Sadtler P.T., NATURE IN PRESS; Saha D, 2013, NAT NEUROSCI, V16, P1830, DOI 10.1038/nn.3570; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Sanger TD, 2014, NAT NEUROSCI, V17, P338, DOI 10.1038/nn.3663; Santhanam G, 2009, J NEUROPHYSIOL, V102, P1315, DOI 10.1152/jn.00097.2009; Sasaki T, 2007, J NEUROSCI, V27, P517, DOI 10.1523/JNEUROSCI.4514-06.2007; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Seidemann E, 1996, J NEUROSCI, V16, P752; Shenoy KV, 2013, ANNU REV NEUROSCI, V36, P337, DOI 10.1146/annurev-neuro-062111-150509; Shimazaki H, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002385; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Smith AC, 2003, NEURAL COMPUT, V15, P965, DOI 10.1162/089976603765202622; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Stokes MG, 2013, NEURON, V78, P364, DOI 10.1016/j.neuron.2013.01.039; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Vidne M, 2012, J COMPUT NEUROSCI, V33, P97, DOI 10.1007/s10827-011-0376-2; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Yu BM, 2006, ADV NEURAL INF PROCE, V18, P1545; Yu BM, 2009, J NEUROPHYSIOL, V102, P614, DOI 10.1152/jn.90941.2008	100	467	471	13	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2014	17	11					1500	1509		10.1038/nn.3776	http://dx.doi.org/10.1038/nn.3776			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AS0LT	25151264	Green Accepted			2022-12-17	WOS:000343969300014
J	Hack, MA; Saghatelyan, A; de Chevigny, A; Pfeifer, A; Ashery-Padan, R; Lledo, PM; Gotz, M				Hack, MA; Saghatelyan, A; de Chevigny, A; Pfeifer, A; Ashery-Padan, R; Lledo, PM; Gotz, M			Neuronal fate determinants of adult olfactory bulb neurogenesis	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; NEWLY GENERATED NEURONS; SUBVENTRICULAR ZONE; MOUSE FOREBRAIN; MAMMALIAN BRAIN; MIGRATION; PAX6; SPECIFICATION; OLIG2; PROGENITORS	Adult neurogenesis in mammals is restricted to two small regions, including the olfactory bulb, where GABAergic and dopaminergic interneurons are newly generated throughout the entire lifespan. However, the mechanisms directing them towards a specific neuronal phenotype are not yet understood. Here, we demonstrate the dual role of the transcription factor Pax6 in generating neuronal progenitors and also in directing them towards a dopaminergic periglomerular phenotype in adult mice. We present further evidence that dopaminergic periglomerular neurons originate in a distinct niche, the rostral migratory stream, and are fewer derived from precursors in the zone lining the ventricle. This regionalization of the adult precursor cells is further supported by the restricted expression of the transcription factor Olig2, which specifies transit-amplifying precursor fate and opposes the neurogenic role of Pax6. Together, these data explain both extrinsic and intrinsic mechanisms controlling neuronal identity in adult neurogenesis.	GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany; Inst Pasteur, CNRS, Unite Rech Associee 2182, Lab Percept & Memory, F-75724 Paris, France; Univ Munich, Ctr Drug Res, Dept Pharm, D-81377 Munich, Germany; Sackler Fac Med, Dept Human Genet & Mol Med, IL-69987 Tel Aviv, Israel; Univ Munich, Inst Physiol, D-80336 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Munich; Tel Aviv University; Sackler Faculty of Medicine; University of Munich	Gotz, M (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	pmlledo@pasteur.fr; magdalena.goetz@gsf.de	Messier, Claude/A-2322-2008; de Chevigny, Antoine/M-7477-2016	Messier, Claude/0000-0002-4791-1763; de Chevigny, Antoine/0000-0002-7413-0591; Gotz, Magdalena/0000-0003-1551-9203; Saghatelyan, Armen/0000-0003-4962-0465				ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bedard A, 2004, DEV BRAIN RES, V151, P159, DOI 10.1016/j.devbrainres.2004.03.021; Beech RD, 2004, J COMP NEUROL, V475, P128, DOI 10.1002/cne.20179; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Huisman E, 2004, MOVEMENT DISORD, V19, P687, DOI 10.1002/mds.10713; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KOSAKA K, 1995, NEUROSCI RES, V23, P73, DOI 10.1016/0168-0102(95)00930-R; Kosaka K, 1998, NEUROSCI RES, V30, P101, DOI 10.1016/S0168-0102(98)00002-9; KOSAKA T, 1985, BRAIN RES, V343, P166, DOI 10.1016/0006-8993(85)91172-2; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Yamasaki T, 2001, DEVELOPMENT, V128, P3133; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	41	467	488	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					865	872		10.1038/nn1479	http://dx.doi.org/10.1038/nn1479			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15951811				2022-12-17	WOS:000230137100013
J	Yoon, K; Gaiano, N				Yoon, K; Gaiano, N			Notch signaling in the mammalian central nervous system: insights from mouse mutants	NATURE NEUROSCIENCE			English	Review							NEURAL STEM-CELLS; SYNAPTIC PLASTICITY; DROSOPHILA HOMOLOG; PROGENITOR CELLS; DELTA HOMOLOG; MICE LACKING; RADIAL GLIA; NUMB; DIFFERENTIATION; DEFECTS	The Notch pathway, although originally identified in fruit flies, is now among the most heavily studied in mammalian biology. In mice, loss-of-function and gain-of-function work has demonstrated that Notch signaling is essential both during development and in the adult in a multitude of tissues. Prominent among these is the CNS, where Notch has been implicated in processes ranging from neural stem cell regulation to learning and memory. Here we review the role of Notch in the mammalian CNS by focusing specifically on mutations generated in mice. These mutations have provided critical insight into Notch function in the CNS and have led to the identification of promising new directions that are likely to generate important discoveries in the future.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Gaiano, N (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gaiano@jhmi.edu		Yoon, Keejung/0000-0002-2361-9039				Arias AM, 2002, CURR OPIN GENET DEV, V12, P524, DOI 10.1016/S0959-437X(02)00336-2; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; FEDER JN, 1993, MOL CELL BIOL, V13, P105, DOI 10.1128/MCB.13.1.105; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Franklin JL, 1999, CURR BIOL, V9, P1448, DOI 10.1016/S0960-9822(00)80114-1; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; FURUKAWA T, 1992, CELL, V69, P1191, DOI 10.1016/0092-8674(92)90640-X; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Handler M, 2000, DEVELOPMENT, V127, P2593; Hartmann D, 1999, CURR BIOL, V9, P719, DOI 10.1016/S0960-9822(99)80331-5; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hojo M, 2000, DEVELOPMENT, V127, P2515; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; Huang EJ, 2005, GENE DEV, V19, P138, DOI 10.1101/gad.1246005; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Klein AL, 2004, DEV BIOL, V266, P161, DOI 10.1016/j.ydbio.2003.10.017; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Krebs LT, 2000, GENE DEV, V14, P1343; Kusumi K, 2004, GENESIS, V39, P115, DOI 10.1002/gene.20034; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lutolf S, 2002, DEVELOPMENT, V129, P373; McCright B, 2001, DEVELOPMENT, V128, P491; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; OKA C, 1995, DEVELOPMENT, V121, P3291; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Sakamoto M, 2003, J BIOL CHEM, V278, P44808, DOI 10.1074/jbc.M300448200; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; SCHWEISGUTH F, 1992, CELL, V69, P1199, DOI 10.1016/0092-8674(92)90641-O; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Sidow A, 1997, NATURE, V389, P722, DOI 10.1038/39587; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Wang SL, 2000, NEURON, V27, P197, DOI 10.1016/S0896-6273(00)00028-3; Wang Y, 2004, P NATL ACAD SCI USA, V101, P9458, DOI 10.1073/pnas.0308126101; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yamamoto N, 2001, J BIOL CHEM, V276, P45031, DOI 10.1074/jbc.M105245200; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Yun K, 2002, DEVELOPMENT, V129, P5029; Zhang N, 2002, GENESIS, V33, P21, DOI 10.1002/gene.10081; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2; Zhong WM, 2000, P NATL ACAD SCI USA, V97, P6844, DOI 10.1073/pnas.97.12.6844; Zhong WM, 2003, NEURON, V37, P11, DOI 10.1016/S0896-6273(02)01178-9; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	87	466	488	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					709	715		10.1038/nn1475	http://dx.doi.org/10.1038/nn1475			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15917835				2022-12-17	WOS:000229345300008
J	Saher, G; Brugger, B; Lappe-Siefke, C; Mobius, W; Tozawa, R; Wehr, MC; Wieland, F; Ishibashi, S; Nave, KA				Saher, G; Brugger, B; Lappe-Siefke, C; Mobius, W; Tozawa, R; Wehr, MC; Wieland, F; Ishibashi, S; Nave, KA			High cholesterol level is essential for myelin membrane growth	NATURE NEUROSCIENCE			English	Article							PROTEOLIPID PROTEIN; SQUALENE SYNTHASE; EMBRYONIC LETHALITY; NERVOUS-SYSTEM; SONIC HEDGEHOG; BASIC-PROTEIN; CELL-SURFACE; SPINAL-CORD; MICE; EXPRESSION	Cholesterol in the mammalian brain is a risk factor for certain neurodegenerative diseases, raising the question of its normal function. In the mature brain, the highest cholesterol content is found in myelin. We therefore created mice that lack the ability to synthesize cholesterol in myelin-forming oligodendrocytes. Mutant oligodendrocytes survived, but CNS myelination was severely perturbed, and mutant mice showed ataxia and tremor. CNS myelination continued at a reduced rate for many months, and during this period, the cholesterol-deficient oligodendrocytes actively enriched cholesterol and assembled myelin with > 70% of the cholesterol content of wild-type myelin. This shows that cholesterol is an indispensable component of myelin membranes and that cholesterol availability in oligodendrocytes is a rate-limiting factor for brain maturation.	Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; Univ Tokyo, Dept Metab Dis, Tokyo 1138655, Japan; Hertie Inst Multiple Sclerosis Res, D-37075 Gottingen, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Utrecht University; Utrecht University Medical Center; University of Tokyo	Nave, KA (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany.	nave@em.mpg.de	Saher, Gesine/AAH-1826-2021; Taylor, Graham/A-4027-2012; Wehr, Michael/J-7989-2019; Nave, Klaus-Armin/C-8883-2011	Saher, Gesine/0000-0003-3507-9604; Wehr, Michael/0000-0003-1770-8323; /0000-0002-2902-7165				Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; Belachew S, 2001, DEV NEUROSCI-BASEL, V23, P287, DOI 10.1159/000048712; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFUTE DL, 1992, J BIOL CHEM, V267, P18308; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Gallyas F, 1979, Neurol Res, V1, P203; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Gu PD, 1998, J BIOL CHEM, V273, P12515, DOI 10.1074/jbc.273.20.12515; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Huber AB, 2002, J NEUROSCI, V22, P3553; JONES BJ, 1968, N-S ARCH PHARMAKOL, V259, P211, DOI 10.1007/BF00537801; JOYNER AL, 1991, BIOESSAYS, V13, P649, DOI 10.1002/bies.950131206; Jung M, 1996, J NEUROSCI, V16, P7920; Jurevics H, 2003, J NEUROSCI RES, V71, P826, DOI 10.1002/jnr.10544; KIM SU, 1975, LAB INVEST, V32, P720; Kramer EM, 2001, MICROSC RES TECHNIQ, V52, P656, DOI 10.1002/jemt.1050; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Larocca JN, 2002, NEUROCHEM RES, V27, P1313, DOI 10.1023/A:1021667515030; Lazzarini R., 2003, MYELIN BIOL DISORDER; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Marcus J, 2002, BBA-GEN SUBJECTS, V1573, P406, DOI 10.1016/S0304-4165(02)00410-5; Michikawa M, 1999, J NEUROCHEM, V72, P2278, DOI 10.1046/j.1471-4159.1999.0722278.x; Morell P, 1996, NEUROCHEM RES, V21, P463, DOI 10.1007/BF02527711; NAVE KA, 2003, MYELIN BIOL DISORDER, V2, P1125; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Nwokoro NA, 2001, MOL GENET METAB, V74, P105, DOI 10.1006/mgme.2001.3226; Ohashi K, 2003, J BIOL CHEM, V278, P42936, DOI 10.1074/jbc.M307228200; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Peters A, 1991, FINE STRUCTURE NERVO; Pfrieger FW, 2003, BIOESSAYS, V25, P72, DOI 10.1002/bies.10195; Plonne D, 1999, ANAL BIOCHEM, V276, P88, DOI 10.1006/abio.1999.4311; POPKO B, 1987, CELL, V48, P713, DOI 10.1016/0092-8674(87)90249-2; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Sandhoff R, 1999, J LIPID RES, V40, P126; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sereda MW, 2003, NAT MED, V9, P1533, DOI 10.1038/nm957; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons M, 2002, J CELL BIOL, V157, P327, DOI 10.1083/jcb.200110138; Simons M, 2000, J CELL BIOL, V151, P143, DOI 10.1083/jcb.151.1.143; Stoffel W, 1997, CURR OPIN NEUROBIOL, V7, P654, DOI 10.1016/S0959-4388(97)80085-2; Tozawa R, 1999, J BIOL CHEM, V274, P30843, DOI 10.1074/jbc.274.43.30843; Verheijen MHG, 2003, GENE DEV, V17, P2450, DOI 10.1101/gad.1116203; Wechsler A, 2003, SCIENCE, V302, P2087, DOI 10.1126/science.1090776	49	466	471	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2005	8	4					468	475		10.1038/nn1426	http://dx.doi.org/10.1038/nn1426			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	911XP	15793579				2022-12-17	WOS:000228040400017
J	Morris, JA; Jordan, CL; Breedlove, SM				Morris, JA; Jordan, CL; Breedlove, SM			Sexual differentiation of the vertebrate nervous system	NATURE NEUROSCIENCE			English	Review							DIMORPHIC MOTOR NUCLEUS; CONGENITAL ADRENAL-HYPERPLASIA; MOSAIC ANDROGEN INSENSITIVITY; GENDER-ROLE BEHAVIOR; FINCH SONG SYSTEM; SPINAL-CORD; PREOPTIC AREA; SIBERIAN HAMSTER; MEDIAL AMYGDALA; TESTOSTERONE PROPIONATE	Understanding the mechanisms that give rise to sex differences in the behavior of nonhuman animals may contribute to the understanding of sex differences in humans. In vertebrate model systems, a single factor-the steroid hormone testosterone-accounts for most, and perhaps all, of the known sex differences in neural structure and behavior. Here we review some of the events triggered by testosterone that masculinize the developing and adult nervous system, promote male behaviors and suppress female behaviors. Testosterone often sculpts the developing nervous system by inhibiting or exacerbating cell death and/or by modulating the formation and elimination of synapses. Experience, too, can interact with testosterone to enhance or diminish its effects on the central nervous system. However, more work is needed to uncover the particular cells and specific genes on which testosterone acts to initiate these events.	Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA	Michigan State University	Breedlove, SM (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.	breedsm@msu.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Breedlove, S. Marc/0000-0003-4359-4315				Agate RJ, 2003, P NATL ACAD SCI USA, V100, P4873, DOI 10.1073/pnas.0636925100; Amateau SK, 2004, NAT NEUROSCI, V7, P643, DOI 10.1038/nn1254; Amateau SK, 2002, J NEUROSCI, V22, P8586; [Anonymous], PHYSL REPRODUCTION, DOI DOI 10.1016/B978-012532104-4/50003-2; ARNOLD AP, 1975, J EXP ZOOL, V191, P309, DOI 10.1002/jez.1401910302; Arnold AP, 1996, DEV NEUROSCI-BASEL, V18, P124, DOI 10.1159/000111400; Arnold AP, 1996, HORM BEHAV, V30, P495, DOI 10.1006/hbeh.1996.0053; Arnold AP, 2004, ENDOCRINOLOGY, V145, P1057, DOI 10.1210/en.2003-1491; Berenbaum SA, 1999, HORM BEHAV, V35, P102, DOI 10.1006/hbeh.1998.1503; BREEDLOVE SM, 1981, BRAIN RES, V225, P297; BREEDLOVE SM, 1980, SCIENCE, V210, P564, DOI 10.1126/science.7423210; Brenowitz EA, 2002, P NATL ACAD SCI USA, V99, P12421, DOI 10.1073/pnas.192308799; CIHAK R, 1970, J ANAT, V106, P93; Cooke BM, 2003, HORM BEHAV, V43, P336, DOI 10.1016/S0018-506X(02)00047-8; Cooke BM, 2002, J BIOL RHYTHM, V17, P147, DOI 10.1177/074873002129002438; Cooke BM, 2001, NEUROSCI LETT, V312, P9, DOI 10.1016/S0304-3940(01)02173-5; Cooke BM, 1999, P NATL ACAD SCI USA, V96, P7538, DOI 10.1073/pnas.96.13.7538; Davis EC, 1996, BRAIN RES, V734, P10, DOI 10.1016/0006-8993(96)00298-3; De Vries GJ, 2002, J NEUROSCI, V22, P9005; DEJONGE FH, 1989, BRAIN RES BULL, V23, P483, DOI 10.1016/0361-9230(89)90194-9; DOHLER KD, 1984, BRAIN RES, V302, P291, DOI 10.1016/0006-8993(84)90242-7; FORGER NG, 1995, J NEUROBIOL, V28, P354, DOI 10.1002/neu.480280308; Forger NG, 1997, J NEUROSCI, V17, P9605; FORGER NG, 1992, HORM BEHAV, V26, P204, DOI 10.1016/0018-506X(92)90042-T; FORGER NG, 1993, J NEUROSCI, V13, P4720; Forger NG, 2003, J NEUROSCI, V23, P8854; FORGER NG, 1986, P NATL ACAD SCI USA, V83, P7527, DOI 10.1073/pnas.83.19.7527; Freeman LM, 1996, HORM BEHAV, V30, P424, DOI 10.1006/hbeh.1996.0047; GORSKI RA, 1978, BRAIN RES, V148, P333, DOI 10.1016/0006-8993(78)90723-0; GRISHAM W, 1994, J NEUROBIOL, V25, P185, DOI 10.1002/neu.480250209; GURNEY ME, 1981, J NEUROSCI, V1, P658; Hegstrom CD, 2002, J NEUROENDOCRINOL, V14, P368, DOI 10.1046/j.0007-1331.2002.00791.x; Hines M, 2004, J SEX RES, V41, P75, DOI 10.1080/00224490409552215; Holloway CC, 2001, NAT NEUROSCI, V4, P170, DOI 10.1038/84001; Holmes MM, 2004, J COMP NEUROL, V471, P180, DOI 10.1002/cne.20027; Ibanez MA, 2001, J NEUROSCI, V21, P5652, DOI 10.1523/JNEUROSCI.21-15-05652.2001; KONISHI M, 1987, CIBA F SYMP, V126, P173; LEVAY S, 1991, SCIENCE, V253, P1034, DOI 10.1126/science.1887219; Martin JT, 2004, HORM BEHAV, V45, P31, DOI 10.1016/j.yhbeh.2003.07.003; McFadden D, 1998, P NATL ACAD SCI USA, V95, P2709, DOI 10.1073/pnas.95.5.2709; MONEY J, 1968, JOHNS HOPKINS MED J, V123, P105; Monks DA, 1999, J NEUROSCI, V19, P5597; Morris J. A., 2003, Hormones and Behavior, V44, P65; NORDEEN EJ, 1985, SCIENCE, V229, P671, DOI 10.1126/science.4023706; NOTTEBOHM F, 1980, BRAIN RES, V189, P429, DOI 10.1016/0006-8993(80)90102-X; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Park JJ, 1998, J NEUROBIOL, V34, P242, DOI 10.1002/(SICI)1097-4695(19980215)34:3<242::AID-NEU4>3.0.CO;2-2; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Rahman Q, 2003, BEHAV NEUROSCI, V117, P1096, DOI 10.1037/0735-7044.117.5.1096; Roselli CE, 2004, ENDOCRINOLOGY, V145, P478, DOI 10.1210/en.2003-1098; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Wagner CK, 2004, ENDOCRINOLOGY, V145, P1046, DOI 10.1210/en.2003-1219; Watson NV, 2001, J NEUROSCI, V21, P1062, DOI 10.1523/JNEUROSCI.21-03-01062.2001; Williams TJ, 2000, NATURE, V404, P455, DOI 10.1038/35006555; Wilson JD, 1999, ENDOCR REV, V20, P726, DOI 10.1210/er.20.5.726; Wisniewski AB, 2000, J CLIN ENDOCR METAB, V85, P2664, DOI 10.1210/jc.85.8.2664; Xu J, 2001, J NEUROSCI, V21, P4366, DOI 10.1523/JNEUROSCI.21-12-04366.2001; YOUNG JK, 1982, BRAIN RES, V239, P233, DOI 10.1016/0006-8993(82)90844-7; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; ZHOU L, 1994, ENDOCRINOLOGY, V134, P2622, DOI 10.1210/en.134.6.2622; Zup SL, 2003, J NEUROSCI, V23, P2357	63	466	471	0	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2004	7	10					1034	1039		10.1038/nn1325	http://dx.doi.org/10.1038/nn1325			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	857YQ	15452574				2022-12-17	WOS:000224156900010
J	Herrup, K				Herrup, Karl			The case for rejecting the amyloid cascade hypothesis	NATURE NEUROSCIENCE			English	Article							NEURONAL CELL-DEATH; ALZHEIMERS ASSOCIATION WORKGROUPS; MILD COGNITIVE IMPAIRMENT; TRANSGENIC MOUSE MODELS; A-BETA; DNA-DAMAGE; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; CYCLE EVENTS; SYNAPSE LOSS	Alzheimer's disease (AD) is a biologically complex neurodegenerative dementia. Nearly 20 years ago, with the combination of observations from biochemistry, neuropathology and genetics, a compelling hypothesis known as the amyloid cascade hypothesis was formulated. The core of this hypothesis is that it is pathological accumulations of amyloid-beta, a peptide fragment of a membrane protein called amyloid precursor protein, that act as the root cause of AD and initiate its pathogenesis. Yet, with the passage of time, growing amounts of data have accumulated that are inconsistent with the basically linear structure of this hypothesis. And while there is fear in the field over the consequences of rejecting it outright, clinging to an inaccurate disease model is the option we should fear most. This Perspective explores the proposition that we are over-reliant on amyloid to define and diagnose AD and that the time has come to face our fears and reject the amyloid cascade hypothesis.	[Herrup, Karl] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Herrup, Karl] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Herrup, K (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	herrup@ust.hk	Herrup, Karl/C-5313-2014	Herrup, Karl/0000-0001-7786-5844	Hong Kong University of Science and Technology; National Key Basic Research Program of China [2013CB530900]; Research Grants Council; Hong Kong Special Administrative Region [GRF660813]; BrightFocus Foundation [A2012101]	Hong Kong University of Science and Technology; National Key Basic Research Program of China(National Basic Research Program of China); Research Grants Council(Hong Kong Research Grants Council); Hong Kong Special Administrative Region; BrightFocus Foundation(BrightFocus Foundation)	The author thanks his many friends and colleagues whose spirited discussions over the years have helped sharpen the arguments raised here. Special thanks to S. Herculano-Houzel for her critical and insightful reading of an early draft of the work. Support for the writing came from The Hong Kong University of Science and Technology, the National Key Basic Research Program of China (2013CB530900), the Research Grants Council, Hong Kong Special Administrative Region (GRF660813) and the BrightFocus Foundation (A2012101).	[Anonymous], [No title captured], DOI DOI 10.1111/ENE.12398; Arendt T, 2010, AM J PATHOL, V177, P15, DOI 10.2353/ajpath.2010.090955; Arendt T, 2009, ACTA NEUROPATHOL, V118, P167, DOI 10.1007/s00401-009-0536-x; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Boeras DI, 2008, NEUROBIOL AGING, V29, P319, DOI 10.1016/j.neurobiolaging.2006.10.027; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Bucholtz N, 2013, DNA REPAIR, V12, P811, DOI 10.1016/j.dnarep.2013.07.005; Busser J, 1998, J NEUROSCI, V18, P2801; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Canugovi C, 2013, DNA REPAIR, V12, P578, DOI 10.1016/j.dnarep.2013.04.010; Cholerton B, 2013, EUR J PHARMACOL, V719, P170, DOI 10.1016/j.ejphar.2013.08.008; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Coppede F, 2009, CURR ALZHEIMER RES, V6, P36, DOI 10.2174/156720509787313970; Cotman CW, 1996, BRAIN PATHOL, V6, P493, DOI 10.1111/j.1750-3639.1996.tb00878.x; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Herrup K, 2013, DNA REPAIR, V12, P600, DOI 10.1016/j.dnarep.2013.04.012; Herrup K, 2012, ADV BIOL PSYCH-KARG, V28, P30; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Hochgrafe K, 2013, FEBS J, V280, P4371, DOI 10.1111/febs.12250; Hock B J Jr, 2001, Trends Genet, V17, pS7, DOI 10.1016/S0168-9525(01)02449-0; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hunter S, 2013, MOL NEUROBIOL, V48, P556, DOI 10.1007/s12035-013-8445-3; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Iourov IY, 2009, NEUROBIOL DIS, V34, P212, DOI 10.1016/j.nbd.2009.01.003; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; KHACHATURIAN ZS, 1987, NEUROBIOL AGING, V8, P345, DOI 10.1016/0197-4580(87)90073-X; Kim J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-15; Kitazawa M, 2012, CURR PHARM DESIGN, V18, P1131, DOI 10.2174/138161212799315786; Klunk W, 2009, PET EVALUATION ALZHE, P119; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Krstic D, 2013, NAT REV NEUROL, V9, P25, DOI 10.1038/nrneurol.2012.236; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; LaFerla FM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006320; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Mathis CA, 2002, BIOORG MED CHEM LETT, V12, P295, DOI 10.1016/S0960-894X(01)00734-X; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McShea A, 1997, AM J PATHOL, V150, P1933; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Mouton-Liger F, 2012, BBA-MOL BASIS DIS, V1822, P885, DOI 10.1016/j.bbadis.2012.01.009; Nagy Z, 1997, ACTA NEUROPATHOL, V94, P6, DOI 10.1007/s004010050665; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Nixon RA, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P277; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Schellenberg GD, 2012, ACTA NEUROPATHOL, V124, P305, DOI 10.1007/s00401-012-0996-2; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045; Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tanzi Rudolph E, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006296; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Varvel NH, 2008, J NEUROSCI, V28, P10786, DOI 10.1523/JNEUROSCI.2441-08.2008; Vellas B, 2013, ALZHEIMERS DEMENT, V9, P438, DOI 10.1016/j.jalz.2013.03.007; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; Wang RS, 2013, CELL METAB, V17, P685, DOI 10.1016/j.cmet.2013.03.016; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Weissman L, 2009, NEUROBIOL AGING, V30, P2080, DOI 10.1016/j.neurobiolaging.2008.02.014; Whalen BM, 2005, NEUROBIOL DIS, V20, P254, DOI 10.1016/j.nbd.2005.03.007; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001; Yang Y, 2003, J NEUROSCI, V23, P2557; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yu JT, 2009, PROG NEUROBIOL, V89, P240, DOI 10.1016/j.pneurobio.2009.07.009; Zhang W, 2007, NUCL MED BIOL, V34, P89, DOI 10.1016/j.nucmedbio.2006.10.003; Zhu XW, 2006, J ALZHEIMERS DIS, V9, P147; Zweig R M, 1989, Prog Clin Biol Res, V317, P353; ZWEIG RM, 1988, ANN NEUROL, V24, P233, DOI 10.1002/ana.410240210	100	463	476	1	206	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2015	18	6					794	799		10.1038/nn.4017	http://dx.doi.org/10.1038/nn.4017			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CJ1CB	26007212				2022-12-17	WOS:000355218300006
J	Schneider, P; Scherg, M; Dosch, HG; Specht, HJ; Gutschalk, A; Rupp, A				Schneider, P; Scherg, M; Dosch, HG; Specht, HJ; Gutschalk, A; Rupp, A			Morphology of Heschl's gyrus reflects enhanced activation in the auditory cortex of musicians	NATURE NEUROSCIENCE			English	Article							ABSOLUTE PITCH; CORTICAL REPRESENTATION; VOLUME MEASUREMENT; BRAIN; FREQUENCY; ASYMMETRY; ORGANIZATION; PLASTICITY; POTENTIALS; PERCEPTION	Using magnetoencephalography (MEG), we compared the processing of sinusoidal tones in the auditory cortex of 12 non-musicians, 12 professional musicians and 13 amateur musicians. We found neurophysiological and anatomical differences between groups. In professional musicians as compared to non-musicians, the activity evoked in primary auditory cortex 19-30 ms after stimulus onset was 102% larger, and the gray matter volume of the anteromedial portion of Heschl's gyrus was 130% larger. Both quantities were highly correlated with musical aptitude, as measured by psychometric evaluation. These results indicate that both the morphology and neurophysiology of Heschl's gyrus have an essential impact on musical aptitude.	Heidelberg Univ, Dept Phys, D-69120 Heidelberg, Germany; Univ Heidelberg Hosp, Dept Neurol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schneider, P (corresponding author), Heidelberg Univ, Dept Phys, Philosophenweg 12, D-69120 Heidelberg, Germany.	Peter_Schneider@med.uni-heidelberg.de	; Specht, Karsten/C-3762-2009	Schneider, Peter/0000-0002-1920-0438; Specht, Karsten/0000-0002-9946-3704				ALTENMULLER E, 1986, EUR ARCH PSY CLIN N, V235, P342, DOI 10.1007/BF00381003; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; BRAAK H, 1978, ANAT EMBRYOL, V154, P213, DOI 10.1007/BF00304663; CRUMMER GC, 1994, J ACOUST SOC AM, V95, P2720, DOI 10.1121/1.409840; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; GALABURDA A, 1980, J COMP NEUROL, V190, P597, DOI 10.1002/cne.901900312; Gordon EdwinE., 1997, LEARNING SEQUENCES M; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hirata Y, 1999, NEUROREPORT, V10, P999, DOI 10.1097/00001756-199904060-00019; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Leonard CM, 1998, CEREB CORTEX, V8, P397, DOI 10.1093/cercor/8.5.397; LIEGEOISCHAUVEL C, 1994, ELECTROEN CLIN NEURO, V92, P204, DOI 10.1016/0168-5597(94)90064-7; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; Menning H, 2000, NEUROREPORT, V11, P817, DOI 10.1097/00001756-200003200-00032; Meyer A., 1977, MUSIC BRAIN, P255; Monaghan P, 1998, NATURE, V394, P434, DOI 10.1038/28775; Morosan P, 2001, NEUROIMAGE, V13, P684, DOI 10.1006/nimg.2000.0715; Munte TF, 2001, NATURE, V409, P580, DOI 10.1038/35054668; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Patel AD, 2001, NAT NEUROSCI, V4, P839, DOI 10.1038/90557; Penhune VB, 1996, CEREB CORTEX, V6, P661, DOI 10.1093/cercor/6.5.661; Preis S, 1999, BRAIN COGNITION, V40, P441, DOI 10.1006/brcg.1998.1072; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; RADEMACHER J, 1993, CEREB CORTEX, V3, P313, DOI 10.1093/cercor/3.4.313; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rivier F, 1997, NEUROIMAGE, V6, P288, DOI 10.1006/nimg.1997.0304; Rupp A, 2000, NEUROREPORT, V11, P3731, DOI 10.1097/00001756-200011270-00028; SCHERG M, 1986, ELECTROEN CLIN NEURO, V65, P344, DOI 10.1016/0168-5597(86)90014-6; SCHERG M, 1985, ELECTROEN CLIN NEURO, V62, P32, DOI 10.1016/0168-5597(85)90033-4; SCHERG M, 1990, ADV AUDIOL, V6, P165; Schiavetto A, 1999, NEUROREPORT, V10, P2467, DOI 10.1097/00001756-199908200-00006; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; SCHNEIDER P, 2000, SOURCE ACTIVITY TONO; SOMOGYI J, 1930, MSCHR PSYCHAT NEUROL, V75, P113; STEINMETZ H, 1989, J COMPUT ASSIST TOMO, V13, P996, DOI 10.1097/00004728-198911000-00011; Talavage TM, 2000, HEARING RES, V150, P225, DOI 10.1016/S0378-5955(00)00203-3; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Wallace MN, 2002, EXP BRAIN RES, V143, P499, DOI 10.1007/s00221-002-1014-z; WAYMAN JW, 1992, J ACOUST SOC AM, V91, P3527, DOI 10.1121/1.402841; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Yakovlev PL, 1967, REGIONAL DEV BRAIN E, P3; Zatorre R. J., 2000, BRAIN MAPPING SYSTEM, P365; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zatorre RJ, 2001, CEREB CORTEX, V11, P946, DOI 10.1093/cercor/11.10.946; ZATORRE RJ, 2001, ANN NY ACAD SCI, V930	50	463	475	1	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					688	694		10.1038/nn871	http://dx.doi.org/10.1038/nn871			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12068300				2022-12-17	WOS:000176414300020
J	Mack, TGA; Reiner, M; Beirowski, B; Mi, WQ; Emanuelli, M; Wagner, D; Thomson, D; Gillingwater, T; Court, F; Conforti, L; Fernando, FS; Tarlton, A; Andressen, C; Addicks, K; Magni, G; Ribchester, RR; Perry, VH; Coleman, MP				Mack, TGA; Reiner, M; Beirowski, B; Mi, WQ; Emanuelli, M; Wagner, D; Thomson, D; Gillingwater, T; Court, F; Conforti, L; Fernando, FS; Tarlton, A; Andressen, C; Addicks, K; Magni, G; Ribchester, RR; Perry, VH; Coleman, MP			Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD INJURY; NEUROMUSCULAR-JUNCTIONS; C57BL/OLA MICE; POLY(ADP-RIBOSE) POLYMERASE; BCL-2 OVEREXPRESSION; CELLULAR REACTIONS; MUTATION WLD(S); WILD-TYPE; MOUSE; NERVE	Axons and their synapses distal to an injury undergo rapid Wallerian degeneration, but axons in the C57BL/Wld(S) mouse are protected. The degenerative and protective mechanisms are unknown. We identified the protective gene, which encodes an N-terminal fragment of ubiquitination factor E4B (Ube4b) fused to nicotinamide mononucleotide adenylyltransferase (Nmnat), and showed that it confers a dose-dependent block of Wallerian degeneration. Transected distal axons survived for two weeks, and neuromuscular junctions were also protected. Surprisingly, the Wld protein was located predominantly in the nucleus, indicating an indirect protective mechanism. Nmnat enzyme activity, but not NAD(+) content, was increased fourfold in Wld(S) tissues. Thus, axon protection is likely to be mediated by altered ubiquitination or pyridine nucleotide metabolism.	Univ Cologne, Ctr Mol Med, D-50674 Cologne, Germany; Univ Cologne, Inst Genet, D-50674 Cologne, Germany; Univ Cologne, Dept Anat 1, D-50931 Cologne, Germany; Univ Ancona, Inst Biochem, I-60131 Ancona, Italy; Univ Edinburgh, Dept Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Mario Negri Inst Pharmacol Res, Mol Neurobiol Lab, I-20157 Milan, Italy; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England	University of Cologne; University of Cologne; University of Cologne; Marche Polytechnic University; University of Edinburgh; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Oxford; University of Oxford; University of Southampton	Coleman, MP (corresponding author), Univ Cologne, Ctr Mol Med, Zuelpicher Str 47, D-50674 Cologne, Germany.	michael.coleman@uni-koeln.de	Perry, V. Hugh/Y-2935-2019	Court, Felipe/0000-0002-9394-7601; Ribchester, Richard/0000-0003-2670-6995; Gillingwater, Thomas/0000-0002-0306-5577				BALDUCCI E, 1995, ANAL BIOCHEM, V228, P64, DOI 10.1006/abio.1995.1315; BROWN MC, 1991, NEUROSCIENCE, V43, P279, DOI 10.1016/0306-4522(91)90435-Q; BUCKMASTER EA, 1995, EUR J NEUROSCI, V7, P1596, DOI 10.1111/j.1460-9568.1995.tb01155.x; Burne JF, 1996, J NEUROSCI, V16, P2064; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Conforti L, 1999, MAMM GENOME, V10, P617, DOI 10.1007/s003359901056; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Costanzo EM, 2000, NAT NEUROSCI, V3, P694, DOI 10.1038/76649; Costanzo EM, 1999, J PHYSIOL-LONDON, V521, P365, DOI 10.1111/j.1469-7793.1999.00365.x; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Finn JT, 2000, J NEUROSCI, V20, P1333; Frei R, 1999, J NEUROSCI, V19, P6058, DOI 10.1523/JNEUROSCI.19-14-06058.1999; Fujiki M, 1996, J COMP NEUROL, V371, P469; Gillingwater TH, 2000, J PHYSIOL-LONDON, V523, p53P; Gillingwater TH, 2001, J PHYSIOL-LONDON, V534, P627, DOI 10.1111/j.1469-7793.2001.00627.x; GLASS JD, 1993, J NEUROCYTOL, V22, P311, DOI 10.1007/BF01195555; Glynn P, 2000, PROG NEUROBIOL, V61, P61, DOI 10.1016/S0301-0082(99)00043-X; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hamilton MH, 2001, J BIOL CHEM, V276, P26324, DOI 10.1074/jbc.M101205200; Houseweart MK, 1999, J NEUROSCI, V19, P6446; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; LYON MF, 1993, P NATL ACAD SCI USA, V90, P9717, DOI 10.1073/pnas.90.20.9717; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; MI W, IN PRESS J NEUROSCI; Nagayama T, 2000, J NEUROCHEM, V74, P1636, DOI 10.1046/j.1471-4159.2000.0741636.x; PERRY VH, 1991, EUR J NEUROSCI, V3, P102, DOI 10.1111/j.1460-9568.1991.tb00815.x; Perry VH, 1999, PHILOS T ROY SOC B, V354, P1641, DOI 10.1098/rstb.1999.0509; PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RIBCHESTER RR, 1995, EUR J NEUROSCI, V7, P1641, DOI 10.1111/j.1460-9568.1995.tb01159.x; RIBCHESTER RR, 1994, P ROY SOC B-BIOL SCI, V255, P61, DOI 10.1098/rspb.1994.0009; Sagot Y, 1996, J NEUROSCI, V16, P2335; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Smith KJ, 2001, ANN NEUROL, V49, P470; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522; Waller A., 1850, PHILOS T R SOC LONDO, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wang NS, 2001, NEUROBIOL DIS, V8, P155; Zhang ZY, 1996, J COMP NEUROL, V371, P485; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	48	463	477	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1199	1206		10.1038/nn770	http://dx.doi.org/10.1038/nn770			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11770485	Green Published			2022-12-17	WOS:000172525000016
J	Lucas, RJ; Douglas, RH; Foster, RG				Lucas, RJ; Douglas, RH; Foster, RG			Characterization of an ocular photopigment capable of driving pupillary constriction in mice	NATURE NEUROSCIENCE			English	Article							LIGHT REFLEX; CIRCADIAN PHOTORECEPTION; RETINAL DEGENERATION; SPECTRAL SENSITIVITY; BODY-TEMPERATURE; VISUAL PIGMENTS; GANGLION-CELLS; ROYAL-COLLEGE; SURGEONS RATS; NON-CONE	This work demonstrates that transgenic mice lacking both rod and cone photoreceptors (rd/rd cl) retain a pupillary light reflex (PLR) that does not rely on local iris photoreceptors. These data, combined with previous reports that rodless and coneless mice show circadian and pineal responses to light, suggest that multiple non-image-forming light responses use non-rod, non-cone ocular photoreceptors in mice. An action spectrum for the PLR in rd/rd cl mice demonstrates that over the range 420-625 nm, this response is driven by a single opsin/vitamin A-based photopigment with peak sensitivity around 479 nm (opsin photopigment/OP479). These data represent the first functional characterization of a non-rod, non-cone photoreceptive system in the mammalian CNS.	Charing Cross Hosp, Imperial Coll, Sch Med,Dept Integrat & Mol Neurosci, Div Neurosci & Psychol Med, London W6 8RF, England; City Univ London, Dept Optometry & Visual Sci, Appl Vis Res Ctr, London EC1V 0HB, England	Imperial College London; City University London	Lucas, RJ (corresponding author), Charing Cross Hosp, Imperial Coll, Sch Med,Dept Integrat & Mol Neurosci, Div Neurosci & Psychol Med, Fulham Palace Rd, London W6 8RF, England.	r.j.lucas@ic.ac.uk		Lucas, Robert/0000-0002-1088-8029				ALPERN M, 1972, VISION RES, V12, P943, DOI 10.1016/0042-6989(72)90016-8; ALPERN M, 1962, J PHYSIOL-LONDON, V164, P478, DOI 10.1113/jphysiol.1962.sp007033; BADIA P, 1991, PHYSIOL BEHAV, V50, P583, DOI 10.1016/0031-9384(91)90549-4; BITO LZ, 1975, COMP BIOCHEM PHYSIOL, V50, P407, DOI 10.1016/0300-9629(75)90034-1; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; BOWMAKER JK, 1972, VISION RES, V12, P529, DOI 10.1016/0042-6989(72)90149-6; BRIDGES CDB, 1959, NATURE, V184, P1727, DOI 10.1038/1841727a0; CAJOCHEN C, 1992, SLEEP, V15, P337; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; FOSTER RG, 1993, J BIOL RHYTHM, V8, pS17; FOSTER RG, 1985, NATURE, V313, P50, DOI 10.1038/313050a0; Foster RG, 1998, NEURON, V20, P829, DOI 10.1016/S0896-6273(00)80464-X; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; GOTO M, 1990, NEUROSCI LETT, V108, P267, DOI 10.1016/0304-3940(90)90652-P; Iwakabe H, 1997, NEUROPHARMACOLOGY, V36, P135, DOI 10.1016/S0028-3908(96)00167-0; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; Keeler CE, 1927, AM J PHYSIOL, V81, P107, DOI 10.1152/ajplegacy.1927.81.1.107; KLEIN DC, 1972, SCIENCE, V177, P532, DOI 10.1126/science.177.4048.532; Knowles A., 1977, PHOTOBIOLOGY VISION; KOVALEVSKY G, 1995, EXP NEUROL, V133, P43, DOI 10.1006/exnr.1995.1006; LAU KC, 1992, J NEUROL SCI, V113, P70, DOI 10.1016/0022-510X(92)90267-O; Lockley SW, 1997, J CLIN ENDOCR METAB, V82, P3763, DOI 10.1210/jc.82.11.3763; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Lythgoe J.N., 1979, ECOLOGY VISION; Mrosovsky N, 1999, J COMP PHYSIOL A, V184, P423, DOI 10.1007/s003590050341; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; NELSON RJ, 1981, COMP BIOCHEM PHYS A, V69, P145, DOI 10.1016/0300-9629(81)90651-4; OHBA N, 1972, VISION RES, V12, P953, DOI 10.1016/0042-6989(72)90017-X; PARTRIDGE JC, 1991, VISION RES, V31, P619, DOI 10.1016/0042-6989(91)90002-M; PICKARD GE, 1985, NEUROSCI LETT, V55, P211, DOI 10.1016/0304-3940(85)90022-9; PROVENCIO I, 1994, VISION RES, V34, P1799, DOI 10.1016/0042-6989(94)90304-2; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; TREJO LJ, 1982, VISION RES, V22, P1163, DOI 10.1016/0042-6989(82)90081-5; von Schantz M, 2000, INVEST OPHTH VIS SCI, V41, P1605; Whiteley SJO, 1996, EXP NEUROL, V140, P100, DOI 10.1006/exnr.1996.0120; Whiteley SJO, 1998, EXP EYE RES, V66, P719, DOI 10.1006/exer.1997.0479; Whiteley SJO, 1998, EXP NEUROL, V154, P560, DOI 10.1006/exnr.1998.6959; Wolken J., 1995, LIGHT DETECTORS PHOT; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797; YOUNG MJ, 1994, NEUROSCIENCE, V62, P481, DOI 10.1016/0306-4522(94)90381-6	48	463	473	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					621	626		10.1038/88443	http://dx.doi.org/10.1038/88443			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369943				2022-12-17	WOS:000169061800015
J	Moon, LDF; Asher, RA; Rhodes, KE; Fawcett, JW				Moon, LDF; Asher, RA; Rhodes, KE; Fawcett, JW			Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC	NATURE NEUROSCIENCE			English	Article							SULFATE PROTEOGLYCAN; NEURITE OUTGROWTH; ASTROCYTES; NEUROCAN; INHIBIT; GROWTH; INJURY		Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England	University of Cambridge	Fawcett, JW (corresponding author), Univ Cambridge, Physiol Lab, Downing St,Tennis Court Rd, Cambridge CB2 3EG, England.		Moon, Lawrence/C-4906-2008	Moon, Lawrence/0000-0001-9622-0312; Fawcett, James/0000-0002-7990-4568				Asher RA, 2000, J NEUROSCI, V20, P2427; Brecknell JE, 1996, NEUROSCIENCE, V71, P913, DOI 10.1016/0306-4522(95)00509-9; BRECKNELL JE, 1995, NEUROSCIENCE, V64, P219, DOI 10.1016/0306-4522(94)00370-K; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; DOU CL, 1994, J NEUROSCI, V14, P7616; GRUMET M, 1993, J CELL BIOL, V120, P815, DOI 10.1083/jcb.120.3.815; LEVINE JM, 1994, J NEUROSCI, V14, P4716; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; SMITHTHOMAS LC, 1995, J CELL SCI, V108, P1307; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Yamada H, 1997, J NEUROSCI, V17, P7784	12	463	498	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					465	466		10.1038/87415	http://dx.doi.org/10.1038/87415			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319553				2022-12-17	WOS:000168412600008
J	Kida, S; Josselyn, SA; de Ortiz, SP; Kogan, JH; Chevere, I; Masushige, S; Silva, AJ				Kida, S; Josselyn, SA; de Ortiz, SP; Kogan, JH; Chevere, I; Masushige, S; Silva, AJ			CREB required for the stability of new and reactivated fear memories	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; ELEMENT-BINDING PROTEIN; SITE-SPECIFIC RECOMBINATION; CAMP-RESPONSIVE ELEMENT; CONTEXTUAL FEAR; MICE; HIPPOCAMPUS; RECONSOLIDATION; CONSOLIDATION; RETRIEVAL	The cAMP-responsive element binding protein (CREB) family of transcription factors is thought to be critical in memory formation. To define the role of CREB in distinct memory processes, we derived transgenic mice with an inducible and reversible CREB repressor by fusing CREBS133A to a tamoxifen (TAM)-dependent mutant of an estrogen receptor ligand-binding domain (LBD). We found that CREB is crucial for the consolidation of long-term conditioned fear memories, but not for encoding, storage or retrieval of these memories. Our studies also showed that CREB is required for the stability of reactivated or retrieved conditioned fear memories. Although the transcriptional processes necessary for the stability of initial and reactivated memories differ, CREB is required for both. The findings presented here delineate the memory processes that require CREB and demonstrate the power of LBD-inducible transgenic systems in the study of complex cognitive processes.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Tokyo Univ Agr, Fac Appl Biosci, Dept Biosci, SetagayaKu, Tokyo 1568502, Japan; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Puerto Rico, Dept Biol, San Juan, PR 00931 USA	University of California System; University of California Los Angeles; Tokyo University of Agriculture; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Silva, AJ (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, 695 Young Dr S,Gonda Bldg, Los Angeles, CA 90095 USA.	silvaa@mednet.ucla.edu	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Chevere Torres, Itzamarie/0000-0001-9001-8172; Silva, Alcino/0000-0001-5525-0494				Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAWSON RG, 1969, SCIENCE, V166, P525, DOI 10.1126/science.166.3904.525; de Ortiz SP, 2000, NEUROBIOL LEARN MEM, V74, P161, DOI 10.1006/nlme.1999.3952; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; GERSON R, 1978, ANIM LEARN BEHAV, V6, P346, DOI 10.3758/BF03209625; GOLD PE, 1972, PHYSIOL BEHAV, V8, P797, DOI 10.1016/0031-9384(72)90286-7; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GORDON WC, 1977, PHYSIOL BEHAV, V18, P95, DOI 10.1016/0031-9384(77)90099-3; GORDON WC, 1977, AM J PSYCHOL, V90, P231, DOI 10.2307/1422045; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hall J, 2001, EUR J NEUROSCI, V13, P1453, DOI 10.1046/j.0953-816x.2001.01531.x; JAMIESON JL, 1970, PSYCHON SCI, V18, P14, DOI 10.3758/BF03332303; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; JUDGE ME, 1982, PHYSIOL BEHAV, V28, P585, DOI 10.1016/0031-9384(82)90034-8; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Lamprecht R, 1997, J NEUROSCI, V17, P8443; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; LOGIE C, 1995, P NATL ACAD SCI USA, V92, P5940, DOI 10.1073/pnas.92.13.5940; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; MACTUTUS CF, 1982, PHYSIOL BEHAV, V28, P939, DOI 10.1016/0031-9384(82)90218-9; MACTUTUS CF, 1980, BEHAV NEURAL BIOL, V30, P260, DOI 10.1016/S0163-1047(80)91150-4; MATTHIES H, 1989, PROG NEUROBIOL, V32, P277, DOI 10.1016/0301-0082(89)90024-5; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Muratake T, 1996, GENOMICS, V36, P63, DOI 10.1006/geno.1996.0426; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Rodriguez WA, 1999, PROG NEURO-PSYCHOPH, V23, P1285, DOI 10.1016/S0278-5846(99)00063-9; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SCHNEIDER AM, 1968, SCIENCE, V159, P219, DOI 10.1126/science.159.3811.219; Sengupta S, 2000, ONCOGENE, V19, P337, DOI 10.1038/sj.onc.1203256; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; SQUIRE LR, 1976, BEHAV BIOL, V18, P335, DOI 10.1016/S0091-6773(76)92295-1; Summers MJ, 1997, COGNITIVE BRAIN RES, V5, P311, DOI 10.1016/S0926-6410(97)00007-4; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	50	462	475	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2002	5	4					348	355		10.1038/nn819	http://dx.doi.org/10.1038/nn819			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	534UQ	11889468				2022-12-17	WOS:000174606900015
J	Lagier-Tourenne, C; Polymenidou, M; Hutt, KR; Vu, AQ; Baughn, M; Huelga, SC; Clutario, KM; Ling, SC; Liang, TY; Mazur, C; Wancewicz, E; Kim, AS; Watt, A; Freier, S; Hicks, GG; Donohue, JP; Shiue, L; Bennett, CF; Ravits, J; Cleveland, DW; Yeo, GW				Lagier-Tourenne, Clotilde; Polymenidou, Magdalini; Hutt, Kasey R.; Vu, Anthony Q.; Baughn, Michael; Huelga, Stephanie C.; Clutario, Kevin M.; Ling, Shuo-Chien; Liang, Tiffany Y.; Mazur, Curt; Wancewicz, Edward; Kim, Aneeza S.; Watt, Andy; Freier, Sue; Hicks, Geoffrey G.; Donohue, John Paul; Shiue, Lily; Bennett, C. Frank; Ravits, John; Cleveland, Don W.; Yeo, Gene W.			Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NEURODEGENERATIVE DISEASE; NASCENT TRANSCRIPTION; FAMILY PROTEINS; FUS PATHOLOGY; MUTATIONS; BINDING; GENE; BRAIN	FUS/TLS (fused in sarcoma/translocated in liposarcoma) and TDP-43 are integrally involved in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia. We found that FUS/TLS binds to RNAs from >5,500 genes in mouse and human brain, primarily through a GUGGU-binding motif. We identified a sawtooth-like binding pattern, consistent with co-transcriptional deposition of FUS/TLS. Depletion of FUS/TLS from the adult nervous system altered the levels or splicing of >950 mRNAs, most of which are distinct from RNAs dependent on TDP-43. Abundance of only 45 RNAs was reduced after depletion of either TDP-43 or FUS/TLS from mouse brain, but among these were mRNAs that were transcribed from genes with exceptionally long introns and that encode proteins that are essential for neuronal integrity. Expression levels of a subset of these were lowered after TDP-43 or FUS/TLS depletion in stem cell derived human neurons and in TDP-43 aggregate containing motor neurons in sporadic ALS, supporting a common loss-of-function pathway as one component underlying motor neuron death from misregulation of TDP-43 or FUS/TLS.	[Lagier-Tourenne, Clotilde; Polymenidou, Magdalini; Clutario, Kevin M.; Ling, Shuo-Chien; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Lagier-Tourenne, Clotilde; Polymenidou, Magdalini; Hutt, Kasey R.; Vu, Anthony Q.; Huelga, Stephanie C.; Clutario, Kevin M.; Ling, Shuo-Chien; Liang, Tiffany Y.; Cleveland, Don W.; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hutt, Kasey R.; Vu, Anthony Q.; Huelga, Stephanie C.; Liang, Tiffany Y.; Yeo, Gene W.] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA; [Hutt, Kasey R.; Vu, Anthony Q.; Huelga, Stephanie C.; Liang, Tiffany Y.; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Baughn, Michael; Ravits, John] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Mazur, Curt; Wancewicz, Edward; Kim, Aneeza S.; Watt, Andy; Freier, Sue; Bennett, C. Frank] ISIS Pharmaceut, Carlsbad, CA 92008 USA; [Hicks, Geoffrey G.] Univ Manitoba, MB Inst Cell Biol, Winnipeg, MB, Canada; [Donohue, John Paul; Shiue, Lily] Univ Calif Santa Cruz, Sinsheimer Labs, Dept Mol Cell & Dev Biol, RNA Ctr, Santa Cruz, CA 95064 USA; [Yeo, Gene W.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Yeo, Gene W.] ASTAR, Mol Engn Lab, Singapore, Singapore	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Isis Pharmaceuticals Inc; University of Manitoba; University of California System; University of California Santa Cruz; National University of Singapore; Agency for Science Technology & Research (A*STAR)	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu; geneyeo@ucsd.edu	Cleveland, Don/AAN-9783-2021; Yeo, Gene/AAE-7676-2019; Polymenidou, Magdalini/D-2254-2014; lagier-Tourenne, Clotilde/ABE-6303-2020	Yeo, Gene/0000-0002-0799-6037; lagier-Tourenne, Clotilde/0000-0002-3058-8322; Baughn, Michael/0000-0001-8525-8024; Liang, Tiffany/0000-0002-1986-5966; Hicks, Geoffrey/0000-0003-4688-2312; Cleveland, Don/0000-0002-1934-3682; LING, Shuo-Chien/0000-0002-0300-8812	US National Institutes of Health [R37NS27036, K99NS075216, HG004659, GM084317]; international Human Frontier Science Program Organization; Muscular Dystrophy Association; Amyotrophic Lateral Sclerosis Association; Ludwig Institute for Cancer Research; US National Science Foundation; US National Institute of Neurological Disorders and Stroke [R01NS075449]; California Institute for Regenerative Medicine [RB1-01413, RB3-05009]; Alfred P. Sloan Research Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075449, R37NS027036, K99NS075216, R01NS027036] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); international Human Frontier Science Program Organization(Human Frontier Science Program); Muscular Dystrophy Association(Muscular Dystrophy Association); Amyotrophic Lateral Sclerosis Association; Ludwig Institute for Cancer Research; US National Science Foundation(National Science Foundation (NSF)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors would like to thank members of B. Ren's laboratory, especially Z. Ye, S. Kuan, U. Wagner and L. Edsall, for technical help with the Illumina sequencing, M. Ares Jr. for generous support, as well as the members of the Yeo and Cleveland laboratories and the team at Isis Pharmaceuticals for critical comments and suggestions on this project. This work was supported by grants from the US National Institutes of Health (R37NS27036 to D.W.C. and K99NS075216 to M.P.). M.P. is the recipient of a long-term fellowship from the international Human Frontier Science Program Organization. C.L.-T. is the recipient of a Career Development Award from the Muscular Dystrophy Association and the Milton-Safenowitz post-doctoral fellowship from the Amyotrophic Lateral Sclerosis Association. D.W.C. receives salary support from the Ludwig Institute for Cancer Research. S.C.H. is funded by a US National Science Foundation Graduate Research Fellowship. This work was also supported by grant number R01NS075449 from the US National Institute of Neurological Disorders and Stroke, and seas partially supported by grants from the US National Institutes of Health (HG004659 and GM084317) and the California Institute for Regenerative Medicine (RB1-01413 and RB3-05009) to G.W.Y. G.W.Y. is a recipient of the Alfred P. Sloan Research Fellowship.	Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; Bodansky A, 2010, AMYOTROPH LATERAL SC, V11, P321, DOI 10.3109/17482961003602363; Colombrita C, 2012, J BIOL CHEM, V287, P15635, DOI 10.1074/jbc.M111.333450; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ishigaki S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00529; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P87, DOI 10.1007/s00401-011-0838-7; Massone S, 2011, J CELL BIOL, V193, P851, DOI 10.1083/jcb.201011053; Mitchelmore C, 2004, NEUROBIOL DIS, V16, P48, DOI 10.1016/j.nbd.2004.01.003; Morohashi Y, 2002, J BIOL CHEM, V277, P14965, DOI 10.1074/jbc.M200897200; Munoz DG, 2009, ACTA NEUROPATHOL, V118, P617, DOI 10.1007/s00401-009-0598-9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Polymenidou M, 2012, BRAIN RES, V1462, P3, DOI 10.1016/j.brainres.2012.02.059; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rabin SJ, 2010, HUM MOL GENET, V19, P313, DOI 10.1093/hmg/ddp498; Rogelj B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00603; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tan AY, 2012, P NATL ACAD SCI USA, V109, P6030, DOI 10.1073/pnas.1203028109; Ticozzi N, 2011, AM J MED GENET B, V156B, P285, DOI 10.1002/ajmg.b.31158; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Woulfe J, 2010, BRAIN PATHOL, V20, P589, DOI 10.1111/j.1750-3639.2009.00337.x; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150	50	461	466	3	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2012	15	11					1488	1497		10.1038/nn.3230	http://dx.doi.org/10.1038/nn.3230			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	028LX	23023293	Green Published, Green Accepted			2022-12-17	WOS:000310424900008
J	Lundstrom, BN; Higgs, MH; Spain, WJ; Fairhall, AL				Lundstrom, Brian N.; Higgs, Matthew H.; Spain, William J.; Fairhall, Adrienne L.			Fractional differentiation by neocortical pyramidal neurons	NATURE NEUROSCIENCE			English	Article							SPIKE-FREQUENCY ADAPTATION; SENSORY ADAPTATION; NEURAL CODE; CORTICAL-NEURONS; ORDER DYNAMICS; BARREL CORTEX; BRAIN-STEM; POWER-LAW; IN-VITRO; MECHANISMS	Neural systems adapt to changes in stimulus statistics. However, it is not known how stimuli with complex temporal dynamics drive the dynamics of adaptation and the resulting firing rate. For single neurons, it has often been assumed that adaptation has a single time scale. We found that single rat neocortical pyramidal neurons adapt with a time scale that depends on the time scale of changes in stimulus statistics. This multiple time scale adaptation is consistent with fractional order differentiation, such that the neuron's firing rate is a fractional derivative of slowly varying stimulus parameters. Biophysically, even though neuronal fractional differentiation effectively yields adaptation with many time scales, we found that its implementation required only a few properly balanced known adaptive mechanisms. Fractional differentiation provides single neurons with a fundamental and general computation that can contribute to efficient information processing, stimulus anticipation and frequency-independent phase shifts of oscillatory neuronal firing.	[Lundstrom, Brian N.; Higgs, Matthew H.; Spain, William J.; Fairhall, Adrienne L.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Higgs, Matthew H.; Spain, William J.] Vet Affairs Puget Sound Hlth Care Syst, Dept Neurol, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Fairhall, AL (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.	fairhall@u.washington.edu			Burroughs-Wellcome Careers at the Scientific Interface grant; McKnight Scholar Award; Sloan Research Fellowship; National Institute of Neurological Disorders and Stroke [F30NS055650]; University of Washington's Medical Scientist Training Program; Achievement Rewards for College Scientists (ARCS) fellowship; Veterans Affairs Merit Review; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS055650] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000386] Funding Source: NIH RePORTER	Burroughs-Wellcome Careers at the Scientific Interface grant(Burroughs Wellcome Fund); McKnight Scholar Award; Sloan Research Fellowship(Alfred P. Sloan Foundation); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Washington's Medical Scientist Training Program(University of Washington); Achievement Rewards for College Scientists (ARCS) fellowship; Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We are grateful to B. Aguera y Arcas, W. Bialek, F. Dunn, M. Famulare, M. Giugliano, S. Hong, M. Maravall, P. Murphy, F. Rieke, L. Sorensen and B. Wark for helpful discussions and/or comments on the manuscript. We thank S. Usher for excellent technical assistance. This work was supported by a Burroughs-Wellcome Careers at the Scientific Interface grant, and a McKnight Scholar Award and a Sloan Research Fellowship to A.L.F.B.N.L. was supported by grant number F30NS055650 from the National Institute of Neurological Disorders and Stroke, the University of Washington's Medical Scientist Training Program (supported by the National Institute of General Medical Sciences), and an Achievement Rewards for College Scientists (ARCS) fellowship. M. H. H. and W.J.S. were supported by a Veterans Affairs Merit Review to W.J.S.	Abel HJ, 2004, J NEUROPHYSIOL, V91, P324, DOI 10.1152/jn.00583.2003; Adrian ED, 1926, J PHYSIOL-LONDON, V61, P151, DOI 10.1113/jphysiol.1926.sp002281; ANASTASIO TJ, 1994, BIOL CYBERN, V72, P69, DOI 10.1007/BF00206239; Anastasio TJ, 1998, BIOL CYBERN, V79, P377, DOI 10.1007/s004220050487; Barlow H., 1961, SENSORY COMMUNICATIO, P217; Benda J, 2003, NEURAL COMPUT, V15, P2523, DOI 10.1162/089976603322385063; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Diaz-Quesada M, 2008, J NEUROSCI, V28, P696, DOI 10.1523/JNEUROSCI.4931-07.2008; Drew PJ, 2006, J NEUROPHYSIOL, V96, P826, DOI 10.1152/jn.00134.2006; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fairhall AL, 2001, ADV NEUR IN, V13, P124; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; French AS, 2008, ANN BIOMED ENG, V36, P153, DOI 10.1007/s10439-007-9392-9; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; Gilboa G, 2005, J NEUROSCI, V25, P6479, DOI 10.1523/JNEUROSCI.0763-05.2005; Hasenstaub A, 2007, J NEUROSCI, V27, P9607, DOI 10.1523/JNEUROSCI.2184-07.2007; Higgs MH, 2006, J NEUROSCI, V26, P8787, DOI 10.1523/JNEUROSCI.1792-06.2006; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Kleinz M., 2000, COLL MATH J, V31, P82, DOI [DOI 10.1080/07468342.2000.11974118, 10.1080/07468342.2000.11974118]; Kondgen H, 2008, CEREB CORTEX, V18, P2086, DOI 10.1093/cercor/bhm235; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; La Camera G, 2006, J NEUROPHYSIOL, V96, P3448, DOI 10.1152/jn.00453.2006; Lundstrom BN, 2006, J NEUROSCI, V26, P9030, DOI 10.1523/JNEUROSCI.0225-06.2006; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Middleton JW, 2006, P NATL ACAD SCI USA, V103, P14596, DOI 10.1073/pnas.0604103103; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Paulin MG, 2004, IEEE T NEURAL NETWOR, V15, P987, DOI 10.1109/TNN.2004.832814; Powers RK, 1999, J PHYSIOL-PARIS, V93, P101, DOI 10.1016/S0928-4257(99)80141-7; Puccini GD, 2007, PLOS COMPUT BIOL, V3, P813, DOI 10.1371/journal.pcbi.0030082; Richardson MJE, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051918; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; SCHWINDT PC, 1988, J NEUROPHYSIOL, V59, P450, DOI 10.1152/jn.1988.59.2.450; SCHWINDT PC, 1989, J NEUROPHYSIOL, V61, P233, DOI 10.1152/jn.1989.61.2.233; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Slee SJ, 2005, J NEUROSCI, V25, P9978, DOI 10.1523/JNEUROSCI.2666-05.2005; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; THORSON J, 1974, SCIENCE, V183, P161, DOI 10.1126/science.183.4121.161; Toib A, 1998, J NEUROSCI, V18, P1893; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001	50	461	465	6	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2008	11	11					1335	1342		10.1038/nn.2212	http://dx.doi.org/10.1038/nn.2212			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	366HZ	18931665	Green Accepted			2022-12-17	WOS:000260472700023
J	Stranahan, AM; Arumugam, TV; Cutler, RG; Lee, K; Egan, JM; Mattson, MP				Stranahan, Alexis M.; Arumugam, Thiruma V.; Cutler, Roy G.; Lee, Kim; Egan, Josephine M.; Mattson, Mark P.			Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; STRESS-INDUCED IMPAIRMENTS; SYNAPTIC PLASTICITY; ADULT NEUROGENESIS; GRANULE CELLS; CORTISOL-LEVELS; SPATIAL MEMORY; DENTATE GYRUS; RAT; HYPERGLYCEMIA	Many organ systems are adversely affected by diabetes, including the brain, which undergoes changes that may increase the risk of cognitive decline. Although diabetes influences the hypothalamic-pituitary-adrenal axis, the role of this neuroendocrine system in diabetes-induced cognitive dysfunction remains unexplored. Here we demonstrate that, in both insulin-deficient rats and insulin-resistant mice, diabetes impairs hippocampus-dependent memory, perforant path synaptic plasticity and adult neurogenesis, and the adrenal steroid corticosterone contributes to these adverse effects. Rats treated with streptozocin have reduced insulin and show hyperglycemia, increased corticosterone, and impairments in hippocampal neurogenesis, synaptic plasticity and learning. Similar deficits are observed in db/db mice, which are characterized by insulin resistance, elevated corticosterone and obesity. Changes in hippocampal plasticity and function in both models are reversed when normal physiological levels of corticosterone are maintained, suggesting that cognitive impairment in diabetes may result from glucocorticoid-mediated deficits in neurogenesis and synaptic plasticity.	[Stranahan, Alexis M.; Arumugam, Thiruma V.; Cutler, Roy G.; Lee, Kim; Mattson, Mark P.] NIA, Intramural Res Program, Neurosci Lab, Cellular & Mol Neurosci Sect, Baltimore, MD 21224 USA; [Egan, Josephine M.] NIA, Intramural Res Program, Diabet Sect, Lab Child Invest, Baltimore, MD 21224 USA; [Stranahan, Alexis M.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Princeton University	Mattson, MP (corresponding author), NIA, Intramural Res Program, Neurosci Lab, Cellular & Mol Neurosci Sect, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	mattsonm@grc.nia.nih.gov	Arumugam, Thiruma/AAG-6958-2019; Mattson, Mark P/F-6038-2012; Stranahan, Alexis/AAF-3559-2020; Arumugam, Thiruma Valavan/B-4898-2011; Arumugam, Thiruma/C-7969-2009; Cutler, Roy G./L-5572-2013	Lee, Kim/0000-0002-5675-1896; Arumugam, Thiruma/0000-0002-3377-0939	NATIONAL INSTITUTE ON AGING [ZIAAG000317, F31AG024690, Z01AG000314, ZIAAG000330, ZIAAG000315, ZIAAG000312, Z01AG000313] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AG000312-07, Z01 AG000314-07, Z01 AG000313-07] Funding Source: Medline; NIA NIH HHS [F31 AG024690-02, F31 AG024690, F31AG024690-03, F31 AG024690-04, F31 AG024690-03, F31 AG024690-01] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alfarez DN, 2003, EUR J NEUROSCI, V17, P1928, DOI 10.1046/j.1460-9568.2003.02622.x; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Chan O, 2005, AM J PHYSIOL-REG I, V289, pR235, DOI 10.1152/ajpregu.00674.2004; Desrocher M, 2004, CHILD NEUROPSYCHOL, V10, P36, DOI 10.1076/chin.10.1.36.26241; Elgh E, 2006, BIOL PSYCHIAT, V59, P155, DOI 10.1016/j.biopsych.2005.06.017; Fontan-Lozano A, 2007, J NEUROSCI, V27, P10185, DOI 10.1523/JNEUROSCI.2757-07.2007; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; GOULD E, 1992, J NEUROSCI, V12, P3642; Green MC, 2005, POLIT PSYCHOL, V26, P1, DOI 10.1111/j.1467-9221.2005.00407.x; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Kamal A, 1999, NEUROSCIENCE, V90, P737, DOI 10.1016/S0306-4522(98)00485-0; Karten YJG, 2006, HIPPOCAMPUS, V16, P312, DOI 10.1002/hipo.20165; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; KERR DS, 1989, SCIENCE, V245, P1505, DOI 10.1126/science.2781293; Korz V, 2003, J NEUROSCI, V23, P7281; Kozorovitskiy Y, 2005, P NATL ACAD SCI USA, V102, P17478, DOI 10.1073/pnas.0508817102; LANGLEY SC, 1990, AM J PHYSIOL, V259, pR539, DOI 10.1152/ajpregu.1990.259.3.R539; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; MacLullich AMJ, 2005, PSYCHONEUROENDOCRINO, V30, P505, DOI 10.1016/j.psyneuen.2004.12.005; Magarinos AM, 2000, P NATL ACAD SCI USA, V97, P11056, DOI 10.1073/pnas.97.20.11056; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; MESSIER C, 2005, AGING S1, V26, pS26; Montaron MF, 2006, NEUROBIOL AGING, V27, P645, DOI 10.1016/j.neurobiolaging.2005.02.014; Moosavi M, 2007, BEHAV BRAIN RES, V176, P230, DOI 10.1016/j.bbr.2006.10.011; Oei NYL, 2006, STRESS, V9, P133, DOI 10.1080/10253890600965773; Oitzl MS, 1998, EUR J NEUROSCI, V10, P3759, DOI 10.1046/j.1460-9568.1998.00381.x; PAVLIDES C, 1993, HIPPOCAMPUS, V3, P183, DOI 10.1002/hipo.450030210; Piroli GG, 2007, NEUROENDOCRINOLOGY, V85, P71, DOI 10.1159/000101694; Reagan LP, 2001, P NATL ACAD SCI USA, V98, P2820, DOI 10.1073/pnas.051629798; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Sandeep TC, 2004, P NATL ACAD SCI USA, V101, P6734, DOI 10.1073/pnas.0306996101; SAPOLSKY RM, 1986, J NEUROSCI, V6, P2240; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; TOKUYAMA K, 1987, AM J PHYSIOL, V252, pE202, DOI 10.1152/ajpendo.1987.252.2.E202; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Watts LM, 2005, DIABETES, V54, P1846, DOI 10.2337/diabetes.54.6.1846; Wright RL, 2006, EUR J NEUROSCI, V24, P595, DOI 10.1111/j.1460-9568.2006.04948.x; Zhang WJ, 2008, ACTA NEUROL SCAND, V117, P205, DOI 10.1111/j.1600-0404.2007.00928.x	48	461	480	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2008	11	3					309	317		10.1038/nn2055	http://dx.doi.org/10.1038/nn2055			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	267ZS	18278039	Green Accepted			2022-12-17	WOS:000253548300014
J	Hilgetag, CC; Theoret, H; Pascual-Leone, A				Hilgetag, CC; Theoret, H; Pascual-Leone, A			Enhanced visual spatial attention ipsilateral to rTMS-induced 'virtual lesions' of human parietal cortex	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; INTERHEMISPHERIC INHIBITION; UNILATERAL NEGLECT; EXCITABILITY; EXTINCTION; LOCALIZATION; HEMINEGLECT; REDUCTION; INDUCTION	The breakdown of attentional mechanisms after brain damage can have drastic behavioral consequences, as in patients suffering from spatial neglect. While much research has concentrated on impaired attention to targets contralateral to sites of brain damage, here we report the ipsilateral enhancement of visual attention after repetitive transcranial magnetic stimulation (rTMS) of parietal cortex at parameters known to reduce cortical excitability. Normal healthy subjects received rTMS (1 Hz, 10 mins) over right or left parietal cortex. Subsequently, detection of visual stimuli contralateral to the stimulated hemisphere was consistently impaired when stimuli were also present in the opposite hemifield, mirroring the extinction phenomenon commonly observed in neglect patients. Additionally, subjects' attention to ipsilateral targets improved significantly over normal levels. These results underline the potential of focal brain dysfunction to produce behavioral improvement and give experimental support to models of interhemispheric competition in the distributed brain network for spatial attention.	Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Neurol, Lab Magnet Brain Stimulat, Boston, MA 02215 USA	Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hilgetag, CC (corresponding author), Int Jacobs Univ Bremen, Campus Ring 1, D-28759 Bremen, Germany.	claush@bu.edu	Hilgetag, Claus C/L-7282-2013; Pascual-Leone, Alvaro/AAC-5101-2019; Pascual-Leone, Alvaro/G-6566-2011; Hilgetag, Claus C/AAH-1760-2020	Hilgetag, Claus C/0000-0003-2129-8910; Pascual-Leone, Alvaro/0000-0001-8975-0382; Hilgetag, Claus C/0000-0003-2129-8910; Theoret, Hugo/0000-0002-7458-8797	NATIONAL EYE INSTITUTE [R01EY012091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057980, R01MH060734] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY12091] Funding Source: Medline; NIMH NIH HHS [R01MH57980, R01MH60734] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Boroojerdi B, 2000, NEUROLOGY, V54, P1529, DOI 10.1212/WNL.54.7.1529; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Fierro B, 2000, NEUROREPORT, V11, P1519, DOI 10.1097/00001756-200005150-00030; Fink GR, 2000, ANN NEUROL, V47, P440; Hilgetag C C, 1999, Prog Brain Res, V121, P121; Hilgetag CC, 2000, NEUROCOMPUTING, V32, P793, DOI 10.1016/S0925-2312(00)00246-0; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Kapur N, 1996, BRAIN, V119, P1775, DOI 10.1093/brain/119.5.1775; Karnath HO, 1998, BRAIN, V121, P2357, DOI 10.1093/brain/121.12.2357; Kinsbourne, 1987, MECH UNILATERAL NEGL; Kinsbourne M, 1977, Adv Neurol, V18, P41; Kinsbourne M., 1993, UNILATERAL NEGLECT C, P63; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Maeda F, 2000, EXP BRAIN RES, V133, P425, DOI 10.1007/s002210000432; Maeda F, 2000, CLIN NEUROPHYSIOL, V111, P800, DOI 10.1016/S1388-2457(99)00323-5; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MOTTAGHY F, IN PRESS CEREB CORTE; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 1999, BRAIN, V122, P1731, DOI 10.1093/brain/122.9.1731; Pascual-Leone A, 1999, PHILOS T R SOC B, V354, P1229, DOI 10.1098/rstb.1999.0476; PASCUALLEONE A, 1994, NEUROLOGY, V44, P494, DOI 10.1212/WNL.44.3_Part_1.494; Pouget A, 2000, CURR OPIN NEUROBIOL, V10, P242, DOI 10.1016/S0959-4388(00)00077-5; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; SEYAL M, 1995, ANN NEUROL, V38, P264, DOI 10.1002/ana.410380221; Smania N, 1998, BRAIN, V121, P1759, DOI 10.1093/brain/121.9.1759; THEORET H, IN PRESS NEUROSCI LE; TOGA AW, 2001, NEUROIMAGE, V14, P1; Vallar G, 1998, TRENDS COGN SCI, V2, P87, DOI 10.1016/S1364-6613(98)01145-0; Vuilleumier P, 1996, NEUROLOGY, V46, P184, DOI 10.1212/WNL.46.1.184; Walsh V, 1998, P ROY SOC B-BIOL SCI, V265, P537, DOI 10.1098/rspb.1998.0328; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wassermann EM, 1998, NEUROSCI LETT, V250, P141, DOI 10.1016/S0304-3940(98)00437-6; WEINTRAUB S, 1987, ARCH NEUROL-CHICAGO, V44, P621, DOI 10.1001/archneur.1987.00520180043014	36	461	470	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					953	957		10.1038/nn0901-953	http://dx.doi.org/10.1038/nn0901-953			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528429				2022-12-17	WOS:000170698600024
J	Warren, WH; Kay, BA; Zosh, WD; Duchon, AP; Sahuc, S				Warren, WH; Kay, BA; Zosh, WD; Duchon, AP; Sahuc, S			Optic flow is used to control human walking	NATURE NEUROSCIENCE			English	Article							MST NEURONS; PERCEPTION; MOTION; LOCOMOTION; DIRECTION; BEHAVIOR; AREA	How is human locomotion visually controlled? Fifty years ago, it was proposed that we steer to a goal using optic flow, the pattern of motion at the eye that specifies the direction of locomotion. However, we might also simply walk in the perceived direction of a goal. These two hypotheses normally predict the same behavior, but we tested them in an immersive virtual environment by displacing the optic flow from the direction of walking, violating the laws of optics. We found that people walked in the visual direction of a lone target, but increasingly relied on optic flow as it was added to the display. The visual control law for steering toward a goal is a linear combination of these two variables weighted by the magnitude of flow, thereby allowing humans to have robust locomotor control under varying environmental conditions.	Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA	Brown University	Warren, WH (corresponding author), Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA.	bill_warren@brown.edu	Warren, William H./AAX-7781-2021		NEI NIH HHS [EY10923, R01 EY010923] Funding Source: Medline; NIMH NIH HHS [K02 MH01353] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001353] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anderson KC, 1999, J NEUROSCI, V19, P2681; BRIDGEMAN B, 1981, PERCEPT PSYCHOPHYS, V29, P336, DOI 10.3758/BF03207342; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; Crowell JA, 1996, VISION RES, V36, P471, DOI 10.1016/0042-6989(95)00121-2; DEJONG BM, 1994, BRAIN, V117, P1039; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Fajen BR, 2000, TRENDS COGN SCI, V4, P369, DOI 10.1016/S1364-6613(00)01532-1; Gibson J.J., 1950, PERCEPTION VISUAL WO; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Harris JM, 1999, TRENDS COGN SCI, V3, P449, DOI 10.1016/S1364-6613(99)01411-4; HECKMANN T, 1991, PERCEPTION, V20, P285, DOI 10.1068/p200285; Li L, 2000, VISION RES, V40, P3873, DOI 10.1016/S0042-6989(00)00196-6; NAKAYAMA K, 1994, PSYCHOL REV, V101, P329, DOI 10.1037/0033-295X.101.2.329; ORBAN GA, 1992, P NATL ACAD SCI USA, V89, P2595, DOI 10.1073/pnas.89.7.2595; ROYDEN CS, 1994, VISION RES, V34, P3197, DOI 10.1016/0042-6989(94)90084-1; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; Rushton SK, 1998, CURR BIOL, V8, P1191, DOI 10.1016/S0960-9822(07)00492-7; SAITO H, 1986, J NEUROSCI, V6, P145; Schoner G, 1995, ROBOT AUTON SYST, V16, P213, DOI 10.1016/0921-8890(95)00049-6; Siegel RM, 1997, CEREB CORTEX, V7, P327, DOI 10.1093/cercor/7.4.327; SMEETS JBJ, 1995, J EXP PSYCHOL HUMAN, V21, P19, DOI 10.1037/0096-1523.21.1.19; Vaina LM, 1998, CURR OPIN NEUROBIOL, V8, P494, DOI 10.1016/S0959-4388(98)80037-8; VANDENBERG AV, 1992, VISION RES, V32, P1285, DOI 10.1016/0042-6989(92)90223-6; Wann J, 2000, TRENDS COGN SCI, V4, P319, DOI 10.1016/S1364-6613(00)01513-8; Warren W. H., 1998, HIGH LEVEL MOTION PR, P315; Warren WH, 1998, ECOL PSYCHOL, V10, P177, DOI 10.1207/s15326969eco103&4_3; WARREN WH, 1988, J EXP PSYCHOL HUMAN, V14, P646, DOI 10.1037/0096-1523.14.4.646; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; Wood RM, 2000, CURR BIOL, V10, pR545, DOI 10.1016/S0960-9822(00)00606-0	29	461	463	1	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2001	4	2					213	216		10.1038/84054	http://dx.doi.org/10.1038/84054			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405UC	11175884				2022-12-17	WOS:000167178100022
J	Sceniak, MP; Ringach, DL; Hawken, MJ; Shapley, R				Sceniak, MP; Ringach, DL; Hawken, MJ; Shapley, R			Contrast's effect on spatial summation by macaque V1 neurons	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; RECEPTIVE-FIELD STRUCTURE; CAT STRIATE CORTEX; SYNAPTIC INTEGRATION; LOCAL CIRCUITS; IN-VITRO; INHIBITION; CELLS; ORGANIZATION; SENSITIVITY	Stimulation outside the receptive field of a primary visual cortical (V1) neuron reveals intracortical neural interactions(1-6). However, previous investigators implicitly or explicitly considered the extent of cortical spatial summation and, therefore, the size of the classical receptive field to be fixed and independent of stimulus characteristics or of surrounding context. On the contrary, we found that the extent of spatial summation in macaque V1 neurons depended on contrast, and was on average 2.3-fold greater at low contrast. This adaptive increase in spatial summation at low contrast was seen in cells throughout V1 and was independent of surround inhibition.	NYU, Ctr Neural Sci, New York, NY 10003 USA; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	New York University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Sceniak, MP (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.			Sceniak, Michael/0000-0003-2415-5800	NEI NIH HHS [EY08300, EY01472] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008300, R01EY001472] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CARANDINI M, 1994, SCIENCE, V264, P1333, DOI 10.1126/science.8191289; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DEANGELIS GC, 1995, P NATL ACAD SCI USA, V92, P9682, DOI 10.1073/pnas.92.21.9682; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HAWKEN MJ, 1988, J NEUROSCI, V8, P3541; Hirsch JA, 1998, J NEUROSCI, V18, P9517; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; LUND JS, 1981, J COMP NEUROL, V202, P19, DOI 10.1002/cne.902020104; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; Markram H, 1996, J PHYSIOLOGY-PARIS, V90, P229, DOI 10.1016/S0928-4257(97)81429-5; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; OHZAWA I, 1985, J NEUROPHYSIOL, V54, P651, DOI 10.1152/jn.1985.54.3.651; PALMER LA, 1981, J NEUROPHYSIOL, V46, P260, DOI 10.1152/jn.1981.46.2.260; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; Sengpiel F, 1997, EXP BRAIN RES, V116, P216, DOI 10.1007/PL00005751; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Zipser K, 1996, J NEUROSCI, V16, P7376	30	460	464	2	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1999	2	8					733	739		10.1038/11197	http://dx.doi.org/10.1038/11197			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259FA	10412063				2022-12-17	WOS:000083882800013
J	Woo, CW; Chang, LJ; Lindquist, MA; Wager, TD				Woo, Choong-Wan; Chang, Luke J.; Lindquist, Martin A.; Wager, Tor D.			Building better biomarkers: brain models in translational neuroimaging	NATURE NEUROSCIENCE			English	Review							PREDICTING TREATMENT RESPONSE; SOCIAL ANXIETY DISORDER; ALZHEIMERS-DISEASE; FUNCTIONAL CONNECTIVITY; MAGNETIC-RESONANCE; NEURAL-NETWORK; BASE-LINE; PATTERN-CLASSIFICATION; PARKINSONS-DISEASE; PANIC DISORDER	Despite its great promise, neuroimaging has yet to substantially impact clinical practice and public health. However, a developing synergy between emerging analysis techniques and data-sharing initiatives has the potential to transform the role of neuroimaging in clinical applications. We review the state of translational neuroimaging and outline an approach to developing brain signatures that can be shared, tested in multiple contexts and applied in clinical settings. The approach rests on three pillars: (i) the use of multivariate pattern-recognition techniques to develop brain signatures for clinical outcomes and relevant mental processes; (ii) assessment and optimization of their diagnostic value; and (iii) a program of broad exploration followed by increasingly rigorous assessment of generalizability across samples, research contexts and populations. Increasingly sophisticated models based on these principles will help to overcome some of the obstacles on the road from basic neuroscience to better health and will ultimately serve both basic and applied goals.	[Woo, Choong-Wan] Inst Basic Sci, Ctr Neurosci Imaging Res, Suwon, South Korea; [Woo, Choong-Wan] Sungkyunkwan Univ, Dept Biomed Engn, Suwon, South Korea; [Woo, Choong-Wan; Wager, Tor D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Woo, Choong-Wan; Wager, Tor D.] Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA; [Chang, Luke J.] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; [Lindquist, Martin A.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA	Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU); University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Dartmouth College; Johns Hopkins University	Wager, TD (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.; Wager, TD (corresponding author), Univ Colorado, Inst Cognit Sci, Boulder, CO 80309 USA.	tor.wager@colorado.edu	Woo, Choong-Wan/J-2030-2019	Woo, Choong-Wan/0000-0002-7423-5422; Chang, Luke/0000-0002-6621-8120	NIH [R01DA035484, R01MH076136]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank our colleagues for discussion of issues surrounding biomarker development and consortium data, including V. Apkarian, M. Banich, D. Barch, P. Bellec, R. Casanova, C. Davatzikos, O. Doyle, D. Eidelberg, G. Glover, S. Mackey, E. Mayer, R. Poldrack, V. Prashanthi, M. Rosenberg, S. Smith, I. Tracey and others. We also thank J. Buhle, L. Van Oudenhove, M. Kano, P. Kragel, H. Giao Ly, P. Dupont, A. Rubio, C. Delon-Martin and B.L. Bonaz for contributing to work discussed in Figure 4 and the authors of published manuscripts using the Neurologic Pain Signature. This work was funded by NIH R01DA035484 and R01MH076136 (T.D.W., PI).	Abi-Dargham A, 2016, NAT MED, V22, P1248, DOI 10.1038/nm.4190; Acuna C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00062; Addington J, 2012, ANNU REV CLIN PSYCHO, V8, P269, DOI 10.1146/annurev-clinpsy-032511-143146; ADLER G, 1993, BIOL PSYCHIAT, V34, P687, DOI 10.1016/0006-3223(93)90041-B; [Anonymous], 2009, PSYCHOL SCI, V20, P1364, DOI 10.1111/j.1467-9280.2009.02460.x; [Anonymous], BIOL PSYCHIAT; Anticevic A, 2014, CEREB CORTEX, V24, P3116, DOI 10.1093/cercor/bht165; Asanuma K, 2006, BRAIN, V129, P2667, DOI 10.1093/brain/awl162; Beardslee WR, 2013, JAMA PSYCHIAT, V70, P1161, DOI 10.1001/jamapsychiatry.2013.295; Borsook D, 2011, DISCOV MED, V11, P197; Bota M, 2005, NEUROINFORMATICS, V3, P15, DOI 10.1385/NI:3:1:015; Brascher AK, 2016, J NEUROSCI, V36, P5013, DOI 10.1523/JNEUROSCI.1954-15.2016; Brodersen KH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002079; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P1265, DOI 10.1002/hbm.20463; Casanova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077949; Chang LJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002180; Clementz BA, 2016, AM J PSYCHIAT, V173, P373, DOI 10.1176/appi.ajp.2015.14091200; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; DELEON MJ, 1983, AM J NEURORADIOL, V4, P568; Deshpande G, 2015, IEEE T CYBERNETICS, V45, P2668, DOI 10.1109/TCYB.2014.2379621; Diatchenko L, 2006, PAIN, V123, P226, DOI 10.1016/j.pain.2006.04.015; Doehrmann O, 2013, JAMA PSYCHIAT, V70, P87, DOI 10.1001/2013.jamapsychiatry.5; Dougherty DD, 2015, BIOL PSYCHIAT, V78, P240, DOI 10.1016/j.biopsych.2014.11.023; Doyle OM, 2015, PSYCHOPHARMACOLOGY, V232, P4179, DOI 10.1007/s00213-015-3968-0; Doyle OM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105542; Drysdale A. T., 2016, NAT MED; Duffy FH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-64; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022193; Eckert T, 2008, MOVEMENT DISORD, V23, P727, DOI 10.1002/mds.21933; Eidelberg D, 2009, TRENDS NEUROSCI, V32, P548, DOI 10.1016/j.tins.2009.06.003; Eldridge J, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-12; Eloyan A, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00061; Etzel JA, 2013, NEUROIMAGE, V78, P261, DOI 10.1016/j.neuroimage.2013.03.041; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fodor J.A., 1983, MODULARITY MIND; Freedman R, 2013, AM J PSYCHIAT, V170, P1, DOI 10.1176/appi.ajp.2012.12091189; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GEMAN S, 1992, NEURAL COMPUT, V4, P1, DOI 10.1162/neco.1992.4.1.1; Geurts JJG, 2012, LANCET NEUROL, V11, P1082, DOI 10.1016/S1474-4422(12)70230-2; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Glover GH, 2012, J MAGN RESON IMAGING, V36, P39, DOI 10.1002/jmri.23572; Gorgolewski KJ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002506; Habes M, 2016, BRAIN, V139, P1164, DOI 10.1093/brain/aww008; Hackmack K, 2012, NEUROIMAGE, V62, P48, DOI 10.1016/j.neuroimage.2012.05.022; Hahn T, 2015, JAMA PSYCHIAT, V72, P68, DOI 10.1001/jamapsychiatry.2014.1741; Hamani C, 2006, PAIN, V125, P188, DOI 10.1016/j.pain.2006.05.019; Hargreaves RJ, 2015, CLIN PHARMACOL THER, V98, P47, DOI 10.1002/cpt.132; Hashmi JA, 2013, BRAIN, V136, P2751, DOI 10.1093/brain/awt211; Hastie T., 2009, SPRINGER, V2nd, DOI DOI 10.1007/978-0-387-21606-5; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2015, NEURON, V87, P257, DOI 10.1016/j.neuron.2015.05.025; Hein G, 2016, SCIENCE, V351, P1074, DOI 10.1126/science.aac7992; Huang CR, 2007, NEUROIMAGE, V34, P714, DOI 10.1016/j.neuroimage.2006.09.003; Huth AG, 2016, NATURE, V532, P453, DOI 10.1038/nature17637; Huys QJM, 2016, NAT NEUROSCI, V19, P404, DOI 10.1038/nn.4238; Iidaka T, 2015, CORTEX, V63, P55, DOI 10.1016/j.cortex.2014.08.011; Insel TR, 2015, SCIENCE, V348, P499, DOI 10.1126/science.aab2358; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kapur S, 2012, MOL PSYCHIATR, V17, P1174, DOI 10.1038/mp.2012.105; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Ketz N, 2014, NEUROIMAGE, V85, P749, DOI 10.1016/j.neuroimage.2013.06.077; Kim J, 2016, NEUROIMAGE, V124, P127, DOI 10.1016/j.neuroimage.2015.05.018; KIPPENHAN JS, 1992, J NUCL MED, V33, P1459; Koutsouleris N, 2009, ARCH GEN PSYCHIAT, V66, P700, DOI 10.1001/archgenpsychiatry.2009.62; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2015, ANNU REV VIS SCI, V1, P417, DOI 10.1146/annurev-vision-082114-035447; Kriegeskorte N, 2010, NEUROIMAGE, V49, P1965, DOI 10.1016/j.neuroimage.2009.09.059; Krishnan A, 2016, ELIFE, V5, DOI 10.7554/eLife.15166; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Landis JR, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-58; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lombardo MV, 2015, NEURON, V86, P567, DOI 10.1016/j.neuron.2015.03.023; Lopez-Solo M., 2016, PAIN; Ma YN, 2016, NEUROIMAGE, V135, P186, DOI 10.1016/j.neuroimage.2016.04.064; Mather M, 2013, PERSPECT PSYCHOL SCI, V8, P41, DOI 10.1177/1745691612469036; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Miyawaki Y, 2008, NEURON, V60, P915, DOI 10.1016/j.neuron.2008.11.004; Mohri M., 2012, FDN MACHINE LEARNING; Moradi E, 2015, NEUROIMAGE, V104, P398, DOI 10.1016/j.neuroimage.2014.10.002; Morishita T, 2014, NEUROTHERAPEUTICS, V11, P475, DOI 10.1007/s13311-014-0282-1; Mure H, 2011, NEUROIMAGE, V54, P1244, DOI 10.1016/j.neuroimage.2010.09.028; Naselaris T, 2011, NEUROIMAGE, V56, P400, DOI 10.1016/j.neuroimage.2010.07.073; Niethammer M, 2014, BRAIN, V137, P3036, DOI 10.1093/brain/awu256; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; O'Reilly RC, 2006, SCIENCE, V314, P91, DOI 10.1126/science.1127242; Olivetti E., 2006, P 12 M ORG HUM BRAIN; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pantazatos SP, 2014, NEUROPSYCHOPHARMACOL, V39, P425, DOI 10.1038/npp.2013.211; Petersen SE, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-46; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Poldrack RA, 2014, NAT NEUROSCI, V17, P1510, DOI 10.1038/nn.3818; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Reddan M. G., 2016, JAMA PSYCHIAT, P3356; Ribeiro M. T., 2016, PREPRINT; Robinson M, 2016, J PAIN, V17, P637, DOI 10.1016/j.jpain.2016.01.476; Rosenberg MD, 2016, NAT NEUROSCI, V19, P165, DOI 10.1038/nn.4179; Roy M, 2012, TRENDS COGN SCI, V16, P147, DOI 10.1016/j.tics.2012.01.005; Roychowdhury S, 2014, ANNU REV GENOM HUM G, V15, P395, DOI 10.1146/annurev-genom-090413-025552; Sanislow CA, 2010, J ABNORM PSYCHOL, V119, P631, DOI 10.1037/a0020909; Sarpal DK, 2016, AM J PSYCHIAT, V173, P69, DOI 10.1176/appi.ajp.2015.14121571; Sato JR, 2015, PSYCHIAT RES-NEUROIM, V233, P289, DOI 10.1016/j.pscychresns.2015.07.001; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Singh G, 2015, J NEUROSCI METH, V256, P30, DOI 10.1016/j.jneumeth.2015.08.011; Sorensen L, 2016, HUM BRAIN MAPP, V37, P1148, DOI 10.1002/hbm.23091; Stephan KE, 2013, NEUROIMAGE, V80, P46, DOI 10.1016/j.neuroimage.2013.03.016; Swartz JR, 2015, NEURON, V85, P505, DOI 10.1016/j.neuron.2014.12.055; Tagliazucchi E, 2014, NEURON, V82, P695, DOI 10.1016/j.neuron.2014.03.020; Tang CC, 2010, LANCET NEUROL, V9, P149, DOI 10.1016/S1474-4422(10)70002-8; Teune LK, 2013, MOVEMENT DISORD, V28, P547, DOI 10.1002/mds.25361; Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5; Todd MT, 2013, NEUROIMAGE, V77, P157, DOI 10.1016/j.neuroimage.2013.03.039; Toledo JB, 2015, NEUROLOGY, V85, P144, DOI 10.1212/WNL.0000000000001738; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Tosun D, 2013, ANN NEUROL, V74, P188, DOI 10.1002/ana.23921; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van Waarde JA, 2015, MOL PSYCHIATR, V20, P609, DOI 10.1038/mp.2014.78; Vemuri P, 2008, NEUROIMAGE, V42, P559, DOI 10.1016/j.neuroimage.2008.05.012; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Wager TD, 2016, P NATL ACAD SCI USA, V113, pE2474, DOI 10.1073/pnas.1600282113; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wager TD, 2011, J NEUROSCI, V31, P439, DOI 10.1523/JNEUROSCI.3420-10.2011; Weiner MW, 2015, ALZHEIMERS DEMENT, V11, P865, DOI 10.1016/j.jalz.2015.04.005; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Weintraub D, 2012, BRAIN, V135, P170, DOI 10.1093/brain/awr277; Welter ML, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.5; Westfall J, 2015, PERSPECT PSYCHOL SCI, V10, P390, DOI 10.1177/1745691614564879; Whelan R, 2014, BIOL PSYCHIAT, V75, P746, DOI 10.1016/j.biopsych.2013.05.014; Whitfield-Gabrieli S, 2016, MOL PSYCHIATR, V21, P680, DOI 10.1038/mp.2015.109; Widge AS, 2013, BRAIN STIMUL, V6, P929, DOI 10.1016/j.brs.2013.05.001; Wiecki TV, 2015, CLIN PSYCHOL SCI, V3, P378, DOI 10.1177/2167702614565359; Woo CW, 2015, PAIN, V156, P1379, DOI 10.1097/j.pain.0000000000000223; Woo CW, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002036; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wu P, 2013, PARKINSONISM RELAT D, V19, P622, DOI 10.1016/j.parkreldis.2013.02.013; Yahata N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11254; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Ye Z, 2016, HUM BRAIN MAPP, V37, P1026, DOI 10.1002/hbm.23087; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zaki J, 2016, TRENDS COGN SCI, V20, P249, DOI 10.1016/j.tics.2016.02.003	150	459	459	9	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2017	20	3					365	377		10.1038/nn.4478	http://dx.doi.org/10.1038/nn.4478			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EL9DU	28230847	Green Accepted			2022-12-17	WOS:000394920400009
J	Guo, JJU; Ma, DKK; Mo, H; Ball, MP; Jang, MH; Bonaguidi, MA; Balazer, JA; Eaves, HL; Xie, B; Ford, E; Zhang, K; Ming, GL; Gao, Y; Song, HJ				Guo, Junjie U.; Ma, Dengke K.; Mo, Huan; Ball, Madeleine P.; Jang, Mi-Hyeon; Bonaguidi, Michael A.; Balazer, Jacob A.; Eaves, Hugh L.; Xie, Bin; Ford, Eric; Zhang, Kun; Ming, Guo-li; Gao, Yuan; Song, Hongjun			Neuronal activity modifies the DNA methylation landscape in the adult brain	NATURE NEUROSCIENCE			English	Article							REGULATES MEMORY FORMATION; EPIGENETIC REGULATION; GENE-REGULATION; DEMETHYLATION; CELLS; TRANSCRIPTION; PLASTICITY; GENOME; NEUROGENESIS; CANCER	DNA methylation has been traditionally viewed as a highly stable epigenetic mark in postmitotic cells. However, postnatal brains appear to show stimulus-induced methylation changes, at least in a few identified CpG dinucleotides. How extensively the neuronal DNA methylome is regulated by neuronal activity is unknown. Using a next-generation sequencing-based method for genome-wide analysis at single-nucleotide resolution, we quantitatively compared the CpG methylation landscape of adult mouse dentate granule neurons in vivo before and after synchronous neuronal activation. About 1.4% of 219,991 CpGs measured showed rapid active demethylation or de novo methylation. Some modifications remained stable for at least 24 h. These activity-modified CpGs showed a broad genomic distribution with significant enrichment in low-CpG density regions, and were associated with brain-specific genes related to neuronal plasticity. Our study implicates modification of the neuronal DNA methylome as a previously underappreciated mechanism for activity-dependent epigenetic regulation in the adult nervous system.	[Guo, Junjie U.; Ma, Dengke K.; Jang, Mi-Hyeon; Bonaguidi, Michael A.; Ming, Guo-li; Gao, Yuan; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Guo, Junjie U.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD USA; [Ma, Dengke K.; Jang, Mi-Hyeon; Bonaguidi, Michael A.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Mo, Huan; Eaves, Hugh L.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Ball, Madeleine P.] Harvard Univ, Sch Med, Dept Genet, Cambridge, MA 02138 USA; [Balazer, Jacob A.] Proofpoint Inc, Sunnyvale, CA USA; [Xie, Bin; Gao, Yuan] Lieber Inst Brain Dev, Div Genom Epigenom & Bioinformat, Baltimore, MD USA; [Ford, Eric] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD USA; [Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Virginia Commonwealth University; Harvard University; Johns Hopkins University; University of California System; University of California San Diego	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.	garygao@gmail.com; shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013; Zhang, Kun/ABE-6349-2020; Gao, Yuan/E-1706-2011	Zhang, Kun/0000-0002-7596-5224; Mo, Huan/0000-0001-6029-458X; Ball, Mad/0000-0003-0544-5925	US National Institutes of Health (NIH) [AG024984, NS047344]; McKnight Scholar Award; NARSAD; NIH [HD069184, NS048271]; Johns Hopkins Brain Science Institute; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Lieber Institute; US National Institute of Mental Health [MH090115]; Maryland Stem Cell Research Fund (MSCRF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH090115, K99MH090115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS047344, R01NS047344, R56NS047344, R01NS048271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025779] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Scholar Award; NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Brain Science Institute(Johns Hopkins University); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Lieber Institute; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Maryland Stem Cell Research Fund (MSCRF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Church, S. Baylin, D. Ginty and K. Christian for comments and suggestions; G. Sun for help with FACS; and W. Y. Kim (Johns Hopkins University) for breeding Gadd45b knockout mice. This work was supported by US National Institutes of Health (NIH; AG024984, NS047344), McKnight Scholar Award and NARSAD (Brain and Behavior Research Fund) to H. S.; by NIH (HD069184, NS048271), Johns Hopkins Brain Science Institute, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, and NARSAD grants to G.-l. M.; and Lieber Institute start-up funds to Y. G. J.U.G. was a FARMS (Foundation for Advanced Research in Medical Sciences) fellow. M.H.J. was supported by a US National Institute of Mental Health K99 award (MH090115). M. A. B. was partially supported by a fellowship from Maryland Stem Cell Research Fund (MSCRF); M. P. B. was supported by grants from the NIH to G. Church.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Day JJ, 2010, NAT NEUROSCI, V13, P1319, DOI 10.1038/nn.2666; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Eaves HL, 2009, BIOINFORMATICS, V25, P969, DOI 10.1093/bioinformatics/btp092; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Ford EC, 2011, RADIAT RES, V175, P774, DOI 10.1667/RR2214.1; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guo JU, 2011, CELL CYCLE, V10, P2662, DOI 10.4161/cc.10.16.17093; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Klug M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r63; LaPlant Q, 2010, NAT NEUROSCI, V13, P1137, DOI 10.1038/nn.2619; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lisanby SH, 2007, NEW ENGL J MED, V357, P1939, DOI 10.1056/NEJMct075234; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Ma DKK, 2010, NAT NEUROSCI, V13, P1338, DOI 10.1038/nn.2672; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; NASS MMK, 1973, J MOL BIOL, V80, P155, DOI 10.1016/0022-2836(73)90239-8; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	50	459	467	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2011	14	10					1345	U172		10.1038/nn.2900	http://dx.doi.org/10.1038/nn.2900			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	825EQ	21874013	Green Accepted			2022-12-17	WOS:000295254200025
J	Parri, HR; Gould, TM; Crunelli, V				Parri, HR; Gould, TM; Crunelli, V			Spontaneous astrocytic Ca2+ oscillations in situ drive NMDAR-mediated neuronal excitation	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; DEPENDENT GLUTAMATE RELEASE; GLIAL CALCIUM WAVES; SYNAPTIC TRANSMISSION; POSTNATAL-DEVELOPMENT; REGIONAL EXPRESSION; RAT-BRAIN; IN-SITU; RECEPTORS; CELLS	Astrocytes respond to chemical, electrical and mechanical stimuli with transient increases in intracellular calcium concentration ([Ca2+](i)). We now show that astrocytes in situ display intrinsic [Ca2+](i) oscillations that are not driven by neuronal activity. These spontaneous astrocytic oscillations can propagate as waves to neighboring astrocytes and trigger slowly decaying NMDA receptor-mediated inward currents in neurons located along the wave path. These findings show that astrocytes in situ can act as a primary source for generating neuronal activity in the mammalian central nervous system.	Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales	Cardiff University	Crunelli, V (corresponding author), Cardiff Univ, Sch Biosci, Museum Ave,POB 911, Cardiff CF10 3US, S Glam, Wales.	crunelli@cardiff.ac.uk	Parri, Rheinallt/D-1748-2013; Crunelli, Vincenzo/A-7258-2010	Parri, Rheinallt/0000-0002-1412-2688; Crunelli, Vincenzo/0000-0001-7154-9752				Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Araque A, 1998, J NEUROSCI, V18, P6822; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Carmignoto G, 2000, PROG NEUROBIOL, V62, P561, DOI 10.1016/S0301-0082(00)00029-0; Catalano SM, 1998, SCIENCE, V281, P559, DOI 10.1126/science.281.5376.559; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; CHARLES AC, 1994, DEV NEUROSCI-BASEL, V16, P196, DOI 10.1159/000112107; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; FINKBEINER SM, 1993, GLIA, V9, P83, DOI 10.1002/glia.440090202; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.3.CO;2-Z; Golshani P, 1998, J NEUROPHYSIOL, V80, P143, DOI 10.1152/jn.1998.80.1.143; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; HASSINGER TD, 1995, J NEUROBIOL, V28, P159, DOI 10.1002/neu.480280204; Innocenti B, 2000, J NEUROSCI, V20, P1800; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LITTLE JDC, 1969, OPER RES, V17, P1, DOI 10.1287/opre.17.1.1; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; MILLER B, 1993, J COMP NEUROL, V335, P16, DOI 10.1002/cne.903350103; Misra C, 2000, J PHYSIOL-LONDON, V525, P299, DOI 10.1111/j.1469-7793.2000.t01-1-00299.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Newman EA, 1998, J NEUROSCI, V18, P4022; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 1998, J NEUROSCI, V18, P854; Pasti L, 1997, J NEUROSCI, V17, P7817; PERKEL DJ, 1993, NEURON, V11, P817, DOI 10.1016/0896-6273(93)90111-4; PORTER JT, 1995, GLIA, V13, P101, DOI 10.1002/glia.440130204; Rajan I, 1998, J NEUROSCI, V18, P7836; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; SCHNITZER J, 1981, J CELL BIOL, V90, P435, DOI 10.1083/jcb.90.2.435; SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103; SPREAFICO R, 1994, DEV BRAIN RES, V82, P231, DOI 10.1016/0165-3806(94)90166-X; TURNER JP, 1994, J PHYSIOL-LONDON, V480, P281, DOI 10.1113/jphysiol.1994.sp020359; Velazquez JLP, 1996, DEV BRAIN RES, V91, P164; Wenzel A, 1996, J NEUROCHEM, V66, P1240; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; Zantua JB, 1996, SOMATOSENS MOT RES, V13, P307, DOI 10.3109/08990229609052585	48	459	475	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					803	812		10.1038/90507	http://dx.doi.org/10.1038/90507			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477426				2022-12-17	WOS:000170137300013
J	Legon, W; Sato, TF; Opitz, A; Mueller, J; Barbour, A; Williams, A; Tyler, WJ				Legon, Wynn; Sato, Tomokazu F.; Opitz, Alexander; Mueller, Jerel; Barbour, Aaron; Williams, Amanda; Tyler, William J.			Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans	NATURE NEUROSCIENCE			English	Article							MAGNETIC STIMULATION; LOW-INTENSITY; EVOKED-POTENTIALS; MOTOR CORTEX; MEDIAN-NERVE; BRAIN; TRANSMISSION; OSCILLATIONS; CIRCUITS; IMPACT	Improved methods of noninvasively modulating human brain function are needed. Here we probed the influence of transcranial focused ultrasound (tFUS) targeted to the human primary somatosensory cortex (Si) on sensory-evoked brain activity and sensory discrimination abilities. The lateral and axial spatial resolution of the tFUS beam implemented were 4.9 mm and 18 mm, respectively. Electroencephalographic recordings showed that tFUS significantly attenuated the amplitudes of somatosensory evoked potentials elicited by median nerve stimulation. We also found that tFUS significantly modulated the spectral content of sensory-evoked brain oscillations. The changes produced by tFUS on sensory-evoked brain activity were abolished when the acoustic beam was focused 1 cm anterior or posterior to Si. Behavioral investigations showed that tFUS targeted to Si enhanced performance on sensory discrimination tasks without affecting task attention or response bias. We conclude that tFUS can be used to focally modulate human cortical function.	[Legon, Wynn; Sato, Tomokazu F.; Opitz, Alexander; Barbour, Aaron; Williams, Amanda; Tyler, William J.] Virginia Tech, Carilion Res Inst, Roanoke, VA 24016 USA; [Opitz, Alexander] Univ Gottingen, Dept Clin Neurophysiol, D-37073 Gottingen, Germany; [Mueller, Jerel; Tyler, William J.] Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA USA; [Tyler, William J.] Virginia Tech, Carilion Sch Med, Dept Psychiat & Behav Med, Roanoke, VA USA	Virginia Polytechnic Institute & State University; University of Gottingen; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Tyler, WJ (corresponding author), Virginia Tech, Carilion Res Inst, Roanoke, VA 24016 USA.	wtyler@vt.edu	friedlander, robert/A-2845-2016	friedlander, robert/0000-0003-4423-9219; Tyler, William/0000-0002-7758-5022	Virginia Tech Carillon Research Institute; Technological Innovation Award from the McKnight Endowment for Neuroscience, Neurotrek, Inc.	Virginia Tech Carillon Research Institute; Technological Innovation Award from the McKnight Endowment for Neuroscience, Neurotrek, Inc.	Funding and equipment for this study was provided by a Technological Innovation Award from the McKnight Endowment for Neuroscience, Neurotrek, Inc. and the Virginia Tech Carillon Research Institute.	ALLISON T, 1991, J NEUROPHYSIOL, V66, P64, DOI 10.1152/jn.1991.66.1.64; ALLISON T, 1989, J NEUROPHYSIOL, V62, P694, DOI 10.1152/jn.1989.62.3.694; Bachtold MR, 1998, ULTRASOUND MED BIOL, V24, P557, DOI 10.1016/S0301-5629(98)00014-3; Burton H, 2000, J CLIN NEUROPHYSIOL, V17, P575, DOI 10.1097/00004691-200011000-00004; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Bystritsky A, 2011, BRAIN STIMUL, V4, P125, DOI 10.1016/j.brs.2011.03.007; Dalecki D, 2004, ANNU REV BIOMED ENG, V6, P229, DOI 10.1146/annurev.bioeng.6.040803.140126; Deffieux T, 2013, CURR BIOL, V23, P2430, DOI 10.1016/j.cub.2013.10.029; ELIAS WJ, 2013, GLOB PUBLIC HEALTH, V8, P640, DOI [DOI 10.1056/NEJMoa1300962, DOI 10.1056/NEJMOA1300962]; FRY FJ, 1958, SCIENCE, V127, P83, DOI 10.1126/science.127.3289.83; Fukuda M, 2008, BRAIN, V131, P1793, DOI 10.1093/brain/awn100; Gavrilov LR, 1996, ULTRASOUND MED BIOL, V22, P179, DOI 10.1016/0301-5629(96)83782-3; Hameroff S, 2013, BRAIN STIMUL, V6, P409, DOI 10.1016/j.brs.2012.05.002; Hari R, 1999, PHILOS T R SOC B, V354, P1145, DOI 10.1098/rstb.1999.0470; Harvey EN, 1929, AM J PHYSIOL, V91, P284, DOI 10.1152/ajplegacy.1929.91.1.284; Hayner M, 2001, J ACOUST SOC AM, V110, P3319, DOI 10.1121/1.1410964; King RL, 2013, ULTRASOUND MED BIOL, V39, P312, DOI 10.1016/j.ultrasmedbio.2012.09.009; Krasovitski B, 2011, P NATL ACAD SCI USA, V108, P3258, DOI 10.1073/pnas.1015771108; Legon W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051177; Leighton TG, 2007, PROG BIOPHYS MOL BIO, V93, P3, DOI 10.1016/j.pbiomolbio.2006.07.026; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; MANLAPAZ JS, 1964, EXP NEUROL, V10, P345, DOI 10.1016/0014-4886(64)90005-6; Menz MD, 2013, J NEUROSCI, V33, P4550, DOI 10.1523/JNEUROSCI.3521-12.2013; MIHRAN RT, 1990, ULTRASOUND MED BIOL, V16, P297, DOI 10.1016/0301-5629(90)90008-Z; Min BK, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-23; Nyborg WL, 2001, ULTRASOUND MED BIOL, V27, P301, DOI 10.1016/S0301-5629(00)00333-1; O'Brien WD, 2007, PROG BIOPHYS MOL BIO, V93, P212, DOI 10.1016/j.pbiomolbio.2006.07.010; O'Reilly MA, 2010, PHYS MED BIOL, V55, P5251, DOI 10.1088/0031-9155/55/18/001; Opitz A, 2013, NEUROIMAGE, V81, P253, DOI 10.1016/j.neuroimage.2013.04.067; Opitz A, 2011, NEUROIMAGE, V58, P849, DOI 10.1016/j.neuroimage.2011.06.069; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; SHEALY CN, 1962, ARCH NEUROL-CHICAGO, V6, P374, DOI 10.1001/archneur.1962.00450230036005; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; SWETS JA, 1961, SCIENCE, V134, P168, DOI 10.1126/science.134.3473.168; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Thielscher A, 2004, CLIN NEUROPHYSIOL, V115, P1697, DOI 10.1016/j.clinph.2004.02.019; Thielscher A, 2011, NEUROIMAGE, V54, P234, DOI 10.1016/j.neuroimage.2010.07.061; Tsui PH, 2005, ULTRASONICS, V43, P560, DOI 10.1016/j.ultras.2004.12.003; Tufail Y, 2011, NAT PROTOC, V6, P1453, DOI 10.1038/nprot.2011.371; Tufail Y, 2010, NEURON, V66, P681, DOI 10.1016/j.neuron.2010.05.008; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Tyler WJ, 2011, NEUROSCIENTIST, V17, P25, DOI 10.1177/1073858409348066; Tyler WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003511; White PJ, 2006, PHYS MED BIOL, V51, P2293, DOI 10.1088/0031-9155/51/9/013; Yoo SS, 2011, NEUROIMAGE, V56, P1267, DOI 10.1016/j.neuroimage.2011.02.058	45	457	489	10	157	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2014	17	2					322	329		10.1038/nn.3620	http://dx.doi.org/10.1038/nn.3620			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AA2FH	24413698				2022-12-17	WOS:000330910000028
J	Davidson, RJ; McEwen, BS				Davidson, Richard J.; McEwen, Bruce S.			Social influences on neuroplasticity: stress and interventions to promote well-being	NATURE NEUROSCIENCE			English	Review							EMOTION REGULATION; BRAIN PLASTICITY; AMYGDALA VOLUME; VISUAL-CORTEX; COMPASSION MEDITATION; STRUCTURAL PLASTICITY; DENDRITIC MORPHOLOGY; PSYCHOSOCIAL STRESS; HIPPOCAMPAL VOLUME; PREFRONTAL CORTEX	Experiential factors shape the neural circuits underlying social and emotional behavior from the prenatal period to the end of life. These factors include both incidental influences, such as early adversity, and intentional influences that can be produced in humans through specific interventions designed to promote prosocial behavior and well-being. Here we review important extant evidence in animal models and humans. Although the precise mechanisms of plasticity are still not fully understood, moderate to severe stress appears to increase the growth of several sectors of the amygdala, whereas the effects in the hippocampus and prefrontal cortex tend to be opposite. Structural and functional changes in the brain have been observed with cognitive therapy and certain forms of meditation and lead to the suggestion that well-being and other prosocial characteristics might be enhanced through training.	[Davidson, Richard J.] Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53706 USA; [Davidson, Richard J.] Univ Wisconsin, Ctr Invest Hlth Minds, Madison, WI USA; [McEwen, Bruce S.] Rockefeller Univ, Harold & Margaret Milliken Hatch Lab Neuroendocri, New York, NY 10021 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Rockefeller University	Davidson, RJ (corresponding author), Univ Wisconsin, Waisman Lab Brain Imaging & Behav, Madison, WI 53706 USA.	rjdavids@wisc.edu; mcewen@mail.rockefeller.edu	Carroll, Joseph/D-1158-2011; McEwen, Bruce/Z-1630-2019	Carroll, Joseph/0000-0003-2656-1378; Davidson, Richard/0000-0002-8506-4964	National Institute of Mental Health [R01-MH43454, P50-MH084051]; National Center for Complementary and Alternative Medicine [P01-AT004952]; Fetzer Institute; John Templeton Foundation; John W Kluge Foundation; US National Institutes of Health [R01 MH41256, 5P01 MH58911]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P01AT004952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH041256, P50MH084051, R01MH043454, P50MH058911] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Fetzer Institute; John Templeton Foundation; John W Kluge Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	R.J.D. is supported by grants from the National Institute of Mental Health (R01-MH43454 and P50-MH084051), the National Center for Complementary and Alternative Medicine (P01-AT004952), the Fetzer Institute, the John Templeton Foundation, and gifts from Bryant Wangard and Ralph Robinson, Ann Down, Keith and Arlene Bronstein, and the John W Kluge Foundation. B.S.M. is supported by US National Institutes of Health grants R01 MH41256 and 5P01 MH58911.	Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Akers KG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002840; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Anda RF, 2010, AM J PREV MED, V39, P93, DOI 10.1016/j.amepre.2010.03.015; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Bloss EB, 2010, J NEUROSCI, V30, P6726, DOI 10.1523/JNEUROSCI.0759-10.2010; Brewer JA, 2011, P NATL ACAD SCI USA, V108, P20254, DOI 10.1073/pnas.1112029108; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Buss C, 2007, J NEUROSCI, V27, P2592, DOI 10.1523/JNEUROSCI.3252-06.2007; Cameron H. A., 1996, RECEPTOR DYNAMICS NE, P141; Carlson MC, 2009, J GERONTOL A-BIOL, V64, P1275, DOI 10.1093/gerona/glp117; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Chambers R, 2009, CLIN PSYCHOL REV, V29, P560, DOI 10.1016/j.cpr.2009.06.005; Chen JR, 2009, CEREB CORTEX, V19, P2719, DOI 10.1093/cercor/bhp048; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Christoffel DJ, 2011, J NEUROSCI, V31, P314, DOI 10.1523/JNEUROSCI.4763-10.2011; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Coplan JD, 2001, BIOL PSYCHIAT, V50, P200, DOI 10.1016/S0006-3223(01)01175-1; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Davidson RJ, 2004, PHILOS T R SOC B, V359, P1395, DOI 10.1098/rstb.2004.1510; de Lange FP, 2008, BRAIN, V131, P2172, DOI 10.1093/brain/awn140; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; DIAMOND MC, 1978, AM SCI, V66, P66; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dumitriu D, 2010, ANN NY ACAD SCI, V1204, P104, DOI 10.1111/j.1749-6632.2010.05529.x; Durlak JA, 2011, CHILD DEV, V82, P405, DOI 10.1111/j.1467-8624.2010.01564.x; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; Fava GA, 1998, PSYCHOL MED, V28, P475, DOI 10.1017/S0033291797006363; Gould E, 1997, J NEUROSCI, V17, P2492; Gould F, 2012, J PSYCHIATR RES, V46, P500, DOI 10.1016/j.jpsychires.2012.01.005; Hanson JL, 2010, J NEUROSCI, V30, P7466, DOI 10.1523/JNEUROSCI.0859-10.2010; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Heim C, 2010, DEV PSYCHOBIOL, V52, P671, DOI 10.1002/dev.20494; Holzel BK, 2010, SOC COGN AFFECT NEUR, V5, P11, DOI 10.1093/scan/nsp034; Hofmann SG, 2011, CLIN PSYCHOL REV, V31, P1126, DOI 10.1016/j.cpr.2011.07.003; Isgor C, 2004, HIPPOCAMPUS, V14, P636, DOI 10.1002/hipo.10207; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kaplan MS, 2001, TRENDS NEUROSCI, V24, P617, DOI 10.1016/S0166-2236(00)01967-6; Katz M, 2009, DEV NEUROSCI-BASEL, V31, P293, DOI 10.1159/000216540; Kaufman D, 2005, J CLIN ENDOCR METAB, V90, P404, DOI 10.1210/jc.2004-0452; Kemeny M.E, 2011, EMOTION; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Kozorovitskiy Y, 2004, J NEUROSCI, V24, P6755, DOI 10.1523/JNEUROSCI.0345-04.2004; Kuhl PK, 2010, NEURON, V67, P713, DOI 10.1016/j.neuron.2010.08.038; LEVINE S, 1967, PHYSIOL BEHAV, V2, P55, DOI 10.1016/0031-9384(67)90011-X; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Liston C, 2011, P NATL ACAD SCI USA, V108, P16074, DOI 10.1073/pnas.1110444108; Loman MM, 2010, NEUROSCI BIOBEHAV R, V34, P867, DOI 10.1016/j.neubiorev.2009.05.007; Lupien SJ, 2011, P NATL ACAD SCI USA, V108, P14324, DOI 10.1073/pnas.1105371108; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Magarinos AM, 1996, J NEUROSCI, V16, P3534; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McEwen BS, 2007, BRAIN RES REV, V55, P343, DOI 10.1016/j.brainresrev.2007.02.006; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Moriceau S, 2006, NAT NEUROSCI, V9, P1004, DOI 10.1038/nn1733; Mosconi MW, 2009, ARCH GEN PSYCHIAT, V66, P509, DOI 10.1001/archgenpsychiatry.2009.19; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; NOTTEBOHM F, 1989, SCI AM, V260, P74, DOI 10.1038/scientificamerican0289-74; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Parker KJ, 2011, NEUROSCI BIOBEHAV R, V35, P1466, DOI 10.1016/j.neubiorev.2010.09.003; Parker KJ, 2005, BIOL PSYCHIAT, V57, P848, DOI 10.1016/j.biopsych.2004.12.024; Parker KJ, 2004, ARCH GEN PSYCHIAT, V61, P933, DOI 10.1001/archpsyc.61.9.933; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Roitman MF, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-11-j0001.2002; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Shonkoff JP, 2011, SCIENCE, V333, P982, DOI 10.1126/science.1206014; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Spolidoro M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1323; Sullivan RM, 2010, NEUROSCI BIOBEHAV R, V34, P835, DOI 10.1016/j.neubiorev.2009.11.010; Tang AC, 2006, P NATL ACAD SCI USA, V103, P15716, DOI 10.1073/pnas.0607374103; Tottenham N, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.068.2009; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; van Hasselt FN, 2012, HIPPOCAMPUS, V22, P255, DOI 10.1002/hipo.20892; Vyas A, 2002, J NEUROSCI, V22, P6810; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006	100	457	466	15	302	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2012	15	5					689	695		10.1038/nn.3093	http://dx.doi.org/10.1038/nn.3093			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	932DI	22534579	Green Accepted			2022-12-17	WOS:000303270200011
J	Maguire, JL; Stell, BM; Rafizadeh, M; Mody, I				Maguire, JL; Stell, BM; Rafizadeh, M; Mody, I			Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety	NATURE NEUROSCIENCE			English	Article							DELTA-SUBUNIT; NEUROACTIVE STEROIDS; ESTROUS-CYCLE; ANTICONVULSANT ACTIVITY; WITHDRAWAL PROPERTIES; LUTEAL-PHASE; PROGESTERONE; ETHANOL; MODEL; NEUROSTEROIDS	Disturbances of neuronal excitability changes during the ovarian cycle may elevate seizure frequency in women with catamenial epilepsy and enhance anxiety in premenstrual dysphoric disorder (PMDD). The mechanisms underlying these changes are unknown, but they could result from the effects of fluctuations in progesterone-derived neurosteroids on the brain. Neurosteroids and some anxiolytics share an important site of action: tonic inhibition mediated by delta subunit - containing GABA(A) receptors (delta GABA(A)Rs). Here we demonstrate periodic alterations in specific GABA(A)R subunits during the estrous cycle in mice, causing cyclic changes of tonic inhibition in hippocampal neurons. In late diestrus (high-progesterone phase), enhanced expression of delta GABA(A)Rs increases tonic inhibition, and a reduced neuronal excitability is reflected by diminished seizure susceptibility and anxiety. Eliminating cycling of delta GABA(A)Rs by antisense RNA treatment or gene knockout prevents the lowering of excitability during diestrus. Our findings are consistent with possible deficiencies in regulatory mechanisms controlling normal cycling of delta GABA(A)Rs in individuals with catamenial epilepsy or PMDD.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Mody, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	mody@ucla.edu		Stell, Brandon/0000-0003-1287-9211; Maguire, Jamie/0000-0002-4085-8605	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007449, P01NS002808, R37NS030549, R01NS030549] Funding Source: NIH RePORTER; NINDS NIH HHS [T32 NS07449, NS30549, NS02808] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agmo A, 1997, PSYCHOPHARMACOLOGY, V129, P372, DOI 10.1007/s002130050203; Backstrom T, 2003, ANN NY ACAD SCI, V1007, P42, DOI 10.1196/annals.1286.005; Belelli D, 2002, NEUROPHARMACOLOGY, V43, P651, DOI 10.1016/S0028-3908(02)00172-7; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Broadbent J, 1999, PSYCHOPHARMACOLOGY, V141, P197, DOI 10.1007/s002130050825; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Dibbens LM, 2004, HUM MOL GENET, V13, P1315, DOI 10.1093/hmg/ddh146; Edwards HE, 1999, BRAIN RES, V838, P136, DOI 10.1016/S0006-8993(99)01619-4; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Guerra-Araiza C, 2003, J NEUROENDOCRINOL, V15, P984, DOI 10.1046/j.1365-2826.2003.01088.x; Gulinello M, 2002, NEUROPHARMACOLOGY, V43, P701, DOI 10.1016/S0028-3908(02)00171-5; Herzog AG, 1997, EPILEPSIA, V38, P1082, DOI 10.1111/j.1528-1157.1997.tb01197.x; Herzog AG, 1999, NEUROLOGY, V52, P1917, DOI 10.1212/WNL.52.9.1917-a; Hevers W, 1998, MOL NEUROBIOL, V18, P35, DOI 10.1007/BF02741459; Jones A, 1997, J NEUROSCI, V17, P1350; Lancel M, 2001, AM J PHYSIOL-ENDOC M, V281, pE130, DOI 10.1152/ajpendo.2001.281.1.E130; MARTIN JV, 1995, LIFE SCI, V57, P1903, DOI 10.1016/0024-3205(95)02177-K; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Molina-Hernandez M, 2001, NEUROPSYCHOBIOLOGY, V43, P29, DOI 10.1159/000054862; Nusser Z, 2002, J NEUROPHYSIOL, V87, P2624, DOI 10.1152/jn.2002.87.5.2624; Nyberg S, 2004, PSYCHONEUROENDOCRINO, V29, P767, DOI 10.1016/S0306-4530(03)00121-5; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Peng ZC, 2004, J NEUROSCI, V24, P8629, DOI 10.1523/JNEUROSCI.2877-04.2004; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Reddy DS, 2001, EPILEPSIA, V42, P328, DOI 10.1046/j.1528-1157.2001.10100.x; Reddy DS, 1999, PHARMACOL BIOCHEM BE, V62, P53, DOI 10.1016/S0091-3057(98)00126-9; Reddy DS, 2004, J PHARMACOL EXP THER, V310, P230, DOI 10.1124/jpet.104.065268; Reddy DS, 2001, EPILEPSIA, V42, P337, DOI 10.1046/j.1528-1157.2001.10200.x; Rogawski MA, 2003, ANN NEUROL, V53, P288, DOI 10.1002/ana.10534; Sanna E, 2004, J NEUROSCI, V24, P6521, DOI 10.1523/JNEUROSCI.0075-04.2004; Shuman Sevie, 2003, Epilepsia, V44, P292; Smith MJ, 2003, BIOL PSYCHIAT, V54, P757, DOI 10.1016/S0006-3223(02)01924-8; Smith MJ, 2002, ANN NEUROL, V51, P599, DOI 10.1002/ana.10180; Smith SS, 1998, NATURE, V392, P926, DOI 10.1038/31948; Smith SS, 2004, ALCOHOL, V33, P41, DOI 10.1016/j.alcohol.2004.04.003; Smith SS, 2002, STEROIDS, V67, P519, DOI 10.1016/S0039-128X(01)00170-2; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; Somogyi P, 1996, NEUROPHARMACOLOGY, V35, P1425, DOI 10.1016/S0028-3908(96)00086-X; Stell BM, 2003, P NATL ACAD SCI USA, V100, P14439, DOI 10.1073/pnas.2435457100; Sundstrom I, 1998, NEUROENDOCRINOLOGY, V67, P126, DOI 10.1159/000054307; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Wei WZ, 2003, J NEUROSCI, V23, P10650; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002	48	457	465	2	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					797	804		10.1038/nn1469	http://dx.doi.org/10.1038/nn1469			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15895085				2022-12-17	WOS:000229345300021
J	Donoghue, JP				Donoghue, JP			Connecting cortex to machines: recent advances in brain interfaces	NATURE NEUROSCIENCE			English	Review							MOVEMENT; PERFORMANCE; NEURONS; VISION; BLIND	Recent technological and scientific advances have generated wide interest in the possibility of creating a brain-machine interface (BMI), particularly as a means to aid paralyzed humans in communication. Advances have been made in detecting neural signals and translating them into command signals that can control devices. We now have systems that use externally derived neural signals as a command source, and faster and potentially more flexible systems that directly use intracortical recording are being tested. Studies in behaving monkeys show that neural output from the motor cortex can be used to control computer cursors almost as effectively as a natural hand would carry out the task. Additional research findings explore the possibility of using computers to return behaviorally useful feedback information to the cortex. Although significant scientific and technological challenges remain, progress in creating useful human BMIs is accelerating.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University	Donoghue, JP (corresponding author), Brown Univ, Dept Neurosci, Box 1953, Providence, RI 02912 USA.	John_Donoghue@Brown.edu						Bai Q, 2001, IEEE T BIO-MED ENG, V48, P911, DOI 10.1109/10.936367; Bauby J.D., 1997, DIVING BELL BUTTERFL, V4th ed.; Benabid AL, 2001, ADV NEUROL, V86, P405; COOPER IS, 1981, NEUROSURGERY, V9, P190, DOI 10.1227/00006123-198108000-00017; DELGADO JMR, 1969, PHYSICAL CONTROL MIN; Dobelle WH, 2000, ASAIO J, V46, P3, DOI 10.1097/00002480-200001000-00002; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; EVARTS EV, 1966, J NEUROPHYSIOL, V29, P1011, DOI 10.1152/jn.1966.29.6.1011; GAO Y, 2002, P ADV NEUR INF PROC, V14; GEORGOPOULOS AP, 1994, INT REV NEUROBIOL, V37, P103; HAMBRECHT FT, 1995, BAILLIERE CLIN NEUR, V4, P147; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Lauer RT, 1999, NEUROREPORT, V10, P1767, DOI 10.1097/00001756-199906030-00026; MARG E, 1967, ELECTROEN CLIN NEURO, V23, P277, DOI 10.1016/0013-4694(67)90126-5; MAURITZ K H, 1987, International Journal of Rehabilitation Research, V10, P57, DOI 10.1097/00004356-198700105-00010; Maynard EM, 2001, ANNU REV BIOMED ENG, V3, P145, DOI 10.1146/annurev.bioeng.3.1.145; Maynard EM, 1997, ELECTROEN CLIN NEURO, V102, P228, DOI 10.1016/S0013-4694(96)95176-0; Maynard EM, 1999, J NEUROSCI, V19, P8083; Moxon KA, 2001, METH NE FRO NEUROSCI, P179; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Normann RA, 1999, VISION RES, V39, P2577, DOI 10.1016/S0042-6989(99)00040-1; PALMER C, 1978, BRAIN RES BULL, V3, P285, DOI 10.1016/0361-9230(78)90129-6; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Rousche PJ, 2001, IEEE T BIO-MED ENG, V48, P361, DOI 10.1109/10.914800; Schmidt EM, 1996, BRAIN, V119, P507, DOI 10.1093/brain/119.2.507; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wickersham I, 1998, CURR BIOL, V8, pR412, DOI 10.1016/S0960-9822(98)70265-9; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3	33	457	513	4	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5			S			1085	1088		10.1038/nn947	http://dx.doi.org/10.1038/nn947			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	611WT	12403992				2022-12-17	WOS:000179041300020
J	Kuwabara, T; Hsieh, J; Muotri, A; Yeo, G; Warashina, M; Lie, DC; Moore, L; Nakashima, K; Asashima, M; Gage, FH				Kuwabara, Tomoko; Hsieh, Jenny; Muotri, Alysson; Yeo, Gene; Warashina, Masaki; Lie, Dieter Chichung; Moore, Lynne; Nakashima, Kinichi; Asashima, Makoto; Gage, Fred H.			Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis	NATURE NEUROSCIENCE			English	Article							DENTATE GYRUS; PROGENITOR CELLS; BETA-CATENIN; HIPPOCAMPAL NEUROGENESIS; LENTIVIRAL VECTOR; CEREBRAL-CORTEX; GRANULE CELLS; STEM-CELLS; IN-VIVO; GENE	In adult hippocampus, new neurons are continuously generated from neural stem cells (NSCs), but the molecular mechanisms regulating adult neurogenesis remain elusive. We found that Wnt signaling, together with the removal of Sox2, triggered the expression of NeuroD1 in mice. This transcriptional regulatory mechanism was dependent on a DNA element containing overlapping Sox2 and T-cell factor/lymphoid enhancer factor (TCF/LEF)-binding sites (Sox/LEF) in the promoter. Notably, Sox/LEF sites were also found in long interspersed nuclear element 1 (LINE-1) elements, consistent with their critical roles in the transition of NSCs to proliferating neuronal progenitors. Our results describe a previously unknown Wnt-mediated regulatory mechanism that simultaneously coordinates activation of NeuroD1 and LINE-1, which is important for adult neurogenesis and survival of neuronal progenitors. Moreover, the discovery that LINE-1 retro-elements embedded in the mammalian genome can function as bi-directional promoters suggests that Sox/LEF regulatory sites may represent a general mechanism, at least in part, for relaying environmental signals to other nearby loci to promote adult hippocampal neurogenesis.	[Kuwabara, Tomoko; Warashina, Masaki; Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Tsukuba, Japan; [Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Muotri, Alysson] Univ Calif San Diego, Sch Med, Dept Pediat Cellular & Mol Med, Stem Cell Program, La Jolla, CA 92093 USA; [Lie, Dieter Chichung] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Adult Neurogenesis & Neural Stem Cell Grp, Munich, Germany; [Moore, Lynne; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA USA; [Nakashima, Kinichi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol Neurosci, Ikoma, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Salk Institute; Nara Institute of Science & Technology	Kuwabara, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Japan.	t.warashina@aist.go.jp	Lie, Dieter Chichung/S-7914-2017; Kuwabara, Tomoko/M-1639-2018; Yeo, Gene/AAE-7676-2019; Lie, Dieter Chichung/AAS-8604-2020	Lie, Dieter Chichung/0000-0002-6035-6442; Kuwabara, Tomoko/0000-0002-7668-0896; Yeo, Gene/0000-0002-0799-6037; Lie, Dieter Chichung/0000-0002-6035-6442	National Institute of Advanced Industrial Science and Technology; US National Institutes of Health [MH082070]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH082070] Funding Source: NIH RePORTER	National Institute of Advanced Industrial Science and Technology; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. Ohtake for assistance with animal care and supporting our in vivo experiments. We thank M. Namihira and J. Kohyama for assistance in obtaining immunostaining data, E. Mosser for the constitutively active beta-catenin construct, and G. Canettieri and M. Montminy for HDAC1. We thank A. Huynh for help with immunohistochemical analysis. We are grateful for the technical assistance of B. Miller and to M. L. Gage for editorial comments. T. K., M. W. and M. A. were supported by various grants from National Institute of Advanced Industrial Science and Technology. T. K. was partly supported by the Grant-in-Aid for Exploratory Research. F. H. G. was supported by grants from the US National Institutes of Health (MH082070) and the G. Harold and Leila Y. Mathers Charitable Foundation.	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Brault V, 2001, DEVELOPMENT, V128, P1253; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collignon J, 1996, DEVELOPMENT, V122, P509; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Farah MH, 2000, DEVELOPMENT, V127, P693; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Galceran J, 2000, DEVELOPMENT, V127, P469; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grove EA, 1998, DEVELOPMENT, V125, P2315; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; Hsieh J, 2004, P NATL ACAD SCI USA, V101, P16659, DOI 10.1073/pnas.0407643101; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; MUOTRI AR, HIPPOCAMPUS IN PRESS; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Solberg N, 2008, DEV DYNAM, V237, P1799, DOI 10.1002/dvdy.21586; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; Yang N, 2003, NUCLEIC ACIDS RES, V31, P4929, DOI 10.1093/nar/gkg663; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	42	456	467	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2009	12	9					1097	U6		10.1038/nn.2360	http://dx.doi.org/10.1038/nn.2360			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487ZD	19701198	Green Accepted			2022-12-17	WOS:000269317300010
J	Peyrache, A; Khamassi, M; Benchenane, K; Wiener, SI; Battaglia, FP				Peyrache, Adrien; Khamassi, Mehdi; Benchenane, Karim; Wiener, Sidney I.; Battaglia, Francesco P.			Replay of rule-learning related neural patterns in the prefrontal cortex during sleep	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; WORKING-MEMORY; SPATIAL MEMORY; HIPPOCAMPAL SUBREGIONS; SLOW OSCILLATIONS; IN-VIVO; RAT; REACTIVATION; CONSOLIDATION; NEOCORTEX	Slow-wave sleep (SWS) is important for memory consolidation. During sleep, neural patterns reflecting previously acquired information are replayed. One possible reason for this is that such replay exchanges information between hippocampus and neocortex, supporting consolidation. We recorded neuron ensembles in the rat medial prefrontal cortex (mPFC) to study memory trace reactivation during SWS following learning and execution of cross-modal strategy shifts. In general, reactivation of learning-related patterns occurred in distinct, highly synchronized transient bouts, mostly simultaneous with hippocampal sharp wave/ripple complexes (SPWRs), when hippocampal ensemble reactivation and cortico-hippocampal interaction is enhanced. During sleep following learning of a new rule, mPFC neural patterns that appeared during response selection replayed prominently, coincident with hippocampal SPWRs. This was learning dependent, as the patterns appeared only after rule acquisition. Therefore, learning, or the resulting reliable reward, influenced which patterns were most strongly encoded and successively reactivated in the hippocampal/prefrontal network.	[Peyrache, Adrien; Khamassi, Mehdi; Benchenane, Karim; Wiener, Sidney I.; Battaglia, Francesco P.] Coll France, Lab Physiol Percept & Act, CNRS, F-75231 Paris, France; [Khamassi, Mehdi] Univ Paris 06, CNRS, Inst Syst Intelligents & Robot, Paris, France; [Battaglia, Francesco P.] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Amsterdam	Wiener, SI (corresponding author), Coll France, Lab Physiol Percept & Act, CNRS, F-75231 Paris, France.	sidney.wiener@college-de-france.fr	benchenane, karim/D-8023-2015; Khamassi, Mehdi/B-2425-2012; Battaglia, Francesco F.P./F-2543-2011	benchenane, karim/0000-0001-7118-0748; Khamassi, Mehdi/0000-0002-2515-1046; Battaglia, Francesco F.P./0000-0003-3715-8875; Wiener, Sidney/0000-0002-5819-1319; Peyrache, Adrien/0000-0001-9708-309X	Fondation Fyssen; Fondation pour la Recherche Medicale; European Community [FP6-IST 027819, FP6-IST-027140, FP6-IST-027017]	Fondation Fyssen; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Community(European Commission)	We thank P. Tierney for valuable discussions and help with the surgical procedures, J.-M. Deniau, Y. Gioanni, A.-M. Thierry, M. B. Zugaro, M. Cencini and A. Aubry for interesting discussions, S. Doutremer for histology, D. Hopkins and N. Quenech'du for the anatomical reconstructions, V. Douchamps for help with the experiments, K. Gothard, K. Hoffman and A. Treves for critical readings of an earlier version of the manuscript, and A Berthoz for support throughout the project. This work was supported by Fondation Fyssen (F. P. B.), Fondation pour la Recherche Medicale (A. P.), and European Community contracts FP6-IST 027819 (Integrating Cognition, Emotion and Autonomy), FP6-IST-027140 (Bayesian Approach to Cognitive Systems) and FP6-IST-027017 (NeuroProbes).	Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Baeg EH, 2007, J NEUROSCI, V27, P909, DOI 10.1523/JNEUROSCI.4759-06.2007; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Birrell JM, 2000, J NEUROSCI, V20, P4320; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Degenetais E, 2003, CEREB CORTEX, V13, P782, DOI 10.1093/cercor/13.7.782; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; FITZPATRICK S, 1987, J AM STAT ASSOC, V82, P875, DOI 10.2307/2288799; Floresco SB, 1999, J NEUROSCI, V19, P11061, DOI 10.1523/JNEUROSCI.19-24-11061.1999; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hoffman KL, 2002, SCIENCE, V297, P2070, DOI 10.1126/science.1073538; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; JAY TM, 1995, EUR J NEUROSCI, V7, P247, DOI 10.1111/j.1460-9568.1995.tb01060.x; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee I, 2002, NAT NEUROSCI, V5, P162, DOI 10.1038/nn790; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marenko VA., 1967, MATH USSR SB, V1, P457, DOI [10.1070/sm1967v001n04abeh001994, 10.1070/SM1967v001n04ABEH001994, DOI 10.1070/SM1967V001N04ABEH001994]; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Seamans JK, 1998, J NEUROSCI, V18, P1613; Sengupta AM, 1999, PHYS REV E, V60, P3389, DOI 10.1103/PhysRevE.60.3389; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Steriade Mircea, 2006, Adv Neurol, V97, P149; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tse D, 2007, SCIENCE, V316, P76, DOI 10.1126/science.1135935; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Winocur G, 2007, NAT NEUROSCI, V10, P555, DOI 10.1038/nn1880	50	456	463	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2009	12	7					919	U143		10.1038/nn.2337	http://dx.doi.org/10.1038/nn.2337			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	462OA	19483687	Green Submitted			2022-12-17	WOS:000267362900020
J	Pun, S; Santos, AF; Saxena, S; Xu, L; Caroni, P				Pun, S; Santos, AF; Saxena, S; Xu, L; Caroni, P			Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CILIARY NEUROTROPHIC FACTOR; MOTOR-NEURON DISEASE; MUTANT SUPEROXIDE-DISMUTASE; UBIQUITIN-PROTEASOME SYSTEM; TRANSGENIC MOUSE MODEL; LINKED SOD1 MUTANTS; ALZHEIMERS-DISEASE; MUSCLE-FIBERS; ALS MICE	Neurodegenerative diseases can have long preclinical phases and insidious progression patterns, but the mechanisms of disease progression are poorly understood. Because quantitative accounts of neuronal circuitry affected by disease have been lacking, it has remained unclear whether disease progression reflects processes of stochastic loss or temporally defined selective vulnerabilities of distinct synapses or axons. Here we derive a quantitative topographic map of muscle innervation in the hindlimb. We show that in two mouse models of motoneuron disease (G93A SOD1 and G85R SOD1), axons of fast-fatiguable motoneurons are affected synchronously, long before symptoms appear. Fast-fatigue-resistant motoneuron axons are affected at symptom-onset, whereas axons of slow motoneurons are resistant. Axonal vulnerability leads to synaptic vesicle stalling and accumulation of BC12a1-a, an anti-apoptotic protein. It is alleviated by ciliary neurotrophic factor and triggers proteasome-dependent pruning of peripheral axon branches. Thus, motoneuron disease involves predictable, selective vulnerability patterns by physiological subtypes of axons, episodes of abrupt pruning in the target region and compensation by resistant axons.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	caroni@fmi.ch	Santos, Alexsandro/HCI-9028-2022	Saxena, Smita/0000-0003-4574-4591				Al-Chalabi A, 2003, ANN NEUROL, V54, P130, DOI 10.1002/ana.10638; Atkin JD, 2005, NEUROMUSCULAR DISORD, V15, P377, DOI 10.1016/j.nmd.2005.02.005; Bommel H, 2002, J CELL BIOL, V159, P563, DOI 10.1083/jcb.200208001; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Burke RE, 1994, MYOLOGY, P464; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; DELIO DA, 1992, J NEUROL SCI, V109, P30, DOI 10.1016/0022-510X(92)90090-8; DENGLER R, 1990, MUSCLE NERVE, V13, P545, DOI 10.1002/mus.880130612; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Frey D, 2000, J NEUROSCI, V20, P2534; Giess R, 2002, AM J HUM GENET, V70, P1277, DOI 10.1086/340427; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Gunawardena S, 2005, ARCH NEUROL-CHICAGO, V62, P46, DOI 10.1001/archneur.62.1.46; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Kuo JJ, 2004, J NEUROPHYSIOL, V91, P571, DOI 10.1152/jn.00665.2003; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; LARSSON L, 1995, J NEUROL SCI, V132, P182, DOI 10.1016/0022-510X(95)00138-R; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Lobsiger CS, 2005, P NATL ACAD SCI USA, V102, P10351, DOI 10.1073/pnas.0503862102; Mittoux V, 2000, HUM GENE THER, V11, P1177, DOI 10.1089/10430340050015220; Nguyen MD, 2000, P NATL ACAD SCI USA, V97, P12306, DOI 10.1073/pnas.97.22.12306; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Peterson WM, 2000, J NEUROSCI, V20, P4081; PINTER MJ, 1995, J NEUROSCI, V15, P3447; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Sagot Y, 1998, J NEUROSCI, V18, P1132; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Shaw PJ, 2000, J NEUROL, V247, P17; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; von Lewinski F, 2005, TRENDS NEUROSCI, V28, P494, DOI 10.1016/j.tins.2005.07.001; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307	50	455	468	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2006	9	3					408	419		10.1038/nn1653	http://dx.doi.org/10.1038/nn1653			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016UI	16474388				2022-12-17	WOS:000235645600021
J	Chiamulera, C; Epping-Jordan, MP; Zocchi, A; Marcon, C; Cottiny, C; Tacconi, S; Corsi, M; Orzi, F; Conquet, F				Chiamulera, C; Epping-Jordan, MP; Zocchi, A; Marcon, C; Cottiny, C; Tacconi, S; Corsi, M; Orzi, F; Conquet, F			Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; AMPHETAMINE; DOPAMINE; NEUROADAPTATIONS; SENSITIZATION; ADDICTION		GlaxoSmithKline R&D, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; GlaxoSmithKline Labs, Dept Biol, I-37100 Verona, Italy; Neuromed Inst, I-86077 Pozzilli, Italy; Univ Roma La Sapienza, Dept Neurol Sci, I-00185 Rome, Italy	GlaxoSmithKline; GlaxoSmithKline; IRCCS Neuromed; Sapienza University Rome	Conquet, F (corresponding author), GlaxoSmithKline R&D, Inst Biol Cellulaire & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.		Chiamulera, Cristiano/C-4917-2015	Chiamulera, Cristiano/0000-0001-5076-8518; Orzi, Francesco/0000-0003-1048-4662; tacconi, stefano/0000-0003-2705-2989				Caine SB, 1999, PSYCHOPHARMACOLOGY, V147, P22, DOI 10.1007/s002130051134; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Ghasemzadeh MB, 1999, J NEUROCHEM, V72, P157, DOI 10.1046/j.1471-4159.1999.0720157.x; Kim JH, 1998, J PHARMACOL EXP THER, V284, P317; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Miner LL, 1995, NEUROREPORT, V6, P2314, DOI 10.1097/00001756-199511270-00011; PARSONS LH, 1993, J NEUROCHEM, V61, P1611, DOI 10.1111/j.1471-4159.1993.tb09794.x; Pierce RC, 1996, J NEUROSCI, V16, P1550; SMITH JA, 1995, BRAIN RES, V683, P264, DOI 10.1016/0006-8993(95)00383-2; Swanson CJ, 2000, J PHARMACOL EXP THER, V292, P406; Tallaksen-Greene SJ, 1998, BRAIN RES, V780, P210, DOI 10.1016/S0006-8993(97)01141-4; Vezina P, 1999, NEUROSCI BIOBEHAV R, V23, P577, DOI 10.1016/S0149-7634(98)00055-4; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; Zocchi A, 1998, NEUROSCIENCE, V82, P521	14	455	497	1	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					873	874		10.1038/nn0901-873	http://dx.doi.org/10.1038/nn0901-873			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528416				2022-12-17	WOS:000170698600011
J	Maquet, P; Laureys, S; Peigneux, P; Fuchs, S; Petiau, C; Phillips, C; Aerts, J; Del Fiore, G; Degueldre, C; Meulemans, T; Luxen, A; Franck, G; Van der Linden, M; Smith, C; Cleeremans, A				Maquet, P; Laureys, S; Peigneux, P; Fuchs, S; Petiau, C; Phillips, C; Aerts, J; Del Fiore, G; Degueldre, C; Meulemans, T; Luxen, A; Franck, G; Van der Linden, M; Smith, C; Cleeremans, A			Experience-dependent changes in cerebral activation during human REM sleep	NATURE NEUROSCIENCE			English	Article							FUNCTIONAL NEUROANATOMY; MOTOR CORTEX; MEMORY; RAT; CONSOLIDATION; PET; REACTIVATION; EXPRESSION; MOVEMENTS; SEQUENCES	The function of rapid-eye-movement (REM) sleep is still unknown. One prevailing hypothesis suggests that REM sleep is important in processing memory traces. Here, using positron emission tomography (PET) and regional cerebral blood flow measurements, we show that waking experience influences regional brain activity during subsequent sleep. Several brain areas activated during the execution of a serial reaction time task during wakefulness were significantly more active during REM sleep in subjects previously trained on the task than in non-trained subjects. These results support the hypothesis that memory traces are processed during REM sleep in humans.	Univ Liege, Cyclotron Res Ctr, B-4000 Liege, Belgium; Univ Liege, Dept Neuropsychol, B-4000 Liege, Belgium; Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada; Free Univ Brussels, Cognit Sci Res Unit, B-1050 Brussels, Belgium	University of Liege; University of Liege; Trent University; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Maquet, P (corresponding author), UCL, Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	maquet@pet.crc.ulg.ac.be	luxen, andre/C-2116-2009; Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021; Phillips, Christophe/M-3025-2017	Laureys, Steven/0000-0002-3096-3807; , Pierre/0000-0003-3106-3357; Peigneux, Philippe/0000-0003-4745-1434; Phillips, Christophe/0000-0002-4990-425X				Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bailey Craig H., 1995, P19; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; CORBETTA M, 1993, J NEUROSCI, V13, P1202; DELACOUR J, 1990, NEUROSCIENCE, V34, P1, DOI 10.1016/0306-4522(90)90299-J; Frackowiak RS., 1997, HUMAN BRAIN FUNCTION; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; Jimenez L, 1996, J EXP PSYCHOL LEARN, V22, P948, DOI 10.1037/0278-7393.22.4.948; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; JULIANO SL, 1991, P NATL ACAD SCI USA, V88, P780, DOI 10.1073/pnas.88.3.780; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Karni A, 1997, CURR OPIN NEUROBIOL, V7, P530, DOI 10.1016/S0959-4388(97)80033-5; Kavanau JL, 1997, NEUROSCIENCE, V79, P7, DOI 10.1016/S0306-4522(96)00610-0; Kleim JA, 1996, J NEUROSCI, V16, P4529; KRUEGER JM, 1993, J SLEEP RES, V2, P63, DOI 10.1111/j.1365-2869.1993.tb00064.x; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lejeune H, 1997, NEUROSCI LETT, V235, P21, DOI 10.1016/S0304-3940(97)00698-8; Maquet P, 1996, NATURE, V383, P163, DOI 10.1038/383163a0; Maquet P, 1997, J NEUROSCI, V17, P2807; MARKS GA, 1995, BEHAV BRAIN RES, V69, P1, DOI 10.1016/0166-4328(95)00018-O; MATELLI M, 1993, NEUROREPORT, V4, P1295, DOI 10.1097/00001756-199309150-00002; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; RECHTSCHAFFEN A, 1989, SLEEP, V12, P68; Rechtschaffen A., 1968, MANUAL STANDARDIZED, V20, P246; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; Schacter D. L., 1994, MEMORY SYSTEMS 1994; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Shen WD, 1998, ACTA PHYS SIN-OV ED, V7, P1; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1998, J NEUROSCI, V18, P8455; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Steriade M, 1993, Curr Opin Neurobiol, V3, P619, DOI 10.1016/0959-4388(93)90064-6; Steriade M., 1990, BRAINSTEM CONTROL WA; Stickgold R, 1998, TRENDS COGN SCI, V2, P484, DOI 10.1016/S1364-6613(98)01258-3; TALAIRACH J, 1988, COPLANAR TEREOTAXIC; TOBLER I, 1995, BEHAV BRAIN RES, V69, P35, DOI 10.1016/0166-4328(95)00025-O; WEBB WB, 1983, SLEEP MECHANISMS FUN, P1; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517	48	455	467	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					831	836		10.1038/77744	http://dx.doi.org/10.1038/77744			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903578	Green Submitted			2022-12-17	WOS:000167177300020
J	Studer, L; Tabar, V; McKay, RDG				Studer, L; Tabar, V; McKay, RDG			Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; MIDBRAIN DOPAMINERGIC-NEURONS; FETAL VENTRAL MESENCEPHALON; LONG-TERM SURVIVAL; STEM-CELLS; NEURAL PROGENITORS; SONIC HEDGEHOG; GRAFT-SURVIVAL; GENE-THERAPY; IN-VIVO	In vitro expansion of central nervous system (CNS) precursors might overcome the limited availability of dopaminergic neurons in transplantation for Parkinson's disease, but generating dopaminergic neurons from in vitro dividing precursors has proven difficult. Here a three-dimensional cell differentiation system was used to convert precursor cells derived from E12 rat ventral mesencephalon into dopaminergic neurons. We demonstrate that CNS precursor cell populations expanded in vitro can efficiently differentiate into dopaminergic neurons, survive intrastriatal transplantation and induce functional recovery in hemiparkinsonian rats. The numerical expansion of primary CNS precursor cells is a new approach that could improve both the ethical and the technical outlook for the use of human fetal tissue in clinical transplantation.	NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Massachusetts, Div Neurosurg, Worcester, MA 01655 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Massachusetts System; University of Massachusetts Worcester	McKay, RDG (corresponding author), NINDS, Mol Biol Lab, NIH, 36 Convent Dr,Bldg 36,Room 5A29, Bethesda, MD 20892 USA.		Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987				BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BRUNDIN P, 1988, DEV BRAIN RES, V39, P233, DOI 10.1016/0165-3806(88)90027-2; BRUSTIE O, 1997, CURRENT PROTOCOLS NE; Brustle O, 1995, NEURON, V15, P1275, DOI 10.1016/0896-6273(95)90007-1; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Deacon T, 1997, NAT MED, V3, P350, DOI 10.1038/nm0397-350; FISHELL G, 1995, DEVELOPMENT, V121, P803; FISHER LJ, 1991, NEURON, V6, P371, DOI 10.1016/0896-6273(91)90246-V; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUYENET PG, 1981, BRAIN RES, V213, P291, DOI 10.1016/0006-8993(81)90235-3; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; HYNES M, 1995, NEURON, V15, P35, DOI 10.1016/0896-6273(95)90062-4; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; JIAO SS, 1993, NATURE, V362, P450, DOI 10.1038/362450a0; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; MARTINEZSERRANO A, 1995, NEURON, V15, P473, DOI 10.1016/0896-6273(95)90051-9; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Olanow CW, 1996, TRENDS NEUROSCI, V19, P102, DOI 10.1016/S0166-2236(96)80038-5; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rosenthal A, 1998, NEURON, V20, P169, DOI 10.1016/S0896-6273(00)80445-6; SABATE O, 1995, NAT GENET, V9, P256, DOI 10.1038/ng0395-256; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; SNYDER EY, 1995, NATURE, V374, P367, DOI 10.1038/374367a0; Spenger C, 1996, EXP BRAIN RES, V112, P47; Studer L, 1996, BRAIN RES BULL, V41, P143, DOI 10.1016/0361-9230(96)00114-1; STUDER L, 1997, CURRENT PROTOCOLS NE; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; TAKAYAMA H, 1995, NAT MED, V1, P53, DOI 10.1038/nm0195-53; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; VICARIOABEJON C, 1995, J NEUROSCI, V15, P6351; WANG MZ, 1995, NAT MED, V1, P1184, DOI 10.1038/nm1195-1184; Wenning GK, 1997, ANN NEUROL, V42, P95, DOI 10.1002/ana.410420115; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	45	455	514	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	1998	1	4					290	295		10.1038/1105	http://dx.doi.org/10.1038/1105			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QD	10195162				2022-12-17	WOS:000076361300012
J	Xu, HX; Delling, M; Jun, JC; Clapham, DE				Xu, HX; Delling, M; Jun, JC; Clapham, DE			Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels	NATURE NEUROSCIENCE			English	Article							GATED ION-CHANNEL; 2-AMINOETHOXYDIPHENYL BORATE; CELLS; RECEPTOR; KERATINOCYTES; HEAT; CURRENTS; THERMOSENSATION; MECHANISMS; STIMULI	Carvacrol, eugenol and thymol are major components of plants such as oregano, savory, clove and thyme. When applied to the tongue, these flavors elicit a warm sensation. They are also known to be skin sensitizers and allergens. The transient receptor potential channel (TRPV3) is a warm-sensitive Ca2+-permeable cation channel highly expressed in the skin, tongue and nose. Here we show that TRPV3 is strongly activated and sensitized by carvacrol, thymol and eugenol. Tongue and skin epithelial cells respond to carvacrol and eugenol with an increase in intracellular Ca2+ levels. We also show that this TRPV3 activity is strongly potentiated by phospholipase C-linked, G protein-coupled receptor stimulation. In addition, carvacrol activates and rapidly desensitizes TRPA1, which may explain the pungency of oregano. Our results support a role for temperature-sensitive TRP channels in chemesthesis in oral and nasal epithelium and suggest that TRPV3 may be a molecular target of plant-derived skin sensitizers.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cardiol, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 	NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARKER JNWN, 1991, LANCET, V337, P211, DOI 10.1016/0140-6736(91)92168-2; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Belitz H.D., 2009, FOOD CHEM, V3rd ed., P643, DOI [10.1007/978-3-540-69934-7, DOI 10.1007/978-3-540-69934-7]; Berova N, 1990, Dermatol Monatsschr, V176, P15; BRYANT B, 2000, NEUROBIOLOGY TASTE S; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Corsini E, 1998, TOXICOLOGY, V129, P193, DOI 10.1016/S0300-483X(98)00088-2; CORSINI E, 1998, TOXICOL LETT, V102, P277; Effendy I, 2000, J APPL TOXICOL, V20, P335, DOI 10.1002/1099-1263(200007/08)20:4<335::AID-JAT698>3.0.CO;2-L; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; FINGER TE, 2000, NEUROBIOLOGY TASTE S; GILBERTSON TA, 1993, NEURON, V10, P931, DOI 10.1016/0896-6273(93)90208-9; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang YJ, 2005, CHEM SENSES, V30, pI39, DOI 10.1093/chemse/bjh102; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Kinnamon SC, 1996, CURR OPIN NEUROBIOL, V6, P506, DOI 10.1016/S0959-4388(96)80057-2; Koizumi S, 2004, BIOCHEM J, V380, P329, DOI 10.1042/BJ20031089; Lee H, 2005, PFLUG ARCH EUR J PHY, V451, P160, DOI 10.1007/s00424-005-1438-y; Lee MH, 2005, J DENT RES, V84, P848, DOI 10.1177/154405910508400913; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Scholl I, 2004, INT ARCH ALLERGY IMM, V135, P247, DOI 10.1159/000081950; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yang BH, 2003, J DENT RES, V82, P781, DOI 10.1177/154405910308201004; YUSPA SH, 1983, J INVEST DERMATOL, V81, pS162, DOI 10.1111/1523-1747.ep12540999; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	39	453	471	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2006	9	5					628	635		10.1038/nn1692	http://dx.doi.org/10.1038/nn1692			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	040YI	16617338				2022-12-17	WOS:000237417200013
J	Delgado, MR; Frank, RH; Phelps, EA				Delgado, MR; Frank, RH; Phelps, EA			Perceptions of moral character modulate the neural systems of reward during the trust game	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; PREDICTION ERRORS; CAUDATE-NUCLEUS; MEMORY-SYSTEMS; BASAL GANGLIA; RESPONSES; STRIATUM; DECISION; COOPERATION; ACTIVATION	Studies of reward learning have implicated the striatum as part of a neural circuit that guides and adjusts future behavior on the basis of reward feedback. Here we investigate whether prior social and moral information about potential trading partners affects this neural circuitry. Participants made risky choices about whether to trust hypothetical trading partners after having read vivid descriptions of life events indicating praiseworthy, neutral or suspect moral character. Despite equivalent reinforcement rates for all partners, participants were persistently more likely to make risky choices with the 'good' partner. As expected from previous studies, activation of the caudate nucleus differentiated between positive and negative feedback, but only for the 'neutral' partner. Notably, it did not do so for the 'good' partner and did so only weakly for the 'bad' partner, suggesting that prior social and moral perceptions can diminish reliance on feedback mechanisms in the neural circuitry of trial-and-error reward learning.	NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA; Cornell Univ, Johnson Grad Sch Management, Ithaca, NY 14853 USA	New York University; New York University; Cornell University	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	liz.phelps@nyu.edu	sarinopoulos, isidoros/B-5453-2010					Beiser, 1995, MODELS INFORM PROCES, P215; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; CAMERER C, 1988, ECONOMETRICA, V56, P1, DOI 10.2307/1911840; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Coleman J.S., 1990, FDN SOCIAL THEORY; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Davidson MC, 2004, NEUROIMAGE, V23, P1039, DOI 10.1016/j.neuroimage.2004.07.049; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Delgado MR, 2005, NEUROIMAGE, V24, P862, DOI 10.1016/j.neuroimage.2004.10.002; Elliott R, 2004, NEUROIMAGE, V21, P984, DOI 10.1016/j.neuroimage.2003.10.010; Elliott R, 1998, PSYCHOL MED, V28, P559, DOI 10.1017/S0033291798006709; Filoteo JV, 2005, NEUROREPORT, V16, P111, DOI 10.1097/00001756-200502080-00007; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Frank R., 2004, WHAT PRICE MORAL HIG; FRANK RH, 1993, ETHOL SOCIOBIOL, V14, P247, DOI 10.1016/0162-3095(93)90020-I; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; MacWhinney B, 1997, SPATIAL VISION, V11, P99, DOI 10.1163/156856897X00113; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROREPORT, V15, P2539, DOI 10.1097/00001756-200411150-00022; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Shohamy D, 2004, BRAIN, V127, P851, DOI 10.1093/brain/awh100; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; Talairach J., 1988, COPLANAR STEREOTAXIC; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; White NM, 1997, CURR OPIN NEUROBIOL, V7, P164, DOI 10.1016/S0959-4388(97)80004-9; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	49	453	467	7	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2005	8	11					1611	1618		10.1038/nn1575	http://dx.doi.org/10.1038/nn1575			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	979TB	16222226				2022-12-17	WOS:000232966600037
J	Escartin, C; Galea, E; Lakatos, A; O'Callaghan, JP; Petzold, GC; Serrano-Pozo, A; Steinhauser, C; Volterra, A; Carmignoto, G; Agarwal, A; Allen, NJ; Araque, A; Barbeito, L; Barzilai, A; Bergles, DE; Bonvento, G; Butt, AM; Chen, WT; Cohen-Salmon, M; Cunningham, C; Deneen, B; De Strooper, B; Diaz-Castro, B; Farina, C; Freeman, M; Gallo, V; Goldman, JE; Goldman, SA; Gotz, M; Gutierrez, A; Haydon, PG; Heiland, DH; Hol, EM; Holt, MG; Iino, M; Kastanenka, KV; Kettenmann, H; Khakh, BS; Koizumi, S; Lee, CJ; Liddelow, SA; MacVicar, BA; Magistretti, P; Messing, A; Mishra, A; Molofsky, AV; Murai, KK; Norris, CM; Okada, S; Oliet, SHR; Oliveira, JF; Panatier, A; Parpura, V; Pekna, M; Pekny, M; Pellerin, L; Perea, G; Perez-Nievas, BG; Pfrieger, FW; Poskanzer, KE; Quintana, FJ; Ransohoff, RM; Riquelme-Perez, M; Robel, S; Rose, CR; Rothstein, JD; Rouach, N; Rowitch, DH; Semyanov, A; Sirko, S; Sontheimer, H; Swanson, RA; Vitorica, J; Wanner, IB; Wood, LB; Wu, JQ; Zheng, BH; Zimmer, ER; Zorec, R; Sofroniew, MV; Verkhratsky, A				Escartin, Carole; Galea, Elena; Lakatos, Andras; O'Callaghan, James P.; Petzold, Gabor C.; Serrano-Pozo, Alberto; Steinhauser, Christian; Volterra, Andrea; Carmignoto, Giorgio; Agarwal, Amit; Allen, Nicola J.; Araque, Alfonso; Barbeito, Luis; Barzilai, Ari; Bergles, Dwight E.; Bonvento, Gilles; Butt, Arthur M.; Chen, Wei-Ting; Cohen-Salmon, Martine; Cunningham, Colm; Deneen, Benjamin; De Strooper, Bart; Diaz-Castro, Blanca; Farina, Cinthia; Freeman, Marc; Gallo, Vittorio; Goldman, James E.; Goldman, Steven A.; Gotz, Magdalena; Gutierrez, Antonia; Haydon, Philip G.; Heiland, Dieter H.; Hol, Elly M.; Holt, Matthew G.; Iino, Masamitsu; Kastanenka, Ksenia V.; Kettenmann, Helmut; Khakh, Baljit S.; Koizumi, Schuichi; Lee, C. Justin; Liddelow, Shane A.; MacVicar, Brian A.; Magistretti, Pierre; Messing, Albee; Mishra, Anusha; Molofsky, Anna V.; Murai, Keith K.; Norris, Christopher M.; Okada, Seiji; Oliet, Stephane H. R.; Oliveira, Joao F.; Panatier, Aude; Parpura, Vladimir; Pekna, Marcela; Pekny, Milos; Pellerin, Luc; Perea, Gertrudis; Perez-Nievas, Beatriz G.; Pfrieger, Frank W.; Poskanzer, Kira E.; Quintana, Francisco J.; Ransohoff, Richard M.; Riquelme-Perez, Miriam; Robel, Stefanie; Rose, Christine R.; Rothstein, Jeffrey D.; Rouach, Nathalie; Rowitch, David H.; Semyanov, Alexey; Sirko, Swetlana; Sontheimer, Harald; Swanson, Raymond A.; Vitorica, Javier; Wanner, Ina-Beate; Wood, Levi B.; Wu, Jiaqian; Zheng, Binhai; Zimmer, Eduardo R.; Zorec, Robert; Sofroniew, Michael V.; Verkhratsky, Alexei			Reactive astrocyte nomenclature, definitions, and future directions	NATURE NEUROSCIENCE			English	Review							FIBRILLARY ACIDIC PROTEIN; MULTIPLE-SCLEROSIS LESIONS; NF-KAPPA-B; MOUSE MODEL; BRAIN-DEVELOPMENT; GENE-EXPRESSION; NERVOUS-SYSTEM; IMPAIRS MEMORY; SCAR FORMATION; ALZHEIMERS	Reactive astrocytes are astrocytes undergoing morphological, molecular, and functional remodeling in response to injury, disease, or infection of the CNS. Although this remodeling was first described over a century ago, uncertainties and controversies remain regarding the contribution of reactive astrocytes to CNS diseases, repair, and aging. It is also unclear whether fixed categories of reactive astrocytes exist and, if so, how to identify them. We point out the shortcomings of binary divisions of reactive astrocytes into good-vs-bad, neurotoxic-vs-neuroprotective or A1-vs-A2. We advocate, instead, that research on reactive astrocytes include assessment of multiple molecular and functional parameters-preferably in vivo-plus multivariate statistics and determination of impact on pathological hallmarks in relevant models. These guidelines may spur the discovery of astrocyte-based biomarkers as well as astrocyte-targeting therapies that abrogate detrimental actions of reactive astrocytes, potentiate their neuro- and glioprotective actions, and restore or augment their homeostatic, modulatory, and defensive functions. Good-bad binary classifications fail to describe reactive astrocytes in CNS disorders. Here, 81 researchers reach consensus on widespread misconceptions and provide definitions and recommendations for future research on reactive astrocytes.	[Escartin, Carole; Bonvento, Gilles; Riquelme-Perez, Miriam] Univ Paris Saclay, CNRS, MIRCen, Lab Malad Neurodegenerat, Fontenay Aux Roses, France; [Galea, Elena] Univ Autonoma Barcelona, Inst Neurociencies, Barcelona, Spain; [Galea, Elena] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain; [Galea, Elena] ICREA, Barcelona, Spain; [Lakatos, Andras] Univ Cambridge, John van Geest Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England; [Lakatos, Andras] Univ Cambridge, Div Stem Cell Neurobiol, Dept Clin Neurosci, Cambridge, England; [Lakatos, Andras; Rowitch, David H.] Cambridge Biomed Campus, Wellcome Trust MRC Cambridge Stem Cell Inst, Cambridge, England; [O'Callaghan, James P.] Natl Inst Occupat Safety & Hlth, Ctr Dis Control & Prevent, Hlth Effects Lab Div, Morgantown, WV USA; [Petzold, Gabor C.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Petzold, Gabor C.] Univ Hosp Bonn, Dept Neurol, Div Vasc Neurol, Bonn, Germany; [Serrano-Pozo, Alberto] Massachusetts Gen Hosp, Dept Neurol, Alzheimer Res Unit, Charlestown, MA USA; [Serrano-Pozo, Alberto] Harvard Med Sch, Boston, MA USA; [Steinhauser, Christian] Univ Bonn, Inst Cellular Neuroscie, Med Fac, Bonn, Germany; [Volterra, Andrea] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Carmignoto, Giorgio] Italian Natl Res Council CNR, Neurosci Inst, Padua, Italy; [Carmignoto, Giorgio] Univ Padua, Dept Biomed Sci, Padua, Italy; [Agarwal, Amit] Heidelberg Univ, Inst Anat & Cell Biol, Chica & Heinz Schaller Res Grp, Heidelberg, Germany; [Allen, Nicola J.] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA USA; [Araque, Alfonso] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Barbeito, Luis] Inst Pasteur Montevideo, Montevideo, Uruguay; [Barzilai, Ari] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, Tel Aviv, Israel; [Barzilai, Ari] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Bergles, Dwight E.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Kavli Neurosci Discovery Inst, Baltimore, MD USA; [Butt, Arthur M.] Univ Portsmouth, Sch Pharm & BioMed Sci, Portsmouth, Hants, England; [Chen, Wei-Ting; De Strooper, Bart] VIB, Ctr Brain & Dis Res, Leuven, Belgium; [Chen, Wei-Ting; De Strooper, Bart] Univ Leuven, Leuven, Belgium; [Cohen-Salmon, Martine] PSL Res Univ, Physiol & Physiopathol Gliovasc Unit, Ctr Interdisciplinary Res Biol CIRB, Res Grp,Unite Mixte Rech 7241,CNRS,Unite1050 INSE, Paris, France; [Cunningham, Colm] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Cunningham, Colm] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Sch Biochem & Immunol, Dublin, Ireland; [Deneen, Benjamin] Baylor Coll Med, Dept Neurosurg, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [De Strooper, Bart] UCL, UK Dementia Res Inst, London, England; [Diaz-Castro, Blanca] Univ Edinburgh, Ctr Discovery Brain Sci, UK Dementia Res Inst, Edinburgh, Midlothian, Scotland; [Farina, Cinthia] Ist Sci San Raffaele, Inst Expt Neurol INSpe, Milan, Italy; [Farina, Cinthia] Ist Sci San Raffaele, Div Neurosci, Milan, Italy; [Freeman, Marc] OHSU, Vollum Inst, Portland, OR USA; [Gallo, Vittorio] Natl Childrens Hosp, Childrens Natl Res Inst, Ctr Neurosci Res, Washington, DC USA; [Goldman, James E.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Goldman, Steven A.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Goldman, Steven A.] Univ Copenhagen, Ctr Translat Neuromed, Fac Hlth & Med Sci, Copenhagen N, Denmark; [Goldman, Steven A.] Univ Copenhagen, Rigshosp, Copenhagen N, Denmark; [Gotz, Magdalena] Ludwig Maximilians Univ Munchen, Biomed Ctr, Physiol Gen, Munich, Germany; [Gotz, Magdalena] Helmholtz Ctr Munich, Inst Stem Cell Res, Munich, Germany; [Gotz, Magdalena] Biomed Ctr, Excellence Cluster Syst Neurol, Synergy, Munich, Germany; [Gutierrez, Antonia] Univ Malaga, Inst Invest Biomed Malaga IBIMA, Dept Biol Celular Genet & Fisiol, Fac Ciencias, Malaga, Spain; [Gutierrez, Antonia; Vitorica, Javier] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Haydon, Philip G.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Heiland, Dieter H.] Univ Freiburg, Fac Med, Med Ctr, Microenvironm & Immunol Res Lab, Freiburg, Germany; [Heiland, Dieter H.] Univ Freiburg, Fac Med, Med Ctr, Dept Neurosurg, Freiburg, Germany; [Hol, Elly M.] Univ Utrecht, Dept Translat Neurosci, Univ Med Ctr Utrecht, Brain Ctr, Utrecht, Netherlands; [Holt, Matthew G.] VIB KU Leuven Ctr Brain & Dis Res, Lab Glia Biol, Leuven, Belgium; [Iino, Masamitsu] Nihon Univ, Div Cellular & Mol Pharmacol, Sch Med, Tokyo, Japan; [Kastanenka, Ksenia V.] Harvard Med Sch, Massachusetts Gen Hosp, Charlestown, MA USA; [Kettenmann, Helmut] Max Delbruck Ctr Mol Med Helmholtz Assoc, Cellular Neurosci, Berlin, Germany; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Koizumi, Schuichi] Univ Yamanashi, Interdisciplinary Grad Sch Med, Dept Neuropharmacol, Yamanashi, Japan; [Lee, C. Justin] Inst for Basic Sci Korea, Ctr Cognit & Social, 55,Expo Ro, Daejeon, South Korea; [Liddelow, Shane A.] NYU, Sch Med, Neurosci Inst, Dept Neurosci & Physiol,Dept Ophthalmol, New York, NY USA; [MacVicar, Brian A.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Magistretti, Pierre] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia; [Magistretti, Pierre] Univ Lausanne, Ctr Neurosci Psychiat, Lausanne, Switzerland; [Magistretti, Pierre] CHU Vaudois, Site Cery, Lausanne, Switzerland; [Messing, Albee] Univ Wisconsin, Waisman Ctr, Madison, WI USA; [Messing, Albee] Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA; [Mishra, Anusha] Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Dept Neurol, Portland, OR 97201 USA; [Mishra, Anusha] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA; [Molofsky, Anna V.] Univ Calif San Francisco, Dept Psychiat, Weill Inst Neurosci, San Francisco, CA USA; [Murai, Keith K.] McGill Univ, Ctr Hlth, Brain Repair & Integrat Neurosci Program, Ctr Res Neurosci,Dept Neurol & Neurosurg,Res Inst, Montreal, PQ, Canada; [Norris, Christopher M.] Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY USA; [Okada, Seiji] Kyushu Univ, Med Inst Bioregulat, Dept Immunobiol & Neurosci, Fukuoka, Japan; [Oliet, Stephane H. R.; Panatier, Aude] Univ Bordeaux, Inserm, Neuroctr Magendie, U1215, Bordeaux, France; [Oliveira, Joao F.] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Med, Braga, Portugal; [Oliveira, Joao F.] ICVS 3Bs PT Govt Associate Lab, Braga Guimaraes, Portugal; [Oliveira, Joao F.] Polytech Inst Cavado & Ave, IPCA EST 2Ai, Appl Artificial Intelligence Lab, Campus IPCA, Barcelos, Portugal; [Parpura, Vladimir] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA; [Pekna, Marcela] Univ Gothenburg, Lab Regenerat Neuroimmunol, Sahlgrenska Acad,Ctr Brain Repair, Dept Clin Neurosci,Inst Neurosci & Physiol, Gothenburg, Sweden; [Pekny, Milos] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Lab Astrocyte Biol, Gothenburg, Sweden; [Pekny, Milos] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, CNS Regenerat,Ctr Brain Repair,Dept Clin Neurosci, Gothenburg, Sweden; [Pellerin, Luc] Univ Poitiers, INSERM U1082, Poitiers, France; [Perea, Gertrudis] CSIC, Dept Funct & Syst Neurobiol, Inst Cajal, Madrid, Spain; [Perez-Nievas, Beatriz G.] Kings Coll London, Dept Basic & Clin Neurosci, Maurice Wohl Clin Neurosci Inst, Inst Psychiat Psychol & Neurosci, London, England; [Pfrieger, Frank W.] Univ Strasbourg, Inst Neurosci Cellulaires & Integrat, CNRS, Strasbourg, France; [Poskanzer, Kira E.] Univ Calif San Francisco, Dept Biochem & Biophys, Kavli Inst Fundamental Neurosci, San Francisco, CA USA; [Quintana, Francisco J.] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA USA; [Quintana, Francisco J.] Broad Inst, Boston, MA USA; [Ransohoff, Richard M.] Third Rock Ventures, Boston, MA USA; [Robel, Stefanie] Virginia Tech, Virginia Tech Caril, Fralin Biomed Res Inst, Sch Neurosci, Roanoke, VA USA; [Rose, Christine R.] Heinrich Heine Univ, Inst Neurobiol, Dusseldorf, Germany; [Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Rouach, Nathalie] PSL Res Univ Paris, Neuroglial Interact Cerebral Physiol & Pathol, Ctr Interdisciplinary Res Biol, Coll France,CNRS,UMR 7241,INSERM U1050,Labex Memo, Paris, France; [Semyanov, Alexey] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Semyanov, Alexey] Sechenov First Moscow State Med Univ, Moscow, Russia; [Sirko, Swetlana] Ludwig Maximilians Univ Munchen, Physiol Genom, Biomed Ctr, Munich, Germany; [Sirko, Swetlana] Helmholtz Zentrum Munich, Inst Stem Cell Res, Neuherberg, Germany; [Sontheimer, Harald] Virginia Tech, Fralin Biomed Res Inst, Virginia Tech Sch Neurosci, Roanoke, VA USA; [Sontheimer, Harald] Virginia Tech, Fralin Biomed Res Inst, Ctr Glial Biol Hlth Dis & Canc, Roanoke, VA USA; [Swanson, Raymond A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Swanson, Raymond A.] San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA USA; [Vitorica, Javier] Univ Seville, Dept Bioquim & Biol Mol, Inst Biomed Sevilla, Hosp Virgen Rocio,CSIC, Seville, Spain; [Wanner, Ina-Beate] Univ Calif Los Angeles, David Geffen Sch Med, IDDRC, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Wood, Levi B.] Georgia Tech & Emory, Wallace H Coulter Dept Biomed Engn, George W Woodruff Sch Mech Engn, Atlanta, GA USA; [Wood, Levi B.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Wu, Jiaqian] Univ Texas Hlth Sci Ctr Houston, UTHlth Grad Sch Biomed Sci, McGovern Med Sch,UTHlth,Vivian L Smith Dept Neuro, Ctr Stem Cell & Regenerat Med,MD Anderson Canc Ct, Houston, TX 77030 USA; [Zheng, Binhai] Univ Calif San Diego, Dept Neurosc, Sch Med, La Jolla, CA USA; [Zheng, Binhai] VA San Diego Res Serv, San Diego, CA USA; [Zimmer, Eduardo R.] Univ Fed Rio Grande do Sul, Dept Pharmacol, Porto Alegre, RS, Brazil; [Zorec, Robert] Univ Ljubljana, Fac Med, Inst Pathophysiol, Lab Neuroendocrinol,Mol Cell Physiol, Ljubljana, Slovenia; [Zorec, Robert] Celica Biomed, Ljubljana 1000, Slovenia; [Sofroniew, Michael V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Verkhratsky, Alexei] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Verkhratsky, Alexei] Basque Fdn Sci, Achucarro Basque Ctr Neurosci, IKERBASQUE, Bilbao, Spain	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Autonomous University of Barcelona; Autonomous University of Barcelona; ICREA; University of Cambridge; University of Cambridge; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Bonn; University of Lausanne; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Padua; Ruprecht Karls University Heidelberg; Salk Institute; University of Minnesota System; University of Minnesota Twin Cities; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Tel Aviv University; Tel Aviv University; Johns Hopkins University; University of Portsmouth; Flanders Institute for Biotechnology (VIB); KU Leuven; UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Trinity College Dublin; Trinity College Dublin; Baylor College of Medicine; University of London; University College London; University of Edinburgh; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Oregon Health & Science University; Children's National Health System; Columbia University; University of Rochester; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Universidad de Malaga; CIBERNED; Tufts University; University of Freiburg; University of Freiburg; Utrecht University; Utrecht University Medical Center; Flanders Institute for Biotechnology (VIB); Nihon University; Harvard University; Massachusetts General Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Yamanashi; Institute for Basic Science - Korea (IBS); New York University; University of British Columbia; King Abdullah University of Science & Technology; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California San Francisco; McGill University; University of Kentucky; Kyushu University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universidade do Minho; Instituto Politecnico do Cavado e do Ave - IPCA; University of Alabama System; University of Alabama Birmingham; University of Gothenburg; University of Gothenburg; University of Gothenburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Virginia Polytechnic Institute & State University; Heinrich Heine University Dusseldorf; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Sechenov First Moscow State Medical University; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of California System; University of California San Francisco; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California San Diego; Universidade Federal do Rio Grande do Sul; University of Ljubljana; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Manchester; Basque Foundation for Science	Escartin, C (corresponding author), Univ Paris Saclay, CNRS, MIRCen, Lab Malad Neurodegenerat, Fontenay Aux Roses, France.; Galea, E (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Barcelona, Spain.; Galea, E (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain.; Galea, E (corresponding author), ICREA, Barcelona, Spain.; Sofroniew, MV (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.; Verkhratsky, A (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.; Verkhratsky, A (corresponding author), Basque Fdn Sci, Achucarro Basque Ctr Neurosci, IKERBASQUE, Bilbao, Spain.	carole.escartin@cea.fr; Elena.Galea@uab.es; sofroniew@mednet.ucla.edu; alexej.verkhratsky@manchester.ac.uk	Rouach, Nathalie/L-4767-2017; Pekna, Marcela/AAM-3261-2021; Semyanov, Alexey/A-7654-2010; Bonvento, Gilles/F-6023-2013; Kettenmann, Helmut/AAJ-5142-2021; Verkhratsky, Alexei/J-4527-2013; Oliveira, João Filipe F/T-6498-2018; Farina, Cinthia/G-8911-2014; Hol, Elly M/F-1891-2013; CHEN, WEI-TING/AFL-9663-2022; Pfrieger, Frank/AAX-3208-2020; Serrano-Pozo, Alberto/L-1519-2019; Zimmer, Eduardo R Rigon/I-2932-2015; Pekna, Marcela/AAM-3249-2021; MacVicar, Brian/P-1553-2015; Pellerin, Luc/A-8912-2017; Escartin, Carole/A-1952-2010; Cunningham, Colm/A-1743-2010	Rouach, Nathalie/0000-0002-5574-888X; Pekna, Marcela/0000-0003-2734-8237; Semyanov, Alexey/0000-0002-6800-0942; Bonvento, Gilles/0000-0002-2886-4228; Verkhratsky, Alexei/0000-0003-2592-9898; Oliveira, João Filipe F/0000-0002-1005-2328; Farina, Cinthia/0000-0002-4466-9676; Hol, Elly M/0000-0001-5604-2603; CHEN, WEI-TING/0000-0003-2730-9529; Pfrieger, Frank/0000-0001-7085-1431; Serrano-Pozo, Alberto/0000-0003-0899-7530; Zimmer, Eduardo R Rigon/0000-0002-5349-0053; Pekna, Marcela/0000-0003-2734-8237; Sirko, Swetlana/0000-0001-5950-616X; MacVicar, Brian/0000-0003-4596-4623; Pellerin, Luc/0000-0002-1016-1970; Zorec, Robert/0000-0002-7478-3875; Lakatos, Andras/0000-0002-1301-2292; Gomez Perez-Nievas, Beatriz/0000-0003-1860-012X; Volterra, Andrea/0000-0003-1069-1602; Robel, Stefanie/0000-0001-6716-3670; Holt, Matthew/0000-0002-8958-4027; Rowitch, David/0000-0002-0079-0060; Riquelme Perez, Miriam/0000-0002-9204-3088; Magistretti, Pierre Julius/0000-0002-6678-320X; Escartin, Carole/0000-0003-3613-4118; Lee, C Justin/0000-0002-3555-0980; Cunningham, Colm/0000-0003-1423-5209; Gutierrez Perez, Antonia/0000-0002-6264-6152; Panatier, Aude/0000-0002-6107-4463; Liddelow, Shane/0000-0002-0840-1437	CNRS; CEA; MCINN [PID2019-107633RB-I00]; ANR; France Alzheimer; Generalitat de Catalunya (Grup de demencies Sant Pau) [2017-SGR547]; US Centers for Disease Control and Prevention; Alzheimer's Association [AACF-17-524184]; NIH-NIA [K08AG064039]; DFG [SPP1757, STE 552/5, STE 552/4]; EU (H2020-MSCA-ITN project) [722053 EU-GliaPhD]; BMBF [16GW0182 CONNEXIN]; Swiss National Science Foundation [31003A 173124/1]; SNSF NCCR 'Transcure' [51NF40-160620]; Synapsis Foundation Heidi Seiler-Stiftung [2018-PI01]; NIH-NINDS [NS084030]; Dr. Miriam and Sheldon G. Adelson Medical Foundation; Wings for Life; MRC [MR/P008658/1] Funding Source: UKRI	CNRS(Centre National de la Recherche Scientifique (CNRS)); CEA(French Atomic Energy Commission); MCINN(European Commission); ANR(French National Research Agency (ANR)); France Alzheimer; Generalitat de Catalunya (Grup de demencies Sant Pau); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Alzheimer's Association(Alzheimer's Association); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DFG(German Research Foundation (DFG)); EU (H2020-MSCA-ITN project); BMBF(Federal Ministry of Education & Research (BMBF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SNSF NCCR 'Transcure'; Synapsis Foundation Heidi Seiler-Stiftung; NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dr. Miriam and Sheldon G. Adelson Medical Foundation; Wings for Life; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: CNRS, CEA, ANR, and France Alzheimer to CE.; MCINN (PID2019-107633RB-I00) and Generalitat de Catalunya (2017-SGR547, Grup de demencies Sant Pau) to E.G. US Centers for Disease Control and Prevention to J. P.O. Alzheimer's Association (AACF-17-524184) and NIH-NIA (K08AG064039) to A.S.-P. DFG (SPP1757, STE 552/5, STE 552/4), EU (H2020-MSCA-ITN project 722053 EU-GliaPhD) and BMBF (16GW0182 CONNEXIN) to C.S. Swiss National Science Foundation grant 31003A 173124/1; SNSF NCCR 'Transcure' (51NF40-160620); Synapsis Foundation Heidi Seiler-Stiftung 2018-PI01 to A.Volterra. NIH-NINDS (NS084030), Dr. Miriam and Sheldon G. Adelson Medical Foundation and Wings for Life to M.V.S. The authors thank T. Yohannan of Alpha Language Services, Barcelona, for expert copy editing.	Achucarro N., 1910, B GOV HOSP INSANE, V2, P81; Al-Dalahmah O, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-0880-6; Almad A, 2018, NAT REV NEUROL, V14, P351, DOI 10.1038/s41582-018-0010-2; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Andriezen W L, 1893, Br Med J, V2, P227; Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Bedner P, 2020, GLIA, V68, P756, DOI 10.1002/glia.23725; Bedner P, 2015, BRAIN, V138, P1208, DOI 10.1093/brain/awv067; Ben Haim L, 2017, NAT REV NEUROSCI, V18, P31, DOI [10.1038/nm.2016.159, 10.1038/nrn.2016.159]; Ben Haim L, 2015, J NEUROSCI, V35, P2817, DOI 10.1523/JNEUROSCI.3516-14.2015; Bindocci E, 2017, SCIENCE, V356, DOI 10.1126/science.aai8185; Black JA, 2010, BRAIN, V133, P835, DOI 10.1093/brain/awq003; Boisvert MM, 2018, CELL REP, V22, P269, DOI 10.1016/j.celrep.2017.12.039; Brusilow SW, 2010, NEUROTHERAPEUTICS, V7, P452, DOI 10.1016/j.nurt.2010.05.015; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cajal, 1913, TRAB LAB INVEST BIOL, V11, P255; Campbell SC, 2020, NEUROCHEM INT, V133, DOI 10.1016/j.neuint.2019.104628; Carter SF, 2019, TRENDS MOL MED, V25, P77, DOI 10.1016/j.molmed.2018.11.006; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Cerbai F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045250; Ceyzeriat K, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0606-1; Chai H, 2017, NEURON, V95, P531, DOI 10.1016/j.neuron.2017.06.029; Chen WT, 2020, CELL, V182, P976, DOI 10.1016/j.cell.2020.06.038; Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Colombo E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00635; Colombo E, 2016, TRENDS IMMUNOL, V37, P608, DOI 10.1016/j.it.2016.06.006; Colombo E, 2012, J EXP MED, V209, P521, DOI 10.1084/jem.20110698; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; Damisah EC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba3239; Das S, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01898-y; Del Rio-Hortega P, 1927, B JOHNS HOPKINS HOSP, V41, P278; Deshpande T, 2017, GLIA, V65, P1809, DOI 10.1002/glia.23196; di Domenico A, 2019, STEM CELL REP, V12, P213, DOI 10.1016/j.stemcr.2018.12.011; Diaz-Castro B, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw8546; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Eraso-Pichot A, 2018, GLIA, V66, P1724, DOI 10.1002/glia.23330; Escartin C, 2019, GLIA, V67, P2221, DOI 10.1002/glia.23687; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Furman JL, 2016, J NEUROSCI, V36, P1502, DOI 10.1523/JNEUROSCI.1930-15.2016; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; Gerics B, 2006, J ANAT, V209, P231, DOI 10.1111/j.1469-7580.2006.00593.x; Giandomenico SL, 2019, NAT NEUROSCI, V22, P669, DOI 10.1038/s41593-019-0350-2; Goetzl EJ, 2020, FASEB J, V34, P3359, DOI 10.1096/fj.201902842R; Gomez-Arboledas A, 2018, GLIA, V66, P637, DOI 10.1002/glia.23270; Griemsmann S, 2015, CEREB CORTEX, V25, P3420, DOI 10.1093/cercor/bhu157; Grubman A, 2019, NAT NEUROSCI, V22, P2087, DOI 10.1038/s41593-019-0539-4; Gui YX, 2020, BRAIN PATHOL, V30, P151, DOI 10.1111/bpa.12763; Guttenplan KA, 2019, J EXP MED, V216, P71, DOI 10.1084/jem.20180200; Habbas S, 2015, CELL, V163, P1730, DOI 10.1016/j.cell.2015.11.023; Habib N, 2020, NAT NEUROSCI, V23, P701, DOI 10.1038/s41593-020-0624-8; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Han XN, 2013, CELL STEM CELL, V12, P342, DOI 10.1016/j.stem.2012.12.015; Heiland DH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10493-6; Hennessy E, 2015, J NEUROSCI, V35, P8411, DOI 10.1523/JNEUROSCI.2745-14.2015; Heo JY, 2020, CURR BIOL, V30, P276, DOI 10.1016/j.cub.2019.11.079; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hirbec H, 2020, GLIA, V68, P1692, DOI 10.1002/glia.23780; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Ioannou MS, 2019, CELL, V177, P1522, DOI 10.1016/j.cell.2019.04.001; Itoh N, 2018, P NATL ACAD SCI USA, V115, pE302, DOI 10.1073/pnas.1716032115; Jiang RT, 2016, J NEUROSCI, V36, P3453, DOI 10.1523/JNEUROSCI.3693-15.2016; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639; Jyothi HJ, 2015, NEUROBIOL AGING, V36, P3321, DOI 10.1016/j.neurobiolaging.2015.08.024; Kamphuis W, 2015, GLIA, V63, P1036, DOI 10.1002/glia.22800; Kimbrough IF, 2015, BRAIN, V138, P3716, DOI 10.1093/brain/awv327; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Le Douce J, 2020, CELL METAB, V31, P503, DOI 10.1016/j.cmet.2020.02.004; Ledur PF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57914-x; Lerchundi R, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00080; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lin CCJ, 2017, NAT NEUROSCI, V20, P396, DOI 10.1038/nn.4493; Lin YT, 2018, NEURON, V98, P1141, DOI 10.1016/j.neuron.2018.05.008; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Messing A, 2012, J NEUROSCI, V32, P5017, DOI 10.1523/JNEUROSCI.5384-11.2012; Michetti F, 2019, J NEUROCHEM, V148, P168, DOI 10.1111/jnc.14574; Moreels M, 2008, NEUROPATH APPL NEURO, V34, P532, DOI 10.1111/j.1365-2990.2007.00910.x; Mucke L, 2000, AM J PATHOL, V157, P2003, DOI 10.1016/S0002-9440(10)64839-0; Nobuta H, 2012, ANN NEUROL, V72, P750, DOI 10.1002/ana.23670; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; OCALLAGHAN JP, 1991, NEUROBIOL AGING, V12, P171, DOI 10.1016/0197-4580(91)90057-Q; OCALLAGHAN JP, 1991, J NEUROCHEM, V57, P860, DOI 10.1111/j.1471-4159.1991.tb08230.x; Oe Y, 2019, ADV NEUROBIOL, V23, P147, DOI 10.1007/978-3-030-27480-1_5; Olabarria M, 2010, GLIA, V58, P831, DOI 10.1002/glia.20967; Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004; Orre M, 2013, BRAIN, V136, P1415, DOI 10.1093/brain/awt083; Osipovitch M, 2019, CELL STEM CELL, V24, P107, DOI 10.1016/j.stem.2018.11.010; Pardo L, 2016, GLIA, V64, P853, DOI 10.1002/glia.22969; Park JH, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav0316; Perriot S, 2018, STEM CELL REP, V11, P1199, DOI 10.1016/j.stemcr.2018.09.015; Peters O, 2009, J ALZHEIMERS DIS, V18, P177, DOI 10.3233/JAD-2009-1140; Polyzos AA, 2019, CELL METAB, V29, P1258, DOI 10.1016/j.cmet.2019.03.004; Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Reichenbach N, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809665; Reichenbach N, 2018, J EXP MED, V215, P1649, DOI 10.1084/jem.20171487; Rodriguez JJ, 2014, NEUROBIOL AGING, V35, P15, DOI 10.1016/j.neurobiolaging.2013.07.002; Rodriguez JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.194; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; Romeo-Guitart D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19767-3; Rossi D, 2008, CELL DEATH DIFFER, V15, P1691, DOI 10.1038/cdd.2008.99; Roybon L, 2013, CELL REP, V4, P1035, DOI 10.1016/j.celrep.2013.06.021; Santello M, 2019, NAT NEUROSCI, V22, P154, DOI 10.1038/s41593-018-0325-8; Schiweck J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00261; Semyanov A, 2020, NAT REV NEUROSCI, V21, P551, DOI 10.1038/s41583-020-0361-8; Serrano-Pozo A, 2013, AM J PATHOL, V182, P2332, DOI 10.1016/j.ajpath.2013.02.031; Simonovitch S, 2016, J ALZHEIMERS DIS, V51, P915, DOI 10.3233/JAD-151101; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sosunov AA, 2014, J NEUROSCI, V34, P2285, DOI 10.1523/JNEUROSCI.4037-13.2014; Sun W, 2017, J NEUROSCI, V37, P4493, DOI 10.1523/JNEUROSCI.3199-16.2017; Tachibana M, 2019, BRAIN DEV-JPN, V41, P85, DOI 10.1016/j.braindev.2018.07.008; Tchieu J, 2019, NAT BIOTECHNOL, V37, P267, DOI 10.1038/s41587-019-0035-0; Theis M, 2003, J NEUROSCI, V23, P766; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Tyzack GE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01283-z; Tyzack GE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5294; Varcianna A, 2019, EBIOMEDICINE, V40, P626, DOI 10.1016/j.ebiom.2018.11.067; Verkhratsky A, 2017, BRAIN PATHOL, V27, P629, DOI 10.1111/bpa.12537; Vezzoli E, 2020, CEREB CORTEX, V30, P2114, DOI 10.1093/cercor/bhz226; Vicente-Gutierrez C, 2019, NAT METAB, V1, P201, DOI 10.1038/s42255-018-0031-6; Virchow R.L.K., 1860, CELLULAR PATHOLOGY; Voss CM, 2020, GLIA, V68, P1824, DOI 10.1002/glia.23808; Wang YZ, 2019, NAT NEUROSCI, V22, P1936, DOI 10.1038/s41593-019-0492-2; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Weigert, 1895, Z PSYCHOL PHYSIOL SI; Wheeler MA, 2020, NATURE, V578, P593, DOI 10.1038/s41586-020-1999-0; Wheeler MA, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a029009; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Wilhelmus MMM, 2006, NEUROPATH APPL NEURO, V32, P119, DOI 10.1111/j.1365-2990.2006.00689.x; Xu LJ, 2010, GLIA, V58, P1042, DOI 10.1002/glia.20985; YAMADA T, 1992, ACTA NEUROPATHOL, V84, P157, DOI 10.1007/BF00311389; Yu XZ, 2020, NAT REV NEUROSCI, V21, P121, DOI 10.1038/s41583-020-0264-8; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang M, 2018, J NEUROPATH EXP NEUR, V77, P1163, DOI 10.1093/jnen/nly102; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhou YY, 2020, NAT MED, V26, P131, DOI 10.1038/s41591-019-0695-9; Zuidema JM, 2018, CELLS TISSUES ORGANS, V205, P372, DOI 10.1159/000494667	149	452	455	34	166	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2021	24	3					312	325		10.1038/s41593-020-00783-4	http://dx.doi.org/10.1038/s41593-020-00783-4		FEB 2021	14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QQ7GU	33589835	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-17	WOS:000618181700004
J	O'Connor, DH; Fukui, MM; Pinsk, MA; Kastner, S				O'Connor, DH; Fukui, MM; Pinsk, MA; Kastner, S			Attention modulates responses in the human lateral geniculate nucleus	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; INTERMODAL SELECTIVE ATTENTION; EXTRASTRIATE CORTEX; DIRECTED ATTENTION; NEURAL MECHANISMS; SPATIAL ATTENTION; FUNCTIONAL MRI; CORTICAL AREAS; HUMAN BRAIN; ACTIVATION	Attentional mechanisms are important for selecting relevant information and filtering out irrelevant information from cluttered visual scenes. Selective attention has previously been shown to affect neural activity in both extrastriate and striate visual cortex. Here, evidence from functional brain imaging shows that attentional response modulation is not confined to cortical processing, but can occur as early as the thalamic level. We found that attention modulated neural activity in the human lateral geniculate nucleus (LGN) in several ways: it enhanced neural responses to attended stimuli, attenuated responses to ignored stimuli and increased baseline activity in the absence of visual stimulation. The LGN, traditionally viewed as the gateway to visual cortex, may also serve as a 'gatekeeper' in controlling attentional response gain.	Princeton Univ, Dept Psychol, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA	Princeton University	Kastner, S (corresponding author), Princeton Univ, Dept Psychol, Ctr Study Brain Mind & Behav, Green Hall, Princeton, NJ 08544 USA.			Kastner, Sabine/0000-0002-9742-965X				Bender DB, 2001, J NEUROPHYSIOL, V85, P219, DOI 10.1152/jn.2001.85.1.219; Chen W, 1998, MAGN RESON MED, V39, P89, DOI 10.1002/mrm.1910390115; Chen W, 1999, P NATL ACAD SCI USA, V96, P2430, DOI 10.1073/pnas.96.5.2430; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Jones EG, 1985, THALAMUS; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KOCH C, 1985, HUM NEUROBIOL, V4, P219; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; Mehta AD, 2000, CEREB CORTEX, V10, P359, DOI 10.1093/cercor/10.4.359; Mehta SD, 2000, CEREB CORTEX, V10, P343, DOI 10.1093/cercor/10.4.343; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sherman S.M., 2001, EXPLORING THALAMUS, V1st Edn; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Talairach I., 1988, COPLANAR STEREOTACTI; Vanduffel W, 2000, CEREB CORTEX, V10, P109, DOI 10.1093/cercor/10.2.109; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004	42	452	460	7	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1203	1209		10.1038/nn957	http://dx.doi.org/10.1038/nn957			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12379861				2022-12-17	WOS:000178884600024
J	Grill-Spector, K; Kushnir, T; Hendler, T; Malach, R				Grill-Spector, K; Kushnir, T; Hendler, T; Malach, R			The dynamics of object-selective activation correlate with recognition performance in humans	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; FUSIFORM FACE AREA; VISUAL AWARENESS; OCCIPITAL CORTEX; CEREBRAL-CORTEX; BRAIN; PERCEPTION; KNOWLEDGE; MASKING; MEMORY	To investigate the relationship between perceptual awareness and brain activity, we measured both recognition performance and fMRI signal from object-related areas in human cortex while images were presented briefly using a masking protocol. Our results suggest that recognition performance is correlated with selective activation in object areas. Selective activation was correlated to object naming when exposure duration was varied from 20 to 500 milliseconds. Subjects' recognition during identical visual stimulation could be enhanced by training, which also increased the fMRI signal. Overall, the correlation between recognition performance and fMRI signal was highest in occipitotemporal object areas (the lateral occipital complex).	Weizmann Inst Sci, Dept Comp Sci, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Chaim Sheba Med Ctr, Dept Diagnost Imaging, IL-52621 Tel Hashomer, Israel; Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Lab Funct Imaging, Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Grill-Spector, K (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.		hendler, talma/C-7677-2012	Grill-Spector, Kalanit/0000-0002-5404-9606				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; ALLISON T, 1994, CEREB CORTEX, V4, P544, DOI 10.1093/cercor/4.5.544; Bar M, 1999, P NATL ACAD SCI USA, V96, P1790, DOI 10.1073/pnas.96.4.1790; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; DAMASIO AR, 1990, TRENDS NEUROSCI, V13, P95, DOI 10.1016/0166-2236(90)90184-C; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; FARAH MJ, 1995, NEUROPSYCHOLOGIA, V33, P661, DOI 10.1016/0028-3932(95)00002-K; Furmanski CS, 2000, VISION RES, V40, P473, DOI 10.1016/S0042-6989(99)00134-0; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grilli A, 1998, ACCAD NAZ VIRG SCI M, V6, P3; Hadjikhani N, 1998, NAT NEUROSCI, V1, P235, DOI 10.1038/681; HALGREN E, 1985, BRAIN COGNITION, V4, P287, DOI 10.1016/0278-2626(85)90022-3; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Moore CJ, 1999, NEUROIMAGE, V10, P181, DOI 10.1006/nimg.1999.0450; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; Reyment R. A., 1993, APPL FACTOR ANAL NAT; Rolls ET, 1999, J COGNITIVE NEUROSCI, V11, P300, DOI 10.1162/089892999563409; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; Rosier AM, 1999, EUR J NEUROSCI, V11, P3701, DOI 10.1046/j.1460-9568.1999.00784.x; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Talairach J., 1988, COPLANAR STEREOTAXIC; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; TOVEE MJ, 1994, CURR BIOL, V4, P1125, DOI 10.1016/S0960-9822(00)00253-0; Vanni S, 1996, NEUROREPORT, V8, P183, DOI 10.1097/00001756-199612200-00037; Whalen PJ, 1998, J NEUROSCI, V18, P411	49	451	455	1	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					837	843		10.1038/77754	http://dx.doi.org/10.1038/77754			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903579				2022-12-17	WOS:000167177300021
J	Jovanovic, JN; Czernik, AJ; Fienberg, AA; Greengard, P; Sihra, TS				Jovanovic, JN; Czernik, AJ; Fienberg, AA; Greengard, P; Sihra, TS			Synapsins as mediators of BDNF-enhanced neurotransmitter release	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLE PHOSPHOPROTEINS; ACTIVATED PROTEIN-KINASE; NEUROTROPHIC FACTOR; GLUTAMATE EXOCYTOSIS; TRANSMISSION; POTENTIATION; PHOSPHORYLATION; RECEPTORS; SYNAPTOSOMES	We examined enhancement of synaptic transmission by neurotrophins at the presynaptic level. In a synaptosomal preparation, brain-derived neurotrophic factor (BDNF) increased mitogen-activated protein (MAP) kinase-dependent synapsin I phosphorylation and acutely facilitated evoked glutamate release. PD98059, used to inhibit MAP kinase activity, markedly decreased synapsin I phosphorylation and concomitantly reduced neurotransmitter release. The stimulation of glutamate release by BDNF was strongly attenuated in mice lacking synapsin I and/or synapsin II. These results indicate at causal link of synapsin phosphorylation via BDNF, TrkB receptors and MAP kinase with downstream facilitation of neurotransmitter release.	UCL, Dept Pharmacol, London WC1E 6BT, England; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	University of London; University College London; Rockefeller University	Sihra, TS (corresponding author), UCL, Dept Pharmacol, Mortimer St, London WC1E 6BT, England.	t.sihra@ucl.ac.uk	Sihra, Talvinder S/A-4581-2009		NIA NIH HHS [AG15072] Funding Source: Medline; NIMH NIH HHS [MH39327] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH039327, R37MH039327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG015072] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Barrie A, 1996, MOL PHARMACOL, V49, P399; Boulanger L, 1999, NAT NEUROSCI, V2, P346, DOI 10.1038/7258; Carmignoto G, 1997, J PHYSIOL-LONDON, V498, P153, DOI 10.1113/jphysiol.1997.sp021848; Fawcett JP, 1997, J BIOL CHEM, V272, P8837; Ferreira A, 1998, MOL MED, V4, P22, DOI 10.1007/BF03401726; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gottschalk W, 1998, J NEUROSCI, V18, P6830; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Hilfiker S, 1998, NAT NEUROSCI, V1, P29, DOI 10.1038/229; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; LESSMANN V, 1994, NEUROREPORT, V6, P21; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; LEVINE ES, 1995, J NEUROSCI, V15, P3084; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Li YX, 1998, J NEUROSCI, V18, P10231; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; LU B, 1991, P NATL ACAD SCI USA, V88, P6289, DOI 10.1073/pnas.88.14.6289; Matsubara M, 1996, J BIOL CHEM, V271, P21108, DOI 10.1074/jbc.271.35.21108; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MCMAHON HT, 1991, BIOCHIM BIOPHYS ACTA, V1059, P243, DOI 10.1016/S0005-2728(05)80210-5; Messaoudi E, 1998, J NEUROPHYSIOL, V79, P496, DOI 10.1152/jn.1998.79.1.496; Nicholls D G, 1987, Soc Gen Physiol Ser, V42, P31; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; NIKODIJEVIC B, 1992, J NEUROSCI RES, V31, P591, DOI 10.1002/jnr.490310402; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Perkinton MS, 1998, J NEUROCHEM, V70, P1513; Perkinton MS, 1999, NEUROSCIENCE, V90, P1281, DOI 10.1016/S0306-4522(98)00573-9; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; SanchezPrieto J, 1996, TRENDS NEUROSCI, V19, P235, DOI 10.1016/0166-2236(96)10031-X; SANGHERA JS, 1990, J BIOL CHEM, V265, P52; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SIHRA TS, 1992, J BIOL CHEM, V267, P1983; SIHRA TS, 1997, POSTTRANSLATIONAL MO, P67; Stoop R, 1996, J NEUROSCI, V16, P3256; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; TOLEDOARAL JJ, 1995, NEURON, V14, P607, DOI 10.1016/0896-6273(95)90317-8; WETMORE C, 1994, J NEUROSCI, V14, P1688, DOI 10.1523/JNEUROSCI.14-03-01688.1994	50	451	472	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2000	3	4					323	329		10.1038/73888	http://dx.doi.org/10.1038/73888			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330CN	10725920				2022-12-17	WOS:000087945400011
J	McCarthy, MM; Arnold, AP				McCarthy, Margaret M.; Arnold, Arthur P.			Reframing sexual differentiation of the brain	NATURE NEUROSCIENCE			English	Review							ESTROGEN-RECEPTOR-ALPHA; COMPLEMENT AFFECTS NOCICEPTION; CHROMOSOME COMPLEMENT; GENE-EXPRESSION; EPIGENETIC REGULATION; CELL-DEATH; ESTRADIOL; BEHAVIOR; ADULT; MASCULINIZATION	In the twentieth century, the dominant model of sexual differentiation stated that genetic sex (XX versus XY) causes differentiation of the gonads, which then secrete gonadal hormones that act directly on tissues to induce sex differences in function. This serial model of sexual differentiation was simple, unifying and seductive. Recent evidence, however, indicates that the linear model is incorrect and that sex differences arise in response to diverse sex-specific signals originating from inherent differences in the genome and involve cellular mechanisms that are specific to individual tissues or brain regions. Moreover, sex-specific effects of the environment reciprocally affect biology, sometimes profoundly, and must therefore be integrated into a realistic model of sexual differentiation. A more appropriate model is a parallel-interactive model that encompasses the roles of multiple molecular signals and pathways that differentiate males and females, including synergistic and compensatory interactions among pathways and an important role for the environment.	[McCarthy, Margaret M.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [McCarthy, Margaret M.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [McCarthy, Margaret M.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Arnold, Arthur P.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles	McCarthy, MM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	mmccarth@umaryland.edu	McCarthy, Margaret/O-2059-2017	McCarthy, Margaret/0000-0003-2243-4726; Arnold, Arthur/0000-0002-9908-9767	 [MH52716];  [NS050525];  [NS043196];  [DC000217]; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH052716, R01MH052716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043196, R56NS050525, R01NS050525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000217] Funding Source: NIH RePORTER	; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Work on this manuscript was supported by grants MH52716 and NS050525 to M.M.M. and grants NS043196 and DC000217 to A.P.A.	ABEL JM, 2011, NEUROENDOCRINOL 0216, DOI DOI 10.1159/000324402; Amateau SK, 2004, NAT NEUROSCI, V7, P643, DOI 10.1038/nn1254; Arnold AP, 2004, NAT REV NEUROSCI, V5, P701, DOI 10.1038/nrn1494; Arnold AP, 2004, ENDOCRINOLOGY, V145, P1057, DOI 10.1210/en.2003-1491; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Arnold AP, 2009, J NEUROENDOCRINOL, V21, P377, DOI 10.1111/j.1365-2826.2009.01831.x; Arnold AP, 2009, FRONT NEUROENDOCRIN, V30, P1, DOI 10.1016/j.yfrne.2008.11.001; Bakker J, 2003, ANN NY ACAD SCI, V1007, P251, DOI 10.1196/annals.1286.024; Bakker J, 2010, J NEUROENDOCRINOL, V22, P728, DOI 10.1111/j.1365-2826.2010.02016.x; Balthazart J, 2006, TRENDS NEUROSCI, V29, P241, DOI 10.1016/j.tins.2006.03.004; Barker JM, 2010, J NEUROSCI, V30, P9140, DOI 10.1523/JNEUROSCI.0548-10.2010; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Becker JB, 2001, ANN NY ACAD SCI, V937, P172, DOI 10.1111/j.1749-6632.2001.tb03564.x; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Bowers J Michael, 2010, Biol Sex Differ, V1, P8, DOI 10.1186/2042-6410-1-8; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Chang SC, 2006, FRONT BIOSCI-LANDMRK, V11, P852, DOI 10.2741/1842; Chen XQ, 2008, DEV NEUROBIOL, V68, P265, DOI 10.1002/dneu.20581; Chen XQ, 2009, EUR J NEUROSCI, V29, P768, DOI 10.1111/j.1460-9568.2009.06610.x; Cox KH, 2011, GENES BRAIN BEHAV, V10, P465, DOI 10.1111/j.1601-183X.2011.00688.x; Davies W, 2006, BIOESSAYS, V28, P35, DOI 10.1002/bies.20341; de Vries GJ, 2008, ENDOCRINOLOGY, V149, P4632, DOI 10.1210/en.2008-0448; De Vries GJ, 2004, ENDOCRINOLOGY, V145, P1063, DOI 10.1210/en.2003-1504; De Vries GJ, 2002, J NEUROSCI, V22, P9005; Dewing P, 2006, CURR BIOL, V16, P415, DOI 10.1016/j.cub.2006.01.017; Fausto-Sterling A., 2000, SEXING BODY GENDER P; Forger NG, 2004, P NATL ACAD SCI USA, V101, P13666, DOI 10.1073/pnas.0404644101; Frome PM, 1998, J PERS SOC PSYCHOL, V74, P435, DOI 10.1037/0022-3514.74.2.435; Garcia-Segura LM, 2008, REPRODUCTION, V135, P419, DOI 10.1530/REP-07-0540; Gatewood JD, 2006, J NEUROSCI, V26, P2335, DOI 10.1523/JNEUROSCI.3743-05.2006; Gioiosa L, 2008, J PAIN, V9, P962, DOI 10.1016/j.jpain.2008.06.001; Gioiosa L, 2008, HORM BEHAV, V53, P124, DOI 10.1016/j.yhbeh.2007.09.003; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; GRISHAM W, 1994, J NEUROBIOL, V25, P185, DOI 10.1002/neu.480250209; HERRMANN K, 1991, J NEUROBIOL, V22, P29, DOI 10.1002/neu.480220104; Hill MN, 2010, J NEUROSCI, V30, P14980, DOI 10.1523/JNEUROSCI.4283-10.2010; Honda S, 1998, BIOCHEM BIOPH RES CO, V252, P445, DOI 10.1006/bbrc.1998.9672; Isgor C, 1998, HORM BEHAV, V34, P183, DOI 10.1006/hbeh.1998.1477; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; Juntti SA, 2008, HORM BEHAV, V53, P627, DOI 10.1016/j.yhbeh.2007.12.012; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Krebs-Kraft DL, 2010, P NATL ACAD SCI USA, V107, P20535, DOI 10.1073/pnas.1005003107; Krishnan S, 2009, P NATL ACAD SCI USA, V106, P16692, DOI 10.1073/pnas.0906293106; Kudwa AE, 2005, P NATL ACAD SCI USA, V102, P4608, DOI 10.1073/pnas.0500752102; Kurian JR, 2010, ENDOCRINOLOGY, V151, P2297, DOI 10.1210/en.2009-0649; Lenz KM, 2006, BRAIN RES, V1092, P87, DOI 10.1016/j.brainres.2006.03.070; Lippa RA, 2010, ARCH SEX BEHAV, V39, P619, DOI 10.1007/s10508-008-9380-7; London SE, 2009, FRONT NEUROENDOCRIN, V30, P302, DOI 10.1016/j.yfrne.2009.05.001; Majdic G, 2011, FRONT NEUROENDOCRIN, V32, P137, DOI 10.1016/j.yfrne.2011.02.009; Matsumoto A, 2000, SEXUAL DIFFERENTIATION OF THE BRAIN, P203; McCarthy MM, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1707; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; McCarthy MM, 2005, FRONT NEUROENDOCRIN, V26, P85, DOI 10.1016/j.yfrne.2005.06.001; McPhie-Lalmansingh AA, 2008, HORM BEHAV, V54, P565, DOI 10.1016/j.yhbeh.2008.05.016; Micevych P, 2009, J NEUROENDOCRINOL, V21, P249, DOI 10.1111/j.1365-2826.2009.01833.x; MIGEON BR, 2007, FEMALES MOSAIC X INA; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Mong JA, 1999, J NEUROSCI, V19, P1464; Mong JA, 2002, J NEUROENDOCRINOL, V14, P45, DOI 10.1046/j.1365-2826.2002.00737.x; MOORE CL, 1984, DEV PSYCHOBIOL, V17, P347, DOI 10.1002/dev.420170403; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Murray EK, 2009, ENDOCRINOLOGY, V150, P4241, DOI 10.1210/en.2009-0458; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5070, DOI 10.1210/en.139.12.5070; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P14737, DOI 10.1073/pnas.250473597; Park JH, 2010, J NEUROSCI, V30, P9967, DOI 10.1523/JNEUROSCI.1988-10.2010; Petrosino S, 2010, CURR OPIN INVEST DR, V11, P51; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Quinn JJ, 2007, NAT NEUROSCI, V10, P1398, DOI 10.1038/nn1994; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Schwarz JM, 2008, HORM BEHAV, V54, P662, DOI 10.1016/j.yhbeh.2008.07.004; Schwarz JM, 2008, NEURON, V58, P584, DOI 10.1016/j.neuron.2008.03.008; Schwarz JM, 2010, ENDOCRINOLOGY, V151, P4871, DOI 10.1210/en.2010-0142; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Smith-Bouvier DL, 2008, J EXP MED, V205, P1099, DOI 10.1084/jem.20070850; SWAAB DF, 1995, TRENDS NEUROSCI, V18, P264, DOI 10.1016/0166-2236(95)93913-I; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Todd BJ, 2007, DEV NEUROBIOL, V67, P304, DOI 10.1002/dneu.20337; Tsai HW, 2009, EPIGENETICS-US, V4, P47, DOI 10.4161/epi.4.1.7288; van Nas A, 2009, ENDOCRINOLOGY, V150, P1235, DOI 10.1210/en.2008-0563; Voskuhl Rhonda, 2011, Biol Sex Differ, V2, P1, DOI 10.1186/2042-6410-2-1; Waters EM, 2009, J NEUROSCI, V29, P9714, DOI 10.1523/JNEUROSCI.0135-09.2009; Westberry JM, 2010, ENDOCRINOLOGY, V151, P731, DOI 10.1210/en.2009-0955; Woolley CS, 2007, ANNU REV PHARMACOL, V47, P657, DOI 10.1146/annurev.pharmtox.47.120505.105219; Wright CL, 2008, DEV NEUROBIOL, V68, P1406, DOI 10.1002/dneu.20665; Wright CL, 2009, J NEUROSCI, V29, P13274, DOI 10.1523/JNEUROSCI.3603-09.2009; Zhang JM, 2008, EUR J NEUROSCI, V27, P791, DOI 10.1111/j.1460-9568.2008.06073.x; Zhao D, 2010, NATURE, V464, P237, DOI 10.1038/nature08852	92	450	461	1	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2011	14	6					677	683		10.1038/nn.2834	http://dx.doi.org/10.1038/nn.2834			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	768SH	21613996	Green Accepted			2022-12-17	WOS:000290958000006
J	Ramasamy, A; Trabzuni, D; Guelfi, S; Varghese, V; Smith, C; Walker, R; De, T; Coin, L; de Silva, R; Cookson, MR; Singleton, AB; Hardy, J; Ryten, M; Weale, ME				Ramasamy, Adaikalavan; Trabzuni, Daniah; Guelfi, Sebastian; Varghese, Vibin; Smith, Colin; Walker, Robert; De, Tisham; Coin, Lachlan; de Silva, Rohan; Cookson, Mark R.; Singleton, Andrew B.; Hardy, John; Ryten, Mina; Weale, Michael E.		UK Brain Expression Consortium; North Amer Brain Expression Consor	Genetic variability in the regulation of gene expression in ten regions of the human brain	NATURE NEUROSCIENCE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; LUNG-CANCER; SUSCEPTIBILITY; METAANALYSIS; DISEASE; ROLES; LOCUS; CD2AP; EPHA1	Germ-line genetic control of gene expression occurs via expression quantitative trait loci (eQTLs). We present a large, exon-specific eQTL data set covering ten human brain regions. We found that cis-eQTL signals (within 1 Mb of their target gene) were numerous, and many acted heterogeneously among regions and exons. Co-regulation analysis of shared eQTL signals produced well-defined modules of region-specific co-regulated genes, in contrast to standard coexpression analysis of the same samples. We report cis-eQTL signals for 23.1% of catalogued genome-wide association study hits for adult-onset neurological disorders. The data set is publicly available via public data repositories and via http://www.braineac.org/. Our study increases our understanding of the regulation of gene expression in the human brain and will be of value to others pursuing functional follow-up of disease-associated variants.	[Ramasamy, Adaikalavan; Varghese, Vibin; Ryten, Mina; Weale, Michael E.] Guys Hosp, Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; [Ramasamy, Adaikalavan; Trabzuni, Daniah; Guelfi, Sebastian; de Silva, Rohan; Hardy, John; Ryten, Mina] UCL, Inst Neurol, Dept Mol Neurosci, Reta Lila Weston Res Labs, London, England; [Trabzuni, Daniah] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Smith, Colin; Walker, Robert] Univ Edinburgh, Dept Neuropathol, MRC Sudden Death Brain Bank Project, Edinburgh, Midlothian, Scotland; [De, Tisham] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sch Publ Hlth, London, England; [Coin, Lachlan] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Cookson, Mark R.; Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; King Faisal Specialist Hospital & Research Center; University of Edinburgh; Imperial College London; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ryten, M (corresponding author), Guys Hosp, Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England.	mina.ryten@ucl.ac.uk; michael.weale@kcl.ac.uk	Weale, Michael E/F-2587-2010; Coin, Lachlan/O-4976-2019; Ramasamy, Adaikalavan/G-2632-2010; de Silva, Rohan/C-1734-2008; Trabzuni, Daniah M/C-4034-2012; Ryten, Mina/Q-8419-2016; Trabzuni, Daniah/AAI-2037-2021; Hardy, John/C-2451-2009; Cookson, Mark/AAW-2516-2021; Singleton, Andrew B/C-3010-2009; Coin, Lachlan JM/A-9001-2014; Gibbs, J. Raphael/A-3984-2010	Weale, Michael E/0000-0003-4593-1186; Coin, Lachlan/0000-0002-4300-455X; Ramasamy, Adaikalavan/0000-0002-7598-2892; de Silva, Rohan/0000-0002-5052-5775; Trabzuni, Daniah M/0000-0003-4826-9570; Trabzuni, Daniah/0000-0003-4826-9570; Hardy, John/0000-0002-3122-0423; Cookson, Mark/0000-0002-1058-3831; Coin, Lachlan JM/0000-0002-4300-455X; Gibbs, J. Raphael/0000-0002-6985-0658; Smith, Colin/0000-0002-4507-5132	US National Institute of Neurological Disorders and Stroke [U24 NS072026]; National Institute on Aging [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Michael J. Fox Foundation for Parkinson's Research; UK Medical Research Council (MRC) through the MRC Sudden Death Brain Bank [G0901254, G0802462]; King Faisal Specialist Hospital and Research Centre, Saudi Arabia; Intramural Research Program of the US National Institute on Aging, National Institutes of Health, Department of Health and Human Services [ZO1 AG000947]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London; NATIONAL INSTITUTE ON AGING [R01AG000947, ZIAAG000932, ZIAAG000947, Z01AG000947, P30AG019610] Funding Source: NIH RePORTER; Alzheimers Research UK [ARUK-PhD2014-16] Funding Source: researchfish; Medical Research Council [MR/K01417X/1, MR/L016400/1, MC_G1000735, G0802462, G0901254, G0501560] Funding Source: researchfish; National Institute for Health Research [ACF-2007-18-011] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish; Brain Research UK [UCC14182] Funding Source: researchfish; MRC [G0802462, MC_G1000735, MR/K01417X/1, G0901254, G0501560, MR/L016400/1] Funding Source: UKRI	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Michael J. Fox Foundation for Parkinson's Research; UK Medical Research Council (MRC) through the MRC Sudden Death Brain Bank; King Faisal Specialist Hospital and Research Centre, Saudi Arabia; Intramural Research Program of the US National Institute on Aging, National Institutes of Health, Department of Health and Human Services; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); Brain Research UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the Banner Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona for the provision of human biospecimens. The Brain and Body Donation Program is supported by the US National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinson's Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimer's Disease Core Center), the Arizona Department of Health Services (contract 211002, Arizona Alzheimer's Research Center), the Arizona Biomedical Research Commission (contracts 4001, 0011, 05-901 and 1001 to the Arizona Parkinson's Disease Consortium) and the Michael J. Fox Foundation for Parkinson's Research. We would like to thank AROS Applied Biotechnology AS company laboratories and Affymetrix for their input. H. Jonvik, L. Stanyer, J. Toombs and M. Gaskin provided invaluable assistance in helping with Our computer infrastructure and in sample handling and databasing. We thank A. Pittman for discussions. This work was supported by the UK Medical Research Council (MRC) through the MRC Sudden Death Brain Bank (C.S.), a Project Grant (G0901254 to J.H. and M.E.W) and Training Fellowship (G0802462 to M.R.). D.T. was supported by the King Faisal Specialist Hospital and Research Centre, Saudi Arabia. This work was also supported in part by the Intramural Research Program of the US National Institute on Aging, National Institutes of Health, Department of Health and Human Services; project ZO1 AG000947. We acknowledge support from the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' National Health Service (NHS) Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Albert FW, 2014, NATURE, V506, P494, DOI 10.1038/nature12904; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hernandez DG, 2012, NEUROBIOL DIS, V47, P20, DOI 10.1016/j.nbd.2012.03.020; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; International Parkinson's Disease Genomics Consortium (IPDGC) & Wellcome Trust Case Control Consortium 2 (WTCCC2), 2011, PLOS GENET, V7; Jellinger K., 1986, RECENT DEV PARKINSON, P33; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kim S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.42; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Liu C, 2010, MOL PSYCHIATR, V15, P779, DOI 10.1038/mp.2009.128; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Norris AD, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00122; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Ramasamy A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt069; Schorge S, 2010, TRENDS NEUROSCI, V33, P211, DOI 10.1016/j.tins.2010.02.005; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	46	448	451	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2014	17	10					1418	1428		10.1038/nn.3801	http://dx.doi.org/10.1038/nn.3801			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AP8KD	25174004	Green Accepted			2022-12-17	WOS:000342327000023
J	Schlosburg, JE; Blankman, JL; Long, JZ; Nomura, DK; Pan, B; Kinsey, SG; Nguyen, PT; Ramesh, D; Booker, L; Burston, JJ; Thomas, EA; Selley, DE; Sim-Selley, LJ; Liu, QS; Lichtman, AH; Cravatt, BF				Schlosburg, Joel E.; Blankman, Jacqueline L.; Long, Jonathan Z.; Nomura, Daniel K.; Pan, Bin; Kinsey, Steven G.; Nguyen, Peter T.; Ramesh, Divya; Booker, Lamont; Burston, James J.; Thomas, Elizabeth A.; Selley, Dana E.; Sim-Selley, Laura J.; Liu, Qing-song; Lichtman, Aron H.; Cravatt, Benjamin F.			Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system	NATURE NEUROSCIENCE			English	Article							ACID AMIDE HYDROLASE; CANNABINOID RECEPTOR ADAPTATION; PRECIPITATED WITHDRAWAL; BRAIN; DELTA(9)-TETRAHYDROCANNABINOL; ANANDAMIDE; TOLERANCE; ENZYMES; IDENTIFICATION; INHIBITION	Prolonged exposure to drugs of abuse, such as cannabinoids and opioids, leads to pharmacological tolerance and receptor desensitization in the nervous system. We found that a similar form of functional antagonism was produced by sustained inactivation of monoacylglycerol lipase (MAGL), the principal degradative enzyme for the endocannabinoid 2-arachidonoylglycerol. After repeated administration, the MAGL inhibitor JZL184 lost its analgesic activity and produced cross-tolerance to cannabinoid receptor (CB1) agonists in mice, effects that were phenocopied by genetic disruption of Mgll (encoding MAGL). Chronic MAGL blockade also caused physical dependence, impaired endocannabinoid-dependent synaptic plasticity and desensitized brain CB1 receptors. These data contrast with blockade of fatty acid amide hydrolase, an enzyme that degrades the other major endocannabinoid anandamide, which produced sustained analgesia without impairing CB1 receptors. Thus, individual endocannabinoids generate distinct analgesic profiles that are either sustained or transitory and associated with agonism and functional antagonism of the brain cannabinoid system, respectively.	[Schlosburg, Joel E.; Kinsey, Steven G.; Nguyen, Peter T.; Ramesh, Divya; Booker, Lamont; Burston, James J.; Selley, Dana E.; Sim-Selley, Laura J.; Lichtman, Aron H.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Blankman, Jacqueline L.; Long, Jonathan Z.; Nomura, Daniel K.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Blankman, Jacqueline L.; Long, Jonathan Z.; Nomura, Daniel K.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Pan, Bin; Liu, Qing-song] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Thomas, Elizabeth A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Virginia Commonwealth University; Scripps Research Institute; Scripps Research Institute; Medical College of Wisconsin; Scripps Research Institute	Lichtman, AH (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	alichtma@vcu.edu; cravatt@scripps.edu	Pan, Bin/D-5626-2011; Pan, Bin/C-9630-2011	Pan, Bin/0000-0002-5134-2508; Long, Jonathan/0000-0003-2631-7463	US National Institutes of Health [DA017259, DA009789, DA025285, DA005274, DA015683, DA03672, DA07027, DA014277, DA023758, DA024741]; Ruth L. Kirschstein US National Institutes of Health [DA023758, DA026261, DA026279, DA028333]; American Cancer Society; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA026261, P50DA005274, T32DA007027, R01DA014277, F31DA026279, F30DA023758, R01DA015683, P01DA009789, R01DA024741, R37DA003672, P01DA017259, R01DA003672, F31DA028333, R01DA025285] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank S. Niessen and H. Hoover for assistance with proteomics studies, I. Beletskaya and R. Abdullah for technical support and the Cravatt and Lichtman laboratories for critical reading of the manuscript. This work was supported by the US National Institutes of Health (grants DA017259, DA009789, DA025285, DA005274, DA015683, DA03672, DA005274, DA07027, DA014277, DA023758 and DA024741), Ruth L. Kirschstein US National Institutes of Health Predoctoral Fellowships (DA026261 to J.L.B., DA026279 to J.E.S., DA028333 to L.B. and DA023758 to P.T.N.), the American Cancer Society (D.K.N.) and the Skaggs Institute for Chemical Biology.	ACETO MD, 1995, EUR J PHARMACOL, V282, pR1, DOI 10.1016/0014-2999(95)00447-S; Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Caille S, 2007, J NEUROSCI, V27, P3695, DOI 10.1523/JNEUROSCI.4403-06.2007; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; DEUTSCH DG, 1993, BIOCHEM PHARMACOL, V46, P791, DOI 10.1016/0006-2952(93)90486-G; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Falenski KW, 2010, NEUROPSYCHOPHARMACOL, V35, P1775, DOI 10.1038/npp.2010.44; FAN F, 1994, J PHARMACOL EXP THER, V271, P1383; Fowler CJ, 2006, FUND CLIN PHARMACOL, V20, P549, DOI 10.1111/j.1472-8206.2006.00442.x; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Haller J, 2009, PSYCHOPHARMACOLOGY, V204, P607, DOI 10.1007/s00213-009-1494-7; Hillard CJ, 2000, PROSTAG OTH LIPID M, V61, P3, DOI 10.1016/S0090-6980(00)00051-4; Jhaveri MD, 2006, J NEUROSCI, V26, P13318, DOI 10.1523/JNEUROSCI.3326-06.2006; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; Kreitzer AC, 2002, CURR OPIN NEUROBIOL, V12, P324, DOI 10.1016/S0959-4388(02)00328-8; Lanoir J, 2006, J COMP NEUROL, V495, P607, DOI 10.1002/cne.20916; Lichtman AH, 2002, J PHARMACOL EXP THER, V302, P73, DOI 10.1124/jpet.302.1.73; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Lichtman AH, 2004, J PHARMACOL EXP THER, V311, P441, DOI 10.1124/jpet.104.069401; Lichtman AH, 2005, HANDB EXP PHARMACOL, V168, P691; Lichtman AH, 1996, J PHARMACOL EXP THER, V276, P585; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Luk T, 2004, BRIT J PHARMACOL, V142, P495, DOI 10.1038/sj.bjp.0705792; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pan B, 2009, J PHARMACOL EXP THER, V331, P591, DOI 10.1124/jpet.109.158162; PERTWEE RG, 1991, NEUROPHARMACOLOGY, V30, P237, DOI 10.1016/0028-3908(91)90150-A; Romero J, 1997, MOL BRAIN RES, V46, P100, DOI 10.1016/S0169-328X(96)00277-X; Schlosburg JE, 2009, AAPS J, V11, P342, DOI 10.1208/s12248-009-9110-7; Sim LJ, 1996, J NEUROSCI, V16, P8057; Sim-Selley LJ, 2002, J PHARMACOL EXP THER, V303, P36, DOI 10.1124/jpet.102.035618; Straiker A, 2009, MOL PHARMACOL, V76, P1220, DOI 10.1124/mol.109.059030; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sun M, 2007, J PHYSIOL-LONDON, V578, P751, DOI 10.1113/jphysiol.2006.120147; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Thomas EA, 2001, J NEUROCHEM, V76, P789, DOI 10.1046/j.1471-4159.2001.00027.x; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545	50	448	460	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1113	U111		10.1038/nn.2616	http://dx.doi.org/10.1038/nn.2616			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20729846	Green Accepted			2022-12-17	WOS:000281332600017
J	Stocker, AA; Simoncelli, EP				Stocker, AA; Simoncelli, EP			Noise characteristics and prior expectations in human visual speed perception	NATURE NEUROSCIENCE			English	Article							BAYESIAN MODEL; OPTICAL-FLOW; AREA MT; MOTION; INFORMATION; CONTRAST; STATISTICS; DISCRIMINATION; COMPUTATION	Human visual speed perception is qualitatively consistent with a Bayesian observer that optimally combines noisy measurements with a prior preference for lower speeds. Quantitative validation of this model, however, is difficult because the precise noise characteristics and prior expectations are unknown. Here, we present an augmented observer model that accounts for the variability of subjective responses in a speed discrimination task. This allowed us to infer the shape of the prior probability as well as the internal noise characteristics directly from psychophysical data. For all subjects, we found that the fitted model provides an accurate description of the data across a wide range of stimulus parameters. The inferred prior distribution shows significantly heavier tails than a Gaussian, and the amplitude of the internal noise is approximately proportional to stimulus speed and depends inversely on stimulus contrast. The framework is general and should prove applicable to other experiments and perceptual modalities.	NYU, Howard Hughes Med Inst, Ctr Neural Sci, New York, NY 10003 USA; NYU, Courant Inst Math Sci, New York, NY 10003 USA	Howard Hughes Medical Institute; New York University; New York University	Stocker, AA (corresponding author), NYU, Howard Hughes Med Inst, Ctr Neural Sci, 4 Washington Pl Rm 809, New York, NY 10003 USA.	alan.stocker@nyu.edu	Stocker, Alan A/A-6514-2008	Stocker, Alan A/0000-0002-2041-1515; Simoncelli, Eero/0000-0002-1206-527X				Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Ascher D, 2000, VISION RES, V40, P3427, DOI 10.1016/S0042-6989(00)00176-0; Betsch BY, 2004, BIOL CYBERN, V90, P41, DOI 10.1007/s00422-003-0434-6; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FENNEMA CL, 1979, COMPUT VISION GRAPH, V9, P301, DOI 10.1016/0146-664X(79)90097-2; Green DM., 1966, SIGNAL DETECTION THE; HEEGER D, 1994, SPATIAL VISION HUMAN; HELMHOLTZ H, 2000, TREATISE PHYSL OPTIC; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Hurlimann F, 2002, VISION RES, V42, P2253, DOI 10.1016/S0042-6989(02)00119-0; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Mamassian P, 2002, NEU INF PRO, P13; MCKEE SP, 1984, VISION RES, V24, P25, DOI 10.1016/0042-6989(84)90140-8; MCKEE SP, 1986, VISION RES, V26, P609, DOI 10.1016/0042-6989(86)90009-X; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Nover H, 2005, J NEUROSCI, V25, P10049, DOI 10.1523/JNEUROSCI.1661-05.2005; Pack CC, 2005, J NEUROPHYSIOL, V93, P1809, DOI 10.1152/jn.00629.2004; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Priebe NJ, 2004, J NEUROSCI, V24, P1907, DOI 10.1523/JNEUROSCI.4233-03.2004; Roth S, 2005, IEEE I CONF COMP VIS, P42; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Simoncelli E, 1993, THESIS MIT; SIMONCELLI EP, 1991, IEEE C COMP VIS PATT, P310, DOI 10.1109/CVPR.1991.139707; SIMONCELLI EP, 2003, VISUAL NEUROSCIENCES; STOCKER A, 2006, ADV NEURAL INFORMATI, V18; STOCKER A, 2005, ADV NEURAL INFORMATI, V17; Stocker A, 2006, ANALOG VLSI CIRCUITS; Stocker AA, 2006, ANALOG INTEGR CIRC S, V46, P121, DOI 10.1007/s10470-005-0439-2; STONE LS, 1992, VISION RES, V32, P1535, DOI 10.1016/0042-6989(92)90209-2; Thompson P, 2006, VISION RES, V46, P782, DOI 10.1016/j.visres.2005.08.005; THOMPSON P, 1982, VISION RES, V22, P377, DOI 10.1016/0042-6989(82)90153-5; WEBER J, 1995, INT J COMPUT VISION, V14, P67, DOI 10.1007/BF01421489; Weiss Y, 2002, NEU INF PRO, P77; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; WELCH L, 1989, NATURE, V337, P734, DOI 10.1038/337734a0; Wickens T. D., 2001, ELEMENTARY SIGNAL DE; YUILLE A, 2004, ADV NEURAL INFORMATI, V16; YUILLE AL, 1988, NATURE, V333, P71, DOI 10.1038/333071a0	46	448	449	3	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2006	9	4					578	585		10.1038/nn1669	http://dx.doi.org/10.1038/nn1669			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	026BC	16547513	Green Submitted			2022-12-17	WOS:000236310700026
J	Hu, WQ; Tian, CP; Li, T; Yang, MP; Hou, H; Shu, YS				Hu, Wenqin; Tian, Cuiping; Li, Tun; Yang, Mingpo; Hou, Han; Shu, Yousheng			Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation	NATURE NEUROSCIENCE			English	Article							SODIUM-CHANNELS; ION CHANNELS; SEGMENT; ACTIVATION; NEURONS; MODEL; SITE; PROPAGATION; CHANDELIER; RECEPTORS	The distal end of the axon initial segment (AIS) is the preferred site for action potential initiation in cortical pyramidal neurons because of its high Na+ channel density. However, it is not clear why action potentials are not initiated at the proximal AIS, which has a similarly high Na+ channel density. We found that low-threshold Na(v)1.6 and high-threshold Na(v)1.2 channels preferentially accumulate at the distal and proximal AIS, respectively, and have distinct functions in action potential initiation and backpropagation. Patch-clamp recording from the axon cut end of pyramidal neurons in the rat prefrontal cortex revealed a high density of Na+ current and a progressive reduction in the half-activation voltage (up to 14 mV) with increasing distance from the soma at the AIS. Further modeling studies and simultaneous somatic and axonal recordings showed that distal Na(v)1.6 promotes action potential initiation, whereas proximal Na(v)1.2 promotes its backpropagation to the soma.	[Hu, Wenqin; Tian, Cuiping; Li, Tun; Yang, Mingpo; Hou, Han; Shu, Yousheng] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Shu, YS (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China.	shu@ion.ac.cn	Hou, Han/GLR-4583-2022; Li, Tun/F-8928-2018; Shu, Yousheng/AAC-3881-2020	Hou, Han/0000-0002-4590-7891; Shu, Yousheng/0000-0002-2834-2876; Li, Tun/0000-0002-6424-8051	973 Program [2006CB806600]; Shanghai Commission of Science and Technology [06DJ14010]; Shanghai Pujiang Program [07PJ14108]; Chinese Academy of Sciences [KSCX2-YW-R-102]; Scientific Research Foundation of the State Human Resource Ministry and the Education Ministry	973 Program(National Basic Research Program of China); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Shanghai Pujiang Program(Shanghai Pujiang Program); Chinese Academy of Sciences(Chinese Academy of Sciences); Scientific Research Foundation of the State Human Resource Ministry and the Education Ministry	We thank M. M. Poo, D. A. McCormick and M. H. Kole for their valuable comments on this work. We are also grateful to Y. Yu for his help in computer modeling. This work was supported by the 973 Program (2006CB806600), a Shanghai Commission of Science and Technology grant (06DJ14010), the Shanghai Pujiang Program (07PJ14108), the Hundreds of Talents Program and Knowledge Innovation Project from Chinese Academy of Sciences (KSCX2-YW-R-102), and Projects of the Scientific Research Foundation of the State Human Resource Ministry and the Education Ministry.	Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boiko T, 2003, J NEUROSCI, V23, P2306; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 1998, J NEUROPHYSIOL, V79, P491, DOI 10.1152/jn.1998.79.1.491; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; DODGE FA, 1973, IBM J RES DEV, V17, P219, DOI 10.1147/rd.173.0219; Duflocq A, 2008, MOL CELL NEUROSCI, V39, P180, DOI 10.1016/j.mcn.2008.06.008; Eccles J. C, 1957, PHYSL NERVE CELLS; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; FATT P, 1957, J NEUROPHYSIOL, V20, P61, DOI 10.1152/jn.1957.20.1.61; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Howard A, 2005, TRENDS NEUROSCI, V28, P310, DOI 10.1016/j.tins.2005.04.004; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Kampa BM, 2004, J PHYSIOL-LONDON, V556, P337, DOI 10.1113/jphysiol.2003.058842; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Komai S, 2006, NAT NEUROSCI, V9, P1125, DOI 10.1038/nn1752; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McCormick DA, 2007, NATURE, V445, pE1, DOI 10.1038/nature05523; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; Milojkovic BA, 2005, J MEMBRANE BIOL, V208, P155, DOI 10.1007/s00232-005-0827-7; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P301, DOI 10.1113/jphysiol.1983.sp014582; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SJORSTROM PJ, 2001, NEURON, V32, P1149; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; WOLLNER DA, 1986, P NATL ACAD SCI USA, V83, P8424, DOI 10.1073/pnas.83.21.8424; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008	50	447	460	1	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2009	12	8					996	U61		10.1038/nn.2359	http://dx.doi.org/10.1038/nn.2359			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	475WS	19633666				2022-12-17	WOS:000268396300013
J	Pelli, DG; Tillman, KA				Pelli, Denis G.; Tillman, Katharine A.			The uncrowded window of object recognition	NATURE NEUROSCIENCE			English	Article							PARAFOVEAL RECOGNITION; FEATURE-INTEGRATION; EYE-MOVEMENTS; SPAN; ORIENTATION; RESOLUTION; SIGNALS; SEARCH; SHAPE	It is now emerging that vision is usually limited by object spacing rather than size. The visual system recognizes an object by detecting and then combining its features. 'Crowding' occurs when objects are too close together and features from several objects are combined into a jumbled percept. Here, we review the explosion of studies on crowding-in grating discrimination, letter and face recognition, visual search, selective attention, and reading-and find a universal principle, the Bouma law. The critical spacing required to prevent crowding is equal for all objects, although the effect is weaker between dissimilar objects. Furthermore, critical spacing at the cortex is independent of object position, and critical spacing at the visual field is proportional to object distance from fixation. The region where object spacing exceeds critical spacing is the 'uncrowded window'. Observers cannot recognize objects outside of this window and its size limits the speed of reading and search.	[Pelli, Denis G.] NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Pelli, DG (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	denis.pelli@nyu.edu		Tillman, Katharine/0000-0001-9440-7239	NATIONAL EYE INSTITUTE [R01EY004432] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY004432, R01 EY004432-22] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Bex PJ, 2003, VISION RES, V43, P2895, DOI 10.1016/S0042-6989(03)00460-7; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Blake R, 2006, P NATL ACAD SCI USA, V103, P4783, DOI 10.1073/pnas.0509634103; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; BOUMA H, 1977, NEUROPSYCHOLOGIA, V15, P69, DOI 10.1016/0028-3932(77)90116-6; BOUMA H, 1973, VISION RES, V13, P767, DOI 10.1016/0042-6989(73)90041-2; Chung STL, 2001, VISION RES, V41, P1833, DOI 10.1016/S0042-6989(01)00071-2; Chung STL, 2007, J VISION, V7, DOI 10.1167/7.2.10; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Freeman J, 2007, J VISION, V7, DOI 10.1167/7.2.22; Geisler W, 2003, NATURE, V423, P696, DOI 10.1038/423696a; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huey E.B., 1908, PSYCHOL PEDAGOGY REA; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Kwon M, 2007, VISION RES, V47, P2889, DOI 10.1016/j.visres.2007.08.002; Ledgeway T, 2005, VISION RES, V45, P2511, DOI 10.1016/j.visres.2005.04.002; Legge GB, 2007, PSYCHOPHYSICS READIN; LEGGE GE, 1985, VISION RES, V25, P239, DOI 10.1016/0042-6989(85)90117-8; Levi DM, 2007, J VISION, V7, DOI 10.1167/7.2.21; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; LEVYSCHOEN A, 1976, TRAV HUMAIN, V39, P63; Martelli M, 2006, PERCEPTION, V35, P174; Martelli M, 2005, J VISION, V5, P58, DOI 10.1167/5.1.6; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; Motter B. C., 2002, J VISION, V2, P274, DOI DOI 10.1167/2.7.274; Motter BC, 2007, J VISION, V7, DOI 10.1167/7.2.6; O'Regan J K, 1990, Rev Oculomot Res, V4, P395; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.i; Pelli DG, 2006, VISION RES, V46, P4646, DOI 10.1016/j.visres.2006.04.023; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Prado C, 2007, VISION RES, V47, P2521, DOI 10.1016/j.visres.2007.06.001; Reddy KR, 2007, J NANOSCI NANOTECHNO, V7, P3117, DOI 10.1166/jnn.2007.692; ROBSON JG, 1981, VISION RES, V21, P409, DOI 10.1016/0042-6989(81)90169-3; Solomon JA, 2006, P ROY SOC B-BIOL SCI, V273, P2681, DOI 10.1098/rspb.2006.3634; Stanovich KE, 1997, J EDUC PSYCHOL, V89, P114, DOI 10.1037/0022-0663.89.1.114; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TAYLOR SE, 1965, AM EDUC RES J, V2, P187, DOI 10.2307/1161646; TOET A, 1992, VISION RES, V32, P1349, DOI 10.1016/0042-6989(92)90227-A; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Ullman S., 2000, HIGH LEVEL VISION OB; Valdois S., 2003, READ WRIT, V16, P541, DOI DOI 10.1023/A:1025501406971; van den Berg R, 2007, J VISION, V7, DOI 10.1167/7.2.14; Vlaskamp BNS, 2005, EXP BRAIN RES, V167, P246, DOI 10.1007/s00221-005-0032-z; Woodworth R.S., 1938, EXP PSYCHOL; [No title captured]	50	447	453	4	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2008	11	10					1129	1135		10.1038/nn.2187	http://dx.doi.org/10.1038/nn.2187			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	352WQ	18828191	Green Accepted			2022-12-17	WOS:000259528500006
J	Summerfield, C; Trittschuh, EH; Monti, JM; Mesulam, MM; Egner, T				Summerfield, Christopher; Trittschuh, Emily H.; Monti, Jim M.; Mesulam, M-Marsel; Egner, Tobias			Neural repetition suppression reflects fulfilled perceptual expectations	NATURE NEUROSCIENCE			English	Article							LATERAL OCCIPITAL COMPLEX; MECHANISMS; ATTENTION; CORTEX; MEMORY; BRAIN	Stimulus-evoked neural activity is attenuated on stimulus repetition (repetition suppression), a phenomenon that is attributed to largely automatic processes in sensory neurons. By manipulating the likelihood of stimulus repetition, we found that repetition suppression in the human brain was reduced when stimulus repetitions were improbable (and thus, unexpected). Our data suggest that repetition suppression reflects a relative reduction in top-down perceptual 'prediction error' when processing an expected, compared with an unexpected, stimulus.	[Trittschuh, Emily H.; Monti, Jim M.; Mesulam, M-Marsel; Egner, Tobias] Northwestern Univ, Feinberg Sch Med, Alzheimers Dis Ctr, Chicago, IL 60611 USA; [Summerfield, Christopher] Univ Paris 06, INSERM, U742, F-75005 Paris, France; [Summerfield, Christopher] Ecole Normale Super, Dept Etudes Cognit, F-75005 Paris, France	Northwestern University; Feinberg School of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Egner, T (corresponding author), Northwestern Univ, Feinberg Sch Med, Alzheimers Dis Ctr, 320 E Super St,Searle 11, Chicago, IL 60611 USA.	t-egner@northwestern.edu	Egner, Tobias/AAD-5864-2022; Egner, Tobias/A-5237-2009	Egner, Tobias/0000-0001-7956-3241; Egner, Tobias/0000-0001-7956-3241	US National Institute of Neurological Disorders and Stroke [NS30863]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030863] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to E. Koechlin and S. Kouider for helpful comments on an earlier version of this manuscript. This work was supported in part by a grant from the US National Institute of Neurological Disorders and Stroke (NS30863, M.-M. M.).	Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Friston KJ, 2006, J PHYSIOL-PARIS, V100, P70, DOI 10.1016/j.jphysparis.2006.10.001; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; MILLER EK, 1991, SCIENCE, V254, P1377, DOI 10.1126/science.1962197; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; SUMMERFIELD C, 2008, NEURON; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	15	447	451	3	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2008	11	9					1004	1006		10.1038/nn.2163	http://dx.doi.org/10.1038/nn.2163			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	341NA	19160497	Green Accepted			2022-12-17	WOS:000258720000009
J	Tong, QC; Ye, CP; Jones, JE; Elmquist, JK; Lowell, BB				Tong, Qingchun; Ye, Chian-Ping; Jones, Juli E.; Elmquist, Joel K.; Lowell, Bradford B.			Synaptic release of GABA by AgRP neurons is required for normal regulation of energy balance	NATURE NEUROSCIENCE			English	Article							AGOUTI-RELATED PROTEIN; NPY/AGRP NEURONS; NEUROPEPTIDE-Y; POMC NEURONS; HOMEOSTASIS; MICE; GHRELIN	The physiologic importance of GABAergic neurotransmission in hypothalamic neurocircuits is unknown. To examine the importance of GABA release from agouti-related protein (AgRP) neurons (which also release AgRP and neuropeptide Y), we generated mice with an AgRP neuron-specific deletion of vesicular GABA transporter. These mice are lean, resistant to obesity and have an attenuated hyperphagic response to ghrelin. Thus, GABA release from AgRP neurons is important in regulating energy balance.	[Tong, Qingchun; Ye, Chian-Ping; Jones, Juli E.; Lowell, Bradford B.] Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, Boston, MA 02215 USA; [Tong, Qingchun; Ye, Chian-Ping; Jones, Juli E.; Lowell, Bradford B.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lowell, BB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol, Dept Med, 99 Brookline Ave, Boston, MA 02215 USA.	blowell@bidmc.harvard.edu		Tong, Qingchun/0000-0002-4561-2540	US National Institutes of Health [RO1 DK071051, PO1 DK56116, RO1 DK071320, RO1 DK53301]; Beth Israel Deaconess Medical Center Transgenic Facility; Boston Obesity Nutrition Research Center [P30 DK046200]; Boston Area Diabetes Endocrinology Research Center [P30 DK057521]; US National Institutes of Health-funded Boston Obesity Nutrition Research Center [P30 DK046200]; North American Association for the Study of Obesity; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, R01DK056690, R01DK053301, P01DK056116, R01DK071051, R01DK071320, P30DK046200] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beth Israel Deaconess Medical Center Transgenic Facility; Boston Obesity Nutrition Research Center; Boston Area Diabetes Endocrinology Research Center; US National Institutes of Health-funded Boston Obesity Nutrition Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North American Association for the Study of Obesity; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health grants (RO1 DK071051 and PO1 DK56116 to B. B. L.; RO1 DK071320, RO1 DK53301 and PO1 DK56116 to J. K. E.) and the Beth Israel Deaconess Medical Center Transgenic Facility, which is supported by the Boston Obesity Nutrition Research Center (P30 DK046200) and the Boston Area Diabetes Endocrinology Research Center (P30 DK057521). Q. T. is the recipient of a Pilot and Feasibility Award from the US National Institutes of Health-funded Boston Obesity Nutrition Research Center (P30 DK046200) and a Young Investigator Award from the North American Association for the Study of Obesity.	Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Flier JS, 2006, CELL METAB, V3, P83, DOI 10.1016/j.cmet.2006.01.003; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016	15	447	453	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2008	11	9					998	1000		10.1038/nn.2167	http://dx.doi.org/10.1038/nn.2167			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	341NA	19160495	Green Accepted			2022-12-17	WOS:000258720000007
J	Morgan, D; Grant, KA; Gage, HD; Mach, RH; Kaplan, JR; Prioleau, O; Nader, SH; Buchheimer, N; Ehrenkaufer, RL; Nader, MA				Morgan, D; Grant, KA; Gage, HD; Mach, RH; Kaplan, JR; Prioleau, O; Nader, SH; Buchheimer, N; Ehrenkaufer, RL; Nader, MA			Social dominance in monkeys: dopamine D-2 receptors and cocaine self-administration	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INDIVIDUAL VULNERABILITY; BINDING CHARACTERISTICS; HOUSING CONDITIONS; RHESUS-MONKEYS; D-AMPHETAMINE; DRUG-ABUSE; RATS; BEHAVIOR; ADDICTION	Disruption of the dopaminergic system has been implicated in the etiology of many pathological conditions, including drug addiction. Here we used positron emission tomography (PET) imaging to study brain dopaminergic function in individually housed and in socially housed cynomolgus macaques (n = 20). Whereas the monkeys did not differ during individual housing, social housing increased the amount or availability of dopamine D-2 receptors in dominant monkeys and produced no change in subordinate monkeys. These neurobiological changes had an important behavioral influence as demonstrated by the finding that cocaine functioned as a reinforcer in subordinate but not dominant monkeys. These data demonstrate that alterations in an organism's environment can produce profound biological changes that have important behavioral associations, including vulnerability to cocaine addiction.	Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol Comparat Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Anthropol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Nader, MA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Med Ctr Blvd, Winston Salem, NC 27157 USA.		Morgan, Drake/A-6373-2008; Morgan, Drake/F-6664-2012		NATIONAL INSTITUTE ON DRUG ABUSE [R37DA010584, R01DA010584] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-10584] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		BLANC G, 1980, NATURE, V284, P265, DOI 10.1038/284265a0; Blum K, 1996, AM SCI, V84, P132; BOWLING SL, 1993, NEUROPHARMACOLOGY, V32, P885, DOI 10.1016/0028-3908(93)90144-R; BOYLE AE, 1991, PHARMACOL BIOCHEM BE, V39, P269, DOI 10.1016/0091-3057(91)90178-5; BOZARTH MA, 1989, PHARMACOL BIOCHEM BE, V33, P903, DOI 10.1016/0091-3057(89)90490-5; Caine SB, 2000, PSYCHOPHARMACOLOGY, V148, P41, DOI 10.1007/s002130050023; Calabresi P, 1997, NEUROSCIENCE, V78, P39; CROWLEY TJ, 1992, DRUG ALCOHOL DEPEN, V29, P205, DOI 10.1016/0376-8716(92)90094-S; CROWLEY TJ, 1974, ARCH GEN PSYCHIAT, V31, P829; Grant KA, 1998, SYNAPSE, V29, P80, DOI 10.1002/(SICI)1098-2396(199805)29:1<80::AID-SYN7>3.0.CO;2-7; Hall FS, 1998, PHARMACOL BIOCHEM BE, V59, P859, DOI 10.1016/S0091-3057(97)00510-8; Hurd YL, 1999, ANN NY ACAD SCI, V877, P499, DOI 10.1111/j.1749-6632.1999.tb09285.x; Khroyan TV, 2000, J PHARMACOL EXP THER, V294, P680; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; LeSage MG, 1999, NEUROSCI BIOBEHAV R, V23, P717, DOI 10.1016/S0149-7634(99)00015-9; Leshner AI, 2000, AM J MED GENET, V96, P590, DOI 10.1002/1096-8628(20001009)96:5<590::AID-AJMG2>3.0.CO;2-2; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Lucas LR, 1998, EUR J NEUROSCI, V10, P3153, DOI 10.1046/j.1460-9568.1998.00321.x; Mach RH, 1996, SYNAPSE, V24, P322, DOI 10.1002/(SICI)1098-2396(199612)24:4<322::AID-SYN2>3.0.CO;2-F; Mach RH, 1997, PHARMACOL BIOCHEM BE, V57, P477, DOI 10.1016/S0091-3057(96)00449-2; Marinelli M, 2000, J NEUROSCI, V20, P8876; MARTIN SP, 1990, PHARMACOL BIOCHEM BE, V37, P493, DOI 10.1016/0091-3057(90)90018-D; MICZEK KA, 1983, PSYCHOPHARMACOLOGY, V81, P183, DOI 10.1007/BF00427259; Morgan D, 2000, AM J PRIMATOL, V52, P115, DOI 10.1002/1098-2345(200011)52:3<115::AID-AJP1>3.0.CO;2-Z; Nader MA, 1999, PSYCHOPHARMACOLOGY, V147, P143, DOI 10.1007/s002130051154; NADER MA, 1991, PSYCHOPHARMACOLOGY, V105, P169, DOI 10.1007/BF02244304; Nader MA, 1999, NEUROPSYCHOPHARMACOL, V21, P589, DOI 10.1016/S0893-133X(98)00101-8; PHILLIPS GD, 1994, PSYCHOPHARMACOLOGY, V115, P407, DOI 10.1007/BF02245084; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Piazza PV, 2000, J NEUROSCI, V20, P4226; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; Piazza PV, 1996, ANNU REV PHARMACOL, V36, P359, DOI 10.1146/annurev.pa.36.040196.002043; RILKE O, 1995, PHARMACOL BIOCHEM BE, V52, P23, DOI 10.1016/0091-3057(95)00093-C; SCHENK S, 1987, NEUROSCI LETT, V81, P227, DOI 10.1016/0304-3940(87)91003-2; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Verhoeff NPLG, 1999, PSYCHOPHARMACOLOGY, V147, P217, DOI 10.1007/s002130051163; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406; Volkow ND, 1999, AM J PSYCHIAT, V156, P1440; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; VOLKOW ND, 1990, AM J PSYCHIAT, V147, P719; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Woods R.P., 1998, J COMPUT ASSIST TOMO, V22, P141	42	447	458	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					169	174		10.1038/nn798	http://dx.doi.org/10.1038/nn798			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802171				2022-12-17	WOS:000173558400020
J	Hansel, C; Linden, DJ; D'Angelo, E				Hansel, C; Linden, DJ; D'Angelo, E			Beyond parallel fiber LTD: the diversity of synaptic and nonsynaptic plasticity in the cerebellum	NATURE NEUROSCIENCE			English	Review							LONG-TERM POTENTIATION; PURKINJE-CELL DENDRITES; GRANULE CELL; CLIMBING FIBER; MOSSY FIBER; INTRINSIC EXCITABILITY; REBOUND POTENTIATION; ELECTROPHYSIOLOGICAL PROPERTIES; POSTSYNAPTIC MECHANISMS; LASTING POTENTIATION	In recent years, it has become dear that motor learning, as revealed by associative eyelid conditioning and adaptation of the vestibule-ocular reflex, contributes to the well-established cerebellar functions of sensorimotor integration and control. Long-term depression of the parallel fiber-Purkinje cell synapse (which is often called 'cerebellar LTD') is a cellular phenomenon that has been suggested to underlie these forms of learning. However, it is clear that parallel fiber LTD, by itself, cannot account for all the properties of cerebellar motor learning. Here we review recent electrophysiological experiments that have described a rich variety of use-dependent plasticity in cerebellum, including long-term potentiation (LTP) and LTD of excitatory and inhibitory synapses, and persistent modulation of intrinsic neuronal excitability. Finally, using associative eyelid conditioning as an example, we propose some ideas about how these cellular phenomena might function and interact to endow the cerebellar circuit with particular computational and mnemonic properties.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Erasmus Univ, Inst Neurosci, Dept Anat, NL-3000 DR Rotterdam, Netherlands; Univ Pavia, Dept Cellular Mol Physiol & Pharmacol, I-27100 Pavia, Italy; INFM, Pavia Unit, I-27100 Pavia, Italy; Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy	Johns Hopkins University; Erasmus University Rotterdam; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Pavia; University of Parma	Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	dlinden@jhmi.edu		D'ANGELO, EGIDIO UGO/0000-0002-6007-7187	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051106, R29MH051106, R01MH061974, R37MH051106] Funding Source: NIH RePORTER; NIMH NIH HHS [MH01590, MH51106, MH61974] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ALKON DL, 1984, J EXP BIOL, V112, P95; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; Bear MF, 2001, SYNAPSES, P455; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BRONS JF, 1980, J NEUROPHYSIOL, V44, P605, DOI 10.1152/jn.1980.44.3.605; Chavis P, 1998, NEURON, V20, P773, DOI 10.1016/S0896-6273(00)81015-6; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; D'Angelo E, 1999, J NEUROPHYSIOL, V81, P277, DOI 10.1152/jn.1999.81.1.277; D'Angelo E, 2001, J NEUROSCI, V21, P759, DOI 10.1523/JNEUROSCI.21-03-00759.2001; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; DISTERHOFT JF, 1986, P NATL ACAD SCI USA, V83, P2733, DOI 10.1073/pnas.83.8.2733; Dittman JS, 1998, J NEUROSCI, V18, P6147; Eilers J, 1997, LEARN MEMORY, V4, P159, DOI 10.1101/lm.4.1.159; Fregnac Y, 1998, NATURE, V391, P845, DOI 10.1038/35996; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; Hashimoto T, 1996, J PHYSIOL-LONDON, V497, P611, DOI 10.1113/jphysiol.1996.sp021794; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HIRANO T, 1990, NEUROSCI LETT, V119, P141, DOI 10.1016/0304-3940(90)90818-T; HIRANO T, 1991, SYNAPSE, V7, P321, DOI 10.1002/syn.890070408; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kano M, 1996, P NATL ACAD SCI USA, V93, P13351, DOI 10.1073/pnas.93.23.13351; Kano M, 1996, BEHAV BRAIN SCI, V19, P354, DOI 10.1017/S0140525X00081450; KASE M, 1980, J PHYSIOL-LONDON, V300, P539, DOI 10.1113/jphysiol.1980.sp013178; Kawaguchi S, 2000, NEURON, V27, P339, DOI 10.1016/S0896-6273(00)00041-6; Khodakhah K, 1997, P NATL ACAD SCI USA, V94, P14009, DOI 10.1073/pnas.94.25.14009; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Kimura S, 1998, J NEUROSCI, V18, P8551; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; Linden DJ, 1998, J NEUROPHYSIOL, V79, P3151, DOI 10.1152/jn.1998.79.6.3151; Linden DJ, 1997, NEURON, V18, P983, DOI 10.1016/S0896-6273(00)80337-2; Linden DJ, 1999, J NEUROSCI, V19, P10221; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Maex R, 1998, J NEUROPHYSIOL, V80, P2521, DOI 10.1152/jn.1998.80.5.2521; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mauk MD, 1997, NEURON, V18, P343, DOI 10.1016/S0896-6273(00)81235-0; MCCORMICK DA, 1984, J NEUROSCI, V4, P2811; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 1999, J NEUROSCI, V19, P7140, DOI 10.1523/JNEUROSCI.19-16-07140.1999; MEDINA JF, IN PRESS J NEUROSCI; Morishita W, 1996, J NEUROPHYSIOL, V76, P59, DOI 10.1152/jn.1996.76.1.59; Ohyama T, 2001, J NEUROSCI, V21, P682, DOI 10.1523/JNEUROSCI.21-02-00682.2001; Ouardouz M, 2000, J NEUROPHYSIOL, V84, P1414, DOI 10.1152/jn.2000.84.3.1414; Pellerin JP, 1997, J NEUROPHYSIOL, V78, P3502, DOI 10.1152/jn.1997.78.6.3502; RACINE RJ, 1986, EXP BRAIN RES, V63, P158; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raymond JL, 2000, PROG BRAIN RES, V124, P235; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; Rossi P, 1996, EUR J NEUROSCI, V8, P1182, DOI 10.1111/j.1460-9568.1996.tb01286.x; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Schreurs BG, 1998, J NEUROSCI, V18, P5498, DOI 10.1523/JNEUROSCI.18-14-05498.1998; Schweighofer N, 2001, NEUROSCIENCE, V103, P35, DOI 10.1016/S0306-4522(00)00548-0; SHIBUKI K, 1992, NEUROREPORT, V3, P231, DOI 10.1097/00001756-199203000-00003; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Strata P, 1998, TRENDS NEUROSCI, V21, P407, DOI 10.1016/S0166-2236(98)01305-8; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	75	447	453	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					467	475		10.1038/87419	http://dx.doi.org/10.1038/87419			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319554				2022-12-17	WOS:000168412600009
J	Musiek, ES; Holtzman, DM				Musiek, Erik S.; Holtzman, David M.			Three dimensions of the amyloid hypothesis: time, space and 'wingmen'	NATURE NEUROSCIENCE			English	Article							TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; A-BETA; PRECURSOR PROTEIN; APOLIPOPROTEIN-E; ALPHA-SYNUCLEIN; NEUROFIBRILLARY TANGLES; CEREBROSPINAL-FLUID; GAMMA-SECRETASE; NEURONAL LOSS	The amyloid hypothesis, which has been the predominant framework for research in Alzheimer's disease (AD), has been the source of considerable controversy. The amyloid hypothesis postulates that amyloid-beta peptide (A beta) is the causative agent in AD. It is strongly supported by data from rare autosomal dominant forms of AD. However, the evidence that A beta causes or contributes to age-associated sporadic AD is more complex and less clear, prompting criticism of the hypothesis. We provide an overview of the major arguments for and against the amyloid hypothesis. We conclude that A beta likely is the key initiator of a complex pathogenic cascade that causes AD. However, we argue that Ab acts primarily as a trigger of other downstream processes, particularly tau aggregation, which mediate neurodegeneration. A beta appears to be necessary, but not sufficient, to cause AD. Its major pathogenic effects may occur very early in the disease process.	[Holtzman, David M.] Washington Univ, Sch Med, Dept Neurol, Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Holtzman, DM (corresponding author), Washington Univ, Sch Med, Dept Neurol, Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA.	holtzman@neuro.wustl.edu		Musiek, Erik/0000-0002-8873-0360	NINDS [K08NS079405]; Alzheimer's Association [NIRG-305476]; NIH [R01 NS090934, R01 AG047644, P01 NS074969, P01 NS080675, PO1-AG03991, R01 NS034467, P01-AG026276, U01 AG032438]; Tau Consortium; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS079405, R01NS090934, P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, R01AG047644, U01AG032438, P01AG026276] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Association(Alzheimer's Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tau Consortium; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	E.S.M. is supported by NINDS grant K08NS079405 and Alzheimer's Association grant NIRG-305476. D.M.H. is supported by NIH grants R01 NS090934, R01 AG047644, P01 NS074969, P01 NS080675, PO1-AG03991, R01 NS034467, P01-AG026276, and U01 AG032438 and from the Tau Consortium and Cure Alzheimer's Fund.	[Anonymous], [No title captured], DOI DOI 10.1111/ENE.12398; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Berger-Sweeney J, 1999, MOL BRAIN RES, V66, P150, DOI 10.1016/S0169-328X(99)00014-5; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; Bien-Ly N, 2012, J NEUROSCI, V32, P4803, DOI 10.1523/JNEUROSCI.0033-12.2012; Boche D, 2010, ACTA NEUROPATHOL, V120, P13, DOI 10.1007/s00401-010-0705-y; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Chetelat G, 2012, NEUROLOGY, V78, P477, DOI 10.1212/WNL.0b013e318246d67a; Chiang GC, 2010, NEUROLOGY, V75, P1976, DOI 10.1212/WNL.0b013e3181ffe4d1; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dasuri K, 2013, FREE RADICAL BIO MED, V62, P170, DOI 10.1016/j.freeradbiomed.2012.09.016; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Donohue MC, 2014, JAMA NEUROL, V71, P961, DOI 10.1001/jamaneurol.2014.803; Durazzo TC, 2014, ALZHEIMERS DEMENT, V10, pS122, DOI 10.1016/j.jalz.2014.04.009; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; Elobeid A, 2012, ACTA NEUROPATHOL, V123, P97, DOI 10.1007/s00401-011-0906-z; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Fagan AM, 2002, NEUROBIOL DIS, V9, P305, DOI 10.1006/nbdi.2002.0483; Ferreira A, 1997, MOL CELL NEUROSCI, V9, P220, DOI 10.1006/mcne.1997.0615; Gao YH, 2001, P NATL ACAD SCI USA, V98, P14979, DOI 10.1073/pnas.261463298; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Guix FX, 2012, EMBO MOL MED, V4, P660, DOI 10.1002/emmm.201200243; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Haass C, 2010, CELL, V142, P356, DOI 10.1016/j.cell.2010.07.032; Handoko M, 2013, JAMA NEUROL, V70, P594, DOI 10.1001/jamaneurol.2013.48; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Head E, 2001, NEUROBIOL DIS, V8, P792, DOI 10.1006/nbdi.2001.0431; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hudry E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007000; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2011, ARCH NEUROL-CHICAGO, V68, P1526, DOI 10.1001/archneurol.2011.183; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kauwe JSK, 2008, P NATL ACAD SCI USA, V105, P8050, DOI 10.1073/pnas.0801227105; Kim J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-15; Kim J, 2012, J EXP MED, V209, P2149, DOI 10.1084/jem.20121274; Kim J, 2011, J NEUROSCI, V31, P18007, DOI 10.1523/JNEUROSCI.3773-11.2011; Knopman DS, 2012, NEUROLOGY, V78, P1576, DOI 10.1212/WNL.0b013e3182563bbe; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kukreja L, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-16; Larson ME, 2012, J NEUROSCI, V32, P10253, DOI 10.1523/JNEUROSCI.0581-12.2012; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lindquist SG, 2008, EUR J NEUROL, V15, P377, DOI 10.1111/j.1468-1331.2008.02069.x; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Liu Y, 2014, J NEUROSCI, V34, P12982, DOI 10.1523/JNEUROSCI.1348-14.2014; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Melnikova T, 2013, J NEUROSCI, V33, P3765, DOI 10.1523/JNEUROSCI.4251-12.2013; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Mills SM, 2013, REV NEUROL-FRANCE, V169, P737, DOI 10.1016/j.neurol.2013.07.017; Moreno-Gonzalez I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2494; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Petersen RC, 2006, ARCH NEUROL-CHICAGO, V63, P665, DOI 10.1001/archneur.63.5.665; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Reed LA, 1997, ANN NEUROL, V42, P564, DOI 10.1002/ana.410420406; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Roe CM, 2013, NEUROLOGY, V80, P1784, DOI 10.1212/WNL.0b013e3182918ca6; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Ryman DC, 2014, NEUROLOGY, V83, P253, DOI 10.1212/WNL.0000000000000596; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Serrano-Pozo A, 2010, BRAIN, V133, P1312, DOI 10.1093/brain/awq056; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shepherd C, 2009, ACTA NEUROPATHOL, V118, P37, DOI 10.1007/s00401-009-0521-4; Siegel SJ, 2007, BIOCHEMISTRY-US, V46, P1503, DOI 10.1021/bi061853s; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1093/brain/awl203; Sunderland T, 2004, BIOL PSYCHIAT, V56, P670, DOI 10.1016/j.biopsych.2004.07.021; Tarawneh R, 2011, ANN NEUROL, V70, P274, DOI 10.1002/ana.22448; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6; Ulrich JD, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-20; Vellas B, 2009, CURR ALZHEIMER RES, V6, P144, DOI 10.2174/156720509787602852; Vemuri P, 2010, ANN NEUROL, V67, P308, DOI 10.1002/ana.21953; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Vos SJB, 2013, LANCET NEUROL, V12, P957, DOI 10.1016/S1474-4422(13)70194-7; Wahlster L, 2013, ACTA NEUROPATHOL, V125, P187, DOI 10.1007/s00401-012-1065-6; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zempel H, 2010, J NEUROSCI, V30, P11938, DOI 10.1523/JNEUROSCI.2357-10.2010; Zhang YG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105725, 10.1371/journal.pone.0109159, 10.1371/journal.pone.0093458, 10.1371/journal.pone.0088491]; Zhang ZT, 2014, NAT MED, V20, P1254, DOI 10.1038/nm.3700; Zhao W, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00210; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	134	445	465	8	173	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2015	18	6					800	806		10.1038/nn.4018	http://dx.doi.org/10.1038/nn.4018			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CJ1CB	26007213	Green Accepted			2022-12-17	WOS:000355218300007
J	Inagaki, N; Chihara, K; Arimura, N; Menager, C; Kawano, Y; Matsuo, N; Nishimura, T; Amano, M; Kaibuchi, K				Inagaki, N; Chihara, K; Arimura, N; Menager, C; Kawano, Y; Matsuo, N; Nishimura, T; Amano, M; Kaibuchi, K			CRMP-2 induces axons in cultured hippocampal neurons	NATURE NEUROSCIENCE			English	Article							GROWTH CONE COLLAPSE; POLARITY; RHO; UNC-33		Nara Inst Sci & Technol, Div Signal Transduct, Nara 6300101, Japan; JST, PRESTO, Recognit & Format, Kumamoto 8600012, Japan; Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4668550, Japan	Nara Institute of Science & Technology; Japan Science & Technology Agency (JST); Nagoya University	Kaibuchi, K (corresponding author), Nara Inst Sci & Technol, Div Signal Transduct, Nara 6300101, Japan.		Amano, Mutsuki/M-4820-2014; Nishimura, Takashi/AAQ-9299-2020; Kawano, Yoji/C-7484-2011; Nishimura, Takashi/D-7672-2017	Amano, Mutsuki/0000-0002-0662-1524; Nishimura, Takashi/0000-0002-6773-0302; Kawano, Yoji/0000-0003-0687-2777; Nishimura, Takashi/0000-0002-6773-0302; Inagaki, Naoyuki/0000-0002-2664-9196				Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Byk T, 1998, EUR J BIOCHEM, V254, P14, DOI 10.1046/j.1432-1327.1998.2540014.x; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Esch T, 1999, J NEUROSCI, V19, P6417; Goshima Y, 1999, J NEUROBIOL, V39, P579, DOI 10.1002/(SICI)1097-4695(19990615)39:4<579::AID-NEU11>3.0.CO;2-9; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; LINDA H, 1985, BRAIN RES, V358, P329, DOI 10.1016/0006-8993(85)90978-3; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1	15	445	458	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					781	782		10.1038/90476	http://dx.doi.org/10.1038/90476			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477421				2022-12-17	WOS:000170137300008
J	Hutchison, WD; Davis, KD; Lozano, AM; Tasker, RR; Dostrovsky, JO				Hutchison, WD; Davis, KD; Lozano, AM; Tasker, RR; Dostrovsky, JO			Pain-related neurons in the human cingulate cortex	NATURE NEUROSCIENCE			English	Article							HUMAN ANTERIOR CINGULATE; REGIONS		Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON M5S 2S8, Canada; Toronto Hosp, Res Inst, Toronto, ON M5S 2S8, Canada; Toronto Hosp, Western Div, Playfair Neurosci Unit, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Hutchison, WD (corresponding author), Univ Toronto, Dept Surg, Div Neurosurg, 399 Bathurst St,EW6-528, Toronto, ON M5S 2S8, Canada.	whutch@playfair.utoronto.ca	Lozano, Andres M/A-5058-2012; Tudusciuc, Oana/C-1339-2011	Lozano, Andres M./0000-0001-8257-3694; Hutchison, William/0000-0002-3866-4940	NINDS NIH HHS [NS36824] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036824] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; COGHILL RC, 1994, J NEUROSCI, V14, P4095; Craig AD, 1996, NATURE, V384, P258, DOI 10.1038/384258a0; Davis KD, 1997, J NEUROPHYSIOL, V77, P3370, DOI 10.1152/jn.1997.77.6.3370; Koyama T, 1998, NEUROREPORT, V9, P2663, DOI 10.1097/00001756-199808030-00044; Lenz FA, 1998, J NEUROPHYSIOL, V79, P2231, DOI 10.1152/jn.1998.79.4.2231; Lozano AM, 1995, ADV STER F, V11, P30; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; SIKES RW, 1992, J NEUROPHYSIOL, V68, P1720, DOI 10.1152/jn.1992.68.5.1720; Talairach I., 1988, COPLANAR STEREOTACTI; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Vogt BA, 1996, EUR J NEUROSCI, V8, P1461, DOI 10.1111/j.1460-9568.1996.tb01608.x	13	445	473	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	1999	2	5					403	405		10.1038/8065	http://dx.doi.org/10.1038/8065			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	271TK	10321241				2022-12-17	WOS:000084609400007
J	Riesenhuber, M; Poggio, T				Riesenhuber, Maximilian; Poggio, Tomaso			Models of object recognition	NATURE NEUROSCIENCE			English	Review								Understanding how biological visual systems recognize objects is one of the ultimate goals in computational neuroscience. From the computational viewpoint of learning, different recognition tasks, such as categorization and identification, are similar, representing different trade-offs between specificity and invariance. Thus, the different tasks do not require different classes of models. We briefly review some recent trends in computational vision and then focus on feedforward, view-based models that are supported by psychophysical and physiological data.	[Poggio, Tomaso] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Ctr Biol & Computat Learning, Cambridge, MA 02142 USA; MIT, Artificial Intelligence Lab, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Poggio, T (corresponding author), MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Ctr Biol & Computat Learning, Cambridge, MA 02142 USA.	tp@ai.mit.edu		Riesenhuber, Maximilian/0000-0002-5744-0408	ONR; DARPA; NSF; ATR; Honda; Merck/MIT; McDonnell Pcw award; Uncas and Helen Whitaker Chair at the Whitaker College, MIT	ONR(Office of Naval Research); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); ATR; Honda; Merck/MIT(Merck & Company); McDonnell Pcw award; Uncas and Helen Whitaker Chair at the Whitaker College, MIT	Supported by grants from ONR, DARPA, NSF, ATR, Honda, a Merck/MIT Fellowship in Bioinformatics, and a McDonnell Pcw award (M. R.). T. P. is supported by the Uncas and Helen Whitaker Chair at the Whitaker College, MIT. For comments and suggestions, we are grateful to Heinrich Bulthoff, Peter Dayan, Shimon Edelman, David Freedman, Christof Koch, Earl Miller, David Perrett, Pawan Sinha and Francis Crick (also for the picture in Fig. 3).	Amit Y, 1999, NEURAL COMPUT, V11, P1691, DOI 10.1162/089976699300016197; ANDERSON CH, 1987, P NATL ACAD SCI USA, V84, P6297, DOI 10.1073/pnas.84.17.6297; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BIEDERMAN I, 1993, J EXP PSYCHOL HUMAN, V19, P1162, DOI 10.1037/0096-1523.19.6.1162; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042, DOI 10.1109/34.254061; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Chelazzi L, 1998, J NEUROPHYSIOL, V80, P2918, DOI 10.1152/jn.1998.80.6.2918; CHEN S, 1995, 479 STANF U DEP STAT; EDELMAN S, 1995, BIOL CYBERN, V72, P207, DOI 10.1007/BF00201485; Edelman S., 1999, REPRESENTATION RECOG; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; FUKUSHIMA K, 1980, BIOL CYBERN, V36, P193, DOI 10.1007/BF00344251; GOCHIN PM, 1994, CEREB CORTEX, V4, P532, DOI 10.1093/cercor/4.5.532; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; HEISELE B, 2000, 1687 CBCL AI LAB; HINTON GE, 1995, SCIENCE, V268, P1158, DOI 10.1126/science.7761831; HUMMEL JE, 1992, PSYCHOL REV, V99, P480, DOI 10.1037/0033-295X.99.3.480; Hyvarinen A, 2000, NEURAL COMPUT, V12, P1705, DOI 10.1162/089976600300015312; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; LOGOTHETIS NK, 1994, CURR BIOL, V4, P401, DOI 10.1016/S0960-9822(00)00089-0; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; Mel BW, 1997, NEURAL COMPUT, V9, P777, DOI 10.1162/neco.1997.9.4.777; Miller EK, 1996, J NEUROSCI, V16, P5154; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MOHAN A, 1999, 1664 CBCL AI LAB; Moses Y, 1996, PERCEPTION, V25, P443, DOI 10.1068/p250443; MOTTER BC, 1994, J NEUROSCI, V14, P2190; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; OREN M, 1997, IEEE C COMP VIS PATT, P193; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; PERRETT DI, 1993, IMAGE VISION COMPUT, V11, P317, DOI 10.1016/0262-8856(93)90011-5; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Rao RPN, 1997, NEURAL COMPUT, V9, P721, DOI 10.1162/neco.1997.9.4.721; Riesenhuber M, 1999, NEURON, V24, P87, DOI 10.1016/S0896-6273(00)80824-7; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; RIESENHUBER M, 1999, 1679 CBCL MIT AI LAB; RIESENHUBER M, 2000, 1682 CBCL MIT AI LAB; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Schneiderman H, 1998, PROC CVPR IEEE, P45, DOI 10.1109/CVPR.1998.698586; SCHNEIDERMAN H, IEEE C COMP IN PRESS; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TARR MJ, 1995, J EXP PSYCHOL HUMAN, V21, P1494, DOI 10.1037/0096-1523.21.6.1494; Tarr MJ, 1998, NAT NEUROSCI, V1, P275, DOI 10.1038/1089; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Ullman S, 2000, LECT NOTES COMPUT SC, V1811, P73; Ullman S., 1996, HIGH LEVEL VISION OB; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; WEBER M, IEEE C COMP IN PRESS; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; [No title captured]	59	444	454	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2000	3	11		S			1199	1204		10.1038/81479	http://dx.doi.org/10.1038/81479			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V18OV	11127838				2022-12-17	WOS:000208015000017
J	Glasser, MF; Smith, SM; Marcus, DS; Andersson, JLR; Auerbach, EJ; Behrens, TEJ; Coalson, TS; Harms, MP; Jenkinson, M; Moeller, S; Robinson, EC; Sotiropoulos, SN; Xu, JQ; Yacoub, E; Ugurbil, K; Van Essen, DC				Glasser, Matthew F.; Smith, Stephen M.; Marcus, Daniel S.; Andersson, Jesper L. R.; Auerbach, Edward J.; Behrens, Timothy E. J.; Coalson, Timothy S.; Harms, Michael P.; Jenkinson, Mark; Moeller, Steen; Robinson, Emma C.; Sotiropoulos, Stamatios N.; Xu, Junqian; Yacoub, Essa; Ugurbil, Kamil; Van Essen, David C.			The Human Connectome Project's neuroimaging approach	NATURE NEUROSCIENCE			English	Review							HUMAN CEREBRAL-CORTEX; RESTING-STATE FMRI; INDEPENDENT COMPONENT ANALYSIS; MAGNETIC-RESONANCE IMAGES; GLOBAL SIGNAL REGRESSION; VIVO DIFFUSION MRI; VOGT-VOGT SCHOOL; END-TIDAL CO2; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY	Noninvasive human neuroimaging has yielded many discoveries about the brain. Numerous methodological advances have also occurred, though inertia has slowed their adoption. This paper presents an integrated approach to data acquisition, analysis and sharing that builds upon recent advances, particularly from the Human Connectome Project (HCP). The 'HCP-style' paradigm has seven core tenets: (i) collect multimodal imaging data from many subjects; (ii) acquire data at high spatial and temporal resolution; (iii) preprocess data to minimize distortions, blurring and temporal artifacts; (iv) represent data using the natural geometry of cortical and subcortical structures; (v) accurately align corresponding brain areas across subjects and studies; (vi) analyze data using neurobiologically accurate brain parcellations; and (vii) share published data via user-friendly databases. We illustrate the HCP-style paradigm using existing HCP data sets and provide guidance for future research. Widespread adoption of this paradigm should accelerate progress in understanding the brain in health and disease.	[Glasser, Matthew F.; Coalson, Timothy S.; Van Essen, David C.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63130 USA; [Smith, Stephen M.; Andersson, Jesper L. R.; Behrens, Timothy E. J.; Jenkinson, Mark; Sotiropoulos, Stamatios N.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, FMRIB Ctr, Oxford, England; [Marcus, Daniel S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Auerbach, Edward J.; Moeller, Steen; Yacoub, Essa; Ugurbil, Kamil] Univ Minnesota, Ctr Magnet Resonance Res CMRR, Minneapolis, MN USA; [Harms, Michael P.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Robinson, Emma C.] Imperial Coll London, Dept Comp, London, England; [Xu, Junqian] Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, New York, NY USA	Washington University (WUSTL); University of Oxford; Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); Imperial College London; Icahn School of Medicine at Mount Sinai	Glasser, MF; Van Essen, DC (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63130 USA.	glasserm@wustl.edu; vanessen@wustl.edu	Glasser, Matthew F./AAE-7291-2019; Jenkinson, Mark/AAC-8861-2019; Sotiropoulos, Stamatios/I-1163-2019; Ugurbil, Kamil/AAD-6058-2022; Xu, Junqian/D-2247-2009; Van Essen, David/ABA-8888-2020; Auerbach, Edward John/D-9980-2015; Yacoub, Essa/AAS-7757-2021	Jenkinson, Mark/0000-0001-6043-0166; Sotiropoulos, Stamatios/0000-0003-4735-5776; Xu, Junqian/0000-0001-8438-2066; Auerbach, Edward John/0000-0003-4553-1545; Harms, Michael/0000-0001-7945-036X; Robinson, Emma Claire/0000-0002-7886-3426; Smith, Stephen/0000-0001-8166-069X; Behrens, Timothy/0000-0003-0048-1177	Human Connectome Project, WU-Minn-Ox Consortium - 16 NIH Institutes and Centers [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; NIH [F30 MH097312, RO1 MH-60974, P41 EB015894]; Wellcome Trust [098369/Z/12/Z, 5R01EB009352, 5P30N5048056, 5R24MH108315]; Engineering and Physical Sciences Research Council [EP/L023067/1] Funding Source: researchfish; EPSRC [EP/L023067/1] Funding Source: UKRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894, R01EB009352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH108315, R01MH060974, U54MH091657, F30MH097312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048056] Funding Source: NIH RePORTER	Human Connectome Project, WU-Minn-Ox Consortium - 16 NIH Institutes and Centers; McDonnell Center for Systems Neuroscience at Washington University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the other investigators and staff members of the Human Connectome Project consortium for invaluable contributions to data acquisition, analysis and sharing. Additionally, we thank the many colleagues outside the HCP upon whose methodological contributions the paradigm espoused in this paper are also based. We thank S. Danker for assistance in manuscript preparation. Supported in part by the Human Connectome Project, WU-Minn-Ox Consortium (1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; the McDonnell Center for Systems Neuroscience at Washington University; and NIH F30 MH097312 (M.F.G.), RO1 MH-60974 (D.C.V.E.), P41 EB015894 (NIBIB; K.U.), Wellcome Trust 098369/Z/12/Z (S.M.S., J.L.R.A., T.E.J.B., M.J., E.C.R., S.N.S.), 5R01EB009352 (D.S.M.), 5P30N5048056 (D.S.M.) and 5R24MH108315 (D.S.M.).	Abdollahi RO, 2014, NEUROIMAGE, V99, P509, DOI 10.1016/j.neuroimage.2014.06.042; Amunts K, 2000, NEUROIMAGE, V11, P66, DOI 10.1006/nimg.1999.0516; Andersson J.L.R., 2016, NEUROIMAGE; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2015, NEUROIMAGE, V122, P166, DOI 10.1016/j.neuroimage.2015.07.067; Anticevic A, 2008, NEUROIMAGE, V41, P835, DOI 10.1016/j.neuroimage.2008.02.052; Auerbach EJ, 2013, MAGN RESON MED, V69, P1261, DOI 10.1002/mrm.24719; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Birn RM, 2012, NEUROIMAGE, V62, P864, DOI 10.1016/j.neuroimage.2012.01.016; Brewer AA, 2002, J NEUROSCI, V22, P10416; Brodmann K., 1909, VERGLEICHENDE LOKALI; Calabrese E, 2015, CEREB CORTEX, V25, P4628, DOI 10.1093/cercor/bhv121; Chang C, 2009, NEUROIMAGE, V47, P1381, DOI 10.1016/j.neuroimage.2009.04.048; Chen JYE, 2015, NEUROIMAGE, V107, P207, DOI 10.1016/j.neuroimage.2014.12.012; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Dalcanton JJ, 2009, NATURE, V457, P41, DOI 10.1038/nature07621; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; De Martino F, 2015, P NATL ACAD SCI USA, V112, P16036, DOI 10.1073/pnas.1507552112; De Martino F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2379; Donahue CJ, 2016, J NEUROSCI, V36, P6758, DOI 10.1523/JNEUROSCI.0493-16.2016; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 1999, II INFLATION FLATTEN, V207, P195, DOI DOI 10.1006/NIMG.1998.0396; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Frost MA, 2012, NEUROIMAGE, V59, P1369, DOI 10.1016/j.neuroimage.2011.08.035; Glasser M.F., 2016, NATURE; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Glasser MF, 2014, NEUROIMAGE, V93, P165, DOI 10.1016/j.neuroimage.2013.03.060; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Golestani AM, 2015, NEUROIMAGE, V104, P266, DOI 10.1016/j.neuroimage.2014.10.031; Gordon EM, 2016, CEREB CORTEX, V26, P288, DOI 10.1093/cercor/bhu239; Gotts SJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00356; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; Hawrylycz M, 2015, NAT NEUROSCI, V18, P1832, DOI 10.1038/nn.4171; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Hillman EMC, 2014, ANNU REV NEUROSCI, V37, P161, DOI 10.1146/annurev-neuro-071013-014111; Hodge MR, 2016, NEUROIMAGE, V124, P1102, DOI 10.1016/j.neuroimage.2015.04.046; Huang SY, 2015, NEUROIMAGE, V106, P464, DOI 10.1016/j.neuroimage.2014.12.008; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jbabdi S, 2015, NAT NEUROSCI, V18, P1546, DOI 10.1038/nn.4134; Jbabdi S, 2012, MAGN RESON MED, V68, P1846, DOI 10.1002/mrm.24204; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Kuhn T., 1962, STRUCTURE SCI REVOLU; Larson-Prior LJ, 2013, NEUROIMAGE, V80, P190, DOI 10.1016/j.neuroimage.2013.05.056; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Liewald D, 2014, BIOL CYBERN, V108, P541, DOI 10.1007/s00422-014-0626-2; Malikovic A, 2007, CEREB CORTEX, V17, P562, DOI 10.1093/cercor/bhj181; Marcus DS, 2007, NEUROINFORMATICS, V5, P11, DOI 10.1385/NI:5:1:11; Marcus DS, 2013, NEUROIMAGE, V80, P202, DOI 10.1016/j.neuroimage.2013.05.077; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Muckli L, 2015, CURR BIOL, V25, P2690, DOI 10.1016/j.cub.2015.08.057; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Nieuwenhuys R, 2015, BRAIN STRUCT FUNCT, V220, P2551, DOI 10.1007/s00429-014-0806-9; Nieuwenhuys R, 2013, BRAIN STRUCT FUNCT, V218, P303, DOI 10.1007/s00429-012-0460-z; Orban GA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00695; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Reveley C, 2015, P NATL ACAD SCI USA, V112, pE2820, DOI 10.1073/pnas.1418198112; Robinson EC, 2014, NEUROIMAGE, V100, P414, DOI 10.1016/j.neuroimage.2014.05.069; Saad ZS, 2013, BRAIN CONNECT, V3, P339, DOI 10.1089/brain.2013.0156; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Setsompop K, 2013, NEUROIMAGE, V80, P220, DOI 10.1016/j.neuroimage.2013.05.078; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Smith SM, 2015, NAT NEUROSCI, V18, P1565, DOI 10.1038/nn.4125; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith S, 2013, NEUROIMAGE, V80, P1, DOI 10.1016/j.neuroimage.2013.07.012; Sotiropoulos SN, 2016, NEUROIMAGE, V134, P396, DOI 10.1016/j.neuroimage.2016.04.014; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Tavor I, 2016, SCIENCE, V352, P216, DOI 10.1126/science.aad8127; Tucholka A, 2012, NEUROIMAGE, V63, P1443, DOI 10.1016/j.neuroimage.2012.06.019; Turner R, 2013, MICROSTRUCTURAL PARC, P179; Turner R, 2014, BRAIN CONNECT, V4, P547, DOI 10.1089/brain.2014.0261; Ugurbil K, 2013, NEUROIMAGE, V80, P80, DOI 10.1016/j.neuroimage.2013.05.012; Van Essen DC, 2012, NEUROIMAGE, V62, P1299, DOI 10.1016/j.neuroimage.2012.01.032; Van Essen D.C., 2016, NEUROIMAGE; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; VANESSEN DC, 1990, COLD SPRING HARB SYM, V55, P679; Vogt C, 1920, J PSYCHOL NEUROL, V25, P279; Vu AT, 2015, NEUROIMAGE, V122, P318, DOI 10.1016/j.neuroimage.2015.08.004; Wandell BA, 2011, VISION RES, V51, P718, DOI 10.1016/j.visres.2010.08.004; Wang DH, 2015, NAT NEUROSCI, V18, P1853, DOI 10.1038/nn.4164; Wang L, 2015, CEREB CORTEX, V25, P3911, DOI 10.1093/cercor/bhu277; Winkler AM, 2015, NEUROIMAGE, V123, P253, DOI 10.1016/j.neuroimage.2015.05.092; Xu JQ, 2013, NEUROIMAGE, V83, P991, DOI 10.1016/j.neuroimage.2013.07.055; Yeo BTT, 2014, NEUROIMAGE, V88, P212, DOI 10.1016/j.neuroimage.2013.10.046; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	115	443	450	8	155	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2016	19	9					1175	1187		10.1038/nn.4361	http://dx.doi.org/10.1038/nn.4361			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DU5SA	27571196	Green Accepted, Green Submitted			2022-12-17	WOS:000382270400013
J	Astafiev, SV; Stanley, CM; Shulman, GL; Corbetta, M				Astafiev, SV; Stanley, CM; Shulman, GL; Corbetta, M			Extrastriate body area in human occipital cortex responds to the performance of motor actions	NATURE NEUROSCIENCE			English	Article							NEURAL REPRESENTATION; SEPARATING PROCESSES; FUNCTIONAL MRI; VISUAL-CORTEX; EYE-MOVEMENTS; BRAIN; ACTIVATION; ATTENTION; NEURONS; ORGANIZATION	A region in human lateral occipital cortex (the 'extrastriate body area' or EBA) has been implicated in the perception of body parts. Here we report functional magnetic resonance imaging (fMRI) evidence that the EBA is strongly modulated by limb (arm, foot) movements to a visual target stimulus, even in the absence of visual feedback from the movement. Therefore, the EBA responds not only during the perception of other people's body parts, but also during goal-directed movements of the observer's body parts. In addition, both limb movements and saccades to a detected stimulus produced stronger signals than stimulus detection without motor movements ('covert detection') in the calcarine sulcus and lingual gyrus. These motor-related modulations cannot be explained by simple visual or attentional factors related to the target stimulus, and suggest a potentially widespread influence of actions on visual cortex.	Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Sch Med, Dept Radiol, 4525 Scott Ave, St Louis, MO 63110 USA.	mau@npg.wustl.edu	Corbetta, Maurizio/AAZ-5219-2020; Astafiev, Serguei/A-9734-2014	CORBETTA, MAURIZIO/0000-0001-8295-3304; Martin, Christine/0000-0003-0407-945X; Astafiev, Serguei/0000-0003-3736-7095	NEI NIH HHS [EY00379, EY001248] Funding Source: Medline; NINDS NIH HHS [5P50NS06833] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS006833] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Chelazzi L, 2000, NEW COGN NEUROSCI, P667; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Coslett HB, 1998, BRAIN COGNITION, V37, P527, DOI 10.1006/brcg.1998.1011; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; EVARTS EV, 1981, CAN J PHYSIOL PHARM, V59, P757, DOI 10.1139/y81-112; Falchier A, 2002, J NEUROSCI, V22, P5749; FISCHER B, 1981, EXP BRAIN RES, V43, P69; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; GOLDBERG ME, 1981, J NEUROPHYSIOL, V46, P773, DOI 10.1152/jn.1981.46.4.773; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; HALLIGAN PW, 1995, CORTEX, V31, P173, DOI 10.1016/S0010-9452(13)80115-3; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Jellema T, 2000, BRAIN COGNITION, V44, P280, DOI 10.1006/brcg.2000.1231; Macaluso E, 2002, NEURON, V34, P647, DOI 10.1016/S0896-6273(02)00678-5; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; MILLER EK, 1993, J NEUROSCI, V13, P1460; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Nakamura K, 2000, J NEUROPHYSIOL, V84, P677, DOI 10.1152/jn.2000.84.2.677; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; PERRETT DI, 1989, J EXP BIOL, V146, P87; Porro CA, 1996, J NEUROSCI, V16, P7688; Rinaman W.C., 1996, STANDARD MATH TABLES, V569-668; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Shulman GL, 1999, J NEUROSCI, V19, P9480; SPELKE E, 1994, COGNITION, V50, P431, DOI 10.1016/0010-0277(94)90039-6; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Talairach J., 1988, COPLANAR STEREOTAXIC; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Tootell RBH, 2003, J NEUROSCI, V23, P3981; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P745, DOI 10.1152/jn.1976.39.4.745; Wurtz RH, 2003, PROG BRAIN RES, V144, P47, DOI 10.1016/S0079-6123(03)14400-3	45	443	450	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2004	7	5					542	548		10.1038/nn1241	http://dx.doi.org/10.1038/nn1241			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	816HP	15107859				2022-12-17	WOS:000221101300032
J	Smith, SM; Nichols, TE; Vidaurre, D; Winkler, AM; Behrens, TEJ; Glasser, MF; Ugurbil, K; Barch, DM; Van Essen, DC; Miller, KL				Smith, Stephen M.; Nichols, Thomas E.; Vidaurre, Diego; Winkler, Anderson M.; Behrens, Timothy E. J.; Glasser, Matthew F.; Ugurbil, Kamil; Barch, Deanna M.; Van Essen, David C.; Miller, Karla L.			A positive-negative mode of population covariation links brain connectivity, demographics and behavior	NATURE NEUROSCIENCE			English	Article							INTELLIGENCE; CORTEX	We investigated the relationship between individual subjects' functional connectomes and 280 behavioral and demographic measures in a single holistic multivariate analysis relating imaging to non-imaging data from 461 subjects in the Human Connectome Project. We identified one strong mode of population co-variation: subjects were predominantly spread along a single 'positive-negative' axis linking lifestyle, demographic and psychometric measures to each other and to a specific pattern of brain connectivity.	[Smith, Stephen M.; Winkler, Anderson M.; Behrens, Timothy E. J.; Miller, Karla L.] Univ Oxford, Ctr Funct MRI Brain FMRIB, Oxford, England; [Nichols, Thomas E.] Univ Warwick, Dept Stat, Coventry CV4 7AL, W Midlands, England; [Nichols, Thomas E.] Univ Warwick, Warwick Mfg Grp, Coventry CV4 7AL, W Midlands, England; [Vidaurre, Diego] Univ Oxford, Ctr Human Brain Act OHBA, Oxford, England; [Glasser, Matthew F.; Barch, Deanna M.; Van Essen, David C.] Washington Univ, Sch Med, St Louis, MO USA; [Ugurbil, Kamil] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA	University of Oxford; University of Warwick; University of Warwick; University of Oxford; Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities	Smith, SM (corresponding author), Univ Oxford, Ctr Funct MRI Brain FMRIB, Oxford, England.	steve@fmrib.ox.ac.uk	Winkler, Anderson M/P-7773-2016; Glasser, Matthew F./AAE-7291-2019; Nichols, Thomas E./N-9902-2017; Van Essen, David/ABA-8888-2020; Ugurbil, Kamil/AAD-6058-2022	Winkler, Anderson M/0000-0002-4169-9781; Nichols, Thomas E./0000-0002-4516-5103; Behrens, Timothy/0000-0003-0048-1177; Smith, Stephen/0000-0001-8166-069X; Vidaurre, Diego/0000-0002-9650-2229; Miller, Karla/0000-0002-2511-3189	US National Institutes of Health [1U54MH091657, P30-NS057091, P41-RR08079/EB015894, F30-MH097312]; Wellcome Trust [098369/Z/12/Z, 091509/Z/10/Z]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH097312, U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/J005444/1] Funding Source: researchfish; Wellcome Trust [104765/Z/14/Z, 100309/A/12/Z] Funding Source: researchfish; EPSRC [EP/J005444/1] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank our many colleagues in the WU-Minn HCP Consortium for their invaluable contributions in generating the publicly available HCP data and implementing the procedures needed to acquire, analyze, visualize and share these data sets. We are grateful for funding from the US National Institutes of Health (grants 1U54MH091657, P30-NS057091, P41-RR08079/EB015894 and F30-MH097312) and the Wellcome Trust (grants 098369/Z/12/Z and 091509/Z/10/Z).	Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Clithero JA, 2014, SOC COGN AFFECT NEUR, V9, P1289, DOI 10.1093/scan/nst106; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Harrison SJ, 2015, NEUROIMAGE, V109, P217, DOI 10.1016/j.neuroimage.2015.01.013; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.2307/2333955; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Schacter DL, 2012, NEURON, V76, P677, DOI 10.1016/j.neuron.2012.11.001; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Thomson GH, 1916, BRIT J PSYCHOL, V8, P271, DOI 10.1111/j.2044-8295.1916.tb00133.x; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Winkler AM, 2015, NEUROIMAGE, V123, P253, DOI 10.1016/j.neuroimage.2015.05.092; Woolgar A, 2010, P NATL ACAD SCI USA, V107, P14899, DOI 10.1073/pnas.1007928107	17	442	446	3	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2015	18	11					1565	1567		10.1038/nn.4125	http://dx.doi.org/10.1038/nn.4125			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CU8YT	26414616	Green Submitted, Green Accepted			2022-12-17	WOS:000363830700011
J	Day, JJ; Roitman, MF; Wightman, RM; Carelli, RM				Day, Jeremy J.; Roitman, Mitchell F.; Wightman, R. Mark; Carelli, Regina M.			Associative learning mediates dynamic shifts in dopamine signaling in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							PAVLOVIAN APPROACH BEHAVIOR; VENTRAL TEGMENTAL AREA; NEURONS ENCODE; REWARD; RECEPTORS; RESPONSES; RELEASE; CORE; PERFORMANCE; STIMULI	The ability to predict favorable outcomes using environmental cues is an essential part of learned behavior. Dopamine neurons in the midbrain encode such stimulus-reward relationships in a manner consistent with contemporary learning models, but it is unclear how encoding this translates into actual dopamine release in target regions. Here, we sampled dopamine levels in the rat nucleus accumbens on a rapid (100 ms) timescale using electrochemical technology during a classical conditioning procedure. Early in conditioning, transient dopamine-release events signaled a primary reward, but not predictive cues. After repeated cue-reward pairings, dopamine signals shifted in time to predictive cue onset and were no longer observed at reward delivery. In the absence of stimulus-reward conditioning, there was no shift in the dopamine signal. Consistent with proposed roles in reward prediction and incentive salience, these results indicate that rapid dopamine release provides a reward signal that is dynamically modified by associative learning.	Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Carelli, RM (corresponding author), Univ N Carolina, Dept Psychol, CB 3270, Chapel Hill, NC 27599 USA.	rcarelli@unc.edu	Day, Jeremy/AAW-2464-2020	Day, Jeremy/0000-0002-7361-3399	NIDA NIH HHS [F31 DA021979-01, DA 10900, DA 017318, F31 DA021979, DA 021979, DA 018298] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA018298, R01DA010900, F31DA021979, R01DA017318] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bassareo V, 1997, J NEUROSCI, V17, P851; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Cardinal RN, 2002, BEHAV NEUROSCI, V116, P553, DOI 10.1037/0735-7044.116.4.553; Cepeda C, 1998, DEV NEUROSCI-BASEL, V20, P1, DOI 10.1159/000017294; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; Cragg SJ, 2003, J NEUROSCI, V23, P4378; Dalley JW, 2005, P NATL ACAD SCI USA, V102, P6189, DOI 10.1073/pnas.0502080102; Day JJ, 2006, EUR J NEUROSCI, V23, P1341, DOI 10.1111/j.1460-9568.2006.04654.x; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Eyny YS, 2003, J NEUROSCI, V23, P1584; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; MARGOLIS EB, 2006, J PHYSL, V15, P907; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Montague PR, 2004, J NEUROSCI, V24, P1754, DOI 10.1523/JNEUROSCI.4279-03.2004; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Pan WX, 2005, J NEUROSCI, V25, P4725, DOI 10.1523/JNEUROSCI.0277-05.2005; Parkinson JA, 2002, BEHAV BRAIN RES, V137, P149, DOI 10.1016/S0166-4328(02)00291-7; Parkinson JA, 1999, J NEUROSCI, V19, P2401; Paxinos G, 2005, RAT BRAIN STEREOTAXI, DOI 10.1016/c2009-0-63235-9; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Phillips PEM, 2003, METH MOLEC MED, V79, P443; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Setlow B, 2003, NEURON, V38, P625, DOI 10.1016/S0896-6273(03)00264-2; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Uslaner JM, 2006, BEHAV BRAIN RES, V169, P320, DOI 10.1016/j.bbr.2006.02.001; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Watson CJ, 2006, ANAL CHEM, V78, P1391, DOI 10.1021/ac0693722; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243	50	442	445	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2007	10	8					1020	1028		10.1038/nn1923	http://dx.doi.org/10.1038/nn1923			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	194PY	17603481				2022-12-17	WOS:000248357500016
J	Rohacs, T; Lopes, CMB; Michailidis, I; Logothetis, DE				Rohacs, T; Lopes, CMB; Michailidis, I; Logothetis, DE			PI(4,5)P-2 regulates the activation and desensitization of TRPM8 channels through the TRP domain	NATURE NEUROSCIENCE			English	Article							RECTIFYING K+ CHANNELS; INOSITOL 1,4,5-TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; STRUCTURAL DETERMINANTS; CAPSAICIN RECEPTOR; POTASSIUM CHANNELS; PIP2; INHIBITION; PHOSPHOINOSITIDES; IDENTIFICATION	The subjective feeling of cold is mediated by the activation of TRPM8 channels in thermoreceptive neurons by cold or by cooling agents such as menthol. Here, we demonstrate a central role for phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) in the activation of recombinant TRPM8 channels by both cold and menthol. Moreover, we show that Ca2+ influx through these channels activates a Ca2+-sensitive phospholipase C and that the subsequent depletion of PI(4,5)P-2 limits channel activity, serving as a unique mechanism for desensitization of TRPM8 channels. Finally, we find that mutation of conserved positive residues in the highly conserved proximal C-terminal TRP domain of TRPM8 and two other family members, TRPM5 and TRPV5, reduces the sensitivity of the channels for PI(4,5)P-2 and increases inhibition by PI(4,5)P-2 depletion. These data suggest that the TRP domain of these channels may serve as a PI(4,5)P-2-interacting site and that regulation by PI(4,5)P-2 is a common feature of members of the TRP channel family.	CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Rohacs, T (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07103 USA.	tibor.rohacs@umdnj.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL59949] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Cho H, 2001, J BIOL CHEM, V276, P159, DOI 10.1074/jbc.M004826200; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; Czirjak G, 2001, AM J PHYSIOL-CELL PH, V281, pC700, DOI 10.1152/ajpcell.2001.281.2.C700; DESMEDT F, 1994, FEBS LETT, V347, P69, DOI 10.1016/0014-5793(94)00509-5; Dodier Y, 2004, J BIOL CHEM, V279, P6853, DOI 10.1074/jbc.M310534200; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Luzzi V, 1998, J BIOL CHEM, V273, P28657, DOI 10.1074/jbc.273.44.28657; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.90.re1; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Ridefelt P, 1998, ANTICANCER RES, V18, P1819; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; SCHAFER K, 1982, J NEUROPHYSIOL, V47, P1017, DOI 10.1152/jn.1982.47.6.1017; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 2000, P NATL ACAD SCI USA, V97, P937, DOI 10.1073/pnas.97.2.937; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V282, pF826, DOI 10.1152/ajprenal.00300.2001; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	50	442	470	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2005	8	5					626	634		10.1038/nn1451	http://dx.doi.org/10.1038/nn1451			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	923FM	15852009				2022-12-17	WOS:000228895100023
J	Dean, C; Scholl, FG; Choih, J; DeMaria, S; Berger, J; Isacoff, E; Scheiffele, P				Dean, C; Scholl, FG; Choih, J; DeMaria, S; Berger, J; Isacoff, E; Scheiffele, P			Neurexin mediates the assembly of presynaptic terminals	NATURE NEUROSCIENCE			English	Article							ALPHA-LATROTOXIN RECEPTORS; ADHESION MOLECULE; TRANSMEMBRANE LIGANDS; CELL-ADHESION; EPH RECEPTORS; PROTEIN; SYNAPSE; ACETYLCHOLINESTERASE; PHOSPHORYLATION; NEUROLIGIN-1	Neurexins are a large family of proteins that act as neuronal cell-surface receptors. The function and localization of the various neurexins, however, have not yet been clarified. Beta-neurexins are candidate receptors for neuroligin-1, a postsynaptic membrane protein that can trigger synapse formation at axon contacts. Here we report that neurexins are concentrated at synapses and that purified neuroligin is sufficient to cluster neurexin and to induce presynaptic differentiation. Oligomerization of neuroligin is required for its function, and we find that beta-neurexin clustering is sufficient to trigger the recruitment of synaptic vesicles through interactions that require the cytoplasmic domain of neurexin. We propose a two-step model in which postsynaptic neuroligin multimers initially cluster axonal neurexins. In response to this clustering, neurexins nucleate the assembly of a cytoplasmic scaffold to which the exocytotic apparatus is recruited.	Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Columbia University; University of California System; University of California Berkeley	Scheiffele, P (corresponding author), Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.	ps2018@columbia.edu	isacoff, ehud/AAP-1459-2020; IBIS, NEUROGENETICA/P-2947-2015; Gomez Scholl, Francisco/K-7780-2018	Isacoff, Ehud Y./0000-0003-4775-9359; Gomez Scholl, Francisco/0000-0003-1762-0700	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060711] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH060711, R01MH60771] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; BON S, 1988, J NEUROCHEM, V51, P776, DOI 10.1111/j.1471-4159.1988.tb01812.x; Bourne Y, 1999, J BIOL CHEM, V274, P2963, DOI 10.1074/jbc.274.5.2963; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hata Y, 1996, J NEUROSCI, V16, P2488; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Kurschner C, 1998, MOL CELL NEUROSCI, V11, P161, DOI 10.1006/mcne.1998.0679; Littleton JT, 1997, J CELL BIOL, V137, P793, DOI 10.1083/jcb.137.4.793; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Russell AB, 1997, J NEUROSCI, V17, P4734; Sanchez R, 1997, PROTEINS, P50; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Sugita S, 1999, NEURON, V22, P489, DOI 10.1016/S0896-6273(00)80704-7; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tobaben S, 2002, J BIOL CHEM, V277, P6359, DOI 10.1074/jbc.M111231200; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	37	442	458	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					708	716		10.1038/nn1074	http://dx.doi.org/10.1038/nn1074			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	694NJ	12796785	Green Accepted			2022-12-17	WOS:000183780400018
J	Goldmann, T; Wieghofer, P; Muller, PF; Wolf, Y; Varol, D; Yona, S; Brendecke, SM; Kierdorf, K; Staszewski, O; Datta, M; Luedde, T; Heikenwalder, M; Jung, S; Prinz, M				Goldmann, Tobias; Wieghofer, Peter; Mueller, Philippe F.; Wolf, Yochai; Varol, Diana; Yona, Simon; Brendecke, Stefanie M.; Kierdorf, Katrin; Staszewski, Ori; Datta, Moumita; Luedde, Tom; Heikenwalder, Mathias; Jung, Steffen; Prinz, Marco			A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; ANTIGEN-PRESENTING CELLS; FRACTALKINE RECEPTOR; MYELOID CELLS; T-CELLS; ACTIVATION; MACROPHAGES; MONOCYTES; ENCEPHALOMYELITIS	Microglia are brain macrophages and, as such, key immune-competent cells that can respond to environmental changes. Understanding the mechanisms of microglia-specific responses during pathologies is hence vital for reducing disease burden. The definition of microglial functions has so far been hampered by the lack of genetic in vivo approaches that allow discrimination of microglia from closely related peripheral macrophage populations in the body. Here we introduce a mouse experimental system that specifically targets microglia to examine the role of a mitogen-associated protein kinase kinase kinase (MAP3K), transforming growth factor (TGF)-beta-activated kinase 1 (TAK1), during autoimmune inflammation. Conditional depletion of TAK1 in microglia only, not in neuroectodermal cells, suppressed disease, significantly reduced CNS inflammation and diminished axonal and myelin damage by cell-autonomous inhibition of the NE-kappa B, JNK and ERK1/2 pathways. Thus, we found TAK1 to be pivotal in CNS autoimmunity, and we present a tool for future investigations of microglial function in the CNS.	[Goldmann, Tobias; Wieghofer, Peter; Mueller, Philippe F.; Brendecke, Stefanie M.; Kierdorf, Katrin; Staszewski, Ori; Datta, Moumita; Prinz, Marco] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Wieghofer, Peter] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Wolf, Yochai; Varol, Diana; Yona, Simon; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Luedde, Tom] Univ Hosp Rhein Westfal TH Aachen, Dept Internal Med 3, Aachen, Germany; [Heikenwalder, Mathias] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-80290 Munich, Germany; [Prinz, Marco] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; Weizmann Institute of Science; RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Freiburg	Prinz, M (corresponding author), Univ Freiburg, Inst Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany.	s.jung@weizmann.ac.il; marco.prinz@uniklinik-freiburg.de	Kierdorf, Katrin/AAO-6288-2021; Yona, Simon/ABE-6572-2020; Heikenwalder, Mathias/AAA-2269-2020; Luedde, Tom/AAE-9135-2022; Datta, Moumita/AAU-8006-2021; Wieghofer, Peter/AAV-9572-2020; Jung, Steffen/K-1409-2012	Luedde, Tom/0000-0002-6288-8821; Jung, Steffen/0000-0003-4290-5716; Pohlmann, Philippe-Fabian/0000-0001-8578-7452; Wolf, Yochai/0000-0003-0270-2025; Staszewski, Ori/0000-0002-0579-6701; Kierdorf, Katrin/0000-0002-9272-4780; Yona, Simon/0000-0002-3984-2008; Goldmann, Tobias/0000-0001-9754-9144	Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft [SFB 992, FOR1336, PR 577/8-1]; Fritz-Thyssen Foundation; Gemeinnutzige Hertie Foundation (GHST); Biogen Idec; Helmholtz Foundation; European Research Council; Helmholtz Alliance Preclinical Comprehensive Cancer Center; Israel Science Foundation;  [SFB620];  [SFB-TR36]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz-Thyssen Foundation; Gemeinnutzige Hertie Foundation (GHST); Biogen Idec(Biogen); Helmholtz Foundation(Helmholtz Association); European Research Council(European Research Council (ERC)European Commission); Helmholtz Alliance Preclinical Comprehensive Cancer Center; Israel Science Foundation(Israel Science Foundation); ; 	We thank M. Oberle, C. Fix and S. Gaupp for excellent technical assistance. Special thanks to M. Olschewski for help with the thorough statistical analysis of our data. M.P. was supported by the Bundesministerium fur Bildung und Forschung-funded competence network of multiple sclerosis (KKNMS), the competence network of neurodegenerative disorders (KNDD), the Deutsche Forschungsgemeinschaft (SFB 992, FOR1336, PR 577/8-1), the Fritz-Thyssen Foundation, the Gemeinnutzige Hertie Foundation (GHST) and Biogen Idec. P.F.M. was supported by an MD educational grant of the SFB620. M.H. was funded by the Helmholtz Foundation, the SFB-TR36, a European Research Council starting grant and the Helmholtz Alliance Preclinical Comprehensive Cancer Center. S.J. was supported by the Deutsche Forschungsgemeinschaft (FOR1336) and by the Israel Science Foundation.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; DIGHE AS, 1995, IMMUNITY, V3, P657, DOI 10.1016/1074-7613(95)90136-1; Flugel A, 2001, J NEUROSCI RES, V66, P74, DOI 10.1002/jnr.1198; FORD AL, 1995, J IMMUNOL, V154, P4309; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kerschensteiner M, 2003, ANN NEUROL, V53, P292, DOI 10.1002/ana.10446; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kim KW, 2011, BLOOD, V118, pE156, DOI 10.1182/blood-2011-04-348946; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Matyszak MK, 1999, EUR J IMMUNOL, V29, P3063, DOI 10.1002/(SICI)1521-4141(199910)29:10<3063::AID-IMMU3063>3.0.CO;2-G; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pfrieger FW, 2012, GLIA, V60, P681, DOI 10.1002/glia.22283; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Raasch J, 2011, BRAIN, V134, P1184, DOI 10.1093/brain/awq359; Rajasekaran K, 2011, J BIOL CHEM, V286, P31213, DOI 10.1074/jbc.M111.261917; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schwartz M, 2001, J NEUROIMMUNOL, V113, P185, DOI 10.1016/S0165-5728(00)00447-1; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Siao CJ, 2003, J NEUROSCI, V23, P3234; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732, DOI 10.1002/jlb.56.6.732; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Wang YY, 2012, P NATL ACAD SCI USA, V109, pE343, DOI 10.1073/pnas.1115635109; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zehntner SP, 2003, FASEB J, V17, P1910, DOI 10.1096/fj.03-0199fje	47	440	444	5	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1618	1626		10.1038/nn.3531	http://dx.doi.org/10.1038/nn.3531			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24077561				2022-12-17	WOS:000326205700019
J	LaPlant, Q; Vialou, V; Covington, HE; Dumitriu, D; Feng, JA; Warren, BL; Maze, I; Dietz, DM; Watts, EL; Iniguez, SD; Koo, JW; Mouzon, E; Renthal, W; Hollis, F; Wang, H; Noonan, MA; Ren, YH; Eisch, AJ; Bolanos, CA; Kabbaj, M; Xiao, GH; Neve, RL; Hurd, YL; Oosting, RS; Fan, GP; Morrison, JH; Nestler, EJ				LaPlant, Quincey; Vialou, Vincent; Covington, Herbert E., III; Dumitriu, Dani; Feng, Jian; Warren, Brandon L.; Maze, Ian; Dietz, David M.; Watts, Emily L.; Iniguez, Sergio D.; Koo, Ja Wook; Mouzon, Ezekiell; Renthal, William; Hollis, Fiona; Wang, Hui; Noonan, Michele A.; Ren, Yanhua; Eisch, Amelia J.; Bolanos, Carlos A.; Kabbaj, Mohamed; Xiao, Guanghua; Neve, Rachael L.; Hurd, Yasmin L.; Oosting, Ronald S.; Fan, Gouping; Morrison, John H.; Nestler, Eric J.			Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens	NATURE NEUROSCIENCE			English	Article							COCAINE-INDUCED PLASTICITY; DENDRITIC SPINES; DNA METHYLATION; CHROMATIN REGULATION; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; IN-VIVO; NEURONS; INCREASES; REWARD	Despite abundant expression of DNA methyltransferases (Dnmts) in brain, the regulation and behavioral role of DNA methylation remain poorly understood. We found that Dnmt3a expression was regulated in mouse nucleus accumbens (NAc) by chronic cocaine use and chronic social defeat stress. Moreover, NAc-specific manipulations that block DNA methylation potentiated cocaine reward and exerted antidepressant-like effects, whereas NAc-specific Dnmt3a overexpression attenuated cocaine reward and was pro-depressant. On a cellular level, we found that chronic cocaine use selectively increased thin dendritic spines on NAc neurons and that DNA methylation was both necessary and sufficient to mediate these effects. These data establish the importance of Dnmt3a in the NAc in regulating cellular and behavioral plasticity to emotional stimuli.	[LaPlant, Quincey; Vialou, Vincent; Covington, Herbert E., III; Dumitriu, Dani; Feng, Jian; Warren, Brandon L.; Maze, Ian; Dietz, David M.; Watts, Emily L.; Iniguez, Sergio D.; Koo, Ja Wook; Mouzon, Ezekiell; Ren, Yanhua; Hurd, Yasmin L.; Oosting, Ronald S.; Morrison, John H.; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA; [LaPlant, Quincey; Renthal, William; Noonan, Michele A.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Warren, Brandon L.; Iniguez, Sergio D.; Bolanos, Carlos A.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Hollis, Fiona; Wang, Hui; Kabbaj, Mohamed] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Oosting, Ronald S.] Univ Utrecht, Dept Pharmacol, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Fan, Gouping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University System of Florida; Florida State University; State University System of Florida; Florida State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Utrecht University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY USA.	eric.nestler@mssm.edu	Iniguez, Sergio D/J-2410-2015; Dietz, David/AAW-4574-2021; feng, jian/G-9313-2011; Yan, Shuo/B-8381-2009; Dietz, David/J-9458-2015; Kabbaj, Mohamed/M-9240-2016; Maze, Ian/P-8077-2018; Morrison, John/F-9229-2012; vialou, vincent/F-2968-2013	Iniguez, Sergio D/0000-0001-5748-4219; Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; vialou, vincent/0000-0002-8212-751X; Hollis, Fiona/0000-0001-6559-5736; Dumitriu, Dani/0000-0002-7873-5192; Eisch, Amelia/0000-0001-6476-5385; Maze, Ian/0000-0003-1490-7781; Renthal, William/0000-0003-0206-2101	National Institute on Drug Abuse; National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA027592, R01DA014133, R21DA027592, P01DA008227] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Jaenisch for the generous gift of the Dnmt3a plasmid and W. G. Janssen for animal perfusions. We also thank A.J. Robison for helpful discussions and comments on the manuscript. This work was supported by grants from the National Institute on Drug Abuse and National Institute of Mental Health.	Azdad K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006908; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; CHRISTOFFELL D, SOC NEUR AB IN PRESS; Clark MS, 2002, J NEUROSCI, V22, P4550, DOI 10.1523/JNEUROSCI.22-11-04550.2002; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Dong E, 2008, P NATL ACAD SCI USA, V105, P13614, DOI 10.1073/pnas.0805493105; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Grimm JW, 2003, J NEUROSCI, V23, P742; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Huang YHH, 2009, NEURON, V63, P40, DOI 10.1016/j.neuron.2009.06.007; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kourrich S, 2007, J NEUROSCI, V27, P7921, DOI 10.1523/JNEUROSCI.1859-07.2007; Kourrich S, 2009, J NEUROSCI, V29, P12275, DOI 10.1523/JNEUROSCI.3028-09.2009; Krishnan V, 2008, BIOL PSYCHIAT, V64, P691, DOI 10.1016/j.biopsych.2008.06.003; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; Li YL, 2004, EUR J NEUROSCI, V20, P1647, DOI 10.1111/j.1460-9568.2004.03612.x; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Malvaez M, 2010, BIOL PSYCHIAT, V67, P36, DOI 10.1016/j.biopsych.2009.07.032; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Noonan MA, 2008, J NEUROSCI, V28, P2516, DOI 10.1523/JNEUROSCI.4661-07.2008; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Radley JJ, 2006, CEREB CORTEX, V16, P313, DOI 10.1093/cercor/bhi104; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Schroeder FA, 2008, NEUROPSYCHOPHARMACOL, V33, P2981, DOI 10.1038/npp.2008.15; Shen HW, 2009, J NEUROSCI, V29, P2876, DOI 10.1523/JNEUROSCI.5638-08.2009; Spano MS, 2007, BIOL PSYCHIAT, V61, P554, DOI 10.1016/j.biopsych.2006.03.073; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009	50	440	454	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2010	13	9					1137	U141		10.1038/nn.2619	http://dx.doi.org/10.1038/nn.2619			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	643XC	20729844	Green Accepted, Green Submitted			2022-12-17	WOS:000281332600020
J	Dechant, G; Barde, YA				Dechant, G; Barde, YA			The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system	NATURE NEUROSCIENCE			English	Review							NF-KAPPA-B; GROWTH-FACTOR RECEPTORS; AFFINITY NGF RECEPTOR; SCHWANN-CELL MIGRATION; P75 RECEPTOR; SYMPATHETIC NEURONS; DEATH DOMAIN; INTERACTING PROTEIN; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE	Neurotrophins have long been known to promote the survival and differentiation of vertebrate neurons. However, these growth factors can also induce cell death through the p75 neurotrophin receptor (p75(NTR)), a member of the tumor necrosis factor receptor superfamily. Consistent with a function in controlling the survival and process formation of neurons, p75(NTR) is mainly expressed during early neuronal development. In the adult, p75(NTR) is re-expressed in various pathological conditions, including epilepsy, axotomy and neurodegeneration. Potentially toxic peptides, including the amyloid beta- (Abeta-) peptide that accumulates in Alzheimer's disease, are ligands for p75(NTR). Recent work also implicates p75(NTR) in the regulation of both synaptic transmission and axonal elongation. It associates with the Nogo receptor, a binding protein for axonal growth inhibitors, and appears to be the transducing subunit of this receptor complex.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Friedrich Miescher Institute for Biomedical Research; Max Planck Society	Barde, YA (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.		Barde, Yves/F-6019-2011	Barde, Yves/0000-0002-7627-461X				Agerman K, 2000, MOL CELL NEUROSCI, V16, P258, DOI 10.1006/mcne.2000.0875; Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; ANTON ES, 1994, P NATL ACAD SCI USA, V91, P2795, DOI 10.1073/pnas.91.7.2795; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Barker PA, 1998, CELL DEATH DIFFER, V5, P346, DOI 10.1038/sj.cdd.4400375; Barker V, 2001, NAT NEUROSCI, V4, P1194, DOI 10.1038/nn755; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bentley CA, 2000, J NEUROSCI, V20, P7706; Benzel I, 2001, GENE, V281, P19, DOI 10.1016/S0378-1119(01)00730-2; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bilderback TR, 1997, J BIOL CHEM, V272, P10922; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brann AB, 1999, J NEUROSCI, V19, P8199; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Casaccia-Bonnefil P, 1998, CELL DEATH DIFFER, V5, P357, DOI 10.1038/sj.cdd.4400377; CASADEMUNT E, 1999, EMBO J, V18; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chittka A, 1999, P NATL ACAD SCI USA, V96, P10705, DOI 10.1073/pnas.96.19.10705; Chung JY, 2002, J CELL SCI, V115, P679; COLLINS F, 1984, J NEUROSCI, V4, P1281; Cosgaya JM, 2001, J NEUROCHEM, V79, P391, DOI 10.1046/j.1471-4159.2001.00573.x; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; DeFreitas MF, 2001, J NEUROSCI, V21, P5121, DOI 10.1523/JNEUROSCI.21-14-05121.2001; Della-Bianca V, 2001, J BIOL CHEM, V276, P38929, DOI 10.1074/jbc.M107454200; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Dobrowsky RT, 2000, J NEUROSCI RES, V61, P237, DOI 10.1002/1097-4547(20000801)61:3<237::AID-JNR1>3.0.CO;2-M; Dobrowsky RT, 1998, ANN NY ACAD SCI, V845, P32, DOI 10.1111/j.1749-6632.1998.tb09660.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Fainzilber M, 1996, SCIENCE, V274, P1540, DOI 10.1126/science.274.5292.1540; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Frade JM, 2000, TRENDS NEUROSCI, V23, P591, DOI 10.1016/S0166-2236(00)01704-5; Frade JM, 1998, BIOESSAYS, V20, P137, DOI 10.1002/(SICI)1521-1878(199802)20:2<137::AID-BIES6>3.0.CO;2-Q; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; FURSHPAN EJ, 1976, P NATL ACAD SCI USA, V73, P4225, DOI 10.1073/pnas.73.11.4225; GAGE FH, 1989, NEURON, V2, P1177, DOI 10.1016/0896-6273(89)90184-0; Gentry JJ, 2000, J BIOL CHEM, V275, P7558, DOI 10.1074/jbc.275.11.7558; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Greferath U, 2000, EUR J NEUROSCI, V12, P885, DOI 10.1046/j.1460-9568.2000.00976.x; Hamanoue M, 1999, MOL CELL NEUROSCI, V14, P28, DOI 10.1006/mcne.1999.0770; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Hempstead BL, 2002, CURR OPIN NEUROBIOL, V12, P260, DOI 10.1016/S0959-4388(02)00321-5; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Irie S, 1999, FEBS LETT, V460, P191, DOI 10.1016/S0014-5793(99)01324-1; JOHNSON EM, 1988, TRENDS NEUROSCI, V11, P299, DOI 10.1016/0166-2236(88)90090-2; Jordan BWM, 2001, J BIOL CHEM, V276, P39985, DOI 10.1074/jbc.C100171200; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Khursigara G, 2001, J NEUROSCI, V21, P5854, DOI 10.1523/JNEUROSCI.21-16-05854.2001; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Kokaia Z, 1998, NEUROSCIENCE, V84, P1113, DOI 10.1016/S0306-4522(97)00579-4; Kong HY, 2001, J NEUROSCI, V21, P176, DOI 10.1523/JNEUROSCI.21-01-00176.2001; Kuner P, 1998, J NEUROSCI RES, V54, P798, DOI 10.1002/(SICI)1097-4547(19981215)54:6<798::AID-JNR7>3.3.CO;2-K; LANGEVIN C, 2002, J BIOL CHEM; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, DEVELOPMENT, V120, P1027; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Lockhart ST, 1997, J NEUROSCI, V17, P9573; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lowry KS, 2001, AMYOTROPH LATERAL SC, V2, P127, DOI 10.1080/146608201753275463; Majdan M, 1997, J NEUROSCI, V17, P6988; Mamidipudi V, 2002, J BIOL CHEM, V277, P28010, DOI 10.1074/jbc.M109730200; McQuillen PS, 2002, J NEUROSCI, V22, P3580; MUFSON EJ, 1992, P NATL ACAD SCI USA, V89, P569, DOI 10.1073/pnas.89.2.569; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Naumann T, 2002, J NEUROSCI, V22, P2409, DOI 10.1523/JNEUROSCI.22-07-02409.2002; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Numakawa T, 1999, BRAIN RES, V842, P431, DOI 10.1016/S0006-8993(99)01867-3; Oh JD, 2000, BRAIN RES, V853, P174, DOI 10.1016/S0006-8993(99)02054-5; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Perini G, 2002, J EXP MED, V195, P907, DOI 10.1084/jem.20011797; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; RENDE M, 1993, J COMP NEUROL, V338, P560, DOI 10.1002/cne.903380406; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Sudhof TC, 2001, ANNU REV NEUROSCI, V24, P933, DOI 10.1146/annurev.neuro.24.1.933; Susen K, 1999, FEBS LETT, V463, P231, DOI 10.1016/S0014-5793(99)01628-2; Taglialatela G, 1997, J NEUROSCI RES, V47, P155; Thoenen H, 2000, PROG BRAIN RES, V128, P183; TROY CM, 2002, J BIOL CHEM; Tuffereau C, 1998, EMBO J, V17, P7250, DOI 10.1093/emboj/17.24.7250; VOLONTE C, 1993, J BIOL CHEM, V268, P21410; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Walsh GS, 1999, J NEUROSCI, V19, P4155; Wang JJL, 2000, J MOL NEUROSCI, V15, P19, DOI 10.1385/JMN:15:1:19; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; WANG KC, NATURE; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Wooten MW, 2001, J BIOL CHEM, V276, P7709, DOI 10.1074/jbc.C000869200; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yang B, 2002, NAT NEUROSCI, V5, P539, DOI 10.1038/nn853; Yang LJS, 1996, P NATL ACAD SCI USA, V93, P814, DOI 10.1073/pnas.93.2.814; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202; Yoon SO, 1998, J NEUROSCI, V18, P3273	103	440	463	1	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1131	1136		10.1038/nn1102-1131	http://dx.doi.org/10.1038/nn1102-1131			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12404007				2022-12-17	WOS:000178884600015
J	Ahmari, SE; Buchanan, J; Smith, SJ				Ahmari, SE; Buchanan, J; Smith, SJ			Assembly of presynaptic active zones from cytoplasmic transport packets	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; SYNAPTIC-LIKE MICROVESICLES; SECRETORY GRANULES; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; FINE-STRUCTURE; VESICLES; AXONS; SYNAPTOGENESIS; CELLS	Little is known about presynaptic assembly during central nervous system synaptogenesis. Here we used time-lapse fluorescence imaging, immunocytochemistry and electron microscopy to study hippocampal neuronal cultures transfected with a fusion construct of the presynaptic vesicle protein VAMP and green fluorescent protein. Our results suggest that major cytoplasmic and membrane-associated protein precursors of the presynaptic active zone are transported along developing axons together as discrete packets. Retrospective electron microscopy demonstrated varied vesicular and tubulovesicular membrane structures. Packets containing these heterogeneous structures were stabilized specifically at new sites of dendrite- and axon-initiated cell-cell contact; within less than one hour, evoked vesicle recycling was observed at these putative nascent synapses. These observations suggest that substantial membrane remodeling may be necessary to produce the uniform vesicles typical of the mature active zone, and that many presynaptic proteins may be united early in their biogenesis and sorting pathways.	Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Smith, SJ (corresponding author), Stanford Univ, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	sjsmith@leland.stanford.edu	Ahmari, Susanne E./J-5812-2013	Ahmari, Susanne E./0000-0003-4576-076X	NIGMS NIH HHS [GM07365] Funding Source: Medline; NIMH NIH HHS [MH48108] Funding Source: Medline; NINDS NIH HHS [NS28587] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028587] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; BUCHANAN J, 1989, J NEUROSCI, V9, P1540; Colman DR, 1997, MOL CELL NEUROSCI, V10, P1, DOI 10.1006/mcne.1997.0648; FLETCHER TL, 1994, J NEUROSCI, V14, P6695; Goslin K., 1998, CULTURING NERVE CELL, P339; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hagler DJ, 1998, NEURON, V20, P1059, DOI 10.1016/S0896-6273(00)80486-9; HOLTZMAN E, 1977, NEUROSCIENCE, V2, P327, DOI 10.1016/0306-4522(77)90001-X; JANETZKO A, 1989, NEUROSCIENCE, V32, P65, DOI 10.1016/0306-4522(89)90108-5; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; LIU Y, 1995, AM J HYPERTENS, V8, P404, DOI 10.1016/0895-7061(94)00205-P; LOWE AW, 1988, J CELL BIOL, V106, P51, DOI 10.1083/jcb.106.1.51; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; PAPINI E, 1995, J BIOL CHEM, V270, P1332, DOI 10.1074/jbc.270.3.1332; REGNIERVIGOUROUX A, 1991, EMBO J, V10, P3589, DOI 10.1002/j.1460-2075.1991.tb04925.x; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Salem N, 1998, NAT NEUROSCI, V1, P551, DOI 10.1038/2787; Smith SJ, 1999, SCIENCE, V283, P1860, DOI 10.1126/science.283.5409.1860; Stefani G, 1997, J PHYSIOL-LONDON, V504, P501, DOI 10.1111/j.1469-7793.1997.501bd.x; Strasser JE, 1999, MOL BIOL CELL, V10, P2619, DOI 10.1091/mbc.10.8.2619; TIXIERVIDAL A, 1988, NEUROSCIENCE, V26, P847, DOI 10.1016/0306-4522(88)90104-2; TSUKITA S, 1980, J CELL BIOL, V84, P513, DOI 10.1083/jcb.84.3.513; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; WINKLER H, 1987, ANN NY ACAD SCI, V493, P3, DOI 10.1111/j.1749-6632.1987.tb27176.x; Xia ZG, 1996, J NEUROSCI, V16, P5425; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	30	439	460	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					445	451		10.1038/74814	http://dx.doi.org/10.1038/74814			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	309DG	10769383				2022-12-17	WOS:000086752000012
J	Cossart, R; Dinocourt, C; Hirsch, JC; Merchan-Perez, A; De Felipe, J; Ben-Ari, Y; Esclapez, M; Bernard, C				Cossart, R; Dinocourt, C; Hirsch, JC; Merchan-Perez, A; De Felipe, J; Ben-Ari, Y; Esclapez, M; Bernard, C			Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy	NATURE NEUROSCIENCE			English	Article							TEMPORAL-LOBE EPILEPSY; GAMMA-AMINOBUTYRIC-ACID; CA1 PYRAMIDAL NEURONS; STRATUM-ORIENS-ALVEUS; RAT HIPPOCAMPUS; GLUTAMATE-DECARBOXYLASE; SELECTIVE LOSS; DENTATE GYRUS; 2 FORMS; POSTSYNAPTIC CURRENTS	Impaired inhibition is thought to be important in temporal lobe epilepsy (TLE), the most common form of epilepsy in adult patients. We report that, in experimental TLE, spontaneous GABAergic inhibition was increased in the soma but reduced in the dendrites of pyramidal neurons. The former resulted from the hyperactivity of somatic projecting interneurons, whereas the latter was probably due to the degeneration of a subpopulation of dendritic projecting interneurons. A deficit in dendritic inhibition could reduce seizure threshold, whereas enhanced somatic inhibition would prevent the continuous occurrence of epileptiform activity.	INSERM, U29, INMED, F-13273 Marseille 09, France; CSIC, Inst Cajal, E-28002 Madrid, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Ben-Ari, Y (corresponding author), INSERM, U29, INMED, Ave Luminy,BP 13, F-13273 Marseille 09, France.		Esclapez, Monique/O-6509-2016; DEFELIPE, JAVIER/D-1195-2014; Merchan-Perez, Angel/D-7417-2014; Cossart, Rosa/E-7674-2014; bernard, christophe/S-5937-2016; Merchan-Perez, Angel/AAY-8947-2020; bernard, christophe/A-4929-2012; Cossart, Rosa/AAT-7934-2020	Esclapez, Monique/0000-0002-8558-1363; DEFELIPE, JAVIER/0000-0001-5484-0660; Merchan-Perez, Angel/0000-0002-7228-5821; Cossart, Rosa/0000-0003-2111-6638; bernard, christophe/0000-0003-3014-1966; Merchan-Perez, Angel/0000-0002-7228-5821; bernard, christophe/0000-0003-3014-1966; Cossart, Rosa/0000-0003-2111-6638; Ben-Ari, Yehezkel/0000-0001-6208-8480				Buckmaster PS, 1999, J NEUROSCI, V19, P9519; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Chen K, 1999, NAT MED, V5, P888, DOI 10.1038/11330; Cohen I, 2000, J PHYSIOL-LONDON, V524, P485, DOI 10.1111/j.1469-7793.2000.00485.x; Cossart R, 2000, NEUROSCIENCE, V99, P593, DOI 10.1016/S0306-4522(00)00231-1; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Esclapez M, 1997, P NATL ACAD SCI USA, V94, P12151, DOI 10.1073/pnas.94.22.12151; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924, DOI 10.1152/jn.1997.77.4.1924; GOODMAN RH, 1982, J BIOL CHEM, V257, P1156; Hirsch JC, 1996, J NEUROPHYSIOL, V76, P4185, DOI 10.1152/jn.1996.76.6.4185; Hirsch JC, 1999, NAT NEUROSCI, V2, P499, DOI 10.1038/9142; Holmes WR, 1997, J NEUROPHYSIOL, V78, P103, DOI 10.1152/jn.1997.78.1.103; Houser C R, 1999, Adv Neurol, V79, P743; HOUSER CR, 1994, HIPPOCAMPUS, V4, P530, DOI 10.1002/hipo.450040503; Houser CR, 1996, EPILEPSY RES, V26, P207, DOI 10.1016/S0920-1211(96)00054-X; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Kapur A, 1997, J NEUROPHYSIOL, V78, P2546, DOI 10.1152/jn.1997.78.5.2546; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; KAUFMAN DL, 1986, SCIENCE, V232, P1138, DOI 10.1126/science.3518061; LACAILLE JC, 1990, NEUROSCIENCE, V36, P349, DOI 10.1016/0306-4522(90)90431-3; LIU Z, 1994, EPILEPSY RES, V17, P237; Loup F, 2000, J NEUROSCI, V20, P5401, DOI 10.1523/JNEUROSCI.20-14-05401.2000; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; MATHERN GW, 1995, J NEUROSCI, V15, P3990; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Morin F, 1998, EPILEPSY RES, V32, P363, DOI 10.1016/S0920-1211(98)00033-3; NADLER JV, 1981, LIFE SCI, V29, P2031; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; OBENAUS A, 1993, J NEUROSCI, V13, P4470; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; OTIS TS, 1994, P NATL ACAD SCI USA, V91, P7698, DOI 10.1073/pnas.91.16.7698; Perez Y, 1996, EUR J NEUROSCI, V8, P736, DOI 10.1111/j.1460-9568.1996.tb01259.x; Peters A, 1996, J NEUROCYTOL, V25, P687, DOI 10.1007/BF02284835; PRINCE DA, 1978, ANNU REV NEUROSCI, V1, P395, DOI 10.1146/annurev.ne.01.030178.002143; Prince DA, 1998, EPILEPSY RES, V32, P83, DOI 10.1016/S0920-1211(98)00042-4; PYAPALI GK, 1994, BRAIN RES, V652, P279, DOI 10.1016/0006-8993(94)90238-0; Rempe DA, 1997, J NEUROPHYSIOL, V78, P1504, DOI 10.1152/jn.1997.78.3.1504; ROBBINS RJ, 1991, ANN NEUROL, V29, P325, DOI 10.1002/ana.410290316; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; TOTH K, 1992, NEUROSCIENCE, V49, P793, DOI 10.1016/0306-4522(92)90357-8; Yanovsky Y, 1997, NEUROSCIENCE, V77, P87, DOI 10.1016/S0306-4522(96)00461-7	49	438	446	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2001	4	1					52	62		10.1038/82900	http://dx.doi.org/10.1038/82900			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UB	11135645				2022-12-17	WOS:000167178000014
J	Zanto, TP; Rubens, MT; Thangavel, A; Gazzaley, A				Zanto, Theodore P.; Rubens, Michael T.; Thangavel, Arul; Gazzaley, Adam			Causal role of the prefrontal cortex in top-down modulation of visual processing and working memory	NATURE NEUROSCIENCE			English	Article							FEATURE-BASED ATTENTION; SELECTIVE ATTENTION; SPATIAL ATTENTION; FUNCTIONAL CONNECTIVITY; EXTRASTRIATE CORTEX; COGNITIVE TASK; INFORMATION; SUPPRESSION; PERFORMANCE; BRAIN	Selective attention filters information to limit what is encoded and maintained in working memory. Although the prefrontal cortex (PFC) is central to both selective attention and working memory, the underlying neural processes that link these cognitive abilities remain elusive. Using functional magnetic resonance imaging to guide repetitive transcranial magnetic stimulation with electroencephalographic recordings in humans, we perturbed PFC function at the inferior frontal junction in participants before they performed a selective-attention, delayed-recognition task. This resulted in diminished top-down modulation of activity in posterior cortex during early encoding stages, which predicted a subsequent decrement in working memory accuracy. Participants with stronger fronto-posterior functional connectivity displayed greater disruptive effects. Our data further suggests that broad alpha-band (7-14 Hz) phase coherence subserved this long-distance top-down modulation. These results suggest that top-down modulation mediated by the prefrontal cortex is a causal link between early attentional processes and subsequent memory performance.	[Zanto, Theodore P.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol & Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zanto, TP (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	theodore.zanto@ucsf.edu; adam.gazzaley@ucsf.edu			US National Institutes of Health [1F32AG030249-01A2, 5R01AG030395]; NATIONAL INSTITUTE ON AGING [F32AG030249, R01AG030395] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank V. Barres and C. Gruson-Daniel for their assistance. This work was supported by US National Institutes of Health grants 1F32AG030249-01A2 (T.P.Z.) and 5R01AG030395 (A.G.).	AnlloVento L, 1996, PERCEPT PSYCHOPHYS, V58, P191, DOI 10.3758/BF03211875; Awh E, 2006, NEUROSCIENCE, V139, P201, DOI 10.1016/j.neuroscience.2005.08.023; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Baddeley Alan, 1986, WORKING MEMORY; Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Bollinger J, 2010, J NEUROSCI, V30, P14399, DOI 10.1523/JNEUROSCI.1547-10.2010; Brass M, 2004, J COGNITIVE NEUROSCI, V16, P609, DOI 10.1162/089892904323057335; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Derrfuss J, 2004, NEUROIMAGE, V23, P604, DOI 10.1016/j.neuroimage.2004.06.007; Desimone Robert, 1994, P75; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Fuggetta G, 2006, J NEUROPHYSIOL, V95, P3277, DOI 10.1152/jn.01273.2005; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Gazzaley A, 2008, P NATL ACAD SCI USA, V105, P13122, DOI 10.1073/pnas.0806074105; Gazzaley A, 2007, CEREB CORTEX, V17, pI125, DOI 10.1093/cercor/bhm113; Gazzaley Adam, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P580, DOI 10.3758/CABN.4.4.580; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Klimesch W, 2010, NEUROSCI BIOBEHAV R, V34, P1002, DOI 10.1016/j.neubiorev.2009.10.004; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Menendez RGD, 2004, NEUROIMAGE, V21, P527, DOI 10.1016/j.neuroimage.2003.09.051; Miller BT, 2011, J COGNITIVE NEUROSCI, V23, P1, DOI 10.1162/jocn.2010.21516; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Morishima Y, 2009, NAT NEUROSCI, V12, P85, DOI 10.1038/nn.2237; NAATANEN R, 1982, PSYCHOL BULL, V92, P605; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Ruff CC, 2008, CEREB CORTEX, V18, P817, DOI 10.1093/cercor/bhm128; Rutman AM, 2010, J COGNITIVE NEUROSCI, V22, P1224, DOI 10.1162/jocn.2009.21257; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schoenfeld MA, 2007, CEREB CORTEX, V17, P2468, DOI 10.1093/cercor/bhl154; Silver MA, 2009, TRENDS COGN SCI, V13, P488, DOI 10.1016/j.tics.2009.08.005; Taylor PCJ, 2007, CEREB CORTEX, V17, P391, DOI 10.1093/cercor/bhj156; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; UNGERLEIDER LG, 1989, EXP BRAIN RES, V76, P473, DOI 10.1007/BF00248903; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; Zanto TP, 2010, NEUROIMAGE, V53, P736, DOI 10.1016/j.neuroimage.2010.06.012; Zanto TP, 2010, NEUROPSYCHOLOGIA, V48, P13, DOI 10.1016/j.neuropsychologia.2009.08.003; Zanto TP, 2009, J NEUROSCI, V29, P3059, DOI 10.1523/JNEUROSCI.4621-08.2009; ZEKI S, 1991, J NEUROSCI, V11, P641; Zhang WW, 2009, NAT NEUROSCI, V12, P24, DOI 10.1038/nn.2223	50	437	443	7	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2011	14	5					656	U156		10.1038/nn.2773	http://dx.doi.org/10.1038/nn.2773			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	754VU	21441920	Green Accepted			2022-12-17	WOS:000289886600023
J	Lutter, M; Sakata, I; Osborne-Lawrence, S; Rovinsky, SA; Anderson, JG; Jung, S; Birnbaum, S; Yanagisawa, M; Elmquist, JK; Nestler, EJ; Zigman, JM				Lutter, Michael; Sakata, Ichiro; Osborne-Lawrence, Sherri; Rovinsky, Sherry A.; Anderson, Jason G.; Jung, Saendy; Birnbaum, Shari; Yanagisawa, Masashi; Elmquist, Joel K.; Nestler, Eric J.; Zigman, Jeffrey M.			The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress	NATURE NEUROSCIENCE			English	Article							OBESITY; MICE	We found that increasing ghrelin levels, through subcutaneous injections or calorie restriction, produced anxiolytic- and antidepressant-like responses in the elevated plus maze and forced swim test. Moreover, chronic social defeat stress, a rodent model of depression, persistently increased ghrelin levels, whereas growth hormone secretagogue receptor (Ghsr) null mice showed increased deleterious effects of chronic defeat. Together, these findings demonstrate a previously unknown function for ghrelin in defending against depressive-like symptoms of chronic stress.	[Sakata, Ichiro; Osborne-Lawrence, Sherri; Rovinsky, Sherry A.; Anderson, Jason G.; Elmquist, Joel K.; Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Lutter, Michael; Jung, Saendy; Birnbaum, Shari; Elmquist, Joel K.; Nestler, Eric J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Sakata, Ichiro; Osborne-Lawrence, Sherri; Rovinsky, Sherry A.; Anderson, Jason G.; Elmquist, Joel K.; Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Endocrinol & Metab, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zigman, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jeffrey.zigman@utsouthwestern.edu	Yan, Shuo/B-8381-2009; Sakata, Ichiro/F-9194-2012	Sakata, Ichiro/0000-0002-6067-0407; Zigman, Jeffrey/0000-0003-3477-1295	Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [RL1 DK081185-01, RL1 DK081185, RL1DK081185, K08DK068069-01A2, R01 DK071320, PL1 DK081182, P01 DK056116, K08 DK068069, R01DK71320, PL1 DK081182-01, P01DK56116] Funding Source: Medline; NIMH NIH HHS [P50 MH066172, P50MH66172] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056116, R01DK071320, PL1DK081182, RL1DK081185, K08DK068069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066172] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Asakawa A, 2001, NEUROENDOCRINOLOGY, V74, P143, DOI 10.1159/000054680; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Jimerson DC, 2004, CNS SPECTRUMS, V9, P516, DOI 10.1017/S1092852900009603; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Kristenssson E, 2006, REGUL PEPTIDES, V134, P114, DOI 10.1016/j.regpep.2006.02.003; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P155, DOI 10.1210/en.143.1.155; Lutter M, 2008, J NEUROSCI, V28, P3071, DOI 10.1523/JNEUROSCI.5584-07.2008; Mundinger TO, 2006, ENDOCRINOLOGY, V147, P2893, DOI 10.1210/en.2005-1182; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	12	437	457	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2008	11	7					752	753		10.1038/nn.2139	http://dx.doi.org/10.1038/nn.2139			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	318KD	18552842	Green Accepted			2022-12-17	WOS:000257089400011
J	Shen, Q; Wang, Y; Dimos, JT; Fasano, CA; Phoenix, TN; Lemischka, IR; Ivanova, NB; Stifani, S; Morrisey, EE; Temple, S				Shen, Qin; Wang, Yue; Dimos, John T.; Fasano, Christopher A.; Phoenix, Timothy N.; Lemischka, Ihor R.; Ivanova, Natalia B.; Stifani, Stefano; Morrisey, Edward E.; Temple, Sally			The timing of cortical neurogenesis is encoded within lineages of individual progenitor cells	NATURE NEUROSCIENCE			English	Article							DEVELOPING CEREBRAL-CORTEX; STEM-CELLS; CAENORHABDITIS-ELEGANS; NEURAL PROGENITORS; NEURONS ARISE; FERRET CORTEX; SELF-RENEWAL; ZONE CELLS; FATE; SPECIFICATION	In the developing cerebral cortex, neurons are born on a predictable schedule. Here we show in mice that the essential timing mechanism is programmed within individual progenitor cells, and its expression depends solely on cell-intrinsic and environmental factors generated within the clonal lineage. Multipotent progenitor cells undergo repeated asymmetric divisions, sequentially generating neurons in their normal in vivo order: first preplate cells, including Cajal-Retzius neurons, then deep and finally superficial cortical plate neurons. As each cortical layer arises, stem cells and neuroblasts become restricted from generating earlier-born neuron types. Growth as neurospheres or in co-culture with younger cells did not restore their plasticity. Using short-hairpin RNA (shRNA) to reduce Foxg1 expression reset the timing of mid- but not late-gestation progenitors, allowing them to remake preplate neurons and then cortical-plate neurons. Our data demonstrate that neural stem cells change neuropotency during development and have a window of plasticity when restrictions can be reversed.	Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; Princeton Univ, Dept Biol Mol, Princeton, NJ 08544 USA; McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Mol Cardiol Res Ctr, Philadelphia, PA 19104 USA	Albany Medical College; Princeton University; McGill University; University of Pennsylvania; University of Pennsylvania	Shen, Q (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	shenq@mail.amc.edu		Stifani, Stefano/0000-0002-2376-7701	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033529] Funding Source: NIH RePORTER; NINDS NIH HHS [R37NS033529] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Al-Kofahi O, 2006, CELL CYCLE, V5, P327, DOI 10.4161/cc.5.3.2426; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Bayer S.A., 1991, NEOCORTICAL DEV; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; Desai AR, 2000, DEVELOPMENT, V127, P2863; DOE CQ, 1993, TRENDS NEUROSCI, V16, P510, DOI 10.1016/0166-2236(93)90195-R; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Isshiki T, 2004, CELL CYCLE, V3, P296; Koop KE, 1996, MECH DEVELOP, V59, P73, DOI 10.1016/0925-4773(96)00582-5; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Morrow T, 2001, DEVELOPMENT, V128, P3585; Muzio L, 2005, J NEUROSCI, V25, P4435, DOI 10.1523/JNEUROSCI.4804-04.2005; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Polleux F, 1997, J COMP NEUROL, V385, P95; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Reid CB, 1997, DEVELOPMENT, V124, P2441; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shen Q, 1998, J NEUROBIOL, V36, P162, DOI 10.1002/(SICI)1097-4695(199808)36:2<162::AID-NEU5>3.0.CO;2-#; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Ware ML, 1999, CEREB CORTEX, V9, P636, DOI 10.1093/cercor/9.6.636; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yao J, 1998, DEV GROWTH DIFFER, V40, P133	46	436	450	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2006	9	6					743	751		10.1038/nn1694	http://dx.doi.org/10.1038/nn1694			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047RA	16680166				2022-12-17	WOS:000237895200014
J	Chaudhari, N; Landin, MA; Roper, SD				Chaudhari, N; Landin, MA; Roper, SD			A metabotropic glutamate receptor variant functions as a taste receptor	NATURE NEUROSCIENCE			English	Article							MONOSODIUM GLUTAMATE; BINDING-PROTEINS; ALPHA-SUBUNIT; RAT; BUDS; EXPRESSION; IDENTIFICATION; RESPONSES; GUSTDUCIN; PATTERNS	Sensory transduction for many taste stimuli such as sugars, some bitter compounds and amino acids is thought to be mediated via G protein-coupled receptors (GPCRs), although no such receptors that respond to taste stimuli are yet identified. Monosodium L-glutamate (L-MSG), a natural component of many foods, is an important gustatory stimulus believed to signal dietary protein. We describe a GPCR cloned from rat taste buds and functionally expressed in CHO cells. The receptor couples negatively to a cAMP cascade and shows an unusual concentration-response relationship. The similarity of its properties to MSG taste suggests that this receptor is a taste receptor for glutamate.	Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33101 USA; Univ Miami, Sch Med, Program Neurosci, Miami, FL 33101 USA	University of Miami; University of Miami	Chaudhari, N (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, POB 016430 R430, Miami, FL 33101 USA.			Roper, Stephen/0000-0001-6049-8320	NIDCD NIH HHS [DC 03013] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC003013] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABE K, 1993, J BIOL CHEM, V268, P12033; Bigiani A, 1997, J NEUROPHYSIOL, V77, P3048, DOI 10.1152/jn.1997.77.6.3048; Bradley SR, 1996, J NEUROSCI, V16, P2044; CAICEDO A, IN PRESS J COMP NEUR; Chaudhari N, 1998, ANN NY ACAD SCI, V855, P398, DOI 10.1111/j.1749-6632.1998.tb10598.x; Chaudhari N, 1996, J NEUROSCI, V16, P3817; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; DELAY ER, IN PRESS CHEM SENSES; FAURION A, 1991, PHYSIOL BEHAV, V49, P905, DOI 10.1016/0031-9384(91)90202-Y; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Han GM, 1999, J BIOL CHEM, V274, P10008, DOI 10.1074/jbc.274.15.10008; Hayashi Y, 1996, BIOPHYS J, V71, P1057, DOI 10.1016/S0006-3495(96)79306-2; Hettinger TP, 1996, CHEM SENSES, V21, P341, DOI 10.1093/chemse/21.3.341; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Kretz O, 1999, J HISTOCHEM CYTOCHEM, V47, P51, DOI 10.1177/002215549904700106; Kurihara K, 1998, ANN NY ACAD SCI, V855, P393, DOI 10.1111/j.1749-6632.1998.tb10597.x; Kusakabe Y, 1996, CHEM SENSES, V21, P335, DOI 10.1093/chemse/21.3.335; Kusakabe Y, 1998, BBA-MOL CELL RES, V1403, P265, DOI 10.1016/S0167-4889(98)00062-7; Lin WH, 1999, J COMP NEUROL, V405, P406, DOI 10.1002/(SICI)1096-9861(19990315)405:3<406::AID-CNE10>3.0.CO;2-F; Lin WH, 1999, J NEUROPHYSIOL, V82, P2061, DOI 10.1152/jn.1999.82.5.2061; Lindemann B, 1999, NAT MED, V5, P381, DOI 10.1038/7377; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; MATSUOKA I, 1993, BIOCHEM BIOPH RES CO, V194, P504, DOI 10.1006/bbrc.1993.1848; MCLAUGHLIN SK, 1994, PHYSIOL BEHAV, V56, P1157, DOI 10.1016/0031-9384(94)90360-3; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; Misaka T, 1997, J BIOL CHEM, V272, P22623, DOI 10.1074/jbc.272.36.22623; Monastyrskaia K, 1999, BRIT J PHARMACOL, V128, P1027, DOI 10.1038/sj.bjp.0702885; NINOMIYA Y, 1991, PHYSIOL BEHAV, V49, P913, DOI 10.1016/0031-9384(91)90203-Z; OGAWA S, 1998, NATURE, V395, P555; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; PIN JP, 1992, P NATL ACAD SCI USA, V89, P10331, DOI 10.1073/pnas.89.21.10331; RIFKIN B, 1980, PHYSIOL BEHAV, V24, P1169, DOI 10.1016/0031-9384(80)90066-9; Sako N, 1999, NEUROSCI LETT, V261, P109, DOI 10.1016/S0304-3940(99)00019-1; TAKAHASHI K, 1993, J BIOL CHEM, V268, P19341; TANABE Y, 1992, NEURON, V8, P169, DOI 10.1016/0896-6273(92)90118-W; TANABE Y, 1993, J NEUROSCI, V13, P1372; Thomsen C, 1997, NEUROPHARMACOLOGY, V36, P21, DOI 10.1016/S0028-3908(96)00153-0; TORII K, 1980, BIOCHIM BIOPHYS ACTA, V627, P313; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Yamaguchi S, 1998, J NEUROCHEM, V71, P60; YAMAMOTO T, 1991, PHYSIOL BEHAV, V49, P919, DOI 10.1016/0031-9384(91)90204-2; Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431, DOI 10.1177/002215549904700402	45	435	489	1	58	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2000	3	2					113	119		10.1038/72053	http://dx.doi.org/10.1038/72053			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	292TC	10649565				2022-12-17	WOS:000085810300007
J	Liu, J; Dietz, K; DeLoyht, JM; Pedre, X; Kelkar, D; Kaur, J; Vialou, V; Lobo, MK; Dietz, DM; Nestler, EJ; Dupree, J; Casaccia, P				Liu, Jia; Dietz, Karen; DeLoyht, Jacqueline M.; Pedre, Xiomara; Kelkar, Dipti; Kaur, Jasbir; Vialou, Vincent; Lobo, Mary Kay; Dietz, David M.; Nestler, Eric J.; Dupree, Jeffrey; Casaccia, Patrizia			Impaired adult myelination in the prefrontal cortex of socially isolated mice	NATURE NEUROSCIENCE			English	Article							WHITE-MATTER; DIFFERENTIATION; REMYELINATION	Protracted social isolation of adult mice induced behavioral, transcriptional and ultrastructural changes in oligodendrocytes of the prefrontal cortex (PFC) and impaired adult myelination. Social re-integration was sufficient to normalize behavioral and transcriptional changes. Short periods of isolation affected chromatin and myelin, but did not induce behavioral changes. Thus, myelinating oligodendrocytes in the adult PFC respond to social interaction with chromatin changes, suggesting that myelination acts as a form of adult plasticity.	[Liu, Jia; Dietz, Karen; Pedre, Xiomara; Kelkar, Dipti; Kaur, Jasbir; Vialou, Vincent; Lobo, Mary Kay; Dietz, David M.; Nestler, Eric J.; Casaccia, Patrizia] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Liu, Jia; Dietz, Karen; Pedre, Xiomara; Kelkar, Dipti; Kaur, Jasbir; Vialou, Vincent; Lobo, Mary Kay; Dietz, David M.; Nestler, Eric J.; Casaccia, Patrizia] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY USA; [DeLoyht, Jacqueline M.; Dupree, Jeffrey] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University	Casaccia, P (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY USA.	patrizia.casaccia@mssm.edu	Dietz, David/AAW-4574-2021; vialou, vincent/F-2968-2013; Liu, Jia/AAN-2112-2020; Dietz, David/J-9458-2015; Lobo, Mary Kay/K-7734-2015	Dietz, David/0000-0002-6927-9236; vialou, vincent/0000-0002-8212-751X; Liu, Jia/0000-0001-6274-2710; Dietz, David/0000-0002-6927-9236; Lobo, Mary Kay/0000-0002-9419-2079; Pedreiturria, Xiomara/0000-0002-3024-3826	US National Institutes of Health [R37-NS42925-10, P50-MH96890]; Center core grant [5P30NS047463]; National Multiple Sclerosis Society [FG1874-A-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS042925, P30NS047463] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center core grant; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Sharp, P. Garg and J. Huynh for help with statistical analysis and multiple correction tests. This work was funded by the US National Institutes of Health (R37-NS42925-10 to P. C. and P50-MH96890 to E.J.N.), a Center core grant to the Virginia Commonwealth University Microscopy Facility (5P30NS047463) and the National Multiple Sclerosis Society (FG1874-A-1 to J.L.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arnett PA, 2008, J INT NEUROPSYCH SOC, V14, P691, DOI 10.1017/S1355617708081174; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Chari DM, 2006, J NEUROSCI RES, V83, P594, DOI 10.1002/jnr.20763; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Kikusui T, 2007, BRAIN RES, V1133, P115, DOI 10.1016/j.brainres.2006.11.031; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Pillai AM, 2009, J NEUROSCI RES, V87, P1773, DOI 10.1002/jnr.22015; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Regenold WT, 2006, BIPOLAR DISORD, V8, P188, DOI 10.1111/j.1399-5618.2006.00281.x; Sexton CE, 2009, BIOL PSYCHIAT, V66, P814, DOI 10.1016/j.biopsych.2009.05.024; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shroff SM, 2009, J NEUROSCI RES, V87, P3403, DOI 10.1002/jnr.22003; Sokolov BP, 2007, INT J NEUROPSYCHOPH, V10, P547, DOI 10.1017/S1461145706007322; Wallace DL, 2009, NAT NEUROSCI, V12, P200, DOI 10.1038/nn.2257; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333	20	434	441	2	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2012	15	12					1621	+		10.1038/nn.3263	http://dx.doi.org/10.1038/nn.3263			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045OR	23143512	Green Accepted			2022-12-17	WOS:000311706700006
J	Tsao, DY; Freiwald, WA; Knutsen, TA; Mandeville, JB; Tootell, RBH				Tsao, DY; Freiwald, WA; Knutsen, TA; Mandeville, JB; Tootell, RBH			Faces and objects in macaque cerebral cortex	NATURE NEUROSCIENCE			English	Article							MONKEY INFEROTEMPORAL CORTEX; CONTRAST AGENT; RECOGNITION; FMRI; AREA; REPRESENTATION; SUBDIVISIONS; ORGANIZATION; SELECTIVITY; FEATURES	How are different object categories organized by the visual system? Current evidence indicates that monkeys and humans process object categories in fundamentally different ways. Functional magnetic resonance imaging (fMRI) studies suggest that humans have a ventral temporal face area, but such evidence is lacking in macaques. Instead, face-responsive neurons in macaques seem to be scattered throughout temporal cortex, with some relative concentration in the superior temporal sulcus (STS). Here, using fMRI in alert fixating macaque monkeys and humans, we found that macaques do have discrete face-selective patches, similar in relative size and number to face patches in humans. The face patches were embedded within a large swath of object-selective cortex extending from V4 to rostral TE. This large region responded better to pictures of intact objects compared to scrambled objects, with different object categories eliciting different patterns of activity, as in the human. Overall, our results suggest that humans and macaques share a similar brain architecture for visual object processing.	Athinoula A Martinos Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Bremen, Ctr Adv Imaging, Bremen, Germany; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Hanse Inst Adv Study, Delmenhorst, Germany; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; University of Bremen; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Tsao, DY (corresponding author), Athinoula A Martinos Ctr, Charlestown, MA 02129 USA.	doris@nmr.mgh.harvard.edu	Tudusciuc, Oana/C-1339-2011		Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [P41 RR014075, P41RR14075] Funding Source: Medline; NIBIB NIH HHS [R01 EB00790 A01, R01 EB000790] Funding Source: Medline; NIMH NIH HHS [R01 MH67529 A01, R01 MH067529] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067529] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLMAN JM, 1988, COMP PRIMATE BIOL, V4, P279; BAYLIS GC, 1987, J NEUROSCI, V7, P330; Biederman I., 1995, VIS COGN, P121; Cavanagh P, 1995, PERCEPTION, V24, P1227, DOI 10.1068/p241227; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Dubowitz DJ, 1998, NEUROREPORT, V9, P2213, DOI 10.1097/00001756-199807130-00012; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; Gauthier I, 2000, COGN NEUROPSYCHOL, V17, P125, DOI 10.1080/026432900380535; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Sakata H, 1998, PHILOS T ROY SOC B, V353, P1363, DOI 10.1098/rstb.1998.0290; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Tsunoda K, 2001, NAT NEUROSCI, V4, P832, DOI 10.1038/90547; TURK M, 1991, J COGNITIVE NEUROSCI, V1995, P71; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P549; Van Essen D. C., 2003, VISUAL NEUROSCIENCES; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665	39	434	442	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2003	6	9					989	995		10.1038/nn1111	http://dx.doi.org/10.1038/nn1111			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	715KH	12925854	Green Accepted			2022-12-17	WOS:000184970400019
J	Saenz, M; Buracas, GT; Boynton, GM				Saenz, M; Buracas, GT; Boynton, GM			Global effects of feature-based attention in human visual cortex	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; SPATIAL ATTENTION; AREA V4; MOTION; NEURONS; FIELD; BRAIN		Salk Inst Biol Studies, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Boynton, GM (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Buracas, Giedrius/A-4904-2011		NEI NIH HHS [EY12925] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012925] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Lee DK, 1999, PERCEPT PSYCHOPHYS, V61, P1241, DOI 10.3758/BF03206177; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; SERENO MI, 1994, CEREB CORTEX, V4, P601, DOI 10.1093/cercor/4.6.601; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Vandenberghe R, 1997, J NEUROSCI, V17, P3739; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79	15	434	441	4	31	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2002	5	7					631	632		10.1038/nn876	http://dx.doi.org/10.1038/nn876			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566EP	12068304				2022-12-17	WOS:000176414300011
J	Goto, Y; Grace, AA				Goto, Y; Grace, AA			Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior	NATURE NEUROSCIENCE			English	Article							SCHIZOPHRENIA; RECEPTOR; RAT; BINDING; SYSTEM; PATHOPHYSIOLOGY; HIPPOCAMPAL; PERFORMANCE; HYPOTHESIS; STRIATUM	Goal-directed behavior is believed to involve interactions of prefrontal cortical and limbic inputs in the nucleus accumbens (NAcc), and their modulation by mesolimbic dopamine (DA) seems to be of primary importance in NAcc function. Using in vivo electrophysiological recordings simultaneously with DA system manipulation in rats, we show that tonic and phasic DA release selectively modulates hippocampal and prefrontal cortical inputs through D1 and D2 receptors, respectively. In addition, we also found that D1 activation and D2 inactivation in the NAcc produced behaviorally selective effects ( learning versus set shifting of response strategy) that correspond to specific afferents. These results suggest that the dynamics of DA release regulate the balance between limbic and cortical drive through activation and inactivation of DA receptor subtypes in the accumbens, and this regulates goal-directed behavior.	Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychiat & Psychol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Goto, Y (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	goto@bns.pitt.edu		Grace, Anthony/0000-0003-1864-5504	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057440, R37MH057440] Funding Source: NIH RePORTER; NIMH NIH HHS [MH57440] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albertin SV, 2000, BEHAV BRAIN RES, V117, P173, DOI 10.1016/S0166-4328(00)00303-X; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Charara A, 2003, NEUROPSYCHOPHARMACOL, V28, P1412, DOI 10.1038/sj.npp.1300220; Christakou A, 2004, J NEUROSCI, V24, P773, DOI 10.1523/JNEUROSCI.0949-03.2004; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; CREESE I, 1983, ANNU REV NEUROSCI, V6, P43, DOI 10.1146/annurev.ne.06.030183.000355; Csernansky JG, 1998, SCHIZOPHRENIA BULL, V24, P231, DOI 10.1093/oxfordjournals.schbul.a033323; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Floresco SB, 1997, J NEUROSCI, V17, P1880; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Floresco SB, 1999, PSYCHOBIOLOGY, V27, P277; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; Goto Y, 2002, P NATL ACAD SCI USA, V99, P13189, DOI 10.1073/pnas.202303199; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Groenewegen HJ, 1999, ANN NY ACAD SCI, V877, P49, DOI 10.1111/j.1749-6632.1999.tb09260.x; Grunder G, 2003, ARCH GEN PSYCHIAT, V60, P974, DOI 10.1001/archpsyc.60.10.974; HALL H, 1985, EUR J PHARMACOL, V111, P191, DOI 10.1016/0014-2999(85)90756-3; Humeau Y, 2002, J NEUROSCI, V22, P7968; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kesner RP, 2004, NEUROBIOL LEARN MEM, V82, P199, DOI 10.1016/j.nlm.2004.05.007; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Phillips PEM, 2004, NAT NEUROSCI, V7, P199, DOI 10.1038/nn0304-199a; Ragozzino ME, 2002, BEHAV NEUROSCI, V116, P105, DOI 10.1037/0735-7044.116.1.105; ROBERTS AC, 1994, J NEUROSCI, V14, P2531; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; Swanson CJ, 1997, PHARMACOL BIOCHEM BE, V58, P933, DOI 10.1016/S0091-3057(97)00043-9; VOORN P, 1986, J COMP NEUROL, V251, P84, DOI 10.1002/cne.902510106; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495	34	433	439	1	46	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2005	8	6					805	812		10.1038/nn1471	http://dx.doi.org/10.1038/nn1471			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929KP	15908948				2022-12-17	WOS:000229345300022
J	Ding, N; Melloni, L; Zhang, H; Tian, X; Poeppel, D				Ding, Nai; Melloni, Lucia; Zhang, Hang; Tian, Xing; Poeppel, David			Cortical tracking of hierarchical linguistic structures in connected speech	NATURE NEUROSCIENCE			English	Article							HUMAN AUDITORY-CORTEX; LANGUAGE COMPREHENSION; BRAIN POTENTIALS; WORD-FREQUENCY; OSCILLATIONS; RESPONSES; REPRESENTATION; NEUROBIOLOGY; ENTRAINMENT; OPERATIONS	The most critical attribute of human language is its unbounded combinatorial nature: smaller elements can be combined into larger structures on the basis of a grammatical system, resulting in a hierarchy of linguistic units, such as words, phrases and sentences. Mentally parsing and representing such structures, however, poses challenges for speech comprehension. In speech, hierarchical linguistic structures do not have boundaries that are clearly defined by acoustic cues and must therefore be internally and incrementally constructed during comprehension. We found that, during listening to connected speech, cortical activity of different timescales concurrently tracked the time course of abstract linguistic structures at different hierarchical levels, such as words, phrases and sentences. Notably, the neural tracking of hierarchical linguistic structures was dissociated from the encoding of acoustic cues and from the predictability of incoming words. Our results indicate that a hierarchy of neural processing timescales underlies grammar-based internal construction of hierarchical linguistic structure.	[Ding, Nai; Tian, Xing; Poeppel, David] NYU, Dept Psychol, New York, NY 10003 USA; [Ding, Nai] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Melloni, Lucia] NYU, Langone Med Ctr, Dept Neurol, New York, NY 10003 USA; [Melloni, Lucia] Max Planck Inst Brain Res, Dept Neurophysiol, Frankfurt, Germany; [Melloni, Lucia] Columbia Univ, Dept Psychiat, New York, NY USA; [Zhang, Hang] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Zhang, Hang] Peking Univ, Beijing Key Lab Behav & Mental Hlth, Beijing 100871, Peoples R China; [Zhang, Hang] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China; [Zhang, Hang] Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Tian, Xing] New York Univ Shanghai, Shanghai, Peoples R China; [Tian, Xing] NYU Shanghai, NYU ECNU Inst Brain & Cognit Sci, Shanghai, Peoples R China; [Poeppel, David] Max Planck Inst Empir Aesthet, Neurosci Dept, Frankfurt, Germany	New York University; Zhejiang University; New York University; NYU Langone Medical Center; Max Planck Society; Columbia University; Peking University; Peking University; Peking University; NYU Shanghai; NYU Shanghai	Ding, N (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	ding_nai@zju.edu.cn; david.poeppel@nyu.edu		Melloni, Lucia/0000-0001-8743-5071	US National Institutes of Health [2R01DC05660]; Major Projects Program of the Shanghai Municipal Science and Technology Commission (STCSM) [15JC1400104]; National Natural Science Foundation of China [31500914]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005660] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Major Projects Program of the Shanghai Municipal Science and Technology Commission (STCSM); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J. Walker for MEG technical support, T. Thesen, W. Doyle and O. Devinsky for their instrumental help in collecting ECoG data, and G. Buzsaki, G. Cogan, S. Dehaene, A.-L. Giraud, G. Hickok, N. Hornstein, E. Lau, A. Marantz, N. Mesgarani, M. Pena, B. Pesaran, L. Pylkkanen, C. Schroeder, J. Simon and W. Singer for their comments on previous versions of the manuscript. This work supported by US National Institutes of Health grant 2R01DC05660 (D.P.) and Major Projects Program of the Shanghai Municipal Science and Technology Commission (STCSM) 15JC1400104 (X.T.) and National Natural Science Foundation of China 31500914 (X.T.).	Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Bastiaansen M, 2010, J COGNITIVE NEUROSCI, V22, P1333, DOI 10.1162/jocn.2009.21283; Bemis DK, 2013, CEREB CORTEX, V23, P1859, DOI 10.1093/cercor/bhs170; Bernacchia A, 2011, NAT NEUROSCI, V14, P366, DOI 10.1038/nn.2752; Berwick RC, 2013, TRENDS COGN SCI, V17, P89, DOI 10.1016/j.tics.2012.12.002; Buiatti M, 2009, NEUROIMAGE, V44, P509, DOI 10.1016/j.neuroimage.2008.09.015; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chomsky Noam, 1957, SYNTACTIC STRUCTURES; Cutler A, 1997, LANG SPEECH, V40, P141, DOI 10.1177/002383099704000203; de Cheveigne A, 2008, J NEUROSCI METH, V171, P331, DOI 10.1016/j.jneumeth.2008.03.015; de Cheveigne A, 2007, J NEUROSCI METH, V165, P297, DOI 10.1016/j.jneumeth.2007.06.003; Ding N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00311; Ding N, 2013, J NEUROSCI, V33, P5728, DOI 10.1523/JNEUROSCI.5297-12.2013; Ding N, 2012, P NATL ACAD SCI USA, V109, P11854, DOI 10.1073/pnas.1205381109; Ding N, 2012, J NEUROPHYSIOL, V107, P78, DOI 10.1152/jn.00297.2011; Efron B., 1993, INTRO BOOTSTRAP; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Frazier L, 2006, TRENDS COGN SCI, V10, P244, DOI 10.1016/j.tics.2006.04.002; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Golumbic EMZ, 2013, NEURON, V77, P980, DOI 10.1016/j.neuron.2012.12.037; Grodzinsky Y, 2006, CURR OPIN NEUROBIOL, V16, P240, DOI 10.1016/j.conb.2006.03.007; Gross J, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001752; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hagoort P, 2014, ANNU REV NEUROSCI, V37, P347, DOI 10.1146/annurev-neuro-071013-013847; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Jackendoff Ray, 2002, FDN LANGUAGE BRAIN M, P1; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Nozaradan S, 2011, J NEUROSCI, V31, P10234, DOI 10.1523/JNEUROSCI.0411-11.2011; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Peelle JE, 2013, CEREB CORTEX, V23, P1378, DOI 10.1093/cercor/bhs118; Pena M, 2002, SCIENCE, V298, P604, DOI 10.1126/science.1072901; Pena M, 2012, J COGNITIVE NEUROSCI, V24, P1149, DOI 10.1162/jocn_a_00144; Phillips C, 2003, LINGUIST INQ, V34, P37, DOI 10.1162/002438903763255922; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Ray S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000610; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sanders LD, 2002, NAT NEUROSCI, V5, P700, DOI 10.1038/nn873; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; VANPETTEN C, 1990, MEM COGNITION, V18, P380, DOI 10.3758/BF03197127; Wang YD, 2012, J NEUROPHYSIOL, V107, P2033, DOI 10.1152/jn.00310.2011; Yang AI, 2012, NEUROIMAGE, V63, P157, DOI 10.1016/j.neuroimage.2012.06.039	58	432	444	18	225	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2016	19	1					158	+		10.1038/nn.4186	http://dx.doi.org/10.1038/nn.4186			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CZ7BH	26642090	Green Accepted			2022-12-17	WOS:000367254400026
J	Nishida, A; Furukawa, A; Koike, C; Tano, Y; Aizawa, S; Matsuo, I; Furukawa, T				Nishida, A; Furukawa, A; Koike, C; Tano, Y; Aizawa, S; Matsuo, I; Furukawa, T			Otx2 homeobox gene controls retinal photoreceptor cell fate and pineal gland development	NATURE NEUROSCIENCE			English	Article							CONE-ROD DYSTROPHY; ANTERIOR NEUROECTODERM; CIRCADIAN ENTRAINMENT; HOMEODOMAIN PROTEIN; XENOPUS-RETINA; NEURAL RETINA; ROSTRAL BRAIN; MOUSE RETINA; BHLH GENES; CRX	Understanding the molecular mechanisms by which distinct cell fate is determined during organogenesis is a central issue in development and disease. Here, using conditional gene ablation in mice, we show that the transcription factor Otx2 is essential for retinal photoreceptor cell fate determination and development of the pineal gland. Otx2-deficiency converted differentiating photoreceptor cells to amacrine-like neurons and led to a total lack of pinealocytes in the pineal gland. We also found that Otx2 transactivates the cone-rod homeobox gene Crx, which is required for terminal differentiation and maintenance of photoreceptor cells. Furthermore, retroviral gene transfer of Otx2 steers retinal progenitor cells toward becoming photoreceptors. Thus, Otx2 is a key regulatory gene for the cell fate determination of retinal photoreceptor cells. Our results reveal the key molecular steps required for photoreceptor cell-fate determination and pinealocyte development.	Osaka Biosci Inst, Osaka 5650874, Japan; Osaka Univ, Sch Med, Dept Ophthalmol, Osaka 5650871, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama, Japan	Osaka University; RIKEN; Japan Science & Technology Agency (JST)	Furukawa, T (corresponding author), Osaka Biosci Inst, 6-2-4 Furuedai, Osaka 5650874, Japan.	furukawa@obi.or.jp		Matsuo, Isao/0000-0002-5916-6246; Koike, Chieko/0000-0002-1927-017X				ACAMPORA D, 1995, DEVELOPMENT, V121, P3279; Ang SL, 1996, DEVELOPMENT, V122, P243; Baas D, 2000, MOL BRAIN RES, V78, P26, DOI 10.1016/S0169-328X(00)00060-7; Blackshaw S, 1997, J NEUROSCI, V17, P8074; Bobola N, 1999, MECH DEVELOP, V82, P165, DOI 10.1016/S0925-4773(98)00162-2; Bovolenta P, 1997, J NEUROSCI, V17, P4243; Brown NL, 2001, DEVELOPMENT, V128, P2497; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Courtois V, 2003, J NEUROCHEM, V84, P840, DOI 10.1046/j.1471-4159.2003.01583.x; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Dyer MA, 2001, J COMP NEUROL, V429, P601; Ezzeddine ZD, 1997, DEVELOPMENT, V124, P1055; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa A, 2002, J NEUROSCI, V22, P1640, DOI 10.1523/JNEUROSCI.22-05-01640.2002; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Inoue T, 2002, DEVELOPMENT, V129, P831; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; LAIRD DW, 1988, INVEST OPHTH VIS SCI, V29, P419; Liu CT, 1998, CANCER GENE THER, V5, P3; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Morrow EM, 1999, DEVELOPMENT, V126, P23; Nothias F, 1998, CURR BIOL, V8, P459, DOI 10.1016/S0960-9822(98)70189-7; Plouhinec JL, 2003, MOL BIOL EVOL, V20, P513, DOI 10.1093/molbev/msg085; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; Tian E, 2002, DEV BIOL, V242, P204, DOI 10.1006/dbio.2001.0531; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Vandendries ER, 1996, DEV BIOL, V173, P243, DOI 10.1006/dbio.1996.0020; Viczian AS, 2003, DEVELOPMENT, V130, P1281, DOI 10.1242/dev.00343; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Yan RT, 1998, J NEUROBIOL, V36, P485	46	432	447	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1255	1263		10.1038/nn1155	http://dx.doi.org/10.1038/nn1155			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14625556				2022-12-17	WOS:000186725600009
J	Peretz, I; Coltheart, M				Peretz, I; Coltheart, M			Modularity of music processing	NATURE NEUROSCIENCE			English	Review							PURE WORD DEAFNESS; AUDITORY AGNOSIA; CONGENITAL AMUSIA; HEMISPHERE DAMAGE; DISSOCIATIONS; RECOGNITION; DISORDER; SCALE	The music faculty is not a monolithic entity that a person either has or does not. Rather, it comprises a set of neurally isolable processing components, each having the potential to be specialized for music. Here we propose a functional architecture for music processing that captures the typical properties of modular organization. The model rests essentially on the analysis of music-related deficits in neurologically impaired individuals, but provides useful guidelines for exploring the music faculty in normal people, using methods such as neuroimaging.	Univ Montreal, Montreal, PQ H3C 3J7, Canada; Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia	Universite de Montreal; Macquarie University	Peretz, I (corresponding author), Univ Montreal, Box 6128,Succ Centreville, Montreal, PQ H3C 3J7, Canada.			Coltheart, Max/0000-0002-6580-0047				Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Balzano G.J., 1982, MUSIC MIND BRAIN NEU, P321, DOI [10.1007/978-1-4684-8917-0_17, DOI 10.1007/978-1-4684-8917-0]; Bregman A. S., 1990, AUDITORY SCENE ANAL; Coltheart M, 1999, TRENDS COGN SCI, V3, P115, DOI 10.1016/S1364-6613(99)01289-9; Coltheart Max, 2001, HDB COGNITIVE NEUROP, P3; DALLABELLA S, IN PRESS ANN NY ACAD; Dowling WJ, 1982, PSYCHOL MUSIC, P413; Fodor J.A., 1983, MODULARITY MIND; Fodor JA, 2001, MIND DOESNT WORK WAY; GARDNER H, 1983, FRAMES MIND, P31; GODEFROY O, 1995, CORTEX, V31, P149, DOI 10.1016/S0010-9452(13)80113-X; Griffiths TD, 1997, BRAIN, V120, P785, DOI 10.1093/brain/120.5.785; Handel S., 1989, LISTENING INTRO PERC, DOI DOI 10.2307/898748; HEBERT S, IN PRESS BRAIN; Jackendoff R., 1987, CONSCIOUSNESS COMPUT; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; LAIGNELLAVASTIN.M, 1921, SOC NEUROLOGIE, V37, P194; Mendez MF, 2001, CORTEX, V37, P139, DOI 10.1016/S0010-9452(08)70563-X; METZLUTZ MN, 1984, BRAIN LANG, V23, P13, DOI 10.1016/0093-934X(84)90002-6; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Peretz I, 1997, CAN J EXP PSYCHOL, V51, P354, DOI 10.1037/1196-1961.51.4.354; PERETZ I, 1994, BRAIN, V117, P1283, DOI 10.1093/brain/117.6.1283; Peretz I, 2002, NEURON, V33, P185, DOI 10.1016/S0896-6273(01)00580-3; PERETZ I, 1993, COGNITIVE NEUROPSYCH, V10, P21, DOI 10.1080/02643299308253455; PERETZ I, 2001, MUSIC EMOTION THEORY, P105; Peretz I., 1989, CONTEMP MUSIC REV, V4, P277, DOI [10.1080/07494468900640361, DOI 10.1080/07494468900640361]; Peretz Isabelle, 2001, HDB COGNITIVE NEUROP, P519; Piccirilli M, 2000, J NEUROL NEUROSUR PS, V69, P541, DOI 10.1136/jnnp.69.4.541; SHEPARD RN, 1984, SCIENCE, V226, P1333, DOI 10.1126/science.226.4680.1333; Steinke WR, 2001, COGN NEUROPSYCHOL, V18, P411, DOI 10.1080/02643290125702; TAKAHASHI N, 1992, CORTEX, V28, P295, DOI 10.1016/S0010-9452(13)80056-1; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885; Trehub SE, 2003, NAT NEUROSCI, V6, P669, DOI 10.1038/nn1084; Trehub SE, 1999, J EXP PSYCHOL HUMAN, V25, P965, DOI 10.1037/0096-1523.25.4.965; WILSON SJ, 1999, MUSIC MED MUSIC THER, P47; YAQUB BA, 1988, BRAIN, V111, P457, DOI 10.1093/brain/111.2.457; Zatorre R., 2001, BIOL FDN MUSIC	39	432	450	2	72	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					688	691		10.1038/nn1083	http://dx.doi.org/10.1038/nn1083			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology	694NJ	12830160				2022-12-17	WOS:000183780400013
J	Figner, B; Knoch, D; Johnson, EJ; Krosch, AR; Lisanby, SH; Fehr, E; Weber, EU				Figner, Bernd; Knoch, Daria; Johnson, Eric J.; Krosch, Amy R.; Lisanby, Sarah H.; Fehr, Ernst; Weber, Elke U.			Lateral prefrontal cortex and self-control in intertemporal choice	NATURE NEUROSCIENCE			English	Article							REWARDS; IMMEDIATE	Disruption of function of left, but not right, lateral prefrontal cortex (LPFC) with low-frequency repetitive transcranial magnetic stimulation (rTMS) increased choices of immediate rewards over larger delayed rewards. rTMS did not change choices involving only delayed rewards or valuation judgments of immediate and delayed rewards, providing causal evidence for a neural lateral-prefrontal cortex-based self-control mechanism in intertemporal choice.	[Figner, Bernd; Johnson, Eric J.; Krosch, Amy R.; Weber, Elke U.] Columbia Univ, Ctr Decis Sci, New York, NY 10027 USA; [Figner, Bernd; Weber, Elke U.] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Knoch, Daria] Univ Basel, Dept Psychol, Basel, Switzerland; [Johnson, Eric J.; Weber, Elke U.] Columbia Univ, Grad Sch Business, New York, NY 10027 USA; [Krosch, Amy R.] NYU, Dept Psychol, New York, NY 10003 USA; [Lisanby, Sarah H.] Columbia Univ, Div Brain Stimulat & Therapeut Modulat, New York, NY USA; [Fehr, Ernst] Univ Zurich, Inst Empir Res Econ, Zurich, Switzerland	Columbia University; Columbia University; University of Basel; Columbia University; New York University; Columbia University; University of Zurich	Figner, B (corresponding author), Columbia Univ, Ctr Decis Sci, New York, NY 10027 USA.	bf2151@columbia.edu	Krosch, Amy/B-9175-2009; Knoch, Daria/H-7324-2012; Lisanby, Sarah Hollingsworth/T-3918-2019; Lisanby, Sarah Hollingsworth/ABE-9003-2020; Johnson, Eric/C-5668-2012	Lisanby, Sarah Hollingsworth/0000-0003-2037-6470; Lisanby, Sarah Hollingsworth/0000-0003-2037-6470; Johnson, Eric/0000-0001-7797-8347	Swiss National Science Foundation [PA001-15327, PBZH1-110268, PP00P1-123381]; US National Science Foundation [SES-0720932, SES-0922743]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Science Foundation(National Science Foundation (NSF))	We thank P. Glimcher, A. Rangel and T. Hare for valuable comments on an earlier draft of this manuscript. This research was supported by Swiss National Science Foundation fellowships (PA001-15327 and PBZH1-110268) to B.F., US National Science Foundation grants (SES-0720932 and SES-0922743) to B.F. and E.U.W. and a Swiss National Science Foundation grant (PP00P1-123381) to D. K.	Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Eisenegger C, 2008, NEUROIMAGE, V42, P379, DOI 10.1016/j.neuroimage.2008.04.172; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Knoch D, 2007, ANN NY ACAD SCI, V1104, P123, DOI 10.1196/annals.1390.004; Luo S, 2009, J NEUROSCI, V29, P14820, DOI 10.1523/JNEUROSCI.4261-09.2009; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167	9	431	466	9	158	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2010	13	5					538	539		10.1038/nn.2516	http://dx.doi.org/10.1038/nn.2516			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588JM	20348919	Green Accepted			2022-12-17	WOS:000277065700010
J	Chawla, D; Rees, G; Friston, KJ				Chawla, D; Rees, G; Friston, KJ			The physiological basis of attentional modulation in extrastriate visual areas	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; FUNCTIONAL-ANALYSIS; DIRECTED ATTENTION; HUMAN MT; CORTEX; FMRI; RESPONSES; PARIETAL; ANATOMY; NETWORK	Selective attention to color or motion enhances activity in specialized areas of extrastriate cortex, but mechanisms of attentional modulation remain unclear. By dissociating modulation of visually evoked transient activity from the baseline for a particular attentional set, human functional neuroimaging was used to investigate the physiological basis of such effects. Baseline activity in motion- and color-sensitive areas of extrastriate cortex was enhanced by selective attention to these attributes, even without moving or colored stimuli. Further, visually evoked responses increased along with baseline activity. These results are consistent with the hypothesis that attention modulates sensitivity of neuronal populations to inputs by changing background activity.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England	University of London; University College London	Chawla, D (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, Queen Sq, London WC1N 3BG, England.	dave@fil.ion.ucl.ac.uk	Friston, Karl/D-9230-2011; Rees, Geraint/C-1493-2008	Friston, Karl/0000-0001-7984-8909; Rees, Geraint/0000-0002-9623-7007	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Buckner RL, 1996, P NATL ACAD SCI USA, V93, P14878, DOI 10.1073/pnas.93.25.14878; Chawla D, 1999, NEURAL COMPUT, V11, P1389, DOI 10.1162/089976699300016287; Chawla D, 1998, NEUROIMAGE, V7, P86, DOI 10.1006/nimg.1997.0319; CHAWLA D, IN PRESS NEURAL COMP; CORBETTA M, 1991, J NEUROSCI, V11, P2383; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; FERRERA VP, 1994, J NEUROSCI, V14, P6171; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Mangun GR, 2014, COGNITIVE ELECTROPHYSIOLOGY OF ATTENTION: SIGNALS OF THE MIND, P1; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MORECRAFT RJ, 1993, ARCH NEUROL-CHICAGO, V50, P279, DOI 10.1001/archneur.1993.00540030045013; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Rees G, 1997, SCIENCE, V275, P835, DOI 10.1126/science.275.5301.835; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Talairach J., 1988, COPLANAR STEREOTAXIC; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; ZEKI S, 1991, J NEUROSCI, V11, P641	26	431	436	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	1999	2	7					671	676		10.1038/10230	http://dx.doi.org/10.1038/10230			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	259EY	10404202				2022-12-17	WOS:000083882600020
J	Fischer, AJ; Reh, TA				Fischer, AJ; Reh, TA			Muller glia are a potential source of neural regeneration in the postnatal chicken retina	NATURE NEUROSCIENCE			English	Article							NEURONAL PRODUCTION; H3 PHOSPHORYLATION; NERVOUS-SYSTEM; OKADAIC ACID; EYE GROWTH; ADULT; CELLS; INDUCTION; DIFFERENTIATION; PROLIFERATION	The retina of warm-blooded vertebrates is believed to be incapable of neural regeneration. Here we provide evidence that the retina of postnatal chickens has the potential to generate new neurons. In response to acute damage, numerous Muller glia re-entered the cell cycle, and shortly thereafter, expressed CASH-1, Pax6 and Chx10, transcription factors expressed by embryonic retinal progenitors. These progenitor-like cells transiently expressed neurofilament. Newly formed cells became distributed throughout the inner and outer nuclear layers of the retina, and remained for at least three weeks after damage. Some of these newly formed cells differentiated into retinal neurons, a few formed Muller glia, and most remained undifferentiated, with continued expression of Pax6 and Chx10. These cells continued to proliferate when grown in culture, with some differentiating into retinal neurons or Muller glia. We propose that, in response to damage, Muller glia in the retina are a potential source of neural regeneration.	Univ Washington, Hlth Sci Ctr, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Reh, TA (corresponding author), Univ Washington, Hlth Sci Ctr, Sch Med, Dept Biol Struct, POB 357420, Seattle, WA 98195 USA.	tomreh@u.washington.edu	Fischer, Andy J./AFF-1827-2022; Fischer, Andrew J/E-3061-2011; Fischer, Andy J./AAE-9817-2022	Fischer, Andy J./0000-0001-6123-7405; Fischer, Andy J./0000-0001-6123-7405	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028308] Funding Source: NIH RePORTER; NINDS NIH HHS [NS28308] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ajiro K, 1996, J BIOL CHEM, V271, P13197, DOI 10.1074/jbc.271.22.13197; ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; BARRINGTON M, 1989, CURR EYE RES, V8, P781, DOI 10.3109/02713688909000868; BeleckyAdams T, 1997, INVEST OPHTH VIS SCI, V38, P1293; BRAISTED JE, 1994, DEVELOPMENT, V122, P1427; CHADEE DN, 1995, J BIOL CHEM, V270, P20098, DOI 10.1074/jbc.270.34.20098; COULOMBRE JL, 1965, DEV BIOL, V12, P79, DOI 10.1016/0012-1606(65)90022-9; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; EHRLICH D, 1990, CIBA F SYMP, V155, P63; Fischer AJ, 2000, DEV BIOL, V220, P197, DOI 10.1006/dbio.2000.9640; Fischer AJ, 1998, J COMP NEUROL, V393, P1; FISCHER AJ, 1999, J NEUROCYTOL, V58, P697; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; JASONI CL, 1994, DEVELOPMENT, V120, P769; JOHNS PR, 1981, NATURE, V293, P141, DOI 10.1038/293141a0; JOHNS PR, 1982, J NEUROSCI, V176, P343; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; NEGISHI K, 1991, DEV BRAIN RES, V63, P71, DOI 10.1016/0165-3806(91)90068-T; OESTERIE EC, 1996, ANN NY ACAD SCI, V78, P34; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; PRADA C, 1991, EUR J NEUROSCI, V3, P559, DOI 10.1111/j.1460-9568.1991.tb00843.x; Raymond P A, 1997, Adv Neurol, V72, P171; REH TA, 1987, J NEUROSCI, V7, P3317; REH TA, 1995, SEMIN CELL BIOL, V6, P137, DOI 10.1006/scel.1995.0019; REH TA, 1988, J NEUROBIOL, V80, P206; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Tomita K, 1996, GENES CELLS, V1, P765, DOI 10.1111/j.1365-2443.1996.tb00016.x; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; TUNG NN, 1990, VISUAL NEUROSCI, V4, P217, DOI 10.1017/S0952523800003369; WILLBOLD E, 1992, EUR J NEUROSCI, V4, P210, DOI 10.1111/j.1460-9568.1992.tb00869.x	34	430	458	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					247	252		10.1038/85090	http://dx.doi.org/10.1038/85090			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224540				2022-12-17	WOS:000167178300011
J	Quinlan, EM; Philpot, BD; Huganir, RL; Bear, MF				Quinlan, EM; Philpot, BD; Huganir, RL; Bear, MF			Rapid, experience-dependent expression of synaptic NMDA receptors in visual cortex in vivo	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTOR; LONG-TERM POTENTIATION; MESSENGER-RNA; TYROSINE PHOSPHORYLATION; ORIENTATIONAL PROPERTIES; FUNCTIONAL-PROPERTIES; REGIONAL EXPRESSION; SUBUNIT COMPOSITION; RAT-BRAIN; PLASTICITY	Sensory experience is crucial in the refinement of synaptic connections in the brain during development. It has been suggested that some forms of experience-dependent synaptic plasticity in vivo are associated with changes in the complement of postsynaptic glutamate receptors, although direct evidence has been lacking. Here we show that visual experience triggers the rapid synaptic insertion of new NMDA receptors in visual cortex. The new receptors have a higher proportion of NR2A subunits and, as a consequence, different functional properties. This effect of experience requires NMDA receptor activation and protein synthesis. Thus, rapid regulation of postsynaptic glutamate receptors is one mechanism for developmental plasticity in the brain. Changes in NMDA receptor expression provide a mechanism by which brief sensory experience can regulate the properties of NMDA receptor-dependent plasticity in visual cortex.	Brown Univ, Dept Neurosci, Howard Hughes Med Inst, Providence, RI 02912 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Brown University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Johns Hopkins University	Bear, MF (corresponding author), Brown Univ, Dept Neurosci, Howard Hughes Med Inst, Providence, RI 02912 USA.			Bear, Mark/0000-0002-9903-2541				Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BEAR MF, 1990, J NEUROSCI, V10, P909; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BUISSERET P, 1982, DEV BRAIN RES, V4, P417, DOI 10.1016/0165-3806(82)90185-7; BUISSERET P, 1978, NATURE, V272, P816, DOI 10.1038/272816a0; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CHURCH J, 1994, BRIT J PHARMACOL, V113, P499, DOI 10.1111/j.1476-5381.1994.tb17017.x; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Flint AC, 1997, J NEUROSCI, V17, P2469; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; GOLD JI, 1994, P NATL ACAD SCI USA, V91, P3941, DOI 10.1073/pnas.91.9.3941; Gottmann K, 1997, J NEUROSCI, V17, P2766; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Paoletti P, 1997, J NEUROSCI, V17, P5711; Ramoa AS, 1997, DEV BRAIN RES, V101, P165, DOI 10.1016/S0165-3806(97)00061-8; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; WILLIAMS K, 1993, NEURON, V10, P267, DOI 10.1016/0896-6273(93)90317-K; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Wyszynski M, 1998, J NEUROSCI, V18, P1383; Zheng F, 1998, NAT NEUROSCI, V1, P185, DOI 10.1038/634	35	430	442	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	1999	2	4					352	357		10.1038/7263	http://dx.doi.org/10.1038/7263			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	200GV	10204542				2022-12-17	WOS:000080532000014
J	Saxena, S; Cabuy, E; Caroni, P				Saxena, Smita; Cabuy, Erik; Caroni, Pico			A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice	NATURE NEUROSCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; MOTOR-NEURON DEGENERATION; ALS-LINKED SOD1; MUTANT SUPEROXIDE-DISMUTASE; WILD-TYPE SOD1; MOUSE MODEL; TRANSGENIC MICE; NEURODEGENERATIVE DISEASE	The mechanisms underlying disease manifestations in neurodegeneration remain unclear, but their understanding is critical to devising effective therapies. We carry out a longitudinal analysis in vivo of identified motoneurons selectively vulnerable (VUL) or resistant (RES) to motoneuron disease (amyotrophic lateral sclerosis, ALS) and show that subtype-selective endoplasmic reticulum (ER) stress responses influence disease manifestations. VUL motoneurons were selectively prone to ER stress and showed gradually upregulated ER stress markers from birth on in three mouse models of familial ALS (FALS). 25-30 days before the earliest denervations, ubiquitin signals increased in both VUL and RES motoneurons, but an unfolded protein response coupled with microglial activation was initiated selectively in VUL motoneurons. This transition was followed by selective axonal degeneration and spreading stress. The ER stress-protective agent salubrinal attenuated disease manifestations and delayed progression, whereas chronic enhancement of ER stress promoted disease. Thus, whereas all motoneurons are preferentially affected in ALS, ER stress responses in specific motoneuron subtypes influence the progressive manifestations of weakening and paralysis.	[Saxena, Smita; Cabuy, Erik; Caroni, Pico] Novartis Res Fdn, Friedrich Miescher Inst, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Novartis	Caroni, P (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst, Basel, Switzerland.	caroni@fmi.ch		Saxena, Smita/0000-0003-4574-4591	European Union	European Union(European Commission)	We thank J. London (Univ. of Paris 7, France) for generously providing to us the transgenic mice overexpressing wild-type human SOD1. We are grateful to our colleagues S. Arber, B. Roska and D. Schubeler (FMI, Basel) for critically reading the manuscript and providing valuable comments. We thank E. Oakley (FMI, Basel) for valuable assistance with the bioinformatics analysis. S. S. was supported by a grant from the European Union (FP6, Network of Excellence NeuroNE). The Friedrich Miescher Institut is a branch of the Novartis Research Foundation.	Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Burke RE, 1994, MYOLOGY, P464; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; David G, 2007, EXP NEUROL, V204, P411, DOI 10.1016/j.expneurol.2006.12.021; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704; Frey D, 2000, J NEUROSCI, V20, P2534; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Ito D, 2009, BRAIN, V132, P8, DOI 10.1093/brain/awn216; Jaarsma D, 2008, J NEUROSCI, V28, P2075, DOI 10.1523/JNEUROSCI.5258-07.2008; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Lobsiger CS, 2007, P NATL ACAD SCI USA, V104, P7319, DOI 10.1073/pnas.0702230104; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Matus S, 2008, CURR MOL MED, V8, P157, DOI 10.2174/156652408784221324; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Nagata T, 2007, NEUROL RES, V29, P767, DOI 10.1179/016164107X229803; Oh YK, 2008, J NEUROCHEM, V104, P993, DOI 10.1111/j.1471-4159.2007.05053.x; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Puttaparthi K, 2003, J NEUROCHEM, V87, P851, DOI 10.1046/j.1471-4159.2003.02028.x; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; Sharp PS, 2005, NEUROSCIENCE, V130, P897, DOI 10.1016/j.neuroscience.2004.09.069; Tobisawa S, 2003, BIOCHEM BIOPH RES CO, V303, P496, DOI 10.1016/S0006-291X(03)00353-X; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Urushitani M, 2008, FASEB J, V22, P2476, DOI 10.1096/fj.07-092783; Yamagishi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001030; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005; Zhong ZH, 2008, NAT NEUROSCI, V11, P420, DOI 10.1038/nn2073	48	429	437	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2009	12	5					627	636		10.1038/nn.2297	http://dx.doi.org/10.1038/nn.2297			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438SJ	19330001				2022-12-17	WOS:000265575400020
J	Tarr, MJ; Gauthier, I				Tarr, MJ; Gauthier, I			FFA: a flexible fusiform area for subordinate-level visual processing automatized by expertise	NATURE NEUROSCIENCE			English	Editorial Material							HUMAN EXTRASTRIATE CORTEX; FACE AREA; TEMPORAL CORTEX; OBJECT RECOGNITION; PERCEPTION; DISCRIMINATION; PROSOPAGNOSIA; CATEGORIZATION; MECHANISMS; INVERSION	Much evidence suggests that the fusiform face area is involved in face processing. In contrast to the accompanying article by Kanwisher, we conclude that the apparent face selectivity of this area reflects a more generalized form of processing not intrinsically specific to faces.	Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA	Brown University; Vanderbilt University	Tarr, MJ (corresponding author), Brown Univ, Dept Cognit & Linguist Sci, Box 1978, Providence, RI 02912 USA.		Tudusciuc, Oana/C-1339-2011	Gauthier, Isabel/0000-0002-6249-4769				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 1999, NEUROREPORT, V10, P823, DOI 10.1097/00001756-199903170-00029; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; FARAH MJ, 1995, NEUROPSYCHOLOGIA, V33, P661, DOI 10.1016/0028-3932(95)00002-K; GAFFAN D, 1993, J COGNITIVE NEUROSCI, V5, P118, DOI 10.1162/jocn.1993.5.1.118; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 2000, COGNITIVE NEUROPSYCH, V17, P143, DOI 10.1080/026432900380544; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Gauthier I, 1998, VISION RES, V38, P2401, DOI 10.1016/S0042-6989(97)00442-2; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; Gauthier I, 2000, TRENDS COGN SCI, V4, P1, DOI 10.1016/S1364-6613(99)01416-3; Halgren E, 1999, HUM BRAIN MAPP, V7, P29; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; JEFFREYS DA, 1989, EXP BRAIN RES, V78, P193; JOLICOEUR P, 1984, COGNITIVE PSYCHOL, V16, P243, DOI 10.1016/0010-0285(84)90009-4; Kanwisher N, 1999, NEUROREPORT, V10, P183, DOI 10.1097/00001756-199901180-00035; Kanwisher N, 1998, COGNITION, V68, pB1, DOI 10.1016/S0010-0277(98)00035-3; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KANWISHER N, IN PRESS HDB FUNCTIO; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; LOGOTHETIS NK, 1995, CEREB CORTEX, V3, P270; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; McCarthy G, 1999, CEREB CORTEX, V9, P431, DOI 10.1093/cercor/9.5.431; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Puce A, 1996, J NEUROSCI, V16, P5205; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; ROSSION B, IN PRESS J COGN NEUR; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SHEINBERG DL, 2000, PERCEPTUAL LEARNING; TANAKA JW, 1997, MECH PERCEPTUAL LEAR, P83; TANAKA JW, IN PRESS PSYCHOL SCI; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; TRANEL D, 1988, NEUROLOGY, V38, P690, DOI 10.1212/WNL.38.5.690; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	49	429	435	1	41	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2000	3	8					764	769		10.1038/77666	http://dx.doi.org/10.1038/77666			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TU	10903568				2022-12-17	WOS:000167177300010
J	Lee, S; Kruglikov, I; Huang, ZJ; Fishell, G; Rudy, B				Lee, Soohyun; Kruglikov, Illya; Huang, Z. Josh; Fishell, Gord; Rudy, Bernardo			A disinhibitory circuit mediates motor integration in the somatosensory cortex	NATURE NEUROSCIENCE			English	Article							EXPRESSING GABAERGIC NEURONS; CELLULAR MECHANISM; PYRAMIDAL NEURONS; BARREL CORTEX; UNIT-ACTIVITY; INTERNEURONS; PROJECTIONS; AFFERENT; ORGANIZATION; LAMINAR	The influence of motor activity on sensory processing is crucial for perception and motor execution. However, the underlying circuits are not known. To unravel the circuit by which activity in the primary vibrissal motor cortex (vM1) modulates sensory processing in the primary somatosensory barrel cortex (Si), we used optogenetics to examine the long-range inputs from vM1 to the various neuronal elements in Si. We found that Si-projecting vM1 pyramidal neurons strongly recruited vasointestinal peptide (VIP)-expressing GABAergic interneurons, a subset of serotonin receptor expressing interneurons. These VIP interneurons preferentially inhibited somatostatin-expressing interneurons, neurons that target the distal dendrites of pyramidal cells. Consistent with this vM1-mediated disinhibitory circuit, the activity of VIP interneurons in vivo increased and that of somatostatin interneurons decreased during whisking. These changes in firing rates during whisking depended on vM1 activity. Our results suggest previously unknown circuitry by which inputs from motor cortex influence sensory processing in sensory cortex.	[Lee, Soohyun; Kruglikov, Illya; Fishell, Gord; Rudy, Bernardo] NYU, Sch Med, Neurosci Inst, Dept Neurosci & Physiol,Smilow Res Ctr, New York, NY 10012 USA; [Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	New York University; Cold Spring Harbor Laboratory	Rudy, B (corresponding author), NYU, Sch Med, Neurosci Inst, Dept Neurosci & Physiol,Smilow Res Ctr, New York, NY 10012 USA.	soohyun.lee@nyumc.org; bernardo.rudy@nyumc.org	Kruglikov, Ilya/AAC-9131-2020	Kruglikov, Ilya/0000-0002-1575-4636; Rudy, Bernardo/0000-0001-5748-6900; Fishell, Gordon/0000-0002-9640-9278; Lee, Soohyun/0000-0003-1532-7041; Huang, Z. Josh/0000-0003-0592-028X	US National Institutes of Health [R01 NS30989, MH071679, P01 NS074972, 1F32NS076316]; Epilepsy Foundation [260691]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074972, F32NS076316, R01NS030989] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all of the members of the Rudy and Fishell laboratories for helpful discussions. We thank K. Deisseroth (Stanford University) for DIO-ChR2-mCherry plasmids, Z. Talbot for help with intrinsic imaging and setting-up a camera for whisking behavior, and E. Merriam for advice on in vivo data analysis. This work was supported by grants from the US National Institutes of Health (R01 NS30989 and P01 NS074972 to B.R., MH071679 and P01 NS074972 to G.F., and 1F32NS076316 to S.L.). I.K. was supported by Epilepsy Foundation grant 260691.	Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Chan CH, 2001, CEREB CORTEX, V11, P1191, DOI 10.1093/cercor/11.12.1191; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Cruikshank SJ, 2012, J NEUROSCI, V32, P17813, DOI 10.1523/JNEUROSCI.3231-12.2012; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; David C, 2007, EUR J NEUROSCI, V25, P2329, DOI 10.1111/j.1460-9568.2007.05496.x; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; DONOGHUE JP, 1983, J COMP NEUROL, V217, P390, DOI 10.1002/cne.902170404; FABRI M, 1991, J COMP NEUROL, V311, P405, DOI 10.1002/cne.903110310; Friedman WA, 2012, J NEUROPHYSIOL, V107, P551, DOI 10.1152/jn.01132.2010; Gentet LJ, 2012, NAT NEUROSCI, V15, P607, DOI 10.1038/nn.3051; Gentet LJ, 2010, NEURON, V65, P422, DOI 10.1016/j.neuron.2010.01.006; Gonchar Y, 1999, J COMP NEUROL, V406, P346, DOI 10.1002/(SICI)1096-9861(19990412)406:3<346::AID-CNE4>3.0.CO;2-E; HERKENHAM M, 1980, SCIENCE, V207, P532, DOI 10.1126/science.7352263; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; JONES EG, 1977, J COMP NEUROL, V175, P391, DOI 10.1002/cne.901750403; KAWAGUCHI Y, 1995, J NEUROSCI, V15, P2638; Kinnischtzke AK, 2014, CEREB CORTEX, V24, P2237, DOI 10.1093/cercor/bht085; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Lee S, 2008, NAT NEUROSCI, V11, P1430, DOI 10.1038/nn.2227; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Masri R, 2008, J NEUROPHYSIOL, V100, P681, DOI 10.1152/jn.01322.2007; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Ohno S, 2012, CEREB CORTEX, V22, P2840, DOI 10.1093/cercor/bhr356; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Porter JT, 1998, EUR J NEUROSCI, V10, P3617, DOI 10.1046/j.1460-9568.1998.00367.x; PORTER LL, 1983, J COMP NEUROL, V214, P279, DOI 10.1002/cne.902140306; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Shirvalkar P, 2006, P NATL ACAD SCI USA, V103, P17007, DOI 10.1073/pnas.0604811103; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; WHITE EL, 1977, J COMP NEUROL, V175, P455, DOI 10.1002/cne.901750405; Williams SR, 1999, J PHYSIOL-LONDON, V521, P467, DOI 10.1111/j.1469-7793.1999.00467.x; Wimmer VC, 2010, CEREB CORTEX, V20, P2265, DOI 10.1093/cercor/bhq068; Xu NL, 2012, NATURE, V492, P247, DOI 10.1038/nature11601; Yu CX, 2006, PLOS BIOL, V4, P819, DOI 10.1371/journal.pbio.0040124	49	428	432	4	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2013	16	11					1662	1670		10.1038/nn.3544	http://dx.doi.org/10.1038/nn.3544			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	241YX	24097044	Green Accepted			2022-12-17	WOS:000326205700024
J	Bai, JL; Ramos, RL; Ackman, JB; Thomas, AM; Lee, RV; LoTurco, JJ				Bai, JL; Ramos, RL; Ackman, JB; Thomas, AM; Lee, RV; LoTurco, JJ			RNAi reveals doublecortin is required for radial migration in rat neocortex	NATURE NEUROSCIENCE			English	Article							DOUBLE CORTEX SYNDROME; MICROTUBULE-ASSOCIATED PROTEIN; NEURONAL MIGRATION; CEREBRAL-CORTEX; GENE; MUTATIONS; BRAIN; PRECURSORS; CELLS	Mutations in the doublecortin gene (DCX) in humans cause malformation of the cerebral neocortex. Paradoxically, genetic deletion of Dcx in mice does not cause neocortical malformation. We used electroporation of plasmids encoding short hairpin RNA to create interference (RNAi) of DCX protein in utero, and we show that DCX is required for radial migration in developing rat neocortex. RNAi of DCX causes both cell-autonomous and non-cell autonomous disruptions in radial migration, and creates two disruptions in neocortical development. First, many neurons prematurely stop migrating to form subcortical band heterotopias within the intermediate zone and then white matter. Second, many neurons migrate into inappropriate neocortical lamina within normotopic cortex. In utero RNAi can therefore be effectively used to study the specific cellular roles of DCX in neocortical development and to produce an animal model of double cortex syndrome.	Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	University of Connecticut	LoTurco, JJ (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, 3107 Horsebarn Hill Rd,U-4156, Storrs, CT 06269 USA.			Ackman, James/0000-0003-0802-6080; Lee, Richard/0000-0003-3386-8212	NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH056524, R01MH056524] Funding Source: NIH RePORTER; NICHD NIH HHS [HD208066] Funding Source: Medline; NIMH NIH HHS [MH056524] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bittman KS, 1999, CEREB CORTEX, V9, P188, DOI 10.1093/cercor/9.2.188; Corbo JC, 2002, J NEUROSCI, V22, P7548; des Portes V, 1998, CELL, V92, P51; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gabel LA, 2001, J NEUROPHYSIOL, V85, P495, DOI 10.1152/jn.2001.85.2.495; Gleeson JG, 2000, AM J HUM GENET, V67, P574, DOI 10.1086/303043; Gleeson JG, 1999, ANN NEUROL, V45, P146, DOI 10.1002/1531-8249(199902)45:2<146::AID-ANA3>3.0.CO;2-N; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gleeson JG, 2000, ANN NEUROL, V47, P265, DOI 10.1002/1531-8249(200002)47:2<265::AID-ANA22>3.3.CO;2-E; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Horesh D, 1999, HUM MOL GENET, V8, P1599, DOI 10.1093/hmg/8.9.1599; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Marin-Padilla M, 1999, REV NEUROLOGIA, V29, P208, DOI 10.33588/rn.2903.99148; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Takahashi M, 2002, DIFFERENTIATION, V70, P155, DOI 10.1046/j.1432-0436.2002.700405.x; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	22	428	443	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2003	6	12					1277	1283		10.1038/nn1153	http://dx.doi.org/10.1038/nn1153			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	746BC	14625554				2022-12-17	WOS:000186725600012
J	Rocha, BA; Fumagalli, F; Gainetdinov, RR; Jones, SR; Ator, R; Giros, B; Miller, GW; Caron, MG				Rocha, BA; Fumagalli, F; Gainetdinov, RR; Jones, SR; Ator, R; Giros, B; Miller, GW; Caron, MG			Cocaine self-administration in dopamine-transporter knockout mice	NATURE NEUROSCIENCE			English	Article							PROGRESSIVE RATIO SCHEDULE; DISCRIMINATIVE STIMULUS; I-125 RTI-55; SEROTONIN TRANSPORTERS; C-FOS; REINFORCING PROPERTIES; INTRAVENOUS COCAINE; NUCLEUS ACCUMBENS; SQUIRREL-MONKEYS; BRAIN REGIONS	The plasma membrane dopamine transporter (DAT) is responsible for clearing dopamine from the synapse. Cocaine blockade of DAT leads to increased extracellular dopamine, an effect widely considered to be the primary cause of the reinforcing and addictive properties of cocaine. In this study we tested whether these properties are limited to the dopaminergic system in mice lacking DAT. In the absence of DAT, these mice exhibit high levels of extracellular dopamine, but paradoxically still self-administer cocaine. Mapping of the sites of cocaine binding and neuronal activation suggests an involvement of serotonergic brain regions in this response. These results demonstrate that the interaction of cocaine with targets other than DAT, possibly the serotonin transporter, can initiate and sustain cocaine self-administration in these mice.	Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Med, Durham, NC 27710 USA; Univ N Texas, Ctr Hlth Sci, Dept Pharmacol, Ft Worth, TX 76107 USA	Duke University; Duke University; University of North Texas System; University of North Texas Health Science Center	Caron, MG (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst Labs, Dept Cell Biol, Durham, NC 27710 USA.	caron002@mc.duke.edu	GIROS, Bruno/ABD-5790-2021; Fumagalli, Fabio/E-8992-2012; Gainetdinov, Raul R/G-5875-2011; Jones, Sara R/K-4816-2014	GIROS, Bruno/0000-0001-5876-9822; Gainetdinov, Raul R/0000-0003-2951-6038; Jones, Sara R/0000-0002-3424-7576; Fumagalli, Fabio/0000-0002-8814-7706	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH040159, P30MH040159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA010457] Funding Source: NIH RePORTER; NIDA NIH HHS [DA-10457A] Funding Source: Medline; NIEHS NIH HHS [ES-09248] Funding Source: Medline; NIMH NIH HHS [MH-40159] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; BARR GA, 1986, DEV BRAIN RES, V24, P193, DOI 10.1016/0165-3806(86)90187-2; BENDOTTI C, 1990, MOL BRAIN RES, V8, P343, DOI 10.1016/0169-328X(90)90048-I; BERGMAN J, 1989, J PHARMACOL EXP THER, V251, P150; BOJA JW, 1992, SYNAPSE, V12, P27, DOI 10.1002/syn.890120104; BROADBENT J, 1991, BEHAV PHARMACOL, V2, P187; CARROLL ME, 1990, PHARMACOL BIOCHEM BE, V35, P237, DOI 10.1016/0091-3057(90)90232-7; CLINE EJ, 1992, SYNAPSE, V12, P37, DOI 10.1002/syn.890120105; CRAWFORD CA, 1995, PSYCHOPHARMACOLOGY, V120, P392, DOI 10.1007/BF02245810; DICHIARA G, 1995, DRUG ALCOHOL DEPEN, V38, P95, DOI 10.1016/0376-8716(95)01118-I; Franklin K. B. J., 1996, MOUSE BRAIN STEREOTA; FUJITA M, 1994, J CHEM NEUROANAT, V7, P13, DOI 10.1016/0891-0618(94)90004-3; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GU H, 1994, J BIOL CHEM, V269, P7124; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; Howell LL, 1995, J PHARMACOL EXP THER, V275, P1551; JOHANSON CE, 1989, PHARMACOL REV, V41, P3; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; KUHAR MJ, 1991, TRENDS NEUROSCI, V14, P299, DOI 10.1016/0166-2236(91)90141-G; LAMB RJ, 1990, PSYCHOPHARMACOLOGY, V102, P183, DOI 10.1007/BF02245920; LOH EA, 1990, PSYCHOPHARMACOLOGY, V101, P262, DOI 10.1007/BF02244137; MADRAS BK, 1989, MOL PHARMACOL, V36, P518; Marek GJ, 1996, J PHARMACOL EXP THER, V278, P1373; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NESTLER EJ, 1993, CRIT REV NEUROBIOL, V7, P23; ORGEN SO, 1984, J NEURAL T, V59, P264; Pagliusi SR, 1996, EUR J NEUROSCI, V8, P2247, DOI 10.1111/j.1460-9568.1996.tb01188.x; Parsons LH, 1996, PSYCHOPHARMACOLOGY, V128, P150, DOI 10.1007/s002130050120; PELTIER R, 1993, PSYCHOPHARMACOLOGY, V110, P390, DOI 10.1007/BF02244643; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; RITZ MC, 1990, LIFE SCI, V46, P635, DOI 10.1016/0024-3205(90)90132-B; ROBERTS DCS, 1994, PHARMACOL BIOCHEM BE, V49, P177, DOI 10.1016/0091-3057(94)90473-1; ROBERTS DCS, 1977, PHARMACOL BIOCHEM BE, V6, P615, DOI 10.1016/0091-3057(77)90084-3; ROBERTS DCS, 1980, PHARMACOL BIOCHEM BE, V12, P781, DOI 10.1016/0091-3057(80)90166-5; ROBERTS DCS, 1993, PSYCHOPHARMACOLOGY, V111, P202, DOI 10.1007/BF02245524; ROCHA BA, 1997, PHARM BIOCH BEHAV, V57, P1; ROCHA BA, 1998, IN PRESS NATURE; Shearman LP, 1996, J PHARMACOL EXP THER, V277, P1770; SNODDY AM, 1983, PHARMACOL BIOCHEM BE, V19, P205, DOI 10.1016/0091-3057(83)90040-0; SPEALMAN RD, 1995, J PHARMACOL EXP THER, V275, P53; STALEY JK, 1994, J NEUROCHEM, V62, P549; Sugita S, 1996, NEUROCHEM INT, V28, P545, DOI 10.1016/0197-0186(95)00127-1; TEJANIBUTT SM, 1992, J PHARMACOL EXP THER, V260, P427; UMINO A, 1995, NEUROCHEM INT, V26, P85, DOI 10.1016/0197-0186(94)00096-D; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Volkow ND, 1997, NATURE, V386, P827, DOI 10.1038/386827a0; Walsh SL, 1997, PSYCHOPHARMACOLOGY, V130, P41, DOI 10.1007/s002130050210; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	49	428	435	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	1998	1	2					132	137		10.1038/381	http://dx.doi.org/10.1038/381			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	127QB	10195128				2022-12-17	WOS:000076361100014
J	Soto, C; Pritzkow, S				Soto, Claudio; Pritzkow, Sandra			Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases	NATURE NEUROSCIENCE			English	Review							ALPHA-SYNUCLEIN STRAINS; CREUTZFELDT-JAKOB-DISEASE; TRANSGENIC MOUSE MODEL; AMYLOID-BETA OLIGOMERS; ALZHEIMERS-DISEASE; A-BETA; CEREBROSPINAL-FLUID; PARKINSONS-DISEASE; PRION STRAINS; CYCLIC AMPLIFICATION	A hallmark event in neurodegenerative diseases (NDs) is the misfolding, aggregation, and accumulation of proteins, leading to cellular dysfunction, loss of synaptic connections, and brain damage. Despite the involvement of distinct proteins in different NDs, the process of protein misfolding and aggregation is remarkably similar. A recent breakthrough in the field was the discovery that misfolded protein aggregates can self-propagate through seeding and spread the pathological abnormalities between cells and tissues in a manner akin to the behavior of infectious prions in prion diseases. This discovery has vast implications for understanding the mechanisms involved in the initiation and progression of NDs, as well as for the design of novel strategies for treatment and diagnosis. In this Review, we provide a critical discussion of the role of protein misfolding and aggregation in NDs. Commonalities and differences between distinct protein aggregates will be highlighted, in addition to evidence supporting the hypothesis that misfolded aggregates can be transmissible by the prion principle. We will also describe the molecular basis and implications for prion-like conformational strains, cross-interaction between different misfolded proteins in the brain, and how these concepts can be applied to the development of novel strategies for therapy and diagnosis.	[Soto, Claudio; Pritzkow, Sandra] Univ Texas Houston, McGovern Med Sch, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Soto, C (corresponding author), Univ Texas Houston, McGovern Med Sch, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Houston, TX 77030 USA.	Claudio.Soto@uth.tmc.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG061878, R42AG058333, R42AG049562] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI077774, R01 AI132695] Funding Source: Medline; NIA NIH HHS [R42 AG058333, R42 AG049562, R56 AG061878] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Aguzzit A, 2016, TRENDS CELL BIOL, V26, P40, DOI 10.1016/j.tcb.2015.08.007; Anderson RM, 2017, LANCET, V390, P2327, DOI 10.1016/S0140-6736(17)32399-1; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bosboom JLW, 2004, J NEURAL TRANSM, V111, P1303, DOI 10.1007/s00702-004-0168-1; Bougard D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1257; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Breydo L, 2015, FEBS LETT, V589, P2640, DOI 10.1016/j.febslet.2015.07.013; Brown DF, 1998, J NEUROPATH EXP NEUR, V57, P39, DOI 10.1097/00005072-199801000-00006; BROWN P, 1990, NEUROLOGY, V40, P226, DOI 10.1212/WNL.40.2.226; Buongiorno M, 2011, J NEUROL SCI, V310, P25, DOI 10.1016/j.jns.2011.06.046; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chai YJ, 2013, FEBS LETT, V587, P452, DOI 10.1016/j.febslet.2013.01.008; Chen SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep34477; Clavaguera F, 2014, ACTA NEUROPATHOL, V127, P299, DOI 10.1007/s00401-013-1231-5; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Concha-Marambio L, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6188; Condello C, 2018, NEUROBIOL DIS, V109, P191, DOI 10.1016/j.nbd.2017.03.014; Costanzo M, 2013, BIOCHEM J, V452, P1, DOI 10.1042/BJ20121898; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Diaz-Espinoza R, 2018, MOL PSYCHIATR, V23, P777, DOI 10.1038/mp.2017.84; Diaz-Espinoza R, 2012, NAT STRUCT MOL BIOL, V19, P370, DOI 10.1038/nsmb.2266; Dickson DW, 2001, CLIN GERIATR MED, V17, P209, DOI 10.1016/S0749-0690(05)70066-5; Duran-Aniotz C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089014; Egorov VV, 2014, PRION, V8, P100, DOI 10.4161/pri.27501; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Elkins MR, 2016, J AM CHEM SOC, V138, P9840, DOI 10.1021/jacs.6b03715; Fairfoul G, 2016, ANN CLIN TRANSL NEUR, V3, P812, DOI 10.1002/acn3.338; Fandrich M, 2009, PRION, V3, P89; Fernandez-Borges N., 2013, INT J CELL BIOL, V2013, DOI [10.1155/2013/583498, DOI 10.1155/2013/583498]; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Friedland RP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006654; Fritschi SK, 2014, BRAIN, V137, P2909, DOI 10.1093/brain/awu255; Funke SA, 2010, REJUV RES, V13, P206, DOI 10.1089/rej.2009.0925; GANOWIAK K, 1994, BIOCHEM BIOPH RES CO, V199, P306, DOI 10.1006/bbrc.1994.1229; Garske T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015626; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Giasson BI, 2003, NEUROMOL MED, V4, P49, DOI 10.1385/NMM:4:1-2:49; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Goedert M, 2017, J PARKINSON DIS, V7, pS53, DOI 10.3233/JPD-179005; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Goedert M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0495-z; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gomez-Rio M, 2016, CURR ALZHEIMER RES, V13, P469, DOI 10.2174/1567205013666151116141603; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q; Hammer ND, 2008, J ALZHEIMERS DIS, V13, P407; Hayden EY, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt226; He ZH, 2018, NAT MED, V24, P29, DOI 10.1038/nm.4443; Heilbronner G, 2013, EMBO REP, V14, P1017, DOI 10.1038/embor.2013.137; Holtta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066381; Hu RD, 2015, ACS CHEM NEUROSCI, V6, P1759, DOI 10.1021/acschemneuro.5b00192; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Irwin DJ, 2013, JAMA NEUROL, V70, P462, DOI 10.1001/jamaneurol.2013.1933; Iseki E, 2004, NEUROPATHOLOGY, V24, P72, DOI 10.1111/j.1440-1789.2003.00530.x; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Josephs KA, 2016, ACTA NEUROPATHOL, V131, P571, DOI 10.1007/s00401-016-1537-1; Kamali-Moghaddam M, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-124; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004; Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005; Lesne SE, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14021; Lewczuk P, 2018, WORLD J BIOL PSYCHIA, V19, P244, DOI 10.1080/15622975.2017.1375556; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li JL, 2011, EMBO REP, V12, P1243, DOI 10.1038/embor.2011.191; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Lubomski M, 2013, J CLIN NEUROSCI, V20, P102, DOI 10.1016/j.jocn.2012.05.015; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; Meisl G, 2017, CHEM SCI, V8, P7087, DOI 10.1039/c7sc01965c; Melki R, 2018, NEUROBIOL DIS, V109, P201, DOI 10.1016/j.nbd.2017.03.011; Melki R, 2015, J PARKINSON DIS, V5, P217, DOI 10.3233/JPD-150543; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Moda F, 2014, NEW ENGL J MED, V371, P530, DOI 10.1056/NEJMoa1404401; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; Morales R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006323; Morales R, 2015, SCI REP-UK, V5, DOI 10.1038/srep09349; Morales R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003537; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Moreno-Gonzalez I, 2017, MOL PSYCHIATR, V22, P1327, DOI 10.1038/mp.2016.230; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Murakami K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29038; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Santos AN, 2007, J ALZHEIMERS DIS, V11, P117; Mohamed NV, 2013, EUR J NEUROSCI, V37, P1939, DOI 10.1111/ejn.12229; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Oelschlegel AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003158; Ono K, 2012, J NEUROCHEM, V122, P883, DOI 10.1111/j.1471-4159.2012.07847.x; Orru CD, 2012, PRION, V6, P147, DOI 10.4161/pri.19430; Oskarsson ME, 2015, AM J PATHOL, V185, P834, DOI 10.1016/j.ajpath.2014.11.016; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pham CLL, 2014, ESSAYS BIOCHEM, V56, P207, DOI [10.1042/BSE0560207, 10.1042/bse0560207]; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; Pigott K, 2015, NEUROLOGY, V85, P1276, DOI 10.1212/WNL.0000000000002001; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Poggiolini Ilaria, 2013, Int J Cell Biol, V2013, P910314, DOI 10.1155/2013/910314; Pooler AM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0199-x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Qiang W, 2017, NATURE, V541, P217, DOI 10.1038/nature20814; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Saijo E, 2017, ACTA NEUROPATHOL, V133, P751, DOI 10.1007/s00401-017-1692-z; Salvadores N, 2014, CELL REP, V7, P261, DOI 10.1016/j.celrep.2014.02.031; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Schuster J, 2016, J ALZHEIMERS DIS, V53, P53, DOI 10.3233/JAD-151029; Shahnawaz M, 2017, JAMA NEUROL, V74, P163, DOI 10.1001/jamaneurol.2016.4547; Gadad BS, 2011, J ALZHEIMERS DIS, V24, P223, DOI 10.3233/JAD-2011-110182; Sierks MR, 2011, INTEGR BIOL-UK, V3, P1188, DOI 10.1039/c1ib00018g; Sims-Robinson C, 2010, NAT REV NEUROL, V6, P551, DOI 10.1038/nrneurol.2010.130; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Soto C, 2002, TRENDS NEUROSCI, V25, P390, DOI 10.1016/S0166-2236(02)02195-1; Soto C, 2012, CELL, V149, P968, DOI 10.1016/j.cell.2012.05.007; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Spires-Jones TL, 2017, ACTA NEUROPATHOL, V134, P187, DOI 10.1007/s00401-017-1709-7; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Stopschinski BE, 2017, LANCET NEUROL, V16, P323, DOI 10.1016/S1474-4422(17)30037-6; Telling GC, 2010, PRION, V4, P252, DOI 10.4161/pri.4.4.13675; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; Uchikado H, 2006, J NEUROPATH EXP NEUR, V65, P685, DOI 10.1097/01.jnen.0000225908.90052.07; Valera E, 2016, NEUROTHERAPEUTICS, V13, P179, DOI 10.1007/s13311-015-0397-z; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Walker LC, 2015, ANNU REV NEUROSCI, V38, P87, DOI 10.1146/annurev-neuro-071714-033828; Walsh DM, 2016, NAT REV NEUROSCI, V17, P251, DOI 10.1038/nrn.2016.13; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Wegmann S, 2016, J NEUROCHEM, V139, P1163, DOI 10.1111/jnc.13866; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; Williams DR, 2006, INTERN MED J, V36, P652, DOI 10.1111/j.1445-5994.2006.01153.x; Xing YM, 2001, LAB INVEST, V81, P493, DOI 10.1038/labinvest.3780257; Yan JM, 2007, AM J PATHOL, V171, P172, DOI 10.2353/ajpath.2007.060576	148	427	433	23	270	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2018	21	10					1332	1340		10.1038/s41593-018-0235-9	http://dx.doi.org/10.1038/s41593-018-0235-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU9FY	30250260	Green Accepted			2022-12-17	WOS:000445651600008
J	Kole, MHP; Ilschner, SU; Kampa, BM; Williams, SR; Ruben, PC; Stuart, GJ				Kole, Maarten H. P.; Ilschner, Susanne U.; Kampa, Bjoern M.; Williams, Stephen R.; Ruben, Peter C.; Stuart, Greg J.			Action potential generation requires a high sodium channel density in the axon initial segment	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; CEREBELLAR PURKINJE-CELLS; GATED ION CHANNELS; SPIKE INITIATION; DENDRITES; VOLTAGE; SITE; PROPAGATION; RANVIER; CHANDELIER	The axon initial segment ( AIS) is a specialized region in neurons where action potentials are initiated. It is commonly assumed that this process requires a high density of voltage-gated sodium ( Na(+)) channels. Paradoxically, the results of patch-clamp studies suggest that the Na(+) channel density at the AIS is similar to that at the soma and proximal dendrites. Here we provide data obtained by antibody staining, whole-cell voltage-clamp and Na(+) imaging, together with modeling, which indicate that the Na(+) channel density at the AIS of cortical pyramidal neurons is similar to 50 times that in the proximal dendrites. Anchoring of Na(+) channels to the cytoskeleton can explain this discrepancy, as disruption of the actin cytoskeleton increased the Na(+) current measured in patches from the AIS. Computational models required a high Na(+) channel density (similar to 2,500 pS mu m(-2)) at the AIS to account for observations on action potential generation and backpropagation. In conclusion, action potential generation requires a high Na(+) channel density at the AIS, which is maintained by tight anchoring to the actin cytoskeleton.	[Kole, Maarten H. P.; Ilschner, Susanne U.; Kampa, Bjoern M.; Williams, Stephen R.; Ruben, Peter C.; Stuart, Greg J.] Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia; [Williams, Stephen R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Ruben, Peter C.] Simon Fraser Univ, Sch Kinesiol, Burnaby, BC V5A 1S6, Canada	Australian National University; John Curtin School of Medical Research; MRC Laboratory Molecular Biology; Simon Fraser University	Stuart, GJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Garran Rd, Canberra, ACT 0200, Australia.	greg.stuart@anu.edu.au	Kampa, Bjoern/A-1612-2008; Kampa, Bjoern M/D-6213-2015; stuart, greg j/F-7328-2011; Kampa, Bjoern/GWC-5714-2022	Kampa, Bjoern M/0000-0002-4343-2634; Kampa, Bjoern/0000-0002-4343-2634; Williams, Stephen/0000-0001-5352-7947; stuart, greg/0000-0001-9395-2219; Kole, Maarten/0000-0002-3883-5682	MRC [MC_U105170644] Funding Source: UKRI; Medical Research Council [MC_U105170644] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akemann W, 2006, J NEUROSCI, V26, P4602, DOI 10.1523/JNEUROSCI.5204-05.2006; Baranauskas G, 2006, J NEUROSCI, V26, P671, DOI 10.1523/JNEUROSCI.2283-05.2006; Boiko T, 2001, NEURON, V30, P91, DOI 10.1016/S0896-6273(01)00265-3; Boiko T, 2003, J NEUROSCI, V23, P2306; Canavier CC, 1999, J COMPUT NEUROSCI, V6, P49, DOI 10.1023/A:1008809000182; Carnevale N. T., 2006, NEURON BOOK; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; DODGE FA, 1973, IBM J RES DEV, V17, P219, DOI 10.1147/rd.173.0219; Eccles, 2013, PHYSL SYNAPSES; FATT P, 1957, J NEUROPHYSIOL, V20, P61, DOI 10.1152/jn.1957.20.1.61; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Howard A, 2005, TRENDS NEUROSCI, V28, P310, DOI 10.1016/j.tins.2005.04.004; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Komai S, 2006, NAT NEUROSCI, V9, P1125, DOI 10.1038/nn1752; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; LASSERROSS N, 1992, P ROY SOC B-BIOL SCI, V247, P35, DOI 10.1098/rspb.1992.0006; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; MILTON RL, 1990, J NEUROSCI, V10, P885; MOORE JW, 1983, J PHYSIOL-LONDON, V336, P301, DOI 10.1113/jphysiol.1983.sp014582; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; NEUMCKE B, 1982, J PHYSIOL-LONDON, V329, P163, DOI 10.1113/jphysiol.1982.sp014296; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; PETERS A, 1968, J CELL BIOL, V39, P604, DOI 10.1083/jcb.39.3.604; Rapp M, 1996, P NATL ACAD SCI USA, V93, P11985, DOI 10.1073/pnas.93.21.11985; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; SHRAGER P, 1989, BRAIN RES, V483, P149, DOI 10.1016/0006-8993(89)90046-2; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; SLOPER JJ, 1979, PHILOS T R SOC B, V285, P173, DOI 10.1098/rstb.1979.0004; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Taddese A, 2002, NEURON, V33, P587, DOI 10.1016/S0896-6273(02)00574-3; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; WOLLNER DA, 1986, P NATL ACAD SCI USA, V83, P8424, DOI 10.1073/pnas.83.21.8424; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	50	427	438	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2008	11	2					178	186		10.1038/nn2040	http://dx.doi.org/10.1038/nn2040			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256FC	18204443				2022-12-17	WOS:000252712100012
J	McKinney, RA; Capogna, M; Durr, R; Gahwiler, BH; Thompson, SM				McKinney, RA; Capogna, M; Durr, R; Gahwiler, BH; Thompson, SM			Miniature synaptic events maintain dendritic spines via AMPA receptor activation	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; RAT CEREBRAL-CORTEX; PYRAMIDAL CELLS; HIPPOCAMPAL-NEURONS; SILENT SYNAPSES; IN-VITRO; CA1; PLASTICITY; EXPRESSION; GLUTAMATE	We investigated the influence of synaptically released glutamate on postsynaptic structure by comparing the effects of deafferentation, receptor antagonists and blockers of glutamate release in hippocampal Slice cultures. CA1 pyramidal cell spine density and length decreased after transection of Schaffer collaterals and after application of AMPA receptor antagonists or botulinum toxin to unlesioned cultures. Loss of spines induced by lesion or by botulinum toxin was prevented by simultaneous AMPA application. Tetrodotoxin did not affect spine density. Synaptically released glutamate thus exerts a trophic effect on spines by acting at AMPA receptors. We conclude that AMPA receptor activation by spontaneous vesicular glutamate release is sufficient to maintain dendritic spines.	Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University of Zurich; University System of Maryland; University of Maryland Baltimore	McKinney, RA (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.		Thompson, Scott M/K-8921-2015	Capogna, Marco/0000-0002-2742-5485				CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; Capogna M, 1997, J NEUROSCI, V17, P7190; COOPER MW, 1992, J NEUROBIOL, V23, P814, DOI 10.1002/neu.480230704; EDWARDS FA, 1995, PHYSIOL REV, V75, P759, DOI 10.1152/physrev.1995.75.4.759; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FORSTER E, 1993, NEUROSCI LETT, V155, P216, DOI 10.1016/0304-3940(93)90711-S; GAHWILER BH, 1991, CULTURING NERVE CELL, P379; GERFINMOSER A, 1995, NEUROSCIENCE, V67, P849, DOI 10.1016/0306-4522(95)00130-B; GOLDOWITZ D, 1979, BRAIN RES, V170, P427, DOI 10.1016/0006-8993(79)90962-4; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hayashi K, 1996, J NEUROSCI, V16, P7161; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HORN G, 1985, J NEUROSCI, V5, P3161; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; LOMO T, 1972, J PHYSIOL-LONDON, V221, P493, DOI 10.1113/jphysiol.1972.sp009764; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; PAPA M, 1995, J NEUROSCI, V15, P1; PARNAVELAS JG, 1974, NATURE, V248, P71, DOI 10.1038/248071a0; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; POULAIN B, 1995, CLOSTRIDIAL NEUROTOX, P243; RUSAKOV DA, 1995, J NEUROSCI METH, V60, P11, DOI 10.1016/0165-0270(94)00215-3; Sorra KE, 1998, J NEUROSCI, V18, P658; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; WESTRUM LE, 1962, J COMP NEUROL, V119, P281, DOI 10.1002/cne.901190303; WICKENS J, 1988, PROG NEUROBIOL, V31, P507, DOI 10.1016/0301-0082(88)90013-5; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WOOLLEY CS, 1994, J NEUROSCI, V14, P7680; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	36	427	434	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	1999	2	1					44	49		10.1038/4548	http://dx.doi.org/10.1038/4548			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163MK	10195179				2022-12-17	WOS:000078409300012
J	Yuen, RKC; Merico, D; Bookman, M; Howe, JL; Thiruvahindrapuram, B; Patel, RV; Whitney, J; Deflaux, N; Bingham, J; Wang, ZZ; Pellecchia, G; Buchanan, JA; Walker, S; Marshall, CR; Uddin, M; Zarrei, M; Deneault, E; D'Abate, L; Chan, AJS; Koyanagi, S; Paton, T; Pereira, SL; Hoang, N; Engchuan, W; Higginbotham, EJ; Ho, K; Lamoureux, S; Li, WL; MacDonald, JR; Nalpathamkalam, T; Sung, WWL; Tsoi, FJ; Wei, J; Xu, LZ; Tasse, AM; Kirby, E; Van Etten, W; Twigger, S; Roberts, W; Drmic, I; Jilderda, S; Modi, BM; Kellam, B; Szego, M; Cytrynbaum, C; Weksberg, R; Zwaigenbaum, L; Woodbury-Smith, M; Brian, J; Senman, L; Iaboni, A; Doyle-Thomas, K; Thompson, A; Chrysler, C; Leef, J; Savion-Lemieux, T; Smith, IM; Liu, XD; Nicolson, R; Seifer, V; Fedele, A; Cook, EH; Dager, S; Estes, A; Gallagher, L; Malow, BA; Parr, JR; Spence, SJ; Vorstman, J; Frey, BJ; Robinson, JT; Strug, LJ; Fernandez, BA; Elsabbagh, M; Carter, MT; Hallmayer, J; Knoppers, BM; Anagnostou, E; Szatmari-, P; Ring, RH; Glazer, D; Pletcher, MT; Scherer, SW				Yuen, Ryan K. C.; Merico, Daniele; Bookman, Matt; Howe, Jennifer L.; Thiruvahindrapuram, Bhooma; Patel, Rohan V.; Whitney, Joe; Deflaux, Nicole; Bingham, Jonathan; Wang, Zhuozhi; Pellecchia, Giovanna; Buchanan, Janet A.; Walker, Susan; Marshall, Christian R.; Uddin, Mohammed; Zarrei, Mehdi; Deneault, Eric; D'Abate, Lia; Chan, Ada J. S.; Koyanagi, Stephanie; Paton, Tara; Pereira, Sergio L.; Hoang, Ny; Engchuan, Worrawat; Higginbotham, Edward J.; Ho, Karen; Lamoureux, Sylvia; Li, Weili; MacDonald, Jeffrey R.; Nalpathamkalam, Thomas; Sung, Wilson W. L.; Tsoi, Fiona J.; Wei, John; Xu, Lizhen; Tasse, Anne-Marie; Kirby, Emily; Van Etten, William; Twigger, Simon; Roberts, Wendy; Drmic, Irene; Jilderda, Sanne; Modi, Bonnie MacKinnon; Kellam, Barbara; Szego, Michael; Cytrynbaum, Cheryl; Weksberg, Rosanna; Zwaigenbaum, Lonnie; Woodbury-Smith, Marc; Brian, Jessica; Senman, Lili; Iaboni, Alana; Doyle-Thomas, Krissy; Thompson, Ann; Chrysler, Christina; Leef, Jonathan; Savion-Lemieux, Tal; Smith, Isabel M.; Liu, Xudong; Nicolson, Rob; Seifer, Vicki; Fedele, Angie; Cook, Edwin H.; Dager, Stephen; Estes, Annette; Gallagher, Louise; Malow, Beth A.; Parr, Jeremy R.; Spence, Sarah J.; Vorstman, Jacob; Frey, Brendan J.; Robinson, James T.; Strug, Lisa J.; Fernandez, Bridget A.; Elsabbagh, Mayada; Carter, Melissa T.; Hallmayer, Joachim; Knoppers, Bartha M.; Anagnostou, Evdokia; Szatmari-, Peter; Ring, Robert H.; Glazer, David; Pletcher, Mathew T.; Scherer, Stephen W.			Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder	NATURE NEUROSCIENCE			English	Article							DE-NOVO MUTATIONS; RISK-FACTORS; VARIANTS; DISEASE; LOCI; DEMETHYLATION; ARCHITECTURE; PHENOTYPES; FRAMEWORK; REVEALS	We are performing whole-genome sequencing of families with autism spectrum disorder (ASD) to build a resource (MSSNG) for subcategorizing the phenotypes and underlying genetic factors involved. Here we report sequencing of 5,205 samples from families with ASD, accompanied by clinical information, creating a database accessible on a cloud platform and through a controlled-access internet portal. We found an average of 73.8 de novo single nucleotide variants and 12.6 de novo insertions and deletions or copy number variations per ASD subject. We identified 18 new candidate ASD-risk genes and found that participants bearing mutations in susceptibility genes had significantly lower adaptive ability (P = 6 x 10(-4)). In 294 of 2,620 (11.2%) of ASD cases, a molecular basis could be determined and 7.2% of these carried copy number variations and/or chromosomal abnormalities, emphasizing the importance of detecting all forms of genetic variation as diagnostic and therapeutic targets in ASD.	[Yuen, Ryan K. C.; Merico, Daniele; Howe, Jennifer L.; Thiruvahindrapuram, Bhooma; Patel, Rohan V.; Whitney, Joe; Wang, Zhuozhi; Pellecchia, Giovanna; Buchanan, Janet A.; Walker, Susan; Marshall, Christian R.; Uddin, Mohammed; Zarrei, Mehdi; Deneault, Eric; D'Abate, Lia; Chan, Ada J. S.; Koyanagi, Stephanie; Paton, Tara; Pereira, Sergio L.; Hoang, Ny; Engchuan, Worrawat; Higginbotham, Edward J.; Ho, Karen; Lamoureux, Sylvia; Li, Weili; MacDonald, Jeffrey R.; Nalpathamkalam, Thomas; Sung, Wilson W. L.; Tsoi, Fiona J.; Wei, John; Xu, Lizhen; Drmic, Irene; Jilderda, Sanne; Modi, Bonnie MacKinnon; Kellam, Barbara; Szego, Michael; Woodbury-Smith, Marc; Strug, Lisa J.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom Genet & Genome Biol, Toronto, ON, Canada; [Merico, Daniele; Frey, Brendan J.] Deep Genom Inc, Toronto, ON, Canada; [Bookman, Matt; Deflaux, Nicole; Bingham, Jonathan; Glazer, David] Google, Mountain View, CA USA; [Bookman, Matt; Deflaux, Nicole; Bingham, Jonathan; Glazer, David] Verily Life Sci, San Francisco, CA USA; [Marshall, Christian R.] Hosp Sick Children, Dept Paediat Lab Med, Genome Diagnost, Toronto, ON, Canada; [D'Abate, Lia; Chan, Ada J. S.; Cytrynbaum, Cheryl; Weksberg, Rosanna; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Hoang, Ny; Roberts, Wendy; Drmic, Irene; Jilderda, Sanne; Modi, Bonnie MacKinnon] Hosp Sick Children, Autism Res Unit, Toronto, ON, Canada; [Tasse, Anne-Marie; Kirby, Emily] McGill Univ, Publ Populat Project Genom & Soc, Montreal, PQ, Canada; [Van Etten, William; Twigger, Simon] BioTeam Inc, Middleton, MA USA; [Szego, Michael; Cytrynbaum, Cheryl] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Szego, Michael; Cytrynbaum, Cheryl] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Cytrynbaum, Cheryl; Weksberg, Rosanna] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON, Canada; [Cytrynbaum, Cheryl; Weksberg, Rosanna; Carter, Melissa T.] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON, Canada; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Woodbury-Smith, Marc; Thompson, Ann; Chrysler, Christina] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Brian, Jessica; Senman, Lili; Iaboni, Alana; Doyle-Thomas, Krissy; Leef, Jonathan; Anagnostou, Evdokia] Univ Toronto, Bloorview Res Inst, Toronto, ON, Canada; [Savion-Lemieux, Tal; Elsabbagh, Mayada] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Smith, Isabel M.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Smith, Isabel M.] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada; [Smith, Isabel M.] IWK Hlth Ctr, Autism Res Ctr, Halifax, NS, Canada; [Liu, Xudong] Queens Univ, Dept Psychiat, Kinston, ON, Canada; [Nicolson, Rob] Childrens Hlth Res Inst, London, ON, Canada; [Nicolson, Rob] Western Univ, London, ON, Canada; [Seifer, Vicki; Fedele, Angie; Pletcher, Mathew T.] Autism Speaks, New York, NY USA; [Cook, Edwin H.] Univ Illinois, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60612 USA; [Dager, Stephen] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Estes, Annette] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; [Gallagher, Louise] Trinity Coll Dublin, Sch Med, Dept Psychiat, Dublin, Ireland; [Malow, Beth A.] Vanderbilt Univ, Sch Med, Dept Neurol, Sleep Disorders Div, Nashville, TN 37212 USA; [Parr, Jeremy R.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Spence, Sarah J.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Vorstman, Jacob] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, Utrecht, Netherlands; [Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Frey, Brendan J.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Robinson, James T.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Strug, Lisa J.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Biostat, Toronto, ON, Canada; [Fernandez, Bridget A.] Mem Univ Newfoundland, Disciplines Genet & Med, St John, NF, Canada; [Fernandez, Bridget A.] Eastern Hlth, Prov Med Genet Program, St John, NF, Canada; [Carter, Melissa T.] Childrens Hosp Eastern Ontario, Reg Genet Program, Ottawa, ON, Canada; [Hallmayer, Joachim] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Knoppers, Bartha M.] McGill Univ, Ctr Genom & Policy, Montreal, PQ, Canada; [Szatmari-, Peter] Ctr Addict & Mental Hlth, Child Youth & Family Serv, Toronto, ON, Canada; [Szatmari-, Peter] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Szatmari-, Peter] Hosp Sick Children, Dept Psychiat, Toronto, ON, Canada; [Ring, Robert H.] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19104 USA; [Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Google Incorporated; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; McMaster University; University of Toronto; McGill University; Dalhousie University; Dalhousie University; Dalhousie University; Queens University - Canada; Western University (University of Western Ontario); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Trinity College Dublin; Vanderbilt University; Newcastle University - UK; Harvard University; Boston Children's Hospital; Utrecht University; Utrecht University Medical Center; University of Toronto; University of Toronto; University of California System; University of California San Diego; University of Toronto; Memorial University Newfoundland; University of Ottawa; Children's Hospital of Eastern Ontario; Stanford University; McGill University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Drexel University; University of Toronto	Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom Genet & Genome Biol, Toronto, ON, Canada.; Scherer, SW (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.; Scherer, SW (corresponding author), Univ Toronto, McLaughlin Ctr, Toronto, ON, Canada.	stephen.scherer@sickkids.ca	Pereira, Sergio L/B-1984-2010; Nicolson, Robert/E-4797-2011; Yuen, Ryan K. C./J-4876-2012; Scherer, Stephen W./B-3785-2013; Ring, Robert/M-1238-2016; MacDonald, Jeffrey Robert/GLU-2255-2022	Pereira, Sergio L/0000-0002-2796-5625; Nicolson, Robert/0000-0001-7086-7038; Yuen, Ryan K. C./0000-0001-7273-4968; Scherer, Stephen W./0000-0002-8326-1999; Ring, Robert/0000-0002-7037-4409; Woodbury-Smith, Marc/0000-0002-0593-8917; Elsabbagh, Mayada/0000-0002-7311-9059; MacDonald, Jeffrey/0000-0001-5058-2393; Glazer, David/0000-0002-6407-8646; Strug, Lisa/0000-0003-0503-9740; Smith, Isabel/0000-0001-5525-2123; Estes, Annette/0000-0003-2687-4155; Twigger, Simon/0000-0001-5659-3632; Sung, Wilson/0000-0002-4703-5118; Deflaux, Nicole/0000-0002-9421-8048; Engchuan, Worrawat/0000-0001-6138-1925; Uddin, Mohammed/0000-0001-6867-5803; Merico, Daniele/0000-0002-3728-4401; Gallagher, Louise/0000-0001-9462-2836	Autism Speaks, Autism Speaks Canada; Canadian Institute for Advanced Research; University of Toronto McLaughlin Centre; Genome Canada/Ontario Genomics Institute; Government of Ontario; Canadian Institutes of Health Research (CIHR); NeuroDevNet; Ontario Brain Institute; Catherine; Maxwell Meighen Foundation; The Hospital for Sick Children Foundation; CIHR Postdoctoral Fellowship; NARSAD Young Investigator; Thrasher Early Career Award; Banting Postdoctoral Fellowship; CIHR (Institute of Genetics) Clinical Investigatorship Award; Stollery Children's Hospital Foundation Chair in Autism Research; Patsy and Jamie Anderson Chair in Child and Youth Mental Health; Canada Research Chair in Law and Medicine; GlaxoSmithKline-CIHR Chair in Genome Sciences at the University of Toronto; The Hospital for Sick Children; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U24CA210004] Funding Source: NIH RePORTER	Autism Speaks, Autism Speaks Canada; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); University of Toronto McLaughlin Centre; Genome Canada/Ontario Genomics Institute(Genome Canada); Government of Ontario; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NeuroDevNet; Ontario Brain Institute; Catherine; Maxwell Meighen Foundation; The Hospital for Sick Children Foundation; CIHR Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); NARSAD Young Investigator(NARSAD); Thrasher Early Career Award; Banting Postdoctoral Fellowship; CIHR (Institute of Genetics) Clinical Investigatorship Award(Canadian Institutes of Health Research (CIHR)); Stollery Children's Hospital Foundation Chair in Autism Research; Patsy and Jamie Anderson Chair in Child and Youth Mental Health; Canada Research Chair in Law and Medicine; GlaxoSmithKline-CIHR Chair in Genome Sciences at the University of Toronto; The Hospital for Sick Children; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the families for their participation in the study, The Centre for Applied Genomics and Google for their analytical and technical support, and staff at Autism Speaks for organizational and fundraising support. This work was funded by Autism Speaks, Autism Speaks Canada, the Canadian Institute for Advanced Research, the University of Toronto McLaughlin Centre, Genome Canada/Ontario Genomics Institute, the Government of Ontario, the Canadian Institutes of Health Research (CIHR), NeuroDevNet, Ontario Brain Institute, the Catherine and Maxwell Meighen Foundation and The Hospital for Sick Children Foundation. Special thanks to B. and (the late) S. Wright for their vision in helping to conceptualize and develop this project and to foundational philanthropic supporters C. Dolan, G. Gund, B. Marcus, V. and J. Morgan and S. Wise. R.K.C.Y. is funded by the CIHR Postdoctoral Fellowship, NARSAD Young Investigator award and Thrasher Early Career Award. R.W. is funded by the Ontario Brain Institute and NeuroDevNet. M.U. is funded by the Banting Postdoctoral Fellowship. M.W. is funded by a CIHR (Institute of Genetics) Clinical Investigatorship Award. L.Z. is funded by the Stollery Children's Hospital Foundation Chair in Autism Research. P.S. is funded by the Patsy and Jamie Anderson Chair in Child and Youth Mental Health. B. M.K. is funded by the Canada Research Chair in Law and Medicine. S.W.S. is funded by the GlaxoSmithKline-CIHR Chair in Genome Sciences at the University of Toronto and The Hospital for Sick Children.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ameis SH, 2016, AM J PSYCHIAT, V173, P1213, DOI 10.1176/appi.ajp.2016.15111435; An JY, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.38; Anagnostou E, 2014, CAN MED ASSOC J, V186, P509, DOI 10.1503/cmaj.121756; Anney R, 2012, HUM MOL GENET, V21, P4781, DOI 10.1093/hmg/dds301; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Carter MT, 2013, CLIN GENET, V83, P399, DOI 10.1111/cge.12101; Ciernia AV, 2016, NAT REV NEUROSCI, V17, P411, DOI 10.1038/nrn.2016.41; Corominas R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4650; de la Torre-Ubieta L, 2016, NAT MED, V22, P345, DOI 10.1038/nm.4071; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Glazer D, 2015, APPL TRANSL GENOM, V6, P11, DOI 10.1016/j.atg.2015.07.004; Global Alliance Genomics Hlth, 2016, SCIENCE, V352, P1278, DOI 10.1126/science.aaf6162; Hadley D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5074; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Jiang YH, 2013, AM J HUM GENET, V93, P249, DOI 10.1016/j.ajhg.2013.06.012; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liu K, 2015, PHARMACOL THERAPEUT, V151, P121, DOI 10.1016/j.pharmthera.2015.04.001; Mannik K, 2015, JAMA-J AM MED ASSOC, V313, P2044, DOI 10.1001/jama.2015.4845; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Merico D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9718; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Miles JH, 2015, JAMA-J AM MED ASSOC, V314, P879, DOI 10.1001/jama.2015.9577; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Noor A, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001267; Pan C., PREPRINT; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Sahin M, 2015, SCIENCE, V350, P890, DOI 10.1126/science.aab3897; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Scherer SW, 2011, HUM GENET, V130, P123, DOI 10.1007/s00439-011-1037-2; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Solomon BD, 2013, P NATL ACAD SCI USA, V110, P9851, DOI 10.1073/pnas.1302575110; Sparrow SS, 1984, VINELAND ADAPTIVE BE; Stavropoulos DJ, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2015.12; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Stender JD, 2012, MOL CELL, V48, P28, DOI 10.1016/j.molcel.2012.07.020; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Tammimies K, 2015, JAMA-J AM MED ASSOC, V314, P895, DOI 10.1001/jama.2015.10078; Uddin M, 2014, NAT GENET, V46, P742, DOI 10.1038/ng.2980; Utami KH, 2014, HUM MUTAT, V35, P1311, DOI 10.1002/humu.22636; Wagner AH, 2016, NUCLEIC ACIDS RES, V44, pD1036, DOI 10.1093/nar/gkv1165; Walker S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-499; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792; Yuen RKC, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.27; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zhu MF, 2012, AM J HUM GENET, V91, P408, DOI 10.1016/j.ajhg.2012.07.004	72	426	433	5	169	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2017	20	4					602	+		10.1038/nn.4524	http://dx.doi.org/10.1038/nn.4524			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EP7LH	28263302	Green Accepted, Green Published			2022-12-17	WOS:000397558800015
J	Perez, CA; Huang, LQ; Rong, MQ; Kozak, JA; Preuss, AK; Zhang, HL; Max, M; Margolskee, RF				Perez, CA; Huang, LQ; Rong, MQ; Kozak, JA; Preuss, AK; Zhang, HL; Max, M; Margolskee, RF			A transient receptor potential channel expressed in taste receptor cells	NATURE NEUROSCIENCE			English	Article							CAPACITATIVE CA2+ ENTRY; TRP GENE FAMILY; SWEET TASTE; ACTIVATED CHANNEL; PLASMA-MEMBRANE; XENOPUS OOCYTES; TRANSDUCTION; BITTER; GUSTDUCIN; MOUSE	We used differential screening of cDNAs from individual taste receptor cells to identify candidate taste transduction elements in mice. Among the differentially expressed clones, one encoded Trpm5, a member of the mammalian family of transient receptor potential (TRP) channels. We found Trpm5 to be expressed in a restricted manner, with particularly high levels in taste tissue. In taste cells, Trpm5 was coexpressed with taste-signaling molecules such as alpha-gustducin, Ggamma(13), phospholipase C-beta(2) (PLC-beta(2)) and inositol 1,4,5-trisphosphate receptor type III (IP(3)R3). Our heterologous expression studies of Trpm5 indicate that it functions as a cationic channel that is gated when internal calcium stores are depleted. Trpm5 may be responsible for capacitative calcium entry in taste receptor cells that respond to bitter and/or sweet compounds.	NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, New York, NY 10029 USA; NYU, Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; Cellular Genom Inc, Branford, CT 06405 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei Province, Peoples R China	Howard Hughes Medical Institute; Icahn School of Medicine at Mount Sinai; New York University; Icahn School of Medicine at Mount Sinai; New York University; University of California System; University of California Irvine; Hebei Medical University	Margolskee, RF (corresponding author), NYU, Mt Sinai Sch Med, Howard Hughes Med Inst, Box 1677,1425 Madison Ave, New York, NY 10029 USA.	margolskee@msvax.mssm.edu	Perez, Cristian A./A-2341-2008	Margolskee, Robert/0000-0002-9572-2887; Huang, Liquan/0000-0003-3400-0685	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003155, R01DC003055] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC03155, DC03055, DC00310] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Asano-Miyoshi M, 2001, CHEM SENSES, V26, P259, DOI 10.1093/chemse/26.3.259; Bachmanov AA, 2001, CHEM SENSES, V26, P925, DOI 10.1093/chemse/26.7.925; Bernhardt SJ, 1996, J PHYSIOL-LONDON, V490, P325, DOI 10.1113/jphysiol.1996.sp021147; Birnbaumer L, 2000, RECENT PROG HORM RES, V55, P127; Bobanovic LK, 1999, BIOCHEM J, V340, P593, DOI 10.1042/0264-6021:3400593; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chan KW, 1996, J GEN PHYSIOL, V107, P381, DOI 10.1085/jgp.107.3.381; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Clapp TR, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-6; Enklaar T, 2000, GENOMICS, V67, P179, DOI 10.1006/geno.2000.6234; Gilbertson TA, 2000, CURR OPIN NEUROBIOL, V10, P519, DOI 10.1016/S0959-4388(00)00118-5; Gillo B, 1996, P NATL ACAD SCI USA, V93, P14146, DOI 10.1073/pnas.93.24.14146; Halaszovich CR, 2000, J BIOL CHEM, V275, P37423, DOI 10.1074/jbc.M007010200; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Lomax RB, 1998, CELL CALCIUM, V23, P229, DOI 10.1016/S0143-4160(98)90121-X; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/ng0501-58; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; Misaka T, 1997, J BIOL CHEM, V272, P22623, DOI 10.1074/jbc.272.36.22623; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Ogura T, 2002, J NEUROPHYSIOL, V87, P3152, DOI 10.1152/jn.2002.87.6.3152; Ogura T, 1997, J NEUROSCI, V17, P3580; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Prawitt D, 2000, HUM MOL GENET, V9, P203, DOI 10.1093/hmg/9.2.203; Putney JW, 1999, BIOESSAYS, V21, P38; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Rossler P, 2000, CHEM SENSES, V25, P413, DOI 10.1093/chemse/25.4.413; Rossler P, 1998, EUR J CELL BIOL, V77, P253; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Stortkuhl KF, 1999, J NEUROSCI, V19, P4839; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999; Yan WT, 2001, AM J PHYSIOL-CELL PH, V280, pC742, DOI 10.1152/ajpcell.2001.280.4.C742; Yatsuki H, 2000, DNA RES, V7, P195, DOI 10.1093/dnares/7.3.195	50	426	452	1	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2002	5	11					1169	1176		10.1038/nn952	http://dx.doi.org/10.1038/nn952			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609CG	12368808				2022-12-17	WOS:000178884600020
J	Snyder, EM; Philpot, BD; Huber, KM; Dong, X; Fallon, JR; Bear, MF				Snyder, EM; Philpot, BD; Huber, KM; Dong, X; Fallon, JR; Bear, MF			Internalization of ionotropic glutamate receptors in response to mGluR activation	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; PROTEIN-SYNTHESIS; SYNAPTIC TRANSMISSION; AMPA RECEPTORS; EXPRESSION; INDUCTION; LTD; CA1; POTENTIATION; ENDOCYTOSIS	Activation of group 1 metabotropic glutamate receptors (mGIuRs) stimulates dendritic protein synthesis and long-term synaptic depression (LTD), but it remains unclear how these effects are related. Here we provide evidence that a consequence of mGluR activation in the hippocampus is the rapid loss of both AMPA and NMDA receptors from synapses. Like mGluR-LTD, the stable expression of this change requires protein synthesis. These data suggest that expression of mGluR-LTD is at least partly postsynaptic, and that a functional consequence of dendritic protein synthesis is the regulation of glutamate receptor trafficking.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Brown Univ, Howard Hughes Med Inst, Providence, RI 02912 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	Brown University; Brown University; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bear, MF (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.		Huber, Kimberly/X-5534-2019	Bear, Mark/0000-0002-9903-2541	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039321] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR015578-020002, P20 RR015578] Funding Source: Medline; NINDS NIH HHS [NS39321, P01 NS039321, P01 NS039321-03] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; Bear MF, 2001, SYNAPSES, P455; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BENKE TA, 1993, P NATL ACAD SCI USA, V90, P7819, DOI 10.1073/pnas.90.16.7819; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Camodeca N, 1999, NEUROPHARMACOLOGY, V38, P1597, DOI 10.1016/S0028-3908(99)00093-3; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chung HJ, 2000, J NEUROSCI, V20, P7258; Cohen AS, 1996, J NEUROPHYSIOL, V76, P953, DOI 10.1152/jn.1996.76.2.953; Doherty AJ, 2000, BRIT J PHARMACOL, V131, P239, DOI 10.1038/sj.bjp.0703574; DUDEK SM, 1989, SCIENCE, V246, P673, DOI 10.1126/science.2573152; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3	34	426	444	0	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1079	1085		10.1038/nn746	http://dx.doi.org/10.1038/nn746			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11687813				2022-12-17	WOS:000171970900010
J	Magee, JC; Cook, EP				Magee, JC; Cook, EP			Somatic EPSP amplitude is independent of synapse location in hippocampal pyramidal neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SYNAPSES; QUANTAL AMPLITUDE; RECEPTOR NUMBER; VARIABILITY; CHANNELS; SLICES; CELLS; AMPA; ARCHITECTURE	Most neurons receive thousands of synaptic inputs onto widely spread dendrites. Because of dendritic filtering, distant synapses should have less efficacy than proximal ones. To investigate this, we characterized the amplitude and kinetics of excitatory synaptic input across the apical dendrites of CA1 pyramidal neurons using dual whole-cell recordings. We found that dendritic EPSP amplitude increases with distance from the soma, counterbalancing the filtering effects of the dendrites and reducing the location dependence of somatic EPSP amplitude. Dendritic current injections and a multi-compartmental computer model demonstrated that dendritic membrane properties have only a minor role in elevating the local EPSP. Instead a progressive increase in synaptic conductance seems to be primarily responsible for normalizing the amplitudes of individual inputs.	Louisiana State Univ, Med Ctr, Ctr Neurosci, New Orleans, LA 70112 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77050 USA	Louisiana State University System; Baylor College of Medicine; Howard Hughes Medical Institute	Magee, JC (corresponding author), Louisiana State Univ, Med Ctr, Ctr Neurosci, 2020 Gravier St, New Orleans, LA 70112 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS035865, R01NS035865, R01NS039458] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35865, NS39458] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN P, 1980, J PHYSIOL-LONDON, V307, P273, DOI 10.1113/jphysiol.1980.sp013435; Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; BANNISTER NJ, 1995, J COMP NEUROL, V360, P161, DOI 10.1002/cne.903600112; Bekkers JM, 1999, J PHYSIOL-LONDON, V516, P227, DOI 10.1111/j.1469-7793.1999.227aa.x; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bykhovskaia M, 1999, J NEUROPHYSIOL, V81, P2234, DOI 10.1152/jn.1999.81.5.2234; Cook EP, 1997, J NEUROPHYSIOL, V78, P2116, DOI 10.1152/jn.1997.78.4.2116; Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639, DOI 10.1152/jn.1997.77.3.1639; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; INASEK R, 1973, J PHYSIOL-LONDON, V234, P665; JACK JJB, 1971, J PHYSIOL-LONDON, V215, P283, DOI 10.1113/jphysiol.1971.sp009472; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; Jaffe DB, 1999, J NEUROPHYSIOL, V82, P3268, DOI 10.1152/jn.1999.82.6.3268; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; JOHNSTON D, 1995, FDN CELLULAR NEUROPH, P294; KORN H, 1993, J NEUROPHYSIOL, V70, P1249, DOI 10.1152/jn.1993.70.3.1249; KULLMANN DM, 1992, NATURE, V357, P240, DOI 10.1038/357240a0; LARKMAN A, 1991, NATURE, V350, P344, DOI 10.1038/350344a0; Larkman AU, 1997, J PHYSIOL-LONDON, V505, P457, DOI 10.1111/j.1469-7793.1997.457bb.x; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; Lim R, 1999, J PHYSIOL-LONDON, V516, P505, DOI 10.1111/j.1469-7793.1999.0505v.x; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; Mainen ZF, 1996, J NEUROPHYSIOL, V76, P1904, DOI 10.1152/jn.1996.76.3.1904; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28, DOI 10.1152/jn.2000.84.1.28; Prange O, 1999, J NEUROPHYSIOL, V81, P1810, DOI 10.1152/jn.1999.81.4.1810; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; RINZEL J, 1974, BIOPHYS J, V14, P759, DOI 10.1016/S0006-3495(74)85948-5; SORRA KE, 1993, J NEUROSCI, V13, P3736; Stricker C, 1996, J PHYSIOL-LONDON, V490, P419, DOI 10.1113/jphysiol.1996.sp021155; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172	41	426	429	0	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2000	3	9					895	903		10.1038/78800	http://dx.doi.org/10.1038/78800			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405TV	10966620				2022-12-17	WOS:000167177400016
J	Karlsson, MP; Frank, LM				Karlsson, Mattias P.; Frank, Loren M.			Awake replay of remote experiences in the hippocampus	NATURE NEUROSCIENCE			English	Article							CA1 PYRAMIDAL CELLS; PLACE CELLS; ENTORHINAL CORTEX; RECENT MEMORY; SHARP WAVES; REACTIVATION; SEQUENCES; SLEEP; PATTERNS; NEURONS	Hippocampal replay is thought to be essential for the consolidation of event memories in hippocampal-neocortical networks. Replay is present during both sleep and waking behavior, but although sleep replay involves the reactivation of stored representations in the absence of specific sensory inputs, awake replay is thought to depend on sensory input from the current environment. Here, we show that stored representations are reactivated during both waking and sleep replay. We found frequent awake replay of sequences of rat hippocampal place cells from a previous experience. This spatially remote replay was as common as local replay of the current environment and was more robust when the rat had recently been in motion than during extended periods of quiescence. Our results indicate that the hippocampus consistently replays past experiences during brief pauses in waking behavior, suggesting a role for waking replay in memory consolidation and retrieval.	[Frank, Loren M.] Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Frank, LM (corresponding author), Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	loren@phy.ucsf.edu		Frank, Loren/0000-0002-1752-5677	John Merck Scholars Program; McKnight Scholars Program; US National Institutes of Health [MH077970, MH080283]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080283, P50MH077970] Funding Source: NIH RePORTER	John Merck Scholars Program; McKnight Scholars Program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Brainard, D. Feldman, S. Lisberger, M. Stryker and the members of the Frank laboratory for comments on the manuscript. We also thank T. Davidson for a helpful discussion and M. Carr for help with histology photographs. This work was supported by the John Merck Scholars Program, the McKnight Scholars Program and US National Institutes of Health grants MH077970 and MH080283.	Battaglia FP, 2004, J NEUROSCI, V24, P4541, DOI 10.1523/JNEUROSCI.4896-03.2004; Brown EN, 1998, J NEUROSCI, V18, P7411; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 2007, EUR J NEUROSCI, V26, P704, DOI 10.1111/j.1460-9568.2007.05684.x; de Hoz L, 2006, HIPPOCAMPUS, V16, P704, DOI 10.1002/hipo.20207; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; FOX SE, 1981, EXP BRAIN RES, V41, P399; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Frank LM, 2004, J NEUROSCI, V24, P7681, DOI 10.1523/JNEUROSCI.1958-04.2004; Frank LM, 2001, J NEUROPHYSIOL, V86, P2029, DOI 10.1152/jn.2001.86.4.2029; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kim SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005494; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Mehta MR, 2007, NAT NEUROSCI, V10, P13, DOI 10.1038/nn0107-13; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sutherland GR, 2000, CURR OPIN NEUROBIOL, V10, P180, DOI 10.1016/S0959-4388(00)00079-9; Suzuki WA, 2006, NEURON, V50, P19, DOI 10.1016/j.neuron.2006.03.029; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	38	425	429	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2009	12	7					913	U132		10.1038/nn.2344	http://dx.doi.org/10.1038/nn.2344			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	462OA	19525943	Green Accepted, Green Submitted			2022-12-17	WOS:000267362900019
J	Ye, F; Chen, Y; Hoang, T; Montgomery, RL; Zhao, XH; Bu, H; Hu, T; Taketo, MM; van Es, JH; Clevers, H; Hsieh, J; Bassel-Duby, R; Olson, EN; Lu, QR				Ye, Feng; Chen, Ying; Hoang, ThaoNguyen; Montgomery, Rusty L.; Zhao, Xian-hui; Bu, Hong; Hu, Tom; Taketo, Makoto M.; van Es, Johan H.; Clevers, Hans; Hsieh, Jenny; Bassel-Duby, Rhonda; Olson, Eric N.; Lu, Q. Richard			HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the beta-catenin-TCF interaction	NATURE NEUROSCIENCE			English	Article							HISTONE DEACETYLASE INHIBITORS; WNT SIGNALING CONTROLS; DEVELOPING RAT-BRAIN; PROGENITOR CELLS; COLON-CARCINOMA; SPINAL-CORD; STEM-CELLS; GENE; MICE; PROTEIN	Oligodendrocyte development is regulated by the interaction of repressors and activators in a complex transcriptional network. We found that two histone-modifying enzymes, HDAC1 and HDAC2, were required for oligodendrocyte formation. Genetic deletion of both Hdac1 and Hdac2 in oligodendrocyte lineage cells resulted in stabilization and nuclear translocation of beta-catenin, which negatively regulates oligodendrocyte development by repressing Olig2 expression. We further identified the oligodendrocyte-restricted transcription factor TCF7L2/TCF4 as a bipartite co-effector of beta-catenin for regulating oligodendrocyte differentiation. Targeted disruption of Tcf7l2 in mice led to severe defects in oligodendrocyte maturation, whereas expression of its dominant-repressive form promoted precocious oligodendrocyte specification in developing chick neural tube. Transcriptional co-repressors HDAC1 and HDAC2 compete with beta-catenin for TCF7L2 interaction to regulate downstream genes involved in oligodendrocyte differentiation. Thus, crosstalk between HDAC1/2 and the canonical Wnt signaling pathway mediated by TCF7L2 serves as a regulatory mechanism for oligodendrocyte differentiation.	[Ye, Feng; Chen, Ying; Hoang, ThaoNguyen; Zhao, Xian-hui; Hu, Tom; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Ye, Feng; Chen, Ying; Hoang, ThaoNguyen; Zhao, Xian-hui; Hu, Tom; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA; [Ye, Feng; Bu, Hong] Sichuan Univ, W China Hosp, Lab Transplant Engn & Immunol, Chengdu, Peoples R China; [Montgomery, Rusty L.; Hsieh, Jenny; Bassel-Duby, Rhonda; Olson, Eric N.; Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; [van Es, Johan H.; Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands; [Lu, Q. Richard] Sichuan Univ, W China Univ Hosp 2, Chengdu, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sichuan University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Kyoto University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Sichuan University	Lu, QR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	qrichard.lu@utsouthwestern.edu	van+Es, Johan/ABD-5411-2021		US National Multiple Sclerosis Society [RG3978, PP0144]; US National Institutes of Health [NS050389]; Harry Weaver Neuroscience Scholar; Basil O'Connor Scholar; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050389] Funding Source: NIH RePORTER	US National Multiple Sclerosis Society(National Multiple Sclerosis Society); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harry Weaver Neuroscience Scholar(National Multiple Sclerosis Society); Basil O'Connor Scholar(March of Dimes); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank J. Johnson and B. Cregg for a critical reading of the manuscript and D. Rowitch for communicating their unpublished results. We thank W. Walker, A. Iavarone, Y. Yokota, K. Kim, R. Miskimins and J. Suh for Id2 and Id4, Mbp promoter reporters, and b- catenin and TCF expression vectors, and X. Xu for technical assistance. This study was funded by grants from the US National Multiple Sclerosis Society (RG3978 and PP0144) and the US National Institutes of Health (NS050389 to Q. R. L.). Q. R. L. is a Harry Weaver Neuroscience Scholar and a Basil O'Connor Scholar.	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cunliffe VT, 2006, MECH DEVELOP, V123, P24, DOI 10.1016/j.mod.2005.10.005; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Marin-Husstege M, 2002, J NEUROSCI, V22, P10333; Megason SG, 2002, DEVELOPMENT, V129, P2087; Memezawa A, 2007, ONCOGENE, V26, P5038, DOI 10.1038/sj.onc.1210320; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Miskimins R, 2002, J NEUROSCI RES, V67, P100, DOI 10.1002/jnr.10080.abs; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Munemitsu S, 1996, MOL CELL BIOL, V16, P4088; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; ONO K, 1995, DEVELOPMENT, V121, P1743; Rockman SP, 2001, J BIOL CHEM, V276, P45113, DOI 10.1074/jbc.M107742200; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shimizu T, 2005, DEV BIOL, V282, P397, DOI 10.1016/j.ydbio.2005.03.020; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stankoff B, 2002, J NEUROSCI, V22, P9221; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wang SZ, 2006, DEVELOPMENT, V133, P3389, DOI 10.1242/dev.02522; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Yamaguchi M, 2005, DEVELOPMENT, V132, P3027, DOI 10.1242/dev.01881; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	50	425	447	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2009	12	7					829	U35		10.1038/nn.2333	http://dx.doi.org/10.1038/nn.2333			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	462OA	19503085	Green Accepted			2022-12-17	WOS:000267362900009
J	Avenanti, A; Bueti, D; Galati, G; Aglioti, SM				Avenanti, A; Bueti, D; Galati, G; Aglioti, SM			Transcranial magnetic stimulation highlights the sensorimotor side of empathy for pain	NATURE NEUROSCIENCE			English	Article							HUMAN MOTOR CORTEX; PHANTOM-LIMB PAIN; COIL ORIENTATION; NEURAL SYSTEMS; MODULATION; IMITATION; ACTIVATION; MECHANISMS; PREMOTOR; BRAIN	Pain is intimately linked with action systems that are involved in observational learning and imitation. Motor responses to one's own pain allow freezing or escape reactions and ultimately survival. Here we show that similar motor responses occur as a result of observation of painful events in others. We used transcranial magnetic stimulation to record changes in corticospinal motor representations of hand muscles of individuals observing needles penetrating hands or feet of a human model or noncorporeal objects. We found a reduction in amplitude of motor-evoked potentials that was specific to the muscle that subjects observed being pricked. This inhibition correlated with the observer's subjective rating of the sensory qualities of the pain attributed to the model and with sensory, but not emotional, state or trait empathy measures. The empathic inference about the sensory qualities of others' pain and their automatic embodiment in the observer's motor system may be crucial for the social learning of reactions to pain.	Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; IRCCS, Fdn Santa Lucia, I-00179 Rome, Italy; Univ G DAnnunzio, Dipartimento Sci Clin & Bioimmagini, I-66010 Chieti, Italy	Sapienza University Rome; IRCCS Santa Lucia; G d'Annunzio University of Chieti-Pescara	Aglioti, SM (corresponding author), Univ Roma La Sapienza, Dipartimento Psicol, Via Marsi 78, I-00185 Rome, Italy.	salvatoremaria.aglioti@uniroma1.it	Galati, Gaspare/F-3277-2011; Avenanti, Alessio/K-5250-2012; Bueti, Domenica/E-7627-2014; Aglioti, Salvatore M/E-9829-2012	Galati, Gaspare/0000-0002-0640-4247; Avenanti, Alessio/0000-0003-1139-9996; Bueti, Domenica/0000-0001-6660-7241; Aglioti, Salvatore Maria/0000-0001-8175-7563				Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Bonino S., 1998, EMPATIA PROCESSI CON; Bradshaw JL, 2001, J NEUROL NEUROSUR PS, V70, P135; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Davis Mark H., 1996, EMPATHY SOCIAL PSYCH; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; EISEN A, 1987, CAN J NEUROL SCI, V14, P501, DOI 10.1017/S0317167100037999; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Farina S, 2003, NEUROL RES, V25, P130, DOI 10.1179/016164103101201283; Farina S, 2001, NEUROSCI LETT, V314, P97, DOI 10.1016/S0304-3940(01)02297-2; Flor H, 2002, LANCET NEUROL, V1, P182, DOI 10.1016/S1474-4422(02)00074-1; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Hutchison WD, 1999, NAT NEUROSCI, V2, P403, DOI 10.1038/8065; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Ingvar M, 1999, PHILOS T R SOC B, V354, P1347, DOI 10.1098/rstb.1999.0483; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jarvelainen J, 2004, NEUROIMAGE, V23, P187, DOI 10.1016/j.neuroimage.2004.06.010; Juottonen K, 2002, PAIN, V98, P315, DOI 10.1016/S0304-3959(02)00119-7; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; KIMURA J, 1993, ELECTRODIAGNOSIS DIS; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Maeda F, 2002, J NEUROPHYSIOL, V87, P1329, DOI 10.1152/jn.00773.2000; MAIANI G, 1985, PAIN, V22, P399, DOI 10.1016/0304-3959(85)90045-4; Meltzoff AN, 2003, PHILOS T R SOC B, V358, P491, DOI 10.1098/rstb.2002.1261; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Porro CA, 2003, NEUROIMAGE, V19, P1738, DOI 10.1016/S1053-8119(03)00184-8; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rainville P, 2002, CURR OPIN NEUROBIOL, V12, P195, DOI 10.1016/S0959-4388(02)00313-6; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Saitoh Y, 1999, LANCET, V353, P212, DOI 10.1016/S0140-6736(05)77223-8; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Svensson P, 2003, EUR J PAIN-LONDON, V7, P55, DOI 10.1016/S1090-3801(02)00050-2; Urban PP, 2004, MUSCLE NERVE, V29, P663, DOI 10.1002/mus.20011; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080; Wittgenstein L., 1958, PHILOS INVESTIGATION, V2nd	50	425	435	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2005	8	7					955	960		10.1038/nn1481	http://dx.doi.org/10.1038/nn1481			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	940IK	15937484				2022-12-17	WOS:000230137100024
J	Impey, S; Smith, DM; Obrietan, K; Donahue, R; Wade, C; Storm, DR				Impey, S; Smith, DM; Obrietan, K; Donahue, R; Wade, C; Storm, DR			Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; HIPPOCAMPAL-LESIONS; MUTANT MICE; LATE-PHASE; BASOLATERAL AMYGDALA; ADENYLATE-CYCLASE; GENE-EXPRESSION; FEAR; POTENTIATION; CREB	Recent studies suggest that the CREB-CRE transcriptional pathway is pivotal in the formation of some types of long-term memory. However, it has not been demonstrated that stimuli that induce learning and memory activate CRE-mediated gene expression. To address this issue, we used a mouse strain transgenic for a CRE-lac Z reporter to examine the effects of hippocampus-dependent learning on CRE-mediated gene expression in the brain. Training for contextual conditioning or passive avoidance led to significant increases in CRE-dependent gene expression in areas CA1 and CA3 of the hippocampus. Auditory cue fear-conditioning, which is amygdala dependent, was associated with increased CRE-mediated gene expression in the amygdala, but not the hippocampus. These data demonstrate that learning in response to behavioral conditioning activates the CRE transcriptional pathway in specific areas of brain.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Mail Box 357280,Hlth Sci Bldg, Seattle, WA 98195 USA.	dstorm@u.washington.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 20498] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; BARONDES SH, 1968, P NATL ACAD SCI USA, V61, P923, DOI 10.1073/pnas.61.3.923; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BRINDLE P, 1995, P NATL ACAD SCI USA, V92, P10521, DOI 10.1073/pnas.92.23.10521; CAMPEAU S, 1996, NEURON, V16, P237; Chen C, 1996, BEHAV NEUROSCI, V110, P1177; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.ne.15.030192.002033; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; DUTAR P, 1995, PHYSIOL REV, V75, P393, DOI 10.1152/physrev.1995.75.2.393; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Good M, 1997, BEHAV NEUROSCI, V111, P487, DOI 10.1037/0735-7044.111.3.487; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P1005, DOI 10.1037/0735-7044.108.5.1005; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; IMPEY S, IN PRESS NEURON; Kandel ER, 1997, J CELL PHYSIOL, V173, P124, DOI 10.1002/(SICI)1097-4652(199711)173:2<124::AID-JCP6>3.3.CO;2-5; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; LUBOW RE, 1973, PSYCHOL BULL, V79, P398, DOI 10.1037/h0034425; Maren S, 1996, BEHAV NEUROSCI, V110, P718, DOI 10.1037/0735-7044.110.4.718; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; Nguyen PV, 1996, J NEUROSCI, V16, P3189; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; PHILLIPS RG, 1995, J NEUROSCI, V15, P5308; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Stevens CF, 1998, NEURON, V20, P1, DOI 10.1016/S0896-6273(00)80426-2; StubleyWeatherly L, 1996, BRAIN RES, V716, P29, DOI 10.1016/0006-8993(95)01589-2; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; YECKEL MF, 1995, HIPPOCAMPUS, V5, P108, DOI 10.1002/hipo.450050204; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; YOVELL Y, 1987, P NATL ACAD SCI USA, V84, P9285, DOI 10.1073/pnas.84.24.9285	50	425	439	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	1998	1	7					595	601		10.1038/2830	http://dx.doi.org/10.1038/2830			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	146NL	10196567				2022-12-17	WOS:000077437100015
J	Sharma, K; Schmitt, S; Bergner, CG; Tyanova, S; Kannaiyan, N; Manrique-Hoyos, N; Kongi, K; Cantuti, L; Hanisch, UK; Philips, MA; Rossner, MJ; Mann, M; Simons, M				Sharma, Kirti; Schmitt, Sebastian; Bergner, Caroline G.; Tyanova, Stefka; Kannaiyan, Nirmal; Manrique-Hoyos, Natalia; Kongi, Karina; Cantuti, Ludovico; Hanisch, Uwe-Karsten; Philips, Mari-Anne; Rossner, Moritz J.; Mann, Matthias; Simons, Mikael			Cell type- and brain region-resolved mouse brain proteome	NATURE NEUROSCIENCE			English	Article							TRANSLATIONAL PROFILING APPROACH; MOLECULAR CHARACTERIZATION; NEURITE OUTGROWTH; MEMBRANE-PROTEIN; GENE-EXPRESSION; TRANSCRIPTOME; NEUROTRIMIN; ASTROCYTES; ACCURATE; INSIGHTS	Brain transcriptome and connectome maps are being generated, but an equivalent effort on the proteome is currently lacking. We performed high-resolution mass spectrometry based proteomics for in-depth analysis of the mouse brain and its major brain regions and cell types. Comparisons of the 12,934 identified proteins in oligodendrocytes, astrocytes, microglia and cortical neurons with deep sequencing data of the transcriptome indicated deep coverage of the proteome. Cell type specific proteins defined as tenfold more abundant than average expression represented about a tenth of the proteome, with an overrepresentation of cell surface proteins. To demonstrate the utility of our resource, we focused on this class of proteins and identified Lsamp, an adhesion molecule of the IgLON family, as a negative regulator of myelination. Our findings provide a framework for a system-level understanding of cell-type diversity in the CNS and serves as a rich resource for analyses of brain development and function.	[Sharma, Kirti; Tyanova, Stefka; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Schmitt, Sebastian; Bergner, Caroline G.; Manrique-Hoyos, Natalia; Cantuti, Ludovico; Rossner, Moritz J.; Simons, Mikael] Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Schmitt, Sebastian; Bergner, Caroline G.; Manrique-Hoyos, Natalia; Cantuti, Ludovico; Simons, Mikael] Univ Gottingen, Dept Neurol, Gottingen, Germany; [Kannaiyan, Nirmal; Rossner, Moritz J.] Univ Munich, Dept Psychiat, D-80539 Munich, Germany; [Kongi, Karina; Philips, Mari-Anne] Univ Tartu, Inst Biomed & Translat Med, Dept Physiol, Tartu, Estonia; [Hanisch, Uwe-Karsten] Univ Gottingen, Dept Neuropathol, D-37073 Gottingen, Germany	Max Planck Society; Max Planck Society; University of Gottingen; University of Munich; University of Tartu; University of Gottingen	Simons, M (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	mmann@biochem.mpg.de; msimons@gwdg.de	Sharma, Kirti/C-5944-2011; Cantuti-Castelvetri, Ludovico/AAH-8208-2019; Sharma, Kirti/GQQ-4921-2022; Philips, Mari-Anne/AAZ-7624-2021	Sharma, Kirti/0000-0003-3704-1466; Cantuti-Castelvetri, Ludovico/0000-0002-0642-1610; Philips, Mari-Anne/0000-0001-7103-4038; Manrique Hoyos, Natalia/0000-0002-2478-7456; Simons, Mikael/0000-0001-5329-192X; Kannaiyan, Nirmal Raman/0000-0002-7408-6842; Rossner, Moritz/0000-0002-0667-3420	German Research Foundation [SI 746/9-1, 10-1, TRR43, RO 4076/3-1]; Tschira-Stiftung; Estonian Research Council [IUT20-41, PUT129]; European Commission under FP7 [ERC-2012-SyG_318987]; MC-ITN IN-SENS [607616]; Boeringer-Ingelheim Fonds; INSENS/FP7-PEOPLE [607616]	German Research Foundation(German Research Foundation (DFG)); Tschira-Stiftung; Estonian Research Council; European Commission under FP7; MC-ITN IN-SENS; Boeringer-Ingelheim Fonds; INSENS/FP7-PEOPLE	We would like to acknowledge the PRIDE Team for upload of proteomics raw data. We thank J. Cox, M.Y. Hein and K. Mayr for helpful discussions, and C. Velte, N. Schwedhelm-Dornmeyer, S. Safaiyan, G. Sowa and M. Dodel for technical assistance. Illumina sequencing was performed by R. Reinhardt at the Max-Planck Genome Center Cologne. The work was supported grants from the German Research Foundation (SI 746/9-1; 10-1; TRR43; RO 4076/3-1), the Tschira-Stiftung, and grants from the Estonian Research Council (IUT20-41 and PUT129). The research leading to these results has received funding from the European Commission under FP7 GA noERC-2012-SyG_318987 - ToPAG and MC-ITN IN-SENS (#607616). S.S. received a PhD scholarship from the Boeringer-Ingelheim Fonds and N.K. this recipient of a Marie-Curie fellowship from the INSENS/FP7-PEOPLE-2013 (607616) framework.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; Azimifar SB, 2014, CELL METAB, V20, P1076, DOI 10.1016/j.cmet.2014.11.002; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Beck M, 2011, CURR OPIN BIOTECH, V22, P3, DOI 10.1016/j.copbio.2010.09.002; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Charles P, 2000, P NATL ACAD SCI USA, V97, P7585, DOI 10.1073/pnas.100076197; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gholami AM, 2013, CELL REP, V4, P609, DOI 10.1016/j.celrep.2013.07.018; Gil OD, 1998, J NEUROSCI, V18, P9312; Gil OD, 2002, J NEUROBIOL, V51, P190, DOI 10.1002/neu.10050; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Innos J, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00032; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kitchen RR, 2014, NAT NEUROSCI, V17, P1491, DOI 10.1038/nn.3829; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Maurel P, 2007, J CELL BIOL, V178, P861, DOI 10.1083/jcb.200705132; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; PIMENTA AF, 1995, NEURON, V15, P287, DOI 10.1016/0896-6273(95)90034-9; Ponten F, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.93; Reed J, 2004, J CELL SCI, V117, P3961, DOI 10.1242/jcs.01261; Reed JE, 2007, NEUROPATH APPL NEURO, V33, P77, DOI 10.1111/j.1365-2990.2006.00786.x; SCHOFIELD PR, 1989, EMBO J, V8, P489, DOI 10.1002/j.1460-2075.1989.tb03402.x; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Snead MP, 1999, J MED GENET, V36, P353; Spiegel I, 2007, NAT NEUROSCI, V10, P861, DOI 10.1038/nn1915; STRUYK AF, 1995, J NEUROSCI, V15, P2141, DOI 10.1523/JNEUROSCI.15-03-02141.1995; Thompson CL, 2014, NEURON, V83, P309, DOI 10.1016/j.neuron.2014.05.033; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wisniewski JR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.44; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	50	424	428	5	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2015	18	12					1819	1831		10.1038/nn.4160	http://dx.doi.org/10.1038/nn.4160			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CX1LV	26523646	Green Accepted			2022-12-17	WOS:000365458600021
J	Maia, TV; Frank, MJ				Maia, Tiago V.; Frank, Michael J.			From reinforcement learning models to psychiatric and neurological disorders	NATURE NEUROSCIENCE			English	Review							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; BASAL GANGLIA; PREFRONTAL CORTEX; PREDICTION-ERROR; DECISION-MAKING; COMPUTATIONAL MODELS; NUCLEUS-ACCUMBENS; WORKING-MEMORY; DOPAMINE MODULATION; OPTOGENETIC CONTROL	Over the last decade and a half, reinforcement learning models have fostered an increasingly sophisticated understanding of the functions of dopamine and cortico-basal ganglia-thalamo-cortical (CBGTC) circuits. More recently, these models, and the insights that they afford, have started to be used to understand important aspects of several psychiatric and neurological disorders that involve disturbances of the dopaminergic system and CBGTC circuits. We review this approach and its existing and potential applications to Parkinson's disease, Tourette's syndrome, attention-deficit/hyperactivity disorder, addiction, schizophrenia and preclinical animal models used to screen new antipsychotic drugs. The approach's proven explanatory and predictive power bodes well for the continued growth of computational psychiatry and computational neurology.	[Maia, Tiago V.] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Maia, Tiago V.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Frank, Michael J.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Frank, Michael J.] Brown Univ, Dept Psychiat & Human Behav, Providence, RI 02912 USA; [Frank, Michael J.] Brown Univ, Brown Inst Brain Sci, Providence, RI 02912 USA	Columbia University; New York State Psychiatry Institute; Brown University; Brown University; Brown University	Maia, TV (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	tmaia@columbia.edu; michael_frank@brown.edu		Maia, Tiago/0000-0002-5254-0389	New York State Psychiatric Institute; Research Foundation for Mental Hygiene; National Institute of Mental Health [R01 MH080066]; Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080066] Funding Source: NIH RePORTER	New York State Psychiatric Institute; Research Foundation for Mental Hygiene; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael J. Fox Foundation for Parkinson's Research; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Preparation of this article was funded by a Research Associate Award from the New York State Psychiatric Institute and the Research Foundation for Mental Hygiene, by National Institute of Mental Health grant R01 MH080066 and by a grant from the Michael J. Fox Foundation for Parkinson's Research.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Baier B, 2010, J NEUROSCI, V30, P9788, DOI 10.1523/JNEUROSCI.1513-10.2010; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bayer HM, 2007, J NEUROPHYSIOL, V98, P1428, DOI 10.1152/jn.01140.2006; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Biederman J, 1999, BIOL PSYCHIAT, V46, P1234, DOI 10.1016/S0006-3223(99)00192-4; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bohlhalter S, 2006, BRAIN, V129, P2029, DOI 10.1093/brain/awl050; Brown JW, 2004, NEURAL NETWORKS, V17, P471, DOI 10.1016/j.neunet.2003.08.006; Charney DS, 2002, RESEARCH AGENDA FOR DSM-V, P31; Cools R, 2010, BRAIN, V133, P225, DOI 10.1093/brain/awp301; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Corlett PR, 2007, J PSYCHOPHARMACOL, V21, P238, DOI 10.1177/0269881107077716; CREESE I, 1983, ANNU REV NEUROSCI, V6, P43, DOI 10.1146/annurev.ne.06.030183.000355; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Dayan P, 2006, NEURAL NETWORKS, V19, P1153, DOI 10.1016/j.neunet.2006.03.002; Dayan P, 2000, NAT NEUROSCI, V3, P1218, DOI 10.1038/81504; DELFS JM, 1990, NEUROSCIENCE, V39, P59, DOI 10.1016/0306-4522(90)90221-O; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dezfouli A, 2009, NEURAL COMPUT, V21, P2869, DOI 10.1162/neco.2009.10-08-882; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; FANTIN G, 1984, EXPERIENTIA, V40, P573, DOI 10.1007/BF01982337; FIBIGER HC, 1974, PHARMACOL BIOCHEM BE, V2, P87, DOI 10.1016/0091-3057(74)90139-7; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2007, PHILOS T R SOC B, V362, P1641, DOI 10.1098/rstb.2007.2058; Frank MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P1583, DOI 10.1038/sj.npp.1301278; Frank MJ, 2006, NEURAL NETWORKS, V19, P1120, DOI 10.1016/j.neunet.2006.03.006; Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gerfen CR, 2000, TRENDS NEUROSCI, V23, pS64, DOI 10.1016/S1471-1931(00)00019-7; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Guillin O, 2007, INT REV NEUROBIOL, V78, P1, DOI 10.1016/S0074-7742(06)78001-1; Gurney K, 2001, BIOL CYBERN, V84, P411, DOI 10.1007/PL00007985; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Hyman SE, 2007, NAT REV NEUROSCI, V8, P725, DOI 10.1038/nrn2218; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kheramin S, 2004, PSYCHOPHARMACOLOGY, V175, P206, DOI 10.1007/s00213-004-1813-y; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Maia TV, 2008, DEV PSYCHOPATHOL, V20, P1251, DOI 10.1017/S0954579408000606; Maia TV, 2010, LEARN BEHAV, V38, P50, DOI 10.3758/LB.38.1.50; Maia TV, 2009, COGN AFFECT BEHAV NE, V9, P343, DOI 10.3758/CABN.9.4.343; Maia TV, 2009, COGNITIVE SCI, V33, P1232, DOI 10.1111/j.1551-6709.2009.01054.x; Maia TV, 2005, TRENDS COGN SCI, V9, P397, DOI 10.1016/j.tics.2005.06.016; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mink JW, 2001, PEDIATR NEUROL, V25, P190, DOI 10.1016/S0887-8994(01)00262-4; Morris G, 2010, EXP BRAIN RES, V200, P307, DOI 10.1007/s00221-009-2060-6; Moustafa AA, 2008, NEUROPSYCHOLOGIA, V46, P3144, DOI 10.1016/j.neuropsychologia.2008.07.011; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Nikolaus S, 2009, BEHAV BRAIN RES, V204, P32, DOI 10.1016/j.bbr.2009.06.009; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Palminteri S, 2009, P NATL ACAD SCI USA, V106, P19179, DOI 10.1073/pnas.0904035106; Panlilio LV, 2007, PHARMACOL BIOCHEM BE, V86, P774, DOI 10.1016/j.pbb.2007.03.005; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Peterson BS, 1999, TOURETTES SYNDROME T, P230; Postuma RB, 2006, CEREB CORTEX, V16, P1508, DOI 10.1093/cercor/bhj088; Prescott T., 2003, HDB BRAIN THEORY NEU, P147; Redish A. D., 2008, BEHAV BRAIN SCI, V31, P437, DOI DOI 10.1017/S0110525X0100472X; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Sagvolden T, 1998, BEHAV BRAIN RES, V94, P1; Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schultz W, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-24; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Smith AJ, 2005, NEURAL COMPUT, V17, P361, DOI 10.1162/0899766053011546; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Stahl SM, 2007, CNS SPECTRUMS, V12, P265, DOI 10.1017/S1092852900021015; Steeves TDL, 2008, PROG BRAIN RES, V172, P495, DOI 10.1016/S0079-6123(08)00924-2; STRAUSS GP, BIOL PSYCHI IN PRESS; Sutton Richard S, 1998, INTRO REINFORCEMENT, V2; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Volkow ND, 2007, ARCH NEUROL-CHICAGO, V64, P1575, DOI 10.1001/archneur.64.11.1575; WADENBERG ML, 1990, BIOL PSYCHIAT, V28, P297, DOI 10.1016/0006-3223(90)90657-N; Wadenberg MLG, 1999, NEUROSCI BIOBEHAV R, V23, P851, DOI 10.1016/S0149-7634(99)00037-8; WALTERS JR, 1987, SCIENCE, V236, P719; Waltz JA, 2007, BIOL PSYCHIAT, V62, P756, DOI 10.1016/j.biopsych.2006.09.042; Waltz JA, 2011, NEUROPSYCHOLOGY, V25, P86, DOI 10.1037/a0020882; Waltz JA, 2009, NEUROPSYCHOPHARMACOL, V34, P1567, DOI 10.1038/npp.2008.214; Wiecki TV, 2010, PROG BRAIN RES, V183, P275, DOI 10.1016/S0079-6123(10)83014-6; Winstanley CA, 2005, NEUROPSYCHOPHARMACOL, V30, P669, DOI 10.1038/sj.npp.1300610; Yin HH, 2008, EUR J NEUROSCI, V28, P1437, DOI 10.1111/j.1460-9568.2008.06422.x; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	101	424	433	2	174	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2011	14	2					154	162		10.1038/nn.2723	http://dx.doi.org/10.1038/nn.2723			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	711MJ	21270784	Green Accepted			2022-12-17	WOS:000286595400011
J	Rypma, B; D'Esposito, M				Rypma, B; D'Esposito, M			Isolating the neural mechanisms of age-related changes in human working memory	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; BRAIN-REGIONS; CORTEX; STORAGE; MODEL; BEHAVIOR; ROLES; LOAD; FMRI	Working memory (WM), the process by which information is coded into memory, actively maintained and subsequently retrieved, declines with age. To test the hypothesis that age-related changes in prefrontal cortex (PFC) may mediate this WM decline, we used functional MRI to investigate age differences in PFC activity during separate WM task components (encoding, maintenance, retrieval). We found greater PFC activity in younger than older adults only in dorsolateral PFC during memory retrieval. Fast younger subjects showed less dorsolateral PFC activation during retrieval than slow younger subjects, whereas older adults showed the opposite pattern. Thus age-related changes in dorsolateral PFC and not ventrolateral PFC account for WM decline with normal aging.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rypma, B (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, 3210 Tolman Hall, Berkeley, CA 94720 USA.	rypma@socrates.berkeley.edu			NIA NIH HHS [AG15793, AG13483] Funding Source: Medline; NINDS NIH HHS [NS01762] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015793, R01AG013483] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; ANDERS TR, 1972, DEV PSYCHOL, V6, P214, DOI 10.1037/h0032103; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; BELSLEY DA, 1980, REGRESSOIN DIAGNOSTI; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Craik F. I. M., 1992, HDB AGING COGNITION, P51, DOI DOI 10.1016/S0022-5371(72)80001-X; D'Esposito M, 1999, NEUROIMAGE, V10, P6, DOI 10.1006/nimg.1999.0444; DESPOSITO M, 1989, BRAIN COGNITION, V41, P66; Fuster J., 1989, DISSERT ABSTRACTS IN, V60, P255; GLANZER M, 1974, J VERB LEARN VERB BE, V13, P114, DOI 10.1016/S0022-5371(74)80036-8; GOLDBERG HI, 1977, STROKE, V8, P6; HAUG H, 1991, NEUROBIOL AGING, V12, P336, DOI 10.1016/0197-4580(91)90013-A; HEILBRONER PL, 1990, ACTA NEUROPATHOL, V81, P60, DOI 10.1007/BF00662638; Kimberg DY, 1997, NEUROREPORT, V8, P3581, DOI 10.1097/00001756-199711100-00032; Kleinbaum D, 1988, APPL REGRESSION ANAL; MITCHELL KJ, IN PRESS PSYCHOL AGI; MYERSON J, 1990, PSYCHOL REV, V97, P475, DOI 10.1037/0033-295X.97.4.475; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PETRIDES M, 1989, HDB NEUROPSYCHOLOGY, V3, P75; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Talairach J., 1988, COPLANAR STEREOTAXIC; VANDERLINDEN M, 1994, BRIT J PSYCHOL, V85, P145; WAUGH NC, 1965, PSYCHOL REV, V72, P89, DOI 10.1037/h0021797; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	32	424	433	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2000	3	5					509	515		10.1038/74889	http://dx.doi.org/10.1038/74889			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	309DG	10769393				2022-12-17	WOS:000086752000022
J	Paulesu, E; McCrory, E; Fazio, F; Menoncello, L; Brunswick, N; Cappa, SF; Cotelli, M; Cossu, G; Corte, F; Lorusso, M; Pesenti, S; Gallagher, A; Perani, D; Price, C; Frith, CD; Frith, U				Paulesu, E; McCrory, E; Fazio, F; Menoncello, L; Brunswick, N; Cappa, SF; Cotelli, M; Cossu, G; Corte, F; Lorusso, M; Pesenti, S; Gallagher, A; Perani, D; Price, C; Frith, CD; Frith, U			A cultural effect on brain function	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION TOMOGRAPHY; WORD RECOGNITION; READING ALOUD; TEMPORAL-LOBE; CONSISTENCY; ACTIVATION; PICTURES; AGRAPHIA; PATIENT; ANATOMY	We present behavioral and anatomical evidence for a multi-component reading system in which different components are differentially weighted depending on culture-specific demands of orthography Italian orthography is consistent, enabling reliable conversion of graphemes to phonemes to yield correct pronunciation of the word. English orthography is inconsistent, complicating mapping of letters to word sounds. In behavioral studies, Italian students showed faster word and non-word reading than English students. In two PET studies, Italians showed greater activation in left superior temporal regions associated with phoneme processing. In contrast, English readers showed greater activations, particularly for non-words, in left posterior inferior temporal gyrus and anterior inferior frontal gyrus, areas associated with word retrieval during both reading and naming tasks.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; Univ Milano Bicocca, CNR, INB, Sci Inst HS Raffaele, Milan, Italy; Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3GB, England; Univ Brescia, Dept Neurol, Brescia, Italy; Univ Vita & Salute H San Raffaele, Dept Psychol, Milan, Italy; Univ Parma, Ist Fisiol Umana, I-43100 Parma, Italy; Sci Inst Eugenio Medea La Nostra Famiglia, Bosisio Parini, Italy	University of London; University College London; Consiglio Nazionale delle Ricerche (CNR); University of Milano-Bicocca; University of London; University College London; University of Brescia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Parma; IRCCS Eugenio Medea	Frith, U (corresponding author), UCL, Inst Cognit Neurosci, 7 Queen Sq, London WC1N 3AR, England.	u.frith@ucl.ac.uk	Frith, Chris D/A-2171-2009; Cappa, Stefano/B-1874-2014; Perani, Daniela/AAN-3221-2020; Cotelli, Maria/K-1355-2016; Frith, Uta/C-1757-2008; Lorusso, Maria Luisa/K-8769-2016; PAULESU, ERALDO/C-2737-2017	Frith, Chris D/0000-0002-8665-0690; Cappa, Stefano/0000-0003-1003-3925; Cotelli, Maria/0000-0003-3208-3798; Frith, Uta/0000-0002-9063-4466; Lorusso, Maria Luisa/0000-0003-4640-306X; Brunswick, Nicola/0000-0002-6652-5016; PAULESU, ERALDO/0000-0002-9224-754X; Price, Catherine/0000-0001-7448-4835	Wellcome Trust [051067] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BEAUVOIS MF, 1979, J NEUROL NEUROSUR PS, V42, P1115, DOI 10.1136/jnnp.42.12.1115; Bookheimer SY, 1995, HUM BRAIN MAPP, V3, P93, DOI 10.1002/hbm.460030206; Cappa SF, 1997, COGNITION, V65, P1, DOI 10.1016/S0010-0277(97)00024-3; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037/0033-295X.100.4.589; COSSU G, 1995, READ WRIT, V7, P9, DOI 10.1007/BF01026945; De Mauro T., 1993, LESSICO FREQUENZA IT; DEMONET JF, 1994, NEUROSCI LETT, V182, P25, DOI 10.1016/0304-3940(94)90196-1; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Friston KJ, 1997, HUMAN BRAIN FUNCTION, P25; Frith U., 1998, SCI STUD READ, V2, P31, DOI [10.1207/s1532799xssr0201_2, DOI 10.1207/S1532799XSSR0201_2]; FROST R, 1987, J EXP PSYCHOL HUMAN, V13, P104, DOI 10.1037/0096-1523.13.1.104; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; Jonsdottir MK, 1996, COGNITION, V59, P169, DOI 10.1016/0010-0277(95)00693-1; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; Marshall, 1980, DEEP DYSLEXIA, P91; Menard MT, 1996, NEUROPSYCHOLOGIA, V34, P185, DOI 10.1016/0028-3932(95)00099-2; Nespor Marina, 1993, FONOLOGIA; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; NYIKOS J, 1988, 14 LACUS FORUM 1987, P146; Patterson K, 1997, J EXP PSYCHOL HUMAN, V23, P1217, DOI 10.1037/0096-1523.23.4.1217; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paulesu E, 1997, NEUROREPORT, V8, P2011, DOI 10.1097/00001756-199705260-00042; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Price CJ, 1996, P ROY SOC B-BIOL SCI, V263, P1501, DOI 10.1098/rspb.1996.0219; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; ROELTGEN DP, 1984, BRAIN, V107, P811, DOI 10.1093/brain/107.3.811; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; SHALLICE T, 1981, BRAIN, V104, P413, DOI 10.1093/brain/104.3.413; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Zorzi M, 1998, J EXP PSYCHOL HUMAN, V24, P1131, DOI 10.1037/0096-1523.24.4.1131	35	423	434	3	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2000	3	1					91	96		10.1038/71163	http://dx.doi.org/10.1038/71163			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	292TB	10607401				2022-12-17	WOS:000085810200018
J	Assinck, P; Duncan, GJ; Hilton, BJ; Plemel, JR; Tetzlaff, W				Assinck, Peggy; Duncan, Greg J.; Hilton, Brett J.; Plemel, Jason R.; Tetzlaff, Wolfram			Cell transplantation therapy for spinal cord injury	NATURE NEUROSCIENCE			English	Review							CENTRAL-NERVOUS-SYSTEM; OLFACTORY ENSHEATHING CELLS; NEURAL STEM-CELLS; IMMUNE-DEFICIENCY SYNDROME; SKIN-DERIVED PRECURSORS; FUNCTIONAL RECOVERY; SCHWANN-CELL; AXONAL REGENERATION; MACROPHAGE ACTIVATION; LOCOMOTOR RECOVERY	Spinal cord injury can lead to severe motor, sensory and autonomic dysfunction. Currently, there is no effective treatment for the injured spinal cord. The transplantation of Schwann cells, neural stem cells or progenitor cells, olfactory ensheathing cells, oligodendrocyte precursor cells and mesenchymal stem cells has been investigated as potential therapies for spinal cord injury. However, little is known about the mechanisms through which these individual cell types promote repair and functional improvements. The five most commonly proposed mechanisms include neuroprotection, immunomodulation, axon regeneration, neuronal relay formation and myelin regeneration. A better understanding of the mechanisms whereby these cells promote functional improvements, as well as an appreciation of the obstacles in implementing these therapies and effectively modeling spinal cord injury, will be important to make cell transplantation a viable clinical option and may lead to the development of more targeted therapies.	[Assinck, Peggy; Duncan, Greg J.; Hilton, Brett J.; Tetzlaff, Wolfram] Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC, Canada; [Assinck, Peggy] Univ British Columbia, Grad Program Neurosci, Vancouver, BC, Canada; [Duncan, Greg J.; Hilton, Brett J.; Tetzlaff, Wolfram] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Plemel, Jason R.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Plemel, Jason R.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Tetzlaff, Wolfram] Univ British Columbia, Dept Surg, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of Calgary; University of Calgary; University of British Columbia	Tetzlaff, W (corresponding author), Univ British Columbia, Int Collaborat Repair Discoveries, Vancouver, BC, Canada.; Tetzlaff, W (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.; Tetzlaff, W (corresponding author), Univ British Columbia, Dept Surg, Vancouver, BC, Canada.	tetzlaff@icord.org	Plemel, Jason/H-5323-2019; Tetzlaff, Wolfram/AAY-4430-2020; Assinck, Peggy/ABA-9634-2020; Assinck, Peggy/ABD-5333-2020; Hilton, Brett/N-9290-2019	Plemel, Jason/0000-0003-1385-1464; Assinck, Peggy/0000-0001-6085-8162; Assinck, Peggy/0000-0001-6085-8162; Hilton, Brett/0000-0003-2813-2294; Duncan, Greg J/0000-0003-0203-9972	Canadian Institute for Health Research (CIHR); CIHR; Multiple Sclerosis Society of Canada; Zoology Graduate Fellowship; Alberta Innovates Health Solutions; John and Penny Ryan British Columbia Leadership Chair in Spinal Cord Research; CIHR [FRN 130475]; Alberta Innovates [201400502] Funding Source: researchfish	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Multiple Sclerosis Society of Canada; Zoology Graduate Fellowship; Alberta Innovates Health Solutions; John and Penny Ryan British Columbia Leadership Chair in Spinal Cord Research; CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	P.A. received a Canadian Institute for Health Research (CIHR) Frederick Banting and Charles Best Canadian Graduate Scholarship-Doctoral Award and the CIHR Transplantation Training Program Award. G.J.D. was supported by a Multiple Sclerosis Society of Canada Doctoral Scholarship and the CIHR Transplantation Training Program Award. B.J.H. holds a CIHR Frederick Banting and Charles Best Canadian Graduate Scholarship-Doctoral Award, a Zoology Graduate Fellowship and a CIHR Transplantation Training Program Award. J.R.P. is supported by the Donna Joan Oxford Postdoctoral Fellowship Award from the Multiple Sclerosis Society of Canada and by postdoctoral fellowship awards from CIHR, Alberta Innovates Health Solutions and T. Chen Fong. W.T. receives support from the John and Penny Ryan British Columbia Leadership Chair in Spinal Cord Research and from CIHR FRN 130475.	Abrams MB, 2009, RESTOR NEUROL NEUROS, V27, P307, DOI 10.3233/RNN-2009-0480; All AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116933; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Barakat DJ, 2005, CELL TRANSPLANT, V14, P225, DOI 10.3727/000000005783983106; Barbour HR, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-106; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Biernaskie J, 2007, J NEUROSCI, V27, P9545, DOI 10.1523/JNEUROSCI.1930-07.2007; Bittner CX, 2010, FRONT NEUROENERGETIC, P2; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7; BREGMAN BS, 1993, EXP NEUROL, V123, P3, DOI 10.1006/exnr.1993.1136; BREGMAN BS, 1986, J COMP NEUROL, V244, P86, DOI 10.1002/cne.902440107; Brommer B, 2016, BRAIN, V139, P692, DOI 10.1093/brain/awv375; Bunge MB, 2016, J PHYSIOL-LONDON, V594, P3533, DOI 10.1113/JP271531; BUNGE RP, 1993, ADV NEUROL, V59, P75; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cantinieaux D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069515; Cao QL, 2010, J NEUROSCI, V30, P2989, DOI 10.1523/JNEUROSCI.3174-09.2010; Cao QL, 2005, J NEUROSCI, V25, P6947, DOI 10.1523/JNEUROSCI.1065-05.2005; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; DAS GD, 1990, NEUROSCI BIOBEHAV R, V14, P389, DOI 10.1016/S0149-7634(05)80061-2; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DeFelipe J., 1991, CAJALS DEGENERATION; DePaul MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16795; Dvorak MF, 2014, J NEUROTRAUM, V31, P1540, DOI 10.1089/neu.2013.3278; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Erturk A, 2013, EXP NEUROL, V242, P57, DOI 10.1016/j.expneurol.2012.10.018; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Filous AR, 2016, PROG NEUROBIOL, V144, P173, DOI 10.1016/j.pneurobio.2016.03.009; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Fouad K, 2012, EXP NEUROL, V235, P91, DOI 10.1016/j.expneurol.2011.02.009; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Geoffroy CG, 2016, CELL REP, V15, P238, DOI 10.1016/j.celrep.2016.03.028; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gu WD, 2010, NEUROPATHOLOGY, V30, P205, DOI 10.1111/j.1440-1789.2009.01063.x; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Hawryluk GWJ, 2014, CELL TRANSPLANT, V23, P365, DOI 10.3727/096368912X662408; Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; HENRY EW, 1988, SCIENCE, V241, P344, DOI 10.1126/science.3388045; Hesp ZC, 2015, J NEUROSCI, V35, P1274, DOI 10.1523/JNEUROSCI.2568-14.2015; Hill CE, 2006, GLIA, V53, P338, DOI 10.1002/glia.20287; Hilton BJ, 2016, J NEUROSCI, V36, P4080, DOI 10.1523/JNEUROSCI.3386-15.2016; Hilton BJ, 2013, J NEUROTRAUM, V30, P1070, DOI 10.1089/neu.2012.2734; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; HORNER PJ, 1995, EXP NEUROL, V133, P231, DOI 10.1006/exnr.1995.1026; Horner PJ, 1996, J COMP NEUROL, V364, P690, DOI 10.1002/(SICI)1096-9861(19960122)364:4<690::AID-CNE7>3.0.CO;2-Z; Hwang DH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-117; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; James ND, 2011, J NEUROSCI, V31, P18543, DOI 10.1523/JNEUROSCI.4306-11.2011; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Kadoya K, 2016, NAT MED, V22, P479, DOI 10.1038/nm.4066; Kakulas BA, 2004, SPINAL CORD, V42, P549, DOI 10.1038/sj.sc.3101670; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Karimi-Abdolrezaee S, 2010, J NEUROSCI, V30, P1657, DOI 10.1523/JNEUROSCI.3111-09.2010; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kobayashi Y., 2012, PLOS ONE; Krishna V, 2013, J SPINAL CORD MED, V36, P174, DOI 10.1179/2045772313Y.0000000095; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Kwon BK, 2013, EXP NEUROL, V248, P30, DOI 10.1016/j.expneurol.2013.05.012; Kwon BK, 2011, J NEUROTRAUM, V28, P1545, DOI 10.1089/neu.2009.1149; Lankford KL, 2002, J COMP NEUROL, V443, P259, DOI 10.1002/cne.10117; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lopez-Vales R, 2004, J NEUROTRAUM, V21, P1031, DOI 10.1089/0897715041651105; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Lu P, 2012, J NEUROSCI, V32, P8208, DOI 10.1523/JNEUROSCI.0308-12.2012; Lytle JM, 2007, EUR J NEUROSCI, V25, P1711, DOI 10.1111/j.1460-9568.2007.05390.x; Mackay-Sim A, 2011, EXP NEUROL, V229, P174, DOI 10.1016/j.expneurol.2010.08.025; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Myers SA, 2016, EXP NEUROL, V283, P560, DOI 10.1016/j.expneurol.2016.04.009; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nishimura S, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-3; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Nori S, 2015, STEM CELL REP, V4, P360, DOI 10.1016/j.stemcr.2015.01.006; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Okon EB, 2013, J NEUROTRAUM, V30, P1564, DOI 10.1089/neu.2013.2956; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Piltti KM, 2013, STEM CELL TRANSL MED, V2, P204, DOI 10.5966/sctm.2012-0110; Plemel JR, 2008, J NEUROTRAUM, V25, P350, DOI 10.1089/neu.2007.0426; Plemel JR, 2014, EXP NEUROL, V258, P91, DOI 10.1016/j.expneurol.2014.01.025; Plemel JR, 2014, PROG NEUROBIOL, V117, P54, DOI 10.1016/j.pneurobio.2014.02.006; Plemel JR, 2011, GLIA, V59, P1891, DOI 10.1002/glia.21232; Powers BE, 2013, P NATL ACAD SCI USA, V110, P4075, DOI 10.1073/pnas.1210293110; Powers BE, 2012, J NEUROSCI, V32, P5120, DOI 10.1523/JNEUROSCI.0002-12.2012; PRIVAT A, 1979, NEUROSCI LETT, V12, P107, DOI 10.1016/0304-3940(79)91489-7; Quaranta Michela, 2012, Bioanal Rev, V4, P115; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; Raisman G, 2001, NAT REV NEUROSCI, V2, P369, DOI 10.1038/35072576; Ramer LM, 2004, J COMP NEUROL, V473, P1, DOI 10.1002/cne.20049; REIER PJ, 1985, NEUROPATH APPL NEURO, V11, P81, DOI 10.1111/j.1365-2990.1985.tb00007.x; Ren YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41122; Richter MW, 2005, J NEUROSCI, V25, P10700, DOI 10.1523/JNEUROSCI.3632-05.2005; Ritfeld GJ, 2015, CELL TRANSPLANT, V24, P2209, DOI 10.3727/096368915X686201; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Saberi H, 2011, J NEUROSURG-SPINE, V15, P515, DOI 10.3171/2011.6.SPINE10917; Salegio EA, 2016, J NEUROTRAUM, V33, P439, DOI 10.1089/neu.2015.3956; Schonberg DL, 2012, J NEUROSCI, V32, P5374, DOI 10.1523/JNEUROSCI.3517-11.2012; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Sontag CJ, 2014, STEM CELL REP, V2, P620, DOI 10.1016/j.stemcr.2014.03.005; Sparling JS, 2015, J NEUROSCI, V35, P6714, DOI 10.1523/JNEUROSCI.1070-14.2015; Steeves JD, 2011, SPINAL CORD, V49, P257, DOI 10.1038/sc.2010.99; Steeves John D, 2012, Top Spinal Cord Inj Rehabil, V18, P1; Steward O, 2014, J NEUROSCI, V34, P14013, DOI 10.1523/JNEUROSCI.3066-14.2014; STOKES BT, 1991, EXP NEUROL, V111, P312, DOI 10.1016/0014-4886(91)90098-W; Takami T, 2002, J NEUROSCI, V22, P6670; Takeoka A, 2011, J NEUROSCI, V31, P4298, DOI 10.1523/JNEUROSCI.4967-10.2011; Tang YS, 2014, P NATL ACAD SCI USA, V111, P18339, DOI 10.1073/pnas.1421844112; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Wang ZM, 2015, J NEUROSCI, V35, P3139, DOI 10.1523/JNEUROSCI.2832-14.2015; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Whittaker MT, 2012, GLIA, V60, P281, DOI 10.1002/glia.21262; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; Wiliams RR, 2012, PROG BRAIN RES, V201, P295, DOI 10.1016/B978-0-444-59544-7.00014-7; Williams RR, 2015, CELL TRANSPLANT, V24, P115, DOI 10.3727/096368913X674657; Wirth ED, 2001, J NEUROTRAUM, V18, P911, DOI 10.1089/089771501750451839; Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309; XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564; Yasuda A, 2011, STEM CELLS, V29, P1983, DOI 10.1002/stem.767; Zhang SX, 2013, NEURAL REGEN RES, V8, P177, DOI 10.3969/j.issn.1673-5374.2013.02.011; Zhang Y, 2013, J NEUROSCI, V33, P12970, DOI 10.1523/JNEUROSCI.1974-13.2013	149	422	445	41	420	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2017	20	5					637	647		10.1038/nn.4541	http://dx.doi.org/10.1038/nn.4541			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET1CU	28440805				2022-12-17	WOS:000400004300005
J	Nelson, LE; Guo, TZ; Lu, J; Saper, CB; Franks, NP; Maze, M				Nelson, LE; Guo, TZ; Lu, J; Saper, CB; Franks, NP; Maze, M			The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway	NATURE NEUROSCIENCE			English	Article							FOS-LIKE IMMUNOREACTIVITY; C-FOS; TUBEROMAMMILLARY NUCLEUS; NITROUS-OXIDE; RAT-BRAIN; NEURONS; PROPOFOL; ACTIVATION; HYPOTHALAMUS; WAKEFULNESS	We investigated the role of regionally discrete GABA (gamma-aminobutyric acid) receptors in the sedative response to pharmacological agents that act on GABA(A) receptors (muscimol, propofol and pentobarbital; 'GABAergic agents') and to ketamine, a general anesthetic that does not affect GABA(A) receptors. Behavioral studies in rats showed that the sedative response to centrally administered GABAergic agents was attenuated by the GABA(A) receptor antagonist gabazine (systemically administered). The sedative response to ketamine, by contrast, was unaffected by gabazine. Using c-Fos as a marker of neuronal activation, we identified a possible role for the tuberomammillary nucleus (TMN): when gabazine was microinjected directly into the TMN, it attenuated the sedative response to GABAergic agents. Furthermore, the GABA(A) receptor agonist muscimol produced a dose-dependent sedation when it was administered into the TMN. We conclude that the TMN is a discrete neural locus that has a key role in the sedative response to GABAergic anesthetics.	Chelsea & Westminster Hosp, Imperial Coll Sch Med, Dept Anaesthet & Intens Care, London SW10 9NH, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Blackett Lab, Biophys Sect, London SW7 2BW, England; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA	Imperial College London; Imperial College London; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Franks, NP (corresponding author), Chelsea & Westminster Hosp, Imperial Coll Sch Med, Dept Anaesthet & Intens Care, London SW10 9NH, England.	n.franks@ic.ac.uk	Saper, Clifford/L-3815-2019	Franks, Nicholas/0000-0003-4874-4212	NHLBI NIH HHS [HL60292] Funding Source: Medline; NIA NIH HHS [AG09975] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009975] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADODRA S, 1995, BRIT J PHARMACOL, V115, P953, DOI 10.1111/j.1476-5381.1995.tb15903.x; AIRAKSINEN MS, 1992, J COMP NEUROL, V323, P103, DOI 10.1002/cne.903230109; AKAIKE N, 1990, AM J PHYSIOL, V258, pC452, DOI 10.1152/ajpcell.1990.258.3.C452; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; BARKER JL, 1973, SCIENCE, V182, P720, DOI 10.1126/science.182.4113.720; Belelli D, 1999, TRENDS PHARMACOL SCI, V20, P496, DOI 10.1016/S0165-6147(99)01405-4; CHENG SC, 1985, ANESTHESIOLOGY, V63, P147, DOI 10.1097/00000542-198508000-00005; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; CIRELLI C, 1993, ARCH ITAL BIOL, V131, P327; Cirelli C, 2000, SLEEP, V23, P453; COLLINGRIDGE GL, 1984, J PHYSIOL-LONDON, V356, P551, DOI 10.1113/jphysiol.1984.sp015482; CORREASALES C, 1992, ANESTHESIOLOGY, V76, P948, DOI 10.1097/00000542-199206000-00013; Depczynski B, 1998, ANN NY ACAD SCI, V863, P120, DOI 10.1111/j.1749-6632.1998.tb10689.x; Devor M, 2001, PAIN, V94, P101, DOI 10.1016/S0304-3959(01)00345-1; Elmquist JK, 1996, J COMP NEUROL, V371, P85, DOI 10.1002/(SICI)1096-9861(19960715)371:1<85::AID-CNE5>3.0.CO;2-H; ERICSON H, 1991, J COMP NEUROL, V305, P462, DOI 10.1002/cne.903050309; Fiset P, 1999, J NEUROSCI, V19, P5506; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; GAGE PW, 1985, BRIT J PHARMACOL, V85, P229, DOI 10.1111/j.1476-5381.1985.tb08851.x; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; HALES TG, 1991, BRIT J PHARMACOL, V104, P619, DOI 10.1111/j.1476-5381.1991.tb12479.x; HARA M, 1993, ANESTHESIOLOGY, V79, P781, DOI 10.1097/00000542-199310000-00021; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Jevtovic-Todorovic V, 1998, NAT MED, V4, P460, DOI 10.1038/nm0498-460; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Lam DW, 1998, BRAIN RES, V784, P179, DOI 10.1016/S0006-8993(97)01334-6; Lin JS, 1996, J NEUROSCI, V16, P1523; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; LIN LH, 1993, J NEUROCHEM, V60, P1548, DOI 10.1111/j.1471-4159.1993.tb03320.x; MONTI JM, 1993, LIFE SCI, V53, P1331, DOI 10.1016/0024-3205(93)90592-Q; Nitz D, 1996, AM J PHYSIOL-REG I, V271, pR1707, DOI 10.1152/ajpregu.1996.271.6.R1707; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pompeiano M, 1995, NEUROPHYSIOL CLIN, V25, P329, DOI 10.1016/0987-7053(96)84906-9; SAPER CB, 1985, J COMP NEUROL, V237, P21, DOI 10.1002/cne.902370103; Sawamura S, 2000, J NEUROSCI, V20, P9242; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Steininger TL, 1999, BRAIN RES, V840, P138, DOI 10.1016/S0006-8993(99)01648-0; Steininger TL, 2001, J COMP NEUROL, V429, P638; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; TANELIAN DL, 1993, ANESTHESIOLOGY, V78, P757, DOI 10.1097/00000542-199304000-00020; VILLAR MJ, 1990, NEUROSCIENCE, V36, P181, DOI 10.1016/0306-4522(90)90361-7; WAUD DR, 1972, J PHARMACOL EXP THER, V183, P577	45	422	436	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2002	5	10					979	984		10.1038/nn913	http://dx.doi.org/10.1038/nn913			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	597VV	12195434				2022-12-17	WOS:000178242200017
J	Tresch, MC; Saltiel, P; Bizzi, E				Tresch, MC; Saltiel, P; Bizzi, E			The construction of movement by the spinal cord	NATURE NEUROSCIENCE			English	Article							MOTOR CONTROL; REFLEXES; ORGANIZATION; HINDLIMB; MUSCLES	We used a computational analysis to identify the basic elements with which the vertebrate spinal cord constructs one complex behavior. This analysis extracted a small set of muscle synergies from the range of muscle activations generated by cutaneous stimulation of the frog hindlimb. The flexible combination of these synergies was able to account for the large number of different motor patterns produced by different animals. These results therefore demonstrate one strategy used by the vertebrate nervous system to produce movement in a computationally simple manner.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Bizzi, E (corresponding author), MIT, Dept Brain & Cognit Sci, E25-526, Cambridge, MA 02139 USA.	emilio@ai.mit.edu	Tresch, Matthew C/B-7634-2009		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009343] Funding Source: NIH RePORTER; NINDS NIH HHS [NS09343] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BERKINBLIT MB, 1986, BEHAV BRAIN SCI, V9, P585, DOI 10.1017/S0140525X00051268; Bernstein NA., 1967, COORDINATION REGULAT; Bishop Christopher M., 1995, NEURAL NETWORKS PATT; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; d'Avella A, 1998, P NATL ACAD SCI USA, V95, P7711, DOI 10.1073/pnas.95.13.7711; FLESHMAN JW, 1984, EXP BRAIN RES, V54, P133; GISZTER SF, 1993, J NEUROSCI, V13, P467; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; Harman H.H., 1976, MODERN FACTOR ANAL; Hertz J., 1991, INTRO THEORY NEURAL, DOI DOI 10.1201/9780429499661; Jacobs R, 1996, J NEUROPHYSIOL, V76, P2402, DOI 10.1152/jn.1996.76.4.2402; Lawson C. L., 1974, SOLVING LEAST SQUARE; LEE WA, 1984, J MOTOR BEHAV, V16, P135; MACPHERSON JM, 1991, LIFE SCI R, V50, P33; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; PRATT CA, 1991, EXP BRAIN RES, V85, P281, DOI 10.1007/BF00229407; SCHOUENBORG J, 1990, EXP BRAIN RES, V83, P67; SCHOUENBORG J, 1994, EXP BRAIN RES, V100, P170; SCHOUENBORG J, 1994, NEWS PHYSIOL SCI, V9, P261; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Stein P.S.G., 1997, NEURONS NETWORKS MOT, P61	22	422	426	2	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	1999	2	2					162	167		10.1038/5721	http://dx.doi.org/10.1038/5721			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	160LF	10195201				2022-12-17	WOS:000078231600016
J	Calabresi, P; Picconi, B; Tozzi, A; Ghiglieri, V; Di Filippo, M				Calabresi, Paolo; Picconi, Barbara; Tozzi, Alessandro; Ghiglieri, Veronica; Di Filippo, Massimiliano			Direct and indirect pathways of basal ganglia: a critical reappraisal	NATURE NEUROSCIENCE			English	Review							TERM SYNAPTIC DEPRESSION; MEDIUM SPINY NEURONS; D2 DOPAMINE-RECEPTORS; PARKINSONS-DISEASE; SUBTHALAMIC NUCLEUS; CHOLINERGIC INTERNEURONS; ENDOCANNABINOID RELEASE; STRIATOPALLIDAL NEURONS; GLUTAMATERGIC SYNAPSES; STRIATAL NEURONS	The basal ganglia are subcortical nuclei controlling voluntary actions and have been implicated in Parkinson's disease (PD). The prevailing model of basal ganglia function states that two circuits, the direct and indirect pathways, originate from distinct populations of striatal medium spiny neurons (MSNs) and project to different output structures. These circuits are believed to have opposite effects on movement. Specifically, the activity of direct pathway MSNs is postulated to promote movement, whereas the activation of indirect pathway MSNs is hypothesized to inhibit it. Recent findings have revealed that this model might not fully account for the concurrent activation of both pathways during movement. Accordingly, we propose a model in which intrastriatal connections are critical and the two pathways are structurally and functionally intertwined. Thus, all MSNs might either facilitate or inhibit movement depending on the form of synaptic plasticity expressed at a certain moment. In PD, alterations of dopamine-dependent synaptic plasticity could alter this coordinated activity.	[Calabresi, Paolo; Tozzi, Alessandro; Di Filippo, Massimiliano] Univ Perugia, Osped Santa Maria della Misericordia, Dipartimento Med, Neurol Clin, I-06100 Perugia, Italy; [Calabresi, Paolo; Picconi, Barbara; Tozzi, Alessandro; Ghiglieri, Veronica] Fdn Santa Lucia, IRCCS, Rome, Italy	Hospital Santa Maria della Misericordia; University of Perugia; IRCCS Santa Lucia	Calabresi, P (corresponding author), Univ Perugia, Osped Santa Maria della Misericordia, Dipartimento Med, Neurol Clin, I-06100 Perugia, Italy.	paolo.calabresi@unipg.it	Tozzi, Alessandro/AAB-8707-2022; Ghiglieri, Veronica/G-7076-2011; Picconi, Barbara/G-8299-2011; Calabresi, Paolo/G-8496-2011	Ghiglieri, Veronica/0000-0003-2885-8298; Picconi, Barbara/0000-0001-6020-1021; Calabresi, Paolo/0000-0003-0326-5509; Tozzi, Alessandro/0000-0003-3153-2424	Progetto di Ricerca di Interesse Nazionale (PRIN) [2010AHHP5H]; Progetto del Minister della Salute, Giovani Ricercatori [GR-2008-1142336, GR-2010-2316671]	Progetto di Ricerca di Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)); Progetto del Minister della Salute, Giovani Ricercatori	We thank A. Pisani for reading the manuscript and for critical discussion. This work was supported by Progetto di Ricerca di Interesse Nazionale (PRIN) 2011 2010AHHP5H (to P.C.) and Progetto del Minister della Salute, Giovani Ricercatori (GR-2008-1142336 to B.P.; GR-2010-2316671 to V.G.).	Adermark L, 2007, P NATL ACAD SCI USA, V104, P20564, DOI 10.1073/pnas.0706873104; Adermark L, 2009, EUR J NEUROSCI, V29, P32, DOI 10.1111/j.1460-9568.2008.06551.x; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alvarez L, 2005, BRAIN, V128, P570, DOI 10.1093/brain/awh397; Andre VM, 2011, J NEUROSCI, V31, P1170, DOI 10.1523/JNEUROSCI.3539-10.2011; Arcangeli S, 2013, J CEREBR BLOOD F MET, V33, P278, DOI 10.1038/jcbfm.2012.167; AZIZ TZ, 1991, MOVEMENT DISORD, V6, P288, DOI 10.1002/mds.870060404; Bagetta V, 2012, J NEUROSCI, V32, P17921, DOI 10.1523/JNEUROSCI.2664-12.2012; Bagetta V, 2011, J NEUROSCI, V31, P12513, DOI 10.1523/JNEUROSCI.2236-11.2011; Bateup HS, 2010, P NATL ACAD SCI USA, V107, P14845, DOI 10.1073/pnas.1009874107; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; BOUYER JJ, 1984, BRAIN RES, V302, P267, DOI 10.1016/0006-8993(84)90239-7; CALABRESI P, 1992, NEUROSCI LETT, V142, P95, DOI 10.1016/0304-3940(92)90628-K; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1999, J NEUROSCI, V19, P2489; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Calabresi P, 2010, LANCET NEUROL, V9, P1106, DOI 10.1016/S1474-4422(10)70218-0; Calabresi P, 2010, NATURE, V466, P449, DOI 10.1038/466449a; Cazorla M, 2014, NEURON, V81, P153, DOI 10.1016/j.neuron.2013.10.041; Cepeda C, 2008, EUR J NEUROSCI, V27, P671, DOI 10.1111/j.1460-9568.2008.06038.x; Chan CS, 2012, J NEUROSCI, V32, P9124, DOI 10.1523/JNEUROSCI.0229-12.2012; Connolly BS, 2012, EXPERT REV NEUROTHER, V12, P1439, DOI [10.1586/ern.12.142, 10.1586/ERN.12.142]; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Day M, 2008, J NEUROSCI, V28, P11603, DOI 10.1523/JNEUROSCI.1840-08.2008; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Deng YP, 2006, J CHEM NEUROANAT, V32, P101, DOI 10.1016/j.jchemneu.2006.07.001; Di Filippo M, 2008, CURR PHARM DESIGN, V14, P2337, DOI 10.2174/138161208785740072; DIFIGLIA M, 1976, BRAIN RES, V114, P245, DOI 10.1016/0006-8993(76)90669-7; DUBE L, 1988, J COMP NEUROL, V267, P455, DOI 10.1002/cne.902670402; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Eshel N, 2010, BIOL PSYCHIAT, V68, P118, DOI 10.1016/j.biopsych.2010.01.027; Fasano A, 2012, LANCET NEUROL, V11, P429, DOI 10.1016/S1474-4422(12)70049-2; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Fino E, 2011, NEUROPHARMACOLOGY, V60, P780, DOI 10.1016/j.neuropharm.2011.01.023; Freeze BS, 2013, J NEUROSCI, V33, P18531, DOI 10.1523/JNEUROSCI.1278-13.2013; Gerdeman GL, 2003, TRENDS NEUROSCI, V26, P184, DOI 10.1016/S0166-2236(03)00065-1; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Gubellini P, 2002, J NEUROSCI, V22, P6900; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Hikida T, 2010, NEURON, V66, P896, DOI 10.1016/j.neuron.2010.05.011; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Jenner P, 2008, NAT REV NEUROSCI, V9, P665, DOI 10.1038/nrn2471; Jia YS, 2010, J NEUROSCI, V30, P14440, DOI 10.1523/JNEUROSCI.3310-10.2010; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Kasanetz F, 2008, P NATL ACAD SCI USA, V105, P8124, DOI 10.1073/pnas.0711113105; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Krack P, 2010, TRENDS NEUROSCI, V33, P474, DOI 10.1016/j.tins.2010.07.002; Kramer PF, 2011, J NEUROSCI, V31, P126, DOI 10.1523/JNEUROSCI.4287-10.2011; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kress GJ, 2013, NAT NEUROSCI, V16, P665, DOI 10.1038/nn.3397; Lang AE, 1997, NEW ENGL J MED, V337, P1036, DOI 10.1056/NEJM199710093371503; LAPPER SR, 1992, NEUROSCIENCE, V51, P533, DOI 10.1016/0306-4522(92)90293-B; Levesque M, 2005, P NATL ACAD SCI USA, V102, P11888, DOI 10.1073/pnas.0502710102; Levy R, 2001, J NEUROPHYSIOL, V86, P249, DOI 10.1152/jn.2001.86.1.249; LeWitt PA, 2008, NEW ENGL J MED, V359, P2468, DOI 10.1056/NEJMct0800326; Lovinger DM, 2010, NEUROPHARMACOLOGY, V58, P951, DOI 10.1016/j.neuropharm.2010.01.008; LOVINGER DM, 1993, J NEUROPHYSIOL, V70, P1937, DOI 10.1152/jn.1993.70.5.1937; Maccarrone M, 2003, J NEUROCHEM, V85, P1018, DOI 10.1046/j.1471-4159.2003.01759.x; Mathur BN, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00066; Mercuri NB, 2005, TRENDS PHARMACOL SCI, V26, P341, DOI 10.1016/j.tips.2005.05.002; Nadjar A, 2006, J NEUROSCI, V26, P8653, DOI 10.1523/JNEUROSCI.2582-06.2006; Nazzaro C, 2012, NAT NEUROSCI, V15, P284, DOI 10.1038/nn.3022; Nelson AB, 2012, J NEUROSCI, V32, P9119, DOI 10.1523/JNEUROSCI.0224-12.2012; Odekerken VJJ, 2013, LANCET NEUROL, V12, P37, DOI 10.1016/S1474-4422(12)70264-8; PARENT A, 1995, BRAIN RES, V698, P280, DOI 10.1016/0006-8993(95)01017-P; Perez-Lloret S, 2010, CNS DRUGS, V24, P941, DOI 10.2165/11537810-000000000-00000; Perreault ML, 2014, NEUROPSYCHOPHARMACOL, V39, P156, DOI 10.1038/npp.2013.148; Picconi B, 2011, BRAIN, V134, P375, DOI 10.1093/brain/awq342; PICKEL VM, 1992, J NEUROSCI RES, V31, P212, DOI 10.1002/jnr.490310203; Pisani V, 2011, MOVEMENT DISORD, V26, P216, DOI 10.1002/mds.23457; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Ronesi J, 2004, J NEUROSCI, V24, P1673, DOI 10.1523/JNEUROSCI.5214-03.2004; Russo SJ, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.059; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Seneca L. A., 1917, COMMUNICATION, V1; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Tai LH, 2012, NAT NEUROSCI, V15, P1281, DOI 10.1038/nn.3188; Toy W. A., NEUROBIOL DIS; Tozzi A, 2011, J NEUROSCI, V31, P1850, DOI 10.1523/JNEUROSCI.4082-10.2011; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Vincent SR, 2010, PROG NEUROBIOL, V90, P246, DOI 10.1016/j.pneurobio.2009.10.007; Vitek JL, 2003, ANN NEUROL, V53, P558, DOI 10.1002/ana.10517; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Voon V, 2009, LANCET NEUROL, V8, P1140, DOI 10.1016/S1474-4422(09)70287-X; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; West AR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00055; Yin HH, 2006, P NATL ACAD SCI USA, V103, P8251, DOI 10.1073/pnas.0510797103; Zold CL, 2012, NEUROBIOL DIS, V47, P38, DOI 10.1016/j.nbd.2012.03.022	100	421	431	1	197	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2014	17	8					1022	1030		10.1038/nn.3743	http://dx.doi.org/10.1038/nn.3743			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AM1XA	25065439				2022-12-17	WOS:000339641400006
J	Agarwal, N; Pacher, P; Tegeder, I; Amaya, F; Constantin, CE; Brenner, GJ; Rubino, T; Michalski, CW; Marsicano, G; Monory, K; Mackie, K; Marian, C; Batkai, S; Parolaro, D; Fischer, MJ; Reeh, P; Kunos, G; Kress, M; Lutz, B; Woolf, CJ; Kuner, R				Agarwal, Nitin; Pacher, Pal; Tegeder, Irmgard; Amaya, Fumimasa; Constantin, Cristina E.; Brenner, Gary J.; Rubino, Tiziana; Michalski, Christoph W.; Marsicano, Giovanni; Monory, Krisztina; Mackie, Ken; Marian, Claudiu; Batkai, Sandor; Parolaro, Daniela; Fischer, Michael J.; Reeh, Peter; Kunos, George; Kress, Michaela; Lutz, Beat; Woolf, Clifford J.; Kuner, Rohini			Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors	NATURE NEUROSCIENCE			English	Article							IN-SITU HYBRIDIZATION; DORSAL-ROOT GANGLIA; NEUROPATHIC PAIN; ENDOGENOUS CANNABINOIDS; SPINAL NEURONS; KNOCKOUT MICE; WIN 55,212-2; RATS; CB1; HYPERALGESIA	Although endocannabinoids constitute one of the first lines of defense against pain, the anatomical locus and the precise receptor mechanisms underlying cannabinergic modulation of pain are uncertain. Clinical exploitation of the system is severely hindered by the cognitive deficits, memory impairment, motor disturbances and psychotropic effects resulting from the central actions of cannabinoids. We deleted the type 1 cannabinoid receptor (CB1) specifically in nociceptive neurons localized in the peripheral nervous system of mice, preserving its expression in the CNS, and analyzed these genetically modified mice in preclinical models of inflammatory and neuropathic pain. The nociceptor-specific loss of CB1 substantially reduced the analgesia produced by local and systemic, but not intrathecal, delivery of cannabinoids. We conclude that the contribution of CB1-type receptors expressed on the peripheral terminals of nociceptors to cannabinoid-induced analgesia is paramount, which should enable the development of peripherally acting CB1 analgesic agonists without any central side effects.	Univ Heidelberg, Inst Pharmacol, D-69120 Heidelberg, Germany; NIH, NIAAA, Lab Physiol Studies, Bethesda, MD 20892 USA; Univ Frankfurt Klinikum, D-60590 Frankfurt, Germany; Massachusetts Gen Hosp, Harvard Med Sch, Dept Anesthesia & Crit Care, Charlestown, MA 02129 USA; Med Univ Innsbruck, Dept Physiol & Med Phys, Div Physiol, A-6020 Innsbruck, Austria; Univ Mainz, Dept Physiol Chem, D-55099 Mainz, Germany; Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany	Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Goethe University Frankfurt; Goethe University Frankfurt Hospital; Harvard University; Massachusetts General Hospital; Medical University of Innsbruck; Johannes Gutenberg University of Mainz; University of Washington; University of Washington Seattle; University of Erlangen Nuremberg	Kuner, R (corresponding author), Univ Heidelberg, Inst Pharmacol, Im Neuenheimer Feld, D-69120 Heidelberg, Germany.	rohini.kuner@pharma.uni-heidelberg.de	Rubino, Tiziana/AAC-8210-2020; Woolf, Clifford/A-9784-2010; Batkai, Sandor/G-3889-2010; Lutz, Beat/AFK-6229-2022; Mackie, Kenneth P/B-7358-2011; Kuner, Rohini/AGU-0204-2022; Mackie, Ken/E-3715-2013; Lutz, Beat/AAG-4538-2022; Tegeder, Irmgard/AAM-2246-2020; Brenner, Gary/AAI-1293-2019; Michalski, Christoph/U-9167-2019; Pacher, Pal/B-6378-2008; Marsicano, Giovanni/I-9603-2016; amaya, fumimasa/AAD-7176-2020; Tegeder, Irmgard/AAM-2266-2020; Reeh, Peter W./J-8981-2012; Batkai, Sandor/H-7983-2014; Fischer, Michael/F-7976-2010; Fischer, Michael J.M./P-8715-2014	Mackie, Ken/0000-0001-8501-6199; Tegeder, Irmgard/0000-0001-7524-8025; Brenner, Gary/0000-0002-4586-1723; Pacher, Pal/0000-0001-7036-8108; Tegeder, Irmgard/0000-0001-7524-8025; Reeh, Peter W./0000-0002-4367-094X; RUBINO, Tiziana/0000-0002-3128-6377; amaya, fumimasa/0000-0003-2934-0845; Kress, Michaela/0000-0002-8921-7470; Marsicano, Giovanni/0000-0003-3804-1951; Fischer, Michael J.M./0000-0002-3811-7066	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS039518, R01NS038253, R01NS039518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000350, Z01AA000375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA000286, R01DA011322] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AA000375-02] Funding Source: Medline; NIDA NIH HHS [K02 DA000286, DA11322, K02 DA000286-04, R01 DA011322, DA00286, R01 DA011322-02] Funding Source: Medline; NINDS NIH HHS [NS039518, R01 NS038253-01S1, R01 NS038253, R37 NS039518, R01 NS039518, NS 038253, R01 NS039518-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Azad SC, 2004, J NEUROSCI, V24, P9953, DOI 10.1523/JNEUROSCI.2134-04.2004; Binzen U, 2006, NEUROSCIENCE, V142, P527, DOI 10.1016/j.neuroscience.2006.06.020; Bridges D, 2003, NEUROSCIENCE, V119, P803, DOI 10.1016/S0306-4522(03)00200-8; Bridges D, 2001, BRIT J PHARMACOL, V133, P586, DOI 10.1038/sj.bjp.0704110; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Coutts AA, 2002, J COMP NEUROL, V448, P410, DOI 10.1002/cne.10270; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Dogrul A, 2003, PAIN, V105, P11, DOI 10.1016/S0304-3959(03)00068-X; Finn DP, 2003, NEUROPHARMACOLOGY, V45, P594, DOI 10.1016/S0028-3908(03)00235-1; Fox A, 2001, PAIN, V92, P91, DOI 10.1016/S0304-3959(00)00474-7; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Hartmann B, 2004, NEURON, V44, P637, DOI 10.1016/j.neuron.2004.10.029; Hohmann AG, 1999, NEUROSCIENCE, V90, P923, DOI 10.1016/S0306-4522(98)00524-7; Ibrahim MM, 2006, PAIN, V122, P36, DOI 10.1016/j.pain.2005.12.018; Janson W., 2003, Current Pharmaceutical Biotechnology, V4, P270, DOI 10.2174/1389201033489766; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Johanek LM, 2001, PAIN, V93, P303, DOI 10.1016/S0304-3959(01)00336-0; Kolesnikov YA, 1996, J PHARMACOL EXP THER, V279, P502; Kress M, 1999, J NEUROPHYSIOL, V81, P2612, DOI 10.1152/jn.1999.81.6.2612; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Ledent C, 1999, SCIENCE, V283, P401, DOI 10.1126/science.283.5400.401; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MARTIN WJ, 1993, BRAIN RES, V629, P300, DOI 10.1016/0006-8993(93)91334-O; Martin WJ, 1999, PAIN, V82, P199, DOI 10.1016/S0304-3959(99)00045-7; Meng ID, 1998, NATURE, V395, P381, DOI 10.1038/26481; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pascual D, 2005, PAIN, V118, P23, DOI 10.1016/j.pain.2005.07.008; Patwardhan AM, 2006, P NATL ACAD SCI USA, V103, P11393, DOI 10.1073/pnas.0603861103; PERTWEE RG, 1972, BRIT J PHARMACOL, V46, P753, DOI 10.1111/j.1476-5381.1972.tb06900.x; Piomelli Daniele, 2005, Curr Opin Investig Drugs, V6, P672; Quartilho A, 2003, ANESTHESIOLOGY, V99, P955, DOI 10.1097/00000542-200310000-00031; Richardson JD, 1998, PAIN, V75, P111, DOI 10.1016/S0304-3959(97)00213-3; Rubino T, 2000, J NEUROCHEM, V75, P2080, DOI 10.1046/j.1471-4159.2000.0752080.x; SHIRE D, 1995, J BIOL CHEM, V270, P3726, DOI 10.1074/jbc.270.8.3726; Sokal DM, 2003, NEUROPHARMACOLOGY, V45, P404, DOI 10.1016/S0028-3908(03)00195-3; TSAY DG, 1987, INVEST RADIOL, V22, P556, DOI 10.1097/00004424-198707000-00005; Ulugol A, 2004, NEUROSCI LETT, V371, P167, DOI 10.1016/j.neulet.2004.08.061; Valiveti S, 2004, PHARM RES-DORDR, V21, P1137, DOI 10.1023/B:PHAM.0000032999.31948.2e; Walker JM, 2005, HANDB EXP PHARMACOL, V168, P509; Wang L, 2003, P NATL ACAD SCI USA, V100, P1393, DOI 10.1073/pnas.0336351100; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	46	421	440	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2007	10	7					870	879		10.1038/nn1916	http://dx.doi.org/10.1038/nn1916			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	183GH	17558404	Green Accepted			2022-12-17	WOS:000247560200017
J	Sugino, K; Hempel, CM; Miller, MN; Hattox, AM; Shapiro, P; Wu, CZ; Huang, ZJ; Nelson, SB				Sugino, K; Hempel, CM; Miller, MN; Hattox, AM; Shapiro, P; Wu, CZ; Huang, ZJ; Nelson, SB			Molecular taxonomy of major neuronal classes in the adult mouse forebrain	NATURE NEUROSCIENCE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GABAERGIC INTERNEURONS; TRANSGENIC MICE; VISUAL-CORTEX; MESSENGER-RNA; DLX GENES; EXPRESSION; NEOCORTEX; PROTEIN; SUBTYPES	Identifying the neuronal cell types that comprise the mammalian forebrain is a central unsolved problem in neuroscience. Global gene expression profiles offer a potentially unbiased way to assess functional relationships between neurons. Here, we carried out microarray analysis of 12 populations of neurons in the adult mouse forebrain. Five of these populations were chosen from cingulate cortex and included several subtypes of GABAergic interneurons and pyramidal neurons. The remaining seven were derived from the somatosensory cortex, hippocampus, amygdala and thalamus. Using these expression profiles, we were able to construct a taxonomic tree that reflected the expected major relationships between these populations, such as the distinction between cortical interneurons and projection neurons. The taxonomic tree indicated highly heterogeneous gene expression even within a single region. This dataset should be useful for the classification of unknown neuronal subtypes, the investigation of specifically expressed genes and the genetic manipulation of specific neuronal circuit elements.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Brandeis University; Brandeis University; Cold Spring Harbor Laboratory	Nelson, SB (corresponding author), Brandeis Univ, Dept Biol, MS 008,415 South St, Waltham, MA 02454 USA.	nelson@brandeis.edu		Nelson, Sacha/0000-0002-0108-8599; Huang, Z. Josh/0000-0003-0592-028X	NINDS NIH HHS [T32 NS007292] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Burette A, 2001, J NEUROSCI, V21, P495, DOI 10.1523/JNEUROSCI.21-02-00495.2001; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Colombo E, 2004, DEV DYNAM, V231, P631, DOI 10.1002/dvdy.20164; Diez del Corral R, 2001, NAT REV NEUROSCI, V2, P835; Dougherty JD, 2005, NEURON, V45, P183, DOI 10.1016/j.neuron.2005.01.007; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; ESCLAPEZ M, 1993, J COMP NEUROL, V331, P339, DOI 10.1002/cne.903310305; Evans SJ, 2003, NEUROBIOL DIS, V14, P240, DOI 10.1016/S0969-9961(03)00126-8; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferezou I, 2002, J NEUROSCI, V22, P7389; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Galarreta M, 2004, J NEUROSCI, V24, P9770, DOI 10.1523/JNEUROSCI.3027-04.2004; Gewin V, 2005, PLOS BIOL, V3, P13, DOI 10.1371/journal.pbio.0030024; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hempel CM, 2000, J NEUROPHYSIOL, V83, P3031, DOI 10.1152/jn.2000.83.5.3031; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Jongen-Relo AL, 2000, J NEUROSCI METH, V101, P9, DOI 10.1016/S0165-0270(00)00240-5; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KUBOTA Y, 1994, JPN J PHYSIOL, V44, pS145; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lopez-Bendito G, 2004, CEREB CORTEX, V14, P1122, DOI 10.1093/cercor/bhh072; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Marin O, 2000, J NEUROSCI, V20, P6063; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Mott DD, 2003, TRENDS NEUROSCI, V26, P484, DOI 10.1016/S0166-2236(03)00200-5; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Ohno S., 1970, EVOLUTION GENE DUPLI; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Paxinos G., 2012, MOUSE BRAIN STEREOTA, V2nd; Poirier K, 2004, MOL BRAIN RES, V122, P35, DOI 10.1016/j.molbrainres.2003.11.021; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Vruwink M, 2001, J COMP NEUROL, V441, P288, DOI 10.1002/cne.1413; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004	50	421	426	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2006	9	1					99	107		10.1038/nn1618	http://dx.doi.org/10.1038/nn1618			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	997ZQ	16369481				2022-12-17	WOS:000234288000023
J	Roesch, MR; Calu, DJ; Schoenbaum, G				Roesch, Matthew R.; Calu, Donna J.; Schoenbaum, Geoffrey			Dopamine neurons encode the better option in rats deciding between differently delayed or sized rewards	NATURE NEUROSCIENCE			English	Article							ORBITAL PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; IMPULSIVE CHOICE; DORSOLATERAL STRIATUM; QUANTITATIVE-ANALYSIS; NUCLEUS-ACCUMBENS; PREDICTION ERROR; REINFORCEMENT; AMYGDALA; LESIONS	The dopamine system is thought to be involved in making decisions about reward. Here we recorded from the ventral tegmental area in rats learning to choose between differently delayed and sized rewards. As expected, the activity of many putative dopamine neurons reflected reward prediction errors, changing when the value of the reward increased or decreased unexpectedly. During learning, neural responses to reward in these neurons waned and responses to cues that predicted reward emerged. Notably, this cue-evoked activity varied with size and delay. Moreover, when rats were given a choice between two differently valued outcomes, the activity of the neurons initially reflected the more valuable option, even when it was not subsequently selected.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Roesch, MR (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, 20 Penn St HSF-2 S251, Baltimore, MD 21201 USA.	mroes001@umaryland.edu		Calu, Donna/0000-0003-2377-9494	NIA NIH HHS [R01 AG027097, R01 AG027097-01A2, R01-AG027097] Funding Source: Medline; NIDA NIH HHS [R01 DA015718-05, K01-DA021609, K01 DA021609, R01-DA015718, R01 DA015718] Funding Source: Medline; NIMH NIH HHS [F31 MH080514, F31-MH085014] Funding Source: Medline; NINDS NIH HHS [T32-NS07375, T32 NS007375] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH080514] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA021609, R01DA015718] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Baxter MG, 2000, J NEUROSCI, V20, P4311; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; BUNNEY BS, 1973, NATURE-NEW BIOL, V245, P123, DOI 10.1038/newbio245123a0; Cardinal RN, 2000, PSYCHOPHARMACOLOGY, V152, P362, DOI 10.1007/s002130000536; Cardinal RN, 2004, ANN NY ACAD SCI, V1021, P33, DOI 10.1196/annals.1308.004; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Evenden JL, 1996, PSYCHOPHARMACOLOGY, V128, P161, DOI 10.1007/s002130050121; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Haber SN, 2000, J NEUROSCI, V20, P2369; Hatfield T, 1996, J NEUROSCI, V16, P5256; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Ho MY, 1999, PSYCHOPHARMACOLOGY, V146, P362, DOI 10.1007/PL00005482; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Kheramin S, 2004, PSYCHOPHARMACOLOGY, V175, P206, DOI 10.1007/s00213-004-1813-y; Kiyatkin EA, 1998, NEUROSCIENCE, V85, P1285, DOI 10.1016/S0306-4522(98)00054-2; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; LOWENSTEIN G, 1992, CHOICE OVER TIME; Lu L, 2005, NAT NEUROSCI, V8, P212, DOI 10.1038/nn1383; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; Nakahara H, 2004, NEURON, V41, P269, DOI 10.1016/S0896-6273(03)00869-9; Niv Y, 2006, NAT NEUROSCI, V9, P987, DOI 10.1038/nn0806-987; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Parkinson JA, 2000, PROG BRAIN RES, V126, P263; Roesch MR, 2007, J NEUROSCI, V27, P245, DOI 10.1523/JNEUROSCI.4080-06.2007; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SKIRBOLL LR, 1979, SCIENCE, V206, P80, DOI 10.1126/science.482929; THALER R, 1981, ECON LETT, V8, P201, DOI 10.1016/0165-1765(81)90067-7; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tobler PN, 2003, J NEUROSCI, V23, P10402; Wade TR, 2000, PSYCHOPHARMACOLOGY, V150, P90; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	47	420	421	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2007	10	12					1615	1624		10.1038/nn2013	http://dx.doi.org/10.1038/nn2013			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	234OH	18026098	Green Accepted			2022-12-17	WOS:000251172900020
J	Mulkey, DK; Stornetta, RL; Weston, MC; Simmons, JR; Parker, A; Bayliss, DA; Guyenet, PG				Mulkey, DK; Stornetta, RL; Weston, MC; Simmons, JR; Parker, A; Bayliss, DA; Guyenet, PG			Respiratory control by ventral surface chemoreceptor neurons in rats	NATURE NEUROSCIENCE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; CENTRAL CHEMOSENSITIVITY; SYMPATHOEXCITATORY NEURONS; NEUROKININ-1 RECEPTORS; SEROTONERGIC NEURONS; RAPHE NEURONS; K+ CHANNEL; MODULATION; CO2; PROJECTIONS	A long-standing theory posits that central chemoreception, the CNS mechanism for CO2 detection and regulation of breathing, involves neurons located at the ventral surface of the medulla oblongata (VMS). Using in vivo and in vitro electrophysiological recordings, we identify VMS neurons within the rat retrotrapezoid nucleus (RTN) that have characteristics befitting these elusive chemoreceptors. These glutamatergic neurons are vigorously activated by CO2 in vivo, whereas serotonergic neurons are not. Their CO2 sensitivity is unaffected by pharmacological blockade of the respiratory pattern generator and persists without carotid body input. RTN CO2-sensitive neurons have extensive dendrites along the VMS and they innervate key pontomedullary respiratory centers. In brainstem slices, a subset of RTN neurons with markedly similar morphology is robustly activated by acidification and CO2. Their pH sensitivity is intrinsic and involves a background K+ current. In short, the CO2-sensitive neurons of the RTN are good candidates for the long sought-after VMS chemoreceptors.	Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Guyenet, PG (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	pgg@virginia.edu		parker, anson/0000-0002-1206-8817; Stornetta, Ruth/0000-0001-7278-8923; Mulkey, Daniel/0000-0002-7040-3927	NHLBI NIH HHS [HL074011, R01 HL028785, R01 HL074011] Funding Source: Medline; NIDDK NIH HHS [5T32DK007646] Funding Source: Medline; NINDS NIH HHS [NS33583, R01 NS033583] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028785, R01HL074011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033583, R29NS033583] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ballantyne D, 2001, RESP PHYSIOL, V129, P5, DOI 10.1016/S0034-5687(01)00297-3; Bayliss DA, 2001, RESP PHYSIOL, V129, P159, DOI 10.1016/S0034-5687(01)00288-2; BIANCHI AL, 1995, PHYSIOL REV, V75, P1, DOI 10.1152/physrev.1995.75.1.1; BOHN MC, 1987, DEV BRAIN RES, V37, P257, DOI 10.1016/0165-3806(87)90247-1; BROWN DL, 1985, CIRC RES, V56, P359; CONNELLY CA, 1989, NEUROSCI LETT, V105, P34, DOI 10.1016/0304-3940(89)90007-4; Cream C, 2002, RESP PHYSIOL NEUROBI, V130, P121, DOI 10.1016/S0034-5687(01)00338-3; ELDRIDGE FL, 1985, J PHYSIOL-LONDON, V358, P285, DOI 10.1113/jphysiol.1985.sp015551; ELLENBERGER HH, 1990, BRAIN RES, V513, P35, DOI 10.1016/0006-8993(90)91086-V; Feldman JL, 2003, ANNU REV NEUROSCI, V26, P239, DOI 10.1146/annurev.neuro.26.041002.131103; FELDMAN JL, 1999, FUNDAMENTAL NEUROSCI, P1063; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; FUKUDA Y, 1993, NEUROSCI LETT, V153, P177, DOI 10.1016/0304-3940(93)90316-D; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; HASELTON JR, 1989, AM J PHYSIOL, V256, pR739, DOI 10.1152/ajpregu.1989.256.3.R739; Kawai A, 1996, J PHYSIOL-LONDON, V492, P277, DOI 10.1113/jphysiol.1996.sp021308; LEONG SK, 1990, J NEUROSCI METH, V32, P15, DOI 10.1016/0165-0270(90)90067-P; Li AH, 2002, RESP PHYSIOL NEUROBI, V133, P11, DOI 10.1016/S1569-9048(02)00134-9; LIPSKI J, 1981, J NEUROSCI METH, V4, P1, DOI 10.1016/0165-0270(81)90015-7; LOESCHCKE HH, 1982, J PHYSIOL-LONDON, V332, P1; Manzke T, 2003, SCIENCE, V301, P226, DOI 10.1126/science.1084674; Mason P, 2001, ANNU REV NEUROSCI, V24, P737, DOI 10.1146/annurev.neuro.24.1.737; MITCHELL RA, 1963, J APPL PHYSIOL, V18, P523, DOI 10.1152/jappl.1963.18.3.523; Nattie EE, 2004, J PHYSIOL-LONDON, V556, P235, DOI 10.1113/jphysiol.2003.059766; Nattie EE, 2001, RESP PHYSIOL, V129, P257, DOI 10.1016/S0034-5687(01)00295-X; Okada Y, 2002, J APPL PHYSIOL, V93, P427, DOI 10.1152/japplphysiol.00620.2000; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; OREM J, 1983, J NEUROPHYSIOL, V50, P1098, DOI 10.1152/jn.1983.50.5.1098; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pineda J, 1997, NEUROSCIENCE, V77, P723, DOI 10.1016/S0306-4522(96)00485-X; Putnam RW, 2004, AM J PHYSIOL-CELL PH, V287, pC1493, DOI 10.1152/ajpcell.00282.2004; Richerson GB, 2004, NAT REV NEUROSCI, V5, P449, DOI 10.1038/nrn1409; RICHERSON GB, 1995, J NEUROPHYSIOL, V73, P933, DOI 10.1152/jn.1995.73.3.933; SATO M, 1992, J APPL PHYSIOL, V73, P96, DOI 10.1152/jappl.1992.73.1.96; Schreihofer AM, 1997, J COMP NEUROL, V387, P524, DOI 10.1002/(SICI)1096-9861(19971103)387:4<524::AID-CNE4>3.0.CO;2-4; Shigetomi E, 2004, J NEUROSCI, V24, P3125, DOI 10.1523/JNEUROSCI.0090-04.2004; SMITH JC, 1989, J COMP NEUROL, V281, P69, DOI 10.1002/cne.902810107; Spyer KM, 2004, EXP PHYSIOL, V89, P53, DOI 10.1113/expphysiol.2003.002659; St-John WM, 1998, PROG NEUROBIOL, V56, P97, DOI 10.1016/S0301-0082(98)00031-8; Stornetta RL, 2003, J COMP NEUROL, V455, P499, DOI 10.1002/cne.10504; Stornetta RL, 2003, J COMP NEUROL, V455, P113, DOI 10.1002/cne.10486; Sun MK, 1996, PHARMACOL REV, V48, P465; SUN MK, 1988, BRAIN RES, V438, P23, DOI 10.1016/0006-8993(88)91320-0; VEASEY SC, 1995, J NEUROSCI, V15, P5346; Washburn CP, 2002, J NEUROSCI, V22, P1256, DOI 10.1523/JNEUROSCI.22-04-01256.2002; Wellner-Kienitz MC, 1998, J NEUROPHYSIOL, V79, P2885, DOI 10.1152/jn.1998.79.6.2885; Weston MC, 2004, J COMP NEUROL, V473, P73, DOI 10.1002/cne.20076; Xu HX, 2000, J PHYSIOL-LONDON, V524, P725, DOI 10.1111/j.1469-7793.2000.00725.x	49	420	427	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2004	7	12					1360	1369		10.1038/nn1357	http://dx.doi.org/10.1038/nn1357			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	874MG	15558061				2022-12-17	WOS:000225353900017
J	Rudebeck, PH; Walton, ME; Smyth, AN; Bannerman, DM; Rushworth, MFS				Rudebeck, Peter H.; Walton, Mark E.; Smyth, Angharad N.; Bannerman, David M.; Rushworth, Matthew F. S.			Separate neural pathways process different decision costs	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; ORBITOFRONTAL CORTEX; BASOLATERAL AMYGDALA; PREFRONTAL CORTEX; NEURONAL SIGNALS; VENTRAL STRIATUM; RAT; LESIONS; SENSITIVITY	Behavioral ecologists and economists emphasize that potential costs, as well as rewards, influence decision making. Although neuroscientists assume that frontal areas are central to decision making, the evidence is contradictory and the critical region remains unclear. Here it is shown that frontal lobe contributions to cost-benefit decision making can be understood by positing the existence of two independent systems that make decisions about delay and effort costs. Anterior cingulate cortex lesions affected how much effort rats decided to invest for rewards. Orbitofrontal cortical lesions affected how long rats decided to wait for rewards. The pattern of disruption suggested the deficit could be related to impaired associative learning. Impairments of the two systems may underlie apathetic and impulsive choice patterns in neurological and psychiatric illnesses. Although the existence of two systems is not predicted by economic accounts of decision making, our results suggest that delay and effort may exert distinct influences on decision making.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Rudebeck, PH (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	peter.rudebeck@psy.ox.ac.uk	Rudebeck, Peter/G-7931-2012; de Cates, Angharad/N-6550-2013	de Cates, Angharad/0000-0001-7848-1295; Bannerman, David/0000-0002-3024-7595; Rudebeck, Peter/0000-0002-1411-7555; Rushworth, Matthew/0000-0002-5578-9884	MRC [G0300665] Funding Source: UKRI; Medical Research Council [G0300665] Funding Source: Medline; Wellcome Trust [087736] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aoki N, 2006, BEHAV BRAIN RES, V168, P1, DOI 10.1016/j.bbr.2005.10.002; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Barbelivien A, 2001, CEREB CORTEX, V11, P1056, DOI 10.1093/cercor/11.11.1056; Bautista LM, 2001, P NATL ACAD SCI USA, V98, P1089, DOI 10.1073/pnas.98.3.1089; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; BURNS SM, 1985, BRAIN RES, V340, P71, DOI 10.1016/0006-8993(85)90774-7; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; CARDINAL RN, IN PRESS NEURAL NETW; Chudasama Y, 2003, J NEUROSCI, V23, P8771; COUSINS MS, 1994, PHARMACOL BIOCHEM BE, V49, P85, DOI 10.1016/0091-3057(94)90460-X; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Denk F, 2005, PSYCHOPHARMACOLOGY, V179, P587, DOI 10.1007/s00213-004-2059-4; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Floresco SB, 2007, CEREB CORTEX, V17, P251, DOI 10.1093/cercor/bhj143; Floyd NS, 2000, J COMP NEUROL, V422, P556, DOI 10.1002/1096-9861(20000710)422:4<556::AID-CNE6>3.0.CO;2-U; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Kacelnik A, 2003, TIME DECISION EC PSY, P115; Kacelnik A, 1997, TRENDS COGN SCI, V1, P304, DOI 10.1016/S1364-6613(97)01093-0; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Kheramin S, 2003, BEHAV PROCESS, V64, P239, DOI 10.1016/S0376-6357(03)00142-6; KOLB B, 1974, BEHAV BIOL, V10, P329, DOI 10.1016/S0091-6773(74)91924-5; Long A, 2005, CURR BIOL, V15, pR874, DOI 10.1016/j.cub.2005.10.024; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; NIV Y, 2005, ADV NEURAL INFORMATI, P1019; Passetti F, 2002, CEREB CORTEX, V12, P1254, DOI 10.1093/cercor/12.12.1254; ROESCH M, IN PRESS NEURON; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Schweimer J, 2005, LEARN MEMORY, V12, P334, DOI 10.1101/lm.90605; Shidara M, 1998, J NEUROSCI, V18, P2613; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Stevens JR, 2005, CURR BIOL, V15, P1855, DOI 10.1016/j.cub.2005.09.016; Stevens JR, 2005, BIOL LETTERS, V1, P223, DOI 10.1098/rsbl.2004.0285; Sugase-Miyamoto Y, 2005, J NEUROSCI, V25, P11071, DOI 10.1523/JNEUROSCI.1796-05.2005; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; THIEBOT MH, 1985, PSYCHOPHARMACOLOGY, V86, P147, DOI 10.1007/BF00431700; Walton ME, 2003, J NEUROSCI, V23, P6475; Walton ME, 2002, J NEUROSCI, V22, P10996; WALTON ME, IN PRESS NEURAL NETW; Winstanley CA, 2004, NEUROPSYCHOPHARMACOL, V29, P1331, DOI 10.1038/sj.npp.1300434; Winstanley CA, 2006, CEREB CORTEX, V16, P106, DOI 10.1093/cercor/bhi088; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004	50	419	427	4	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1161	1168		10.1038/nn1756	http://dx.doi.org/10.1038/nn1756			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16921368				2022-12-17	WOS:000240080800018
J	Rossi, DJ; Brady, JD; Mohr, C				Rossi, David J.; Brady, James D.; Mohr, Claudia			Astrocyte metabolism and signaling during brain ischemia	NATURE NEUROSCIENCE			English	Review							GLUTAMATE TRANSPORTER GLT-1; GAP-JUNCTION HEMICHANNELS; FOCAL CEREBRAL-ISCHEMIA; CULTURED RAT ASTROCYTES; EXCITATORY AMINO-ACIDS; CELL-DEATH; VESICULAR GLUTAMATE; IN-VIVO; SYNAPTIC-TRANSMISSION; SIMULATED ISCHEMIA	Brain ischemia results from cardiac arrest, stroke or head trauma. These conditions can cause severe brain damage and are a leading cause of death and long-term disability. Neurons are far more susceptible to ischemic damage than neighboring astrocytes, but astrocytes have diverse and important functions in many aspects of ischemic brain damage. Here we review three main roles of astrocytes in ischemic brain damage. First, we consider astrocyte glycogen stores, which can defend the brain against hypoglycemic brain damage but may aggravate brain damage during ischemia due to enhanced lactic acidosis. Second, we review recent breakthroughs in understanding astrocytic mechanisms of transmitter release, particularly for those transmitters with known roles in ischemic brain damage: glutamate, D-serine, ATP and adenosine. Third, we discuss the role of gap-junctionally connected networks of astrocytes in mediating the spread of damaging molecules to healthy 'bystanders' during infarct expansion in stroke.	Oregon Hlth & Sci Univ, Inst Neurol Sci, Beaverton, OR 97232 USA	Oregon Health & Science University	Rossi, DJ (corresponding author), Oregon Hlth & Sci Univ, Inst Neurol Sci, 505 NW 185th Ave, Beaverton, OR 97232 USA.	rossid@ohsu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051561] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS051561, 5R01NS051561] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdullaev IF, 2006, J PHYSIOL-LONDON, V572, P677, DOI 10.1113/jphysiol.2005.103820; Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Andrade-Rozental AF, 2000, BRAIN RES REV, V32, P308, DOI 10.1016/S0165-0173(99)00099-5; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; Bal-Price A, 2002, GLIA, V40, P312, DOI 10.1002/glia.10124; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Brown AM, 2005, J NEUROSCI RES, V79, P74, DOI 10.1002/jnr.20335; Cavelier P, 2005, J PHYSIOL-LONDON, V564, P397, DOI 10.1113/jphysiol.2004.082131; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; Chesler M, 2005, GLIA, V50, P398, DOI 10.1002/glia.20141; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; CHOI DW, 1987, J NEUROSCI, V7, P357; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cotrina ML, 1998, J NEUROSCI, V18, P2520; Cusato K, 2003, J NEUROSCI, V23, P6413; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dawson DA, 2001, BRAIN RES, V892, P344, DOI 10.1016/S0006-8993(00)03269-8; Devuyst G, 2001, J NEUROL, V248, P735, DOI 10.1007/s004150170087; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Duffy S, 1996, J NEUROSCI, V16, P71; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Feustel PJ, 2004, STROKE, V35, P1164, DOI 10.1161/01.STR.0000124127.57946.a1; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Figiel M, 2007, MOL CELL NEUROSCI, V35, P130, DOI 10.1016/j.mcn.2007.02.009; Folbergrova J, 1997, EXP BRAIN RES, V114, P44, DOI 10.1007/PL00005622; Gallagher CJ, 2003, J NEUROSCI, V23, P6728; Gebhardt C, 2002, J CEREBR BLOOD F MET, V22, P569, DOI 10.1097/00004647-200205000-00008; Gorovits R, 1997, P NATL ACAD SCI USA, V94, P7024, DOI 10.1073/pnas.94.13.7024; Hamann M, 2005, BRAIN, V128, P2408, DOI 10.1093/brain/awh619; Hamann M, 2002, EUR J NEUROSCI, V15, P308, DOI 10.1046/j.0953-816x.2001.01861.x; HANSEN AJ, 1988, NEUROCHEM PATHOL, V9, P195; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Higuchi T, 2002, J CEREBR BLOOD F MET, V22, P71, DOI 10.1097/00004647-200201000-00009; Hoshi A, 2006, J NEUROSCI RES, V84, P130, DOI 10.1002/jnr.20869; Hua X, 2004, J NEUROSCI RES, V76, P86, DOI 10.1002/jnr.20061; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; KATCHMAN AN, 1993, J NEUROPHYSIOL, V70, P1; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; KRAIG RP, 1983, J NEUROPHYSIOL, V49, P831, DOI 10.1152/jn.1983.49.3.831; Lammer A, 2006, EUR J NEUROSCI, V23, P2824, DOI 10.1111/j.1460-9568.2006.04825.x; Li PA, 1996, STROKE, V27, P1592, DOI 10.1161/01.STR.27.9.1592; Li PA, 1997, ACTA PHYSIOL SCAND, V161, P567, DOI 10.1046/j.1365-201X.1997.00264.x; LI PA, 1995, NEUROBIOL DIS, V2, P97, DOI 10.1006/nbdi.1995.0010; Lin JHC, 2003, J NEUROSCI, V23, P430, DOI 10.1523/JNEUROSCI.23-02-00430.2003; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Lindsberg PJ, 2004, STROKE, V35, P363, DOI 10.1161/01.STR.0000115297.92132.84; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lo EH, 2001, BRAIN RES REV, V38, P140, DOI 10.1016/S0165-0173(01)00083-2; LOWRY OH, 1964, J BIOL CHEM, V239, P18; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Martin ED, 2007, GLIA, V55, P36, DOI 10.1002/glia.20431; Martineau M, 2006, TRENDS NEUROSCI, V29, P481, DOI 10.1016/j.tins.2006.06.008; Martins-Ferreira H, 2000, BRAIN RES REV, V32, P215, DOI 10.1016/S0165-0173(99)00083-1; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Mitani A, 2003, J NEUROSCI, V23, P7176, DOI 10.1523/JNEUROSCI.23-18-07176.2003; Montana V, 2004, J NEUROSCI, V24, P2633, DOI 10.1523/JNEUROSCI.3770-03.2004; Montana V, 2006, GLIA, V54, P700, DOI 10.1002/glia.20367; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; NICHOLLS DG, 2007, J NEUROSCI RES  0423, DOI DOI 10.1002/JNR.2190; Ottersen OP, 1996, J CHEM NEUROANAT, V12, P1, DOI 10.1016/S0891-0618(96)00178-0; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Parkinson FE, 2004, J NEUROCHEM, V88, P1305, DOI 10.1046/j.1471-4159.2003.02266.x; Parpura V, 2004, NEUROCHEM INT, V45, P259, DOI 10.1016/j.neuint.2003.12.011; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Phillis JW, 2000, BRAIN RES, V868, P105, DOI 10.1016/S0006-8993(00)02303-9; Phillis JW, 1996, NEUROCHEM INT, V29, P115, DOI 10.1016/0197-0186(95)00154-9; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; Queiroz G, 1999, NEUROSCIENCE, V91, P1171, DOI 10.1016/S0306-4522(98)00644-7; Ranat S, 2007, NEUROSCI LETT, V415, P45, DOI 10.1016/j.neulet.2006.12.043; Ransom BR, 1997, GLIA, V21, P134; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; Rawanduzy A, 1997, J NEUROSURG, V87, P916, DOI 10.3171/jns.1997.87.6.0916; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; RUDOLPHI KA, 1992, TRENDS PHARMACOL SCI, V13, P439, DOI 10.1016/0165-6147(92)90141-R; Schubert P, 1994, J Neural Transm Suppl, V44, P73; Schurr A, 2002, CRIT CARE, V6, P330; Seki Y, 1999, STROKE, V30, P433, DOI 10.1161/01.STR.30.2.433; Shaked I, 2002, J NEUROCHEM, V83, P574, DOI 10.1046/j.1471-4159.2002.01168.x; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; SILVER IA, 1994, J NEUROSCI, V14, P5068; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Takahashi M, 1997, J EXP BIOL, V200, P401; Tekkok SB, 2005, J NEUROSCI RES, V81, P644, DOI 10.1002/jnr.20573; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Uyttenboogaart M, 2007, BRAIN, V130, P1626, DOI 10.1093/brain/awm087; WOLOSKER H, 2006, SCI STKE, pE41; Wygoda MR, 1997, CANCER RES, V57, P1699; XIE M, 2007, J CEREB BLOOD F 0822, DOI DOI 10.1038/5J.JCBFM.9600545; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zhang M, 2007, J CEREBR BLOOD F MET, V27, P1352, DOI 10.1038/sj.jcbfm.9600441	100	418	444	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2007	10	11					1377	1386		10.1038/nn2004	http://dx.doi.org/10.1038/nn2004			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	225HT	17965658	Green Accepted			2022-12-17	WOS:000250508400012
J	Toni, N; Teng, EM; Bushong, EA; Aimone, JB; Zhao, CM; Consiglio, A; van Praag, H; Martone, ME; Ellisman, MH; Gage, FH				Toni, Nicolas; Teng, E. Matthew; Bushong, Eric A.; Aimone, James B.; Zhao, Chunmei; Consiglio, Antonella; van Praag, Henriette; Martone, Maryann E.; Ellisman, Mark H.; Gage, Fred H.			Synapse formation on neurons born in the adult hippocampus	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; DENDRITIC SPINES; DENTATE GYRUS; IN-VIVO; 3-DIMENSIONAL STRUCTURE; STRUCTURAL PLASTICITY; GRANULE CELLS; NEUROGENESIS; FILOPODIA	Although new and functional neurons are produced in the adult brain, little is known about how they integrate into mature networks. Here we explored the mechanisms of synaptogenesis on neurons born in the adult mouse hippocampus using confocal microscopy, electron microscopy and live imaging. We report that new neurons, similar to mature granule neurons, were contacted by axosomatic, axodendritic and axospinous synapses. Consistent with their putative role in synaptogenesis, dendritic filopodia were more abundant during the early stages of maturation and, when analyzed in three dimensions, the tips of all filopodia were found within 200 nm of preexisting boutons that already synapsed on other neurons. Furthermore, dendritic spines primarily synapsed on multiple-synapse boutons, suggesting that initial contacts were preferentially made with preexisting boutons already involved in a synapse. The connectivity of new neurons continued to change until at least 2 months, long after the formation of the first dendritic protrusions.	Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu	Toni, Nicolas/M-2057-2014; consiglio, antonella/G-1815-2016; van Praag, Henriette/F-3939-2015; consiglio, antonella/AAA-5864-2019; Aimone, James Bradley/H-4694-2016; Aimone, James B/C-7821-2011	Toni, Nicolas/0000-0001-5585-268X; consiglio, antonella/0000-0002-3988-6254; van Praag, Henriette/0000-0002-5727-434X; consiglio, antonella/0000-0002-3988-6254; Aimone, James Bradley/0000-0002-7361-253X; Martone, Maryann/0000-0002-8406-3871	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000328, ZIAAG000328] Funding Source: NIH RePORTER; NINDS NIH HHS [NS050217-02] Funding Source: Medline; PHS HHS [RRP41-04050] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Capani F, 2001, J COMP NEUROL, V435, P156, DOI 10.1002/cne.1199; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; FRIEDLANDER MJ, 1991, J NEUROSCI, V11, P3268; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1995, TRENDS NEUROSCI, V18, P365, DOI 10.1016/0166-2236(95)93930-V; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HARRIS MI, 1997, INT TXB DIABETES MEL, V1, P9; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Richards DA, 2005, P NATL ACAD SCI USA, V102, P6166, DOI 10.1073/pnas.0501881102; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shepherd GMG, 2002, P NATL ACAD SCI USA, V99, P6340, DOI 10.1073/pnas.052151299; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	50	418	440	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2007	10	6					727	734		10.1038/nn1908	http://dx.doi.org/10.1038/nn1908			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	172JI	17486101				2022-12-17	WOS:000246799800015
J	Tsai, J; Grutzendler, J; Duff, K; Gan, WB				Tsai, J; Grutzendler, J; Duff, K; Gan, WB			Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches	NATURE NEUROSCIENCE			English	Article							ALZHEIMERS-DISEASE; TRANSGENIC MICE; HYPOTHESIS; CALCIUM	Amyloid plaques are a hallmark of Alzheimer disease, but their importance in its pathogenesis is controversial. By neuronal labeling and transcranial two-photon imaging, we show in a transgenic mouse model of Alzheimer disease that dendrites passing through or near fibrillar amyloid deposits undergo spine loss and shaft atrophy, and nearby axons develop large varicosities, together leading to neurite breakage and large-scale, permanent disruption of neuronal connections. Thus, fibrillar amyloid deposition is more detrimental to neuronal circuitry than previously thought, underscoring the importance of prevention and early clearance of plaques.	NYU, Sch Med, Mol Neurobiol Program, Skirball Inst, New York, NY 10016 USA; NYU, Sch Med, Dept Neurosci & Physiol, New York, NY 10016 USA; NYU, Sch Med, Orangeburg, NY 10962 USA; Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA	New York University; New York University; New York University; Nathan Kline Institute for Psychiatric Research	Gan, WB (corresponding author), NYU, Sch Med, Mol Neurobiol Program, Skirball Inst, New York, NY 10016 USA.	gan@saturn.med.nyu.edu	Grutzendler, Jaime/F-3691-2010; Duff, Karen EK/C-2510-2009	Duff, Karen/0000-0002-6177-868X				Canevari L, 2004, NEUROCHEM RES, V29, P637, DOI 10.1023/B:NERE.0000014834.06405.af; Cummings BJ, 1996, NEUROBIOL AGING, V17, P921, DOI 10.1016/S0197-4580(96)00170-4; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Knowles RB, 1999, P NATL ACAD SCI USA, V96, P5274, DOI 10.1073/pnas.96.9.5274; MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464; MASLIAH E, 1993, J NEUROPATH EXP NEUR, V52, P619, DOI 10.1097/00005072-199311000-00009; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Phinney AL, 1999, J NEUROSCI, V19, P8552; SCHEIBEL AB, 1978, EXP NEUROL, V60, P1, DOI 10.1016/0014-4886(78)90164-4; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001	15	418	435	1	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2004	7	11					1181	1183		10.1038/nn1335	http://dx.doi.org/10.1038/nn1335			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	866CB	15475950				2022-12-17	WOS:000224749400007
J	Amedi, A; Raz, N; Pianka, P; Malach, R; Zohary, E				Amedi, A; Raz, N; Pianka, P; Malach, R; Zohary, E			Early 'visual' cortex activation correlates with superior verbal memory performance in the blind	NATURE NEUROSCIENCE			English	Article							CROSS-MODAL PLASTICITY; ADAPTIVE-CHANGES; MENTAL-IMAGERY; CONNECTIONS; LANGUAGE; AREAS; FMRI; RECOGNITION; GENERATION; PATTERN	The visual cortex may be more modifiable than previously considered. Using functional magnetic resonance imaging (fMRI) in ten congenitally blind human participants, we found robust occipital activation during a verbal-memory task (in the absence of any sensory input), as well as during verb generation and Braille reading. We also found evidence for reorganization and specialization of the occipital cortex, along the anterior-posterior axis. Whereas anterior regions showed preference for Braille, posterior regions (including V1) showed preference for verbal-memory and verb generation (which both require memory of verbal material). No such occipital activation was found in sighted subjects. This difference between the groups was mirrored by superior performance of the blind in various verbal-memory tasks. Moreover, the magnitude of V1 activation during the verbal-memory condition was highly correlated with the blind individual's abilities in a variety of verbal-memory tests, suggesting that the additional occipital activation may have a functional role.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Tel Aviv, Israel; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Weizmann Institute of Science	Amedi, A (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel.	amir@lobster.ls.huji.ac.il		Amedi, Amir/0000-0001-5042-2533				Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Arno P, 2001, NEUROIMAGE, V13, P632, DOI 10.1006/nimg.2000.0731; Avidan G, 2002, J NEUROPHYSIOL, V87, P3102, DOI 10.1152/jn.2002.87.6.3102; Baker JT, 2001, NEUROREPORT, V12, P1251, DOI 10.1097/00001756-200105080-00039; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Buchel C, 1998, NATURE, V394, P274, DOI 10.1038/28389; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; De Volder AG, 2001, NEUROIMAGE, V14, P129, DOI 10.1006/nimg.2001.0782; DEHAY C, 1984, EXP BRAIN RES, V57, P208; DISTLER C, 1993, J COMP NEUROL, V334, P125, DOI 10.1002/cne.903340111; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K.J., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Giraud AL, 2001, BRAIN, V124, P1307, DOI 10.1093/brain/124.7.1307; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; HULL T, 1995, J VISUAL IMPAIR BLIN, V89, P166; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; KARNI A, 1995, NATURE, V377, P155; KUJALA T, 1995, NEUROSCI LETT, V183, P143, DOI 10.1016/0304-3940(94)11135-6; Maguire EA, 2003, NAT NEUROSCI, V6, P90, DOI 10.1038/nn988; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; PETRIDES M, 1995, P NATL ACAD SCI USA, V92, P5803, DOI 10.1073/pnas.92.13.5803; POZAR L, 1982, STUD PSYCHOL, V24, P311; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; Psychological Corporation, 1997, WECHSL MEM SCAL; Rempel-Clower NL, 2000, CEREB CORTEX, V10, P851, DOI 10.1093/cercor/10.9.851; ROCKLAND KS, 1994, CEREB CORTEX, V4, P300, DOI 10.1093/cercor/4.3.300; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Roder B, 2001, COGNITIVE BRAIN RES, V11, P289, DOI 10.1016/S0926-6410(01)00002-7; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Talairach J., 1988, COPLANAR STEREOTAXIC; TILLMAN MH, 1968, PSYCHOL REP, V23, P523, DOI 10.2466/pr0.1968.23.2.523; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; VanEssen DC, 1997, J NEUROSCI, V17, P7079; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Weeks R, 2000, J NEUROSCI, V20, P2664; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	50	418	425	3	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2003	6	7					758	766		10.1038/nn1072	http://dx.doi.org/10.1038/nn1072			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	694NJ	12808458				2022-12-17	WOS:000183780400025
J	Knott, GW; Holtmaat, A; Wilbrecht, L; Welker, E; Svoboda, K				Knott, Graham W.; Holtmaat, Anthony; Wilbrecht, Linda; Welker, Egbert; Svoboda, Karel			Spine growth precedes synapse formation in the adult neocortex in vivo	NATURE NEUROSCIENCE			English	Article							RAT VISUAL-CORTEX; DENDRITIC SPINES; CELL-TYPE; 3-DIMENSIONAL STRUCTURE; STRUCTURAL PLASTICITY; NMDA RECEPTORS; AMPA; CA1; SYNAPTOGENESIS; EXPERIENCE	Dendritic spines appear and disappear in an experience-dependent manner. Although some new spines have been shown to contain synapses, little is known about the relationship between spine addition and synapse formation, the relative time course of these events, or whether they are coupled to de novo growth of axonal boutons. We imaged dendrites in barrel cortex of adult mice over 1 month, tracking gains and losses of spines. Using serial section electron microscopy, we analyzed the ultrastructure of spines and associated boutons. Spines reconstructed shortly after they appeared often lacked synapses, whereas spines that persisted for 4 d or more always had synapses. New spines had a large surface-to-volume ratio and preferentially contacted boutons with other synapses. In some instances, two new spines contacted the same axon. Our data show that spine growth precedes synapse formation and that new synapses form preferentially onto existing boutons.	Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	University of Lausanne; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Knott, GW (corresponding author), Univ Lausanne, Dept Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland.	Graham.Knott@unil.ch	Wilbrecht, Linda/J-7988-2013	Holtmaat, Anthony/0000-0002-7577-0769; Knott, Graham W/0000-0002-2956-9052				ADAMS I, 1982, BRAIN RES, V239, P349, DOI 10.1016/0006-8993(82)90514-5; BEAULIEU C, 1985, J COMP NEUROL, V231, P180, DOI 10.1002/cne.902310206; Braitenberg V, 1991, ANATOMY CORTEX; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; COLONNIER MARC, 1968, BRAIN RES, V9, P268, DOI 10.1016/0006-8993(68)90234-5; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS MI, 1997, INT TXB DIABETES MEL, V1, P9; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Jones TA, 1997, NEUROBIOL LEARN MEM, V68, P13, DOI 10.1006/nlme.1997.3774; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kharazia VN, 1999, J COMP NEUROL, V412, P292, DOI 10.1002/(SICI)1096-9861(19990920)412:2<292::AID-CNE8>3.0.CO;2-G; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Peters A, 1991, FINE STRUCTURE NERVO; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; TURNER AM, 1985, BRAIN RES, V329, P195, DOI 10.1016/0006-8993(85)90525-6; VAUGHAN DW, 1973, J COMP NEUROL, V149, P355, DOI 10.1002/cne.901490305; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	48	417	423	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2006	9	9					1117	1124		10.1038/nn1747	http://dx.doi.org/10.1038/nn1747			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	078DE	16892056				2022-12-17	WOS:000240080800012
